Citrus Sinensis ID: 041757

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-
Protein Sequence
LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLATCKAVIGRATEQLNKYFTKQKKPIFDLRQEKWSRDQKRLFSCGCMP
Secondary Structure (PSIPRED)
cccccEEEEccccccccccccccccccHHHHHHHHcccccccccccccccEEEcccccccccHHHHHHHHHcccccccccEEEccccccccccccEEEEEEEcccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEEcccccccccccccccEEccccccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccHHHHHccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccHHHccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccEcHHHHHHHHccccHHcccccccccEEEccccccHHHHHHHHHHHHHHHHHHHHHHHHHEEcccccccccEEEEEEEcccccHHHHHccccHcHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEccccccEEEEEEEEEEcccccHHHHHcccEEEcccHEHHHEEEEEEHcccccccccccccHHHHHHHHHHHcccHHHHccHHHccccccccHHHHHHcccccccccHHHHHHHHHHHHHHHHccHcccccHHHHHHHHcccHcccccccccccccccccccccccccccccccccccccccccEEcccccEEEEEccc
Coil and Loop (DISEMBL)
LPSLLIALDvsgnkltgslhievgklknlEILDVSRNMLEENLIsagtfgfshlRRQGAFKSFIAECKALRNIRHRNLIKVLTACLgvdyqgndFKALVYEFMHNRslkewlypiskedetykrprnlNLLRRLNIAIDVASALNylhhdcqpvtahcvlkpsnvlldddmtarvgdfglarflpptrtqtssidvkgsigyiapeygvgnevstigdVYSYGILLLELMIrekpsdimfegdmNLHKFAKMALSNHVKDIVdsillnddeklvvrgdqkqTQAKINIIRECVISMVRIGVacsmespqdrmkMTNVVHELQSIkntllgpknlATCKAVIGRATEQLNKYFTkqkkpifdlRQEKWSRDQKrlfscgcmp
Flexible Loop (DISEMBL)
LPSLLIALDvsgnkltgslhievgklknLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEwlypiskedetykrprnlnLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGlarflpptrtqtssidvkgsIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLvvrgdqkqtqakiniirECVISMVRIGVACSMESPQDRMKMTNVVHELQSikntllgpknLATCKAVIGRATEQLNkyftkqkkpifdlrqekwsrdqkrlfscgcmp
Low Complexity Region (SEG)
LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPrnlnllrrlnIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLATCKAVIGRATEQLNKYFTKQKKPIFDLRQEKWSRDQKRLFSCGCMP
Disordered region (IsUnstruct)
***LLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSM********MTNVVHELQSIKNTLLGPKNLATCKAVIGRATEQLNKYFTKQKKPIFDLRQEKW**************
Disordered Region (DISOPRED)
*PSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK******RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP**********VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLV********QAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN************************************************FSCGC**
Disordered Region (DISEMBL)
LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLATCKAVIGRATEQLNKYFTKQKKPIFDLRQEKWSRDQKRLFSCGCMP
Disordered Region (DISPRO)
********************IEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED*TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKN********************************KWSRDQKRLFSCGCMP
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLATCKAVIGRATEQLNKYFTKQKKPIFDLRQEKWSRDQKRLFSCGCMP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	381	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.750	0.283	0.445	2e-70
Q9SD62	1025	Putative receptor-like pr	no	no	0.753	0.28	0.439	8e-66
C0LGT6	1031	LRR receptor-like serine/	no	no	0.742	0.274	0.410	5e-61
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.658	0.256	0.372	1e-45
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.716	0.228	0.317	7e-35
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.616	0.225	0.362	2e-34
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.629	0.198	0.338	1e-33
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.629	0.198	0.338	2e-33
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.687	0.209	0.305	5e-33
C0LGX3	993	LRR receptor-like serine/	no	no	0.664	0.254	0.333	9e-33

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  266 bits (679), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 146/328 (44%), Positives = 199/328 (60%), Gaps = 42/328 (12%)

Query: 21  IEVGKLKNLEILDVSRNMLEENLISAGTFGFSH-----------------LRRQGAFKSF 63
           I  G L+N      +      N++ +G+FG  +                 ++R+GA KSF
Sbjct: 690 ISYGDLRN-----ATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSF 744

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           +AEC++L++IRHRNL+K+LTAC  +D+QGN+F+AL+YEFM N SL  WL+P  +E E   
Sbjct: 745 MAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHP--EEVEEIH 802

Query: 124 RP-RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           RP R L LL RLNIAIDVAS L+YLH  C    AHC LKPSNVLLDDD+TA V DFGLAR
Sbjct: 803 RPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLAR 862

Query: 183 FL-----PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
            L          Q SS  V+G+IGY APEYGVG + S  GDVYS+GILLLE+   ++P++
Sbjct: 863 LLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTN 922

Query: 238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMV 297
            +F G+  L+ + K AL   + DIVD  +L+   ++               + EC+  + 
Sbjct: 923 ELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFP------------VVECLTMVF 970

Query: 298 RIGVACSMESPQDRMKMTNVVHELQSIK 325
            +G+ C  ESP +R+  + VV EL SI+
Sbjct: 971 EVGLRCCEESPMNRLATSIVVKELISIR 998

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  251 bits (640), Expect = 8e-66,   Method: Compositional matrix adjust.
 Identities = 142/323 (43%), Positives = 189/323 (58%), Gaps = 36/323 (11%)

Query: 30   EILDVSRNMLEENLISAGTFG-----------------FSHLRRQGAFKSFIAECKALRN 72
            E+   +      NLI +G FG                   +L ++GA KSFIAEC+AL  
Sbjct: 711  ELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGG 770

Query: 73   IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLR 132
            IRHRNL+K++T C   D++GNDF+ALVYEFM N +L  WL+P  + +ET    R L L  
Sbjct: 771  IRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP-DEIEETGNPSRTLGLFA 829

Query: 133  RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL-----PPT 187
            RLNIAIDVASAL YLH  C    AHC +KPSN+LLD D+TA V DFGLA+ L        
Sbjct: 830  RLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTF 889

Query: 188  RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247
              Q SS  V+G+IGY APEYG+G   S +GDVYS+GI+LLE+   ++P++ +F   + LH
Sbjct: 890  HIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLH 949

Query: 248  KFAKMALSN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSME 306
             F K AL      DI D  +L        RG   Q     N++ EC+  + R+GV+CS E
Sbjct: 950  SFTKSALQKRQALDITDETIL--------RGAYAQ---HFNMV-ECLTLVFRVGVSCSEE 997

Query: 307  SPQDRMKMTNVVHELQSIKNTLL 329
            SP +R+ M   + +L SI+ +  
Sbjct: 998  SPVNRISMAEAISKLVSIRESFF 1020

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  235 bits (599), Expect = 5e-61,   Method: Compositional matrix adjust.
 Identities = 135/329 (41%), Positives = 177/329 (53%), Gaps = 46/329 (13%)

Query: 30   EILDVSRNMLEENLISAGTFG-----------------FSHLRRQGAFKSFIAECKALRN 72
            E+   +      NLI +G FG                   +L + GA KSF+AEC+  + 
Sbjct: 704  ELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKG 763

Query: 73   IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLR 132
            IRHRNL+K++T C  +D +GNDF+ALVYEFM   SL  WL  +   +      R+L    
Sbjct: 764  IRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ-LEDLERVNDHSRSLTPAE 822

Query: 133  RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL-----PPT 187
            +LNIAIDVASAL YLH  C    AHC +KPSN+LLDDD+TA V DFGLA+ L        
Sbjct: 823  KLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESF 882

Query: 188  RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247
              Q SS  V+G+IGY APEYG+G + S  GDVYS+GILLLE+   +KP+D  F GD NLH
Sbjct: 883  LNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLH 942

Query: 248  KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMES 307
             + K  LS                          +    N I E +  ++++G+ CS E 
Sbjct: 943  SYTKSILSGCT-----------------------SSGGSNAIDEGLRLVLQVGIKCSEEY 979

Query: 308  PQDRMKMTNVVHELQSIKNTLLGPKNLAT 336
            P+DRM+    V EL SI++     K   T
Sbjct: 980  PRDRMRTDEAVRELISIRSKFFSSKTTIT 1008

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  184 bits (467), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 104/279 (37%), Positives = 154/279 (55%), Gaps = 28/279 (10%)

Query: 62  SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
           SF  EC+ L+  RHRNLI+++T C         F ALV   M N SL+  LYP       
Sbjct: 702 SFKRECQILKRTRHRNLIRIITTC-----SKPGFNALVLPLMPNGSLERHLYPGEYSS-- 754

Query: 122 YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
               +NL+L++ +NI  DVA  + YLHH       HC LKPSN+LLDD+MTA V DFG++
Sbjct: 755 ----KNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGIS 810

Query: 182 RFLPPTRTQTSSID----------VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
           R +       S+ D          + GS+GYIAPEYG+G   ST GDVYS+G+LLLE++ 
Sbjct: 811 RLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVS 870

Query: 232 REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE 291
             +P+D++     +LH+F K    +H  D ++ I+   ++ L     Q + +    + RE
Sbjct: 871 GRRPTDVLVNEGSSLHEFMK----SHYPDSLEGII---EQALSRWKPQGKPEKCEKLWRE 923

Query: 292 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 330
            ++ M+ +G+ C+  +P  R  M +V HE+  +K  L  
Sbjct: 924 VILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFA 962

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  148 bits (373), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 101/318 (31%), Positives = 153/318 (48%), Gaps = 45/318 (14%)

Query: 25   KLKNLEILDVSRNMLEENLISAGTFG-----------------FSHLRRQGAFKSFIAEC 67
            KL   ++L  +     ++LI +G FG                   H+  QG  + F+AE 
Sbjct: 870  KLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGD-REFMAEM 928

Query: 68   KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRN 127
            + +  I+HRNL+ +L  C     +  D + LVYEFM   SL++ L+      +  K    
Sbjct: 929  ETIGKIKHRNLVPLLGYC-----KVGDERLLVYEFMKYGSLEDVLH------DPKKAGVK 977

Query: 128  LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT 187
            LN   R  IAI  A  L +LHH+C P   H  +K SNVLLD+++ ARV DFG+AR +   
Sbjct: 978  LNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAM 1037

Query: 188  RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247
             T  S   + G+ GY+ PEY      ST GDVYSYG++LLEL+  ++P+D    GD NL 
Sbjct: 1038 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLV 1097

Query: 248  KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMES 307
             + K      + D+ D  L+ +D  L +                 ++  +++ VAC  + 
Sbjct: 1098 GWVKQHAKLRISDVFDPELMKEDPALEIE----------------LLQHLKVAVACLDDR 1141

Query: 308  PQDRMKMTNVVHELQSIK 325
               R  M  V+   + I+
Sbjct: 1142 AWRRPTMVQVMAMFKEIQ 1159

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  146 bits (369), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 95/262 (36%), Positives = 137/262 (52%), Gaps = 27/262 (10%)

Query: 64   IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
            +AE   L N+RHRN++++L  C        D   L+YE+M N SL + L+     D+T  
Sbjct: 767  LAEVDVLGNVRHRNIVRLLGCC-----TNRDCTMLLYEYMPNGSLDDLLH---GGDKTMT 818

Query: 124  RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
                   L +  IAI VA  + YLHHDC PV  H  LKPSN+LLD D  ARV DFG+A+ 
Sbjct: 819  AAAEWTALYQ--IAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKL 876

Query: 184  LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
            +   +T  S   V GS GYIAPEY    +V    D+YSYG++LLE++  ++  +  F   
Sbjct: 877  I---QTDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEG 933

Query: 244  MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVAC 303
             ++  + +  L    K+ V+ +L             K      ++IRE +  M+RI + C
Sbjct: 934  NSIVDWVRSKL--KTKEDVEEVL------------DKSMGRSCSLIREEMKQMLRIALLC 979

Query: 304  SMESPQDRMKMTNVVHELQSIK 325
            +  SP DR  M +V+  LQ  K
Sbjct: 980  TSRSPTDRPPMRDVLLILQEAK 1001

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  144 bits (363), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 138/269 (51%), Gaps = 29/269 (10%)

Query: 25   KLKNLEILDVSRNMLEENLISAGTFG-----------------FSHLRRQGAFKSFIAEC 67
            KL   ++L+ +     ++L+ +G FG                   H+  QG  + F AE 
Sbjct: 875  KLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD-REFTAEM 933

Query: 68   KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRN 127
            + +  I+HRNL+ +L  C     +  + + LVYE+M   SL++ L+      +  K    
Sbjct: 934  ETIGKIKHRNLVPLLGYC-----KVGEERLLVYEYMKYGSLEDVLH------DRKKTGIK 982

Query: 128  LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT 187
            LN   R  IAI  A  L +LHH+C P   H  +K SNVLLD+++ ARV DFG+AR +   
Sbjct: 983  LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAM 1042

Query: 188  RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247
             T  S   + G+ GY+ PEY      ST GDVYSYG++LLEL+  ++P+D    GD NL 
Sbjct: 1043 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLV 1102

Query: 248  KFAKMALSNHVKDIVDSILLNDDEKLVVR 276
             + K+     + D+ D  LL +D  + + 
Sbjct: 1103 GWVKLHAKGKITDVFDRELLKEDASIEIE 1131

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  143 bits (361), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 138/269 (51%), Gaps = 29/269 (10%)

Query: 25   KLKNLEILDVSRNMLEENLISAGTFG-----------------FSHLRRQGAFKSFIAEC 67
            KL   ++L+ +     ++L+ +G FG                   H+  QG  + F AE 
Sbjct: 875  KLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD-REFTAEM 933

Query: 68   KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRN 127
            + +  I+HRNL+ +L  C     +  + + LVYE+M   SL++ L+      +  K    
Sbjct: 934  ETIGKIKHRNLVPLLGYC-----KVGEERLLVYEYMKYGSLEDVLH------DRKKIGIK 982

Query: 128  LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT 187
            LN   R  IAI  A  L +LHH+C P   H  +K SNVLLD+++ ARV DFG+AR +   
Sbjct: 983  LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAM 1042

Query: 188  RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247
             T  S   + G+ GY+ PEY      ST GDVYSYG++LLEL+  ++P+D    GD NL 
Sbjct: 1043 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLV 1102

Query: 248  KFAKMALSNHVKDIVDSILLNDDEKLVVR 276
             + K+     + D+ D  LL +D  + + 
Sbjct: 1103 GWVKLHAKGKITDVFDRELLKEDASIEIE 1131

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  142 bits (357), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 91/298 (30%), Positives = 155/298 (52%), Gaps = 36/298 (12%)

Query: 17   GSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHR 76
            GS  +   +LKN E + V + + +++L+S               KSF  E K L  IRHR
Sbjct: 958  GSGKVYKAELKNGETIAVKKILWKDDLMSN--------------KSFNREVKTLGTIRHR 1003

Query: 77   NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNI 136
            +L+K++  C     + +    L+YE+M N S+ +WL+     +E  K+   L    RL I
Sbjct: 1004 HLVKLMGYC---SSKADGLNLLIYEYMANGSVWDWLH----ANENTKKKEVLGWETRLKI 1056

Query: 137  AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP---TRTQTSS 193
            A+ +A  + YLH+DC P   H  +K SNVLLD ++ A +GDFGLA+ L     T T++++
Sbjct: 1057 ALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNT 1116

Query: 194  IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
            +   GS GYIAPEY    + +   DVYS GI+L+E++  + P++ MF+ + ++ ++ +  
Sbjct: 1117 M-FAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETV 1175

Query: 254  LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDR 311
            L           L++ + K ++  ++           E    ++ I + C+   PQ+R
Sbjct: 1176 LDTPPGSEAREKLIDSELKSLLPCEE-----------EAAYQVLEIALQCTKSYPQER 1222

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  141 bits (355), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 142/273 (52%), Gaps = 20/273 (7%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F +E + L  +RH N++K+L  C      G +F+ LVYEFM N SL + L+     ++ +
Sbjct: 730 FRSEVETLGRVRHGNIVKLLMCC-----NGEEFRFLVYEFMENGSLGDVLH----SEKEH 780

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +    L+   R +IA+  A  L+YLHHD  P   H  +K +N+LLD +M  RV DFGLA+
Sbjct: 781 RAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAK 840

Query: 183 FLPPTRTQTSSID------VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236
             P  R     +       V GS GYIAPEYG  ++V+   DVYS+G++LLEL+  ++P+
Sbjct: 841 --PLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPN 898

Query: 237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIR---ECV 293
           D  F  + ++ KFA  A   +     +   +N D     R   K    K+ +     E +
Sbjct: 899 DSSFGENKDIVKFAMEAALCYPSPSAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEI 958

Query: 294 ISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326
             ++ + + C+   P +R  M  VV  L+  K+
Sbjct: 959 EKVLDVALLCTSSFPINRPTMRKVVELLKEKKS 991

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	381
224097750	1023	predicted protein [Populus trichocarpa]	0.787	0.293	0.532	1e-90
224097748	1032	predicted protein [Populus trichocarpa]	0.782	0.288	0.525	3e-90
224097752	1025	predicted protein [Populus trichocarpa]	0.787	0.292	0.529	7e-90
359482058	1040	PREDICTED: probable LRR receptor-like se	0.758	0.277	0.528	1e-87
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.758	0.151	0.528	2e-87
359486510	965	PREDICTED: probable LRR receptor-like se	0.787	0.310	0.507	8e-87
224113117	1006	predicted protein [Populus trichocarpa]	0.792	0.300	0.501	1e-86
224127492	1022	predicted protein [Populus trichocarpa]	0.824	0.307	0.487	1e-86
255581223	1015	receptor-kinase, putative [Ricinus commu	0.742	0.278	0.529	2e-85
255586722	936	serine-threonine protein kinase, plant-t	0.713	0.290	0.571	2e-83

>gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa]

 Score =  339 bits (870), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 173/325 (53%), Positives = 228/325 (70%), Gaps = 25/325 (7%)

Query: 30   EILDVSRNMLEENLISAGTFGFSH-----------------LRRQGAFKSFIAECKALRN 72
            ++L  ++     NLI AG+FG  +                 L R+GA KSF+AEC AL N
Sbjct: 697  DLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKSFMAECAALIN 756

Query: 73   IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLR 132
            IRHRNL+KVLTAC G+D+QGNDFKALVYEFM N SL+EWL+P+   DE + R R+L+LL+
Sbjct: 757  IRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQISDEAHVR-RDLSLLQ 815

Query: 133  RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTR---- 188
            RLNIAIDVASAL+YLH+ CQ   AHC LKPSNVLLD DMTA VGDFGLAR LP       
Sbjct: 816  RLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGDFGLARLLPQASHQLC 875

Query: 189  -TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247
              QTSSI +KG+IGY APEYG+G+EVS  GDVYSYGILLLE+    +P++ +F+  +NLH
Sbjct: 876  LDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTNGLFKDGLNLH 935

Query: 248  KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMES 307
             FAK AL   V +++D +L+ + E+    GD  +  + I    EC+ ++V++GVACS E 
Sbjct: 936  NFAKTALPISVAEVLDPVLVTEAEE--TSGDASRRMSHIGNHMECLAAIVKVGVACSAEF 993

Query: 308  PQDRMKMTNVVHELQSIKNTLLGPK 332
            P++RM++++V  EL+ I++ LLGP+
Sbjct: 994  PRERMEISSVAVELRRIRHILLGPQ 1018

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097748|ref|XP_002311065.1| predicted protein [Populus trichocarpa] gi|222850885|gb|EEE88432.1| predicted protein [Populus trichocarpa]

 Score =  338 bits (867), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 174/331 (52%), Positives = 227/331 (68%), Gaps = 33/331 (9%)

Query: 30   EILDVSRNMLEENLISAGTFGFSH--------------------LRRQGAFKSFIAECKA 69
            ++L  +      NLI +G+FG  +                    L R+GA KSF+AEC A
Sbjct: 696  DLLQATNGFSAANLIGSGSFGSVYKGILKTDGAAVATVAVKVFNLLREGASKSFMAECAA 755

Query: 70   LRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLN 129
            L NIRHRNL+KVLTAC G+D+QGNDFKALVYEFM N SL+EWL+P+   DE ++R R+L+
Sbjct: 756  LVNIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVRISDEAHRR-RDLS 814

Query: 130  LLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP---- 185
            LL+RLNIAIDVASAL+YLH+ CQ    HC LKPSNVLLD D+TA VGDFGLAR L     
Sbjct: 815  LLQRLNIAIDVASALDYLHNHCQIAVVHCDLKPSNVLLDGDLTAHVGDFGLARLLTQASH 874

Query: 186  -PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM 244
             P   QTSSI +KG+IGY APEYG+G+EVST GDVYSYGILLLE+   ++P+D MF+ +M
Sbjct: 875  QPGLDQTSSIGLKGTIGYAAPEYGMGSEVSTFGDVYSYGILLLEMFTGKRPTDTMFKDEM 934

Query: 245  NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN-----IIRECVISMVRI 299
            NLH FAKMA  N V +I+D  L+ + E+     D   T +  N      I EC++ ++++
Sbjct: 935  NLHNFAKMASPNRVTEILDPALVREAEE--TSADHASTSSARNHNGTEKIMECLVLIIKV 992

Query: 300  GVACSMESPQDRMKMTNVVHELQSIKNTLLG 330
            GVAC++ESP++R+ ++NV  EL  I+  L+G
Sbjct: 993  GVACAVESPRERIDISNVATELYRIRKILIG 1023

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa]

 Score =  337 bits (863), Expect = 7e-90,   Method: Compositional matrix adjust.
 Identities = 172/325 (52%), Positives = 226/325 (69%), Gaps = 25/325 (7%)

Query: 30   EILDVSRNMLEENLISAGTFGFSH-----------------LRRQGAFKSFIAECKALRN 72
            ++L  +      NLI AG+FG  +                 L R+GA KSF+AEC AL N
Sbjct: 699  DLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKSFMAECAALIN 758

Query: 73   IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLR 132
            IRHRNL+KVLTAC G+D+QGNDFKALVYEFM N SL+EWL+P    DE ++R R+L+LL+
Sbjct: 759  IRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAHRR-RDLSLLQ 817

Query: 133  RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTR---- 188
            RLNIAIDVASAL+YLH+ CQ    HC LKPSNVLLD D+TA VGDFGLAR LP       
Sbjct: 818  RLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARLLPQASHQLC 877

Query: 189  -TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247
              QTSSI +KG+IGY APEYG+G+EVS  GDVYSYGILLLE+    +P+D +F+  +NLH
Sbjct: 878  LDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTDGLFKDGLNLH 937

Query: 248  KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMES 307
             FAK AL   V +++D +L+ + E+    GD  +  + I    EC+ ++V++GVACS E 
Sbjct: 938  NFAKTALPISVAEVLDPVLVTEAEE--TSGDASRRMSHIGNHMECLAAIVKVGVACSAEF 995

Query: 308  PQDRMKMTNVVHELQSIKNTLLGPK 332
            P++RM++++V  EL+ I++ LLGP+
Sbjct: 996  PRERMEISSVAVELRRIRHILLGPQ 1020

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  329 bits (844), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 166/314 (52%), Positives = 209/314 (66%), Gaps = 25/314 (7%)

Query: 42   NLISAGTFGFSH-----------------LRRQGAFKSFIAECKALRNIRHRNLIKVLTA 84
            NLI  G FG  +                 L ++GA KSF AEC+ALRNIRHRNL+KVLT 
Sbjct: 717  NLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTT 776

Query: 85   CLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL 144
            C  VDYQGNDFKALVYEFM N SL+ WL+P+   DE     R L+L +RLNIAIDVASAL
Sbjct: 777  CSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASAL 836

Query: 145  NYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTR-----TQTSSIDVKGS 199
            +YLHH C     HC LKPSN+LLD+DMTA VGDFGLARF+P        +Q+SSI +KG+
Sbjct: 837  DYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGT 896

Query: 200  IGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK 259
            IGY APEYG+G +VS +GD YSYGILLLE+   ++P++ MF   +NLH F KMAL   + 
Sbjct: 897  IGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIA 956

Query: 260  DIVDSILLND---DEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN 316
            DI+D   L+    +E+            K   + EC+IS++RIGV+CS+ESP++RM +T 
Sbjct: 957  DIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITE 1016

Query: 317  VVHELQSIKNTLLG 330
             + ELQ I+  LLG
Sbjct: 1017 AIKELQLIRKILLG 1030

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  328 bits (842), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 166/314 (52%), Positives = 209/314 (66%), Gaps = 25/314 (7%)

Query: 42   NLISAGTFGFSH-----------------LRRQGAFKSFIAECKALRNIRHRNLIKVLTA 84
            NLI  G FG  +                 L ++GA KSF AEC+ALRNIRHRNL+KVLT 
Sbjct: 748  NLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTT 807

Query: 85   CLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL 144
            C  VDYQGNDFKALVYEFM N SL+ WL+P+   DE     R L+L +RLNIAIDVASAL
Sbjct: 808  CSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASAL 867

Query: 145  NYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTR-----TQTSSIDVKGS 199
            +YLHH C     HC LKPSN+LLD+DMTA VGDFGLARF+P        +Q+SSI +KG+
Sbjct: 868  DYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGT 927

Query: 200  IGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK 259
            IGY APEYG+G +VS +GD YSYGILLLE+   ++P++ MF   +NLH F KMAL   + 
Sbjct: 928  IGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIA 987

Query: 260  DIVDSILLND---DEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN 316
            DI+D   L+    +E+            K   + EC+IS++RIGV+CS+ESP++RM +T 
Sbjct: 988  DIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITE 1047

Query: 317  VVHELQSIKNTLLG 330
             + ELQ I+  LLG
Sbjct: 1048 AIKELQLIRKILLG 1061

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  327 bits (837), Expect = 8e-87,   Method: Compositional matrix adjust.
 Identities = 164/323 (50%), Positives = 215/323 (66%), Gaps = 23/323 (7%)

Query: 30  EILDVSRNMLEENLISAGTFGFSH-----------------LRRQGAFKSFIAECKALRN 72
            +L  +      NLI  G+FG  +                 L R+GA KSFIAEC+ALRN
Sbjct: 630 SLLRATDGFSSSNLIGVGSFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFIAECEALRN 689

Query: 73  IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLR 132
           IRHRNL+KVLTAC GVDYQGNDFKA+VYEFM N SL++WL+P     E    PR LN L+
Sbjct: 690 IRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQ 749

Query: 133 RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT--- 189
           RLNIAIDVA AL+YLHH CQ    HC LKPSNVLLD +MT  VGDFG+A+FLP   T   
Sbjct: 750 RLNIAIDVACALDYLHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVP 809

Query: 190 --QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247
             Q+SSI ++G+IGY APEYG+G+EVST GDVYS+GILLLE+   ++P++ MF+  +N+H
Sbjct: 810 EIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIH 869

Query: 248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMES 307
            F K A+   V +I D +LL +  ++     Q++  A  +  +EC+IS+  IG+ACS E 
Sbjct: 870 NFVKTAVPERVAEIADPVLLQEGVEMDNTTSQRR-MASSHDAQECLISIFGIGLACSAEL 928

Query: 308 PQDRMKMTNVVHELQSIKNTLLG 330
           P++R  +T+   EL S+++  LG
Sbjct: 929 PRERKNITDAAAELNSVRDIFLG 951

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa]

 Score =  326 bits (836), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 163/325 (50%), Positives = 218/325 (67%), Gaps = 23/325 (7%)

Query: 30   EILDVSRNMLEENLISAGTFGFSH-----------------LRRQGAFKSFIAECKALRN 72
            E+   +      N I  G+FG  +                 L R+GA KS++AEC AL N
Sbjct: 680  ELYQATGGFSSSNFIGGGSFGSVYKAILAPDGMIVAVKVFNLLRKGASKSYMAECAALIN 739

Query: 73   IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLR 132
            IRHRNL+K+LTAC  +D++GNDFKALVYEFM N SL+EWL+P+   DE  +   NLNL++
Sbjct: 740  IRHRNLVKILTACSSLDFRGNDFKALVYEFMVNGSLEEWLHPVHTSDEE-REQGNLNLIQ 798

Query: 133  RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP-----T 187
            RLN+AIDVASAL+YLH+ CQ    HC LKPSNVLLD DMTA VGDFGLARF P      +
Sbjct: 799  RLNVAIDVASALDYLHYHCQMAVVHCDLKPSNVLLDGDMTAHVGDFGLARFRPEASVQLS 858

Query: 188  RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 247
              Q SSI +KG++GY APEYG+GNEVST GDVYSYGILLLE++  + P+D  F+  +NLH
Sbjct: 859  SNQNSSIGLKGTVGYAAPEYGIGNEVSTYGDVYSYGILLLEILTGKTPTDGSFKEGLNLH 918

Query: 248  KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMES 307
            K+ KMAL + V ++VD ILL + E+          +   + + EC++S++ +GV+CS++ 
Sbjct: 919  KYVKMALPDRVVEVVDPILLREIEQTSANASDGMKRIGNDKVLECLVSIMEVGVSCSVDL 978

Query: 308  PQDRMKMTNVVHELQSIKNTLLGPK 332
            P++R  ++NVV EL  I+  LLG +
Sbjct: 979  PRERTNISNVVAELHRIRGILLGTR 1003

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  326 bits (835), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 162/332 (48%), Positives = 223/332 (67%), Gaps = 18/332 (5%)

Query: 18   SLHIEVGKLKNLEILDVSRNMLEENLISAGTFG-----------------FSHLRRQGAF 60
            SL     ++   ++L  +      NLI  G+FG                   +L R+GA 
Sbjct: 689  SLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLNLLRKGAS 748

Query: 61   KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
            KSF+AEC+AL++IRHRNL+K+LT C  +D+QGNDFKALVYEFM N +L+EWL+P+   DE
Sbjct: 749  KSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLHPVQTSDE 808

Query: 121  TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                P+ L+L+ RLNIAI +ASALNYLHHDCQ    HC LKPSN+LLD +MTA VGDFGL
Sbjct: 809  A-NGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAHVGDFGL 867

Query: 181  ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
            ARF      QTSS+ +KG+IGY APEYG+G +VST GDVYSYGILLLE+   ++P D MF
Sbjct: 868  ARFHSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLLEMFTGKRPVDGMF 927

Query: 241  EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG 300
            +  +NLH +AKMAL + + ++VD +L+ +   +    +        + I  C+++++++G
Sbjct: 928  KDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPHEISACLMTIIKMG 987

Query: 301  VACSMESPQDRMKMTNVVHELQSIKNTLLGPK 332
            VACS+E P++RM + +VV EL  IK+TLLG +
Sbjct: 988  VACSVELPRERMDIGDVVTELNRIKDTLLGTR 1019

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis]

 Score =  322 bits (825), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 164/310 (52%), Positives = 214/310 (69%), Gaps = 27/310 (8%)

Query: 42   NLISAGTFGFSH-----------------LRRQGAFKSFIAECKALRNIRHRNLIKVLTA 84
            NLI  G+FG  +                 L   GA  SFIAEC+ALRNIRHRNL+KVLTA
Sbjct: 706  NLIGRGSFGHVYKGFLDEGNVTIAVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVLTA 765

Query: 85   CLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL 144
            C G+DYQGNDFKALVYE+M N SL+EWL+PI + +E  + PR+LNLL+RLNIAIDVASAL
Sbjct: 766  CSGIDYQGNDFKALVYEYMVNGSLEEWLHPIPRTEEV-EPPRSLNLLQRLNIAIDVASAL 824

Query: 145  NYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTR-----TQTSSIDVKGS 199
            +YLH+ C     HC LKPSNVLLD +M   V DFGLA+ L  +      +Q+SSI V+G+
Sbjct: 825  DYLHNQCTTPIVHCDLKPSNVLLDSEMNGHVSDFGLAKILSESTNSFPVSQSSSIGVRGT 884

Query: 200  IGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK 259
            +G+  PEYGVG+ VST GDVYSYGILLLEL   ++P+D MF+ D+NLH FA++A  + + 
Sbjct: 885  VGFAPPEYGVGSNVSTYGDVYSYGILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQLA 944

Query: 260  DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH 319
            ++ D ILL +      R + ++ Q     + EC+ SM+RIGVACS E PQ+RMK+ +VV 
Sbjct: 945  EVADPILLQETAVRETRLNSRKCQR----LEECLFSMLRIGVACSTEMPQERMKINDVVT 1000

Query: 320  ELQSIKNTLL 329
             L +I++ L+
Sbjct: 1001 GLHAIRDKLV 1010

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  315 bits (808), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 159/278 (57%), Positives = 200/278 (71%), Gaps = 6/278 (2%)

Query: 53  HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
           +L R GAFKSFIAEC+ALRNIRHRNL+KVLTAC  VDYQGN+FKALVYEFM N SL+EWL
Sbjct: 662 NLMRHGAFKSFIAECEALRNIRHRNLVKVLTACSSVDYQGNEFKALVYEFMVNGSLEEWL 721

Query: 113 YPISKEDETYKRPRN-LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
           +P    DE    PRN LN+L+RLNIA+DVA AL+YLH+ C+    HC LKPSN+LLD++M
Sbjct: 722 HP---PDEAKAIPRNNLNILQRLNIAVDVACALDYLHNHCETPIIHCDLKPSNILLDNEM 778

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
           T  VGDFGLA+F      Q+SSI ++GS+GY   EYG GNEVST GDVYSYGILLLE+  
Sbjct: 779 TGHVGDFGLAKFYRERSHQSSSIGIRGSLGYAPAEYGTGNEVSTSGDVYSYGILLLEIFT 838

Query: 232 REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE 291
            ++P D  F  D++LH + K AL   V +I+D  L  + E  +     +++ A IN   E
Sbjct: 839 GKRPMDDWFNEDVSLHNYVKNALPEQVVEILDPTLFQEGEGGISL--IRRSNASINRTME 896

Query: 292 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL 329
           C+IS+  IGVACS E+P +RM + +V  +L SI+N LL
Sbjct: 897 CLISICEIGVACSAETPGERMNICDVAGQLVSIRNKLL 934

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	381
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.679	0.256	0.473	1e-63
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.574	0.436	0.508	5.4e-63
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.687	0.255	0.459	5.5e-63
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.706	0.262	0.446	1.1e-62
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.706	0.266	0.439	5.8e-62
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.682	0.257	0.435	9.4e-61
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.530	0.195	0.509	6.5e-60
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.669	0.260	0.356	4.2e-44
TAIR|locus:2169975	993	HSL2 "HAESA-like 2" [Arabidops	0.664	0.254	0.336	4.5e-35
TAIR|locus:2005498	1196	BRI1 "BRASSINOSTEROID INSENSIT	0.553	0.176	0.372	5.4e-35

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 607 (218.7 bits), Expect = 1.0e-63, Sum P(2) = 1.0e-63
 Identities = 132/279 (47%), Positives = 180/279 (64%)

Query:    53 HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
             +++R+GA KSF+AEC++L++IRHRNL+K+LTAC  +D+QGN+F+AL+YEFM N SL  WL
Sbjct:   734 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWL 793

Query:   113 YPISKEDETYKRPXXXXXXXXXX-IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
             +P  +E E   RP           IAIDVAS L+YLH  C    AHC LKPSNVLLDDD+
Sbjct:   794 HP--EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDL 851

Query:   172 TARVGDFGLARFL-----PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
             TA V DFGLAR L          Q SS  V+G+IGY APEYGVG + S  GDVYS+GILL
Sbjct:   852 TAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILL 911

Query:   227 LELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI 286
             LE+   ++P++ +F G+  L+ + K AL   + DIVD  +L+    + +R          
Sbjct:   912 LEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILH----IGLR-------VGF 960

Query:   287 NIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325
              ++ EC+  +  +G+ C  ESP +R+  + VV EL SI+
Sbjct:   961 PVV-ECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 529 (191.3 bits), Expect = 5.4e-63, Sum P(3) = 5.4e-63
 Identities = 117/230 (50%), Positives = 144/230 (62%)

Query:    33 DVSRNML--EENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDY 90
             DV + +L  EE L++       +L + GA KSFIAEC++ + IRHRNL K++T C  +D 
Sbjct:   222 DVFKGLLGLEEKLVAVKVL---NLLKHGATKSFIAECESFKGIRHRNLAKLITVCSSLDS 278

Query:    91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHD 150
             QGNDF+ALVYEFM   SL  WL P   E                 IAIDVASAL YLH  
Sbjct:   279 QGNDFRALVYEFMPKGSLDMWLQPEDLESAN-NHSRSLTFAEKVNIAIDVASALEYLHVY 337

Query:   151 CQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP--PTRT---QTSSIDVKGSIGYIAP 205
             C    AHC +KPSNVLLDDD+TA V DFGLAR L     +T   Q SS  V+G+IGY AP
Sbjct:   338 CHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAP 397

Query:   206 EYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS 255
             EYG+G++ S  GDVYS+G+LLLE+   +KP+D  F G  NLH + K  LS
Sbjct:   398 EYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYNLHGYTKSVLS 447

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 580 (209.2 bits), Expect = 5.5e-63, Sum P(2) = 5.5e-63
 Identities = 129/281 (45%), Positives = 173/281 (61%)

Query:    53 HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
             +L ++GA KSFIAEC+AL  IRHRNL+K++T C   D++GNDF+ALVYEFM N +L  WL
Sbjct:   751 NLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWL 810

Query:   113 YPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
             +P  + +ET              IAIDVASAL YLH  C    AHC +KPSN+LLD D+T
Sbjct:   811 HP-DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLT 869

Query:   173 ARVGDFGLARFL-----PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLL 227
             A V DFGLA+ L          Q SS  V+G+IGY APEYG+G   S +GDVYS+GI+LL
Sbjct:   870 AHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLL 929

Query:   228 ELMIREKPSDIMFEGDMNLHKFAKMALSNH-VKDIVDSILLNDDEKLVVRGDQKQTQAKI 286
             E+   ++P++ +F   + LH F K AL      DI D  +L        RG   Q     
Sbjct:   930 EIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL--------RGAYAQ---HF 978

Query:   287 NIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT 327
             N++ EC+  + R+GV+CS ESP +R+ M   + +L SI+ +
Sbjct:   979 NMV-ECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRES 1018

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 602 (217.0 bits), Expect = 1.1e-62, Sum P(2) = 1.1e-62
 Identities = 126/282 (44%), Positives = 176/282 (62%)

Query:    54 LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
             L    A KSF AEC+ALRN+RHRNL+K++T C  +D +GNDFKA+VY+FM N SL++W++
Sbjct:   740 LENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIH 799

Query:   114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMT 172
             P    D+  +R           I +DVA AL+YLH H  +PV  HC +K SNVLLD DM 
Sbjct:   800 P-ETNDQADQR--HLNLHRRVTILLDVACALDYLHRHGPEPVV-HCDIKSSNVLLDSDMV 855

Query:   173 ARVGDFGLARFLPP----TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
             A VGDFGLAR L       +  TSS+   G+IGY APEYGVG   ST GD+YSYGIL+LE
Sbjct:   856 AHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLE 915

Query:   229 LMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINI 288
             ++  ++P+D  F  D+ L ++ ++ L   V D+VD+ L+ D E  +         +    
Sbjct:   916 IVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWL----NSTNNSPCRR 971

Query:   289 IRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 330
             I EC++ ++R+G++CS E P  R    +++ EL +IK  L G
Sbjct:   972 ITECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNLSG 1013

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 595 (214.5 bits), Expect = 5.8e-62, Sum P(2) = 5.8e-62
 Identities = 127/289 (43%), Positives = 180/289 (62%)

Query:    53 HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
             +++R+GA KSF+AEC++L++IRHRNL+K+LTAC  +D+QGN+F+AL+YEFM N SL +WL
Sbjct:   733 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWL 792

Query:   113 YPISKEDETYKRPXXXXXXXXXX-IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
             +P  +E E   RP           IAIDVAS L+YLH  C    AHC LKPSN+LLDDD+
Sbjct:   793 HP--EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDL 850

Query:   172 TARVGDFGLARFL-----PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
             TA V DFGLAR L          Q SS  V+G+IGY APEYG+G + S  GDVYS+G+L+
Sbjct:   851 TAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLV 910

Query:   227 LELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI 286
             LE+   ++P++ +F G+  L+ + K AL   V DI D  +L+   ++   G         
Sbjct:   911 LEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRV---GFP------- 960

Query:   287 NIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLA 335
               + EC+  ++ +G+ C  ESP +R+  +    EL SI+      +  A
Sbjct:   961 --VLECLKGILDVGLRCCEESPLNRLATSEAAKELISIRERFFKTRRTA 1007

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 9.4e-61, Sum P(2) = 9.4e-61
 Identities = 121/278 (43%), Positives = 175/278 (62%)

Query:    53 HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
             +++R+GA KSF+AEC++L++ RHRNL+K+LTAC   D+QGN+F+AL+YE++ N S+  WL
Sbjct:   735 NMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWL 794

Query:   113 YPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
             +P  + +E  + P          I IDVAS L+YLH  C    AHC LKPSNVLL+DD+T
Sbjct:   795 HP-EEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLT 853

Query:   173 ARVGDFGLARFL-----PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLL 227
             A V DFGLAR L          Q SS  V+G+IGY APEYG+G + S  GDVYS+G+LLL
Sbjct:   854 AHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLL 913

Query:   228 ELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN 287
             E+   ++P+D +F G++ LH + K+AL   V +I D  +L+   ++  R           
Sbjct:   914 EMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFR----------- 962

Query:   288 IIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325
                EC+  ++ +G+ C  E P +R+  + V  EL SI+
Sbjct:   963 -TAECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIR 999

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 6.5e-60, Sum P(3) = 6.5e-60
 Identities = 106/208 (50%), Positives = 132/208 (63%)

Query:    53 HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
             +L + GA KSF+AEC+  + IRHRNL+K++T C  +D +GNDF+ALVYEFM   SL  WL
Sbjct:   744 NLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL 803

Query:   113 YPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
               +   +                IAIDVASAL YLH  C    AHC +KPSN+LLDDD+T
Sbjct:   804 Q-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLT 862

Query:   173 ARVGDFGLARFL-----PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLL 227
             A V DFGLA+ L          Q SS  V+G+IGY APEYG+G + S  GDVYS+GILLL
Sbjct:   863 AHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLL 922

Query:   228 ELMIREKPSDIMFEGDMNLHKFAKMALS 255
             E+   +KP+D  F GD NLH + K  LS
Sbjct:   923 EMFSGKKPTDESFAGDYNLHSYTKSILS 950

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 419 (152.6 bits), Expect = 4.2e-44, Sum P(2) = 4.2e-44
 Identities = 101/283 (35%), Positives = 149/283 (52%)

Query:    62 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
             SF  EC+ L+  RHRNLI+++T C      G  F ALV   M N SL+  LYP     + 
Sbjct:   702 SFKRECQILKRTRHRNLIRIITTC---SKPG--FNALVLPLMPNGSLERHLYPGEYSSKN 756

Query:   122 YKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
                           I  DVA  + YLHH       HC LKPSN+LLDD+MTA V DFG++
Sbjct:   757 LD------LIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGIS 810

Query:   182 RFLPPTRTQTSSID----------VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
             R +       S+ D          + GS+GYIAPEYG+G   ST GDVYS+G+LLLE++ 
Sbjct:   811 RLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVS 870

Query:   232 REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE 291
               +P+D++     +LH+F K    +H  D ++ I+     +   +G  ++ +    + RE
Sbjct:   871 GRRPTDVLVNEGSSLHEFMK----SHYPDSLEGIIEQALSRWKPQGKPEKCE---KLWRE 923

Query:   292 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNL 334
              ++ M+ +G+ C+  +P  R  M +V HE+  +K  L    +L
Sbjct:   924 VILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFACPSL 966

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 345 (126.5 bits), Expect = 4.5e-35, Sum P(2) = 4.5e-35
 Identities = 92/273 (33%), Positives = 140/273 (51%)

Query:    63 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
             F +E + L  +RH N++K+L  C      G +F+ LVYEFM N SL + L+  S+++   
Sbjct:   730 FRSEVETLGRVRHGNIVKLLMCC-----NGEEFRFLVYEFMENGSLGDVLH--SEKEHRA 782

Query:   123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
               P          IA+  A  L+YLHHD  P   H  +K +N+LLD +M  RV DFGLA+
Sbjct:   783 VSPLDWTTRFS--IAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAK 840

Query:   183 FLPPTRTQTSSID------VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236
               P  R     +       V GS GYIAPEYG  ++V+   DVYS+G++LLEL+  ++P+
Sbjct:   841 --PLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPN 898

Query:   237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINI-IREC--V 293
             D  F  + ++ KFA  A   +     +   +N D     R   K    K+ +  RE   +
Sbjct:   899 DSSFGENKDIVKFAMEAALCYPSPSAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEI 958

Query:   294 ISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326
               ++ + + C+   P +R  M  VV  L+  K+
Sbjct:   959 EKVLDVALLCTSSFPINRPTMRKVVELLKEKKS 991

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 341 (125.1 bits), Expect = 5.4e-35, Sum P(2) = 5.4e-35
 Identities = 83/223 (37%), Positives = 120/223 (53%)

Query:    53 HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
             H+  QG  + F+AE + +  I+HRNL+ +L  C     +  D + LVYEFM   SL++ L
Sbjct:   915 HVSGQGD-REFMAEMETIGKIKHRNLVPLLGYC-----KVGDERLLVYEFMKYGSLEDVL 968

Query:   113 YPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
             +      +  K            IAI  A  L +LHH+C P   H  +K SNVLLD+++ 
Sbjct:   969 H------DPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLE 1022

Query:   173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
             ARV DFG+AR +    T  S   + G+ GY+ PEY      ST GDVYSYG++LLEL+  
Sbjct:  1023 ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTG 1082

Query:   233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVV 275
             ++P+D    GD NL  + K      + D+ D  L+ +D  L +
Sbjct:  1083 KRPTDSPDFGDNNLVGWVKQHAKLRISDVFDPELMKEDPALEI 1125

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

GO:0010224 "response to UV-B" evidence=IGI

GO:0005768 "endosome" evidence=IDA

GO:0046982 "protein heterodimerization activity" evidence=IPI

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0010268 "brassinosteroid homeostasis" evidence=IEP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0043234 "protein complex" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0009911 "positive regulation of flower development" evidence=IGI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IEP;IMP

GO:0010584 "pollen exine formation" evidence=IMP

GO:0048657 "tapetal cell differentiation" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0005496 "steroid binding" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	381
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-27
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-23
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-23
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-22
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-14
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-12
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-12
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-11
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-10
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-09
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-09
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-09
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-08
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-08
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-08
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-07
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-07
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-06
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-06
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-06
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-06
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-06
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-06
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-06
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-06
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-06
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-06
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-05
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-05
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-05
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-05
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-05
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-04
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-04
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-04
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-04
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-04
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-04
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-04
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-04
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-04
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-04
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.001
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.001
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	0.001
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.001
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	0.001
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.001
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.001
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	0.001
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	0.001
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.001
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	0.001
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	0.002
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	0.002
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	0.002
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.002
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	0.002
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	0.003
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	0.003
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	0.004
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  108 bits (271), Expect = 1e-27
 Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 21/181 (11%)

Query: 51  FSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKE 110
                     +  + E + L+ + H N++K+     GV ++  +   LV E+    SLK+
Sbjct: 26  IKKEDSSSLLEELLREIEILKKLNHPNIVKLY----GV-FEDENHLYLVMEYCEGGSLKD 80

Query: 111 WLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-D 169
            L          +    L+    L I + +   L YLH     +  H  LKP N+LLD D
Sbjct: 81  LLK---------ENEGKLSEDEILRILLQILEGLEYLHS--NGI-IHRDLKPENILLDSD 128

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLE 228
           +   ++ DFGL++ L   ++   +I   G+  Y+APE  +G    S   D++S G++L E
Sbjct: 129 NGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186

Query: 229 L 229
           L
Sbjct: 187 L 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  107 bits (269), Expect = 6e-27
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           +  + E K L+ ++H N++++        ++  D   LV E+     L + L        
Sbjct: 42  ERILREIKILKKLKHPNIVRLYDV-----FEDEDKLYLVMEYCEGGDLFDLL-------- 88

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
             K+   L+          + SAL YLH   + +  H  LKP N+LLD+D   ++ DFGL
Sbjct: 89  --KKRGRLSEDEARFYLRQILSALEYLH--SKGI-VHRDLKPENILLDEDGHVKLADFGL 143

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR L P    T+ +   G+  Y+APE  +G       D++S G++L EL+  + P    F
Sbjct: 144 ARQLDPGEKLTTFV---GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----F 196

Query: 241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRG 277
            GD  L +  K               ++ + K ++R 
Sbjct: 197 PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 96.8 bits (242), Expect = 4e-23
 Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 23/173 (13%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ + H N+++     LGV  QG     +V E+M    L ++L        
Sbjct: 46  EEFLEEASIMKKLSHPNIVR----LLGVCTQGEPLY-IVTEYMPGGDLLDFLR------- 93

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
             K    L L   L +A+ +A  + YL       + + V   L   N L+ +++  ++ D
Sbjct: 94  --KHGEKLTLKDLLQMALQIAKGMEYLE------SKNFVHRDLAARNCLVTENLVVKISD 145

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           FGL+R +            K  I ++APE     + ++  DV+S+G+LL E+ 
Sbjct: 146 FGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 96.8 bits (242), Expect = 4e-23
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 29/176 (16%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E + +R + H N++K+L  C   +        +V E+M    L ++L        
Sbjct: 46  EEFLREARIMRKLDHPNIVKLLGVCTEEEPL-----MIVMEYMPGGDLLDYL-------- 92

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
              RP+ L+L   L+ A+ +A  + YL         + +   L   N L+ +++  ++ D
Sbjct: 93  RKNRPKELSLSDLLSFALQIARGMEYLES------KNFIHRDLAARNCLVGENLVVKISD 146

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           FGL+R L            K  I ++APE    G     S   DV+S+G+LL E+ 
Sbjct: 147 FGLSRDLYDDDYYKVK-GGKLPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 96.5 bits (241), Expect = 5e-23
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 15/173 (8%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           K F+ E + ++ + H N+++     LGV  +      LV E+M    L ++L   S+   
Sbjct: 41  KDFLKEARVMKKLGHPNVVR----LLGVCTEEEPLY-LVLEYMEGGDLLDYLR-KSRPVF 94

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
                  L+L   L+ AI +A  + YL           V   L   N L+ +D+  ++ D
Sbjct: 95  PSPEKSTLSLKDLLSFAIQIAKGMEYLAS------KKFVHRDLAARNCLVGEDLVVKISD 148

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           FGL+R +            K  I ++APE       ++  DV+S+G+LL E+ 
Sbjct: 149 FGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 93.5 bits (233), Expect = 6e-22
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 21/177 (11%)

Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++   E + LR + H N+++++ A     ++  D   LV E+     L ++L       
Sbjct: 42  DQTARREIRILRRLSHPNIVRLIDA-----FEDKDHLYLVMEYCEGGDLFDYL------- 89

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
               R   L+      IA+ +   L YLH     +  H  LKP N+LLD++   ++ DFG
Sbjct: 90  ---SRGGPLSEDEAKKIALQILRGLEYLHS--NGI-IHRDLKPENILLDENGVVKIADFG 143

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE-YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA+ L   ++ +S     G+  Y+APE    GN      DV+S G++L EL+  + P
Sbjct: 144 LAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 92.6 bits (231), Expect = 1e-21
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 30/176 (17%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E + +R + H N++K+L  C   +        +V E+M    L  +L        
Sbjct: 46  EEFLREARIMRKLDHPNVVKLLGVCTEEEPL-----YIVMEYMEGGDLLSYLR------- 93

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
             K    L+L   L+ A+ +A  + YL         + +   L   N L+ +++  ++ D
Sbjct: 94  --KNRPKLSLSDLLSFALQIARGMEYLES------KNFIHRDLAARNCLVGENLVVKISD 145

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           FGL+R L            K  I ++APE    G     S   DV+S+G+LL E+ 
Sbjct: 146 FGLSRDLYDDDY-YRKRGGKLPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 78/318 (24%), Positives = 136/318 (42%), Gaps = 69/318 (21%)

Query: 27  KNLEILDVSRNMLEENLISAGTFGFSHLRRQGAF----------------KSFIAECKAL 70
           K++ I D+  ++ EEN+IS G  G S+  +                     S IA+   +
Sbjct: 681 KSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---M 737

Query: 71  RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNL 130
             ++H N++K++  C     +      L++E++  ++L E L             RNL+ 
Sbjct: 738 GKLQHPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVL-------------RNLSW 779

Query: 131 LRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD--DDMTARVGDFGLARFLPPTR 188
            RR  IAI +A AL +LH  C P      L P  +++D  D+   R+   GL        
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLL------- 832

Query: 189 TQTSSIDVKGSI--GYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL 246
                 D K  I   Y+APE     +++   D+Y +G++L+EL+  + P+D  F    ++
Sbjct: 833 ----CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888

Query: 247 HKFAKMALSN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSM 305
            ++A+   S+ H+   +D           +RGD    Q       E V  M  + + C+ 
Sbjct: 889 VEWARYCYSDCHLDMWIDPS---------IRGDVSVNQ------NEIVEVM-NLALHCTA 932

Query: 306 ESPQDRMKMTNVVHELQS 323
             P  R    +V+  L+S
Sbjct: 933 TDPTARPCANDVLKTLES 950

Length = 968

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 59/182 (32%), Positives = 89/182 (48%), Gaps = 39/182 (21%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
             A ++F+AE   +  +RH NL+++L    GV  QGN    +V E+M   SL ++L    
Sbjct: 41  STAAQAFLAEASVMTTLRHPNLVQLL----GVVLQGNPL-YIVTEYMAKGSLVDYL---- 91

Query: 117 KEDETYKRPRN---LNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLL 167
                  R R    + L ++L  A+DV   + YL      H D         L   NVL+
Sbjct: 92  -------RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRD---------LAARNVLV 135

Query: 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLL 227
            +D+ A+V DFGLA+    ++ Q S    K  + + APE     + ST  DV+S+GILL 
Sbjct: 136 SEDLVAKVSDFGLAK--EASQGQDSG---KLPVKWTAPEALREKKFSTKSDVWSFGILLW 190

Query: 228 EL 229
           E+
Sbjct: 191 EI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 38/193 (19%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F  E +AL+ +RH++LI +   C        +   ++ E M   SL  +L   S E    
Sbjct: 49  FQKEVQALKRLRHKHLISLFAVC-----SVGEPVYIITELMEKGSLLAFLR--SPEG--- 98

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
              + L +   +++A  VA  + YL      H D         L   N+L+ +D+  +V 
Sbjct: 99  ---QVLPVASLIDMACQVAEGMAYLEEQNSIHRD---------LAARNILVGEDLVCKVA 146

Query: 177 DFGLARFL--PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR +      +    I  K    + APE       ST  DV+S+GILL E+    +
Sbjct: 147 DFGLARLIKEDVYLSSDKKIPYK----WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQ 202

Query: 235 PSDIMFEGDMNLH 247
              + + G MN H
Sbjct: 203 ---VPYPG-MNNH 211

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 33/178 (18%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVD--YQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           K F+AE + ++ +RH  LI++   C   +  Y       +V E M   SL E+L      
Sbjct: 46  KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY-------IVTELMKYGSLLEYL------ 92

Query: 119 DETYKRPRNLNLLRRLNIAIDVASAL------NYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
                  R L L + +++A  VAS +      NY+H D         L   NVL+ ++  
Sbjct: 93  --QGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRD---------LAARNVLVGENNI 141

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            +V DFGLAR +       +    K  I + APE  + N  S   DV+S+GILL E++
Sbjct: 142 CKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 76.3 bits (186), Expect = 2e-15
 Identities = 53/185 (28%), Positives = 79/185 (42%), Gaps = 22/185 (11%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E + L ++ H   I  L       +Q      LV E++   SL++ L       +
Sbjct: 42  ERFLREIQILASLNHPPNIVKLYDF----FQDEGSLYLVMEYVDGGSLEDLL-------K 90

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMTARVGDFG 179
              R   L+    L I   + SAL YLH        H  +KP N+LLD D    ++ DFG
Sbjct: 91  KIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFG 147

Query: 180 LARFLPPTRT----QTSSIDVKGSIGYIAPEY---GVGNEVSTIGDVYSYGILLLELMIR 232
           LA+ LP   +            G+ GY+APE          S+  D++S GI L EL+  
Sbjct: 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG 207

Query: 233 EKPSD 237
             P +
Sbjct: 208 LPPFE 212

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 33/178 (18%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVD--YQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           ++F+ E + ++ +RH  L+++   C   +  Y       +V E+M   SL ++L    K 
Sbjct: 46  EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY-------IVTEYMSKGSLLDFL----KS 94

Query: 119 DETYKRPRNLNLLRRLNIAIDVASAL------NYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
            E     + L L + +++A  +A  +      NY+H D         L   N+L+ +++ 
Sbjct: 95  GEG----KKLRLPQLVDMAAQIAEGMAYLESRNYIHRD---------LAARNILVGENLV 141

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 142 CKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 19/176 (10%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQ-GNDFKALVYEFMHNRSLKEWLYPISKED 119
           ++   E + L +++H N+++      G +     +   +  E++   SL   L    K  
Sbjct: 44  EALEREIRILSSLQHPNIVR----YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP 99

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E         ++R+      +   L YLH     V  H  +K +N+L+D D   ++ DFG
Sbjct: 100 E--------PVIRKY--TRQILEGLAYLH-SNGIV--HRDIKGANILVDSDGVVKLADFG 146

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
            A+ L    T   +  V+G+  ++APE   G E     D++S G  ++E M   KP
Sbjct: 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIE-MATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 26/172 (15%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+AE   +  +RH NL+++L    GV  +      +V E+M   SL ++L        
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVDYL-------- 91

Query: 121 TYKRPRNLNLL---RRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
              R R  ++L     L  ++DV  A+ YL  +      H  L   NVL+ +D  A+V D
Sbjct: 92  ---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSD 145

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           FGL +    T+  T  + VK    + APE     + ST  DV+S+GILL E+
Sbjct: 146 FGLTKEASSTQ-DTGKLPVK----WTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 29/177 (16%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
             + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   +++
Sbjct: 45  EVEEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ 99

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMT 172
           +        +N +  L +A  ++SA+ YL      H D         L   N L+ ++  
Sbjct: 100 E--------VNAVVLLYMATQISSAMEYLEKKNFIHRD---------LAARNCLVGENHL 142

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
            +V DFGL+R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 143 VKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 24/170 (14%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E   +  + H+NL+++L   L   + G     +V E M   +L  +L        
Sbjct: 44  QAFLEETAVMTKLHHKNLVRLLGVIL---HNG---LYIVMELMSKGNLVNFLR------- 90

Query: 121 TYKRPRNL-NLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
              R R L ++++ L  ++DVA  + YL         H  L   N+L+ +D  A+V DFG
Sbjct: 91  --TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFG 145

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           LAR +       S + VK    + APE     + S+  DV+SYG+LL E+
Sbjct: 146 LAR-VGSMGVDNSKLPVK----WTAPEALKHKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 48/226 (21%)

Query: 32  LDVSRNMLEENLISAGTFG---FSHLRRQG------AFKS------------FIAECKAL 70
           +DVS   +EE +I AG FG      L+  G      A K+            F++E   +
Sbjct: 1   IDVSCVKIEE-VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 59

Query: 71  RNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRN 127
               H N+I    V+T    V         ++ EFM N +L  +L    + D  +   + 
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPV--------MIITEFMENGALDSFL---RQNDGQFTVIQL 108

Query: 128 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT 187
           + +LR +   +   S +NY+H D         L   N+L++ ++  +V DFGL+RFL   
Sbjct: 109 VGMLRGIAAGMKYLSEMNYVHRD---------LAARNILVNSNLVCKVSDFGLSRFLEDD 159

Query: 188 R---TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
               T TSS+  K  I + APE     + ++  DV+SYGI++ E+M
Sbjct: 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.8 bits (165), Expect = 7e-13
 Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 20/173 (11%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 46  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGEMG 96

Query: 121 TYKR-PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P+ +++  ++   +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 97  KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 147

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 148 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 199

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 67.1 bits (165), Expect = 1e-12
 Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 35/193 (18%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   L+ ++H N++K+L               LV+E+  +  LK++L       +    P
Sbjct: 48  EISLLKELKHPNIVKLLDVIHT-----ERKLYLVFEYC-DMDLKKYL-------DKRPGP 94

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLA 181
            + NL++   I   +   L Y H       +H +    LKP N+L++ D   ++ DFGLA
Sbjct: 95  LSPNLIKS--IMYQLLRGLAYCH-------SHRILHRDLKPQNILINRDGVLKLADFGLA 145

Query: 182 R-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIM 239
           R F  P RT T  + V  ++ Y APE  +G++  +   D++S G +  E MI  KP   +
Sbjct: 146 RAFGIPLRTYTHEV-V--TLWYRAPEILLGSKHYSTAVDIWSVGCIFAE-MITGKP---L 198

Query: 240 FEGDMNLHKFAKM 252
           F GD  + +  K+
Sbjct: 199 FPGDSEIDQLFKI 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 18/167 (10%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K +  + H NL+++   C     Q   F  +V E+M N  L  +L          
Sbjct: 46  FIEEAKVMMKLSHPNLVQLYGVCT---KQRPIF--IVTEYMANGCLLNYLR--------- 91

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +R   L     L++  DV  A+ YL  +      H  L   N L+ +D   +V DFGLAR
Sbjct: 92  ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           ++   +  TSS   K  + +  PE    +  S+  DV+S+G+L+ E+
Sbjct: 149 YVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 44/195 (22%)

Query: 53  HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
            L  +   +  I E + L+  +H N++K   +     Y   D   +V EF    SLK+  
Sbjct: 34  KLESKEKKEKIINEIQILKKCKHPNIVKYYGS-----YLKKDELWIVMEFCSGGSLKD-- 86

Query: 113 YPISKEDETYKRPRNLNLLRRLN------IAIDVASALNYL------HHDCQPVTAHCVL 160
             + K           +  + L       +  ++   L YL      H D         +
Sbjct: 87  --LLK-----------STNQTLTESQIAYVCKELLKGLEYLHSNGIIHRD---------I 124

Query: 161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVY 220
           K +N+LL  D   ++ DFGL+  L  T+ + + +   G+  ++APE   G       D++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDYKADIW 181

Query: 221 SYGILLLELMIREKP 235
           S GI  +EL   + P
Sbjct: 182 SLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 30/178 (16%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           +SF+ E + ++ +RH  L+++            +   +V E+M   SL ++L    K+ E
Sbjct: 46  ESFLEEAQIMKKLRHDKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL----KDGE 95

Query: 121 TYKRPRNLNLLRRLNIAIDVASAL------NYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                R L L   +++A  VA+ +      NY+H D         L+ +N+L+ D +  +
Sbjct: 96  G----RALKLPNLVDMAAQVAAGMAYIERMNYIHRD---------LRSANILVGDGLVCK 142

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           + DFGLAR +      T+    K  I + APE  +    +   DV+S+GILL EL+ +
Sbjct: 143 IADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 19/171 (11%)

Query: 65  AECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKR 124
            E K LR+     ++K    C G  Y+  +  ++V E+M   SL + L  + K  E    
Sbjct: 48  RELKTLRSCESPYVVK----CYGAFYKEGEI-SIVLEYMDGGSLADLLKKVGKIPEPV-- 100

Query: 125 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184
              L       IA  +   L+YLH     +  H  +KPSN+L++     ++ DFG+++ L
Sbjct: 101 ---LAY-----IARQILKGLDYLHTKRHII--HRDIKPSNLLINSKGEVKIADFGISKVL 150

Query: 185 PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
             T  Q ++    G++ Y++PE   G   S   D++S G+ LLE  + + P
Sbjct: 151 ENTLDQCNTF--VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 36/217 (16%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + LR + H N++K    C   +  G     L+ E++ + SL+++L          +  
Sbjct: 56  EIEILRTLDHENIVKYKGVC---EKPGGRSLRLIMEYLPSGSLRDYLQ---------RHR 103

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGDFGLAR 182
             +NL R L  +  +   ++YL       +   +   L   N+L++ +   ++ DFGLA+
Sbjct: 104 DQINLKRLLLFSSQICKGMDYLG------SQRYIHRDLAARNILVESEDLVKISDFGLAK 157

Query: 183 FLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE 241
            LP  +      +   S I + APE    ++ S+  DV+S+G+ L EL            
Sbjct: 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY--------- 208

Query: 242 GDMNLH---KFAKMALSNHVKDIVDSI--LLNDDEKL 273
           GD +     +F +M      + IV  +  LL + E+L
Sbjct: 209 GDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 34/175 (19%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + LRN+ H N++K    C   +  GN  K L+ EF+ + SLKE+L            P
Sbjct: 56  EIEILRNLYHENIVKYKGIC--TEDGGNGIK-LIMEFLPSGSLKEYL------------P 100

Query: 126 RN---LNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
           RN   +NL ++L  A+ +   ++YL      H D         L   NVL++ +   ++G
Sbjct: 101 RNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRD---------LAARNVLVESEHQVKIG 151

Query: 177 DFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           DFGL + +   +   T   D+   + + APE  + ++     DV+S+G+ L EL+
Sbjct: 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 20/177 (11%)

Query: 62  SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
            +  E   L+ + H N++K    C     QG     L+ E++   SL+++L         
Sbjct: 52  GWKKEINILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYL--------- 99

Query: 122 YKRPRN-LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
              P++ LNL + L  A  +   + YLH        H  L   NVLLD+D   ++GDFGL
Sbjct: 100 ---PKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGL 153

Query: 181 ARFLPPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236
           A+ +P          D    + + A E    N+ S   DV+S+G+ L EL+      
Sbjct: 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.8 bits (152), Expect = 3e-11
 Identities = 45/173 (26%), Positives = 85/173 (49%), Gaps = 20/173 (11%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+ +            +   +V EFM   SL ++L    + D 
Sbjct: 46  EAFLQEAQIMKKLRHDKLVPLYAVV------SEEPIYIVTEFMGKGSLLDFL---KEGDG 96

Query: 121 TY-KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y K P+ +++  ++   +     +NY+H D         L+ +N+L+ D++  ++ DFG
Sbjct: 97  KYLKLPQLVDMAAQIADGMAYIERMNYIHRD---------LRAANILVGDNLVCKIADFG 147

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL+ +
Sbjct: 148 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 30/173 (17%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K +  + H  L+++   C     Q   +  +V E+M N  L  +L       E  
Sbjct: 46  FIEEAKVMMKLSHEKLVQLYGVC---TKQRPIY--IVTEYMSNGCLLNYL------REHG 94

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
           KR +   LL    +  DV   + YL      H D         L   N L+DD    +V 
Sbjct: 95  KRFQPSQLLE---MCKDVCEGMAYLESKQFIHRD---------LAARNCLVDDQGCVKVS 142

Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           DFGL+R++      TSS+  K  + +  PE  + ++ S+  DV+++G+L+ E+
Sbjct: 143 DFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 46/177 (25%), Positives = 85/177 (48%), Gaps = 24/177 (13%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   +    H N+I++     GV  +      ++ E+M N SL ++L    + D  +
Sbjct: 52  FLTEASIMGQFDHPNIIRLE----GVVTKSRPV-MIITEYMENGSLDKFL---RENDGKF 103

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
              + + +LR +   +   S +NY+H D         L   N+L++ ++  +V DFGL+R
Sbjct: 104 TVGQLVGMLRGIASGMKYLSEMNYVHRD---------LAARNILVNSNLVCKVSDFGLSR 154

Query: 183 FLPPTRTQTSSIDVKG---SIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKP 235
            L       ++   KG    I + APE     + ++  DV+S+GI++ E+M   E+P
Sbjct: 155 RL---EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 61.4 bits (150), Expect = 8e-11
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 7/93 (7%)

Query: 139 DVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK 197
           ++  AL YLH         +  LKP N+LLD D   ++ DFGLA+ L    ++T++    
Sbjct: 101 EIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF--C 154

Query: 198 GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           G+  Y+APE  +G       D +S G+LL E++
Sbjct: 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML 187

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 42/181 (23%)

Query: 62  SFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           +F+AE   ++ ++H  L++   V+T          +   ++ E+M N SL ++L    K 
Sbjct: 47  AFLAEANLMKQLQHPRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL----KT 93

Query: 119 DETYKRPRNLNLLRRLNIAIDVASAL------NYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
            E  K    L + + +++A  +A  +      NY+H D         L+ +N+L+ + + 
Sbjct: 94  PEGIK----LTINKLIDMAAQIAEGMAFIERKNYIHRD---------LRAANILVSETLC 140

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLEL 229
            ++ DFGLAR +      T+    K  I + APE   YG     +   DV+S+GILL E+
Sbjct: 141 CKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEI 196

Query: 230 M 230
           +
Sbjct: 197 V 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 37/203 (18%)

Query: 44  ISAGTFGFSHLR-------------RQGAF--KSFIAECKALRNIRHRNLIKVLTACLGV 88
           I +G FG   L              R+GA   + FI E + +  + H  L+++   C   
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE- 70

Query: 89  DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRR--LNIAIDVASALNY 146
                    LV+EFM +  L ++L           R +     +   L + +DV   + Y
Sbjct: 71  ----RSPICLVFEFMEHGCLSDYL-----------RAQRGKFSQETLLGMCLDVCEGMAY 115

Query: 147 LHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE 206
           L         H  L   N L+ ++   +V DFG+ RF+   +  TSS   K  + + +PE
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPE 171

Query: 207 YGVGNEVSTIGDVYSYGILLLEL 229
               ++ S+  DV+S+G+L+ E+
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 14/107 (13%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
              ++  AL YLH   + +  H  +KP N+LLD+     + DF +A  + P    T +  
Sbjct: 105 WICEIVLALEYLHS--KGII-HRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTS 158

Query: 196 VKGSIGYIAPE----YGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238
             G+ GY+APE     G    V    D +S G+   E +  ++P   
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 25/189 (13%)

Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLK 109
           G++  +RQ     F++E   +    H N+I++     GV  +      ++ E+M N +L 
Sbjct: 44  GYTEKQRQ----DFLSEASIMGQFSHHNIIRLE----GVVTKFKPA-MIITEYMENGALD 94

Query: 110 EWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169
           ++L      D  +   + + +LR +   +   S +NY+H D         L   N+L++ 
Sbjct: 95  KYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRD---------LAARNILVNS 142

Query: 170 DMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLL 227
           ++  +V DFGL+R L   P  T T+S   K  I + APE     + ++  DV+S+GI++ 
Sbjct: 143 NLECKVSDFGLSRVLEDDPEGTYTTS-GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201

Query: 228 ELM-IREKP 235
           E+M   E+P
Sbjct: 202 EVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 18/162 (11%)

Query: 69  ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNL 128
           A+ ++ H  ++++L  C G   Q      LV +     SL + +          +   +L
Sbjct: 62  AMGSLDHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVR---------QHRDSL 106

Query: 129 NLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTR 188
           +  R LN  + +A  + YL         H  L   N+LL  D   ++ DFG+A  L P  
Sbjct: 107 DPQRLLNWCVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163

Query: 189 TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            +    + K  I ++A E  +    +   DV+SYG+ + E+M
Sbjct: 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 60.6 bits (148), Expect = 2e-10
 Identities = 37/128 (28%), Positives = 61/128 (47%), Gaps = 10/128 (7%)

Query: 134 LNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
           L+  + +  AL YLH   + +  H  +KP N+ L  +   ++GDFG+++ L  T     +
Sbjct: 106 LDWFVQLCLALKYLHS--RKIL-HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT 162

Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
             V G+  Y++PE       +   D++S G +L EL   + P    FEG+ NL + A   
Sbjct: 163 --VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE-NLLELALKI 215

Query: 254 LSNHVKDI 261
           L      I
Sbjct: 216 LKGQYPPI 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 17/188 (9%)

Query: 49  FGFSHLRRQGAFKSFIAECKALR-NIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRS 107
           FG     R  +    ++E   ++  +RH N+++     L      ND   +V + +    
Sbjct: 41  FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-----NDRLYIVMDLIEGAP 95

Query: 108 LKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL 167
           L E    + ++ + +   R        NI + +  AL YLH + + V  H  L P+N++L
Sbjct: 96  LGEHFNSLKEKKQRFTEER------IWNIFVQMVLALRYLHKEKRIV--HRDLTPNNIML 147

Query: 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLL 227
            +D    + DFGLA+   P    TS   V G+I Y  PE           DV+++G +L 
Sbjct: 148 GEDDKVTITDFGLAKQKQPESKLTS---VVGTILYSCPEIVKNEPYGEKADVWAFGCILY 204

Query: 228 ELMIREKP 235
           ++   + P
Sbjct: 205 QMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 26/175 (14%)

Query: 61  KSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           + F++E   +    H N+I    V+T    V         +V E+M N SL  +L    K
Sbjct: 50  RDFLSEASIMGQFDHPNIIHLEGVVTKSKPV--------MIVTEYMENGSLDAFL---RK 98

Query: 118 EDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            D  +   + + +LR +   +   S + Y+H D         L   N+L++ ++  +V D
Sbjct: 99  HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNILVNSNLVCKVSD 149

Query: 178 FGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           FGL+R L   P    T+    K  I + APE     + ++  DV+SYGI++ E+M
Sbjct: 150 FGLSRVLEDDPEAAYTTR-GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 41/168 (24%), Positives = 84/168 (50%), Gaps = 9/168 (5%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
            + E   L  + H+N++ +L  C+    +  +   ++Y +M+  +LK +L      +   
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN- 109

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
             P+ L+  + +++AI +A  ++YLH   +    H  +   N ++D+++  ++ D  L+R
Sbjct: 110 -NPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            L P        +    + ++A E  V  E S+  DV+S+G+LL ELM
Sbjct: 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 32/185 (17%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           A K F  E + L N +H N++K    C     +G D   +V+E+M +  L ++L     +
Sbjct: 51  ARKDFEREAELLTNFQHENIVKFYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPD 105

Query: 119 DETYKRPRN----LNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLD 168
               K P +    L L + L IA+ +AS + YL      H D         L   N L+ 
Sbjct: 106 AAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRD---------LATRNCLVG 156

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGS----IGYIAPEYGVGNEVSTIGDVYSYGI 224
            D+  ++GDFG++R +      T    V G     I ++ PE  +  + +T  DV+S+G+
Sbjct: 157 YDLVVKIGDFGMSRDV----YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 212

Query: 225 LLLEL 229
           +L E+
Sbjct: 213 VLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 59.1 bits (144), Expect = 8e-10
 Identities = 54/203 (26%), Positives = 80/203 (39%), Gaps = 71/203 (34%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMH--------NRSL------- 108
           + E K L+ ++H N+I  L    G          LV+EFM         ++S+       
Sbjct: 50  LREIKLLQELKHPNIIG-LLDVFGHK----SNINLVFEFMETDLEKVIKDKSIVLTPADI 104

Query: 109 KEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168
           K ++               L  LR     ++   +   LH D         LKP+N+L+ 
Sbjct: 105 KSYM---------------LMTLR----GLEYLHSNWILHRD---------LKPNNLLIA 136

Query: 169 DDMTARVGDFGLARFLP-PTRTQTSSIDVKGSIGYIAPE-------YGVGNEVSTIGDVY 220
            D   ++ DFGLAR    P R  T  +    +  Y APE       YGVG       D++
Sbjct: 137 SDGVLKLADFGLARSFGSPNRKMTHQV---VTRWYRAPELLFGARHYGVG------VDMW 187

Query: 221 SYGILLLELMIREKP-----SDI 238
           S G +  EL++R  P     SDI
Sbjct: 188 SVGCIFAELLLR-VPFLPGDSDI 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 49/232 (21%), Positives = 87/232 (37%), Gaps = 33/232 (14%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           K+ +   KA R I          A L   +Q  D+  LV E+++       +  +    E
Sbjct: 37  KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE 96

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
            + +              +V   +  LH        H  +KP N+L+D     ++ DFGL
Sbjct: 97  DWAK----------QYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGL 143

Query: 181 AR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP--- 235
           +R                 G+  Y+APE  +G     + D +S G ++ E +    P   
Sbjct: 144 SRNGLENK--------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195

Query: 236 --SDIMFE----GDMNLHKFAKMALSNHVKDIVDSILLND-DEKLVVRGDQK 280
              D +F+      +N  +  K   S    D+++ +L  D  ++L   G Q+
Sbjct: 196 ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 28/180 (15%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PIS--- 116
           F  E + + +++H N++ +L  C            +++E++ +  L E+L    P S   
Sbjct: 55  FRQEAELMSDLQHPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVG 109

Query: 117 --KEDETYKRPRNLNLLRRLNIAIDVASALNYL--HHDCQPVTAHCVLKPSNVLLDDDMT 172
               DET K    L+    L+IAI +A+ + YL  HH       H  L   N L+ + +T
Sbjct: 110 AESGDETVKSS--LDCSDFLHIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLT 162

Query: 173 ARVGDFGLARFLPPT---RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
            ++ DFGL+R +      R Q+ S+     + ++ PE  +  + +T  D++S+G++L E+
Sbjct: 163 VKISDFGLSRDIYSADYYRVQSKSLL---PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 42/181 (23%), Positives = 76/181 (41%), Gaps = 28/181 (15%)

Query: 63  FIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
           F++E   +++  H N++K++  C      Q      ++  FM +  L  +L         
Sbjct: 48  FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL- 106

Query: 122 YKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARV 175
              P  L L   L   +D+A  + YL      H D         L   N +L +DMT  V
Sbjct: 107 ---PEKLPLQTLLKFMVDIALGMEYLSNRNFIHRD---------LAARNCMLREDMTVCV 154

Query: 176 GDFGLARFLPP----TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
            DFGL++ +       + + + + VK    +IA E       ++  DV+++G+ + E+  
Sbjct: 155 ADFGLSKKIYSGDYYRQGRIAKMPVK----WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Query: 232 R 232
           R
Sbjct: 211 R 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 42/190 (22%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA-LVYEFMHNRSLKEWLYPISKEDETY 122
           I E   L+ + H N++K+L      D    + K  LV+EF+H + LK+++      D + 
Sbjct: 47  IREISLLKELNHPNIVKLL------DVIHTENKLYLVFEFLH-QDLKKFM------DASP 93

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVT---AHCV----LKPSNVLLDDDMTARV 175
                L L++            +YL    Q +    +H V    LKP N+L++ +   ++
Sbjct: 94  LSGIPLPLIK------------SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKL 141

Query: 176 GDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIRE 233
            DFGLAR F  P RT T  +    ++ Y APE  +G +  ST  D++S G +  E++ R 
Sbjct: 142 ADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Query: 234 KPSDIMFEGD 243
                +F GD
Sbjct: 199 A----LFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 22/185 (11%)

Query: 56  RQGA----FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
           R+GA     K F+ E   + N  H N++K+L  CL      N+ + ++ E M    L  +
Sbjct: 35  RKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQYIIMELMEGGDLLSY 89

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNV 165
           L     E      P  L L   L+I +DVA    YL      H D      +C++     
Sbjct: 90  LRDARVER---FGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDL--AARNCLVSEKG- 143

Query: 166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL 225
             D D   ++GDFGLAR +  +       +    + ++APE  +  + +T  DV+S+G+L
Sbjct: 144 -YDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVL 202

Query: 226 LLELM 230
           + E++
Sbjct: 203 MWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 29/181 (16%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E K L+ + H N+IK+L     V     D   LV+EFM        LY + K     +R 
Sbjct: 48  EIKLLKELNHPNIIKLLD----VFRHKGDL-YLVFEFMD-----TDLYKLIK---DRQRG 94

Query: 126 RNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR-F 183
              +L++  +    +   L + H H       H  LKP N+L++ +   ++ DFGLAR F
Sbjct: 95  LPESLIK--SYLYQLLQGLAFCHSHGI----LHRDLKPENLLINTEGVLKLADFGLARSF 148

Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEG 242
             P R  T  +  +    Y APE  +G++  +   D++S G +  EL+ R      +F G
Sbjct: 149 GSPVRPYTHYVVTR---WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR----PLFPG 201

Query: 243 D 243
            
Sbjct: 202 K 202

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 16/182 (8%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           L+++  ++  + E + L  +  R ++ +  A     +Q      LV   M+   L+  +Y
Sbjct: 31  LKKRKGYEGAMVEKRILAKVHSRFIVSLAYA-----FQTKTDLCLVMTIMNGGDLRYHIY 85

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
            + +E+  +  PR             + S L +LH   Q    +  LKP NVLLD+D   
Sbjct: 86  NVDEENPGFPEPRACFY------TAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNV 136

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE 233
           R+ D GLA  L   +++T      G+ G++APE   G E     D ++ G+ L E++   
Sbjct: 137 RISDLGLAVELKDGQSKTKG--YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Query: 234 KP 235
            P
Sbjct: 195 GP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 32/181 (17%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
             A K  + E   + ++ H +++++L  CL    Q      L+ + M    L +++    
Sbjct: 50  PKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQ------LITQLMPLGCLLDYV---- 99

Query: 117 KEDETYKRPR-NLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDD 169
                 +  + N+     LN  + +A  ++YL      H D         L   NVL+  
Sbjct: 100 ------RNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD---------LAARNVLVKT 144

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
               ++ DFGLA+ L     +  +   K  I ++A E  +    +   DV+SYG+ + EL
Sbjct: 145 PQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204

Query: 230 M 230
           M
Sbjct: 205 M 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 14/149 (9%)

Query: 86  LGVDYQGNDFKALV-YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL 144
           LGV   G     LV  E M    LK +L     E E         L + + +A ++A  +
Sbjct: 75  LGVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 145 NYLH--HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG--SI 200
            YL           H  L   N ++ +D+T ++GDFG+ R +    T       KG   +
Sbjct: 133 AYLAAKKFV-----HRDLAARNCMVAEDLTVKIGDFGMTRDI--YETDYYRKGGKGLLPV 185

Query: 201 GYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
            ++APE       +T  DV+S+G++L E+
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 42/180 (23%), Positives = 76/180 (42%), Gaps = 37/180 (20%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPI----SKED 119
           ++E   LR ++H N+++         Y         Y+ + +RS  + LY +       D
Sbjct: 47  VSEVNILRELKHPNIVR---------Y---------YDRIIDRS-NQTLYIVMEYCEGGD 87

Query: 120 --ETYKRPRNLNLLRRL------NIAIDVASALNYLHH--DCQPVTAHCVLKPSNVLLDD 169
             +  ++ +     + +       I   +  AL   H+  D      H  LKP+N+ LD 
Sbjct: 88  LAQLIQKCKKER--KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA 145

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +   ++GDFGLA+ L    +  +   V G+  Y++PE           D++S G L+ EL
Sbjct: 146 NNNVKLGDFGLAKIL-GHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 22/177 (12%)

Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            K  + E   L       ++    A       G+    +  E+M   SL          D
Sbjct: 43  QKQILRELDILHKCNSPYIVGFYGAFY---NNGDISICM--EYMDGGSL----------D 87

Query: 120 ETYKRPRNLNLLRRLN-IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           +  K  +     R L  IA+ V   L YLH   + +  H  +KPSN+L++     ++ DF
Sbjct: 88  KILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII--HRDVKPSNILVNSRGQIKLCDF 145

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           G++  L  +  +T      G+  Y+APE   GN+ S   D++S G+ L+EL     P
Sbjct: 146 GVSGQLVNSLAKTFV----GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 6e-09
 Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 40/183 (21%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           + A KS + E   L+N++H N++K + +      + +D   ++ E+  N SL++      
Sbjct: 40  EEALKSIMQEIDLLKNLKHPNIVKYIGS-----IETSDSLYIILEYAENGSLRQ------ 88

Query: 117 KEDETYKR----PRNLNLLRRLNIAIDVA---SALNYLHHDCQPVTAHCVLKPSNVLLDD 169
                 K+    P +L       +A+ V      L YLH   Q V  H  +K +N+L   
Sbjct: 89  ----IIKKFGPFPESL-------VAVYVYQVLQGLAYLHE--QGVI-HRDIKAANILTTK 134

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIG---YIAPEYGVGNEVSTIGDVYSYGILL 226
           D   ++ DFG+A     T+    S D    +G   ++APE    +  ST  D++S G  +
Sbjct: 135 DGVVKLADFGVA-----TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTV 189

Query: 227 LEL 229
           +EL
Sbjct: 190 IEL 192

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 16/151 (10%)

Query: 86  LGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALN 145
           L   Y+  D   LV   M+   LK  +Y +   +  ++  R +        A ++   L 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFY------AAEICCGLE 116

Query: 146 YLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAP 205
            LH   Q    +  LKP N+LLDD    R+ D GLA  +P  +T    +   G++GY+AP
Sbjct: 117 DLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAP 170

Query: 206 EYGVGNEVSTIG-DVYSYGILLLELMIREKP 235
           E  V NE  T   D ++ G LL E++  + P
Sbjct: 171 EV-VKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 44/178 (24%), Positives = 69/178 (38%), Gaps = 26/178 (14%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIK----VLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
                 F+ E   + ++ H NLI+    VLT  L           +V E     SL + L
Sbjct: 37  SDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPL----------MMVTELAPLGSLLDRL 86

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
               ++D       +  +    + A+ +A+ + YL         H  L   N+LL  D  
Sbjct: 87  ----RKD----ALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDK 135

Query: 173 ARVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
            ++GDFGL R LP           +K    + APE       S   DV+ +G+ L E+
Sbjct: 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 40/130 (30%), Positives = 68/130 (52%), Gaps = 12/130 (9%)

Query: 160 LKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG 217
           LK  N+LLD D   ++ DFG+ +   L   +T T      G+  YIAPE  +G + +T  
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC----GTPDYIAPEILLGQKYNTSV 177

Query: 218 DVYSYGILLLELMIREKP-----SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
           D +S+G+LL E++I + P      + +F+     +      L+   KDI+  + + + E+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237

Query: 273 -LVVRGDQKQ 281
            L V+GD +Q
Sbjct: 238 RLGVKGDIRQ 247

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 28/126 (22%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL--VYEFMHNRSLKEWLYPISKEDETYK 123
           E K LR++RH N+I +L           DF  +  V E M    L + +   S +  T  
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSP--EDFNDVYIVTELMET-DLHKVIK--SPQPLTDD 103

Query: 124 RPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGDF 178
             +     +LR           L YLH      +A+ +   LKPSN+L++ +   ++ DF
Sbjct: 104 HIQYFLYQILR----------GLKYLH------SANVIHRDLKPSNILVNSNCDLKICDF 147

Query: 179 GLARFL 184
           GLAR +
Sbjct: 148 GLARGV 153

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 56/220 (25%), Positives = 88/220 (40%), Gaps = 40/220 (18%)

Query: 44  ISAGTFGFSHLR-------------RQGAF--KSFIAECKALRNIRHRNLIKVLTACLGV 88
           + +G FG  HL               +GA   + FI E K +  + H  L+++   C   
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-- 69

Query: 89  DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRR--LNIAIDVASALNY 146
             Q      +V EFM N  L  +L           R R   L +   L++  DV   + Y
Sbjct: 70  --QQKPL-YIVTEFMENGCLLNYL-----------RQRQGKLSKDMLLSMCQDVCEGMEY 115

Query: 147 LHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE 206
           L    +    H  L   N L+      +V DFG+ R++      TSS   K  + +  PE
Sbjct: 116 LE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPE 171

Query: 207 YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL 246
               ++ S+  DV+S+G+L+ E+    K   + FE   N 
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGK---MPFEKKSNY 208

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 53/188 (28%), Positives = 76/188 (40%), Gaps = 29/188 (15%)

Query: 56  RQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMH---NRSLKEWL 112
                K    E K L  ++H NL+K      GV+         VY FM      +L+E L
Sbjct: 39  DPKTIKEIADEMKVLELLKHPNLVK----YYGVEVHREK----VYIFMEYCSGGTLEELL 90

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
                 DE   R   L LL            L YLH        H  +KP+N+ LD +  
Sbjct: 91  EHGRILDEHVIRVYTLQLLE----------GLAYLH---SHGIVHRDIKPANIFLDHNGV 137

Query: 173 ARVGDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGNEVSTIG---DVYSYGILLL 227
            ++GDFG A  L    T        + G+  Y+APE   G +    G   D++S G ++L
Sbjct: 138 IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197

Query: 228 ELMIREKP 235
           E+   ++P
Sbjct: 198 EMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 41/202 (20%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFMHNRSLKEWLYPISKED--ET 121
           E K LR+ +H N+I +          G DFK   +V + M +  L   ++  S +   E 
Sbjct: 54  ELKILRHFKHDNIIAIRDILRP---PGADFKDVYVVMDLMES-DLHHIIH--SDQPLTEE 107

Query: 122 YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
           + R     LLR           L Y+H        H  LKPSN+L+++D   R+GDFG+A
Sbjct: 108 HIRYFLYQLLR----------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154

Query: 182 RFLPPTRTQTSSIDVKG-------SIGYIAPEYG-VGNEVSTIGDVYSYGILLLELMIRE 233
           R L      +S  + K        +  Y APE      E +T  D++S G +  E++ R 
Sbjct: 155 RGL-----SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Query: 234 KPSDIMFEGDMNLHKFAKMALS 255
           +    +F G   +H+  K+ LS
Sbjct: 210 Q----LFPGKNYVHQL-KLILS 226

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 31/187 (16%)

Query: 53  HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
               +     F  E      + H N++ +L +  G           V+E++  R+L+E L
Sbjct: 15  APEEEHQRARFRRETALCARLYHPNIVALLDS--GE--APPGLLFAVFEYVPGRTLREVL 70

Query: 113 Y---PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL-- 167
                +   +          L+ ++  A+  A     +H D         LKP N+++  
Sbjct: 71  AADGALPAGE-------TGRLMLQVLDALACAHNQGIVHRD---------LKPQNIMVSQ 114

Query: 168 -DDDMTARVGDFGLARFLPPTR-----TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
                 A+V DFG+   LP  R     T T + +V G+  Y APE   G  V+   D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 222 YGILLLE 228
           +G++ LE
Sbjct: 175 WGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 43/151 (28%), Positives = 58/151 (38%), Gaps = 14/151 (9%)

Query: 85  CLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL 144
            L   ++  D   LV   M+   LK   Y I    E           R +  A  +   L
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDLK---YHIYNVGE-----PGFPEARAIFYAAQIICGL 108

Query: 145 NYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIA 204
            +LH   Q    +  LKP NVLLDD    R+ D GLA  L   +         G+ GY+A
Sbjct: 109 EHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMA 162

Query: 205 PEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           PE   G       D ++ G  L E++    P
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 38/188 (20%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           I E   L+ + H N++++L     V +  N    LV+EF+ +  LK+++      D +  
Sbjct: 46  IREISLLKELNHPNIVRLLD----VVHSENKL-YLVFEFL-DLDLKKYM------DSSPL 93

Query: 124 RPRNLNLLRRLNIAIDVASALNY------LHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
              +  L++     +     + Y      LH D         LKP N+L+D +   ++ D
Sbjct: 94  TGLDPPLIKSYLYQL--LQGIAYCHSHRVLHRD---------LKPQNLLIDREGALKLAD 142

Query: 178 FGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKP 235
           FGLAR F  P RT T  +    ++ Y APE  +G+ + ST  D++S G +  E M+  +P
Sbjct: 143 FGLARAFGVPVRTYTHEVV---TLWYRAPEILLGSRQYSTPVDIWSIGCIFAE-MVNRRP 198

Query: 236 SDIMFEGD 243
              +F GD
Sbjct: 199 ---LFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 20/180 (11%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP---- 114
           A K F  E + L N++H +++K    C        D   +V+E+M +  L ++L      
Sbjct: 50  ARKDFQREAELLTNLQHEHIVKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPD 104

Query: 115 --ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDD 169
             I  + +  +    L L + L+IA  +AS + YL       + H V   L   N L+  
Sbjct: 105 AMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL------ASQHFVHRDLATRNCLVGA 158

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           ++  ++GDFG++R +  T            I ++ PE  +  + +T  DV+S+G++L E+
Sbjct: 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 53.7 bits (130), Expect = 4e-08
 Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 50/225 (22%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L++IRH  L+ +  +     +Q +    LV E++    L   L    +  E   
Sbjct: 49  LNEKRILQSIRHPFLVNLYGS-----FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA 103

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGDFGL 180
           R            A  V  AL YLH          V   LKP N+LLD D   ++ DFG 
Sbjct: 104 R----------FYAAQVVLALEYLHS------LDIVYRDLKPENLLLDSDGYIKITDFGF 147

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEY----GVGNEVSTIGDVYSYGILLLELMI----- 231
           A+ +   RT T      G+  Y+APE     G G  V    D ++ GIL+ E++      
Sbjct: 148 AKRV-KGRTYTLC----GTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPPF 198

Query: 232 -REKPSDI---MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
             + P  I   + EG +    F     S   KD++ ++L  D  K
Sbjct: 199 FDDNPIQIYEKILEGKVRFPSF----FSPDAKDLIRNLLQVDLTK 239

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 53/198 (26%), Positives = 82/198 (41%), Gaps = 34/198 (17%)

Query: 53  HLRR--QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKE 110
            LRR   G     + E KAL+  +H  ++K+L         G+ F  LV E+M    L E
Sbjct: 34  ALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP----HGSGF-VLVMEYM-PSDLSE 87

Query: 111 WLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170
            L     E+      +  + +R L   +    A   +H D         LKP+N+L+  D
Sbjct: 88  VL---RDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD---------LKPANLLISAD 135

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE--YGV---GNEVSTIGDVYSYGIL 225
              ++ DFGLAR       +  S  V  +  Y APE  YG       V    D+++ G +
Sbjct: 136 GVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYDPGV----DLWAVGCI 190

Query: 226 LLELMIREKPSDIMFEGD 243
             E ++   P   +F G+
Sbjct: 191 FAE-LLNGSP---LFPGE 204

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 56/225 (24%)

Query: 17  GSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHR 76
           GS+   V  +K+ + ++V+   L++  I+AG             K F+ E   +  + H 
Sbjct: 9   GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK------------KEFLREASVMAQLDHP 56

Query: 77  NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNI 136
            +++++  C G      +   LV E      L ++L          K+ R + +     +
Sbjct: 57  CIVRLIGVCKG------EPLMLVMELAPLGPLLKYL----------KKRREIPVSDLKEL 100

Query: 137 AIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT--- 187
           A  VA  + YL      H D         L   NVLL +   A++ DFG++R L      
Sbjct: 101 AHQVAMGMAYLESKHFVHRD---------LAARNVLLVNRHQAKISDFGMSRALGAGSDY 151

Query: 188 -RTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLE 228
            R  T+    +  + + APE   YG   + S+  DV+SYG+ L E
Sbjct: 152 YRATTAG---RWPLKWYAPECINYG---KFSSKSDVWSYGVTLWE 190

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 32/195 (16%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           A   F+ E K +  +++ N+I++L  C+      +D   ++ E+M N  L ++L     E
Sbjct: 60  ARNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIE 114

Query: 119 DETYKRPRNLNLLRRLNI---AIDVAS------ALNYLHHDCQPVTAHCVLKPSNVLLDD 169
             T+    N+  +   N+   A+ +AS      +LN++H D         L   N L+ +
Sbjct: 115 -STFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRD---------LATRNCLVGN 164

Query: 170 DMTARVGDFGLARFLPPT---RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
             T ++ DFG++R L      R Q  ++     I ++A E  +  + +T  DV+++G+ L
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVL---PIRWMAWESILLGKFTTASDVWAFGVTL 221

Query: 227 LELMI--REKPSDIM 239
            E+    +E+P  ++
Sbjct: 222 WEMFTLCKEQPYSLL 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 40/128 (31%), Positives = 62/128 (48%), Gaps = 8/128 (6%)

Query: 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDV 219
           LK  NVLLD D   ++ DFG+ +       + S+    G+  YIAPE   G + +   D 
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--CGTPDYIAPEILKGQKYNESVDW 179

Query: 220 YSYGILLLELMIREKP-----SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK-L 273
           +S+G+LL E++I + P      D +F+  +N        +S   KD +  +   D  K L
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239

Query: 274 VVRGDQKQ 281
            V GD +Q
Sbjct: 240 GVDGDIRQ 247

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 44/185 (23%), Positives = 83/185 (44%), Gaps = 29/185 (15%)

Query: 60  FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PI 115
               ++E + ++ I +H+N+I +L  C     +G  +  +V E+  + +L+++L    P 
Sbjct: 59  LSDLVSEMEMMKMIGKHKNIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPP 113

Query: 116 SKEDETYKRPR----NLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNV 165
             E  +   PR     L     ++ A  VA  + +L      H D         L   NV
Sbjct: 114 G-EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD---------LAARNV 163

Query: 166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL 225
           L+ +D   ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+L
Sbjct: 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 223

Query: 226 LLELM 230
           L E+ 
Sbjct: 224 LWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 25/182 (13%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           I E   L+ ++H N++ +      V  Q +    L++EF+ +  LK++L  + K  +   
Sbjct: 47  IREISLLKELQHPNIVCLQD----VLMQESRL-YLIFEFL-SMDLKKYLDSLPK-GQYMD 99

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR- 182
                + L ++   I    +   LH D         LKP N+L+D+    ++ DFGLAR 
Sbjct: 100 AELVKSYLYQILQGILFCHSRRVLHRD---------LKPQNLLIDNKGVIKLADFGLARA 150

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFE 241
           F  P R  T  +    ++ Y APE  +G+   ST  D++S G +  E M  +KP   +F 
Sbjct: 151 FGIPVRVYTHEVV---TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAE-MATKKP---LFH 203

Query: 242 GD 243
           GD
Sbjct: 204 GD 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 43/176 (24%), Positives = 82/176 (46%), Gaps = 29/176 (16%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E   ++ ++H  L+++            +   ++ E+M   SL ++L    K DE
Sbjct: 46  QAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYIITEYMAKGSLLDFL----KSDE 96

Query: 121 TYKRPRNLNLLRRLNIAIDVASAL------NYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
             K    + L + ++ +  +A  +      NY+H D         L+ +NVL+ + +  +
Sbjct: 97  GGK----VLLPKLIDFSAQIAEGMAYIERKNYIHRD---------LRAANVLVSESLMCK 143

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 144 IADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 46/179 (25%), Positives = 81/179 (45%), Gaps = 22/179 (12%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
            HLR       F  E + L++++H N++K    C      G     LV E++   SL+++
Sbjct: 47  EHLR------DFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLRLVMEYLPYGSLRDY 97

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
           L    K  E     + L    ++   ++   +  Y+H D         L   N+L++ + 
Sbjct: 98  L---QKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRD---------LATRNILVESEN 145

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
             ++GDFGL + LP  +      +   S I + APE    ++ S   DV+S+G++L EL
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 38/147 (25%), Positives = 60/147 (40%), Gaps = 22/147 (14%)

Query: 137 AIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQ 190
           A ++   L +LH          +    LK  NVLLD +   ++ DFG+ +   L    T 
Sbjct: 102 AAEIVLGLQFLH-------ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154

Query: 191 TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI-----MFEGDMN 245
           T      G+  YIAPE           D ++ G+LL E++  + P +      +F+  + 
Sbjct: 155 TFC----GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210

Query: 246 LHKFAKMALSNHVKDIVDSILLNDDEK 272
                   LS   K I+ S L  + EK
Sbjct: 211 DEVRYPRWLSKEAKSILKSFLTKNPEK 237

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 48/189 (25%), Positives = 77/189 (40%), Gaps = 21/189 (11%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E   L+ + H N+IK L +     +  N+   +V E      L   +    K+     
Sbjct: 50  LKEIDLLKQLDHPNVIKYLAS-----FIENNELNIVLELADAGDLSRMIKHFKKQKRLIP 104

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
                         + + SAL ++H        H  +KP+NV +      ++GD GL RF
Sbjct: 105 ERTIWKYF------VQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF 155

Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
                T   S+   G+  Y++PE    N  +   D++S G LL E+   + P    F GD
Sbjct: 156 FSSKTTAAHSL--VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGD 209

Query: 244 -MNLHKFAK 251
            MNL+   K
Sbjct: 210 KMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 35/212 (16%)

Query: 36  RNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95
           R+ L ENL++       H   +GA  + I E   L+N++H N++  L   +  +      
Sbjct: 25  RSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIV-TLHDIIHTERC---- 77

Query: 96  KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI---DVASALNYLHHDCQ 152
             LV+E++ +  LK++L                NL+   N+ I    +   L+Y H    
Sbjct: 78  LTLVFEYLDS-DLKQYLDNCG------------NLMSMHNVKIFMFQLLRGLSYCHKR-- 122

Query: 153 PVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP-PTRTQTSSIDVKGSIGYIAPEYGVGN 211
               H  LKP N+L+++    ++ DFGLAR    PT+T ++ +    ++ Y  P+  +G+
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV---VTLWYRPPDVLLGS 178

Query: 212 -EVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
            E ST  D++  G +L E M   +P   MF G
Sbjct: 179 TEYSTPIDMWGVGCILYE-MATGRP---MFPG 206

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 11/175 (6%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PI 115
           A K F  E + L N++H +++K    C+    +G+    +V+E+M +  L ++L    P 
Sbjct: 50  ARKDFHREAELLTNLQHEHIVKFYGVCV----EGDPL-IMVFEYMKHGDLNKFLRAHGPD 104

Query: 116 SKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175
           +       RP  L   + L+IA  +A+ + YL         H  L   N L+ +++  ++
Sbjct: 105 AVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKI 161

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           GDFG++R +  T            I ++ PE  +  + +T  DV+S G++L E+ 
Sbjct: 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 22/154 (14%)

Query: 86  LGVDYQGNDFKALVYEFMHNRSLKEWLYPISK---EDETYKRPRNLNLLRRLNIAIDVAS 142
           L   Y+  D   LV   M+   LK  +Y +     E+E           R L  A ++  
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE-----------RALFYAAEILC 113

Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGY 202
            L  LH   +  T +  LKP N+LLDD    R+ D GLA  +P   +    +   G++GY
Sbjct: 114 GLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGY 167

Query: 203 IAPEYGVGNEVSTIG-DVYSYGILLLELMIREKP 235
           +APE  + N+  T+  D +  G L+ E++  + P
Sbjct: 168 MAPEV-LNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 10/101 (9%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL--PPTRTQTSSIDVK 197
           V   L YLH + Q    H  +K  N+LL +D + ++ DFG++  L     RT+       
Sbjct: 111 VLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167

Query: 198 GSIGYIAPEYGVGNEVSTIG---DVYSYGILLLELMIREKP 235
           G+  ++APE  V  +V       D++S+GI  +EL     P
Sbjct: 168 GTPCWMAPE--VMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 55/195 (28%), Positives = 83/195 (42%), Gaps = 54/195 (27%)

Query: 75  HRNLIKVLTACLGVDYQGNDFKA-------LVYEFM----HNRSLKEWLYPISKEDETYK 123
           H N++K+L          N  KA       LV+E+M    H       L  + K    Y+
Sbjct: 66  HPNIVKLL----------NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQ 115

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGDFGL 180
                 LL+          AL Y+H      + + +   LKPSN+LL+ D   ++ DFGL
Sbjct: 116 ------LLK----------ALKYIH------SGNVIHRDLKPSNILLNSDCRVKLADFGL 153

Query: 181 ARFLPPTRTQTSSIDVKGSIG---YIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPS 236
           AR L        +  +   +    Y APE  +G+   T G D++S G +L E M+  KP 
Sbjct: 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGE-MLLGKP- 211

Query: 237 DIMFEGDMNLHKFAK 251
             +F G   L++  K
Sbjct: 212 --LFPGTSTLNQLEK 224

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 50/193 (25%), Positives = 78/193 (40%), Gaps = 36/193 (18%)

Query: 98  LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTA 156
           LV E++    L   L  +   DE   R              ++  AL YLH +       
Sbjct: 70  LVMEYLPGGDLASLLENVGSLDEDVAR----------IYIAEIVLALEYLHSNGI----I 115

Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK------GSIGYIAPEYGVG 210
           H  LKP N+L+D +   ++ DFGL++     R    + D K      G+  YIAPE  +G
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 211 NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK-----------MALSNHVK 259
              S   D +S G +L E ++   P    F G+     F             + +S+   
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPP----FHGETPEEIFQNILNGKIEWPEDVEVSDEAI 231

Query: 260 DIVDSILLNDDEK 272
           D++  +L+ D EK
Sbjct: 232 DLISKLLVPDPEK 244

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 48/178 (26%), Positives = 87/178 (48%), Gaps = 30/178 (16%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           + ++F+AE   ++ ++H  L+K L A +       +   ++ EFM   SL ++L    K 
Sbjct: 44  SVEAFLAEANVMKTLQHDKLVK-LHAVVT-----KEPIYIITEFMAKGSLLDFL----KS 93

Query: 119 DETYKRPRNLNLLRRLNIAIDVASAL------NYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
           DE  K+P    L + ++ +  +A  +      NY+H D         L+ +N+L+   + 
Sbjct: 94  DEGSKQP----LPKLIDFSAQIAEGMAFIEQRNYIHRD---------LRAANILVSASLV 140

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL+E++
Sbjct: 141 CKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 49/184 (26%), Positives = 84/184 (45%), Gaps = 31/184 (16%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + LR++ H N++K    C  +     + + L+ EFM   SL+     I+ E       
Sbjct: 122 EIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADEQFL---- 170

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
                    ++A  + S + YLH   +    H  +KPSN+L++     ++ DFG++R L 
Sbjct: 171 --------ADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219

Query: 186 PTRTQ-TSSIDVKGSIGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 239
            T     SS+   G+I Y++PE        G      GD++S G+ +LE  +   P  + 
Sbjct: 220 QTMDPCNSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276

Query: 240 FEGD 243
            +GD
Sbjct: 277 RQGD 280

Length = 353

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 25/192 (13%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PISKEDE 120
           +A  K L    H N+++++  C            LV+E + ++ L+ +L    P     E
Sbjct: 50  VALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAE 108

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
           T K     +L+R+          L++LH +C     H  LKP N+L+      ++ DFGL
Sbjct: 109 TIK-----DLMRQF------LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR       Q +   V  ++ Y APE  + +  +T  D++S G +  E M R KP   +F
Sbjct: 155 ARIY---SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE-MFRRKP---LF 207

Query: 241 EGDMNLHKFAKM 252
            G+    +  K+
Sbjct: 208 CGNSEADQLGKI 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 21/177 (11%)

Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP-----IS 116
            ++E + ++ I +H+N+I +L AC     Q      LV E+    +L+E+L       + 
Sbjct: 64  LVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMD 118

Query: 117 KEDETYKRP-RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMT 172
              +T K P   L     ++ A  VA  + YL       +  C+   L   NVL+ +D  
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL------ASQKCIHRDLAARNVLVTEDNV 172

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
            ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+
Sbjct: 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 44/213 (20%), Positives = 92/213 (43%), Gaps = 38/213 (17%)

Query: 66  ECKALRNIRHRNLIKVL-------TACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           E   L+N+ H ++I++          C+ + +    + + +Y ++  RS           
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH----YSSDLYTYLTKRS----------- 151

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
                  R L + + L I   +   L YLH        H  +K  N+ ++D     +GD 
Sbjct: 152 -------RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDL 201

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238
           G A+F  P     + + + G++   APE    ++ ++  D++S GI+L E++    PS I
Sbjct: 202 GAAQF--PV-VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML--AYPSTI 256

Query: 239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDE 271
             +      ++ K    +H+  I+ ++ ++ +E
Sbjct: 257 FEDPPSTPEEYVKSC-HSHLLKIISTLKVHPEE 288

Length = 357

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 43/181 (23%), Positives = 81/181 (44%), Gaps = 19/181 (10%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY--- 113
           + A + F  E + L  ++H+++++    C            +V+E+M +  L  +L    
Sbjct: 48  ESARQDFQREAELLTVLQHQHIVRFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHG 102

Query: 114 PISK--EDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLD 168
           P +K         P  L L + L IA  +AS + YL       + H V   L   N L+ 
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL------ASLHFVHRDLATRNCLVG 156

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
             +  ++GDFG++R +  T            I ++ PE  +  + +T  D++S+G++L E
Sbjct: 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE 216

Query: 229 L 229
           +
Sbjct: 217 I 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 8/115 (6%)

Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSID 195
           A ++  ALN+LH   +    +  LK  NVLLD D   ++ D+G+ +  L P  T ++   
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC- 157

Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG-DMNLHKF 249
             G+  YIAPE   G E     D ++ G+L+ E+M    P DI+ +  DMN   +
Sbjct: 158 --GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 20/179 (11%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGN-DFKALVYEFMHNRSLKEWLYPISKED 119
           + F+ E   ++   H N+IK++   L    +G      ++  FM +  L  +L      +
Sbjct: 46  EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE 105

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTA 173
           E    P  L L   +   ID+AS + YL      H D         L   N +L+++MT 
Sbjct: 106 E----PFTLPLQTLVRFMIDIASGMEYLSSKNFIHRD---------LAARNCMLNENMTV 152

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
            V DFGL++ +            K  + ++A E    N  +T  DV+++G+ + E+M R
Sbjct: 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 43/140 (30%), Positives = 56/140 (40%), Gaps = 35/140 (25%)

Query: 101 EFMHNRSLKEWLYPISKEDETYKRPRNLN-------LLRRLNIAIDVASALNYLHHDCQP 153
           E+    SL          D  YK+ +          L +   IA  V   L+YLH     
Sbjct: 81  EYCEGGSL----------DSIYKKVKKRGGRIGEKVLGK---IAESVLKGLSYLH---SR 124

Query: 154 VTAHCVLKPSNVLLDDDMTARVGDFG----LARFLPPTRTQTSSIDVKGSIGYIAPEYGV 209
              H  +KPSN+LL      ++ DFG    L   L  T T TS         Y+APE   
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF--------YMAPERIQ 176

Query: 210 GNEVSTIGDVYSYGILLLEL 229
           G   S   DV+S G+ LLE+
Sbjct: 177 GKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 32/187 (17%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKE--------WL 112
             F  E   +    H N++K+L  C      G     L++E+M    L E          
Sbjct: 53  ADFQREAALMAEFDHPNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQ 107

Query: 113 YPISKEDETYK----RPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKP 162
             +S    + +     P  L+   +L IA  VA+ + YL      H D         L  
Sbjct: 108 CSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRD---------LAT 158

Query: 163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSY 222
            N L+ ++M  ++ DFGL+R +       +S +    I ++ PE    N  +T  DV++Y
Sbjct: 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218

Query: 223 GILLLEL 229
           G++L E+
Sbjct: 219 GVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 36/115 (31%), Positives = 55/115 (47%), Gaps = 10/115 (8%)

Query: 138 IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK 197
           + + SAL ++H        H  +KP+NV +      ++GD GL RF     T   S+   
Sbjct: 113 VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--V 167

Query: 198 GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MNLHKFAK 251
           G+  Y++PE    N  +   D++S G LL E+   + P    F GD MNL+   K
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 20/204 (9%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+N++H  +++    CL    + ++  ++  E+M   S+K+ L       ET  R 
Sbjct: 54  EIQLLKNLQHERIVQYY-GCL----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK 108

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
               +L            + YLH +   +  H  +K +N+L D     ++GDFG ++ L 
Sbjct: 109 YTRQILE----------GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155

Query: 186 PTRTQTSSI-DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM 244
              +  + +  V G+  +++PE   G       DV+S G  ++E M+ EKP    FE   
Sbjct: 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVE-MLTEKPPWAEFEAMA 214

Query: 245 NLHKFAKMALSNHVKDIVDSILLN 268
            + K A    +  +   V     N
Sbjct: 215 AIFKIATQPTNPQLPSHVSPDARN 238

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 43/195 (22%), Positives = 81/195 (41%), Gaps = 43/195 (22%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           +  I E   +++ +H N++    +     Y   D   +V E+M   SL + +        
Sbjct: 60  ELIINEILIMKDCKHPNIVDYYDS-----YLVGDELWVVMEYMDGGSLTDIITQNFV--- 111

Query: 121 TYKRPRNLNLLRRLN------IAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDM 171
                       R+N      +  +V   L YLH      + + +   +K  N+LL  D 
Sbjct: 112 ------------RMNEPQIAYVCREVLQGLEYLH------SQNVIHRDIKSDNILLSKDG 153

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM- 230
           + ++ DFG A  L   +++ +S  V G+  ++APE     +     D++S GI+ +E+  
Sbjct: 154 SVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE 211

Query: 231 -----IREKPSDIMF 240
                +RE P   +F
Sbjct: 212 GEPPYLREPPLRALF 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 38/174 (21%)

Query: 66  ECKALRNIRHRNLIKVLTACL--GVDYQGNDFKALVYEFMHNRSLKEWL--YPISKEDET 121
           E K LR +RH N++ +  A    G  Y       LV+E++  R+L E L   P     + 
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLY-------LVFEYVE-RTLLELLEASPGGLPPDA 101

Query: 122 YKRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
            +                +  A+ Y H H+      H  +KP N+L+ +    ++ DFG 
Sbjct: 102 VRS-----------YIWQLLQAIAYCHSHNI----IHRDIKPENILVSESGVLKLCDFGF 146

Query: 181 ARFL--PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG---DVYSYGILLLEL 229
           AR L   P    T  +  +    Y APE  VG+  +  G   DV++ G ++ EL
Sbjct: 147 ARALRARPASPLTDYVATR---WYRAPELLVGD--TNYGKPVDVWAIGCIMAEL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 41/120 (34%), Positives = 64/120 (53%), Gaps = 15/120 (12%)

Query: 116 SKEDETYKRPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCVLKPSNVLLDDDMTAR 174
           SK++E  +    L+L   L  +  VA  +++L   +C     H  +   NVLL D   A+
Sbjct: 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAK 252

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGS----IGYIAPEYGVGNEVSTI-GDVYSYGILLLEL 229
           + DFGLAR +       S+  VKG+    + ++APE  + + V T+  DV+SYGILL E+
Sbjct: 253 ICDFGLARDI----MNDSNYVVKGNARLPVKWMAPE-SIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 37/120 (30%), Positives = 55/120 (45%), Gaps = 28/120 (23%)

Query: 128 LNLLRR-----------LNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTA 173
           LN LRR           L+ +  VA  + +L       + +C+   L   NVLL      
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFL------ASKNCIHRDLAARNVLLTHGKIV 180

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGS----IGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           ++ DFGLAR +       S+  VKG+    + ++APE       +   DV+SYGILL E+
Sbjct: 181 KICDFGLARDI----MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 26/211 (12%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+N++H  +++    CL    +      +  E+M   S+K+ L       E+  R 
Sbjct: 54  EIQLLKNLQHERIVQYY-GCL--RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK 110

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
               +L            ++YLH +   +  H  +K +N+L D     ++GDFG ++ L 
Sbjct: 111 YTRQILE----------GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157

Query: 186 PTRTQTSSI-DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM 244
                 + I  V G+  +++PE   G       DV+S G  ++E M+ EKP    +E   
Sbjct: 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVE-MLTEKPPWAEYEAMA 216

Query: 245 NLHKFAKMA--------LSNHVKDIVDSILL 267
            + K A           +S H +D +  I +
Sbjct: 217 AIFKIATQPTNPQLPSHISEHARDFLGCIFV 247

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 35/193 (18%)

Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
            A + F+ E K L  +   N+ ++L  C       +    ++ E+M N  L ++L     
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCT-----VDPPLCMIMEYMENGDLNQFLQ--KH 113

Query: 118 EDETYKRPRNLNLLRR---LNIAIDVAS------ALNYLHHDCQPVTAHCVLKPSNVLLD 168
             ET     N   L     L +A  +AS      +LN++H D         L   N L+ 
Sbjct: 114 VAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD---------LATRNCLVG 164

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGS----IGYIAPEYGVGNEVSTIGDVYSYGI 224
            + T ++ DFG++R L      +    V+G     I ++A E  +  + +T  DV+++G+
Sbjct: 165 KNYTIKIADFGMSRNL----YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220

Query: 225 LLLELMI--REKP 235
            L E++   RE+P
Sbjct: 221 TLWEILTLCREQP 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 35/162 (21%)

Query: 98  LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH 157
           LV+E++ +  LK+++      D   + P            +   +  ++++   + V AH
Sbjct: 83  LVFEYL-DSDLKKFM------DSNGRGPGR---------PLPAKTIKSFMYQLLKGV-AH 125

Query: 158 CV--------LKPSNVLLDDD-MTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEY 207
           C         LKP N+L+D      ++ D GL R F  P ++ T  I    ++ Y APE 
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI---VTLWYRAPEV 182

Query: 208 GVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK 248
            +G    ST  D++S G +  E M R++P   +F GD  L +
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAE-MSRKQP---LFPGDSELQQ 220

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 21/177 (11%)

Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PISKE 118
            I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P   E
Sbjct: 70  LISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGME 124

Query: 119 ---DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMT 172
              + T      L+    ++ A  VA  + YL       +  C+   L   NVL+ +D  
Sbjct: 125 YCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTEDNV 178

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
            ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+
Sbjct: 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 49/183 (26%), Positives = 88/183 (48%), Gaps = 30/183 (16%)

Query: 61  KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY-------EFMHNRSLKEWL 112
           + F  E + L  +  H N+I +L AC   + +G  + A+ Y       +F+    + E  
Sbjct: 47  RDFAGELEVLCKLGHHPNIINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETD 103

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
              +KE  T     +  LL+    A DVA+ + YL  + Q +  H  L   NVL+ +++ 
Sbjct: 104 PAFAKEHGTASTLTSQQLLQ---FASDVATGMQYLS-EKQFI--HRDLAARNVLVGENLA 157

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIG-----YIAPEYGVGNEVSTIGDVYSYGILLL 227
           +++ DFGL+R           + VK ++G     ++A E    +  +T  DV+S+G+LL 
Sbjct: 158 SKIADFGLSR--------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209

Query: 228 ELM 230
           E++
Sbjct: 210 EIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 31/126 (24%)

Query: 130 LLRRLN----------IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           LL+R+           + + +  AL+YL      +  H  +KPSN+LLD     ++ DFG
Sbjct: 103 LLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI--HRDVKPSNILLDASGNVKLCDFG 160

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE----------YGVGNEVSTIGDVYSYGILLLEL 229
           ++  L  ++ +T S    G   Y+APE          Y +        DV+S GI L+EL
Sbjct: 161 ISGRLVDSKAKTRS---AGCAAYMAPERIDPPDPNPKYDIR------ADVWSLGISLVEL 211

Query: 230 MIREKP 235
              + P
Sbjct: 212 ATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 24/176 (13%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E +  R+++H NL++ L  C  V         LV EF     LK +L    K +   
Sbjct: 42  FLEEAQPYRSLQHSNLLQCLGQCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMT 96

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
             P  L       +A ++A  L +LH +      H  L   N LL  D+T ++GD+GL+ 
Sbjct: 97  PDPTTLQ-----RMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSH 148

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV---------STIGDVYSYGILLLEL 229
                    +   +   + +IAPE  + +EV         +   +V+S G+ + EL
Sbjct: 149 NKYKEDYYVTPDQLWVPLRWIAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 45/213 (21%)

Query: 35  SRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94
           +R++    +++     +S  +    ++  I E + L+ +RH N I         +Y+G  
Sbjct: 34  ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI---------EYKG-- 82

Query: 95  FKALVYEFMHNRSLKEWL---YPI-SKED--ETYKRPRNLNLLRRLNIAI---DVASALN 145
                    + R    WL   Y + S  D  E +K+P     L+ + IA         L 
Sbjct: 83  --------CYLREHTAWLVMEYCLGSASDILEVHKKP-----LQEVEIAAICHGALQGLA 129

Query: 146 YLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAP 205
           YLH        H  +K  N+LL +  T ++ DFG A  + P  +        G+  ++AP
Sbjct: 130 YLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAP 180

Query: 206 EYGVG-NEVSTIG--DVYSYGILLLELMIREKP 235
           E  +  +E    G  DV+S GI  +EL  R+ P
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 30/77 (38%), Positives = 42/77 (54%), Gaps = 5/77 (6%)

Query: 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-D 218
           LKP N+LLDD    R+ D GLA  +P   T    +   G++GY+APE  V NE  T   D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---GTVGYMAPEV-VKNERYTFSPD 183

Query: 219 VYSYGILLLELMIREKP 235
            +  G L+ E++  + P
Sbjct: 184 WWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 41/174 (23%), Positives = 81/174 (46%), Gaps = 9/174 (5%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 56  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 110

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                 +L + + +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 111 PVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 51/192 (26%), Positives = 77/192 (40%), Gaps = 36/192 (18%)

Query: 134 LNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
           LN  + +A  ++YL  + + V  H  L   NVL+      ++ DFGLAR L    T+  +
Sbjct: 112 LNWCVQIAKGMSYLE-EVRLV--HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 168

Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKPSDIMFEGDMNLHKFAKM 252
              K  I ++A E  +    +   DV+SYG+ + ELM    KP D               
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD--------------- 213

Query: 253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM 312
                 ++I D  LL   E+L         Q  I     C I +  I V C M   + R 
Sbjct: 214 --GIPAREIPD--LLEKGERL--------PQPPI-----CTIDVYMIMVKCWMIDSECRP 256

Query: 313 KMTNVVHELQSI 324
           +   +V E   +
Sbjct: 257 RFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 33/187 (17%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK---EDE 120
           IA  K L +  H N++++L  C G          LV+E +  + L  +L    K     E
Sbjct: 49  IALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPE 107

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVG 176
           T K     +L+R+L         +++LH       +H +    LKP N+L+  D   ++ 
Sbjct: 108 TIK-----DLMRQL------LRGVDFLH-------SHRIVHRDLKPQNILVTSDGQVKIA 149

Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236
           DFGLAR        TS   V  ++ Y APE  + +  +T  D++S G +  EL  R +P 
Sbjct: 150 DFGLARIYSFEMALTS---VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRR-RP- 204

Query: 237 DIMFEGD 243
             +F G 
Sbjct: 205 --LFRGT 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 24/185 (12%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
           R++   K+  +E + L+++ H N++      LG +    ++ ++  E++   S+   L  
Sbjct: 47  RQKDMVKALRSEIETLKDLDHLNIV----QYLGFE-TTEEYLSIFLEYVPGGSIGSCLRT 101

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
             + +E   R        +      V   L YLH        H  LK  N+L+D D   +
Sbjct: 102 YGRFEEQLVR----FFTEQ------VLEGLAYLHSKG---ILHRDLKADNLLVDADGICK 148

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE----YGVGNEVSTIGDVYSYGILLLELM 230
           + DFG+++          ++ ++GS+ ++APE    Y  G   S   D++S G ++LE+ 
Sbjct: 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMF 206

Query: 231 IREKP 235
              +P
Sbjct: 207 AGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 45/176 (25%), Positives = 78/176 (44%), Gaps = 19/176 (10%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   + ++ H +L+++L  CL    Q      LV + M +  L ++++         
Sbjct: 56  FMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVH--------- 100

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +   N+     LN  + +A  + YL    +    H  L   NVL+      ++ DFGLAR
Sbjct: 101 EHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKPSD 237
            L     + ++   K  I ++A E     + +   DV+SYG+ + ELM    KP D
Sbjct: 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 47.5 bits (114), Expect = 5e-06
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 62/209 (29%)

Query: 64  IAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           I E K L+ +RH N+++   ++T+      +G+ +  +V+E+M                 
Sbjct: 46  IREIKLLQKLRHPNIVRLKEIVTSKG----KGSIY--MVFEYM----------------- 82

Query: 121 TYKRPRNLN-LLRRLNIAIDVA----------SALNYLHHDCQPVTAHCVLKPSNVLLDD 169
                 +L  LL    +    +            L YLH     +  H  +K SN+L+++
Sbjct: 83  ----DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-NGIL--HRDIKGSNILINN 135

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-------YGVGNEVSTIGDVYSY 222
           D   ++ DFGLAR      +   +  V  ++ Y  PE       Y  G EV    D++S 
Sbjct: 136 DGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRY--GPEV----DMWSV 188

Query: 223 GILLLELMIREKPSDIMFEGDMNLHKFAK 251
           G +L EL +  KP   +F+G   L +  K
Sbjct: 189 GCILAELFLG-KP---IFQGSTELEQLEK 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 5/77 (6%)

Query: 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-D 218
           LKP N+LLDD    R+ D GLA  +P   T    +   G++GY+APE  + NE  T   D
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEV-INNEKYTFSPD 183

Query: 219 VYSYGILLLELMIREKP 235
            +  G L+ E++  + P
Sbjct: 184 WWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 5/110 (4%)

Query: 121 TY--KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           TY   R R L L +   +A  + SA++Y+H   + +  H  +K  NVL++      +GDF
Sbjct: 248 TYLGARLRPLGLAQVTAVARQLLSAIDYIH--GEGII-HRDIKTENVLVNGPEDICLGDF 304

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
           G A F   + +      + G++   APE   G+  +   D++S G+++ E
Sbjct: 305 GAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 25/179 (13%)

Query: 63  FIAECKALRNIRHRNLIKVLTA-------CLGVDY--QGNDFKALVYEFMHNRSLKEWLY 113
           F  E   +  + H N++ +L         C+  +Y  QG+     ++EF+  RS    + 
Sbjct: 54  FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD-----LHEFLIMRSPHSDVG 108

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
             S ED T K   +L+    L+IAI +A+ + YL         H  L   N+L+ + +  
Sbjct: 109 CSSDEDGTVKS--SLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHV 163

Query: 174 RVGDFGLARFLPPT---RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           ++ D GL+R +      R Q  S+     I ++ PE  +  + S+  D++S+G++L E+
Sbjct: 164 KISDLGLSREIYSADYYRVQPKSLL---PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 8/100 (8%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSI 194
           + + +   L YLH +      H  LK SN+LL D    ++ DFGLAR +  P +  T  +
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 195 DVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIRE 233
               ++ Y APE  +G    T   D+++ G +L EL+  +
Sbjct: 170 ---VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 36/195 (18%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA------LVYEFM-HNRS--LKEWLYP 114
           I E K LR + HRN++  L   +       DFK       LV+E+M H+    L+  L  
Sbjct: 54  IREIKILRQLNHRNIVN-LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH 112

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
            S++          + +++L   ++     N+LH D         +K SN+LL++    +
Sbjct: 113 FSED-------HIKSFMKQLLEGLNYCHKKNFLHRD---------IKCSNILLNNKGQIK 156

Query: 175 VGDFGLARFL--PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMI 231
           + DFGLAR      +R  T+ +    ++ Y  PE  +G E      DV+S G +L EL  
Sbjct: 157 LADFGLARLYNSEESRPYTNKVI---TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Query: 232 REKPSDIMFEGDMNL 246
           + KP   +F+ +  L
Sbjct: 214 K-KP---IFQANQEL 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 46.6 bits (110), Expect = 7e-06
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 23/185 (12%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E   L+ + H N+IK L +     +  ++   +V E      L + +       + +K
Sbjct: 50  VKEIDLLKQLNHPNVIKYLDS-----FIEDNELNIVLELADAGDLSQMI-------KYFK 97

Query: 124 RPRNLNLLRRL-NIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           + + L   R +    + + SA+ ++H        H  +KP+NV +      ++GD GL R
Sbjct: 98  KQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR 154

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           F     T   S+   G+  Y++PE    N  +   D++S G LL E+   + P    F G
Sbjct: 155 FFSSKTTAAHSL--VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYG 208

Query: 243 D-MNL 246
           D MNL
Sbjct: 209 DKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 46.8 bits (112), Expect = 8e-06
 Identities = 48/202 (23%), Positives = 78/202 (38%), Gaps = 44/202 (21%)

Query: 98  LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH 157
            V E+  N  L +++      DE   R            A ++  AL YLH        H
Sbjct: 79  FVLEYAPNGELLQYIRKYGSLDEKCTR----------FYAAEILLALEYLH---SKGIIH 125

Query: 158 CVLKPSNVLLDDDMTARVGDFGLARFLPP------TRTQTSSIDVKGSIG---------- 201
             LKP N+LLD DM  ++ DFG A+ L P       +   ++ID +              
Sbjct: 126 RDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGT 185

Query: 202 --YIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK-MALS--- 255
             Y++PE           D+++ G ++ + M+  KP    F G      F K + L    
Sbjct: 186 AEYVSPELLNEKPAGKSSDLWALGCIIYQ-MLTGKP---PFRGSNEYLTFQKILKLEYSF 241

Query: 256 -----NHVKDIVDSILLNDDEK 272
                   KD+++ +L+ D + 
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQD 263

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 30/183 (16%)

Query: 61  KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           + F  E + L  +  H N+I +L AC   +++G  +  L  E+  + +L ++L   S+  
Sbjct: 52  RDFAGELEVLCKLGHHPNIINLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRK-SRVL 105

Query: 120 ET-------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
           ET             L+  + L+ A DVA  ++YL    Q    H  L   N+L+ ++  
Sbjct: 106 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV 162

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIG-----YIAPEYGVGNEVSTIGDVYSYGILLL 227
           A++ DFGL+R           + VK ++G     ++A E    +  +T  DV+SYG+LL 
Sbjct: 163 AKIADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214

Query: 228 ELM 230
           E++
Sbjct: 215 EIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 29/146 (19%)

Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           A ++  AL YLH        +  LKP N+LLD +   ++ DFG A+ L   RT T    +
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT----L 158

Query: 197 KGSIGYIAPEY----GVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
            G+  Y+APE     G    V    D ++ GIL+ E+++   P    F  D     + K+
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP----FFDDNPFGIYEKI 210

Query: 253 ---------ALSNHVKDIVDSILLND 269
                     L  + KD++  +L+ D
Sbjct: 211 LAGKLEFPRHLDLYAKDLIKKLLVVD 236

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 39/138 (28%), Positives = 66/138 (47%), Gaps = 20/138 (14%)

Query: 147 LHHDCQPVTAHCVLKPSNVLLDD-DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAP 205
           LHH    +  H  LK  N+LLD   M  ++GDFG+++ L    +++ +  V G+  YI+P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISP 170

Query: 206 EYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL---------HKFAKMA--L 254
           E   G   +   D+++ G +L EL   ++     FE   NL           FA ++   
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRA----FEAA-NLPALVLKIMSGTFAPISDRY 225

Query: 255 SNHVKDIVDSILLNDDEK 272
           S  ++ ++ S+L  D  K
Sbjct: 226 SPDLRQLILSMLNLDPSK 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 11/107 (10%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           IA+ +  AL YLH     +  H  +KPSNVL++ +   ++ DFG++ +L  +  +T  ID
Sbjct: 108 IAVSIVKALEYLHSKLSVI--HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT--ID 163

Query: 196 VKGSIGYIAPEYGVGNEVSTIG-----DVYSYGILLLELMIREKPSD 237
             G   Y+APE  +  E++  G     DV+S GI ++EL     P D
Sbjct: 164 A-GCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 35/100 (35%), Positives = 47/100 (47%), Gaps = 24/100 (24%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL-PPTRTQTS 192
           V  A  YLH+      D         LKP N+LLD +   ++ DFG A+ L    +T T 
Sbjct: 102 VVLAFEYLHNRGIIYRD---------LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT- 151

Query: 193 SIDVKGSIGYIAPE--YGVGNEVSTIGDVYSYGILLLELM 230
                G+  Y+APE     G + S   D +S GILL EL+
Sbjct: 152 ---FCGTPEYVAPEIILNKGYDFSV--DYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 9/105 (8%)

Query: 128 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGDFGLARFL 184
           L  L  L+    VA  + +L       + +CV   L   NVLL      ++ DFGLAR +
Sbjct: 234 LTTLDLLSFTYQVARGMEFL------ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287

Query: 185 PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
                  S       + ++APE    N  +T+ DV+SYGILL E+
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 64/262 (24%), Positives = 105/262 (40%), Gaps = 59/262 (22%)

Query: 43  LISAGTFGFSHLRRQGAFKSFIA--------------------ECKALRNIRHRNLIKVL 82
           L+  GTFG   L R+ A   + A                    E + L+N RH  L    
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS-- 59

Query: 83  TACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVAS 142
              L   +Q  D    V E+++     E  + +S+E       R  +  R      ++ S
Sbjct: 60  ---LKYSFQTKDRLCFVMEYVNG---GELFFHLSRE-------RVFSEDRTRFYGAEIVS 106

Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK---GS 199
           AL+YLH        +  LK  N++LD D   ++ DFGL +        T +  +K   G+
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-----EGITDAATMKTFCGT 158

Query: 200 IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI---------REKPSDIMFEGDMNLHKFA 250
             Y+APE    N+     D +  G+++ E+M           EK  +++   D+   KF 
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI---KFP 215

Query: 251 KMALSNHVKDIVDSILLNDDEK 272
           +  LS   K ++  +L+ D  K
Sbjct: 216 R-TLSADAKSLLSGLLIKDPNK 236

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 26/179 (14%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   +++  H N++ +L  CL    +G+    +V  +M +  L+ +   I  E    
Sbjct: 43  FLKEGIIMKDFSHPNVLSLLGICL--PSEGSPL--VVLPYMKHGDLRNF---IRSET--- 92

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
               N  +   +   + VA  + YL         H  L   N +LD+  T +V DFGLAR
Sbjct: 93  ---HNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Query: 183 ------FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
                 +        + + VK    ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 147 DIYDKEYYSVHNHTGAKLPVK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 25/170 (14%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E + L+   H N++K++  C  V  Q      +V E +   SL  +L          
Sbjct: 39  FLQEAEILKQYDHPNIVKLIGVC--VQKQP---IYIVMELVPGGSLLTFL---------- 83

Query: 123 KRPRN-LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
           ++ +N L + + L +++D A+ + YL         H  L   N L+ ++   ++ DFG++
Sbjct: 84  RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMS 140

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLE 228
           R         S    +  I + APE   YG     ++  DV+SYGILL E
Sbjct: 141 REEEGGIYTVSDGLKQIPIKWTAPEALNYG---RYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 58/200 (29%), Positives = 86/200 (43%), Gaps = 53/200 (26%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET---- 121
           E K LR++ H N+I +         +  +   +VYE M        L+ I +  +T    
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDD 108

Query: 122 ------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175
                 Y+      LLR L     + SA N LH D         LKPSN+LL+ +   ++
Sbjct: 109 HCQYFLYQ------LLRGLKY---IHSA-NVLHRD---------LKPSNLLLNANCDLKI 149

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVG-NEVSTIGDVYSYGILLLE 228
            DFGLAR        T+S        Y+      APE  +  +E +T  DV+S G +  E
Sbjct: 150 CDFGLAR--------TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201

Query: 229 LMIREKPSDIMFEGDMNLHK 248
           L+ R KP   +F G   +H+
Sbjct: 202 LLGR-KP---LFPGKDYVHQ 217

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 5/105 (4%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           +++ ALNYLH   +    +  LK  NVLLD +   ++ D+G+ +     R   ++    G
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCG 158

Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
           +  YIAPE   G +     D ++ G+L+ E+M    P DI+   D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 45/191 (23%), Positives = 88/191 (46%), Gaps = 25/191 (13%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   ++ ++H N++++            +   LV+E+M    LK+++    
Sbjct: 39  EGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLMLVFEYMDK-DLKKYM---- 88

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
              +T+     L+     +    +   + + H   +    H  LKP N+L++     ++ 
Sbjct: 89  ---DTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLA 142

Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREK 234
           DFGLAR F  P  T ++ +    ++ Y AP+  +G+   ST  D++S G ++ E MI  +
Sbjct: 143 DFGLARAFGIPVNTFSNEV---VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAE-MITGR 198

Query: 235 PSDIMFEGDMN 245
           P   +F G  N
Sbjct: 199 P---LFPGTNN 206

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 48/199 (24%), Positives = 94/199 (47%), Gaps = 37/199 (18%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           + A   F+ E K L  ++  N+I++L  C+       D   ++ E+M N  L ++L    
Sbjct: 60  KNARNDFLKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLSSHH 114

Query: 117 KEDET----YKRPRNLNLL-----RRLNIAIDVAS------ALNYLHHDCQPVTAHCVLK 161
            +D+        P    L        L++A+ +AS      +LN++H D         L 
Sbjct: 115 LDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD---------LA 165

Query: 162 PSNVLLDDDMTARVGDFGLARFLPPT---RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGD 218
             N L+ +++T ++ DFG++R L      R Q  ++     I ++A E  +  + +T  D
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL---PIRWMAWECILMGKFTTASD 222

Query: 219 VYSYGILLLELMI--REKP 235
           V+++G+ L E+++  +E+P
Sbjct: 223 VWAFGVTLWEILMLCKEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 13/118 (11%)

Query: 128 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLP 185
            +L R    A ++   L +LH        +  LK  NV+LD D   ++ DFG+ +     
Sbjct: 93  FDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149

Query: 186 PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
             R  T      G+  YIAPE   G + +   D +S+G+LL E++I + P    F GD
Sbjct: 150 DNRASTFC----GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 39/175 (22%), Positives = 79/175 (45%), Gaps = 12/175 (6%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           + F++E   ++   H N+++++  CL  V+ +G     ++  FM +  L  +L      D
Sbjct: 45  EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104

Query: 120 ETYKRPRNLNLLRRLNIA--IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
                P  + +    +IA  ++  S+ +++H D         L   N +L+++M   V D
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRD---------LAARNCMLNENMNVCVAD 155

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           FGL++ +            K  + +IA E       +T  DV+S+G+ + E+  R
Sbjct: 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 25/168 (14%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+ ++H NL+ ++       ++      LV+E+  +  L          +E  K P
Sbjct: 50  EIRMLKQLKHPNLVNLIEV-----FRRKRKLHLVFEYCDHTVL----------NELEKNP 94

Query: 126 RNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184
           R +       I      A+N+ H H+C     H  +KP N+L+      ++ DFG AR L
Sbjct: 95  RGVPEHLIKKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL 150

Query: 185 -PPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELM 230
             P    T   D   +  Y APE  VG+ +     DV++ G +  EL+
Sbjct: 151 TGPGDDYT---DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 18/134 (13%)

Query: 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVT 155
           F+ ++SL + +    + DE YK P  L  L  ++ +  VA  + +L      H D     
Sbjct: 147 FIEDKSLSD-VEEDEEGDELYKEPLTLEDL--ISYSFQVARGMEFLASRKCIHRD----- 198

Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST 215
               L   N+LL ++   ++ DFGLAR +          D +  + ++APE       +T
Sbjct: 199 ----LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 216 IGDVYSYGILLLEL 229
             DV+S+G+LL E+
Sbjct: 255 QSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 19/106 (17%)

Query: 136 IAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT 189
           IA+ V   L YL      H D         +KPSN+L++     ++ DFG++  L  +  
Sbjct: 100 IAVAVVKGLTYLWSLKILHRD---------VKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150

Query: 190 QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +T      G+  Y+APE   G +     DV+S GI  +EL +   P
Sbjct: 151 KTYV----GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 15/105 (14%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           +AID    L Y+H D         +KP NVLLD +   R+ DFG    L    T  S++ 
Sbjct: 113 LAIDSVHQLGYVHRD---------IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA 163

Query: 196 VKGSIGYIAPEY--GVGNEVSTIG---DVYSYGILLLELMIREKP 235
           V G+  YI+PE    + +     G   D +S G+ + E++  E P
Sbjct: 164 V-GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 20/167 (11%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F++E + L+   H N++K++  C          +  +Y  M      ++L  + K+ +  
Sbjct: 39  FLSEARILKQYDHPNIVKLIGVCTQ--------RQPIYIVMELVPGGDFLSFLRKKKD-- 88

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
                L   + +  A+D A+ + YL   +C     H  L   N L+ ++   ++ DFG++
Sbjct: 89  ----ELKTKQLVKFALDAAAGMAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMS 140

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
           R        +S +  +  I + APE       S+  DV+SYGILL E
Sbjct: 141 RQEDDGIYSSSGLK-QIPIKWTAPEALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 34/153 (22%)

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDF 178
           +R R  +  R    A +V  AL +LH        H V    LK  N+LLD +   ++ DF
Sbjct: 88  QRSRKFDEPRSRFYAAEVTLALMFLHR-------HGVIYRDLKLDNILLDAEGHCKLADF 140

Query: 179 GLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236
           G+ +   L    T T      G+  YIAPE     E     D ++ G+L+ E+M  + P 
Sbjct: 141 GMCKEGILNGVTTTTFC----GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP- 195

Query: 237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLND 269
              FE D             +  D+ +SIL +D
Sbjct: 196 ---FEAD-------------NEDDLFESILHDD 212

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 25/196 (12%)

Query: 36  RNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95
           R+ L ENL++       H   +GA  + I E   L++++H N++  L   +  D      
Sbjct: 26  RSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIV-TLHDIVHTDKS---- 78

Query: 96  KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVT 155
             LV+E++ ++ LK+++                N++   N+ I +   L  L +  +   
Sbjct: 79  LTLVFEYL-DKDLKQYMDDCG------------NIMSMHNVKIFLYQILRGLAYCHRRKV 125

Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLP-PTRTQTSSIDVKGSIGYIAPEYGVG-NEV 213
            H  LKP N+L+++    ++ DFGLAR    PT+T ++ +    ++ Y  P+  +G +E 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV---VTLWYRPPDVLLGSSEY 182

Query: 214 STIGDVYSYGILLLEL 229
           ST  D++  G +  E+
Sbjct: 183 STQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 10/110 (9%)

Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGY 202
            L++LH        H  LKP N+L+      ++ DFGLAR     +   +S+ V  ++ Y
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVV--TLWY 175

Query: 203 IAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
            APE  + +  +T  D++S G +  E M R KP   +F G  ++ +  K+
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAE-MFRRKP---LFRGSSDVDQLGKI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 36/145 (24%), Positives = 61/145 (42%), Gaps = 13/145 (8%)

Query: 98  LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH 157
           +V E+  N  L + L           RP   + + R  I I +   L +LH        H
Sbjct: 76  IVMEYAENGDLHKLLK------MQRGRPLPEDQVWRFFIQILLG--LAHLHSK---KILH 124

Query: 158 CVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG 217
             +K  N+ LD     ++GD G+A+ L       ++I   G+  Y++PE       +   
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VGTPYYLSPELCEDKPYNEKS 182

Query: 218 DVYSYGILLLELMIREKPSDIMFEG 242
           DV++ G++L E    + P D   +G
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQG 207

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 38/183 (20%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   +    H+N+++     +GV ++    + ++ E M    LK +L    +     
Sbjct: 56  FLMEALIMSKFNHQNIVR----LIGVSFERLP-RFILLELMAGGDLKSFL---RENRPRP 107

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTA-HCVLK---PSNVLLDDDMT 172
           +RP +L +   L  A DVA    YL      H D   + A +C+L    P  V       
Sbjct: 108 ERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRD---IAARNCLLTCKGPGRV------- 157

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGS-----IGYIAPEYGVGNEVSTIGDVYSYGILLL 227
           A++ DFG+AR +       +S   KG      I ++ PE  +    ++  DV+S+G+LL 
Sbjct: 158 AKIADFGMARDI-----YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLW 212

Query: 228 ELM 230
           E+ 
Sbjct: 213 EIF 215

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 14/138 (10%)

Query: 98  LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH 157
           LV   M+   LK  +Y + +        R L + R ++ +  +   + +LH        +
Sbjct: 70  LVMSLMNGGDLKYHIYNVGE--------RGLEMERVIHYSAQITCGILHLH---SMDIVY 118

Query: 158 CVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG 217
             +KP NVLLDD    R+ D GLA  L   +T T      G+ GY+APE       S   
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILKEEPYSYPV 175

Query: 218 DVYSYGILLLELMIREKP 235
           D ++ G  + E++    P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.3 bits (104), Expect = 6e-05
 Identities = 35/110 (31%), Positives = 51/110 (46%), Gaps = 15/110 (13%)

Query: 131 LRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ 190
           L  + IAID    L+Y+H D         +KP N+L+D +   R+ DFG    L    T 
Sbjct: 108 LAEMVIAIDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158

Query: 191 TSSIDVKGSIGYIAPEYGVGNE-----VSTIGDVYSYGILLLELMIREKP 235
            SS+ V G+  YI+PE     E          D +S G+ + E++  E P
Sbjct: 159 QSSVAV-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 33/129 (25%), Positives = 61/129 (47%), Gaps = 20/129 (15%)

Query: 131 LRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ 190
           L  L +A+D   +L  ++ D         LKP N+LLD++   ++ DFGL++       +
Sbjct: 104 LAELALALDHLHSLGIIYRD---------LKPENILLDEEGHIKLTDFGLSK--ESIDHE 152

Query: 191 TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-----MN 245
             +    G++ Y+APE       +   D +S+G+L+ E++    P    F+G      M 
Sbjct: 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMT 208

Query: 246 LHKFAKMAL 254
           +   AK+ +
Sbjct: 209 MILKAKLGM 217

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 22/175 (12%)

Query: 63  FIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
           F+ E +  R + H N+++ L  C+  + Y       LV EF     LK +L         
Sbjct: 42  FLQEVQPYRELNHPNVLQCLGQCIESIPY------LLVLEFCPLGDLKNYL---RSNRGM 92

Query: 122 YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
             +    ++L+R+  A +VAS L +LH   Q    H  L   N  L  D++ ++GD+GLA
Sbjct: 93  VAQMAQKDVLQRM--ACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEY--GVGNEVSTI-----GDVYSYGILLLEL 229
               P     +       + ++APE     G ++         +++S G+ + EL
Sbjct: 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 43.7 bits (104), Expect = 7e-05
 Identities = 32/124 (25%), Positives = 57/124 (45%), Gaps = 30/124 (24%)

Query: 66  ECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKR 124
           E K+LR +  H N++K+        ++ ND    V+E+M        LY + K+ +   +
Sbjct: 47  EVKSLRKLNEHPNIVKLKEV-----FRENDELYFVFEYMEGN-----LYQLMKDRK--GK 94

Query: 125 PRNLNLLRRLNIAIDVASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           P + +++R  +I   +   L ++H       D         LKP N+L+      ++ DF
Sbjct: 95  PFSESVIR--SIIYQILQGLAHIHKHGFFHRD---------LKPENLLVSGPEVVKIADF 143

Query: 179 GLAR 182
           GLAR
Sbjct: 144 GLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 5/119 (4%)

Query: 147 LHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE 206
           +HH       H  +K +N+LL  +   ++GDFG ++    T +        G+  Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 207 YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSI 265
                  S   D++S G+LL EL+  ++P    F+G+ N+ +     L+     +  SI
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE-NMEEVMHKTLAGRYDPLPPSI 269

Length = 496

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 22/202 (10%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL--YPISKEDETYK 123
           E + L+N+RH  +++    CL  D +       V E+M   S+K+ L  Y    E+ T +
Sbjct: 54  EIQLLKNLRHDRIVQYY-GCLR-DPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVTRR 110

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
             R             +   ++YLH +   +  H  +K +N+L D     ++GDFG ++ 
Sbjct: 111 YTRQ------------ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155

Query: 184 LPPTRTQTSSI-DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           +       + I  V G+  +++PE   G       DV+S    ++E M+ EKP    +E 
Sbjct: 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVE-MLTEKPPWAEYEA 214

Query: 243 DMNLHKFAKMALSNHVKDIVDS 264
              + K A       + D V  
Sbjct: 215 MAAIFKIATQPTKPMLPDGVSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 40/131 (30%), Positives = 63/131 (48%), Gaps = 27/131 (20%)

Query: 144 LNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI 203
           L Y+H        H  LKPSN+L++++   ++ DFGLAR   P  T   S        Y 
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YR 172

Query: 204 APE-------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--L 254
           APE       Y V  EV    D++S G +  E M+  KP   +F G  ++++F+ +   L
Sbjct: 173 APEIMLTWQKYDV--EV----DIWSAGCIFAE-MLEGKP---LFPGKDHVNQFSIITDLL 222

Query: 255 SNHVKDIVDSI 265
                D++++I
Sbjct: 223 GTPPDDVINTI 233

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 30/213 (14%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL--YPISKEDETYK 123
           E + L+N+ H  +++    CL  D       ++  E M   S+K+ L  Y    E+ T K
Sbjct: 54  EIQLLKNLLHERIVQYY-GCLR-DPMERTL-SIFMEHMPGGSIKDQLKSYGALTENVTRK 110

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
             R             +   ++YLH +   +  H  +K +N+L D     ++GDFG ++ 
Sbjct: 111 YTRQ------------ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155

Query: 184 LPPT-RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           L     + T    V G+  +++PE   G       D++S G  ++E M+ EKP    FE 
Sbjct: 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVE-MLTEKPPWAEFEA 214

Query: 243 DMNLHKFAKMA--------LSNHVKDIVDSILL 267
              + K A           +S+H +D +  I +
Sbjct: 215 MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV 247

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 30/183 (16%)

Query: 61  KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY-------EFMHNRSLKEWL 112
           + F  E + L  +  H N+I +L AC   +++G  + A+ Y       +F+    + E  
Sbjct: 40  RDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 96

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
              +  + T     +  LL     A DVA  ++YL    Q    H  L   N+L+ ++  
Sbjct: 97  PAFAIANSTASTLSSQQLLH---FAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 150

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIG-----YIAPEYGVGNEVSTIGDVYSYGILLL 227
           A++ DFGL+R           + VK ++G     ++A E    +  +T  DV+SYG+LL 
Sbjct: 151 AKIADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202

Query: 228 ELM 230
           E++
Sbjct: 203 EIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 42/175 (24%), Positives = 78/175 (44%), Gaps = 17/175 (9%)

Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PISKE 118
            ++E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P   E
Sbjct: 67  LVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGME 121

Query: 119 ---DETYKRPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCVLKPSNVLLDDDMTAR 174
              D        +     ++    VA  + YL    C     H  L   NVL+ ++   +
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMK 177

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           + DFGLAR +        + + +  + ++APE       +   DV+S+G+L+ E+
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 5/101 (4%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++   L+YLH + +    H  +K +NVLL +    ++ DFG+A  L  T TQ       G
Sbjct: 109 EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVG 163

Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 239
           +  ++APE    +   +  D++S GI  +EL   E P+  M
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 25/143 (17%)

Query: 160 LKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEY-----GVGNEV 213
           +K  N+LLD +    + DFGL++ FL   + +T S    G+I Y+APE      G G  V
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF--CGTIEYMAPEIIRGKGGHGKAV 188

Query: 214 STIGDVYSYGILLLELMIREKPSDIMFEGDMNLH-----KFAKMA------LSNHVKDIV 262
               D +S GIL+ EL+    P     EG+ N       +  K        +    +D++
Sbjct: 189 ----DWWSLGILIFELLTGASP--FTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLL 242

Query: 263 DSILLNDDEKLVVRGDQKQTQAK 285
             +L  D +K +  G Q  ++ K
Sbjct: 243 HKLLRKDPKKRLGAGPQGASEIK 265

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 12/103 (11%)

Query: 136 IAIDVASALNYL---HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTS 192
           IA+ V   L YL   H        H  +KPSN+L++     ++ DFG++  L  +   T 
Sbjct: 108 IAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT- 161

Query: 193 SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
                G+  Y++PE   G + +   DV+S GI ++EL + + P
Sbjct: 162 ---FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 39/190 (20%), Positives = 78/190 (41%), Gaps = 26/190 (13%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL---- 112
               +  ++E   L+ + H ++IK+  AC       +    L+ E+    SL+ +L    
Sbjct: 44  SSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQDGPLLLIVEYAKYGSLRSFLRESR 98

Query: 113 ------------YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL 160
                          S  D   +R   +  L  ++ A  ++  + YL    +    H  L
Sbjct: 99  KVGPSYLGSDGNRNSSYLDNPDERALTMGDL--ISFAWQISRGMQYL---AEMKLVHRDL 153

Query: 161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVY 220
              NVL+ +    ++ DFGL+R +    +       +  + ++A E    +  +T  DV+
Sbjct: 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213

Query: 221 SYGILLLELM 230
           S+G+LL E++
Sbjct: 214 SFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 21/177 (11%)

Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY------PI 115
            I+E + ++ I +H+N+I +L  C     Q      +V E+    +L+E+L       P 
Sbjct: 64  LISEMELMKLIGKHKNIINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPD 118

Query: 116 SKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMT 172
              D T      L+    ++ A  VA  + YL       +  C+   L   NVL+ +D  
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE------SRRCIHRDLAARNVLVTEDNV 172

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
            ++ DFGLAR +        + + +  + ++APE       +   DV+S+GIL+ E+
Sbjct: 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 46/196 (23%), Positives = 92/196 (46%), Gaps = 25/196 (12%)

Query: 36  RNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF 95
           R+ L +NL++       H   +GA  + I E   L++++H N++      L         
Sbjct: 26  RSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT-----LHDIIHTEKS 78

Query: 96  KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVT 155
             LV+E++ ++ LK++L                N +   N+ + +   L  L++  +   
Sbjct: 79  LTLVFEYL-DKDLKQYLDDCG------------NSINMHNVKLFLFQLLRGLNYCHRRKV 125

Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLP-PTRTQTSSIDVKGSIGYIAPEYGVGN-EV 213
            H  LKP N+L+++    ++ DFGLAR    PT+T ++ +    ++ Y  P+  +G+ + 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV---VTLWYRPPDILLGSTDY 182

Query: 214 STIGDVYSYGILLLEL 229
           ST  D++  G +  E+
Sbjct: 183 STQIDMWGVGCIFYEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 33/186 (17%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+ +RH NL+ ++        +      LV+EF+ +  L          D+  K P
Sbjct: 50  EIRMLKQLRHENLVNLIEVF-----RRKKRLYLVFEFVDHTVL----------DDLEKYP 94

Query: 126 RNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184
             L+  R       +   + + H H+      H  +KP N+L+      ++ DFG AR L
Sbjct: 95  NGLDESRVRKYLFQILRGIEFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTL 150

Query: 185 P-PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG---DVYSYGILLLELMIREKPSDIMF 240
             P    T   D   +  Y APE  VG+  +  G   D+++ G L+ E++  E     +F
Sbjct: 151 AAPGEVYT---DYVATRWYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEP----LF 201

Query: 241 EGDMNL 246
            GD ++
Sbjct: 202 PGDSDI 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 24/171 (14%)

Query: 76  RNLIKVLTAC--LGVDYQGNDFKA-----LVYEFMHNRSLKEWLYPISKEDETYKRPRNL 128
           R+ +  L AC   G+    +DFK+     L+ E+     L + +    KE   ++     
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 129 NLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTR 188
            L  ++ +A+D   +   +H D         LK +N+ L      ++GDFG ++      
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRD---------LKSANIFLMPTGIIKLGDFGFSK----QY 219

Query: 189 TQTSSIDVKGSIG----YIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           + + S+DV  S      Y+APE       S   D++S G++L EL+   +P
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 19/172 (11%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L+N RH      LTA L   +Q +D    V E+ +     E  + +S+E     
Sbjct: 43  LTENRVLQNSRH----PFLTA-LKYSFQTHDRLCFVMEYANG---GELFFHLSRE----- 89

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
             R  +  R      ++ SAL+YLH +   V     LK  N++LD D   ++ DFGL + 
Sbjct: 90  --RVFSEDRARFYGAEIVSALDYLHSEKNVVYRD--LKLENLMLDKDGHIKITDFGLCK- 144

Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
               +   +     G+  Y+APE    N+     D +  G+++ E+M    P
Sbjct: 145 -EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 7/89 (7%)

Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS--IDVKGSIGYIAPEYGVGNEVS 214
           H  LKP N+L++ D   ++ DFGLAR       + +    +   +  Y APE  +  +  
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187

Query: 215 TIG-DVYSYGILLLELMIREKPSDIMFEG 242
           T   DV+S G +L EL+ R KP   +F+G
Sbjct: 188 TKAIDVWSVGCILAELLGR-KP---VFKG 212

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 19/104 (18%)

Query: 134 LNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGDFGLARFLPPTRTQ 190
           L+ +  VA  +++L       + +C+   L   N+LL      ++ DFGLAR +      
Sbjct: 217 LSFSYQVAKGMSFL------ASKNCIHRDLAARNILLTHGRITKICDFGLARDI----RN 266

Query: 191 TSSIDVKGS----IGYIAPEYGVGNEVSTI-GDVYSYGILLLEL 229
            S+  VKG+    + ++APE  + N V T   DV+SYGILL E+
Sbjct: 267 DSNYVVKGNARLPVKWMAPE-SIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 16/101 (15%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++  A  YLH     +     LKP N+LLD+    +V DFG A+ + P RT T    + G
Sbjct: 126 ELVLAFEYLH-SKDIIYRD--LKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT----LCG 177

Query: 199 SIGYIAPEY----GVGNEVSTIGDVYSYGILLLELMIREKP 235
           +  Y+APE     G G  V    D ++ G+LL E +    P
Sbjct: 178 TPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 22/160 (13%)

Query: 134 LNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGDFGLARFLPPTRTQ 190
           +  +  VA+ + +L       + +CV   L   NVL+ +    ++ DFGLAR +     +
Sbjct: 242 VGFSYQVANGMEFL------ASKNCVHRDLAARNVLICEGKLVKICDFGLARDI----MR 291

Query: 191 TSSIDVKGS----IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI---REKPSDIMFEGD 243
            S+   KGS    + ++APE    N  +T+ DV+S+GILL E+        P   M E  
Sbjct: 292 DSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351

Query: 244 MN-LHKFAKMALSNHVKDIVDSILLND-DEKLVVRGDQKQ 281
            N + +  +MA   H  D +  I+    +EK  +R D  Q
Sbjct: 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 56/231 (24%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGND-------FKAL--VYEFMHN--RSLK 109
           K  + E K +R + H N++KV            +         ++  V E+M     ++ 
Sbjct: 47  KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL 106

Query: 110 EWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD- 168
           E   P+S+E   + R     LLR L     + SA N LH D         LKP+NV ++ 
Sbjct: 107 EQ-GPLSEE---HARLFMYQLLRGLKY---IHSA-NVLHRD---------LKPANVFINT 149

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIG-------YIAPEYGVG-NEVSTIGDVY 220
           +D+  ++GDFGLAR + P  +       KG +        Y +P   +  N  +   D++
Sbjct: 150 EDLVLKIGDFGLARIVDPHYSH------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 203

Query: 221 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDE 271
           + G +  E M+  KP   +F G    H+  +M L      I++S+ +  +E
Sbjct: 204 AAGCIFAE-MLTGKP---LFAGA---HELEQMQL------ILESVPVVREE 241

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 35/181 (19%)

Query: 63  FIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
           F+ +    R ++H N+++ L  C+  + Y       LV+E+     LK +L   S+E   
Sbjct: 42  FLQQGDPYRILQHPNILQCLGQCVEAIPY------LLVFEYCELGDLKSYL---SQEQWH 92

Query: 122 YKRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
            +  + L L R   +A ++A+ + ++H H+      H  L   N  L  D+T +VGD+G+
Sbjct: 93  RRNSQLLLLQR---MACEIAAGVTHMHKHN----FLHSDLALRNCFLTSDLTVKVGDYGI 145

Query: 181 ARFLPPTRTQTSSI----DVKGSIGYIAPEYGVGN--------EVSTIGDVYSYGILLLE 228
                P+R +   I    D    + ++APE  VG         E +   +V++ G+ L E
Sbjct: 146 G----PSRYKEDYIETEDDKCVPLRWLAPEL-VGEFHGGLITAEQTKPSNVWALGVTLWE 200

Query: 229 L 229
           L
Sbjct: 201 L 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 42/172 (24%), Positives = 79/172 (45%), Gaps = 22/172 (12%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+AE   L    H N++++     GV  +GN    +V E+M N +L  +L        
Sbjct: 51  RGFLAEALTLGQFDHSNIVRLE----GVITRGNTM-MIVTEYMSNGALDSFLR------- 98

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
             K    L   + + +   +AS + YL    +    H  L    VL++ D+  ++  F  
Sbjct: 99  --KHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF-- 151

Query: 181 ARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            R L   +++   +++  K  + + APE    +  S+  DV+S+GI++ E+M
Sbjct: 152 -RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 6/100 (6%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           ++I V   L YL    Q    H  +KPSN+L++     ++ DFG++  L  +   +    
Sbjct: 108 VSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 161

Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
             G+  Y++PE   G   S   D++S G+ L+EL I   P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 7/101 (6%)

Query: 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-YGVGNEVSTIGD 218
           LKP+N+LLD+    R+ D GLA      +   S     G+ GY+APE    G    +  D
Sbjct: 123 LKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGTAYDSSAD 178

Query: 219 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK 259
            +S G +L +L+    P       D   H+  +M L+ +V+
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTVNVE 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 9/105 (8%)

Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTSSI 194
           + +++ ALN+LH   +    +  LK  NVLLD +   ++ D+G+ +    P   T T   
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC- 157

Query: 195 DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 239
              G+  YIAPE   G +     D ++ G+L+ E+M    P DI+
Sbjct: 158 ---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 34/122 (27%), Positives = 47/122 (38%), Gaps = 24/122 (19%)

Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           A+D    L Y+H D          KP N L+D     ++ DFGL+         T +  V
Sbjct: 113 AVDALHELGYIHRDL---------KPENFLIDASGHIKLTDFGLS-----KGIVTYANSV 158

Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD------MNLHKFA 250
            GS  Y+APE   G       D +S G +L E +    P    F G        NL  + 
Sbjct: 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP----FSGSTPNETWENLKYWK 214

Query: 251 KM 252
           + 
Sbjct: 215 ET 216

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 17/106 (16%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           +AI     L+Y+H D         +KP NVLLD +   R+ DFG    +    T  SS+ 
Sbjct: 113 LAIHSIHQLHYVHRD---------IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA 163

Query: 196 VKGSIGYIAPEY------GVGNEVSTIGDVYSYGILLLELMIREKP 235
           V G+  YI+PE       G+G +     D +S G+ + E++  E P
Sbjct: 164 V-GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 12/99 (12%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           IA+    ALNYL  + + +  H  +KPSN+LLD +   ++ DFG++  L  +  +T   D
Sbjct: 112 IAVATVKALNYLKEELKII--HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR--D 167

Query: 196 VKGSIGYIAPE-----YGVGNEVSTIGDVYSYGILLLEL 229
             G   Y+APE        G +V +  DV+S GI L E+
Sbjct: 168 A-GCRPYMAPERIDPSARDGYDVRS--DVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 9/80 (11%)

Query: 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEY---GVGNEVSTI 216
           LKP+N+LLD+    R+ D GLA      +   S     G+ GY+APE    GV  + S  
Sbjct: 123 LKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDSS-- 176

Query: 217 GDVYSYGILLLELMIREKPS 236
            D +S G +L +L+    P 
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 24/93 (25%), Positives = 48/93 (51%), Gaps = 5/93 (5%)

Query: 138 IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK 197
             + SA++Y+H   +    H  +K  N+ L      ++GDFG+++ L    +   +  V 
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VV 162

Query: 198 GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           G+  Y++PE   G + +   D+++ G +L EL+
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 7/96 (7%)

Query: 135 NIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI 194
            I I +   L  LH + + +  H  LK +N+LL  +   ++GD G+++ L     +T   
Sbjct: 107 RIFIQLLRGLQALH-EQKIL--HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT--- 160

Query: 195 DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
              G+  Y+APE   G   S   D++S G LL E+ 
Sbjct: 161 -QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA 195

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 32/178 (17%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E K +  I+H N++ ++       Y   DF  LV + M +  LK+ +    +  E+  + 
Sbjct: 70  ELKIMNEIKHENIMGLVDV-----YVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKC 123

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR-FL 184
             L +L  LN    V     ++H D         L P+N+ ++     ++ DFGLAR + 
Sbjct: 124 ILLQILNGLN----VLHKWYFMHRD---------LSPANIFINSKGICKIADFGLARRYG 170

Query: 185 PPTRTQTSSIDVKGS-----------IGYIAPEYGVGNEVSTIG-DVYSYGILLLELM 230
            P  + T S D               + Y APE  +G E      D++S G +  EL+
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228

Length = 335

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 4/105 (3%)

Query: 134 LNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
           LN  + +A  +NYL    +    H  L   NVL+      ++ DFGLA+ L     +  +
Sbjct: 112 LNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168

Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKPSD 237
              K  I ++A E  +    +   DV+SYG+ + ELM    KP D
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 5/111 (4%)

Query: 125 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184
           P  L+  +   I  ++   L+YLH + +    H  +K +NVLL +    ++ DFG+A  L
Sbjct: 95  PGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL 151

Query: 185 PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
             T TQ       G+  ++APE    +   +  D++S GI  +EL   E P
Sbjct: 152 --TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 24/80 (30%), Positives = 39/80 (48%), Gaps = 6/80 (7%)

Query: 160 LKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG 217
           LK  NV+LD +   ++ DFG+ +        T+T      G+  YIAPE           
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC----GTPDYIAPEIIAYQPYGKSV 182

Query: 218 DVYSYGILLLELMIREKPSD 237
           D +++G+LL E++  + P D
Sbjct: 183 DWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 37/122 (30%), Positives = 58/122 (47%), Gaps = 18/122 (14%)

Query: 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDV 219
           LKP N+LLD D   ++ DFG A+ +  TRT T    + G+  YIAPE  +        D 
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKVV-DTRTYT----LCGTPEYIAPEILLNVGHGKAADW 211

Query: 220 YSYGILLLELMIREKP---------SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDD 270
           ++ GI + E+++   P            + EG +   KF    L N+ K ++  +L +D 
Sbjct: 212 WTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF----LDNNCKHLMKKLLSHDL 267

Query: 271 EK 272
            K
Sbjct: 268 TK 269

Length = 340

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 43/191 (22%), Positives = 87/191 (45%), Gaps = 29/191 (15%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY--- 113
           + A   F+ E K +  ++  N+I++L  C+      +D   ++ E+M N  L ++L    
Sbjct: 60  KNARNDFLKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHE 114

Query: 114 ---PISKEDETYKRPRNL-NLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169
                 K D        L  +  ++   +   S+LN++H D         L   N L+  
Sbjct: 115 PQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD---------LATRNCLVGK 165

Query: 170 DMTARVGDFGLARFLPPT---RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
           + T ++ DFG++R L      R Q  ++     I +++ E  +  + +T  DV+++G+ L
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVL---PIRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 227 LELMI--REKP 235
            E++   +E+P
Sbjct: 223 WEILTLCKEQP 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 33/129 (25%), Positives = 61/129 (47%), Gaps = 7/129 (5%)

Query: 102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCVL 160
           F+  +SL +     +++++ YK+   L  L  +  +  VA  + +L    C     H  L
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDL--ICYSFQVAKGMEFLASRKC----IHRDL 205

Query: 161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVY 220
              N+LL ++   ++ DFGLAR +          D +  + ++APE       +   DV+
Sbjct: 206 AARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 265

Query: 221 SYGILLLEL 229
           S+G+LL E+
Sbjct: 266 SFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 37/187 (19%), Positives = 78/187 (41%), Gaps = 26/187 (13%)

Query: 51  FSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKE 110
               + +     F  E    R + H+N++++L  C     +  +   ++ E+     LK+
Sbjct: 43  LQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQ 97

Query: 111 WLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLL 167
           +L     +DE  K P  L+  +++ +   +A  +++L        A  V   L   N L+
Sbjct: 98  FLRATKSKDEKLK-PPPLSTKQKVALCTQIALGMDHLS------NARFVHRDLAARNCLV 150

Query: 168 DDDMTARVGDFGLARFLPPTRTQTSS-----IDVKGSIGYIAPEYGVGNEVSTIGDVYSY 222
                 +V    L      ++   +S      +    + ++APE    ++ ST  DV+S+
Sbjct: 151 SSQREVKVSLLSL------SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSF 204

Query: 223 GILLLEL 229
           G+L+ E+
Sbjct: 205 GVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 28/199 (14%)

Query: 90  YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHH 149
           +Q  D   LV E+     L   L  +++ ++ +        L  L +AI     + Y+H 
Sbjct: 70  FQDKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126

Query: 150 DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV 209
           D         +KP NVL+D     ++ DFG A  L   +   S + V G+  YIAPE   
Sbjct: 127 D---------IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLT 176

Query: 210 ---GNEVSTIG---DVYSYGILLLELMIREKP-----SDIMFEGDMNLHKFAKMA----L 254
              G+   T G   D +S G++  E++    P     S   +   MN  +F K      +
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236

Query: 255 SNHVKDIVDSILLNDDEKL 273
           S+   D++ S+L    E+L
Sbjct: 237 SSDFLDLIQSLLCGQKERL 255

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 4/139 (2%)

Query: 98  LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH 157
           +V E M +  LK +L  +  E E         L   + +A ++A  + YL+        H
Sbjct: 86  VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVH 142

Query: 158 CVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG 217
             L   N ++  D T ++GDFG+ R +  T            + ++APE       +T  
Sbjct: 143 RDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS 202

Query: 218 DVYSYGILLLEL-MIREKP 235
           D++S+G++L E+  + E+P
Sbjct: 203 DMWSFGVVLWEITSLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 22/154 (14%)

Query: 133 RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQT 191
           R+ IA ++  AL++LH   Q    +  +K  N+LLD +    + DFGL++ FL     + 
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 192 SSIDVKGSIGYIAPEYGVGNEV--STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK- 248
            S    G+I Y+APE   G         D +S G+L  EL+    P  +  +G+ N    
Sbjct: 164 YSF--CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV--DGEQNSQSE 219

Query: 249 FAKMALSNH----------VKDIVDSILLNDDEK 272
            ++  L +            +D +  +L  D +K
Sbjct: 220 ISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKK 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 7/87 (8%)

Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR      T         +  Y APE  +G      
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197

Query: 217 GDVYSYGILLLELMIREKPSDIMFEGD 243
            D++S G ++ E MIR     ++F G 
Sbjct: 198 VDIWSVGCIMGE-MIRGT---VLFPGT 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 45/185 (24%), Positives = 89/185 (48%), Gaps = 22/185 (11%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
           R++    +   E   L+ ++H N+++ L + L  D+  N F     E++   S+   L  
Sbjct: 45  RKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL-NIF----LEYVPGGSVAALLNN 99

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
               +ET  R    N +R+      +   LNYLH+       H  +K +N+L+D+    +
Sbjct: 100 YGAFEETLVR----NFVRQ------ILKGLNYLHNRG---IIHRDIKGANILVDNKGGIK 146

Query: 175 VGDFGLARFLPP----TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + DFG+++ L      T+T  +   ++GS+ ++APE       +   D++S G L++E++
Sbjct: 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206

Query: 231 IREKP 235
             + P
Sbjct: 207 TGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 23/144 (15%)

Query: 99  VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI---DVASALNYLHHDCQPVT 155
           + E+    S  + L P  K DETY             IA    +V   L YLH +     
Sbjct: 77  IMEYCGGGSCLDLLKP-GKLDETY-------------IAFILREVLLGLEYLHEE---GK 119

Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST 215
            H  +K +N+LL ++   ++ DFG++  L  T T +      G+  ++APE    +    
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177

Query: 216 IGDVYSYGILLLELMIREKP-SDI 238
             D++S GI  +EL   E P SD+
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 33/137 (24%), Positives = 60/137 (43%), Gaps = 33/137 (24%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA---LVYEF--------MHNRSLKEWLYP 114
           E K L+ ++H N++ ++  C       N +K    LV+EF        + N+++K  L  
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
           I K            +++ L       + L Y+H +      H  +K +N+L+  D   +
Sbjct: 121 IKK------------VMKML------LNGLYYIHRN---KILHRDMKAANILITKDGILK 159

Query: 175 VGDFGLAR-FLPPTRTQ 190
           + DFGLAR F     ++
Sbjct: 160 LADFGLARAFSLSKNSK 176

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 43/212 (20%)

Query: 35  SRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND 94
           +R++    +++     +S  +    ++  I E + L+ +RH N I          Y+G  
Sbjct: 34  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI---------QYRGCY 84

Query: 95  FKA----LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALN---YL 147
            +     LV E+         L   S   E +K+P     L+ + IA     AL    YL
Sbjct: 85  LREHTAWLVMEYC--------LGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYL 131

Query: 148 H-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE 206
           H H+      H  +K  N+LL +    ++GDFG A  + P           G+  ++APE
Sbjct: 132 HSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPE 181

Query: 207 YGVG-NEVSTIG--DVYSYGILLLELMIREKP 235
             +  +E    G  DV+S GI  +EL  R+ P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 34/118 (28%), Positives = 50/118 (42%), Gaps = 7/118 (5%)

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
           RN+ +   L I   V  A+ YLH +      H  +K  N+ ++      +GDFG A F P
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF-P 232

Query: 186 PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
                       G+I   APE    +      D++S GI+L E+       D +FE D
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKD 287

Length = 391

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 41/177 (23%), Positives = 77/177 (43%), Gaps = 26/177 (14%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   +R   H +++K++           +   +V E      L+ +L       +  
Sbjct: 54  FLQEAYIMRQFDHPHIVKLIGVIT------ENPVWIVMELAPLGELRSYL-------QVN 100

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGDFG 179
           K   +L+L   +  +  +++AL YL       +   V   +   NVL+      ++GDFG
Sbjct: 101 KY--SLDLASLILYSYQLSTALAYLE------SKRFVHRDIAARNVLVSSPDCVKLGDFG 152

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE-LMIREKP 235
           L+R+L       +S   K  I ++APE       ++  DV+ +G+ + E LM+  KP
Sbjct: 153 LSRYLEDESYYKASK-GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 32/128 (25%), Positives = 59/128 (46%), Gaps = 20/128 (15%)

Query: 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV--STIG 217
           +K  N+LLD +    + DFGL++       +  +    G+I Y+AP+   G +       
Sbjct: 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAV 189

Query: 218 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-------------LSNHVKDIVDS 264
           D +S G+L+ EL+    P  +  +G+ N    A+++             +S   KDI+  
Sbjct: 190 DWWSMGVLMYELLTGASPFTV--DGEKNSQ--AEISRRILKSEPPYPQEMSALAKDIIQR 245

Query: 265 ILLNDDEK 272
           +L+ D +K
Sbjct: 246 LLMKDPKK 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 6/101 (5%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++   L+YLH + +    H  +K +NVLL +    ++ DFG+A  L  T TQ       G
Sbjct: 109 EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVG 163

Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP-SDI 238
           +  ++APE    +      D++S GI  +EL   E P SD+
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 22/179 (12%)

Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++   E + +  + H ++I+     LG   + + F   V E+M   S+   L       
Sbjct: 47  VEALRKEIRLMARLNHPHIIR----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFK 101

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MTARVGDF 178
           E         LLR           L+YLH + Q +  H  +K +N+L+D      R+ DF
Sbjct: 102 EAVIINYTEQLLR----------GLSYLH-ENQII--HRDVKGANLLIDSTGQRLRIADF 148

Query: 179 GLARFLPPTRTQTSSIDVK--GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           G A  L    T       +  G+I ++APE   G +     DV+S G +++E M   KP
Sbjct: 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE-MATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 20/172 (11%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L+N RH      LTA L   +Q +D    V E+ +     E  + +S+E     
Sbjct: 43  VTESRVLQNTRH----PFLTA-LKYAFQTHDRLCFVMEYANG---GELFFHLSRE----- 89

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
             R     R      ++ SAL YLH        +  +K  N++LD D   ++ DFGL + 
Sbjct: 90  --RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK- 143

Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
                   +     G+  Y+APE    N+     D +  G+++ E+M    P
Sbjct: 144 -EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 20/167 (11%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L+N RH  L       L   +Q +D    V E+ +     E  + +S+E   + 
Sbjct: 43  LTESRVLQNTRHPFLTA-----LKYSFQTHDRLCFVMEYANG---GELFFHLSRE-RVFS 93

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
             R      R   A ++ SAL YLH  C  V     LK  N++LD D   ++ DFGL + 
Sbjct: 94  EDRA-----RFYGA-EIVSALGYLH-SCDVVYRD--LKLENLMLDKDGHIKITDFGLCKE 144

Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
                    +    G+  Y+APE    N+     D +  G+++ E+M
Sbjct: 145 GISDGATMKTF--CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 35/179 (19%), Positives = 71/179 (39%), Gaps = 33/179 (18%)

Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
             +F      +  + H++L+K+   C+  +        +V E++    L  +L+      
Sbjct: 45  SLAFFETASLMSQLSHKHLVKLYGVCVRDENI------MVEEYVKFGPLDVFLH------ 92

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL--DDDMT----- 172
              +   N++L  +L++A  +ASAL+YL         H  +   N+L+            
Sbjct: 93  ---REKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF 146

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEY--GVGNEVSTIGDVYSYGILLLEL 229
            ++ D G+   +     +   I       +IAPE        ++   D +S+G  LLE+
Sbjct: 147 IKLSDPGIPITVLSREERVERIP------WIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 62/251 (24%), Positives = 102/251 (40%), Gaps = 36/251 (14%)

Query: 43  LISAGTFGFSHLRRQGAFKSFIA----ECKAL------------RNIRHRNLIKVLTACL 86
           +I  G+FG   L R  A + F A    + KA+            RN+  +N+       L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 87  GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNY 146
              +Q  D    V ++++     E  Y + +E   +  PR      R   A ++ASAL Y
Sbjct: 62  HFSFQTADKLYFVLDYING---GELFYHLQRE-RCFLEPR-----ARF-YAAEIASALGY 111

Query: 147 LHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE 206
           LH        +  LKP N+LLD      + DFGL +        TS+    G+  Y+APE
Sbjct: 112 LH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF--CGTPEYLAPE 166

Query: 207 YGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNLHKFAKMALSNHVKDI 261
                      D +  G +L E++    P     +  M++  +N     K  ++N  + +
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 226

Query: 262 VDSILLNDDEK 272
           ++ +L  D  K
Sbjct: 227 LEGLLQKDRTK 237

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 40.5 bits (94), Expect = 0.001
 Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 5/93 (5%)

Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGY 202
           AL++LH +      H  +K  N+LL  D + ++ DFG    + P +++ S++   G+  +
Sbjct: 127 ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYW 181

Query: 203 IAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +APE           D++S GI+ +E++  E P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.5 bits (94), Expect = 0.001
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)

Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 198

Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 199 VDIWSVGCIMGE-MVRHK---ILFPG 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 30/98 (30%), Positives = 44/98 (44%), Gaps = 10/98 (10%)

Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGY 202
           ALN+LH        H  LK  N+LL  D   ++ DFG++     T  +  +    G+  +
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYW 169

Query: 203 IAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKP 235
           +APE         N      D++S GI L+EL   E P
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 40/147 (27%), Positives = 61/147 (41%), Gaps = 22/147 (14%)

Query: 137 AIDVASALNYLH------HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ 190
           A ++ASAL YLH       D         LKP N+LLD      + DFGL +        
Sbjct: 102 AAEIASALGYLHSLNIIYRD---------LKPENILLDSQGHVVLTDFGLCKEGIEHSKT 152

Query: 191 TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP---SDIMFEGDMNLH 247
           TS+    G+  Y+APE           D +  G +L E++    P    D     D  L+
Sbjct: 153 TSTF--CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210

Query: 248 KFAKM--ALSNHVKDIVDSILLNDDEK 272
           K  ++   +S   + +++ +L  D  K
Sbjct: 211 KPLRLKPNISVSARHLLEGLLQKDRTK 237

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 46/213 (21%), Positives = 79/213 (37%), Gaps = 49/213 (23%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY---EFMHNRSLKEWLYPISK 117
           K F+ E K   ++ H  ++ V + C             VY    ++   +LK  L  + +
Sbjct: 47  KRFLREAKIAADLIHPGIVPVYSIC--------SDGDPVYYTMPYIEGYTLKSLLKSVWQ 98

Query: 118 EDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV-------TAHCVLKPSNVLLDDD 170
           ++         +L + L     V + L+  H  C  +         H  LKP N+LL   
Sbjct: 99  KE---------SLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF 149

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVK----------------GSIGYIAPEYGVGNEVS 214
               + D+G A F          IDV                 G+  Y+APE  +G   S
Sbjct: 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209

Query: 215 TIGDVYSYGILLLELMI------REKPSDIMFE 241
              D+Y+ G++L +++       R+K   I + 
Sbjct: 210 ESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242

Length = 932

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 8/97 (8%)

Query: 136 IAIDVASALN---YLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTS 192
           IA  +   L    YLH        H  +K  N+LL+++  A++ DFG++  L  T  + +
Sbjct: 101 IAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157

Query: 193 SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +  V G+  ++APE       +   D++S GI  +E+
Sbjct: 158 T--VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 40.1 bits (93), Expect = 0.001
 Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 23/169 (13%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           I E   L+ ++H N++      L       +   LV+E++H   L +++     +     
Sbjct: 51  IREASLLKGLKHANIV-----LLHDIIHTKETLTLVFEYVHT-DLCQYM----DKHPGGL 100

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
            P N+ L         +   L+Y+H   Q    H  LKP N+L+ D    ++ DFGLAR 
Sbjct: 101 HPENVKLF-----LFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARA 152

Query: 184 LP-PTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELM 230
              P+ T ++ +    ++ Y  P+  +G+ E ST  D++  G + +E++
Sbjct: 153 KSVPSHTYSNEV---VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 29/174 (16%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   L  ++H N++ V    +G +    D   +V E++ +  LK  +       ET K+P
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNL---DKIYMVMEYVEH-DLKSLM-------ETMKQP 102

Query: 126 RNL----NLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
                   L+ +L       S + +LH +      H  LK SN+LL++    ++ DFGLA
Sbjct: 103 FLQSEVKCLMLQL------LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLA 153

Query: 182 R-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIRE 233
           R +  P +  T  + V  ++ Y APE  +G +  ST  D++S G +  EL+ ++
Sbjct: 154 REYGSPLKPYTQLV-V--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 6/100 (6%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           ++I V   L YL    +    H  +KPSN+L++     ++ DFG++  L  +   +    
Sbjct: 108 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 161

Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
             G+  Y++PE   G   S   D++S G+ L+E+ I   P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 5/93 (5%)

Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGY 202
           AL +LH +      H  +K  N+LL  D + ++ DFG    + P +++ S   + G+  +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYW 182

Query: 203 IAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +APE           D++S GI+ +E++  E P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 45/182 (24%), Positives = 83/182 (45%), Gaps = 21/182 (11%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           LR+Q   +    E   +R+  H N++ +  +     Y   D   +V EF+   +L + + 
Sbjct: 57  LRKQQRRELLFNEVVIMRDYHHENVVDMYNS-----YLVGDELWVVMEFLEGGALTDIV- 110

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                  T+ R   +N  +   + + V  AL+YLH+  Q V  H  +K  ++LL  D   
Sbjct: 111 -------THTR---MNEEQIATVCLSVLRALSYLHN--QGVI-HRDIKSDSILLTSDGRI 157

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE 233
           ++ DFG    +     +  S+   G+  ++APE        T  D++S GI+++E++  E
Sbjct: 158 KLSDFGFCAQVSKEVPKRKSL--VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Query: 234 KP 235
            P
Sbjct: 216 PP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.1 bits (93), Expect = 0.002
 Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 25/173 (14%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDY-----QGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           E  AL  + H N++K+              Q  DF   +Y FM++ +  +W     K+  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAF-DW-----KDRP 264

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
             K+ R         I   +  A+ Y+H        H  +K  N+ L+ D    +GDFG 
Sbjct: 265 LLKQTRA--------IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGT 313

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE 233
           A      R       V G++   +PE   G+    I D++S G++LL+++  +
Sbjct: 314 AMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365

Length = 501

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 20/101 (19%)

Query: 142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIG 201
             L YLH      T H  +K +N+L+D +   ++ DFG+A+ +       S    KGS  
Sbjct: 113 LGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS---FKGSPY 166

Query: 202 YIAPE-------YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++APE       YG+        D++S G  +LE M   KP
Sbjct: 167 WMAPEVIAQQGGYGLA------ADIWSLGCTVLE-MATGKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 41/209 (19%)

Query: 37  NMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK 96
           N     +++     +S  +    ++  I E K L+ ++H N I         +Y+G   K
Sbjct: 42  NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI---------EYKGCYLK 92

Query: 97  A----LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALN---YLHH 149
                LV E+         L   S   E +K+P     L+ + IA     AL    YLH 
Sbjct: 93  EHTAWLVMEYC--------LGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHS 139

Query: 150 DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV 209
                  H  +K  N+LL +    ++ DFG A    P  +        G+  ++APE  +
Sbjct: 140 HNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVIL 190

Query: 210 G-NEVSTIG--DVYSYGILLLELMIREKP 235
             +E    G  DV+S GI  +EL  R+ P
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 7/96 (7%)

Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR        T  +  +    Y APE  +G      
Sbjct: 146 HRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR---YYRAPEVILGMGYKEN 202

Query: 217 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
            D++S G ++ EL+       ++F+G  ++ ++ K+
Sbjct: 203 VDIWSVGCIMGELV----KGSVIFQGTDHIDQWNKV 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 38/177 (21%), Positives = 69/177 (38%), Gaps = 39/177 (22%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVD--------YQGNDFKALVYEFMHNRSLKEWLYP 114
           F+ E + L+   H N+++++  C             QG DF      F+           
Sbjct: 40  FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT----FLRTEG------- 88

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDM 171
                     PR L +   + +  + A+ + YL       + HC+   L   N L+ +  
Sbjct: 89  ----------PR-LKVKELIQMVENAAAGMEYLE------SKHCIHRDLAARNCLVTEKN 131

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
             ++ DFG++R        ++    +  + + APE       S+  DV+S+GILL E
Sbjct: 132 VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 6/98 (6%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           +V  AL Y+H     V  H  +K +N+L+ +    ++ DFG+A  L    ++ S+    G
Sbjct: 109 EVLVALKYIHKV--GVI-HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VG 163

Query: 199 SIGYIAPEYGV-GNEVSTIGDVYSYGILLLELMIREKP 235
           +  ++APE    G    T  D++S GI + E+     P
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.003
 Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 25/154 (16%)

Query: 62  SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA-LVYEFM-HNRSLKEWLYPISKED 119
           S   E   LR ++H N++ ++   L    +  D    L++++  H+      L+ I K  
Sbjct: 48  SACREIALLRELKHENVVSLVEVFL----EHADKSVYLLFDYAEHD------LWQIIKF- 96

Query: 120 ETYKRPRNLNLLRRL--NIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL--DDDMTARV 175
             +++ + +++   +  ++   + + ++YLH        H  LKP+N+L+  +      V
Sbjct: 97  --HRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVV 151

Query: 176 --GDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPE 206
             GD GLAR F  P +       V  +I Y APE
Sbjct: 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 20/161 (12%)

Query: 70  LRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLN 129
           L+N++H  L+      L   +Q  +    V +F++     E  + + +E  ++  PR   
Sbjct: 50  LKNVKHPFLVG-----LHYSFQTTEKLYFVLDFVNG---GELFFHLQRE-RSFPEPR--- 97

Query: 130 LLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT 189
              R   A ++ASAL YLH        +  LKP N+LLD      + DFGL +       
Sbjct: 98  --ARFYAA-EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151

Query: 190 QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            T++    G+  Y+APE           D +  G +L E++
Sbjct: 152 TTTTF--CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 8/94 (8%)

Query: 157 HCVLKPSNVLLDDD-MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST 215
           H  +K  N+ L  + M A++GDFG+AR L    +   +    G+  Y++PE       + 
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPEICQNRPYNN 181

Query: 216 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249
             D++S G +L EL   + P    FEG+ NLH+ 
Sbjct: 182 KTDIWSLGCVLYELCTLKHP----FEGN-NLHQL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	381
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.98
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
PRK10345	210	hypothetical protein; Provisional	99.79
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
smart00090	237	RIO RIO-like kinase.	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.55
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.47
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
KOG1243	690	consensus Protein kinase [General function predict	99.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.12
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.12
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.06
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.04
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.04
KOG3087	229	consensus Serine/threonine protein kinase [General	98.95
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.95
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.84
COG4248	637	Uncharacterized protein with protein kinase and he	98.81
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.78
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.76
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.75
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.7
PRK09902	216	hypothetical protein; Provisional	98.57
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.45
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.36
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.33
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.28
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.04
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.98
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.87
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.79
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.75
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.62
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.59
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.57
PF01636	239	APH: Phosphotransferase enzyme family This family	97.55
PLN02876	822	acyl-CoA dehydrogenase	97.53
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.44
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.29
PRK10593	297	hypothetical protein; Provisional	96.94
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.82
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.65
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.55
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.44
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.31
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.07
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.67
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.36
PLN02756	418	S-methyl-5-thioribose kinase	94.57
PRK05231	319	homoserine kinase; Provisional	93.95
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	93.89
PHA03111	444	Ser/Thr kinase; Provisional	93.83
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.79
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.66
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.22
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.12
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	92.89
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	92.59
COG2334	331	Putative homoserine kinase type II (protein kinase	92.56
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	92.33
KOG2270	520	consensus Serine/threonine protein kinase involved	92.26
PRK10271	188	thiK thiamine kinase; Provisional	92.24
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	91.67
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	90.79
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	90.58
PTZ00384	383	choline kinase; Provisional	90.57
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	90.31
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	89.8
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	89.79
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	89.5

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-49  Score=369.32  Aligned_cols=274  Identities=35%  Similarity=0.592  Sum_probs=225.2

Q ss_pred             ccccccchhhhhccccccccceecCCCceEEEecc---------------ccc-HHHHHHHHHHHHccCCCcccceeeee
Q 041757           22 EVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRR---------------QGA-FKSFIAECKALRNIRHRNLIKVLTAC   85 (381)
Q Consensus        22 ~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~---------------~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~   85 (381)
                      .+..+..-++..+|++|...++||+|+||.||++.               ... .++|.+|+.++.+++|||+|+++|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45567778889999999999999999999998743               122 56799999999999999999999999


Q ss_pred             ccccccCCc-eEEEEEEcccCCCHHHhhccccCCcccccCCC-cccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757           86 LGVDYQGND-FKALVYEFMHNRSLKEWLYPISKEDETYKRPR-NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS  163 (381)
Q Consensus        86 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~  163 (381)
                      .+     .+ ..+||+||+++|+|.++|+.         ... .++|..+++|+.++|+||+|||..+...||||||||+
T Consensus       141 ~e-----~~~~~~LVYEym~nGsL~d~L~~---------~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss  206 (361)
T KOG1187|consen  141 LE-----GGEHRLLVYEYMPNGSLEDHLHG---------KKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS  206 (361)
T ss_pred             ec-----CCceEEEEEEccCCCCHHHHhCC---------CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence            74     33 68999999999999999974         222 8899999999999999999999887778999999999


Q ss_pred             CeeeCCCCCeEEeecccceecCC-CCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccc-c
Q 041757          164 NVLLDDDMTARVGDFGLARFLPP-TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF-E  241 (381)
Q Consensus       164 Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~-~  241 (381)
                      |||+|.++.+||+|||+|+.... .......  ..||.+|+|||+......+.|+|||||||++.|++||+.|.+... .
T Consensus       207 NILLD~~~~aKlsDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~  284 (361)
T KOG1187|consen  207 NILLDEDFNAKLSDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR  284 (361)
T ss_pred             HeeECCCCCEEccCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence            99999999999999999976654 2221111  059999999999998899999999999999999999999876443 3


Q ss_pred             CCCcHHHHHHHHhhc-hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          242 GDMNLHKFAKMALSN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      +...+..|.+..+.. .+.+++|+.+......                .......+..++.+|++.+|.+||+|.+|+++
T Consensus       285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~----------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYP----------------DEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             ccccHHHHHHHHHHCcchhheeCCCccCCCCC----------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence            344567776655555 5788888776521110                11567789999999999999999999999999


Q ss_pred             HHHhhhh
Q 041757          321 LQSIKNT  327 (381)
Q Consensus       321 L~~i~~~  327 (381)
                      |+.+...
T Consensus       349 L~~~~~~  355 (361)
T KOG1187|consen  349 LEGILSL  355 (361)
T ss_pred             HHhhccc
Confidence            9665443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-49  Score=366.95  Aligned_cols=249  Identities=31%  Similarity=0.437  Sum_probs=198.8

Q ss_pred             ccccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ......+.||.|+||+||.+.-.                  ..+.|.+|+.+|.+++|||||+++|+|..    .....+
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~----~~~~~~  116 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS----PPGSLC  116 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC----CCCceE
Confidence            34455667999999999764311                  14599999999999999999999999864    122689


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC-ceeeccCCCCeeeCCCC-CeEE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV-TAHCVLKPSNVLLDDDM-TARV  175 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-ivHrDlkp~Nill~~~~-~~kl  175 (381)
                      |||||+++|+|.++++.        .....+++..++.++.||++||.|||   +.+ ||||||||+|||++.++ ++||
T Consensus       117 iVtEy~~~GsL~~~l~~--------~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI  185 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHK--------KRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKI  185 (362)
T ss_pred             EEEEeCCCCcHHHHHhh--------cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEE
Confidence            99999999999999963        13678999999999999999999999   456 99999999999999997 9999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcC--CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV--GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      +|||+++.......  ......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....     ...... 
T Consensus       186 ~DFGlsr~~~~~~~--~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~-  257 (362)
T KOG0192|consen  186 ADFGLSREKVISKT--SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASA-  257 (362)
T ss_pred             CCCccceeeccccc--cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHH-
Confidence            99999987765431  112256999999999999  56899999999999999999999999863322     111111 


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  332 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~  332 (381)
                             ++....                  ++.++..++..+..++.+||+.||..||++.+++..|+.+........
T Consensus       258 -------v~~~~~------------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~  311 (362)
T KOG0192|consen  258 -------VVVGGL------------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG  311 (362)
T ss_pred             -------HHhcCC------------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence                   111000                  111233588899999999999999999999999999999988776543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-50  Score=343.99  Aligned_cols=245  Identities=23%  Similarity=0.336  Sum_probs=198.5

Q ss_pred             cccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      -.+|.+.++||+|.||.||++.                   ....+...+|+.+|++|+|||||+++++.+   .++...
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence            3568999999999999998864                   345678889999999999999999999643   244556


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeeccCCCCeeeCCCCCe
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV--TAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivHrDlkp~Nill~~~~~~  173 (381)
                      ++||||||..|||...++..+      +..+.+++..++.++.|++.||.++|... .+  |+||||||.||+++.+|.+
T Consensus        95 lnivmE~c~~GDLsqmIk~~K------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvv  167 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFK------KQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVV  167 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHH------hccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCce
Confidence            899999999999999996554      55778999999999999999999999521 34  9999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++.+........  +.+|||.||+||.+.+..|+.+|||||+||++|||+.-++||.    ++ ++..+    
T Consensus       168 KLGDfGL~r~l~s~~tfA~--S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~----g~-n~~~L----  236 (375)
T KOG0591|consen  168 KLGDFGLGRFLSSKTTFAH--SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY----GD-NLLSL----  236 (375)
T ss_pred             eeccchhHhHhcchhHHHH--hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc----cc-cHHHH----
Confidence            9999999998876544333  3789999999999999999999999999999999999999975    22 33222    


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHH-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINII-RECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                              ..+.-..+..               +.+ ...+.++..|+..|+..||+.||+...++..+.+
T Consensus       237 --------~~KI~qgd~~---------------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  237 --------CKKIEQGDYP---------------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --------HHHHHcCCCC---------------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                    2222211111               012 4677889999999999999999997655555543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=352.05  Aligned_cols=236  Identities=22%  Similarity=0.315  Sum_probs=195.7

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc-eE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND-FK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~-~~   96 (381)
                      .+....+.||+|..|+|+++.+                  ...+++.+|++++++.+||+||++||.|+.     +. ..
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~i  153 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEI  153 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceE
Confidence            3566779999999999988653                  346788999999999999999999999753     44 69


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      .|+||||.+|+|++++          ...+++++.....++.++++||.|||+  ..+||||||||+|||++..|.+||+
T Consensus       154 sI~mEYMDgGSLd~~~----------k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKic  221 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDIL----------KRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKIC  221 (364)
T ss_pred             EeehhhcCCCCHHHHH----------hhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEec
Confidence            9999999999999999          445789999999999999999999995  2599999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||.++.+.....    .+++||..|||||.+.+..|+.++||||||++++|+.+|+.||.........           
T Consensus       222 DFGVS~~lvnS~a----~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-----------  286 (364)
T KOG0581|consen  222 DFGVSGILVNSIA----NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-----------  286 (364)
T ss_pred             cccccHHhhhhhc----ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-----------
Confidence            9999998776622    2378999999999999999999999999999999999999997633111122           


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIR-ECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       .-+++.......+..               .+. .+.+++..++..||++||.+|||+.|+++
T Consensus       287 -~~~Ll~~Iv~~ppP~---------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  287 -IFELLCAIVDEPPPR---------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -HHHHHHHHhcCCCCC---------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             233344333322211               123 37788999999999999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-48  Score=367.03  Aligned_cols=231  Identities=23%  Similarity=0.346  Sum_probs=200.6

Q ss_pred             ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ..|..+++||+|||+.||.++                    ....+...+|+++.++|+|||||+++++     |++.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence            569999999999999998765                    3456788899999999999999999999     678999


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      +|||+|+|+.++|..++          ++.+.+++.+++.++.||+.||.|||   +.+|+|||||..|++++++..+||
T Consensus        93 VYivLELC~~~sL~el~----------Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKI  159 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELL----------KRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKI  159 (592)
T ss_pred             eEEEEEecCCccHHHHH----------HhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEe
Confidence            99999999999999999          56788999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+|..+..+......  .+|||.|.|||++....++..+||||+||++|.|+.|++||+                 .
T Consensus       160 gDFGLAt~le~~~Erk~T--lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe-----------------t  220 (592)
T KOG0575|consen  160 GDFGLATQLEYDGERKKT--LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE-----------------T  220 (592)
T ss_pred             cccceeeeecCcccccce--ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc-----------------c
Confidence            999999988765433332  689999999999999999999999999999999999999986                 2


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..+++..++....+...                |.....+..+|+.++|+.||.+|||+++|+.
T Consensus       221 k~vkety~~Ik~~~Y~~----------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  221 KTVKETYNKIKLNEYSM----------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             chHHHHHHHHHhcCccc----------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            23444444443333321                3456677889999999999999999999995

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=359.60  Aligned_cols=241  Identities=26%  Similarity=0.407  Sum_probs=197.0

Q ss_pred             ccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           38 MLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      +...+.||+|-||.|++.+               ....+.|.+|+++|++|+|+|||+++++|..     ++.++|||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVtE~  282 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVTEY  282 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEEEe
Confidence            4456899999999997754               2345789999999999999999999999864     4579999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      |+.|+|.++|..        .....+...+.+.++.|||+|++||.   ++++|||||..+|||++++..+||+|||+|+
T Consensus       283 m~~GsLl~yLr~--------~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  283 MPKGSLLDYLRT--------REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             cccCcHHHHhhh--------cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccc
Confidence            999999999963        24677889999999999999999999   7799999999999999999999999999999


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      ...++... ......-++.|.|||.+....|+.|||||||||+||||+| |+.|+..+.    +             .++
T Consensus       352 ~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms----n-------------~ev  413 (468)
T KOG0197|consen  352 LIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS----N-------------EEV  413 (468)
T ss_pred             ccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC----H-------------HHH
Confidence            55544432 2222345789999999999999999999999999999998 888854221    1             111


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      +...-               ...+.+.|..||..+.++|..||+.+|++|||+..+...|+.+...
T Consensus       414 ~~~le---------------~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  414 LELLE---------------RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HHHHh---------------ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            11100               0112223568999999999999999999999999999999887653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-47  Score=344.24  Aligned_cols=237  Identities=18%  Similarity=0.250  Sum_probs=188.8

Q ss_pred             ccccccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~   89 (381)
                      ..+.|.+.+.||+|+||.|.++.+                        .......+|+++|++|+|||||+++++     
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----  244 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----  244 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----
Confidence            346688889999999999966431                        112234689999999999999999999     


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                      +...+..|+||||+.||+|.+++          ...+.+.+.....++.|++.|+.|||   +.||+||||||+|||+..
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~v----------v~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~  311 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKV----------VANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSN  311 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHH----------HhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEecc
Confidence            55677889999999999999999          56778888888999999999999999   779999999999999976


Q ss_pred             C---CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCcc---CcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757          170 D---MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV---STIGDVYSYGILLLELMIREKPSDIMFEGD  243 (381)
Q Consensus       170 ~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~sDiwSlG~il~el~tg~~Pf~~~~~~~  243 (381)
                      +   ..+||+|||+|+.........   ..+||+.|.|||++.+..+   ..++||||+||+||-+++|.+||.......
T Consensus       312 ~~e~~llKItDFGlAK~~g~~sfm~---TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~  388 (475)
T KOG0615|consen  312 DAEDCLLKITDFGLAKVSGEGSFMK---TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP  388 (475)
T ss_pred             CCcceEEEecccchhhccccceehh---hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence            6   689999999999877443332   3789999999999987543   457899999999999999999987444332


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .-..++....+.-                            .+........+..+++.+||..||++|||+.|+++
T Consensus       389 sl~eQI~~G~y~f----------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  389 SLKEQILKGRYAF----------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cHHHHHhcCcccc----------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            2222221111110                            01113466778899999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-47  Score=339.25  Aligned_cols=184  Identities=28%  Similarity=0.481  Sum_probs=163.9

Q ss_pred             hccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..-++|...+.||+|+||+||+++.                   ..++.+.+|+.+|+.++|||||++++++     ...
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~   81 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDD   81 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecC
Confidence            3467899999999999999998752                   2456678899999999999999999995     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC---
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD---  170 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---  170 (381)
                      ++.|||||||.||||.+|+          ...+.+++..+..++.||+.||++||   +++||||||||+|||++..   
T Consensus        82 ~~i~lVMEyC~gGDLs~yi----------~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~  148 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYI----------RRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARN  148 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHH----------HHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCC
Confidence            8999999999999999999          45668999999999999999999999   7799999999999999765   


Q ss_pred             ---CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          171 ---MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       171 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                         -.+||+|||+|+.+.......   ..+|++.|||||++....|+.|+|+||+|+++|++++|+.||+
T Consensus       149 ~~~~~LKIADFGfAR~L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  149 DTSPVLKIADFGFARFLQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             CCCceEEecccchhhhCCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence               468999999999887554433   2679999999999999999999999999999999999999986

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-46  Score=329.80  Aligned_cols=184  Identities=27%  Similarity=0.357  Sum_probs=166.1

Q ss_pred             ccccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .-++|...++||+|+||+|+.++                    ....+...+|..+|.+++||.||+++..     +++.
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence            35789999999999999997765                    2346677889999999999999999988     7889


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +.+|+|+||+.||.|..+|          .+...+++..+.-++.+|+.||.|||   +++||||||||+|||+|.+|++
T Consensus        98 ~kLylVld~~~GGeLf~hL----------~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi  164 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHL----------QREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHI  164 (357)
T ss_pred             CeEEEEEeccCCccHHHHH----------HhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcE
Confidence            9999999999999999999          56788999999999999999999999   7799999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +|+|||+++........+.  .++||+.|||||++.+..|+..+|+||+|+++|||++|.+||.
T Consensus       165 ~LtDFgL~k~~~~~~~~t~--tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~  226 (357)
T KOG0598|consen  165 KLTDFGLCKEDLKDGDATR--TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY  226 (357)
T ss_pred             EEeccccchhcccCCCccc--cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence            9999999986554433333  2789999999999999999999999999999999999999975

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.4e-46  Score=360.76  Aligned_cols=253  Identities=23%  Similarity=0.390  Sum_probs=206.5

Q ss_pred             ccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           36 RNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .+-...+.||+|+||+||+++                       ....++|.+|+++|..|+|||||+++|+|..     
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----  560 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----  560 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----
Confidence            445556889999999997754                       2367899999999999999999999999864     


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccC----CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKR----PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                      ++..++|+|||..|||.+||..........-.    +..++..+.+.|+.|||.|+.||-   +..+|||||..+|+||.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence            78899999999999999999755443222212    445999999999999999999999   66999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH  247 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~  247 (381)
                      ++..|||+|||+++.+-...+......-.-+++|||||.+..++|+++||||||||+|||+++ |+.||......+    
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----  713 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----  713 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence            999999999999998777666554433335789999999999999999999999999999997 899975222110    


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                               .+..+-+..+                   .+.++.||.++.+||..||+.+|.+||+++||-..|+.....
T Consensus       714 ---------VIe~i~~g~l-------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 ---------VIECIRAGQL-------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ---------HHHHHHcCCc-------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                     0111111111                   122568999999999999999999999999999999998765


Q ss_pred             c
Q 041757          328 L  328 (381)
Q Consensus       328 ~  328 (381)
                      .
T Consensus       766 s  766 (774)
T KOG1026|consen  766 S  766 (774)
T ss_pred             C
Confidence            4

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=331.22  Aligned_cols=245  Identities=21%  Similarity=0.296  Sum_probs=189.4

Q ss_pred             cccccccceecCCCceEEEeccccc-----------------HHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQGA-----------------FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ..++..++.||+|+||+||++....                 .+.+.+|+.+|.+|+|||||+++|....   ......+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~---~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS---RENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc---ccCeeeE
Confidence            4668889999999999998865321                 5568999999999999999999997322   1113689


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEEe
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARVG  176 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~  176 (381)
                      +.|||+++|+|.+++..         ....+++..+..+..||++||.|||   +++||||||||+|||++. ++.+||+
T Consensus        93 i~mEy~~~GsL~~~~~~---------~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~Kla  160 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKR---------YGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLA  160 (313)
T ss_pred             eeeeccCCCcHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEec
Confidence            99999999999999953         1227999999999999999999999   779999999999999999 7999999


Q ss_pred             ecccceecCCC-CCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          177 DFGLARFLPPT-RTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       177 Dfg~~~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |||+++..... ..........||+.|||||++... ....++|||||||++.||+||+.||...   ............
T Consensus       161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~  237 (313)
T KOG0198|consen  161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGR  237 (313)
T ss_pred             cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhc
Confidence            99999876641 111222346799999999999853 3445999999999999999999998633   111111111111


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ....                           +.++...+.+..+++.+|+..||++|||+.++++.--..
T Consensus       238 ~~~~---------------------------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  238 EDSL---------------------------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             cCCC---------------------------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence            1100                           012445677888999999999999999999999855433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-45  Score=336.27  Aligned_cols=237  Identities=22%  Similarity=0.339  Sum_probs=196.3

Q ss_pred             hhccccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY   90 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~   90 (381)
                      .....+|..++.||.|+|++|++++                    +..++....|-.+|.+| .||.|+++|..     +
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence            3346789999999999999997765                    33455566799999999 69999999988     6


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ++...+|+|+||+++|+|.++|          .+.+.+++..++.++.+|+.||+|||   +.|||||||||+|||+|++
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i----------~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~d  210 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLI----------KKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKD  210 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHH----------HHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCC
Confidence            7799999999999999999999          56788999999999999999999999   6799999999999999999


Q ss_pred             CCeEEeecccceecCCCCCc---------ccc--cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcc
Q 041757          171 MTARVGDFGLARFLPPTRTQ---------TSS--IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM  239 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~---------~~~--~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~  239 (381)
                      +++||+|||.|+.+......         ...  ..++||..|.+||+|.....+..+|||+|||++|.|+.|++||.  
T Consensus       211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr--  288 (604)
T KOG0592|consen  211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR--  288 (604)
T ss_pred             CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc--
Confidence            99999999999988754222         111  45889999999999999999999999999999999999999975  


Q ss_pred             ccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          240 FEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        +...+.-+             .+.+..+.                .+++..++.+.+|+.+.|..||.+|+|..+|.+
T Consensus       289 --a~NeyliF-------------qkI~~l~y----------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  289 --AANEYLIF-------------QKIQALDY----------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             --cccHHHHH-------------HHHHHhcc----------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence              22222211             11111111                123456677888899999999999999988865

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-45  Score=331.94  Aligned_cols=263  Identities=21%  Similarity=0.266  Sum_probs=201.2

Q ss_pred             hhccccccccceecCCCceEEEecccc------cHHHH------------HHHHHHHHccC-CCcccceeeeeccccccC
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQG------AFKSF------------IAECKALRNIR-HRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~~------------~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~   92 (381)
                      ....++|...++||.|+||.||+++..      +++..            +||++.|++|+ |||||++.+++.+    .
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~   81 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----N   81 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----c
Confidence            345688999999999999999998632      12221            47999999998 9999999999643    2


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ...+++|||||+. +|.++++         .+.+.+++..+..|+.||+.||+|+|   ..|+.|||+||+|||+.....
T Consensus        82 ~~~L~fVfE~Md~-NLYqLmK---------~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~  148 (538)
T KOG0661|consen   82 DRILYFVFEFMDC-NLYQLMK---------DRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDV  148 (538)
T ss_pred             CceEeeeHHhhhh-hHHHHHh---------hcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccce
Confidence            3389999999965 9999997         45788999999999999999999999   669999999999999998899


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+|+.+......+.   ++.|..|+|||++.. ..|+.+.||||+|||++|+.+-++.    |+|...++++.+
T Consensus       149 iKiaDFGLARev~SkpPYTe---YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL----FPG~sE~Dqi~K  221 (538)
T KOG0661|consen  149 IKIADFGLAREVRSKPPYTE---YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL----FPGASEIDQIYK  221 (538)
T ss_pred             eEecccccccccccCCCcch---hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc----CCCCcHHHHHHH
Confidence            99999999998876655543   678999999998664 6789999999999999999998887    566666666555


Q ss_pred             HH---hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          252 MA---LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       252 ~~---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      ..   ..+...++......  ....-+...+..........+.+..+.++++.+|+.+||.+|||+.+.++.
T Consensus       222 Ic~VLGtP~~~~~~eg~~L--a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  222 ICEVLGTPDKDSWPEGYNL--ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhCCCccccchhHHHH--HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            43   12211111110000  000001111122222334445688899999999999999999999999873

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-44  Score=311.84  Aligned_cols=257  Identities=19%  Similarity=0.295  Sum_probs=193.6

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      +.|+...++|+|+||+|++.+.                   ...+-.++|+++|++|+|+|+|.++.+     +......
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence            3577788999999999987652                   134556899999999999999999999     5568899


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      +||+|||+. ++.+-|.         ..+..++...+..++.|++.|+.|+|   +.++|||||||+|||++.++.+||+
T Consensus        77 hLVFE~~dh-TvL~eLe---------~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLC  143 (396)
T KOG0593|consen   77 HLVFEYCDH-TVLHELE---------RYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLC  143 (396)
T ss_pred             EEEeeecch-HHHHHHH---------hccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEec
Confidence            999999977 5555553         45677899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--  253 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--  253 (381)
                      |||+|+.+..+.....  .++.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+-|    ++...+.++....  
T Consensus       144 DFGFAR~L~~pgd~YT--DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~----PG~SDiDQLy~I~kt  217 (396)
T KOG0593|consen  144 DFGFARTLSAPGDNYT--DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW----PGRSDIDQLYLIRKT  217 (396)
T ss_pred             cchhhHhhcCCcchhh--hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC----CCcchHHHHHHHHHH
Confidence            9999998875444333  3679999999999988 67999999999999999999999985    4555444443322  


Q ss_pred             hhc---hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +.+   ....++..--   .-..+...........+.-.+....-+++++..|++.||++|++.+|++.
T Consensus       218 LG~L~prhq~iF~~N~---~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  218 LGNLIPRHQSIFSSNP---FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HcccCHHHHHHhccCC---ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111   1111111100   00000011111122222223455568899999999999999999999984

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.2e-44  Score=334.48  Aligned_cols=254  Identities=22%  Similarity=0.316  Sum_probs=192.6

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~   90 (381)
                      .++|...++||+|+||.||++..                       ...+.+.+|+.++..+ +||||++++++|.    
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT----   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec----
Confidence            46799999999999999987631                       1235688999999999 8999999999864    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcc--------------------------------------------------
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE--------------------------------------------------  120 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------------  120 (381)
                      ......++||||+++|+|.+++........                                                  
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            234568999999999999999864221000                                                  


Q ss_pred             --cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccC
Q 041757          121 --TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG  198 (381)
Q Consensus       121 --~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  198 (381)
                        .......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...............+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence              0001235788899999999999999999   66999999999999999999999999999986644332222222346


Q ss_pred             ccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcc
Q 041757          199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRG  277 (381)
Q Consensus       199 t~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  277 (381)
                      ++.|+|||++.+..++.++|||||||++|||++ |..||......    ..+...        +.+....          
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~~~~~~--------~~~~~~~----------  296 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----EEFCQR--------LKDGTRM----------  296 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHH--------HhcCCCC----------
Confidence            788999999998899999999999999999997 99997532111    111110        0000000          


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          278 DQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                               ..+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       297 ---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         297 ---------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                     0012445678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-43  Score=326.15  Aligned_cols=261  Identities=22%  Similarity=0.265  Sum_probs=198.5

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .+.|+..++||+|+||.||+++.                   +...-..+||.+|++|.||||+++.+..++   .....
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~s  192 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSGS  192 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCce
Confidence            35688899999999999999762                   344567899999999999999999999654   33678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      +|||+|||+. ||..++.         ...-.+++.++..++.|++.||+|+|   ..+|+|||||.+|||||.+|.+||
T Consensus       193 iYlVFeYMdh-DL~GLl~---------~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKi  259 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLS---------SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKI  259 (560)
T ss_pred             EEEEEecccc-hhhhhhc---------CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEe
Confidence            9999999976 9999985         44668999999999999999999999   779999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH---HHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH---KFAK  251 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~---~~~~  251 (381)
                      +|||+|+++....... .+..+-|..|+|||.+.+ ..|+.++|+||.||||.||++|++.|.    +...+.   .+.+
T Consensus       260 aDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~----G~tEveQl~kIfk  334 (560)
T KOG0600|consen  260 ADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ----GRTEVEQLHKIFK  334 (560)
T ss_pred             ccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC----CccHHHHHHHHHH
Confidence            9999999877655432 233568999999999887 469999999999999999999999854    443333   3333


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...++.-.. ...  ..-|.-..+.................+...++|+..+|..||++|.|+.++++
T Consensus       335 lcGSP~e~~-W~~--~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  335 LCGSPTEDY-WPV--SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HhCCCChhc-ccc--ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            333322111 110  00011011111111111122224556678899999999999999999999886

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=330.53  Aligned_cols=233  Identities=23%  Similarity=0.296  Sum_probs=189.4

Q ss_pred             hccccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccC-CCcccceeeeecccc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVD   89 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~   89 (381)
                      ...++|..++.||+|+||+|+++..                      ...+...+|+.+++.++ ||||++++.+     
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev-----   88 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV-----   88 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE-----
Confidence            3567899999999999999977642                      12345567999999999 9999999999     


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                      +......++|||||.+|+|.+++          ....++.+..+..++.|++.|++|||   +.+|+||||||+|||++.
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i----------~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~  155 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYI----------VNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDG  155 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHH----------HHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecC
Confidence            55677799999999999999999          44778999999999999999999999   679999999999999999


Q ss_pred             C-CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc-cC-cccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          170 D-MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VS-TIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       170 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                      + +.+||+|||++......  .......+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+.     .+.
T Consensus       156 ~~~~~Kl~DFG~s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~  228 (370)
T KOG0583|consen  156 NEGNLKLSDFGLSAISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNV  228 (370)
T ss_pred             CCCCEEEeccccccccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccH
Confidence            9 99999999999887411  11222368999999999999977 85 789999999999999999999873     111


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHH-HHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIREC-VISMVRIGVACSMESPQDRMKMTNVV  318 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~~vl  318 (381)
                      ...            ..+......                .++... ..++..++.+|+..||.+|+|+.+++
T Consensus       229 ~~l------------~~ki~~~~~----------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  229 PNL------------YRKIRKGEF----------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHH------------HHHHhcCCc----------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            111            111111100                112233 67889999999999999999999999

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-44  Score=358.03  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=207.8

Q ss_pred             cccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           37 NMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      +-...+.||+|.||.||.+.                       ...+..|.+|..+|++++|||||+++|+|..     .
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~  767 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S  767 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence            34456899999999997743                       3467889999999999999999999999864     6


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...+|++|||++|||..||+..+...   .....++..+.+.++.|||+|+.||+   .+++|||||..+|+|++....+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~---~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAP---FQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhccccc---CCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcE
Confidence            77899999999999999997544322   22677999999999999999999999   7799999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||+|+.+....+........-+..|||||.+....|+.|+|||||||++||++| |..||..    ..+...+.. 
T Consensus       842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~----~~n~~v~~~-  916 (1025)
T KOG1095|consen  842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS----RSNFEVLLD-  916 (1025)
T ss_pred             EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC----cchHHHHHH-
Confidence            9999999996655554443332234689999999999999999999999999999998 8888642    222211110 


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  332 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~  332 (381)
                              +..                   .++.+.+..|+..+.++|..||+.+|++||++..+++++.++........
T Consensus       917 --------~~~-------------------ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~  969 (1025)
T KOG1095|consen  917 --------VLE-------------------GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI  969 (1025)
T ss_pred             --------HHh-------------------CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence                    111                   01223356899999999999999999999999999999999988776654


Q ss_pred             Ccc
Q 041757          333 NLA  335 (381)
Q Consensus       333 ~~~  335 (381)
                      ...
T Consensus       970 ~~~  972 (1025)
T KOG1095|consen  970 YGP  972 (1025)
T ss_pred             ccc
Confidence            433

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=334.74  Aligned_cols=245  Identities=26%  Similarity=0.409  Sum_probs=197.5

Q ss_pred             ccccccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      +....+..||+|.||+||+++                ....+.|.+|+.++++-+|.||+-+.|+|.      +....||
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~------~p~~AIi  465 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM------NPPLAII  465 (678)
T ss_pred             HHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc------CCceeee
Confidence            445567999999999998865                346789999999999999999999999975      3344999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      +-+|+|.+|+.+|+         .....+...+.+.|+.||+.|+.|||   .++|||||||..||++.++++|||+|||
T Consensus       466 TqwCeGsSLY~hlH---------v~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLH---------VQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             ehhccCchhhhhcc---------chhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccc
Confidence            99999999999998         45578999999999999999999999   8899999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ++..-..-..........|.+.|||||+++.   .+|++.|||||||+|+|||++|..||....     -+++..+..+.
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-----~dqIifmVGrG  608 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-----RDQIIFMVGRG  608 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-----hhheEEEeccc
Confidence            9865433222222223568999999998874   569999999999999999999999986221     12222221111


Q ss_pred             h-HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          257 H-VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       257 ~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      . ..++.                        .....|++++.+|+..||..++++||.+.+|+..|+.+..+
T Consensus       609 ~l~pd~s------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  609 YLMPDLS------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ccCccch------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            1 11111                        11347888999999999999999999999999999888765

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-43  Score=328.36  Aligned_cols=230  Identities=27%  Similarity=0.396  Sum_probs=195.2

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|-+.+.||+|+||+||+++.                   ...+.+.+|+++++.|+|||||.++++     +++..+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence            4677888999999999998762                   245668899999999999999999999     6789999


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      |+|+|||.| +|..+|          .....++++.+..++.|++.||.|||   +.+|+|||+||+|||++.++.+|++
T Consensus        77 ~vVte~a~g-~L~~il----------~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Klc  142 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTIL----------EQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLC  142 (808)
T ss_pred             EEEehhhhh-hHHHHH----------HhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeec
Confidence            999999977 999999          56788999999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||+|+.+.....-  ...+.||+.|||||.+.+..|+..+|+||+||++||+++|++||.                 ..
T Consensus       143 dFg~Ar~m~~~t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-----------------a~  203 (808)
T KOG0597|consen  143 DFGLARAMSTNTSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-----------------AR  203 (808)
T ss_pred             hhhhhhhcccCcee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-----------------HH
Confidence            99999987664332  223679999999999999999999999999999999999999974                 22


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .+..++..++..+..                .+......+..++...+..||..|.|..+++.
T Consensus       204 si~~Lv~~I~~d~v~----------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  204 SITQLVKSILKDPVK----------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHHHHHHhcCCCC----------------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            233344433322211                13356678888999999999999999999985

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-43  Score=327.27  Aligned_cols=234  Identities=20%  Similarity=0.278  Sum_probs=193.9

Q ss_pred             cccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ...|..-.+||+|+.|.||.+.                 +...+..++|+.+|+..+|+|||.+++.+..     .+.+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-----~deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-----GDELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-----cceeE
Confidence            4557778999999999998765                 3456778899999999999999999999653     57899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||++||+|.+.+.           ...+++.++..|+++++.||+|||   ..+|+|||||.+|||++.+|.+||+|
T Consensus       347 VVMEym~ggsLTDvVt-----------~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltD  412 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVT-----------KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTD  412 (550)
T ss_pred             EEEeecCCCchhhhhh-----------cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEee
Confidence            9999999999999983           455999999999999999999999   77999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++..+........  ..+||+.|||||++....|++++||||||++++||+-|++||-+    +..+..+....-...
T Consensus       413 FGFcaqi~~~~~KR~--TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng~  486 (550)
T KOG0578|consen  413 FGFCAQISEEQSKRS--TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNGT  486 (550)
T ss_pred             eeeeeccccccCccc--cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcCC
Confidence            999988876654333  36799999999999999999999999999999999999999732    223222222111110


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                  +              ....+......+.+++.+||..|+++||++.++|+
T Consensus       487 ------------P--------------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  487 ------------P--------------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ------------C--------------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence                        0              00113456678899999999999999999999996

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-42  Score=295.86  Aligned_cols=257  Identities=22%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      +.|...++||+|.||.||++++                   +.....++|++.|+.++|+||+.++++     +...+..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence            4688899999999999988752                   234578899999999999999999999     5668889


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      .||+||++. ||+..++         .+...++..++..++.++++|++|||   .+.|+||||||.|+|++.+|.+||+
T Consensus        77 ~lVfEfm~t-dLe~vIk---------d~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiA  143 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIK---------DKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIA  143 (318)
T ss_pred             EEEEEeccc-cHHHHhc---------ccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEee
Confidence            999999976 9999997         46678999999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--  253 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--  253 (381)
                      |||+++.+.........  .+-|..|+|||.+.| ..|+..+||||.||++.||+.|.+-    +.++..++++....  
T Consensus       144 DFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~----fpG~sDidQL~~If~~  217 (318)
T KOG0659|consen  144 DFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF----FPGDSDIDQLSKIFRA  217 (318)
T ss_pred             cccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC----CCCCchHHHHHHHHHH
Confidence            99999988766544333  257999999998887 4699999999999999999998876    56776666654433  


Q ss_pred             -hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          254 -LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       254 -~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                       ..+.....-+-.-..+..+......    .........+..+.++++..+|.+||.+|+|++|+++.
T Consensus       218 LGTP~~~~WP~~~~lpdY~~~~~~P~----~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  218 LGTPTPDQWPEMTSLPDYVKIQQFPK----PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cCCCCcccCccccccccHHHHhcCCC----CccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence             1211111111111111111110000    00111334566778999999999999999999999873

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-43  Score=329.55  Aligned_cols=244  Identities=24%  Similarity=0.372  Sum_probs=192.9

Q ss_pred             cccccceecCCCceEEEecc------------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           37 NMLEENLISAGTFGFSHLRR------------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~------------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      +-...++||+|+||.|+.++                        ...+.+|++|+++|++++|||||++||++.     .
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~-----~  232 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV-----L  232 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----C
Confidence            33445999999999995532                        235678999999999999999999999965     4


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ...++||||+|.||+|.++|.         +....++..+...++.+.+.||+|||   +++++||||..+|+|++.++.
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~---------k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLK---------KNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHH---------hCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCe
Confidence            788999999999999999995         33346999999999999999999999   789999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++.-...  ........-++.|+|||.+....|+.++|||||||++||+++ |..||....    ...    
T Consensus       301 vKISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~----~~~----  370 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK----NYE----  370 (474)
T ss_pred             EEeCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC----HHH----
Confidence            999999998754411  111111235789999999999999999999999999999998 888965221    111    


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  330 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~  330 (381)
                               +........              .+...+...+..+..++.+||..||++||||.++.+.|+.+......
T Consensus       371 ---------v~~kI~~~~--------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  371 ---------VKAKIVKNG--------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ---------HHHHHHhcC--------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                     111110000              00011235667888888899999999999999999999999876543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=326.80  Aligned_cols=239  Identities=24%  Similarity=0.359  Sum_probs=195.7

Q ss_pred             ccceecCCCceEEEeccc----ccHHH----HHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHh
Q 041757           40 EENLISAGTFGFSHLRRQ----GAFKS----FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW  111 (381)
Q Consensus        40 ~~~~lG~G~fg~V~~~~~----~~~~~----~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~  111 (381)
                      ..+-||.|+-|.|++.+-    .+++.    -..+|+-|++|+||||+.|.|+|..     ...++||||||..|.|..+
T Consensus       128 ELeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecC-----CceeEEeeeccccccHHHH
Confidence            358899999999988652    22222    2347888999999999999999975     6788999999999999999


Q ss_pred             hccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcc
Q 041757          112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQT  191 (381)
Q Consensus       112 l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  191 (381)
                      |          +....++......|..+||.|+.|||   ...|||||||.-||||..+..+||+|||-++...+.   .
T Consensus       203 L----------ka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S  266 (904)
T KOG4721|consen  203 L----------KAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S  266 (904)
T ss_pred             H----------hccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence            9          56788999999999999999999999   669999999999999999999999999999876554   2


Q ss_pred             cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCch
Q 041757          192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDE  271 (381)
Q Consensus       192 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  271 (381)
                      ....++||..|||||++...+.+.|+||||||||||||+||..||.+.-..     .+++...++.+             
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGVGsNsL-------------  328 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGVGSNSL-------------  328 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEeccCCcc-------------
Confidence            233478999999999999999999999999999999999999998633211     11111111111             


Q ss_pred             hhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 041757          272 KLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  330 (381)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~  330 (381)
                                   -...+..|++.+.-|+++||+..|..||++.+++..|+-...++..
T Consensus       329 -------------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~  374 (904)
T KOG4721|consen  329 -------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS  374 (904)
T ss_pred             -------------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence                         1122568999999999999999999999999999999866555543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1e-41  Score=312.64  Aligned_cols=252  Identities=19%  Similarity=0.261  Sum_probs=192.2

Q ss_pred             cccccchhhhhccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeee
Q 041757           23 VGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTA   84 (381)
Q Consensus        23 ~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~   84 (381)
                      +.+++.+...++  +......||+|++|.||++..                  ...+.|.+|+.+|.+++||||++++++
T Consensus         9 ~~~~~~i~~~~i--~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~   86 (283)
T PHA02988          9 INDIKCIESDDI--DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF   86 (283)
T ss_pred             cCcceecCHHHc--CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence            444555444444  233336799999999977541                  114677899999999999999999999


Q ss_pred             eccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCC
Q 041757           85 CLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSN  164 (381)
Q Consensus        85 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~N  164 (381)
                      +.+. .......++||||+++|+|.+++.          ....+++...+.++.|++.||.|||..  .+++||||||+|
T Consensus        87 ~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~n  153 (283)
T PHA02988         87 IIDI-VDDLPRLSLILEYCTRGYLREVLD----------KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVS  153 (283)
T ss_pred             EEec-ccCCCceEEEEEeCCCCcHHHHHh----------hCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhh
Confidence            7531 123457899999999999999994          345688899999999999999999942  378899999999


Q ss_pred             eeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       165 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      |+++.++.+||+|||+++.......     ...|+..|+|||++.+  ..++.++|||||||++|||++|+.||....  
T Consensus       154 ill~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--  226 (283)
T PHA02988        154 FLVTENYKLKIICHGLEKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--  226 (283)
T ss_pred             EEECCCCcEEEcccchHhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--
Confidence            9999999999999999986543322     2358899999999876  679999999999999999999999986321  


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                         ....            ..........              ...+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       227 ---~~~~------------~~~i~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~  277 (283)
T PHA02988        227 ---TKEI------------YDLIINKNNS--------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS  277 (283)
T ss_pred             ---HHHH------------HHHHHhcCCC--------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence               1111            1111100000              0011245678899999999999999999999999999


Q ss_pred             Hhh
Q 041757          323 SIK  325 (381)
Q Consensus       323 ~i~  325 (381)
                      .+.
T Consensus       278 ~~~  280 (283)
T PHA02988        278 LYK  280 (283)
T ss_pred             HHH
Confidence            875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=327.06  Aligned_cols=231  Identities=21%  Similarity=0.306  Sum_probs=196.7

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .+-|+.++-||.|+-|.|.++++                    .......+|+.+|+-+.||||+++|++     ++++.
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence            35588999999999999977662                    234567889999999999999999999     77899


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ++|+|.||+++|-|.+++          ...+.+++.++.+++.||+.|+.|+|   ..+|+||||||+|+|++..+.+|
T Consensus        86 ~lylvlEyv~gGELFdyl----------v~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIK  152 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYL----------VRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIK  152 (786)
T ss_pred             eEEEEEEecCCchhHHHH----------HhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEe
Confidence            999999999999999999          67889999999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||+|..-..+.....   .||++.|+|||++.+.+| +.++||||.|||||.|+||+.||+     +.+        
T Consensus       153 IADFGMAsLe~~gklLeT---SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdN--------  216 (786)
T KOG0588|consen  153 IADFGMASLEVPGKLLET---SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDN--------  216 (786)
T ss_pred             eeccceeecccCCccccc---cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----Ccc--------
Confidence            999999986555444333   579999999999999988 578999999999999999999986     222        


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          ++.++.+.-.+                ...++.+.+.+..+|+.+|+..||+.|.|+.||++
T Consensus       217 ----ir~LLlKV~~G----------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  217 ----IRVLLLKVQRG----------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ----HHHHHHHHHcC----------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                23333322222                12335677889999999999999999999999987

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=309.72  Aligned_cols=247  Identities=21%  Similarity=0.278  Sum_probs=192.9

Q ss_pred             ccccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      -.+.|+...+||.|.-++||++.                  +.....+.+|+..|+.++||||++++..|+     .+..
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~~~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VDSE   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----ecce
Confidence            46789999999999999998865                  234678899999999999999999999965     4888


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      +|+||.||.+|++.+.++.        .-+..+++..+..|+.++++||.|||   ..|.||||||+.||||+.+|.+||
T Consensus        99 LWvVmpfMa~GS~ldIik~--------~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkL  167 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKT--------YYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKL  167 (516)
T ss_pred             eEEeehhhcCCcHHHHHHH--------HccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEE
Confidence            9999999999999999964        23456999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCc-ccc-cCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          176 GDFGLARFLPPTRTQ-TSS-IDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~-~~~-~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +|||.+..+...... ... ..++||+.|||||++..  ..|+.|+||||||++..|+.+|..||...-+.     +...
T Consensus       168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvLl  242 (516)
T KOG0582|consen  168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVLL  242 (516)
T ss_pred             cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHHH
Confidence            999988766554321 111 34679999999999654  46999999999999999999999998633221     1111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..+.+.           .|.....       ....+........+.+++..||..||.+|||++++++
T Consensus       243 ~tLqn~-----------pp~~~t~-------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  243 LTLQND-----------PPTLLTS-------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             HHhcCC-----------CCCcccc-------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111111           1100000       0000112345558888999999999999999999986

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=305.63  Aligned_cols=272  Identities=22%  Similarity=0.294  Sum_probs=202.7

Q ss_pred             hhhhccccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           30 EILDVSRNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      +...+...|...+.||+|+||.|..+.                   ....++..+|+++|+.++|+||+.+++++.....
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            445566777778999999999995533                   2245677889999999999999999999776444


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ..-+..|+|+|+| +-||.+.+          +....++...+..++.|++.||.|+|   +.+|+||||||+|++++.+
T Consensus        96 ~~f~DvYiV~elM-etDL~~ii----------k~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~  161 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQII----------KSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNAD  161 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHH----------HcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccC
Confidence            5677889999999 55999999          45566999999999999999999999   7799999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcC-CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      ..+||+|||+|+...........+..+.|..|+|||.+. ...|+.+.||||.|||+.||++|++-|    .|.....++
T Consensus       162 c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF----pG~d~v~Ql  237 (359)
T KOG0660|consen  162 CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF----PGKDYVHQL  237 (359)
T ss_pred             CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC----CCCchHHHH
Confidence            999999999999886543233334577899999999765 578999999999999999999999985    444443333


Q ss_pred             HHH--HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKM--ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...  ..+..-.+.+...-.......+...............+...+..++|+.+||..||.+|+|++|+++
T Consensus       238 ~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  238 QLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            221  1111112222211111111111111122222223334567778999999999999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=297.41  Aligned_cols=180  Identities=24%  Similarity=0.366  Sum_probs=163.5

Q ss_pred             cccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|...+.||.|+||+|.+++                    ...++...+|..+|+.+.||.++++++.     +.+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence            4678889999999999997765                    2356677889999999999999999998     45689


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      +.++||||.+||.|..++          .+.+++++..++-++.||+.||+|||   +.+|++|||||+|||+|.+|.+|
T Consensus       118 ~lymvmeyv~GGElFS~L----------rk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iK  184 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYL----------RKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIK  184 (355)
T ss_pred             eEEEEEeccCCccHHHHH----------HhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEE
Confidence            999999999999999999          56788999999999999999999999   77999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      |+|||+|+.+....     ...+||+.|+|||++....|+.++|.|||||++|||+.|.+||.
T Consensus       185 itDFGFAK~v~~rT-----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~  242 (355)
T KOG0616|consen  185 ITDFGFAKRVSGRT-----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY  242 (355)
T ss_pred             EEeccceEEecCcE-----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence            99999999876542     12689999999999999999999999999999999999999975

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=321.69  Aligned_cols=235  Identities=21%  Similarity=0.284  Sum_probs=195.1

Q ss_pred             ccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce-
Q 041757           36 RNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF-   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~-   95 (381)
                      ++|...+++|+|+||.+++.+                   ....+...+|+.+++++.|||||.+++.++     .++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~-----~~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE-----EDGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh-----cCCce
Confidence            678899999999999986544                   223457889999999999999999999953     3555 


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .+|||+||+||++.+.+..        .+...++++.+..++.|++.|+.|||   ...|+|||||+.||+++.+..+||
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~--------~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkL  147 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKE--------QKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKL  147 (426)
T ss_pred             EEEEEeecCCCCHHHHHHH--------HhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceee
Confidence            9999999999999999964        33567899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+|+.+........  .++||+.||+||.+.+.+|+.|+|||||||++|||++-+++|..                 
T Consensus       148 gDfGlaK~l~~~~~~a~--tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-----------------  208 (426)
T KOG0589|consen  148 GDFGLAKILNPEDSLAS--TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-----------------  208 (426)
T ss_pred             cchhhhhhcCCchhhhh--eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-----------------
Confidence            99999999877653222  36799999999999999999999999999999999999999751                 


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      .++..++.+......               .+.+.....++..++..|+..+|+.||++.+++.+
T Consensus       209 ~~m~~Li~ki~~~~~---------------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  209 SNMSELILKINRGLY---------------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cchHHHHHHHhhccC---------------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            122223322221110               11234677889999999999999999999999976

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-41  Score=314.85  Aligned_cols=255  Identities=21%  Similarity=0.346  Sum_probs=188.3

Q ss_pred             cccccccceecCCCceEEEecc----------------------------------cccHHHHHHHHHHHHccCCCcccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR----------------------------------QGAFKSFIAECKALRNIRHRNLIK   80 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~----------------------------------~~~~~~~~~E~~~l~~l~h~nIv~   80 (381)
                      .++|...++||+|+||.||++.                                  ......|.+|+++|.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999998753                                  112457889999999999999999


Q ss_pred             eeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCccc---------ccCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 041757           81 VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET---------YKRPRNLNLLRRLNIAIDVASALNYLHHDC  151 (381)
Q Consensus        81 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  151 (381)
                      +++++.     ..+..++||||+++|+|.+++.........         ......+++..++.++.|++.||.|||   
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---  155 (304)
T cd05096          84 LLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---  155 (304)
T ss_pred             EEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---
Confidence            999964     356789999999999999998532211000         112245788899999999999999999   


Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI  231 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t  231 (381)
                      +.+|+||||||+||+++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||++
T Consensus       156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence            66999999999999999999999999999986644332222222346788999999988889999999999999999987


Q ss_pred             --CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCC
Q 041757          232 --REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQ  309 (381)
Q Consensus       232 --g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  309 (381)
                        +..||.....     ......     ............               ....++.++..+.+++.+||+.||.
T Consensus       236 ~~~~~p~~~~~~-----~~~~~~-----~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~  290 (304)
T cd05096         236 LCKEQPYGELTD-----EQVIEN-----AGEFFRDQGRQV---------------YLFRPPPCPQGLYELMLQCWSRDCR  290 (304)
T ss_pred             ccCCCCCCcCCH-----HHHHHH-----HHHHhhhccccc---------------cccCCCCCCHHHHHHHHHHccCCch
Confidence              5567642211     111000     000000000000               0000124567899999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 041757          310 DRMKMTNVVHELQ  322 (381)
Q Consensus       310 ~RPs~~~vl~~L~  322 (381)
                      +|||+.+|.+.|+
T Consensus       291 ~RPs~~~i~~~l~  303 (304)
T cd05096         291 ERPSFSDIHAFLT  303 (304)
T ss_pred             hCcCHHHHHHHHh
Confidence            9999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.8e-42  Score=317.47  Aligned_cols=230  Identities=20%  Similarity=0.276  Sum_probs=186.4

Q ss_pred             ccccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...++||+|+||.||+++                    .+.++....|-.+|....+|.||++|..     |++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence            35789999999999999999876                    3467788899999999999999999988     6789


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +++||||||++|||+..+|          .+...|++..+..++.+++.|++.+|   +.|+|||||||+|+|||..|++
T Consensus       214 ~~LYLiMEylPGGD~mTLL----------~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHi  280 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLL----------MRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHI  280 (550)
T ss_pred             CeeEEEEEecCCccHHHHH----------HhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCE
Confidence            9999999999999999999          57788999999999999999999999   7799999999999999999999


Q ss_pred             EEeecccceecCCC---------------------CCcc------------------------cccCccCccceeCCCCc
Q 041757          174 RVGDFGLARFLPPT---------------------RTQT------------------------SSIDVKGSIGYIAPEYG  208 (381)
Q Consensus       174 kl~Dfg~~~~~~~~---------------------~~~~------------------------~~~~~~gt~~y~aPE~l  208 (381)
                      ||+|||++..+...                     ....                        ...+.+|||-|+|||++
T Consensus       281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl  360 (550)
T KOG0605|consen  281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL  360 (550)
T ss_pred             eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence            99999998543220                     0000                        01136799999999999


Q ss_pred             CCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhh--hccCchhhhhcccchhhhhHH
Q 041757          209 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSI--LLNDDEKLVVRGDQKQTQAKI  286 (381)
Q Consensus       209 ~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~~~~~  286 (381)
                      .+..|+..+|+||||||+|||+.|.+||.    ++.....+.+.         +...  +....                
T Consensus       361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~----s~tp~~T~rkI---------~nwr~~l~fP~----------------  411 (550)
T KOG0605|consen  361 LGKGYGKECDWWSLGCIMYEMLVGYPPFC----SETPQETYRKI---------VNWRETLKFPE----------------  411 (550)
T ss_pred             hcCCCCccccHHHHHHHHHHHHhCCCCCC----CCCHHHHHHHH---------HHHhhhccCCC----------------
Confidence            99999999999999999999999999975    22222222111         1110  11111                


Q ss_pred             HHHHHHHHHHHHHHHhccCCCCCCCCC
Q 041757          287 NIIRECVISMVRIGVACSMESPQDRMK  313 (381)
Q Consensus       287 ~~~~~~~~~l~~l~~~cl~~dP~~RPs  313 (381)
                        ...+..+..+||.+|+. ||++|.-
T Consensus       412 --~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  412 --EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             --cCcccHHHHHHHHHHhc-CHHHhcC
Confidence              12344688899999998 9999975

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-41  Score=324.00  Aligned_cols=251  Identities=22%  Similarity=0.252  Sum_probs=189.5

Q ss_pred             cccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~   90 (381)
                      .++|..+++||+|+||.||++.                       ....+.+.+|+++|..+ +||||++++++|.    
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~----  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT----  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence            4579999999999999997652                       11235688999999999 7999999999964    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcc--------------------------------------------------
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE--------------------------------------------------  120 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------------  120 (381)
                       .....++|||||++|+|.+++........                                                  
T Consensus       110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence             46778999999999999999854221000                                                  


Q ss_pred             ---------------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757          121 ---------------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP  185 (381)
Q Consensus       121 ---------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~  185 (381)
                                     .......+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                           0001235788899999999999999999   6699999999999999999999999999998765


Q ss_pred             CCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhh
Q 041757          186 PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDS  264 (381)
Q Consensus       186 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (381)
                      ............++..|+|||++.+..++.++|||||||++|||++ |..||......    ..+..         .+..
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~---------~~~~  332 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYK---------MIKE  332 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHH---------HHHh
Confidence            4433222222335678999999999999999999999999999998 88887532111    11111         1110


Q ss_pred             hhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          265 ILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       265 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      .....                  .+...+.++.+++.+||+.||++|||+.+|++.|++.
T Consensus       333 ~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         333 GYRML------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CccCC------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            00000                  0112345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.4e-41  Score=323.63  Aligned_cols=253  Identities=22%  Similarity=0.292  Sum_probs=191.0

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVD   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~   89 (381)
                      ..++|...+.||+|+||.||++..                       ...+.+.+|+++++.+ +|+||++++++|.   
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---  112 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---  112 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec---
Confidence            456899999999999999986431                       1235678999999999 7999999999954   


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCC---------------------------------------------------
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKE---------------------------------------------------  118 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------  118 (381)
                        .....++|||||++|+|.+++......                                                   
T Consensus       113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence              467889999999999999998532100                                                   


Q ss_pred             ---------cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCC
Q 041757          119 ---------DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT  189 (381)
Q Consensus       119 ---------~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  189 (381)
                               .........+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                     000011245788999999999999999999   66999999999999999999999999999986654332


Q ss_pred             cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhcc
Q 041757          190 QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLN  268 (381)
Q Consensus       190 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (381)
                      ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+.            ..+......
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~------------~~~~~~~~~  334 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFY------------KMVKRGYQM  334 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHH------------HHHHcccCc
Confidence            222222335678999999988899999999999999999997 999986322111 000            111100000


Q ss_pred             CchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          269 DDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                      .                  .+...+.++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus       335 ~------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 S------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             c------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            0                  01123467889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=298.49  Aligned_cols=263  Identities=20%  Similarity=0.215  Sum_probs=193.5

Q ss_pred             cccccccceecCCCceEEEeccccc-------------------HHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQGA-------------------FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~~-------------------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      -++|...++|++|+||.||.++...                   --..++|+.+|.+++|||||.+-.+.++   .+-+.
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccce
Confidence            4678889999999999999987432                   2245789999999999999999999764   45666


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      +|+|||||+. ||..++.         .-..++...++..+..|+++|++|||   ...|+||||||+|+|++..|.+||
T Consensus       152 iy~VMe~~Eh-DLksl~d---------~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKi  218 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLME---------TMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKI  218 (419)
T ss_pred             eeeeHHHHHh-hHHHHHH---------hccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEe
Confidence            9999999976 9999996         34568999999999999999999999   559999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH-
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-  253 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~-  253 (381)
                      +|||+|+.+........  ..+-|..|+|||.+.+. .|+++.|+||+|||+.|++++++.|    .+...+.++.+.. 
T Consensus       219 aDFGLAR~ygsp~k~~T--~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf----~G~sE~dQl~~If~  292 (419)
T KOG0663|consen  219 ADFGLAREYGSPLKPYT--PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF----PGKSEIDQLDKIFK  292 (419)
T ss_pred             cccchhhhhcCCcccCc--ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC----CCCchHHHHHHHHH
Confidence            99999998877643332  35689999999998874 5999999999999999999999985    4444444332221 


Q ss_pred             -hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 -LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 -~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       +......+....-.....+......+.....+..+... ....-.+|+...+.+||.+|.|++|.++
T Consensus       293 llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  293 LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             11111111100000000000111111111111111111 3456788899999999999999999886

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-43  Score=335.01  Aligned_cols=245  Identities=24%  Similarity=0.384  Sum_probs=204.2

Q ss_pred             ccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           38 MLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++++||.|.||.|+..+                     ..+...|+.|+.||.+++||||+++.|+     .......
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~Pv  705 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKPV  705 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCcee
Confidence            4567999999999996543                     4567899999999999999999999999     4558889


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      +||+|||++|+|+.||+         ...+.++..+...+++.|+.|+.||-   .+++|||||..+|||++.+-.+|++
T Consensus       706 MIiTEyMENGsLDsFLR---------~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVs  773 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLR---------QNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVS  773 (996)
T ss_pred             EEEhhhhhCCcHHHHHh---------hcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEec
Confidence            99999999999999997         45677999999999999999999999   7799999999999999999999999


Q ss_pred             ecccceecCCCCC-cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHh
Q 041757          177 DFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       177 Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |||+++.+.++.. ........-+++|.|||.+...+++.+|||||||++|||+++ |..||..+...+           
T Consensus       774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-----------  842 (996)
T KOG0196|consen  774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----------  842 (996)
T ss_pred             cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----------
Confidence            9999998866552 222222334689999999999999999999999999999886 999976443211           


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  331 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~  331 (381)
                        .++.+-+.                   .+.+.|.+|+..|.+||+.||++|-.+||++.||+..|+++......-
T Consensus       843 --VIkaIe~g-------------------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  843 --VIKAIEQG-------------------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             --HHHHHHhc-------------------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence              11111111                   122235689999999999999999999999999999999998765443

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-42  Score=288.40  Aligned_cols=258  Identities=19%  Similarity=0.266  Sum_probs=202.5

Q ss_pred             hhccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ..-.++|.+.+.||+|||+.|++++                 ....+..++|++..++++||||++++++++........
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3346789999999999999998876                 24677889999999999999999999998754344567


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..||+++|...|+|.+.+....      .+...+++.+.+.|+.++++||.+||+. ...+.||||||.|||+.+.+.++
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLK------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHh------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceE
Confidence            7999999999999999996543      3456799999999999999999999966 44599999999999999999999


Q ss_pred             EeecccceecCCCCCccc-------ccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757          175 VGDFGLARFLPPTRTQTS-------SIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM  244 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~  244 (381)
                      |.|||.+...........       ...-..|..|+|||.+.   +...++++|||||||++|+|+.|..||+..+..+.
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg  249 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG  249 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence            999999876553221111       11234789999999876   34578999999999999999999999986654332


Q ss_pred             cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          245 NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ++.-.           +....+.. |+                 ....+..+.+++..|++.||.+||++.+++..++.+
T Consensus       250 SlaLA-----------v~n~q~s~-P~-----------------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  250 SLALA-----------VQNAQISI-PN-----------------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             eEEEe-----------eecccccc-CC-----------------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            21110           00000000 00                 012667899999999999999999999999998876


Q ss_pred             h
Q 041757          325 K  325 (381)
Q Consensus       325 ~  325 (381)
                      .
T Consensus       301 i  301 (302)
T KOG2345|consen  301 I  301 (302)
T ss_pred             c
Confidence            3

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-42  Score=289.67  Aligned_cols=232  Identities=21%  Similarity=0.320  Sum_probs=193.7

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|.+++.||+|.||.||+++.                    +...++.+|+++.+.|+||||+++|++     +.+..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eeccc
Confidence            47899999999999999999762                    234677899999999999999999999     55688


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..||++||.++|.|...|..        .....+++.....+..|+|.||.|+|   .++|+||||||+|+|++..+.+|
T Consensus        96 riyLilEya~~gel~k~L~~--------~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lk  164 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQE--------GRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELK  164 (281)
T ss_pred             eeEEEEEecCCchHHHHHHh--------cccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCee
Confidence            99999999999999999953        24567889999999999999999999   77999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||.+...+.+...+    .+||.-|.+||+..+..++..+|+|++|++.||++.|.+||..... +..+..+...  
T Consensus       165 iAdfGwsV~~p~~kR~t----lcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~--  237 (281)
T KOG0580|consen  165 IADFGWSVHAPSNKRKT----LCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKV--  237 (281)
T ss_pred             ccCCCceeecCCCCcee----eecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHc--
Confidence            99999998766333332    6799999999999999999999999999999999999999874431 1111111111  


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                 -..                   ++...+....+++.+|+..+|.+|.+..|++.
T Consensus       238 -----------~~~-------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  238 -----------DLK-------------------FPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             -----------ccc-------------------CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                       000                   12355668889999999999999999999875

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-42  Score=305.97  Aligned_cols=230  Identities=21%  Similarity=0.300  Sum_probs=191.1

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ...|++.+.||+|+||.|.++..                    ...-...+|+++|+.|+||||+.+|.+     |++.+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence            46688899999999999966542                    234456789999999999999999999     78899


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      .+.|||||..+|.|++|+          ...+.+++.++..+++||..|+.|+|   +.+++|||||.+|||+|.++.+|
T Consensus       127 KIvivMEYaS~GeLYDYi----------Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiK  193 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYI----------SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIK  193 (668)
T ss_pred             eEEEEEEecCCccHHHHH----------HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCee
Confidence            999999999999999999          56788999999999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||++-.+.......   .++|++.|.+||++.+.+| ++.+|-|||||+||.|+.|..||+..              
T Consensus       194 IADFGLSNly~~~kfLq---TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------------  256 (668)
T KOG0611|consen  194 IADFGLSNLYADKKFLQ---TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------------  256 (668)
T ss_pred             eeccchhhhhccccHHH---HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------------
Confidence            99999998776655443   3789999999999999988 57899999999999999999998621              


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         +.+.++..+-...+.                 -++.+....-|++.||..||+.|.|+.+|..
T Consensus       257 ---Dhk~lvrQIs~GaYr-----------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  257 ---DHKRLVRQISRGAYR-----------------EPETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             ---hHHHHHHHhhccccc-----------------CCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence               112222222211111                 0233446677888999999999999999875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-41  Score=317.79  Aligned_cols=267  Identities=18%  Similarity=0.201  Sum_probs=184.7

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .|...++||+|+||.||++..                   .....+.+|++++++++||||+++++++...+.......+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999987641                   1234578999999999999999999987643333345689


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +|||||. ++|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        81 lv~e~~~-~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~D  146 (338)
T cd07859          81 VVFELME-SDLHQVIK----------ANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICD  146 (338)
T ss_pred             EEEecCC-CCHHHHHH----------hcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEcc
Confidence            9999995 69999883          4456899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCc-ccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          178 FGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       178 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      ||+++........ .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....  ...........
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~  224 (338)
T cd07859         147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLL  224 (338)
T ss_pred             CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHh
Confidence            9999765332211 11123568999999998865  6789999999999999999999999853211  00001111111


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .....+.............................+.....+.+++.+||+.||++|||+.++++
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            11101111100000000000000000000000001123457789999999999999999999996

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=312.38  Aligned_cols=228  Identities=22%  Similarity=0.290  Sum_probs=182.7

Q ss_pred             ccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||.||++...                    ..+.+.+|+.++++++||||++++++     +.+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence            46888999999999999876521                    23457789999999999999999988     455788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl  142 (291)
T cd05612          76 LYMLMEYVPGGELFSYLR----------NSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKL  142 (291)
T ss_pred             EEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEE
Confidence            999999999999999993          4556889999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+++.......     ...|++.|+|||++.+..++.++|||||||++|+|++|+.||....    . ...      
T Consensus       143 ~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~----~-~~~------  206 (291)
T cd05612         143 TDFGFAKKLRDRTW-----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----P-FGI------  206 (291)
T ss_pred             EecCcchhccCCcc-----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----H-HHH------
Confidence            99999976543221     2458999999999999889999999999999999999999985221    1 111      


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                            .........                .++......+.+++.+||+.||.+||+     +.++++
T Consensus       207 ------~~~i~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         207 ------YEKILAGKL----------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ------HHHHHhCCc----------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                  111110000                001233457889999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-41  Score=316.23  Aligned_cols=225  Identities=24%  Similarity=0.310  Sum_probs=178.8

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      ++||+|+||.||++..                    .....+.+|+.++++++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            4699999999987642                    1234677899999999999999999984     45788999999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      |+++|+|.+++.          ....+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a  142 (323)
T cd05571          76 YANGGELFFHLS----------RERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence            999999999983          4567899999999999999999999   679999999999999999999999999998


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      +........  .....||+.|+|||++.+..++.++|||||||++|||++|..||...     .....            
T Consensus       143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~------------  203 (323)
T cd05571         143 KEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKL------------  203 (323)
T ss_pred             cccccCCCc--ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-----CHHHH------------
Confidence            754322211  12256999999999999999999999999999999999999998521     11111            


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                      .........                .++.....++.+++.+||+.||++||     ++.++++
T Consensus       204 ~~~~~~~~~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         204 FELILMEEI----------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHcCCC----------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            111110000                01123456788999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=308.82  Aligned_cols=239  Identities=22%  Similarity=0.271  Sum_probs=185.2

Q ss_pred             cccccccceecCCCceEEEeccc-------------------------------ccHHHHHHHHHHHHccCCCcccceee
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------------------GAFKSFIAECKALRNIRHRNLIKVLT   83 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~   83 (381)
                      -++|..++.||+|.||.|.++..                               ...+...+|+.+|++++|||||+++.
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            46799999999999999966541                               13468889999999999999999999


Q ss_pred             eeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCc-ccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           84 ACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRN-LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        84 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                      +.-   ....+.+|||+|||..|.+...-           .... +++.+++.+++++..||+|||   .++||||||||
T Consensus       176 vLD---DP~s~~~YlVley~s~G~v~w~p-----------~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKP  238 (576)
T KOG0585|consen  176 VLD---DPESDKLYLVLEYCSKGEVKWCP-----------PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKP  238 (576)
T ss_pred             eec---CcccCceEEEEEeccCCccccCC-----------CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccch
Confidence            943   35678899999999998876432           2333 999999999999999999999   77999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCC---cccccCccCccceeCCCCcCCCc----cCcccchhhhhHHHHHHHhCCCC
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRT---QTSSIDVKGSIGYIAPEYGVGNE----VSTIGDVYSYGILLLELMIREKP  235 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~el~tg~~P  235 (381)
                      +|+|++++|++||+|||.+........   .......+||+.|+|||...+..    -+.+.||||+||+||.++.|+.|
T Consensus       239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P  318 (576)
T KOG0585|consen  239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP  318 (576)
T ss_pred             hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence            999999999999999999987643311   11112357999999999887632    35678999999999999999999


Q ss_pred             CCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          236 SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                      |-.    +             ...++.+++....-.-              +..++....+.+|+.++|.+||+.|.+..
T Consensus       319 F~~----~-------------~~~~l~~KIvn~pL~f--------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~  367 (576)
T KOG0585|consen  319 FFD----D-------------FELELFDKIVNDPLEF--------------PENPEINEDLKDLIKRLLEKDPEQRITLP  367 (576)
T ss_pred             ccc----c-------------hHHHHHHHHhcCcccC--------------CCcccccHHHHHHHHHHhhcChhheeehh
Confidence            742    1             1223333332211100              00124567888999999999999999999


Q ss_pred             HHHHHH
Q 041757          316 NVVHEL  321 (381)
Q Consensus       316 ~vl~~L  321 (381)
                      +|....
T Consensus       368 ~ik~Hp  373 (576)
T KOG0585|consen  368 DIKLHP  373 (576)
T ss_pred             hheecc
Confidence            987543

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=330.76  Aligned_cols=255  Identities=20%  Similarity=0.225  Sum_probs=198.7

Q ss_pred             ccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccC-CCcccceeeeecc-ccccC-C
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLG-VDYQG-N   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~-~~~~~-~   93 (381)
                      ...+..++++|.+|||+.||++.                 ....+...+|+++|++|+ |+|||.+++.... ....+ .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            45667888999999999999875                 235677889999999997 9999999994322 11122 3


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      -.++|.||||.||.|-+++..        .....|++.++++|+.|+|+|+.+||.. +..|||||||-+||||+.++..
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~--------Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~  185 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNT--------RLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNY  185 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHH--------HHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCE
Confidence            567899999999999999964        2345599999999999999999999977 7789999999999999999999


Q ss_pred             EEeecccceecCCCCCcccc-------cCccCccceeCCCCc---CCCccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757          174 RVGDFGLARFLPPTRTQTSS-------IDVKGSIGYIAPEYG---VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  243 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~-------~~~~gt~~y~aPE~l---~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~  243 (381)
                      ||||||.+............       .....|+.|+|||++   .+..+++|+|||||||+||.|+....||+....- 
T Consensus       186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-  264 (738)
T KOG1989|consen  186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-  264 (738)
T ss_pred             EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-
Confidence            99999998643332211111       113368999999975   4678999999999999999999999998622110 


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                                      .+++.    .+              ..+..+.+...+.+||..||+.||.+||++.+|++.+..
T Consensus       265 ----------------aIlng----~Y--------------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  265 ----------------AILNG----NY--------------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ----------------eEEec----cc--------------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                            01110    00              001124678899999999999999999999999999999


Q ss_pred             hhhhcCCCC
Q 041757          324 IKNTLLGPK  332 (381)
Q Consensus       324 i~~~~~~~~  332 (381)
                      +........
T Consensus       311 l~~~~~~~~  319 (738)
T KOG1989|consen  311 LANKPCPIP  319 (738)
T ss_pred             HhcCCCCcc
Confidence            987655433

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.7e-41  Score=307.27  Aligned_cols=262  Identities=18%  Similarity=0.214  Sum_probs=186.9

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...+.||+|+||.||++..                   ...+.+.+|+.+++.++||||+++++++     ...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            4688999999999999987542                   1245678999999999999999999984     457789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||++++.+..+.          .....+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~  142 (287)
T cd07848          76 YLVFEYVEKNMLELLE----------EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLC  142 (287)
T ss_pred             EEEEecCCCCHHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEe
Confidence            9999999987776554          23456889999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||++.......... .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... ....
T Consensus       143 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~-~~~~  219 (287)
T cd07848         143 DFGFARNLSEGSNAN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQK-VLGP  219 (287)
T ss_pred             eccCccccccccccc-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hhCC
Confidence            999998764432211 112468999999999998889999999999999999999999985321111 0011100 0000


Q ss_pred             hHHHHHhhhhccCchh--hhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEK--LVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...+..... ..++..  ....................+..+.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         220 LPAEQMKLF-YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CCHHHHHhh-hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000111000 000000  00000000000011112235668999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.8e-41  Score=304.38  Aligned_cols=240  Identities=22%  Similarity=0.314  Sum_probs=187.9

Q ss_pred             cccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...+.||+|+||.||++..                     .....|.+|+.++.+++||||+++++++.     ..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence            35688999999999999976521                     12356889999999999999999999953     46


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++|+|.+++.         .....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~---------~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~  146 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLR---------KHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVC  146 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcE
Confidence            78999999999999999985         22356899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +++|||.+.......... .....++..|+|||++.+..++.++|||||||++||+++ |..||.....     ..... 
T Consensus       147 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~-  219 (266)
T cd05064         147 KISGFRRLQEDKSEAIYT-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIK-  219 (266)
T ss_pred             EECCCcccccccccchhc-ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHH-
Confidence            999999876543222111 111335678999999998899999999999999999875 9999853211     11100 


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                             .+.+....                   ..+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       220 -------~~~~~~~~-------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         220 -------AVEDGFRL-------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------HHHCCCCC-------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   01000000                   01234667899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.1e-41  Score=307.01  Aligned_cols=235  Identities=22%  Similarity=0.282  Sum_probs=182.3

Q ss_pred             cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      +|...+.||+|+||.||++..                    .....+.+|+.++.+++|+||+++++++     ...+..
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            477889999999999977541                    1123577899999999999999999985     446789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++|+|..++..        .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~~g~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~  144 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYN--------MGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRIS  144 (285)
T ss_pred             EEEEEecCCCcHHHHHHh--------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEe
Confidence            999999999999988742        12346889999999999999999999   7799999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||++..........   ...||..|+|||++.+..++.++|||||||++|||++|+.||....... ....        
T Consensus       145 Dfg~~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~--------  212 (285)
T cd05631         145 DLGLAVQIPEGETVR---GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREE--------  212 (285)
T ss_pred             eCCCcEEcCCCCeec---CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHH--------
Confidence            999998764332221   2458999999999999999999999999999999999999986322110 0000        


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                           +...+....               ...+...+..+.+++.+||+.||.+||+     +.++++
T Consensus       213 -----~~~~~~~~~---------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         213 -----VDRRVKEDQ---------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -----HHHHhhccc---------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                 110000000               0001234567889999999999999997     677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-41  Score=316.05  Aligned_cols=229  Identities=18%  Similarity=0.220  Sum_probs=183.4

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|...+.||+|+||.||++..                    ...+.+.+|+.++++++||||+++++++     ...+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            36789999999999999987642                    1235678899999999999999999984     4578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+|
T Consensus        92 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  158 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLR----------KAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVK  158 (329)
T ss_pred             EEEEEEcCCCCChHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEE
Confidence            8999999999999999994          4556888999999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++.......     ...||+.|+|||++.+..++.++|||||||++|+|++|..||...    ..... ..   
T Consensus       159 l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~-~~---  225 (329)
T PTZ00263        159 VTDFGFAKKVPDRTF-----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD----TPFRI-YE---  225 (329)
T ss_pred             EeeccCceEcCCCcc-----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC----CHHHH-HH---
Confidence            999999987644322     245899999999999989999999999999999999999997521    11111 11   


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                           .+...    ...                .+......+.+++.+||+.||.+||+     +.+++.
T Consensus       226 -----~i~~~----~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        226 -----KILAG----RLK----------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             -----HHhcC----CcC----------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 01110    000                01123456788999999999999997     577664

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=318.34  Aligned_cols=235  Identities=23%  Similarity=0.356  Sum_probs=200.5

Q ss_pred             cceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           41 ENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .++||.|-||.||.+.                      ....+.|+.|..+|++++|||||+++|+|.      ....||
T Consensus       394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~------e~P~Wi  467 (974)
T KOG4257|consen  394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV------EQPMWI  467 (974)
T ss_pred             HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee------ccceeE
Confidence            4899999999997642                      235788999999999999999999999986      567899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      |||+++.|.|..||.         .....++......++.||+.||+|||   ++++|||||..+|||+.....+||+||
T Consensus       468 vmEL~~~GELr~yLq---------~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  468 VMELAPLGELREYLQ---------QNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             EEecccchhHHHHHH---------hccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeeccc
Confidence            999999999999997         45677999999999999999999999   789999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhch
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      |+++.+........+. ..-++.|||||.+....++.+||||-|||.+||++. |..||......+.             
T Consensus       536 GLSR~~ed~~yYkaS~-~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------------  601 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKASR-GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------------  601 (974)
T ss_pred             chhhhccccchhhccc-cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------------
Confidence            9999998877666553 446789999999999999999999999999999875 9999864332221             


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                          +..               .....+.+.+++|++.+..|+.+||.+||.+||.+.++...|+.+..
T Consensus       602 ----I~~---------------iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 ----IGH---------------IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ----EEE---------------ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                110               01112334567999999999999999999999999999999988765

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-40  Score=304.85  Aligned_cols=249  Identities=20%  Similarity=0.336  Sum_probs=191.7

Q ss_pred             ccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .+|+..+.||+|+||.||++..                       .....|.+|+.++.+++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            4678889999999999986531                       12356889999999999999999999953     4


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCccc------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDET------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                      ....+++|||+++|+|.+++.........      ......+++..++.++.|++.||.|||   ..+++||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence            67789999999999999999643211100      011256888999999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCc
Q 041757          167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMN  245 (381)
Q Consensus       167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~  245 (381)
                      +++++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....    
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~----  232 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN----  232 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence            99999999999999986544332222222446888999999988889999999999999999998 9999753211    


Q ss_pred             HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                       ..            +.........               ...+..++.++.+++.+||+.||.+||++.+|++.|+++
T Consensus       233 -~~------------~~~~i~~~~~---------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 -QE------------VIEMIRSRQL---------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             -HH------------HHHHHHcCCc---------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence             11            1111000000               001235678899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-40  Score=311.70  Aligned_cols=182  Identities=23%  Similarity=0.303  Sum_probs=157.8

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .++|...+.||+|+||.||++..                  ...+.+.+|+++|++++||||+++++++.     ..+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence            57899999999999999977542                  12457889999999999999999999954     46789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++|+|.+++.          ....+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~  146 (331)
T cd06649          79 SICMEHMDGGSLDQVLK----------EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLC  146 (331)
T ss_pred             EEEeecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEc
Confidence            99999999999999994          445688999999999999999999942  269999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      |||++........    ....|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       147 Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~  203 (331)
T cd06649         147 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP  203 (331)
T ss_pred             cCccccccccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            9999876543322    12458999999999999899999999999999999999999985

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-41  Score=311.74  Aligned_cols=222  Identities=22%  Similarity=0.272  Sum_probs=175.3

Q ss_pred             ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ||+|+||.||++..                    .....+.+|+.++.+++||||+++++++     ...+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            79999999987642                    1235677899999999999999999984     4577899999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        76 ~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~  142 (312)
T cd05585          76 NGGELFHHLQ----------REGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL  142 (312)
T ss_pred             CCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence            9999999994          4456899999999999999999999   67999999999999999999999999999875


Q ss_pred             cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757          184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD  263 (381)
Q Consensus       184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (381)
                      .......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...     .....            ..
T Consensus       143 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~------------~~  203 (312)
T cd05585         143 NMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEM------------YR  203 (312)
T ss_pred             CccCCCc--cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHH------------HH
Confidence            4332221  12256899999999999999999999999999999999999998521     11111            11


Q ss_pred             hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH---HHHH
Q 041757          264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM---TNVV  318 (381)
Q Consensus       264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~---~~vl  318 (381)
                      ..+....                ..+......+.+++.+||+.||.+||++   .+++
T Consensus       204 ~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         204 KILQEPL----------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHcCCC----------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            1111100                0112345678899999999999999864   4554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-40  Score=310.31  Aligned_cols=244  Identities=23%  Similarity=0.324  Sum_probs=191.2

Q ss_pred             cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..+|+..+.||+|+||.||++..                      ...+.+.+|+.+++.++||||++++++|..     
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-----   80 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   80 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----
Confidence            35699999999999999987531                      124578889999999999999999999752     


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                       ...++|+||+++|+|.+++.         .....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.
T Consensus        81 -~~~~~v~e~~~~g~l~~~l~---------~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~  147 (316)
T cd05108          81 -STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQH  147 (316)
T ss_pred             -CCceeeeecCCCCCHHHHHH---------hccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCc
Confidence             34679999999999999985         23446888899999999999999999   679999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||...     ....+. 
T Consensus       148 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~-----~~~~~~-  221 (316)
T cd05108         148 VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEIS-  221 (316)
T ss_pred             EEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----CHHHHH-
Confidence            99999999987654433222222335678999999999899999999999999999998 99997522     111111 


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                              ..+..... .+                 .+..++.++.+++.+||..||++|||+.+++..+..+....
T Consensus       222 --------~~~~~~~~-~~-----------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         222 --------SILEKGER-LP-----------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             --------HHHhCCCC-CC-----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                    11110000 00                 01234557889999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.2e-41  Score=315.08  Aligned_cols=229  Identities=21%  Similarity=0.250  Sum_probs=183.6

Q ss_pred             cccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...+.||+|+||.||++..                     ...+.+.+|+.+++.++||||+++++++     .+.
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            46799999999999999987641                     1234577899999999999999999995     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~i  170 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLR----------RNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFI  170 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCE
Confidence            78999999999999999993          4557899999999999999999999   7799999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|..||...    .... ...  
T Consensus       171 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~----~~~~-~~~--  238 (340)
T PTZ00426        171 KMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN----EPLL-IYQ--  238 (340)
T ss_pred             EEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC----CHHH-HHH--
Confidence            999999998764322     1246999999999999888999999999999999999999998522    1111 000  


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                            .+......                    .+......+.+++.+|++.||++|+     ++.++++
T Consensus       239 ------~i~~~~~~--------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        239 ------KILEGIIY--------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ------HHhcCCCC--------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                  11111000                    0112345678899999999999995     7887765

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-40  Score=326.70  Aligned_cols=238  Identities=17%  Similarity=0.202  Sum_probs=188.1

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ..|...+.||+|+||.||++..                  .....+.+|+.+|+.++|||||++++++     ...+..+
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEE
Confidence            3488999999999999987642                  1234577899999999999999999995     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++|+|.+++....      .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       142 lv~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~D  212 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGD  212 (478)
T ss_pred             EEEECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEe
Confidence            9999999999999885321      23456889999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||....     .           
T Consensus       213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~-----------  276 (478)
T PTZ00267        213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----Q-----------  276 (478)
T ss_pred             CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----H-----------
Confidence            999987655433222233569999999999999899999999999999999999999975211     1           


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       .+++...+.....               ..+..++..+.+++.+||+.||++||++.+++.
T Consensus       277 -~~~~~~~~~~~~~---------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        277 -REIMQQVLYGKYD---------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -HHHHHHHHhCCCC---------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             1111111111100               001234567899999999999999999999874

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-40  Score=318.56  Aligned_cols=253  Identities=22%  Similarity=0.296  Sum_probs=192.7

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~   90 (381)
                      .+.|.++++||+|+||.||.+..                       ...+.+.+|+++|+++. ||||++++++|.    
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~----  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT----  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence            56788999999999999976431                       12457889999999996 999999999964    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcc--------------------------------------------------
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE--------------------------------------------------  120 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------------  120 (381)
                       .....++|||||++|+|.+++........                                                  
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence             46789999999999999999854211000                                                  


Q ss_pred             ------------------------------------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCC
Q 041757          121 ------------------------------------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSN  164 (381)
Q Consensus       121 ------------------------------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~N  164 (381)
                                                          .......+++..++.++.|++.||.|||   ..+|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence                                                0001234788889999999999999999   6699999999999


Q ss_pred             eeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCC
Q 041757          165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGD  243 (381)
Q Consensus       165 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~  243 (381)
                      |+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999987654333222223446788999999988889999999999999999997 999975332111


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                          ...         ..+.....  .                ..+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus       348 ----~~~---------~~~~~~~~--~----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         348 ----TFY---------NKIKSGYR--M----------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             ----HHH---------HHHhcCCC--C----------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence                000         00000000  0                0122456788999999999999999999999999998


Q ss_pred             hhh
Q 041757          324 IKN  326 (381)
Q Consensus       324 i~~  326 (381)
                      +.+
T Consensus       397 l~~  399 (400)
T cd05105         397 LLP  399 (400)
T ss_pred             HcC
Confidence            753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-41  Score=318.33  Aligned_cols=227  Identities=21%  Similarity=0.313  Sum_probs=191.6

Q ss_pred             ccccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~   92 (381)
                      .-++|...++||+|.||+|.++.                    ...++..+.|.+++.... ||.+++++..     +++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence            35789999999999999996654                    457888999999999885 9999999999     788


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      .+++|.||||+.|||+..+.           ....+++..+.-++..++.||.|||   +++||+||||.+|||+|..|.
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~-----------~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh  506 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHI-----------HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGH  506 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEE-----------ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCc
Confidence            99999999999999954443           4578999999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +||+|||+++........  ...++||+.|||||++.+..|+.++|.|||||+||||+.|+.||.    ++         
T Consensus       507 ~kiADFGlcKe~m~~g~~--TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~----gd---------  571 (694)
T KOG0694|consen  507 VKIADFGLCKEGMGQGDR--TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP----GD---------  571 (694)
T ss_pred             EEecccccccccCCCCCc--cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC----CC---------
Confidence            999999999865433332  234899999999999999999999999999999999999999975    22         


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                          +-.++++.++.-++.                .|..++.+.+.|+.+.+..+|++|.-+
T Consensus       572 ----dEee~FdsI~~d~~~----------------yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  572 ----DEEEVFDSIVNDEVR----------------YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----CHHHHHHHHhcCCCC----------------CCCcccHHHHHHHHHHhccCcccccCC
Confidence                123455555544332                145677889999999999999999765

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-40  Score=311.33  Aligned_cols=225  Identities=24%  Similarity=0.307  Sum_probs=177.7

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      ++||+|+||.||++..                    .....+.+|+++++.++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            4699999999987542                    1234567899999999999999999984     45778999999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      |+++|+|..++.          ....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  142 (323)
T cd05595          76 YANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHh
Confidence            999999999883          4557899999999999999999999   669999999999999999999999999998


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      +........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||....     ...            .
T Consensus       143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~------------~  203 (323)
T cd05595         143 KEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HER------------L  203 (323)
T ss_pred             ccccCCCCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-----HHH------------H
Confidence            753322211  112568999999999999899999999999999999999999985221     111            1


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                      ..........                .+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       204 ~~~~~~~~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         204 FELILMEEIR----------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHhcCCCC----------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            1111100000                0123456788999999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-40  Score=311.41  Aligned_cols=225  Identities=25%  Similarity=0.321  Sum_probs=178.7

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      ++||+|+||.||++..                    .....+.+|+++++.++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            4699999999987642                    2345678899999999999999999884     55788999999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      |+++|+|..++.          ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        76 y~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~  142 (328)
T cd05593          76 YVNGGELFFHLS----------RERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLC  142 (328)
T ss_pred             CCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCC
Confidence            999999999883          4557899999999999999999999   679999999999999999999999999998


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      +........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....     ....            
T Consensus       143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~------------  203 (328)
T cd05593         143 KEGITDAAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKL------------  203 (328)
T ss_pred             ccCCCcccc--cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHH------------
Confidence            754322211  122568999999999998899999999999999999999999985221     1111            


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                      .........                .++.....++.+++.+||..||.+||     ++.++++
T Consensus       204 ~~~~~~~~~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         204 FELILMEDI----------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHhccCCc----------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            111110000                00123455788899999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-40  Score=307.53  Aligned_cols=184  Identities=22%  Similarity=0.327  Sum_probs=154.2

Q ss_pred             cccccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .++|...+.||+|+||.||++...                  ....+.+|+.+++.++||||+++++++     .+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            578999999999999999876521                  124578899999999999999999994     457789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+. ++|.+++.         .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~  145 (303)
T cd07869          79 TLVFEYVH-TDLCQYMD---------KHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLA  145 (303)
T ss_pred             EEEEECCC-cCHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEC
Confidence            99999995 68888874         23456888999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      |||++..........  ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus       146 Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         146 DFGLARAKSVPSHTY--SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             CCCcceeccCCCccC--CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999987654322211  12458999999998765 4588999999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=310.33  Aligned_cols=234  Identities=21%  Similarity=0.252  Sum_probs=191.6

Q ss_pred             ccccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ....|...+.||+|+||.||++.                  ...++...+|+.+|.+++++||.++|+.++     .+..
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-----~g~~   85 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-----KGTK   85 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-----eccc
Confidence            44567777999999999998865                  335677888999999999999999999955     4778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      ++++||||.||++.+.+          .....+.+..+..++++++.||.|||   ..+.+|||||+.|||+..+|.+||
T Consensus        86 LwiiMey~~gGsv~~lL----------~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl  152 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLL----------KSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKL  152 (467)
T ss_pred             HHHHHHHhcCcchhhhh----------ccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEE
Confidence            99999999999999999          34555588888889999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||.+..+.......  ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+....+ .     +.
T Consensus       153 ~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-l-----Ip  224 (467)
T KOG0201|consen  153 ADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-L-----IP  224 (467)
T ss_pred             Eecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-e-----cc
Confidence            9999998887765554  23789999999999999999999999999999999999999976433211000 0     00


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..           .|            +   .....+.+.+.+++..||..||+.||++.++++
T Consensus       225 k~-----------~P------------P---~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  225 KS-----------AP------------P---RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CC-----------CC------------C---ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            00           00            0   001145667889999999999999999999985

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.5e-40  Score=300.06  Aligned_cols=244  Identities=23%  Similarity=0.342  Sum_probs=189.7

Q ss_pred             cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .++|...+.||+|+||+||++..                      .....+..|+..+.+++||||+++++++.      
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------   79 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------   79 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------
Confidence            35788889999999999987541                      12345677888899999999999999853      


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++++||+++|+|.+++.         .....+++..+..++.|++.||.|||   ..+++||||||+||+++.++.
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~---------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~  147 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVR---------QHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSI  147 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCc
Confidence            345689999999999999995         23456899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||.....     ..   
T Consensus       148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~---  219 (279)
T cd05111         148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HE---  219 (279)
T ss_pred             EEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HH---
Confidence            99999999987654332222222457788999999988889999999999999999998 9999752211     00   


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                            ..+++........                  +..++..+.+++.+||..||++|||+.++++.|..+.+..
T Consensus       220 ------~~~~~~~~~~~~~------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         220 ------VPDLLEKGERLAQ------------------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             ------HHHHHHCCCcCCC------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                  1111111000000                  1124456788999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.5e-40  Score=310.77  Aligned_cols=254  Identities=21%  Similarity=0.293  Sum_probs=192.1

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~   90 (381)
                      .++|++.++||+|+||.||++..                       ...+.+.+|+.++.++ +|+||++++++|.    
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~----   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT----   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence            35799999999999999987631                       1234577899999999 7999999999874    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcc--------------------------------------------------
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE--------------------------------------------------  120 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------------  120 (381)
                      ......+++|||+++++|.+++........                                                  
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            345678999999999999999854221000                                                  


Q ss_pred             -cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCc
Q 041757          121 -TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS  199 (381)
Q Consensus       121 -~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  199 (381)
                       .......+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.++|+|||++..+.............++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence             0001236789999999999999999999   669999999999999999999999999999876543322222224467


Q ss_pred             cceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhccc
Q 041757          200 IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGD  278 (381)
Q Consensus       200 ~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  278 (381)
                      ..|+|||++.+..++.++|||||||++|||++ |..||......    ..+.         ..+......          
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~~---------~~~~~~~~~----------  295 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEFC---------RRLKEGTRM----------  295 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHHH---------HHHhccCCC----------
Confidence            88999999999999999999999999999998 99997532111    0110         000000000          


Q ss_pred             chhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          279 QKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                              ..+.....++.+++.+||+.+|++||++.+|++.|+.+..
T Consensus       296 --------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         296 --------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             --------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                    0012345678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-40  Score=314.43  Aligned_cols=258  Identities=19%  Similarity=0.229  Sum_probs=186.4

Q ss_pred             cccccccceecCCCceEEEeccc-----------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ..+|...++||+|+||.||++..           .....+.+|+++|++++||||+++++++     ......++|||++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~lv~e~~  165 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCLILPRY  165 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEEEEecC
Confidence            46799999999999999988653           2345678999999999999999999985     4477889999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      . ++|..++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       166 ~-~~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        166 K-TDLYCYLA----------AKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             C-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            5 68988883          4456889999999999999999999   66999999999999999999999999999975


Q ss_pred             cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcccc--CCC----cHHHHHHHHhh--
Q 041757          184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE--GDM----NLHKFAKMALS--  255 (381)
Q Consensus       184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~--~~~----~~~~~~~~~~~--  255 (381)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||++|..||-....  +..    .+.........  
T Consensus       232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p  310 (391)
T PHA03212        232 PVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP  310 (391)
T ss_pred             ccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence            4322111 11225699999999999998999999999999999999999988632211  111    11111111000  


Q ss_pred             ----c----hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 ----N----HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ----~----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          .    .+.............     .....  .........+.++.+++.+||+.||.+|||+.|+++
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        311 NEFPIDAQANLDEIYIGLAKKSSR-----KPGSR--PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhcCcchhHHHHHHHHHHHhccCC-----CCCCC--CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                0    001111000000000     00000  001112245668899999999999999999999985

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9e-42  Score=303.54  Aligned_cols=264  Identities=21%  Similarity=0.250  Sum_probs=193.1

Q ss_pred             ccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      -.|...+++|.|+||.||.+.-.             ..+---+|+++|+.++|||||++..++......+.-...+||||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            35778899999999999886521             11222369999999999999999988775322223356689999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CCeEEeecccc
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MTARVGDFGLA  181 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg~~  181 (381)
                      ++. +|.++++...      .....++...+.-+..||.+||+|||   ..+|+||||||+|+|+|.+ |.+||+|||.|
T Consensus       104 mP~-tL~~~~r~~~------~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYT------RANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             chH-HHHHHHHHHh------hcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            987 9999995332      34577888889999999999999999   6799999999999999976 89999999999


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH---HHHHhhch
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF---AKMALSNH  257 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~~~~~~  257 (381)
                      +.+..+....+   +..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|    .|+....++   .+....+.
T Consensus       174 K~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF----pG~s~~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  174 KVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF----PGDSSVDQLVEIIKVLGTPT  246 (364)
T ss_pred             eeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc----CCCCHHHHHHHHHHHhCCCC
Confidence            98876655433   568999999998887 57999999999999999999999985    444443333   33333333


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . +-+..+... ....... .-....+..-.....+++.++++.+++.++|.+|.++.|++.
T Consensus       247 ~-e~I~~mn~~-y~~~~~p-~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  247 R-EDIKSMNPN-YTEFKFP-QIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             H-HHHhhcCcc-cccccCc-ccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            2 223322211 0000000 000011111123456778999999999999999999999985

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.6e-40  Score=303.15  Aligned_cols=261  Identities=20%  Similarity=0.261  Sum_probs=183.2

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...++||.|+||.||++..                  .....+.+|+.++++++||||+++++++     ......+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence            5688899999999999987641                  1234678999999999999999999994     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++ +|.+++.         .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~D  146 (288)
T cd07871          80 LVFEYLDS-DLKQYLD---------NCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLAD  146 (288)
T ss_pred             EEEeCCCc-CHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECc
Confidence            99999975 9999884         23345788999999999999999999   67999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||+++.........  ....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ .+..... ....
T Consensus       147 fG~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~-~~~~  222 (288)
T cd07871         147 FGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFR-LLGT  222 (288)
T ss_pred             CcceeeccCCCccc--cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCC
Confidence            99997654332211  12457999999998865 568999999999999999999999985321110 0111111 1111


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...+..........-. .....................+..+++.+|+..||.+|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         223 PTEETWPGITSNEEFR-SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CChHHhhccccchhhh-ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111111100000000 0000000000000111223456789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=284.09  Aligned_cols=236  Identities=19%  Similarity=0.251  Sum_probs=187.2

Q ss_pred             ccccccccceecCCCceEEEec-------------------ccccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLR-------------------RQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~-------------------~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .+++|+..++||+|.|+.|+..                   .....+.+.+|+++.+.|+|||||++.+.     .....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence            4788999999999999999442                   13356778899999999999999999998     66788


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CC
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DM  171 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~  171 (381)
                      +.|+|+|++.|++|..-+          .....+++..+-.++.||+++|.|+|   ..+|||||+||+|+++..   ..
T Consensus        84 ~~ylvFe~m~G~dl~~eI----------V~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A  150 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDI----------VAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGA  150 (355)
T ss_pred             eeEEEEecccchHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCC
Confidence            999999999999998766          34466788999999999999999999   669999999999999954   33


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      -+||+|||++..+...   ......+|||.|||||++...+|+..+|||+.||+||-|+.|.+||...            
T Consensus       151 ~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~------------  215 (355)
T KOG0033|consen  151 AVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------------  215 (355)
T ss_pred             ceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc------------
Confidence            6899999999988732   2233467999999999999999999999999999999999999997521            


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           ...++....+....+-..            +..+...++..+|+++||..||.+|.|+.|.++
T Consensus       216 -----~~~rlye~I~~g~yd~~~------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  216 -----DQHRLYEQIKAGAYDYPS------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -----cHHHHHHHHhccccCCCC------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                 122222222222211000            002345556778888999999999999888764

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-40  Score=302.78  Aligned_cols=252  Identities=23%  Similarity=0.394  Sum_probs=193.7

Q ss_pred             ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ++|.+.+.||+|+||.||++..                      ...+.+.+|+.++++++||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            5788999999999999987541                      12456889999999999999999999954     46


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcc---cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDE---TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      +..++||||+++++|.+++........   .......+++..++.++.|++.||+|||   +.+++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence            788999999999999999853221100   0012345899999999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~  249 (381)
                      +.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.....     .  
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----~--  229 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----N--  229 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----H--
Confidence            9999999999986544332222222345778999999998889999999999999999998 8999752211     1  


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                                +.+.........               ..+..++.++.+++.+||+.||.+|||+.+|++.|+++.+.
T Consensus       230 ----------~~~~~i~~~~~~---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         230 ----------EVIECITQGRVL---------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             ----------HHHHHHHcCCcC---------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                      111111100000               00113445789999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.4e-40  Score=301.93  Aligned_cols=252  Identities=23%  Similarity=0.399  Sum_probs=193.8

Q ss_pred             ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ++|...+.||+|+||.||++..                      ...+.+.+|+.++++++|+||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence            5678889999999999987631                      1235788999999999999999999995     446


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCc------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKED------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                      ...++||||+++++|.+++.......      ........+++..++.++.|++.||+|||   ..+|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence            77899999999999999996422100      00012345889999999999999999999   6699999999999999


Q ss_pred             CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcH
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL  246 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~  246 (381)
                      +.++.++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||.....     
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----  231 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----  231 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999976544332222222446788999999998899999999999999999998 9999752211     


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      ..            .++........               ..+..++..+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus       232 ~~------------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         232 TE------------VIECITQGRVL---------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HH------------HHHHHhCCCCC---------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            00            11111100000               0012345678899999999999999999999999999976


Q ss_pred             h
Q 041757          327 T  327 (381)
Q Consensus       327 ~  327 (381)
                      .
T Consensus       285 ~  285 (291)
T cd05094         285 A  285 (291)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7e-40  Score=300.36  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=188.4

Q ss_pred             ccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           38 MLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      |...+.||+|+||+||++.                      ......+.+|++++++++||||+++++++..   .....
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence            4788999999999996521                      0134578899999999999999999998653   33556


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++++|.+++.           ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|
T Consensus        83 ~~lv~e~~~~~~l~~~~~-----------~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l  148 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLP-----------KHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKI  148 (283)
T ss_pred             EEEEecCCCCCCHHHHHH-----------HcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEE
Confidence            899999999999999984           235899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCccc-ccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          176 GDFGLARFLPPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      +|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|..||......   +........
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~  225 (283)
T cd05080         149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQ  225 (283)
T ss_pred             eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccc
Confidence            99999987654322111 11123567799999998888999999999999999999999997532111   111110000


Q ss_pred             h----chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          255 S----NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       255 ~----~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                      .    ..+.+.++.....                  ..+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         226 GQMTVVRLIELLERGMRL------------------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cccchhhhhhhhhcCCCC------------------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0    0011111111000                  011245678999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=309.39  Aligned_cols=237  Identities=18%  Similarity=0.188  Sum_probs=185.6

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||.||++..                    ...+.+.+|++++..++||||+++++++     ...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            4688999999999999987642                    1335678899999999999999999984     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL  142 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLN----------NLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKL  142 (333)
T ss_pred             EEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEE
Confidence            999999999999999993          4556889999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||....    . .........
T Consensus       143 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~-~~~~~~i~~  212 (333)
T cd05600         143 TDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST----P-NETWENLKY  212 (333)
T ss_pred             EeCcCCcccccc-----cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC----H-HHHHHHHHh
Confidence            999999765431     122568999999999999899999999999999999999999985221    1 111000000


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                           . ...+. .+..             .......+.++.+++.+||..+|.+||++.++++.
T Consensus       213 -----~-~~~~~-~~~~-------------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         213 -----W-KETLQ-RPVY-------------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -----c-ccccc-CCCC-------------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                 0 00000 0000             00001345678899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-40  Score=323.45  Aligned_cols=248  Identities=20%  Similarity=0.256  Sum_probs=191.7

Q ss_pred             hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc--
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY--   90 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--   90 (381)
                      ....++|.+.++||+|+||+||+++.                   .....+.+|+.++..++|+||++++..+...+.  
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34568999999999999999987642                   234567889999999999999998877543111  


Q ss_pred             -cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           91 -QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        91 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                       ......++||||+++|+|.+++....      .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~------~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~  178 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRA------KTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCS  178 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeC
Confidence             11224689999999999999985321      23456889999999999999999999   679999999999999999


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...     ...  
T Consensus       179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~--  251 (496)
T PTZ00283        179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NME--  251 (496)
T ss_pred             CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHH--
Confidence            9999999999998765433222223356999999999999999999999999999999999999998521     111  


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                                +++...+.....               ..+...+.++.+++.+||+.||.+||++.++++.
T Consensus       252 ----------~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 ----------EVMHKTLAGRYD---------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----------HHHHHHhcCCCC---------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                      111111111100               0123456678999999999999999999999863

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5e-40  Score=300.36  Aligned_cols=249  Identities=19%  Similarity=0.324  Sum_probs=188.4

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      .+++|+..+.||+|+||.||.+..                       .....+.+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            467899999999999999986320                       1234578999999999999999999995     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ......++||||+++|+|.+++...............+++..++.++.|++.||.|||   +.+++||||||+||+++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence            4467889999999999999998643211111111234678889999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~  249 (381)
                      +.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....     ....
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~  230 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQV  230 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHH
Confidence            9999999999876544332222222345788999999988889999999999999999999 788874221     1111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      ...        +.......                   .+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       231 ~~~--------~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         231 LRF--------VMEGGLLD-------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHH--------HHcCCcCC-------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            110        00000000                   01234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.5e-40  Score=307.46  Aligned_cols=225  Identities=22%  Similarity=0.229  Sum_probs=177.1

Q ss_pred             ceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           42 NLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++||+|+||.||+++.                        .....+.+|+.+|+.++||||+++++++     ..++..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence            6799999999987542                        1123467899999999999999999984     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  143 (323)
T cd05584          77 LILEYLSGGELFMHLE----------REGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTD  143 (323)
T ss_pred             EEEeCCCCchHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEee
Confidence            9999999999999983          4556788889999999999999999   67999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+++.........  ....||+.|+|||++.+..++.++|||||||++|||++|+.||....    . ....       
T Consensus       144 fg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~----~-~~~~-------  209 (323)
T cd05584         144 FGLCKESIHEGTVT--HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN----R-KKTI-------  209 (323)
T ss_pred             CcCCeecccCCCcc--cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC----H-HHHH-------
Confidence            99987543322211  12468999999999998889999999999999999999999985221    1 1111       


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                       ..+......                    .+......+.+++.+||+.||++||     ++.++++
T Consensus       210 -~~~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         210 -DKILKGKLN--------------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -HHHHcCCCC--------------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             111111000                    0123455788999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=296.01  Aligned_cols=240  Identities=22%  Similarity=0.356  Sum_probs=189.4

Q ss_pred             ccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|...+.||+|+||+||++..                     .....|.+|+.++++++||||+++++.+     ...+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence            5788999999999999987531                     1245788899999999999999999984     4467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++..         ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~  146 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRE---------NDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCK  146 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEE
Confidence            78999999999999999852         2346889999999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |..||.....     ..     
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~-----  216 (266)
T cd05033         147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QD-----  216 (266)
T ss_pred             ECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HH-----
Confidence            999999987753222211112335678999999998899999999999999999998 9999742211     00     


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                             +.+.......               .+.+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       217 -------~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         217 -------VIKAVEDGYR---------------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -------HHHHHHcCCC---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   1111000000               000124556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.9e-40  Score=294.91  Aligned_cols=236  Identities=23%  Similarity=0.371  Sum_probs=184.3

Q ss_pred             ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++|...+.||+|+||.||++..               .....+.+|+.++++++||||+++++++.     .....++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEEE
Confidence            4577889999999999987542               12467889999999999999999999953     467789999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|.+++..         ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||.
T Consensus        79 e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~  146 (256)
T cd05114          79 EFMENGCLLNYLRQ---------RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGM  146 (256)
T ss_pred             EcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCC
Confidence            99999999999852         2345889999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      ++......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||....    . ......       
T Consensus       147 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~-~~~~~~-------  213 (256)
T cd05114         147 TRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----N-YEVVEM-------  213 (256)
T ss_pred             ccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----H-HHHHHH-------
Confidence            87654332221 112335678999999988889999999999999999999 899975221    1 111110       


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                       +........                   +...+..+.+++.+||..+|.+|||+.++++.|
T Consensus       214 -i~~~~~~~~-------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         214 -ISRGFRLYR-------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -HHCCCCCCC-------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             000000000                   112345789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.2e-40  Score=309.88  Aligned_cols=226  Identities=24%  Similarity=0.299  Sum_probs=177.5

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      +.||+|+||.||++..                    .....+.+|+++++.++||||+++++++     ......++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            4699999999987542                    1235667899999999999999999884     45778999999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      |+++|+|..++          .....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l----------~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~  143 (325)
T cd05594          76 YANGGELFFHL----------SRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLC  143 (325)
T ss_pred             CCCCCcHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCC
Confidence            99999999988          3455789999999999999999999931  59999999999999999999999999998


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      +.........  ....||+.|+|||++.+..++.++|||||||++|||++|..||....     ......          
T Consensus       144 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~~~----------  206 (325)
T cd05594         144 KEGIKDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFE----------  206 (325)
T ss_pred             eecCCCCccc--ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HHHHHH----------
Confidence            7543322211  12459999999999998899999999999999999999999985211     111111          


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                        ........                .+.....++.+++.+||+.||.+|+     ++.++++
T Consensus       207 --~i~~~~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         207 --LILMEEIR----------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             --HHhcCCCC----------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence              10000000                0123455788899999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.3e-40  Score=300.51  Aligned_cols=263  Identities=20%  Similarity=0.244  Sum_probs=185.3

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc---CCCcccceeeeeccccccC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI---RHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~   92 (381)
                      ++|...+.||+|+||.||++..                    .....+.+|+.+++.+   +||||++++++|.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688899999999999988642                    0123567788887766   6999999999976433344


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+. ++|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~  148 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDK--------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQ  148 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCC
Confidence            667899999996 599999853        22345889999999999999999999   679999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +||+|||+++........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+......
T Consensus       149 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~  224 (290)
T cd07862         149 IKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV  224 (290)
T ss_pred             EEEccccceEeccCCccc---ccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHH
Confidence            999999999876543211   22458999999999988889999999999999999999999976321110 01111100


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .......+.... ... +..   ..............+.....+.+++.+||+.||++|||+.++++
T Consensus       225 ~~~~~~~~~~~~-~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         225 IGLPGEEDWPRD-VAL-PRQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hCCCChhhchhh-hcc-cch---hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000000000000 000 000   00000001111122345567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=295.01  Aligned_cols=248  Identities=22%  Similarity=0.360  Sum_probs=189.0

Q ss_pred             ccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc-cCCc
Q 041757           38 MLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY-QGND   94 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~~~   94 (381)
                      |...+.||+|+||.||.+..                      .....+.+|++.++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56778999999999986531                      123578899999999999999999998764221 2234


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|..++......    .....+++..+..++.|++.||.|||   ..+++||||||+||++++++.+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhcc----CCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEE
Confidence            579999999999999998532211    12346899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....    . ..     
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~----~-~~-----  223 (273)
T cd05035         154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE----N-HE-----  223 (273)
T ss_pred             ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----H-HH-----
Confidence            999999987654433222212235678999999988889999999999999999999 888874221    1 01     


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                             +.+........               ..+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       224 -------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         224 -------IYDYLRHGNRL---------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -------HHHHHHcCCCC---------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   11111100000               01224566899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.3e-40  Score=307.66  Aligned_cols=235  Identities=21%  Similarity=0.261  Sum_probs=181.0

Q ss_pred             cccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccC-CCcccceeeeecccccc
Q 041757           37 NMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~   91 (381)
                      +|...++||+|+||.||+++.                        ...+.+.+|+.++..++ |+||++++++     +.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence            578899999999999987542                        11245678999999995 9999999988     45


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~  142 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEG  142 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCC
Confidence            5778999999999999999983          4456899999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      .+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++|..||....... ....+ 
T Consensus       143 ~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~-  219 (332)
T cd05614         143 HVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEV-  219 (332)
T ss_pred             CEEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHH-
Confidence            99999999997654332221 1125699999999998865 47889999999999999999999985322111 11111 


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                                 ........+.                .+...+..+.+++.+||+.||++||     ++.++++
T Consensus       220 -----------~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         220 -----------SRRILKCDPP----------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -----------HHHHhcCCCC----------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                       1111111110                0123455778899999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.3e-40  Score=307.68  Aligned_cols=182  Identities=22%  Similarity=0.302  Sum_probs=157.1

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .++|...++||+|+||.||++..                  ...+.+.+|++++++++||||++++++|.     ..+..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence            57899999999999999987542                  12356889999999999999999999964     46789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++|+|.+++.          ....+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~  146 (333)
T cd06650          79 SICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC  146 (333)
T ss_pred             EEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEe
Confidence            99999999999999994          345688899999999999999999942  379999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      |||++........    ....|+..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       147 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~  203 (333)
T cd06650         147 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP  203 (333)
T ss_pred             eCCcchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            9999875533221    12458999999999998889999999999999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.7e-39  Score=298.96  Aligned_cols=250  Identities=20%  Similarity=0.334  Sum_probs=191.2

Q ss_pred             cccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      +|...++||+|+||.||++..                       .....+.+|+.+++.++||||+++++.|.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            467789999999999987531                       12356889999999999999999999854     46


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcc--------------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDE--------------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV  159 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD  159 (381)
                      +..++||||+.+|+|.+++........              .......+++..++.++.|++.||.|||   +.+++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence            678999999999999999864321110              0012346889999999999999999999   66999999


Q ss_pred             cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCc
Q 041757          160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDI  238 (381)
Q Consensus       160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~  238 (381)
                      |||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999976543332211222346778999999888889999999999999999998 9999752


Q ss_pred             cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757          239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV  318 (381)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  318 (381)
                      ..     ...+         .+.+.......                  .+..++.++.+++.+||+.+|.+||++.+++
T Consensus       233 ~~-----~~~~---------~~~~~~~~~~~------------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~  280 (290)
T cd05045         233 IA-----PERL---------FNLLKTGYRME------------------RPENCSEEMYNLMLTCWKQEPDKRPTFADIS  280 (290)
T ss_pred             CC-----HHHH---------HHHHhCCCCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            21     1111         11111111000                  0123456788999999999999999999999


Q ss_pred             HHHHHhhh
Q 041757          319 HELQSIKN  326 (381)
Q Consensus       319 ~~L~~i~~  326 (381)
                      +.|+++..
T Consensus       281 ~~l~~~~~  288 (290)
T cd05045         281 KELEKMMV  288 (290)
T ss_pred             HHHHHHHh
Confidence            99998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-39  Score=295.58  Aligned_cols=245  Identities=21%  Similarity=0.279  Sum_probs=191.6

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||.||++..                    .....+.+|+++++.++||||+++++++.     ..+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence            5788999999999999987642                    12346888999999999999999999854     4678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++....      .....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l  147 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFK------KQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhh------hccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEE
Confidence            899999999999999885322      23345788999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++..........  ....+++.|+|||.+.+..++.++||||||+++|||++|..||....   .....+...   
T Consensus       148 ~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~---  219 (267)
T cd08228         148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLFSLCQK---  219 (267)
T ss_pred             CccccceeccchhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc---ccHHHHHHH---
Confidence            9999988765432211  12458889999999988889999999999999999999999974221   111111111   


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                            +....  .+.               ......+..+.+++.+||..+|++||++.+|++.++++.
T Consensus       220 ------~~~~~--~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         220 ------IEQCD--YPP---------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ------HhcCC--CCC---------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                  00000  000               001245567899999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.3e-39  Score=294.99  Aligned_cols=248  Identities=20%  Similarity=0.334  Sum_probs=186.4

Q ss_pred             ccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccc-cCCce
Q 041757           38 MLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDF   95 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~~~~   95 (381)
                      +..+++||+|+||.||++.                     ....+.+.+|+++++.++|+||+++++++..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999998653                     1234678889999999999999999998754211 12345


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++......    .....+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl  153 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCV  153 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhccc----CCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEE
Confidence            78999999999999987421110    22345889999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      +|||+++...............+++.|+|||++.+..++.++||||||+++||+++ |+.||....    . .....   
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~-~~~~~---  225 (272)
T cd05075         154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE----N-SEIYD---  225 (272)
T ss_pred             CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC----H-HHHHH---
Confidence            99999987654332211112346778999999998889999999999999999999 788875211    1 11110   


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                            .+.   .....               ..+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       226 ------~~~---~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         226 ------YLR---QGNRL---------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ------HHH---cCCCC---------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  000   00000               00123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.9e-40  Score=305.39  Aligned_cols=221  Identities=24%  Similarity=0.260  Sum_probs=173.9

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||+++.                    ...+.+.+|..++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            4699999999987641                    1235567888888877 699999999984     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 Ey~~~g~L~~~i~----------~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~  142 (320)
T cd05590          76 EFVNGGDLMFHIQ----------KSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM  142 (320)
T ss_pred             cCCCCchHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence            9999999999983          4557899999999999999999999   67999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....     ...            
T Consensus       143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~------------  203 (320)
T cd05590         143 CKEGIFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDD------------  203 (320)
T ss_pred             CeecCcCCCc--ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHH------------
Confidence            8754322221  122468999999999998899999999999999999999999985221     111            


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                      +..........                .+...+.++.+++.+||+.||.+||++.
T Consensus       204 ~~~~i~~~~~~----------------~~~~~~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         204 LFEAILNDEVV----------------YPTWLSQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             HHHHHhcCCCC----------------CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence            11111111100                0112455788999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-39  Score=304.46  Aligned_cols=228  Identities=21%  Similarity=0.271  Sum_probs=176.0

Q ss_pred             ccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHH---HccCCCcccceeeeeccccccCCc
Q 041757           38 MLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKAL---RNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      |...++||+|+||.||++..                    ...+.+.+|++++   +.++||||+++++++     ...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            56778999999999987642                    1234566676655   466799999999984     4578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|..++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~k  141 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----------TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVK  141 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEE
Confidence            8999999999999998873           246899999999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++........  .....|++.|+|||++.+..++.++|||||||++|||++|+.||....    . .       
T Consensus       142 L~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~----~-~-------  207 (324)
T cd05589         142 IADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD----E-E-------  207 (324)
T ss_pred             eCcccCCccCCCCCCc--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC----H-H-------
Confidence            9999998754322221  122568999999999999899999999999999999999999985221    1 1       


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                           ++..........                .+...+..+.+++.+||+.||.+||+     +.++++
T Consensus       208 -----~~~~~i~~~~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         208 -----EVFDSIVNDEVR----------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----HHHHHHHhCCCC----------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 111111111100                01234567889999999999999994     556554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-39  Score=293.52  Aligned_cols=241  Identities=20%  Similarity=0.331  Sum_probs=189.1

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      -++|+..++||+|+||.||++..               ...+.+.+|+.+++.++|+||+++++.+     ......++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   79 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYII   79 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEEE
Confidence            36788899999999999987541               1346788999999999999999999984     446778999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++..        .....+++..++.++.|++.||+|||   ..+++||||||+||+++.++.++|+|||
T Consensus        80 ~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg  148 (261)
T cd05072          80 TEYMAKGSLLDFLKS--------DEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFG  148 (261)
T ss_pred             EecCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCc
Confidence            999999999999853        22456788889999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.....     ......      
T Consensus       149 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~------  216 (261)
T cd05072         149 LARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----SDVMSA------  216 (261)
T ss_pred             cceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----HHHHHH------
Confidence            998765433211 112346778999999988889999999999999999998 9999752211     000000      


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                         +..... .+                 ....++.++.+++.+||+.+|++||++.++.+.|+++
T Consensus       217 ---~~~~~~-~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         217 ---LQRGYR-MP-----------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ---HHcCCC-CC-----------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence               000000 00                 0123456788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-39  Score=300.07  Aligned_cols=256  Identities=19%  Similarity=0.318  Sum_probs=189.2

Q ss_pred             cccccccceecCCCceEEEecc----------------------------------cccHHHHHHHHHHHHccCCCcccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR----------------------------------QGAFKSFIAECKALRNIRHRNLIK   80 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~----------------------------------~~~~~~~~~E~~~l~~l~h~nIv~   80 (381)
                      .++|+..++||+|+||.||++.                                  ....+.+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3578999999999999999752                                  112357889999999999999999


Q ss_pred             eeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcc-cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757           81 VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE-TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV  159 (381)
Q Consensus        81 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD  159 (381)
                      +++++.     ..+..++||||+++|+|.+++........ .......+++..+..++.|++.||+|||   +.+++|||
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~d  155 (296)
T cd05095          84 LLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRD  155 (296)
T ss_pred             EEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeeccc
Confidence            999954     46678999999999999999864321111 0122345788899999999999999999   66999999


Q ss_pred             cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh--CCCCCC
Q 041757          160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI--REKPSD  237 (381)
Q Consensus       160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t--g~~Pf~  237 (381)
                      |||+||+++.++.++|+|||+++.+.............+++.|+|||+..+..++.++|||||||++|||++  |..||.
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            999999999999999999999976544322221112335678999998888889999999999999999998  778875


Q ss_pred             ccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757          238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV  317 (381)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v  317 (381)
                      ....     ......     .............               ...+..++..+.+++.+||+.||.+|||+.+|
T Consensus       236 ~~~~-----~~~~~~-----~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  290 (296)
T cd05095         236 QLSD-----EQVIEN-----TGEFFRDQGRQVY---------------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEI  290 (296)
T ss_pred             ccCh-----HHHHHH-----HHHHHhhcccccc---------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            2211     111110     0000100000000               00012355788999999999999999999999


Q ss_pred             HHHHHH
Q 041757          318 VHELQS  323 (381)
Q Consensus       318 l~~L~~  323 (381)
                      ++.|++
T Consensus       291 ~~~l~~  296 (296)
T cd05095         291 HATLLE  296 (296)
T ss_pred             HHHHhC
Confidence            998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2e-39  Score=296.57  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=190.9

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      .++|...+.||+|+||.||++..                       ...+.+.+|+++|+.++|+||+++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   78 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT-----   78 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence            35688889999999999987531                       13467899999999999999999999954     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcc----cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDE----TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                      .....++||||+++++|.+++........    .......+++..+..++.|++.|+.|||   +.+++||||||+||++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili  155 (280)
T cd05049          79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLV  155 (280)
T ss_pred             cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEE
Confidence            46789999999999999999964321100    0123456889999999999999999999   6699999999999999


Q ss_pred             CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcH
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL  246 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~  246 (381)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||.....     
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----  230 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----  230 (280)
T ss_pred             cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence            9999999999999976544332222222346788999999999999999999999999999998 9999752211     


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                      ..            .++........               ..+...+..+.+++.+||..||++||++.||++.|++
T Consensus       231 ~~------------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         231 EE------------VIECITQGRLL---------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HH------------HHHHHHcCCcC---------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            11            11110000000               0012355678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.8e-39  Score=293.22  Aligned_cols=240  Identities=22%  Similarity=0.359  Sum_probs=188.2

Q ss_pred             ccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .+|...++||+|+||.||++..                .....+.+|+++++.++|+||+++++++.     ..+..++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence            4578889999999999977531                13467899999999999999999999954     46678999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++..        .....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+||+|||
T Consensus        81 ~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~  149 (263)
T cd05052          81 TEFMTYGNLLDYLRE--------CNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFG  149 (263)
T ss_pred             EEeCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCc
Confidence            999999999999853        22346888999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++........... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...     ........      
T Consensus       150 ~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~------  217 (263)
T cd05052         150 LSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYEL------  217 (263)
T ss_pred             cccccccceeecc-CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH------
Confidence            9987654322211 11224668999999988899999999999999999998 89997421     11111111      


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                         +......                  ..+..++..+.+++.+||..||++|||+.++++.|+++
T Consensus       218 ---~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         218 ---LEKGYRM------------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---HHCCCCC------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               1000000                  00123556889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-40  Score=299.44  Aligned_cols=234  Identities=29%  Similarity=0.456  Sum_probs=177.7

Q ss_pred             ccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           40 EENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        40 ~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ..+.||.|.||.|+.+..                      ...+.|.+|++.+++++||||++++|+|.     ..+..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence            457899999999976431                      13678999999999999999999999975     355589


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +|||||++|+|.++|..        .....+++..+..++.||+.||.|||   +.+++|+||+++||+++.++.+||+|
T Consensus        78 lv~e~~~~g~L~~~L~~--------~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~  146 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKS--------KNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSD  146 (259)
T ss_dssp             EEEE--TTEBHHHHHHH--------TCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEES
T ss_pred             ccccccccccccccccc--------cccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            99999999999999963        12467899999999999999999999   55899999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||++....................|+|||.+....++.++||||||+++||+++ |+.||...     ....+...    
T Consensus       147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~----  217 (259)
T PF07714_consen  147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEK----  217 (259)
T ss_dssp             TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHH----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccc----
Confidence            999988743333222223447889999999998889999999999999999999 67886422     11111111    


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                          +.+....                   ..+..++..+.+++.+||+.||++|||+.++++.|
T Consensus       218 ----~~~~~~~-------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  218 ----LKQGQRL-------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----HHTTEET-------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ccccccc-------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                1000000                   01224567889999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.7e-39  Score=315.14  Aligned_cols=269  Identities=19%  Similarity=0.208  Sum_probs=184.8

Q ss_pred             ccccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeeccccc---cCCceEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY---QGNDFKA   97 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---~~~~~~~   97 (381)
                      ..++|...++||+|+||.||++...             ......+|+.+|+.++||||+++++++....+   ....+.+
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            3567999999999999999876421             12344579999999999999999887643211   2234577


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEe
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVG  176 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~  176 (381)
                      +||||+++ +|.+++....      .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++ .+||+
T Consensus       144 lvmE~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYA------RNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             EEEecCCc-cHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence            99999975 7877764221      23457899999999999999999999   67999999999999998654 79999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |||+++.+.......   ...||+.|+|||++.+ ..++.++|||||||++|||++|.+||...... ..+.........
T Consensus       214 DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~  289 (440)
T PTZ00036        214 DFGSAKNLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGT  289 (440)
T ss_pred             ccccchhccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence            999998665433222   2458999999998776 46899999999999999999999997532111 011111111111


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .....+ ..+ ....... .............++...+.++.+++.+||..||.+|||+.|+++
T Consensus       290 p~~~~~-~~~-~~~~~~~-~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        290 PTEDQL-KEM-NPNYADI-KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCHHHH-HHh-chhhhcc-cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            111111 000 0000000 000000011111222345568999999999999999999999984

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-39  Score=304.64  Aligned_cols=225  Identities=24%  Similarity=0.278  Sum_probs=176.0

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||++..                    ...+.+..|.+++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            4699999999987641                    1234567899999876 799999999994     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~  142 (321)
T cd05591          76 EYVNGGDLMFQIQ----------RSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGM  142 (321)
T ss_pred             eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeeccc
Confidence            9999999999883          4556889999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      +..........  ....||+.|+|||++.+..++.++|||||||++|||++|+.||....    . .            +
T Consensus       143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~----~-~------------~  203 (321)
T cd05591         143 CKEGILNGVTT--TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN----E-D------------D  203 (321)
T ss_pred             ceecccCCccc--cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC----H-H------------H
Confidence            87643322211  22468999999999998899999999999999999999999985221    1 1            1


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-------KMTNVVH  319 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~~vl~  319 (381)
                      .+.........                .+.....++.+++.+||+.||++||       ++.++++
T Consensus       204 ~~~~i~~~~~~----------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         204 LFESILHDDVL----------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            11111111100                0112345788999999999999999       6677764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=309.93  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=197.6

Q ss_pred             cccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .......++||+|-||.|.+..                 ....++|.+|+++|.+|+|||||+++|+|+.     ++.++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePic  611 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLC  611 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchH
Confidence            3455667999999999996643                 3456899999999999999999999999975     67889


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +|+||+++|+|.+|+....        ...+.-....+|+.||+.||+||.   +.++|||||.+.|+|+++++++||+|
T Consensus       612 mI~EYmEnGDLnqFl~ahe--------apt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiad  680 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHE--------LPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIAD  680 (807)
T ss_pred             HHHHHHhcCcHHHHHHhcc--------CcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecC
Confidence            9999999999999996421        122455566789999999999999   77999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh--CCCCCCccccCCCcHHHHHHHHhh
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI--REKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t--g~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      ||+++-+-...........+-+++|||||.+.-++++++||||+||+++||+++  ...||.......          .-
T Consensus       681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----------vv  750 (807)
T KOG1094|consen  681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----------VV  750 (807)
T ss_pred             cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----------HH
Confidence            999997777666655555667899999999999999999999999999999864  788875332211          11


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ++..++++.    .+...           -...++-|+..+.++|.+||..|-.+|||++++...|++.
T Consensus       751 en~~~~~~~----~~~~~-----------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  751 ENAGEFFRD----QGRQV-----------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HhhhhhcCC----CCcce-----------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            111111111    00000           0122467899999999999999999999999999988764

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=296.24  Aligned_cols=248  Identities=21%  Similarity=0.323  Sum_probs=189.3

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      .++|...+.||+|+||.||++..                       .....+.+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            35788899999999999986431                       12346889999999999999999999954     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+++|+|.+++...............+++..++.++.|++.||.|||   +.+++||||||+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCC
Confidence            467889999999999999999643221111012335788899999999999999999   67999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~  250 (381)
                      .+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |..||....     .....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~  231 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVL  231 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHH
Confidence            999999999886654432222222446789999999988889999999999999999998 898874211     11111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      ..        +......                   ..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       232 ~~--------~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         232 KF--------VIDGGHL-------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HH--------HhcCCCC-------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            10        0000000                   001234668899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.8e-39  Score=302.44  Aligned_cols=224  Identities=22%  Similarity=0.294  Sum_probs=173.4

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||++..                    ...+.+..|..++..+ +||||+++++++     ......++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            4699999999987642                    1233456677777654 799999999984     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~gg~L~~~~~----------~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~  142 (316)
T cd05592          76 EYLNGGDLMFHIQ----------SSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGM  142 (316)
T ss_pred             cCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcC
Confidence            9999999999983          4456899999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||....    . ...           
T Consensus       143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~----~-~~~-----------  204 (316)
T cd05592         143 CKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED----E-DEL-----------  204 (316)
T ss_pred             CeECCCCCCc--cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC----H-HHH-----------
Confidence            9765332211  122568999999999999899999999999999999999999985221    1 111           


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT-NVV  318 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl  318 (381)
                       ........+.                .+.....++.+++.+||+.||.+||++. +++
T Consensus       205 -~~~i~~~~~~----------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         205 -FDSILNDRPH----------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -HHHHHcCCCC----------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             1111110000                0123445678899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.3e-39  Score=299.44  Aligned_cols=253  Identities=21%  Similarity=0.348  Sum_probs=191.9

Q ss_pred             cccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGV   88 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~   88 (381)
                      .++|.+++.||+|+||.||++..                         .....+.+|+.+++.+ +||||+++++++.  
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence            36799999999999999986531                         1234678899999999 7999999999964  


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                         .....++||||+++|+|.+++........      .......+++.+++.++.|++.||+|||   +.+++||||||
T Consensus        95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp  168 (307)
T cd05098          95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  168 (307)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccH
Confidence               46678999999999999999964321100      0012235889999999999999999999   66999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE  241 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~  241 (381)
                      +||+++.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...  
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--  246 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--  246 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--
Confidence            999999999999999999876643322211111234578999999988889999999999999999998 88886421  


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                         ........         +.....                  ...+..++.++.+++.+||+.+|.+|||+.+|++.|
T Consensus       247 ---~~~~~~~~---------~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l  296 (307)
T cd05098         247 ---PVEELFKL---------LKEGHR------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  296 (307)
T ss_pred             ---CHHHHHHH---------HHcCCC------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence               11111111         110000                  001124556888999999999999999999999999


Q ss_pred             HHhhhh
Q 041757          322 QSIKNT  327 (381)
Q Consensus       322 ~~i~~~  327 (381)
                      +++...
T Consensus       297 ~~~~~~  302 (307)
T cd05098         297 DRILAL  302 (307)
T ss_pred             HHHHHH
Confidence            998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.8e-39  Score=303.51  Aligned_cols=225  Identities=20%  Similarity=0.227  Sum_probs=175.7

Q ss_pred             cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCC-cccceeeeeccccccCCce
Q 041757           37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~~~~   95 (381)
                      +|...+.||+|+||.||++..                    ...+.+..|.+++..+.|+ +|+++++++     ...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            578889999999999987642                    2345677899999999765 578888874     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL  142 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKI  142 (324)
T ss_pred             EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEE
Confidence            999999999999999983          4456889999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||....    . ..       
T Consensus       143 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~-~~-------  208 (324)
T cd05587         143 ADFGMCKENIFGGKT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----E-DE-------  208 (324)
T ss_pred             eecCcceecCCCCCc--eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----H-HH-------
Confidence            999998753222211  112468999999999999899999999999999999999999985221    1 11       


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                           .+.........                .+......+.+++.+||+.||.+|++.
T Consensus       209 -----~~~~i~~~~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         209 -----LFQSIMEHNVS----------------YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -----HHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                 11111110000                011344578899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.1e-39  Score=298.42  Aligned_cols=253  Identities=19%  Similarity=0.352  Sum_probs=193.2

Q ss_pred             cccccccceecCCCceEEEecc-------------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-------------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGV   88 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-------------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~   88 (381)
                      .++|...+.||+|+||.||++.                         ....+.+.+|+.+++.+ +||||+++++.+.  
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence            5778899999999999998663                         11235678899999999 7999999999953  


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccc------cCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY------KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                         .....++||||+++|+|.+++..........      .....+++..++.++.|++.||.|||   +.+++||||||
T Consensus        92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp  165 (304)
T cd05101          92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAA  165 (304)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence               4678899999999999999996432110000      11245788899999999999999999   66999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE  241 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~  241 (381)
                      +||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|++++ |..||...  
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--  243 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--  243 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--
Confidence            999999999999999999987654332222222346778999999988889999999999999999998 77886421  


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                         ........            ......               ...+..++..+.+++.+||+.+|.+|||+.++++.|
T Consensus       244 ---~~~~~~~~------------~~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l  293 (304)
T cd05101         244 ---PVEELFKL------------LKEGHR---------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL  293 (304)
T ss_pred             ---CHHHHHHH------------HHcCCc---------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence               11111111            100000               000124566888999999999999999999999999


Q ss_pred             HHhhhh
Q 041757          322 QSIKNT  327 (381)
Q Consensus       322 ~~i~~~  327 (381)
                      +++...
T Consensus       294 ~~~~~~  299 (304)
T cd05101         294 DRILTL  299 (304)
T ss_pred             HHHHHh
Confidence            988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.3e-39  Score=289.39  Aligned_cols=232  Identities=21%  Similarity=0.308  Sum_probs=179.6

Q ss_pred             ceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           42 NLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ++||+|+||.||++..                  .....+.+|++++++++||||++++++|.     .....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence            4699999999987531                  12456899999999999999999999964     467789999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ++++|.+++.         .....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus        76 ~~~~L~~~~~---------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  143 (252)
T cd05084          76 QGGDFLTFLR---------TEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE  143 (252)
T ss_pred             cCCcHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcc
Confidence            9999999984         22345889999999999999999999   66999999999999999999999999999876


Q ss_pred             cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHH
Q 041757          184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIV  262 (381)
Q Consensus       184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (381)
                      ..............++..|+|||.+.+..++.++||||||+++||+++ |..||.....     .         .....+
T Consensus       144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~---------~~~~~~  209 (252)
T cd05084         144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----Q---------QTREAI  209 (252)
T ss_pred             cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----H---------HHHHHH
Confidence            543221111111123567999999988889999999999999999998 8888752211     0         011111


Q ss_pred             hhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          263 DSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       263 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      ......                  ..+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       210 ~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         210 EQGVRL------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HcCCCC------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            110000                  011234568899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.2e-39  Score=297.42  Aligned_cols=251  Identities=20%  Similarity=0.337  Sum_probs=192.1

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~   90 (381)
                      .++|...+.||+|+||.||++..                       .....+.+|+.++.++ +|+||+++++++.    
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----   86 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT----   86 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence            46788899999999999987531                       1234688899999999 7999999999954    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSN  164 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~N  164 (381)
                       ..+..++||||+++|+|.+++........      .......+++..++.++.|++.||+|||   ..+|+||||||+|
T Consensus        87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~N  162 (293)
T cd05053          87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARN  162 (293)
T ss_pred             -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceee
Confidence             46778999999999999999964321100      0022456889999999999999999999   6699999999999


Q ss_pred             eeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCC
Q 041757          165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGD  243 (381)
Q Consensus       165 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~  243 (381)
                      |+++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |..||....   
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---  239 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---  239 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC---
Confidence            9999999999999999987655432222222335678999999988889999999999999999997 888874211   


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                        ......         .+.....  +                ..+..++..+.+++.+||..||.+|||+.++++.|++
T Consensus       240 --~~~~~~---------~~~~~~~--~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         240 --VEELFK---------LLKEGYR--M----------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             --HHHHHH---------HHHcCCc--C----------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence              111111         0100000  0                0012345678899999999999999999999999988


Q ss_pred             hh
Q 041757          324 IK  325 (381)
Q Consensus       324 i~  325 (381)
                      +.
T Consensus       291 ~~  292 (293)
T cd05053         291 ML  292 (293)
T ss_pred             hh
Confidence            74

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.1e-39  Score=306.69  Aligned_cols=232  Identities=21%  Similarity=0.293  Sum_probs=177.5

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..+|...++||+|+||.||++..                  .....+.+|+++++.++|+||+++++++     ...+..
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence            35677889999999999987642                  1245688999999999999999999994     457789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++|+|....              ...+..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       148 ~lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~  210 (353)
T PLN00034        148 QVLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIA  210 (353)
T ss_pred             EEEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEc
Confidence            9999999999986532              2456677889999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      |||+++.+.......  ....||..|+|||++..     ...+.++|||||||++|||++|+.||.....  ..+.....
T Consensus       211 DfG~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~  286 (353)
T PLN00034        211 DFGVSRILAQTMDPC--NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMC  286 (353)
T ss_pred             ccccceecccccccc--cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHH
Confidence            999998765432211  12468999999998753     2345689999999999999999999862211  11111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                  .......               ...+..+..++.+++.+||+.||++|||+.|+++
T Consensus       287 ------------~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        287 ------------AICMSQP---------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ------------HHhccCC---------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                        0000000               0001245567899999999999999999999987

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.8e-39  Score=290.43  Aligned_cols=237  Identities=25%  Similarity=0.353  Sum_probs=187.1

Q ss_pred             ccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           36 RNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      ++|...+.||+|+||.||++.             ....+.+.+|+.++++++|+||+++++++.    ......++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEEEEEC
Confidence            578888999999999998753             223567899999999999999999999753    345678999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +++++|.+++..        .....+++..++.++.|++.||+|||   ..+++||||||+||+++.++.+||+|||++.
T Consensus        82 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          82 MAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             CCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccce
Confidence            999999999853        12335788999999999999999999   6699999999999999999999999999987


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      .......     ...++..|+|||++.+..++.++|||||||++|+|++ |+.||...     ........         
T Consensus       151 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~---------  211 (256)
T cd05082         151 EASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPR---------  211 (256)
T ss_pred             eccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH---------
Confidence            6543221     1235678999999988889999999999999999997 99997421     11111111         


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                         ......               ...+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       212 ---~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         212 ---VEKGYK---------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ---HhcCCC---------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence               000000               001124566888999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.7e-39  Score=299.53  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=189.3

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|...+.||+|+||.||++..                    .....+.+|++++.++ +|+||+++++++     ...+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence            5788889999999999988741                    1234678899999999 799999999995     4467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCccc------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDET------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                      ..++||||+++++|.+++.........      ......+++..++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEec
Confidence            899999999999999999643211000      012236889999999999999999999   67999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH  247 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~  247 (381)
                      .++.+||+|||++.........   ....++..|+|||++.+..++.++|||||||++|||+| |..||.....     .
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~  230 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A  230 (303)
T ss_pred             CCCcEEeCccccCcccchhhhc---ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----H
Confidence            9999999999998643211111   11224667999999988889999999999999999998 9999752211     1


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      ..            .+.......               ...+...+..+.+++.+||+.+|++||++.++++.|.++...
T Consensus       231 ~~------------~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         231 EL------------YEKLPQGYR---------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HH------------HHHHhcCCc---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11            110000000               000112445788999999999999999999999999988665


Q ss_pred             cC
Q 041757          328 LL  329 (381)
Q Consensus       328 ~~  329 (381)
                      ..
T Consensus       284 ~~  285 (303)
T cd05088         284 RK  285 (303)
T ss_pred             hh
Confidence            43

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.9e-39  Score=292.04  Aligned_cols=237  Identities=21%  Similarity=0.340  Sum_probs=185.1

Q ss_pred             ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++|...+.||+|+||.||+++.               .....+.+|+.++++++||||+++++++.     .....++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~   78 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIVT   78 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEEE
Confidence            4678889999999999977641               12457899999999999999999999954     356789999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+.+|+|.+++..         ....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.
T Consensus        79 e~~~~~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~  146 (256)
T cd05113          79 EYMSNGCLLNYLRE---------HGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGL  146 (256)
T ss_pred             EcCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCcc
Confidence            99999999999852         2336899999999999999999999   67999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      ++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....     ..           
T Consensus       147 ~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~-----------  209 (256)
T cd05113         147 SRYVLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----SE-----------  209 (256)
T ss_pred             ceecCCCceee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HH-----------
Confidence            88665433221 112335678999999988889999999999999999998 9999752211     00           


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                       +..........               ..+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       210 -~~~~~~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         210 -TVEKVSQGLRL---------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -HHHHHhcCCCC---------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             11111100000               001123567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.7e-40  Score=305.93  Aligned_cols=231  Identities=22%  Similarity=0.278  Sum_probs=176.9

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||++..                    ...+.+.+|..++..+ +||||+++++++     ......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            4799999999987642                    1234577899999998 699999999984     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      |||++|+|..++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~  142 (329)
T cd05588          76 EFVSGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcc
Confidence            9999999999883          4567999999999999999999999   77999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCC---cHHHHHHHHhhch
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM---NLHKFAKMALSNH  257 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~---~~~~~~~~~~~~~  257 (381)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||+.....+.   ....+..      
T Consensus       143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~------  214 (329)
T cd05588         143 CKEGIRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF------  214 (329)
T ss_pred             ccccccCCCc--cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH------
Confidence            8753222211  1125689999999999999999999999999999999999999863221110   0001000      


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK------MTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~~vl~  319 (381)
                       ..+...    ..                ..+...+..+.+++.+||+.||.+||+      +.++++
T Consensus       215 -~~~~~~----~~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         215 -QVILEK----QI----------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -HHHHcC----CC----------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             000110    00                011234557889999999999999998      556653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.9e-39  Score=302.62  Aligned_cols=225  Identities=22%  Similarity=0.251  Sum_probs=177.3

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||+||++..                    .....+.+|.+++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            4699999999987642                    1234567899999888 699999999984     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  142 (318)
T cd05570          76 EYVNGGDLMFHIQ----------RSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGM  142 (318)
T ss_pred             cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCC
Confidence            9999999999883          4557899999999999999999999   67999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++.........  ....|++.|+|||++.+..++.++|||||||++|+|++|+.||....     .....          
T Consensus       143 ~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~----------  205 (318)
T cd05570         143 CKEGILGGVTT--STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELF----------  205 (318)
T ss_pred             CeecCcCCCcc--cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHH----------
Confidence            87533222211  12458999999999999999999999999999999999999985221     11111          


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM-----TNVVH  319 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~vl~  319 (381)
                        .........                .+...+..+.+++.+||+.||.+|||+     .++++
T Consensus       206 --~~i~~~~~~----------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         206 --QSILEDEVR----------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             --HHHHcCCCC----------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence              111100000                012345678899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.7e-39  Score=293.22  Aligned_cols=244  Identities=23%  Similarity=0.326  Sum_probs=190.4

Q ss_pred             cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .++|...++||.|+||+||++..                      ...+.+.+|+.+++.++||||+++++++.      
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------   79 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL------   79 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc------
Confidence            56788899999999999987531                      12456788999999999999999999964      


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++++||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+++||||||+||++++++.
T Consensus        80 ~~~~~l~~~~~~~g~l~~~l~---------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~  147 (279)
T cd05109          80 TSTVQLVTQLMPYGCLLDYVR---------ENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNH  147 (279)
T ss_pred             CCCcEEEEEcCCCCCHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCc
Confidence            234679999999999999985         22456899999999999999999999   679999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++||+++ |..||.....     ..   
T Consensus       148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~---  219 (279)
T cd05109         148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----RE---  219 (279)
T ss_pred             EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HH---
Confidence            99999999987754332222212235678999999988889999999999999999998 8999752211     00   


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                            ....+.......                  .+..++..+.+++.+||+.||++||++.++++.|+.+....
T Consensus       220 ------~~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         220 ------IPDLLEKGERLP------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ------HHHHHHCCCcCC------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                  111111100000                  01235567889999999999999999999999998775543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.2e-40  Score=306.04  Aligned_cols=229  Identities=23%  Similarity=0.273  Sum_probs=173.9

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||++..                    .....+.+|+.++.++ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            4699999999987641                    1234567888888877 799999999984     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~  142 (329)
T cd05618          76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            9999999998883          4567899999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++.........  ....||+.|+|||++.+..++.++|||||||++|||++|+.||.............        ...
T Consensus       143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~--------~~~  212 (329)
T cd05618         143 CKEGLRPGDTT--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--------EDY  212 (329)
T ss_pred             cccccCCCCcc--ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc--------HHH
Confidence            87543222111  22568999999999999999999999999999999999999986322111110000        000


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                      +.........                ..+......+.+++.+||+.||.+||++
T Consensus       213 ~~~~i~~~~~----------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         213 LFQVILEKQI----------------RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhcCCC----------------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            0000010000                0122345578899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.8e-39  Score=297.00  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=189.1

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|...++||+|+||.||++..                    ...+.+.+|+.++.++ +||||+++++++     ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            5788899999999999987531                    1235688899999999 699999999985     3466


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                      ..++||||+++++|.+++........      .......+++..++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence            78999999999999999954221100      0012245889999999999999999999   66999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH  247 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~  247 (381)
                      .++.+||+|||++..........   ....+..|+|||++.+..++.++|||||||++|||++ |..||.....     .
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~  225 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYVKKT---MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----A  225 (297)
T ss_pred             CCCeEEECCcCCCccccceeccC---CCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence            99999999999986432211111   1123567999999988889999999999999999997 9999752211     1


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      .....        +... ....                  .+..++..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       226 ~~~~~--------~~~~-~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         226 ELYEK--------LPQG-YRME------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HHHHH--------HhcC-CCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11110        0000 0000                  0123556788999999999999999999999999988766


Q ss_pred             c
Q 041757          328 L  328 (381)
Q Consensus       328 ~  328 (381)
                      .
T Consensus       279 ~  279 (297)
T cd05089         279 R  279 (297)
T ss_pred             h
Confidence            5

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.3e-39  Score=295.86  Aligned_cols=248  Identities=21%  Similarity=0.311  Sum_probs=188.0

Q ss_pred             ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ++|+..+.||+|+||.||++..                      .....+.+|+.+++.++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence            5678889999999999987531                      1235688999999999999999999984     446


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCc-------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKED-------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                      ...++||||+++++|.+++.......       ........+++..++.++.|++.||.|||   +.+++||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence            78899999999999999984321100       00011345788999999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCc
Q 041757          167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMN  245 (381)
Q Consensus       167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~  245 (381)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....    .
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~----~  232 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----N  232 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----H
Confidence            99999999999999987644332222222346778999999988889999999999999999998 988974211    0


Q ss_pred             HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                       ......         +......                  ..+..++..+.+++.+||+.||.+||++.+|.+.|..
T Consensus       233 -~~~~~~---------~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 -QEVIEM---------VRKRQLL------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHH---------HHcCCcC------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             111111         1000000                  0012345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-39  Score=299.76  Aligned_cols=243  Identities=23%  Similarity=0.297  Sum_probs=188.7

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~   90 (381)
                      .++|...+.||+|+||.||++..                       ...+.+.+|+++++++ +||||+++++++.    
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----  109 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----  109 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe----
Confidence            46799999999999999976531                       1234688999999999 7999999999954    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                       ..+..++||||+++|+|.+++..        .....+++.++..++.|++.||.|||   +.+++|+||||+||+++.+
T Consensus       110 -~~~~~~lv~e~~~~~~L~~~i~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~  177 (302)
T cd05055         110 -IGGPILVITEYCCYGDLLNFLRR--------KRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHG  177 (302)
T ss_pred             -cCCceEEEEEcCCCCcHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCC
Confidence             46678999999999999999953        12234899999999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~  249 (381)
                      +.++|+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |..||......    ..+
T Consensus       178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----~~~  253 (302)
T cd05055         178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----SKF  253 (302)
T ss_pred             CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----HHH
Confidence            9999999999986654332211122346788999999998889999999999999999998 99997532111    010


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                               ...+.......                  .+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       254 ---------~~~~~~~~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 ---------YKLIKEGYRMA------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---------HHHHHcCCcCC------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                     11111100000                  0112345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=298.36  Aligned_cols=255  Identities=21%  Similarity=0.330  Sum_probs=186.9

Q ss_pred             cccccccceecCCCceEEEeccc--------------------------------ccHHHHHHHHHHHHccCCCccccee
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------------------GAFKSFIAECKALRNIRHRNLIKVL   82 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------------------~~~~~~~~E~~~l~~l~h~nIv~~~   82 (381)
                      .++|...++||+|+||.||++..                                .....|.+|++++++++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            46789999999999999986431                                1234688899999999999999999


Q ss_pred             eeeccccccCCceEEEEEEcccCCCHHHhhccccCC--cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeecc
Q 041757           83 TACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE--DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL  160 (381)
Q Consensus        83 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDl  160 (381)
                      +++.     .....++||||+++++|.+++......  .........+++..++.++.|++.||.|||   +.+++||||
T Consensus        84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dl  155 (295)
T cd05097          84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDL  155 (295)
T ss_pred             EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeecccc
Confidence            9954     467889999999999999998532100  000011234688899999999999999999   669999999


Q ss_pred             CCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh--CCCCCCc
Q 041757          161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI--REKPSDI  238 (381)
Q Consensus       161 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t--g~~Pf~~  238 (381)
                      ||+||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++  |..||..
T Consensus       156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999999999999999999976544332222222345778999999988889999999999999999998  5667642


Q ss_pred             cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757          239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV  318 (381)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  318 (381)
                      ...     ......     ..............               ..+...+..+.+++.+||+.||++|||+.+|+
T Consensus       236 ~~~-----~~~~~~-----~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~  290 (295)
T cd05097         236 LSD-----EQVIEN-----TGEFFRNQGRQIYL---------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH  290 (295)
T ss_pred             cCh-----HHHHHH-----HHHhhhhccccccC---------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            111     111000     00000000000000               00113456899999999999999999999999


Q ss_pred             HHHH
Q 041757          319 HELQ  322 (381)
Q Consensus       319 ~~L~  322 (381)
                      +.|+
T Consensus       291 ~~l~  294 (295)
T cd05097         291 HFLR  294 (295)
T ss_pred             HHHh
Confidence            9886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=295.68  Aligned_cols=235  Identities=22%  Similarity=0.258  Sum_probs=181.9

Q ss_pred             cccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           37 NMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      +|+..++||+|+||.||++...                    ....+.+|+.+++.++||||+++++++     ...+..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            4778899999999999775421                    123467899999999999999999984     446789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++|+|.+++..        .....+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~  144 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYN--------MGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             EEEEeccCCCcHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEe
Confidence            999999999999988842        12346899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||++..........   ...|++.|+|||++.+..++.++|||||||++||+++|+.||...... .....+       
T Consensus       145 Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~-------  213 (285)
T cd05605         145 DLGLAVEIPEGETIR---GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEV-------  213 (285)
T ss_pred             eCCCceecCCCCccc---cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHH-------
Confidence            999998764332221   245899999999998888999999999999999999999998632110 000000       


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                        ...+....   .                ..+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       214 --~~~~~~~~---~----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         214 --ERRVKEDQ---E----------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             --HHHhhhcc---c----------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence              00000000   0                00123556788999999999999999     6777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.1e-39  Score=298.92  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=189.6

Q ss_pred             cccccccceecCCCceEEEeccc----------------------------------ccHHHHHHHHHHHHccCCCcccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------------------------GAFKSFIAECKALRNIRHRNLIK   80 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------------------~~~~~~~~E~~~l~~l~h~nIv~   80 (381)
                      ..+|...+.||+|+||.||++..                                  ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            46788999999999999986321                                  23567889999999999999999


Q ss_pred             eeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCccc-ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757           81 VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET-YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV  159 (381)
Q Consensus        81 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD  159 (381)
                      +++++.     .....++||||+++++|.+++......... ......+++..++.++.|++.||.|||   +.+++|||
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d  155 (296)
T cd05051          84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD  155 (296)
T ss_pred             EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence            999954     457889999999999999999543211000 112236899999999999999999999   66999999


Q ss_pred             cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh--CCCCCC
Q 041757          160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI--REKPSD  237 (381)
Q Consensus       160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t--g~~Pf~  237 (381)
                      |||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++  |..||.
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999986654433222223456788999999988889999999999999999998  677764


Q ss_pred             ccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757          238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV  317 (381)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v  317 (381)
                      ....     .....        .... ........           .....+..++.++.+++.+||+.||.+|||+.+|
T Consensus       236 ~~~~-----~~~~~--------~~~~-~~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el  290 (296)
T cd05051         236 HLTD-----QQVIE--------NAGH-FFRDDGRQ-----------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI  290 (296)
T ss_pred             CcCh-----HHHHH--------HHHh-cccccccc-----------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence            2211     00000        0000 00000000           0000012345689999999999999999999999


Q ss_pred             HHHHH
Q 041757          318 VHELQ  322 (381)
Q Consensus       318 l~~L~  322 (381)
                      ++.|+
T Consensus       291 ~~~L~  295 (296)
T cd05051         291 HLFLQ  295 (296)
T ss_pred             HHHhc
Confidence            99885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4e-39  Score=294.44  Aligned_cols=245  Identities=21%  Similarity=0.285  Sum_probs=186.5

Q ss_pred             cccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      .++|...+.||+|+||.||++...                       ....|.+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-----   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence            467899999999999999865321                       2346889999999999999999999854     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+++++|.+++.......   .....+++..++.++.||+.||+|||   +.+++||||||+||+++.++
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~  153 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKG  153 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccC
Confidence            3567799999999999999996432111   12236899999999999999999999   66999999999999998654


Q ss_pred             ---CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757          172 ---TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH  247 (381)
Q Consensus       172 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~  247 (381)
                         .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||.....     .
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~  228 (277)
T cd05036         154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----Q  228 (277)
T ss_pred             CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence               689999999987643322211111234578999999988889999999999999999997 9999752211     1


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      ....         .+......                  ..+..++..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       229 ~~~~---------~~~~~~~~------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 EVME---------FVTGGGRL------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHH---------HHHcCCcC------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111         11100000                  001234568899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.6e-39  Score=293.36  Aligned_cols=252  Identities=21%  Similarity=0.345  Sum_probs=194.0

Q ss_pred             cccccccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .++|...++||+|+||.||.+...                      ..+.+.+|+.+++.++|+||+++++++..    .
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE----D   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence            567889999999999999876421                      24668899999999999999999998643    3


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++++||+++++|.+++.......  ......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCc
Confidence            567899999999999999985422110  012256899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||...    .. ..+..
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~-~~~~~  230 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI----DP-FEMAA  230 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC----CH-HHHHH
Confidence            99999999986644332211112346778999999988889999999999999999999 99997522    11 11111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                               .+.....  ..                ....++..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       231 ---------~~~~~~~--~~----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         231 ---------YLKDGYR--LA----------------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ---------HHHcCCC--CC----------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                     0000000  00                0123456789999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.6e-39  Score=301.38  Aligned_cols=224  Identities=22%  Similarity=0.282  Sum_probs=173.6

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||++..                    ...+.+..|..++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            4799999999987642                    1234566788888765 899999999984     4578899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++.          ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05620          76 EFLNGGDLMFHIQ----------DKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGM  142 (316)
T ss_pred             CCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCC
Confidence            9999999999983          4456889999999999999999999   67999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|||++|..||....    . ...           
T Consensus       143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~-~~~-----------  204 (316)
T cd05620         143 CKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----E-DEL-----------  204 (316)
T ss_pred             CeecccCCCc--eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----H-HHH-----------
Confidence            8753222111  123568999999999999999999999999999999999999985221    1 111           


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT-NVV  318 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl  318 (381)
                       ........+.                .+.....++.+++.+||+.||++||++. +++
T Consensus       205 -~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         205 -FESIRVDTPH----------------YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -HHHHHhCCCC----------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             1111000000                0112345678899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.4e-39  Score=294.68  Aligned_cols=248  Identities=23%  Similarity=0.380  Sum_probs=188.7

Q ss_pred             cccccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .++|...++||+|+||.||++.                      ....+.+.+|+++++.++|+||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   78 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----E   78 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----c
Confidence            3567788999999999998753                      112457889999999999999999999853     4


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCc-----ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKED-----ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                      ....++||||+++++|.+++.......     ........+++..++.++.|++.||+|||   +.+++||||||+||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~  155 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLV  155 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEE
Confidence            677899999999999999986432110     00011245889999999999999999999   6699999999999999


Q ss_pred             CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcH
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL  246 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~  246 (381)
                      ++++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......    
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----  231 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----  231 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----
Confidence            9999999999999976544322221222335788999999998899999999999999999998 89997522110    


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                                   +.+.........               ..+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       232 -------------~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 -------------EAIECITQGREL---------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -------------HHHHHHHcCccC---------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                         001111000000               001245567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=307.88  Aligned_cols=235  Identities=21%  Similarity=0.271  Sum_probs=185.8

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||+||++..                    .....+.+|++++..++||||+++++++     .+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            4688999999999999987652                    2345678899999999999999999884     55788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++++|.+++.          ....+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL  142 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLI----------RKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKL  142 (350)
T ss_pred             EEEEEcCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEe
Confidence            999999999999999994          3467899999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCC---------------------------CcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHH
Q 041757          176 GDFGLARFLPPTR---------------------------TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE  228 (381)
Q Consensus       176 ~Dfg~~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~e  228 (381)
                      +|||++.......                           .........||+.|+|||++.+..++.++|||||||++||
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  222 (350)
T cd05573         143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE  222 (350)
T ss_pred             ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence            9999998665433                           0011123568999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh--hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCC
Q 041757          229 LMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD--SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSME  306 (381)
Q Consensus       229 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  306 (381)
                      |++|+.||....    ....+         ..+..  ..+....                  ....+..+.+++.+|+. 
T Consensus       223 ll~g~~Pf~~~~----~~~~~---------~~i~~~~~~~~~p~------------------~~~~~~~~~~li~~ll~-  270 (350)
T cd05573         223 MLYGFPPFYSDT----LQETY---------NKIINWKESLRFPP------------------DPPVSPEAIDLICRLLC-  270 (350)
T ss_pred             hccCCCCCCCCC----HHHHH---------HHHhccCCcccCCC------------------CCCCCHHHHHHHHHHcc-
Confidence            999999985221    11110         01111  0000000                  01245678899999997 


Q ss_pred             CCCCCCC-HHHHHHH
Q 041757          307 SPQDRMK-MTNVVHE  320 (381)
Q Consensus       307 dP~~RPs-~~~vl~~  320 (381)
                      ||.+||+ +.++++.
T Consensus       271 dp~~R~~s~~~ll~h  285 (350)
T cd05573         271 DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ChhhcCCCHHHHhcC
Confidence            9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3e-39  Score=307.73  Aligned_cols=261  Identities=19%  Similarity=0.247  Sum_probs=184.1

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|+..++||+|+||.||++..                   ...+.+.+|+++++.++|+||+++++++...+.......+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999987652                   1235688999999999999999999996542222223789


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+. ++|.+++          .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~-~~l~~~~----------~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~D  146 (372)
T cd07853          81 VVTELMQ-SDLHKII----------VSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICD  146 (372)
T ss_pred             EEeeccc-cCHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecc
Confidence            9999996 5888887          34567899999999999999999999   67999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||+++......... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+.......
T Consensus       147 fg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~  224 (372)
T cd07853         147 FGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTP  224 (372)
T ss_pred             ccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCC
Confidence            99998654332211 1224578999999998774 4789999999999999999999998532211 0111111111111


Q ss_pred             hHHHHHhh------hhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDS------ILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~------~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...++...      .+...+..      ................++.+++.+||+.||.+|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         225 SLEAMRSACEGARAHILRGPHK------PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             CHHHHHHhhHHHHHHHHhCCCC------CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            11111000      00000000      00000000111233567889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.2e-39  Score=294.86  Aligned_cols=231  Identities=23%  Similarity=0.301  Sum_probs=177.3

Q ss_pred             ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ||+|+||+||++..                    ...+.+..|+++++.++|+||+++++++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            79999999987531                    1234567899999999999999999884     4577899999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ++|+|..++....      .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        76 ~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  146 (280)
T cd05608          76 NGGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVE  146 (280)
T ss_pred             CCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence            9999998874321      23456899999999999999999999   67999999999999999999999999999986


Q ss_pred             cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757          184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD  263 (381)
Q Consensus       184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (381)
                      ........  ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..            ..+..
T Consensus       147 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~------------~~~~~  211 (280)
T cd05608         147 LKDGQSKT--KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-EN------------KELKQ  211 (280)
T ss_pred             cCCCCccc--cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hH------------HHHHH
Confidence            65433221  12468999999999999999999999999999999999999986321110 00            01111


Q ss_pred             hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                      .......                ..+...+..+.+++.+||+.||++||     ++.++++
T Consensus       212 ~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         212 RILNDSV----------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             hhcccCC----------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            1110000                01124556788999999999999999     5566664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.9e-40  Score=305.17  Aligned_cols=222  Identities=21%  Similarity=0.243  Sum_probs=175.5

Q ss_pred             ceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           42 NLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      +.||+|+||.||+++.                      .....+.+|++++++++||||+++++++     ......++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            5799999999986532                      1234567899999999999999999984     457789999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        77 ~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg  143 (318)
T cd05582          77 LDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG  143 (318)
T ss_pred             EcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeecc
Confidence            99999999999983          4556899999999999999999999   6799999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      +++........  .....|++.|+|||++.+..++.++|||||||++|||++|+.||....    . ...          
T Consensus       144 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~----~-~~~----------  206 (318)
T cd05582         144 LSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD----R-KET----------  206 (318)
T ss_pred             CCcccCCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC----H-HHH----------
Confidence            98765433221  122568999999999998889999999999999999999999985221    1 111          


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                        .........                ..+...+..+.+++.+||+.||++||++.+
T Consensus       207 --~~~i~~~~~----------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         207 --MTMILKAKL----------------GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --HHHHHcCCC----------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              111110000                001234567889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.9e-39  Score=300.15  Aligned_cols=224  Identities=23%  Similarity=0.313  Sum_probs=173.9

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      +.||+|+||.||++..                    ...+.+..|..++..+ +||||+++++++     .+.+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            4699999999987642                    1234566788888764 899999999994     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 ey~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05619          76 EYLNGGDLMFHIQ----------SCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGM  142 (316)
T ss_pred             eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCc
Confidence            9999999999983          4456889999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++.........  ....||+.|+|||++.+..++.++|||||||++|||++|..||....     ....           
T Consensus       143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~-----------  204 (316)
T cd05619         143 CKENMLGDAKT--CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEEL-----------  204 (316)
T ss_pred             ceECCCCCCce--eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHH-----------
Confidence            87543222111  12468999999999999899999999999999999999999985221     1111           


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT-NVV  318 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl  318 (381)
                       ........+.                .+.....++.+++.+||+.||.+||++. ++.
T Consensus       205 -~~~i~~~~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         205 -FQSIRMDNPC----------------YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             -HHHHHhCCCC----------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence             1110000000                0112345678899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-39  Score=303.38  Aligned_cols=254  Identities=20%  Similarity=0.292  Sum_probs=189.0

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~   90 (381)
                      .++|...+.||+|+||.||++..                       .....+.+|+.++.++ +||||++++++|..   
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---   82 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence            46799999999999999987631                       1235678899999999 68999999998642   


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCccc-------------------------------------------------
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDET-------------------------------------------------  121 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------------------------------------------------  121 (381)
                       .....++|||||++|+|.+++.........                                                 
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence             345779999999999999998542110000                                                 


Q ss_pred             --------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccc
Q 041757          122 --------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS  193 (381)
Q Consensus       122 --------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  193 (381)
                              ......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                    000134688889999999999999999   679999999999999999999999999999865433222222


Q ss_pred             cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchh
Q 041757          194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK  272 (381)
Q Consensus       194 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  272 (381)
                      ....++..|+|||++.+..++.++||||||+++|++++ |..||......    ......        +........   
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~--------~~~~~~~~~---  303 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRR--------LKEGTRMRA---  303 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHHH--------HhccCCCCC---
Confidence            22335678999999988889999999999999999997 89997532110    011000        000000000   


Q ss_pred             hhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          273 LVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                                      +.....++.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus       304 ----------------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         304 ----------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             ----------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                            11233468899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.1e-39  Score=301.82  Aligned_cols=225  Identities=20%  Similarity=0.225  Sum_probs=176.1

Q ss_pred             cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCce
Q 041757           37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      +|...++||+|+||.||++..                    ...+.+..|..++..+ +|++|+++++++     ...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            578889999999999987641                    1223466788888877 489999999884     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL  142 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQ----------QVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             EEEEEcCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEE
Confidence            999999999999999983          4456889999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||....    . ...      
T Consensus       143 ~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~-~~~------  209 (323)
T cd05616         143 ADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----E-DEL------  209 (323)
T ss_pred             ccCCCceecCCCCCc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC----H-HHH------
Confidence            999999754322211  112568999999999999999999999999999999999999985221    1 111      


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                            ..........                .+.....++.+++.+|++.||.+|++.
T Consensus       210 ------~~~i~~~~~~----------------~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         210 ------FQSIMEHNVA----------------YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ------HHHHHhCCCC----------------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                  1111110000                012345578889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-38  Score=288.76  Aligned_cols=245  Identities=23%  Similarity=0.295  Sum_probs=192.3

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||.||++..                    ...+.+.+|++++++++|+||+++++.+.     ..+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence            6789999999999999977542                    12567889999999999999999999954     4678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++....      .....+++..++.++.+++.||.|||   +.+++||||+|+||+++.++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l  147 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFK------KQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhc------ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEE
Confidence            899999999999999985321      23456889999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++..........  ....++..|+|||.+.+..++.++||||||+++|+|++|..||...   .......      
T Consensus       148 ~d~~~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~------  216 (267)
T cd08224         148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLYSL------  216 (267)
T ss_pred             eccceeeeccCCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC---CccHHHH------
Confidence            9999987654432211  1245888999999998888999999999999999999999997422   1111111      


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                            .+.........              ......+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus       217 ------~~~~~~~~~~~--------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         217 ------CKKIEKCDYPP--------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------HhhhhcCCCCC--------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  11110000000              001245567889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=305.34  Aligned_cols=239  Identities=23%  Similarity=0.374  Sum_probs=195.5

Q ss_pred             cccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           39 LEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      ....+||-|.||.||...                ...+++|++|+.+|+.++|||+|+++|+|..     +..+|||+||
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIiTEf  344 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYIITEF  344 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEEEec
Confidence            345899999999996532                3467899999999999999999999999874     7788999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      |.+|+|.+||++        .....++....+.++.||+.|++||.   .+++|||||..+|+|+.++..+|++|||+++
T Consensus       345 M~yGNLLdYLRe--------cnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  345 MCYGNLLDYLRE--------CNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             ccCccHHHHHHH--------hchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence            999999999964        23445677778899999999999999   7899999999999999999999999999999


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      .+..+.+.... ...-++.|.|||.+..+.++.|+|||+|||+|||+.| |..||.    + ..+.+         ..++
T Consensus       414 lMtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP----G-idlSq---------VY~L  478 (1157)
T KOG4278|consen  414 LMTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP----G-IDLSQ---------VYGL  478 (1157)
T ss_pred             hhcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC----C-ccHHH---------HHHH
Confidence            98876554332 2334788999999999999999999999999999987 888853    2 11111         1222


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      +.+-                  .+.+.+..|++.+.+||+.||+++|.+||++.|+-+.++.+..
T Consensus       479 LEkg------------------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  479 LEKG------------------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             Hhcc------------------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            2211                  1112256899999999999999999999999999999887644

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.4e-39  Score=298.10  Aligned_cols=254  Identities=20%  Similarity=0.341  Sum_probs=192.6

Q ss_pred             cccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGV   88 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~   88 (381)
                      .++|.++++||+|+||.||++..                         .....+.+|+++++++ +||||++++++|.  
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence            36788999999999999987531                         1235678899999999 5999999999954  


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                         .....++||||+++|+|.+++........      .......+++..+..++.|++.||.|||   +.+++||||||
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp  162 (314)
T cd05099          89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAA  162 (314)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence               36678999999999999999964321000      0012345889999999999999999999   66999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE  241 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~  241 (381)
                      +||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|++++ |..||...  
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--  240 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--  240 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC--
Confidence            999999999999999999986654322221111234568999999988889999999999999999999 88887422  


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                         ........         +.   ....               ...+..++.++.+++.+||+.||++|||+.++++.|
T Consensus       241 ---~~~~~~~~---------~~---~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l  290 (314)
T cd05099         241 ---PVEELFKL---------LR---EGHR---------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL  290 (314)
T ss_pred             ---CHHHHHHH---------HH---cCCC---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence               11111111         00   0000               000124456788999999999999999999999999


Q ss_pred             HHhhhhc
Q 041757          322 QSIKNTL  328 (381)
Q Consensus       322 ~~i~~~~  328 (381)
                      .++....
T Consensus       291 ~~~~~~~  297 (314)
T cd05099         291 DKVLAAV  297 (314)
T ss_pred             HHHHHHh
Confidence            9987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.8e-39  Score=308.39  Aligned_cols=252  Identities=20%  Similarity=0.272  Sum_probs=190.4

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~   90 (381)
                      .++|..+++||+|+||.||++..                       ...+.+.+|+++|.++. ||||++++++|.    
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~----  111 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT----  111 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence            45688889999999999987641                       12347889999999997 999999999964    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCc---------------------------------------------------
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKED---------------------------------------------------  119 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  119 (381)
                       .....++|||||++|+|.++++......                                                   
T Consensus       112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence             3567899999999999999996432100                                                   


Q ss_pred             -------------------------------------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757          120 -------------------------------------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus       120 -------------------------------------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                                                           ........+++..++.++.|++.||.|||   ..+++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence                                                 00011234677888999999999999999   67999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE  241 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~  241 (381)
                      +||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.... 
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~-  346 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP-  346 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-
Confidence            999999999999999999986543322222222346788999999988889999999999999999998 888975221 


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                         ......         ..+..-...                  ..+..++..+.+++.+||+.+|.+||++.+|++.|
T Consensus       347 ---~~~~~~---------~~~~~~~~~------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L  396 (401)
T cd05107         347 ---MNEQFY---------NAIKRGYRM------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV  396 (401)
T ss_pred             ---chHHHH---------HHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence               111100         111100000                  00123456889999999999999999999999999


Q ss_pred             HHhh
Q 041757          322 QSIK  325 (381)
Q Consensus       322 ~~i~  325 (381)
                      +++.
T Consensus       397 ~~~~  400 (401)
T cd05107         397 GDLL  400 (401)
T ss_pred             HHHh
Confidence            8864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=288.36  Aligned_cols=241  Identities=29%  Similarity=0.378  Sum_probs=188.8

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...+.||+|+||.||++..               ...+.+.+|+.++++++||||+++++++     ...+..++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeeee
Confidence            46688899999999999987531               1346789999999999999999999985     346778999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++..        .....+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||
T Consensus        80 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg  148 (261)
T cd05068          80 TELMKYGSLLEYLQG--------GAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFG  148 (261)
T ss_pred             eecccCCcHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcc
Confidence            999999999999953        12346889999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      +++.......... .....+..|+|||++.+..++.++||||||+++|||++ |+.||....    ....+         
T Consensus       149 ~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~---------  214 (261)
T cd05068         149 LARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT----NAEVL---------  214 (261)
T ss_pred             eEEEccCCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHH---------
Confidence            9987764322211 11223467999999998899999999999999999999 999975221    10000         


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                       ..+......                  ..+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       215 -~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         215 -QQVDQGYRM------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -HHHHcCCCC------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence             001000000                  00123456789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.7e-39  Score=308.90  Aligned_cols=183  Identities=21%  Similarity=0.297  Sum_probs=155.2

Q ss_pred             cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      +|...++||+|+||+||++..                    ...+.+.+|++++++++||||+++++++     .+.+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            578889999999999987642                    1235678899999999999999999995     457789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++|||||++|+|.+++.          ....+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~  143 (381)
T cd05626          77 YFVMDYIPGGDMMSLLI----------RMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLT  143 (381)
T ss_pred             EEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEe
Confidence            99999999999999983          4456889999999999999999999   6799999999999999999999999


Q ss_pred             ecccceecCCCCC---------------------------------------------cccccCccCccceeCCCCcCCC
Q 041757          177 DFGLARFLPPTRT---------------------------------------------QTSSIDVKGSIGYIAPEYGVGN  211 (381)
Q Consensus       177 Dfg~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~  211 (381)
                      |||+++.......                                             .......+||+.|+|||++.+.
T Consensus       144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  223 (381)
T cd05626         144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK  223 (381)
T ss_pred             eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence            9999764321000                                             0001124699999999999988


Q ss_pred             ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          212 EVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       212 ~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      .++.++|||||||++|||++|..||.
T Consensus       224 ~~~~~~DiwSlG~il~elltG~~Pf~  249 (381)
T cd05626         224 GYTQLCDWWSVGVILFEMLVGQPPFL  249 (381)
T ss_pred             CCCCccceeehhhHHHHHHhCCCCCc
Confidence            89999999999999999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.5e-39  Score=290.20  Aligned_cols=241  Identities=28%  Similarity=0.431  Sum_probs=191.6

Q ss_pred             ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ...+|...++||.|+||.||++..                .....+.+|+.+++.++|+||+++++++     ......+
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence            356789999999999999987642                1356788999999999999999999985     4467889


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++..        .....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|
T Consensus        79 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d  147 (261)
T cd05148          79 IITELMEKGSLLAFLRS--------PEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVAD  147 (261)
T ss_pred             EEEeecccCCHHHHHhc--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEcc
Confidence            99999999999999953        23456889999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||.+...........  ...++..|+|||.+....++.++||||||+++|+|++ |+.||....    . .         
T Consensus       148 ~g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----~-~---------  211 (261)
T cd05148         148 FGLARLIKEDVYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----N-H---------  211 (261)
T ss_pred             ccchhhcCCcccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----H-H---------
Confidence            999987654332222  2346778999999988889999999999999999998 899975221    0 0         


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                         +.+.......               ....+..++..+.+++.+||..||.+|||+.++++.|+.+
T Consensus       212 ---~~~~~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         212 ---EVYDQITAGY---------------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---HHHHHHHhCC---------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               0111000000               0001124566889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.9e-39  Score=294.19  Aligned_cols=252  Identities=19%  Similarity=0.286  Sum_probs=190.5

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      ..++|.+.++||+|+||.||++..                       .....+.+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----   78 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-----   78 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            357899999999999999986420                       1234578899999999999999999985     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ......++||||+++|+|.+++...............++...+..++.|++.||.|||   +.+|+||||||+||+++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~  155 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCC
Confidence            3466789999999999999999643221111112344567788999999999999999   6799999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~  249 (381)
                      +.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....     ... 
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----~~~-  229 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----NEQ-  229 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----HHH-
Confidence            9999999999886544332222222345778999999988889999999999999999998 788875211     111 


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                                 +.+........               ..+..++..+.+++.+||+.||.+|||+.++++.|++..
T Consensus       230 -----------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         230 -----------VLKFVMDGGYL---------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             -----------HHHHHHcCCCC---------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                       11111100000               001234568999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.1e-39  Score=302.95  Aligned_cols=221  Identities=24%  Similarity=0.286  Sum_probs=171.4

Q ss_pred             ceecCCCceEEEecccc--------------------cHHHHHHHHH-HHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQG--------------------AFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||+||++...                    ..+.+.+|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            46999999999876421                    1233445554 45778999999999984     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++.          ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~  142 (323)
T cd05575          76 DYVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL  142 (323)
T ss_pred             cCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCC
Confidence            9999999999983          4557889999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|||++|..||...     ...            +
T Consensus       143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~------------~  203 (323)
T cd05575         143 CKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTA------------E  203 (323)
T ss_pred             CcccccCCCc--cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHH------------H
Confidence            8754322221  12256899999999999989999999999999999999999998522     111            1


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                      +.+..+.....                .....+..+.+++.+||+.||.+||++.
T Consensus       204 ~~~~i~~~~~~----------------~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         204 MYDNILNKPLR----------------LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11111111100                0123456788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7e-39  Score=293.81  Aligned_cols=254  Identities=24%  Similarity=0.400  Sum_probs=189.0

Q ss_pred             cccccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..+|+..+.||+|+||.||.+.                     ....+.+.+|++++++++||||+++++++..   .+.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCC
Confidence            4578889999999999998753                     1124578899999999999999999998653   335


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++|+|.+++..         ....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~  147 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQK---------HRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRV  147 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeE
Confidence            568999999999999999852         2345889999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCccc-ccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||++........... .....++..|+|||++.+..++.++||||||+++|||++|..|+.....      .+...
T Consensus       148 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~  221 (284)
T cd05081         148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRM  221 (284)
T ss_pred             EECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhh
Confidence            9999999987654332111 1112245569999999888899999999999999999998877532110      00000


Q ss_pred             Hhhc-----hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          253 ALSN-----HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       253 ~~~~-----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ....     ....+.+. +....              ....+..++..+.+++.+||..+|++|||+.+|++.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~-~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         222 MGNDKQGQMIVYHLIEL-LKNNG--------------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccccccccchHHHHHH-HhcCC--------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000     00011100 00000              0001124556799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.2e-39  Score=293.81  Aligned_cols=231  Identities=22%  Similarity=0.257  Sum_probs=177.0

Q ss_pred             ecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           44 ISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        44 lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ||+|+||.||++...                    ..+.+..|++++++++||||+++++++     ....+.++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            799999999875421                    123456799999999999999999884     4577899999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ++++|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        76 ~g~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~  144 (277)
T cd05607          76 NGGDLKYHIYN--------VGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVE  144 (277)
T ss_pred             CCCCHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence            99999988842        22345888899999999999999999   67999999999999999999999999999987


Q ss_pred             cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757          184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD  263 (381)
Q Consensus       184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (381)
                      ........   ...|+..|+|||++.+..++.++|||||||++|||++|..||...... ....            ++..
T Consensus       145 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~------------~~~~  208 (277)
T cd05607         145 LKDGKTIT---QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKE------------ELKR  208 (277)
T ss_pred             cCCCceee---ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHH------------HHHH
Confidence            65433221   245899999999999888999999999999999999999998532111 0101            1111


Q ss_pred             hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      ..+......               .....+.++.+++.+||+.||.+||++.|+++.+
T Consensus       209 ~~~~~~~~~---------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         209 RTLEDEVKF---------------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             Hhhcccccc---------------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            111000000               0113455788999999999999999998876444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6e-39  Score=294.10  Aligned_cols=248  Identities=18%  Similarity=0.249  Sum_probs=187.7

Q ss_pred             ccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .+|...+.||+|+||.||++..                       ...+.+.+|+.++..++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence            3477788999999999987631                       12356888999999999999999999954     4


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCC------cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKE------DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                      ....++++||+.+++|.+++......      .........+++..++.++.|++.||.|||   +.+|+||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil  156 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVL  156 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheE
Confidence            66789999999999999998422100      000012345788899999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCc
Q 041757          167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMN  245 (381)
Q Consensus       167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~  245 (381)
                      +++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....    .
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~  232 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----N  232 (283)
T ss_pred             ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----H
Confidence            99999999999999886654332222222346789999999988889999999999999999998 888865211    1


Q ss_pred             HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                       ..            +..........               ..+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       233 -~~------------~~~~i~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 -QD------------VIEMIRNRQVL---------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HH------------HHHHHHcCCcC---------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             11            11111111000               0123466778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.3e-39  Score=305.66  Aligned_cols=184  Identities=23%  Similarity=0.304  Sum_probs=157.6

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|+..++||+|+||+||++..                    .....+.+|+.++.+++|+||+++++.+     .+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            4788999999999999987642                    1234577899999999999999999984     55788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|||||++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL  142 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLM----------KKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKL  142 (363)
T ss_pred             EEEEEcCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEE
Confidence            999999999999999994          4567899999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCc---------------------------------ccccCccCccceeCCCCcCCCccCcccchhhh
Q 041757          176 GDFGLARFLPPTRTQ---------------------------------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSY  222 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSl  222 (381)
                      +|||+++........                                 ......+||+.|+|||++.+..++.++|||||
T Consensus       143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl  222 (363)
T cd05628         143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL  222 (363)
T ss_pred             eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence            999998765321100                                 00113569999999999999999999999999


Q ss_pred             hHHHHHHHhCCCCCC
Q 041757          223 GILLLELMIREKPSD  237 (381)
Q Consensus       223 G~il~el~tg~~Pf~  237 (381)
                      ||++|||++|+.||.
T Consensus       223 Gvil~ell~G~~Pf~  237 (363)
T cd05628         223 GVIMYEMLIGYPPFC  237 (363)
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=307.44  Aligned_cols=184  Identities=21%  Similarity=0.306  Sum_probs=157.2

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||+||++..                    .....+.+|+.+|..++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence            4788999999999999987642                    1234567899999999999999999994     55788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|||||++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl  142 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLM----------KKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKL  142 (364)
T ss_pred             EEEEECCCCCcHHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEE
Confidence            999999999999999984          4456899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcc------------------------------------cccCccCccceeCCCCcCCCccCcccch
Q 041757          176 GDFGLARFLPPTRTQT------------------------------------SSIDVKGSIGYIAPEYGVGNEVSTIGDV  219 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~sDi  219 (381)
                      +|||++..+.......                                    .....+||+.|+|||++.+..++.++||
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  222 (364)
T cd05599         143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW  222 (364)
T ss_pred             eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence            9999987653321100                                    0012459999999999998899999999


Q ss_pred             hhhhHHHHHHHhCCCCCC
Q 041757          220 YSYGILLLELMIREKPSD  237 (381)
Q Consensus       220 wSlG~il~el~tg~~Pf~  237 (381)
                      |||||++|||++|..||.
T Consensus       223 wSlG~il~el~~G~~Pf~  240 (364)
T cd05599         223 WSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ecchhHHHHhhcCCCCCC
Confidence            999999999999999985

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-39  Score=288.61  Aligned_cols=236  Identities=25%  Similarity=0.366  Sum_probs=184.1

Q ss_pred             ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      .+|...+.||+|+||.||++..               .....+.+|++++++++||||+++++++     ......++||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence            3577889999999999987531               1235788999999999999999999985     4467889999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++++|.+++..         ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        79 e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~  146 (256)
T cd05059          79 EYMANGCLLNYLRE---------RKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGL  146 (256)
T ss_pred             ecCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCccc
Confidence            99999999999852         2346889999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      ++.......... ....++..|+|||.+.+..++.++||||||+++|++++ |..||......     .....       
T Consensus       147 ~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~-------  213 (256)
T cd05059         147 ARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVES-------  213 (256)
T ss_pred             ceeccccccccc-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHHH-------
Confidence            986643322111 11224567999999998899999999999999999999 89997522110     00000       


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                        +.....  .                ..+..++..+.+++.+||..+|++|||+.++++.|
T Consensus       214 --~~~~~~--~----------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         214 --VSAGYR--L----------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --HHcCCc--C----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              000000  0                00123566899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.3e-39  Score=291.27  Aligned_cols=245  Identities=23%  Similarity=0.278  Sum_probs=191.2

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||.||++..                    .....+.+|+.+++.++|+||+++++++.     ..+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence            4788889999999999987541                    12357888999999999999999999854     4678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .+++|||+++++|.+++....      .....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l  147 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFK------KQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEE
Confidence            899999999999999985321      23456899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++..........  ....++..|+|||++.+..++.++||||||+++|+|++|..||....   .......     
T Consensus       148 ~dfg~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~-----  217 (267)
T cd08229         148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLC-----  217 (267)
T ss_pred             CcchhhhccccCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc---chHHHHh-----
Confidence            9999987664433221  12458899999999988889999999999999999999999975221   1111111     


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                             ..........              ......+..+.+++.+||..||.+|||+.+|++.++++.
T Consensus       218 -------~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         218 -------KKIEQCDYPP--------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -------hhhhcCCCCC--------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                   1100000000              001235567889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-39  Score=287.70  Aligned_cols=267  Identities=21%  Similarity=0.284  Sum_probs=189.2

Q ss_pred             ccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCc-ccceeeeecccc-ccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRN-LIKVLTACLGVD-YQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~-~~~~~   94 (381)
                      ..|...++||+|+||+||+++                   ++.....++|+.+|++|+|+| ||++++++.... .....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            457777889999999998865                   124456789999999999999 999999976421 12234


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++|+||+.. +|..++.....      ....++...+..++.||+.||+|||   +.+|+||||||+|||++++|.+|
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~------~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lK  160 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPK------KPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLK  160 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccc------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEe
Confidence            78899999965 99999964321      1146777899999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||+|+....+....  ...++|..|+|||++.+. .|+...||||+||+++||++++.-|    .++..........
T Consensus       161 laDFGlAra~~ip~~~y--t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF----pG~se~~ql~~If  234 (323)
T KOG0594|consen  161 LADFGLARAFSIPMRTY--TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF----PGDSEIDQLFRIF  234 (323)
T ss_pred             eeccchHHHhcCCcccc--cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC----CCCcHHHHHHHHH
Confidence            99999999665443322  235689999999999886 7999999999999999999998875    4444433332221


Q ss_pred             h---hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          254 L---SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       254 ~---~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      .   .+.....-.-....+... .+ .............+.......+++..|++.+|.+|.|+..+++.
T Consensus       235 ~~lGtP~e~~Wp~v~~~~~~k~-~f-~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  235 RLLGTPNEKDWPGVSSLPDYKA-PF-PKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHcCCCCccCCCCccccccccc-cC-cCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1   110000000000000000 00 00000111111112222478999999999999999999999875

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-38  Score=287.54  Aligned_cols=237  Identities=23%  Similarity=0.369  Sum_probs=179.2

Q ss_pred             ceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      +.||+|+||.||++..                     ...+.+.+|+.+++.++||||+++++++..    .+...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence            4689999999986431                     124577889999999999999999998642    345678999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+.+|+|.+++..         ....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+||+|||+
T Consensus        77 e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          77 PYMKHGDLRNFIRS---------ETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             ecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccc
Confidence            99999999999952         2344677788899999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCc--ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhC-CCCCCccccCCCcHHHHHHHHhhch
Q 041757          181 ARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR-EKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       181 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ++........  .......++..|+|||.+.+..++.++||||||+++|||++| .+||...    .. ...        
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~----~~-~~~--------  211 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----DS-FDI--------  211 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC----CH-HHH--------
Confidence            9765432211  111123467789999999888899999999999999999995 5554321    11 111        


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                          ..........               ..+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus       212 ----~~~~~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         212 ----TVYLLQGRRL---------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ----HHHHhcCCCC---------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                1111100000               0011345678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.3e-39  Score=301.85  Aligned_cols=226  Identities=24%  Similarity=0.266  Sum_probs=172.6

Q ss_pred             ceecCCCceEEEecccc--------------------cHHHHHHHHH-HHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQG--------------------AFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      +.||+|+||+||++...                    ....+.+|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            46999999999876421                    1123344444 46778999999999984     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~  142 (325)
T cd05602          76 DYINGGELFYHLQ----------RERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL  142 (325)
T ss_pred             eCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCC
Confidence            9999999999983          4456788889999999999999999   67999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||....    . .....        .
T Consensus       143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~-~~~~~--------~  207 (325)
T cd05602         143 CKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----T-AEMYD--------N  207 (325)
T ss_pred             CcccccCCCC--cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC----H-HHHHH--------H
Confidence            8754332221  122569999999999999999999999999999999999999985221    1 11111        1


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      +......                    ..+..+..+.+++.+||+.||.+||++.+.+..
T Consensus       208 i~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         208 ILNKPLQ--------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             HHhCCcC--------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            1111000                    012345678889999999999999998755443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.6e-38  Score=286.73  Aligned_cols=240  Identities=23%  Similarity=0.383  Sum_probs=188.3

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      ..+|.+.++||+|+||.||++..               ...+.+.+|+++++.++||||+++++.+.      ....++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv   78 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIV   78 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEEE
Confidence            45689999999999999987642               12467899999999999999999998742      3457999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++|+|.+++..        .....+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||
T Consensus        79 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg  147 (262)
T cd05071          79 TEYMSKGSLLDFLKG--------EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG  147 (262)
T ss_pred             EEcCCCCcHHHHHhh--------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCC
Confidence            999999999999953        12345788999999999999999999   6799999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      .++.......... ....++..|+|||+..+..++.++||||||+++|++++ |..||.....    .            
T Consensus       148 ~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~------------  210 (262)
T cd05071         148 LARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----R------------  210 (262)
T ss_pred             ceeeccccccccc-cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----H------------
Confidence            9987654432211 12346778999999988889999999999999999999 8888753211    0            


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                       +..........               ......++..+.+++.+||+.||++||++.++++.|+..
T Consensus       211 -~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         211 -EVLDQVERGYR---------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -HHHHHHhcCCC---------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             00111000000               000134567889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.4e-39  Score=306.05  Aligned_cols=237  Identities=19%  Similarity=0.196  Sum_probs=182.7

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .++|...++||+|+||.||+++.                    ...+.+.+|+.+++.++||||+++++++     .+..
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            57899999999999999987642                    1224467899999999999999999884     5578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~-----------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~k  182 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMS-----------NYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLK  182 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEE
Confidence            8999999999999999984           234788889999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCC----ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN----EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      |+|||++........... ....||+.|+|||++.+.    .++.++|||||||++|||++|+.||...    .....+ 
T Consensus       183 L~DfG~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~-  256 (370)
T cd05596         183 LADFGTCMKMDANGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTY-  256 (370)
T ss_pred             EEeccceeeccCCCcccC-CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC----CHHHHH-
Confidence            999999987654322111 125699999999988653    4789999999999999999999998522    111111 


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQD--RMKMTNVVHE  320 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~~  320 (381)
                              ..+.........                +.....+..+.+++.+|+..+|.+  |||+.++++.
T Consensus       257 --------~~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         257 --------SKIMDHKNSLTF----------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             --------HHHHcCCCcCCC----------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                    111110000000                001134567888999999999987  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=287.78  Aligned_cols=236  Identities=19%  Similarity=0.281  Sum_probs=185.7

Q ss_pred             ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ++|...++||+|+||.||.+..                      ...+.+.+|++++++++||||+++++++     ...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            5799999999999999987531                      1235678899999999999999999995     446


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++|+||+++++|.+++.          ....+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~  143 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLK----------AYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNV  143 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHH----------HhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence            78999999999999999984          3456888999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCccc-ccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|+|||+++.......... .....++..|+|||++.+..++.++||||||+++||+++|+.||...    .........
T Consensus       144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~~~  219 (263)
T cd06625         144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF----EAMAAIFKI  219 (263)
T ss_pred             EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc----chHHHHHHH
Confidence            9999999976543222111 01245788999999999988999999999999999999999997522    111111110


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      ....         .  .                ...+......+.+++.+||..+|.+|||+.++++.
T Consensus       220 ~~~~---------~--~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 ATQP---------T--N----------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             hccC---------C--C----------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            0000         0  0                00122455678899999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.6e-39  Score=302.62  Aligned_cols=227  Identities=25%  Similarity=0.286  Sum_probs=173.6

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHH-HHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||+||++..                    .....+.+|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            4699999999987642                    12234455655 46778999999999884     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++          .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l----------~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~  142 (325)
T cd05604          76 DFVNGGELFFHL----------QRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGL  142 (325)
T ss_pred             cCCCCCCHHHHH----------HHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCC
Confidence            999999999888          34567899999999999999999999   67999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|||++|..||...    . ...            
T Consensus       143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~----~-~~~------------  203 (325)
T cd05604         143 CKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR----D-VAE------------  203 (325)
T ss_pred             cccCCCCCCC--cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC----C-HHH------------
Confidence            8754322211  12256999999999999999999999999999999999999998521    1 111            


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      +.+..+.....                ..+.....+.+++.+|++.||.+||++.+.++.+
T Consensus       204 ~~~~~~~~~~~----------------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         204 MYDNILHKPLV----------------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             HHHHHHcCCcc----------------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence            11111111000                0112345678899999999999999986544433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-38  Score=285.25  Aligned_cols=234  Identities=20%  Similarity=0.269  Sum_probs=186.5

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||+|+||.||++..                   .....+.+|++++++++||||+++++++.     ..+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            477889999999999987631                   24567889999999999999999999954     467899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++..        .....+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|
T Consensus        76 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~d  144 (256)
T cd08529          76 IVMEYAENGDLHKLLKM--------QRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGD  144 (256)
T ss_pred             EEEEeCCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcc
Confidence            99999999999999953        12456889999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+++.........  ....|++.|+|||++.+..++.++||||||+++|+|++|+.||.....     ...        
T Consensus       145 f~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~--------  209 (256)
T cd08529         145 LGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GAL--------  209 (256)
T ss_pred             cccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHH--------
Confidence            99998765443221  124588999999999988899999999999999999999999853221     110        


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                          ..........               ......+..+.+++.+||+.+|++||++.++++.
T Consensus       210 ----~~~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         210 ----ILKIIRGVFP---------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----HHHHHcCCCC---------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                1110000000               0112455678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-39  Score=304.54  Aligned_cols=235  Identities=20%  Similarity=0.222  Sum_probs=182.4

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||.||++..                    ...+.+.+|+.+++.++|+||+++++++     .....
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            4788999999999999987541                    1345677899999999999999999984     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++..         ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL  143 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNR---------YEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKL  143 (330)
T ss_pred             EEEEECCCCCCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEe
Confidence            9999999999999999952         2357899999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcC------CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      +|||++.......... .....||+.|+|||++.      ...++.++|||||||++|||++|+.||...    .....+
T Consensus       144 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~----~~~~~~  218 (330)
T cd05601         144 ADFGSAARLTANKMVN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG----TSAKTY  218 (330)
T ss_pred             ccCCCCeECCCCCcee-eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC----CHHHHH
Confidence            9999998765443221 11245899999999886      456789999999999999999999998522    111111


Q ss_pred             HHHHhhchHHHHHhhh-hccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSI-LLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                               ..+.... ....+.                 ....+..+.+++..|+. +|.+|||+.++++
T Consensus       219 ---------~~i~~~~~~~~~~~-----------------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         219 ---------NNIMNFQRFLKFPE-----------------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ---------HHHHcCCCccCCCC-----------------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                     1111100 000000                 01245567888899997 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.7e-38  Score=287.20  Aligned_cols=232  Identities=20%  Similarity=0.308  Sum_probs=180.1

Q ss_pred             eecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           43 LISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        43 ~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      .||+|+||.||++.                    ....+.+.+|+.++++++||||+++++++.      ....++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence            38999999998642                    112356889999999999999999999853      3467999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +++++|.+++.         .....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+||+|||++.
T Consensus        76 ~~~~~L~~~l~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          76 ASGGPLNKFLS---------GKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             CCCCCHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccc
Confidence            99999999985         23456899999999999999999999   6699999999999999999999999999997


Q ss_pred             ecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          183 FLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       183 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ......... ......++..|+|||++....++.++||||||+++||+++ |..||......     ..         ..
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~---------~~  209 (257)
T cd05115         144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EV---------MS  209 (257)
T ss_pred             cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HH---------HH
Confidence            654432211 1111224578999999988889999999999999999996 99997532110     00         01


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      .+......                  ..+..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus       210 ~~~~~~~~------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         210 FIEQGKRL------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHCCCCC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11110000                  01224567888999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.2e-38  Score=300.38  Aligned_cols=185  Identities=24%  Similarity=0.233  Sum_probs=153.6

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~   93 (381)
                      ..++|...+.||+|+||.||++..                   .....+.+|+.+++.++||||+++++++.... ....
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            458899999999999999977642                   23456788999999999999999999865311 1223


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+.+ +|.+.+.            ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~  162 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  162 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCE
Confidence            457999999965 6766662            23778889999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||+|||+++........   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       163 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~  223 (359)
T cd07876         163 KILDFGLARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ  223 (359)
T ss_pred             EEecCCCccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            99999999765433221   12458999999999999999999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-39  Score=307.88  Aligned_cols=184  Identities=21%  Similarity=0.277  Sum_probs=155.6

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||.||++..                    ...+.+.+|++++++++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            4788899999999999987542                    1235677899999999999999999994     45788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .|+||||+++|+|.+++.          ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl  142 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLI----------KYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKL  142 (377)
T ss_pred             eEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEE
Confidence            999999999999999993          4456889999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCC------------cc---------------------------------cccCccCccceeCCCCcCC
Q 041757          176 GDFGLARFLPPTRT------------QT---------------------------------SSIDVKGSIGYIAPEYGVG  210 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~------------~~---------------------------------~~~~~~gt~~y~aPE~l~~  210 (381)
                      +|||+++.......            ..                                 .....+||+.|+|||++.+
T Consensus       143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  222 (377)
T cd05629         143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ  222 (377)
T ss_pred             eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence            99999864321100            00                                 0012469999999999999


Q ss_pred             CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          211 NEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       211 ~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ..++.++|||||||++|||++|..||.
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~  249 (377)
T cd05629         223 QGYGQECDWWSLGAIMFECLIGWPPFC  249 (377)
T ss_pred             CCCCCceeeEecchhhhhhhcCCCCCC
Confidence            899999999999999999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-38  Score=287.25  Aligned_cols=231  Identities=20%  Similarity=0.294  Sum_probs=180.5

Q ss_pred             eecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           43 LISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        43 ~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      .||+|+||.||++.                     ....+.+.+|+.+++.++||||+++++++.      .+..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence            58999999998752                     112457889999999999999999999853      345689999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      |+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~  142 (257)
T cd05116          76 LAELGPLNKFLQ----------KNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLS  142 (257)
T ss_pred             cCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccc
Confidence            999999999993          3456889999999999999999999   679999999999999999999999999999


Q ss_pred             eecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          182 RFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       182 ~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      .......... ......++..|+|||.+....++.++|||||||++|||++ |..||.....     ....         
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~---------  208 (257)
T cd05116         143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVT---------  208 (257)
T ss_pred             cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH---------
Confidence            8765443211 1111234678999999988889999999999999999998 9999853211     1111         


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      +.+......                  ..+..++.++.+++.+||+.||++||++.+|.+.|++.
T Consensus       209 ~~i~~~~~~------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         209 QMIESGERM------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHHCCCCC------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            111110000                  01124566789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.8e-39  Score=300.28  Aligned_cols=221  Identities=24%  Similarity=0.283  Sum_probs=170.4

Q ss_pred             ceecCCCceEEEecccc--------------------cHHHHHHHHH-HHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQG--------------------AFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||+++..                    ....+.+|.. +++.++||||+++++++     .+.+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999886521                    1233455554 57889999999999884     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++.          ....+++..+..++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  142 (321)
T cd05603          76 DYVNGGELFFHLQ----------RERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL  142 (321)
T ss_pred             cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCC
Confidence            9999999998883          4556888999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|||++|..||...     .....           
T Consensus       143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~-----------  204 (321)
T cd05603         143 CKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQM-----------  204 (321)
T ss_pred             CccCCCCCCc--cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHHH-----------
Confidence            8753222211  12256899999999999888999999999999999999999998521     11111           


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                       .+.......                ..+......+.+++.+||+.||.+||++.
T Consensus       205 -~~~i~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         205 -YDNILHKPL----------------QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -HHHHhcCCC----------------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             111111000                00123445788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-38  Score=294.77  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=189.4

Q ss_pred             cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..+|...+.||+|+||.||++..                      .....+.+|+.+++.++||||++++++|..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence            46778889999999999987531                      112367889999999999999999998642     


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                       ...++++||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        81 -~~~~~v~e~~~~g~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~  147 (303)
T cd05110          81 -PTIQLVTQLMPHGCLLDYVH---------EHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNH  147 (303)
T ss_pred             -CCceeeehhcCCCCHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCc
Confidence             34579999999999999985         23446888999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||....     ....  
T Consensus       148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~--  220 (303)
T cd05110         148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREI--  220 (303)
T ss_pred             eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHH--
Confidence            99999999987654332222222345778999999988889999999999999999997 889975221     1111  


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                             .+++...... +                 .+..++..+.+++.+||..+|++||++.++++.|+.+.+..
T Consensus       221 -------~~~~~~~~~~-~-----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         221 -------PDLLEKGERL-P-----------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             -------HHHHHCCCCC-C-----------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence                   1111110000 0                 01134457889999999999999999999999999886654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.8e-38  Score=294.81  Aligned_cols=261  Identities=20%  Similarity=0.262  Sum_probs=183.5

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...++||+|+||.||++..                  .....+.+|+.++++++||||+++++++     ...+..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence            5688899999999999987541                  1234678899999999999999999995     4467899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++ +|.+++.         .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~D  147 (309)
T cd07872          81 LVFEYLDK-DLKQYMD---------DCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLAD  147 (309)
T ss_pred             EEEeCCCC-CHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECc
Confidence            99999975 8888874         23445788999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||+++.........  ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ........ ...
T Consensus       148 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~-~~~  223 (309)
T cd07872         148 FGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRL-LGT  223 (309)
T ss_pred             cccceecCCCcccc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH-hCC
Confidence            99997654332211  12357899999998765 468899999999999999999999985322111 11111111 111


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...+.............. ...................++.+++.+|++.||.+|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         224 PTEETWPGISSNDEFKNY-NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCHHHHhhhcchhhhhhh-hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            111111110000000000 00000000001112234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.2e-39  Score=307.17  Aligned_cols=183  Identities=21%  Similarity=0.298  Sum_probs=154.9

Q ss_pred             cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .|...++||+|+||.||++..                    .....+.+|++++++++||||+++++.+     .+.+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            588899999999999988652                    1234678899999999999999999995     457789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++|||||++|+|.+++.          ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~  143 (382)
T cd05625          77 YFVMDYIPGGDMMSLLI----------RMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLT  143 (382)
T ss_pred             EEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEe
Confidence            99999999999999984          3456888999999999999999999   6799999999999999999999999


Q ss_pred             ecccceecCCCCC---------------------------------------------cccccCccCccceeCCCCcCCC
Q 041757          177 DFGLARFLPPTRT---------------------------------------------QTSSIDVKGSIGYIAPEYGVGN  211 (381)
Q Consensus       177 Dfg~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~  211 (381)
                      |||++........                                             .......+||+.|+|||++.+.
T Consensus       144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  223 (382)
T cd05625         144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT  223 (382)
T ss_pred             ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence            9999753311000                                             0001124689999999999999


Q ss_pred             ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          212 EVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       212 ~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      .++.++|||||||++|||++|+.||.
T Consensus       224 ~~~~~~DiwSlGvil~elltG~~Pf~  249 (382)
T cd05625         224 GYTQLCDWWSVGVILYEMLVGQPPFL  249 (382)
T ss_pred             CCCCeeeEEechHHHHHHHhCCCCCC
Confidence            99999999999999999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-38  Score=298.69  Aligned_cols=265  Identities=18%  Similarity=0.198  Sum_probs=183.7

Q ss_pred             hccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccC
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQG   92 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~   92 (381)
                      .+.++|...+.||.|+||.||++..                   ...+.+.+|+++|++++||||+++++++.... ...
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            4567899999999999999987641                   12345778999999999999999999865311 122


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++++|++ +++|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~  156 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK-----------CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCE  156 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCC
Confidence            34578999988 779988873           345899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus       157 ~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~  230 (343)
T cd07878         157 LRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIME  230 (343)
T ss_pred             EEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence            9999999998654322     12458999999999876 56899999999999999999999998522110 00111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . ......+...................................+.+++.+|++.||.+|||+.++++
T Consensus       231 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         231 V-VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             H-hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0 000111111110000000000000000000000011123345789999999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-38  Score=290.72  Aligned_cols=256  Identities=23%  Similarity=0.385  Sum_probs=188.6

Q ss_pred             ccccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      +.|.+.++||+|+||.||+++                      ......+.+|+++++.++||||+++++++..   .+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence            557888999999999998653                      1123578899999999999999999998653   224


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++++|.+++..         ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~  148 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPR---------NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV  148 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCE
Confidence            678999999999999999842         2345899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|+|||+++........ .......++..|+|||++.+..++.++||||||+++||++++..|+.....   ........
T Consensus       149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~---~~~~~~~~  225 (284)
T cd05079         149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT---LFLKMIGP  225 (284)
T ss_pred             EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc---hhhhhccc
Confidence            99999999876543221 111124467789999999888899999999999999999998776432111   00000000


Q ss_pred             Hhhc-hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          253 ALSN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       253 ~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      .... .....+.......               ..+.+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         226 THGQMTVTRLVRVLEEGK---------------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccccccHHHHHHHHHcCc---------------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000 0000110000000               0001123567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.8e-38  Score=293.59  Aligned_cols=190  Identities=21%  Similarity=0.303  Sum_probs=150.6

Q ss_pred             cceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           41 ENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      +++||+|+||+||++...                 ....+.+|+++|++++||||+++++++..   ......++||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEecc
Confidence            578999999999887521                 23467899999999999999999998653   3456789999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee----CCCCCeEEeecc
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDMTARVGDFG  179 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~Dfg  179 (381)
                      . ++|.+++........ ......+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||
T Consensus        83 ~-~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          83 E-HDLWHIIKFHRASKA-NKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             C-CCHHHHHHhcccccc-cCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            5 588888743221110 022346899999999999999999999   6699999999999999    456789999999


Q ss_pred             cceecCCCCCc-ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          180 LARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       180 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      +++........ .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            99876543221 11223568999999999876 4589999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-38  Score=322.38  Aligned_cols=241  Identities=19%  Similarity=0.248  Sum_probs=184.2

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .++|.+.++||.|+||+||++..                   .....|..|+.+|++|+|||||++++++..   .....
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~~~   88 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KANQK   88 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCCCE
Confidence            46899999999999999987642                   234678899999999999999999998653   34567


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC----CCCceeeccCCCCeeeCC--
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC----QPVTAHCVLKPSNVLLDD--  169 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----~~~ivHrDlkp~Nill~~--  169 (381)
                      .||||||+++|+|.++|....      .....+++..++.|+.||+.||.|||...    ..+||||||||+|||++.  
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            899999999999999985321      12356899999999999999999999531    146999999999999954  


Q ss_pred             ---------------CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhC
Q 041757          170 ---------------DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIR  232 (381)
Q Consensus       170 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg  232 (381)
                                     .+.+||+|||++..+.......   ...||+.|+|||++.+  ..++.++|||||||++|||++|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~---s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCcccccccccccc---ccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                           2358999999998664432221   2468999999998864  4588999999999999999999


Q ss_pred             CCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC
Q 041757          233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM  312 (381)
Q Consensus       233 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  312 (381)
                      ..||..    ......+....         .   . .+..               .....+.++.+|+..||..+|.+||
T Consensus       240 k~PF~~----~~~~~qli~~l---------k---~-~p~l---------------pi~~~S~eL~dLI~~~L~~dPeeRP  287 (1021)
T PTZ00266        240 KTPFHK----ANNFSQLISEL---------K---R-GPDL---------------PIKGKSKELNILIKNLLNLSAKERP  287 (1021)
T ss_pred             CCCCCc----CCcHHHHHHHH---------h---c-CCCC---------------CcCCCCHHHHHHHHHHhcCChhHCc
Confidence            999852    11222111110         0   0 0000               0012356788999999999999999


Q ss_pred             CHHHHHH
Q 041757          313 KMTNVVH  319 (381)
Q Consensus       313 s~~~vl~  319 (381)
                      ++.+++.
T Consensus       288 Sa~QlL~  294 (1021)
T PTZ00266        288 SALQCLG  294 (1021)
T ss_pred             CHHHHhc
Confidence            9999984

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.6e-38  Score=287.71  Aligned_cols=240  Identities=23%  Similarity=0.375  Sum_probs=186.3

Q ss_pred             ccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ..|...+.||+|+||.||++..                     ...+.|.+|+.++++++||||+++++++     ....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            3578889999999999986431                     1345788999999999999999999994     4577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+|
T Consensus        79 ~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          79 PVMIITEFMENGALDSFLR---------QNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             ceEEEEecCCCCcHHHHHh---------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEE
Confidence            8899999999999999985         23456889999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCccccc---CccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSI---DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~  250 (381)
                      |+|||++.............   ....+..|+|||++.+..++.++|||||||++||+++ |..||.....     ....
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~  221 (269)
T cd05065         147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVI  221 (269)
T ss_pred             ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHH
Confidence            99999987665432211111   1112457999999998899999999999999999886 9999752211     1110


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ..         +..... .                 +.+..++..+.+++.+||..+|.+||++.+|+..|+++
T Consensus       222 ~~---------i~~~~~-~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         222 NA---------IEQDYR-L-----------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HH---------HHcCCc-C-----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00         000000 0                 00124566788999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-38  Score=289.54  Aligned_cols=240  Identities=21%  Similarity=0.262  Sum_probs=173.3

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      +.||+|+||.||++..                    .....+.+|+.+++.++|+||+++++.+.     .....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence            3699999999987521                    12346789999999999999999999854     4677899999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      |+++|+|.+++.....     ......++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  147 (269)
T cd05042          76 FCPLGDLKNYLRSNRG-----MVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA  147 (269)
T ss_pred             eCCCCcHHHHHHhccc-----cccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccc
Confidence            9999999999954221     11233567788899999999999999   669999999999999999999999999998


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCC-------CccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVG-------NEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ................+++.|+|||++..       ..++.++|||||||++|||++ |..||....    ........ 
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~~~~~-  222 (269)
T cd05042         148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS----DEQVLKQV-  222 (269)
T ss_pred             cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC----HHHHHHHH-
Confidence            75433322111122346778999998642       356889999999999999999 778864221    11111000 


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      .......+..      +                ......+..+.+++..|| .||++|||+.+|++.|.
T Consensus       223 ~~~~~~~~~~------~----------------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         223 VREQDIKLPK------P----------------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             hhccCccCCC------C----------------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0000000000      0                011234556777888999 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.3e-38  Score=290.93  Aligned_cols=262  Identities=20%  Similarity=0.228  Sum_probs=183.8

Q ss_pred             cccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHcc---CCCcccceeeeeccccccCCc
Q 041757           37 NMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNI---RHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +|...+.||+|+||+||++...                   ....+.+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999886421                   123567788887766   699999999987653334456


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+.+ +|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~k  148 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDK--------VPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVK  148 (288)
T ss_pred             eEEEEEccccc-CHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence            78999999975 89888853        12345899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++.........   ...+|..|+|||++.+..++.++|||||||++|+|++|.+||...... ..+........
T Consensus       149 l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~  224 (288)
T cd07863         149 LADFGLARIYSCQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIG  224 (288)
T ss_pred             ECccCccccccCcccCC---CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhC
Confidence            99999998665332221   245899999999998889999999999999999999999997522111 00111111000


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ........ ..... +..   ..............+.....+.+++.+|++.||++|||+.+++.
T Consensus       225 ~~~~~~~~-~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         225 LPPEDDWP-RDVTL-PRG---AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCChhhCc-ccccc-ccc---ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000000 00000 000   00000001111222345567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-39  Score=276.48  Aligned_cols=235  Identities=21%  Similarity=0.294  Sum_probs=187.2

Q ss_pred             cccccccceecCCCceEEEec-----------c--------------cccHHHHHHHHHHHHccC-CCcccceeeeeccc
Q 041757           35 SRNMLEENLISAGTFGFSHLR-----------R--------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGV   88 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~-----------~--------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~   88 (381)
                      ..+|...+.||+|..++|...           +              ....+.-.+|+.+|+++. ||+|+++.++    
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~----   91 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV----   91 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence            356777889999999888221           0              123455678999999996 9999999999    


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                       ++++.+.++|+|.|+.|.|.++|          ...-.+++....+|+.|+.+|+.|||   ..+||||||||+|||++
T Consensus        92 -yes~sF~FlVFdl~prGELFDyL----------ts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILld  157 (411)
T KOG0599|consen   92 -YESDAFVFLVFDLMPRGELFDYL----------TSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLD  157 (411)
T ss_pred             -ccCcchhhhhhhhcccchHHHHh----------hhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeec
Confidence             67799999999999999999999          56678999999999999999999999   77999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcC------CCccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      ++..+||+|||++..+..+.....   .+|||+|.|||.+.      ...|+..+|+||.||++|.++.|.+||....  
T Consensus       158 dn~~i~isDFGFa~~l~~GekLre---lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--  232 (411)
T KOG0599|consen  158 DNMNIKISDFGFACQLEPGEKLRE---LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--  232 (411)
T ss_pred             cccceEEeccceeeccCCchhHHH---hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--
Confidence            999999999999998877665443   67999999999875      2458899999999999999999999984110  


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           ++.          .+.-.+.+..            +...+...+......+|+.+||+.||.+|.|+.|++.
T Consensus       233 -----Qml----------MLR~ImeGky------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 -----QML----------MLRMIMEGKY------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -----HHH----------HHHHHHhccc------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                 000          0011111111            0111113466677889999999999999999999985

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.9e-38  Score=285.93  Aligned_cols=239  Identities=24%  Similarity=0.399  Sum_probs=186.4

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|.+.++||+|+||.||++..               ...+.+.+|+.++++++|+||+++++++.      ....++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv   78 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYIV   78 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEEE
Confidence            35788899999999999987541               13467899999999999999999998842      3457899


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++..        .....+++..++.++.|++.||.|||   +.+++||||||+||++++++.++|+|||
T Consensus        79 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg  147 (260)
T cd05070          79 TEYMSKGSLLDFLKD--------GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFG  147 (260)
T ss_pred             EEecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCce
Confidence            999999999999853        12345889999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++.......... .....++..|+|||++.+..++.++||||||+++|++++ |..||....    .. .          
T Consensus       148 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~-~----------  211 (260)
T cd05070         148 LARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NR-E----------  211 (260)
T ss_pred             eeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HH-H----------
Confidence            998765433211 111235678999999988889999999999999999999 888975221    10 0          


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                        ..+.......               ...+...+..+.+++.+||..+|.+|||+.++.+.|++
T Consensus       212 --~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         212 --VLEQVERGYR---------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --HHHHHHcCCC---------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              1111100000               00012345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.5e-39  Score=290.66  Aligned_cols=240  Identities=22%  Similarity=0.262  Sum_probs=173.7

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      +.||+|+||.||++..                    .....+.+|+.++++++||||+++++++.     .....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            3699999999987530                    12246888999999999999999999854     4567899999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      |+++|+|.+++.....     ......++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~  147 (269)
T cd05087          76 FCPLGDLKGYLRSCRK-----AELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLS  147 (269)
T ss_pred             CCCCCcHHHHHHHhhh-----cccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCcccc
Confidence            9999999999953211     11234567778889999999999999   669999999999999999999999999998


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCCC-------ccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-------EVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      +...............++..|+|||++.+.       .++.++||||||+++|||++ |..||......    ... ...
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~-~~~  222 (269)
T cd05087         148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVL-TYT  222 (269)
T ss_pred             ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHH-HHH
Confidence            755433322222224578889999987642       35789999999999999996 99998532111    000 000


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      .......+      ..+.                ........+.+++.+|| .+|++|||+.+|+..|+
T Consensus       223 ~~~~~~~~------~~~~----------------~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         223 VREQQLKL------PKPR----------------LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hhcccCCC------CCCc----------------cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00000000      0000                00123346778888999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.3e-38  Score=284.86  Aligned_cols=239  Identities=21%  Similarity=0.340  Sum_probs=188.0

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...++||+|+||.||++..               .....+.+|+.++++++|+||+++++++.      ....++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEEE
Confidence            56788899999999999987542               23468899999999999999999998742      4568999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++..        .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||
T Consensus        79 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          79 TEYMENGSLVDFLKT--------PEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             EEcCCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCc
Confidence            999999999999853        23456888999999999999999999   6799999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++.......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.....     ......      
T Consensus       148 ~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~------  215 (260)
T cd05067         148 LARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQN------  215 (260)
T ss_pred             ceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHH------
Confidence            998765332211 112346778999999988889999999999999999999 9999852211     010000      


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                         +......                  ..+...+.++.+++.+||+.+|++|||+++++..|+.
T Consensus       216 ---~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         216 ---LERGYRM------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---HHcCCCC------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               0000000                  0012345579999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.5e-39  Score=307.78  Aligned_cols=184  Identities=22%  Similarity=0.298  Sum_probs=155.6

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .+|...+.||+|+||.||+++.                    .....+.+|+++|++++|+||+++++.+     .+.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence            3688999999999999988652                    1234577899999999999999999984     55789


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|||||++|+|.+++.          ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL  142 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLI----------RLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL  142 (376)
T ss_pred             EEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEE
Confidence            999999999999999994          4456888999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCC-----------------------------------------CcccccCccCccceeCCCCcCCCccC
Q 041757          176 GDFGLARFLPPTR-----------------------------------------TQTSSIDVKGSIGYIAPEYGVGNEVS  214 (381)
Q Consensus       176 ~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~  214 (381)
                      +|||++..+....                                         .........||+.|+|||++.+..++
T Consensus       143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  222 (376)
T cd05598         143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT  222 (376)
T ss_pred             EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence            9999975331000                                         00001124699999999999999999


Q ss_pred             cccchhhhhHHHHHHHhCCCCCC
Q 041757          215 TIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       215 ~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      .++|||||||++|||++|+.||.
T Consensus       223 ~~~DiwSlGvilyell~G~~Pf~  245 (376)
T cd05598         223 QLCDWWSVGVILYEMLVGQPPFL  245 (376)
T ss_pred             cceeeeeccceeeehhhCCCCCC
Confidence            99999999999999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6e-38  Score=285.34  Aligned_cols=239  Identities=22%  Similarity=0.293  Sum_probs=172.6

Q ss_pred             ceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           42 NLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      +.||+|+||.||++.                    ....+.+.+|+.+++.++||||+++++.|.     .....++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence            359999999998753                    113467899999999999999999999964     4667899999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      |+++|+|.+++....      ......+...+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~  146 (268)
T cd05086          76 YCELGDLKSYLSQEQ------WHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG  146 (268)
T ss_pred             cCCCCcHHHHHHhhh------cccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccc
Confidence            999999999995321      11234667778899999999999999   669999999999999999999999999998


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCC-------CccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVG-------NEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ................++..|+|||++..       ..++.++||||||+++|||++ |..||...    ... ......
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~----~~~-~~~~~~  221 (268)
T cd05086         147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL----SDR-EVLNHV  221 (268)
T ss_pred             cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC----CHH-HHHHHH
Confidence            64332222122223457889999998753       245789999999999999997 56676421    111 111111


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      .......+.++.+                      .......+.+++..|| .+|++||++.+|++.|.
T Consensus       222 ~~~~~~~~~~~~~----------------------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         222 IKDQQVKLFKPQL----------------------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HhhcccccCCCcc----------------------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1110000111000                      1123456777888999 68999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=285.02  Aligned_cols=233  Identities=23%  Similarity=0.338  Sum_probs=181.8

Q ss_pred             ceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||++.                     ....+.+.+|+.+++.+.|+||+++++++.      .+..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            479999999997652                     013457889999999999999999999853      34579999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|.+++.          ....+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||+
T Consensus        75 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~  141 (257)
T cd05060          75 ELAPLGPLLKYLK----------KRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGM  141 (257)
T ss_pred             EeCCCCcHHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccc
Confidence            9999999999994          3347899999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          181 ARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       181 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||.....     ......      
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~------  210 (257)
T cd05060         142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAM------  210 (257)
T ss_pred             cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHH------
Confidence            98664433211 1111224568999999988889999999999999999998 9999753211     111110      


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                         +...   ..               ...+..++..+.+++.+||..+|.+||++.++++.|+++.
T Consensus       211 ---~~~~---~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         211 ---LESG---ER---------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ---HHcC---Cc---------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence               0000   00               0001245568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-38  Score=299.96  Aligned_cols=182  Identities=22%  Similarity=0.337  Sum_probs=153.5

Q ss_pred             ccccccccceecCCCceEEEecccc-----------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-----------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      ...+|.+.+.||+|+||.||++...           .......|+.++++++||||+++++++.     .....++||||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~  138 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLPH  138 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEEc
Confidence            4567999999999999999887632           2334567999999999999999999954     46778999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +. ++|.+++.         .....+++..++.++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus       139 ~~-~~l~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        139 YS-SDLYTYLT---------KRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             cC-CcHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence            95 68988884         33456899999999999999999999   6699999999999999999999999999987


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS  236 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf  236 (381)
                      ........   ....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       206 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        206 FPVVAPAF---LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccCccc---ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            54332221   1245899999999999989999999999999999999865553

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2e-38  Score=286.16  Aligned_cols=234  Identities=17%  Similarity=0.255  Sum_probs=184.7

Q ss_pred             cccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           37 NMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      +|...++||.|+||.||++.                  ....+.+.+|+.+++.++|+||+++++.+     ......++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            47788999999999997653                  12346788899999999999999999984     45788999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++|+|.+++..        .....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+||
T Consensus        76 v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~df  144 (255)
T cd08219          76 VMEYCDGGDLMQKIKL--------QRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDF  144 (255)
T ss_pred             EEeeCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEccc
Confidence            9999999999998853        23445789999999999999999999   679999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      |.+..........  ....|++.|+|||++.+..++.++||||||+++|+|++|..||...     .......       
T Consensus       145 g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~-------  210 (255)
T cd08219         145 GSARLLTSPGAYA--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLIL-------  210 (255)
T ss_pred             Ccceeeccccccc--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHH-------
Confidence            9998665433221  1245889999999998888999999999999999999999998521     1111111       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                           ........               ..+...+..+.+++.+||+.||++|||+.+++..
T Consensus       211 -----~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         211 -----KVCQGSYK---------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----HHhcCCCC---------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 00000000               0012344568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-38  Score=287.14  Aligned_cols=240  Identities=24%  Similarity=0.375  Sum_probs=187.2

Q ss_pred             ccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .+|.+.+.||+|+||.||++..                     ...+.+.+|+.++++++||||+++++++     ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            5788899999999999976431                     1245788999999999999999999995     3467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++..         ....+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~  146 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRK---------HDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCK  146 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEE
Confidence            88999999999999999952         2346788999999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCccc-ccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      |+|||++........... .....++..|+|||++.+..++.++||||||+++||+++ |..||......     .    
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~----  217 (267)
T cd05066         147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----D----  217 (267)
T ss_pred             eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----H----
Confidence            999999987654322111 111223568999999998889999999999999999886 99997522110     0    


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                              ..........               .+.+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       218 --------~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         218 --------VIKAIEEGYR---------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --------HHHHHhCCCc---------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                    1111000000               000123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-38  Score=296.63  Aligned_cols=253  Identities=21%  Similarity=0.339  Sum_probs=192.3

Q ss_pred             ccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVD   89 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~   89 (381)
                      .+|.+++.||+|+||.||++..                         ...+.+.+|+++++++ +||||++++++|.   
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT---   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence            4688899999999999987631                         1245788999999999 7999999999964   


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS  163 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~  163 (381)
                        .....+++|||+++|+|.+++........      .......+++..++.++.|++.||.|||   ..+++||||||+
T Consensus        89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~  163 (334)
T cd05100          89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR  163 (334)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence              36678999999999999999964221000      0012345788899999999999999999   669999999999


Q ss_pred             CeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccC
Q 041757          164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEG  242 (381)
Q Consensus       164 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~  242 (381)
                      ||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...   
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---  240 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---  240 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---
Confidence            99999999999999999987654332222222335678999999999899999999999999999998 88887421   


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                        ...........        ....                   ..+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       241 --~~~~~~~~~~~--------~~~~-------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         241 --PVEELFKLLKE--------GHRM-------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             --CHHHHHHHHHc--------CCCC-------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence              11111111100        0000                   001234567889999999999999999999999999


Q ss_pred             Hhhhhc
Q 041757          323 SIKNTL  328 (381)
Q Consensus       323 ~i~~~~  328 (381)
                      ++...-
T Consensus       292 ~~~~~~  297 (334)
T cd05100         292 RVLTVT  297 (334)
T ss_pred             HHhhhc
Confidence            987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.6e-38  Score=296.99  Aligned_cols=226  Identities=20%  Similarity=0.243  Sum_probs=176.0

Q ss_pred             cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757           37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      +|...++||+|+||.||++..                    ...+.+..|..++..+. |++|+++++++     ...+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            467778999999999987641                    12345778999998886 57788888874     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL  142 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEE
Confidence            999999999999999983          4567899999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+++........  .....||+.|+|||++.+..++.++|||||||++|||++|..||.....     ..       
T Consensus       143 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~-------  208 (323)
T cd05615         143 ADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DE-------  208 (323)
T ss_pred             eccccccccCCCCcc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HH-------
Confidence            999998754332221  1124589999999999988899999999999999999999999853211     11       


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                           ++...+.....                .+...+.++.+++.+||+.||.+|++..
T Consensus       209 -----~~~~i~~~~~~----------------~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         209 -----LFQSIMEHNVS----------------YPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             -----HHHHHHhCCCC----------------CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence                 11111111100                0123445778899999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-38  Score=289.17  Aligned_cols=205  Identities=22%  Similarity=0.287  Sum_probs=158.7

Q ss_pred             HHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHH
Q 041757           61 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDV  140 (381)
Q Consensus        61 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi  140 (381)
                      ..|.+|+.+++.++||||++++++|..     ....++||||+++|+|..++.         .....+++..+..++.|+
T Consensus        61 ~~~~~~~~~~~~l~h~niv~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~---------~~~~~~~~~~~~~i~~qi  126 (274)
T cd05076          61 LAFFETASLMSQVSHIHLAFVHGVCVR-----GSENIMVEEFVEHGPLDVCLR---------KEKGRVPVAWKITVAQQL  126 (274)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEEe-----CCceEEEEecCCCCcHHHHHH---------hcCCCCCHHHHHHHHHHH
Confidence            467889999999999999999999653     667899999999999999984         234568899999999999


Q ss_pred             HHHHHHhhcCCCCCceeeccCCCCeeeCCCC-------CeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-Cc
Q 041757          141 ASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-------TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NE  212 (381)
Q Consensus       141 ~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~  212 (381)
                      +.||+|||   +.+|+||||||+||+++..+       .+|++|||++........      ..++..|+|||.+.+ ..
T Consensus       127 ~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~aPe~~~~~~~  197 (274)
T cd05076         127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE------RVERIPWIAPECVPGGNS  197 (274)
T ss_pred             HHHHHHHH---cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccccc------cccCCcccCchhhcCCCC
Confidence            99999999   67999999999999997543       479999998764322211      247888999998875 56


Q ss_pred             cCcccchhhhhHHHHHHH-hCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHH
Q 041757          213 VSTIGDVYSYGILLLELM-IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE  291 (381)
Q Consensus       213 ~~~~sDiwSlG~il~el~-tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  291 (381)
                      ++.++||||||+++||++ +|..||.......              .......... .                   +..
T Consensus       198 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~~~-~-------------------~~~  243 (274)
T cd05076         198 LSTAADKWSFGTTLLEICFDGEVPLKERTPSE--------------KERFYEKKHR-L-------------------PEP  243 (274)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCccccChHH--------------HHHHHHhccC-C-------------------CCC
Confidence            899999999999999985 6899975321110              0011111000 0                   011


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          292 CVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       292 ~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      ....+.+++.+||+.+|++|||+.+|++.|+
T Consensus       244 ~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         244 SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            2246888999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=288.10  Aligned_cols=241  Identities=23%  Similarity=0.330  Sum_probs=180.5

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||++..                    ...+.+.+|++++.++ +||||+++++++.     ..+..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence            4699999999977531                    1235678899999999 7999999999954     466789999


Q ss_pred             EcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757          101 EFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ||+++|+|.+++........      .......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence            99999999999964321100      0012235789999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||++........   ......+..|+|||++....++.++||||||+++|||++ |..||....     ...     
T Consensus       153 l~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~-----  219 (270)
T cd05047         153 IADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAE-----  219 (270)
T ss_pred             ECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHH-----
Confidence            999999853221111   111224567999999988889999999999999999997 999975221     111     


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                             ..........               ...+..++.++.+++.+||+.||.+|||+.+++..|+++.
T Consensus       220 -------~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         220 -------LYEKLPQGYR---------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -------HHHHHhCCCC---------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                   1111000000               0001234457889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.2e-38  Score=285.91  Aligned_cols=241  Identities=21%  Similarity=0.326  Sum_probs=188.7

Q ss_pred             ccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|...++||+|+||.||++..                     ...+.+.+|+.++++++||||+++++++.      ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------EN   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------CC
Confidence            4578889999999999987531                     13457889999999999999999999853      34


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++..         ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+|
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~  147 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQV---------NKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVK  147 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeE
Confidence            56899999999999999952         2345899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||+++........... ...++..|+|||.+....++.++||||||+++||+++ |..||......    .....  
T Consensus       148 l~d~g~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~--  220 (270)
T cd05056         148 LGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGR--  220 (270)
T ss_pred             EccCceeeecccccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHH--
Confidence            9999999876554322111 1234568999999988889999999999999999986 99997532111    11100  


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                                 ......               ...+..++..+.+++.+||..+|.+|||+.+++..|+++..+
T Consensus       221 -----------~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         221 -----------IENGER---------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -----------HHcCCc---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                       000000               001224566889999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.7e-38  Score=286.50  Aligned_cols=241  Identities=22%  Similarity=0.365  Sum_probs=188.0

Q ss_pred             cccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...+.||+|+||.||++..                     ...+.+.+|++++++++|+||+++++++     ...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence            35788889999999999986531                     1245688899999999999999999995     446


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++++|.+++.         .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~  146 (268)
T cd05063          79 KPAMIITEYMENGALDKYLR---------DHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLEC  146 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcE
Confidence            77899999999999999985         23456889999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccc-cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSS-IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      ||+|||++............ .....+..|+|||++.+..++.++|||||||++||+++ |..||.....     .....
T Consensus       147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~  221 (268)
T cd05063         147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMK  221 (268)
T ss_pred             EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHH
Confidence            99999999866543222111 11223567999999988889999999999999999997 9999752211     11111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      .         +.... ..+                 ....++.++.+++.+||..+|++||++.+|++.|+++
T Consensus       222 ~---------i~~~~-~~~-----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         222 A---------INDGF-RLP-----------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             H---------HhcCC-CCC-----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0         00000 000                 0123556789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.8e-38  Score=290.47  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=189.0

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      .++|...+.||+|+||.||++..                       ...+.+.+|+.++++++||||+++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            46789999999999999987541                       12456888999999999999999999854     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCccc------------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDET------------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV  159 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD  159 (381)
                      .....++||||+++|+|.+++.........            ......+++..++.++.|++.||.|||   ..+++|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d  155 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD  155 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence            466789999999999999999643211100            011235788999999999999999999   66999999


Q ss_pred             cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCc
Q 041757          160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDI  238 (381)
Q Consensus       160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~  238 (381)
                      |||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999876544332221212235678999999988889999999999999999997 8888642


Q ss_pred             cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757          239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV  318 (381)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  318 (381)
                      ...     .....        .+.+.....                   .+..++.++.+++.+||+.||.+|||+.|++
T Consensus       236 ~~~-----~~~~~--------~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~  283 (288)
T cd05050         236 MAH-----EEVIY--------YVRDGNVLS-------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASIN  283 (288)
T ss_pred             CCH-----HHHHH--------HHhcCCCCC-------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            211     11111        000000000                   0123456889999999999999999999999


Q ss_pred             HHHHH
Q 041757          319 HELQS  323 (381)
Q Consensus       319 ~~L~~  323 (381)
                      +.|++
T Consensus       284 ~~l~~  288 (288)
T cd05050         284 RILQR  288 (288)
T ss_pred             HHhhC
Confidence            98863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.6e-38  Score=297.54  Aligned_cols=227  Identities=24%  Similarity=0.286  Sum_probs=174.5

Q ss_pred             ceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||++..                    ...+.+.+|+.++.++ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            4799999999987641                    1234577899999988 599999999984     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++.          ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (327)
T cd05617          76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGM  142 (327)
T ss_pred             eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEecccc
Confidence            9999999999883          4457899999999999999999999   67999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCC-CcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~  259 (381)
                      ++.........  ....||+.|+|||++.+..++.++|||||||++|||++|..||....... ........        
T Consensus       143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~--------  212 (327)
T cd05617         143 CKEGLGPGDTT--STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF--------  212 (327)
T ss_pred             ceeccCCCCce--ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH--------
Confidence            87533222111  12568999999999999999999999999999999999999986332211 11111100        


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                         ........                ..+...+..+.+++.+||+.||.+||++.
T Consensus       213 ---~~~~~~~~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         213 ---QVILEKPI----------------RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             ---HHHHhCCC----------------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence               00000000                01123445678899999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-38  Score=303.18  Aligned_cols=184  Identities=22%  Similarity=0.285  Sum_probs=156.3

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...++||+|+||.||++..                    .....+.+|+.+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            357899999999999999987642                    1234577899999999999999999984     557


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++|||||++|+|.+++.           ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~-----------~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCE
Confidence            88999999999999999984           234788899999999999999999   6799999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCc----cCcccchhhhhHHHHHHHhCCCCCC
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE----VSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||+|||++........... ....||+.|+|||++.+..    ++.++|||||||++|||++|..||.
T Consensus       182 kL~DFG~a~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~  248 (370)
T cd05621         182 KLADFGTCMKMDETGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY  248 (370)
T ss_pred             EEEecccceecccCCceec-ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence            9999999987654332111 2356999999999987543    7889999999999999999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-38  Score=287.71  Aligned_cols=243  Identities=21%  Similarity=0.343  Sum_probs=190.1

Q ss_pred             cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..+|...+.||+|+||.||++..                      .....+.+|+.++++++||||++++++|..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            46788889999999999987531                      123578899999999999999999999642     


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                       ...++||||+++|+|.+++.         .....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~  147 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVR---------NHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQH  147 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCe
Confidence             57899999999999999985         23445899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||.++...............++..|+|||.+....++.++||||||+++||+++ |+.||....     ...+..
T Consensus       148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~  222 (279)
T cd05057         148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-----AVEIPD  222 (279)
T ss_pred             EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Confidence            99999999987654332221111224678999999988889999999999999999998 999975221     111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                               .+..   ....               ..+..+...+.+++.+||..||.+||++.++++.|+++.+.
T Consensus       223 ---------~~~~---~~~~---------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         223 ---------LLEK---GERL---------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             ---------HHhC---CCCC---------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence                     1110   0000               00112445688899999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-38  Score=304.66  Aligned_cols=185  Identities=22%  Similarity=0.260  Sum_probs=158.1

Q ss_pred             cccccccceecCCCceEEEecccc--------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG--------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~--------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ..+|...+.||+|+||.||++...              ....+.+|+++|++++||||+++++++     ......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEEe
Confidence            456999999999999999876311              123457899999999999999999984     4577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      |++. ++|.+++          .....+++..++.++.|++.||.|||   ..+|+||||||+|||++.++.++|+|||+
T Consensus       166 e~~~-~~l~~~l----------~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~  231 (392)
T PHA03207        166 PKYK-CDLFTYV----------DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGA  231 (392)
T ss_pred             hhcC-CCHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcc
Confidence            9995 6899888          34567899999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      +................||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  289 (392)
T PHA03207        232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG  289 (392)
T ss_pred             ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            9876554333333345699999999999999999999999999999999999999853

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-38  Score=283.71  Aligned_cols=237  Identities=27%  Similarity=0.393  Sum_probs=188.4

Q ss_pred             cccccccceecCCCceEEEeccc--------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      .++|...+.||.|+||.||.+..              ...+++.+|+.+++.++|+||+++++++.     .....++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEEEE
Confidence            46788899999999999987542              13568899999999999999999999954     477889999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++++|.+++..        .....+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||.
T Consensus        80 e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~  148 (256)
T cd05039          80 EYMAKGSLVDYLRS--------RGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGL  148 (256)
T ss_pred             EecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccc
Confidence            99999999999953        12236899999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      ++.......     ....+..|+|||++....++.++||||||+++|++++ |..||....     ......        
T Consensus       149 ~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~--------  210 (256)
T cd05039         149 AKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVP--------  210 (256)
T ss_pred             ccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH--------
Confidence            987643222     1235678999999988889999999999999999997 999975221     111100        


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                       .+.....  .                ..+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus       211 -~~~~~~~--~----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         211 -HVEKGYR--M----------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -HHhcCCC--C----------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence             0000000  0                00123456889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-38  Score=306.07  Aligned_cols=185  Identities=22%  Similarity=0.329  Sum_probs=157.0

Q ss_pred             ccccccccceecCCCceEEEecccc-----------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-----------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      ...+|.+.+.||+|+||.||++...           ....+.+|+++|++++|+|||++++++.     ..+..++|||+
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~lv~e~  241 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTCLVLPK  241 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEEEEEEc
Confidence            3557999999999999999887632           2345778999999999999999999854     36788999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +. ++|.+++.         .....+++..++.++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus       242 ~~-~~L~~~l~---------~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~  308 (461)
T PHA03211        242 YR-SDLYTYLG---------ARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAAC  308 (461)
T ss_pred             cC-CCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence            95 68988884         23346899999999999999999999   6699999999999999999999999999998


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS  236 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf  236 (381)
                      ...............||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            765433222222356999999999999999999999999999999999988764

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.3e-38  Score=298.77  Aligned_cols=185  Identities=23%  Similarity=0.242  Sum_probs=154.5

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~   93 (381)
                      ..++|...+.||+|+||.||.+..                   ...+.+.+|+.+++.++||||+++++++.... ....
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            468899999999999999977531                   13456788999999999999999999865321 1233


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+.+ +|.+.+.            ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~  158 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCE
Confidence            567999999965 6777662            24788889999999999999999   6799999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||+|||+++.........   ...||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       159 kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  219 (355)
T cd07874         159 KILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP  219 (355)
T ss_pred             EEeeCcccccCCCccccC---CccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999998654432221   2458999999999999899999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.5e-38  Score=291.44  Aligned_cols=181  Identities=23%  Similarity=0.297  Sum_probs=155.7

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...+.||+|+||.||++..                  .....+.+|++++++++||||+++++++.     ..+..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence            4688999999999999977541                  12356889999999999999999999954     477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++.          ....+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|
T Consensus        76 lv~ey~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~d  143 (308)
T cd06615          76 ICMEHMDGGSLDQVLK----------KAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD  143 (308)
T ss_pred             EEeeccCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEcc
Confidence            9999999999999994          345688999999999999999999941  4899999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||++........    ....++..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus       144 fg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~  199 (308)
T cd06615         144 FGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP  199 (308)
T ss_pred             CCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            999876543222    12458899999999988889999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.7e-38  Score=285.80  Aligned_cols=223  Identities=18%  Similarity=0.278  Sum_probs=171.6

Q ss_pred             ceecCCCceEEEeccc-----------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           42 NLISAGTFGFSHLRRQ-----------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~-----------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      +.||+|+||.||++..                             .....|.+|+.++..++||||+++++++.     .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence            4689999999987641                             12346778999999999999999999964     3


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+++|+|..++.         .....+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~  143 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMH---------RKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGI  143 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCc
Confidence            567799999999999999884         23456899999999999999999999   779999999999999986654


Q ss_pred             -------eEEeecccceecCCCCCcccccCccCccceeCCCCcC-CCccCcccchhhhhHHHHHHH-hCCCCCCccccCC
Q 041757          173 -------ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-GNEVSTIGDVYSYGILLLELM-IREKPSDIMFEGD  243 (381)
Q Consensus       173 -------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~el~-tg~~Pf~~~~~~~  243 (381)
                             ++++|||++.......      ...++..|+|||.+. +..++.++|||||||++|||+ +|..||....   
T Consensus       144 ~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---  214 (262)
T cd05077         144 DGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT---  214 (262)
T ss_pred             cCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc---
Confidence                   8999999986543221      134788999999886 466899999999999999998 5888864221   


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                        ....         ..+.......                    ......++.+++.+||+.||.+||++.+|++.+
T Consensus       215 --~~~~---------~~~~~~~~~~--------------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         215 --LAEK---------ERFYEGQCML--------------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --hhHH---------HHHHhcCccC--------------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              0000         0000000000                    011235678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.3e-38  Score=283.06  Aligned_cols=238  Identities=22%  Similarity=0.368  Sum_probs=185.8

Q ss_pred             ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++|...+.||+|+||.||++..               ...+.+.+|++++++++|+|++++++++.      ....++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v~   79 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYIVT   79 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEEEE
Confidence            5688889999999999987641               12357889999999999999999998842      34578999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++++|.+++..        .....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||+
T Consensus        80 e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~  148 (260)
T cd05069          80 EFMGKGSLLDFLKE--------GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGL  148 (260)
T ss_pred             EcCCCCCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCcc
Confidence            99999999999953        12345788999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      +.......... .....++..|+|||+..+..++.++||||||+++||+++ |..||.....    ...           
T Consensus       149 ~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~-----------  212 (260)
T cd05069         149 ARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REV-----------  212 (260)
T ss_pred             ceEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHH-----------
Confidence            98764432211 112336778999999988889999999999999999999 8999753211    000           


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                        .........               ...+...+..+.+++.+||+.||.+||++.+|++.|++
T Consensus       213 --~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         213 --LEQVERGYR---------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --HHHHHcCCC---------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              000000000               00012445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-38  Score=289.40  Aligned_cols=244  Identities=20%  Similarity=0.215  Sum_probs=186.0

Q ss_pred             hhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccccc-CC
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQ-GN   93 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~-~~   93 (381)
                      .++++.|...+.||+|+||.||++..                .....+.+|+.++.++ +|+||+++++++...... ..
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35678899999999999999987642                2346788999999999 699999999997642211 23


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++++|.+++..        .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCE
Confidence            568999999999999999853        12346889999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      +|+|||++.........  .....|+..|+|||++.     +..++.++|||||||++|||++|..||....    ....
T Consensus       151 ~l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~----~~~~  224 (272)
T cd06637         151 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PMRA  224 (272)
T ss_pred             EEccCCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC----HHHH
Confidence            99999999865432211  12245899999999886     3457889999999999999999999975221    1111


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ....         ..     .+...             .....++..+.+++.+||..||.+|||+.++++
T Consensus       225 ~~~~---------~~-----~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         225 LFLI---------PR-----NPAPR-------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHH---------hc-----CCCCC-------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0000         00     00000             001134457889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-38  Score=282.61  Aligned_cols=240  Identities=23%  Similarity=0.365  Sum_probs=186.1

Q ss_pred             ceecCCCceEEEecccc---------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQG---------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~~---------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||.+...                     ..+.+.+|++.+..++|+||+++++++.     .....++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence            46999999999776432                     1578889999999999999999999954     477899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++++|.+++....... .......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||.
T Consensus        76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccc
Confidence            9999999999995321000 0001367899999999999999999999   67999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      +................++..|+|||.+....++.++||||||+++|+|++ |..||....     ....          
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~----------  216 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEV----------  216 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHHH----------
Confidence            987765432222223457889999999988889999999999999999999 699976331     1111          


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                        ........               ....+..++.++.+++.+||..||.+|||+.++++.|+
T Consensus       217 --~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         217 --LEYLRKGY---------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --HHHHHcCC---------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              11111000               00012344678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5e-38  Score=288.52  Aligned_cols=234  Identities=22%  Similarity=0.293  Sum_probs=181.3

Q ss_pred             ccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      |+..++||+|+||.||++..                    .....+.+|+.++++++|+||+.+++.+     ...+..+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence            67778999999999976431                    1124567899999999999999999985     4467899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|
T Consensus        77 lv~e~~~g~~L~~~l~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~D  145 (285)
T cd05630          77 LVLTLMNGGDLKFHIYH--------MGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISD  145 (285)
T ss_pred             EEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEee
Confidence            99999999999998842        22345889999999999999999999   67999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++..........   ...|+..|+|||++.+..++.++||||||+++|+|++|..||....... ....         
T Consensus       146 fg~~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~---------  212 (285)
T cd05630         146 LGLAVHVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE---------  212 (285)
T ss_pred             ccceeecCCCcccc---CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHH---------
Confidence            99987654332211   2358999999999998899999999999999999999999986322110 0000         


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                      ...+......                   ..+......+.+++.+||+.||++|||     +.++++
T Consensus       213 ~~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         213 VERLVKEVQE-------------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHhhhhhhhh-------------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            0011110000                   001234556889999999999999999     778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4e-38  Score=299.15  Aligned_cols=185  Identities=22%  Similarity=0.228  Sum_probs=154.5

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~   93 (381)
                      ..++|...+.||+|+||.||.+..                   ...+.+.+|+.+++.++||||+++++++.... ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            468899999999999999976531                   23456788999999999999999999865311 1234


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++ +|.+++.            ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  165 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  165 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcE
Confidence            567999999965 7877772            23778889999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||+|||+++........   ....+|..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       166 kL~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  226 (364)
T cd07875         166 KILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP  226 (364)
T ss_pred             EEEeCCCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence            99999999865443221   12458999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=305.09  Aligned_cols=229  Identities=21%  Similarity=0.288  Sum_probs=183.9

Q ss_pred             ceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEccc
Q 041757           42 NLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMH  104 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~  104 (381)
                      -+||+|+||+||-++.                 ...+-+..|+.+.++|+|.|||+++|.|     ..+++.-|.||-.+
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVP  655 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCC
Confidence            5899999999988762                 2455678899999999999999999994     45778999999999


Q ss_pred             CCCHHHhhccccCCcccccCCCcc--cHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC-CCCCeEEeecccc
Q 041757          105 NRSLKEWLYPISKEDETYKRPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMTARVGDFGLA  181 (381)
Q Consensus       105 ~g~L~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~  181 (381)
                      ||+|.++|.         .+-+++  ++..+--+..||++||.|||   ...|||||||-+|+|++ -.|.+||+|||-+
T Consensus       656 GGSLSsLLr---------skWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTs  723 (1226)
T KOG4279|consen  656 GGSLSSLLR---------SKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTS  723 (1226)
T ss_pred             CCcHHHHHH---------hccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccc
Confidence            999999995         334455  78888889999999999999   56999999999999996 5789999999999


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCCC--ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGN--EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      +.+..-...+.  .+.||..|||||++..+  .|+.++|||||||++.||.||++||....   .....+.+.       
T Consensus       724 KRLAginP~TE--TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg---spqAAMFkV-------  791 (1226)
T KOG4279|consen  724 KRLAGINPCTE--TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG---SPQAAMFKV-------  791 (1226)
T ss_pred             hhhccCCcccc--ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC---ChhHhhhhh-------
Confidence            87755433322  36699999999998864  58999999999999999999999985322   111111111       


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          .+....|                ++|.+...+...++++|+.+||.+||++.++++
T Consensus       792 ----GmyKvHP----------------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  792 ----GMYKVHP----------------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ----cceecCC----------------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence                1111111                235677888999999999999999999999986

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.5e-38  Score=300.84  Aligned_cols=184  Identities=21%  Similarity=0.267  Sum_probs=156.2

Q ss_pred             ccccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...+.||+|+||.||++...                    ..+.+.+|+.+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  115 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            3588999999999999999876421                    234467899999999999999999984     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++|||||++|+|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~-----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~i  181 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL  181 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCE
Confidence            88999999999999999984           234788889999999999999999   6799999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCC----ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN----EVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||+|||+++.......... ....||+.|+|||++.+.    .++.++|||||||++|||++|..||.
T Consensus       182 kL~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  248 (371)
T cd05622         182 KLADFGTCMKMNKEGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  248 (371)
T ss_pred             EEEeCCceeEcCcCCcccc-cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence            9999999987654332211 225699999999998754    37899999999999999999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.9e-38  Score=287.85  Aligned_cols=250  Identities=21%  Similarity=0.209  Sum_probs=189.4

Q ss_pred             hhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccC
Q 041757           30 EILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~   92 (381)
                      .+.+..++|...+.||+|+||.||++..                .....+.+|+.+++.+ +||||+++++++.......
T Consensus        12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            3445789999999999999999987531                1235678899999999 6999999999876533455


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+++++|.+++....      .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCC
Confidence            678999999999999999874221      23456888999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      +||+|||+++.........  ....|++.|+|||++..     ..++.++|||||||++|||++|+.||....    ...
T Consensus       163 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~----~~~  236 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH----PMR  236 (286)
T ss_pred             EEEccCCceeecccCCCcc--ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc----hhH
Confidence            9999999998765432221  12458999999998753     447889999999999999999999975221    111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      ....         ....   ..+.              ...+..+...+.+++.+||+.||++|||+.+|++.
T Consensus       237 ~~~~---------~~~~---~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         237 ALFK---------IPRN---PPPT--------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHhh---------cccc---CCCc--------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            1100         0000   0000              00011234568899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-38  Score=293.29  Aligned_cols=237  Identities=20%  Similarity=0.255  Sum_probs=182.0

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .+.|++.++||+||.+.||++..                  .....|.+|+..|.+|+ |.+||++|+|-     -.+++
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~  434 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY  434 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence            45699999999999999988753                  34567899999999996 99999999994     45889


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      +|+||||= ..||..+|..         ....++.-.+..+..|++.++.++|   ..||||.||||.|+|+-. |.+||
T Consensus       435 lYmvmE~G-d~DL~kiL~k---------~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKL  500 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKK---------KKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKL  500 (677)
T ss_pred             EEEEeecc-cccHHHHHHh---------ccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEe
Confidence            99999965 5699999963         2333443478889999999999999   669999999999999864 68999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCc-----------cCcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-----------VSTIGDVYSYGILLLELMIREKPSDIMFEGDM  244 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~  244 (381)
                      +|||.|..+..+.........+||+.||+||.+....           .+.+|||||+|||||+|+.|+.||....    
T Consensus       501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----  576 (677)
T KOG0596|consen  501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----  576 (677)
T ss_pred             eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----
Confidence            9999999888776655555678999999999876432           5688999999999999999999975110    


Q ss_pred             cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          245 NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +.  +.      .+..+.+      |...+....         .  ....+++++|..||..||.+|||..++++
T Consensus       577 n~--~a------Kl~aI~~------P~~~Iefp~---------~--~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  577 NQ--IA------KLHAITD------PNHEIEFPD---------I--PENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HH--HH------HHHhhcC------CCccccccC---------C--CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            00  00      0111111      110000000         0  11123899999999999999999999986

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-38  Score=289.23  Aligned_cols=239  Identities=18%  Similarity=0.236  Sum_probs=183.1

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++|...+.||+|+||.||++..                 .....+.+|+.++++++||||+++++++.     .....
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~   81 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKL   81 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEE
Confidence            356799999999999999987641                 13446778999999999999999999954     46788


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++++|.+++.          ....+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.++|+
T Consensus        82 ~iv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~  148 (267)
T cd06646          82 WICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLA  148 (267)
T ss_pred             EEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEC
Confidence            99999999999999984          3456889999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |||++..........  ....++..|+|||.+.   ...++.++|||||||++|||++|+.||.......    ....  
T Consensus       149 dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~----~~~~--  220 (267)
T cd06646         149 DFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----ALFL--  220 (267)
T ss_pred             cCccceeeccccccc--CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh----hhee--
Confidence            999998664332111  1245889999999874   3457889999999999999999999974221100    0000  


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                             +......  +..             .......+..+.+++.+||..+|++|||+.++++.
T Consensus       221 -------~~~~~~~--~~~-------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         221 -------MSKSNFQ--PPK-------------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             -------eecCCCC--CCC-------------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence                   0000000  000             00011334678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-38  Score=282.47  Aligned_cols=237  Identities=22%  Similarity=0.286  Sum_probs=189.6

Q ss_pred             ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      +.|+..+.||.|.-|+||+++                    .....+...|.+||+.++||.++.+|+.     ++..++
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence            457788999999999999876                    2345667779999999999999999999     677999


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|||||+||+|..+++.        .....+++..++-++.+++-||+|||   -.|||.|||||+||||.++|++-|
T Consensus       152 ~cl~meyCpGGdL~~Lrqk--------Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIML  220 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQK--------QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIML  220 (459)
T ss_pred             eEEEEecCCCccHHHHHhh--------CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEe
Confidence            9999999999999999865        45678999999999999999999999   889999999999999999999999


Q ss_pred             eecccceecCCC--------------------------------C-C---------------------cccccCccCccc
Q 041757          176 GDFGLARFLPPT--------------------------------R-T---------------------QTSSIDVKGSIG  201 (381)
Q Consensus       176 ~Dfg~~~~~~~~--------------------------------~-~---------------------~~~~~~~~gt~~  201 (381)
                      +||.++......                                . .                     .....+++||-.
T Consensus       221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE  300 (459)
T KOG0610|consen  221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE  300 (459)
T ss_pred             eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence            999987543210                                0 0                     011124779999


Q ss_pred             eeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchh
Q 041757          202 YIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQ  281 (381)
Q Consensus       202 y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  281 (381)
                      |.|||++.+...+.++|+|+|||++|||+.|..||.    +..+-.-         +.+++.+-+....           
T Consensus       301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFK----G~~~~~T---------l~NIv~~~l~Fp~-----------  356 (459)
T KOG0610|consen  301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFK----GSNNKET---------LRNIVGQPLKFPE-----------  356 (459)
T ss_pred             cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcC----CCCchhh---------HHHHhcCCCcCCC-----------
Confidence            999999999999999999999999999999999975    3332222         2222222111110           


Q ss_pred             hhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 041757          282 TQAKINIIRECVISMVRIGVACSMESPQDRMK----MTNVVH  319 (381)
Q Consensus       282 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~~vl~  319 (381)
                             .++....+.+||.+.|.+||.+|.-    +.||-+
T Consensus       357 -------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  357 -------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             -------CCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence                   1245567889999999999999988    666653

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=285.82  Aligned_cols=233  Identities=19%  Similarity=0.259  Sum_probs=193.4

Q ss_pred             ccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           38 MLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      |.+..+||+|+||.|+++-               ....++.++|+.+|++.+.|+||++||.++     .+..+|+||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEeehhh
Confidence            7778999999999996643               456789999999999999999999999964     36778999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      |..|++.+.++         -+...+++.++..++...+.||+|||   ...-+|||||..|||++.+|.+||+|||.+.
T Consensus       110 CGAGSiSDI~R---------~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAG  177 (502)
T KOG0574|consen  110 CGAGSISDIMR---------ARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAG  177 (502)
T ss_pred             cCCCcHHHHHH---------HhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccc
Confidence            99999999996         46778999999999999999999999   6688999999999999999999999999998


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHH
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIV  262 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (381)
                      .+.+......  .+.||+.|||||++..-.|+.++||||||++..||..|++||....+....+                
T Consensus       178 QLTDTMAKRN--TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------------  239 (502)
T KOG0574|consen  178 QLTDTMAKRN--TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------------  239 (502)
T ss_pred             hhhhhHHhhC--ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------------
Confidence            8776544333  2679999999999999999999999999999999999999986432211000                


Q ss_pred             hhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          263 DSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       263 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                    .....++.....+.....++.+++++||-.+|++|-|+.++++
T Consensus       240 --------------MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  240 --------------MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             --------------eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence                          0000011111225567788999999999999999999998876

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.4e-38  Score=318.71  Aligned_cols=254  Identities=20%  Similarity=0.251  Sum_probs=189.8

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||.||++..                    ...++|.+|++++++++||||+++++++.     +.+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            5788999999999999988641                    12457899999999999999999999953     4678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCc-ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKED-ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      .++||||++||+|.+++....... ........++...++.++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence            899999999999999985321110 00011234667788999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCC----------------cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          175 VGDFGLARFLPPTRT----------------QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      |+|||+++.......                .......+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999987622110                0111124699999999999999999999999999999999999999853


Q ss_pred             cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-CHHHH
Q 041757          239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-KMTNV  317 (381)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~v  317 (381)
                      ......                 ........+..             .......+..+.+++.+||+.||++|| ++.++
T Consensus       234 ~~~~ki-----------------~~~~~i~~P~~-------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        234 KKGRKI-----------------SYRDVILSPIE-------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             cchhhh-----------------hhhhhccChhh-------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            111000                 00000000000             000124556788899999999999995 67778


Q ss_pred             HHHHHHhhhh
Q 041757          318 VHELQSIKNT  327 (381)
Q Consensus       318 l~~L~~i~~~  327 (381)
                      ++.|+.....
T Consensus       284 l~~Le~~lq~  293 (932)
T PRK13184        284 KQDLEPHLQG  293 (932)
T ss_pred             HHHHHHHHhc
Confidence            8888877654

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.8e-38  Score=280.99  Aligned_cols=231  Identities=23%  Similarity=0.319  Sum_probs=179.2

Q ss_pred             ceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEccc
Q 041757           42 NLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMH  104 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~  104 (381)
                      ++||+|+||.||++..                 .....+.+|+++++.++||||+++++++.     .....++||||++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECCC
Confidence            4699999999987541                 12346889999999999999999999954     4667899999999


Q ss_pred             CCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757          105 NRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL  184 (381)
Q Consensus       105 ~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~  184 (381)
                      +++|.+++..         ....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+||+|||++...
T Consensus        76 ~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  143 (250)
T cd05085          76 GGDFLSFLRK---------KKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQE  143 (250)
T ss_pred             CCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceec
Confidence            9999999842         2345789999999999999999999   669999999999999999999999999998765


Q ss_pred             CCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757          185 PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVD  263 (381)
Q Consensus       185 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (381)
                      ........ ....++..|+|||++.+..++.++||||||+++|++++ |..||.....     ......         +.
T Consensus       144 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~~---------~~  208 (250)
T cd05085         144 DDGIYSSS-GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQAREQ---------VE  208 (250)
T ss_pred             cccccccC-CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH---------HH
Confidence            43322111 11234677999999988889999999999999999998 9999752211     111000         00


Q ss_pred             hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      .....                  ..+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       209 ~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         209 KGYRM------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             cCCCC------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            00000                  001234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.9e-38  Score=285.72  Aligned_cols=223  Identities=20%  Similarity=0.293  Sum_probs=171.4

Q ss_pred             ceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           42 NLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +.||.|+||.||++..                        ...+.+.+|+.+++.++||||+++++++.     .....+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence            4699999999988642                        12346778999999999999999999964     356789


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC-----
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT-----  172 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~-----  172 (381)
                      +||||+++|+|.+++..         ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.     
T Consensus        76 lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~  143 (258)
T cd05078          76 MVQEYVKFGSLDTYLKK---------NKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGN  143 (258)
T ss_pred             EEEecCCCCcHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCC
Confidence            99999999999999952         2346889999999999999999999   779999999999999987664     


Q ss_pred             ---eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCC-CCCCccccCCCcHH
Q 041757          173 ---ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIRE-KPSDIMFEGDMNLH  247 (381)
Q Consensus       173 ---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~-~Pf~~~~~~~~~~~  247 (381)
                         ++++|||++.......      ...+++.|+|||++.+ ..++.++||||||+++||+++|. .||...    ....
T Consensus       144 ~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~----~~~~  213 (258)
T cd05078         144 PPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL----DSQK  213 (258)
T ss_pred             CceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc----cHHH
Confidence               6999999886543221      1347889999999887 45789999999999999999985 554311    1000


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      .          ..+.....                    ..+.....++.+++.+||+.||++|||+.++++.|
T Consensus       214 ~----------~~~~~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         214 K----------LQFYEDRH--------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             H----------HHHHHccc--------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            0          00000000                    00112335688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=301.56  Aligned_cols=236  Identities=22%  Similarity=0.268  Sum_probs=189.0

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .+-|.+...||.|+||.||++..                 ...+.|+-|++||..+.||+||++++.|+     ..+.+|
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceE
Confidence            45577888999999999988753                 34678889999999999999999999954     477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      |..|||.||-++..+.         .-...+++.++..+++|++.||.|||   +.+|||||||..|||++-+|.++|+|
T Consensus       106 iliEFC~GGAVDaiml---------EL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLAD  173 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIML---------ELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLAD  173 (1187)
T ss_pred             EEEeecCCchHhHHHH---------HhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeec
Confidence            9999999999999886         35678999999999999999999999   77999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCc-----CCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYG-----VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||.+...........  .+.|||.|||||+.     ...+|+.++||||||++|.||..+.+|..    .-..+..+.+.
T Consensus       174 FGVSAKn~~t~qkRD--sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh----elnpMRVllKi  247 (1187)
T KOG0579|consen  174 FGVSAKNKSTRQKRD--SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH----ELNPMRVLLKI  247 (1187)
T ss_pred             ccccccchhHHhhhc--cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc----ccchHHHHHHH
Confidence            999865444332222  37799999999974     45789999999999999999999999943    11222222222


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..++. .-                         ...+......+.+++.+||..||..||++.++++
T Consensus       248 aKSeP-PT-------------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  248 AKSEP-PT-------------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hhcCC-Cc-------------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            11111 00                         0113356667889999999999999999999985

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-38  Score=285.99  Aligned_cols=236  Identities=24%  Similarity=0.343  Sum_probs=181.4

Q ss_pred             ccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      |+..+.||+|+||+||+++..                   ......+|+.++++++||||+++++++.     .....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence            667899999999999886521                   1223456999999999999999999954     4788899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+.+++|.+++.          ....+++..++.++.|++.||.+||   +.+++|+||||+||+++.++.++|+||
T Consensus        76 v~~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Df  142 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----------KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDF  142 (260)
T ss_dssp             EEEEETTEBHHHHHH----------HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSG
T ss_pred             ccccccccccccccc----------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence            999999999999993          4567899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcC-CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      |.+........  ......++..|+|||++. +..++.++||||+|+++|+|++|..||....  .............. 
T Consensus       143 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~-  217 (260)
T PF00069_consen  143 GSSVKLSENNE--NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKR-  217 (260)
T ss_dssp             TTTEESTSTTS--EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHT-
T ss_pred             ccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhcccc-
Confidence            99986522211  222355899999999988 7889999999999999999999999986330  00000000000000 


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        .......                     ........+.+++.+||+.||++|||+.++++
T Consensus       218 --~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 --PLPSSSQ---------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             --HHHHHTT---------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             --ccccccc---------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0000000                     00111368999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1e-37  Score=290.68  Aligned_cols=191  Identities=21%  Similarity=0.312  Sum_probs=150.7

Q ss_pred             ccceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           40 EENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        40 ~~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      .+.+||+|+||.||++...                 ....+.+|++++++++||||+++++++..   ......++||||
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~   81 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY   81 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence            4578999999999887521                 23467899999999999999999998753   346678999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee----CCCCCeEEeec
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDMTARVGDF  178 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~Df  178 (381)
                      +.+ +|.+++........ ......+++..+..++.|++.||.|||   +.+|+||||||+||++    +.++.+||+||
T Consensus        82 ~~~-~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          82 AEH-DLWHIIKFHRASKA-NKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eCC-cHHHHHHhhhcccc-CCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            865 88887742211100 022345889999999999999999999   6799999999999999    55678999999


Q ss_pred             ccceecCCCCCc-ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          179 GLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       179 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      |+++........ .......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            999876543221 11122458999999999876 4589999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=292.82  Aligned_cols=236  Identities=22%  Similarity=0.277  Sum_probs=190.8

Q ss_pred             hccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccC-CCcccceeeeecccccc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~   91 (381)
                      .....|..++.||+|.||.||.+..                    .....+.+|+.+|+++. |||||.++++     ++
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e  106 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FE  106 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EE
Confidence            3567799999999999999977542                    13468899999999998 9999999999     56


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-  170 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-  170 (381)
                      +....++|||+|.||.|.+.+..          . .+++..+..++.|++.++.|||   ..||+||||||+|+|+... 
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~----------~-~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~  172 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVK----------K-HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKD  172 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHH----------c-cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeecccc
Confidence            68899999999999999999942          2 3999999999999999999999   6799999999999999543 


Q ss_pred             ---CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          171 ---MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       171 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                         +.+|++|||++.........   ...+||+.|+|||++....|+..+||||+||++|.|++|.+||....    ...
T Consensus       173 ~~~~~ik~~DFGla~~~~~~~~~---~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~----~~~  245 (382)
T KOG0032|consen  173 EGSGRIKLIDFGLAKFIKPGERL---HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET----EFE  245 (382)
T ss_pred             CCCCcEEEeeCCCceEccCCceE---eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC----hhH
Confidence               47999999999988762222   23679999999999999999999999999999999999999975322    211


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...         .+........                ..........+.+++.+++..||.+|+|+.++++
T Consensus       246 ~~~---------~i~~~~~~f~----------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  246 IFL---------AILRGDFDFT----------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHH---------HHHcCCCCCC----------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            111         1111100000                0112355678888999999999999999999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=330.58  Aligned_cols=251  Identities=24%  Similarity=0.428  Sum_probs=193.8

Q ss_pred             ccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      ..|...++||+|+||.||++...             ......+|++.+++++|||||+++++|..     ....++||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeC
Confidence            34566789999999999987521             11223467999999999999999999753     5678999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +++|+|.++++             .+++..+..++.|++.||+|||...+.+|+||||||+||+++.++..++. ||...
T Consensus       765 ~~~g~L~~~l~-------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        765 IEGKNLSEVLR-------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             CCCCcHHHHHh-------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            99999999993             27888999999999999999997666799999999999999998888775 66554


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch-HHHH
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH-VKDI  261 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~  261 (381)
                      .....      ....+|+.|+|||++.+..++.++|||||||++|||++|+.||+...........+........ ....
T Consensus       831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (968)
T PLN00113        831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW  904 (968)
T ss_pred             ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe
Confidence            32211      1135789999999999999999999999999999999999999755555555555554433221 2223


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      +++.+....                .....+..++.+++.+||+.||++||||.+|++.|+++.+.
T Consensus       905 ~~~~~~~~~----------------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        905 IDPSIRGDV----------------SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             eCccccCCC----------------CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            332221111                11235566889999999999999999999999999988664

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=286.40  Aligned_cols=285  Identities=22%  Similarity=0.298  Sum_probs=225.0

Q ss_pred             CceEeEEccCCccccccccccccccchhhhhccccccccceecCCCceEEEecc------------cccHHHHHHHHHHH
Q 041757            3 SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRR------------QGAFKSFIAECKAL   70 (381)
Q Consensus         3 ~~~~~l~~~~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~------------~~~~~~~~~E~~~l   70 (381)
                      +|...|+.+....||+      .++.|....+.+.....+.||+|.||.||.++            ....+++.+|.++.
T Consensus       184 tl~Dll~~~~tSGSGS------GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIY  257 (513)
T KOG2052|consen  184 TLKDLLDDLETSGSGS------GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIY  257 (513)
T ss_pred             cHHHHHHhhccCCCCC------CchhHhHHhhhheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHH
Confidence            3444555566666666      78899999999999999999999999998765            34568899999999


Q ss_pred             Hc--cCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhh
Q 041757           71 RN--IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLH  148 (381)
Q Consensus        71 ~~--l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH  148 (381)
                      +.  |+|+||+.|++.-... -..-..+|||++|-+.|||.+||.           ...++....++++..+|.||+|||
T Consensus       258 qTvmLRHENILgFIaaD~~~-~gs~TQLwLvTdYHe~GSL~DyL~-----------r~tv~~~~ml~LalS~AsGLaHLH  325 (513)
T KOG2052|consen  258 QTVMLRHENILGFIAADNKD-NGSWTQLWLVTDYHEHGSLYDYLN-----------RNTVTTEGMLKLALSIASGLAHLH  325 (513)
T ss_pred             HHHHhccchhhhhhhccccC-CCceEEEEEeeecccCCcHHHHHh-----------hccCCHHHHHHHHHHHhhhHHHHH
Confidence            85  5899999999884321 133567899999999999999994           367899999999999999999999


Q ss_pred             c-----CCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCC--cccccCccCccceeCCCCcCCCc----c--Cc
Q 041757          149 H-----DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPEYGVGNE----V--ST  215 (381)
Q Consensus       149 ~-----~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~----~--~~  215 (381)
                      -     ..++.|.|||||..|||+.+++.+.|+|+|+|........  .......+||-+|||||++....    +  -.
T Consensus       326 ~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk  405 (513)
T KOG2052|consen  326 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYK  405 (513)
T ss_pred             HHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhh
Confidence            3     3367899999999999999999999999999987665421  22223467999999999987532    2  13


Q ss_pred             ccchhhhhHHHHHHHhC----------CCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhH
Q 041757          216 IGDVYSYGILLLELMIR----------EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAK  285 (381)
Q Consensus       216 ~sDiwSlG~il~el~tg----------~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  285 (381)
                      .+||||||.|+||+..+          +.||....+.+.+++.+.+......++-.+.....                  
T Consensus       406 ~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~------------------  467 (513)
T KOG2052|consen  406 RADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK------------------  467 (513)
T ss_pred             HHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc------------------
Confidence            57999999999999753          67898888888888877665443332222221111                  


Q ss_pred             HHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          286 INIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       286 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                         ..++...+.++|..||..+|..|-|+--+-+.|.++.+
T Consensus       468 ---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  468 ---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             ---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence               23677889999999999999999999999999998875

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2e-37  Score=280.60  Aligned_cols=239  Identities=22%  Similarity=0.356  Sum_probs=186.6

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...++||+|+||.||++..               ...+.+.+|+++++.++|+||+++++.+.     . ...+++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~~v   78 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIYII   78 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeEEE
Confidence            46789999999999999987541               13467889999999999999999998843     3 567999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++..        .....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+||+|||
T Consensus        79 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          79 TEFMAKGSLLDFLKS--------DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             EEeCCCCcHHHHHHh--------CCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCc
Confidence            999999999999953        12345788889999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      .+.......... .....++..|+|||++....++.++||||||+++|++++ |..||....    . .....       
T Consensus       148 ~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~-~~~~~-------  214 (260)
T cd05073         148 LARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----N-PEVIR-------  214 (260)
T ss_pred             ceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC----H-HHHHH-------
Confidence            997664432211 111335678999999988889999999999999999999 899975221    1 01000       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                        .+.....  .                ..+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       215 --~~~~~~~--~----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         215 --ALERGYR--M----------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --HHhCCCC--C----------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              0000000  0                0012345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-38  Score=296.79  Aligned_cols=231  Identities=20%  Similarity=0.350  Sum_probs=192.5

Q ss_pred             cccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           39 LEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +...+||+|+|=+||++-.                     ...++|..|+.+|+.|+|||||++|..+.+   ..+....
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d---~~n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD---TDNKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec---CCCceee
Confidence            3467899999999998742                     234789999999999999999999999775   3346788


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEEe
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARVG  176 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~  176 (381)
                      +|+|++..|+|..|+          ++.+.++...+..|++||++||.|||++ .++|||||||-+||+|++ .|.|||+
T Consensus       120 ~iTEL~TSGtLr~Y~----------kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  120 FITELFTSGTLREYR----------KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             eeeecccCCcHHHHH----------HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeec
Confidence            999999999999999          5677889999999999999999999998 889999999999999976 5799999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |+|+|..........    +.|||.|||||+.. ..|+..+||||||+.+.||+|+..||    ....+-..+.+...++
T Consensus       189 DLGLAtl~r~s~aks----vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY----sEC~n~AQIYKKV~SG  259 (632)
T KOG0584|consen  189 DLGLATLLRKSHAKS----VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY----SECTNPAQIYKKVTSG  259 (632)
T ss_pred             chhHHHHhhccccce----eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh----hhhCCHHHHHHHHHcC
Confidence            999998776544332    67999999999886 68999999999999999999999995    4556666666665555


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...+-+.+.                          --+++.+++.+|+.. .++|||+.|+|.
T Consensus       260 iKP~sl~kV--------------------------~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  260 IKPAALSKV--------------------------KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CCHHHhhcc--------------------------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            433333321                          123677888899999 999999999986

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-37  Score=285.86  Aligned_cols=254  Identities=21%  Similarity=0.187  Sum_probs=191.5

Q ss_pred             cccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeecc
Q 041757           25 KLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLG   87 (381)
Q Consensus        25 ~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~   87 (381)
                      .+.-.++.+.+++|...+.||+|+||.||++..                .....+.+|+.++.++ +||||+++++++..
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344455666789999999999999999987542                1235677899999999 79999999999765


Q ss_pred             ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           88 VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        88 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                      .+.......++||||+++++|.+++....      .....+++..++.++.|++.||.|||   ..+++||||||+||++
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili  161 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLL------ICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILL  161 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEE
Confidence            33334467899999999999999885321      23456889999999999999999999   6699999999999999


Q ss_pred             CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-----ccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-----EVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      +.++.+||+|||++...........  ...|+..|+|||++...     .++.++|||||||++|||++|+.||..... 
T Consensus       162 ~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-  238 (291)
T cd06639         162 TTEGGVKLVDFGVSAQLTSTRLRRN--TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-  238 (291)
T ss_pred             cCCCCEEEeecccchhccccccccc--CccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-
Confidence            9999999999999876554322211  24588999999987643     368899999999999999999999753211 


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         .......         ..    .....             ...+......+.+++.+||+.+|++||++.++++
T Consensus       239 ---~~~~~~~---------~~----~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         239 ---VKTLFKI---------PR----NPPPT-------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ---HHHHHHH---------hc----CCCCC-------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               1111100         00    00000             0001233456889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-37  Score=279.87  Aligned_cols=234  Identities=18%  Similarity=0.307  Sum_probs=185.3

Q ss_pred             cccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|+..++||.|+||.|+.++                   ....+.+.+|++++++++|+||+++++++     ......+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence            57888999999999875543                   12346788999999999999999999995     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      ++|||+++++|.+++..        .....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|
T Consensus        76 ~~~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d  144 (256)
T cd08221          76 IEMEYANGGTLYDKIVR--------QKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGD  144 (256)
T ss_pred             EEEEecCCCcHHHHHHh--------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECc
Confidence            99999999999999953        12456889999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++.........  .....+++.|+|||++.+..++.++||||||+++|+|++|..||...    .. .          
T Consensus       145 ~~~~~~~~~~~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~-~----------  207 (256)
T cd08221         145 FGISKILGSEYSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT----NP-L----------  207 (256)
T ss_pred             CcceEEccccccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC----CH-H----------
Confidence            9999876544321  12245899999999998888899999999999999999999997521    11 1          


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                        +...........               ......+..+.+++.+||+.+|.+||++.++++.
T Consensus       208 --~~~~~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         208 --NLVVKIVQGNYT---------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             --HHHHHHHcCCCC---------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence              111111111000               0012345678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.5e-38  Score=285.92  Aligned_cols=256  Identities=23%  Similarity=0.341  Sum_probs=191.1

Q ss_pred             ccccccceecCCCceEEEeccc--------------------c--cHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------G--AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      +.|...+.||+|+||.||++..                    .  ..+.|.+|+++++.++|+||+++++++..   ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            5677789999999999987641                    1  25678999999999999999999998642   336


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++++|.+++..         ....+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~---------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~  148 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQR---------HRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLV  148 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHh---------CccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCE
Confidence            678999999999999999952         2336899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|+|||.+......... .......++..|+|||.+.+..++.++||||||+++|||++|..||................
T Consensus       149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  228 (284)
T cd05038         149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG  228 (284)
T ss_pred             EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc
Confidence            99999999877633221 11111235667999999988889999999999999999999999975322211000000000


Q ss_pred             -HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          253 -ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       253 -~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                       .....+.+.+......                  ..+..++.++.+++.+||+.+|.+|||+.+|+++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         229 QMIVTRLLELLKEGERL------------------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cccHHHHHHHHHcCCcC------------------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence             0000011111110000                  00124557899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.4e-38  Score=289.86  Aligned_cols=238  Identities=19%  Similarity=0.231  Sum_probs=186.7

Q ss_pred             hhhccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           31 ILDVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        31 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      +.+...+|...+.||.|+||.||++..                 ...+.+.+|+.+++.++|+||+++++.+.     ..
T Consensus        15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~   89 (296)
T cd06654          15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VG   89 (296)
T ss_pred             cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eC
Confidence            344567899999999999999987641                 23467889999999999999999999854     46


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++++|.+++.           ...+++.++..++.|++.||.|||   ..+|+||||||+||+++.++.+
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~  155 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV  155 (296)
T ss_pred             CEEEEeecccCCCCHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCE
Confidence            78999999999999999984           234788899999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      +|+|||++..........  ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.....    ...+....
T Consensus       156 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~~~  229 (296)
T cd06654         156 KLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIA  229 (296)
T ss_pred             EECccccchhcccccccc--CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHHHh
Confidence            999999987654332211  123588999999999888899999999999999999999999852211    11110000


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                  ....+.              ...+...+..+.+++.+||..||++|||+.+++.
T Consensus       230 ------------~~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         230 ------------TNGTPE--------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ------------cCCCCC--------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                        000000              0001234567888999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-37  Score=286.00  Aligned_cols=234  Identities=23%  Similarity=0.278  Sum_probs=179.4

Q ss_pred             ccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      |...++||+|+||+||++..                    .....+.+|+++|++++|+||+.+++.+     ...+..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            56678899999999977542                    1123467899999999999999999884     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|
T Consensus        77 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~D  145 (285)
T cd05632          77 LVLTIMNGGDLKFHIYN--------MGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEEeccCccHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEec
Confidence            99999999999988852        22346899999999999999999999   77999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++.........   ....|+..|+|||++.+..++.++||||||+++|++++|..||....... ....         
T Consensus       146 fg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~---------  212 (285)
T cd05632         146 LGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE---------  212 (285)
T ss_pred             CCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH---------
Confidence            9998765433221   12458999999999988889999999999999999999999985221100 0000         


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                          +.........               ......+..+.+++.+||+.||++||+     +.+++.
T Consensus       213 ----~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         213 ----VDRRVLETEE---------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ----HHHhhhcccc---------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                0000000000               001234556788999999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-37  Score=306.37  Aligned_cols=261  Identities=18%  Similarity=0.159  Sum_probs=180.9

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------------------ccHHHHHHHHHHHHccCCCccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------------------GAFKSFIAECKALRNIRHRNLI   79 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------------------~~~~~~~~E~~~l~~l~h~nIv   79 (381)
                      .++|.+.++||+|+||+||++..                                   .....+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            46899999999999999996421                                   1234577899999999999999


Q ss_pred             ceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeec
Q 041757           80 KVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV  159 (381)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrD  159 (381)
                      ++++++     ...+..++|+|++. ++|.+++.....     ..........+..++.|++.||.|||   +.+|||||
T Consensus       227 ~l~~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrD  292 (501)
T PHA03210        227 KIEEIL-----RSEANTYMITQKYD-FDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRD  292 (501)
T ss_pred             cEeEEE-----EECCeeEEEEeccc-cCHHHHHhhccc-----cccccccHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            999995     44678899999995 578887742211     11223345677889999999999999   67999999


Q ss_pred             cCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcc
Q 041757          160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM  239 (381)
Q Consensus       160 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~  239 (381)
                      |||+|||++.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..++...
T Consensus       293 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~  371 (501)
T PHA03210        293 IKLENIFLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD  371 (501)
T ss_pred             CCHHHEEECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence            99999999999999999999998765433222 12256999999999999999999999999999999999987653211


Q ss_pred             ccCCCcHHHHHHHHh---------hchHHHHHhhhhccCchhhhhcccchhhhhHHHHH--HHHHHHHHHHHHhccCCCC
Q 041757          240 FEGDMNLHKFAKMAL---------SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINII--RECVISMVRIGVACSMESP  308 (381)
Q Consensus       240 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP  308 (381)
                      ... .....+.....         ......+.+........        ..........  ...+.++.+++.+|++.||
T Consensus       372 ~~~-~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP  442 (501)
T PHA03210        372 GGG-KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEID--------HAGHSVPPLIRNLGLPADFEYPLVKMLTFDW  442 (501)
T ss_pred             CCC-CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcc--------cCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence            111 11111111110         00001111100000000        0000000000  1234567788999999999


Q ss_pred             CCCCCHHHHHH
Q 041757          309 QDRMKMTNVVH  319 (381)
Q Consensus       309 ~~RPs~~~vl~  319 (381)
                      .+|||+.|++.
T Consensus       443 ~~Rpsa~elL~  453 (501)
T PHA03210        443 HLRPGAAELLA  453 (501)
T ss_pred             ccCcCHHHHhh
Confidence            99999999986

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-38  Score=300.32  Aligned_cols=184  Identities=23%  Similarity=0.316  Sum_probs=157.1

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||.||++..                    .....+.+|+.++.+++||||+++++.     +.+...
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-----~~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-----FQDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence            4688899999999999987542                    123567789999999999999999998     455788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|||||++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL  142 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLM----------KKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKL  142 (360)
T ss_pred             EEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEE
Confidence            999999999999999993          4566899999999999999999999   779999999999999999999999


Q ss_pred             eecccceecCCCCCc---------------------------------ccccCccCccceeCCCCcCCCccCcccchhhh
Q 041757          176 GDFGLARFLPPTRTQ---------------------------------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSY  222 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSl  222 (381)
                      +|||++.........                                 ......+||+.|+|||++.+..++.++|||||
T Consensus       143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl  222 (360)
T cd05627         143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL  222 (360)
T ss_pred             eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence            999998754321100                                 00112469999999999999999999999999


Q ss_pred             hHHHHHHHhCCCCCC
Q 041757          223 GILLLELMIREKPSD  237 (381)
Q Consensus       223 G~il~el~tg~~Pf~  237 (381)
                      ||++|||++|..||.
T Consensus       223 Gvilyel~tG~~Pf~  237 (360)
T cd05627         223 GVIMYEMLIGYPPFC  237 (360)
T ss_pred             cceeeecccCCCCCC
Confidence            999999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-37  Score=284.09  Aligned_cols=235  Identities=22%  Similarity=0.295  Sum_probs=180.7

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...++||+|+||.||++..                  ...+.+.+|++++++++||||+++++.+.     ..+..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEE
Confidence            3577889999999999987641                  12356889999999999999999999964     367789


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|..+.              .+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|
T Consensus        76 lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~d  138 (279)
T cd06619          76 ICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCD  138 (279)
T ss_pred             EEEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEee
Confidence            999999999996543              3567788899999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++.........    ...|+..|+|||++.+..++.++||||||+++|+|++|+.||............         
T Consensus       139 fg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------  205 (279)
T cd06619         139 FGVSTQLVNSIAK----TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------  205 (279)
T ss_pred             CCcceeccccccc----CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------
Confidence            9999765433221    246899999999999889999999999999999999999998643322211100         


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                       ...........+...              .......++.+++.+||+.||++||++.++++.
T Consensus       206 -~~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         206 -LQLLQCIVDEDPPVL--------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -HHHHHHHhccCCCCC--------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             000111000000000              001234568899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.7e-38  Score=285.09  Aligned_cols=238  Identities=18%  Similarity=0.224  Sum_probs=182.6

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++|...++||+|+||.||.+..                 .....+.+|+.+++.++||||+++++.+     ...+..
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~   81 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKL   81 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEE
Confidence            356899999999999999987642                 1234577899999999999999999985     447788


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++++|.+++.          ....+++.+++.++.|++.||.|||   ..+++|+||||+||+++.++.++|+
T Consensus        82 ~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~  148 (267)
T cd06645          82 WICMEFCGGGSLQDIYH----------VTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLA  148 (267)
T ss_pred             EEEEeccCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEC
Confidence            99999999999999983          4457899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |||++.........  .....|+..|+|||++.   ...++.++|||||||++|+|++|..||......    .......
T Consensus       149 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~----~~~~~~~  222 (267)
T cd06645         149 DFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RALFLMT  222 (267)
T ss_pred             cceeeeEccCcccc--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch----hhHHhhh
Confidence            99998765433221  12245899999999874   455889999999999999999999997422111    0000000


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                               .........               ......+..+.+++.+||..+|++|||+.+|++
T Consensus       223 ---------~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         223 ---------KSNFQPPKL---------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ---------ccCCCCCcc---------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                     000000000               000123446788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-37  Score=283.80  Aligned_cols=246  Identities=20%  Similarity=0.335  Sum_probs=186.7

Q ss_pred             ccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .+|...+.||+|+||.||+++.                       ...+.+.+|++++++++|+||+++++++     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            5788889999999999987651                       0245789999999999999999999985     44


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+++|+|.+++........ ......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDE-KLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccc-cccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCc
Confidence            6778999999999999999953221000 011236899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      ++++|||++.......... .....++..|+|||.+.+..++.++||||||+++|++++ |..||.....     ..+..
T Consensus       156 ~~l~~~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~~~~  229 (275)
T cd05046         156 VKVSLLSLSKDVYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EEVLN  229 (275)
T ss_pred             EEEcccccccccCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HHHHH
Confidence            9999999987543322211 112346778999999988888999999999999999998 7888742211     11111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      ....        .....                  .....++..+.+++.+||+.+|.+|||+.+++..|.
T Consensus       230 ~~~~--------~~~~~------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 RLQA--------GKLEL------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHc--------CCcCC------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            0000        00000                  001234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-37  Score=279.69  Aligned_cols=233  Identities=23%  Similarity=0.332  Sum_probs=181.4

Q ss_pred             ceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||.||++..                     ...+.+.+|+.++++++||||+++++.+.     . ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence            4689999999987531                     23567889999999999999999999853     3 6789999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++++|.+++...        ....+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||+
T Consensus        75 e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~  143 (257)
T cd05040          75 ELAPLGSLLDRLRKD--------ALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGL  143 (257)
T ss_pred             EecCCCcHHHHHHhc--------ccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccc
Confidence            999999999999531        1146899999999999999999999   67999999999999999999999999999


Q ss_pred             ceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          181 ARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       181 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.....     ......      
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~------  212 (257)
T cd05040         144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----SQILKK------  212 (257)
T ss_pred             cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH------
Confidence            9876543221 11112447789999999988889999999999999999998 9999752211     111110      


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                        + ...... .                ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       213 --~-~~~~~~-~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         213 --I-DKEGER-L----------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --H-HhcCCc-C----------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              0 000000 0                001234567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-37  Score=285.12  Aligned_cols=234  Identities=20%  Similarity=0.250  Sum_probs=180.3

Q ss_pred             cccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .|...+.||.|+||.||++..                 ...+.+.+|+++++.++||||+++++.+.     ..+..++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence            367788999999999977541                 23567889999999999999999999964     36788999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|..++.         .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||
T Consensus        81 ~e~~~~~~l~~~~~---------~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          81 IEFCAGGAVDAVML---------ELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             EEecCCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccc
Confidence            99999999999874         23456899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      ++..........  ....++..|+|||++.     +..++.++|||||||++|||++|+.||....    ........  
T Consensus       149 ~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~~--  220 (282)
T cd06643         149 VSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN----PMRVLLKI--  220 (282)
T ss_pred             cccccccccccc--ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC----HHHHHHHH--
Confidence            987654322211  1245899999999874     3457889999999999999999999975221    11111100  


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                 ....+..             ...+...+..+.+++.+||+.||.+||++.++++
T Consensus       221 -----------~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         221 -----------AKSEPPT-------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -----------hhcCCCC-------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                       0000000             0001234567889999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-37  Score=281.83  Aligned_cols=241  Identities=20%  Similarity=0.261  Sum_probs=182.7

Q ss_pred             hhhhccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           30 EILDVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      +....++++....+||+|+||.||++..                 ...+.+.+|+.+++.++|+||+++++++.     .
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~   76 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----E   76 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----c
Confidence            3445567777778999999999987641                 13457889999999999999999999954     4


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcc--cHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-  169 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-  169 (381)
                      .+..++|+||+++++|.+++..         ....+  ++..+..++.|++.||+|||   ..+|+||||||+||+++. 
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~  144 (268)
T cd06624          77 NGFFKIFMEQVPGGSLSALLRS---------KWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTY  144 (268)
T ss_pred             CCEEEEEEecCCCCCHHHHHHH---------hcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCC
Confidence            6789999999999999999852         22334  77888899999999999999   669999999999999976 


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc--cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE--VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      ++.++|+|||.+..........  ....++..|+|||++....  ++.++||||||+++|+|++|..||.......   .
T Consensus       145 ~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~  219 (268)
T cd06624         145 SGVVKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---A  219 (268)
T ss_pred             CCeEEEecchhheecccCCCcc--ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---h
Confidence            6789999999987654322211  1234789999999986643  7899999999999999999999975221100   0


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .....           ......+                ..+......+.+++.+||+.+|.+|||+.+++.
T Consensus       220 ~~~~~-----------~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         220 AMFKV-----------GMFKIHP----------------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hHhhh-----------hhhccCC----------------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00000           0000000                012245567889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-37  Score=288.40  Aligned_cols=261  Identities=19%  Similarity=0.235  Sum_probs=183.1

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...++||.|+||.||++..                  .....+.+|+.+++.++||||+++++++     ......+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeEE
Confidence            5688899999999999987642                  1234678899999999999999999995     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+. ++|.+++.         .....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|
T Consensus        81 lv~e~~~-~~l~~~l~---------~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d  147 (301)
T cd07873          81 LVFEYLD-KDLKQYLD---------DCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLAD  147 (301)
T ss_pred             EEEeccc-cCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECc
Confidence            9999997 59998885         23446788999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||++..........  ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......  ............
T Consensus       148 fg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~  223 (301)
T cd07873         148 FGLARAKSIPTKTY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGT  223 (301)
T ss_pred             CcchhccCCCCCcc--cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCC
Confidence            99987654332211  12347889999998765 45788999999999999999999998532110  001111111111


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .........+...... ...................+..+.+++.+|++.||.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         224 PTEETWPGILSNEEFK-SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CChhhchhhhcccccc-ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1111111111000000 0000000000001111234557889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=286.74  Aligned_cols=247  Identities=19%  Similarity=0.185  Sum_probs=176.5

Q ss_pred             cccccccceecCCCceEEEecccccH-------------------------------HHHHHHHHHHHccCCCcccceee
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQGAF-------------------------------KSFIAECKALRNIRHRNLIKVLT   83 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~~~-------------------------------~~~~~E~~~l~~l~h~nIv~~~~   83 (381)
                      .+.|.+.++||+|+||+||++.....                               .....+...+..+.|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46899999999999999988652110                               11122334456678999999998


Q ss_pred             eeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757           84 ACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS  163 (381)
Q Consensus        84 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~  163 (381)
                      ++... .......++++|++.. ++.+.+.          .....++..+..++.|++.||.|||   +.+|+||||||+
T Consensus        91 ~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~  155 (294)
T PHA02882         91 CGSFK-RCRMYYRFILLEKLVE-NTKEIFK----------RIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPE  155 (294)
T ss_pred             eeeEe-cCCceEEEEEEehhcc-CHHHHHH----------hhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence            75421 1112355788888744 6766663          2233567788999999999999999   679999999999


Q ss_pred             CeeeCCCCCeEEeecccceecCCCCCc-----ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          164 NVLLDDDMTARVGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       164 Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      |||++.++.++|+|||+++........     .......||+.|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus       156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            999999999999999999876432211     111124699999999999999999999999999999999999999864


Q ss_pred             cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757          239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV  318 (381)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  318 (381)
                      .......... ..       .+++........                 ....++..+.+++..||..+|++||++.+++
T Consensus       236 ~~~~~~~~~~-~~-------~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~  290 (294)
T PHA02882        236 FGHNGNLIHA-AK-------CDFIKRLHEGKI-----------------KIKNANKFIYDFIECVTKLSYEEKPDYDALI  290 (294)
T ss_pred             cccchHHHHH-hH-------HHHHHHhhhhhh-----------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence            3221111111 00       111111111000                 0124567899999999999999999999999


Q ss_pred             HHH
Q 041757          319 HEL  321 (381)
Q Consensus       319 ~~L  321 (381)
                      +.|
T Consensus       291 ~~~  293 (294)
T PHA02882        291 KIF  293 (294)
T ss_pred             Hhh
Confidence            876

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.6e-37  Score=280.96  Aligned_cols=238  Identities=26%  Similarity=0.394  Sum_probs=181.6

Q ss_pred             ceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           42 NLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +.||+|+||.||+++.                        .....+.+|+.+++.++||||+++++++.     .....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence            4699999999986541                        13456788999999999999999999954     466789


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-----C
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-----T  172 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-----~  172 (381)
                      +||||+++++|.+++.......   .....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++     .
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~  149 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRV  149 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcc
Confidence            9999999999999996422110   02345788999999999999999999   67999999999999999877     8


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      ++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...    .... ...
T Consensus       150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~----~~~~-~~~  224 (269)
T cd05044         150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL----NNQE-VLQ  224 (269)
T ss_pred             eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc----CHHH-HHH
Confidence            99999999976544322222222345788999999998899999999999999999998 99997522    1111 000


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      .         +....                  ....+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       225 ~---------~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         225 H---------VTAGG------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             H---------HhcCC------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            0         00000                  00012245667899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.1e-37  Score=285.27  Aligned_cols=237  Identities=20%  Similarity=0.241  Sum_probs=182.8

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++|.+.++||.|+||.||+++.                 ...+.+.+|+.+++.++||||+++++.+.     .....
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   84 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKL   84 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeE
Confidence            457899999999999999987642                 23467888999999999999999999854     46789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++++|..++.         .....+++..+..++.|++.||.|||   ..+++||||||+||+++.++.++|+
T Consensus        85 ~lv~e~~~~~~l~~~~~---------~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~  152 (292)
T cd06644          85 WIMIEFCPGGAVDAIML---------ELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLA  152 (292)
T ss_pred             EEEEecCCCCcHHHHHH---------hhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEc
Confidence            99999999999998874         23456899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      |||++..........  ....++..|+|||++.     ...++.++|||||||++|+|++|..||....    .......
T Consensus       153 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~  226 (292)
T cd06644         153 DFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLK  226 (292)
T ss_pred             cCccceecccccccc--ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc----HHHHHHH
Confidence            999987543322111  1245788999999875     3456889999999999999999999975221    1111000


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                   ........             ...+...+.++.+++.+||+.||++||++.++++
T Consensus       227 -------------~~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         227 -------------IAKSEPPT-------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -------------HhcCCCcc-------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                         00000000             0001234457888999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.3e-37  Score=279.05  Aligned_cols=234  Identities=24%  Similarity=0.390  Sum_probs=183.6

Q ss_pred             ccccccceecCCCceEEEeccc-------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      ++|...+.||+|+||.||.+..             ...+.+.+|+.+++.++||||+++++++.      .+..++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL------HNGLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEc------CCCcEEEEEC
Confidence            5688899999999999977541             23457889999999999999999999853      2346899999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +++++|.+++..        .....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        80 ~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          80 MSKGNLVNFLRT--------RGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             CCCCCHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccce
Confidence            999999999953        12345788999999999999999999   6699999999999999999999999999987


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      ........     ...+..|+|||++.+..++.++||||||+++|+|++ |..||....     .....         ..
T Consensus       149 ~~~~~~~~-----~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~---------~~  209 (254)
T cd05083         149 VGSMGVDN-----SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVK---------EC  209 (254)
T ss_pred             eccccCCC-----CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHH---------HH
Confidence            65432111     234678999999988889999999999999999998 999975221     11111         11


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                      +.......+                  +..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus       210 ~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         210 VEKGYRMEP------------------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HhCCCCCCC------------------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            111000000                  12345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-37  Score=285.46  Aligned_cols=245  Identities=20%  Similarity=0.261  Sum_probs=188.1

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|+..++||+|+||+||++..                  ...+.+.+|+++++.++||||+++++.+.     .....+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            5788889999999999987541                  23467889999999999999999999954     467899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++.          ....+++..+..++.+++.||.|||+  ..+++||||+|+||+++.++.++|+|
T Consensus        80 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d  147 (284)
T cd06620          80 MCMEFMDCGSLDRIYK----------KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCD  147 (284)
T ss_pred             EEEecCCCCCHHHHHH----------hccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEcc
Confidence            9999999999999983          34568899999999999999999994  24899999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++.........    ...|+..|+|||++.+..++.++|||||||++|++++|..||.........  .    .....
T Consensus       148 ~gl~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~--~----~~~~~  217 (284)
T cd06620         148 FGVSGELINSIAD----TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG--Q----DDPMG  217 (284)
T ss_pred             CCcccchhhhccC----ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh--h----hhhhH
Confidence            9998654322211    245899999999998888999999999999999999999998744322110  0    00001


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      +.+.+...+...+..              ......+..+.+++.+||+.||++|||+.++++..
T Consensus       218 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         218 ILDLLQQIVQEPPPR--------------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHHHHHHHhhccCCC--------------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            112222221111100              00112556788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-37  Score=303.46  Aligned_cols=182  Identities=20%  Similarity=0.269  Sum_probs=148.0

Q ss_pred             ccccccccceecCCCceEEEecccc----------------cHHHHHHHHHHHHccCCC------cccceeeeecccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG----------------AFKSFIAECKALRNIRHR------NLIKVLTACLGVDYQ   91 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~----------------~~~~~~~E~~~l~~l~h~------nIv~~~~~~~~~~~~   91 (381)
                      ..++|.+.++||+|+||+||++...                ....+..|++++..++|.      +++++++++.    .
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~----~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ----N  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE----c
Confidence            3578999999999999999887421                123456788888887654      4788887753    2


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      ...+.++|||++ +++|.+++.          ....+++..+..++.||+.||.|||+.  .+||||||||+|||++.++
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIM----------KHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSD  269 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCC
Confidence            346789999998 779999883          445789999999999999999999931  4999999999999998665


Q ss_pred             ----------------CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCC
Q 041757          172 ----------------TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP  235 (381)
Q Consensus       172 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~P  235 (381)
                                      .+||+|||.+......     ....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence                            4999999987543221     1235699999999999999999999999999999999999999


Q ss_pred             CC
Q 041757          236 SD  237 (381)
Q Consensus       236 f~  237 (381)
                      |.
T Consensus       345 f~  346 (467)
T PTZ00284        345 YD  346 (467)
T ss_pred             CC
Confidence            85

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=280.25  Aligned_cols=240  Identities=23%  Similarity=0.395  Sum_probs=188.2

Q ss_pred             cccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|.+.++||.|+||.||++.               ....+.+.+|+.++++++|+||+++++++     ......++|
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v   79 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIYIV   79 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceEEE
Confidence            5788999999999999998753               12346789999999999999999999984     446778999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++..        .....+++..+..++.|++.|+.|||   ..+++|+||||+||+++.++.+||+|||
T Consensus        80 ~e~~~~~~L~~~i~~--------~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          80 TEYMSKGSLLDFLKS--------GEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             EeccCCCCHHHHHhc--------cccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccc
Confidence            999999999999953        22346889999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++........... ....++..|+|||.+.+..++.++||||||+++|++++ |+.||...    ... ....       
T Consensus       149 ~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~----~~~-~~~~-------  215 (261)
T cd05034         149 LARLIEDDEYTAR-EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNR-EVLE-------  215 (261)
T ss_pred             cceeccchhhhhh-hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC----CHH-HHHH-------
Confidence            9987654221111 11235678999999988889999999999999999998 99997422    110 1000       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                       .+........                   +...+..+.+++.+||..+|.+||++.++.+.|+.
T Consensus       216 -~~~~~~~~~~-------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         216 -QVERGYRMPR-------------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -HHHcCCCCCC-------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             0000000000                   12335678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=292.38  Aligned_cols=184  Identities=25%  Similarity=0.253  Sum_probs=155.4

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||.||+++.                    ...+.+.+|+.++..++|+||+++++++     .+.++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            4788999999999999987542                    1234578899999999999999999984     45788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++.         .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl  143 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLS---------KFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRL  143 (331)
T ss_pred             EEEEEecCCCCcHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEE
Confidence            999999999999999994         22456889999999999999999999   779999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +|||++........... ....||+.|+|||++..     ..++.++|||||||++|+|++|+.||.
T Consensus       144 ~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         144 ADFGSCLRLLADGTVQS-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             EECCceeecCCCCCccc-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence            99999876654332211 11358999999999863     457889999999999999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=291.10  Aligned_cols=275  Identities=19%  Similarity=0.231  Sum_probs=190.8

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      +.++|...++||+|+||.||.+..                  .....+.+|+.++++++|+||+++++++...++.....
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            568899999999999999987631                  13356788999999999999999999876544445567


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|+||+.+ +|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        83 ~~lv~e~~~~-~l~~~~~-----------~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl  147 (336)
T cd07849          83 VYIVQELMET-DLYKLIK-----------TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKI  147 (336)
T ss_pred             EEEEehhccc-CHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEE
Confidence            8999999964 8888773           346889999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcc-cccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          176 GDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      +|||++.......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....  ..........
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~  225 (336)
T cd07849         148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGV  225 (336)
T ss_pred             CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence            9999998764432211 1122458899999998654 5688999999999999999999999752110  0000001111


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhh
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSIK  325 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~i~  325 (381)
                      ......+.............................+....++.+++.+||+.||++|||+.++++.  ++...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            1111111111111100000000000000000011122345678999999999999999999999985  54443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-38  Score=287.27  Aligned_cols=233  Identities=20%  Similarity=0.325  Sum_probs=191.8

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +.+=|..++.||+|.|+.|.+++.                   .....+++|++.|+-++|||||++|.+     ..+..
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQT   90 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQT   90 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccc
Confidence            455688889999999999977652                   234678899999999999999999999     66788


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee-CCCCCe
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL-DDDMTA  173 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill-~~~~~~  173 (381)
                      .+|||+|+-.+|+|.+||-         +....+.+..+..++.||..|+.|+|   +..+|||||||+|+++ ..-|.+
T Consensus        91 KlyLiLELGD~GDl~DyIm---------KHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlV  158 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIM---------KHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLV  158 (864)
T ss_pred             eEEEEEEecCCchHHHHHH---------hhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCce
Confidence            8999999999999999996         56678999999999999999999999   7899999999999977 456899


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccC-cccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVS-TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||.|||++-.+........   .+|+..|.|||++.+..|+ +++||||||||||-|++|+.||....+.+.        
T Consensus       159 KLTDFGFSNkf~PG~kL~T---sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------  227 (864)
T KOG4717|consen  159 KLTDFGFSNKFQPGKKLTT---SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------  227 (864)
T ss_pred             EeeeccccccCCCcchhhc---ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------
Confidence            9999999977665544333   6799999999999999986 678999999999999999999874433221        


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           +.-++|.    .+.                .+.....++.+|+.+||..||.+|.+.++|..
T Consensus       228 -----LTmImDC----KYt----------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  228 -----LTMIMDC----KYT----------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -----hhhhhcc----ccc----------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                 1112221    111                13466778889999999999999999998875

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=298.54  Aligned_cols=229  Identities=24%  Similarity=0.318  Sum_probs=182.4

Q ss_pred             ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .-|...+.||.|+||.||.++                    ....+.+++|+++|++++|||+|.+-|+|.     .+..
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~T  100 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHT  100 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccch
Confidence            447788999999999998875                    235678899999999999999999999954     4777


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .|||||||- |+-.+++.         ....++.+.++..|+.+.+.||+|||   +.+.||||||..|||+++.|.|||
T Consensus       101 aWLVMEYCl-GSAsDlle---------VhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKL  167 (948)
T KOG0577|consen  101 AWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKL  167 (948)
T ss_pred             HHHHHHHHh-ccHHHHHH---------HHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeee
Confidence            899999995 58888886         34677999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|||.|..+....      +++|||.|||||++..   +.|+.++||||||+++.||..+++|.-++..    +..+...
T Consensus       168 aDFGSAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALYHI  237 (948)
T KOG0577|consen  168 ADFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHI  237 (948)
T ss_pred             ccccchhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHHHH
Confidence            9999987654322      3789999999998764   5799999999999999999999999532211    1111100


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .-.            ..|.-               ...+....+..++..||+.-|.+|||..+++.
T Consensus       238 AQN------------esPtL---------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  238 AQN------------ESPTL---------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             Hhc------------CCCCC---------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            000            00000               01255667788888999999999999988765

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=278.39  Aligned_cols=238  Identities=21%  Similarity=0.271  Sum_probs=185.7

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .++|...+.||.|+||.||++..                 ...+.+.+|+.++++++||||+++++++     ......+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   76 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLW   76 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEE
Confidence            46889999999999999987642                 1356789999999999999999999984     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      ++|||+++++|.+++..         ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|
T Consensus        77 l~~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d  144 (262)
T cd06613          77 IVMEYCGGGSLQDIYQV---------TRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLAD  144 (262)
T ss_pred             EEEeCCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECc
Confidence            99999999999999842         2256889999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCC---ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN---EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      ||++..........  ....++..|+|||.+.+.   .++.++||||||+++|+|++|+.||....    ........  
T Consensus       145 ~g~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~----~~~~~~~~--  216 (262)
T cd06613         145 FGVSAQLTATIAKR--KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH----PMRALFLI--  216 (262)
T ss_pred             cccchhhhhhhhcc--ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH--
Confidence            99987654432111  124578899999998776   78999999999999999999999975221    11110000  


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                             .....  .+..             .......+.++.+++.+||..+|.+|||+.+|+.
T Consensus       217 -------~~~~~--~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         217 -------SKSNF--PPPK-------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -------HhccC--CCcc-------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   00000  0000             0001244567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.8e-37  Score=277.23  Aligned_cols=234  Identities=19%  Similarity=0.279  Sum_probs=183.5

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||.|+||.||++..                   ...+.+.+|++++++++|+|++++++.+.    ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            478889999999999976541                   12356788999999999999999998742    2345689


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++..        .....+++.++..++.|++.|+.+||   +.+++|+||||+||+++.++.++|+|
T Consensus        77 lv~e~~~~~~l~~~l~~--------~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~d  145 (257)
T cd08223          77 IVMGFCEGGDLYHKLKE--------QKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGD  145 (257)
T ss_pred             EEecccCCCcHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEec
Confidence            99999999999999953        22345899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++.........  .....+++.|+|||++.+..++.++||||||+++|++++|+.||...     ........     
T Consensus       146 f~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~-----  213 (257)
T cd08223         146 LGIARVLENQCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYR-----  213 (257)
T ss_pred             ccceEEecccCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHH-----
Confidence            9999876443221  11245889999999999988999999999999999999999997521     11111111     


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         +....+.                   ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       214 ---~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         214 ---IIEGKLP-------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ---HHhcCCC-------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               1110000                   001245567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-37  Score=280.72  Aligned_cols=233  Identities=20%  Similarity=0.309  Sum_probs=182.8

Q ss_pred             cccccceecCCCceEEEecccc--------------------------cHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           37 NMLEENLISAGTFGFSHLRRQG--------------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~--------------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      .|..+..||.|+||.||.+...                          ..+.+.+|+.++++++||||+++++++     
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS-----   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence            3667889999999999876411                          124678899999999999999999995     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ......++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++||||+|+||+++.+
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~  142 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLN----------NYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNK  142 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHH----------hccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCC
Confidence            44678899999999999999993          4456888899999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcc----cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          171 MTARVGDFGLARFLPPTRTQT----SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                      +.++|+|||.++.........    ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...    ...
T Consensus       143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~  218 (267)
T cd06628         143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC----TQL  218 (267)
T ss_pred             CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc----cHH
Confidence            999999999998765322111    111235788999999998888999999999999999999999998522    111


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ....         .....   ..+                ..+...+..+.+++.+||+.||.+||++.++++
T Consensus       219 ~~~~---------~~~~~---~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         219 QAIF---------KIGEN---ASP----------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHH---------HHhcc---CCC----------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            1110         00000   000                011245567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.6e-37  Score=282.46  Aligned_cols=259  Identities=21%  Similarity=0.272  Sum_probs=184.7

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...+.||+|+||.||++..                   ...+.+.+|+.++++++|+||+++++++     ......
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            4688889999999999988642                   1234578999999999999999999995     447788


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++++|..++          .....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.++|+
T Consensus        76 ~~v~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~  142 (286)
T cd07847          76 HLVFEYCDHTVLNELE----------KNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLC  142 (286)
T ss_pred             EEEEeccCccHHHHHH----------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEEC
Confidence            9999999999888877          34456899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |||++..........  ....++..|+|||++.+ ..++.++||||||+++|+|++|..||......+ ....... ...
T Consensus       143 dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~-~~~  218 (286)
T cd07847         143 DFGFARILTGPGDDY--TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRK-TLG  218 (286)
T ss_pred             ccccceecCCCcccc--cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhC
Confidence            999998765543211  12347889999998876 457899999999999999999999985322111 0111110 000


Q ss_pred             ch---HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NH---VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..   ..+..+..   ........................+..+.+++.+||+.||++|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         219 DLIPRHQQIFSTN---QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCChHHhhhcccc---cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00   00000000   000000000000000001112234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.7e-38  Score=297.68  Aligned_cols=258  Identities=23%  Similarity=0.301  Sum_probs=188.6

Q ss_pred             ccccccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccC-C-----CcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIR-H-----RNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~~~~~~~~~~~   93 (381)
                      ..|.+.++||+|+||.|-++.                .....+-..|+.+|..|+ |     -|+|+++++     +...
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr  260 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR  260 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence            368889999999999995443                123345566999999997 4     389999999     4558


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC--
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM--  171 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~--  171 (381)
                      ++.|||+|.+.. +|.++++.        ++...++...++.++.||+.||.+||   +.+|||+||||+|||+...+  
T Consensus       261 ~HlciVfELL~~-NLYellK~--------n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKN--------NKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcC
Confidence            999999999954 99999975        45667999999999999999999999   67999999999999996543  


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      .+||+|||.|.........     +..+..|+|||++.+.+|+.+.||||||||++||++|.+.    |.++.....+..
T Consensus       329 ~vKVIDFGSSc~~~q~vyt-----YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL----fpG~ne~DQl~~  399 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQRVYT-----YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL----FPGDNEYDQLAR  399 (586)
T ss_pred             ceeEEecccccccCCccee-----eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc----cCCCCHHHHHHH
Confidence            7999999999887665542     5578999999999999999999999999999999999776    556655555444


Q ss_pred             HHh--hch----------HHHHHhhh-------hccCc-------hhhh----hcccchhh----hhHHHHHHHHHHHHH
Q 041757          252 MAL--SNH----------VKDIVDSI-------LLNDD-------EKLV----VRGDQKQT----QAKINIIRECVISMV  297 (381)
Q Consensus       252 ~~~--~~~----------~~~~~~~~-------l~~~~-------~~~~----~~~~~~~~----~~~~~~~~~~~~~l~  297 (381)
                      ..-  ...          ...++++.       ...+.       ....    .......+    ..........-..++
T Consensus       400 I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~  479 (586)
T KOG0667|consen  400 IIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFI  479 (586)
T ss_pred             HHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHH
Confidence            321  100          11112220       00000       0000    00000011    011111123445789


Q ss_pred             HHHHhccCCCCCCCCCHHHHHH
Q 041757          298 RIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       298 ~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +++.+|+.+||.+|+|..++++
T Consensus       480 dflk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  480 DFLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             HHHHHHhccCchhcCCHHHHhc
Confidence            9999999999999999999986

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3e-37  Score=278.53  Aligned_cols=236  Identities=24%  Similarity=0.392  Sum_probs=183.8

Q ss_pred             ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      .+|...+.||.|+||.||++..               .....|.+|++++++++||||+++++++     ......++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~   78 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLVF   78 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEEE
Confidence            3577789999999999987531               1246789999999999999999999984     4467789999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++++|.+++.         .....+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||.
T Consensus        79 e~~~~~~L~~~~~---------~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~  146 (256)
T cd05112          79 EFMEHGCLSDYLR---------AQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGM  146 (256)
T ss_pred             EcCCCCcHHHHHH---------hCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcc
Confidence            9999999999985         23345788999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      +........... ....++..|+|||++.+..++.++||||||+++||+++ |..||.....     .            
T Consensus       147 ~~~~~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~------------  208 (256)
T cd05112         147 TRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----S------------  208 (256)
T ss_pred             eeecccCccccc-CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----H------------
Confidence            876544322111 11235678999999988889999999999999999998 9999752211     1            


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      +++........ .              ..+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       209 ~~~~~~~~~~~-~--------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         209 EVVETINAGFR-L--------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHHhCCCC-C--------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            11111100000 0              00112346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-37  Score=280.64  Aligned_cols=236  Identities=17%  Similarity=0.220  Sum_probs=187.4

Q ss_pred             cccccccceecCCCceEEEecccc---------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG---------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~---------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...++||.|+||.||++...               ..+.+.+|++++++++|+||+++++++.     .....+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEE
Confidence            468999999999999999876521               2567999999999999999999999954     46789999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      +||+++++|.+++.         .....+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||
T Consensus        77 ~e~~~~~~L~~~l~---------~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg  144 (256)
T cd06612          77 MEYCGAGSVSDIMK---------ITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFG  144 (256)
T ss_pred             EecCCCCcHHHHHH---------hCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccc
Confidence            99999999999984         23456899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      ++..........  ....++..|+|||++.+..++.++||||||+++|+|++|+.||.......    ...         
T Consensus       145 ~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~~---------  209 (256)
T cd06612         145 VSGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AIF---------  209 (256)
T ss_pred             cchhcccCcccc--ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hhh---------
Confidence            998765433211  12347889999999988889999999999999999999999986321110    000         


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . +.......                ...+......+.+++.+||+.||.+|||+.+|++
T Consensus       210 ~-~~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         210 M-IPNKPPPT----------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             h-hccCCCCC----------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0 00000000                0002234567889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-37  Score=291.87  Aligned_cols=184  Identities=23%  Similarity=0.233  Sum_probs=154.5

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||.||++..                    .....+.+|+.++..++|+||+++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            4788899999999999987542                    1223477899999999999999999984     45788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++..         ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL  143 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRL  143 (332)
T ss_pred             EEEEEeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEE
Confidence            9999999999999999952         2456889999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +|||++........... ....||+.|+|||++.     ...++.++|||||||++|||++|+.||.
T Consensus       144 ~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~  209 (332)
T cd05623         144 ADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY  209 (332)
T ss_pred             eecchheecccCCccee-cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence            99999876543322211 1246999999999886     3457899999999999999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.6e-37  Score=280.88  Aligned_cols=247  Identities=21%  Similarity=0.230  Sum_probs=186.2

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...+.||.|+||.||++..                  .....+.+|++++++++||||+++++++..   ......+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence            4688889999999999977542                  134678999999999999999999998753   3355789


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++....      .....+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|
T Consensus        78 lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d  148 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVK------KRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCD  148 (287)
T ss_pred             EEEEecCCCCHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEee
Confidence            9999999999999874321      23456888999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++.........    ...++..|+|||.+.+..++.++||||||+++|+|++|..||.....................
T Consensus       149 fg~~~~~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd06621         149 FGVSGELVNSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP  224 (287)
T ss_pred             ccccccccccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence            9998755432221    234788999999998889999999999999999999999998644221111111111100000


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...     +...+.                .....+..+.+++.+||+.+|.+|||+.|+++
T Consensus       225 ~~~-----~~~~~~----------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         225 NPE-----LKDEPG----------------NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             chh-----hccCCC----------------CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            000     000000                00123457889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-37  Score=284.41  Aligned_cols=260  Identities=17%  Similarity=0.215  Sum_probs=180.8

Q ss_pred             cccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||+|+||.||++...                   ....+.+|+.++++++||||++++++     +.+....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence            4778899999999999876421                   12457789999999999999999999     45577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +|+||+. ++|.+++.         .....+++..++.++.||+.||.|||   ..+++||||||+||+++.++.+||+|
T Consensus        76 lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d  142 (284)
T cd07839          76 LVFEYCD-QDLKKYFD---------SCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLAD  142 (284)
T ss_pred             EEEecCC-CCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECc
Confidence            9999996 58888874         23456899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||+++.........  ....++..|+|||++.+. .++.++|||||||++|+|++|..||.........+..........
T Consensus       143 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  220 (284)
T cd07839         143 FGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  220 (284)
T ss_pred             cchhhccCCCCCCc--CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            99998654332211  123478899999988764 478999999999999999999999632211111111111000000


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . .+.... +...+....... ...........+.....+.+++.+||+.||.+|||+.++++
T Consensus       221 ~-~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         221 T-EESWPG-VSKLPDYKPYPM-YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             C-hHHhHH-hhhcccccccCC-CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0 000000 000000000000 00000001112235567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3e-37  Score=283.12  Aligned_cols=260  Identities=19%  Similarity=0.277  Sum_probs=185.0

Q ss_pred             ccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...++||+|+||.||++...                   ..+.+.+|+++++.++||||+++++++     ......
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            46888899999999999875421                   234678899999999999999999995     457789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++++|..+..          ....+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~  142 (286)
T cd07846          76 YLVFEFVDHTVLDDLEK----------YPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLC  142 (286)
T ss_pred             EEEEecCCccHHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEE
Confidence            99999999999988773          3445899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh-
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL-  254 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~-  254 (381)
                      |||++..........  ....++..|+|||++.+ ..++.++||||||+++|||++|+.||...    .....+..... 
T Consensus       143 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~----~~~~~~~~~~~~  216 (286)
T cd07846         143 DFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD----SDIDQLYHIIKC  216 (286)
T ss_pred             eeeeeeeccCCcccc--CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC----chHHHHHHHHHH
Confidence            999998765433221  12457889999998875 44788999999999999999999987522    22111111100 


Q ss_pred             hchHHHHHhhhhccCchh-hhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEK-LVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...+...........+.. .................+..+..+.+++.+||+.+|++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         217 LGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000000000000 00000000000011112345678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-37  Score=284.49  Aligned_cols=247  Identities=19%  Similarity=0.203  Sum_probs=187.2

Q ss_pred             hhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc-
Q 041757           29 LEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY-   90 (381)
Q Consensus        29 l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~-   90 (381)
                      .+.....+.|...++||.|+||.||++..                .....+..|+.+++++ +|+||+++++++..... 
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            34455678899999999999999987542                2345778899999999 69999999999753211 


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ......+++|||+++|+|.+++..        .....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.+
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~  157 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKN--------TKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence            235688999999999999999853        12345788889999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCc
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN  245 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~  245 (381)
                      +.++|+|||++.........  .....|+..|+|||.+.     ...++.++|||||||++|||++|..||.....    
T Consensus       158 ~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~----  231 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP----  231 (282)
T ss_pred             CCEEEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH----
Confidence            99999999998765432211  11245899999999876     34578899999999999999999999852211    


Q ss_pred             HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ......         .... .  .+.               .....++..+.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~---------~~~~-~--~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         232 MRALFL---------IPRN-P--PPK---------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             Hhhhhh---------HhhC-C--CCC---------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            110000         0000 0  000               001235568899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4e-37  Score=277.68  Aligned_cols=233  Identities=20%  Similarity=0.292  Sum_probs=185.0

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|+..++||+|+||.||++..                   ...+.+.+|+.++++++||||+++++++     ...+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            478889999999999976431                   2335788999999999999999999984     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++..        .....+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|
T Consensus        76 lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d  144 (256)
T cd08218          76 IVMDYCEGGDLYKKINA--------QRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGD  144 (256)
T ss_pred             EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEee
Confidence            99999999999999853        12345788999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++..........  ....|++.|+|||++.+..++.++|||||||++|++++|..||...    .             
T Consensus       145 ~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~-------------  205 (256)
T cd08218         145 FGIARVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG----N-------------  205 (256)
T ss_pred             ccceeecCcchhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC----C-------------
Confidence            99998665433221  1235788999999998888999999999999999999999997521    1             


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..+.+...+.....               ..+...+.++.+++.+||+.+|.+||++.+|++
T Consensus       206 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         206 MKNLVLKIIRGSYP---------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HHHHHHHHhcCCCC---------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11111111111100               012245667899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.5e-37  Score=282.48  Aligned_cols=259  Identities=19%  Similarity=0.259  Sum_probs=181.4

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||+|+||.||++..                   ...+.+.+|+.++++++||||+++++++.     .+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            477889999999999988642                   12356889999999999999999999954     477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||++ ++|.+++...       .....+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|
T Consensus        76 ~v~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d  144 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSL-------PKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLAD  144 (285)
T ss_pred             EEEecCC-CCHHHHHhcC-------CCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECc
Confidence            9999997 6898888532       12356899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--h
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--L  254 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~  254 (381)
                      ||++..........  ....+++.|+|||++.+. .++.++||||||+++|+|++|+.||...    ..........  .
T Consensus       145 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~----~~~~~~~~~~~~~  218 (285)
T cd07861         145 FGLARAFGIPVRVY--THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD----SEIDQLFRIFRIL  218 (285)
T ss_pred             ccceeecCCCcccc--cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHHHh
Confidence            99987654332111  113468899999987654 5788999999999999999999997532    1111111100  0


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .....................  ...............+.++.+++.+||..||.+|||+.+|++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         219 GTPTEDVWPGVTSLPDYKNTF--PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CCCChhhhhcchhhHHHHhhc--cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000000000000000  000000000111234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-37  Score=291.82  Aligned_cols=184  Identities=23%  Similarity=0.248  Sum_probs=155.8

Q ss_pred             ccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||.||+++..                    ....+.+|+.++..++|+||+++++++     .+.+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            47889999999999999876521                    223467899999999999999999984     45788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++..         ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl  143 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRL  143 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEE
Confidence            9999999999999999952         2456889999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +|||+++.......... ....||+.|+|||++.+     ..++.++|||||||++|||++|+.||.
T Consensus       144 ~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         144 ADFGSCLKMNQDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             EeccceeeccCCCceee-ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence            99999987654332221 12458999999998875     457889999999999999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=299.84  Aligned_cols=243  Identities=23%  Similarity=0.337  Sum_probs=193.9

Q ss_pred             hhccccccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      +...+.....++||+|.||.|+.+.                     .....+|++|+.+|.+|+|+|+|++||+..    
T Consensus       106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl----  181 (1039)
T KOG0199|consen  106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL----  181 (1039)
T ss_pred             eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec----
Confidence            3444556667899999999996643                     226789999999999999999999999954    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                        .....+|||+++.|+|.+.|+.        .....|.......++.|||.||.||-   .+++|||||..+|+++...
T Consensus       182 --~qp~mMV~ELaplGSLldrLrk--------a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasp  248 (1039)
T KOG0199|consen  182 --DQPAMMVFELAPLGSLLDRLRK--------AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASP  248 (1039)
T ss_pred             --cchhhHHhhhcccchHHHHHhh--------ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheeccc
Confidence              3667899999999999999974        24556778888999999999999999   7799999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccc-cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSS-IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHK  248 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~  248 (381)
                      ..+||+|||+.+.+......... ....-...|.|||.+....|+.+||||+|||++|||+| |+.||-    +-.....
T Consensus       249 rtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~----G~~g~qI  324 (1039)
T KOG0199|consen  249 RTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV----GCRGIQI  324 (1039)
T ss_pred             ceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC----CCCHHHH
Confidence            99999999999988876544322 22335678999999999999999999999999999997 788874    1111111


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                                ...+|..                  .+..-+..|+.++++++..||..+|.+|||+..|.+.+-.
T Consensus       325 ----------L~~iD~~------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  325 ----------LKNIDAG------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             ----------HHhcccc------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence                      1111100                  0111145799999999999999999999999999865543

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.2e-37  Score=279.61  Aligned_cols=248  Identities=21%  Similarity=0.351  Sum_probs=185.0

Q ss_pred             ccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC-Cc
Q 041757           38 MLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG-ND   94 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~-~~   94 (381)
                      |...++||+|+||.||++..                      ...+.+.+|++++++++||||+++++++....... ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            56678999999999986531                      12446889999999999999999999875421111 12


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++++||+.+|+|.+++......    .....++...++.++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEE
Confidence            347899999999999887421110    12345788999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||+++...............++..|++||.+....++.++||||||+++|+|++ |..||....    . .......
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~----~-~~~~~~~  228 (273)
T cd05074         154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE----N-SEIYNYL  228 (273)
T ss_pred             ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC----H-HHHHHHH
Confidence            999999987654332222222345678999999988889999999999999999999 888865221    1 1111000


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ..            ....               ..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       229 ~~------------~~~~---------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IK------------GNRL---------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             Hc------------CCcC---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00            0000               00123456899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-37  Score=275.62  Aligned_cols=232  Identities=24%  Similarity=0.349  Sum_probs=180.1

Q ss_pred             ceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEccc
Q 041757           42 NLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMH  104 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~  104 (381)
                      ++||.|+||.||.+...                 ....+.+|++++++++|+||+++++++     ......++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcCC
Confidence            46999999999875421                 346788999999999999999999985     44678899999999


Q ss_pred             CCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757          105 NRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL  184 (381)
Q Consensus       105 ~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~  184 (381)
                      +++|.+++.         .....+++..++.++.+++.||.|||   ..+++||||||+||+++.++.+||+|||++...
T Consensus        76 ~~~l~~~l~---------~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~  143 (251)
T cd05041          76 GGSLLTFLR---------KKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREE  143 (251)
T ss_pred             CCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence            999999985         22346788999999999999999999   669999999999999999999999999999765


Q ss_pred             CCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757          185 PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVD  263 (381)
Q Consensus       185 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (381)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..||.....     ...         ...+.
T Consensus       144 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~~---------~~~~~  209 (251)
T cd05041         144 EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQT---------RERIE  209 (251)
T ss_pred             cCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HHH---------HHHHh
Confidence            43222211111234667999999988889999999999999999999 8888742211     000         01111


Q ss_pred             hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      .....                  ..+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus       210 ~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         210 SGYRM------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCCC------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            00000                  001234568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-38  Score=293.21  Aligned_cols=224  Identities=21%  Similarity=0.190  Sum_probs=168.6

Q ss_pred             ecCCCceEEEecccc--------------------cHHHHHHHHHHHHcc---CCCcccceeeeeccccccCCceEEEEE
Q 041757           44 ISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        44 lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ||+|+||+||+++..                    ....+..|..++..+   .||||+++++++     ......++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            799999999876421                    123345567777665   699999999984     5577899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|..++          .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l----------~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (330)
T cd05586          76 DYMSGGELFWHL----------QKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGL  142 (330)
T ss_pred             cCCCCChHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCc
Confidence            999999999998          34567899999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      ++........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||....     ....          
T Consensus       143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~----------  205 (330)
T cd05586         143 SKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQM----------  205 (330)
T ss_pred             CcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHH----------
Confidence            8754332221  1225699999999998764 48999999999999999999999975211     1111          


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK----MTNVVH  319 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~~vl~  319 (381)
                        ...........         .      .......+.+++.+||+.||.+||+    +.++++
T Consensus       206 --~~~i~~~~~~~---------~------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         206 --YRNIAFGKVRF---------P------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --HHHHHcCCCCC---------C------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              11110000000         0      0123456788999999999999985    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.3e-37  Score=277.79  Aligned_cols=236  Identities=19%  Similarity=0.277  Sum_probs=179.3

Q ss_pred             ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .+|...++||+|+||.||++..                      .....+.+|+.++++++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            4788999999999999977631                      123467889999999999999999998542   234


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...+++|||+++++|.+++.          ....+++...+.++.|++.||.|||   ..+++||||||+||+++.++.+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~  145 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLK----------AYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNV  145 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence            67899999999999999994          3445888999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCC-cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||+++....... ........++..|+|||++.+..++.++|||||||++||+++|+.||...    .........
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~----~~~~~~~~~  221 (266)
T cd06651         146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY----EAMAAIFKI  221 (266)
T ss_pred             EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc----chHHHHHHH
Confidence            9999999876543211 11111245788999999999888999999999999999999999998522    111111000


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                               ....  ..+                ..+......+..++ +||..+|++||++.+|++
T Consensus       222 ---------~~~~--~~~----------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         222 ---------ATQP--TNP----------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---------hcCC--CCC----------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                     0000  000                01123344555565 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.7e-37  Score=281.66  Aligned_cols=227  Identities=22%  Similarity=0.242  Sum_probs=181.4

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||.||++..                    ...+.+.+|++++++++||||+++++++     .....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            4788899999999999987542                    2345678899999999999999999994     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++++|.+++.          ....+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.+||
T Consensus        76 ~~~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl  142 (290)
T cd05580          76 LYLVMEYVPGGELFSHLR----------KSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKI  142 (290)
T ss_pred             EEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEE
Confidence            999999999999999994          4567899999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++.......     ....+++.|+|||.+.+...+.++||||||+++|+|++|..||....    . ......   
T Consensus       143 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~-~~~~~~---  209 (290)
T cd05580         143 TDFGFAKRVKGRT-----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----P-IQIYEK---  209 (290)
T ss_pred             eeCCCccccCCCC-----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----H-HHHHHH---
Confidence            9999998765441     12458899999999988888999999999999999999999975221    1 110000   


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVV  318 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl  318 (381)
                           +...    ..                ..+......+.+++.+||..||.+||     ++.+++
T Consensus       210 -----~~~~----~~----------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         210 -----ILEG----KV----------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -----HhcC----Cc----------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                 0000    00                00123356788899999999999998     555655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-37  Score=282.81  Aligned_cols=237  Identities=22%  Similarity=0.291  Sum_probs=184.5

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++|.+.+.||.|+||.||++..                 ...+.+.+|++++++++||||+++++.+     ......
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   77 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKL   77 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeE
Confidence            457899999999999999987642                 2345788999999999999999999995     447788


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+|+|+||||+||+++.++.++|+
T Consensus        78 ~lv~e~~~~~~L~~~~~---------~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~  145 (280)
T cd06611          78 WILIEFCDGGALDSIML---------ELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLA  145 (280)
T ss_pred             EEEeeccCCCcHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEc
Confidence            99999999999999985         23456899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      |||++..........  ....+++.|+|||++.     ...++.++||||||+++|+|++|+.||....    .......
T Consensus       146 d~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~----~~~~~~~  219 (280)
T cd06611         146 DFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN----PMRVLLK  219 (280)
T ss_pred             cCccchhhccccccc--ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC----HHHHHHH
Confidence            999887554332211  1245889999999874     3457889999999999999999999975321    1111100


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                   .....+..             ...+...+..+.+++.+||+.+|.+||++.++++
T Consensus       220 -------------~~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         220 -------------ILKSEPPT-------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             -------------HhcCCCCC-------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence                         00000000             0001234557889999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.2e-37  Score=278.15  Aligned_cols=239  Identities=22%  Similarity=0.364  Sum_probs=184.5

Q ss_pred             cccccceecCCCceEEEecccc----------------------------cHHHHHHHHHHHHc-cCCCcccceeeeecc
Q 041757           37 NMLEENLISAGTFGFSHLRRQG----------------------------AFKSFIAECKALRN-IRHRNLIKVLTACLG   87 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~----------------------------~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~   87 (381)
                      +|...+.||+|+||.||++...                            ....+.+|+.++.+ ++||||+++++++. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            4788899999999999775421                            22457788888875 78999999999954 


Q ss_pred             ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           88 VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        88 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                          ..+..++||||+++++|.+++....      .....+++..++.++.|++.||.|||+.  .+++|+||+|+||++
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~  147 (269)
T cd08528          80 ----ENDRLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIML  147 (269)
T ss_pred             ----cCCeEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEE
Confidence                4778999999999999999884321      2345688999999999999999999942  479999999999999


Q ss_pred             CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      +.++.+||+|||.+........   .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...     ...
T Consensus       148 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~  219 (269)
T cd08528         148 GEDDKVTITDFGLAKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NML  219 (269)
T ss_pred             CCCCcEEEecccceeecccccc---cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHH
Confidence            9999999999999987654431   12245889999999999888999999999999999999999997521     111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      ....        .+.........                  ....+..+.+++.+||+.||++||++.++.++++
T Consensus       220 ~~~~--------~~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         220 SLAT--------KIVEAVYEPLP------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHH--------HHhhccCCcCC------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1110        11111000000                  0123457889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-36  Score=278.42  Aligned_cols=233  Identities=20%  Similarity=0.259  Sum_probs=185.5

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ...|...+.||.|+||.||.+..                  .....+.+|+.+++++.|+||+++++.+.     +....
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKL   77 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEE
Confidence            35677889999999999987642                  13456888999999999999999999954     47789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++|+|.+++.           ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+
T Consensus        78 ~lv~e~~~~~~L~~~i~-----------~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~  143 (277)
T cd06640          78 WIIMEYLGGGSALDLLR-----------AGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLA  143 (277)
T ss_pred             EEEEecCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEc
Confidence            99999999999999984           235788899999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||++..........  ....++..|+|||++.+..++.++|+||||+++|||++|..||.......    ..       
T Consensus       144 dfg~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~-------  210 (277)
T cd06640         144 DFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VL-------  210 (277)
T ss_pred             ccccceeccCCcccc--ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hh-------
Confidence            999997765433221  12357889999999988889999999999999999999999975322110    00       


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                         ..+..   ..+               ......++..+.+++.+||+.+|.+||++.+++..
T Consensus       211 ---~~~~~---~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         211 ---FLIPK---NNP---------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ---hhhhc---CCC---------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence               00000   000               01123466788999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-37  Score=278.52  Aligned_cols=246  Identities=22%  Similarity=0.247  Sum_probs=188.1

Q ss_pred             hccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccc-cCCc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY-QGND   94 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~-~~~~   94 (381)
                      ..+++|...+.||.|+||.||++..                ...+.+.+|+.+++++ .|+||+++++++..... ....
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            3578999999999999999988652                1346788999999999 69999999999765222 2356


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++....      .....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~  153 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLR------KKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVK  153 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEE
Confidence            7899999999999999985321      12467899999999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      |+|||++..........  ....++..|+|||++..     ..++.++||||||+++|++++|..||.....    ....
T Consensus       154 l~d~~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~  227 (275)
T cd06608         154 LVDFGVSAQLDSTLGRR--NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP----MRAL  227 (275)
T ss_pred             ECCCccceecccchhhh--cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch----HHHH
Confidence            99999987654432211  12458899999998753     3467889999999999999999999852211    1111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..         +..    .....             ..........+.+++.+||..||++|||+.++++
T Consensus       228 ~~---------~~~----~~~~~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         228 FK---------IPR----NPPPT-------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HH---------hhc----cCCCC-------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00         000    00000             0001235567889999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.5e-37  Score=283.06  Aligned_cols=240  Identities=20%  Similarity=0.201  Sum_probs=183.1

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||.||++..                    ...+.+.+|+++++.++||||+++++.+     ...+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            4688899999999999986541                    1245677899999999999999999984     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l  142 (305)
T cd05609          76 LCMVMEYVEGGDCATLLK----------NIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKL  142 (305)
T ss_pred             EEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEE
Confidence            999999999999999993          3456889999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCC-------------cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          176 GDFGLARFLPPTRT-------------QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      +|||+++.......             ........++..|+|||.+.+..++.++||||||+++||+++|..||...   
T Consensus       143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~---  219 (305)
T cd05609         143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---  219 (305)
T ss_pred             eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence            99999864211100             00111234788999999998888999999999999999999999997421   


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                       .. ...........        .. .+.                .....+..+.+++.+||+.||++||++.++.+.|+
T Consensus       220 -~~-~~~~~~~~~~~--------~~-~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         220 -TP-EELFGQVISDD--------IE-WPE----------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             -CH-HHHHHHHHhcc--------cC-CCC----------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence             11 11111100000        00 000                00134567899999999999999999876666665


Q ss_pred             H
Q 041757          323 S  323 (381)
Q Consensus       323 ~  323 (381)
                      .
T Consensus       273 ~  273 (305)
T cd05609         273 H  273 (305)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-37  Score=281.21  Aligned_cols=237  Identities=19%  Similarity=0.240  Sum_probs=182.2

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...+.||+|+||.||++..                  .....+.+|+.++++++|+||+++++.+     ...+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence            3678889999999999977542                  1245788999999999999999999984     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|..++...       .....+++..+..++.|++.||.|||+  +.+++||||||+||+++.++.+||+|
T Consensus        76 lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d  146 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGG-------VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCD  146 (286)
T ss_pred             EEEeecCCCCHHHHHHhc-------cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEee
Confidence            999999999999988421       113468999999999999999999994  24899999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCc------cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE------VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      ||++.........    ...++..|+|||.+.+..      ++.++|||||||++|+|++|..||.....  .....   
T Consensus       147 fg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~---  217 (286)
T cd06622         147 FGVSGNLVASLAK----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFA---  217 (286)
T ss_pred             cCCcccccCCccc----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHH---
Confidence            9998765433222    134788999999886543      58899999999999999999999853211  00000   


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           ....+..    ..+.               ..+..+..++.+++.+||+.+|++||++.++++
T Consensus       218 -----~~~~~~~----~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         218 -----QLSAIVD----GDPP---------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -----HHHHHhh----cCCC---------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                 0011111    0000               012346677889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.3e-37  Score=281.93  Aligned_cols=235  Identities=19%  Similarity=0.244  Sum_probs=185.2

Q ss_pred             ccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ...+|...+.||.|+||.||++.                 ....+.+.+|+.+++.++||||+++++.+.     ..+..
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~   91 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDEL   91 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceE
Confidence            34579999999999999998653                 123567889999999999999999999954     47789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++|+||+++++|..++.           ...+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+
T Consensus        92 ~lv~e~~~~~~L~~~~~-----------~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~  157 (296)
T cd06655          92 FVVMEYLAGGSLTDVVT-----------ETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLT  157 (296)
T ss_pred             EEEEEecCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEc
Confidence            99999999999999883           235889999999999999999999   6799999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||++..........  ....++..|+|||.+.+..++.++|||||||++|++++|+.||....    ........    
T Consensus       158 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~----~~~~~~~~----  227 (296)
T cd06655         158 DFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRALYLI----  227 (296)
T ss_pred             cCccchhcccccccC--CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH----
Confidence            999987654432221  12458889999999988889999999999999999999999975221    11111000    


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           ..   ...+.              ...+...+..+.+++.+||..||.+|||+.+++.
T Consensus       228 -----~~---~~~~~--------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         228 -----AT---NGTPE--------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -----Hh---cCCcc--------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                 00   00000              0001234557888999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.8e-37  Score=278.04  Aligned_cols=238  Identities=20%  Similarity=0.275  Sum_probs=182.1

Q ss_pred             cccccceecCCCceEEEecccc---------------------------cHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757           37 NMLEENLISAGTFGFSHLRRQG---------------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD   89 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~---------------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~   89 (381)
                      +|...+.||.|+||.||++...                           ..+.+.+|+.+++.++||||+++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            4778899999999999876310                           1235778999999999999999999853   


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                        ..+..++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~  143 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLR----------TYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDA  143 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcC
Confidence              4678899999999999999994          3456888999999999999999999   669999999999999999


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc--cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE--VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      ++.++|+|||+++...............++..|+|||++....  ++.++|+||||+++|++++|..||...    ....
T Consensus       144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~~~  219 (272)
T cd06629         144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----EAIA  219 (272)
T ss_pred             CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc----chHH
Confidence            9999999999997654332222222345889999999887654  789999999999999999999997421    1111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ....         +.........              .......++..+.+++.+||..+|++|||+.+|++
T Consensus       220 ~~~~---------~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         220 AMFK---------LGNKRSAPPI--------------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHH---------hhccccCCcC--------------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1110         0000000000              00011235678899999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.4e-37  Score=277.88  Aligned_cols=235  Identities=18%  Similarity=0.250  Sum_probs=182.1

Q ss_pred             cccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           37 NMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +|..++.||.|+||.||++..                      .....+.+|++++++++|+||+++++++.     ...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DDN   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cCC
Confidence            477889999999999987531                      11356788999999999999999999954     467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++.          ....+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~  142 (265)
T cd06631          76 TISIFMEFVPGGSISSILN----------RFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIK  142 (265)
T ss_pred             eEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEE
Confidence            8999999999999999993          3456788999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCC----cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          175 VGDFGLARFLPPTRT----QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      |+|||++........    ........++..|+|||++.+..++.++||||||+++|++++|..||...    .......
T Consensus       143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~----~~~~~~~  218 (265)
T cd06631         143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM----DRLAAMF  218 (265)
T ss_pred             eccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC----ChHHHHH
Confidence            999999876532111    11111245889999999999888999999999999999999999998522    1111110


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..         ... ....+                ..+......+.+++.+||+.+|.+||++.++++
T Consensus       219 ~~---------~~~-~~~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         219 YI---------GAH-RGLMP----------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             Hh---------hhc-cCCCC----------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00         000 00000                001234567889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.5e-37  Score=279.41  Aligned_cols=236  Identities=21%  Similarity=0.292  Sum_probs=185.3

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...+.||.|+||.||++..                  ...+.+.+|++++++++||||+++++.+.     .....+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence            4677888999999999977542                  23456889999999999999999999954     468899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeeccCCCCeeeCCCCCeEEe
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQ-PVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      +|+||+++++|.+++..         ....+++..+..++.|++.||.|||   + .+++|+||||+||+++.++.++|+
T Consensus        76 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~  143 (265)
T cd06605          76 ICMEYMDGGSLDKILKE---------VQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLC  143 (265)
T ss_pred             EEEEecCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEe
Confidence            99999999999999952         2267889999999999999999999   5 699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||.+..........    ..++..|+|||.+.+..++.++||||||+++|++++|..||...........         
T Consensus       144 d~g~~~~~~~~~~~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---------  210 (265)
T cd06605         144 DFGVSGQLVNSLAKT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF---------  210 (265)
T ss_pred             ecccchhhHHHHhhc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH---------
Confidence            999987654322111    4588899999999988999999999999999999999999863322111111         


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIR-ECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         +.+...+......               .+. .....+.+++.+||..||.+|||+.+++.
T Consensus       211 ---~~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         211 ---ELLQYIVNEPPPR---------------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---HHHHHHhcCCCCC---------------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence               1111111111000               011 25567899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-36  Score=280.37  Aligned_cols=184  Identities=20%  Similarity=0.335  Sum_probs=152.1

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++++|...+.||+|+||.||++..                  .....+.+|+.+++.++|+||+++++++     .....
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence            467899999999999999987531                  1223678899999999999999999994     45678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+. ++|.+++.         .....+++..+..++.|++.||.|||   ..+|+|+||||+||+++.++.+||
T Consensus        78 ~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l  144 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMI---------QHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKL  144 (291)
T ss_pred             EEEEEeccc-CCHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEE
Confidence            899999995 68877763         22345778888999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +|||+++.........  ....++..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus       145 ~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~  205 (291)
T cd07870         145 ADFGLARAKSIPSQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP  205 (291)
T ss_pred             eccccccccCCCCCCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999987654332211  12347889999999876 457889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-36  Score=275.23  Aligned_cols=240  Identities=20%  Similarity=0.269  Sum_probs=187.4

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||.|+||.||++..                   ...+.+.+|+++++.++|+||+++++++..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            477889999999999986531                   234568889999999999999999997642   3456789


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC--CCCceeeccCCCCeeeCCCCCeEE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC--QPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      ++|||+++++|.+++....      .....+++..++.++.|++.||.|||...  ..+++|+||+|+||+++.++.+||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCK------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             EEehhccCCCHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence            9999999999999995321      23467899999999999999999999332  448999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++..........  ....++..|+|||++.+..++.++||||||+++|+|++|..||....     ...+...   
T Consensus       152 ~d~g~~~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~---  221 (265)
T cd08217         152 GDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASK---  221 (265)
T ss_pred             ecccccccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHH---
Confidence            9999998765543211  12458999999999988889999999999999999999999975221     1111111   


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            +.....                  ...+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       222 ------~~~~~~------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         222 ------IKEGKF------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ------HhcCCC------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                  000000                  0012345678899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.9e-37  Score=286.55  Aligned_cols=269  Identities=21%  Similarity=0.239  Sum_probs=188.0

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +.++|...+.||.|+||.||++..                   ...+.+.+|+.+|++++||||+++++++.... ....
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~   81 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFK   81 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCc
Confidence            458899999999999999976541                   23456788999999999999999999865321 2356


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+. ++|.+++.          ....+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+|
T Consensus        82 ~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~k  147 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIH----------SDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELR  147 (334)
T ss_pred             eEEEEEehhh-hhHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEE
Confidence            7899999995 69999983          4456899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcc--cccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      |+|||++..........  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......  .......
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~  225 (334)
T cd07855         148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLIL  225 (334)
T ss_pred             ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHH
Confidence            99999997664432211  1112468899999998765 46899999999999999999999998532111  0001111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ........++............................+..+.++.+++.+||+.+|++|||+.+++.
T Consensus       226 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11111111111110000000000000000000001112345678999999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.7e-37  Score=276.52  Aligned_cols=222  Identities=22%  Similarity=0.322  Sum_probs=172.2

Q ss_pred             ceecCCCceEEEeccc--------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           42 NLISAGTFGFSHLRRQ--------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~--------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      +.||+|+||.||++..                          .....+.+|+.+++.++||||+++++++..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            4689999999975431                          114578899999999999999999998642      45


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC----
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM----  171 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----  171 (381)
                      .++||||+++|+|.+++..         ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    
T Consensus        75 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~  142 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHR---------EKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEG  142 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccC
Confidence            6899999999999999952         2236889999999999999999999   67999999999999999887    


Q ss_pred             ---CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC--ccCcccchhhhhHHHHHHHh-CCCCCCccccCCCc
Q 041757          172 ---TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN--EVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMN  245 (381)
Q Consensus       172 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~  245 (381)
                         .+||+|||++.......      ...++..|+|||++.+.  .++.++||||||+++|++++ |..||......  .
T Consensus       143 ~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~  214 (259)
T cd05037         143 YVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--E  214 (259)
T ss_pred             CceeEEeCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--h
Confidence               79999999998654411      13467789999998876  78999999999999999999 57776432110  0


Q ss_pred             HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      ......           .....  +                   ......+.+++.+||..+|.+|||+.+|++.|
T Consensus       215 ~~~~~~-----------~~~~~--~-------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         215 KERFYQ-----------DQHRL--P-------------------MPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             HHHHHh-----------cCCCC--C-------------------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            000000           00000  0                   01115788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-37  Score=281.29  Aligned_cols=182  Identities=21%  Similarity=0.313  Sum_probs=151.9

Q ss_pred             ccccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...+.||.|+||.||++...                  ....+.+|++++++++|+||+++++++     ......+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence            67889999999999999876421                  224567899999999999999999994     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+.+ +|.+++..         ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~~-~L~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d  146 (291)
T cd07844          80 LVFEYLDT-DLKQYMDD---------CGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLAD  146 (291)
T ss_pred             EEEecCCC-CHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECc
Confidence            99999975 99998852         2346889999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||+++.........  ....++..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus       147 fg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~  205 (291)
T cd07844         147 FGLARAKSVPSKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP  205 (291)
T ss_pred             cccccccCCCCccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99987543222111  11246888999998875 458899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.9e-37  Score=287.23  Aligned_cols=273  Identities=21%  Similarity=0.230  Sum_probs=189.7

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +.+.|...+.||+|+||+||.+..                   .....+.+|+.+++.++|+||+++++++.........
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            467899999999999999987542                   1234677899999999999999999986643223335


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+. ++|.+++          .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+|
T Consensus        83 ~~~lv~e~~~-~~L~~~~----------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~k  148 (337)
T cd07858          83 DVYIVYELMD-TDLHQII----------RSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLK  148 (337)
T ss_pred             cEEEEEeCCC-CCHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEE
Confidence            6899999995 6899888          34567899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||+++........  .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||....  ...........
T Consensus       149 L~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~  224 (337)
T cd07858         149 ICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD--YVHQLKLITEL  224 (337)
T ss_pred             ECcCccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHH
Confidence            9999999876543211  112457889999998764 468999999999999999999999985321  00111111111


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHh
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSI  324 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~i  324 (381)
                      ......+...........+.................+.++.++.+++.+||+.||++|||+.++++.  +..+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            1100000000000000000000000000000011123456788999999999999999999999975  5444

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.9e-37  Score=286.45  Aligned_cols=183  Identities=19%  Similarity=0.170  Sum_probs=146.4

Q ss_pred             ccceecCC--CceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           40 EENLISAG--TFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        40 ~~~~lG~G--~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..++||+|  +||+||++..                   ...+.+.+|+.+++.++||||+++++++.     .++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence            35789999  6788866541                   12345667999999999999999999964     4678899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++|+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.++++||
T Consensus        77 v~e~~~~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~  145 (327)
T cd08227          77 VTSFMAYGSAKDLICT--------HFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGL  145 (327)
T ss_pred             EEeccCCCcHHHHHHh--------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEccc
Confidence            9999999999999842        12345889999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcc-----cccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          179 GLARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       179 g~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      +.+..........     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            8654332211100     0111346778999999876  4589999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=318.66  Aligned_cols=237  Identities=23%  Similarity=0.295  Sum_probs=187.4

Q ss_pred             ccccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++-++..+.+||.|.||.||.+-                   ....+...+|..++..|+|||+|++||+-     -+.+
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE-----vHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE-----VHRE 1307 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee-----ecHH
Confidence            35567778999999999998753                   33456677899999999999999999994     4577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..+|.||||.+|+|.+.+          ...+..++.-...+..|++.|++|||   +.|||||||||.||+++.+|.+|
T Consensus      1308 kv~IFMEyC~~GsLa~ll----------~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLL----------EHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred             HHHHHHHHhccCcHHHHH----------HhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEE
Confidence            889999999999999999          45666777777888999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCc--ccccCccCccceeCCCCcCCCc---cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          175 VGDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGNE---VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      ++|||.|..+......  .......||+.|||||++.+..   ...++||||+|||+.||+||+.||...   +.++.-+
T Consensus      1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~---dne~aIM 1451 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL---DNEWAIM 1451 (1509)
T ss_pred             eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc---cchhHHH
Confidence            9999999987665211  1122467999999999988643   567899999999999999999998622   2222222


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ......            ..                +++|.....+-.+++.+|+..||.+|.++.|+++
T Consensus      1452 y~V~~g------------h~----------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1452 YHVAAG------------HK----------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             hHHhcc------------CC----------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            221111            11                1123445667778888999999999999887776

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.4e-37  Score=281.68  Aligned_cols=232  Identities=19%  Similarity=0.233  Sum_probs=183.2

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ..|...+.||.|+||.||++..                  ...+.+.+|++++++++||||+++++++     ......+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceE
Confidence            4577788899999999987631                  1234688999999999999999999995     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++.           ...+++..+..++.|++.|+.|||   ..+++|+||+|+||+++.++.++|+|
T Consensus        79 lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06642          79 IIMEYLGGGSALDLLK-----------PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLAD  144 (277)
T ss_pred             EEEEccCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEcc
Confidence            9999999999999883           245788999999999999999999   67999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++..........  ....++..|+|||++.+..++.++||||||+++|||++|..||.......    .. .      
T Consensus       145 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~-~------  211 (277)
T cd06642         145 FGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VL-F------  211 (277)
T ss_pred             ccccccccCcchhh--hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HH-h------
Confidence            99987665432211  12357889999999998889999999999999999999999975322110    00 0      


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                         .+....  .+                ......+..+.+++.+||+.+|++||++.++++.
T Consensus       212 ---~~~~~~--~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         212 ---LIPKNS--PP----------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ---hhhcCC--CC----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence               000000  00                0012345678899999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-36  Score=273.96  Aligned_cols=232  Identities=22%  Similarity=0.358  Sum_probs=182.3

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||+|+||.||++..                   ...+.+.+|+++++.++||||+++++.+     ...+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            477889999999999986431                   2356788999999999999999999984     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CCeEEe
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MTARVG  176 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~  176 (381)
                      +||||+++++|.+++..        .....+++..+..++.+++.||.|||   +.+++|+||+|+||+++.+ +.+||+
T Consensus        76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~  144 (256)
T cd08220          76 IVMEYAPGGTLAEYIQK--------RCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIG  144 (256)
T ss_pred             EEEecCCCCCHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEc
Confidence            99999999999999953        12345889999999999999999999   6699999999999999855 468999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||.+..........   ...++..|+|||.+.+..++.++||||||+++|+|++|..||....     ........   
T Consensus       145 d~~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~~~~---  213 (256)
T cd08220         145 DFGISKILSSKSKAY---TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----LPALVLKI---  213 (256)
T ss_pred             cCCCceecCCCcccc---ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----hHHHHHHH---
Confidence            999998765443221   2458889999999998888999999999999999999999975221     11111100   


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           ......                   ..+...+..+.+++.+||+.||.+|||+.+++.
T Consensus       214 -----~~~~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         214 -----MSGTFA-------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -----HhcCCC-------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 000000                   001234567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.6e-37  Score=284.46  Aligned_cols=237  Identities=18%  Similarity=0.209  Sum_probs=186.1

Q ss_pred             hhccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -+..++|...+.||.|+||.||++..                 ...+.+.+|+.+++.++|+||+++++++.     ...
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   89 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGD   89 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCC
Confidence            34567899999999999999987642                 23466788999999999999999999954     477


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++.           ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++
T Consensus        90 ~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~  155 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVK  155 (297)
T ss_pred             EEEEeecccCCCCHHHHHH-----------hCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence            8999999999999999983           234788899999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||++..........  ....+++.|+|||.+.+..++.++|||||||++|++++|..||.......    .....  
T Consensus       156 l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~----~~~~~--  227 (297)
T cd06656         156 LTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALYLI--  227 (297)
T ss_pred             ECcCccceEccCCccCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch----heeee--
Confidence            99999987654433221  12358889999999988889999999999999999999999985221100    00000  


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                .....+.              ...+...+..+.+++.+||+.||++||++.++++
T Consensus       228 ----------~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         228 ----------ATNGTPE--------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ----------ccCCCCC--------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      0000000              0001234556788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=292.89  Aligned_cols=232  Identities=21%  Similarity=0.280  Sum_probs=190.6

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -..+|.+.+.||+|.|+.|.++..                   ...+.+.+|+++|+.|+|||||+++.+     .+...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecc
Confidence            457799999999999999977652                   234568899999999999999999999     56788


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      .+|+||||+.+|.+.+++          .+...+.+..+..++.|+.+|++|||   ++.|||||||++|||++.+..+|
T Consensus       129 ~lylV~eya~~ge~~~yl----------~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYL----------VKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             eeEEEEEeccCchhHHHH----------HhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhccccccccee
Confidence            999999999999999999          56777888999999999999999999   77999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||++..+.......   .++|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||+...             
T Consensus       196 IaDfgfS~~~~~~~~lq---t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-------------  259 (596)
T KOG0586|consen  196 IADFGFSTFFDYGLMLQ---TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-------------  259 (596)
T ss_pred             eeccccceeeccccccc---ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------------
Confidence            99999998887544333   3689999999999999776 688999999999999999999986221             


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          ++++-.+.+....                .++.-...++.+++++++-.+|.+|+++.++.+
T Consensus       260 ----lk~Lr~rvl~gk~----------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  260 ----LKELRPRVLRGKY----------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ----cccccchheeeee----------------cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                1111111111111                112234456778888999999999999999876

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=278.54  Aligned_cols=260  Identities=19%  Similarity=0.241  Sum_probs=185.9

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...++||+|+||.||++..                   ...+.+.+|++++++++|+||+++++++.     ..+..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence            3688899999999999987542                   12357889999999999999999999954     46789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||++++.+..+.          .....+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+
T Consensus        76 ~iv~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~  142 (288)
T cd07833          76 YLVFEYVERTLLELLE----------ASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLC  142 (288)
T ss_pred             EEEEecCCCCHHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEE
Confidence            9999999987777665          34456899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH--H
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM--A  253 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~--~  253 (381)
                      |||++.......... .....++..|+|||++.+. .++.++||||||+++|+|++|..||....    ........  .
T Consensus       143 d~g~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~----~~~~~~~~~~~  217 (288)
T cd07833         143 DFGFARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS----DIDQLYLIQKC  217 (288)
T ss_pred             eeecccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHH
Confidence            999988765543211 1224578899999999887 78999999999999999999999975221    11111110  0


Q ss_pred             hhchHHHHHhhhhccCchhhh-hcccch-hhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLV-VRGDQK-QTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ........... ...+..... ...... ........+..++..+.+++.+||..+|++|||+.++++
T Consensus       218 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         218 LGPLPPSHQEL-FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hCCCCHHHhhh-cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000000000 000000000 000000 000011112234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=277.43  Aligned_cols=231  Identities=19%  Similarity=0.210  Sum_probs=183.9

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...+.||.|+||.||++..                  .....+.+|+++++.++|+||+++++.+.     +....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence            4688889999999999987642                  22456889999999999999999999854     467899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +|+||+++++|.+++.          . ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|
T Consensus        76 ~v~e~~~~~~L~~~~~----------~-~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d  141 (274)
T cd06609          76 IIMEYCGGGSCLDLLK----------P-GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLAD  141 (274)
T ss_pred             EEEEeeCCCcHHHHHh----------h-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcc
Confidence            9999999999999984          2 27899999999999999999999   67999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+++........  .....++..|+|||++.+..++.++||||||+++|+|++|..||......     ...       
T Consensus       142 ~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~-------  207 (274)
T cd06609         142 FGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVL-------  207 (274)
T ss_pred             cccceeecccccc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHH-------
Confidence            9999877654221  11245788999999999888999999999999999999999998532110     000       


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        ..+........                  ... .+..+.+++.+||..||++|||+.++++
T Consensus       208 --~~~~~~~~~~~------------------~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         208 --FLIPKNNPPSL------------------EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --HHhhhcCCCCC------------------cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              00000000000                  011 4557888999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.4e-36  Score=272.50  Aligned_cols=234  Identities=25%  Similarity=0.430  Sum_probs=182.5

Q ss_pred             cccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           39 LEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ...+.||.|+||.||.+...                      ..+.+..|+.++..++|+||+++++++.     ..+..
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCee
Confidence            45688999999999775321                      3568889999999999999999999954     45789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      +++|||+++++|.+++...        ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+
T Consensus        77 ~~i~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~  145 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKN--------RPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS  145 (258)
T ss_pred             EEEEeccCCCCHHHHHHhh--------hhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEc
Confidence            9999999999999999521        1122899999999999999999999   6799999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhh
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |||++............ ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...     ........   
T Consensus       146 dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~---  216 (258)
T smart00219      146 DFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEY---  216 (258)
T ss_pred             ccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH---
Confidence            99999877654332221 1236789999999988889999999999999999998 78886521     11111110   


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                           +......                   ..+...+.++.+++.+||..||++|||+.++++.|
T Consensus       217 -----~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      217 -----LKKGYRL-------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----HhcCCCC-------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 0000000                   00123566789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-37  Score=278.89  Aligned_cols=260  Identities=23%  Similarity=0.280  Sum_probs=194.2

Q ss_pred             cccccceecCCCceEEEecc------------cccHHHHHHHHHHHHcc--CCCcccceeeeeccccccCCceEEEEEEc
Q 041757           37 NMLEENLISAGTFGFSHLRR------------QGAFKSFIAECKALRNI--RHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~------------~~~~~~~~~E~~~l~~l--~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      .....++||+|+||.||++.            ...++.|.+|-+|....  +|+||++|++.-...+. ....++||+||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLVt~f  289 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLVTEF  289 (534)
T ss_pred             chhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEEeee
Confidence            34445779999999998875            34678899999998854  79999999998433211 14478999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC------CCCceeeccCCCCeeeCCCCCeEEe
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC------QPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      .+.|+|.+||.           ...++|....+++..+++||+|||++.      ++.|+|||||..|||+.+++++.|+
T Consensus       290 h~kGsL~dyL~-----------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  290 HPKGSLCDYLK-----------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             ccCCcHHHHHH-----------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            99999999994           467999999999999999999999643      5679999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCc-cC-----cccchhhhhHHHHHHHhCCCCC------------Cc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VS-----TIGDVYSYGILLLELMIREKPS------------DI  238 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-----~~sDiwSlG~il~el~tg~~Pf------------~~  238 (381)
                      |||+|..+............+||.+|||||++.+.. +.     .+.||||+|.|+|||+++-.-+            ..
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            999999888665555555578999999999988743 22     3579999999999999864433            21


Q ss_pred             cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757          239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV  318 (381)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  318 (381)
                      .......+..+....+....+-.+....                  +   -...+..+.+.+.-||..||+.|.|+.-|.
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W------------------~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAW------------------R---KHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhh------------------h---cCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence            1122222333222222111110000000                  0   013456788889999999999999999999


Q ss_pred             HHHHHhhhhcC
Q 041757          319 HELQSIKNTLL  329 (381)
Q Consensus       319 ~~L~~i~~~~~  329 (381)
                      +++.++.....
T Consensus       498 eR~~~l~~~~~  508 (534)
T KOG3653|consen  498 ERMAELMMLWE  508 (534)
T ss_pred             HHHHHHhccCC
Confidence            99998876654

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-36  Score=273.98  Aligned_cols=236  Identities=18%  Similarity=0.226  Sum_probs=180.4

Q ss_pred             ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .+|...++||+|+||.||.+..                      ...+.+.+|+.++++++||||+++++++.+   ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence            4788999999999999976531                      123567889999999999999999998532   224


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~  145 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLK----------SYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNV  145 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCE
Confidence            56789999999999999984          3455788889999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|+|||++......... .......++..|+|||++.+..++.++||||||+++|++++|+.||...    .........
T Consensus       146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~~~~~~~  221 (265)
T cd06652         146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF----EAMAAIFKI  221 (265)
T ss_pred             EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc----chHHHHHHH
Confidence            99999998765432111 1111245889999999998888999999999999999999999997521    111111100


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ....           ..+                ..+......+.+++.+||. +|.+||++++|++
T Consensus       222 ~~~~-----------~~~----------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         222 ATQP-----------TNP----------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hcCC-----------CCC----------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0000           000                0123445677888889984 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.2e-37  Score=282.76  Aligned_cols=234  Identities=19%  Similarity=0.250  Sum_probs=181.3

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .+.|.....||.|+||.||++..                 ...+.+.+|+.+++.++|+||+++++.+.     ..+..+
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~   95 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELW   95 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEE
Confidence            45566667899999999987642                 23456889999999999999999999853     467889


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++.           ...+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|
T Consensus        96 lv~e~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~d  161 (292)
T cd06658          96 VVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD  161 (292)
T ss_pred             EEEeCCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcc
Confidence            9999999999999883           235788999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++..........  ....|+..|+|||.+.+..++.++||||||+++||+++|..||...    ........      
T Consensus       162 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~~~~~~~------  229 (292)
T cd06658         162 FGFCAQVSKEVPKR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE----PPLQAMRR------  229 (292)
T ss_pred             CcchhhcccccccC--ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHH------
Confidence            99987554332211  1245889999999998888999999999999999999999997521    11111100      


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          +...+.....                ........+.+++.+||..||.+|||+.++++
T Consensus       230 ----~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         230 ----IRDNLPPRVK----------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             ----HHhcCCCccc----------------cccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                0000000000                01123456788899999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2e-36  Score=277.37  Aligned_cols=258  Identities=20%  Similarity=0.254  Sum_probs=181.2

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|+..+.||.|+||.||++..                   .....+.+|++++++++||||+++++++     .+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            588889999999999988642                   1225688999999999999999999994     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+. ++|.+++..        .....+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|
T Consensus        76 ~v~e~~~-~~l~~~~~~--------~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~d  143 (284)
T cd07860          76 LVFEFLH-QDLKKFMDA--------SPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD  143 (284)
T ss_pred             EEeeccc-cCHHHHHHh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEee
Confidence            9999996 689998853        22456889999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCc-cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--h
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--L  254 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~  254 (381)
                      ||++..........  ....++..|+|||++.+.. ++.++||||||+++|+|+||+.||...    ..........  .
T Consensus       144 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~  217 (284)
T cd07860         144 FGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD----SEIDQLFRIFRTL  217 (284)
T ss_pred             ccchhhcccCcccc--ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHHHh
Confidence            99987654332211  1134688899999887644 588899999999999999999997522    1111111100  0


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .......... ....+.... ..............+.....+.+++.+||+.||.+|||+.+++.
T Consensus       218 ~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         218 GTPDEVVWPG-VTSLPDYKP-SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             CCCChhhhhh-hhHHHHHHh-hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000000000 000000000 00000000011112234456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=278.55  Aligned_cols=244  Identities=24%  Similarity=0.299  Sum_probs=190.8

Q ss_pred             cccccchhhhhcccc-ccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccce
Q 041757           23 VGKLKNLEILDVSRN-MLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKV   81 (381)
Q Consensus        23 ~~~~~~l~~~~~~~~-~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~   81 (381)
                      +.+-++||...++.+ |+.-++||+||||.|+-..                    .......++|-.+|.+++.+.||.+
T Consensus       171 FlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl  250 (591)
T KOG0986|consen  171 FLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL  250 (591)
T ss_pred             HHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence            345567777666655 6777999999999994322                    2344556789999999999999988


Q ss_pred             eeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC
Q 041757           82 LTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK  161 (381)
Q Consensus        82 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk  161 (381)
                      -..     +++.+.+++||..|.||||.-+|+.        .....+++..++-++.+|+.||++||   ..+||.||||
T Consensus       251 aYA-----feTkd~LClVLtlMNGGDLkfHiyn--------~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLK  314 (591)
T KOG0986|consen  251 AYA-----FETKDALCLVLTLMNGGDLKFHIYN--------HGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLK  314 (591)
T ss_pred             eee-----ecCCCceEEEEEeecCCceeEEeec--------cCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCC
Confidence            666     6789999999999999999999864        23457999999999999999999999   5699999999


Q ss_pred             CCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcccc
Q 041757          162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE  241 (381)
Q Consensus       162 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~  241 (381)
                      |+|||+|+.|+++|+|+|+|..+........   .+||.+|||||++.+..|+...|.||+||++|||+.|+.||.....
T Consensus       315 PeNILLDd~GhvRISDLGLAvei~~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  315 PENILLDDHGHVRISDLGLAVEIPEGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             hhheeeccCCCeEeeccceEEecCCCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence            9999999999999999999998877665543   3699999999999999999999999999999999999999863221


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                      ..              -.+-++.+...++.+               .+....++..+|....|..||.+|.-.
T Consensus       392 Kv--------------k~eEvdrr~~~~~~e---------------y~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  392 KV--------------KREEVDRRTLEDPEE---------------YSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hh--------------hHHHHHHHHhcchhh---------------cccccCHHHHHHHHHHHccCHHHhccC
Confidence            11              112233333333222               123444566666667778888877543

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.2e-36  Score=284.89  Aligned_cols=185  Identities=23%  Similarity=0.231  Sum_probs=154.5

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~   93 (381)
                      ..++|...+.||+|+||.||++..                   .....+.+|+.+++.++|+||+++++++.... ..+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            458899999999999999977641                   12346778999999999999999999865311 1233


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+. ++|.+.+.          .  .++...+..++.|++.||.|||   ..+++||||||+||+++.++.+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~----------~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~  157 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQ----------M--DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  157 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHh----------h--cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence            56799999996 58888873          2  2788899999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||+|||+++........   ....++..|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus       158 kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~  218 (353)
T cd07850         158 KILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP  218 (353)
T ss_pred             EEccCccceeCCCCCCC---CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence            99999999876543321   12457889999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.5e-36  Score=275.95  Aligned_cols=258  Identities=20%  Similarity=0.243  Sum_probs=184.7

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||.|+||.||++..                   .....+.+|+.++++++||||+++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            478889999999999987641                   1246788999999999999999999995     4477889


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+ +++|.+++..         ....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|
T Consensus        76 ~v~e~~-~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~d  142 (286)
T cd07832          76 LVMEYM-PSDLSEVLRD---------EERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIAD  142 (286)
T ss_pred             EEeccc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEee
Confidence            999999 9999999852         3356899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--h
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--L  254 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~  254 (381)
                      ||++......... ......++..|+|||++.+. .++.++||||+|+++|||++|.+||..    ......+....  .
T Consensus       143 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~----~~~~~~~~~~~~~~  217 (286)
T cd07832         143 FGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG----ENDIEQLAIVFRTL  217 (286)
T ss_pred             eeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC----CCHHHHHHHHHHHc
Confidence            9999876544321 11124588999999988654 468999999999999999999877642    22211111110  0


Q ss_pred             hchHHHHHhhhhc-cCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILL-NDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ............. ........  ............++....+.+++.+||..||.+|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         218 GTPNEETWPGLTSLPDYNKITF--PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCCChHHHhhccCcchhhcccC--CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000000000000 00000000  000000011112344578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-36  Score=274.48  Aligned_cols=237  Identities=21%  Similarity=0.310  Sum_probs=183.9

Q ss_pred             cccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      +|+.++.||+|+||.||.+..                       ...+.+.+|++++++++|+||+++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            578889999999999987531                       1246788999999999999999999994     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-C
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-T  172 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~  172 (381)
                      +..++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++ .
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~  142 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLS----------KYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQR  142 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHH----------HhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence            78999999999999999984          3456889999999999999999999   66999999999999998775 6


Q ss_pred             eEEeecccceecCCCCCcc--cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +||+|||.+..........  ......++..|+|||.+.+..++.++||||+|+++|++++|..||......  ......
T Consensus       143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~  220 (268)
T cd06630         143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALI  220 (268)
T ss_pred             EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHH
Confidence            9999999987765432111  111245788999999998888999999999999999999999998522111  101100


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .        .....  ...+                ..+.....++.+++.+||..+|.+|||+.++++
T Consensus       221 ~--------~~~~~--~~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         221 F--------KIASA--TTAP----------------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             H--------HHhcc--CCCC----------------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0        00000  0000                112345678889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.7e-36  Score=273.66  Aligned_cols=242  Identities=20%  Similarity=0.232  Sum_probs=186.5

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|+..+.||.|+||+||.+..                  ...+.+.+|+++++.++|+||+++++.+     ......+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence            4788999999999999976541                  1356788999999999999999999985     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++....       ....+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|
T Consensus        76 iv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~d  145 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSY-------PRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIAD  145 (267)
T ss_pred             EEEeccCCCcHHHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcc
Confidence            9999999999999995311       1246889999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcc--cccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          178 FGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       178 fg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      ||++..........  ......|+..|+|||++... .++.++|+||||+++|+|++|+.||......    ..+..   
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~---  218 (267)
T cd06610         146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVLML---  218 (267)
T ss_pred             cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhHHH---
Confidence            99987765543321  12224588999999998776 7899999999999999999999998633111    11100   


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            ...    ..+....  .        .......+..+.+++.+||..||++|||+.++++
T Consensus       219 ------~~~----~~~~~~~--~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         219 ------TLQ----NDPPSLE--T--------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ------Hhc----CCCCCcC--C--------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  000    0000000  0        0001245567889999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.7e-36  Score=274.07  Aligned_cols=231  Identities=20%  Similarity=0.282  Sum_probs=184.2

Q ss_pred             cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      +|...++||.|+||.||++..                    ...+.+.+|++++++++||||+++++.     +.+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence            588899999999999977642                    235678899999999999999999998     4567889


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++|+||+.+++|.+++.          ....+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~  142 (258)
T cd05578          76 YLVVDLLLGGDLRYHLS----------QKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHIT  142 (258)
T ss_pred             EEEEeCCCCCCHHHHHH----------hcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEe
Confidence            99999999999999994          3457889999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||.+.........   ....|+..|+|||.+....++.++|+||||+++|++++|..||......  ....+...    
T Consensus       143 d~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~----  213 (258)
T cd05578         143 DFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAK----  213 (258)
T ss_pred             ecccccccCCCccc---cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH----
Confidence            99998766543221   1245888999999998888999999999999999999999998633211  01111100    


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM--TNVV  318 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~~vl  318 (381)
                           ...   ..                ...+...+..+.+++.+||+.||.+||++  .|++
T Consensus       214 -----~~~---~~----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         214 -----QET---AD----------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -----hcc---cc----------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                 000   00                01123455788999999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.9e-36  Score=272.16  Aligned_cols=235  Identities=23%  Similarity=0.322  Sum_probs=188.5

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...+.||.|+||.||++..                  .....+.+|+..+.+++|+||+++++++.     .....+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence            4688889999999999977642                  23577899999999999999999999954     468899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeeccCCCCeeeCCCCCeEEe
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQ-PVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      +||||+++++|.+++.          ....+++..++.++.|++.|+.|||   . .+++|+||+|+||+++.++.++|+
T Consensus        76 lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~  142 (264)
T cd06623          76 IVLEYMDGGSLADLLK----------KVGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIA  142 (264)
T ss_pred             EEEEecCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEc
Confidence            9999999999999994          3467899999999999999999999   6 799999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||.+..........  ....++..|+|||.+....++.++||||||+++|+|++|..||.....  .....        
T Consensus       143 df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~--------  210 (264)
T cd06623         143 DFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFE--------  210 (264)
T ss_pred             cCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHH--------
Confidence            999998765443322  124578899999999888899999999999999999999999853322  11111        


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          +..........               ..... .+..+.+++.+||+.+|++|||+.++++
T Consensus       211 ----~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         211 ----LMQAICDGPPP---------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ----HHHHHhcCCCC---------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                11111100000               00112 5678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7e-36  Score=277.16  Aligned_cols=234  Identities=24%  Similarity=0.311  Sum_probs=180.9

Q ss_pred             hhccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      .+..+.|...++||+|+||.||++..                    ...+.+.+|+++++.++||||++++++|.     
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----   85 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----   85 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----
Confidence            34567799999999999999987641                    12356889999999999999999999965     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+. |+|.+++.         .....+++..+..++.|++.||.|||   ..+++||||+|+||+++.++
T Consensus        86 ~~~~~~lv~e~~~-g~l~~~~~---------~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~  152 (307)
T cd06607          86 REHTAWLVMEYCL-GSASDILE---------VHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPG  152 (307)
T ss_pred             eCCeEEEEHHhhC-CCHHHHHH---------HcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCC
Confidence            3667899999996 57777764         22346899999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      .++|+|||++.......      ...++..|+|||++.   ...++.++||||||+++|||++|+.||....    ....
T Consensus       153 ~~kL~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~----~~~~  222 (307)
T cd06607         153 TVKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSA  222 (307)
T ss_pred             CEEEeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc----HHHH
Confidence            99999999987654322      134788999999874   3568899999999999999999999974221    1000


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      ...         +..   ...+..               ....++..+.+++.+||+.||.+||++.+|+..
T Consensus       223 ~~~---------~~~---~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         223 LYH---------IAQ---NDSPTL---------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHH---------Hhc---CCCCCC---------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000         000   000000               012355678999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.4e-36  Score=282.96  Aligned_cols=267  Identities=20%  Similarity=0.254  Sum_probs=185.4

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~   93 (381)
                      +.++|...++||+|+||.||++..                   .....+.+|+.+++++ +||||+++++++..   .+.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            567899999999999999987531                   1234567899999999 99999999998642   334


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||++ ++|..++.          .. .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~----------~~-~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~  146 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIR----------AN-ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRV  146 (337)
T ss_pred             ceEEEEecccc-cCHHHHHh----------cC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcE
Confidence            56899999997 59999884          22 6788889999999999999999   6799999999999999999999


Q ss_pred             EEeecccceecCCCCCc---ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ---TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      ||+|||++.........   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....... .....
T Consensus       147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~  225 (337)
T cd07852         147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKI  225 (337)
T ss_pred             EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence            99999999866543321   12223568899999998765 457899999999999999999999975221110 01111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      .... .......+..+........................+..+.++.+++.+||+.||++|||+.++++.
T Consensus       226 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         226 IEVI-GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHh-CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000 000000000000000000000000000000111122356789999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-36  Score=271.36  Aligned_cols=231  Identities=21%  Similarity=0.260  Sum_probs=181.9

Q ss_pred             cccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           37 NMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +|...+.||+|+||.||++..                      ...+.+.+|+.+++.++|+||+++++++     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            367788999999999977531                      1346788999999999999999999985     4467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+|
T Consensus        76 ~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~k  142 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLK----------KYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVK  142 (258)
T ss_pred             eEEEEEEecCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence            8899999999999999994          3456889999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCc-cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||++.........   ....++..|+|||.+.... ++.++|+||||+++|++++|+.||....    .........
T Consensus       143 l~d~~~~~~~~~~~~~---~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~  215 (258)
T cd06632         143 LADFGMAKQVVEFSFA---KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----GVAAVFKIG  215 (258)
T ss_pred             EccCccceeccccccc---cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc----HHHHHHHHH
Confidence            9999998776443311   1245889999999887766 8999999999999999999999985321    111100000


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ....        .                   ...+......+.+++.+||+.+|.+||++.+++.
T Consensus       216 ~~~~--------~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         216 RSKE--------L-------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             hccc--------C-------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            0000        0                   0011234567888999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=282.03  Aligned_cols=237  Identities=22%  Similarity=0.251  Sum_probs=183.2

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||.||++..                    ...+.+.+|+++++.++|+||+++++.+     .....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence            4688889999999999987642                    1345688899999999999999999994     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+.+++|.+++..        .....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|
T Consensus        76 ~~lv~e~~~~~~L~~~~~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l  144 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQR--------QPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIML  144 (316)
T ss_pred             EEEEEEecCCCCHHHHHHh--------CCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEE
Confidence            9999999999999999852        22356899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCc---------------------------ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHH
Q 041757          176 GDFGLARFLPPTRTQ---------------------------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE  228 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~e  228 (381)
                      +|||++.........                           .......|+..|+|||++.+..++.++||||||+++|+
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~  224 (316)
T cd05574         145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE  224 (316)
T ss_pred             eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence            999998755332110                           01112457889999999998889999999999999999


Q ss_pred             HHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCC
Q 041757          229 LMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESP  308 (381)
Q Consensus       229 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  308 (381)
                      |++|..||.....    ...+         ..+.........                  ....+..+.+++.+||+.||
T Consensus       225 l~~g~~pf~~~~~----~~~~---------~~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p  273 (316)
T cd05574         225 MLYGTTPFKGSNR----DETF---------SNILKKEVTFPG------------------SPPVSSSARDLIRKLLVKDP  273 (316)
T ss_pred             HhhCCCCCCCCch----HHHH---------HHHhcCCccCCC------------------ccccCHHHHHHHHHHccCCH
Confidence            9999999852211    1111         111110000000                  11246789999999999999


Q ss_pred             CCCCC----HHHHHH
Q 041757          309 QDRMK----MTNVVH  319 (381)
Q Consensus       309 ~~RPs----~~~vl~  319 (381)
                      ++|||    +.+++.
T Consensus       274 ~~R~s~~~~~~~ll~  288 (316)
T cd05574         274 SKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHCCCchhhHHHHHc
Confidence            99999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.5e-36  Score=277.22  Aligned_cols=264  Identities=21%  Similarity=0.188  Sum_probs=182.5

Q ss_pred             ccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...+.||.|+||.||++...                   ....+.+|+.++++++||||+++++++..   .+....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcE
Confidence            57888999999999999886521                   12356789999999999999999998653   223789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+.+ +|.+++..         ....+++..++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+
T Consensus        82 ~lv~e~~~~-~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~  148 (293)
T cd07843          82 YMVMEYVEH-DLKSLMET---------MKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKIC  148 (293)
T ss_pred             EEEehhcCc-CHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEe
Confidence            999999974 99998852         2346899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |||++..........  ....++..|+|||.+.+. .++.++||||||+++|+|++|..||...... ............
T Consensus       149 d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~  225 (293)
T cd07843         149 DFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGT  225 (293)
T ss_pred             ecCceeeccCCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence            999998765542211  123478899999988764 4689999999999999999999998532110 011111110000


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . ..............................++.. ....+.+++.+||+.||++|||+.|+++
T Consensus       226 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         226 P-TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             C-chHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0 0000000000000000000000000000001111 3567889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=263.24  Aligned_cols=246  Identities=17%  Similarity=0.167  Sum_probs=189.8

Q ss_pred             cccccccc-ceecCCCceEEEecccc------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEE
Q 041757           34 VSRNMLEE-NLISAGTFGFSHLRRQG------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        34 ~~~~~~~~-~~lG~G~fg~V~~~~~~------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      ++++|.+. ++||-|-.|.|....+.            ......+|+++.-..+ |||||++++++.. .+.+...+.+|
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rkcLLiV  137 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYEN-SYQGRKCLLIV  137 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCceeeEee
Confidence            56777754 79999999999443211            2345678999877775 9999999999764 35667888999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CCCeEEe
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DMTARVG  176 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~  176 (381)
                      ||.|+||.|..-+..        .....+++.++..|+.||+.|+.|||   +.+|.||||||+|+|...   +..+||+
T Consensus       138 mE~meGGeLfsriq~--------~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  138 MECMEGGELFSRIQD--------RGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             eecccchHHHHHHHH--------cccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence            999999999999965        45677999999999999999999999   779999999999999965   4479999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||+|+.........   ..+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.+.....          +++
T Consensus       207 DfGFAK~t~~~~~L~---TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------isp  273 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLM---TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISP  273 (400)
T ss_pred             ccccccccCCCcccc---CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------CCh
Confidence            999998765433322   3568999999999999999999999999999999999999997543321          122


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .++.-+..---.-|               .+-....+.+..++++..|..+|++|.|+.++++
T Consensus       274 gMk~rI~~gqy~FP---------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  274 GMKRRIRTGQYEFP---------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hHHhHhhccCccCC---------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            22221111000000               0113456667788889999999999999999986

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.3e-36  Score=275.79  Aligned_cols=236  Identities=19%  Similarity=0.273  Sum_probs=177.1

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHH-HHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKA-LRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...+.||+|+||.||++..                  .....+..|+.+ ++.++||||+++++++.     ..+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence            4788899999999999988642                  123456667765 55668999999999954     46678


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeeccCCCCeeeCCCCCeEE
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP-VTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      ++||||++ |+|.+++....      .....+++..++.++.|++.||.|||   +. +++||||||+||+++.++.+||
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl  145 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVY------DKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKL  145 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEE
Confidence            99999996 68888875321      23356899999999999999999999   54 8999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC----CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +|||++..........   ...++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||....   ....... 
T Consensus       146 ~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~-  218 (283)
T cd06617         146 CDFGISGYLVDSVAKT---IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK---TPFQQLK-  218 (283)
T ss_pred             eecccccccccccccc---cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc---cCHHHHH-
Confidence            9999987654332211   1347889999998865    446889999999999999999999975211   1111111 


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              ..........+                  ....+.++.+++.+||..+|.+||++.++++
T Consensus       219 --------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         219 --------QVVEEPSPQLP------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --------HHHhcCCCCCC------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    11110000000                  0124567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-36  Score=278.89  Aligned_cols=234  Identities=18%  Similarity=0.244  Sum_probs=181.5

Q ss_pred             ccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..|.....||+|+||.||++..                 ...+.+.+|+.++..++||||+++++.+.     ..+..++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~i   95 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWV   95 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEE
Confidence            4455566899999999977631                 23457889999999999999999999854     4678999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++++|..++.           ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+||
T Consensus        96 v~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~df  161 (297)
T cd06659          96 LMEFLQGGALTDIVS-----------QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDF  161 (297)
T ss_pred             EEecCCCCCHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeec
Confidence            999999999999873           245789999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      |++..........  ....|+..|+|||++.+..++.++|||||||++|||++|+.||...    .........      
T Consensus       162 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~~~~~~~------  229 (297)
T cd06659         162 GFCAQISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD----SPVQAMKRL------  229 (297)
T ss_pred             hhHhhcccccccc--cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH------
Confidence            9987554332211  1245889999999998888999999999999999999999997521    111111100      


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                          ........                ......+..+.+++.+||+.+|.+||++.++++.
T Consensus       230 ----~~~~~~~~----------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         230 ----RDSPPPKL----------------KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ----hccCCCCc----------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                00000000                0011234567889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-35  Score=274.51  Aligned_cols=256  Identities=20%  Similarity=0.245  Sum_probs=182.3

Q ss_pred             cccccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           37 NMLEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +|...++||.|+||.||++...                      ....+..|++++++++|+||+++++++     .+..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence            4777889999999999876411                      124567899999999999999999995     4477


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+ +|+|.+++..         ....+++..++.++.|+++||.|||   ..+++|+||+|+||+++.++.++
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~---------~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~  142 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKD---------KSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLK  142 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEE
Confidence            899999999 8999999942         2236899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||++...........  ...+++.|+|||.+.+ ..++.++|||||||++|||++|.+||..    ......+....
T Consensus       143 l~dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~----~~~~~~~~~~~  216 (298)
T cd07841         143 LADFGLARSFGSPNRKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG----DSDIDQLGKIF  216 (298)
T ss_pred             EccceeeeeccCCCcccc--ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC----CccHHHHHHHH
Confidence            999999987654322211  1346788999998765 4578999999999999999999777642    22222111110


Q ss_pred             --hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 --LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 --~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        .............. .+..  .....................+.+++.+||+.||.+|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         217 EALGTPTEENWPGVTS-LPDY--VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             HHcCCCchhhhhhccc-cccc--ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence              00000000000000 0000  000000000111122345678899999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.8e-36  Score=279.00  Aligned_cols=262  Identities=20%  Similarity=0.272  Sum_probs=184.6

Q ss_pred             hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ...+++|...+.||.|+||.||++..                   ...+.+.+|++++++++||||+++++++.    ..
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~   81 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI----SP   81 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----cC
Confidence            45788999999999999999987641                   12457889999999999999999999863    23


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+ +++|.+++.           ...+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~  146 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLT-----------SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCD  146 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCC
Confidence            55789999998 568988873           235778888899999999999999   679999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      ++|+|||.+.......     ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....  ........
T Consensus       147 ~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~  219 (328)
T cd07856         147 LKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIIT  219 (328)
T ss_pred             EEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Confidence            9999999987543221     12357889999998765 5689999999999999999999999853211  01111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ........++............................+.....+.+++.+||+.+|++|||+.+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111111111111110000000000000000001111234578899999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4e-36  Score=276.97  Aligned_cols=236  Identities=19%  Similarity=0.224  Sum_probs=184.6

Q ss_pred             ccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++|...+.||.|+||.||++.                 ....+.+.+|+.+++.++||||+++++.+.     ..+..
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~   91 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDEL   91 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcE
Confidence            35789999999999999998763                 123456888999999999999999999854     46788


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++|+||+++++|.+++.           ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+
T Consensus        92 ~lv~e~~~~~~L~~~~~-----------~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~  157 (293)
T cd06647          92 WVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLT  157 (293)
T ss_pred             EEEEecCCCCcHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEc
Confidence            99999999999999984           234778889999999999999999   6799999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||++..........  ....+++.|+|||.+....++.++||||||+++|++++|+.||.......    .......  
T Consensus       158 dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~----~~~~~~~--  229 (293)
T cd06647         158 DFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALYLIAT--  229 (293)
T ss_pred             cCcceeccccccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh----heeehhc--
Confidence            999887654433221  12458889999999988889999999999999999999999986322111    0000000  


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                                ...+.              .......+..+.+++.+||..+|++||++.+++..
T Consensus       230 ----------~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 ----------NGTPE--------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ----------CCCCC--------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00000              00012344568889999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=287.74  Aligned_cols=272  Identities=20%  Similarity=0.196  Sum_probs=190.4

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~~~~   96 (381)
                      ..+...+.||+|+||.||..+.                  ...+...+|+++|++|+|+|||+++++-.+.. .......
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            5567788999999999988662                  23566778999999999999999999833211 1114456


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC----CCC
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD----DMT  172 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~----~~~  172 (381)
                      .+|||||.+|||...|..-       .....+++.+.+.++.+++.||.|||   ..+|+||||||.||++-.    ...
T Consensus        93 vlvmEyC~gGsL~~~L~~P-------EN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~I  162 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSP-------ENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSI  162 (732)
T ss_pred             eEEEeecCCCcHHHHhcCc-------ccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceE
Confidence            8999999999999999532       34567999999999999999999999   559999999999999832    236


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      .||+|||.|+.+.++....   +.+||..|.+||+... ..|+..+|.|||||++|+++||..||........+.+....
T Consensus       163 yKLtDfG~Arel~d~s~~~---S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~  239 (732)
T KOG4250|consen  163 YKLTDFGAARELDDNSLFT---SLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH  239 (732)
T ss_pred             EeeecccccccCCCCCeee---eecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence            7999999999887766333   4789999999999984 78999999999999999999999998644333222222111


Q ss_pred             HHhhchHHHHH--hhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHHhhh
Q 041757          252 MALSNHVKDIV--DSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM--KMTNVVHELQSIKN  326 (381)
Q Consensus       252 ~~~~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~~vl~~L~~i~~  326 (381)
                      .. ......+.  ...-...|-......     +......+.....+..++..++..+|.+|-  .+.+....+..|..
T Consensus       240 ~~-tkkp~~v~i~~~~~eNgpv~~s~~l-----P~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  240 II-TKKPSGVAIGAQEEENGPVEWSSTL-----PQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             hh-ccCCCceeEeeecccCCceeeeccC-----CCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            11 11100000  000000010000000     001111234444566666777788888888  77777777766655

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-35  Score=271.76  Aligned_cols=232  Identities=20%  Similarity=0.269  Sum_probs=182.9

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .-|...+.||.|+||.||++..                  ...+.+.+|+.++.+++||||+++++++     ..+...+
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~   78 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLW   78 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEE
Confidence            3477788999999999987531                  1235688899999999999999999995     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++.           ...+++..+..++.|++.|+.|||   ..+++|+||+|+||+++.++.++|+|
T Consensus        79 lv~e~~~~~~l~~~i~-----------~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~d  144 (277)
T cd06641          79 IIMEYLGGGSALDLLE-----------PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLAD  144 (277)
T ss_pred             EEEEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEee
Confidence            9999999999999983           235789999999999999999999   67999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++..........  ....++..|+|||.+.+..++.++|||||||++|++++|..||.....     ......     
T Consensus       145 fg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-----  212 (277)
T cd06641         145 FGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFL-----  212 (277)
T ss_pred             cccceecccchhhh--ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHH-----
Confidence            99987665432211  123578899999999888889999999999999999999999752211     000000     


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                          +..   ....               ......+..+.+++.+||+.+|.+||++.++++.
T Consensus       213 ----~~~---~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         213 ----IPK---NNPP---------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ----Hhc---CCCC---------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                000   0000               0012345678899999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.2e-36  Score=270.35  Aligned_cols=233  Identities=21%  Similarity=0.285  Sum_probs=182.1

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||+|+||.||++..                   ...+.+.+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            577889999999999987542                   2345778999999999999999999985     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEe
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVG  176 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~  176 (381)
                      +|+||+++++|.+++..        .....+++..+..++.|++.||.|||   ..+++|+||||+||++++++ .+||+
T Consensus        76 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~  144 (257)
T cd08225          76 IVMEYCDGGDLMKRINR--------QRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLG  144 (257)
T ss_pred             EEEecCCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEec
Confidence            99999999999999853        22335789999999999999999999   66999999999999998875 46999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||.+..........  ....|++.|+|||++.+..++.++|+||||+++|++++|..||....     .......    
T Consensus       145 d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~----  213 (257)
T cd08225         145 DFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLK----  213 (257)
T ss_pred             ccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHH----
Confidence            999987665433221  12358899999999988889999999999999999999999975221     1111111    


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          ........                   .....+.++.+++.+||..+|++|||+.+++.
T Consensus       214 ----~~~~~~~~-------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         214 ----ICQGYFAP-------------------ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----HhcccCCC-------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                11100000                   01133457889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.8e-35  Score=270.58  Aligned_cols=258  Identities=18%  Similarity=0.193  Sum_probs=179.5

Q ss_pred             ccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      |...++||+|+||.||++..                  .......+|+.++.++. |+||+++++++.+   ...+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEE
Confidence            56778999999999988642                  11223457999999996 9999999999653   22367899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+. |+|.+++.         .....+++..++.++.|++.||.|||   ..+++||||+|+||+++. +.+||+||
T Consensus        78 v~e~~~-~~l~~~l~---------~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~df  143 (282)
T cd07831          78 VFELMD-MNLYELIK---------GRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADF  143 (282)
T ss_pred             EEecCC-ccHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEec
Confidence            999996 58888874         22356899999999999999999999   669999999999999999 99999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      |+++.........   ...++..|+|||++.. ..++.++|||||||++|||++|..||.....  ..............
T Consensus       144 g~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~  218 (282)
T cd07831         144 GSCRGIYSKPPYT---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTP  218 (282)
T ss_pred             ccccccccCCCcC---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCC
Confidence            9998765433222   1347889999997654 5578899999999999999999999753211  00111111111111


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...+... ....... ...................+..+.+++.+||+.+|++|||+.++++
T Consensus       219 ~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         219 DAEVLKK-FRKSRHM-NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CHHHHHh-hcccccc-cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            1111100 0000000 0000000111112223456788999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.5e-36  Score=273.61  Aligned_cols=225  Identities=20%  Similarity=0.235  Sum_probs=169.1

Q ss_pred             eecCCCceEEEecccc--------------------cHHHHHHHHHHHHc---cCCCcccceeeeeccccccCCceEEEE
Q 041757           43 LISAGTFGFSHLRRQG--------------------AFKSFIAECKALRN---IRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        43 ~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~---l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      +||+|+||.||++...                    ....+.+|..+++.   ..||||+.+++.+     ...+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence            4899999999875421                    11234455544443   4699999999884     446788999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        76 ~e~~~~~~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          76 LDLMNGGDLHYHLS----------QHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             EecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCC
Confidence            99999999999983          3456899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcC-CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGV-GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++.........    ...|+..|+|||.+. +..++.++|||||||++|+|++|..||.......  .........    
T Consensus       143 ~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~----  212 (279)
T cd05633         143 LACDFSKKKPH----ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTL----  212 (279)
T ss_pred             cceeccccCcc----CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHhh----
Confidence            98755432221    235899999999886 4568999999999999999999999986332211  111100000    


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                              ....                ..+...+.++.+++.+||..||.+||     |+.++++
T Consensus       213 --------~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         213 --------TVNV----------------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             --------cCCc----------------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence                    0000                01234566888999999999999999     5888766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-35  Score=270.64  Aligned_cols=261  Identities=18%  Similarity=0.212  Sum_probs=184.1

Q ss_pred             cccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      +|+..++||.|+||.||++..                  .....+.+|+.++++++|+||+++++++.     ..+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence            588899999999999987652                  12467788999999999999999999954     4678899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++ +|.+++...       .....+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+||
T Consensus        76 v~e~~~~-~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~  144 (284)
T cd07836          76 VFEYMDK-DLKKYMDTH-------GVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADF  144 (284)
T ss_pred             EEecCCc-cHHHHHHhc-------CCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeec
Confidence            9999985 898888432       11246899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      |++..........  ....++..|+|||++.+. .++.++||||||+++|++++|+.||...... .......... ...
T Consensus       145 g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~-~~~  220 (284)
T cd07836         145 GLARAFGIPVNTF--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIM-GTP  220 (284)
T ss_pred             chhhhhcCCcccc--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHh-CCC
Confidence            9997554332211  123478899999987663 5788999999999999999999997532211 0111111110 000


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..+....... .+. .................+..+..+.+++.+||+.||.+||++.++++
T Consensus       221 ~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         221 TESTWPGISQ-LPE-YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ChhhHHHHhc-Cch-hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0011110000 000 00000000011112223345678899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-36  Score=299.77  Aligned_cols=251  Identities=20%  Similarity=0.324  Sum_probs=194.0

Q ss_pred             ccccccceecCCCceEEEecc-------------------------cccHHHHHHHHHHHHccC-CCcccceeeeecccc
Q 041757           36 RNMLEENLISAGTFGFSHLRR-------------------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVD   89 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-------------------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~   89 (381)
                      ++....+.||+|.||.|+++.                         ....+.+..|+++|+.+. |+||+.++|+|..  
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--  373 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--  373 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence            334556799999999996643                         234678999999999995 9999999999864  


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccC-----C--CcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKR-----P--RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-----~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                         ....++|+||+..|+|.++++..+... ....     .  ..++..+.+.++.|||.|++||+   +.++|||||..
T Consensus       374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~-~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa  446 (609)
T KOG0200|consen  374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTE-SIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA  446 (609)
T ss_pred             ---CCceEEEEEeccCCcHHHHHHhccccc-cccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence               778899999999999999997544000 0001     1  24899999999999999999999   77999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCc-cCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV-KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMF  240 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~  240 (381)
                      +|||+..+..+||+|||+++.............. .-+..|||||.+....|+.+||||||||+|||++| |..||... 
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-
Confidence            9999999999999999999976655444322110 12556999999999999999999999999999998 88886421 


Q ss_pred             cCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                         .....+..         .+..                  ..+...|..|..++.++|+.||+.+|++||++.++.+.
T Consensus       526 ---~~~~~l~~---------~l~~------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~  575 (609)
T KOG0200|consen  526 ---PPTEELLE---------FLKE------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF  575 (609)
T ss_pred             ---CcHHHHHH---------HHhc------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence               10111111         1110                  01112245788999999999999999999999999999


Q ss_pred             HHHhhh
Q 041757          321 LQSIKN  326 (381)
Q Consensus       321 L~~i~~  326 (381)
                      +.....
T Consensus       576 ~~~~l~  581 (609)
T KOG0200|consen  576 FEKHLQ  581 (609)
T ss_pred             HHHHHH
Confidence            998643

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.1e-36  Score=260.66  Aligned_cols=193  Identities=24%  Similarity=0.292  Sum_probs=161.0

Q ss_pred             hhccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGV   88 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~   88 (381)
                      ++.-..|+....||+|+||.||++..                       +.-.+..+|+.+++.++||||+.+..++.. 
T Consensus        20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~-   98 (438)
T KOG0666|consen   20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS-   98 (438)
T ss_pred             HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc-
Confidence            34456788999999999999999731                       122455689999999999999999999753 


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                         .+...++++||.+. ||.+.++-.+.     .....++...+..|+.||+.|+.|||   +.-|+||||||.|||+.
T Consensus        99 ---~d~~v~l~fdYAEh-DL~~II~fHr~-----~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvm  166 (438)
T KOG0666|consen   99 ---HDKKVWLLFDYAEH-DLWHIIKFHRA-----SKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVM  166 (438)
T ss_pred             ---cCceEEEEehhhhh-hHHHHHHHhcc-----chhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEe
Confidence               37889999999976 99999865443     23357889999999999999999999   55899999999999998


Q ss_pred             CC----CCeEEeecccceecCCCCCcc-cccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          169 DD----MTARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       169 ~~----~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      .+    |.+||+|||+++.+...-... ....++.|+.|+|||.+.+. .|+.+.||||.|||+.||+|-++.|.
T Consensus       167 gdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  167 GDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             ccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            77    899999999999887654322 33346789999999998885 58999999999999999999988874

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-35  Score=272.85  Aligned_cols=239  Identities=21%  Similarity=0.241  Sum_probs=188.3

Q ss_pred             hhccccccccceecCCCceEEEecccc----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQG----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~~----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      -+..++|...+.||.|+||.||.+...                ..+.+.+|+++++.++|+||+++++.+.     ....
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   89 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL-----VGDE   89 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCE
Confidence            456788999999999999999875432                2567889999999999999999999954     3678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|+||+++++|.+++..         ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|
T Consensus        90 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l  157 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQ---------NFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKL  157 (286)
T ss_pred             EEEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEE
Confidence            9999999999999999952         1237899999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++..........  ....++..|+|||++.+..++.++||||||+++|+|++|..||...    ........    
T Consensus       158 ~d~~~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~----~~~~~~~~----  227 (286)
T cd06614         158 ADFGFAAQLTKEKSKR--NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE----PPLRALFL----  227 (286)
T ss_pred             Cccchhhhhccchhhh--ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC----CHHHHHHH----
Confidence            9999987554332211  1234788999999998888999999999999999999999997521    11111100    


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           +.........                 ....++..+.+++.+||+.+|.+|||+.++++
T Consensus       228 -----~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         228 -----ITTKGIPPLK-----------------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -----HHhcCCCCCc-----------------chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                 0000000000                 01235567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=274.54  Aligned_cols=192  Identities=21%  Similarity=0.291  Sum_probs=153.7

Q ss_pred             cccccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           37 NMLEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .|...++||+|+||.||++...                      ..+.+.+|+.++++++||||+++++++..   ....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            3777889999999999876531                      12567789999999999999999999753   2237


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC----C
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD----D  170 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~----~  170 (381)
                      ..++||||+++ +|.+++.....     .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.    +
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~  148 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPER  148 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhcc-----CCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCcc
Confidence            89999999975 77777642211     12246889999999999999999999   679999999999999999    8


Q ss_pred             CCeEEeecccceecCCCCC-cccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccc
Q 041757          171 MTARVGDFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMF  240 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~  240 (381)
                      +.+||+|||++........ ........++..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            9999999999987654332 111222457889999998766 457899999999999999999999986443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-37  Score=293.95  Aligned_cols=242  Identities=23%  Similarity=0.361  Sum_probs=201.0

Q ss_pred             ccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           38 MLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .+..++||+|+||+||+.-                      ...-.+++.|+-+|.+++|||+++++++|..      +.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~------s~  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML------ST  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc------ch
Confidence            4556899999999996632                      2346789999999999999999999999863      33


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      ..||++|++.|+|.++++         .....+.....+.|+.||++||.|||   .+++|||||..+|+|+.....+||
T Consensus       772 ~qlvtq~mP~G~LlDyvr---------~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvki  839 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVR---------EHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKI  839 (1177)
T ss_pred             HHHHHHhcccchHHHHHH---------HhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEE
Confidence            789999999999999997         35677888999999999999999999   779999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      .|||+++...............-.+.|||-|.+....|+.++|||||||++||++| |..|+..+...            
T Consensus       840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------  907 (1177)
T KOG1025|consen  840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------  907 (1177)
T ss_pred             EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------
Confidence            99999998877655444444556789999999999999999999999999999998 99997533211            


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  329 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~  329 (381)
                        ++.+++..-                  .+...++.|+.+++.++.+||..|+..||+++++.+.+.+..+.+.
T Consensus       908 --eI~dlle~g------------------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  908 --EIPDLLEKG------------------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             --HhhHHHhcc------------------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence              122332211                  1123356899999999999999999999999999999998877543

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-35  Score=271.59  Aligned_cols=233  Identities=18%  Similarity=0.255  Sum_probs=181.9

Q ss_pred             ccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .+|...++||+|+||.||++..                 ...+.+.+|+.+++.++||||+++++++     ...+..++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~   93 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWV   93 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEE
Confidence            3566678999999999987642                 1345688999999999999999999985     34678899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      |+||+++++|.+++.          . ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+||
T Consensus        94 v~e~~~~~~L~~~~~----------~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~  159 (285)
T cd06648          94 VMEFLEGGALTDIVT----------H-TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDF  159 (285)
T ss_pred             EEeccCCCCHHHHHH----------h-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEccc
Confidence            999999999999984          2 45888999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      |.+..........  ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...    ........       
T Consensus       160 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~----~~~~~~~~-------  226 (285)
T cd06648         160 GFCAQVSKEVPRR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE----PPLQAMKR-------  226 (285)
T ss_pred             ccchhhccCCccc--ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC----CHHHHHHH-------
Confidence            9887554332211  1245889999999998888999999999999999999999997521    11111100       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        + .........                .....+..+.+++.+||+.+|.+|||+.++++
T Consensus       227 --~-~~~~~~~~~----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         227 --I-RDNLPPKLK----------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --H-HhcCCCCCc----------------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              0 000000000                01124567899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-35  Score=267.46  Aligned_cols=236  Identities=22%  Similarity=0.296  Sum_probs=182.9

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||+|+||.||.+..                   ...+.+.+|+.+++.++|+||+++++.+     .+.+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            477889999999999977631                   2467788999999999999999999984     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +|+||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|
T Consensus        76 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d  142 (264)
T cd06626          76 IFMEYCSGGTLEELLE----------HGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGD  142 (264)
T ss_pred             EEEecCCCCcHHHHHh----------hcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcc
Confidence            9999999999999994          3455788999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccc--cCccCccceeCCCCcCCCc---cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          178 FGLARFLPPTRTQTSS--IDVKGSIGYIAPEYGVGNE---VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||++............  ....++..|+|||++.+..   ++.++||||||+++|++++|..||....   .........
T Consensus       143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~---~~~~~~~~~  219 (264)
T cd06626         143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD---NEFQIMFHV  219 (264)
T ss_pred             cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc---chHHHHHHH
Confidence            9999876544322111  1245788999999988766   8899999999999999999999985221   111100000


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       ....        ....+.                 .......+.+++.+||+.+|.+|||+.+++.
T Consensus       220 -~~~~--------~~~~~~-----------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         220 -GAGH--------KPPIPD-----------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -hcCC--------CCCCCc-----------------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0000        000000                 0123556788999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.9e-35  Score=274.17  Aligned_cols=192  Identities=22%  Similarity=0.313  Sum_probs=154.2

Q ss_pred             hccccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccc---
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY---   90 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---   90 (381)
                      +.-++|...++||+|+||.||++...                   ....+.+|++++++++||||++++++|.....   
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            34567999999999999999876421                   12356789999999999999999999765221   


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ......++||||+.+ +|.+++.         .....+++.+++.++.|++.||.|||   ..+++|+||||+||+++.+
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~  155 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLS---------NKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKD  155 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCC
Confidence            123567999999964 8888874         23346899999999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCc--ccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          171 MTARVGDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +.+||+|||++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~  225 (310)
T cd07865         156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ  225 (310)
T ss_pred             CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence            99999999999866443221  111123478889999987664 47889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2e-35  Score=274.32  Aligned_cols=262  Identities=22%  Similarity=0.219  Sum_probs=182.0

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .++|...+.||.|+||.||++..                   .....+.+|+.++++++|+||+++++++.+   ...+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence            57899999999999999977642                   112346789999999999999999999653   23356


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+.+ +|.+++..         ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||
T Consensus        83 ~~lv~e~~~~-~l~~~l~~---------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL  149 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDN---------MPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKI  149 (309)
T ss_pred             EEEEEecCCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence            8999999964 89888852         2356899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH--H
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK--M  252 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~--~  252 (381)
                      +|||++..........  ....++..|+|||.+.+ ..++.++|||||||++|||++|..||...    .....+..  .
T Consensus       150 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~----~~~~~~~~~~~  223 (309)
T cd07845         150 ADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK----SEIEQLDLIIQ  223 (309)
T ss_pred             CccceeeecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHH
Confidence            9999998765432111  11235788999998865 45789999999999999999999997522    11111111  0


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ............... -+.........................+.+++.+||+.||++|||+.+++.
T Consensus       224 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         224 LLGTPNESIWPGFSD-LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcCCCChhhchhhhc-ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000000000 000000000000000000001123567788999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=270.85  Aligned_cols=230  Identities=19%  Similarity=0.269  Sum_probs=180.4

Q ss_pred             cccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC---CCcccceeeeeccccccCCce
Q 041757           37 NMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR---HRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .|+..++||.|+||.||++..                  ...+.+.+|+.++++++   |||++++++++.     ....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            577788999999999987541                  23457888999999996   999999999854     4678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++++|.+++.          . ..+++..++.++.|++.||.|||   ..+++|+||+|+||+++.++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~~~----------~-~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l  142 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMK----------A-GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKL  142 (277)
T ss_pred             EEEEEecCCCCcHHHHHH----------c-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEE
Confidence            899999999999999883          2 36889999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      +|||++..........  ....|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.....     .....   
T Consensus       143 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~---  212 (277)
T cd06917         143 CDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMM---  212 (277)
T ss_pred             ccCCceeecCCCcccc--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhh---
Confidence            9999998765543221  22458899999998765 4578999999999999999999999853211     00000   


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHH-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINII-RECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            .+...   .+..               .. ...+.++.+++.+||+.||++||++.+++.
T Consensus       213 ------~~~~~---~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         213 ------LIPKS---KPPR---------------LEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ------ccccC---CCCC---------------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                  00000   0000               00 114557889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-35  Score=277.23  Aligned_cols=274  Identities=20%  Similarity=0.231  Sum_probs=190.5

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||.|+||.||++..                   ...+.+.+|+.+++.++|+||+++++++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            478889999999999987642                   1345788999999999999999999996542222335789


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||++ ++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.++|+|
T Consensus        81 lv~e~~~-~~l~~~l~----------~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~d  146 (330)
T cd07834          81 IVTELME-TDLHKVIK----------SPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICD  146 (330)
T ss_pred             EEecchh-hhHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcc
Confidence            9999997 48999883          4457899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCc-ccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          178 FGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       178 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      ||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||....... .+... .....
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i-~~~~~  224 (330)
T cd07834         147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLI-VEVLG  224 (330)
T ss_pred             cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHH-HHhcC
Confidence            9999876554310 111124578899999999887 78999999999999999999999985332100 00000 00000


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhhh
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSIKN  326 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~i~~  326 (381)
                      ....+.............................+..+..+.+++.+||+.+|.+|||+.+++..  ++++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            00000000000000000000000000001111123356788999999999999999999999973  555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.2e-35  Score=270.91  Aligned_cols=266  Identities=17%  Similarity=0.184  Sum_probs=182.7

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|+..+.||+|+||.||++..                   .....+.+|+.+++.+. ||||+++++++...+......
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4788999999999999988642                   12356788999999995 699999999865422222334


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTAR  174 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~k  174 (381)
                      .++||||+++ +|.+++.....     .....+++..++.++.||+.||.|||   ..+++||||||+||+++. ++.+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGR-----GPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcc-----cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEE
Confidence            7999999985 89988853211     11346899999999999999999999   669999999999999998 88999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||+++.........  ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||..    ...........
T Consensus       152 l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~----~~~~~~~~~~~  225 (295)
T cd07837         152 IADLGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG----DSELQQLLHIF  225 (295)
T ss_pred             EeecccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHH
Confidence            99999987654322111  11346888999998765 4578999999999999999999999752    22222111110


Q ss_pred             h--hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 L--SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .  ............. .... . ..............+.....+.+++.+||..||.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~-~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         226 KLLGTPTEQVWPGVSK-LRDW-H-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHhCCCChhhCcchhh-ccch-h-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0  0000000000000 0000 0 00000001111112345677899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-35  Score=276.85  Aligned_cols=266  Identities=18%  Similarity=0.186  Sum_probs=181.3

Q ss_pred             cccccceecCCCceEEEecccc---------------------cHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757           37 NMLEENLISAGTFGFSHLRRQG---------------------AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~---------------------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +|...+.||+|+||.||++...                     ..+.+.+|+.+++++ .||||+++++.+... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            4778899999999999776522                     134678899999999 499999999875431 12345


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++++||+. ++|.+++.          ....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+|
T Consensus        80 ~~~~~~e~~~-~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~k  145 (332)
T cd07857          80 ELYLYEELME-ADLHQIIR----------SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELK  145 (332)
T ss_pred             cEEEEEeccc-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEE
Confidence            6789999985 69999883          4556899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCc--ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      |+|||+++........  .......|+..|+|||++.+ ..++.++||||||+++|++++|..||...... ..+.....
T Consensus       146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~  224 (332)
T cd07857         146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ  224 (332)
T ss_pred             eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH
Confidence            9999999866543221  11122468999999998765 56899999999999999999999997532110 00111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . ......+.+.................................+.+++.+||+.||.+|||+.+++.
T Consensus       225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         225 V-LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             H-hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0 000001111110000000000000000000000111223567889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-35  Score=268.98  Aligned_cols=233  Identities=19%  Similarity=0.248  Sum_probs=175.6

Q ss_pred             cccccccccee--cCCCceEEEecccc-----------cHHHH-HHHHHHHHcc-CCCcccceeeeeccccccCCceEEE
Q 041757           34 VSRNMLEENLI--SAGTFGFSHLRRQG-----------AFKSF-IAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        34 ~~~~~~~~~~l--G~G~fg~V~~~~~~-----------~~~~~-~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..++|...+.+  |.|+||.||++...           ....+ ..|+.....+ +||||+++++.+.     ..+..++
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~i   86 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVL   86 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEE
Confidence            34566666665  99999999876521           11111 1234333333 6999999999954     4668999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEee
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVGD  177 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~D  177 (381)
                      ||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++ .++|+|
T Consensus        87 v~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         87 IMDYIKDGDLFDLLK----------KEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             EEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999994          3447899999999999999999999   66999999999999999988 999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++........      ..++..|+|||++.+..++.++||||||+++|+|++|..||............+....    
T Consensus       154 fg~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----  223 (267)
T PHA03390        154 YGLCKIIGTPSC------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ----  223 (267)
T ss_pred             CccceecCCCcc------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh----
Confidence            999876643321      3488999999999988899999999999999999999999873332221111111110    


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-MTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~vl~  319 (381)
                               ....                ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus       224 ---------~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 ---------QKKL----------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---------cccC----------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                     0000                011245667899999999999999996 588874

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-35  Score=276.40  Aligned_cols=237  Identities=24%  Similarity=0.299  Sum_probs=182.0

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ....|...+.||+|+||.||++..                    ...+.+.+|++++++++|||++++++++.     ..
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   97 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----RE   97 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eC
Confidence            445588899999999999977541                    12356889999999999999999999964     36


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+. |+|.+.+.         .....+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.+
T Consensus        98 ~~~~lv~e~~~-g~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~  164 (317)
T cd06635          98 HTAWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQV  164 (317)
T ss_pred             CeEEEEEeCCC-CCHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCE
Confidence            67899999996 48877774         23456889999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +|+|||++.......      ...++..|+|||++.   ...++.++|||||||++|+|++|..||...    ...... 
T Consensus       165 kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~~~~~-  233 (317)
T cd06635         165 KLADFGSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSAL-  233 (317)
T ss_pred             EEecCCCccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc----cHHHHH-
Confidence            999999987543321      135888999999874   456889999999999999999999997521    111100 


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                              ..+.........                  ....+..+.+++.+||+.+|.+||++.++++.+-.+.
T Consensus       234 --------~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         234 --------YHIAQNESPTLQ------------------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             --------HHHHhccCCCCC------------------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                    000100000000                  1234557889999999999999999999998665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.3e-35  Score=267.15  Aligned_cols=226  Identities=22%  Similarity=0.288  Sum_probs=176.5

Q ss_pred             ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ||.|+||.||++..                    ...+.+.+|+.+++.++||||+++++.+     .+....++||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            68999999877542                    2335688999999999999999999984     4577899999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ++++|.+++.          +...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~~L~~~l~----------~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~  142 (262)
T cd05572          76 LGGELWTILR----------DRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKK  142 (262)
T ss_pred             CCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence            9999999994          3455889999999999999999999   67999999999999999999999999999987


Q ss_pred             cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757          184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD  263 (381)
Q Consensus       184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (381)
                      .......   ....++..|+|||.+.+..++.++|+||||+++|++++|..||......  . .            +...
T Consensus       143 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~-~------------~~~~  204 (262)
T cd05572         143 LKSGQKT---WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--P-M------------EIYN  204 (262)
T ss_pred             cCccccc---ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--H-H------------HHHH
Confidence            6544311   1245788999999988888999999999999999999999998633210  1 1            1111


Q ss_pred             hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                      .......              ....+...+..+.+++.+||+.||++||+     +.|+++
T Consensus       205 ~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         205 DILKGNG--------------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHhccCC--------------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1110000              00011233568999999999999999999     555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=268.63  Aligned_cols=262  Identities=20%  Similarity=0.218  Sum_probs=182.1

Q ss_pred             ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      |...+.||.|+||.||++..                   .....+.+|+++++.++|+|++++++++..   ......++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS---KGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEec---CCCCcEEE
Confidence            56778999999999988642                   123568899999999999999999999643   11378999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++ +|.+++.         .....+++..++.++.|++.||+|||   ..+++|+||+|+||++++++.+||+||
T Consensus        78 v~e~~~~-~l~~~~~---------~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~  144 (287)
T cd07840          78 VFEYMDH-DLTGLLD---------SPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADF  144 (287)
T ss_pred             Eeccccc-cHHHHHh---------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccc
Confidence            9999975 8998884         22357899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      |++.......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..............
T Consensus       145 g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~  222 (287)
T cd07840         145 GLARPYTKRNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPT  222 (287)
T ss_pred             cceeeccCCCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCc
Confidence            9998765543211 112346788999997765 45789999999999999999999997532211 00111111000000


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE-CVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .... ...... ...................... ++..+.+++.+||..+|.+||++.++++
T Consensus       223 ~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         223 DENW-PGVSKL-PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhc-cccccc-hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000 000000 0000000000001111111222 3678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.3e-35  Score=265.86  Aligned_cols=234  Identities=18%  Similarity=0.245  Sum_probs=180.5

Q ss_pred             cccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           37 NMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .|...++||+|+||.||++..                      .....+..|+.+++.++||||+++++++     ....
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence            377889999999999986531                      1223466799999999999999999985     4466


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++....      .....+++..++.++.|++.||.|||   +.+++|+||+|+||+++. +.++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~  145 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELK------HTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLK  145 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHh------hcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEe
Confidence            7899999999999999885321      23457899999999999999999999   669999999999999975 5699


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||++..........  ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...    .. .....   
T Consensus       146 l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~~-~~~~~---  215 (260)
T cd08222         146 IGDFGVSRLLMGSCDLA--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NF-LSVVL---  215 (260)
T ss_pred             ecccCceeecCCCcccc--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cH-HHHHH---
Confidence            99999987764433221  1245788999999988888899999999999999999999997421    11 11111   


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                               ........               ..+..++.++.+++.+||..||++||++.++++
T Consensus       216 ---------~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         216 ---------RIVEGPTP---------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---------HHHcCCCC---------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                     00000000               012345668889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.5e-35  Score=270.88  Aligned_cols=239  Identities=21%  Similarity=0.250  Sum_probs=182.3

Q ss_pred             cccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccccc
Q 041757           37 NMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~   91 (381)
                      +|...+.||+|+||.||++..                        ...+.+.+|++++.++ +||||+++++.     +.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence            477889999999999987431                        1224577899999999 59999999988     45


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   ..+++||||+|+||+++.++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~  142 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLY----------QREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEG  142 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHh----------hcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCC
Confidence            5778899999999999999983          3456888999999999999999999   67999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc--cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE--VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      .++|+|||++.......... .....|+..|+|||.+.+..  .+.++||||||+++|+|++|..||...... ..... 
T Consensus       143 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~-  219 (288)
T cd05583         143 HVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSE-  219 (288)
T ss_pred             CEEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHH-
Confidence            99999999987654432211 11245889999999987654  788999999999999999999998522110 00111 


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                                 +........+.                .+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus       220 -----------~~~~~~~~~~~----------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         220 -----------ISRRILKSKPP----------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----------HHHHHHccCCC----------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                       11111110000                012344578889999999999999999988776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.4e-35  Score=269.47  Aligned_cols=225  Identities=24%  Similarity=0.260  Sum_probs=172.2

Q ss_pred             ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ||+|+||+||++..                    .....+.+|+++++.++||||+++++++     ...+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            69999999987531                    1234567899999999999999999984     4577899999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ++++|.+++..        .....+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.++|+|||.+..
T Consensus        76 ~~~~L~~~l~~--------~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~  144 (277)
T cd05577          76 NGGDLKYHIYN--------VGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVE  144 (277)
T ss_pred             CCCcHHHHHHH--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence            99999999853        12246899999999999999999999   67999999999999999999999999999876


Q ss_pred             cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757          184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD  263 (381)
Q Consensus       184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (381)
                      ........   ...++..|+|||++.+..++.++||||||+++|+|++|+.||....... .....            ..
T Consensus       145 ~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~------------~~  208 (277)
T cd05577         145 LKGGKKIK---GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEEL------------KR  208 (277)
T ss_pred             hccCCccc---cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHH------------Hh
Confidence            54322211   2347889999999988889999999999999999999999985322110 00110            00


Q ss_pred             hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                      .... .+               ...+......+.+++.+||+.||.+||++.+
T Consensus       209 ~~~~-~~---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         209 RTLE-MA---------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             cccc-cc---------------ccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence            0000 00               0011234567889999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9e-36  Score=273.72  Aligned_cols=241  Identities=22%  Similarity=0.246  Sum_probs=177.0

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...++||+|+||.||.+..                  .....+.+|+.++.++. |+||+++++++.     .....
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~   78 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDC   78 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcE
Confidence            4667778999999999976431                  23456788999999996 999999999853     46778


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      +++|||+.. ++.++......     .....+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+
T Consensus        79 ~~~~e~~~~-~l~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~  150 (288)
T cd06616          79 WICMELMDI-SLDKFYKYVYE-----VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLC  150 (288)
T ss_pred             EEEEecccC-CHHHHHHHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEe
Confidence            999999864 66554321000     223568999999999999999999994  2489999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCC---ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN---EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |||++..........   ...|+..|+|||++.+.   .++.++|||||||++|+|++|+.||....   .....     
T Consensus       151 dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~-----  219 (288)
T cd06616         151 DFGISGQLVDSIAKT---RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQ-----  219 (288)
T ss_pred             ecchhHHhccCCccc---cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHH-----
Confidence            999987654332221   13478899999998776   68999999999999999999999975221   00000     


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              +.......+...           .......++.++.+++.+||+.||++|||+.+|++
T Consensus       220 --------~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         220 --------LTQVVKGDPPIL-----------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             --------HhhhcCCCCCcC-----------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    000000000000           00001235667899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=268.74  Aligned_cols=257  Identities=20%  Similarity=0.256  Sum_probs=179.7

Q ss_pred             ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      |+..++||.|++|.||++..                   ...+.+.+|+++++.++||||+++++++.     +.+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            56778999999999987541                   12356889999999999999999999954     4688999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+. ++|.+++..        .....+++..++.++.|++.||+|||   +.+++||||+|+||+++.++.++|+||
T Consensus        76 v~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df  143 (283)
T cd07835          76 VFEFLD-LDLKKYMDS--------SPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADF  143 (283)
T ss_pred             EEeccC-cCHHHHHhh--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeec
Confidence            999995 699999842        11246899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--hh
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LS  255 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~~  255 (381)
                      |++..........  ....++..|+|||++.+. .++.++||||||+++|+|++|+.||...    ..........  ..
T Consensus       144 ~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~  217 (283)
T cd07835         144 GLARAFGVPVRTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD----SEIDQLFRIFRTLG  217 (283)
T ss_pred             ccccccCCCcccc--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhC
Confidence            9997654332111  113468899999987664 5788999999999999999999997522    1111111100  00


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ......... ....+.-... ................+..+.+++.+||+.||.+|||+.++++
T Consensus       218 ~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         218 TPDEDVWPG-VTSLPDYKPT-FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CCChHHhhh-hhhchhhhhh-cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000 0000000000 0000000001112234467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.4e-35  Score=264.01  Aligned_cols=233  Identities=19%  Similarity=0.230  Sum_probs=184.8

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...++||.|+||.||++..                   .....+.+|++++++++|+||+++++++     ......+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence            477889999999999987531                   2245678899999999999999999985     4468899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++....      .....+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|
T Consensus        76 ~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d  146 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRK------KKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGD  146 (256)
T ss_pred             EEehhcCCCCHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEee
Confidence            9999999999999985321      12356889999999999999999999   67999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||++.........    ...++..|+|||.+.+..++.++|+||||+++|++++|+.||....     ........    
T Consensus       147 ~g~~~~~~~~~~~----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~----  213 (256)
T cd08530         147 LGISKVLKKNMAK----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRYKV----  213 (256)
T ss_pred             ccchhhhccCCcc----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHH----
Confidence            9999876554211    1347889999999988889999999999999999999999975221     11111110    


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              .....               ...+.....++.+++.+||+.+|++|||+.++++
T Consensus       214 --------~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         214 --------QRGKY---------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             --------hcCCC---------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    00000               0012245667899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-35  Score=266.58  Aligned_cols=257  Identities=22%  Similarity=0.253  Sum_probs=184.2

Q ss_pred             ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      |...+.||.|++|.||++..                   .....+.+|+.++++++|+||+++++++     ......++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence            55678899999999977641                   1245678899999999999999999995     44688999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++ +|.+++.         .....+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.++|+||
T Consensus        76 v~e~~~~-~l~~~l~---------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df  142 (283)
T cd05118          76 VFEFMDT-DLYKLIK---------DRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADF  142 (283)
T ss_pred             EEeccCC-CHHHHHH---------hhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeee
Confidence            9999975 8888884         23357899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--hh
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LS  255 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--~~  255 (381)
                      |.+.........  .....++..|+|||.+.+. .++.++||||||+++|++++|+.||...    .....+....  ..
T Consensus       143 ~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~----~~~~~~~~~~~~~~  216 (283)
T cd05118         143 GLARSFGSPVRP--YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK----SEIDQLFKIFRTLG  216 (283)
T ss_pred             eeeEecCCCccc--ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHcC
Confidence            999876554311  1123478889999998776 7899999999999999999999997522    2221111110  00


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ................... ..............+..+.++.+++.+||+.||.+||++.+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         217 TPDPEVWPKFTSLARNYKF-SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             CCchHhcccchhhhhhhhh-hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000100000000000000 00000001112223456788999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-35  Score=274.97  Aligned_cols=267  Identities=16%  Similarity=0.182  Sum_probs=183.2

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~   93 (381)
                      +.++|...+.||+|+||.||++..                   .....+.+|+.+++.++||||+++++++.... ....
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            357899999999999999987541                   12345788999999999999999999865321 1123


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++|+||+.. +|..++            ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~  156 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM------------GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCEL  156 (342)
T ss_pred             ceEEEEeccccc-CHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence            456999999964 777665            235788899999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||+++......     ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...    .....+...
T Consensus       157 kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~----~~~~~~~~~  227 (342)
T cd07879         157 KILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK----DYLDQLTQI  227 (342)
T ss_pred             EEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Confidence            999999987643322     12457889999998876 46889999999999999999999998522    111111110


Q ss_pred             --HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhh
Q 041757          253 --ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSIK  325 (381)
Q Consensus       253 --~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~--L~~i~  325 (381)
                        ........+.+..........................+.....+.+++.+||+.||.+||++.+++..  ++...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence              00011111111110000000000000000000001112345678899999999999999999999853  55543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.3e-36  Score=300.28  Aligned_cols=241  Identities=20%  Similarity=0.288  Sum_probs=174.3

Q ss_pred             cccccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeecc---------
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLG---------   87 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---------   87 (381)
                      ..+|++.++||+||||.|++++..                  ......+|+..|.+|+|||||++|..+++         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            467888999999999999887632                  34557789999999999999999887543         


Q ss_pred             ---------------------------------------------cc----------------------c----------
Q 041757           88 ---------------------------------------------VD----------------------Y----------   90 (381)
Q Consensus        88 ---------------------------------------------~~----------------------~----------   90 (381)
                                                                   ..                      .          
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                         00                      0          


Q ss_pred             --------------------cCC--------ceEEEEEEcccCCCHHHhhccccCCcccccCCCcc-cHHHHHHHHHHHH
Q 041757           91 --------------------QGN--------DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNL-NLLRRLNIAIDVA  141 (381)
Q Consensus        91 --------------------~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l-~~~~~~~i~~qi~  141 (381)
                                          ..+        ..+||-||||+.-.|.+++..          .... .....++++++|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----------N~~~~~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----------NHFNSQRDEAWRLFREIL  707 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----------cccchhhHHHHHHHHHHH
Confidence                                001        356899999999888877742          1111 4677899999999


Q ss_pred             HHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCC----------------CCCcccccCccCccceeCC
Q 041757          142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP----------------TRTQTSSIDVKGSIGYIAP  205 (381)
Q Consensus       142 ~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~----------------~~~~~~~~~~~gt~~y~aP  205 (381)
                      +||.|+|   ++|||||||||.||+++.+..|||+|||+|.....                .......+..+||.-|+||
T Consensus       708 EGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  708 EGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            9999999   77999999999999999999999999999987220                0111123457799999999


Q ss_pred             CCcCCC---ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhh
Q 041757          206 EYGVGN---EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQT  282 (381)
Q Consensus       206 E~l~~~---~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  282 (381)
                      |++.+.   .|+.|+|+||+|||++||+.   ||....+    -...        +.++-+..+..+             
T Consensus       785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----Ra~i--------L~~LR~g~iP~~-------------  836 (1351)
T KOG1035|consen  785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----RASI--------LTNLRKGSIPEP-------------  836 (1351)
T ss_pred             HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH----HHHH--------HHhcccCCCCCC-------------
Confidence            998875   49999999999999999984   4431111    1111        111111111000             


Q ss_pred             hhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          283 QAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       283 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         ..+..+....-.+++.++++.||.+|||+.|+++
T Consensus       837 ---~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  837 ---ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ---cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence               0111233345567888999999999999999986

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-35  Score=264.74  Aligned_cols=236  Identities=18%  Similarity=0.222  Sum_probs=181.7

Q ss_pred             ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .+|...+.||+|+||.||++..                      .....+.+|++++++++|+||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            4788999999999999977641                      123477889999999999999999998643   234


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~  145 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLK----------AYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNV  145 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCE
Confidence            56889999999999999984          3345788899999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCC-cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|+|||+++....... ........++..|+|||++.+..++.++|||||||++|++++|+.||...    .........
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~  221 (264)
T cd06653         146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY----EAMAAIFKI  221 (264)
T ss_pred             EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc----CHHHHHHHH
Confidence            9999999986543211 11111245889999999998888999999999999999999999998522    111111110


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                   .....              ....+......+.+++.+||. +|..||++.+++.
T Consensus       222 -------------~~~~~--------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         222 -------------ATQPT--------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -------------HcCCC--------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                         00000              001123455678999999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.2e-35  Score=262.93  Aligned_cols=237  Identities=21%  Similarity=0.279  Sum_probs=186.5

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||+|+||.||.+..                   ...+.+.+|+.++++++|+||+++++.+..   ......+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD---EEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEec---CCCCeEE
Confidence            477789999999999977642                   235678999999999999999999999643   1127889


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +|+||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|
T Consensus        78 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d  144 (260)
T cd06606          78 IFLEYVSGGSLSSLLK----------KFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLAD  144 (260)
T ss_pred             EEEEecCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcc
Confidence            9999999999999994          3347899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||.+................++..|+|||.+.+...+.++||||||+++|++++|..||....    ........     
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~-----  215 (260)
T cd06606         145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYK-----  215 (260)
T ss_pred             cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHh-----
Confidence            999987766543111122458899999999988889999999999999999999999986322    11110000     


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         +...   ..               ....+...+..+.+++.+||+.||.+||++.+++.
T Consensus       216 ---~~~~---~~---------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         216 ---IGSS---GE---------------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---cccc---CC---------------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               0000   00               00012234678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=262.54  Aligned_cols=182  Identities=27%  Similarity=0.334  Sum_probs=159.2

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||+|-+++.                    ..+..-+.|-++|+..+||.+..+-..     ++..+.
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~dr  242 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQDR  242 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCce
Confidence            6788889999999999965542                    234455678899999999999887655     678999


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      ++.||||..||.|.-+|          .+...+++....-+..+|+.||.|||   +.+||.||||.+|.|+|.+|++||
T Consensus       243 lCFVMeyanGGeLf~HL----------srer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHL----------SRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             EEEEEEEccCceEeeeh----------hhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEe
Confidence            99999999999999988          56778999999999999999999999   679999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +|||+++.--....  ....++|||.|.|||++....|+.++|.|.+||++|||++|+.||.
T Consensus       310 tDFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  310 TDFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             eecccchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence            99999985433222  2234899999999999999999999999999999999999999986

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.9e-35  Score=262.63  Aligned_cols=235  Identities=22%  Similarity=0.319  Sum_probs=185.8

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||.|+||.||.+..                   ...+.+.+|+++++.++|+|++++++.+.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence            577889999999999976542                   24567889999999999999999999853     468899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +|+||+++++|.+++....      .....+++..+..++.+++.||.|||   ..+++|+||+|+||+++.++.++|+|
T Consensus        76 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d  146 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGD  146 (258)
T ss_pred             EEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECC
Confidence            9999999999999995321      12467899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||.+..........  ....|++.|+|||.+.+..++.++||||+|+++|+|++|..||....     ...         
T Consensus       147 ~~~~~~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~---------  210 (258)
T cd08215         147 FGISKVLSSTVDLA--KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLE---------  210 (258)
T ss_pred             ccceeecccCccee--cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHH---------
Confidence            99998765543111  12458889999999988889999999999999999999999975221     111         


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         +..........               ..+...+..+.+++.+||..+|++|||+.++++
T Consensus       211 ---~~~~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         211 ---LALKILKGQYP---------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ---HHHHHhcCCCC---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               11111110000               001134567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-35  Score=275.10  Aligned_cols=264  Identities=18%  Similarity=0.211  Sum_probs=184.3

Q ss_pred             hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-cc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQ   91 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~   91 (381)
                      -...++|...+.||+|+||.||++..                   .....+.+|+.+|++++||||+++++++.... ..
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            34578899999999999999977531                   12345788999999999999999999865311 11


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+ +++|.+++.           ...+++..++.++.|++.||.|||   ..+|+||||||+||+++.++
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~  155 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK-----------HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDC  155 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence            123568999999 779998873           245889999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      .++|+|||++........     ...+++.|+|||++.+ ..++.++||||||+++|++++|..||....    ......
T Consensus       156 ~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~----~~~~~~  226 (343)
T cd07880         156 ELKILDFGLARQTDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD----HLDQLM  226 (343)
T ss_pred             CEEEeecccccccccCcc-----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHH
Confidence            999999999976543221     2347889999998876 458899999999999999999999986321    111111


Q ss_pred             HHH-h-hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMA-L-SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~-~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ... . .....++..................................+.+++.+|++.||.+|||+.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         227 EIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            100 0 00011111111000000000000000000011112345567889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9e-35  Score=267.42  Aligned_cols=235  Identities=21%  Similarity=0.261  Sum_probs=177.7

Q ss_pred             cccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccccc
Q 041757           37 NMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~   91 (381)
                      +|...+.||.|+||.||.+..                        ...+.+.+|++++.++ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            578889999999999987542                        1235577899999999 599999999884     4


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .+...++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++||||+|+||+++.++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~  142 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLS----------QRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNG  142 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCC
Confidence            5678899999999999999994          3456888899999999999999999   67999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC--ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN--EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      .+||+|||++.......... .....|+..|+|||.+...  .++.++||||||+++|+|++|..||...... ....  
T Consensus       143 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~--  218 (290)
T cd05613         143 HVVLTDFGLSKEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQA--  218 (290)
T ss_pred             CEEEeeCccceecccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHH--
Confidence            99999999997654432211 1124588999999998753  4678999999999999999999998522111 1111  


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                                ++........+.                .+......+.+++.+||+.||++||     ++.+++.
T Consensus       219 ----------~~~~~~~~~~~~----------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         219 ----------EISRRILKSEPP----------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----------HHHHHhhccCCC----------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                      111111111100                0123455778999999999999997     5555543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4e-35  Score=265.41  Aligned_cols=227  Identities=23%  Similarity=0.307  Sum_probs=176.3

Q ss_pred             ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ||.|+||.||++..                    ...+.+.+|++++++++||||+++++.+     ......++||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            68899999977652                    2345788899999999999999999884     4578899999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ++++|.+++.          +...+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~  142 (265)
T cd05579          76 PGGDLASLLE----------NVGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV  142 (265)
T ss_pred             CCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence            9999999994          3347899999999999999999999   66999999999999999999999999999876


Q ss_pred             cCCCCCc------ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          184 LPPTRTQ------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       184 ~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      .......      .......++..|+|||.......+.++||||||+++|++++|..||....     ..          
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~----------  207 (265)
T cd05579         143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PE----------  207 (265)
T ss_pred             cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HH----------
Confidence            5433211      11122457889999999988889999999999999999999999985221     01          


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE--CVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                        +...........                .+..  .+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus       208 --~~~~~~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         208 --EIFQNILNGKIE----------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --HHHHHHhcCCcC----------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence              111111100000                0111  256789999999999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.1e-34  Score=269.89  Aligned_cols=240  Identities=18%  Similarity=0.191  Sum_probs=167.3

Q ss_pred             cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757           59 AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI  138 (381)
Q Consensus        59 ~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  138 (381)
                      ..+.+.+|+++++.++|+||+++++++     ...+..+++|||+++|+|.+++..        .....+++..+..++.
T Consensus        42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~l~~--------~~~~~~~~~~~~~~~~  108 (314)
T cd08216          42 DLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLMAYGSCEDLLKT--------HFPEGLPELAIAFILK  108 (314)
T ss_pred             HHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEeccCCCCHHHHHHH--------hcccCCCHHHHHHHHH
Confidence            456889999999999999999999984     457788999999999999999953        1234578899999999


Q ss_pred             HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCc-----ccccCccCccceeCCCCcCC--C
Q 041757          139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVG--N  211 (381)
Q Consensus       139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~  211 (381)
                      |++.||.|||   +.+|+||||||+||+++.++.+||+|||.+.........     .......++..|+|||++..  .
T Consensus       109 ~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  185 (314)
T cd08216         109 DVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ  185 (314)
T ss_pred             HHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCC
Confidence            9999999999   669999999999999999999999999988755432211     11112347788999999876  3


Q ss_pred             ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchh-hh-----hcccchhhhhH
Q 041757          212 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK-LV-----VRGDQKQTQAK  285 (381)
Q Consensus       212 ~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~-----~~~~~~~~~~~  285 (381)
                      .++.++|||||||++|||++|..||......    ...... .......+++......... ..     ...........
T Consensus       186 ~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (314)
T cd08216         186 GYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEK-VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVD  260 (314)
T ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-HhccCccccccCchhhhcCCcCcccccccccchhhhhh
Confidence            5889999999999999999999998632111    111110 0100000000000000000 00     00000000000


Q ss_pred             HHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          286 INIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       286 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .........++.+++.+||..||++|||+.++++
T Consensus       261 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         261 HPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            1112334567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.6e-35  Score=269.74  Aligned_cols=229  Identities=19%  Similarity=0.246  Sum_probs=177.6

Q ss_pred             ccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           40 EENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        40 ~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      ...+||+|+||.||.+..                 .....+.+|+.+++.++|+||+++++.+     ...+..++||||
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~   98 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVMEF   98 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEec
Confidence            346799999999977532                 2345688899999999999999999985     447789999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +++++|.+++.           ...+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++.
T Consensus        99 ~~~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~  164 (292)
T cd06657          99 LEGGALTDIVT-----------HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCA  164 (292)
T ss_pred             CCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccce
Confidence            99999999873           235788999999999999999999   6699999999999999999999999999987


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHH
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIV  262 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (381)
                      .........  ....++..|+|||.+.+..++.++||||||+++|+|++|..||...    ...... .         .+
T Consensus       165 ~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~----~~~~~~-~---------~~  228 (292)
T cd06657         165 QVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAM-K---------MI  228 (292)
T ss_pred             ecccccccc--cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHH-H---------HH
Confidence            654332111  1245889999999998888899999999999999999999997521    111110 0         00


Q ss_pred             hhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          263 DSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       263 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...+....                ......+..+.+++.+||..||.+||++.++++
T Consensus       229 ~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         229 RDNLPPKL----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HhhCCccc----------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            00000000                001134456788899999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.6e-35  Score=268.65  Aligned_cols=269  Identities=19%  Similarity=0.207  Sum_probs=183.0

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-----
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-----   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----   89 (381)
                      ..++|...++||+|+||.||++..                   .....+.+|+++++.++||||+++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            357899999999999999977542                   12246778999999999999999999875421     


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                      .......++|+||+++ ++..++.         .....+++..++.++.|++.||+|||   ..+|+|+||||+||++++
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~  151 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLE---------SGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNN  151 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHh---------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            1123478999999976 7777764         23456899999999999999999999   669999999999999999


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      ++.+||+|||++........... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+..
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~  229 (302)
T cd07864         152 KGQIKLADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLEL  229 (302)
T ss_pred             CCcEEeCcccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Confidence            99999999999987654332111 11236788999998765 3578899999999999999999999852210 001111


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +... ............... +......................+..+.+++.+||+.||.+|||+.+++.
T Consensus       230 ~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         230 ISRL-CGSPCPAVWPDVIKL-PYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHH-hCCCChhhccccccc-ccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111 000000000000000 00000000000000000111124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.3e-35  Score=272.18  Aligned_cols=265  Identities=18%  Similarity=0.194  Sum_probs=178.3

Q ss_pred             ceecCC--CceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAG--TFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G--~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ..||+|  +||+||++..                   ...+.+.+|+.+++.++||||+++++++     ...+..++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            456666  8899977642                   1246788999999999999999999995     4477889999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+.+++|.+++...        ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.
T Consensus        79 e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~  147 (328)
T cd08226          79 PFMAYGSANSLLKTY--------FPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSH  147 (328)
T ss_pred             ecccCCCHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHH
Confidence            999999999998531        2345888999999999999999999   66999999999999999999999999986


Q ss_pred             ceecCCCCCcc-----cccCccCccceeCCCCcCCC--ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          181 ARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVGN--EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       181 ~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      +..........     ......++..|+|||++.+.  .++.++|||||||++|+|++|..||.......    ......
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----~~~~~~  223 (328)
T cd08226         148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKL  223 (328)
T ss_pred             HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH----HHHHHh
Confidence            54332211110     00012246679999998763  47899999999999999999999986332111    110000


Q ss_pred             hhch------------HHHHHhhhhccC---chhhhh---cccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          254 LSNH------------VKDIVDSILLND---DEKLVV---RGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       254 ~~~~------------~~~~~~~~l~~~---~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                      ....            ............   ......   ................+...+.+++.+||+.||++|||+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~  303 (328)
T cd08226         224 KGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS  303 (328)
T ss_pred             cCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHH
Confidence            0000            000000000000   000000   0000000011122345677899999999999999999999


Q ss_pred             HHHH--HHHHhhh
Q 041757          316 NVVH--ELQSIKN  326 (381)
Q Consensus       316 ~vl~--~L~~i~~  326 (381)
                      ++++  .+..+.+
T Consensus       304 e~l~~~~~~~~~~  316 (328)
T cd08226         304 SLLSHAFFKQVKE  316 (328)
T ss_pred             HHhhCHHHHHHHH
Confidence            9984  4444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=263.90  Aligned_cols=258  Identities=21%  Similarity=0.224  Sum_probs=179.3

Q ss_pred             ccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      |...+.||.|+||+||++...                  ......+|+..+.+++ |+||+++++++.     ..+..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence            567789999999999876521                  1123457999999999 999999999954     4788999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+ +|+|.+++..        .....+++..+..++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+||
T Consensus        76 v~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~  143 (283)
T cd07830          76 VFEYM-EGNLYQLMKD--------RKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADF  143 (283)
T ss_pred             EEecC-CCCHHHHHHh--------cccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeec
Confidence            99999 8899998852        12347899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      |++..........   ...++..|+|||++.. ..++.++||||||+++|+|++|+.||......+ .............
T Consensus       144 ~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~  219 (283)
T cd07830         144 GLAREIRSRPPYT---DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPT  219 (283)
T ss_pred             ccceeccCCCCcC---CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCC
Confidence            9998765433222   2357889999998754 457899999999999999999999975321110 0000000000000


Q ss_pred             HHHHHhhh-hccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSI-LLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .....+.. +........   ..................+.+++.+||+.||++|||+.|++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         220 KQDWPEGYKLASKLGFRF---PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhhhHhhhhccccccc---cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000 000000000   000000001111122567899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-35  Score=275.31  Aligned_cols=265  Identities=17%  Similarity=0.203  Sum_probs=184.4

Q ss_pred             hhhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc-
Q 041757           31 ILDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY-   90 (381)
Q Consensus        31 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-   90 (381)
                      +....++|...+.||+|+||.||++..                   ...+.+.+|+.++++++||||+++++++...+. 
T Consensus        10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            335678899999999999999987642                   123456789999999999999999987543111 


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ......++|+||+ +++|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.+
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~  154 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVK-----------CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNED  154 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCC
Confidence            1223489999999 669999883           246899999999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      +.++|+|||++.......     ....++..|+|||.+.+ ..++.++||||||+++|++++|+.||...    .....+
T Consensus       155 ~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~----~~~~~~  225 (343)
T cd07851         155 CELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS----DHIDQL  225 (343)
T ss_pred             CCEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChHHHH
Confidence            999999999997654331     12457889999998765 46789999999999999999999997522    111111


Q ss_pred             HH--HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AK--MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~--~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..  .........+..................................+.+++.+||+.||.+|||+.+|++
T Consensus       226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         226 KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            10  00000011111111000000000000000000001111234678999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-34  Score=259.73  Aligned_cols=233  Identities=23%  Similarity=0.290  Sum_probs=183.5

Q ss_pred             cccccceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      +|...+.||+|+||.||.+...                 ..+.+.+|++++++++|+||+++++.+.     .....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence            4677889999999999776421                 4467889999999999999999999853     46788999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      +||+++++|.+++..         ....+++..+..++.|++.||.+||   ..+++|+||+|+||+++.++.++|+|||
T Consensus        76 ~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~  143 (253)
T cd05122          76 MEFCSGGSLKDLLKS---------TNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFG  143 (253)
T ss_pred             EecCCCCcHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecc
Confidence            999999999999852         2257899999999999999999999   6799999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      .+........   .....++..|+|||.+.+..++.++||||||+++|++++|+.||....    ........ ....  
T Consensus       144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~-~~~~--  213 (253)
T cd05122         144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP----PMKALFKI-ATNG--  213 (253)
T ss_pred             cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc----hHHHHHHH-HhcC--
Confidence            9887655432   112458899999999988888999999999999999999999975221    10000000 0000  


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            ....+.                 ....+..+.+++.+||..||.+|||+.++++
T Consensus       214 ------~~~~~~-----------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         214 ------PPGLRN-----------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ------CCCcCc-----------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  000000                 1122567899999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9e-35  Score=265.91  Aligned_cols=225  Identities=20%  Similarity=0.217  Sum_probs=169.3

Q ss_pred             eecCCCceEEEecccc--------------------cHHHHHHHHH---HHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           43 LISAGTFGFSHLRRQG--------------------AFKSFIAECK---ALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        43 ~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~---~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      +||+|+||.||++...                    ....+..|..   .++...||||+++++++     ...+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            4899999999875421                    1112344443   34445799999999884     457789999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++|+|..++.          ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||
T Consensus        76 ~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg  142 (278)
T cd05606          76 LDLMNGGDLHYHLS----------QHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG  142 (278)
T ss_pred             EecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCc
Confidence            99999999999883          4457899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++.........    ...|+..|+|||++.+ ..++.++||||+|+++|+|++|+.||........  ......      
T Consensus       143 ~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~------  210 (278)
T cd05606         143 LACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRM------  210 (278)
T ss_pred             CccccCccCCc----CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHH------
Confidence            98765432221    2458999999999875 4689999999999999999999999863311111  000000      


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                            .....+                ..+...+..+.+++.+|+..+|.+||     ++.++++
T Consensus       211 ------~~~~~~----------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         211 ------TLTMAV----------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ------hhccCC----------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                  000000                00123456788999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-35  Score=264.99  Aligned_cols=227  Identities=20%  Similarity=0.247  Sum_probs=171.2

Q ss_pred             ceecCCCceEEEecccc--------------------cHHHHHHHHHHHH-ccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRRQG--------------------AFKSFIAECKALR-NIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      +.||.|+||.||++...                    ....+..|..++. ..+|+||+++++++     ...+..++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            56999999999876421                    1123344555444 45799999999995     4477899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+
T Consensus        77 e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  143 (260)
T cd05611          77 EYLNGGDCASLIK----------TLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL  143 (260)
T ss_pred             eccCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeeccc
Confidence            9999999999993          3456889999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      +.......      ...++..|+|||.+.+..++.++||||||+++|++++|..||.....     .....        .
T Consensus       144 ~~~~~~~~------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~--------~  204 (260)
T cd05611         144 SRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFD--------N  204 (260)
T ss_pred             ceeccccc------cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHH--------H
Confidence            87643311      24578899999999888889999999999999999999999852211     11100        0


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      +.........                .....++..+.+++.+||+.||++||++.++.+.|
T Consensus       205 ~~~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         205 ILSRRINWPE----------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHhcccCCCC----------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            0000000000                01124567889999999999999999886665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.1e-35  Score=266.63  Aligned_cols=233  Identities=22%  Similarity=0.327  Sum_probs=183.8

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|...+.||.|+||.||.+..                    ...+.+.+|+.+++++. |+||+++++++     ...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            4688899999999999987542                    12356788999999998 99999999984     4577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++.          ....+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~  142 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIR----------KYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIK  142 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEE
Confidence            8999999999999999994          4457999999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCc------------------ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757          175 VGDFGLARFLPPTRTQ------------------TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS  236 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf  236 (381)
                      |+|||++.........                  .......++..|+|||+.....++.++||||||++++++++|..||
T Consensus       143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence            9999998876543321                  1112245788999999988888999999999999999999999997


Q ss_pred             CccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH--
Q 041757          237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM--  314 (381)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--  314 (381)
                      ....    ....+         ......    ..                ..+...+..+.+++.+||+.+|.+|||+  
T Consensus       223 ~~~~----~~~~~---------~~~~~~----~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  269 (280)
T cd05581         223 RGSN----EYLTF---------QKILKL----EY----------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNE  269 (280)
T ss_pred             CCcc----HHHHH---------HHHHhc----CC----------------CCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence            6221    11100         011000    00                0012345678899999999999999999  


Q ss_pred             --HHHHH
Q 041757          315 --TNVVH  319 (381)
Q Consensus       315 --~~vl~  319 (381)
                        .++++
T Consensus       270 ~~~~ll~  276 (280)
T cd05581         270 GYDELKA  276 (280)
T ss_pred             CHHHHhc
Confidence              66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.3e-35  Score=271.43  Aligned_cols=233  Identities=23%  Similarity=0.293  Sum_probs=178.7

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..+.|...+.||+|+||.||++..                    ...+.+.+|+++++.++|+|++++++++.     ..
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   87 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----RE   87 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cC
Confidence            445578889999999999986541                    12346788999999999999999999964     36


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+. |+|.+++.         .....+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.+
T Consensus        88 ~~~~lv~e~~~-~~l~~~~~---------~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~  154 (308)
T cd06634          88 HTAWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLV  154 (308)
T ss_pred             CeeEEEEEccC-CCHHHHHH---------HcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcE
Confidence            78899999996 58887774         23345789999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +|+|||++.......      ...++..|+|||++.   ...++.++|||||||++|+|++|..||....    ..... 
T Consensus       155 kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~-  223 (308)
T cd06634         155 KLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSAL-  223 (308)
T ss_pred             EECCcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc----HHHHH-
Confidence            999999987654322      134788999999874   3467889999999999999999999974221    00000 


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                              ..+..... ...                 ........+.+++.+||..+|.+||++.++++.-
T Consensus       224 --------~~~~~~~~-~~~-----------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         224 --------YHIAQNES-PAL-----------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --------HHHhhcCC-CCc-----------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                    00000000 000                 0123456788999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=262.01  Aligned_cols=261  Identities=20%  Similarity=0.223  Sum_probs=181.7

Q ss_pred             ccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHcc---CCCcccceeeeeccccccCCce
Q 041757           38 MLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      |+..++||.|+||.||++...                   ....+.+|+.+++++   .|+||+++++++...+......
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999776521                   123566788887766   5999999999976533223345


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .+++|||+.+ +|.+++..        .....+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.+||
T Consensus        81 ~~l~~e~~~~-~l~~~l~~--------~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l  148 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSK--------CPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKI  148 (287)
T ss_pred             eEEEehhccc-CHHHHHHH--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEE
Confidence            8999999974 89988852        12235899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++..........   ...++..|+|||++.+..++.++||||||+++|+|++|..||...... ..+..+......
T Consensus       149 ~dfg~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~  224 (287)
T cd07838         149 ADFGLARIYSFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGL  224 (287)
T ss_pred             eccCcceeccCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCC
Confidence            9999998765433221   134788999999999888999999999999999999999997532211 111111110000


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .........   ........  ............+.....+.+++.+||+.||.+||++.+++.
T Consensus       225 ~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         225 PSEEEWPRN---VSLPRSSF--PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CChHhcCCC---cccchhhc--ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000000000   00000000  000001112223345678889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-34  Score=266.67  Aligned_cols=258  Identities=19%  Similarity=0.232  Sum_probs=178.5

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...+.||+|+||.||++..                   ...+.+.+|++++++++||||+++++++     ......
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            4688899999999999988642                   1235678899999999999999999995     457789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEE
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARV  175 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl  175 (381)
                      ++||||++ ++|.+++..        .....+++..+..++.||+.||+|||   ..+++||||+|+||+++. ++.+||
T Consensus        77 ~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl  144 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDS--------SPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKL  144 (294)
T ss_pred             EEEEeccc-ccHHHHHHh--------CCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEE
Confidence            99999996 588887742        12334578888899999999999999   669999999999999985 557999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH-
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-  253 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~-  253 (381)
                      +|||++..........  ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||....    ......... 
T Consensus       145 ~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~----~~~~~~~~~~  218 (294)
T PLN00009        145 ADFGLARAFGIPVRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS----EIDELFKIFR  218 (294)
T ss_pred             cccccccccCCCcccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHH
Confidence            9999997654322111  12347889999998866 457899999999999999999999975321    111111100 


Q ss_pred             -hhchHHHHHhhhhc-cCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 -LSNHVKDIVDSILL-NDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 -~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       .............. .+... ...  ...........+.....+.+++.+|++.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        219 ILGTPNEETWPGVTSLPDYKS-AFP--KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HhCCCChhhccccccchhhhh-hcc--cCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00000000000000 00000 000  00000000111234567889999999999999999999986

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-34  Score=268.49  Aligned_cols=268  Identities=18%  Similarity=0.174  Sum_probs=182.9

Q ss_pred             cccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccc---cC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY---QG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---~~   92 (381)
                      .++|...++||.|+||.||++...                   ....+.+|+++++.++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999886521                   12457889999999999999999998654211   23


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+.+ +|...+.         .....+++..+..++.|+++||.|||   +.+++|+||||+||++++++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~---------~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~  153 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLE---------NPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGI  153 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHh---------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCC
Confidence            4567999999965 7777774         23456899999999999999999999   679999999999999999999


Q ss_pred             eEEeecccceecCCCCCccc---------ccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          173 ARVGDFGLARFLPPTRTQTS---------SIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~---------~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      ++|+|||+++..........         .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus       154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~  233 (311)
T cd07866         154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI  233 (311)
T ss_pred             EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999976544322111         1123568889999987653 5789999999999999999999997522111


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhh-hccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSI-LLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       ...................... +........   ..................+.+++.+||+.||.+|||+.+++.
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         234 -DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHS---FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             -HHHHHHHHHhCCCChhhchhhhhccccccccc---CCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence             0011111100000000000000 000000000   000000001111223367889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=259.55  Aligned_cols=231  Identities=23%  Similarity=0.324  Sum_probs=184.2

Q ss_pred             cccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +|...+.||+|+||.||.+..                   .....+.+|++++++++|+|++++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence            477889999999999987531                   2456789999999999999999999985     3467899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|
T Consensus        76 ~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d  142 (254)
T cd06627          76 IILEYAENGSLRQIIK----------KFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLAD  142 (254)
T ss_pred             EEEecCCCCcHHHHHH----------hccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEec
Confidence            9999999999999983          3467899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||.+.........  .....++..|+|||.+.+..++.++||||||+++|+|++|..||....    ........     
T Consensus       143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~-----  211 (254)
T cd06627         143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRI-----  211 (254)
T ss_pred             cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHH-----
Confidence            9999876554332  112458899999999888778999999999999999999999975221    11111000     


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          ...   ..+                ..+...+..+.+++.+||..+|++|||+.+++.
T Consensus       212 ----~~~---~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         212 ----VQD---DHP----------------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ----hcc---CCC----------------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                000   000                001234567889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-34  Score=272.71  Aligned_cols=270  Identities=17%  Similarity=0.188  Sum_probs=184.5

Q ss_pred             hhhhhccccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757           29 LEILDVSRNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD   89 (381)
Q Consensus        29 l~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~   89 (381)
                      -++..+.++|...+.||+|+||.||++...                   ..+.+.+|+.++++++||||+++++++....
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            344557899999999999999999775311                   1356778999999999999999999865311


Q ss_pred             -ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           90 -YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        90 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                       .......+++++++ +++|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~  154 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVN  154 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEc
Confidence             12334578888887 789988873           235889999999999999999999   66999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      .++.+||+|||++.......     ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+.
T Consensus       155 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~  228 (345)
T cd07877         155 EDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLK  228 (345)
T ss_pred             CCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH
Confidence            99999999999987643321     12457889999998766 5688999999999999999999999752211 01111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      ..... .......+..................................+.+++.+|++.||.+||++.+++..
T Consensus       229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         229 LILRL-VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHH-hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            11111 0111111111100000000000000000000000001234578899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=291.17  Aligned_cols=184  Identities=25%  Similarity=0.313  Sum_probs=162.6

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .++|.+.++||+|+||.|.+++.                    ....-|..|-.+|..-+.+-|+.++..     |+++.
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA-----FQD~~  148 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA-----FQDER  148 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----hcCcc
Confidence            47899999999999999977653                    234567789999999999999999877     78899


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ++|+|||||+||||..++.          +...+++..+.-++..|..||.-||   +.|+|||||||+|||+|..|++|
T Consensus       149 ~LYlVMdY~pGGDlltLlS----------k~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLS----------KFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             ceEEEEecccCchHHHHHh----------hcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEe
Confidence            9999999999999999994          4458999999999999999999999   88999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      |+|||.+-.+..++.-.... .+|||-|.+||++..     +.|+..+|.||+||++|||+.|..||.
T Consensus       216 LADFGsClkm~~dG~V~s~~-aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  216 LADFGSCLKMDADGTVRSSV-AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             eccchhHHhcCCCCcEEecc-ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            99999998887665544443 679999999998863     568999999999999999999999975

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3e-34  Score=266.95  Aligned_cols=229  Identities=24%  Similarity=0.292  Sum_probs=175.6

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      +-|...++||+|+||.||++..                    ...+.+.+|+++++.++|||++++++++.     +...
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   95 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHT   95 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCE
Confidence            3366778899999999988641                    12356788999999999999999999954     4678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+. |+|.+++.         .....+++..++.++.|++.||.|||   ..+++|+||+|+||+++.++.+||
T Consensus        96 ~~lv~e~~~-~~l~~~l~---------~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL  162 (313)
T cd06633          96 AWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKL  162 (313)
T ss_pred             EEEEEecCC-CCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEE
Confidence            899999996 57887774         23456889999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|||++......      ....|+..|+|||++.   ...++.++|||||||++|+|++|..||....    ........
T Consensus       163 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~----~~~~~~~~  232 (313)
T cd06633         163 ADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHI  232 (313)
T ss_pred             eecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHH
Confidence            999988643221      1245889999999874   3568889999999999999999999974221    11111100


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .         ..   ..+..               .....+..+.+++.+||+.+|.+||++.+++.
T Consensus       233 ~---------~~---~~~~~---------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         233 A---------QN---DSPTL---------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             H---------hc---CCCCC---------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0         00   00000               00123456888999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-34  Score=272.37  Aligned_cols=266  Identities=18%  Similarity=0.231  Sum_probs=180.8

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-------
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-------   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-------   89 (381)
                      ...+|...+.||.|+||.||++..                 ...+.+.+|++++++++||||+++++++....       
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            457899999999999999987642                 23467889999999999999999998754311       


Q ss_pred             --ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           90 --YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        90 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                        .......++||||+. ++|.+++.           ...+++..++.++.||+.||.|||   ..+++||||||+||++
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili  147 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLE-----------QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFI  147 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence              111245799999997 59988873           235889999999999999999999   6699999999999999


Q ss_pred             CC-CCCeEEeecccceecCCCCCcc-cccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757          168 DD-DMTARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM  244 (381)
Q Consensus       168 ~~-~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~  244 (381)
                      +. ++.+||+|||.+.......... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.....   
T Consensus       148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---  224 (342)
T cd07854         148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE---  224 (342)
T ss_pred             cCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence            74 5578999999998654322111 1111347889999997654 5688899999999999999999999853221   


Q ss_pred             cHHHHHHHHhh--chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          245 NLHKFAKMALS--NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       245 ~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       ..........  ....+.........+........ ...............++.+++.+||..||.+|||+.+++.
T Consensus       225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         225 -LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG-EPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             -HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhccc-ccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence             1111110000  00000000000000000000000 0000000111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-34  Score=259.90  Aligned_cols=256  Identities=21%  Similarity=0.272  Sum_probs=180.8

Q ss_pred             ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      |...+.||+|+||.||.+..                   ...+.+.+|+.+++.++|+||+++++++     ......++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence            45678899999999977542                   1235678899999999999999999995     44678999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||++ ++|.+++..         ....+++..+..++.|++.||.|||   ..+++||||+|+||++++++.++|+||
T Consensus        76 v~e~~~-~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~  142 (282)
T cd07829          76 VFEYCD-MDLKKYLDK---------RPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADF  142 (282)
T ss_pred             EecCcC-cCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecC
Confidence            999997 599999952         2256899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH--Hhh
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM--ALS  255 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~--~~~  255 (381)
                      |.+...........  ...++..|+|||.+.+. .++.++||||||+++||+++|..||....    ....+...  ...
T Consensus       143 g~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~----~~~~~~~~~~~~~  216 (282)
T cd07829         143 GLARAFGIPLRTYT--HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS----EIDQLFKIFQILG  216 (282)
T ss_pred             CcccccCCCccccC--ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHHHhC
Confidence            99986654332111  13467789999988766 78999999999999999999999975321    11111110  000


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ....................  ............+.....+.+++.+||..||++||++.+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         217 TPTEESWPGVTKLPDYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CCcHHHHHhhcccccccccc--cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000000000000000  000000001111233668999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.7e-34  Score=268.87  Aligned_cols=259  Identities=19%  Similarity=0.244  Sum_probs=181.3

Q ss_pred             ccccccc-cceecCCCceEEEecccc---------------c----------------HHHHHHHHHHHHccCCCcccce
Q 041757           34 VSRNMLE-ENLISAGTFGFSHLRRQG---------------A----------------FKSFIAECKALRNIRHRNLIKV   81 (381)
Q Consensus        34 ~~~~~~~-~~~lG~G~fg~V~~~~~~---------------~----------------~~~~~~E~~~l~~l~h~nIv~~   81 (381)
                      +.++|.. .+.||.|+||.||++...               .                ...+.+|++++++++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            4566764 578999999999886411               0                1147789999999999999999


Q ss_pred             eeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC
Q 041757           82 LTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK  161 (381)
Q Consensus        82 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk  161 (381)
                      ++++     ...+..++||||+. |+|.+++.          ....+++.....++.|++.||.|||   +.+++|+||+
T Consensus        86 ~~~~-----~~~~~~~lv~e~~~-~~l~~~l~----------~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~  146 (335)
T PTZ00024         86 VDVY-----VEGDFINLVMDIMA-SDLKKVVD----------RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLS  146 (335)
T ss_pred             eEEE-----ecCCcEEEEEeccc-cCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccc
Confidence            9995     44778999999996 69999983          4556899999999999999999999   6799999999


Q ss_pred             CCCeeeCCCCCeEEeecccceecCCCCC------------cccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHH
Q 041757          162 PSNVLLDDDMTARVGDFGLARFLPPTRT------------QTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLE  228 (381)
Q Consensus       162 p~Nill~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~e  228 (381)
                      |+||+++.++.++|+|||++........            ........++..|+|||++.+. .++.++|||||||++|+
T Consensus       147 ~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~e  226 (335)
T PTZ00024        147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE  226 (335)
T ss_pred             HHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHH
Confidence            9999999999999999999986652110            0111123467889999998764 46899999999999999


Q ss_pred             HHhCCCCCCccccCCCcHHHHHHH--Hhh-chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccC
Q 041757          229 LMIREKPSDIMFEGDMNLHKFAKM--ALS-NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSM  305 (381)
Q Consensus       229 l~tg~~Pf~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  305 (381)
                      |++|..||....    ....+...  ... .....+..........    ....................+.+++.+||+
T Consensus       227 l~tg~~p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (335)
T PTZ00024        227 LLTGKPLFPGEN----EIDQLGRIFELLGTPNEDNWPQAKKLPLYT----EFTPRKPKDLKTIFPNASDDAIDLLQSLLK  298 (335)
T ss_pred             HHhCCCCCCCCC----HHHHHHHHHHHhCCCchhhCcchhhccccc----ccCcCCcccHHHhCcCCChHHHHHHHHHcC
Confidence            999999975221    11111100  000 0000000000000000    000000011111122345678899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 041757          306 ESPQDRMKMTNVVH  319 (381)
Q Consensus       306 ~dP~~RPs~~~vl~  319 (381)
                      .+|++|||+.+++.
T Consensus       299 ~~P~~R~s~~~~l~  312 (335)
T PTZ00024        299 LNPLERISAKEALK  312 (335)
T ss_pred             CCchhccCHHHHhc
Confidence            99999999999986

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=266.65  Aligned_cols=244  Identities=20%  Similarity=0.271  Sum_probs=187.6

Q ss_pred             ccccccccceecCCCceEEEecc------------------------cccHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR------------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVD   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~------------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~   89 (381)
                      +.+.|....+||+|||+.||++-                        ....+...+|.++.+.|.||.||++|+++.   
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs---  537 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS---  537 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee---
Confidence            46778889999999999996642                        234566778999999999999999999964   


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                       -+.+.++-|+|||+|.+|+-+|          +....+++.++..|+.||+.||.||.+- +.+|||-||||.|||+.+
T Consensus       538 -lDtdsFCTVLEYceGNDLDFYL----------KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~  605 (775)
T KOG1151|consen  538 -LDTDSFCTVLEYCEGNDLDFYL----------KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVN  605 (775)
T ss_pred             -eccccceeeeeecCCCchhHHH----------HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEec
Confidence             3566789999999999999999          5678899999999999999999999976 889999999999999954


Q ss_pred             ---CCCeEEeecccceecCCCCCccc-----ccCccCccceeCCCCcCC----CccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          170 ---DMTARVGDFGLARFLPPTRTQTS-----SIDVKGSIGYIAPEYGVG----NEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       170 ---~~~~kl~Dfg~~~~~~~~~~~~~-----~~~~~gt~~y~aPE~l~~----~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                         .|.+||+|||+++++..+.....     .....||.+|.+||.+.-    ...+.|+||||+|||+|.++.|+.||.
T Consensus       606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG  685 (775)
T KOG1151|consen  606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG  685 (775)
T ss_pred             CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence               46899999999999987655422     223669999999997653    247899999999999999999999986


Q ss_pred             ccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757          238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV  317 (381)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v  317 (381)
                      ......    .+...      .-+++..-..-|.+                 +....+...++++||++.-++|....++
T Consensus       686 hnqsQQ----dILqe------NTIlkAtEVqFP~K-----------------PvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  686 HNQSQQ----DILQE------NTILKATEVQFPPK-----------------PVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             CchhHH----HHHhh------hchhcceeccCCCC-----------------CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence            332211    11110      00111110111111                 2344567788889999999999887776


Q ss_pred             HH
Q 041757          318 VH  319 (381)
Q Consensus       318 l~  319 (381)
                      ..
T Consensus       739 A~  740 (775)
T KOG1151|consen  739 AC  740 (775)
T ss_pred             cc
Confidence            53

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.1e-34  Score=264.74  Aligned_cols=237  Identities=19%  Similarity=0.227  Sum_probs=176.8

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      -++|...+.||+|+||.||++..                  .....+.+|+.++.+.. ||||+++++++.     ....
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence            46788899999999999977542                  12345667887777775 999999999964     4678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+. ++|.+++.         .....+++..+..++.|++.||.|||+.  .+|+||||+|+||++++++.+||
T Consensus        89 ~~~v~e~~~-~~l~~l~~---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL  156 (296)
T cd06618          89 VFICMELMS-TCLDKLLK---------RIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKL  156 (296)
T ss_pred             EEEEeeccC-cCHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEE
Confidence            999999985 47777764         2234688999999999999999999931  48999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCc----cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE----VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +|||++..+.......   ...++..|+|||++.+..    ++.++||||||+++|+|++|+.||.....   .....  
T Consensus       157 ~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~--  228 (296)
T cd06618         157 CDFGISGRLVDSKAKT---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---EFEVL--  228 (296)
T ss_pred             CccccchhccCCCccc---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---HHHHH--
Confidence            9999987654432221   134788999999987654    78899999999999999999999752111   11110  


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                             ...+.......+.                 ...++.++.+++.+||+.||.+||++.+++..
T Consensus       229 -------~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         229 -------TKILQEEPPSLPP-----------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -------HHHhcCCCCCCCC-----------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   0111100000000                 01245578999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=232.71  Aligned_cols=259  Identities=20%  Similarity=0.257  Sum_probs=184.5

Q ss_pred             ccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .+|...++||+|+||+|++++                   ++...+.++|+-+|+.++|.|||+++++     ...++..
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkkl   76 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKL   76 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCcee
Confidence            357778999999999997765                   2345678999999999999999999999     5668889


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      .+|+|||.. +|..+..         ...+.++.+.+..++.|+++||.|+|   +.++.||||||+|.+|+.+|.+|++
T Consensus        77 tlvfe~cdq-dlkkyfd---------slng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkla  143 (292)
T KOG0662|consen   77 TLVFEFCDQ-DLKKYFD---------SLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_pred             EEeHHHhhH-HHHHHHH---------hcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEec
Confidence            999999955 9999886         45677899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCc-cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh-
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL-  254 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~-  254 (381)
                      |||+++-+..+......  .+.|..|++|.++.+.. |++..|+||-||++.|+.....|   .|++.....+..+... 
T Consensus       144 dfglarafgipvrcysa--evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp---lfpg~dvddqlkrif~~  218 (292)
T KOG0662|consen  144 DFGLARAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRL  218 (292)
T ss_pred             ccchhhhcCCceEeeec--eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC---CCCCCcHHHHHHHHHHH
Confidence            99999987765433322  35799999999988854 88999999999999999875555   2444433333322211 


Q ss_pred             -hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 -SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 -~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       ....++-...+-. -++-...... .....-.++.+.....=.+++...+.-+|..|.+++..++
T Consensus       219 lg~p~ed~wps~t~-lpdyk~yp~y-pattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  219 LGTPTEDQWPSMTK-LPDYKPYPIY-PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             hCCCccccCCcccc-CCCCcccCCc-cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence             0000110000000 0000000000 0011111222333333455666777889999999988764

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=257.70  Aligned_cols=261  Identities=18%  Similarity=0.195  Sum_probs=186.9

Q ss_pred             cccccccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccC--CCc----ccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIR--HRN----LIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~--h~n----Iv~~~~~~~~~~~~~   92 (381)
                      ++.|.+...+|+|+||.|-...                ....+..+-|+++|+++.  -|+    +|.+.++     ++-
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fdy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FDY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hhc
Confidence            7789999999999999994322                123344556999999994  232    6777777     556


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---  169 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---  169 (381)
                      .++.+||+|.+ |-|+.++|..        +...+++...+..++.|++++++|||   +.+++|-||||+|||+.+   
T Consensus       163 rghiCivfell-G~S~~dFlk~--------N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKE--------NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhcc--------CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccce
Confidence            88999999988 6699999964        45667899999999999999999999   669999999999999832   


Q ss_pred             -----------------CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhC
Q 041757          170 -----------------DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR  232 (381)
Q Consensus       170 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg  232 (381)
                                       +..++|+|||.|....+...     ..+.|..|+|||++.+-.++.++||||+||||+|+++|
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                             23589999999987655442     25689999999999999999999999999999999999


Q ss_pred             CCCCCccccCCCcHHHHHHHHhhchHHHHHhhhh--------ccCchhhhhc-------ccchhhhhHHHHHHHHHHHHH
Q 041757          233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSIL--------LNDDEKLVVR-------GDQKQTQAKINIIRECVISMV  297 (381)
Q Consensus       233 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--------~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~  297 (381)
                      ...|...  ++.....++...+.+-....+.+.-        ..++......       ..................++.
T Consensus       306 ~~LFqtH--en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf  383 (415)
T KOG0671|consen  306 ETLFQTH--ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF  383 (415)
T ss_pred             ceecccC--CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence            9987522  1222223333333332222222210        1111000000       001111111122345566899


Q ss_pred             HHHHhccCCCCCCCCCHHHHHH
Q 041757          298 RIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       298 ~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +|+.+||..||.+|+|+.|++.
T Consensus       384 DLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  384 DLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHccCccccccHHHHhc
Confidence            9999999999999999999885

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-34  Score=254.90  Aligned_cols=220  Identities=25%  Similarity=0.311  Sum_probs=174.1

Q ss_pred             ecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcc
Q 041757           44 ISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        44 lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ||.|+||.||.+..                    .....+.+|+.++++++|+||+++++.     +......++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence            68999999976542                    134478899999999999999999988     45688899999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ++++|.+++.          ....+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||.+..
T Consensus        76 ~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~  142 (250)
T cd05123          76 PGGELFSHLS----------KEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKE  142 (250)
T ss_pred             CCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCccee
Confidence            9999999994          3446899999999999999999999   66999999999999999999999999999987


Q ss_pred             cCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757          184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD  263 (381)
Q Consensus       184 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (381)
                      .......  .....++..|+|||...+...+.++|+||||+++|++++|..||.....     ...            ..
T Consensus       143 ~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~------------~~  203 (250)
T cd05123         143 LSSEGSR--TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEI------------YE  203 (250)
T ss_pred             cccCCCc--ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHH------------HH
Confidence            6543211  1124578899999999888889999999999999999999999852211     111            11


Q ss_pred             hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                      .......                ..+...+..+.+++.+||..||++||++.+
T Consensus       204 ~~~~~~~----------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         204 KILKDPL----------------RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHhcCCC----------------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1100000                011233567889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-34  Score=276.25  Aligned_cols=244  Identities=20%  Similarity=0.223  Sum_probs=198.6

Q ss_pred             hccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCce
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      +.++-|.+.++||.|.+|.||+++.                ...++...|.++|+.+. |||++.+||++.-.+....+.
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            4678899999999999999988762                34566778999999885 999999999998766678899


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      +|||||||.+|+..++++..        ...++.+..+..|++.++.|+.+||   ...++|||+|-.|||++.++.+||
T Consensus        96 LWLVMEfC~gGSVTDLVKn~--------~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNT--------KGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             EEEEeeccCCccHHHHHhhh--------cccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence            99999999999999999642        3678999999999999999999999   558999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCC-----ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-----EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +|||.+..++........  ..||+.|||||++.-.     .|+..+|+||||++..||.-|.+|+..+.+.        
T Consensus       165 vDFGvSaQldsT~grRnT--~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------  234 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVGRRNT--FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------  234 (953)
T ss_pred             eeeeeeeeeecccccccC--cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------
Confidence            999999988776554433  6799999999998643     4788999999999999999999996533221        


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              +.++.-              .++++-....+..-.+++.+++..|+..|.+.||++.++++
T Consensus       235 --------raLF~I--------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  235 --------RALFLI--------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --------hhhccC--------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                    011100              00111111124567788999999999999999999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-35  Score=246.67  Aligned_cols=268  Identities=18%  Similarity=0.243  Sum_probs=186.6

Q ss_pred             ccccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeecccc---cc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD---YQ   91 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---~~   91 (381)
                      ....|....+||+|.||.|++++..                   .-...++|+++|..|+|+|++.++.+|....   ..
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3456777899999999999776532                   2234568999999999999999999987521   22


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....|+|+.+|+. +|..+|.         +...+++..++..++.++.+||.|+|   ...|+|||+||+|+||+.++
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLs---------n~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dg  161 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLS---------NRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDG  161 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhc---------CccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCc
Confidence            34568999999976 9999995         45578999999999999999999999   55899999999999999999


Q ss_pred             CeEEeecccceecCCCCC--cccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          172 TARVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      .+||+|||+++.+.....  ....+..+.|..|++||.+.+ ..|+++.|||.-||++.||++|.+.+.    ++.....
T Consensus       162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq----gnteqqq  237 (376)
T KOG0669|consen  162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ----GNTEQQQ  237 (376)
T ss_pred             eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc----CChHHHH
Confidence            999999999976543321  222233456999999998887 568999999999999999999999854    3333222


Q ss_pred             HH--HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHH------HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          249 FA--KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV------ISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       249 ~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      +.  ........++....+-...--..+....  -..+......+..      +...+|+..++..||.+|+++++++..
T Consensus       238 l~~Is~LcGs~tkevWP~~d~lpL~~sie~eP--l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  238 LHLISQLCGSITKEVWPNVDNLPLYQSIELEP--LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HHHHHHHhccCCcccCCCcccchHHHhccCCC--CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            21  1111111111111000000000000000  0000111112222      267788889999999999999999863

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=255.68  Aligned_cols=243  Identities=23%  Similarity=0.274  Sum_probs=179.8

Q ss_pred             ccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++.+....||.|+||+|++..                  +...++++.|.+...+- +.||||++||.++.     ++..
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdc  138 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDC  138 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCce
Confidence            445566889999999994421                  34567888899876665 58999999999753     6778


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      |+.||+|.- ||+.+....     .......+++...-.|......||.||-+  ...|||||+||+|||++..|.+||+
T Consensus       139 WiCMELMd~-SlDklYk~v-----y~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  139 WICMELMDI-SLDKLYKRV-----YSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             eeeHHHHhh-hHHHHHHHH-----HHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeee
Confidence            999999954 776654211     11345678888888899999999999986  4589999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |||.+..+..+-..+.   -.|...|||||.+..  ..|+.+|||||||++|||+.||..|+..-.   ..++++..   
T Consensus       211 DFGIcGqLv~SiAkT~---daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~---svfeql~~---  281 (361)
T KOG1006|consen  211 DFGICGQLVDSIAKTV---DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD---SVFEQLCQ---  281 (361)
T ss_pred             cccchHhHHHHHHhhh---ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH---HHHHHHHH---
Confidence            9999987765543333   348999999998764  358999999999999999999999964110   01111111   


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                                ....++........          ..+....+..++..|+..|-.+||+..++.+.
T Consensus       282 ----------Vv~gdpp~l~~~~~----------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  282 ----------VVIGDPPILLFDKE----------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ----------HHcCCCCeecCccc----------ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                      11112211111000          12456789999999999999999999998763

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=270.44  Aligned_cols=228  Identities=19%  Similarity=0.183  Sum_probs=178.2

Q ss_pred             ccccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .+..|.....+|.|+||.|......             ......+|+.++... +||||+++.++     +.+..+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecce-----ecCCceeeee
Confidence            4677888888999999999554311             122345678777766 59999999999     5668899999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee-CCCCCeEEeec
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL-DDDMTARVGDF  178 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill-~~~~~~kl~Df  178 (381)
                      ||++.++-|.+-+.          ...... ..+..|+.+|+.|+.|||   .+|+|||||||+|||+ ++.+.++|+||
T Consensus       395 ~e~l~g~ell~ri~----------~~~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  395 MELLDGGELLRRIR----------SKPEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             ehhccccHHHHHHH----------hcchhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEe
Confidence            99999998887773          233333 778889999999999999   6799999999999999 68899999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      |.++.....     ..+.+-|..|.|||++....|+.++||||||++||+|++|+.||.....+    ..+...      
T Consensus       461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~------  525 (612)
T KOG0603|consen  461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTR------  525 (612)
T ss_pred             chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHh------
Confidence            999877655     11234688999999999999999999999999999999999998644333    111111      


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            +.....                  ....+....+|+..||+.||.+||++.++..
T Consensus       526 ------i~~~~~------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  526 ------IQMPKF------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ------hcCCcc------------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                  111100                  1245567788889999999999999999975

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=255.67  Aligned_cols=183  Identities=21%  Similarity=0.274  Sum_probs=154.3

Q ss_pred             cccccccceecCCCceEEEecccccH--------------------HHHHHHHHHHHccC-CCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQGAF--------------------KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~~~--------------------~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..+|....+||+|+||.|-++.....                    +--+.|-++|.-.. -|.+++++.+     +++-
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm  422 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM  422 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence            35677789999999999977764332                    33344767776664 6778888877     6778


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +.+|.||||+.||+|.-.+          ..-+.+.+..+.-++.+|+-||-+||   +++|+.||||.+|||++.+|++
T Consensus       423 DRLyFVMEyvnGGDLMyhi----------QQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHi  489 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHI----------QQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHI  489 (683)
T ss_pred             hheeeEEEEecCchhhhHH----------HHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCce
Confidence            8999999999999999988          45667888889999999999999999   7799999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||+|||+++.---....  ...++||+-|+|||++...+|+..+|.|||||+||||+.|++||+
T Consensus       490 Ki~DFGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd  551 (683)
T KOG0696|consen  490 KIADFGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD  551 (683)
T ss_pred             EeeecccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence            99999999754333322  224789999999999999999999999999999999999999976

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-34  Score=247.34  Aligned_cols=247  Identities=18%  Similarity=0.235  Sum_probs=180.9

Q ss_pred             cceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEEEEc
Q 041757           41 ENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      .+.||+|+|+.|....                 .....+..+|++++.+.+ |+||++++++     ++++...|||||-
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~~FYLVfEK  157 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDTRFYLVFEK  157 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccceEEEEEec
Confidence            4789999999993322                 235678999999999996 9999999999     6778999999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC---CeEEeecc
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM---TARVGDFG  179 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg  179 (381)
                      |.||+|..+|          .+...+++.++.++..+|+.||.|||   .+||.||||||+|||.....   -+||+||.
T Consensus       158 m~GGplLshI----------~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  158 MRGGPLLSHI----------QKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ccCchHHHHH----------HHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            9999999999          45678999999999999999999999   77999999999999996554   57999998


Q ss_pred             cceecCCCCC-----cccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          180 LARFLPPTRT-----QTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       180 ~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      +..-+.....     .......+|+..|||||+..     ...|+.++|.||||||+|-|++|.+||..+-..+..+..-
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            8765443222     11223467999999999743     2458999999999999999999999987554433322110


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .  ....-...++..+.....+-            ...-......+..+++...+..|+.+|-++.++++
T Consensus       305 e--~Cr~CQ~~LFesIQEGkYeF------------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 E--VCRVCQNKLFESIQEGKYEF------------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             C--ccHHHHHHHHHHHhccCCcC------------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            0  00001222333222221110            00011234455666677777789999988888876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3e-33  Score=283.82  Aligned_cols=129  Identities=26%  Similarity=0.338  Sum_probs=113.9

Q ss_pred             ccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|.+.++||+|+||.||++...                    ....+.+|+.++..++||||+++++++     .....
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            67889999999999999876421                    136788899999999999999999884     44778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+.+++|.+++.          ....+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||
T Consensus        79 ~~lVmEy~~g~~L~~li~----------~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL  145 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLH----------IYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKL  145 (669)
T ss_pred             EEEEEeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEE
Confidence            999999999999999994          3456788899999999999999999   669999999999999999999999


Q ss_pred             eecccce
Q 041757          176 GDFGLAR  182 (381)
Q Consensus       176 ~Dfg~~~  182 (381)
                      +|||+++
T Consensus       146 ~DFGls~  152 (669)
T cd05610         146 TDFGLSK  152 (669)
T ss_pred             EeCCCCc
Confidence            9999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=247.24  Aligned_cols=232  Identities=19%  Similarity=0.242  Sum_probs=175.2

Q ss_pred             cccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEE
Q 041757           39 LEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .....||.|+-|.|++.+                  ....++.+..++++..-. .|.||+-+|+|+     .+...++.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~Ic  169 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVFIC  169 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHHHH
Confidence            345679999999996643                  224456667777766654 899999999965     36678899


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      ||.|.. -++.++.         .-...+++..+-.+...+++||.||.+  +++|+|||+||+|||+|..|.+||+|||
T Consensus       170 MelMs~-C~ekLlk---------rik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  170 MELMST-CAEKLLK---------RIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             HHHHHH-HHHHHHH---------HhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccc
Confidence            998843 5666664         234568999999999999999999975  5699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      .+..+.++...+.   ..|.+.|||||.+.-   ..|+.++||||||++++||.||+.||..-   +..+..+.      
T Consensus       238 IsGrlvdSkAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c---~tdFe~lt------  305 (391)
T KOG0983|consen  238 ISGRLVDSKAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC---KTDFEVLT------  305 (391)
T ss_pred             ccceeeccccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC---CccHHHHH------
Confidence            9988776654443   359999999998764   46899999999999999999999997521   12222211      


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                             +.+...|....             -.......+.+++..||..|+.+||...++++
T Consensus       306 -------kvln~ePP~L~-------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  306 -------KVLNEEPPLLP-------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -------HHHhcCCCCCC-------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                   11111110000             00125567888999999999999999999886

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=263.66  Aligned_cols=226  Identities=20%  Similarity=0.300  Sum_probs=185.0

Q ss_pred             ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .+++....||-||||.|.+++                    ....+....|-.+|...+.|.||++|..     +.+..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence            345556779999999996643                    3345667789999999999999999998     677999


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .|+.||-|-||.|-..|          ...+.++...+.-++..+.+|++|||   .++||.|||||+|.+++.+|.+||
T Consensus       495 vYmLmEaClGGElWTiL----------rdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KL  561 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTIL----------RDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKL  561 (732)
T ss_pred             hhhhHHhhcCchhhhhh----------hhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEE
Confidence            99999999999999999          46778888999999999999999999   779999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      .|||+|+.+......-   .++||+.|.|||++.....+.++|.||||+++|||++|.+||.    +...+..+-.....
T Consensus       562 VDFGFAKki~~g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs----~~dpmktYn~ILkG  634 (732)
T KOG0614|consen  562 VDFGFAKKIGSGRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS----GVDPMKTYNLILKG  634 (732)
T ss_pred             eehhhHHHhccCCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC----CCchHHHHHHHHhh
Confidence            9999999887665433   3789999999999999999999999999999999999999975    22222221111100


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK  313 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  313 (381)
                            ++                     ...+|........+++++.+..+|.+|.-
T Consensus       635 ------id---------------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  635 ------ID---------------------KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ------hh---------------------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                  01                     11224456677888899999999999976

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=265.97  Aligned_cols=178  Identities=24%  Similarity=0.368  Sum_probs=155.8

Q ss_pred             ccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           40 EENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        40 ~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ..++||.|.||+||-++                   ......+.+|+.||+++.||.||.+-..     +++.+..++||
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVM  642 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVM  642 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEe
Confidence            36899999999997654                   2345778899999999999999999888     56789999999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC---CeEEee
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM---TARVGD  177 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~D  177 (381)
                      |-+.| |..+.+..        ...+++++....-++.||+.||.|||   .++|+|+||||+|||+.+..   .+||+|
T Consensus       643 EKl~G-DMLEMILS--------sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCD  710 (888)
T KOG4236|consen  643 EKLHG-DMLEMILS--------SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCD  710 (888)
T ss_pred             hhhcc-hHHHHHHH--------hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecc
Confidence            99955 66666643        45678999999999999999999999   77999999999999996543   799999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ||+|+++.+......   ++||+.|.|||++....|+..-|+||.||++|.-++|..||.
T Consensus       711 FGfARiIgEksFRrs---VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  711 FGFARIIGEKSFRRS---VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             ccceeecchhhhhhh---hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence            999999988766554   679999999999999999999999999999999999999975

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.9e-33  Score=249.10  Aligned_cols=210  Identities=19%  Similarity=0.113  Sum_probs=161.7

Q ss_pred             CCceEEEecccc------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhcc
Q 041757           47 GTFGFSHLRRQG------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP  114 (381)
Q Consensus        47 G~fg~V~~~~~~------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  114 (381)
                      |.||.||++...            ....+.+|...+....||||+++++++     ......++||||+++|+|.+++. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~-   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS-   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH-
Confidence            778888775531            112345666666677899999999984     45778999999999999999984 


Q ss_pred             ccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCccccc
Q 041757          115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI  194 (381)
Q Consensus       115 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  194 (381)
                               ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++++|||.+........     
T Consensus        78 ---------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----  140 (237)
T cd05576          78 ---------KFLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----  140 (237)
T ss_pred             ---------HhcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc-----
Confidence                     3345899999999999999999999   67999999999999999999999999998765543221     


Q ss_pred             CccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhh
Q 041757          195 DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLV  274 (381)
Q Consensus       195 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  274 (381)
                      ...++..|+|||.+.+..++.++||||+|+++||+++|..||.......                   .....       
T Consensus       141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~~-------  194 (237)
T cd05576         141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHTT-------  194 (237)
T ss_pred             cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------ccccc-------
Confidence            1335778999999988889999999999999999999998864211000                   00000       


Q ss_pred             hcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          275 VRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                                 ...+......+.+++.+||+.||.+||++.+
T Consensus       195 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         195 -----------LNIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             -----------cCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence                       0011234557888999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=245.60  Aligned_cols=252  Identities=20%  Similarity=0.265  Sum_probs=197.9

Q ss_pred             ccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           36 RNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .++....++-+|+||.||.+-                       +-++..++.|.-.+..+.|||+.++.++++.    +
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie----~  359 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE----D  359 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----c
Confidence            346777889999999997751                       2345667788889999999999999999863    5


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++++.++.-|+|..||..-+..+  .+....++..+...++.|++.|++|||   ..++||.||..+|++|++.-.
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~--~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDD--PSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCC--CccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence            677889999999999999996222111  134566888899999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|=.+++.+-........-+...+..||+||.+....|+.++|||||||++|||+| |+.|+...-    ++ .   
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID----Pf-E---  506 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID----PF-E---  506 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC----HH-H---
Confidence            99999999987765544332222346889999999999999999999999999999998 899964221    11 1   


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                            +...+..                  ..+...|.+|++++..+|..||..+|++||++.|+...|.+....+
T Consensus       507 ------m~~ylkd------------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  507 ------MEHYLKD------------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             ------HHHHHhc------------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence                  1111110                  0112224589999999999999999999999999999998876543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-32  Score=249.48  Aligned_cols=138  Identities=23%  Similarity=0.333  Sum_probs=118.0

Q ss_pred             CCccccccccccccccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccC-
Q 041757           12 GNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIR-   74 (381)
Q Consensus        12 ~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~-   74 (381)
                      .+.-.|.+|..||...+      ...|-+.++||.|-|++||++..                ...+..+.||++|++++ 
T Consensus        60 dY~kGGYHpV~IGD~F~------~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~  133 (590)
T KOG1290|consen   60 DYRKGGYHPVRIGDVFN------GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE  133 (590)
T ss_pred             hhhcCCCceeecccccc------CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence            45678999999998886      78999999999999999999763                23456678999999984 


Q ss_pred             ----C---CcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHh
Q 041757           75 ----H---RNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL  147 (381)
Q Consensus        75 ----h---~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L  147 (381)
                          |   .+||++++.|... ..++.++++|+|++ |-+|..+|..        ...+.++...+..|+.|++.||.||
T Consensus       134 ~Dp~~~~~~~VV~LlD~Fkhs-GpNG~HVCMVfEvL-GdnLLklI~~--------s~YrGlpl~~VK~I~~qvL~GLdYL  203 (590)
T KOG1290|consen  134 GDPNDPGKKCVVQLLDHFKHS-GPNGQHVCMVFEVL-GDNLLKLIKY--------SNYRGLPLSCVKEICRQVLTGLDYL  203 (590)
T ss_pred             cCCCCCCCceeeeeeccceec-CCCCcEEEEEehhh-hhHHHHHHHH--------hCCCCCcHHHHHHHHHHHHHHHHHH
Confidence                2   3699999997653 45788999999999 7799999964        4567899999999999999999999


Q ss_pred             hcCCCCCceeeccCCCCeee
Q 041757          148 HHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus       148 H~~~~~~ivHrDlkp~Nill  167 (381)
                      |+.+  +|||-||||+|||+
T Consensus       204 H~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  204 HREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             HHhc--CccccCCCcceeee
Confidence            9876  99999999999998

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=4.5e-32  Score=269.05  Aligned_cols=267  Identities=14%  Similarity=0.095  Sum_probs=161.3

Q ss_pred             ccccccccceecCCCceEEEecccccH--------------HHHHHHHHHHHcc---CCCcccceeeeecccc-ccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQGAF--------------KSFIAECKALRNI---RHRNLIKVLTACLGVD-YQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~~~--------------~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~-~~~~~~   95 (381)
                      ..++|...++||+|+||.||++.....              ..-..|..+..++   .+.+++.++..+.... ......
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            467899999999999999998753211              1111233333333   2333433332221111 134677


Q ss_pred             EEEEEEcccCCCHHHhhccccCCc----------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCe
Q 041757           96 KALVYEFMHNRSLKEWLYPISKED----------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNV  165 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Ni  165 (381)
                      .++||||+.+++|.+++.......          .............+..++.|++.||.|||   +.+|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHE
Confidence            899999999999999985321000          00000111223456689999999999999   66999999999999


Q ss_pred             eeCC-CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC----------------------ccCcccchhhh
Q 041757          166 LLDD-DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN----------------------EVSTIGDVYSY  222 (381)
Q Consensus       166 ll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~~sDiwSl  222 (381)
                      |++. ++.+||+|||+++.+....... .....+++.|+|||.+...                      .++.++|||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9985 5799999999998654432221 1235689999999965322                      23456799999


Q ss_pred             hHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc--hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHH
Q 041757          223 GILLLELMIREKPSDIMFEGDMNLHKFAKMALSN--HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG  300 (381)
Q Consensus       223 G~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  300 (381)
                      ||++|||+++..|++      .....+.......  ....+... .....        ...................+|+
T Consensus       366 GviL~el~~~~~~~~------~~~~~~~~~l~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~d~~~~~~~dLi  430 (566)
T PLN03225        366 GLIFLQMAFPNLRSD------SNLIQFNRQLKRNDYDLVAWRKL-VEPRA--------SPDLRRGFEVLDLDGGAGWELL  430 (566)
T ss_pred             HHHHHHHHhCcCCCc------hHHHHHHHHHHhcCCcHHHHHHh-hcccc--------chhhhhhhhhccccchHHHHHH
Confidence            999999999776643      1122221111100  01111000 00000        0000000011112233456899


Q ss_pred             HhccCCCCCCCCCHHHHHH
Q 041757          301 VACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       301 ~~cl~~dP~~RPs~~~vl~  319 (381)
                      .+|++.||.+|||+.++++
T Consensus       431 ~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        431 KSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHHccCCcccCCCHHHHhC
Confidence            9999999999999999987

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=3.4e-32  Score=256.03  Aligned_cols=190  Identities=21%  Similarity=0.295  Sum_probs=160.9

Q ss_pred             cccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           37 NMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .|..++-||-|+||.|-++++                    ..+.....|-.||..-+++-||++|..     |++.+.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdnL  704 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDNL  704 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCce
Confidence            367789999999999966552                    234456679999999999999999988     6789999


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      |+||+|++|||+..+|          -+.+.+.+..++-++.++..|+++.|   ..|+|||||||+|||||.+|++||+
T Consensus       705 YFVMdYIPGGDmMSLL----------IrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLT  771 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLL----------IRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLT  771 (1034)
T ss_pred             EEEEeccCCccHHHHH----------HHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeee
Confidence            9999999999999999          56778899999999999999999999   8899999999999999999999999


Q ss_pred             ecccceecCC---CCCc-------------------------------------ccccCccCccceeCCCCcCCCccCcc
Q 041757          177 DFGLARFLPP---TRTQ-------------------------------------TSSIDVKGSIGYIAPEYGVGNEVSTI  216 (381)
Q Consensus       177 Dfg~~~~~~~---~~~~-------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~  216 (381)
                      |||++.-+.-   ..+.                                     ...-..+||+.|+|||++....|+..
T Consensus       772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~  851 (1034)
T KOG0608|consen  772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL  851 (1034)
T ss_pred             eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence            9999853320   0000                                     00013569999999999999999999


Q ss_pred             cchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757          217 GDVYSYGILLLELMIREKPSDIMFEGDM  244 (381)
Q Consensus       217 sDiwSlG~il~el~tg~~Pf~~~~~~~~  244 (381)
                      +|.||.|||||||+.|+.||.....++.
T Consensus       852 cdwws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence            9999999999999999999976655553

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-32  Score=237.69  Aligned_cols=184  Identities=24%  Similarity=0.320  Sum_probs=158.9

Q ss_pred             ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .+|...++||+|+|++|.+++                    ...+.....|-.+..+- +||.+|.++.+     ++++.
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqtes  324 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTES  324 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcccc
Confidence            568888999999999995443                    12334445576777766 59999999988     67899


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      .+++|.||.+||+|.-++          .+...++++.+.-+..+|+.||.|||   +.|||.||||.+|+|++..|.+|
T Consensus       325 rlffvieyv~ggdlmfhm----------qrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHM----------QRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             eEEEEEEEecCcceeeeh----------hhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCcee
Confidence            999999999999998888          56778999999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcc
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM  239 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~  239 (381)
                      |+|+|+++.--.+...+.  .++||+.|.|||.+.+..|+..+|.|++||+++||+.|+.||+..
T Consensus       392 ltdygmcke~l~~gd~ts--tfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPGDTTS--TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             ecccchhhcCCCCCcccc--cccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            999999986554444433  378999999999999999999999999999999999999999744

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=7.1e-32  Score=225.64  Aligned_cols=261  Identities=20%  Similarity=0.247  Sum_probs=193.5

Q ss_pred             ccccccccceecCCCceEEEecc--------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR--------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~--------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..++|++.+++|+|.|+.|+.+.              ....+...+|+++|..|. ||||++++++..+   .......|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchh
Confidence            35789999999999999995543              234677889999999998 9999999999664   34566789


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CCeEEee
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MTARVGD  177 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~D  177 (381)
                      |+||..+.+...+.             ..++..++..++.+++.||.|+|   ++||.|||+||.|++||.. -.++|+|
T Consensus       113 iFE~v~n~Dfk~ly-------------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlID  176 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY-------------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLID  176 (338)
T ss_pred             HhhhhccccHHHHh-------------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeee
Confidence            99999998877654             45777889999999999999999   8899999999999999864 4789999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH---
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA---  253 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~---  253 (381)
                      +|+|...........   .+.+..|--||.+.. ..|+..-|+|||||++..|+..+.||   |.+..+..++++..   
T Consensus       177 WGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF---FhG~dN~DQLVkIakVL  250 (338)
T KOG0668|consen  177 WGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF---FHGHDNYDQLVKIAKVL  250 (338)
T ss_pred             cchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc---cCCCCCHHHHHHHHHHh
Confidence            999988766654433   346778889998876 45788899999999999999999997   67777766665544   


Q ss_pred             hhchHHHHHhhhh-ccCchhhhhcccc-hh--hhhHHHHHH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSIL-LNDDEKLVVRGDQ-KQ--TQAKINIIR-ECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l-~~~~~~~~~~~~~-~~--~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ....+...+++.- ..++.-....... +.  ......-.. -..++.++++.+.|..|-.+|||+.|.+.
T Consensus       251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            3344444444322 1122111100000 00  000000011 12367889999999999999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=225.54  Aligned_cols=187  Identities=23%  Similarity=0.332  Sum_probs=153.4

Q ss_pred             cccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .++...+..||+|+||.|.+.+                  ....++.++|+.+..+. ..|.+|.+||.     .-....
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~regd  119 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LFREGD  119 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hhcccc
Confidence            3455567889999999983321                  34556778888887766 59999999998     445778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .|+.||.|.. ||+.+-...      ......+++.-+-+|+..+.+||.|||+  +..++|||+||+|||++.+|++|+
T Consensus       120 vwIcME~M~t-Sldkfy~~v------~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKi  190 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKV------LKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKI  190 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHH------HhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEE
Confidence            9999999955 888776432      2567889999999999999999999997  458999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC----CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG----NEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      +|||.+..+.++...+..   .|.-.|||||.+..    ..|+.+|||||||+++.||.+++.||+.
T Consensus       191 CDFGIsG~L~dSiAkt~d---aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  191 CDFGISGYLVDSIAKTMD---AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             cccccceeehhhhHHHHh---cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            999999888766544422   38889999998653    4699999999999999999999999763

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=265.41  Aligned_cols=235  Identities=23%  Similarity=0.307  Sum_probs=174.9

Q ss_pred             ccccceecCCCceEE-----EecccccHHH--------HHHHHHHHHccC-CCcccceeeeeccccccCCceEEEEEEcc
Q 041757           38 MLEENLISAGTFGFS-----HLRRQGAFKS--------FIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V-----~~~~~~~~~~--------~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      |...+++|.|+-|+|     |-.+.-++++        ..+|+..|+.-+ |||||++|+.     ..+..+.||..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEehHh
Confidence            556788999999987     3344444444        357999999885 9999999998     67899999999999


Q ss_pred             cCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---C--CCeEEeec
Q 041757          104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---D--MTARVGDF  178 (381)
Q Consensus       104 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~--~~~kl~Df  178 (381)
                      .. +|.+++.... .     ..........+.++.|+++||++||   +.+||||||||+||||+.   +  .+++|+||
T Consensus       586 ~~-sL~dlie~~~-~-----d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  586 AC-SLQDLIESSG-L-----DVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             hh-hHHHHHhccc-c-----chhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccc
Confidence            55 9999996420 0     0011111455778899999999999   679999999999999975   2  47899999


Q ss_pred             ccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhC-CCCCCccccCCCcHHHHHHHHhhc
Q 041757          179 GLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR-EKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       179 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |+++.+..+... .......||-+|+|||++....-+.++||+|+||++|++++| .+||......+.++..      ..
T Consensus       656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~------~~  729 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT------GN  729 (903)
T ss_pred             ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc------Cc
Confidence            999988766432 223446799999999999998888899999999999999885 9998754433222111      00


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .  .+..  +.  +                  ..++  ...+|+.+|++++|..||++.+|+.
T Consensus       730 ~--~L~~--L~--~------------------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  730 Y--TLVH--LE--P------------------LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             c--ceee--ec--c------------------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0  0000  00  0                  0122  6788889999999999999999974

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.6e-30  Score=231.59  Aligned_cols=210  Identities=26%  Similarity=0.328  Sum_probs=166.2

Q ss_pred             HHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHH
Q 041757           60 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAID  139 (381)
Q Consensus        60 ~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q  139 (381)
                      .+.+.+|++.+++++|+||+++++.+.     .....++++||+++++|.+++.          ....++...++.++.+
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~   95 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLFDLLK----------KRGRLSEDEARFYARQ   95 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHHHHHH----------hccCCCHHHHHHHHHH
Confidence            688999999999999999999999964     3578899999999999999984          2233889999999999


Q ss_pred             HHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccch
Q 041757          140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDV  219 (381)
Q Consensus       140 i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDi  219 (381)
                      ++.++.+||   ..+++|+||+|+||+++.++.++|+|||.+..........   ...++..|+|||.+.+..++.++||
T Consensus        96 l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~pE~~~~~~~~~~~Di  169 (244)
T smart00220       96 ILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLT---TFVGTPEYMAPEVLLGKGYGKAVDV  169 (244)
T ss_pred             HHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccc---cccCCcCCCCHHHHccCCCCchhhH
Confidence            999999999   6699999999999999999999999999998766543111   2457889999999988888999999


Q ss_pred             hhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHH
Q 041757          220 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRI  299 (381)
Q Consensus       220 wSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  299 (381)
                      ||||+++|++++|..||...    .....            +.+.........             .......+..+.++
T Consensus       170 ~slG~~l~~l~~~~~p~~~~----~~~~~------------~~~~~~~~~~~~-------------~~~~~~~~~~~~~~  220 (244)
T smart00220      170 WSLGVILYELLTGKPPFPGD----DQLLE------------LFKKIGKPKPPF-------------PPPEWKISPEAKDL  220 (244)
T ss_pred             HHHHHHHHHHHhCCCCCCCC----CcHHH------------HHHHHhccCCCC-------------ccccccCCHHHHHH
Confidence            99999999999999997532    11111            111111000000             00000155688999


Q ss_pred             HHhccCCCCCCCCCHHHHHH
Q 041757          300 GVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       300 ~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +.+||..+|++||++.++++
T Consensus       221 i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      221 IRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHccCCchhccCHHHHhh
Confidence            99999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=227.91  Aligned_cols=262  Identities=18%  Similarity=0.231  Sum_probs=196.8

Q ss_pred             CCccccccccccccccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccC-
Q 041757           12 GNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIR-   74 (381)
Q Consensus        12 ~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~-   74 (381)
                      +++..|.++.-  ....|+.++..+.|.+.+.||+|.||.+.++++                ...++|.+|...--.|. 
T Consensus         2 ~k~~~g~ih~I--~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~   79 (378)
T KOG1345|consen    2 DKNDGGQIHLI--PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSP   79 (378)
T ss_pred             CCCCCCccccc--ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeecc
Confidence            35556664432  233466677889999999999999999977652                35688999988777775 


Q ss_pred             CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC
Q 041757           75 HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV  154 (381)
Q Consensus        75 h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~  154 (381)
                      |.||+.-|++.    +++.+..+++|||++.|||..-+.           ...+.+.....++.|+++|+.|||   +++
T Consensus        80 H~hIi~tY~va----Fqt~d~YvF~qE~aP~gdL~snv~-----------~~GigE~~~K~v~~ql~SAi~fMH---skn  141 (378)
T KOG1345|consen   80 HQHIIDTYEVA----FQTSDAYVFVQEFAPRGDLRSNVE-----------AAGIGEANTKKVFAQLLSAIEFMH---SKN  141 (378)
T ss_pred             chhhhHHHHHH----hhcCceEEEeeccCccchhhhhcC-----------cccccHHHHHHHHHHHHHHHHHhh---ccc
Confidence            99999998885    567889999999999999998873           356788888999999999999999   789


Q ss_pred             ceeeccCCCCeeeC--CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC---C--ccCcccchhhhhHHHH
Q 041757          155 TAHCVLKPSNVLLD--DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---N--EVSTIGDVYSYGILLL  227 (381)
Q Consensus       155 ivHrDlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~--~~~~~sDiwSlG~il~  227 (381)
                      +||||||.+||||-  +..++||+|||..+..+.....     ..-+..|.+||....   .  ...+.+|||.||+++|
T Consensus       142 lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f  216 (378)
T KOG1345|consen  142 LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFF  216 (378)
T ss_pred             hhhcccccceEEEecCCccEEEeeecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeee
Confidence            99999999999993  2348999999998765443322     224667899996543   2  2467789999999999


Q ss_pred             HHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCC
Q 041757          228 ELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMES  307 (381)
Q Consensus       228 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  307 (381)
                      .++||..||......+..+..|.....+...         ..|.+                .......+.++..+-+..+
T Consensus       217 ~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---------~~P~~----------------F~~fs~~a~r~Fkk~lt~~  271 (378)
T KOG1345|consen  217 YCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---------ALPKK----------------FNPFSEKALRLFKKSLTPR  271 (378)
T ss_pred             eeecCCCcchhhhccCchHHHHHHHhcccCc---------cCchh----------------hcccCHHHHHHHHHhcCCc
Confidence            9999999998777777776666554332221         11111                2234456677777889999


Q ss_pred             CCCCCCHHHHHHHHHH
Q 041757          308 PQDRMKMTNVVHELQS  323 (381)
Q Consensus       308 P~~RPs~~~vl~~L~~  323 (381)
                      |++|-...++.++...
T Consensus       272 ~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  272 FKDRCKIWTAKKMRKC  287 (378)
T ss_pred             ccccchhHHHHHHHHH
Confidence            9999666666655543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=233.87  Aligned_cols=185  Identities=23%  Similarity=0.310  Sum_probs=151.7

Q ss_pred             ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .+-.+-||.|+||.||-+..                   ...+++.+|+++|..++|.|++..++........--...|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44568899999999985431                   24577889999999999999999998843221122234578


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ++|+|.. +|...+          ..+..++...+.-++.||++||.|||   +.+|.||||||.|.|++.+..+||+||
T Consensus       135 ~TELmQS-DLHKII----------VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDF  200 (449)
T KOG0664|consen  135 LTELMQS-DLHKII----------VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDF  200 (449)
T ss_pred             HHHHHHh-hhhhee----------ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccc
Confidence            9998854 898888          67888999999999999999999999   779999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      |+++.......... +..+.|-.|+|||.+.+. .|+.+.||||.||++.|++-++..|.
T Consensus       201 GLARvee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ  259 (449)
T KOG0664|consen  201 GLARTWDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ  259 (449)
T ss_pred             ccccccchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence            99987655443322 224568899999999885 58999999999999999998888765

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.4e-30  Score=250.97  Aligned_cols=262  Identities=16%  Similarity=0.147  Sum_probs=169.2

Q ss_pred             ccccccccceecCCCceEEEeccc---------------------------------ccHHHH--------------HHH
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------------------------GAFKSF--------------IAE   66 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------------------------~~~~~~--------------~~E   66 (381)
                      ..++|.+.++||+|+||+||++..                                 ...+.|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999986521                                 011223              346


Q ss_pred             HHHHHccCCCcc-----cceeeeecccc---ccCCceEEEEEEcccCCCHHHhhccccCCc--------------ccccC
Q 041757           67 CKALRNIRHRNL-----IKVLTACLGVD---YQGNDFKALVYEFMHNRSLKEWLYPISKED--------------ETYKR  124 (381)
Q Consensus        67 ~~~l~~l~h~nI-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~  124 (381)
                      +.++.+++|.++     ++++++|....   .......+|||||+++++|.++++......              .....
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777776654     66777765311   112456899999999999999996421100              00011


Q ss_pred             CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeC
Q 041757          125 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIA  204 (381)
Q Consensus       125 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  204 (381)
                      ...+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||+|||++............ ...+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~-~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPL-YGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCcc-ccCCCcceeC
Confidence            234567788999999999999999   669999999999999999999999999999765433221111 1235789999


Q ss_pred             CCCcCCCc--------------------c--CcccchhhhhHHHHHHHhCCC-CCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          205 PEYGVGNE--------------------V--STIGDVYSYGILLLELMIREK-PSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       205 PE~l~~~~--------------------~--~~~sDiwSlG~il~el~tg~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      ||.+....                    +  ..+.||||+||++|+|++|.. ||.....-...+.     .........
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~-----~~~~~~~~~  453 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELR-----QYDNDLNRW  453 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHh-----hccchHHHH
Confidence            99875422                    1  124699999999999999875 6532110000000     000111000


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESP---QDRMKMTNVVH  319 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~~vl~  319 (381)
                      . .......              .............+++.+++..+|   .+|+|+.|+++
T Consensus       454 r-~~~~~~~--------------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        454 R-MYKGQKY--------------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             H-hhcccCC--------------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0 0000000              000122345678888889999766   68999999985

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=247.10  Aligned_cols=181  Identities=22%  Similarity=0.359  Sum_probs=157.1

Q ss_pred             ccccccceecCCCceEEEeccccc----------------HHHHH---------HHHHHHHccC---CCcccceeeeecc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQGA----------------FKSFI---------AECKALRNIR---HRNLIKVLTACLG   87 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~~----------------~~~~~---------~E~~~l~~l~---h~nIv~~~~~~~~   87 (381)
                      .+|...+.+|.|+||.|+++....                ...++         .|++||..|+   |+||++++++   
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf---  637 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF---  637 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe---
Confidence            458889999999999997764221                11122         3999999997   9999999999   


Q ss_pred             ccccCCceEEEEEEc-ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           88 VDYQGNDFKALVYEF-MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        88 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                        ++++++.||+||- -++.+|.+++          .....+++.++..|+.|++.|+++||   +.+|||||||-+|++
T Consensus       638 --FEddd~yyl~te~hg~gIDLFd~I----------E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvi  702 (772)
T KOG1152|consen  638 --FEDDDYYYLETEVHGEGIDLFDFI----------EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVI  702 (772)
T ss_pred             --eecCCeeEEEecCCCCCcchhhhh----------hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEE
Confidence              6789999999996 4567999999          56788999999999999999999999   779999999999999


Q ss_pred             eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCc
Q 041757          167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      ++.+|.+||+|||.+..........    ++||..|.|||++.+..| +..-|||++|++||.++....||.+
T Consensus       703 vd~~g~~klidfgsaa~~ksgpfd~----f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  703 VDSNGFVKLIDFGSAAYTKSGPFDV----FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EecCCeEEEeeccchhhhcCCCcce----eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999999999998877766554    679999999999999887 4567999999999999999999753

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=226.05  Aligned_cols=240  Identities=19%  Similarity=0.199  Sum_probs=171.4

Q ss_pred             cccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHH
Q 041757           57 QGAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLN  135 (381)
Q Consensus        57 ~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~  135 (381)
                      ....++..+|..++..+.|+||++++.++.-.. .+.....|+|||||. ++|.+++.            -.++-..+..
T Consensus        56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~------------~elDH~tis~  122 (369)
T KOG0665|consen   56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL------------MELDHETISY  122 (369)
T ss_pred             CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH------------HhcchHHHHH
Confidence            345577789999999999999999999976311 223456799999995 49998883            3467788899


Q ss_pred             HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCc
Q 041757          136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST  215 (381)
Q Consensus       136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~  215 (381)
                      ++.|++.|+.|||   +.+|+||||||+||++..+..+||.|||+++.....   ...+.++.|..|.|||++.+..|..
T Consensus       123 i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke  196 (369)
T KOG0665|consen  123 ILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKE  196 (369)
T ss_pred             HHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcc
Confidence            9999999999999   779999999999999999999999999999865544   2223467899999999999988999


Q ss_pred             ccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh--chHHHHHhhh-------hccCchhhh--hcccchhh--
Q 041757          216 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS--NHVKDIVDSI-------LLNDDEKLV--VRGDQKQT--  282 (381)
Q Consensus       216 ~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-------l~~~~~~~~--~~~~~~~~--  282 (381)
                      .+||||+||++.||++|..-|    .+...+.+|.+..-.  ..-..+.+.+       ....+.-..  +.......  
T Consensus       197 ~vdiwSvGci~gEli~~~Vlf----~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f  272 (369)
T KOG0665|consen  197 NVDIWSVGCIMGELILGTVLF----PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLF  272 (369)
T ss_pred             cchhhhhhhHHHHHhhceEEe----cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccc
Confidence            999999999999999999885    466666666554311  1111111111       111110000  00000000  


Q ss_pred             hhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          283 QAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       283 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .......+.......+++.+||-.||++|.|+.+++.
T Consensus       273 ~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  273 PVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             cccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            0000001123345677888999999999999999886

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.2e-28  Score=223.05  Aligned_cols=265  Identities=21%  Similarity=0.239  Sum_probs=189.2

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +.+.|...++||.|+|++||++..                  ....+..+|+++|..+. +.||+++.++     +..++
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~-----~rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGC-----FRNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhh-----hccCC
Confidence            457789999999999999977542                  23466788999999996 9999999999     67899


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCe
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTA  173 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~  173 (381)
                      ...+||||++.-+..++..             .++..++..++..++.||.++|   ..|||||||||+|+|.+. .++-
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg  172 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRG  172 (418)
T ss_pred             eeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCc
Confidence            9999999999988888873             3668889999999999999999   779999999999999975 4577


Q ss_pred             EEeecccceecCCCC------------------------------------------CcccccCccCccceeCCCCcCC-
Q 041757          174 RVGDFGLARFLPPTR------------------------------------------TQTSSIDVKGSIGYIAPEYGVG-  210 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~l~~-  210 (381)
                      .|+|||+|.......                                          .........||++|+|||++.. 
T Consensus       173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~  252 (418)
T KOG1167|consen  173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC  252 (418)
T ss_pred             eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence            899999987221100                                          0000113559999999999876 


Q ss_pred             CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH---HHhh--hhcc-----Cchhhhhcccc-
Q 041757          211 NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD---IVDS--ILLN-----DDEKLVVRGDQ-  279 (381)
Q Consensus       211 ~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~l~~-----~~~~~~~~~~~-  279 (381)
                      ...++++||||.|||+.-+++++.||-....+-..+..++.......++.   +.+.  ....     .++........ 
T Consensus       253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~  332 (418)
T KOG1167|consen  253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH  332 (418)
T ss_pred             cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence            45689999999999999999999998655544444544444433333222   1111  0000     00000000000 


Q ss_pred             -------hhh-hhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          280 -------KQT-QAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       280 -------~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                             .+. ..........+..+++++.+|++.||.+|.|+++.+.
T Consensus       333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                   000 1111122233448899999999999999999999885

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=8.1e-29  Score=257.15  Aligned_cols=203  Identities=18%  Similarity=0.218  Sum_probs=140.3

Q ss_pred             HHccCC-Ccccceeeeeccc--cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHH
Q 041757           70 LRNIRH-RNLIKVLTACLGV--DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNY  146 (381)
Q Consensus        70 l~~l~h-~nIv~~~~~~~~~--~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~  146 (381)
                      .+.++| +||++++++|...  +......++.+|||+ +++|.++|.         .....+++.+++.++.||+.||.|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~al~~   95 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLD---------NPDRSVDAFECFHVFRQIVEIVNA   95 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHh---------cccccccHHHHHHHHHHHHHHHHH
Confidence            445667 6888888886321  112234567888987 669999995         234568999999999999999999


Q ss_pred             hhcCCCCCceeeccCCCCeeeCC-------------------CCCeEEeecccceecCCCCC--------------cccc
Q 041757          147 LHHDCQPVTAHCVLKPSNVLLDD-------------------DMTARVGDFGLARFLPPTRT--------------QTSS  193 (381)
Q Consensus       147 LH~~~~~~ivHrDlkp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~~--------------~~~~  193 (381)
                      ||   +.+|+||||||+|||++.                   ++.+|++|||+++.......              ....
T Consensus        96 lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (793)
T PLN00181         96 AH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQ  172 (793)
T ss_pred             HH---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccc
Confidence            99   679999999999999954                   34566667776654221000              0000


Q ss_pred             cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhh
Q 041757          194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKL  273 (381)
Q Consensus       194 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  273 (381)
                      ....||+.|||||++.+..++.++|||||||+||||++|..|+....   ..            ...+....+  .+.  
T Consensus       173 ~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~------------~~~~~~~~~--~~~--  233 (793)
T PLN00181        173 ILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RT------------MSSLRHRVL--PPQ--  233 (793)
T ss_pred             cccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HH------------HHHHHHhhc--Chh--
Confidence            11357889999999999999999999999999999999988853110   00            000000000  000  


Q ss_pred             hhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          274 VVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                     ..........++.+||+.||.+||++.++++
T Consensus       234 ---------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        234 ---------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ---------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence                           0112234567788999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=6.6e-28  Score=205.17  Aligned_cols=169  Identities=23%  Similarity=0.267  Sum_probs=125.9

Q ss_pred             CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757          106 RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP  185 (381)
Q Consensus       106 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~  185 (381)
                      |+|.+++.         .....+++..++.++.|++.||.|||+.   +      ||+||+++.++.+|+  ||+++...
T Consensus         1 GsL~~~l~---------~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750        1 VSLADILE---------VRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CcHHHHHH---------HhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence            68999885         2345699999999999999999999944   4      999999999999999  99998764


Q ss_pred             CCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhh
Q 041757          186 PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSI  265 (381)
Q Consensus       186 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (381)
                      ...       ..||+.|+|||++.+..++.++|||||||++|||++|+.||........            ....++...
T Consensus        61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~------------~~~~~~~~~  121 (176)
T smart00750       61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA------------ILEILLNGM  121 (176)
T ss_pred             ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH------------HHHHHHHHh
Confidence            422       2488999999999999999999999999999999999999753221111            111111111


Q ss_pred             hccCchhhhhcccchhhhhHHHHHHHHH--HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          266 LLNDDEKLVVRGDQKQTQAKINIIRECV--ISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       266 l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      ....+..             ........  ..+.+++.+||..||.+|||+.++++.+..+..
T Consensus       122 ~~~~~~~-------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      122 PADDPRD-------------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ccCCccc-------------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            1111000             00011222  268999999999999999999999998876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=3e-27  Score=205.31  Aligned_cols=194  Identities=27%  Similarity=0.453  Sum_probs=162.9

Q ss_pred             ecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccC
Q 041757           44 ISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHN  105 (381)
Q Consensus        44 lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~  105 (381)
                      ||.|++|.||++...                  ..+.+.+|++.++.++|++|+++++++.     .....++++||+.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence            688888888775421                  1367999999999999999999999953     45788999999999


Q ss_pred             CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEEeecccceec
Q 041757          106 RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARVGDFGLARFL  184 (381)
Q Consensus       106 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~~~  184 (381)
                      ++|.+++..         ....++...+..++.+++.++.+||   ..+++|+||+|.||+++. ++.++|+|||.+...
T Consensus        76 ~~l~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          76 GSLKDLLKE---------NEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             CcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            999999842         1146889999999999999999999   669999999999999999 899999999999876


Q ss_pred             CCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHh
Q 041757          185 PPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVD  263 (381)
Q Consensus       185 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (381)
                      .....  ......+...|++||.+... .++.++|+|++|++++++                                  
T Consensus       144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------  187 (215)
T cd00180         144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------  187 (215)
T ss_pred             cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence            55431  11113478889999998877 788999999999999997                                  


Q ss_pred             hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          264 SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       264 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                                                    ..+.+++..|+..||.+||++.++++.
T Consensus       188 ------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                          156778889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=5.1e-29  Score=236.12  Aligned_cols=239  Identities=20%  Similarity=0.286  Sum_probs=184.0

Q ss_pred             hccccccccceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ...++|....++|.|+||.||+++..                 .++-...|+-+++..+|||||.++|.+     .....
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dk   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDK   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcC
Confidence            45788999999999999999998742                 344556799999999999999999994     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .|+.||||.+|+|.+.-+          -...+++.++...++..+.||.|||   +++=+|||||-.||++++.|.+|+
T Consensus        87 lwicMEycgggslQdiy~----------~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvkl  153 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKL  153 (829)
T ss_pred             cEEEEEecCCCcccceee----------ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceee
Confidence            899999999999999773          4678999999999999999999999   778899999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|||.+..+........  .+.||+.|||||+..   ...|...+|||++|+...|+-.-++|-   |.-. .......+
T Consensus       154 aDfgvsaqitati~Krk--sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl---fdlh-pmr~l~Lm  227 (829)
T KOG0576|consen  154 ADFGVSAQITATIAKRK--SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL---FDLH-PMRALFLM  227 (829)
T ss_pred             cccCchhhhhhhhhhhh--cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc---cccc-hHHHHHHh
Confidence            99999877665433332  367999999999753   456899999999999999998877772   2211 11111111


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..+.     +++.-..++                   ..-...+.++++.|+..+|.+|||++.++.
T Consensus       228 TkS~-----~qpp~lkDk-------------------~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  228 TKSG-----FQPPTLKDK-------------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             hccC-----CCCCcccCC-------------------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1000     010000011                   123446778888999999999999987764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=4e-28  Score=224.17  Aligned_cols=184  Identities=22%  Similarity=0.248  Sum_probs=152.9

Q ss_pred             ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCC------Ccccceeeeecccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRH------RNLIKVLTACLGVDYQ   91 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h------~nIv~~~~~~~~~~~~   91 (381)
                      +...|.+....|+|-||+|..+..                ...+.=++|+++|++|..      -|.++++-.     |.
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F~  504 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----FK  504 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----hh
Confidence            456788888999999999965542                234556789999999952      378888888     45


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      ..+++|||+|-+. -+|.++|+..       .....|....+..++.|+..||..|-   .-+|+|+||||+|||+++..
T Consensus       505 hknHLClVFE~Ls-lNLRevLKKy-------G~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  505 HKNHLCLVFEPLS-LNLREVLKKY-------GRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESK  573 (752)
T ss_pred             hcceeEEEehhhh-chHHHHHHHh-------CcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCc
Confidence            6899999999884 4999999654       24556888899999999999999999   66999999999999998754


Q ss_pred             -CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          172 -TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       172 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                       .+||||||.|..+.......    +..+..|.|||++.+..|+...|+||.||+||||.||+..|.
T Consensus       574 ~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             ceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence             68999999998776654333    335778999999999999999999999999999999998864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.6e-26  Score=203.70  Aligned_cols=181  Identities=29%  Similarity=0.405  Sum_probs=152.7

Q ss_pred             ccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      |...+.||.|+||.||++...                  ..+.+.+|++.+.+++|+|++++++.+.     .....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence            456788999999999776421                  4678889999999999999999999853     45788999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCc-ccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRN-LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      +||+++++|.+++.          .... +++..+..++.+++.++.+||   ..+++|+|++|+||+++.++.++|+||
T Consensus        76 ~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~  142 (225)
T smart00221       76 MEYCEGGDLFDYLR----------KKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADF  142 (225)
T ss_pred             EeccCCCCHHHHHH----------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeC
Confidence            99999999999994          2233 788999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCc-CCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYG-VGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      |.+......... ......++..|++||.+ ....++.++||||||+++++|++|+.||.
T Consensus       143 g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      143 GLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            999877654311 11124578889999998 66678889999999999999999999985

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=8.2e-24  Score=197.23  Aligned_cols=248  Identities=21%  Similarity=0.218  Sum_probs=183.5

Q ss_pred             cccccceecCCCceEEEeccccc------------------HHHHHHHHHHHHccCC----CcccceeeeeccccccCCc
Q 041757           37 NMLEENLISAGTFGFSHLRRQGA------------------FKSFIAECKALRNIRH----RNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~~------------------~~~~~~E~~~l~~l~h----~nIv~~~~~~~~~~~~~~~   94 (381)
                      +|.+.++||+|+||.||++....                  ...+..|+.++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            89999999999999998876321                  1157789999999973    58888888731    3577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC----
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD----  170 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~----  170 (381)
                      +.++||+.+ |.+|.++...        .....++..+++.++.|++.+|.+||   +.|++||||||+|+++...    
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~--------~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~  162 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKR--------NPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSE  162 (322)
T ss_pred             eeEEEEecc-CccHHHHHHh--------CCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcc
Confidence            899999988 7899998742        22478999999999999999999999   7799999999999999765    


Q ss_pred             -CCeEEeecccce--ecCCCCC------cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcccc
Q 041757          171 -MTARVGDFGLAR--FLPPTRT------QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE  241 (381)
Q Consensus       171 -~~~kl~Dfg~~~--~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~  241 (381)
                       ..+.|.|||+++  .......      ........||..|+++.+..+...+.+.|+||++.++.+++.|..||.....
T Consensus       163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence             368999999998  3222211      1112235699999999999999999999999999999999999999853322


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      ... ...+......    .....                       .....+..+.++...+-..+..++|....+...+
T Consensus       243 ~~~-~~~~~~~~~~----~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l  294 (322)
T KOG1164|consen  243 TDL-KSKFEKDPRK----LLTDR-----------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL  294 (322)
T ss_pred             cch-HHHHHHHhhh----hcccc-----------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence            211 1111110000    00000                       0112334555555566668999999999999999


Q ss_pred             HHhhhhc
Q 041757          322 QSIKNTL  328 (381)
Q Consensus       322 ~~i~~~~  328 (381)
                      +......
T Consensus       295 ~~~~~~~  301 (322)
T KOG1164|consen  295 KDVFDSE  301 (322)
T ss_pred             HHHHHhc
Confidence            8887665

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=3.2e-25  Score=219.79  Aligned_cols=238  Identities=19%  Similarity=0.222  Sum_probs=177.0

Q ss_pred             cccceecCCCceEEEeccc------ccH-----------------HHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           39 LEENLISAGTFGFSHLRRQ------GAF-----------------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~~------~~~-----------------~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ....++|.|++|.|+....      ...                 ..+..|+-+-..|.|+|++..+..+.+     ...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-----~~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-----IDG  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-----ccc
Confidence            4568999999995533210      001                 113446666667899999887777543     223


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      ..-+||||++ ||..++          .....++..++..++.|++.|++|+|   ..||.|||+|++|+++..++.+||
T Consensus       396 ~~~~mE~~~~-Dlf~~~----------~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki  461 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLV----------MSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKI  461 (601)
T ss_pred             chhhhhcccH-HHHHHH----------hcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEE
Confidence            3334999999 999999          34457889999999999999999999   779999999999999999999999


Q ss_pred             eecccceecCCCCCc--ccccCccCccceeCCCCcCCCccCcc-cchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          176 GDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGNEVSTI-GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~-sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|||.+....-....  ......+|+-.|+|||++.+..|.+. .||||.|+++..|.+|+.||......+..+   ...
T Consensus       462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~  538 (601)
T KOG0590|consen  462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTN  538 (601)
T ss_pred             eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhh
Confidence            999998776554443  44445789999999999999998755 699999999999999999997555444332   000


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .....                     .........+....+.....++.++++.||.+|.|+.+|++
T Consensus       539 ~~~~~---------------------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  539 NYSDQ---------------------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccc---------------------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00000                     00011112234566778888999999999999999999986

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-23  Score=184.17  Aligned_cols=266  Identities=15%  Similarity=0.173  Sum_probs=202.7

Q ss_pred             hccccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceE
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .+.-+|.++++||+|+||..+..+               +....++..|.+..+.|. .++|..+|-+     .+.+.+.
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeee-----ccccchh
Confidence            346689999999999999985543               445678888999999996 7899998877     5668888


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-----
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-----  171 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-----  171 (381)
                      .||+|++ |.+|++++.         -..+.++..+++.++.|++.-++|+|   .+.+|.|||||+|+||...+     
T Consensus       100 iLVidLL-GPSLEDLFD---------~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n  166 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFD---------LCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDAN  166 (449)
T ss_pred             hhhhhhh-CcCHHHHHH---------HhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCc
Confidence            9999988 889999885         56788999999999999999999999   77999999999999997544     


Q ss_pred             CeEEeecccceecCCCCCc-----ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          172 TARVGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                      .+.++|||+|+.+.+....     ....+..||.+||+-....+.+.+.+.|+=|+|-++.+.+-|..||..... +.+-
T Consensus       167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA-~tnK  245 (449)
T KOG1165|consen  167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-DTNK  245 (449)
T ss_pred             eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC-cchH
Confidence            5889999999987664321     122235699999999999999999999999999999999999999974432 2222


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      ..+.+..-..                        +......+....|.++..-+...-..+-.+-|...-+...+..+..
T Consensus       246 ~kYeKIGe~K------------------------r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  246 EKYEKIGETK------------------------RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             HHHHHhcccc------------------------ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            2222221111                        1111122233455566666666667788999999999888888877


Q ss_pred             hcCCCCCcccccccc
Q 041757          327 TLLGPKNLATCKAVI  341 (381)
Q Consensus       327 ~~~~~~~~~~~~~~~  341 (381)
                      ......+-..+|..+
T Consensus       302 r~g~t~Dg~yDW~~l  316 (449)
T KOG1165|consen  302 RLGETDDGEYDWMGL  316 (449)
T ss_pred             hcCCccccccccccc
Confidence            766555555555443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4.8e-24  Score=180.10  Aligned_cols=270  Identities=19%  Similarity=0.196  Sum_probs=209.4

Q ss_pred             chhhhhccccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCC-Ccccceeeeecccccc
Q 041757           28 NLEILDVSRNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRH-RNLIKVLTACLGVDYQ   91 (381)
Q Consensus        28 ~l~~~~~~~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~   91 (381)
                      .++.+...++|...++||.|+||.+|++.               ......+..|.++...|++ ..|..+..+     ..
T Consensus         7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~   81 (341)
T KOG1163|consen    7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHY-----GT   81 (341)
T ss_pred             chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhh-----cc
Confidence            34555667899999999999999998764               2234667889999999985 556666655     34


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-  170 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-  170 (381)
                      +..+..+||+++ |.+|.+++.         -....++..+++.++-|++.-++|+|   .+++|||||||+|+|..-+ 
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfn---------fC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgr  148 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFN---------FCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGR  148 (341)
T ss_pred             ccccceeeeecc-CccHHHHHH---------HHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeecccc
Confidence            577889999988 889999885         45678999999999999999999999   6699999999999998543 


Q ss_pred             --CCeEEeecccceecCCCCC-----cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757          171 --MTARVGDFGLARFLPPTRT-----QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  243 (381)
Q Consensus       171 --~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~  243 (381)
                        ..+.++|||+|+.+.+...     ........||.+|.+-....+.+.+.+.|+=|+|.+|.+.--|..||.......
T Consensus       149 h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t  228 (341)
T KOG1163|consen  149 HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT  228 (341)
T ss_pred             ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence              3678999999997765322     222334679999999998888888999999999999999999999997554322


Q ss_pred             --CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          244 --MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       244 --~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                        ...+.+.....+..+..+                           ....|.++.-.+..|-..--++-|...-+.+.+
T Consensus       229 k~QKyEkI~EkK~s~~ie~L---------------------------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  229 KKQKYEKISEKKMSTPIEVL---------------------------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             HHHHHHHHHHhhcCCCHHHH---------------------------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence              112222222222222222                           235566788888899999999999999999999


Q ss_pred             HHhhhhcCCCCCccccccccC
Q 041757          322 QSIKNTLLGPKNLATCKAVIG  342 (381)
Q Consensus       322 ~~i~~~~~~~~~~~~~~~~~~  342 (381)
                      .-+...+....+...+|+.+.
T Consensus       282 riLfr~ln~~~d~iyDW~~lk  302 (341)
T KOG1163|consen  282 RILFRTLNHQYDYIYDWTMLK  302 (341)
T ss_pred             HHHHhhccccCCeEeeHHHHH
Confidence            999998888888888887765

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.5e-23  Score=195.59  Aligned_cols=152  Identities=21%  Similarity=0.147  Sum_probs=116.8

Q ss_pred             hhccccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeeccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGV   88 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~   88 (381)
                      ....++|...++||+|+||+||++...                       ..+.|.+|+++|++++|+||+..+..    
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence            345788999999999999999876310                       13458899999999999999863322    


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeecc-CCCCeee
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL-KPSNVLL  167 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDl-kp~Nill  167 (381)
                          ....++||||++|++|.. +.          ...      ...++.+++.||.|||   +.+|+|||| ||+|||+
T Consensus        90 ----~~~~~LVmE~~~G~~L~~-~~----------~~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv  145 (365)
T PRK09188         90 ----TGKDGLVRGWTEGVPLHL-AR----------PHG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLM  145 (365)
T ss_pred             ----cCCcEEEEEccCCCCHHH-hC----------ccc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEE
Confidence                124699999999999963 21          111      1457889999999999   679999999 9999999


Q ss_pred             CCCCCeEEeecccceecCCCCCccc------ccCccCccceeCCCCcCCC
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTS------SIDVKGSIGYIAPEYGVGN  211 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~  211 (381)
                      +.++.+||+|||+++.+........      .....+++.|+|||++...
T Consensus       146 ~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        146 GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999999999999997765432111      1235678889999988753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=3.1e-23  Score=197.01  Aligned_cols=221  Identities=24%  Similarity=0.359  Sum_probs=162.7

Q ss_pred             HHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhc
Q 041757           70 LRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHH  149 (381)
Q Consensus        70 l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  149 (381)
                      |+.+.|.|+.+++|.++.     ....++|.+||..|+|.+.+.         .....+++.....+..+|+.||+|||.
T Consensus         1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~---------~~~~~~d~~F~~s~~rdi~~Gl~ylh~   66 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILS---------NEDIKLDYFFILSFIRDISKGLAYLHN   66 (484)
T ss_pred             CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHh---------ccccCccHHHHHHHHHHHHHHHHHHhc
Confidence            467899999999999865     478899999999999999996         456778999999999999999999995


Q ss_pred             CCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc-------cCcccchhhh
Q 041757          150 DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-------VSTIGDVYSY  222 (381)
Q Consensus       150 ~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~sDiwSl  222 (381)
                      . + ...|+.+++.|++++..+.+||+|||+.................-..-|.|||.+.+..       .+.++|||||
T Consensus        67 s-~-i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~  144 (484)
T KOG1023|consen   67 S-P-IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF  144 (484)
T ss_pred             C-c-ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence            4 2 23999999999999999999999999987764311111111122456799999988642       3667999999


Q ss_pred             hHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHh
Q 041757          223 GILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVA  302 (381)
Q Consensus       223 G~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  302 (381)
                      |++++|+++++.||+........ ......... .....+.+                   .... ..+....+..++..
T Consensus       145 ~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP-------------------~i~~-~~e~~~~l~~l~~~  202 (484)
T KOG1023|consen  145 GIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFRP-------------------SIEL-LNELPPELLLLVAR  202 (484)
T ss_pred             HHHHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcCc-------------------chhh-hhhcchHHHHHHHH
Confidence            99999999999999754433332 111111000 00000000                   0000 01344578999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          303 CSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       303 cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                      ||..+|.+||++.+|...++.+....
T Consensus       203 cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  203 CWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             hcccChhhCccHHHHHhhhhhhcccc
Confidence            99999999999999999998886654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=1.6e-21  Score=180.59  Aligned_cols=247  Identities=25%  Similarity=0.328  Sum_probs=179.7

Q ss_pred             ccccceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCC-cccceeeeeccccccCCceEEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      |...+.||.|+||.||.+...                 ....+.+|+.++..+.|+ +|+++++.+     ......+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEEEEE
Confidence            667788999999999776421                 367789999999999988 799999995     335558999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEeec
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVGDF  178 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~Df  178 (381)
                      ++++.++++.+++....      .. ..+.......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++||
T Consensus        77 ~~~~~~~~l~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          77 MEYVDGGSLEDLLKKIG------RK-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             EecCCCCcHHHHHHhcc------cc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEecc
Confidence            99999999997774210      00 37899999999999999999999   66899999999999999988 7999999


Q ss_pred             ccceecCCCCCcc----cccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          179 GLARFLPPTRTQT----SSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       179 g~~~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      |.++.........    ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||...... ....... 
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~-  224 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTL-  224 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHH-
Confidence            9998665543321    2234679999999999887   57889999999999999999999996422211 0001100 


Q ss_pred             HHhhchHHHHHhhhhcc-CchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          252 MALSNHVKDIVDSILLN-DDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                              +.+...... ....    ..       ..........+.+++..|+..+|..|.+..+....
T Consensus       225 --------~~~~~~~~~~~~~~----~~-------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         225 --------KIILELPTPSLASP----LS-------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --------HHHHhcCCcccccc----cC-------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                    001000000 0000    00       00001223567788889999999999999887764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=7.1e-23  Score=175.95  Aligned_cols=213  Identities=24%  Similarity=0.345  Sum_probs=160.2

Q ss_pred             cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757           59 AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI  138 (381)
Q Consensus        59 ~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  138 (381)
                      .-+.|..|.-.|+-+.||||+.+++.|..     .....++..||+.|+|..+|+..        ..-.++..++.+++.
T Consensus       230 isrdfneefp~lrifshpnilpvlgacns-----ppnlv~isq~mp~gslynvlhe~--------t~vvvd~sqav~fal  296 (448)
T KOG0195|consen  230 ISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVIISQYMPFGSLYNVLHEQ--------TSVVVDHSQAVRFAL  296 (448)
T ss_pred             hcchhhhhCcceeeecCCchhhhhhhccC-----CCCceEeeeeccchHHHHHHhcC--------ccEEEecchHHHHHH
Confidence            34568889999999999999999999754     67789999999999999999863        345577889999999


Q ss_pred             HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe--ecccceecCCCCCcccccCccCccceeCCCCcCCCcc---
Q 041757          139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG--DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV---  213 (381)
Q Consensus       139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---  213 (381)
                      ++++|++|||+. ..-|.---|....+++|++.+.+|+  |--++..         .....-.+.||+||.+...+-   
T Consensus       297 diargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n  366 (448)
T KOG0195|consen  297 DIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLN  366 (448)
T ss_pred             HHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcc
Confidence            999999999976 3444445689999999999877764  3222211         111234788999999887543   


Q ss_pred             CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHH
Q 041757          214 STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV  293 (381)
Q Consensus       214 ~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (381)
                      -.++|+|||.+++||+.|+..||......+....    .        -+..                   .+..+++...
T Consensus       367 ~raadmwsfaillwel~trevpfadlspmecgmk----i--------aleg-------------------lrv~ippgis  415 (448)
T KOG0195|consen  367 IRAADMWSFAILLWELNTREVPFADLSPMECGMK----I--------ALEG-------------------LRVHIPPGIS  415 (448)
T ss_pred             hhhhhHHHHHHHHHHhhccccccccCCchhhhhh----h--------hhcc-------------------ccccCCCCcc
Confidence            3568999999999999999999864433222111    0        0111                   0112245667


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          294 ISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       294 ~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                      ..+.+|+.-|...||.+||.+..|+-.|++..
T Consensus       416 ~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  416 RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            78899999999999999999999998888753

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=2.7e-21  Score=168.21  Aligned_cols=162  Identities=12%  Similarity=0.105  Sum_probs=121.6

Q ss_pred             hccccccccceecCCCceEEEeccc------------------ccHHH------HHHHHHHHHccCCCcccceeeeeccc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKS------FIAECKALRNIRHRNLIKVLTACLGV   88 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~------~~~E~~~l~~l~h~nIv~~~~~~~~~   88 (381)
                      .+.++|+..++||.|+||.|++...                  ....+      +.+|++.+.++.|++|..+.+++...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            3689999999999999999987542                  11222      57899999999999999998885531


Q ss_pred             cc---cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCe
Q 041757           89 DY---QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNV  165 (381)
Q Consensus        89 ~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Ni  165 (381)
                      ..   ......+|||||++|.+|.++..              +++    ....+++.++..+|   ..|++|||+||+||
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Ni  166 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNF  166 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHE
Confidence            11   11345789999999999988741              122    24569999999999   66999999999999


Q ss_pred             eeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHH
Q 041757          166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM  230 (381)
Q Consensus       166 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~  230 (381)
                      +++.++ ++|+|||............              .++....|..++||||||+++.-..
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence            999888 9999999886543221110              0233445678899999999986543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=2.2e-21  Score=184.65  Aligned_cols=169  Identities=25%  Similarity=0.272  Sum_probs=144.1

Q ss_pred             eecCCCceEEEecc----------------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEE
Q 041757           43 LISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        43 ~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      ++|.|.||.|.+++                      .........|..++...+ ||.+|++...     ++.....+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            47899999995543                      112225566888999997 9999999888     5678889999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      ++|..+|+|...+          .....+++.....+...++-+++++|   +.+++|||+|++||+++.+|.+++.|||
T Consensus        76 ld~~rgg~lft~l----------~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfg  142 (612)
T KOG0603|consen   76 LDFLRGGDLFTRL----------SKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFG  142 (612)
T ss_pred             hhhcccchhhhcc----------ccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCch
Confidence            9999999999888          56677888888889999999999999   7799999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +++..-.....      +||..|||||++.  .....+|.||||++++||+||..||.
T Consensus       143 lske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~  192 (612)
T KOG0603|consen  143 LSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG  192 (612)
T ss_pred             hhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence            99865443322      6899999999987  56788999999999999999999986

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=6.4e-20  Score=165.48  Aligned_cols=202  Identities=21%  Similarity=0.245  Sum_probs=142.3

Q ss_pred             CCCcccceeeeecc----------------------ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHH
Q 041757           74 RHRNLIKVLTACLG----------------------VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLL  131 (381)
Q Consensus        74 ~h~nIv~~~~~~~~----------------------~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~  131 (381)
                      +|||||++.+.|.+                      .........|+||.-++. +|.+++.           ....+..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----------~~~~s~r  341 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----------TRHRSYR  341 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----------cCCCchH
Confidence            59999999998875                      112346678999998865 9999984           3445667


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee--CCCC--CeEEeecccceecCCC----CCcccccCccCcccee
Q 041757          132 RRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL--DDDM--TARVGDFGLARFLPPT----RTQTSSIDVKGSIGYI  203 (381)
Q Consensus       132 ~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill--~~~~--~~kl~Dfg~~~~~~~~----~~~~~~~~~~gt~~y~  203 (381)
                      ...-++.|+++|+.|||   ++||.|||+|.+|||+  ++++  .+.|+|||++---+..    .........-|.-.-|
T Consensus       342 ~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm  418 (598)
T KOG4158|consen  342 TGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM  418 (598)
T ss_pred             HHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence            77889999999999999   6699999999999999  3343  5689999987533321    1112222344788899


Q ss_pred             CCCCcCCCc------cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcc
Q 041757          204 APEYGVGNE------VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRG  277 (381)
Q Consensus       204 aPE~l~~~~------~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  277 (381)
                      |||+....+      .-.|+|.|+.|.+.||++....||...-+.......+....                        
T Consensus       419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q------------------------  474 (598)
T KOG4158|consen  419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ------------------------  474 (598)
T ss_pred             chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh------------------------
Confidence            999876432      23679999999999999999999864211111111111110                        


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          278 DQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                             .+.++..++..+.+++...++.||++|++..=..+.|
T Consensus       475 -------LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  475 -------LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             -------CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence                   0112345677788888899999999999976555444

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=8.2e-20  Score=155.72  Aligned_cols=174  Identities=21%  Similarity=0.113  Sum_probs=125.0

Q ss_pred             cccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757           39 LEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .....|++|+||+|+++...                   ....+.+|+++|++|. |++|.+++++        . ..++
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--------~-~~~l   75 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--------D-GRHL   75 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--------c-CEEE
Confidence            45678999999999876522                   1225789999999996 5889998886        1 2589


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeecc-CCCCeeeCCCCCeEEee
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL-KPSNVLLDDDMTARVGD  177 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDl-kp~Nill~~~~~~kl~D  177 (381)
                      +|||+.|.+|.+.+.          .       ....++.|++.+|.++|   ..||+|||| ||+|||++.++.++|+|
T Consensus        76 vmeyI~G~~L~~~~~----------~-------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LID  135 (218)
T PRK12274         76 DRSYLAGAAMYQRPP----------R-------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVID  135 (218)
T ss_pred             EEeeecCccHHhhhh----------h-------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEE
Confidence            999999999875441          1       11347789999999999   669999999 79999999999999999


Q ss_pred             cccceecCCCCCc----c-c------ccCccCccceeCCCCcCC-CccC-cccchhhhhHHHHHHHhCCCCCCcccc
Q 041757          178 FGLARFLPPTRTQ----T-S------SIDVKGSIGYIAPEYGVG-NEVS-TIGDVYSYGILLLELMIREKPSDIMFE  241 (381)
Q Consensus       178 fg~~~~~~~~~~~----~-~------~~~~~gt~~y~aPE~l~~-~~~~-~~sDiwSlG~il~el~tg~~Pf~~~~~  241 (381)
                      ||++.........    . .      ......++.|++|+.-.- ...+ ...+.++-|.-+|.++||..|+....+
T Consensus       136 FG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        136 FQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             CCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            9999865443210    0 0      000114555666653221 1223 345778999999999999999654433

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=1.2e-20  Score=188.58  Aligned_cols=255  Identities=18%  Similarity=0.194  Sum_probs=170.1

Q ss_pred             cCCccccccccccccccchhhhhccccccccceecCCCceEEEecc----------------cccHHHHH---HHHHHHH
Q 041757           11 SGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRR----------------QGAFKSFI---AECKALR   71 (381)
Q Consensus        11 ~~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~---~E~~~l~   71 (381)
                      .+|+++|  |.++.....+- -+...++...+.||.+.|=+|.+++                .-....|.   +|++ ..
T Consensus         1 MGnqls~--~sQi~~~e~yf-sd~~~e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~   76 (1431)
T KOG1240|consen    1 MGNQLSL--PSQISPVEVYF-SDLSVECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FA   76 (1431)
T ss_pred             CCccccc--ccccchHHHHh-hcCccceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HH
Confidence            3788887  44432222110 1112256667888988887663322                11234444   4444 45


Q ss_pred             ccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 041757           72 NIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC  151 (381)
Q Consensus        72 ~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  151 (381)
                      .++|||.+.+..+     .....-.|||-+|... +|.+.+          ....-+...+..-|+.|++.||.-+|   
T Consensus        77 l~~~pn~lPfqk~-----~~t~kAAylvRqyvkh-nLyDRl----------STRPFL~~iEKkWiaFQLL~al~qcH---  137 (1431)
T KOG1240|consen   77 LMKAPNCLPFQKV-----LVTDKAAYLVRQYVKH-NLYDRL----------STRPFLVLIEKKWIAFQLLKALSQCH---  137 (1431)
T ss_pred             hhcCCcccchHHH-----HHhhHHHHHHHHHHhh-hhhhhh----------ccchHHHHHHHHHHHHHHHHHHHHHH---
Confidence            5689999998877     4557778899999855 999988          45566788889999999999999999   


Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCccccc-----CccCccceeCCCCcCC----------Cc-cCc
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-----DVKGSIGYIAPEYGVG----------NE-VST  215 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~-----~~~gt~~y~aPE~l~~----------~~-~~~  215 (381)
                      ..||+|+|||.+||||+.-..+.|+||...+..--+.......     ....-..|.|||.+..          .. .++
T Consensus       138 ~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~p  217 (1431)
T KOG1240|consen  138 KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTP  217 (1431)
T ss_pred             HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccCh
Confidence            7799999999999999998899999998776543222221111     0112346999997543          12 567


Q ss_pred             ccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHH
Q 041757          216 IGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVI  294 (381)
Q Consensus       216 ~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (381)
                      +-||||+||++.|+++ |++||.        +.++.......  .+.....++..                      ...
T Consensus       218 aMDIFS~GCViaELf~Eg~PlF~--------LSQL~aYr~~~--~~~~e~~Le~I----------------------ed~  265 (1431)
T KOG1240|consen  218 AMDIFSAGCVIAELFLEGRPLFT--------LSQLLAYRSGN--ADDPEQLLEKI----------------------EDV  265 (1431)
T ss_pred             hhhhhhhhHHHHHHHhcCCCccc--------HHHHHhHhccC--ccCHHHHHHhC----------------------cCc
Confidence            8899999999999987 688875        11111111110  11111111111                      112


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          295 SMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       295 ~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      .+..++..|++.||++|.++++.++.
T Consensus       266 ~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  266 SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cHHHHHHHHHccCchhccCHHHHHHh
Confidence            67788889999999999999999986

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=6.7e-19  Score=152.66  Aligned_cols=125  Identities=16%  Similarity=0.147  Sum_probs=94.4

Q ss_pred             cccceecCCCceEEEecc--------------cccHHHHHHHHHHHHcc-----CCCcccceeeeeccccccCCce-EEE
Q 041757           39 LEENLISAGTFGFSHLRR--------------QGAFKSFIAECKALRNI-----RHRNLIKVLTACLGVDYQGNDF-KAL   98 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~--------------~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~~~~~~~~~-~~l   98 (381)
                      ...++||+|+||.||...              ....+.+.+|+++++.+     .||||+++++++.+  ...... ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et--~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET--DCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe--CCCCeEEEEE
Confidence            456789999999997632              11456789999999999     57999999999643  111134 337


Q ss_pred             EEEc--ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHH-HHhhcCCCCCceeeccCCCCeeeCC----CC
Q 041757           99 VYEF--MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL-NYLHHDCQPVTAHCVLKPSNVLLDD----DM  171 (381)
Q Consensus        99 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~ivHrDlkp~Nill~~----~~  171 (381)
                      ||||  +.+|+|.+++.          . ..+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    ++
T Consensus        83 I~e~~G~~~~tL~~~l~----------~-~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         83 IADFDGKPSITLTEFAE----------Q-CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             EecCCCCcchhHHHHHH----------c-ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCC
Confidence            8999  66899999994          2 234444  35678888888 9999   669999999999999974    34


Q ss_pred             CeEEeecccc
Q 041757          172 TARVGDFGLA  181 (381)
Q Consensus       172 ~~kl~Dfg~~  181 (381)
                      .++|+||+.+
T Consensus       147 ~~~LiDg~G~  156 (210)
T PRK10345        147 IPVVCDNIGE  156 (210)
T ss_pred             cEEEEECCCC
Confidence            8999995433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.79  E-value=3.2e-19  Score=153.15  Aligned_cols=99  Identities=15%  Similarity=0.108  Sum_probs=78.5

Q ss_pred             HHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHH
Q 041757           65 AECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL  144 (381)
Q Consensus        65 ~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l  144 (381)
                      +|++++.++.++++.....+.     . . ..+|||||++++++.....          ....++...+..++.|++.+|
T Consensus        68 ~E~~~l~~l~~~~v~~p~~~~-----~-~-~~~iVmE~i~g~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L  130 (190)
T cd05147          68 KEMRNLKRLVTAGIPCPEPIL-----L-K-SHVLVMEFIGDDGWAAPRL----------KDAPLSESKARELYLQVIQIM  130 (190)
T ss_pred             HHHHHHHHHHHCCCCCCcEEE-----e-c-CCEEEEEEeCCCCCcchhh----------hcCCCCHHHHHHHHHHHHHHH
Confidence            499999999888774433321     1 1 2389999999887765531          234688899999999999999


Q ss_pred             HHh-hcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757          145 NYL-HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL  184 (381)
Q Consensus       145 ~~L-H~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~  184 (381)
                      .++ |   ..+|+||||||+||+++ ++.++|+|||+|...
T Consensus       131 ~~l~H---~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         131 RILYQ---DCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HHHHH---hCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            999 6   55999999999999998 478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.77  E-value=2.2e-18  Score=148.29  Aligned_cols=102  Identities=19%  Similarity=0.099  Sum_probs=80.6

Q ss_pred             HHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHH
Q 041757           64 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASA  143 (381)
Q Consensus        64 ~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~  143 (381)
                      .+|.+.+.++.|++|.....+..      . ..++||||++++++.....          ....++......++.|++.+
T Consensus        67 ~~E~~~l~~l~~~~i~~p~~~~~------~-~~~lVmE~~~g~~~~~~~l----------~~~~~~~~~~~~i~~~l~~~  129 (190)
T cd05145          67 EKEFRNLKRLYEAGVPVPEPILL------K-KNVLVMEFIGDDGSPAPRL----------KDVPLEEEEAEELYEQVVEQ  129 (190)
T ss_pred             HHHHHHHHHHHhCCCCCceEEEe------c-CCEEEEEEecCCCchhhhh----------hhccCCHHHHHHHHHHHHHH
Confidence            57899999999998754444321      1 2489999999886544321          23456788899999999999


Q ss_pred             HHHhhcCCC-CCceeeccCCCCeeeCCCCCeEEeecccceecCC
Q 041757          144 LNYLHHDCQ-PVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP  186 (381)
Q Consensus       144 l~~LH~~~~-~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~  186 (381)
                      +.++|   . .||+||||||+||+++ ++.++|+|||++.....
T Consensus       130 l~~lH---~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         130 MRRLY---QEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             HHHHH---HhCCEecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence            99999   5 6999999999999998 78999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=1.1e-19  Score=170.10  Aligned_cols=126  Identities=29%  Similarity=0.477  Sum_probs=106.6

Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ..+.||.|++|...+|.+||...       ......++...+.++.|++.|+.|      ++.+|||+||.||+...+..
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr-------~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q  394 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRR-------RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQ  394 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCC-------CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchh
Confidence            34678999999999999999532       233456677889999999999999      38999999999999999999


Q ss_pred             eEEeecccceecCCCC----CcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh
Q 041757          173 ARVGDFGLARFLPPTR----TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI  231 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t  231 (381)
                      +||.|||+........    .....+..+||..||+||.+.+..|+.++||||||++++|+++
T Consensus       395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            9999999987766554    1223334679999999999999999999999999999999986

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=2.4e-18  Score=174.71  Aligned_cols=183  Identities=14%  Similarity=0.127  Sum_probs=141.8

Q ss_pred             cccccccceecCCCceEEEecccccHHH-------------HHHHHHHHHccC---CCcccceeeeeccccccCCceEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQGAFKS-------------FIAECKALRNIR---HRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~-------------~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ...|.+.+.||+|+||+||.+....-+.             |.-=.+++.+|+   -+-|..+....+     ..+-.+|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~-----~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHV-----FQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHc-----cCCccee
Confidence            4568899999999999999987544111             111224455554   233444444422     2455689


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-------CC
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-------DM  171 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-------~~  171 (381)
                      |+||.+.|+|.+++          +....+++..++.+..|++.-++.||   ..+|||+||||+|+||..       ..
T Consensus       772 v~ey~~~Gtlld~~----------N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLI----------NTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             eeeccccccHHHhh----------ccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCccc
Confidence            99999999999999          56778999999999999999999999   779999999999999943       33


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCC
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP  235 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~P  235 (381)
                      -++|+|||.+-.+.--.....-...++|-.+-++|+..+..++...|-|.|+.+++.|+.|+..
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            6899999998765543333333346688899999999999999999999999999999998764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=8.2e-19  Score=157.23  Aligned_cols=227  Identities=17%  Similarity=0.190  Sum_probs=136.6

Q ss_pred             ccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCC---C-------cccceeeee
Q 041757           36 RNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRH---R-------NLIKVLTAC   85 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h---~-------nIv~~~~~~   85 (381)
                      .....++.||.|+|+.|+.+.                    ...++.+.+|.-....+.+   |       .++--++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            455677899999999997754                    2356777777755555433   1       111111111


Q ss_pred             cc---cc-c---cCCc-----eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC
Q 041757           86 LG---VD-Y---QGND-----FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP  153 (381)
Q Consensus        86 ~~---~~-~---~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~  153 (381)
                      .-   .. .   ....     ..+++|+-+ .+||.+++.......   .....+.....+.+..|+++.+++||   ..
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~---~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~  164 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA---QTHSPLAFAARLSLTVQMIRLVANLH---SY  164 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc---cccchhHHHHHHHHHHHHHHHHHHHh---hc
Confidence            10   00 0   1111     236788877 458988864221110   11233555566777899999999999   66


Q ss_pred             CceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC--------CccCcccchhhhhHH
Q 041757          154 VTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--------NEVSTIGDVYSYGIL  225 (381)
Q Consensus       154 ~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDiwSlG~i  225 (381)
                      |+||+||+|+|++++.+|.+.|+||+.....+.....     ...+..|.+||....        ..++.+.|.|++|++
T Consensus       165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             ceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            9999999999999999999999999987765443221     124577899996533        247888999999999


Q ss_pred             HHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccC
Q 041757          226 LLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSM  305 (381)
Q Consensus       226 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  305 (381)
                      +|.|.++..||+..........             .+..                        ..+.+..+..|+..+|+
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~~-------------~f~~------------------------C~~~Pe~v~~LI~~lL~  282 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPEW-------------DFSR------------------------CRDMPEPVQFLIRGLLQ  282 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSGG-------------GGTT------------------------SS---HHHHHHHHHHT-
T ss_pred             HHHHHHccCCCCCCCccccccc-------------cchh------------------------cCCcCHHHHHHHHHHcc
Confidence            9999999999875433221110             0000                        12566778888889999


Q ss_pred             CCCCCC
Q 041757          306 ESPQDR  311 (381)
Q Consensus       306 ~dP~~R  311 (381)
                      .||.+|
T Consensus       283 ~~~~~R  288 (288)
T PF14531_consen  283 RNPEDR  288 (288)
T ss_dssp             SSGGGS
T ss_pred             CCcccC
Confidence            999987

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=2e-18  Score=172.45  Aligned_cols=164  Identities=26%  Similarity=0.319  Sum_probs=118.4

Q ss_pred             ccccccccceecCCCceEEEeccccc-HHHHHHHHHHHHccCCCcccce-eeeeccccccCCceEEEEEEcccCCCHHHh
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQGA-FKSFIAECKALRNIRHRNLIKV-LTACLGVDYQGNDFKALVYEFMHNRSLKEW  111 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~-~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~  111 (381)
                      ...+|..++.|..|+||.||++++.. .++|..      +++-.|+|-= +..     +  .+..+.|      ||-...
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~------kiNkq~lilRnilt-----~--a~npfvv------gDc~tl  141 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM------KINKQNLILRNILT-----F--AGNPFVV------GDCATL  141 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhh------cccccchhhhcccc-----c--cCCccee------chhhhh
Confidence            35789999999999999999997653 344432      3333333211 111     1  1122333      566666


Q ss_pred             hccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCC--
Q 041757          112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT--  189 (381)
Q Consensus       112 l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  189 (381)
                      +          +..+.++..        .+.+++|||   ..+|+|||+||+|.+|..-|++|+.|||+++.......  
T Consensus       142 l----------k~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  142 L----------KNIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             c----------ccCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence            6          233333322        278999999   66999999999999999999999999999875432111  


Q ss_pred             -----------cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          190 -----------QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       190 -----------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                                 ......++||+.|.|||++....|+..+|+|++|+++||.+.|..||.
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff  259 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  259 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence                       112234689999999999999999999999999999999999999974

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=7.7e-17  Score=160.33  Aligned_cols=122  Identities=21%  Similarity=0.260  Sum_probs=100.0

Q ss_pred             cccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      ...|...++||+|+||+||++..                       ...+++.+|++++..++|++++....++.     
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----  406 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV-----  406 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE-----
Confidence            44556789999999999987220                       01246788999999999999988766643     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+++++|.+++.                  ....++.+++.+|.+||   +.+++||||||+||++ .++
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~  464 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDD  464 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECC
Confidence            2445689999999999999882                  34678999999999999   6799999999999999 577


Q ss_pred             CeEEeeccccee
Q 041757          172 TARVGDFGLARF  183 (381)
Q Consensus       172 ~~kl~Dfg~~~~  183 (381)
                      .++|+|||+++.
T Consensus       465 ~~~liDFGla~~  476 (535)
T PRK09605        465 RLYLIDFGLGKY  476 (535)
T ss_pred             cEEEEeCccccc
Confidence            899999999864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=2.7e-16  Score=137.69  Aligned_cols=119  Identities=20%  Similarity=0.241  Sum_probs=96.8

Q ss_pred             ceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           42 NLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      +.||+|++|.||++...                       ....+.+|++++..+.|+||.....++.     .....++
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~l   76 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENFII   76 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCCEE
Confidence            57999999999876310                       1235778999999999999877666643     2456789


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||++|++|.+++..          ..   . ....++.+++.+|.++|   ..+++|+|++|.||+++ ++.++|+||
T Consensus        77 v~e~~~G~~L~~~~~~----------~~---~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf  138 (211)
T PRK14879         77 VMEYIEGEPLKDLINS----------NG---M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDF  138 (211)
T ss_pred             EEEEeCCcCHHHHHHh----------cc---H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEEC
Confidence            9999999999999842          11   1 77889999999999999   77999999999999999 788999999


Q ss_pred             cccee
Q 041757          179 GLARF  183 (381)
Q Consensus       179 g~~~~  183 (381)
                      |.+..
T Consensus       139 ~~a~~  143 (211)
T PRK14879        139 GLAEF  143 (211)
T ss_pred             CcccC
Confidence            98753

>smart00090 RIO RIO-like kinase

Probab=99.67  E-value=2.9e-16  Score=139.44  Aligned_cols=125  Identities=16%  Similarity=0.046  Sum_probs=96.1

Q ss_pred             cccccceecCCCceEEEecc-cc-------------c----------------------------HHHHHHHHHHHHccC
Q 041757           37 NMLEENLISAGTFGFSHLRR-QG-------------A----------------------------FKSFIAECKALRNIR   74 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~-~~-------------~----------------------------~~~~~~E~~~l~~l~   74 (381)
                      .|.+.+.||+|+||.||.+. ..             .                            ...+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48889999999999998875 10             0                            012467999999997


Q ss_pred             CCc--ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCC
Q 041757           75 HRN--LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQ  152 (381)
Q Consensus        75 h~n--Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~  152 (381)
                      +.+  +.++++.        . ..++||||+++++|.....          ....+....+..++.|++.++.+||   .
T Consensus       109 ~~~i~~p~~~~~--------~-~~~lV~E~~~g~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH---~  166 (237)
T smart00090      109 EAGVPVPKPIAW--------R-RNVLVMEFIGGDGLPAPRL----------KDVEPEEEEEFELYDDILEEMRKLY---K  166 (237)
T ss_pred             hcCCCCCeeeEe--------c-CceEEEEEecCCccccccc----------ccCCcchHHHHHHHHHHHHHHHHHH---h
Confidence            533  3344433        1 2489999999988876542          2234556667899999999999999   6


Q ss_pred             CC-ceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757          153 PV-TAHCVLKPSNVLLDDDMTARVGDFGLARFL  184 (381)
Q Consensus       153 ~~-ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~  184 (381)
                      .+ ++||||||+||+++ ++.++|+|||.+...
T Consensus       167 ~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      167 EGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             cCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            68 99999999999999 789999999998643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=1.7e-17  Score=164.92  Aligned_cols=242  Identities=21%  Similarity=0.213  Sum_probs=177.4

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~   93 (381)
                      ...|...+-||+|+|+.|.....                    ........|..+-..+. |+|++++++.     ....
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence            45677777899999999944321                    12233344788888887 9999999999     5668


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-C
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-T  172 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~  172 (381)
                      ...+++++|..++++.+.+..        ......+...+-.++.|+..++.|+|.  ..++.|||+||+|.+++..+ .
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~--------~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~  163 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISH--------PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSA  163 (601)
T ss_pred             cccccccCccccccccccccc--------CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCc
Confidence            889999999999999888720        222256667788899999999999993  23899999999999999999 9


Q ss_pred             eEEeecccceecCC-CCCcccccCccC-ccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          173 ARVGDFGLARFLPP-TRTQTSSIDVKG-SIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      .+++|||+|..+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..||......+..+..+
T Consensus       164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~  243 (601)
T KOG0590|consen  164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW  243 (601)
T ss_pred             ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence            99999999987766 444434444668 9999999998884 45677899999999999999999987554444322222


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ......          ....                  ..........+++.+++..+|..|.+.+++..
T Consensus       244 ~~~~~~----------~~~~------------------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  244 KSNKGR----------FTQL------------------PWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccccc----------cccC------------------ccccCChhhhhcccccccCCchhccccccccc
Confidence            211100          0000                  01133345667777888899999999887754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=5.1e-16  Score=134.64  Aligned_cols=115  Identities=21%  Similarity=0.288  Sum_probs=90.6

Q ss_pred             eecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           43 LISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        43 ~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .||+|+||.||++...                       ...++.+|++++..+.|+++.....++.     .....++|
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~lv   75 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKTIV   75 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCEEE
Confidence            4899999999876510                       1255678999999999887554444422     24456899


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||++|++|.+++..          ...       .++.+++.+|.+||   ..+++|+|++|.||+++ ++.++++|||
T Consensus        76 ~e~~~g~~l~~~~~~----------~~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg  134 (199)
T TIGR03724        76 MEYIEGKPLKDVIEE----------GND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFG  134 (199)
T ss_pred             EEEECCccHHHHHhh----------cHH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECC
Confidence            999999999998731          111       78899999999999   67999999999999999 7899999999


Q ss_pred             ccee
Q 041757          180 LARF  183 (381)
Q Consensus       180 ~~~~  183 (381)
                      +++.
T Consensus       135 ~a~~  138 (199)
T TIGR03724       135 LGKY  138 (199)
T ss_pred             CCcC
Confidence            8754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.62  E-value=2e-15  Score=130.81  Aligned_cols=121  Identities=17%  Similarity=0.052  Sum_probs=94.2

Q ss_pred             cccccceecCCCceEEEecccc--------------------------------------cHHHHHHHHHHHHccCCCc-
Q 041757           37 NMLEENLISAGTFGFSHLRRQG--------------------------------------AFKSFIAECKALRNIRHRN-   77 (381)
Q Consensus        37 ~~~~~~~lG~G~fg~V~~~~~~--------------------------------------~~~~~~~E~~~l~~l~h~n-   77 (381)
                      .|...+.||.|+||.||.+...                                      ....+.+|+.++..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            4788899999999999876431                                      0113567899999998774 


Q ss_pred             -ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 041757           78 -LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA  156 (381)
Q Consensus        78 -Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv  156 (381)
                       +...++.         ...++||||+++++|.....          .      .....++.+++.++.++|   ..+++
T Consensus        96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~----------~------~~~~~~~~~i~~~l~~lh---~~gi~  147 (198)
T cd05144          96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV----------L------EDPEEVLDEILEEIVKAY---KHGII  147 (198)
T ss_pred             CCCceeec---------CCceEEEEEeCCcchhhccc----------c------ccHHHHHHHHHHHHHHHH---HCCCC
Confidence             4444332         23489999999999976541          0      234678899999999999   67999


Q ss_pred             eeccCCCCeeeCCCCCeEEeecccceecC
Q 041757          157 HCVLKPSNVLLDDDMTARVGDFGLARFLP  185 (381)
Q Consensus       157 HrDlkp~Nill~~~~~~kl~Dfg~~~~~~  185 (381)
                      ||||||+||+++.++.++|+|||.+....
T Consensus       148 H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         148 HGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=5.5e-15  Score=130.90  Aligned_cols=160  Identities=23%  Similarity=0.346  Sum_probs=122.4

Q ss_pred             HHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHh
Q 041757           68 KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL  147 (381)
Q Consensus        68 ~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L  147 (381)
                      ..|-++-|.|||+++.++.+..+++.....++.||+..|+|..+|++..      +....+......+|+.||+.||.||
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~------~~~~a~~~~~wkkw~tqIlsal~yL  192 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK------KNQKALFQKAWKKWCTQILSALSYL  192 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH------HhhhhhhHHHHHHHHHHHHhhhhhh
Confidence            3455667999999999987766667778899999999999999996543      4556788888899999999999999


Q ss_pred             hcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCC--CCCcccccCccCccceeCCCCcCCCccCcccchhhhhHH
Q 041757          148 HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP--TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL  225 (381)
Q Consensus       148 H~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~i  225 (381)
                      |+- ...|+|+++.-+.|++..++.+|+.--........  ...........+-++|.|||+-.....+.++|||+||..
T Consensus       193 hs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  193 HSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC  271 (458)
T ss_pred             hcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence            987 88999999999999999998888753211110000  000000111236788999998777778889999999999


Q ss_pred             HHHHHhCCC
Q 041757          226 LLELMIREK  234 (381)
Q Consensus       226 l~el~tg~~  234 (381)
                      ..||..+..
T Consensus       272 AlemailEi  280 (458)
T KOG1266|consen  272 ALEMAILEI  280 (458)
T ss_pred             HHHHHHhee
Confidence            999987754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=8.9e-14  Score=123.72  Aligned_cols=104  Identities=19%  Similarity=0.141  Sum_probs=79.0

Q ss_pred             HHHHHHHHHHHccCCCcc--cceeeeeccccccCCceEEEEEEcccC-CCHHHhhccccCCcccccCCCcccHHHHHHHH
Q 041757           61 KSFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFMHN-RSLKEWLYPISKEDETYKRPRNLNLLRRLNIA  137 (381)
Q Consensus        61 ~~~~~E~~~l~~l~h~nI--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  137 (381)
                      ..+.+|++++.+|.|++|  +..+++.... .......++||||+++ .+|.+++..           ..++..    .+
T Consensus        85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~-~~~~~~~~lV~e~l~G~~~L~~~l~~-----------~~l~~~----~~  148 (239)
T PRK01723         85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVR-HGLFYRADILIERIEGARDLVALLQE-----------APLSEE----QW  148 (239)
T ss_pred             hHHHHHHHHHHHHHhCCCCCceeEeeeeee-cCcceeeeEEEEecCCCCCHHHHHhc-----------CCCCHH----HH
Confidence            457789999999998875  6666663321 0111123599999997 699988831           234433    35


Q ss_pred             HHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          138 IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       138 ~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      .+++.+|.+||   ..||+||||||.|||++.++.++|+|||.+..
T Consensus       149 ~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        149 QAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            78999999999   67999999999999999888999999998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.47  E-value=3.1e-13  Score=111.10  Aligned_cols=122  Identities=23%  Similarity=0.247  Sum_probs=96.6

Q ss_pred             ccceecCCCceEEEeccc-----------cc--HHHHHHHHHHHHccCC--CcccceeeeeccccccCCceEEEEEEccc
Q 041757           40 EENLISAGTFGFSHLRRQ-----------GA--FKSFIAECKALRNIRH--RNLIKVLTACLGVDYQGNDFKALVYEFMH  104 (381)
Q Consensus        40 ~~~~lG~G~fg~V~~~~~-----------~~--~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~~~~~~lv~e~~~  104 (381)
                      +.+.||.|.++.||....           ..  ...+.+|+.++..++|  .++.+++++.     ...+..+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEecC
Confidence            346799999999976542           11  2478999999999976  5888888873     33567899999998


Q ss_pred             CCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          105 NRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       105 ~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ++++..+                 +......++.+++.++.++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        77 g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8766532                 3455677889999999999954235799999999999999988999999998853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.46  E-value=2.3e-13  Score=116.72  Aligned_cols=75  Identities=20%  Similarity=0.130  Sum_probs=58.0

Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeeccCCCCeeeCCCCCeE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQ-PVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      .++||||++++++.....         .. .... ..+..++.+++.++.++|   . .+|+||||||+||+++ ++.++
T Consensus        90 ~~lv~e~~~g~~~~~~~l---------~~-~~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~  154 (187)
T cd05119          90 HVLVMEFIGGDGIPAPRL---------KD-VRLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVY  154 (187)
T ss_pred             CEEEEEEeCCCCccChhh---------hh-hhhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEE
Confidence            589999999965432110         00 0011 567889999999999999   5 6999999999999999 88999


Q ss_pred             EeecccceecC
Q 041757          175 VGDFGLARFLP  185 (381)
Q Consensus       175 l~Dfg~~~~~~  185 (381)
                      |+|||.+....
T Consensus       155 liDfg~a~~~~  165 (187)
T cd05119         155 IIDVPQAVEID  165 (187)
T ss_pred             EEECccccccc
Confidence            99999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.7e-12  Score=124.19  Aligned_cols=180  Identities=23%  Similarity=0.236  Sum_probs=141.6

Q ss_pred             ccccceecC--CCceEEEecccc---------------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCC
Q 041757           38 MLEENLISA--GTFGFSHLRRQG---------------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        38 ~~~~~~lG~--G~fg~V~~~~~~---------------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~   93 (381)
                      |-..+-+|.  |.+|.||..+..                     ...+=.+|+...+.++ |+|.++.+..     +++.
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~~  190 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEGS  190 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cccC
Confidence            445678999  999999776531                     1122345777777775 9999997777     6778


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHH----HHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVAS----ALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                      +..++-+|+|. .+|.++.+         .....++...++..+.+...    ||.++|   ..+++|-|+||+||++..
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~---------~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~  257 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCH---------TPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTS  257 (524)
T ss_pred             Ccceeeecccc-chhHHhhh---------cccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccc
Confidence            89999999995 68888875         33445788888899999999    999999   669999999999999999


Q ss_pred             C-CCeEEeecccceecCCCCCcccc---cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757          170 D-MTARVGDFGLARFLPPTRTQTSS---IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS  236 (381)
Q Consensus       170 ~-~~~kl~Dfg~~~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf  236 (381)
                      + ..++++|||+...+.........   ....|...|++||.+.+ -++..+||||+|.++.+..++..++
T Consensus       258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence            8 78999999999887765422211   11247788999998765 6788999999999999999887764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.29  E-value=3.2e-11  Score=116.81  Aligned_cols=167  Identities=18%  Similarity=0.157  Sum_probs=122.8

Q ss_pred             ceecCCCceEEEecccc---cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCC
Q 041757           42 NLISAGTFGFSHLRRQG---AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE  118 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~  118 (381)
                      ..-..|++-.|+..+..   ......+-++.|+.++||||++++..     ++..+..|||+|-+.  .|..++..    
T Consensus        32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~----  100 (690)
T KOG1243|consen   32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKE----  100 (690)
T ss_pred             ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHH----
Confidence            45666777777554432   24567788999999999999999998     566789999999873  67777742    


Q ss_pred             cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccC
Q 041757          119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG  198 (381)
Q Consensus       119 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  198 (381)
                               +....+...+.||+.||.|||+++  +++|++|..+.|+++..|..||++|.++...........  ...-
T Consensus       101 ---------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~--~~~~  167 (690)
T KOG1243|consen  101 ---------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK--SLYL  167 (690)
T ss_pred             ---------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc--cchh
Confidence                     335666777889999999999755  999999999999999999999999998765433221000  0111


Q ss_pred             ccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCC
Q 041757          199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK  234 (381)
Q Consensus       199 t~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~  234 (381)
                      -..|..|+.+....  -..|.|-||++++|++.|..
T Consensus       168 ~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  168 IESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             hhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence            22355666443322  34599999999999999933

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=2.1e-11  Score=116.80  Aligned_cols=179  Identities=20%  Similarity=0.158  Sum_probs=132.4

Q ss_pred             cccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccC-CCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..+|.....||.|.|+.|+.+...                    ....-..|+-+...+. |.++++++..     +...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~~  338 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQL  338 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cccc
Confidence            456888899999999988553211                    1111234666666664 8899988777     3445


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CC
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MT  172 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~  172 (381)
                      ...++-.|||.++++....          .....+.+...+++..|++.++.++|   ++.++|+|+||+||++..+ +.
T Consensus       339 r~~~ip~e~~~~~s~~l~~----------~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRS----------VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             ccccCchhhhcCcchhhhh----------HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhh
Confidence            6677999999999987766          23456778888999999999999999   8899999999999999886 78


Q ss_pred             eEEeecccceecCCCCCcccccCccCccce-eCCCCcCCCccCcccchhhhhHHHHHHHhCCCC
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGY-IAPEYGVGNEVSTIGDVYSYGILLLELMIREKP  235 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y-~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~P  235 (381)
                      .++.|||.+..+.-.....    ...+..| .++.......+..+.|++|||..+.+..++..-
T Consensus       406 ~~~~~~~~~t~~~~~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAFSSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             hhccccccccccceecccc----cccccccccchhhccccccccccccccccccccccccCccc
Confidence            8999999986532221111    1123334 355556667788999999999999999888654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.12  E-value=3.2e-11  Score=121.74  Aligned_cols=186  Identities=18%  Similarity=0.217  Sum_probs=131.4

Q ss_pred             cccccccceecCCCceEEEecccccHH-----HHHHHH---------------HHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQGAFK-----SFIAEC---------------KALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~~~E~---------------~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -+.+.+.+-+-+|.||.+..++...-.     ....++               .++-.-.||-++....-     +.-..
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~rs  877 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCRS  877 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCCC
Confidence            456777778889999988665532211     122222               22222233444443322     23466


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..+||++|+.+++|...|+.          ....+..-+......+..++++||   ...++|||++|.|+++..++..+
T Consensus       878 P~~L~~~~~~~~~~~Skl~~----------~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~  944 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHN----------SGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRP  944 (1205)
T ss_pred             CcchhhHHhccCCchhhhhc----------CCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcc
Confidence            78999999999999999853          334455555666778889999999   55799999999999999999999


Q ss_pred             EeecccceecCCC-------------------------CCc----ccccCccCccceeCCCCcCCCccCcccchhhhhHH
Q 041757          175 VGDFGLARFLPPT-------------------------RTQ----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL  225 (381)
Q Consensus       175 l~Dfg~~~~~~~~-------------------------~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~i  225 (381)
                      +.|||.......-                         ...    .......||+.|.+||.+.+......+|+|++|++
T Consensus       945 l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~ 1024 (1205)
T KOG0606|consen  945 LTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVC 1024 (1205)
T ss_pred             cCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhh
Confidence            9999833222110                         000    11223568999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCc
Q 041757          226 LLELMIREKPSDI  238 (381)
Q Consensus       226 l~el~tg~~Pf~~  238 (381)
                      ++|.++|.+||..
T Consensus      1025 l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 1025 LFEVLTGIPPFNA 1037 (1205)
T ss_pred             hhhhhcCCCCCCC
Confidence            9999999999863

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.12  E-value=2.6e-10  Score=110.28  Aligned_cols=104  Identities=19%  Similarity=0.202  Sum_probs=69.2

Q ss_pred             HHHHHHHHHccC----CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757           63 FIAECKALRNIR----HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI  138 (381)
Q Consensus        63 ~~~E~~~l~~l~----h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  138 (381)
                      |.+|++.+.++.    |.+-+.+-.++.+    .....+|||||++|++|.++...         .....+   ...++.
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~---------~~~~~~---~~~ia~  263 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAAL---------DEAGLD---RKALAE  263 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHH---------HhcCCC---HHHHHH
Confidence            444666665552    3333333333322    13346899999999999887631         011111   234555


Q ss_pred             HHHH-HHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757          139 DVAS-ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP  185 (381)
Q Consensus       139 qi~~-~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~  185 (381)
                      .++. .+..+|   ..|++|+|+||.||+++.++.++++|||++..+.
T Consensus       264 ~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       264 NLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            5555 467788   5599999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.06  E-value=3.3e-10  Score=95.35  Aligned_cols=96  Identities=22%  Similarity=0.155  Sum_probs=68.9

Q ss_pred             HHHHHHHHHHHccCCCccc-ceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHH
Q 041757           61 KSFIAECKALRNIRHRNLI-KVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAID  139 (381)
Q Consensus        61 ~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q  139 (381)
                      ..+.+|+.++..+.+.+++ +++...       ....++||||++|.++....                  .....++.+
T Consensus        37 ~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~i~G~~l~~~~------------------~~~~~~~~~   91 (170)
T cd05151          37 INRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEFIEGSELLTED------------------FSDPENLEK   91 (170)
T ss_pred             cCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEecCCCcccccc------------------ccCHHHHHH
Confidence            3467899999999765544 444441       22347999999998775421                  011235678


Q ss_pred             HHHHHHHhhcCC--CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          140 VASALNYLHHDC--QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       140 i~~~l~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ++.+|+.||...  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        92 l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          92 IAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            999999999441  12359999999999998 5689999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.04  E-value=9.7e-10  Score=93.88  Aligned_cols=99  Identities=18%  Similarity=0.094  Sum_probs=73.2

Q ss_pred             HHHHHHHHccC--CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHH
Q 041757           64 IAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVA  141 (381)
Q Consensus        64 ~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  141 (381)
                      .+|++.|+++.  .-++.+.+++         ...+|||||+.+..+..-.          -+...++......+..+++
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~----------Lkd~~~~~~~~~~i~~~i~  134 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPK----------LKDAKLNDEEMKNAYYQVL  134 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchh----------hhccccCHHHHHHHHHHHH
Confidence            48999999996  3466666654         2358999999765442211          0112344556677889999


Q ss_pred             HHHHHh-hcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757          142 SALNYL-HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP  185 (381)
Q Consensus       142 ~~l~~L-H~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~  185 (381)
                      .+|..| |   ..++||+||++.||+++ ++.+.|+|||.+....
T Consensus       135 ~~l~~l~H---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         135 SMMKQLYK---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHHHHHH---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999 7   56999999999999997 4679999999887553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=1.1e-09  Score=90.59  Aligned_cols=96  Identities=24%  Similarity=0.284  Sum_probs=75.4

Q ss_pred             cHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHH
Q 041757           59 AFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNI  136 (381)
Q Consensus        59 ~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i  136 (381)
                      ...+..+|++++.++.--  +...++++       +.....|+|||.+|..|.+.+..          .       ...+
T Consensus        42 rr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~~~~I~me~I~G~~lkd~l~~----------~-------~~~~   97 (204)
T COG3642          42 RRERTRREARILAKAREAGVPVPIVYDV-------DPDNGLIVMEYIEGELLKDALEE----------A-------RPDL   97 (204)
T ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCCCCEEEEEEeCChhHHHHHHh----------c-------chHH
Confidence            356678899999998643  44445554       35556899999999999988842          1       2456


Q ss_pred             HHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       137 ~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +..+-.-+.-||   ..+|+|+||.++||++.++. +.++|||++.
T Consensus        98 ~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          98 LREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             HHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            777888889999   66999999999999998764 9999999986

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.95  E-value=5.5e-09  Score=86.23  Aligned_cols=125  Identities=20%  Similarity=0.203  Sum_probs=88.0

Q ss_pred             ccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcc--cceeeeeccccccCCc
Q 041757           40 EENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNL--IKVLTACLGVDYQGND   94 (381)
Q Consensus        40 ~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nI--v~~~~~~~~~~~~~~~   94 (381)
                      ....|-+|+-+.|+...                       +-..++..+|+++|.++.--.|  .+++.+       +..
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-------D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-------DTY   83 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-------ecC
Confidence            55678888888774432                       2245677889999999864333  223322       244


Q ss_pred             eEEEEEEcccC-CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC--
Q 041757           95 FKALVYEFMHN-RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM--  171 (381)
Q Consensus        95 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~--  171 (381)
                      ...|+|||.+| .++.+++....        ...........++..|-+.+.-||   ..+|+|+||..+||++..++  
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~--------~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~  152 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTM--------EDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQ  152 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHc--------cCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCc
Confidence            45799999977 47888874321        222233333678889999999999   66999999999999997655  


Q ss_pred             -CeEEeecccce
Q 041757          172 -TARVGDFGLAR  182 (381)
Q Consensus       172 -~~kl~Dfg~~~  182 (381)
                       .+.++|||++.
T Consensus       153 ~~~~lIdfgls~  164 (229)
T KOG3087|consen  153 ITPILIDFGLSS  164 (229)
T ss_pred             CceEEEeecchh
Confidence             45899999985

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.95  E-value=1.2e-09  Score=107.03  Aligned_cols=80  Identities=16%  Similarity=0.045  Sum_probs=56.0

Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-  171 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-  171 (381)
                      ....+|||||+.|+++.++-.-..    .......+....+..++.|+..     |     |++|+|+||.||+++.++ 
T Consensus       233 st~~VLvmE~i~G~~l~d~~~l~~----~g~d~~~la~~~v~~~~~Qif~-----~-----GffHaDpHPGNIlv~~~g~  298 (537)
T PRK04750        233 CSETVMVMERMYGIPVSDVAALRA----AGTDMKLLAERGVEVFFTQVFR-----D-----GFFHADMHPGNIFVSYDPP  298 (537)
T ss_pred             CCCceEEEeeecCccHHhHHHHHh----cCCCHHHHHHHHHHHHHHHHHh-----C-----CeeeCCCChHHeEEecCCC
Confidence            345689999999999987521000    0011123444455555555542     3     999999999999999887 


Q ss_pred             ---CeEEeecccceecCC
Q 041757          172 ---TARVGDFGLARFLPP  186 (381)
Q Consensus       172 ---~~kl~Dfg~~~~~~~  186 (381)
                         .++++|||++..+..
T Consensus       299 ~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        299 ENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             CCCeEEEEecceEEECCH
Confidence               999999999987765

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.84  E-value=1.1e-09  Score=106.74  Aligned_cols=152  Identities=13%  Similarity=0.172  Sum_probs=100.9

Q ss_pred             HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCccc-------ccCccCccceeCCCCc
Q 041757          136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTS-------SIDVKGSIGYIAPEYG  208 (381)
Q Consensus       136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~l  208 (381)
                      -+.+.+.|+.|+|+.  .++||++|.|++|.++..+.+||+.|+++...........       ..-..-...|.|||++
T Consensus       104 nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  104 NLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            345566999999974  4899999999999999999999999998876554211110       0012245679999999


Q ss_pred             CCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHH
Q 041757          209 VGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN  287 (381)
Q Consensus       209 ~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  287 (381)
                      .+...+.++|+||+|+++|.+.. |+..+.    .......+.......+.....                         
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~----a~~~~~~~~~~~~~~~~~~~~-------------------------  232 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIA----ANGGLLSYSFSRNLLNAGAFG-------------------------  232 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhh----ccCCcchhhhhhccccccccc-------------------------
Confidence            99888999999999999999984 444432    111111111111111100000                         


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757          288 IIRECVISMVRIGVACSMESPQDRMKMTNVV  318 (381)
Q Consensus       288 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  318 (381)
                      ...+.+.++.+-+.+.+..++.-||++.++.
T Consensus       233 ~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  233 YSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            0135566777777788889999999766654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.81  E-value=2.2e-07  Score=86.06  Aligned_cols=265  Identities=12%  Similarity=0.054  Sum_probs=155.6

Q ss_pred             ccceecCCCceEEEecccc-----------cHHHHHHHHHHHHcc-CCCcccceeeeecc-c-cccCCceEEEEEEcccC
Q 041757           40 EENLISAGTFGFSHLRRQG-----------AFKSFIAECKALRNI-RHRNLIKVLTACLG-V-DYQGNDFKALVYEFMHN  105 (381)
Q Consensus        40 ~~~~lG~G~fg~V~~~~~~-----------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-~-~~~~~~~~~lv~e~~~~  105 (381)
                      .++-||+|+-+.+|-..+.           -...--+.+..|... .||-+-.-+.+-.. + .........+.|+.+++
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~g   94 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVSG   94 (637)
T ss_pred             CCccccCCccceeeecchhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCCC
Confidence            4577999999988654311           001111223334433 46654331111110 0 01233446788888876


Q ss_pred             C-CHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757          106 R-SLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL  184 (381)
Q Consensus       106 g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~  184 (381)
                      . .+..++.....    ........|...++.++.++.+.+-||   ..|.+-+|+.++|+|+++++.+.|.|=.....-
T Consensus        95 ~~pI~~~y~p~tR----Rqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          95 KEPIHMIYSPATR----RQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             ccchhhhcCchhh----cccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence            4 33333322111    123455789999999999999999999   668999999999999999999999874433222


Q ss_pred             CCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhC-CCCCCccccCC---CcHHHHHHHHhh
Q 041757          185 PPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIR-EKPSDIMFEGD---MNLHKFAKMALS  255 (381)
Q Consensus       185 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg-~~Pf~~~~~~~---~~~~~~~~~~~~  255 (381)
                      ..+....   ..+|...|.+||.-.     +-.-+...|-|.||+++++++.| ++||.......   ...+.       
T Consensus       168 ~ng~~~~---cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~-------  237 (637)
T COG4248         168 ANGTLHL---CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET-------  237 (637)
T ss_pred             cCCceEe---cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh-------
Confidence            2222221   246889999999643     34456778999999999999876 99987553221   11110       


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHHHHhhhhcC
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSME--SPQDRMKMTNVVHELQSIKNTLL  329 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~~vl~~L~~i~~~~~  329 (381)
                          ++........++.    .....+.-+.......+.++..+..+|+..  ++.-|||++.-+..|..+..++.
T Consensus       238 ----~Ia~g~f~ya~~~----~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         238 ----DIAHGRFAYASDQ----RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             ----hhhcceeeechhc----cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence                1111111111100    000000001111234455677777788875  46789999999888888776553

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=3e-08  Score=84.38  Aligned_cols=102  Identities=20%  Similarity=0.181  Sum_probs=67.5

Q ss_pred             cHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEccc--CCCHHHhhccccCCcccccCCCcccHHHHH
Q 041757           59 AFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMH--NRSLKEWLYPISKEDETYKRPRNLNLLRRL  134 (381)
Q Consensus        59 ~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~  134 (381)
                      ......+|.+.|.++..-  ++.+++++        . ...|||||++  |..+..+..            ..++.....
T Consensus        51 ~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--------~-~~~ivME~I~~~G~~~~~l~~------------~~~~~~~~~  109 (188)
T PF01163_consen   51 IREWAKKEFRNLKRLYEAGVPVPKPYDY--------N-RNVIVMEYIGEDGVPLPRLKD------------VDLSPEEPK  109 (188)
T ss_dssp             HHHHHHHHHHHHHHCCCTT-SS--EEEE--------E-TTEEEEE--EETTEEGGCHHH------------CGGGGSTHH
T ss_pred             HHHHHHHHHHHHHHHHHCCccCCcEEEE--------e-CCEEEEEecCCCccchhhHHh------------ccccchhHH
Confidence            345677899999999755  56777765        1 2379999998  655544331            111233456


Q ss_pred             HHHHHHHHHHHH-hhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757          135 NIAIDVASALNY-LHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP  185 (381)
Q Consensus       135 ~i~~qi~~~l~~-LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~  185 (381)
                      .++.+++..+.. +|   ..|++|+||.+.||+++++ .+.|+|||.+....
T Consensus       110 ~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  110 ELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            677788885555 57   6699999999999999887 89999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.76  E-value=4.2e-08  Score=88.43  Aligned_cols=110  Identities=14%  Similarity=0.062  Sum_probs=79.3

Q ss_pred             HHHHHHHHHHccCCCcc--cceeeeeccccccCCceEEEEEEcccCC-CHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757           62 SFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFMHNR-SLKEWLYPISKEDETYKRPRNLNLLRRLNIAI  138 (381)
Q Consensus        62 ~~~~E~~~l~~l~h~nI--v~~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  138 (381)
                      .+.+|...+.+|...+|  ...+++............+||||++++- +|.+++...        .....+......++.
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~--------~~~~~~~~~~~~ll~  145 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADW--------ATNPPDPRLKRMLIK  145 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhh--------cccCCCHHHHHHHHH
Confidence            47899999998854333  3334442210011134578999999886 899987321        123345667778999


Q ss_pred             HHHHHHHHhhcCCCCCceeeccCCCCeeeCC-------CCCeEEeecccce
Q 041757          139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDD-------DMTARVGDFGLAR  182 (381)
Q Consensus       139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-------~~~~kl~Dfg~~~  182 (381)
                      +++..+.-||   ..||+|+|+++.|||++.       +..+.++||+.+.
T Consensus       146 ~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        146 RVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999999999   679999999999999975       4678999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.75  E-value=6.7e-08  Score=84.83  Aligned_cols=110  Identities=26%  Similarity=0.276  Sum_probs=77.7

Q ss_pred             HHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHH
Q 041757           60 FKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIA  137 (381)
Q Consensus        60 ~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  137 (381)
                      ...+.+|+++++.+.+.  ++.+++.+....  ...+..++||||++|.++.+.+.          . ..++......++
T Consensus        39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e~i~G~~l~~~~~----------~-~~~~~~~~~~i~  105 (223)
T cd05154          39 AHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVMERVDGRVLRDRLL----------R-PELSPEERRALA  105 (223)
T ss_pred             cccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEEEeCCEecCCCCC----------C-CCCCHHHHHHHH
Confidence            45788999999999753  456677763220  01135689999999988876541          0 235555666667


Q ss_pred             HHHHHHHHHhhcC-----------------------------------------------------CCCCceeeccCCCC
Q 041757          138 IDVASALNYLHHD-----------------------------------------------------CQPVTAHCVLKPSN  164 (381)
Q Consensus       138 ~qi~~~l~~LH~~-----------------------------------------------------~~~~ivHrDlkp~N  164 (381)
                      .+++..|..||+-                                                     ....++|+|++|.|
T Consensus       106 ~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~N  185 (223)
T cd05154         106 RALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGN  185 (223)
T ss_pred             HHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCccc
Confidence            7777777777631                                                     12467999999999


Q ss_pred             eeeCC--CCCeEEeecccce
Q 041757          165 VLLDD--DMTARVGDFGLAR  182 (381)
Q Consensus       165 ill~~--~~~~kl~Dfg~~~  182 (381)
                      |+++.  ++.+.|+||+.+.
T Consensus       186 il~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         186 VLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             EEEcCCCCcEEEEEeccccc
Confidence            99998  5668999998875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.75  E-value=3e-07  Score=87.21  Aligned_cols=148  Identities=18%  Similarity=0.209  Sum_probs=111.0

Q ss_pred             HHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccC-CCHHHhhccccCCc-----ccccCCCcccHHHHHHHHH
Q 041757           65 AECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHN-RSLKEWLYPISKED-----ETYKRPRNLNLLRRLNIAI  138 (381)
Q Consensus        65 ~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~  138 (381)
                      .-++.++++.|+|||++.+++....+ ....+++|++|+++ ++|.++-.......     .....+...++...|.++.
T Consensus       322 ~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~  400 (655)
T KOG3741|consen  322 SLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYIS  400 (655)
T ss_pred             HHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHH
Confidence            45788999999999999999874333 35667899999887 68877754322211     2223456788999999999


Q ss_pred             HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccc
Q 041757          139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGD  218 (381)
Q Consensus       139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD  218 (381)
                      |+..||.++|   +.|+.-+-|.|.+|+++++.+++|+..|....+..+..                |-+.   --.+-|
T Consensus       401 QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------------~~le---~~Qq~D  458 (655)
T KOG3741|consen  401 QLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------------EPLE---SQQQND  458 (655)
T ss_pred             HHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCCC----------------cchh---HHhhhh
Confidence            9999999999   66888899999999999998899988777655443331                0011   123458


Q ss_pred             hhhhhHHHHHHHhCCCC
Q 041757          219 VYSYGILLLELMIREKP  235 (381)
Q Consensus       219 iwSlG~il~el~tg~~P  235 (381)
                      .=.||.++..|.||..-
T Consensus       459 ~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  459 LRDLGLLLLALATGTEN  475 (655)
T ss_pred             HHHHHHHHHHHhhcccc
Confidence            88999999999999543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=8.5e-08  Score=83.46  Aligned_cols=111  Identities=22%  Similarity=0.198  Sum_probs=83.4

Q ss_pred             cHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccCC-CHHHhhccccCCcccccCCCcccHHHHHH
Q 041757           59 AFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHNR-SLKEWLYPISKEDETYKRPRNLNLLRRLN  135 (381)
Q Consensus        59 ~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~  135 (381)
                      ....+.+|...+..|..-  .+.+.+++...... .....++|+|++++. +|.+++.          .....+......
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~----------~~~~~~~~~~~~  122 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQ----------QWEQLDPSQRRE  122 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHH----------hhcccchhhHHH
Confidence            445788899988888533  34455555332111 124568999999884 8999984          222366677888


Q ss_pred             HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC---CeEEeeccccee
Q 041757          136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM---TARVGDFGLARF  183 (381)
Q Consensus       136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~~  183 (381)
                      ++.+++..++-||   ..||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       123 ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  123 LLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999   66999999999999998887   889999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.57  E-value=6.8e-07  Score=76.73  Aligned_cols=112  Identities=16%  Similarity=0.143  Sum_probs=82.2

Q ss_pred             cHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccC-CCHHHhhccccCCcccccCCCcccHHHHHH
Q 041757           59 AFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHN-RSLKEWLYPISKEDETYKRPRNLNLLRRLN  135 (381)
Q Consensus        59 ~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~  135 (381)
                      ....|.+|+..+.+|..-  .+.+....... .....-..+||+|-+.+ .||.+++..        ......+......
T Consensus        62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~-k~~~~~rA~LVTe~L~g~~~L~~~l~~--------~~~~~~~~~~k~~  132 (216)
T PRK09902         62 GRPTIVREVAVIKELERAGVIVPKIVFGEAV-KIEGEWRALLVTEDMAGFISIADWYAQ--------HAVSPYSDEVRQA  132 (216)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCccceeeee-ccCCceEEEEEEEeCCCCccHHHHHhc--------CCcCCcchHHHHH
Confidence            467899999999999632  34444422111 11224456899997754 689998842        1123557777889


Q ss_pred             HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC--eEEeecccce
Q 041757          136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT--ARVGDFGLAR  182 (381)
Q Consensus       136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~Dfg~~~  182 (381)
                      ++.+++..++-||   ..|+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       133 il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        133 MLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             HHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9999999999999   779999999999999986666  9999998664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.45  E-value=8.1e-07  Score=78.25  Aligned_cols=118  Identities=17%  Similarity=0.077  Sum_probs=84.6

Q ss_pred             ccccceecCCCceEEEeccc--------------------------------------ccHHHHHHHHHHHHccCCC--c
Q 041757           38 MLEENLISAGTFGFSHLRRQ--------------------------------------GAFKSFIAECKALRNIRHR--N   77 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~--------------------------------------~~~~~~~~E~~~l~~l~h~--n   77 (381)
                      ..+++.||-|.-|.||.+..                                      -......+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            44578899999999866431                                      1234556799999999754  7


Q ss_pred             ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 041757           78 LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH  157 (381)
Q Consensus        78 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  157 (381)
                      |.+.+++         +...+||||.+|-.|...-               ++....-.++..|+.-+.-.-   ..|+||
T Consensus       173 VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~---~~GiVH  225 (304)
T COG0478         173 VPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAY---RRGIVH  225 (304)
T ss_pred             CCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHH---HcCccc
Confidence            7776665         3458999999886654322               123334445555556555555   348999


Q ss_pred             eccCCCCeeeCCCCCeEEeecccce
Q 041757          158 CVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       158 rDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +|+.+=||+++++|.+.++||-.+.
T Consensus       226 GDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         226 GDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCchheEEEecCCCEEEEeCcccc
Confidence            9999999999999999999997654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.36  E-value=1.3e-07  Score=91.65  Aligned_cols=170  Identities=18%  Similarity=0.139  Sum_probs=123.8

Q ss_pred             cceecCCCceEEEecccccH-----------HHHHHHHHHHHccCCCc-ccceeeeeccccccCCceEEEEEEcccCC-C
Q 041757           41 ENLISAGTFGFSHLRRQGAF-----------KSFIAECKALRNIRHRN-LIKVLTACLGVDYQGNDFKALVYEFMHNR-S  107 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~~~~~-----------~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g-~  107 (381)
                      -+-+++|+++++++.+....           ....-++++|.+++||| .+..++-     .+.+...+++|+++.++ +
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhhhhcCCcc
Confidence            35578888888877664322           23345889999999999 5555544     56688899999999887 3


Q ss_pred             HHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCC
Q 041757          108 LKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT  187 (381)
Q Consensus       108 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~  187 (381)
                      ......         .....+...+...+.+.-.++++++|+   ..=+|||    ||+..+ +..+..||+....+...
T Consensus       322 ~~~~~~---------~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  322 SALEMT---------VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             ccccCC---------hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcc
Confidence            322221         223345555566677788889999994   3458888    777665 57899999988776655


Q ss_pred             CCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCC
Q 041757          188 RTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP  235 (381)
Q Consensus       188 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~P  235 (381)
                      ..   .....+++.|+|||+...+.+....|+||+|+-..++.-|.+|
T Consensus       385 ~~---~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  385 MK---PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cc---cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            42   2225689999999999999999999999999877777777666

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.33  E-value=4.9e-06  Score=71.77  Aligned_cols=127  Identities=17%  Similarity=0.186  Sum_probs=79.5

Q ss_pred             ccccccccceecCCCceEEEecc------------------cccHHH------HHHHHHHHHccCC---Ccccceeeeec
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR------------------QGAFKS------FIAECKALRNIRH---RNLIKVLTACL   86 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~------~~~E~~~l~~l~h---~nIv~~~~~~~   86 (381)
                      .+++|...+++-......|.+..                  +.....      ..+++..+.++..   .....++.+..
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            57788888888888888773321                  011111      1234444444432   23333333322


Q ss_pred             cccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           87 GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        87 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                      -..+.-....+++|||++|..|.++..              +++    .+...+..++.-||   ..|++|+|..|.|++
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFl  167 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED--------------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFL  167 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh--------------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEE
Confidence            211222345578999999988876541              222    24456778899999   669999999999999


Q ss_pred             eCCCCCeEEeecccce
Q 041757          167 LDDDMTARVGDFGLAR  182 (381)
Q Consensus       167 l~~~~~~kl~Dfg~~~  182 (381)
                      ++++ .++++||+..+
T Consensus       168 v~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  168 VSNN-GIRIIDTQGKR  182 (229)
T ss_pred             EECC-cEEEEECcccc
Confidence            9865 49999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.28  E-value=4e-05  Score=65.45  Aligned_cols=105  Identities=21%  Similarity=0.205  Sum_probs=80.9

Q ss_pred             HHHHHHHHccCC-CcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHH
Q 041757           64 IAECKALRNIRH-RNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVAS  142 (381)
Q Consensus        64 ~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  142 (381)
                      ..|.-+|+.+.+ +++.+++|.|-         .++|.||...+++...-...       ..-...+|..+.+|+.++++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l-------~~~~~~~w~~R~~iA~~lL~   70 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPL-------SQFLQSPWEQRAKIALQLLE   70 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCcccccccccc-------ccccccCHHHHHHHHHHHHH
Confidence            358889999975 69999999983         26899999877654210000       12234689999999999999


Q ss_pred             HHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757          143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL  184 (381)
Q Consensus       143 ~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~  184 (381)
                      .+.++++.....+.-+|++|+|+.+++++++|++|...+...
T Consensus        71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   71 LLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999763345666999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.04  E-value=5.1e-05  Score=66.93  Aligned_cols=61  Identities=15%  Similarity=0.117  Sum_probs=40.3

Q ss_pred             ceecCCCceEEEecc-----------cccHHHHHHHHHHHHccCCCc--ccceeeeeccccccCCceEEEEEEcccCCC
Q 041757           42 NLISAGTFGFSHLRR-----------QGAFKSFIAECKALRNIRHRN--LIKVLTACLGVDYQGNDFKALVYEFMHNRS  107 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~-----------~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~  107 (381)
                      ..||.|..+.||...           ........+|.+++..+..-+  +.+.++++     ...+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTHKTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEecCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecCCcc
Confidence            456777777766521           112456788999999986433  45666663     33555688999999864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.98  E-value=1.6e-05  Score=82.43  Aligned_cols=200  Identities=21%  Similarity=0.195  Sum_probs=133.7

Q ss_pred             HHHHHHHHHHccCCCcccceeeeeccccccCCc-eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHH
Q 041757           62 SFIAECKALRNIRHRNLIKVLTACLGVDYQGND-FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDV  140 (381)
Q Consensus        62 ~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi  140 (381)
                      ....|...+.++.|+|++.++.+....  ...+ ...+..|+|..-++...+          ..-..++....+.+..++
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~--~~~g~~~~v~~~~~s~~~~~~~~----------q~v~~i~~~~~r~~~~~~  295 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLER--LFRGIVLDVLQEICSKVELRSLL----------QSVGSIPLETLRILHQKL  295 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehh--hcchHHHHHHHhhcCccchHHHH----------hhccccCHHHHHHHHHHH
Confidence            334567778888999999999985531  1112 223456788888888888          456778889999999999


Q ss_pred             HHHHHHhhcCCCCCceeeccCCC---CeeeCCCCCeEEe--ecccceecCCCCCcccccCccCccceeCCCCcCCCccCc
Q 041757          141 ASALNYLHHDCQPVTAHCVLKPS---NVLLDDDMTARVG--DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST  215 (381)
Q Consensus       141 ~~~l~~LH~~~~~~ivHrDlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~  215 (381)
                      ..||.|+|+.   ...|.-+..+   +-..+..+.+.++  ||+.++...........   .-+..|.++|......+..
T Consensus       296 ~~GL~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~---~~~~~~~~~e~~~~~~~~~  369 (1351)
T KOG1035|consen  296 LEGLAYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD---LLAEIRNADEDLKENTAKK  369 (1351)
T ss_pred             hhhHHHHHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh---cCccccccccccccccchh
Confidence            9999999944   4445444444   3344555566666  88888776654433322   2455677888777665544


Q ss_pred             c--cchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHH
Q 041757          216 I--GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV  293 (381)
Q Consensus       216 ~--sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (381)
                      +  .|+|.+|.....+..|..+-.    .            ......+++                          ....
T Consensus       370 ~r~~dL~~lgll~~~~~~~~~i~~----~------------~~~~~~~l~--------------------------~~~~  407 (1351)
T KOG1035|consen  370 SRLTDLWCLGLLLLQLSQGEDISE----K------------SAVPVSLLD--------------------------VLST  407 (1351)
T ss_pred             hhhhHHHHHHHHHhhhhhcCcccc----c------------ccchhhhhc--------------------------cccc
Confidence            4  699999999999988876621    0            000011111                          1111


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          294 ISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       294 ~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      ..+.....+|+..++++|+++.+++...
T Consensus       408 ~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  408 SELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhhhhhhcchhhhhccchhhhhhch
Confidence            1456667799999999999999998754

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.87  E-value=3.6e-05  Score=75.29  Aligned_cols=80  Identities=16%  Similarity=0.177  Sum_probs=59.2

Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC----
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD----  168 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~----  168 (381)
                      .....|+||||+|..+.+.-.         -....++...+..-+.++..-+-+-|     |++|+|-+|.||+++    
T Consensus       274 st~RVLtME~~~G~~i~Dl~~---------i~~~gi~~~~i~~~l~~~~~~qIf~~-----GffHaDPHPGNilv~~~~~  339 (538)
T KOG1235|consen  274 STKRVLTMEYVDGIKINDLDA---------IDKRGISPHDILNKLVEAYLEQIFKT-----GFFHADPHPGNILVRPNPE  339 (538)
T ss_pred             CcceEEEEEecCCccCCCHHH---------HHHcCCCHHHHHHHHHHHHHHHHHhc-----CCccCCCCCCcEEEecCCC
Confidence            446789999999987776632         23445666666666666555555556     899999999999998    


Q ss_pred             CCCCeEEeecccceecCC
Q 041757          169 DDMTARVGDFGLARFLPP  186 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~  186 (381)
                      .++.+.+.|||+...+..
T Consensus       340 ~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  340 GDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccEEEEcccccccccH
Confidence            366899999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.79  E-value=0.00035  Score=60.03  Aligned_cols=99  Identities=15%  Similarity=0.178  Sum_probs=67.8

Q ss_pred             cHHHHHHHHHHHHccC------CCcccceeeeeccccccCCceEEEEEEcccC------CCHHHhhccccCCcccccCCC
Q 041757           59 AFKSFIAECKALRNIR------HRNLIKVLTACLGVDYQGNDFKALVYEFMHN------RSLKEWLYPISKEDETYKRPR  126 (381)
Q Consensus        59 ~~~~~~~E~~~l~~l~------h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~  126 (381)
                      ..+++.+|+.....+.      +.+|.+++|+     .+++.-..+|+|...+      .+|.+++.           ..
T Consensus        54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~-----veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----------~~  117 (199)
T PF10707_consen   54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF-----VETNLGLGLVVELIRDADGNISPTLEDYLK-----------EG  117 (199)
T ss_pred             hhHHHHHHHHHHHHHhhccCCcccccccEeEE-----EecCCceEEEEEEEECCCCCcCccHHHHHH-----------cC
Confidence            3677888888877776      7889999999     5667778899998643      35666662           23


Q ss_pred             cccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC----CeEEee-ccc
Q 041757          127 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM----TARVGD-FGL  180 (381)
Q Consensus       127 ~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~D-fg~  180 (381)
                      .++. .....+.+..   .||-   ..+|+.+|++|.||++....    .+.|+| ||.
T Consensus       118 ~~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  118 GLTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             CccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence            3444 4444444444   4444   44799999999999995332    577777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.75  E-value=9e-05  Score=72.71  Aligned_cols=106  Identities=14%  Similarity=0.169  Sum_probs=68.5

Q ss_pred             HHHHHHHHHccC----CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757           63 FIAECKALRNIR----HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI  138 (381)
Q Consensus        63 ~~~E~~~l~~l~----h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  138 (381)
                      +.+|...+.+++    +..=+.+=.++    ++-.....|+|||++|-.+.+...         .+...++...+...+.
T Consensus       208 y~~EA~n~~~~~~nf~~~~~v~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~---------l~~~g~d~k~ia~~~~  274 (517)
T COG0661         208 YRREAANAERFRENFKDDPDVYVPKVY----WEYTTRRVLTMEWIDGIKISDIAA---------LKSAGIDRKELAELLV  274 (517)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeceee----hhccCCcEEEEEeeCCEecccHHH---------HHhcCCCHHHHHHHHH
Confidence            345777777663    22222233332    223455689999999988888742         1123344334333333


Q ss_pred             HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCC
Q 041757          139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP  186 (381)
Q Consensus       139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~  186 (381)
                      ++.--.-+-|     |++|.|.+|.||+++.++.+.+.|||+...+..
T Consensus       275 ~~f~~q~~~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         275 RAFLRQLLRD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHHhc-----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            3333333445     999999999999999999999999999887654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.62  E-value=0.00048  Score=60.39  Aligned_cols=99  Identities=20%  Similarity=0.182  Sum_probs=69.7

Q ss_pred             HHHHHHHHccC--CCcccceeeeeccccccCCceEEEEEEcccCCCH-HHhhccccCCcccccCCCcccHHHHHHHHHHH
Q 041757           64 IAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSL-KEWLYPISKEDETYKRPRNLNLLRRLNIAIDV  140 (381)
Q Consensus        64 ~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi  140 (381)
                      .+|+..|.++.  +-.+.+-+++         ....|||||+..... .-.|           +.-.+...+...+..++
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~L-----------kDv~~e~~e~~~~~~~~  175 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRL-----------KDVPLELEEAEGLYEDV  175 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCc-----------ccCCcCchhHHHHHHHH
Confidence            45888888884  4455555555         234799999855311 1111           12223333677888889


Q ss_pred             HHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757          141 ASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP  185 (381)
Q Consensus       141 ~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~  185 (381)
                      +..+.-|..  ..++||+||..=|||+. ++.+.|+|||.|....
T Consensus       176 v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         176 VEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            999998884  25999999999999999 7799999999886544

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.59  E-value=0.00064  Score=60.38  Aligned_cols=31  Identities=39%  Similarity=0.493  Sum_probs=26.4

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ...++|+|+.+.||+++++....|+||+.+.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            4569999999999999877666799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.57  E-value=0.00049  Score=61.42  Aligned_cols=31  Identities=19%  Similarity=0.157  Sum_probs=27.0

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ...++|+|+.|.|||++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            4569999999999999987778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.55  E-value=0.00033  Score=61.65  Aligned_cols=67  Identities=21%  Similarity=0.221  Sum_probs=43.5

Q ss_pred             ceecCCCceEEEeccc-------------ccHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccCC
Q 041757           42 NLISAGTFGFSHLRRQ-------------GAFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHNR  106 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~~-------------~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g  106 (381)
                      +.|+.|..+.||....             .....+.+|..+++.+...  .+.+++..+..  .......+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEEEeccc
Confidence            4567777776655432             2346788899999988633  35566664322  23344579999999998


Q ss_pred             CHHH
Q 041757          107 SLKE  110 (381)
Q Consensus       107 ~L~~  110 (381)
                      ++..
T Consensus        81 ~~~~   84 (239)
T PF01636_consen   81 PLDD   84 (239)
T ss_dssp             EHHH
T ss_pred             cccc
Confidence            8877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.53  E-value=0.00088  Score=70.53  Aligned_cols=46  Identities=20%  Similarity=0.330  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHHccC-CCcc--cceeeeeccccccCCceEEEEEEcccCCCH
Q 041757           61 KSFIAECKALRNIR-HRNL--IKVLTACLGVDYQGNDFKALVYEFMHNRSL  108 (381)
Q Consensus        61 ~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  108 (381)
                      ..+.+|+++|+.+. |.+|  .+++.+|.+.  ...+..|+||||++|..+
T Consensus        83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~flVME~v~G~~~  131 (822)
T PLN02876         83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCceEEEEecCCccc
Confidence            56889999999996 6665  7777776431  122456899999988653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.44  E-value=0.00055  Score=56.85  Aligned_cols=122  Identities=18%  Similarity=0.128  Sum_probs=79.4

Q ss_pred             hhccccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHccCCCccc-ceeeeeccccccCCceEE
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNIRHRNLI-KVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~~~~~~   97 (381)
                      ......-...+.||+|++|.||+..             ......+..|+++|..+.-.++. ++|.+.         ..+
T Consensus        18 ~~~~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg---------~~~   88 (201)
T COG2112          18 EEGKYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG---------EDF   88 (201)
T ss_pred             eccchhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec---------hhh
Confidence            3344555667899999999998843             34577899999999999876664 345541         234


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC-CCCeeeCCCCCeEEe
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK-PSNVLLDDDMTARVG  176 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk-p~Nill~~~~~~kl~  176 (381)
                      +.|||..|.+|.++-..             .+...+.    .+++.---|-   ..||-|..|. |..+++.++..+-|+
T Consensus        89 i~me~i~G~~L~~~~~~-------------~~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iI  148 (201)
T COG2112          89 IRMEYIDGRPLGKLEIG-------------GDRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYII  148 (201)
T ss_pred             hhhhhhcCcchhhhhhc-------------ccHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEE
Confidence            66999999898876521             0222222    2333322222   3467777764 444555555589999


Q ss_pred             ecccce
Q 041757          177 DFGLAR  182 (381)
Q Consensus       177 Dfg~~~  182 (381)
                      ||..|.
T Consensus       149 DFd~At  154 (201)
T COG2112         149 DFDSAT  154 (201)
T ss_pred             Eccchh
Confidence            998876

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.29  E-value=2.9e-05  Score=82.61  Aligned_cols=165  Identities=10%  Similarity=-0.067  Sum_probs=114.0

Q ss_pred             HHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHH
Q 041757           61 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDV  140 (381)
Q Consensus        61 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi  140 (381)
                      +-.+.|...++...|+++...+.-..   ......-+.+++|+.+|++.+.+-...      .+...+...-+.....+.
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~---ps~s~ee~~r~~~~~~g~~f~iIikg~------ee~~~ld~~~v~~~~kvs 1344 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIP---PSESTEEYIRSLYVEFGKLFSIIIKGL------EESPDLDRSPVHLRHKVS 1344 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCC---CCCChHHHHHHHHHHHhHHHHHHHhcc------ccCCcchhchHHHHHHHH
Confidence            33445666666778999887665422   345666789999999999999985433      122223333333333333


Q ss_pred             HHHHHHhhcC--CCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccc
Q 041757          141 ASALNYLHHD--CQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGD  218 (381)
Q Consensus       141 ~~~l~~LH~~--~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD  218 (381)
                      ..+..-+|+.  .....+|+++|+-|.+|..+..+|++++|+.++........  ....+++.|++|+......++.++|
T Consensus      1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~--Gl~l~sp~~v~qli~N~ik~t~rsd 1422 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF--GLELCSPIYVLQLIKNEIKFTKRSD 1422 (2724)
T ss_pred             HhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhh--hhhhCCHHHHHHHHHHHHhhhhHHH
Confidence            5555555532  23457899999999999999999999999998433222211  1245788899999888888888899


Q ss_pred             hhhhhHHHHHHHhCCCCC
Q 041757          219 VYSYGILLLELMIREKPS  236 (381)
Q Consensus       219 iwSlG~il~el~tg~~Pf  236 (381)
                      +|+.|+-+|+..-|..+|
T Consensus      1423 ilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHHHhcccHHH
Confidence            999999999987777664

>PRK10593 hypothetical protein; Provisional

Probab=96.94  E-value=0.011  Score=54.45  Aligned_cols=67  Identities=13%  Similarity=-0.027  Sum_probs=45.8

Q ss_pred             ccceecCCCceEEEecc------------cc-cHHHHHHHHHHHHccCC---CcccceeeeeccccccCCceEEEEEEcc
Q 041757           40 EENLISAGTFGFSHLRR------------QG-AFKSFIAECKALRNIRH---RNLIKVLTACLGVDYQGNDFKALVYEFM  103 (381)
Q Consensus        40 ~~~~lG~G~fg~V~~~~------------~~-~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~~~~~~~~~~lv~e~~  103 (381)
                      ..+-||.|..+.||...            .. ....+.+|.+.|+.|.-   -.+.+++++|..  ....+..+||||++
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~--~~~~g~~~LVmE~i   95 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTH--EQSPGPDVLLLERL   95 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEecc--CCcCCCeEEEEecc
Confidence            34567788877775521            11 23578899999999953   367888887542  12345679999999


Q ss_pred             cCCCH
Q 041757          104 HNRSL  108 (381)
Q Consensus       104 ~~g~L  108 (381)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.82  E-value=0.0078  Score=58.16  Aligned_cols=48  Identities=23%  Similarity=0.325  Sum_probs=36.5

Q ss_pred             HHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhc
Q 041757           61 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY  113 (381)
Q Consensus        61 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  113 (381)
                      .....-...++.+.|+|...++++...    ......+|||++ +-+|++.+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~----~~~r~IVV~e~~-~~Sled~~~   74 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRG----KHERVIVVMEHY-TMSLEDILK   74 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecC----ccceEEEEehhh-ccchHHHHH
Confidence            344556778899999999999988542    234478999999 559999884

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.65  E-value=0.0053  Score=56.05  Aligned_cols=117  Identities=14%  Similarity=0.035  Sum_probs=76.9

Q ss_pred             ccccceecCCCceEEEecccc--------------------------------------cHHHHHHHHHHHHccC-C-Cc
Q 041757           38 MLEENLISAGTFGFSHLRRQG--------------------------------------AFKSFIAECKALRNIR-H-RN   77 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~~--------------------------------------~~~~~~~E~~~l~~l~-h-~n   77 (381)
                      ++.++.||-|.-+.||.+-..                                      ..-...+|...|+.|. | --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            567788888888888664311                                      1122346888888885 3 23


Q ss_pred             ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 041757           78 LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH  157 (381)
Q Consensus        78 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  157 (381)
                      |.+.+++         +..++|||++.+-.|.+.-+             .-+...+..-+..++   .-|-   ..|+||
T Consensus       174 VPkpiD~---------~RH~Vvmelv~g~Pl~~v~~-------------v~d~~~ly~~lm~~I---v~la---~~GlIH  225 (465)
T KOG2268|consen  174 VPKPIDH---------NRHCVVMELVDGYPLRQVRH-------------VEDPPTLYDDLMGLI---VRLA---NHGLIH  225 (465)
T ss_pred             CCCcccc---------cceeeHHHhhcccceeeeee-------------cCChHHHHHHHHHHH---HHHH---HcCcee
Confidence            4444444         45689999999988866542             112223333233322   3333   449999


Q ss_pred             eccCCCCeeeCCCCCeEEeecccce
Q 041757          158 CVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       158 rDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +|..-=||++++++.++++||-...
T Consensus       226 gDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  226 GDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             cccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999997654

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.55  E-value=0.02  Score=54.77  Aligned_cols=30  Identities=17%  Similarity=0.221  Sum_probs=25.9

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ...++|+|+.+.||++..+ .++++||.++.
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~  251 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF  251 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence            5579999999999999776 58999998764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.44  E-value=0.032  Score=47.83  Aligned_cols=116  Identities=19%  Similarity=0.274  Sum_probs=78.7

Q ss_pred             cccccccceecCCCc-eEEEeccc------------------------------------ccHHHHHHHHHHHHccC---
Q 041757           35 SRNMLEENLISAGTF-GFSHLRRQ------------------------------------GAFKSFIAECKALRNIR---   74 (381)
Q Consensus        35 ~~~~~~~~~lG~G~f-g~V~~~~~------------------------------------~~~~~~~~E~~~l~~l~---   74 (381)
                      +.+++..+.||.|.- |.|++++-                                    .....|..|.+...+|+   
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            378889999999999 99955430                                    12345788999888885   


Q ss_pred             CCcc--cceeeeeccc-------------cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHH
Q 041757           75 HRNL--IKVLTACLGV-------------DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAID  139 (381)
Q Consensus        75 h~nI--v~~~~~~~~~-------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q  139 (381)
                      +.++  |+.+|+..=.             .........||-||.+...                   .++    .+-+.+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------------~~~----~~~~~~  172 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------------PLQ----IRDIPQ  172 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------------ccc----hhHHHH
Confidence            4566  8888885310             0011223356777664422                   122    233567


Q ss_pred             HHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       140 i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      +.+-+..+|   ..||+-+|+++.|..     .-||+|||.+
T Consensus       173 ~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  173 MLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            777888999   779999999999987     3489999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.31  E-value=0.0091  Score=53.67  Aligned_cols=29  Identities=14%  Similarity=0.164  Sum_probs=25.4

Q ss_pred             CCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          153 PVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       153 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ..++|+|+.|.||++++++ +.|+||..+.
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            4689999999999999876 7899998774

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.07  E-value=0.024  Score=49.03  Aligned_cols=124  Identities=11%  Similarity=0.088  Sum_probs=78.4

Q ss_pred             cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757           59 AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI  138 (381)
Q Consensus        59 ~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  138 (381)
                      ...-|.++.+++.++.  .|+++..       .+.-...++.|.|-.                   ......    .++.
T Consensus       101 ~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~-------------------~~i~~~----N~i~  148 (308)
T PF07387_consen  101 NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYK-------------------IKINFS----NFIT  148 (308)
T ss_pred             chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccC-------------------cccchh----HHHH
Confidence            3455677888888775  3555442       234556789999833                   111111    1122


Q ss_pred             HHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccc
Q 041757          139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGD  218 (381)
Q Consensus       139 qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD  218 (381)
                      -=+.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+.-.              ..+.-|.--|   ....+.++.
T Consensus       149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--------------~~~V~~vN~~---Y~~lT~~aE  210 (308)
T PF07387_consen  149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--------------ENQVNMVNIE---YESLTQEAE  210 (308)
T ss_pred             HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--------------hheeeEEeee---ccccChHHH
Confidence            225678888976 7799999999999999999999999976431              0222233312   123466777


Q ss_pred             hhhhhHHHHHHHhC
Q 041757          219 VYSYGILLLELMIR  232 (381)
Q Consensus       219 iwSlG~il~el~tg  232 (381)
                      +-+|-.-+.++...
T Consensus       211 ~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  211 VKVFVKSCLKLVEK  224 (308)
T ss_pred             HHHHHHHHHHHHHH
Confidence            77777777776653

The function of this family is unknown.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.67  E-value=0.057  Score=49.86  Aligned_cols=32  Identities=31%  Similarity=0.515  Sum_probs=28.5

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ...++|+|+.+.|++++....+-+.||+++..
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            35699999999999999988899999999864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.36  E-value=0.069  Score=49.76  Aligned_cols=74  Identities=19%  Similarity=0.184  Sum_probs=54.5

Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      ...+.|++|++- |+++.-              ...-.+.++..++.+.+.-+.-+-.  .-..-|||+.-.||||+ .|
T Consensus       297 e~~y~yl~~kdh-gt~is~--------------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~G  358 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISI--------------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EG  358 (488)
T ss_pred             CceEEEEEEecC-Cceeee--------------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cC
Confidence            345556777754 445432              2234567788888887777776653  44788999999999999 89


Q ss_pred             CeEEeeccccee
Q 041757          172 TARVGDFGLARF  183 (381)
Q Consensus       172 ~~kl~Dfg~~~~  183 (381)
                      .+.|+||-+++.
T Consensus       359 nvtLIDfklsRl  370 (488)
T COG5072         359 NVTLIDFKLSRL  370 (488)
T ss_pred             ceEEEEeeeeec
Confidence            999999999983

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.57  E-value=0.42  Score=45.79  Aligned_cols=30  Identities=23%  Similarity=0.207  Sum_probs=24.9

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ....+|+||.|.||+++.++ .+++|..++.
T Consensus       229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~  258 (418)
T PLN02756        229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF  258 (418)
T ss_pred             ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence            56799999999999998875 8888876653

>PRK05231 homoserine kinase; Provisional

Probab=93.95  E-value=0.1  Score=48.53  Aligned_cols=31  Identities=29%  Similarity=0.238  Sum_probs=26.7

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ..++||+|+.|.||+++++....|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            5689999999999999876666899998774

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=93.89  E-value=0.035  Score=29.15  Aligned_cols=21  Identities=48%  Similarity=0.589  Sum_probs=17.0

Q ss_pred             eEeEEccCCccccccccccccc
Q 041757            5 LIALDVSGNKLTGSLHIEVGKL   26 (381)
Q Consensus         5 ~~~l~~~~n~~~g~~~~~~~~~   26 (381)
                      |+.|||++|+++ .+|..++++
T Consensus         2 L~~Ldls~n~l~-~ip~~~~~l   22 (22)
T PF00560_consen    2 LEYLDLSGNNLT-SIPSSFSNL   22 (22)
T ss_dssp             ESEEEETSSEES-EEGTTTTT-
T ss_pred             ccEEECCCCcCE-eCChhhcCC
Confidence            567999999999 889887653

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>PHA03111 Ser/Thr kinase; Provisional

Probab=93.83  E-value=0.077  Score=48.75  Aligned_cols=38  Identities=21%  Similarity=0.031  Sum_probs=26.4

Q ss_pred             HHHHHHHHHHHHHHHHhhcCC-CCCceeeccCCCCeeeC
Q 041757          131 LRRLNIAIDVASALNYLHHDC-QPVTAHCVLKPSNVLLD  168 (381)
Q Consensus       131 ~~~~~i~~qi~~~l~~LH~~~-~~~ivHrDlkp~Nill~  168 (381)
                      +-+.-++.|++--.-.+.+.. ..+.+|-||||+|||+-
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            445667778776553443322 45799999999999994

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.79  E-value=0.38  Score=42.12  Aligned_cols=48  Identities=23%  Similarity=0.334  Sum_probs=36.9

Q ss_pred             cccHHHHHHHHHHHHccCC---CcccceeeeeccccccCCceEEEEEEcccCCCHH
Q 041757           57 QGAFKSFIAECKALRNIRH---RNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLK  109 (381)
Q Consensus        57 ~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~  109 (381)
                      ......|..|+.-|..|.-   -++.+++.+     .....+.|+||||++-|.+.
T Consensus        49 ~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~-----G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          49 REQLSMFTAEADGLELLARSNTITVPKVIAV-----GASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             hhhHHHHHHHHHHHHHHHhcCCccccceEEe-----cCCCCeeEEEEeeccCCCCC
Confidence            4455778899998888853   456677776     56688999999999987776

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.66  E-value=0.14  Score=47.16  Aligned_cols=31  Identities=29%  Similarity=0.267  Sum_probs=27.3

Q ss_pred             CCCceeeccCCCCeeeCCC----CCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDD----MTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~  182 (381)
                      ...++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            5689999999999999874    789999998774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.22  E-value=0.1  Score=48.25  Aligned_cols=55  Identities=20%  Similarity=0.158  Sum_probs=34.6

Q ss_pred             HHHHHHHHHHHHHHHHhhcCC-CCCceeeccCCCCeeeCC------------------CCCeEEeecccceecC
Q 041757          131 LRRLNIAIDVASALNYLHHDC-QPVTAHCVLKPSNVLLDD------------------DMTARVGDFGLARFLP  185 (381)
Q Consensus       131 ~~~~~i~~qi~~~l~~LH~~~-~~~ivHrDlkp~Nill~~------------------~~~~kl~Dfg~~~~~~  185 (381)
                      +-+.-++.|++--.--..+.. ..+.+|-||||+|||+-+                  ...++|.||.+++...
T Consensus       275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence            345556667654322133221 457999999999999932                  2346778888876543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.12  E-value=0.14  Score=45.25  Aligned_cols=31  Identities=19%  Similarity=0.282  Sum_probs=26.9

Q ss_pred             CCCceeeccCCCCeeeCC-CCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDD-DMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~~~  182 (381)
                      ...++|+|+.+.||++++ ++.+.++||..|.
T Consensus       169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            457999999999999997 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=92.89  E-value=0.2  Score=46.36  Aligned_cols=31  Identities=39%  Similarity=0.387  Sum_probs=27.4

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            5689999999999999988777899998763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=92.59  E-value=0.079  Score=48.61  Aligned_cols=31  Identities=35%  Similarity=0.292  Sum_probs=27.2

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ..+++|+|+.|.||+++++..+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            4579999999999999988777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.56  E-value=0.25  Score=46.11  Aligned_cols=144  Identities=21%  Similarity=0.227  Sum_probs=75.7

Q ss_pred             cccccccceecCCCceEEEecccc-cHHHHHHHHHHHHccCCCcc------cceeeeeccccccCCceEEEEEEcccCCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-AFKSFIAECKALRNIRHRNL------IKVLTACLGVDYQGNDFKALVYEFMHNRS  107 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~~~~E~~~l~~l~h~nI------v~~~~~~~~~~~~~~~~~~lv~e~~~~g~  107 (381)
                      +.+|..  ....|.+ .++..+.. .......|...|..|.-.+|      ...=|-... ......+.+-+.+|++|..
T Consensus        39 N~~f~~--~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~-~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          39 NSNFRV--QTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLE-ALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             CceEEE--EecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhh-hccCCceeEEEEEecCCcC
Confidence            444544  3667777 66665554 66777889999998842222      111111111 0111247788999999988


Q ss_pred             HHH-hh--------------ccccCCcc--cccCCCcccHH-------------HHHHHHHHHHHHHHHhh----cCCCC
Q 041757          108 LKE-WL--------------YPISKEDE--TYKRPRNLNLL-------------RRLNIAIDVASALNYLH----HDCQP  153 (381)
Q Consensus       108 L~~-~l--------------~~~~~~~~--~~~~~~~l~~~-------------~~~~i~~qi~~~l~~LH----~~~~~  153 (381)
                      +.. .-              +.....-.  .........|.             .......++...+..+.    .....
T Consensus       115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~  194 (331)
T COG2334         115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA  194 (331)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence            873 11              10000000  00000011111             00112223333333333    22233


Q ss_pred             C---ceeeccCCCCeeeCCCCC-eEEeecccce
Q 041757          154 V---TAHCVLKPSNVLLDDDMT-ARVGDFGLAR  182 (381)
Q Consensus       154 ~---ivHrDlkp~Nill~~~~~-~kl~Dfg~~~  182 (381)
                      .   +||+|+.|.||+++.+.. +.++||+-+.
T Consensus       195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            3   999999999999998874 8899999774

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=92.33  E-value=0.071  Score=33.56  Aligned_cols=33  Identities=45%  Similarity=0.591  Sum_probs=27.6

Q ss_pred             eEeEEccCCccccccccccccccchhhhhccccc
Q 041757            5 LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNM   38 (381)
Q Consensus         5 ~~~l~~~~n~~~g~~~~~~~~~~~l~~~~~~~~~   38 (381)
                      |+.|++++|+++ .+|.+++++++|+.++++++.
T Consensus         3 L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~   35 (44)
T PF12799_consen    3 LEELDLSNNQIT-DLPPELSNLPNLETLNLSNNP   35 (44)
T ss_dssp             -SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSC
T ss_pred             ceEEEccCCCCc-ccCchHhCCCCCCEEEecCCC
Confidence            567999999999 678889999999999988774

...

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=92.26  E-value=0.48  Score=44.46  Aligned_cols=102  Identities=17%  Similarity=0.177  Sum_probs=70.4

Q ss_pred             HHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHH
Q 041757           63 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVAS  142 (381)
Q Consensus        63 ~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  142 (381)
                      ..+|++.|.+|+...|.-.--..       -....|||+|+..-   .|-.+.       -+...++...+..+-.+++.
T Consensus       213 AEKE~RNLkRl~~aGIP~PePIl-------Lk~hVLVM~FlGrd---gw~aPk-------LKd~~ls~~ka~~~Y~~~v~  275 (520)
T KOG2270|consen  213 AEKEMRNLKRLNNAGIPCPEPIL-------LKNHVLVMEFLGRD---GWAAPK-------LKDASLSTSKARELYQQCVR  275 (520)
T ss_pred             HHHHHHHHHHHHhcCCCCCCcee-------eecceEeeeeccCC---CCcCcc-------cccccCChHHHHHHHHHHHH
Confidence            34688999998766653222111       12347999999532   121110       23455677778888889999


Q ss_pred             HHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757          143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL  184 (381)
Q Consensus       143 ~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~  184 (381)
                      -+.-|...+  ++||.||.-=|+|+.+ |.+.|+|-+.+...
T Consensus       276 ~MR~lY~~c--~LVHADLSEfN~Lyhd-G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  276 IMRRLYQKC--RLVHADLSEFNLLYHD-GKLYIIDVSQSVEH  314 (520)
T ss_pred             HHHHHHHHh--ceeccchhhhhheEEC-CEEEEEEccccccC
Confidence            999998655  8999999999999864 58999998877543

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.24  E-value=0.1  Score=44.31  Aligned_cols=29  Identities=17%  Similarity=0.167  Sum_probs=25.3

Q ss_pred             CCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          153 PVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       153 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ...+|+|+.|.|+++++++ ++|+||+.+.
T Consensus        77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            4579999999999998877 8899999874

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=91.67  E-value=0.34  Score=44.68  Aligned_cols=30  Identities=27%  Similarity=0.183  Sum_probs=25.7

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            458999999999999987 578899998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=90.79  E-value=0.44  Score=43.14  Aligned_cols=46  Identities=28%  Similarity=0.303  Sum_probs=33.9

Q ss_pred             HHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       136 i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      .+..+-.++.-.+.. ...++|+|+.|.|++.++.+.++|+||.-|.
T Consensus       137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            334444445555532 2469999999999999998999999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=90.58  E-value=0.17  Score=44.00  Aligned_cols=30  Identities=33%  Similarity=0.483  Sum_probs=21.3

Q ss_pred             CCceeeccCCCCeee-CCCCCeEEeecccce
Q 041757          153 PVTAHCVLKPSNVLL-DDDMTARVGDFGLAR  182 (381)
Q Consensus       153 ~~ivHrDlkp~Nill-~~~~~~kl~Dfg~~~  182 (381)
                      ..++|.|+.|.||++ +.++.++++||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            468999999999999 788899999998774

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=90.57  E-value=1.1  Score=42.92  Aligned_cols=28  Identities=25%  Similarity=0.140  Sum_probs=23.7

Q ss_pred             CCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          153 PVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       153 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      ...+|.|+-+.||+.+++ .+.++||..|
T Consensus       227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA  254 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFA  254 (383)
T ss_pred             eeeeeccCCcccEEecCC-CEEEEEeccc
Confidence            578999999999997654 6999999765

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=90.31  E-value=0.73  Score=42.16  Aligned_cols=44  Identities=20%  Similarity=0.231  Sum_probs=26.1

Q ss_pred             ccHHHHHHHHHHHHccC---CCcccceeeeeccccccCCceEEEEEEcccCC
Q 041757           58 GAFKSFIAECKALRNIR---HRNLIKVLTACLGVDYQGNDFKALVYEFMHNR  106 (381)
Q Consensus        58 ~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g  106 (381)
                      .....|..|.+-|+.|.   --.+.+++++.     ...+..+|||||++.+
T Consensus        51 ~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G-----~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   51 SGRDMFEGEAEGLKALAEANPIRVPKVIAWG-----EYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             GGCCHHHHHHHHHHHHCHTTTSBS--EEEEE-----E-SSCCEEEEE-----
T ss_pred             hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----eecCCceEEEEeecCC
Confidence            34567899999999994   33567778773     2344559999999776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=89.80  E-value=0.23  Score=45.26  Aligned_cols=30  Identities=30%  Similarity=0.498  Sum_probs=25.2

Q ss_pred             CCceeeccCCCCeeeCCCCC-eEEeecccce
Q 041757          153 PVTAHCVLKPSNVLLDDDMT-ARVGDFGLAR  182 (381)
Q Consensus       153 ~~ivHrDlkp~Nill~~~~~-~kl~Dfg~~~  182 (381)
                      ..++|+|++|.||++++++. ..|+||+.+.
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            46899999999999987554 5699999874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=89.79  E-value=0.25  Score=42.47  Aligned_cols=31  Identities=26%  Similarity=0.275  Sum_probs=25.7

Q ss_pred             CCCceeeccCCCCeeeCCCC-----CeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDM-----TARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~-----~~kl~Dfg~~~  182 (381)
                      ...++|+|+.+.||++..++     .+.++||..++
T Consensus       119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            45799999999999997543     58999998774

subfamily of choline kinases

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=89.50  E-value=0.5  Score=43.70  Aligned_cols=31  Identities=26%  Similarity=0.247  Sum_probs=27.9

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ..+++|+|+.++|+++++++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            5589999999999999998899999998774

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	381
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-23
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-06
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-06
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-06
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-06
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-06
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-06
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-06
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-06
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-06
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-06
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-05
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-05
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-05
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-05
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-05
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-05
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-05
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-05
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-05
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-05
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-05
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-05
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-05
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-05
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-05
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-05
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-05
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-04
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-04
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-04
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-04
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-04
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-04
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-04
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-04
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-04
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-04
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-04
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-04
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-04
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-04
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-04
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/325 (27%), Positives = 143/325 (44%), Gaps = 50/325 (15%)
Query: 21  IEVGKLKNLEILDV---SRNMLEENLISAGTFG-----------------FSHLRRQGAF 60
           + +G+LK   + ++   S N   +N++  G FG                     R QG  
Sbjct: 20  VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGE 79
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
             F  E + +    HRNL+++   C+         + LVY +M N S+   L    +   
Sbjct: 80  LQFQTEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQP 134
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
               P          IA+  A  L YLH  C P   H  +K +N+LLD++  A VGDFGL
Sbjct: 135 PLDWPKRQR------IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 188
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           A+ +           V+G+IG+IAPEY    + S   DV+ YG++LLEL+  ++  D+  
Sbjct: 189 AKLMDYKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL-- 245
Query: 241 EGDMNLHKFAKMALSNHVK--DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVR 298
                    A++A  + V   D V  +L     + +V  D      + N   E V  +++
Sbjct: 246 ---------ARLANDDDVMLLDWVKGLLKEKKLEALVDVD-----LQGNYKDEEVEQLIQ 291
Query: 299 IGVACSMESPQDRMKMTNVVHELQS 323
           + + C+  SP +R KM+ VV  L+ 
Sbjct: 292 VALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 89/326 (27%), Positives = 142/326 (43%), Gaps = 50/326 (15%)
Query: 20  HIEVGKLKNLEILDV---SRNMLEENLISAGTFG-----------------FSHLRRQGA 59
            + +G+LK   + ++   S N   +N++  G FG                     R QG 
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG 70
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
              F  E + +    HRNL+++   C+         + LVY +M N S+   L    +  
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQ 125
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
                P          IA+  A  L YLH  C P   H  +K +N+LLD++  A VGDFG
Sbjct: 126 PPLDWPKRQR------IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 239
           LA+ +           V+G IG+IAPEY    + S   DV+ YG++LLEL+  ++  D+ 
Sbjct: 180 LAKLMDYKDXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL- 237
Query: 240 FEGDMNLHKFAKMALSNHVK--DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMV 297
                     A++A  + V   D V  +L     + +V  D +      N   E V  ++
Sbjct: 238 ----------ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG-----NYKDEEVEQLI 282
Query: 298 RIGVACSMESPQDRMKMTNVVHELQS 323
           ++ + C+  SP +R KM+ VV  L+ 
Sbjct: 283 QVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 16/170 (9%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F  E K +   +H NL+++L    G    G+D   LVY +M N SL + L   S  D 
Sbjct: 69  QQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRL---SCLDG 120
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
           T              IA   A+ +N+LH +      H  +K +N+LLD+  TA++ DFGL
Sbjct: 121 T----PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 173
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           AR             + G+  Y+APE  +  E++   D+YS+G++LLE++
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 222

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 28/176 (15%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY------P 114
           + F  E K +   +H NL+++L    G    G+D   LVY +M N SL + L       P
Sbjct: 75  QQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 115 ISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
           +S                   IA   A+ +N+LH +      H  +K +N+LLD+  TA+
Sbjct: 130 LSWH-------------MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAK 173
Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + DFGLAR             + G+  Y+APE  +  E++   D+YS+G++LLE++
Sbjct: 174 ISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 228

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 28/176 (15%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY------P 114
           + F  E K +   +H NL+++L    G    G+D   LVY +M N SL + L       P
Sbjct: 75  QQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 115 ISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
           +S                   IA   A+ +N+LH +      H  +K +N+LLD+  TA+
Sbjct: 130 LSWH-------------MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAK 173
Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + DFGLAR             + G+  Y+APE  +  E++   D+YS+G++LLE++
Sbjct: 174 ISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 228

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++ +RH N++  + A      Q  +  ++V E++   SL   L+     ++  
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +R           +A DVA  +NYLH+   P+  H  LK  N+L+D   T +V DFGL+R
Sbjct: 136 ER-------RRLSMAYDVAKGMNYLHNRNPPIV-HRNLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
                 T  SS    G+  ++APE       +   DVYS+G++L EL   ++P
Sbjct: 188 LK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 28  NLEILDVSRNMLEENLISAGTFG-------------FSHLRRQGAFKSFIAECKALRNIR 74
           +L ++D     +EE ++  G FG                +  +   K+FI E + L  + 
Sbjct: 1   SLHMIDYKEIEVEE-VVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVN 59
Query: 75  HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXX 134
           H N++K+  ACL       +   LV E+    SL   L+    E   Y            
Sbjct: 60  HPNIVKLYGACL-------NPVCLVMEYAEGGSLYNVLH--GAEPLPY-----YTAAHAM 105
Query: 135 XIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA-RVGDFGLARFLPPTRTQTSS 193
              +  +  + YLH        H  LKP N+LL    T  ++ DFG A        QT  
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHM 160
Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
            + KGS  ++APE   G+  S   DV+S+GI+L E++ R KP D
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 28  NLEILDVSRNMLEENLISAGTFG-------------FSHLRRQGAFKSFIAECKALRNIR 74
           +L ++D     +EE ++  G FG                +  +   K+FI E + L  + 
Sbjct: 2   SLHMIDYKEIEVEE-VVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVN 60
Query: 75  HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXX 134
           H N++K+  ACL       +   LV E+    SL   L+    E   Y            
Sbjct: 61  HPNIVKLYGACL-------NPVCLVMEYAEGGSLYNVLH--GAEPLPY-----YTAAHAM 106
Query: 135 XIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA-RVGDFGLARFLPPTRTQTSS 193
              +  +  + YLH        H  LKP N+LL    T  ++ DFG A        QT  
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHM 161
Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
            + KGS  ++APE   G+  S   DV+S+GI+L E++ R KP D
Sbjct: 162 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 28/176 (15%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY------P 114
           + F  E K     +H NL+++L    G    G+D   LVY +  N SL + L       P
Sbjct: 66  QQFDQEIKVXAKCQHENLVELL----GFSSDGDDL-CLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 115 ISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
           +S                   IA   A+ +N+LH +      H  +K +N+LLD+  TA+
Sbjct: 121 LSWHXRC-------------KIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAK 164
Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + DFGLAR             + G+  Y APE  +  E++   D+YS+G++LLE++
Sbjct: 165 ISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEII 219

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 51/221 (23%)
Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
            ++   K F  E      + H+N++    + + VD + +D   LV E++   +L E++  
Sbjct: 50  EKEETLKRFEREVHNSSQLSHQNIV----SMIDVD-EEDDCYYLVMEYIEGPTLSEYI-- 102
Query: 115 ISKEDETYKRPXXXXXXXXXXIAIDVASALNYLH---------HDCQPVTAHCVLKPSNV 165
                E++               + V +A+N+ +         HD + V  H  +KP N+
Sbjct: 103 -----ESHG-------------PLSVDTAINFTNQILDGIKHAHDMRIV--HRDIKPQNI 142
Query: 166 LLDDDMTARVGDFGLARFLPPTR-TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           L+D + T ++ DFG+A+ L  T  TQT+   V G++ Y +PE   G       D+YS GI
Sbjct: 143 LIDSNKTLKIFDFGIAKALSETSLTQTNH--VLGTVQYFSPEQAKGEATDECTDIYSIGI 200
Query: 225 LLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSI 265
           +L E+++ E P    F G+         A+S  +K I DS+
Sbjct: 201 VLYEMLVGEPP----FNGE--------TAVSIAIKHIQDSV 229

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           F++F  E   LR  RH N++      L + Y   D  A+V ++    SL + L+    + 
Sbjct: 76  FQAFRNEVAVLRKTRHVNIL------LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKF 129
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           + ++            IA   A  ++YLH        H  +K +N+ L + +T ++GDFG
Sbjct: 130 QMFQ---------LIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFG 177
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA                GS+ ++APE       N  S   DVYSYGI+L ELM  E P
Sbjct: 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++ +RH N++  + A      Q  +  ++V E++   SL   L+     ++  
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +R           +A DVA  +NYLH+   P+  H  LK  N+L+D   T +V DFGL+R
Sbjct: 136 ER-------RRLSMAYDVAKGMNYLHNRNPPIV-HRDLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
                     S    G+  ++APE       +   DVYS+G++L EL   ++P
Sbjct: 188 LK--ASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 75  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 128
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 129 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 176
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 177 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 76  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 129
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 130 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 177
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 178 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 50  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 103
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 104 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 151
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 152 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 74  RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXX 133
           RH +L+ ++  C        +   L+Y++M N +LK  LY       +            
Sbjct: 93  RHPHLVSLIGFC-----DERNEMILIYKYMENGNLKRHLYGSDLPTMS------MSWEQR 141
Query: 134 XXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
             I I  A  L+YLH        H  +K  N+LLD++   ++ DFG+++           
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLX 198
Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
             VKG++GYI PEY +   ++   DVYS+G++L E++
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 53  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 106
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 107 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 154
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 155 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 48  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 101
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 102 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 74  RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXX 133
           RH +L+ ++  C        +   L+Y++M N +LK  LY       +            
Sbjct: 93  RHPHLVSLIGFC-----DERNEMILIYKYMENGNLKRHLYGSDLPTMS------MSWEQR 141
Query: 134 XXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
             I I  A  L+YLH        H  +K  N+LLD++   ++ DFG+++           
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLX 198
Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
             VKG++GYI PEY +   ++   DVYS+G++L E++
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 53  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 106
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 107 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 154
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 155 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 48  LQAFKNEVGVLRKTRHVNIL------LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKF 101
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 102 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 68  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 121
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 122 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 169
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 170 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 76  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 129
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 130 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 177
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 178 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+ I  + 
Sbjct: 48  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 101
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 102 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 150 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 33/202 (16%)
Query: 44  ISAGTFGFSHLR-------------RQGAF--KSFIAECKALRNIRHRNLIKVLTACLGV 88
           I +G FG  HL              R+GA   + FI E + +  + H  L+++   CL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE- 73
Query: 89  DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLH 148
                    LV+EFM +  L ++L           +           + +DV   + YL 
Sbjct: 74  ----QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 149 HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG 208
             C     H  L   N L+ ++   +V DFG+ RF+   +  TSS   K  + + +PE  
Sbjct: 121 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 176
Query: 209 VGNEVSTIGDVYSYGILLLELM 230
             +  S+  DV+S+G+L+ E+ 
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVF 198

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 33/202 (16%)
Query: 44  ISAGTFGFSHLR-------------RQGAF--KSFIAECKALRNIRHRNLIKVLTACLGV 88
           I +G FG  HL              R+GA   + FI E + +  + H  L+++   CL  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE- 71
Query: 89  DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLH 148
                    LV+EFM +  L ++L           +           + +DV   + YL 
Sbjct: 72  ----QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 149 HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG 208
             C     H  L   N L+ ++   +V DFG+ RF+   +  TSS   K  + + +PE  
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVF 174
Query: 209 VGNEVSTIGDVYSYGILLLELM 230
             +  S+  DV+S+G+L+ E+ 
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVF 196

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 33/202 (16%)
Query: 44  ISAGTFGFSHLR-------------RQGAF--KSFIAECKALRNIRHRNLIKVLTACLGV 88
           I +G FG  HL              R+GA   + FI E + +  + H  L+++   CL  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE- 76
Query: 89  DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLH 148
                    LV+EFM +  L ++L           +           + +DV   + YL 
Sbjct: 77  ----QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE 123
Query: 149 HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG 208
             C     H  L   N L+ ++   +V DFG+ RF+   +  TSS   K  + + +PE  
Sbjct: 124 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVF 179
Query: 209 VGNEVSTIGDVYSYGILLLELM 230
             +  S+  DV+S+G+L+ E+ 
Sbjct: 180 SFSRYSSKSDVWSFGVLMWEVF 201

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M+  SL ++L     E  
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFL---KGETG 105
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 106 KYLRLPQLVDMSAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 156
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 157 LARLI-EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 208

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 48  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIXIVTEYMSKGSLLDFL---KGETG 98
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 99  KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 149
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 150 LARLIEDNEX-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 201

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 77/179 (43%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+    + 
Sbjct: 52  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKF 105
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D T ++GDFG
Sbjct: 106 EMKK---------LIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG 153
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 154 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M+  SL ++L     E  
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFL---KGETG 105
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 106 KYLRLPQLVDMSAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 156
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 157 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 208

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ IRH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 58  EAFLQEAQVMKKIRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGEMG 108
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 77/179 (43%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+    + 
Sbjct: 64  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKF 117
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D T ++GDFG
Sbjct: 118 EMKK---------LIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG 165
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 51  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGETG 101
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 102 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 152
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 153 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 204

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVIEYMSKGSLLDFL---KGEMG 108
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLIEDNEX-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGETG 274
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 325
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 326 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGETG 274
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 325
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 326 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           +SF+ E + ++ ++H  L+++            +   +V E+M+  SL ++L     E  
Sbjct: 49  ESFLEEAQIMKKLKHDKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFLK--DGEGR 100
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
             K P            +     +NY+H D         L+ +N+L+ + +  ++ DFGL
Sbjct: 101 ALKLPNLVDMAAQVAAGMAYIERMNYIHRD---------LRSANILVGNGLICKIADFGL 151
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           AR +      T+    K  I + APE  +    +   DV+S+GILL EL+ +
Sbjct: 152 ARLIEDNEX-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 202

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 77/179 (43%), Gaps = 21/179 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++      L + Y      A+V ++    SL   L+    + 
Sbjct: 64  LQAFKNEVGVLRKTRHVNIL------LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKF 117
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E  K            IA   A  ++YLH        H  LK +N+ L +D T ++GDFG
Sbjct: 118 EMKK---------LIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG 165
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 22/177 (12%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           ++     ++F+AE   +  +RH NL+++L     V+ +G  +  +V E+M   SL ++L 
Sbjct: 37  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLR 92
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
              +                   ++DV  A+ YL  +      H  L   NVL+ +D  A
Sbjct: 93  SRGRS--------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 141
Query: 174 RVGDFGLARFLPPTRTQTSSIDV-KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +V DFGL      T+  +S+ D  K  + + APE     + ST  DV+S+GILL E+
Sbjct: 142 KVSDFGL------TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVIEYMSKGSLLDFL---KGEMG 108
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 22/172 (12%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+AE   ++ ++H  L+K+            +   ++ EFM   SL ++L    K DE
Sbjct: 55  EAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYIITEFMAKGSLLDFL----KSDE 104
Query: 121 TYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
             K+P          IA  +A     NY+H D         L+ +N+L+   +  ++ DF
Sbjct: 105 GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD---------LRAANILVSASLVCKIADF 155
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           GLAR +      T+    K  I + APE       +   DV+S+GILL+E++
Sbjct: 156 GLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 206

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           ++     ++F+AE   +  +RH NL+++L     V+ +G  +  +V E+M   SL ++L 
Sbjct: 52  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLR 107
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
              +                   ++DV  A+ YL  +      H  L   NVL+ +D  A
Sbjct: 108 SRGRS--------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 156
Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +V DFGL +    T+  T  + VK    + APE     + ST  DV+S+GILL E+
Sbjct: 157 KVSDFGLTKEASSTQ-DTGKLPVK----WTAPEALREKKFSTKSDVWSFGILLWEI 207

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGEMG 108
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 47  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGEMG 97
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 98  KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 148
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 149 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 200

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVGEYMSKGSLLDFL---KGETG 274
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 325
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 326 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 33/202 (16%)
Query: 44  ISAGTFGFSHLR-------------RQGAF--KSFIAECKALRNIRHRNLIKVLTACLGV 88
           I +G FG  HL              R+GA   + FI E + +  + H  L+++   CL  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE- 74
Query: 89  DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLH 148
                    LV EFM +  L ++L           +           + +DV   + YL 
Sbjct: 75  ----QAPICLVTEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 149 HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG 208
             C     H  L   N L+ ++   +V DFG+ RF+   +  TSS   K  + + +PE  
Sbjct: 122 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 177
Query: 209 VGNEVSTIGDVYSYGILLLELM 230
             +  S+  DV+S+G+L+ E+ 
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVF 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 49  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGEMG 99
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 100 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 150
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 151 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 202

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           + ++F+AE   ++ ++H  L+K+            +   ++ EFM   SL ++L    K 
Sbjct: 226 SVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYIITEFMAKGSLLDFL----KS 275
Query: 119 DETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
           DE  K+P          IA  +A     NY+H D         L+ +N+L+   +  ++ 
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD---------LRAANILVSASLVCKIA 326
Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           DFGLAR +      T+    K  I + APE       +   DV+S+GILL+E++
Sbjct: 327 DFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVCEYMSKGSLLDFL---KGEMG 108
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGETG 357
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 408
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 409 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 47/217 (21%)
Query: 41  ENLISAGTFG---FSHLRRQG------AFKS------------FIAECKALRNIRHRNLI 79
           E +I AG FG     HL+  G      A K+            F++E   +    H N+I
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 80  K---VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXI 136
               V+T    V         ++ EFM N SL  +L    + D  +              
Sbjct: 98  HLEGVVTKSTPV--------MIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAA 146
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL---PPTRTQTSS 193
            +   + +NY+H D         L   N+L++ ++  +V DFGL+RFL       T TS+
Sbjct: 147 GMKYLADMNYVHRD---------LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           +  K  I + APE     + ++  DV+SYGI++ E+M
Sbjct: 198 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 116 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 162
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 163 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 222
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L      A     +D+V+ +L+ D  K
Sbjct: 223 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLDATK 278

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 66/139 (47%), Gaps = 8/139 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++ SAL YLH        H  LKP N+LL++DM  ++ DFG A+ L P   Q  +    G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-----IREKPSDIMFEGDMNLHKFAKMA 253
           +  Y++PE       S   D+++ G ++ +L+      R     ++F+  + L       
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 256
Query: 254 LSNHVKDIVDSILLNDDEK 272
                +D+V+ +L+ D  K
Sbjct: 257 FFPKARDLVEKLLVLDATK 275

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 22/177 (12%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           ++     ++F+AE   +  +RH NL+++L     V+ +G  +  +V E+M   SL ++L 
Sbjct: 224 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLR 279
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
              +                   ++DV  A+ YL  +      H  L   NVL+ +D  A
Sbjct: 280 SRGRS--------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 328
Query: 174 RVGDFGLARFLPPTRTQTSSIDV-KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +V DFGL      T+  +S+ D  K  + + APE     + ST  DV+S+GILL E+
Sbjct: 329 KVSDFGL------TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 33/202 (16%)
Query: 44  ISAGTFGFSHLR-------------RQGAFKS--FIAECKALRNIRHRNLIKVLTACLGV 88
           I +G FG  HL              ++G+     FI E + +  + H  L+++   CL  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE- 93
Query: 89  DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLH 148
                    LV+EFM +  L ++L           +           + +DV   + YL 
Sbjct: 94  ----QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE 140
Query: 149 HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG 208
             C     H  L   N L+ ++   +V DFG+ RF+   +  TSS   K  + + +PE  
Sbjct: 141 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 196
Query: 209 VGNEVSTIGDVYSYGILLLELM 230
             +  S+  DV+S+G+L+ E+ 
Sbjct: 197 SFSRYSSKSDVWSFGVLMWEVF 218

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 29/203 (14%)
Query: 40  EENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFK 96
           +E+ ++  T    +  RQ   + F++E   +    H N+I+   V+T  + V        
Sbjct: 43  KESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHPNIIRLEGVVTNSMPV-------- 92
Query: 97  ALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA 156
            ++ EFM N +L  +L      D  +               +   + ++Y+H D      
Sbjct: 93  MILTEFMENGALDSFL---RLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRD------ 143
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTR---TQTSSIDVKGSIGYIAPEYGVGNEV 213
              L   N+L++ ++  +V DFGL+RFL       T+TSS+  K  I + APE     + 
Sbjct: 144 ---LAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKF 200
Query: 214 STIGDVYSYGILLLELM-IREKP 235
           ++  D +SYGI++ E+M   E+P
Sbjct: 201 TSASDAWSYGIVMWEVMSFGERP 223

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGEMG 108
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L  +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LAAANILVGENLVCKVADFG 159
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + LRN+ H N++K    C   +  GN  K L+ EF+ + SLKE+L P +K     K+ 
Sbjct: 73  EIEILRNLYHENIVKYKGIC--TEDGGNGIK-LIMEFLPSGSLKEYL-PKNKNKINLKQQ 128
Query: 126 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
                       +D   +  Y+H D         L   NVL++ +   ++GDFGL + + 
Sbjct: 129 LKYAVQICK--GMDYLGSRQYVHRD---------LAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 186 PTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
             +   +  D + S + + APE  + ++     DV+S+G+ L EL+
Sbjct: 178 TDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + LRN+ H N++K    C   +  GN  K L+ EF+ + SLKE+L P +K     K+ 
Sbjct: 61  EIEILRNLYHENIVKYKGIC--TEDGGNGIK-LIMEFLPSGSLKEYL-PKNKNKINLKQQ 116
Query: 126 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
                       +D   +  Y+H D         L   NVL++ +   ++GDFGL + + 
Sbjct: 117 LKYAVQICK--GMDYLGSRQYVHRD---------LAARNVLVESEHQVKIGDFGLTKAIE 165
Query: 186 PTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
             +   +  D + S + + APE  + ++     DV+S+G+ L EL+
Sbjct: 166 TDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           ++     ++F+AE   +  +RH NL+++L     V+ +G  +  +V E+M   SL ++L 
Sbjct: 43  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLR 98
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
              +                   ++DV  A+ YL  +      H  L   NVL+ +D  A
Sbjct: 99  SRGRS--------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 147
Query: 174 RVGDFGLARFLPPTRTQTSSIDV-KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +V DFGL      T+  +S+ D  K  + + APE       ST  DV+S+GILL E+
Sbjct: 148 KVSDFGL------TKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 16/177 (9%)
Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
            ++  + E K L  +  R ++ +  A     ++      LV   M+   ++  +Y + ++
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 119 DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           +  ++ P              + S L +LH   Q    +  LKP NVLLDDD   R+ D 
Sbjct: 283 NPGFQEPRAIF------YTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           GLA  L   +T+T      G+ G++APE  +G E     D ++ G+ L E++    P
Sbjct: 334 GLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 16/177 (9%)
Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
            ++  + E K L  +  R ++ +  A     ++      LV   M+   ++  +Y + ++
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 119 DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           +  ++ P              + S L +LH   Q    +  LKP NVLLDDD   R+ D 
Sbjct: 283 NPGFQEPRAIF------YTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           GLA  L   +T+T      G+ G++APE  +G E     D ++ G+ L E++    P
Sbjct: 334 GLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 33/202 (16%)
Query: 44  ISAGTFGFSHLR-------------RQGAF--KSFIAECKALRNIRHRNLIKVLTACLGV 88
           I +G FG  HL              R+GA   + FI E + +  + H  L+++   CL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE- 73
Query: 89  DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLH 148
                    LV+EFM +  L ++L           +           + +DV   + YL 
Sbjct: 74  ----QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 149 HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG 208
              +    H  L   N L+ ++   +V DFG+ RF+   +  TSS   K  + + +PE  
Sbjct: 121 ---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 176
Query: 209 VGNEVSTIGDVYSYGILLLELM 230
             +  S+  DV+S+G+L+ E+ 
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVF 198

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 16/177 (9%)
Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
            ++  + E K L  +  R ++ +  A     ++      LV   M+   ++  +Y + ++
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 119 DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           +  ++ P              + S L +LH   Q    +  LKP NVLLDDD   R+ D 
Sbjct: 283 NPGFQEPRAIF------YTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           GLA  L   +T+T      G+ G++APE  +G E     D ++ G+ L E++    P
Sbjct: 334 GLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 16/177 (9%)
Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
            ++  + E K L  +  R ++ +  A     ++      LV   M+   ++  +Y + ++
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 119 DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           +  ++ P              + S L +LH   Q    +  LKP NVLLDDD   R+ D 
Sbjct: 283 NPGFQEPRAIF------YTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           GLA  L   +T+T      G+ G++APE  +G E     D ++ G+ L E++    P
Sbjct: 334 GLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 12/107 (11%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLL-----DDDMT---ARVGDFGLARFLPPTR 188
           A+ +A  +NYLH +      H  LK SN+L+     + D++    ++ DFGLAR      
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EW 166
Query: 189 TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
            +T+ +   G+  ++APE    +  S   DV+SYG+LL EL+  E P
Sbjct: 167 HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 32/174 (18%)
Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           + ++F+AE   ++ ++H  L+K+            +   ++ EFM   SL ++L    K 
Sbjct: 220 SVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYIITEFMAKGSLLDFL----KS 269
Query: 119 DETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
           DE  K+P          IA  +A     NY+H D         L+ +N+L+   +  ++ 
Sbjct: 270 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD---------LRAANILVSASLVCKIA 320
Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           DFGLAR           +  K  I + APE       +   DV+S+GILL+E++
Sbjct: 321 DFGLAR-----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 363

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M    L ++L     E  
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVMEYMSKGCLLDFL---KGEMG 108
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 105
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 106 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 155
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 156 SRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 105
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 106 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 155
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 156 SRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M    L ++L     E  
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGCLLDFL---KGEMG 108
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           LAR +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 107
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 108 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTAC-LGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           + F+ E   ++ I+H NL+++L  C L   +       +V E+M   +L ++L   ++E+
Sbjct: 73  EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFY------IVTEYMPYGNLLDYLRECNREE 126
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            T              +A  ++SA+ YL    +    H  L   N L+ ++   +V DFG
Sbjct: 127 VT--------AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFG 175
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           L+R +    T T+    K  I + APE    N  S   DV+++G+LL E+
Sbjct: 176 LSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 55  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 108
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 109 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 158
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 159 SRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 107
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 108 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 29/203 (14%)
Query: 40  EENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFK 96
           +E+ ++  T    +  RQ   + F++E   +    H N+I+   V+T  + V        
Sbjct: 41  KESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHPNIIRLEGVVTNSMPV-------- 90
Query: 97  ALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA 156
            ++ EFM N +L  +L      D  +               +   + ++Y+H D      
Sbjct: 91  MILTEFMENGALDSFL---RLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRD------ 141
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTR---TQTSSIDVKGSIGYIAPEYGVGNEV 213
              L   N+L++ ++  +V DFGL+RFL       T TSS+  K  I + APE     + 
Sbjct: 142 ---LAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKF 198
Query: 214 STIGDVYSYGILLLELM-IREKP 235
           ++  D +SYGI++ E+M   E+P
Sbjct: 199 TSASDAWSYGIVMWEVMSFGERP 221

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 20/173 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L     E  
Sbjct: 225 EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGEMG 275
Query: 121 TYKR-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 276 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 326
Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           L R +      T+    K  I + APE  +    +   DV+S+GILL EL  +
Sbjct: 327 LGRLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 378

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ EF+   SL+E+L    K  
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEFLPYGSLREYL---QKHK 111
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 112 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 162
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 222
Query: 234 KPSDIM 239
            P++ M
Sbjct: 223 PPAEFM 228

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 55  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 108
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 109 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 158
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 159 SRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++ SAL YLH        H  LKP N+LL++DM  ++ DFG A+ L P   Q  +    G
Sbjct: 117 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-----IREKPSDIMFEGDMNLHKFAKMA 253
           +  Y++PE           D+++ G ++ +L+      R     ++F+  + L       
Sbjct: 174 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 233
Query: 254 LSNHVKDIVDSILLNDDEK 272
                +D+V+ +L+ D  K
Sbjct: 234 FFPKARDLVEKLLVLDATK 252

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++ SAL YLH        H  LKP N+LL++DM  ++ DFG A+ L P   Q  +    G
Sbjct: 116 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-----IREKPSDIMFEGDMNLHKFAKMA 253
           +  Y++PE           D+++ G ++ +L+      R     ++F+  + L       
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 232
Query: 254 LSNHVKDIVDSILLNDDEK 272
                +D+V+ +L+ D  K
Sbjct: 233 FFPKARDLVEKLLVLDATK 251

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 107
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 108 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 112
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 113 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 112
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 113 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++ SAL YLH        H  LKP N+LL++DM  ++ DFG A+ L P   Q  +    G
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-----IREKPSDIMFEGDMNLHKFAKMA 253
           +  Y++PE           D+++ G ++ +L+      R     ++F+  + L       
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 253
Query: 254 LSNHVKDIVDSILLNDDEK 272
                +D+V+ +L+ D  K
Sbjct: 254 FFPKARDLVEKLLVLDATK 272

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 107
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 108 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++ SAL YLH        H  LKP N+LL++DM  ++ DFG A+ L P   Q  +    G
Sbjct: 115 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-----IREKPSDIMFEGDMNLHKFAKMA 253
           +  Y++PE           D+++ G ++ +L+      R     ++F+  + L       
Sbjct: 172 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 231
Query: 254 LSNHVKDIVDSILLNDDEK 272
                +D+V+ +L+ D  K
Sbjct: 232 FFPKARDLVEKLLVLDATK 250

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 109
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 110 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 159
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 160 SRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++ SAL YLH        H  LKP N+LL++DM  ++ DFG A+ L P   Q  +    G
Sbjct: 118 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-----IREKPSDIMFEGDMNLHKFAKMA 253
           +  Y++PE           D+++ G ++ +L+      R     ++F+  + L       
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 234
Query: 254 LSNHVKDIVDSILLNDDEK 272
                +D+V+ +L+ D  K
Sbjct: 235 FFPKARDLVEKLLVLDATK 253

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 11/178 (6%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           Q   + F++E   +++  H N+I++L  C+ +  QG     ++  FM    L  +L    
Sbjct: 77  QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR 136
Query: 117 KEDETYKRPXXXXXXXXXXIAI--DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
            E      P          IA+  +  S  N+LH D         L   N +L DDMT  
Sbjct: 137 LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD---------LAARNCMLRDDMTVC 187
Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           V DFGL++ +            K  + +IA E       ++  DV+++G+ + E+  R
Sbjct: 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 112
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 113 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 47/217 (21%)
Query: 41  ENLISAGTFG---FSHLRRQG------AFKS------------FIAECKALRNIRHRNLI 79
           E +I AG FG     HL+  G      A K+            F++E   +    H N+I
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 80  K---VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXI 136
               V+T    V         ++ EFM N SL  +L    + D  +              
Sbjct: 72  HLEGVVTKSTPV--------MIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAA 120
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL---PPTRTQTSS 193
            +   + +NY+H           L   N+L++ ++  +V DFGL+RFL       T TS+
Sbjct: 121 GMKYLADMNYVHR---------ALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 171
Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           +  K  I + APE     + ++  DV+SYGI++ E+M
Sbjct: 172 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 112
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 113 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 109
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 110 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 159
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 160 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 67  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 120
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 121 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 170
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 171 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 218

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 109
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 110 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 159
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 160 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 114 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 160
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 161 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 220
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 221 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 276

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++ SAL YLH        H  LKP N+LL++DM  ++ DFG A+ L P   Q  +    G
Sbjct: 122 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-----IREKPSDIMFEGDMNLHKFAKMA 253
           +  Y++PE           D+++ G ++ +L+      R     ++F+  + L       
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 238
Query: 254 LSNHVKDIVDSILLNDDEK 272
                +D+V+ +L+ D  K
Sbjct: 239 FFPKARDLVEKLLVLDATK 257

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 112
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 113 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 107
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 108 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 111
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 112 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 161
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 162 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 107
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 108 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++ SAL YLH        H  LKP N+LL++DM  ++ DFG A+ L P   Q  +    G
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-----IREKPSDIMFEGDMNLHKFAKMA 253
           +  Y++PE           D+++ G ++ +L+      R     ++F+  + L       
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 253
Query: 254 LSNHVKDIVDSILLNDDEK 272
                +D+V+ +L+ D  K
Sbjct: 254 FFPKARDLVEKLLVLDATK 272

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 105
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 106 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 155
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 156 SRLMT-GDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 118 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 164
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 165 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 224
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 225 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 280

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 113 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 159
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 275

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 113 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 159
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 275

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 111 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 157
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 273

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 114 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 160
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 161 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 220
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 221 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 276

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 113 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 159
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 275

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 111 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 157
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 273

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 111 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 157
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 273

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 111 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 157
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F+  + L            +D+V+ +L+ D  K
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 273

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 113 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 159
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F   + L            +D+V+ +L+ D  K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 275

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 18/176 (10%)
Query: 102 FMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLK 161
           +  N  L +++  I   DET  R              ++ SAL YLH        H  LK
Sbjct: 113 YAKNGELLKYIRKIGSFDETCTR----------FYTAEIVSALEYLHGKG---IIHRDLK 159
Query: 162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYS 221
           P N+LL++DM  ++ DFG A+ L P   Q  +    G+  Y++PE           D+++
Sbjct: 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWA 219
Query: 222 YGILLLELM-----IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            G ++ +L+      R     ++F   + L            +D+V+ +L+ D  K
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 275

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 314
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 315 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGL 364
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 365 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EFM   +L ++L   ++++ 
Sbjct: 300 EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 353
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                          +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 354 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGL 403
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           +R +    T T+    K  I + APE    N+ S   DV+++G+LL E+
Sbjct: 404 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 451

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT-RTQTSSIDVK 197
           D   ALN+ H +      H  +KP+N+++      +V DFG+AR +  +  + T +  V 
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 198 GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
           G+  Y++PE   G+ V    DVYS G +L E++  E P    F GD
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT-RTQTSSIDVK 197
           D   ALN+ H +      H  +KP+N+++      +V DFG+AR +  +  + T +  V 
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 198 GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
           G+  Y++PE   G+ V    DVYS G +L E++  E P    F GD
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT-RTQTSSIDVK 197
           D   ALN+ H +      H  +KP+N+++      +V DFG+AR +  +  + T +  V 
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 198 GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
           G+  Y++PE   G+ V    DVYS G +L E++  E P    F GD
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 12/108 (11%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTR---TQTSSID 195
           D   ALN+ H +      H  +KP+N+++      +V DFG+AR +  +    TQT++  
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-- 178
Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
           V G+  Y++PE   G+ V    DVYS G +L E++  E P    F GD
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT-RTQTSSIDVK 197
           D   ALN+ H +      H  +KP+N+++      +V DFG+AR +  +  + T +  V 
Sbjct: 141 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 197
Query: 198 GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
           G+  Y++PE   G+ V    DVYS G +L E++  E P    F GD
Sbjct: 198 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 239

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 15/153 (9%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTSSI 194
           A ++   L +LH        +  LK  N+LLD D   ++ DFG+ +   L   +T     
Sbjct: 125 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---- 177
Query: 195 DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNLHKF 249
           +  G+  YIAPE  +G + +   D +S+G+LL E++I + P      + +F      + F
Sbjct: 178 EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 237
Query: 250 AKMALSNHVKDIVDSILLNDDEK-LVVRGDQKQ 281
               L    KD++  + + + EK L VRGD +Q
Sbjct: 238 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 270

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 15/153 (9%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTSSI 194
           A ++   L +LH        +  LK  N+LLD D   ++ DFG+ +   L   +T     
Sbjct: 124 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC- 179
Query: 195 DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNLHKF 249
              G+  YIAPE  +G + +   D +S+G+LL E++I + P      + +F      + F
Sbjct: 180 ---GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 236
Query: 250 AKMALSNHVKDIVDSILLNDDEK-LVVRGDQKQ 281
               L    KD++  + + + EK L VRGD +Q
Sbjct: 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 53  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 106
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 107 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 157
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 158 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 217
Query: 234 KPSDIM 239
            P++ M
Sbjct: 218 PPAEFM 223

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 39/201 (19%)
Query: 90  YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHH 149
           Y+ + F  LV++ M    L ++L       E   R           I   +  A+++LH 
Sbjct: 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSLLEAVSFLHA 218
Query: 150 DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEY-- 207
           +      H  LKP N+LLDD+M  R+ DFG +  L P        ++ G+ GY+APE   
Sbjct: 219 NN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEILK 272
Query: 208 --------GVGNEVSTIGDVYSYGILLLELMIREKPS---------DIMFEGDMNLHKFA 250
                   G G EV    D+++ G++L  L+    P           ++ EG        
Sbjct: 273 CSMDETHPGYGKEV----DLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328
Query: 251 KMALSNHVKDIVDSILLNDDE 271
               S+ VKD++  +L  D E
Sbjct: 329 WDDRSSTVKDLISRLLQVDPE 349

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 126
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 127 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 177
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 237
Query: 234 KPSDIM 239
            P++ M
Sbjct: 238 PPAEFM 243

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 85/196 (43%), Gaps = 27/196 (13%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K + N+ H  L+++   C     Q   F  ++ E+M N  L  +L  +    +T 
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ 120
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +            +  DV  A+ YL         H  L   N L++D    +V DFGL+R
Sbjct: 121 Q---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           ++     +TSS+  K  + +  PE  + ++ S+  D++++G+L+ E         I   G
Sbjct: 169 YVLDDE-ETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE---------IYSLG 218
Query: 243 DMNLHKFAKMALSNHV 258
            M   +F     + H+
Sbjct: 219 KMPYERFTNSETAEHI 234

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 52  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 104
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H D         L+ +N+L+ D +
Sbjct: 105 ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTL 152
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 153 SCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 54  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 107
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 108 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 158
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 159 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 218
Query: 234 KPSDIM 239
            P++ M
Sbjct: 219 PPAEFM 224

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 55  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 108
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 159
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 234 KPSDIM 239
            P++ M
Sbjct: 220 PPAEFM 225

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 55  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 108
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 159
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 234 KPSDIM 239
            P++ M
Sbjct: 220 PPAEFM 225

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 54  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 106
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H D         L+ +N+L+ D +
Sbjct: 107 ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTL 154
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 155 SCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 46  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 98
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H D         L+ +N+L+ D +
Sbjct: 99  ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTL 146
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 147 SCKIADFGLARLIEDAEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 59  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 112
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 113 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 163
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 164 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 223
Query: 234 KPSDIM 239
            P++ M
Sbjct: 224 PPAEFM 229

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 86  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 139
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 190
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 191 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250
Query: 234 KPSDIM 239
            P++ M
Sbjct: 251 PPAEFM 256

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 60  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 113
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 114 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 164
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 165 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 224
Query: 234 KPSDIM 239
            P++ M
Sbjct: 225 PPAEFM 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 126
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 127 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 177
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 237
Query: 234 KPSDIM 239
            P++ M
Sbjct: 238 PPAEFM 243

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 55  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 107
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H D         L+ +N+L+ D +
Sbjct: 108 ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTL 155
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 156 SCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 213

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 20/177 (11%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 46  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLK 99
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
             S    T  +           +A       NY+H D         L+ +N+L+ D ++ 
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAF--IEERNYIHRD---------LRAANILVSDTLSC 148
Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 149 KIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 56  RQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPI 115
           + G  ++ + E K L+ + H N+I +L A     ++ N   +LV++FM        L  I
Sbjct: 52  KDGINRTALREIKLLQELSHPNIIGLLDA---FGHKSN--ISLVFDFMETD-----LEVI 101
Query: 116 SKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175
            K++     P          +       L YLH   Q    H  LKP+N+LLD++   ++
Sbjct: 102 IKDNSLVLTPSHIKAYMLMTL-----QGLEYLH---QHWILHRDLKPNNLLLDENGVLKL 153
Query: 176 GDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIRE 233
            DFGLA+ F  P R     +  +    Y APE   G  +  +G D+++ G +L EL++R 
Sbjct: 154 ADFGLAKSFGSPNRAYXHQVVTR---WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
Query: 234 KPSDIMFEGDMNLHKFAKM 252
                   GD +L +  ++
Sbjct: 211 P----FLPGDSDLDQLTRI 225

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 62  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 115
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 116 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 166
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 167 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 226
Query: 234 KPSDIM 239
            P++ M
Sbjct: 227 PPAEFM 232

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 111
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 112 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 162
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 222
Query: 234 KPSDIM 239
            P++ M
Sbjct: 223 PPAEFM 228

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 61  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 114
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 115 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 165
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 166 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 225
Query: 234 KPSDIM 239
            P++ M
Sbjct: 226 PPAEFM 231

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 20/177 (11%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 47  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLK 100
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
             S    T  +           +A       NY+H D         L+ +N+L+ D ++ 
Sbjct: 101 TPSGIKLTINKLLDMAAQIAEGMAF--IEERNYIHRD---------LRAANILVSDTLSC 149
Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 150 KIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 205

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 46  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 98
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H D         L+ +N+L+ D +
Sbjct: 99  ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTL 146
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 147 SCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 48  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 100
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H D         L+ +N+L+ D +
Sbjct: 101 ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTL 148
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 149 SCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 206

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 20/177 (11%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 41  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLK 94
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
             S    T  +           +A       NY+H D         L+ +N+L+ D ++ 
Sbjct: 95  TPSGIKLTINKLLDMAAQIAEGMAF--IEERNYIHRD---------LRAANILVSDTLSC 143
Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 144 KIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 199

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 56  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 108
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H D         L+ +N+L+ D +
Sbjct: 109 ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTL 156
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 157 SCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 214

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 13/115 (11%)
Query: 136 IAIDVASALNYLHHDC--------QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPT 187
           +A  ++  L+YLH D         +P  AH   K  NVLL  D+TA + DFGLA    P 
Sbjct: 117 VAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPG 176
Query: 188 RTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSD 237
           +    +    G+  Y+APE   G      +     D+Y+ G++L EL+ R K +D
Sbjct: 177 KPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 51  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 103
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H D         L+ +N+L+ D +
Sbjct: 104 ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTL 151
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 152 SCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 209

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 12/108 (11%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT---QTSSID 195
           D   ALN+ H +      H  +KP+N+L+      +V DFG+AR +  +     QT++  
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA-- 178
Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
           V G+  Y++PE   G+ V    DVYS G +L E++  E P    F GD
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 52  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 104
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H D         L+ +N+L+ D +
Sbjct: 105 ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTL 152
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 153 SCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 27/196 (13%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K + N+ H  L+++   C     Q   F  ++ E+M N  L  +L  +    +T 
Sbjct: 46  FIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ 100
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +            +  DV  A+ YL         H  L   N L++D    +V DFGL+R
Sbjct: 101 Q---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           ++      TSS+  K  + +  PE  + ++ S+  D++++G+L+ E         I   G
Sbjct: 149 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE---------IYSLG 198
Query: 243 DMNLHKFAKMALSNHV 258
            M   +F     + H+
Sbjct: 199 KMPYERFTNSETAEHI 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 81/201 (40%), Gaps = 36/201 (17%)
Query: 46  AGTFGFSHLRRQGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFMH 104
            G   FS    Q   ++ + E   LR +  H N+I+     L   Y+ N F  LV++ M 
Sbjct: 53  TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ-----LKDTYETNTFFFLVFDLMK 107
Query: 105 NRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSN 164
              L ++L     E  T                I     LN +H D         LKP N
Sbjct: 108 KGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKLNIVHRD---------LKPEN 154
Query: 165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEY----------GVGNEVS 214
           +LLDDDM  ++ DFG +  L P     S   V G+  Y+APE           G G EV 
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEKLRS---VCGTPSYLAPEIIECSMNDNHPGYGKEV- 210
Query: 215 TIGDVYSYGILLLELMIREKP 235
              D++S G+++  L+    P
Sbjct: 211 ---DMWSTGVIMYTLLAGSPP 228

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 20/177 (11%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 46  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLK 99
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
             S    T  +           +A       NY+H D         L+ +N+L+ D ++ 
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAF--IEERNYIHRD---------LRAANILVSDTLSC 148
Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 149 KIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 27/196 (13%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K + N+ H  L+++   C     Q   F  ++ E+M N  L  +L  +    +T 
Sbjct: 50  FIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ 104
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +            +  DV  A+ YL         H  L   N L++D    +V DFGL+R
Sbjct: 105 Q---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 152
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           ++      TSS+  K  + +  PE  + ++ S+  D++++G+L+ E         I   G
Sbjct: 153 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE---------IYSLG 202
Query: 243 DMNLHKFAKMALSNHV 258
            M   +F     + H+
Sbjct: 203 KMPYERFTNSETAEHI 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 86  LGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALN 145
           L   Y+  D   LV   M+   LK  +Y + +      R            A ++   L 
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR--------AVFYAAEICCGLE 300
Query: 146 YLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAP 205
            LH +      +  LKP N+LLDD    R+ D GLA  +P  +T    +   G++GY+AP
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAP 354
Query: 206 EYGVGNEVSTIG-DVYSYGILLLELMIREKP 235
           E  V NE  T   D ++ G LL E++  + P
Sbjct: 355 EV-VKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 27/196 (13%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K + N+ H  L+++   C     Q   F  ++ E+M N  L  +L  +    +T 
Sbjct: 51  FIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ 105
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +            +  DV  A+ YL         H  L   N L++D    +V DFGL+R
Sbjct: 106 Q---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           ++      TSS+  K  + +  PE  + ++ S+  D++++G+L+ E         I   G
Sbjct: 154 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE---------IYSLG 203
Query: 243 DMNLHKFAKMALSNHV 258
            M   +F     + H+
Sbjct: 204 KMPYERFTNSETAEHI 219

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 66/304 (21%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E K +R + H N++K +    GV Y+       + E++   +L+  +  +  +  
Sbjct: 52  RTFLKEVKVMRCLEHPNVLKFI----GVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYP 106
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
             +R            A D+AS + YLH        H  L   N L+ ++    V DFGL
Sbjct: 107 WSQR---------VSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGL 154
Query: 181 ARFLPPTRTQTSSI------------DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
           AR +   +TQ   +             V G+  ++APE   G       DV+S+GI+L E
Sbjct: 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214
Query: 229 LMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINI 288
           ++ R                         V    D +    D  L VRG   +       
Sbjct: 215 IIGR-------------------------VNADPDYLPRTMDFGLNVRGFLDRYCPP--- 246
Query: 289 IRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLATCKAVIGRATEQL 348
              C  S   I V C    P+ R     + H L++++  L G          +G   EQL
Sbjct: 247 --NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG-------HLPLGPQLEQL 297
Query: 349 NKYF 352
           ++ F
Sbjct: 298 DRGF 301

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 27/196 (13%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K + N+ H  L+++   C     Q   F  ++ E+M N  L  +L  +    +T 
Sbjct: 57  FIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ 111
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +            +  DV  A+ YL         H  L   N L++D    +V DFGL+R
Sbjct: 112 Q---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 159
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           ++      TSS+  K  + +  PE  + ++ S+  D++++G+L+ E         I   G
Sbjct: 160 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE---------IYSLG 209
Query: 243 DMNLHKFAKMALSNHV 258
            M   +F     + H+
Sbjct: 210 KMPYERFTNSETAEHI 225

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 86  LGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALN 145
           L   Y+  D   LV   M+   LK  +Y + +      R            A ++   L 
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR--------AVFYAAEICCGLE 300
Query: 146 YLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAP 205
            LH +      +  LKP N+LLDD    R+ D GLA  +P  +T    +   G++GY+AP
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAP 354
Query: 206 EYGVGNEVSTIG-DVYSYGILLLELMIREKP 235
           E  V NE  T   D ++ G LL E++  + P
Sbjct: 355 EV-VKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 27/196 (13%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K + N+ H  L+++   C     Q   F  ++ E+M N  L  +L  +    +T 
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ 120
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +            +  DV  A+ YL         H  L   N L++D    +V DFGL+R
Sbjct: 121 Q---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           ++      TSS+  K  + +  PE  + ++ S+  D++++G+L+ E         I   G
Sbjct: 169 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE---------IYSLG 218
Query: 243 DMNLHKFAKMALSNHV 258
            M   +F     + H+
Sbjct: 219 KMPYERFTNSETAEHI 234

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 27/192 (14%)
Query: 56  RQGAFKSFIAECKALRNIRHRNLIKVLTACLGVD----YQGNDFKALVY---EFMHNRSL 108
           R+ A +  + E KAL  + H  +++   A L  +     Q +  K  +Y   +     +L
Sbjct: 43  RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL 102
Query: 109 KEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168
           K+W+      +E  +            I + +A A+ +LH        H  LKPSN+   
Sbjct: 103 KDWMNGRCTIEERER-------SVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFT 152
Query: 169 DDMTARVGDFGLA----------RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGD 218
            D   +VGDFGL             L P           G+  Y++PE   GN  S   D
Sbjct: 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVD 212
Query: 219 VYSYGILLLELM 230
           ++S G++L EL+
Sbjct: 213 IFSLGLILFELL 224

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 72  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 122
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 123 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 176 FGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 81/201 (40%), Gaps = 36/201 (17%)
Query: 46  AGTFGFSHLRRQGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFMH 104
            G   FS    Q   ++ + E   LR +  H N+I+     L   Y+ N F  LV++ M 
Sbjct: 40  TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ-----LKDTYETNTFFFLVFDLMK 94
Query: 105 NRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSN 164
              L ++L     E  T                I     LN +H D         LKP N
Sbjct: 95  KGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKLNIVHRD---------LKPEN 141
Query: 165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEY----------GVGNEVS 214
           +LLDDDM  ++ DFG +  L P        +V G+  Y+APE           G G EV 
Sbjct: 142 ILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEV- 197
Query: 215 TIGDVYSYGILLLELMIREKP 235
              D++S G+++  L+    P
Sbjct: 198 ---DMWSTGVIMYTLLAGSPP 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 55  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 108
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 159
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219
Query: 234 KPSDIM 239
            P++ M
Sbjct: 220 PPAEFM 225

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 81/201 (40%), Gaps = 36/201 (17%)
Query: 46  AGTFGFSHLRRQGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFMH 104
            G   FS    Q   ++ + E   LR +  H N+I+     L   Y+ N F  LV++ M 
Sbjct: 53  TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ-----LKDTYETNTFFFLVFDLMK 107
Query: 105 NRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSN 164
              L ++L     E  T                I     LN +H D         LKP N
Sbjct: 108 KGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKLNIVHRD---------LKPEN 154
Query: 165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEY----------GVGNEVS 214
           +LLDDDM  ++ DFG +  L P        +V G+  Y+APE           G G EV 
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEV- 210
Query: 215 TIGDVYSYGILLLELMIREKP 235
              D++S G+++  L+    P
Sbjct: 211 ---DMWSTGVIMYTLLAGSPP 228

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 73  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 123
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 124 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 91  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 141
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 142 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 194
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 195 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 73  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 123
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 124 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 92  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 142
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 143 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 195
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 196 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 71  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 121
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 122 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 175 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 72  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 122
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 123 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 176 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 70  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 120
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 121 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 173
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 174 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 65  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 115
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 116 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 168
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 169 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 68  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 118
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + YL         H  L   N +LD+  T +V D
Sbjct: 119 RNETHN----PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 171
Query: 178 FGLAR--FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR  +     +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 26/180 (14%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F  EC  LR   H N++ VL AC            L+  +M   SL    Y +  E  
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGAC---QSPPAPHPTLITHWMPYGSL----YNVLHEGT 104
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV--GDF 178
            +              A+D+A  + +LH   +P+     L   +V++D+DMTAR+   D 
Sbjct: 105 NF----VVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADV 159
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST---IGDVYSYGILLLELMIREKP 235
             + F  P R    +        ++APE        T     D++S+ +LL EL+ RE P
Sbjct: 160 KFS-FQSPGRMYAPA--------WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/186 (22%), Positives = 82/186 (44%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L   ++  
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQAHAERI 114
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           +  K              ++      Y+H D         L   N+L++++   ++GDFG
Sbjct: 115 DHIK---LLQYTSQICKGMEYLGTKRYIHRD---------LATRNILVENENRVKIGDFG 162
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 222
Query: 234 KPSDIM 239
            P++ M
Sbjct: 223 PPAEFM 228

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 56  RQGAFK--SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +QG+    +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L 
Sbjct: 42  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFL- 94
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              K     K            IA  +A     NY+H +         L+ +N+L+ D +
Sbjct: 95  ---KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRN---------LRAANILVSDTL 142
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + ++ DFGLAR +      T+    K  I + APE       +   DV+S+GILL E++
Sbjct: 143 SCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 200

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/186 (22%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            + F  E + L++++H N++K    C      G     L+ E++   SL+++L    K  
Sbjct: 56  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 109
Query: 120 ETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
           E                 ++      Y+H +         L   N+L++++   ++GDFG
Sbjct: 110 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRN---------LATRNILVENENRVKIGDFG 160
Query: 180 LARFLPPTRTQTSSIDVKGS-IGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----RE 233
           L + LP  +      +   S I + APE    ++ S   DV+S+G++L EL       + 
Sbjct: 161 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 220
Query: 234 KPSDIM 239
            P++ M
Sbjct: 221 PPAEFM 226

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 26/175 (14%)
Query: 61  KSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           + F++E   +    H N+I    V+T C  V         ++ E+M N SL  +L    K
Sbjct: 54  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDAFL---RK 102
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            D  +               +   S ++Y+H D         L   N+L++ ++  +V D
Sbjct: 103 NDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRD---------LAARNILVNSNLVCKVSD 153
Query: 178 FGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           FG++R L   P    T+    K  I + APE     + ++  DV+SYGI++ E+M
Sbjct: 154 FGMSRVLEDDPEAAYTTR-GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 26/175 (14%)
Query: 61  KSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           + F++E   +    H N+I    V+T C  V         ++ E+M N SL  +L    K
Sbjct: 60  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDAFL---RK 108
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            D  +               +   S ++Y+H D         L   N+L++ ++  +V D
Sbjct: 109 NDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRD---------LAARNILVNSNLVCKVSD 159
Query: 178 FGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           FG++R L   P    T+    K  I + APE     + ++  DV+SYGI++ E+M
Sbjct: 160 FGMSRVLEDDPEAAYTTR-GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 213

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 84  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 131
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 132 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 179
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGLAR L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 180 INSNLVCKVSDFGLARVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 225 LLLELM 230
           +L E+M
Sbjct: 239 VLWEVM 244

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 83/196 (42%), Gaps = 27/196 (13%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K + N+ H  L+++   C     Q   F  ++ E+M N  L  +L  +    +T 
Sbjct: 51  FIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ 105
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +            +  DV  A+ YL         H  L   N L++D    +V DFGL+R
Sbjct: 106 Q---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
           ++      TSS   K  + +  PE  + ++ S+  D++++G+L+ E         I   G
Sbjct: 154 YVLDDEY-TSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE---------IYSLG 203
Query: 243 DMNLHKFAKMALSNHV 258
            M   +F     + H+
Sbjct: 204 KMPYERFTNSETAEHI 219

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 21/178 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F++E   +    H N+I++     GV  +G     +V E+M N SL  +L      D 
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLE----GVVTRGR-LAMIVTEYMENGSLDTFL---RTHDG 146
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
            +               +   S L Y+H D         L   NVL+D ++  +V DFGL
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRD---------LAARNVLVDSNLVCKVSDFGL 197
Query: 181 ARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE-LMIREKP 235
           +R L   P    T++   K  I + APE       S+  DV+S+G+++ E L   E+P
Sbjct: 198 SRVLEDDPDAAXTTT-GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 25/178 (14%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL--VYEFMHNRSLKEWLYPISKEDE 120
           F+ E   +    H N+I++           + +K +  + E+M N +L ++L    ++D 
Sbjct: 93  FLGEAGIMGQFSHHNIIRLEGVI-------SKYKPMMIITEYMENGALDKFL---REKDG 142
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
            +               +   + +NY+H D         L   N+L++ ++  +V DFGL
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYLANMNYVHRD---------LAARNILVNSNLVCKVSDFGL 193
Query: 181 ARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR-EKP 235
           +R L   P  T T+S   K  I + APE     + ++  DV+S+GI++ E+M   E+P
Sbjct: 194 SRVLEDDPEATYTTS-GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 74  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 124
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + +L         H  L   N +LD+  T +V D
Sbjct: 125 RNETHN----PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 178 FGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR +      +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 178 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 74  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 124
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + +L         H  L   N +LD+  T +V D
Sbjct: 125 RNETHN----PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 178 FGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR +      +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 178 FGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 78  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 128
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + +L         H  L   N +LD+  T +V D
Sbjct: 129 RNETHN----PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 181
Query: 178 FGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR +      +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 182 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 21/178 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F++E   +    H N+I++     GV  +G     +V E+M N SL  +L      D 
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLE----GVVTRGR-LAMIVTEYMENGSLDTFL---RTHDG 146
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
            +               +   S L Y+H D         L   NVL+D ++  +V DFGL
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRD---------LAARNVLVDSNLVCKVSDFGL 197
Query: 181 ARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE-LMIREKP 235
           +R L   P    T++   K  I + APE       S+  DV+S+G+++ E L   E+P
Sbjct: 198 SRVLEDDPDAAYTTT-GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 71  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 121
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + +L         H  L   N +LD+  T +V D
Sbjct: 122 RNETHN----PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 178 FGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR +      +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 175 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 13/138 (9%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           A +V  AL YLH        +  LKP N+LLD +   ++ DFG A+++P       +  +
Sbjct: 112 AAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYXL 163
Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP---SDIM--FEGDMNLHKFAK 251
            G+  YIAPE       +   D +S+GIL+ E++    P   S+ M  +E  +N      
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP 223
Query: 252 MALSNHVKDIVDSILLND 269
              +  VKD++  ++  D
Sbjct: 224 PFFNEDVKDLLSRLITRD 241

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 73  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 123
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + +L         H  L   N +LD+  T +V D
Sbjct: 124 RNETHN----PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 178 FGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR +      +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 73  GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 123
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + +L         H  L   N +LD+  T +V D
Sbjct: 124 RNETHN----PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 178 FGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR +      +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           G    F+ E   +++  H N++ +L  CL    +      +V  +M +  L+ ++     
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFI----- 182
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            +ET+               + VA  + +L         H  L   N +LD+  T +V D
Sbjct: 183 RNETHN----PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 178 FGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           FGLAR +      +  +    K  + ++A E     + +T  DV+S+G+LL ELM R  P
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 83/192 (43%), Gaps = 31/192 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 72  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 119
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 120 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 167
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 168 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 226
Query: 225 LLLELM-IREKP 235
           +L E+M   E+P
Sbjct: 227 VLWEVMSYGERP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 55  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 102
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 103 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 150
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 151 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 209
Query: 225 LLLELM 230
           +L E+M
Sbjct: 210 VLWEVM 215

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G +  ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 57/115 (49%), Gaps = 10/115 (8%)
Query: 138 IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK 197
           + + SAL ++H        H  +KP+NV +      ++GD GL RF   +   T++  + 
Sbjct: 143 VQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 197
Query: 198 GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MNLHKFAK 251
           G+  Y++PE    N  +   D++S G LL E+   + P    F GD MNL+   K
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 248

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 41/210 (19%)
Query: 136 IAIDVASALNYLHHDC-------QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTR 188
           IA  +A  L YLH D        +P  +H  +K  NVLL +++TA + DFGLA      +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 189 TQTSSIDVKGSIG---YIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSD--- 237
              S+ D  G +G   Y+APE   G      +     D+Y+ G++L EL  R   +D   
Sbjct: 186 ---SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 238 ----IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINI----I 289
               + FE ++  H          ++D+   ++++  ++ V+R D  Q  A + +    I
Sbjct: 243 DEYMLPFEEEIGQHP--------SLEDM-QEVVVHKKKRPVLR-DYWQKHAGMAMLCETI 292
Query: 290 RECV--ISMVRIGVACSMESPQDRMKMTNV 317
            EC    +  R+   C  E      ++TN+
Sbjct: 293 EECWDHDAEARLSAGCVGERITQMQRLTNI 322

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 84  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 131
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 132 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 179
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 225 LLLELM 230
           +L E+M
Sbjct: 239 VLWEVM 244

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 50  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 101
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 102 SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 152
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G +  ST  D++S G +  E++ R  
Sbjct: 153 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA 209
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 210 ----LFPGDSEIDQLFRI 223

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 48/105 (45%), Gaps = 13/105 (12%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA----------RFLP 185
           I I +A A+ +LH        H  LKPSN+    D   +VGDFGL             L 
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 186 PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           P     +     G+  Y++PE   GN  S   D++S G++L EL+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           +   ++Y+H        H  LKPSN+ L D    ++GDFGL   L     +T S   KG+
Sbjct: 145 ITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS---KGT 198
Query: 200 IGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           + Y++PE     +     D+Y+ G++L EL+
Sbjct: 199 LRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 93
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 94  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 144
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 145 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 202 ----LFPGDSEIDQLFRI 215

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 84  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 131
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 132 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 179
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 225 LLLELM 230
           +L E+M
Sbjct: 239 VLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 84  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 131
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 132 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 179
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 225 LLLELM 230
           +L E+M
Sbjct: 239 VLWEVM 244

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 93
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 94  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 144
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 145 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 202 ----LFPGDSEIDQLFRI 215

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 93
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 94  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 144
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 145 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 202 ----LFPGDSEIDQLFRI 215

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 82  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 129
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 130 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 177
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 178 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 236
Query: 225 LLLELM 230
           +L E+M
Sbjct: 237 VLWEVM 242

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 84  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 131
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 132 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 179
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 180 INSNLVCKVSDFGLGRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 225 LLLELM 230
           +L E+M
Sbjct: 239 VLWEVM 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 84  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 131
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 132 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 179
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 225 LLLELM 230
           +L E+M
Sbjct: 239 VLWEVM 244

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 95
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 96  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 146
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 147 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 203
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 204 ----LFPGDSEIDQLFRI 217

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 47  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 98
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 99  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 149
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 150 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 206
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 207 ----LFPGDSEIDQLFRI 220

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 78/179 (43%), Gaps = 11/179 (6%)
Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PI 115
           A K F  E + L N++H +++K    C+       D   +V+E+M +  L ++L    P 
Sbjct: 58  ARKDFHREAELLTNLQHEHIVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPD 112
Query: 116 SKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175
           +        P          IA  +A+ + YL         H  L   N L+ +++  ++
Sbjct: 113 AVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKI 169
Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK 234
           GDFG++R +  T            I ++ PE  +  + +T  DV+S G++L E+    K
Sbjct: 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 50  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 101
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 102 SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 152
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT T  +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 153 DFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 209
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 210 ----LFPGDSEIDQLFRI 223

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 20/167 (11%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + LR + H +++K    C   + QG     LV E++   SL+++L            P
Sbjct: 61  EIEILRTLYHEHIVKYKGCC---EDQGEKSVQLVMEYVPLGSLRDYL------------P 105
Query: 126 XXXXXXXXXXI-AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184
                     + A  +   + YLH        H  L   NVLLD+D   ++GDFGLA+ +
Sbjct: 106 RHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV 162
Query: 185 PPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           P          D    + + APE     +     DV+S+G+ L EL+
Sbjct: 163 PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 20/167 (11%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + LR + H +++K    C   + QG     LV E++   SL+++L            P
Sbjct: 60  EIEILRTLYHEHIVKYKGCC---EDQGEKSVQLVMEYVPLGSLRDYL------------P 104
Query: 126 XXXXXXXXXXI-AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184
                     + A  +   + YLH        H  L   NVLLD+D   ++GDFGLA+ +
Sbjct: 105 RHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV 161
Query: 185 PPTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           P          D    + + APE     +     DV+S+G+ L EL+
Sbjct: 162 PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 25/192 (13%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL---YPISKEDE 120
           +A  + L    H N+++++  C            LV+E + ++ L+ +L    P     E
Sbjct: 54  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAE 112
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
           T K            +       L++LH +C     H  LKP N+L+    T ++ DFGL
Sbjct: 113 TIK-----------DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 158
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR       Q +   V  ++ Y APE  + +  +T  D++S G +  E M R KP   +F
Sbjct: 159 ARIY---SYQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE-MFRRKP---LF 211
Query: 241 EGDMNLHKFAKM 252
            G+    +  K+
Sbjct: 212 CGNSEADQLGKI 223

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 25/192 (13%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL---YPISKEDE 120
           +A  + L    H N+++++  C            LV+E + ++ L+ +L    P     E
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAE 120
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
           T K            +       L++LH +C     H  LKP N+L+    T ++ DFGL
Sbjct: 121 TIK-----------DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 166
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR       Q +   V  ++ Y APE  + +  +T  D++S G +  E M R KP   +F
Sbjct: 167 ARIY---SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE-MFRRKP---LF 219
Query: 241 EGDMNLHKFAKM 252
            G+    +  K+
Sbjct: 220 CGNSEADQLGKI 231

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 44/239 (18%)
Query: 21  IEVGKLKNLEILD------VSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRN-- 72
           +++  LK LE++       V +  L+E  ++   F F++  RQ    +FI E    R   
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN--RQ----NFINEKNIYRVPL 63
Query: 73  IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXX 132
           + H N+ + +     V   G     LV E+  N SL ++L   + +  +  R        
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR-------- 115
Query: 133 XXXIAIDVASALNYLHHDC------QPVTAHCVLKPSNVLLDDDMTARVGDFGLA----- 181
              +A  V   L YLH +       +P  +H  L   NVL+ +D T  + DFGL+     
Sbjct: 116 ---LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 182 -RFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIG--DVYSYGILLLELMIR 232
            R + P     ++I   G+I Y+APE   G     +  S +   D+Y+ G++  E+ +R
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 69/166 (41%), Gaps = 18/166 (10%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   LR + H ++IK    C   + QG     LV E++   SL+++L   S         
Sbjct: 66  EIDILRTLYHEHIIKYKGCC---EDQGEKSLQLVMEYVPLGSLRDYLPRHS--------- 113
Query: 126 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
                      A  +   + YLH        H  L   NVLLD+D   ++GDFGLA+ +P
Sbjct: 114 --IGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP 168
Query: 186 PTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
                     D    + + APE     +     DV+S+G+ L EL+
Sbjct: 169 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 25/192 (13%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL---YPISKEDE 120
           +A  + L    H N+++++  C            LV+E + ++ L+ +L    P     E
Sbjct: 54  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAE 112
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
           T K            +       L++LH +C     H  LKP N+L+    T ++ DFGL
Sbjct: 113 TIK-----------DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 158
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR       Q +   V  ++ Y APE  + +  +T  D++S G +  E M R KP   +F
Sbjct: 159 ARIY---SYQMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE-MFRRKP---LF 211
Query: 241 EGDMNLHKFAKM 252
            G+    +  K+
Sbjct: 212 CGNSEADQLGKI 223

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 21/149 (14%)
Query: 90  YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHH 149
           ++ +DF  +V E    RSL E           +KR                   + YLH+
Sbjct: 95  FEDDDFVYVVLEICRRRSLLEL----------HKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 150 DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ---TSSIDVKGSIGYIAPE 206
           +      H  LK  N+ L+DDM  ++GDFGLA     T+ +       D+ G+  YIAPE
Sbjct: 145 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPE 196
Query: 207 YGVGNEVSTIGDVYSYGILLLELMIREKP 235
                  S   D++S G +L  L++ + P
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 69/166 (41%), Gaps = 18/166 (10%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   LR + H ++IK    C   + QG     LV E++   SL+++L   S         
Sbjct: 66  EIDILRTLYHEHIIKYKGCC---EDQGEKSLQLVMEYVPLGSLRDYLPRHS--------- 113
Query: 126 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
                      A  +   + YLH        H  L   NVLLD+D   ++GDFGLA+ +P
Sbjct: 114 --IGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP 168
Query: 186 PTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
                     D    + + APE     +     DV+S+G+ L EL+
Sbjct: 169 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E+M N 
Sbjct: 84  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENG 131
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + ++H D         L   N+L
Sbjct: 132 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRD---------LAARNIL 179
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 225 LLLELM 230
           +L E+M
Sbjct: 239 VLWEVM 244

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 14/183 (7%)
Query: 58  GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP--- 114
            A K F  E + L N++H +++K    C        D   +V+E+M +  L ++L     
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVC-----GDGDPLIMVFEYMKHGDLNKFLRAHGP 113
Query: 115 ---ISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              I  + +  +            IA  +AS + YL         H  L   N L+  ++
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANL 170
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
             ++GDFG++R +  T            I ++ PE  +  + +T  DV+S+G++L E+  
Sbjct: 171 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
Query: 232 REK 234
             K
Sbjct: 231 YGK 233

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 21/149 (14%)
Query: 90  YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHH 149
           ++ +DF  +V E    RSL E           +KR                   + YLH+
Sbjct: 111 FEDDDFVYVVLEICRRRSLLEL----------HKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 150 DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ---TSSIDVKGSIGYIAPE 206
           +      H  LK  N+ L+DDM  ++GDFGLA     T+ +       D+ G+  YIAPE
Sbjct: 161 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPE 212
Query: 207 YGVGNEVSTIGDVYSYGILLLELMIREKP 235
                  S   D++S G +L  L++ + P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E M N 
Sbjct: 55  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEXMENG 102
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 103 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 150
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 151 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 209
Query: 225 LLLELM 230
           +L E+M
Sbjct: 210 VLWEVM 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 37/193 (19%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTA-----CLGVDYQGNDFKALVYEFMHNRSLKEW 111
           +G   + I E   L+ + H N++ ++       CL           LV+EFM  + LK+ 
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL----------TLVFEFM-EKDLKK- 107
Query: 112 LYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              +  E++T              I I +   L  + H  Q    H  LKP N+L++ D 
Sbjct: 108 ---VLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG 156
Query: 172 TARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLEL 229
             ++ DFGLAR F  P R+ T  +    ++ Y AP+  +G+ + ST  D++S G +  E 
Sbjct: 157 ALKLADFGLARAFGIPVRSYTHEV---VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE- 212
Query: 230 MIREKPSDIMFEG 242
           MI  KP   +F G
Sbjct: 213 MITGKP---LFPG 222

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 37/193 (19%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTA-----CLGVDYQGNDFKALVYEFMHNRSLKEW 111
           +G   + I E   L+ + H N++ ++       CL           LV+EFM  + LK+ 
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL----------TLVFEFM-EKDLKK- 107
Query: 112 LYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              +  E++T              I I +   L  + H  Q    H  LKP N+L++ D 
Sbjct: 108 ---VLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG 156
Query: 172 TARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLEL 229
             ++ DFGLAR F  P R+ T  +    ++ Y AP+  +G+ + ST  D++S G +  E 
Sbjct: 157 ALKLADFGLARAFGIPVRSYTHEV---VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE- 212
Query: 230 MIREKPSDIMFEG 242
           MI  KP   +F G
Sbjct: 213 MITGKP---LFPG 222

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKDFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPENLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E M N 
Sbjct: 84  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEXMENG 131
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 132 SLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNIL 179
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 225 LLLELM 230
           +L E+M
Sbjct: 239 VLWEVM 244

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 30/177 (16%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+  RH ++IK+      V     DF  +V E++    L +++    + +E   R 
Sbjct: 61  EIQNLKLFRHPHIIKLYQ----VISTPTDF-FMVMEYVSGGELFDYICKHGRVEEMEAR- 114
Query: 126 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
                     +   + SA++Y H   + +  H  LKP NVLLD  M A++ DFGL+  + 
Sbjct: 115 ---------RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162
Query: 186 PTRTQTSSIDVKGSIGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
                 +S    GS  Y APE        G EV    D++S G++L  L+    P D
Sbjct: 163 DGEFLRTSC---GSPNYAAPEVISGRLYAGPEV----DIWSCGVILYALLCGTLPFD 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 26/175 (14%)
Query: 61  KSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
           + F++E   +    H N+I    V+T C  V         ++ E+M N SL  +L    K
Sbjct: 75  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDAFL---RK 123
Query: 118 EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
            D  +               +   S ++ +H D         L   N+L++ ++  +V D
Sbjct: 124 NDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRD---------LAARNILVNSNLVCKVSD 174
Query: 178 FGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           FG++R L   P    T+    K  I + APE     + ++  DV+SYGI++ E+M
Sbjct: 175 FGMSRVLEDDPEAAYTTR-GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 25/192 (13%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL---YPISKEDE 120
           +A  + L    H N+++++  C            LV+E + ++ L+ +L    P     E
Sbjct: 54  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAE 112
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
           T K            +       L++LH +C     H  LKP N+L+    T ++ DFGL
Sbjct: 113 TIK-----------DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 158
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR       Q +   V  ++ Y APE  + +  +T  D++S G +  E M R KP   +F
Sbjct: 159 ARIY---SYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE-MFRRKP---LF 211
Query: 241 EGDMNLHKFAKM 252
            G+    +  K+
Sbjct: 212 CGNSEADQLGKI 223

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 93
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 94  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 144
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 145 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 202 ----LFPGDSEIDQLFRI 215

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 95
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 96  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 146
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 147 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 203
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 204 ----LFPGDSEIDQLFRI 217

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 93
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 94  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 144
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 145 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 202 ----LFPGDSEIDQLFRI 215

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 95
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 96  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPENLLINTEGAIKLA 146
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 147 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 203
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 204 ----LFPGDSEIDQLFRI 217

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLD----VIHTENKL-YLVFEFLH-QDLKKFM--DA 97
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 98  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 148
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 149 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 205
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 206 ----LFPGDSEIDQLFRI 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 47  EGVPSTAIREISLLKELNHPNIVKLLD----VIHTENKL-YLVFEFLH-QDLKKFM--DA 98
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 99  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 149
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 150 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 206
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 207 ----LFPGDSEIDQLFRI 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 97
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 98  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 148
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 149 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 205
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 206 ----LFPGDSEIDQLFRI 219

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 96
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 97  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 147
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 148 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 204
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 205 ----LFPGDSEIDQLFRI 218

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 18/172 (10%)
Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           +F++      A+ ++ H +++++L  C G   Q      LV +++   SL          
Sbjct: 76  SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLL--------- 120
Query: 119 DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           D   +              + +A  + YL         H  L   NVLL      +V DF
Sbjct: 121 DHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADF 177
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           G+A  LPP   Q    + K  I ++A E     + +   DV+SYG+ + ELM
Sbjct: 178 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 96
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 97  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 147
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 148 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 204
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 205 ----LFPGDSEIDQLFRI 218

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I    V+T    V         +V E+M N 
Sbjct: 61  GYTEKQR----RDFLGEASIMGQFDHPNIIHLEGVVTKSKPV--------MIVTEYMENG 108
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +               +   S + Y+H D         L   N+L
Sbjct: 109 SLDTFL---KKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRD---------LAARNIL 156
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + APE     + ++  DV+SYGI
Sbjct: 157 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTAPEAIAFRKFTSASDVWSYGI 215
Query: 225 LLLELM 230
           ++ E++
Sbjct: 216 VMWEVV 221

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 96
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 97  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPENLLINTEGAIKLA 147
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 148 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 204
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 205 ----LFPGDSEIDQLFRI 218

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 94
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 95  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 145
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 146 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 202
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 203 ----LFPGDSEIDQLFRI 216

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 60  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 114
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 115 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 171
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 172 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 225

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK+++   +
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLL----DVIHTENKL-YLVFEFLH-QDLKKFM--DA 95
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 96  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 146
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 147 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 203
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 204 ----LFPGDSEIDQLFRI 217

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 18/172 (10%)
Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           +F++      A+ ++ H +++++L  C G   Q      LV +++   SL          
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLL--------- 102
Query: 119 DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           D   +              + +A  + YL         H  L   NVLL      +V DF
Sbjct: 103 DHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADF 159
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           G+A  LPP   Q    + K  I ++A E     + +   DV+SYG+ + ELM
Sbjct: 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/175 (22%), Positives = 73/175 (41%), Gaps = 12/175 (6%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGN-DFKALVYEFMHNRSLKEWLYPISKED 119
           + F+ E   ++   H ++ K++   L    +G      ++  FM +  L  +L      +
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 120 ETYKRPXXXXXXXXXXIA--IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
             +  P          IA  ++  S+ N++H D         L   N +L +DMT  V D
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRD---------LAARNCMLAEDMTVCVAD 180
Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           FGL+R +            K  + ++A E    N  +   DV+++G+ + E+M R
Sbjct: 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 30/177 (16%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+  RH ++IK+      V     DF  +V E++    L +++    + +E   R 
Sbjct: 61  EIQNLKLFRHPHIIKLYQ----VISTPTDF-FMVMEYVSGGELFDYICKHGRVEEMEAR- 114
Query: 126 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
                     +   + SA++Y H   + +  H  LKP NVLLD  M A++ DFGL+  + 
Sbjct: 115 ---------RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162
Query: 186 PTRTQTSSIDVKGSIGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
                  S    GS  Y APE        G EV    D++S G++L  L+    P D
Sbjct: 163 DGEFLRDSC---GSPNYAAPEVISGRLYAGPEV----DIWSCGVILYALLCGTLPFD 212

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 69  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 123
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 124 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 181 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 234

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 25/176 (14%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDY-----QGNDFKA------LVYEFMHNRSLKEWLYP 114
           E KAL  + H N++       G DY       N  ++      +  EF    +L++W+  
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 115 ISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                   +R           +   +   ++Y+H        +  LKPSN+ L D    +
Sbjct: 114 --------RRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK 162
Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           +GDFGL   L     +  S   KG++ Y++PE     +     D+Y+ G++L EL+
Sbjct: 163 IGDFGLVTSLKNDGKRXRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 24/183 (13%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLK 109
           G++  +R    + F+ E   +    H N++ +     GV  +G     +V EFM N +L 
Sbjct: 82  GYTEKQR----RDFLCEASIMGQFDHPNVVHLE----GVVTRGKPV-MIVIEFMENGALD 132
Query: 110 EWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169
            +L    K D  +               +   + + Y+H D         L   N+L++ 
Sbjct: 133 AFL---RKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRD---------LAARNILVNS 180
Query: 170 DMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLL 227
           ++  +V DFGL+R +   P    T++   K  + + APE     + ++  DV+SYGI++ 
Sbjct: 181 NLVCKVSDFGLSRVIEDDPEAVYTTT-GGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMW 239
Query: 228 ELM 230
           E+M
Sbjct: 240 EVM 242

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 63/149 (42%), Gaps = 21/149 (14%)
Query: 90  YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHH 149
           ++ +DF  +V E    RSL E           +KR                   + YLH+
Sbjct: 111 FEDDDFVYVVLEICRRRSLLEL----------HKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 150 DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK---GSIGYIAPE 206
           +      H  LK  N+ L+DDM  ++GDFGLA     T+ +      K   G+  YIAPE
Sbjct: 161 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKTLCGTPNYIAPE 212
Query: 207 YGVGNEVSTIGDVYSYGILLLELMIREKP 235
                  S   D++S G +L  L++ + P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 22/188 (11%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   ++ ++H N++++      V +  N    LV+EFM N  LK+++    
Sbjct: 44  EGTPSTAIREISLMKELKHENIVRLYD----VIHTENKL-TLVFEFMDN-DLKKYM---- 93
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P              +   L + H +      H  LKP N+L++     ++G
Sbjct: 94  DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLG 150
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREK 234
           DFGLAR F  P  T +S +    ++ Y AP+  +G+   ST  D++S G +L E MI  K
Sbjct: 151 DFGLARAFGIPVNTFSSEVV---TLWYRAPDVLMGSRTYSTSIDIWSCGCILAE-MITGK 206
Query: 235 PSDIMFEG 242
           P   +F G
Sbjct: 207 P---LFPG 211

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 63/149 (42%), Gaps = 21/149 (14%)
Query: 90  YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHH 149
           ++ +DF  +V E    RSL E           +KR                   + YLH+
Sbjct: 111 FEDDDFVYVVLEICRRRSLLEL----------HKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 150 DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK---GSIGYIAPE 206
           +      H  LK  N+ L+DDM  ++GDFGLA     T+ +      K   G+  YIAPE
Sbjct: 161 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKXLCGTPNYIAPE 212
Query: 207 YGVGNEVSTIGDVYSYGILLLELMIREKP 235
                  S   D++S G +L  L++ + P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 26/198 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ + H N++K+L     V +  N    LV+EF+H + LK ++   +
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLD----VIHTENKL-YLVFEFLH-QDLKTFM--DA 97
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                   P            +    +   LH D         LKP N+L++ +   ++ 
Sbjct: 98  SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLA 148
Query: 177 DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK 234
           DFGLAR F  P RT    +    ++ Y APE  +G    ST  D++S G +  E++ R  
Sbjct: 149 DFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 205
Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F GD  + +  ++
Sbjct: 206 ----LFPGDSEIDQLFRI 219

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVS 214
           H  LKP N+L++ +   ++ DFGLAR F  P RT T  +    ++ Y APE  +G    S
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYS 181
Query: 215 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
           T  D++S G +  E++ R      +F GD  + +  ++
Sbjct: 182 TAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRI 215

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 5/107 (4%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           + +++ ALNYLH   +    +  LK  NVLLD +   ++ D+G+ +     R   ++   
Sbjct: 127 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXF 181
Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
            G+  YIAPE   G +     D ++ G+L+ E+M    P DI+   D
Sbjct: 182 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 228

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSID 195
           + +++ ALNYLH        +  LK  NVLLD +   ++ D+G+ +  L P  T ++   
Sbjct: 159 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC- 214
Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
             G+  YIAPE   G +     D ++ G+L+ E+M    P DI+   D
Sbjct: 215 --GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 78/176 (44%), Gaps = 21/176 (11%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E   ++ ++H  L+++            +   ++ EFM   SL ++L    K DE
Sbjct: 52  QAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYIITEFMAKGSLLDFL----KSDE 102
Query: 121 TYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
             K            IA  +A     NY+H D         L+ +NVL+ + +  ++ DF
Sbjct: 103 GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD---------LRAANVLVSESLMCKIADF 153
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK 234
           GLAR +      T+    K  I + APE       +   +V+S+GILL E++   K
Sbjct: 154 GLARVIEDNE-YTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGK 208

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           + +++ ALNYLH        +  LK  NVLLD +   ++ D+G+ +     R   ++   
Sbjct: 112 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXF 166
Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
            G+  YIAPE   G +     D ++ G+L+ E+M    P DI+   D
Sbjct: 167 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 24/187 (12%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E   ++ ++H  L+++            +   ++ E+M   SL ++L    K DE
Sbjct: 53  QAFLEEANLMKTLQHDKLVRLYAVV-----TREEPIYIITEYMAKGSLLDFL----KSDE 103
Query: 121 TYKRPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
             K            IA  +A     NY+H D         L+ +NVL+ + +  ++ DF
Sbjct: 104 GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD---------LRAANVLVSESLMCKIADF 154
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238
           GLAR +      T+    K  I + APE       +   DV+S+GILL E++   K   I
Sbjct: 155 GLARVIEDNE-YTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGK---I 210
Query: 239 MFEGDMN 245
            + G  N
Sbjct: 211 PYPGRTN 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 18/105 (17%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL--------PPTR 188
           A+ V    N +H D         LKPSN+L++ +   +V DFGLAR +         PT 
Sbjct: 124 AVKVLHGSNVIHRD---------LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 189 TQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIR 232
            Q+  ++   +  Y APE  + + + S   DV+S G +L EL +R
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  +G     +V E M +  LK +L  +  E E  
Sbjct: 64  FLNEASVMKGFTCHHVVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENN 118
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+        H  L   N ++  D T ++GDFG+ R
Sbjct: 119 PGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKP 235
            +  T            + ++APE       +T  D++S+G++L E+  + E+P
Sbjct: 176 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 229

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 60  FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PI 115
               I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P 
Sbjct: 77  LSDLISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPP 131
Query: 116 SKE---DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDD 169
             E   + ++              A  VA  + YL       +  C+   L   NVL+ +
Sbjct: 132 GLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTE 185
Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           D   ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+
Sbjct: 186 DNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           + +++ ALNYLH        +  LK  NVLLD +   ++ D+G+ +     R   ++   
Sbjct: 116 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXF 170
Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
            G+  YIAPE   G +     D ++ G+L+ E+M    P DI+   D
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  +G     +V E M +  LK +L  +  E E  
Sbjct: 67  FLNEASVMKGFTCHHVVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENN 121
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+        H  L   N ++  D T ++GDFG+ R
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKP 235
            +  T            + ++APE       +T  D++S+G++L E+  + E+P
Sbjct: 179 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  +G     +V E M +  LK +L  +  E E  
Sbjct: 67  FLNEASVMKGFTCHHVVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENN 121
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+        H  L   N ++  D T ++GDFG+ R
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKP 235
            +  T            + ++APE       +T  D++S+G++L E+  + E+P
Sbjct: 179 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 62  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 116
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 117 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 173
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 174 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 227

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 7/99 (7%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           + S ++Y H   + +  H  LKP NVLLD  M A++ DFGL+  +        S    GS
Sbjct: 125 ILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GS 178
Query: 200 IGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
             Y APE   G   +    D++S G++L  L+    P D
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 82/186 (44%), Gaps = 30/186 (16%)
Query: 50  GFSHLRRQGAFKSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFMHNR 106
           G++  +R    + F+ E   +    H N+I+   V+T    V         +V E M N 
Sbjct: 84  GYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEXMENG 131
Query: 107 SLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVL 166
           SL  +L    K D  +             +   +AS + YL  D   V  H  L   N+L
Sbjct: 132 SLDSFL---RKHDAQF------TVIQLVGMLRGIASGMKYLS-DMGAV--HRDLAARNIL 179
Query: 167 LDDDMTARVGDFGLARFLP--PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           ++ ++  +V DFGL+R L   P    T+    K  I + +PE     + ++  DV+SYGI
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTR-GGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 225 LLLELM 230
           +L E+M
Sbjct: 239 VLWEVM 244

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 22/196 (11%)
Query: 75  HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXX 134
           HR+L           ++ NDF  +V E    RSL E           +KR          
Sbjct: 93  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL----------HKRRKALTEPEAR 142
Query: 135 XIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI 194
                +     YLH +      H  LK  N+ L++D+  ++GDFGLA     T+ +    
Sbjct: 143 YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGE 194
Query: 195 DVK---GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH-KFA 250
             K   G+  YIAPE       S   DV+S G ++  L++ + P +     +  L  K  
Sbjct: 195 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 254
Query: 251 KMALSNHVKDIVDSIL 266
           + ++  H+  +  S++
Sbjct: 255 EYSIPKHINPVAASLI 270

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 58/107 (54%), Gaps = 11/107 (10%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           IA+ +  AL +LH     +  H  +KPSNVL++     ++ DFG++ +L  +  +T  ID
Sbjct: 158 IAVSIVKALEHLHSKLSVI--HRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKT--ID 213
Query: 196 VKGSIGYIAPEYGVGNEVSTIG-----DVYSYGILLLELMIREKPSD 237
             G   Y+APE  +  E++  G     D++S GI ++EL I   P D
Sbjct: 214 A-GCKPYMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 66  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 120
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 121 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 231

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 21/173 (12%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE---- 118
            ++E   LR ++H N+++     +    + N    +V E+     L   +   +KE    
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 119 DETYKRPXXXXXXXXXXIAIDVASALNYLHH--DCQPVTAHCVLKPSNVLLDDDMTARVG 176
           DE +             +   +  AL   H   D      H  LKP+NV LD     ++G
Sbjct: 109 DEEF----------VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158
Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           DFGLAR L     +  + +  G+  Y++PE       +   D++S G LL EL
Sbjct: 159 DFGLARIL--NHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 22/196 (11%)
Query: 75  HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXX 134
           HR+L           ++ NDF  +V E    RSL E           +KR          
Sbjct: 71  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL----------HKRRKALTEPEAR 120
Query: 135 XIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI 194
                +     YLH +      H  LK  N+ L++D+  ++GDFGLA     T+ +    
Sbjct: 121 YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGE 172
Query: 195 DVK---GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH-KFA 250
             K   G+  YIAPE       S   DV+S G ++  L++ + P +     +  L  K  
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 232
Query: 251 KMALSNHVKDIVDSIL 266
           + ++  H+  +  S++
Sbjct: 233 EYSIPKHINPVAASLI 248

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 22/196 (11%)
Query: 75  HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXX 134
           HR+L           ++ NDF  +V E    RSL E           +KR          
Sbjct: 71  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL----------HKRRKALTEPEAR 120
Query: 135 XIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI 194
                +     YLH +      H  LK  N+ L++D+  ++GDFGLA     T+ +    
Sbjct: 121 YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGE 172
Query: 195 DVK---GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH-KFA 250
             K   G+  YIAPE       S   DV+S G ++  L++ + P +     +  L  K  
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 232
Query: 251 KMALSNHVKDIVDSIL 266
           + ++  H+  +  S++
Sbjct: 233 EYSIPKHINPVAASLI 248

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 68  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 233

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 22/196 (11%)
Query: 75  HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXX 134
           HR+L           ++ NDF  +V E    RSL E           +KR          
Sbjct: 75  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL----------HKRRKALTEPEAR 124
Query: 135 XIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI 194
                +     YLH +      H  LK  N+ L++D+  ++GDFGLA     T+ +    
Sbjct: 125 YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGE 176
Query: 195 DVK---GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH-KFA 250
             K   G+  YIAPE       S   DV+S G ++  L++ + P +     +  L  K  
Sbjct: 177 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 236
Query: 251 KMALSNHVKDIVDSIL 266
           + ++  H+  +  S++
Sbjct: 237 EYSIPKHINPVAASLI 252

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 22/196 (11%)
Query: 75  HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXX 134
           HR+L           ++ NDF  +V E    RSL E           +KR          
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL----------HKRRKALTEPEAR 118
Query: 135 XIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI 194
                +     YLH +      H  LK  N+ L++D+  ++GDFGLA     T+ +    
Sbjct: 119 YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGE 170
Query: 195 DVK---GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH-KFA 250
             K   G+  YIAPE       S   DV+S G ++  L++ + P +     +  L  K  
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230
Query: 251 KMALSNHVKDIVDSIL 266
           + ++  H+  +  S++
Sbjct: 231 EYSIPKHINPVAASLI 246

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 22/196 (11%)
Query: 75  HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXX 134
           HR+L           ++ NDF  +V E    RSL E           +KR          
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL----------HKRRKALTEPEAR 144
Query: 135 XIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI 194
                +     YLH +      H  LK  N+ L++D+  ++GDFGLA     T+ +    
Sbjct: 145 YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGE 196
Query: 195 DVK---GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH-KFA 250
             K   G+  YIAPE       S   DV+S G ++  L++ + P +     +  L  K  
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256
Query: 251 KMALSNHVKDIVDSIL 266
           + ++  H+  +  S++
Sbjct: 257 EYSIPKHINPVAASLI 272

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 68  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 233

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 69  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 123
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 124 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 181 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 234

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 21/181 (11%)
Query: 60  FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PI 115
               I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P 
Sbjct: 62  LSDLISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPP 116
Query: 116 SKE---DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDD 169
             E   + ++              A  VA  + YL       +  C+   L   NVL+ +
Sbjct: 117 GLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTE 170
Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           D   ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+
Sbjct: 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230
Query: 230 M 230
Sbjct: 231 F 231

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PISKE 118
            I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P   E
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQAREPPGLE 134
Query: 119 ---DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMT 172
              + ++              A  VA  + YL       +  C+   L   NVL+ +D  
Sbjct: 135 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTEDNV 188
Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+ 
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PISKE 118
            I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P   E
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLE 134
Query: 119 ---DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMT 172
              + ++              A  VA  + YL       +  C+   L   NVL+ +D  
Sbjct: 135 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTEDNV 188
Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+ 
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PISKE 118
            I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P   E
Sbjct: 69  LISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLE 123
Query: 119 ---DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMT 172
              + ++              A  VA  + YL       +  C+   L   NVL+ +D  
Sbjct: 124 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTEDNV 177
Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+ 
Sbjct: 178 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 97  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 151
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 152 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 208
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 209 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 262

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PISKE 118
            I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P   E
Sbjct: 72  LISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLE 126
Query: 119 ---DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMT 172
              + ++              A  VA  + YL       +  C+   L   NVL+ +D  
Sbjct: 127 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTEDNV 180
Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+ 
Sbjct: 181 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 238

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PISKE 118
            I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P   E
Sbjct: 73  LISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLE 127
Query: 119 ---DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMT 172
              + ++              A  VA  + YL       +  C+   L   NVL+ +D  
Sbjct: 128 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTEDNV 181
Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+ 
Sbjct: 182 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 239

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 15/105 (14%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           IAID    L+Y+H D         +KP N+L+D +   R+ DFG    L    T  SS+ 
Sbjct: 186 IAIDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 196 VKGSIGYIAPEY-----GVGNEVSTIGDVYSYGILLLELMIREKP 235
           V G+  YI+PE      G         D +S G+ + E++  E P
Sbjct: 237 V-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 60  FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PI 115
               I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P 
Sbjct: 77  LSDLISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPP 131
Query: 116 SKE---DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDD 169
             E   + ++              A  VA  + YL       +  C+   L   NVL+ +
Sbjct: 132 GLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTE 185
Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           D   ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+
Sbjct: 186 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 75  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 129
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T S    G
Sbjct: 117 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----G 169
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 220

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           +  A+ Y H        H  LKP N+LLDD++  ++ DFGL+  +       +S    GS
Sbjct: 117 IICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GS 170
Query: 200 IGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
             Y APE        G EV    DV+S GI+L  +++   P D  F
Sbjct: 171 PNYAAPEVINGKLYAGPEV----DVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           + SA+ Y H   +    H  LKP N+LLD+ +  ++ DFGL+  +       +S    GS
Sbjct: 122 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 175
Query: 200 IGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
             Y APE        G EV    DV+S G++L  ++ R  P D
Sbjct: 176 PNYAAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 214

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 25/192 (13%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE---DE 120
           +A  + L    H N++++   C            LV+E + ++ L  +L  + +     E
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
           T K            +   +   L++LH        H  LKP N+L+      ++ DFGL
Sbjct: 121 TIK-----------DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR       Q +   V  ++ Y APE  + +  +T  D++S G +  E M R KP   +F
Sbjct: 167 ARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE-MFRRKP---LF 219
Query: 241 EGDMNLHKFAKM 252
            G  ++ +  K+
Sbjct: 220 RGSSDVDQLGKI 231

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R      D+ G
Sbjct: 117 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCG 169
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 220

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 31/196 (15%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW-LYPISKEDETYKR 124
           E K L+ +RH NL+ +L  C     +      LV+EF+ +  L +  L+P   + +  ++
Sbjct: 74  EIKLLKQLRHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQK 128
Query: 125 PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL 184
                        I    + N +H D         +KP N+L+      ++ DFG AR L
Sbjct: 129 YLFQIIN-----GIGFCHSHNIIHRD---------IKPENILVSQSGVVKLCDFGFARTL 174
Query: 185 -PPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
             P       +  +    Y APE  VG+ +     DV++ G L+ E+ + E     +F G
Sbjct: 175 AAPGEVYDDEVATR---WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP----LFPG 227
Query: 243 DMNLHKFAK--MALSN 256
           D ++ +     M L N
Sbjct: 228 DSDIDQLYHIMMCLGN 243

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 121 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 173
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 174 TLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 224

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           + SA+ Y H   +    H  LKP N+LLD+ +  ++ DFGL+  +       +S    GS
Sbjct: 121 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 174
Query: 200 IGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
             Y APE        G EV    DV+S G++L  ++ R  P D
Sbjct: 175 PNYAAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 213

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R      D+ G
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCG 173
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           + SA+ Y H   +    H  LKP N+LLD+ +  ++ DFGL+  +       +S    GS
Sbjct: 112 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 165
Query: 200 IGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
             Y APE        G EV    DV+S G++L  ++ R  P D
Sbjct: 166 PNYAAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 204

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R      D+ G
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCG 168
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 219

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 68/166 (40%), Gaps = 18/166 (10%)
Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   LR + H ++IK    C   +  G     LV E++   SL+++L   S         
Sbjct: 83  EIDILRTLYHEHIIKYKGCC---EDAGAASLQLVMEYVPLGSLRDYLPRHS--------- 130
Query: 126 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
                      A  +   + YLH        H  L   NVLLD+D   ++GDFGLA+ +P
Sbjct: 131 --IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 186 PTRTQTS-SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
                     D    + + APE     +     DV+S+G+ L EL+
Sbjct: 186 EGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY---PISKE 118
            I+E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L    P   E
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLE 175
Query: 119 ---DETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMT 172
              + ++              A  VA  + YL       +  C+   L   NVL+ +D  
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL------ASKKCIHRDLAARNVLVTEDNV 229
Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+ 
Sbjct: 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R      D+ G
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCG 168
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           + SA+ Y H   +    H  LKP N+LLD+ +  ++ DFGL+  +       +S    GS
Sbjct: 116 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 169
Query: 200 IGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
             Y APE        G EV    DV+S G++L  ++ R  P D
Sbjct: 170 PNYAAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 208

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 25/192 (13%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE---DE 120
           +A  + L    H N++++   C            LV+E + ++ L  +L  + +     E
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
           T K            +   +   L++LH        H  LKP N+L+      ++ DFGL
Sbjct: 121 TIK-----------DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR       Q +   V  ++ Y APE  + +  +T  D++S G +  E M R KP   +F
Sbjct: 167 ARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE-MFRRKP---LF 219
Query: 241 EGDMNLHKFAKM 252
            G  ++ +  K+
Sbjct: 220 RGSSDVDQLGKI 231

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 25/192 (13%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE---DE 120
           +A  + L    H N++++   C            LV+E + ++ L  +L  + +     E
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
           T K            +   +   L++LH        H  LKP N+L+      ++ DFGL
Sbjct: 121 TIK-----------DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR       Q +   V  ++ Y APE  + +  +T  D++S G +  E M R KP   +F
Sbjct: 167 ARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE-MFRRKP---LF 219
Query: 241 EGDMNLHKFAKM 252
            G  ++ +  K+
Sbjct: 220 RGSSDVDQLGKI 231

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R      D+ G
Sbjct: 142 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----DLCG 194
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 245

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 71/199 (35%), Gaps = 19/199 (9%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           L +  A   FI E  A+ ++ HRNLI++    L    +      +V E     SL     
Sbjct: 49  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLL---- 98
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                D   K             A+ VA  + YL         H  L   N+LL      
Sbjct: 99  -----DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 150
Query: 174 RVGDFGLARFLPPTRTQTSSID-VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           ++GDFGL R LP         +  K    + APE       S   D + +G+ L E+   
Sbjct: 151 KIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210
Query: 233 EKPSDIMFEGDMNLHKFAK 251
            +   I   G   LHK  K
Sbjct: 211 GQEPWIGLNGSQILHKIDK 229

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL--------PPTR 188
           A+ V    N +H D         LKPSN+L++ +   +V DFGLAR +         PT 
Sbjct: 124 AVKVLHGSNVIHRD---------LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 189 TQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIR 232
            Q+   +   +  Y APE  + + + S   DV+S G +L EL +R
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL--------PPTR 188
           A+ V    N +H D         LKPSN+L++ +   +V DFGLAR +         PT 
Sbjct: 124 AVKVLHGSNVIHRD---------LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 189 TQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIR 232
            Q+   +   +  Y APE  + + + S   DV+S G +L EL +R
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 71/199 (35%), Gaps = 19/199 (9%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           L +  A   FI E  A+ ++ HRNLI++    L    +      +V E     SL     
Sbjct: 59  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLL---- 108
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                D   K             A+ VA  + YL         H  L   N+LL      
Sbjct: 109 -----DRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLV 160
Query: 174 RVGDFGLARFLPPTRTQTSSID-VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           ++GDFGL R LP         +  K    + APE       S   D + +G+ L E+   
Sbjct: 161 KIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 220
Query: 233 EKPSDIMFEGDMNLHKFAK 251
            +   I   G   LHK  K
Sbjct: 221 GQEPWIGLNGSQILHKIDK 239

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 71/199 (35%), Gaps = 19/199 (9%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           L +  A   FI E  A+ ++ HRNLI++    L    +      +V E     SL     
Sbjct: 53  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLL---- 102
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                D   K             A+ VA  + YL         H  L   N+LL      
Sbjct: 103 -----DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 154
Query: 174 RVGDFGLARFLPPTRTQTSSID-VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           ++GDFGL R LP         +  K    + APE       S   D + +G+ L E+   
Sbjct: 155 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 214
Query: 233 EKPSDIMFEGDMNLHKFAK 251
            +   I   G   LHK  K
Sbjct: 215 GQEPWIGLNGSQILHKIDK 233

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  +G     +V E M +  LK +L  +  E E  
Sbjct: 67  FLNEASVMKGFTCHHVVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENN 121
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+        H  L   N ++  D T ++GDFG+ R
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKP 235
            +  T            + ++APE       +T  D++S+G++L E+  + E+P
Sbjct: 179 DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  +G     +V E M +  LK +L  +  E E  
Sbjct: 66  FLNEASVMKGFTCHHVVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENN 120
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+        H  L   N ++  D T ++GDFG+ R
Sbjct: 121 PGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKP 235
            +  T            + ++APE       +T  D++S+G++L E+  + E+P
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 231

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 133 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 185
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 186 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 236

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++   L+YLH + +    H  +K +NVLL +    ++ DFG+A  L  T TQ       G
Sbjct: 128 EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVG 182
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 239
           +  ++APE    +   +  D++S GI  +EL   E P+  M
Sbjct: 183 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  +G     +V E M +  LK +L  +  E E  
Sbjct: 68  FLNEASVMKGFTCHHVVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENN 122
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+        H  L   N ++  D T ++GDFG+ R
Sbjct: 123 PGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTR 179
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKP 235
            +  T            + ++APE       +T  D++S+G++L E+  + E+P
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 233

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 71/199 (35%), Gaps = 19/199 (9%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           L +  A   FI E  A+ ++ HRNLI++    L    +      +V E     SL     
Sbjct: 53  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLL---- 102
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                D   K             A+ VA  + YL         H  L   N+LL      
Sbjct: 103 -----DRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLV 154
Query: 174 RVGDFGLARFLPPTRTQTSSID-VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           ++GDFGL R LP         +  K    + APE       S   D + +G+ L E+   
Sbjct: 155 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 214
Query: 233 EKPSDIMFEGDMNLHKFAK 251
            +   I   G   LHK  K
Sbjct: 215 GQEPWIGLNGSQILHKIDK 233

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 21/173 (12%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE---- 118
            ++E   LR ++H N+++     +    + N    +V E+     L   +   +KE    
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 119 DETYKRPXXXXXXXXXXIAIDVASALNYLHH--DCQPVTAHCVLKPSNVLLDDDMTARVG 176
           DE +             +   +  AL   H   D      H  LKP+NV LD     ++G
Sbjct: 109 DEEF----------VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158
Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           DFGLAR L      + +    G+  Y++PE       +   D++S G LL EL
Sbjct: 159 DFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  +G     +V E M +  LK +L  +  E E  
Sbjct: 67  FLNEASVMKGFTCHHVVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENN 121
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+        H  L   N ++  D T ++GDFG+ R
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKP 235
            +  T            + ++APE       +T  D++S+G++L E+  + E+P
Sbjct: 179 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVS 214
           H  LKP N+L++ +   ++ DFGLAR F  P RT    +    ++ Y APE  +G    S
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYS 185
Query: 215 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
           T  D++S G +  E++ R      +F GD  + +  ++
Sbjct: 186 TAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRI 219

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 71/199 (35%), Gaps = 19/199 (9%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           L +  A   FI E  A+ ++ HRNLI++    L    +      +V E     SL     
Sbjct: 49  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLL---- 98
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                D   K             A+ VA  + YL         H  L   N+LL      
Sbjct: 99  -----DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 150
Query: 174 RVGDFGLARFLPPTRTQTSSID-VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           ++GDFGL R LP         +  K    + APE       S   D + +G+ L E+   
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210
Query: 233 EKPSDIMFEGDMNLHKFAK 251
            +   I   G   LHK  K
Sbjct: 211 GQEPWIGLNGSQILHKIDK 229

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL--PPTRTQTSSIDVKGSI 200
            L Y+H   Q +  H  LKPSN+L++++   ++GDFG+AR L   P   Q    +   + 
Sbjct: 170 GLKYMH-SAQVI--HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 201 GYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249
            Y APE  +  +E +   D++S G +  E++ R +    +F G   +H+ 
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ----LFPGKNYVHQL 272

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 37/220 (16%)
Query: 21  IEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIK 80
           +++GK K     DV+  M++E  +S                 F  E + +  + H  L+K
Sbjct: 24  VKLGKWKGQ--YDVAVKMIKEGSMSE--------------DEFFQEAQTMMKLSHPKLVK 67
Query: 81  VLTACLGVDYQGNDFK-ALVYEFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAID 139
               C        ++   +V E++ N  L  +L    K  E               +  D
Sbjct: 68  FYGVC------SKEYPIYIVTEYISNGCLLNYLRSHGKGLEP---------SQLLEMCYD 112
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           V   + +L         H  L   N L+D D+  +V DFG+ R++   +   SS+  K  
Sbjct: 113 VCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFP 168
Query: 200 IGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKPSDI 238
           + + APE     + S+  DV+++GIL+ E+  + + P D+
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +  E E  
Sbjct: 62  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 116
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N  + +D T ++GDFG+ R
Sbjct: 117 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTR 173
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 174 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 227

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 18/109 (16%)
Query: 136 IAIDVASALNYLHHDCQPV-------TAHCV---LKPSNVLLDDDMTARVGDFGLARFLP 185
           IA   AS  + LH   Q         + +C+   +   NVLL +   A++GDFGLAR + 
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI- 214
Query: 186 PTRTQTSSIDVKGS----IGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
                 S+  VKG+    + ++APE       +   DV+SYGILL E+ 
Sbjct: 215 ---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 117 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT----LCG 169
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 220

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 121 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 173
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 224

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 171
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 222

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVS 214
           H  LKP N+L++ +   ++ DFGLAR F  P RT    +    ++ Y APE  +G    S
Sbjct: 127 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYS 183
Query: 215 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
           T  D++S G +  E++ R      +F GD  + +  ++
Sbjct: 184 TAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRI 217

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVS 214
           H  LKP N+L++ +   ++ DFGLAR F  P RT    +    ++ Y APE  +G    S
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYS 184
Query: 215 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
           T  D++S G +  E++ R      +F GD  + +  ++
Sbjct: 185 TAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRI 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 71/199 (35%), Gaps = 19/199 (9%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           L +  A   FI E  A+ ++ HRNLI++    L    +      +V E     SL     
Sbjct: 49  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLL---- 98
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                D   K             A+ VA  + YL         H  L   N+LL      
Sbjct: 99  -----DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 150
Query: 174 RVGDFGLARFLPPTRTQTSSID-VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           ++GDFGL R LP         +  K    + APE       S   D + +G+ L E+   
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210
Query: 233 EKPSDIMFEGDMNLHKFAK 251
            +   I   G   LHK  K
Sbjct: 211 GQEPWIGLNGSQILHKIDK 229

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVS 214
           H  LKP N+L++ +   ++ DFGLAR F  P RT    +    ++ Y APE  +G    S
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYS 185
Query: 215 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
           T  D++S G +  E++ R      +F GD  + +  ++
Sbjct: 186 TAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRI 219

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  +G     +V E M +  LK +L  +  E E  
Sbjct: 67  FLNEASVMKGFTCHHVVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENN 121
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+        H  L   N ++  D T ++GDFG+ R
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKP 235
            +  T            + ++APE       +T  D++S+G++L E+  + E+P
Sbjct: 179 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 68/144 (47%), Gaps = 18/144 (12%)
Query: 98  LVYEFMHNRSL---KEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPV 154
           ++YE+M N S+    E+ + + K    +             I   V ++ +Y+H+  +  
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCF-----IPIQVIKCIIKSVLNSFSYIHN--EKN 172
Query: 155 TAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVS 214
             H  +KPSN+L+D +   ++ DFG + ++   + + S    +G+  ++ PE+   NE S
Sbjct: 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS----RGTYEFMPPEF-FSNESS 227
Query: 215 TIG---DVYSYGILLLELMIREKP 235
             G   D++S GI L  +     P
Sbjct: 228 YNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 142 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 194
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 245

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVS 214
           H  LKP N+L++ +   ++ DFGLAR F  P RT    +    ++ Y APE  +G    S
Sbjct: 129 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VTLWYRAPEILLGCKYYS 185
Query: 215 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
           T  D++S G +  E++ R      +F GD  + +  ++
Sbjct: 186 TAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRI 219

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 121 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 173
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 224

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 21/173 (12%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE---- 118
            ++E   LR ++H N+++     +    + N    +V E+     L   +   +KE    
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 119 DETYKRPXXXXXXXXXXIAIDVASALNYLHH--DCQPVTAHCVLKPSNVLLDDDMTARVG 176
           DE +             +   +  AL   H   D      H  LKP+NV LD     ++G
Sbjct: 109 DEEF----------VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158
Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           DFGLAR L      + +    G+  Y++PE       +   D++S G LL EL
Sbjct: 159 DFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 38/74 (51%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  L   N+LL ++   ++ DFGLAR +          D +  + ++APE       ST 
Sbjct: 222 HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTK 281
Query: 217 GDVYSYGILLLELM 230
            DV+SYG+LL E+ 
Sbjct: 282 SDVWSYGVLLWEIF 295

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL--PPTRTQTSSIDVKGSI 200
            L Y+H   Q +  H  LKPSN+L++++   ++GDFG+AR L   P   Q    +   + 
Sbjct: 171 GLKYMH-SAQVI--HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 201 GYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249
            Y APE  +  +E +   D++S G +  E++ R +    +F G   +H+ 
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ----LFPGKNYVHQL 273

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 168
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 71/199 (35%), Gaps = 19/199 (9%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           L +  A   FI E  A+ ++ HRNLI++    L    +      +V E     SL     
Sbjct: 59  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLL---- 108
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                D   K             A+ VA  + YL         H  L   N+LL      
Sbjct: 109 -----DRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLV 160
Query: 174 RVGDFGLARFLPPTRTQTSSID-VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
           ++GDFGL R LP         +  K    + APE       S   D + +G+ L E+   
Sbjct: 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 220
Query: 233 EKPSDIMFEGDMNLHKFAK 251
            +   I   G   LHK  K
Sbjct: 221 GQEPWIGLNGSQILHKIDK 239

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 2/76 (2%)
Query: 160 LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDV 219
           LKP N+LLD++   ++ DFGL++       +  +    G++ Y+APE       S   D 
Sbjct: 156 LKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADW 213
Query: 220 YSYGILLLELMIREKP 235
           +SYG+L+ E++    P
Sbjct: 214 WSYGVLMFEMLTGSLP 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R      D+ G
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----DLCG 171
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 171
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 81/179 (45%), Gaps = 46/179 (25%)
Query: 73  IRHRNLIKVLTAC-------LGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           +  RN +K +TA        + ++Y  N     +Y+ +H+ +L +      + DE ++  
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCEN---GTLYDLIHSENLNQ------QRDEYWR-- 120
Query: 126 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF-- 183
                     +   +  AL+Y+H   Q +  H  LKP N+ +D+    ++GDFGLA+   
Sbjct: 121 ----------LFRQILEALSYIH--SQGII-HRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 184 -------LPPTRTQTSSIDVKGSIG---YIAPEY--GVGNEVSTIGDVYSYGILLLELM 230
                  L       SS ++  +IG   Y+A E   G G+    I D+YS GI+  E++
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI-DMYSLGIIFFEMI 225

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           +AID    L+Y+H D         +KP NVLLD +   R+ DFG    +    T  SS+ 
Sbjct: 186 LAIDSIHQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA 236
Query: 196 VKGSIGYIAPEY------GVGNEVSTIGDVYSYGILLLELMIREKP 235
           V G+  YI+PE       G+G +     D +S G+ + E++  E P
Sbjct: 237 V-GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 20/186 (10%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           Q +    + E +A+    H N++   T+     +   D   LV + +   S+ + +  I 
Sbjct: 54  QTSMDELLKEIQAMSQCHHPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIV 108
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
            + E   +           I  +V   L YLH + Q    H  +K  N+LL +D + ++ 
Sbjct: 109 AKGE--HKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIA 163
Query: 177 DFGLARFLPP----TRTQTSSIDVKGSIGYIAPEYGVGNEVSTI---GDVYSYGILLLEL 229
           DFG++ FL      TR +     V G+  ++APE  V  +V       D++S+GI  +EL
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPE--VMEQVRGYDFKADIWSFGITAIEL 220
Query: 230 MIREKP 235
                P
Sbjct: 221 ATGAAP 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 26/201 (12%)
Query: 41  ENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY 100
           +N I       S +      ++F+ E   +R + H N++    A +G+         ++ 
Sbjct: 47  QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL----ALIGIMLPPEGLPHVLL 102
Query: 101 EFMHNRSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVL 160
            +M +  L +++    + + T K              + VA  + YL    +    H  L
Sbjct: 103 PYMCHGDLLQFIRS-PQRNPTVK--------DLISFGLQVARGMEYL---AEQKFVHRDL 150
Query: 161 KPSNVLLDDDMTARVGDFGLAR------FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVS 214
              N +LD+  T +V DFGLAR      +    + + + + VK    + A E       +
Sbjct: 151 AARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK----WTALESLQTYRFT 206
Query: 215 TIGDVYSYGILLLELMIREKP 235
           T  DV+S+G+LL EL+ R  P
Sbjct: 207 TKSDVWSFGVLLWELLTRGAP 227

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 115 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 167
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 168 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 218

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           +AID    L+Y+H D         +KP NVLLD +   R+ DFG    +    T  SS+ 
Sbjct: 202 LAIDSIHQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA 252
Query: 196 VKGSIGYIAPEY------GVGNEVSTIGDVYSYGILLLELMIREKP 235
           V G+  YI+PE       G+G +     D +S G+ + E++  E P
Sbjct: 253 V-GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 20/186 (10%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           Q +    + E +A+    H N++   T+     +   D   LV + +   S+ + +  I 
Sbjct: 49  QTSMDELLKEIQAMSQCHHPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIV 103
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
            + E   +           I  +V   L YLH + Q    H  +K  N+LL +D + ++ 
Sbjct: 104 AKGE--HKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIA 158
Query: 177 DFGLARFLPP----TRTQTSSIDVKGSIGYIAPEYGVGNEVSTI---GDVYSYGILLLEL 229
           DFG++ FL      TR +     V G+  ++APE  V  +V       D++S+GI  +EL
Sbjct: 159 DFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPE--VMEQVRGYDFKADIWSFGITAIEL 215
Query: 230 MIREKP 235
                P
Sbjct: 216 ATGAAP 221

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 120 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 172
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 36/174 (20%)
Query: 73  IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP--ISKEDETYKRPXXXXX 130
           +  RN +K +TA   V  +   F  +  E+  NR+L + ++   ++++ + Y R      
Sbjct: 72  LERRNFVKPMTA---VKKKSTLFIQM--EYCENRTLYDLIHSENLNQQRDEYWR------ 120
Query: 131 XXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF------- 183
                +   +  AL+Y+H   Q +  H  LKP N+ +D+    ++GDFGLA+        
Sbjct: 121 -----LFRQILEALSYIH--SQGII-HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 184 --LPPTRTQTSSIDVKGSIG---YIAPEY--GVGNEVSTIGDVYSYGILLLELM 230
             L       SS ++  +IG   Y+A E   G G+    I D+YS GI+  E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI-DMYSLGIIFFEMI 225

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R  T    + G
Sbjct: 113 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCG 165
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 166 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 61  KSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           ++ ++E K L +I H  N++ +L AC      G     +V EF    +L  +L     E 
Sbjct: 76  RALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEF 131
Query: 120 ETYKRPXXXXXXXXXX-----IAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDM 171
             YK P                +  VA  + +L       +  C+   L   N+LL +  
Sbjct: 132 VPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL------ASRKCIHRDLAARNILLSEKN 185
Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI-GDVYSYGILLLELM 230
             ++ DFGLAR +          D +  + ++APE  + + V TI  DV+S+G+LL E+ 
Sbjct: 186 VVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL  +   ++ DFG +   P +R  T    + G
Sbjct: 120 ELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT----LCG 172
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++   P
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R       + G
Sbjct: 121 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX----LXG 173
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++   L+YLH + +    H  +K +NVLL +    ++ DFG+A  L  T TQ       G
Sbjct: 112 EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVG 166
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +  ++APE    +   +  D++S GI  +EL   E P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/115 (25%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R      ++ G
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTELCG 168
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 219

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 19/172 (11%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L+N RH      LTA L   +Q +D    V E+ +   L    + +S+E     
Sbjct: 199 LTENRVLQNSRH----PFLTA-LKYSFQTHDRLCFVMEYANGGEL---FFHLSRE----- 245
Query: 124 RPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
                          ++ SAL+YLH +   V  +  LK  N++LD D   ++ DFGL + 
Sbjct: 246 --RVFSEDRARFYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCK- 300
Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
               +   +     G+  Y+APE    N+     D +  G+++ E+M    P
Sbjct: 301 -EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 19/172 (11%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L+N RH      LTA L   +Q +D    V E+ +   L    + +S+E     
Sbjct: 196 LTENRVLQNSRH----PFLTA-LKYSFQTHDRLCFVMEYANGGEL---FFHLSRE----- 242
Query: 124 RPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
                          ++ SAL+YLH +   V  +  LK  N++LD D   ++ DFGL + 
Sbjct: 243 --RVFSEDRARFYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCK- 297
Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
               +   +     G+  Y+APE    N+     D +  G+++ E+M    P
Sbjct: 298 -EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL  +   ++ DFG +   P +R  T    + G
Sbjct: 120 ELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT----LCG 172
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++   P
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           IA+ +  AL +LH     +  H  +KPSNVL++     ++ DFG++ +L         ID
Sbjct: 114 IAVSIVKALEHLHSKLSVI--HRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDID 169
Query: 196 VKGSIGYIAPEYGVGNEVSTIG-----DVYSYGILLLELMIREKPSD 237
             G   Y+APE  +  E++  G     D++S GI ++EL I   P D
Sbjct: 170 A-GCKPYMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++   L+YLH + +    H  +K +NVLL +    ++ DFG+A  L  T TQ       G
Sbjct: 112 EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVG 166
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +  ++APE    +   +  D++S GI  +EL   E P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++   L+YLH + +    H  +K +NVLL +    ++ DFG+A  L  T TQ       G
Sbjct: 127 EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVG 181
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +  ++APE    +   +  D++S GI  +EL   E P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/71 (39%), Positives = 40/71 (56%), Gaps = 8/71 (11%)
Query: 164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS----IGYIAPEYGVGNEVSTIGDV 219
           NVLL +   A++GDFGLAR +       S+  VKG+    + ++APE       +   DV
Sbjct: 196 NVLLTNGHVAKIGDFGLARDI----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 251
Query: 220 YSYGILLLELM 230
           +SYGILL E+ 
Sbjct: 252 WSYGILLWEIF 262

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/67 (35%), Positives = 36/67 (53%)
Query: 164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYG 223
           NVLL +   A++GDFGLAR +          + +  + ++APE       +   DV+SYG
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 241
Query: 224 ILLLELM 230
           ILL E+ 
Sbjct: 242 ILLWEIF 248

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/67 (35%), Positives = 36/67 (53%)
Query: 164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYG 223
           NVLL +   A++GDFGLAR +          + +  + ++APE       +   DV+SYG
Sbjct: 190 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 249
Query: 224 ILLLELM 230
           ILL E+ 
Sbjct: 250 ILLWEIF 256

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 96/249 (38%), Gaps = 36/249 (14%)
Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
           S L ++G       E +   ++RH N++++                  Y + H+R     
Sbjct: 51  SQLEKEGVEHQLRREIEIQSHLRHPNILRM------------------YNYFHDRKRIYL 92
Query: 112 LYPISKEDETYKRPXXXXXXXXXXIAI---DVASALNYLHHDCQPVTAHCVLKPSNVLLD 168
           +   +   E YK             A    ++A AL+Y H   +    H  +KP N+L+ 
Sbjct: 93  MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMG 149
Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
                ++ DFG +   P  R +       G++ Y+ PE   G       D++  G+L  E
Sbjct: 150 YKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 205
Query: 229 LMIREKPSDIMFEGDMNLH------KFAKMALSNHVKDIVDSIL-LNDDEKLVVRGDQKQ 281
            ++   P D     + +        KF    LS+  KD++  +L  +  ++L ++G  + 
Sbjct: 206 FLVGMPPFDSPSHTETHRRIVNVDLKFPPF-LSDGSKDLISKLLRYHPPQRLPLKGVMEH 264
Query: 282 TQAKINIIR 290
              K N  R
Sbjct: 265 PWVKANSRR 273

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/71 (39%), Positives = 40/71 (56%), Gaps = 8/71 (11%)
Query: 164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS----IGYIAPEYGVGNEVSTIGDV 219
           NVLL +   A++GDFGLAR +       S+  VKG+    + ++APE       +   DV
Sbjct: 194 NVLLTNGHVAKIGDFGLARDI----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 220 YSYGILLLELM 230
           +SYGILL E+ 
Sbjct: 250 WSYGILLWEIF 260

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 96/249 (38%), Gaps = 36/249 (14%)
Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
           S L ++G       E +   ++RH N++++                  Y + H+R     
Sbjct: 50  SQLEKEGVEHQLRREIEIQSHLRHPNILRM------------------YNYFHDRKRIYL 91
Query: 112 LYPISKEDETYKRPXXXXXXXXXXIAI---DVASALNYLHHDCQPVTAHCVLKPSNVLLD 168
           +   +   E YK             A    ++A AL+Y H   +    H  +KP N+L+ 
Sbjct: 92  MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMG 148
Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
                ++ DFG +   P  R +       G++ Y+ PE   G       D++  G+L  E
Sbjct: 149 YKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204
Query: 229 LMIREKPSDIMFEGDMNLH------KFAKMALSNHVKDIVDSIL-LNDDEKLVVRGDQKQ 281
            ++   P D     + +        KF    LS+  KD++  +L  +  ++L ++G  + 
Sbjct: 205 FLVGMPPFDSPSHTETHRRIVNVDLKFPPF-LSDGSKDLISKLLRYHPPQRLPLKGVMEH 263
Query: 282 TQAKINIIR 290
              K N  R
Sbjct: 264 PWVKANSRR 272

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++   L+YLH + +    H  +K +NVLL +    ++ DFG+A  L  T TQ       G
Sbjct: 132 EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVG 186
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +  ++APE    +   +  D++S GI  +EL   E P
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 68/179 (37%), Gaps = 24/179 (13%)
Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F  EC  LR   H N++ VL AC            L+  +    SL    Y +  E  
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQS---PPAPHPTLITHWXPYGSL----YNVLHEGT 104
Query: 121 TYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
            +              A+D A    +LH   +P+     L   +V +D+D TAR+    +
Sbjct: 105 NF----VVDQSQAVKFALDXARGXAFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADV 159
Query: 181 A-RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST---IGDVYSYGILLLELMIREKP 235
              F  P R    +        ++APE        T     D +S+ +LL EL+ RE P
Sbjct: 160 KFSFQSPGRXYAPA--------WVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK-G 198
           + SA+ Y H   Q    H  LK  N+LLD DM  ++ DFG +       T  + +D   G
Sbjct: 123 IVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF----TVGNKLDTFCG 175
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
           S  Y APE   G +      DV+S G++L  L+    P D
Sbjct: 176 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/71 (39%), Positives = 40/71 (56%), Gaps = 8/71 (11%)
Query: 164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS----IGYIAPEYGVGNEVSTIGDV 219
           NVLL +   A++GDFGLAR +       S+  VKG+    + ++APE       +   DV
Sbjct: 188 NVLLTNGHVAKIGDFGLARDI----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 243
Query: 220 YSYGILLLELM 230
           +SYGILL E+ 
Sbjct: 244 WSYGILLWEIF 254

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK-G 198
           + SA+ Y H   Q    H  LK  N+LLD DM  ++ DFG +       T  + +D   G
Sbjct: 115 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCG 167
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
           S  Y APE   G +      DV+S G++L  L+    P D
Sbjct: 168 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 19/172 (11%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L+N RH      LTA L   +Q +D    V E+ +   L    + +S+E     
Sbjct: 56  LTENRVLQNSRH----PFLTA-LKYSFQTHDRLCFVMEYANGGEL---FFHLSRE----- 102
Query: 124 RPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
                          ++ SAL+YLH +   V  +  LK  N++LD D   ++ DFGL + 
Sbjct: 103 --RVFSEDRARFYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCK- 157
Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
               +   +     G+  Y+APE    N+     D +  G+++ E+M    P
Sbjct: 158 -EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A AL++LH        +  LKP N+LLD++   ++ DFGL++       +  +    G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 188
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+APE       +   D +S+G+L+ E++    P
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A AL++LH        +  LKP N+LLD++   ++ DFGL++       +  +    G
Sbjct: 135 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 189
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+APE       +   D +S+G+L+ E++    P
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/115 (25%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ +FG +   P +R  T    + G
Sbjct: 118 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCG 170
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 221

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK-G 198
           + SA+ Y H   Q    H  LK  N+LLD DM  ++ DFG +       T  + +D   G
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCG 174
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
           S  Y APE   G +      DV+S G++L  L+    P D
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK-G 198
           + SA+ Y H   Q    H  LK  N+LLD DM  ++ DFG +       T  + +D   G
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCG 174
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
           S  Y APE   G +      DV+S G++L  L+    P D
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 19/172 (11%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L+N RH      LTA L   +Q +D    V E+ +   L    + +S+E     
Sbjct: 57  LTENRVLQNSRH----PFLTA-LKYSFQTHDRLCFVMEYANGGEL---FFHLSRE----- 103
Query: 124 RPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
                          ++ SAL+YLH +   V  +  LK  N++LD D   ++ DFGL + 
Sbjct: 104 --RVFSEDRARFYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCK- 158
Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
               +   +     G+  Y+APE    N+     D +  G+++ E+M    P
Sbjct: 159 -EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 19/172 (11%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L+N RH      LTA L   +Q +D    V E+ +   L    + +S+E     
Sbjct: 58  LTENRVLQNSRH----PFLTA-LKYSFQTHDRLCFVMEYANGGEL---FFHLSRE----- 104
Query: 124 RPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF 183
                          ++ SAL+YLH +   V  +  LK  N++LD D   ++ DFGL + 
Sbjct: 105 --RVFSEDRARFYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCK- 159
Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
               +   +     G+  Y+APE    N+     D +  G+++ E+M    P
Sbjct: 160 -EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK-G 198
           + SA+ Y H   Q    H  LK  N+LLD DM  ++ DFG +       T  + +D   G
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCG 174
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
           S  Y APE   G +      DV+S G++L  L+    P D
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 36/158 (22%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           + SA++++H D   V  H  LKP N+L    +D++  ++ DFG AR  PP      +   
Sbjct: 115 LVSAVSHMH-DVGVV--HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILL----------------------LELMIREK 234
             ++ Y APE    N      D++S G++L                      +E+M + K
Sbjct: 172 --TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229
Query: 235 PSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
             D  FEG+      A   +S   KD++  +L  D  K
Sbjct: 230 KGDFSFEGE------AWKNVSQEAKDLIQGLLTVDPNK 261

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/115 (25%), Positives = 54/115 (46%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R       + G
Sbjct: 118 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX----LCG 170
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 221

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A AL++LH        +  LKP N+LLD++   ++ DFGL++       +  +    G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCG 188
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+APE       +   D +S+G+L+ E++    P
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++   L+YLH + +    H  +K +NVLL +    ++ DFG+A  L  T TQ       G
Sbjct: 124 EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNXFVG 178
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236
           +  ++APE    +      D++S GI  +EL   E P+
Sbjct: 179 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 216

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVL---LDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           V  A+ YLH D   V  H  LKP N+L   LD+D    + DFGL++   P    +++   
Sbjct: 125 VLDAVKYLH-DLGIV--HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-- 179
Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
            G+ GY+APE       S   D +S G++   L+    P
Sbjct: 180 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 26/154 (16%)
Query: 90  YQGNDFKALVYEFMHN----RSLKEWLYPISKEDETYKRPXXXXXXXXXXIAIDVASALN 145
           ++ +++  LV E  HN    R LK  + P S+ +  +                 + + + 
Sbjct: 80  FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-------------FMHQIITGML 126
Query: 146 YLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL--PPTRTQTSSIDVKGSIGYI 203
           YLH        H  L  SN+LL  +M  ++ DFGLA  L  P  +  T    + G+  YI
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT----LCGTPNYI 179
Query: 204 APEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
           +PE    +      DV+S G +   L+I   P D
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R       + G
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCG 171
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/115 (25%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ +FG +   P +R  T    + G
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCG 171
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
           ++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRIS 222

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVL---LDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           V  A+ YLH D   V  H  LKP N+L   LD+D    + DFGL++   P    +++   
Sbjct: 125 VLDAVKYLH-DLGIV--HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-- 179
Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
            G+ GY+APE       S   D +S G++   L+    P
Sbjct: 180 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID-VKG 198
           + SA+ Y H   Q    H  LK  N+LLD DM  ++ DFG +       T  + +D   G
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDEFCG 174
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
           S  Y APE   G +      DV+S G++L  L+    P D
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
            A DVA  ++YL    Q    H  L   N+L+ ++  A++ DFGL+R           + 
Sbjct: 144 FAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--------GQEVY 192
Query: 196 VKGSIG-----YIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           VK ++G     ++A E    +  +T  DV+SYG+LL E++
Sbjct: 193 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 46/100 (46%), Gaps = 9/100 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK-G 198
           + SA+ Y H   Q    H  LK  N+LLD DM  ++ DFG +       T    +D   G
Sbjct: 120 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF----TVGGKLDTFCG 172
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
           S  Y APE   G +      DV+S G++L  L+    P D
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           ++I V   L YL    Q    H  +KPSN+L++     ++ DFG++  L      + +  
Sbjct: 119 VSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS 172
Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
             G+  Y+APE   G   S   D++S G+ L+EL +   P
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
            A DVA  ++YL    Q    H  L   N+L+ ++  A++ DFGL+R           + 
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVY 195
Query: 196 VKGSIG-----YIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           VK ++G     ++A E    +  +T  DV+SYG+LL E++
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R       + G
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCG 168
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 13/105 (12%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++  AL+YL +       H  +KP N+LLD+     + DF +A  LP    +T    + G
Sbjct: 123 ELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAG 176
Query: 199 SIGYIAPEY-----GVGNEVSTIGDVYSYGILLLELMIREKPSDI 238
           +  Y+APE      G G   +   D +S G+   EL+   +P  I
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRRPYHI 219

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R       + G
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX----LCG 171
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
            A DVA  ++YL    Q    H  L   N+L+ ++  A++ DFGL+R           + 
Sbjct: 137 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVY 185
Query: 196 VKGSIG-----YIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           VK ++G     ++A E    +  +T  DV+SYG+LL E++
Sbjct: 186 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R       + G
Sbjct: 116 ELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCG 168
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVL---LDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           V  A+ YLH D   V  H  LKP N+L   LD+D    + DFGL++   P    +++   
Sbjct: 125 VLDAVKYLH-DLGIV--HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-- 179
Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
            G+ GY+APE       S   D +S G++   L+    P
Sbjct: 180 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 31/192 (16%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY--- 113
           + A + F  E + L  ++H+++++    C     +G     +V+E+M +  L  +L    
Sbjct: 61  ESARQDFQREAELLTMLQHQHIVRFFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHG 115
Query: 114 PISK-----EDETYKRPXXXXXXXXXXIAIDVASALNYL------HHDCQPVTAHCVLKP 162
           P +K     ED     P          +A  VA+ + YL      H D         L  
Sbjct: 116 PDAKLLAGGEDVA---PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD---------LAT 163
Query: 163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSY 222
            N L+   +  ++GDFG++R +  T            I ++ PE  +  + +T  DV+S+
Sbjct: 164 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 223
Query: 223 GILLLELMIREK 234
           G++L E+    K
Sbjct: 224 GVVLWEIFTYGK 235

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 25/189 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY--- 113
           + A + F  E + L  ++H+++++    C     +G     +V+E+M +  L  +L    
Sbjct: 55  ESARQDFQREAELLTMLQHQHIVRFFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHG 109
Query: 114 PISK-----EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNV 165
           P +K     ED     P          +A  VA+ + YL         H V   L   N 
Sbjct: 110 PDAKLLAGGEDVA---PGPLGLGQLLAVASQVAAGMVYL------AGLHFVHRDLATRNC 160
Query: 166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL 225
           L+   +  ++GDFG++R +  T            I ++ PE  +  + +T  DV+S+G++
Sbjct: 161 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 220
Query: 226 LLELMIREK 234
           L E+    K
Sbjct: 221 LWEIFTYGK 229

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARF---------LPPTRTQ 190
           +  AL+Y+H   Q +  H  LKP N+ +D+    ++GDFGLA+          L      
Sbjct: 125 ILEALSYIH--SQGII-HRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 191 TSSIDVKGSIG---YIAPEY--GVGNEVSTIGDVYSYGILLLELM 230
            SS ++  +IG   Y+A E   G G+    I D YS GI+  E +
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKI-DXYSLGIIFFEXI 225

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVL---LDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           V  A+ YLH D   V  H  LKP N+L   LD+D    + DFGL++   P    +++   
Sbjct: 125 VLDAVKYLH-DLGIV--HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-- 179
Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
            G+ GY+APE       S   D +S G++   L+    P
Sbjct: 180 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/234 (21%), Positives = 101/234 (43%), Gaps = 25/234 (10%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           LR+Q   +    E   +R+  H N++ + ++     Y   D   +V EF+   +L + + 
Sbjct: 80  LRKQQRRELLFNEVVIMRDYHHDNVVDMYSS-----YLVGDELWVVMEFLEGGALTDIVT 134
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                +E               + + V  AL+YLH+       H  +K  ++LL  D   
Sbjct: 135 HTRMNEEQ-----------IATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRI 180
Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE 233
           ++ DFG    +  ++       + G+  ++APE        T  D++S GI+++E++  E
Sbjct: 181 KLSDFGFCAQV--SKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238
Query: 234 KPSDIMFEGDMNLHKFAKMALSNHVKDI--VDSILLNDDEKLVVRGDQKQTQAK 285
            P     E  +   +  + +L   VKD+  V S+L    + ++VR   ++  A+
Sbjct: 239 PP--YFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQ 290

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 12/174 (6%)
Query: 61  KSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           ++ ++E K L +I H  N++ +L AC      G     +V EF    +L  +L     E 
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEF 130
Query: 120 ETYKRPXXXXXXXXXXI--AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
             YK            I  +  VA  + +L         H  L   N+LL +    ++ D
Sbjct: 131 VPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXD 187
Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI-GDVYSYGILLLELM 230
           FGLAR +          D +  + ++APE  + + V TI  DV+S+G+LL E+ 
Sbjct: 188 FGLARDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R       + G
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX----LCG 168
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           ++A+AL+Y H        H  +KP N+LL      ++ DFG +   P +R       + G
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTXLCG 168
Query: 199 SIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           ++ Y+ PE   G       D++S G+L  E ++ + P
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK-G 198
           + SA+ Y H   Q    H  LK  N+LLD DM  ++ DFG +       T  + +D   G
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDAFCG 174
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
           +  Y APE   G +      DV+S G++L  L+    P D
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 74/177 (41%), Gaps = 19/177 (10%)
Query: 62  SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
            F+ E   + ++ H +L+++L  CL    Q      LV + M +  L E+++        
Sbjct: 63  EFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH-------- 108
Query: 122 YKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
            +              + +A  + YL    +    H  L   NVL+      ++ DFGLA
Sbjct: 109 -EHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA 164
Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKPSD 237
           R L     + ++   K  I ++A E     + +   DV+SYG+ + ELM    KP D
Sbjct: 165 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 25/189 (13%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY--- 113
           + A + F  E + L  ++H+++++    C     +G     +V+E+M +  L  +L    
Sbjct: 84  ESARQDFQREAELLTMLQHQHIVRFFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHG 138
Query: 114 PISK-----EDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNV 165
           P +K     ED     P          +A  VA+ + YL         H V   L   N 
Sbjct: 139 PDAKLLAGGEDVA---PGPLGLGQLLAVASQVAAGMVYL------AGLHFVHRDLATRNC 189
Query: 166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL 225
           L+   +  ++GDFG++R +  T            I ++ PE  +  + +T  DV+S+G++
Sbjct: 190 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249
Query: 226 LLELMIREK 234
           L E+    K
Sbjct: 250 LWEIFTYGK 258

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 206 VDIWSVGCIMGE-MVRHK---ILFPG 227

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 12/102 (11%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           A ++   L ++H+       +  LKP+N+LLD+    R+ D GLA      +   S    
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 197 KGSIGYIAPEY---GVGNEVSTIGDVYSYGILLLELMIREKP 235
            G+ GY+APE    GV  + S   D +S G +L +L+    P
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 390

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 12/102 (11%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           A ++   L ++H+       +  LKP+N+LLD+    R+ D GLA      +   S    
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 197 KGSIGYIAPEY---GVGNEVSTIGDVYSYGILLLELMIREKP 235
            G+ GY+APE    GV  + S   D +S G +L +L+    P
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 390

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 206 VDIWSVGCIMGE-MVRHK---ILFPG 227

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 12/102 (11%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           A ++   L ++H+       +  LKP+N+LLD+    R+ D GLA      +   S    
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 197 KGSIGYIAPEY---GVGNEVSTIGDVYSYGILLLELMIREKP 235
            G+ GY+APE    GV  + S   D +S G +L +L+    P
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 390

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 17/177 (9%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
           +  E + ++ + H N++       G+     ND   L  E+     L+++L         
Sbjct: 59  WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-------NQ 111
Query: 122 YKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD---DDMTARVGDF 178
           ++            +  D++SAL YLH +      H  LKP N++L      +  ++ D 
Sbjct: 112 FENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           G A+ L      T  +   G++ Y+APE     + +   D +S+G L  E +   +P
Sbjct: 169 GYAKELDQGELCTEFV---GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 12/174 (6%)
Query: 61  KSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           ++ ++E K L +I H  N++ +L AC      G     +V EF    +L  +L     E 
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEF 130
Query: 120 ETYKRPXXXXXXXXXXI--AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD 177
             YK            I  +  VA  + +L         H  L   N+LL +    ++ D
Sbjct: 131 VPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICD 187
Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI-GDVYSYGILLLELM 230
           FGLAR +          D +  + ++APE  + + V TI  DV+S+G+LL E+ 
Sbjct: 188 FGLARDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 17/177 (9%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
           +  E + ++ + H N++       G+     ND   L  E+     L+++L         
Sbjct: 60  WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-------NQ 112
Query: 122 YKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD---DDMTARVGDF 178
           ++            +  D++SAL YLH +      H  LKP N++L      +  ++ D 
Sbjct: 113 FENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 169
Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           G A+ L      T  +   G++ Y+APE     + +   D +S+G L  E +   +P
Sbjct: 170 GYAKELDQGELCTEFV---GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGY 202
           AL +LH +      H  +K  N+LL  D + ++ DFG    + P +++ S++   G+  +
Sbjct: 129 ALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYW 183
Query: 203 IAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +APE           D++S GI+ +E++  E P
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 12/102 (11%)
Query: 137 AIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           A ++   L ++H+       +  LKP+N+LLD+    R+ D GLA      +   S    
Sbjct: 297 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 350
Query: 197 KGSIGYIAPEY---GVGNEVSTIGDVYSYGILLLELMIREKP 235
            G+ GY+APE    GV  + S   D +S G +L +L+    P
Sbjct: 351 -GTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 389

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 44/76 (57%), Gaps = 5/76 (6%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVS 214
           H  LKP N+L++ +   ++ DFGLAR F  P R  T  I    ++ Y AP+  +G+ + S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI---VTLWYRAPDVLMGSKKYS 179
Query: 215 TIGDVYSYGILLLELM 230
           T  D++S G +  E++
Sbjct: 180 TTIDIWSVGCIFAEMV 195

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 22/182 (12%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED--- 119
           F  E   +    + N++K+L  C            L++E+M    L E+L  +S      
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151
Query: 120 ------ETYKR-----PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168
                  T  R     P          IA  VA+ + YL         H  L   N L+ 
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVG 208
Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
           ++M  ++ DFGL+R +       +  +    I ++ PE    N  +T  DV++YG++L E
Sbjct: 209 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268
Query: 229 LM 230
           + 
Sbjct: 269 IF 270

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 206 VDIWSVGCIMGE-MVRHK---ILFPG 227

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGY 202
           AL +LH +      H  +K  N+LL  D + ++ DFG    + P +++ S++   G+  +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYW 182
Query: 203 IAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +APE           D++S GI+ +E++  E P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 142 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 198
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 199 VDIWSVGCIMGE-MVRHK---ILFPG 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 206 VDIWSVGCIMGE-MVRHK---ILFPG 227

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 143 ALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGY 202
           AL +LH +      H  +K  N+LL  D + ++ DFG    + P +++ S  ++ G+  +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--EMVGTPYW 182
Query: 203 IAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           +APE           D++S GI+ +E++  E P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 74/177 (41%), Gaps = 19/177 (10%)
Query: 62  SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET 121
            F+ E   + ++ H +L+++L  CL    Q      LV + M +  L E+++        
Sbjct: 86  EFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH-------- 131
Query: 122 YKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
            +              + +A  + YL    +    H  L   NVL+      ++ DFGLA
Sbjct: 132 -EHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA 187
Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM-IREKPSD 237
           R L     + ++   K  I ++A E     + +   DV+SYG+ + ELM    KP D
Sbjct: 188 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 75/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +       
Sbjct: 65  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANN 119
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 120 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 176
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 177 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 230

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 9/100 (9%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK-G 198
           + SA+ Y H   Q    H  LK  N+LLD DM  ++ DFG +       T    +D   G
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF----TVGGKLDAFCG 175
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSD 237
           +  Y APE   G +      DV+S G++L  L+    P D
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 35/204 (17%)
Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +G   + I E   L+ ++HRN+I++ +         N    L++E+  N  LK+++    
Sbjct: 74  EGVPGTAIREVSLLKELQHRNIIELKSVI-----HHNHRLHLIFEYAEN-DLKKYM---D 124
Query: 117 KEDETYKRPXXXXXXXXXXIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLL-----DDD 170
           K  +   R               + + +N+ H   C     H  LKP N+LL      + 
Sbjct: 125 KNPDVSMR-------VIKSFLYQLINGVNFCHSRRC----LHRDLKPQNLLLSVSDASET 173
Query: 171 MTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLE 228
              ++GDFGLAR F  P R  T  I    ++ Y  PE  +G+   ST  D++S   +  E
Sbjct: 174 PVLKIGDFGLARAFGIPIRQFTHEII---TLWYRPPEILLGSRHYSTSVDIWSIACIWAE 230
Query: 229 LMIREKPSDIMFEGDMNLHKFAKM 252
           ++++      +F GD  + +  K+
Sbjct: 231 MLMKTP----LFPGDSEIDQLFKI 250

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 33/183 (18%)
Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL--------- 112
            ++E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L         
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGME 141
Query: 113 --YPISK---EDETYKRPXXXXXXXXXXIAIDVASALNYL-HHDCQPVTAHCVLKPSNVL 166
             Y I++   E  T+K                +A  + YL    C     H  L   NVL
Sbjct: 142 YSYDINRVPEEQMTFK--------DLVSCTYQLARGMEYLASQKC----IHRDLAARNVL 189
Query: 167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
           + ++   R+ DFGLAR +        + + +  + ++APE       +   DV+S+G+L+
Sbjct: 190 VTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 227 LEL 229
            E+
Sbjct: 250 WEI 252

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 206 VDIWSVGCIMGE-MVRHK---ILFPG 227

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 148 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 204
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 205 VDIWSVGCIMGE-MVRHK---ILFPG 226

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 205
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 206 VDIWSVGCIMGE-MVRHK---ILFPG 227

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 243
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 244 VDIWSVGCIMGE-MVRHK---ILFPG 265

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 206
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 207 VDIWSVGCIMGE-MVRHK---ILFPG 228

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 206
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 207 VDIWSVGCIMGE-MVRHK---ILFPG 228

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 198
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 199 VDIWSVGCIMGE-MVRHK---ILFPG 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 199
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 200 VDIWSVGCIMGE-MVRHK---ILFPG 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 199
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 200 VDIWSVGCIMGE-MVRHK---ILFPG 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 239
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 240 ILGILGS 246

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI 216
           H  LKPSN+++  D T ++ DFGLAR    +   T  +  +    Y APE  +G      
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKEN 243
Query: 217 GDVYSYGILLLELMIREKPSDIMFEG 242
            D++S G ++ E M+R K   I+F G
Sbjct: 244 VDIWSVGCIMGE-MVRHK---ILFPG 265

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           LR+Q   +    E   +R+ +H N++++  + L     G +   L+ EF+   +L + + 
Sbjct: 80  LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL----VGEELWVLM-EFLQGGALTDIVS 134
Query: 114 PISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
            +   +E               +   V  AL YLH   Q V  H  +K  ++LL  D   
Sbjct: 135 QVRLNEEQ-----------IATVCEAVLQALAYLH--AQGVI-HRDIKSDSILLTLDGRV 180
Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE 233
           ++ DFG    +  ++       + G+  ++APE    +  +T  D++S GI+++E++  E
Sbjct: 181 KLSDFGFCAQI--SKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
Query: 234 KP--SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAK 285
            P  SD   +    L       L N  K  V  +L +  E+++VR  Q++  A+
Sbjct: 239 PPYFSDSPVQAMKRLRDSPPPKLKNSHK--VSPVLRDFLERMLVRDPQERATAQ 290

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 243
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 244 ILGILGS 250

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 61  KSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL------- 112
           ++ ++E K L +I H  N++ +L AC      G     +V EF    +L  +L       
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEF 130
Query: 113 --YPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLL 167
             Y ++ ED  YK             +  VA  + +L       +  C+   L   N+LL
Sbjct: 131 VPYKVAPED-LYK--DFLTLEHLICYSFQVAKGMEFL------ASRKCIHRDLAARNILL 181
Query: 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI-GDVYSYGILL 226
            +    ++ DFGLAR +          D +  + ++APE  + + V TI  DV+S+G+LL
Sbjct: 182 SEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLL 240
Query: 227 LELM 230
            E+ 
Sbjct: 241 WEIF 244

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           IA+ +  AL +LH     +  H  +KPSNVL++     +  DFG++ +L         ID
Sbjct: 141 IAVSIVKALEHLHSKLSVI--HRDVKPSNVLINALGQVKXCDFGISGYL--VDDVAKDID 196
Query: 196 VKGSIGYIAPEYGVGNEVSTIG-----DVYSYGILLLELMIREKPSD 237
             G   Y APE  +  E++  G     D++S GI  +EL I   P D
Sbjct: 197 A-GCKPYXAPER-INPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 75/174 (43%), Gaps = 9/174 (5%)
Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     +++++L    GV  QG     ++ E M    LK +L  +       
Sbjct: 75  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 123 KRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
                        +A ++A  + YL+ +      H  L   N ++ +D T ++GDFG+ R
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL-MIREKP 235
            +  T            + +++PE       +T  DV+S+G++L E+  + E+P
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-S 214
            H  +KP N+LLD+    ++ DFGLA        +     + G++ Y+APE     E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 215 TIGDVYSYGILLLELMIREKPSD 237
              DV+S GI+L  ++  E P D
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 5/76 (6%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVS 214
           H  LKP N+L++ +   ++ DFGLAR F  P R  T  +    ++ Y AP+  +G+ + S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYRAPDVLMGSKKYS 179
Query: 215 TIGDVYSYGILLLELM 230
           T  D++S G +  E++
Sbjct: 180 TTIDIWSVGCIFAEMV 195

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 33/186 (17%)
Query: 60  FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL------ 112
               ++E + ++ I +H+N+I +L AC     Q      +V E+    +L+E+L      
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPP 138
Query: 113 -----YPISK---EDETYKRPXXXXXXXXXXIAIDVASALNYL-HHDCQPVTAHCVLKPS 163
                Y I++   E  T+K                +A  + YL    C     H  L   
Sbjct: 139 GMEXSYDINRVPEEQMTFK--------DLVSCTYQLARGMEYLASQKC----IHRDLAAR 186
Query: 164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYG 223
           NVL+ ++   ++ DFGLAR +        + + +  + ++APE       +   DV+S+G
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 224 ILLLEL 229
           +L+ E+
Sbjct: 247 VLMWEI 252

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 5/76 (6%)
Query: 157 HCVLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVS 214
           H  LKP N+L++ +   ++ DFGLAR F  P R  T  +    ++ Y AP+  +G+ + S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYRAPDVLMGSKKYS 179
Query: 215 TIGDVYSYGILLLELM 230
           T  D++S G +  E++
Sbjct: 180 TTIDIWSVGCIFAEMV 195

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 239
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 240 ILGILGS 246

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 243
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 244 ILGILGS 250

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 61  KSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL------- 112
           ++ ++E K L +I H  N++ +L AC      G     +V EF    +L  +L       
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEF 121
Query: 113 --YPISKEDETYKRPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLL 167
             Y ++ ED  YK             +  VA  + +L       +  C+   L   N+LL
Sbjct: 122 VPYKVAPED-LYK--DFLTLEHLICYSFQVAKGMEFL------ASRKCIHRDLAARNILL 172
Query: 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI-GDVYSYGILL 226
            +    ++ DFGLAR +          D +  + ++APE  + + V TI  DV+S+G+LL
Sbjct: 173 SEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLL 231
Query: 227 LELM 230
            E+ 
Sbjct: 232 WEIF 235

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 23/169 (13%)
Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E + L+ ++H NL+ +L       ++      LV+E+  +  L E         + Y+
Sbjct: 50  LREIRMLKQLKHPNLVNLLEV-----FRRKRRLHLVFEYCDHTVLHEL--------DRYQ 96
Query: 124 RPXXXXXXXXXXIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           R           I      A+N+ H H+C     H  +KP N+L+      ++ DFG AR
Sbjct: 97  R--GVPEHLVKSITWQTLQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFAR 150
Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELM 230
            L  T       D   +  Y +PE  VG+ +     DV++ G +  EL+
Sbjct: 151 LL--TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 29/184 (15%)
Query: 60  FKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYEFMHNRSLK-- 109
               ++E + ++ I +H+N+I +L AC         V+Y     K  + E++  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREYLRARRPPGM 140
Query: 110 EWLYPISK---EDETYKRPXXXXXXXXXXIAIDVASALNYL-HHDCQPVTAHCVLKPSNV 165
           E+ Y I++   E  T+K                +A  + YL    C     H  L   NV
Sbjct: 141 EYSYDINRVPEEQMTFK--------DLVSCTYQLARGMEYLASQKC----IHRDLAARNV 188
Query: 166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL 225
           L+ ++   ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+L
Sbjct: 189 LVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 226 LLEL 229
           + E+
Sbjct: 249 MWEI 252

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 243
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 244 ILGILGS 250

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 244
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 245 ILGILGS 251

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 139 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 245
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 246 ILGILGS 252

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 130 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 236
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 237 ILGILGS 243

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 243
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 244 ILGILGS 250

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 237
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 238 ILGILGS 244

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSI-DVKG 198
           +   L Y+H        H  LKPSN+LL+     ++ DFGLAR   P    T  + +   
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 199 SIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH 257
           +  Y APE  + ++  T   D++S G +L E M+  +P   +F G   L +       NH
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRP---IFPGKHYLDQL------NH 259
Query: 258 VKDIVDS 264
           +  I+ S
Sbjct: 260 ILGILGS 266

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	381
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-58
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-49
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-48
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-44
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-38
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-37
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-36
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-34
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-29
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-18
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-17
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-17
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-16
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-16
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-16
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-16
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-16
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-16
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-16
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-15
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-15
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-14
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-14
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-14
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-14
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-14
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-13
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-13
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-12
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-12
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-12
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-11
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-11
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-11
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-11
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-10
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-10
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-10
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-10
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-10
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-10
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-10
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-10
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-10
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-10
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-10
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-10
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-09
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-09
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-09
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-09
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-09
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-09
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-09
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-09
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-09
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-09
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-09
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-09
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-09
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-09
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-09
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-09
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-09
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-09
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-09
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-08
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-08
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-08
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-08
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-08
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-08
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-08
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-08
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-08
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-08
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-08
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-08
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-08
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-08
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-08
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-08
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-08
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-08
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-08
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-08
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-08
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-08
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-07
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-07
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-07
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-07
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-07
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-07
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-07
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-07
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-07
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-06
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-06
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-05
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-05
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-05
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-04
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-07
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-07
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-06
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-06
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-04
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-04
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-04
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-06
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-06
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-06
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-05
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-04
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-05
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-05
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-05
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-05
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-05
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-04
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-04
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-04
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-04
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-04
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-04
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  192 bits (490), Expect = 1e-58
 Identities = 89/315 (28%), Positives = 143/315 (45%), Gaps = 51/315 (16%)

Query: 30  EILDVSRNMLEENLISAGTFGF-----------------SHLRRQGAFKSFIAECKALRN 72
           E+   S N   +N++  G FG                     R QG    F  E + +  
Sbjct: 24  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83

Query: 73  IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLR 132
             HRNL+++   C+       + + LVY +M N S+   L       E  +    L+  +
Sbjct: 84  AVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR------ERPESQPPLDWPK 132

Query: 133 RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTS 192
           R  IA+  A  L YLH  C P   H  +K +N+LLD++  A VGDFGLA+ +    T  +
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192

Query: 193 SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF---EGDMNLHKF 249
           +  V+G+IG+IAPEY    + S   DV+ YG++LLEL+  ++  D+     + D+ L  +
Sbjct: 193 T-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 250 AKMALSN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESP 308
            K  L    ++ +VD  L                  + N   E V  ++++ + C+  SP
Sbjct: 252 VKGLLKEKKLEALVDVDL------------------QGNYKDEEVEQLIQVALLCTQSSP 293

Query: 309 QDRMKMTNVVHELQS 323
            +R KM+ VV  L+ 
Sbjct: 294 MERPKMSEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  168 bits (429), Expect = 1e-49
 Identities = 77/314 (24%), Positives = 132/314 (42%), Gaps = 52/314 (16%)

Query: 30  EILDVSRNMLEENLISAGTFG-----------------FSHLRRQGAFKSFIAECKALRN 72
           ++ + + N   + LI  G FG                  +    QG  + F  E + L  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG-IEEFETEIETLSF 91

Query: 73  IRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLR 132
            RH +L+ ++  C   +        L+Y++M N +LK  LY       +     +++  +
Sbjct: 92  CRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLY------GSDLPTMSMSWEQ 140

Query: 133 RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTS 192
           RL I I  A  L+YLH        H  +K  N+LLD++   ++ DFG+++          
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197

Query: 193 SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF-EGDMNLHKFAK 251
           S  VKG++GYI PEY +   ++   DVYS+G++L E++              +NL ++A 
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257

Query: 252 MALSN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQD 310
            + +N  ++ IVD  L                  KI    E +       V C   S +D
Sbjct: 258 ESHNNGQLEQIVDPNL----------------ADKIRP--ESLRKFGDTAVKCLALSSED 299

Query: 311 RMKMTNVVHELQSI 324
           R  M +V+ +L+  
Sbjct: 300 RPSMGDVLWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  164 bits (418), Expect = 3e-48
 Identities = 68/271 (25%), Positives = 110/271 (40%), Gaps = 39/271 (14%)

Query: 56  RQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPI 115
            +   + F  E K +   +H NL+++L         G+D   LVY +M N SL + L   
Sbjct: 71  EEL-KQQFDQEIKVMAKCQHENLVELLGFSS----DGDD-LCLVYVYMPNGSLLDRLS-- 122

Query: 116 SKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175
                    P  L+   R  IA   A+ +N+LH +      H  +K +N+LLD+  TA++
Sbjct: 123 ---CLDGTPP--LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKI 174

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
            DFGLAR          +  + G+  Y+APE   G E++   D+YS+G++LLE++     
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233

Query: 236 SDIMFEGDMNLHKFAKMALSN--HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV 293
            D   E    L    +        ++D +D  + + D   V                   
Sbjct: 234 VDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEA----------------- 275

Query: 294 ISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
             M  +   C  E    R  +  V   LQ +
Sbjct: 276 --MYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  154 bits (390), Expect = 5e-44
 Identities = 54/274 (19%), Positives = 101/274 (36%), Gaps = 34/274 (12%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
              E  +L  ++H N+++ + A         D   L+  F    SL ++L          
Sbjct: 65  NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFL---------- 113

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHD-------CQPVTAHCVLKPSNVLLDDDMTARV 175
            +   ++     +IA  +A  L YLH D        +P  +H  +K  NVLL +++TA +
Sbjct: 114 -KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEY-----GVGNEVSTIGDVYSYGILLLELM 230
            DFGLA      ++   +    G+  Y+APE          +     D+Y+ G++L EL 
Sbjct: 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

Query: 231 IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIR 290
            R   +D   +  M       +     +        L D +++VV   ++          
Sbjct: 233 SRCTAADGPVDEYM-------LPFEEEIGQHPS---LEDMQEVVVHKKKRPVLRDYWQKH 282

Query: 291 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
             +  +      C     + R+    V   +  +
Sbjct: 283 AGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  138 bits (349), Expect = 4e-38
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 15/177 (8%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
               F+ E   ++ +RH N++  + A      Q  +  ++V E++   SL   L+     
Sbjct: 77  RVNEFLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVTEYLSRGSLYRLLH----- 126

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
                    L+  RRL++A DVA  +NYLH+   P   H  LK  N+L+D   T +V DF
Sbjct: 127 --KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDF 183

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           GL+R    T   + S    G+  ++APE       +   DVYS+G++L EL   ++P
Sbjct: 184 GLSRLKASTFLSSKS--AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  137 bits (347), Expect = 1e-37
 Identities = 60/297 (20%), Positives = 107/297 (36%), Gaps = 41/297 (13%)

Query: 61  KSFIAECK--ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           ++FI E     +  + H N+ + +     V   G     LV E+  N SL ++L      
Sbjct: 50  QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------ 103

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHD------CQPVTAHCVLKPSNVLLDDDMT 172
                     + +    +A  V   L YLH +       +P  +H  L   NVL+ +D T
Sbjct: 104 -----SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158

Query: 173 ARVGDFGLARFLPPTR------TQTSSIDVKGSIGYIAPEY-------GVGNEVSTIGDV 219
             + DFGL+  L   R         ++I   G+I Y+APE                  D+
Sbjct: 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218

Query: 220 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQ 279
           Y+ G++  E+ +R   +D+     +  +   +MA    V +        D + LV R  Q
Sbjct: 219 YALGLIYWEIFMR--CTDLFPGESVPEY---QMAFQTEVGNHPT---FEDMQVLVSREKQ 270

Query: 280 KQT-QAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLA 335
           +             V S+      C  +  + R+        +  +       K+++
Sbjct: 271 RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  135 bits (341), Expect = 5e-37
 Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 50/279 (17%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +  +   K+FI E + L  + H N++K+  ACL      N    LV E+    SL   L+
Sbjct: 39  IESESERKAFIVELRQLSRVNHPNIVKLYGACL------NPV-CLVMEYAEGGSLYNVLH 91

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT- 172
                    +          ++  +  +  + YLH        H  LKP N+LL    T 
Sbjct: 92  -------GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
            ++ DFG A  +    T       KGS  ++APE   G+  S   DV+S+GI+L E++ R
Sbjct: 145 LKICDFGTACDIQTHMTNN-----KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR 199

Query: 233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIREC 292
            KP    F+            +      I+ ++  ++  +               +I+  
Sbjct: 200 RKP----FDE-----------IGGPAFRIMWAV--HNGTRPP-------------LIKNL 229

Query: 293 VISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP 331
              +  +   C  + P  R  M  +V  +  +     G 
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  132 bits (335), Expect = 2e-36
 Identities = 51/274 (18%), Positives = 96/274 (35%), Gaps = 59/274 (21%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
             + F  EC  LR   H N++ VL AC            L+  +M   SL   L+     
Sbjct: 50  KSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHE---- 102

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
                    ++  + +  A+D+A  + +LH   +P+     L   +V++D+DMTAR+   
Sbjct: 103 ----GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMA 157

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMIR 232
            +             +    +  ++APE             +   D++S+ +LL EL+ R
Sbjct: 158 DVKFS----FQSPGRM---YAPAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTR 207

Query: 233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIREC 292
           E P    F   ++  +         +                          +  I    
Sbjct: 208 EVP----FAD-LSNMEIGMKVALEGL--------------------------RPTIPPGI 236

Query: 293 VISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326
              + ++   C  E P  R K   +V  L+ +++
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  126 bits (320), Expect = 3e-34
 Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 28/185 (15%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
             ++   E K    ++H N+I +   CL    +  +   LV EF     L   L      
Sbjct: 49  TIENVRQEAKLFAMLKHPNIIALRGVCL----KEPNL-CLVMEFARGGPLNRVL------ 97

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD--------DD 170
                  + +     +N A+ +A  +NYLH +      H  LK SN+L+          +
Sbjct: 98  -----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
              ++ DFGLAR       +T+ +   G+  ++APE    +  S   DV+SYG+LL EL+
Sbjct: 153 KILKITDFGLAREW----HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208

Query: 231 IREKP 235
             E P
Sbjct: 209 TGEVP 213

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  126 bits (319), Expect = 5e-34
 Identities = 48/272 (17%), Positives = 97/272 (35%), Gaps = 58/272 (21%)

Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           F+ F  E   + N+ H N++K+            +   +V EF+    L   L       
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDLYHRLL------ 113

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-----DDMTAR 174
               +   +    +L + +D+A  + Y+ +   P   H  L+  N+ L        + A+
Sbjct: 114 ---DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE--YGVGNEVSTIGDVYSYGILLLELMIR 232
           V DFGL++      + +  +   G+  ++APE         +   D YS+ ++L  ++  
Sbjct: 170 VADFGLSQQS--VHSVSGLL---GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

Query: 233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIREC 292
           E P    F+   +  K   +                    ++     + T     I  +C
Sbjct: 225 EGP----FDE-YSYGKIKFIN-------------------MIREEGLRPT-----IPEDC 255

Query: 293 VISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
              +  +   C    P+ R   + +V EL  +
Sbjct: 256 PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  126 bits (319), Expect = 5e-34
 Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 21/180 (11%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
             ++F  E   LR  RH N++  +              A+V ++    SL   L+     
Sbjct: 63  QLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL------AIVTQWCEGSSLYHHLH----- 111

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
                      + + ++IA   A  ++YLH   + +  H  LK +N+ L +D T ++GDF
Sbjct: 112 ----ASETKFEMKKLIDIARQTARGMDYLH--AKSII-HRDLKSNNIFLHEDNTVKIGDF 164

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP 235
           GLA              + GSI ++APE       N  S   DVY++GI+L ELM  + P
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  118 bits (298), Expect = 8e-31
 Identities = 42/189 (22%), Positives = 70/189 (37%), Gaps = 30/189 (15%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
             K+F  E  A R  RH N++  + AC+          A++      R+L   +      
Sbjct: 72  QLKAFKREVMAYRQTRHENVVLFMGACM----SPPHL-AIITSLCKGRTLYSVVR----- 121

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
                    L++ +   IA ++   + YLH   + +  H  LK  NV   D+    + DF
Sbjct: 122 ----DAKIVLDVNKTRQIAQEIVKGMGYLH--AKGIL-HKDLKSKNVFY-DNGKVVITDF 173

Query: 179 GLARFLPPTRTQTSSIDVK---GSIGYIAPE---------YGVGNEVSTIGDVYSYGILL 226
           GL       +       ++   G + ++APE                S   DV++ G + 
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233

Query: 227 LELMIREKP 235
            EL  RE P
Sbjct: 234 YELHAREWP 242

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  118 bits (298), Expect = 1e-30
 Identities = 57/285 (20%), Positives = 100/285 (35%), Gaps = 40/285 (14%)

Query: 60  FKSFIAECK--ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
             S+  E +      +RH N++  + A +           L+ ++  N SL ++L     
Sbjct: 73  EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL-YLITDYHENGSLYDYL----- 126

Query: 118 EDETYKRPRNLNLLRRLNIAIDVASALNYLH-----HDCQPVTAHCVLKPSNVLLDDDMT 172
                 +   L+    L +A    S L +LH        +P  AH  LK  N+L+  + T
Sbjct: 127 ------KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIG---YIAPE------YGVGNEVSTIGDVYSYG 223
             + D GLA       T    I     +G   Y+ PE           +   + D+YS+G
Sbjct: 181 CCIADLGLAVKFISD-TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

Query: 224 ILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQ 283
           ++L E+  R     I+ E  +  H       S             D  ++V     + + 
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPS-----------YEDMREIVCIKKLRPSF 288

Query: 284 AKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL 328
                  EC+  M ++   C   +P  R+    V   L  +  + 
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  117 bits (295), Expect = 1e-30
 Identities = 48/280 (17%), Positives = 106/280 (37%), Gaps = 38/280 (13%)

Query: 60  FKSFIAECK--ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISK 117
            KS+  E +      +RH N++  + + +   +       L+  +    SL ++L     
Sbjct: 44  EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL-WLITHYHEMGSLYDYL----- 97

Query: 118 EDETYKRPRNLNLLRRLNIAIDVASALNYLHHD-----CQPVTAHCVLKPSNVLLDDDMT 172
                 +   L+ +  L I + +AS L +LH +      +P  AH  LK  N+L+  +  
Sbjct: 98  ------QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151

Query: 173 ARVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPE------YGVGNEVSTIGDVYSYGI 224
             + D GLA     +       +    G+  Y+APE           +     D++++G+
Sbjct: 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211

Query: 225 LLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQA 284
           +L E+  R   + I+ +       F  +  ++   + +  ++  D ++  +         
Sbjct: 212 VLWEVARRMVSNGIVEDYKP---PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFS--- 265

Query: 285 KINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
                   + S+ ++   C  ++P  R+    +   L  I
Sbjct: 266 -----DPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  113 bits (285), Expect = 8e-29
 Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 29/195 (14%)

Query: 61  KSFIAECK--ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           +S+  E +      +RH N++  + A    +        LV ++  + SL ++L      
Sbjct: 79  RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYL------ 131

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHD-----CQPVTAHCVLKPSNVLLDDDMTA 173
                    + +   + +A+  AS L +LH +      +P  AH  LK  N+L+  + T 
Sbjct: 132 -----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIG---YIAPE--YGVGN----EVSTIGDVYSYGI 224
            + D GLA       T T  I     +G   Y+APE      N    E     D+Y+ G+
Sbjct: 187 CIADLGLAVRHDSA-TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245

Query: 225 LLLELMIREKPSDIM 239
           +  E+  R     I 
Sbjct: 246 VFWEIARRCSIGGIH 260

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  112 bits (282), Expect = 2e-28
 Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 29/187 (15%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E K +R + H N++K +       Y+       + E++   +L+  +        
Sbjct: 52  RTFLKEVKVMRCLEHPNVLKFIGVL----YKDKRL-NFITEYIKGGTLRGIIK------- 99

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                      +R++ A D+AS + YLH     +  H  L   N L+ ++    V DFGL
Sbjct: 100 --SMDSQYPWSQRVSFAKDIASGMAYLH--SMNII-HRDLNSHNCLVRENKNVVVADFGL 154

Query: 181 ARFLPPTRTQTSSID------------VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
           AR +   +TQ   +             V G+  ++APE   G       DV+S+GI+L E
Sbjct: 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214

Query: 229 LMIREKP 235
           ++ R   
Sbjct: 215 IIGRVNA 221

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 28/195 (14%)

Query: 52  SHLRRQGAFKS-FIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFMHNRSLK 109
              R +      F  E      + H+N++ ++      D  + +D   LV E++   +L 
Sbjct: 46  IPPREKEETLKRFEREVHNSSQLSHQNIVSMI------DVDEEDDCYYLVMEYIEGPTLS 99

Query: 110 EWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169
           E++          +    L++   +N    +   + +  HD + V  H  +KP N+L+D 
Sbjct: 100 EYI----------ESHGPLSVDTAINFTNQILDGIKH-AHDMRIV--HRDIKPQNILIDS 146

Query: 170 DMTARVGDFGLARFL-PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
           + T ++ DFG+A+ L   + TQT+   V G++ Y +PE   G       D+YS GI+L E
Sbjct: 147 NKTLKIFDFGIAKALSETSLTQTNH--VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204

Query: 229 LMIREKPSDIMFEGD 243
           +++ E P    F G+
Sbjct: 205 MLVGEPP----FNGE 215

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 94.5 bits (235), Expect = 3e-21
 Identities = 35/185 (18%), Positives = 71/185 (38%), Gaps = 27/185 (14%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
            +AE + L  + H +++++       D  G+    +V E++  +SLK             
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR------------ 173

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
            + + L +   +   +++  AL+YLH     +  +  LKP N++L ++   ++ D G   
Sbjct: 174 SKGQKLPVAEAIAYLLEILPALSYLHS--IGL-VYNDLKPENIMLTEE-QLKLIDLGAVS 229

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
                        + G+ G+ APE       +   D+Y+ G  L  L +          G
Sbjct: 230 ----RINSFGY--LYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT----RNG 278

Query: 243 DMNLH 247
                
Sbjct: 279 RYVDG 283

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 32/200 (16%)

Query: 52  SHLRRQGAFKS-FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA-LVYEFMHNRSLK 109
           + L R  +F   F  E +    + H  ++ V     G           +V E++   +L+
Sbjct: 47  ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT--GEAETPAGPLPYIVMEYVDGVTLR 104

Query: 110 EWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVL 166
           + +               +   R + +  D   ALN+ H           H  +KP+N++
Sbjct: 105 DIV----------HTEGPMTPKRAIEVIADACQALNFSHQ------NGIIHRDVKPANIM 148

Query: 167 LDDDMTARVGDFGLARFL---PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYG 223
           +      +V DFG+AR +     + TQT++  V G+  Y++PE   G+ V    DVYS G
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQARGDSVDARSDVYSLG 206

Query: 224 ILLLELMIREKPSDIMFEGD 243
            +L E++  E P    F GD
Sbjct: 207 CVLYEVLTGEPP----FTGD 222

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 41/181 (22%), Positives = 78/181 (43%), Gaps = 29/181 (16%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F++E   +++  H N+I++L  C+ +  QG     ++  FM    L  +L        
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----LYSR 136

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
               P+++ L   L   +D+A  + YL         + +   L   N +L DDMT  V D
Sbjct: 137 LETGPKHIPLQTLLKFMVDIALGMEYLS------NRNFLHRDLAARNCMLRDDMTVCVAD 190

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGILLLEL 229
           FGL++ +      +     +G I  +     A E     V    ++  DV+++G+ + E+
Sbjct: 191 FGLSKKI-----YSGDYYRQGRIAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEI 242

Query: 230 M 230
            
Sbjct: 243 A 243

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 19/169 (11%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++ I+H NL++     LGV  +   F  ++ EFM   +L ++L          
Sbjct: 263 FLKEAAVMKEIKHPNLVQ----LLGVCTREPPFY-IITEFMTYGNLLDYL--------RE 309

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
              + ++ +  L +A  ++SA+ YL   +      H  L   N L+ ++   +V DFGL+
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLS 365

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           R +    T T+    K  I + APE    N+ S   DV+++G+LL E+ 
Sbjct: 366 RLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 38/182 (20%), Positives = 70/182 (38%), Gaps = 25/182 (13%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
              E +    ++  +++ +     G    G  +  +    ++   L   L          
Sbjct: 81  MQREARTAGRLQEPHVVPIHDF--GEI-DGQLY--VDMRLINGVDLAAML---------- 125

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
           +R   L   R + I   + SAL+  H        H  +KP N+L+  D  A + DFG+A 
Sbjct: 126 RRQGPLAPPRAVAIVRQIGSALDAAHAA-GAT--HRDVKPENILVSADDFAYLVDFGIAS 182

Query: 183 FLP-PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE 241
                  TQ  +    G++ Y+APE    +  +   D+Y+   +L E +    P    ++
Sbjct: 183 ATTDEKLTQLGN--TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQ 236

Query: 242 GD 243
           GD
Sbjct: 237 GD 238

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 40/185 (21%), Positives = 73/185 (39%), Gaps = 36/185 (19%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL-VYEFMHNRSLKEWLYPISKED 119
           + F+ E   ++   H ++ K++   L    +G     + +  FM +  L  +L       
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL----LAS 125

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTA 173
              + P NL L   +   +D+A  + YL      H D         L   N +L +DMT 
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRD---------LAARNCMLAEDMTV 176

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGIL 225
            V DFGL+R +      +     +G    +     A E     +    +   DV+++G+ 
Sbjct: 177 CVADFGLSRKI-----YSGDYYRQGCASKLPVKWLALESLADNL---YTVHSDVWAFGVT 228

Query: 226 LLELM 230
           + E+M
Sbjct: 229 MWEIM 233

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 20/169 (11%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E + ++ +RH  L+++            +   +V E+M   SL ++L          
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL--------KG 271

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
           +  + L L + +++A  +AS + Y+   +      H  L+ +N+L+ +++  +V DFGLA
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLA 327

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           R +      T+    K  I + APE  +    +   DV+S+GILL EL 
Sbjct: 328 RLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 87.2 bits (216), Expect = 7e-19
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 20/169 (11%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E + ++ +RH  L+++            +   +V E+M   SL ++L          
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL--------KG 354

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
           +  + L L + +++A  +AS + Y+   +      H  L+ +N+L+ +++  +V DFGLA
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLA 410

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           R +      T+    K  I + APE  +    +   DV+S+GILL EL 
Sbjct: 411 RLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 22/171 (12%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+AE   +  +RH NL+++L   +    +      +V E+M   SL ++L        
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYL-------- 278

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
             +    L     L  ++DV  A+ YL  ++      H  L   NVL+ +D  A+V DFG
Sbjct: 279 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFG 334

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           L +        ++    K  + + APE     + ST  DV+S+GILL E+ 
Sbjct: 335 LTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 38/169 (22%), Positives = 75/169 (44%), Gaps = 20/169 (11%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+AE   ++ ++H  L+K+            +   ++ EFM   SL ++L          
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKS-------- 275

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA 181
                  L + ++ +  +A  + ++   +      H  L+ +N+L+   +  ++ DFGLA
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLA 331

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           R +      T+    K  I + APE       +   DV+S+GILL+E++
Sbjct: 332 RVIEDN-EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 41/183 (22%), Positives = 74/183 (40%), Gaps = 36/183 (19%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
             A K  + E   + ++ + ++ ++L  CL    Q      L+ + M    L +++    
Sbjct: 58  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR--- 108

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDD 170
                 +   N+     LN  + +A  +NYL      H D         L   NVL+   
Sbjct: 109 ------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD---------LAARNVLVKTP 153

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLL 227
              ++ DFGLA+ L     +  +   K  I ++A E   + +    +   DV+SYG+ + 
Sbjct: 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI---YTHQSDVWSYGVTVW 210

Query: 228 ELM 230
           ELM
Sbjct: 211 ELM 213

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 82.3 bits (204), Expect = 6e-18
 Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 44/228 (19%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA-----------LVYEFMHNRSLKEWLYP 114
           E KAL  + H N++       G DY                  +  EF    +L++W   
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW--- 110

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLH-----H-DCQPVTAHCVLKPSNVLLD 168
           I K     +R   L+ +  L +   +   ++Y+H     + D         LKPSN+ L 
Sbjct: 111 IEK-----RRGEKLDKVLALELFEQITKGVDYIHSKKLINRD---------LKPSNIFLV 156

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
           D    ++GDFGL   L     +T S    G++ Y++PE     +     D+Y+ G++L E
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

Query: 229 LMIREKPSDIMFEGDMNLHKFAKMALSNHV----KDIVDSILLNDDEK 272
           L+         FE            +S+      K ++  +L    E 
Sbjct: 214 LLHVCDT---AFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPED 258

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 41/179 (22%), Positives = 76/179 (42%), Gaps = 30/179 (16%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   ++     ++++     LGV  QG     ++ E M    LK +L  +       
Sbjct: 75  FLNEASVMKEFNCHHVVR----LLGVVSQGQPT-LVIMELMTRGDLKSYLRSLRPAMANN 129

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGDFG 179
                 +L + + +A ++A  + YL+          V   L   N ++ +D T ++GDFG
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLN------ANKFVHRDLAARNCMVAEDFTVKIGDFG 183

Query: 180 LARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGILLLELM 230
           + R +       +    KG  G +     +PE    GV    +T  DV+S+G++L E+ 
Sbjct: 184 MTRDI-----YETDYYRKGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIA 234

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 33/178 (18%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
             F+ E + L+   H N+++     +GV  Q      +V E +       +L        
Sbjct: 157 AKFLQEARILKQYSHPNIVR----LIGVCTQKQPI-YIVMELVQGGDFLTFLR------- 204

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
                  L +   L +  D A+ + YL       +  C+   L   N L+ +    ++ D
Sbjct: 205 --TEGARLRVKTLLQMVGDAAAGMEYLE------SKCCIHRDLAARNCLVTEKNVLKISD 256

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYI-----APEYGVGNEVSTIGDVYSYGILLLELM 230
           FG++R               G +  +     APE       S+  DV+S+GILL E  
Sbjct: 257 FGMSREE-----ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 30/178 (16%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           +F++      A+ ++ H +++++L  C G   Q      LV +++   SL + +      
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVR----- 106

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMT 172
               +    L     LN  + +A  + YL      H +         L   NVLL     
Sbjct: 107 ----QHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRN---------LAARNVLLKSPSQ 153

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
            +V DFG+A  LPP   Q    + K  I ++A E     + +   DV+SYG+ + ELM
Sbjct: 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 41/180 (22%), Positives = 73/180 (40%), Gaps = 30/180 (16%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
             A K  + E   + ++ + ++ ++L  CL    Q      L+ + M    L +++    
Sbjct: 58  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR--- 108

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDD 170
                 +   N+     LN  + +A  +NYL      H D         L   NVL+   
Sbjct: 109 ------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD---------LAARNVLVKTP 153

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
              ++ DFGLA+ L     +  +   K  I ++A E  +    +   DV+SYG+ + ELM
Sbjct: 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 46/181 (25%), Positives = 65/181 (35%), Gaps = 31/181 (17%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
             A   FI E  A+ ++ HRNLI++    L    +      +V E     SL + L    
Sbjct: 62  PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLR--- 112

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDD 170
                 K   +  L      A+ VA  + YL      H D         L   N+LL   
Sbjct: 113 ------KHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD---------LAARNLLLATR 157

Query: 171 MTARVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
              ++GDFGL R LP            K    + APE       S   D + +G+ L E+
Sbjct: 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

Query: 230 M 230
            
Sbjct: 218 F 218

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 34/245 (13%), Positives = 75/245 (30%), Gaps = 27/245 (11%)

Query: 33  DVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG 92
           +  + M EE L      G  + ++      FI     +++ + + +I+V        +  
Sbjct: 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD-ERDMWVL 178

Query: 93  NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQ 152
           + F        + ++  E L   S   ++      L    RL + + V   L  LHH   
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKS------LVHHARLQLTLQVIRLLASLHH--Y 230

Query: 153 PVTAHCVLKPSNVLLDDDMTARVGDFGLARFL-PPTRTQTSSIDVKGSIGYIAPEYGVGN 211
            +  H  L+P +++LD      +  F           +              A       
Sbjct: 231 GL-VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGR--GFAPPETTAERMLPFG 287

Query: 212 EVSTIG-----DVYSYGILLLELMIREKPSDIMFEGD-----MNLHKFAKMALSNHVKDI 261
           +          D ++ G+ +  +   + P       D           +   +   V+ +
Sbjct: 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAALGGSEWIFRSCKNIPQPVRAL 343

Query: 262 VDSIL 266
           ++  L
Sbjct: 344 LEGFL 348

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 40/176 (22%), Positives = 74/176 (42%), Gaps = 18/176 (10%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F  E + L+ ++H N+++   +             LV E M + +LK +L        
Sbjct: 70  QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI-VLVTELMTSGTLKTYL-------- 120

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMTARVGDFG 179
             KR + + +    +    +   L +LH    P   H  LK  N+ +     + ++GD G
Sbjct: 121 --KRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           LA     +  +     V G+  ++APE     +     DVY++G+ +LE+   E P
Sbjct: 178 LATLKRASFAKA----VIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 45/177 (25%), Positives = 71/177 (40%), Gaps = 30/177 (16%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
             +  E   LR + H ++IK    C            LV E++   SL+++L        
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL---QLVMEYVPLGSLRDYL-------- 126

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
                 ++ L + L  A  +   + YLH        H +   L   NVLLD+D   ++GD
Sbjct: 127 ---PRHSIGLAQLLLFAQQICEGMAYLH------AQHYIHRDLAARNVLLDNDRLVKIGD 177

Query: 178 FGLARFLPPTRTQ-TSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           FGLA+ +P          D    + + APE              DV+S+G+ L EL+
Sbjct: 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK---FYYASDVWSFGVTLYELL 231

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 40/174 (22%), Positives = 78/174 (44%), Gaps = 22/174 (12%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F  E + L++++H N++K    C      G     L+ E++   SL+++L        
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQ------- 105

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
             K    ++ ++ L     +   + YL       T   +   L   N+L++++   ++GD
Sbjct: 106 --KHKERIDHIKLLQYTSQICKGMEYLG------TKRYIHRDLATRNILVENENRVKIGD 157

Query: 178 FGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           FGL + LP  +         +  I + APE    ++ S   DV+S+G++L EL 
Sbjct: 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 39/179 (21%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVD--YQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           F+ E   ++ I+H NL+++L  C      Y       ++ EFM   +L ++L        
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPFY-------IITEFMTYGNLLDYL-------- 100

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                + ++ +  L +A  ++SA+ YL      H D         L   N L+ ++   +
Sbjct: 101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD---------LAARNCLVGENHLVK 151

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           V DFGL+R +    T T+    K  I + APE   Y      S   DV+++G+LL E+ 
Sbjct: 152 VADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK---FSIKSDVWAFGVLLWEIA 206

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 42/254 (16%), Positives = 85/254 (33%), Gaps = 56/254 (22%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIK-----VLTACLGVDYQGNDFKALVY---EFMHNR 106
             +    + ++E   L ++ H+ +++     +              K+ ++   E+  N 
Sbjct: 41  HTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENG 100

Query: 107 SLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLH-----H-DCQPVTAHCVL 160
           +L + ++             N        +   +  AL+Y+H     H D         L
Sbjct: 101 TLYDLIH---------SENLNQQRDEYWRLFRQILEALSYIHSQGIIHRD---------L 142

Query: 161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK------------GSIGYIAPEYG 208
           KP N+ +D+    ++GDFGLA+ +  +                      G+  Y+A E  
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE-- 200

Query: 209 VGNEVSTIG---DVYSYGILLLEL-------MIREKPSDIMFEGDMNLHKFAKMALSNHV 258
           V +         D+YS GI+  E+       M R      +    +              
Sbjct: 201 VLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE 260

Query: 259 KDIVDSILLNDDEK 272
           K I+  ++ +D  K
Sbjct: 261 KKIIRLLIDHDPNK 274

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 42/180 (23%), Positives = 71/180 (39%), Gaps = 42/180 (23%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F  E + +  + H  L+K      GV  +      +V E++ N  L  +L          
Sbjct: 50  FFQEAQTMMKLSHPKLVK----FYGVCSKEYPI-YIVTEYISNGCLLNYLR--------- 95

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
              + L   + L +  DV   + +L      H D         L   N L+D D+  +V 
Sbjct: 96  SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRD---------LAARNCLVDRDLCVKVS 146

Query: 177 DFGLARFLPP---TRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           DFG+ R++       +  +   VK    + APE   Y      S+  DV+++GIL+ E+ 
Sbjct: 147 DFGMTRYVLDDQYVSSVGTKFPVK----WSAPEVFHYFK---YSSKSDVWAFGILMWEVF 199

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 38/179 (21%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+AE   +  +RH NL+++L   +    +      +V E+M   SL ++L        
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRS------ 108

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTAR 174
             +    L     L  ++DV  A+ YL      H D         L   NVL+ +D  A+
Sbjct: 109 --RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD---------LAARNVLVSEDNVAK 157

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           V DFGL +        ++    K  + + APE          ST  DV+S+GILL E+ 
Sbjct: 158 VSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKK---FSTKSDVWSFGILLWEIY 208

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 77.2 bits (191), Expect = 2e-16
 Identities = 42/179 (23%), Positives = 72/179 (40%), Gaps = 40/179 (22%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVD--YQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           FI E + +  + H  L+++   CL             LV EFM +  L ++L        
Sbjct: 50  FIEEAEVMMKLSHPKLVQLYGVCLEQAPIC-------LVTEFMEHGCLSDYLR------- 95

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTAR 174
              +         L + +DV   + YL      H D         L   N L+ ++   +
Sbjct: 96  --TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD---------LAARNCLVGENQVIK 144

Query: 175 VGDFGLARFLPP---TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           V DFG+ RF+     T +  +   VK    + +PE    +  S+  DV+S+G+L+ E+ 
Sbjct: 145 VSDFGMTRFVLDDQYTSSTGTKFPVK----WASPEVFSFSRYSSKSDVWSFGVLMWEVF 199

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 41/174 (23%), Positives = 73/174 (41%), Gaps = 22/174 (12%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F  E + L+ +    ++K      G    G     LV E++ +  L+++L        
Sbjct: 69  RDFQREIQILKALHSDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQ------- 118

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
             +    L+  R L  +  +   + YL       +  CV   L   N+L++ +   ++ D
Sbjct: 119 --RHRARLDASRLLLYSSQICKGMEYLG------SRRCVHRDLAARNILVESEAHVKIAD 170

Query: 178 FGLARFLPPTR-TQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           FGLA+ LP  +         +  I + APE    N  S   DV+S+G++L EL 
Sbjct: 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 44/177 (24%), Positives = 83/177 (46%), Gaps = 36/177 (20%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L    K     
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFL----KTP--- 101

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                L + + L++A  +A  + ++      H D         L+ +N+L+ D ++ ++ 
Sbjct: 102 -SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD---------LRAANILVSDTLSCKIA 151

Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           DFGLAR +      T+    K  I + APE   YG     +   DV+S+GILL E++
Sbjct: 152 DFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIV 204

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 39/174 (22%), Positives = 78/174 (44%), Gaps = 22/174 (12%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F  E + L++++H N++K    C     +      L+ E++   SL+++L        
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQ------- 136

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
             K    ++ ++ L     +   + YL       T   +   L   N+L++++   ++GD
Sbjct: 137 --KHKERIDHIKLLQYTSQICKGMEYLG------TKRYIHRDLATRNILVENENRVKIGD 188

Query: 178 FGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           FGL + LP  +         +  I + APE    ++ S   DV+S+G++L EL 
Sbjct: 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 40/181 (22%), Positives = 72/181 (39%), Gaps = 36/181 (19%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
             F+ E   +++  H N++ +L  CL    +G+    +V  +M +  L+ ++        
Sbjct: 135 SQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR------- 183

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
                 N  +   +   + VA  + +L       +   V   L   N +LD+  T +V D
Sbjct: 184 --NETHNPTVKDLIGFGLQVAKGMKFLA------SKKFVHRDLAARNCMLDEKFTVKVAD 235

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGILLLEL 229
           FGLAR +     +        +   +     A E          +T  DV+S+G+LL EL
Sbjct: 236 FGLARDM---YDKEFDSVHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWEL 289

Query: 230 M 230
           M
Sbjct: 290 M 290

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 46/214 (21%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQG----NDFKALVY---EFMHNRSLKEWLY 113
           +  + E KAL  + H  +++   A L  +       +  K  +Y   +     +LK+W  
Sbjct: 48  EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW-- 105

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLH-----H-DCQPVTAHCVLKPSNVLL 167
            ++      +R R++ L    +I + +A A+ +LH     H D         LKPSN+  
Sbjct: 106 -MNGRCTIEERERSVCL----HIFLQIAEAVEFLHSKGLMHRD---------LKPSNIFF 151

Query: 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIG----------YIAPEYGVGNEVSTIG 217
             D   +VGDFGL   +     + + +    +            Y++PE   GN  S   
Sbjct: 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV 211

Query: 218 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251
           D++S G++L EL+         F   M   +   
Sbjct: 212 DIFSLGLILFELLYP-------FSTQMERVRTLT 238

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 43/262 (16%), Positives = 84/262 (32%), Gaps = 40/262 (15%)

Query: 23  VGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVL 82
           V         +  + M EE L      G  + ++      FI     +++ + + +I+V 
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164

Query: 83  TACLGVDYQGNDFKALVYEFMH--NRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDV 140
                  +  + F   +Y  M    ++  E L   S   ++      L    RL + + V
Sbjct: 165 -LDERDMWVLSRF--FLYPRMQSNLQTFGEVLLSHSSTHKS------LVHHARLQLTLQV 215

Query: 141 ASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSI 200
              L  LHH    +  H  L+P +++LD      +  F             SS     S 
Sbjct: 216 IRLLASLHH--YGL-VHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGARVVSS----VSR 266

Query: 201 GYIAPEYGVGNEVSTIG-----------DVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249
           G+  PE        +             D ++ G+++  +   + P       D  L   
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP----ITKDAALGGS 322

Query: 250 AK-----MALSNHVKDIVDSIL 266
                    +   V+ +++  L
Sbjct: 323 EWIFRSCKNIPQPVRALLEGFL 344

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 43/180 (23%), Positives = 73/180 (40%), Gaps = 42/180 (23%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           FI E K + N+ H  L++      GV  +      ++ E+M N  L  +L          
Sbjct: 66  FIEEAKVMMNLSHEKLVQ----LYGVCTKQRPI-FIITEYMANGCLLNYLR--------- 111

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
           +        + L +  DV  A+ YL      H D         L   N L++D    +V 
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD---------LAARNCLVNDQGVVKVS 162

Query: 177 DFGLARFLPP---TRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           DFGL+R++     T +  S   V+    +  PE   Y      S+  D++++G+L+ E+ 
Sbjct: 163 DFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK---FSSKSDIWAFGVLMWEIY 215

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 36/181 (19%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
                E + LRN+ H N++K    C      G +   L+ EF+ + SLKE+L        
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLP------- 117

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
             K    +NL ++L  A+ +   ++YL       +   V   L   NVL++ +   ++GD
Sbjct: 118 --KNKNKINLKQQLKYAVQICKGMDYLG------SRQYVHRDLAARNVLVESEHQVKIGD 169

Query: 178 FGLARFLPP-----TRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLEL 229
           FGL + +       T        V     + APE              DV+S+G+ L EL
Sbjct: 170 FGLTKAIETDKEYYTVKDDRDSPVF----WYAPECLMQSK---FYIASDVWSFGVTLHEL 222

Query: 230 M 230
           +
Sbjct: 223 L 223

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 41/186 (22%), Positives = 78/186 (41%), Gaps = 46/186 (24%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E   +R + H N++ ++   L           ++  +M +  L +++        
Sbjct: 67  EAFLREGLLMRGLNHPNVLALIGIML----PPEGLPHVLLPYMCHGDLLQFI-------- 114

Query: 121 TYKRPR-NLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTA 173
             + P+ N  +   ++  + VA  + YL      H D         L   N +LD+  T 
Sbjct: 115 --RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRD---------LAARNCMLDESFTV 163

Query: 174 RVGDFGLARFL------PPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGI 224
           +V DFGLAR +         + + + + VK    + A E          +T  DV+S+G+
Sbjct: 164 KVADFGLARDILDREYYSVQQHRHARLPVK----WTALESLQTYR---FTTKSDVWSFGV 216

Query: 225 LLLELM 230
           LL EL+
Sbjct: 217 LLWELL 222

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 42/179 (23%), Positives = 74/179 (41%), Gaps = 32/179 (17%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
             F+ E   +++  H N++ +L  CL    +G+    +V  +M +  L+ ++        
Sbjct: 71  SQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR------- 119

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTARVGD 177
                 N  +   +   + VA  + YL       +   V   L   N +LD+  T +V D
Sbjct: 120 --NETHNPTVKDLIGFGLQVAKGMKYLA------SKKFVHRDLAARNCMLDEKFTVKVAD 171

Query: 178 FGLARFL---PPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           FGLAR +           +   K  + ++A E          +T  DV+S+G+LL ELM
Sbjct: 172 FGLARDMYDKEYYSVHNKT-GAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELM 226

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 34/175 (19%), Positives = 68/175 (38%), Gaps = 31/175 (17%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
            + E + +  + +  +++++  C            LV E      L ++L          
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQAEALM------LVMEMAGGGPLHKFLV--------- 427

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
            +   + +     +   V+  + YL      H +         L   NVLL +   A++ 
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN---------LAARNVLLVNRHYAKIS 478

Query: 177 DFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           DFGL++ L    +  T+    K  + + APE     + S+  DV+SYG+ + E +
Sbjct: 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 76.2 bits (188), Expect = 9e-16
 Identities = 41/207 (19%), Positives = 77/207 (37%), Gaps = 30/207 (14%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E    R   H N+++++  CL      ++   L+  F    +L   +      +    + 
Sbjct: 76  EADMHRLFNHPNILRLVAYCLRERGAKHEAW-LLLPFFKRGTLWNEI------ERLKDKG 128

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
             L   + L + + +   L  +H   +   AH  LKP+N+LL D+    + D G      
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIHA--KGY-AHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185

Query: 186 PTRTQTSS-------IDVKGSIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMIR 232
                +            + +I Y APE      + V +E +   DV+S G +L  +M  
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFG 242

Query: 233 EKPSDIMFEGDMNLHKFAKMALSNHVK 259
           E P    ++          +A+ N + 
Sbjct: 243 EGP----YDMVFQKGDSVALAVQNQLS 265

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 42/184 (22%), Positives = 76/184 (41%), Gaps = 35/184 (19%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL-----YPISK 117
           F  E + L  ++H+++++      GV  +G     +V+E+M +  L  +L          
Sbjct: 90  FQREAELLTMLQHQHIVR----FFGVCTEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLL 144

Query: 118 EDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTAR 174
                  P  L L + L +A  VA+ + YL         H V   L   N L+   +  +
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLA------GLHFVHRDLATRNCLVGQGLVVK 198

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGILL 226
           +GDFG++R +      ++     G    +      PE   Y      +T  DV+S+G++L
Sbjct: 199 IGDFGMSRDIY-----STDYYRVGGRTMLPIRWMPPESILYRK---FTTESDVWSFGVVL 250

Query: 227 LELM 230
            E+ 
Sbjct: 251 WEIF 254

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 42/186 (22%), Positives = 88/186 (47%), Gaps = 21/186 (11%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + + +I++   +     C G+     D   ++YE+M N S+ ++       D+ Y   
Sbjct: 93  ELQIITDIKNEYCLT----CEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP 185
             + +++   I   V ++ +Y+H++      H  +KPSN+L+D +   ++ DFG + ++ 
Sbjct: 148 IPIQVIKC--IIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 186 PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG---DVYSYGILLLELMIREKPSDIMFEG 242
             + + S    +G+  ++ PE+   NE S  G   D++S GI L  +     P    F  
Sbjct: 204 DKKIKGS----RGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSL 254

Query: 243 DMNLHK 248
            ++L +
Sbjct: 255 KISLVE 260

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 45/185 (24%), Positives = 83/185 (44%), Gaps = 36/185 (19%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL------YPIS 116
           F  E + L N++H +++K      GV   G+    +V+E+M +  L ++L        I 
Sbjct: 64  FQREAELLTNLQHEHIVK----FYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMIL 118

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTA 173
            + +  +    L L + L+IA  +AS + YL       + H V   L   N L+  ++  
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLA------SQHFVHRDLATRNCLVGANLLV 172

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGIL 225
           ++GDFG++R +      ++     G    +      PE   Y      +T  DV+S+G++
Sbjct: 173 KIGDFGMSRDV-----YSTDYYRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVI 224

Query: 226 LLELM 230
           L E+ 
Sbjct: 225 LWEIF 229

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 36/182 (19%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   +    H+N+++    C+GV  Q      ++ E M    LK +L          
Sbjct: 80  FLMEALIISKFNHQNIVR----CIGVSLQSLPR-FILMELMAGGDLKSFLRETRPRPS-- 132

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLD---DDMTARVG 176
            +P +L +L  L++A D+A    YL         H +   +   N LL        A++G
Sbjct: 133 -QPSSLAMLDLLHVARDIACGCQYLE------ENHFIHRDIAARNCLLTCPGPGRVAKIG 185

Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGILLLE 228
           DFG+AR +       +S   KG    +      PE    G+    ++  D +S+G+LL E
Sbjct: 186 DFGMARDI-----YRASYYRKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWE 237

Query: 229 LM 230
           + 
Sbjct: 238 IF 239

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 38/178 (21%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
            +AE   ++ + +  +++++  C    +       LV E      L ++L          
Sbjct: 65  LLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKYL---------- 108

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
           ++ R++     + +   V+  + YL      H D         L   NVLL     A++ 
Sbjct: 109 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD---------LAARNVLLVTQHYAKIS 159

Query: 177 DFGLARFLPPTRTQ-TSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           DFGL++ L        +    K  + + APE   Y      S+  DV+S+G+L+ E  
Sbjct: 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK---FSSKSDVWSFGVLMWEAF 214

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 38/185 (20%), Positives = 71/185 (38%), Gaps = 36/185 (19%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL------YPIS 116
           F  E      ++H N++      LGV  +     ++++ +  +  L E+L        + 
Sbjct: 59  FRHEAMLRARLQHPNVVC----LLGVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVG 113

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTA 173
             D+       L     +++   +A+ + YL       + H V   L   NVL+ D +  
Sbjct: 114 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLS------SHHVVHKDLATRNVLVYDKLNV 167

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGIL 225
           ++ D GL R +       +          +     APE   YG     S   D++SYG++
Sbjct: 168 KISDLGLFREV-----YAADYYKLLGNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVV 219

Query: 226 LLELM 230
           L E+ 
Sbjct: 220 LWEVF 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 35/178 (19%), Positives = 68/178 (38%), Gaps = 37/178 (20%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
            + E + +  + +  +++++  C            LV E      L ++L          
Sbjct: 57  MMREAQIMHQLDNPYIVRLIGVCQAEALM------LVMEMAGGGPLHKFLV--------- 101

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
            +   + +     +   V+  + YL      H D         L   NVLL +   A++ 
Sbjct: 102 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD---------LAARNVLLVNRHYAKIS 152

Query: 177 DFGLARFLPPTRTQ-TSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           DFGL++ L    +  T+    K  + + APE   +      S+  DV+SYG+ + E +
Sbjct: 153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK---FSSRSDVWSYGVTMWEAL 207

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 36/182 (19%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   +    H+N+++    C+GV  Q      ++ E M    LK +L          
Sbjct: 121 FLMEALIISKFNHQNIVR----CIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPS-- 173

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLD---DDMTARVG 176
            +P +L +L  L++A D+A    YL         H +   +   N LL        A++G
Sbjct: 174 -QPSSLAMLDLLHVARDIACGCQYLE------ENHFIHRDIAARNCLLTCPGPGRVAKIG 226

Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGILLLE 228
           DFG+AR +       +    KG    +      PE    G+    ++  D +S+G+LL E
Sbjct: 227 DFGMARDI-----YRAGYYRKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWE 278

Query: 229 LM 230
           + 
Sbjct: 279 IF 280

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 74.5 bits (183), Expect = 4e-15
 Identities = 37/139 (26%), Positives = 59/139 (42%), Gaps = 20/139 (14%)

Query: 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL 160
           +     +LK+W+              +      L+I I +A A+ +LH        H  L
Sbjct: 141 QLCRKENLKDWM-------NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDL 190

Query: 161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVK-------GSIG---YIAPEYGVG 210
           KPSN+    D   +VGDFGL   +     + + +          G +G   Y++PE   G
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250

Query: 211 NEVSTIGDVYSYGILLLEL 229
           N  S   D++S G++L EL
Sbjct: 251 NNYSHKVDIFSLGLILFEL 269

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 43/196 (21%), Positives = 76/196 (38%), Gaps = 50/196 (25%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL---------- 112
            ++E   L+ + H ++IK+  AC     Q      L+ E+    SL+ +L          
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGY 127

Query: 113 ----YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKP 162
                  +     +   R L +   ++ A  ++  + YL      H D         L  
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD---------LAA 178

Query: 163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVS 214
            N+L+ +    ++ DFGL+R +           VK S G I     A E     +    +
Sbjct: 179 RNILVAEGRKMKISDFGLSRDV-----YEEDSYVKRSQGRIPVKWMAIESLFDHI---YT 230

Query: 215 TIGDVYSYGILLLELM 230
           T  DV+S+G+LL E++
Sbjct: 231 TQSDVWSFGVLLWEIV 246

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 42/183 (22%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F++E   +    H N+I++     GV  +G     +V E+M N SL  +L        
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLE----GVVTRGRLA-MIVTEYMENGSLDTFLR------- 142

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                    +++ + +   V + + YL      H D         L   NVL+D ++  +
Sbjct: 143 --THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD---------LAARNVLVDSNLVCK 191

Query: 175 VGDFGLARFLP----PTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLL 227
           V DFGL+R L        T T     K  I + APE   +      S+  DV+S+G+++ 
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGG---KIPIRWTAPEAIAFRT---FSSASDVWSFGVVMW 245

Query: 228 ELM 230
           E++
Sbjct: 246 EVL 248

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 73.8 bits (182), Expect = 5e-15
 Identities = 35/182 (19%), Positives = 75/182 (41%), Gaps = 43/182 (23%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   +R   H +++K++               ++ E      L+ +L        
Sbjct: 61  EKFLQEALTMRQFDHPHIVKLIGVITENPVW------IIMELCTLGELRSFLQ------- 107

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTAR 174
              R  +L+L   +  A  +++AL YL      H D         +   NVL+  +   +
Sbjct: 108 --VRKYSLDLASLILYAYQLSTALAYLESKRFVHRD---------IAARNVLVSSNDCVK 156

Query: 175 VGDFGLARFLPP---TRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLE 228
           +GDFGL+R++      +     + +K    ++APE   +      ++  DV+ +G+ + E
Sbjct: 157 LGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRR---FTSASDVWMFGVCMWE 209

Query: 229 LM 230
           ++
Sbjct: 210 IL 211

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 28/251 (11%), Positives = 60/251 (23%), Gaps = 47/251 (18%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTAC-----------------LGVDYQGND 94
                +   +       A   +   +  +                        +    +D
Sbjct: 98  GAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDD 157

Query: 95  FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV 154
           +    Y  +   +  +     S  D  Y    +  +L    +   +      L       
Sbjct: 158 YAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS----- 212

Query: 155 TAHCV---LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEY--GV 209
               V     P N+ +  D    +GD         TR   SS      + Y   E+    
Sbjct: 213 -KGLVHGHFTPDNLFIMPDGRLMLGDVSALW-KVGTRGPASS----VPVTYAPREFLNAS 266

Query: 210 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--------------LS 255
               +   + +  G+ +  +     P  ++  G     K   +               L 
Sbjct: 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP 326

Query: 256 NHVKDIVDSIL 266
           + VK ++   L
Sbjct: 327 DFVKTLIGRFL 337

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 41/184 (22%), Positives = 79/184 (42%), Gaps = 44/184 (23%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
             F+ E   +    H N+I+      GV  +      ++ E+M N +L ++L        
Sbjct: 91  VDFLGEAGIMGQFSHHNIIR----LEGVISKYKPM-MIITEYMENGALDKFLR------- 138

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTAR 174
             ++    ++L+ + +   +A+ + YL      H D         L   N+L++ ++  +
Sbjct: 139 --EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRD---------LAARNILVNSNLVCK 187

Query: 175 VGDFGLARFL-----PPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILL 226
           V DFGL+R L         T    I ++    + APE   Y      ++  DV+S+GI++
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIR----WTAPEAISYRK---FTSASDVWSFGIVM 240

Query: 227 LELM 230
            E+M
Sbjct: 241 WEVM 244

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 73.5 bits (181), Expect = 7e-15
 Identities = 42/190 (22%), Positives = 74/190 (38%), Gaps = 36/190 (18%)

Query: 59  AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL----- 112
             ++ ++E K L +I  H N++ +L AC     +      ++ EF    +L  +L     
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRN 128

Query: 113 -YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLD 168
            +   K          L L   +  +  VA  + +L       +  C+   L   N+LL 
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA------SRKCIHRDLAARNILLS 182

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVY 220
           +    ++ DFGLAR +           V+     +     APE     V    +   DV+
Sbjct: 183 EKNVVKICDFGLARDI-----YKDPDYVRKGDARLPLKWMAPETIFDRV---YTIQSDVW 234

Query: 221 SYGILLLELM 230
           S+G+LL E+ 
Sbjct: 235 SFGVLLWEIF 244

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 40/190 (21%), Positives = 76/190 (40%), Gaps = 37/190 (19%)

Query: 59  AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL----- 112
                ++E + ++ I +H+N+I +L AC     Q      ++ E+    +L+E+L     
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRP 137

Query: 113 -YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLD 168
                  D        +     ++    +A  + YL       +  C+   L   NVL+ 
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL------ASQKCIHRDLAARNVLVT 191

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVY 220
           ++   ++ DFGLAR +            K + G +     APE     V    +   DV+
Sbjct: 192 ENNVMKIADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRV---YTHQSDVW 243

Query: 221 SYGILLLELM 230
           S+G+L+ E+ 
Sbjct: 244 SFGVLMWEIF 253

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 45/193 (23%), Positives = 79/193 (40%), Gaps = 43/193 (22%)

Query: 59  AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL----- 112
                I+E + ++ I +H+N+I +L AC     Q      ++ E+    +L+E+L     
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRP 171

Query: 113 -YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNV 165
                  + ++     L+    ++ A  VA  + YL      H D         L   NV
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD---------LAARNV 222

Query: 166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIG 217
           L+ +D   ++ DFGLAR +            K + G +     APE     +    +   
Sbjct: 223 LVTEDNVMKIADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRI---YTHQS 274

Query: 218 DVYSYGILLLELM 230
           DV+S+G+LL E+ 
Sbjct: 275 DVWSFGVLLWEIF 287

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 44/193 (22%), Positives = 74/193 (38%), Gaps = 44/193 (22%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL---------- 112
           F  E   +    + N++K     LGV   G     L++E+M    L E+L          
Sbjct: 97  FQREAALMAEFDNPNIVK----LLGVCAVGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCS 151

Query: 113 ----YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNV 165
                  ++   +   P  L+   +L IA  VA+ + YL           V   L   N 
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS------ERKFVHRDLATRNC 205

Query: 166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIG 217
           L+ ++M  ++ DFGL+R +      ++          I      PE   Y      +T  
Sbjct: 206 LVGENMVVKIADFGLSRNI-----YSADYYKADGNDAIPIRWMPPESIFYNR---YTTES 257

Query: 218 DVYSYGILLLELM 230
           DV++YG++L E+ 
Sbjct: 258 DVWAYGVVLWEIF 270

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 41/231 (17%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           +  ++E   LR ++H N+++       +D        +V E+     L   +       +
Sbjct: 50  QMLVSEVNLLRELKHPNIVRYYDRI--IDRTNTTLY-IVMEYCEGGDLASVI------TK 100

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA--HCVLKPSNVLLDDDMTARVGDF 178
             K  + L+    L +   +  AL   H          H  LKP+NV LD     ++GDF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMIR 232
           GLAR L    +   +    G+  Y++PE      Y   NE S   D++S G LL EL   
Sbjct: 161 GLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSY---NEKS---DIWSLGCLLYELCAL 212

Query: 233 EKPSDIMFEGDMNLHKFAKM-----------ALSNHVKDIVDSILLNDDEK 272
             P    F    +  + A               S+ + +I+  +L   D  
Sbjct: 213 MPP----FTAF-SQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYH 258

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 38/181 (20%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   +    H N+I+      GV  +      +V E+M N SL  +L        
Sbjct: 91  RDFLGEASIMGQFDHPNIIR----LEGVVTKSKPV-MIVTEYMENGSLDSFLR------- 138

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTAR 174
             K      +++ + +   +AS + YL      H D         L   N+L++ ++  +
Sbjct: 139 --KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNILINSNLVCK 187

Query: 175 VGDFGLARFL-----PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           V DFGL R L         T+   I ++    + +PE     + ++  DV+SYGI+L E+
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEV 243

Query: 230 M 230
           M
Sbjct: 244 M 244

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 40/210 (19%), Positives = 71/210 (33%), Gaps = 54/210 (25%)

Query: 66  ECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVY-----------EFMHNRSLKEWLY 113
           E   ++ +  H N+++  +A      + +  +A              EF+     +  L 
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL- 133

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                D              L I      A+ ++H   +P   H  LK  N+LL +  T 
Sbjct: 134 ---SCDTV------------LKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTI 177

Query: 174 RVGDFGLARFLPPTRTQTSS----------IDVKGSIGYIAPE-------YGVGNEVSTI 216
           ++ DFG A  +      + S          I    +  Y  PE       + +G +    
Sbjct: 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ--- 234

Query: 217 GDVYSYGILLLELMIREKPSDIMFEGDMNL 246
            D+++ G +L  L  R+ P    FE    L
Sbjct: 235 -DIWALGCILYLLCFRQHP----FEDGAKL 259

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 42/184 (22%), Positives = 75/184 (40%), Gaps = 35/184 (19%)

Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL----YPISK 117
            ++E K + ++ +H N++ +L AC      G     ++ E+     L  +L      +  
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLET 150

Query: 118 EDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDDMTAR 174
           +          +    L+ +  VA  + +L       + +C+   +   NVLL +   A+
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLA------SKNCIHRDVAARNVLLTNGHVAK 204

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSYGILL 226
           +GDFGLAR +        S  +      +     APE     V    +   DV+SYGILL
Sbjct: 205 IGDFGLARDI-----MNDSNYIVKGNARLPVKWMAPESIFDCV---YTVQSDVWSYGILL 256

Query: 227 LELM 230
            E+ 
Sbjct: 257 WEIF 260

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 40/190 (21%), Positives = 76/190 (40%), Gaps = 37/190 (19%)

Query: 59  AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL----- 112
                ++E + ++ I +H+N+I +L AC     Q      ++ E+    +L+E+L     
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRP 183

Query: 113 -YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLD 168
                  D        +     ++    +A  + YL       +  C+   L   NVL+ 
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL------ASQKCIHRDLAARNVLVT 237

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVY 220
           ++   ++ DFGLAR +            K + G +     APE     V    +   DV+
Sbjct: 238 ENNVMKIADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRV---YTHQSDVW 289

Query: 221 SYGILLLELM 230
           S+G+L+ E+ 
Sbjct: 290 SFGVLMWEIF 299

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 38/185 (20%)

Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL------YPI 115
           F  E + L  +  H N+I +L AC    Y       L  E+  + +L ++L         
Sbjct: 72  FAGELEVLCKLGHHPNIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETD 126

Query: 116 SKEDETYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDD 169
                       L+  + L+ A DVA  ++YL      H D         L   N+L+ +
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD---------LAARNILVGE 177

Query: 170 DMTARVGDFGLARFLPPTRTQTSS-IDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGIL 225
           +  A++ DFGL+R       +T   + V+    ++A E   Y V    +T  DV+SYG+L
Sbjct: 178 NYVAKIADFGLSRGQEVYVKKTMGRLPVR----WMAIESLNYSV---YTTNSDVWSYGVL 230

Query: 226 LLELM 230
           L E++
Sbjct: 231 LWEIV 235

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 70.7 bits (174), Expect = 5e-14
 Identities = 30/180 (16%), Positives = 75/180 (41%), Gaps = 43/180 (23%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F++E   ++N+ H +++K++           +   ++ E      L  +L          
Sbjct: 60  FMSEAVIMKNLDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLE--------- 104

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
           +   +L +L  +  ++ +  A+ YL      H D         +   N+L+      ++G
Sbjct: 105 RNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD---------IAVRNILVASPECVKLG 155

Query: 177 DFGLARFLPP---TRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
           DFGL+R++      +   + + +K    +++PE   +      +T  DV+ + + + E++
Sbjct: 156 DFGLSRYIEDEDYYKASVTRLPIK----WMSPESINFRR---FTTASDVWMFAVCMWEIL 208

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 39/188 (20%)

Query: 63  FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL--------Y 113
            ++E K L  +  H N++ +L AC      G     ++ E+     L  +L         
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPSNVLLDDD 170
             +           L+L   L+ +  VA  + +L       + +C+   L   N+LL   
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL------ASKNCIHRDLAARNILLTHG 181

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVSTIGDVYSY 222
              ++ DFGLAR +     +  S  V      +     APE     V    +   DV+SY
Sbjct: 182 RITKICDFGLARDI-----KNDSNYVVKGNARLPVKWMAPESIFNCV---YTFESDVWSY 233

Query: 223 GILLLELM 230
           GI L EL 
Sbjct: 234 GIFLWELF 241

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 39/189 (20%), Positives = 76/189 (40%), Gaps = 34/189 (17%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           +    E   L N++H N+++   +     ++ N    +V ++     L +    I+ +  
Sbjct: 68  EESRREVAVLANMKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFKR---INAQKG 119

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLH-----H-DCQPVTAHCVLKPSNVLLDDDMTAR 174
              +   +     L+  + +  AL ++H     H D         +K  N+ L  D T +
Sbjct: 120 VLFQEDQI-----LDWFVQICLALKHVHDRKILHRD---------IKSQNIFLTKDGTVQ 165

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK 234
           +GDFG+AR L  T     +    G+  Y++PE       +   D+++ G +L EL   + 
Sbjct: 166 LGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223

Query: 235 PSDIMFEGD 243
                FE  
Sbjct: 224 A----FEAG 228

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 22/152 (14%)

Query: 134 LNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
               + + SAL ++H        H  +KP+NV +      ++GD GL RF     T   S
Sbjct: 139 WKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195

Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MNLHKFAKM 252
             + G+  Y++PE    N  +   D++S G LL E+   + P    F GD MNL+   K 
Sbjct: 196 --LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKK 249

Query: 253 ------------ALSNHVKDIVDSILLNDDEK 272
                         S  ++ +V+  +  D EK
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEK 281

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 35/177 (19%), Positives = 73/177 (41%), Gaps = 37/177 (20%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
           F+ E   +R   H +++K++               ++ E      L+ +L          
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITENPVW------IIMELCTLGELRSFLQ--------- 482

Query: 123 KRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
            R  +L+L   +  A  +++AL YL      H D         +   NVL+  +   ++G
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRD---------IAARNVLVSSNDCVKLG 533

Query: 177 DFGLARFLPP---TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
           DFGL+R++      +     + +K    ++APE       ++  DV+ +G+ + E++
Sbjct: 534 DFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFTSASDVWMFGVCMWEIL 586

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 47/195 (24%), Positives = 73/195 (37%), Gaps = 44/195 (22%)

Query: 61  KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL------- 112
           ++ ++E K +  +  H N++ +L AC            L++E+     L  +L       
Sbjct: 93  EALMSELKMMTQLGSHENIVNLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKF 147

Query: 113 ------YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV---LKPS 163
                 Y   K  E  +    L     L  A  VA  + +L          CV   L   
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL------EFKSCVHRDLAAR 201

Query: 164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI-----APE---YGVGNEVST 215
           NVL+      ++ DFGLAR +      + S  V      +     APE    G+    + 
Sbjct: 202 NVLVTHGKVVKICDFGLARDI-----MSDSNYVVRGNARLPVKWMAPESLFEGI---YTI 253

Query: 216 IGDVYSYGILLLELM 230
             DV+SYGILL E+ 
Sbjct: 254 KSDVWSYGILLWEIF 268

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 30/108 (27%), Positives = 44/108 (40%), Gaps = 19/108 (17%)

Query: 134 LNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL-PPTRTQTS 192
                D   AL +LH        H  +KP+N+ L      ++GDFGL   L      +  
Sbjct: 160 WGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV- 215

Query: 193 SIDVKGSIGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKP 235
               +G   Y+APE     YG      T  DV+S G+ +LE+    + 
Sbjct: 216 ---QEGDPRYMAPELLQGSYG------TAADVFSLGLTILEVACNMEL 254

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 31/146 (21%), Positives = 64/146 (43%), Gaps = 28/146 (19%)

Query: 140 VASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           +A+AL+Y H       +  V    +KP N+LL      ++ DFG +   P +R       
Sbjct: 118 LANALSYCH-------SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 168

Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-- 253
             G++ Y+ PE   G       D++S G+L  E ++ + P    FE +     + +++  
Sbjct: 169 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRV 222

Query: 254 -------LSNHVKDIVDSILLNDDEK 272
                  ++   +D++  +L ++  +
Sbjct: 223 EFTFPDFVTEGARDLISRLLKHNPSQ 248

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 36/185 (19%), Positives = 73/185 (39%), Gaps = 44/185 (23%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           +SF      +  + H++L+       GV   G++   LV EF+   SL  +L        
Sbjct: 57  ESFFEAASMMSKLSHKHLVL----NYGVCVCGDEN-ILVQEFVKFGSLDTYLK------- 104

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYL------HHDCQPVTAHCVLKPSNVLLD------ 168
             K    +N+L +L +A  +A+A+++L      H +         +   N+LL       
Sbjct: 105 --KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGN---------VCAKNILLIREEDRK 153

Query: 169 --DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-YGVGNEVSTIGDVYSYGIL 225
             +    ++ D G++  +           ++  I ++ PE       ++   D +S+G  
Sbjct: 154 TGNPPFIKLSDPGISITV------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTT 207

Query: 226 LLELM 230
           L E+ 
Sbjct: 208 LWEIC 212

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 42/195 (21%), Positives = 80/195 (41%), Gaps = 38/195 (19%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFMH---NRSLKEWLYPISKEDE 120
           E   ++ + H+N+I +L           +F+   +V E M     + ++  L        
Sbjct: 74  ELVLMKCVNHKNIIGLLNV-FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 132

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLLDDDMTARVGD 177
            Y+      +L            + +LH      +A   H  LKPSN+++  D T ++ D
Sbjct: 133 LYQ------MLC----------GIKHLH------SAGIIHRDLKPSNIVVKSDCTLKILD 170

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
           FGLAR    +   T  +    +  Y APE  +G       D++S G ++ E++       
Sbjct: 171 FGLARTAGTSFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GV-- 224

Query: 238 IMFEGDMNLHKFAKM 252
            +F G  ++ ++ K+
Sbjct: 225 -LFPGTDHIDQWNKV 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 64.1 bits (157), Expect = 8e-12
 Identities = 49/239 (20%), Positives = 85/239 (35%), Gaps = 51/239 (21%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY---EFMHNRSL 108
           S L +    +    E    R++ H++++          +   +    V+   E    RSL
Sbjct: 51  SLLLKPHQREKMSMEISIHRSLAHQHVVGF--------HGFFEDNDFVFVVLELCRRRSL 102

Query: 109 KEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSN 164
            E      K  +    P     LR++           YLH        + V    LK  N
Sbjct: 103 LELH----KRRKALTEPEARYYLRQI------VLGCQYLH-------RNRVIHRDLKLGN 145

Query: 165 VLLDDDMTARVGDFGLARFL--PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSY 222
           + L++D+  ++GDFGLA  +     R +       G+  YIAPE       S   DV+S 
Sbjct: 146 LFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVLSKKGHSFEVDVWSI 201

Query: 223 GILLLELMIREKPSDIMFEGD--MNLHKFAKMA-------LSNHVKDIVDSILLNDDEK 272
           G ++  L++ + P    FE       +   K         ++     ++  +L  D   
Sbjct: 202 GCIMYTLLVGKPP----FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTA 256

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 64.6 bits (158), Expect = 9e-12
 Identities = 44/192 (22%), Positives = 80/192 (41%), Gaps = 30/192 (15%)

Query: 66  ECKALRNIR-HRNLIKVLTACLGVDYQGNDFK-ALVYEFMHNRSLKEWLYPISKEDETYK 123
           E K L N+R   N+I +      +         ALV+E ++N   K+    ++  D  + 
Sbjct: 80  EIKILENLRGGPNIITLAD----IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF- 134

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMTARVGDFGLAR 182
                  +  +  A+D   ++  +H D         +KP NV++D +    R+ D+GLA 
Sbjct: 135 ------YMYEILKALDYCHSMGIMHRD---------VKPHNVMIDHEHRKLRLIDWGLAE 179

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFE 241
           F  P +     +    S  +  PE  V         D++S G +L  ++ R++P    F 
Sbjct: 180 FYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFH 233

Query: 242 GDMNLHKFAKMA 253
           G  N  +  ++A
Sbjct: 234 GHDNYDQLVRIA 245

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 50/245 (20%), Positives = 84/245 (34%), Gaps = 63/245 (25%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY---EFMHNRSL 108
           S L +    +    E    R++ H++++          +   +    V+   E    RSL
Sbjct: 77  SLLLKPHQREKMSMEISIHRSLAHQHVVGF--------HGFFEDNDFVFVVLELCRRRSL 128

Query: 109 KEWLYPISK--EDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKP 162
            E         E E           R       +     YLH        + V    LK 
Sbjct: 129 LELHKRRKALTEPEA----------RY--YLRQIVLGCQYLH-------RNRVIHRDLKL 169

Query: 163 SNVLLDDDMTARVGDFGLARFL--PPTRTQTSSIDVKGSIGYIAPEY----GVGNEVSTI 216
            N+ L++D+  ++GDFGLA  +     R +       G+  YIAPE     G   EV   
Sbjct: 170 GNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVLSKKGHSFEV--- 222

Query: 217 GDVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAKMA-------LSNHVKDIVDSILL 267
            DV+S G ++  L++ + P    FE       +   K         ++     ++  +L 
Sbjct: 223 -DVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277

Query: 268 NDDEK 272
            D   
Sbjct: 278 TDPTA 282

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 28/175 (16%)

Query: 66  ECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKR 124
           E + LR    H N+I+          +   F+ +  E     +L+E+   + ++D  +  
Sbjct: 67  EVQLLRESDEHPNVIR----YFCT-EKDRQFQYIAIELCAA-TLQEY---VEQKDFAHLG 117

Query: 125 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL-----DDDMTARVGDFG 179
              + LL+         S L +LH     +  H  LKP N+L+        + A + DFG
Sbjct: 118 LEPITLLQ------QTTSGLAHLHS--LNI-VHRDLKPHNILISMPNAHGKIKAMISDFG 168

Query: 180 LARFLPPTRTQTSSI-DVKGSIGYIAPEYGVGNEVSTIG---DVYSYGILLLELM 230
           L + L   R   S    V G+ G+IAPE    +         D++S G +   ++
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 32/146 (21%), Positives = 58/146 (39%), Gaps = 28/146 (19%)

Query: 140 VASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           +A AL+Y H          V    +KP N+L+      ++ DFG +   P  R +T    
Sbjct: 123 LADALHYCH-------ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-- 173

Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-- 253
             G++ Y+ PE   G       D++  G+L  E ++   P    F+   +     ++   
Sbjct: 174 --GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSPSHTETHRRIVNV 227

Query: 254 -------LSNHVKDIVDSILLNDDEK 272
                  LS+  KD++  +L     +
Sbjct: 228 DLKFPPFLSDGSKDLISKLLRYHPPQ 253

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 62.2 bits (152), Expect = 4e-11
 Identities = 51/234 (21%), Positives = 90/234 (38%), Gaps = 46/234 (19%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA-LVYEFMHNRSLKE 110
             + + G  +    E K    ++H +++++       +Y  +     LV E  HN  +  
Sbjct: 47  KAMYKAGMVQRVQNEVKIHCQLKHPSILELY------NYFEDSNYVYLVLEMCHNGEMNR 100

Query: 111 WLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVL 166
           +L           R +  +     +    + + + YLH       +H +    L  SN+L
Sbjct: 101 YLK---------NRVKPFSENEARHFMHQIITGMLYLH-------SHGILHRDLTLSNLL 144

Query: 167 LDDDMTARVGDFGLARFL--PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGI 224
           L  +M  ++ DFGLA  L  P  +  T      G+  YI+PE    +      DV+S G 
Sbjct: 145 LTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEIATRSAHGLESDVWSLGC 200

Query: 225 LLLELMIREKPSDIMFEGD--MNLHKFAKMA-------LSNHVKDIVDSILLND 269
           +   L+I   P    F+ D   N      +A       LS   KD++  +L  +
Sbjct: 201 MFYTLLIGRPP----FDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRN 250

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 45/198 (22%), Positives = 77/198 (38%), Gaps = 44/198 (22%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFMH---NRSLKEWLYPISKEDE 120
           E   ++ + H+N+I +L           +F+   LV E M     + ++  L        
Sbjct: 111 ELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
            Y+    +  L    I          +H D         LKPSN+++  D T ++ DFGL
Sbjct: 170 LYQMLCGIKHLHSAGI----------IHRD---------LKPSNIVVKSDCTLKILDFGL 210

Query: 181 ARFLPPTRTQTSSIDVKGSIGYI------APEYGVGNEVSTIGDVYSYGILLLELMIREK 234
           AR    +   T          Y+      APE  +G       D++S G ++ E M+R K
Sbjct: 211 ARTAGTSFMMT---------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MVRHK 260

Query: 235 PSDIMFEGDMNLHKFAKM 252
               +F G   + ++ K+
Sbjct: 261 I---LFPGRDYIDQWNKV 275

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 39/238 (16%), Positives = 88/238 (36%), Gaps = 46/238 (19%)

Query: 66  ECKALR-NIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKR 124
           E K L  +  H N+I+            + F  +  E   N +L++    +  ++ + + 
Sbjct: 58  EIKLLTESDDHPNVIR----YYCS-ETTDRFLYIALELC-NLNLQDL---VESKNVSDEN 108

Query: 125 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-------------DDM 171
            +       +++   +AS + +LH        H  LKP N+L+              +++
Sbjct: 109 LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL 165

Query: 172 TARVGDFGLARFLPPTRTQTSSI--DVKGSIGYIAPEYGVGNEVSTIG-------DVYSY 222
              + DFGL + L   ++   +   +  G+ G+ APE    +             D++S 
Sbjct: 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSM 225

Query: 223 GILLLELMIREKP--------SDIMFEGDMNLHKFAKMA---LSNHVKDIVDSILLND 269
           G +   ++ + K            +  G  +L +   +    L     D++  ++ +D
Sbjct: 226 GCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 46/235 (19%), Positives = 76/235 (32%), Gaps = 35/235 (14%)

Query: 17  GSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFIA----------- 65
           G L  E  K  + E  +    M  +  +  G+FG  H  +        A           
Sbjct: 39  GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV 98

Query: 66  -ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKR 124
            E  A   +    ++       G   +G     +  E +   SL + +  +    E    
Sbjct: 99  EELVACAGLSSPRIVP----LYGAVREGPWVN-IFMELLEGGSLGQLIKQMGCLPEDRAL 153

Query: 125 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MTARVGDFGLARF 183
                              L YLH        H  +K  NVLL  D   A + DFG A  
Sbjct: 154 ----------YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC 200

Query: 184 LPP---TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           L P    ++  +   + G+  ++APE  +G       D++S   ++L  M+    
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH-MLNGCH 254

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 60.6 bits (148), Expect = 1e-10
 Identities = 41/186 (22%), Positives = 83/186 (44%), Gaps = 34/186 (18%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E   L+ ++H+N++++      V +       LV+EF     LK++        ++  
Sbjct: 49  LREICLLKELKHKNIVRLH----DVLHSDKKL-TLVFEFCDQ-DLKKYF-------DSCN 95

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFG 179
              +  +++       +   L + H          V    LKP N+L++ +   ++ +FG
Sbjct: 96  GDLDPEIVKSF--LFQLLKGLGFCHS-------RNVLHRDLKPQNLLINRNGELKLANFG 146

Query: 180 LAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSD 237
           LAR F  P R  ++ + V  ++ Y  P+   G ++ ST  D++S G +  EL    +P  
Sbjct: 147 LARAFGIPVRCYSAEV-V--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP-- 201

Query: 238 IMFEGD 243
            +F G+
Sbjct: 202 -LFPGN 206

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 32/144 (22%), Positives = 57/144 (39%), Gaps = 6/144 (4%)

Query: 87  GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNY 146
            +D   +   +    F+  +SL +       E         L L   +  +  VA  + +
Sbjct: 152 RLDSITSSQSSASSGFVEEKSLSDVEEE---EAPEDLYKDFLTLEHLICYSFQVAKGMEF 208

Query: 147 LHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE 206
           L    +    H  L   N+LL +    ++ DFGLAR +          D +  + ++APE
Sbjct: 209 LA--SRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265

Query: 207 YGVGNEVSTIGDVYSYGILLLELM 230
                  +   DV+S+G+LL E+ 
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIF 289

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 20/97 (20%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           +   +  LH     +  H  LKP N+LLDDDM  ++ DFG +  L P        +V G+
Sbjct: 133 LLEVICALHK--LNI-VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGT 186

Query: 200 IGYIAPE----------YGVGNEVSTIGDVYSYGILL 226
             Y+APE           G G EV    D++S G+++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIM 219

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 29/225 (12%), Positives = 65/225 (28%), Gaps = 25/225 (11%)

Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           F       + L+       +K  +A     +   +   LV E     +L   +       
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTP 165

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL-----------D 168
           E     + +     ++ A+ +   +  +H DC+ +  H  +KP N +L           D
Sbjct: 166 E-----KVMPQGLVISFAMRMLYMIEQVH-DCEII--HGDIKPDNFILGNGFLEQDDEDD 217

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
                 + D G +  +      T       + G+   E       +   D +     +  
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277

Query: 229 LMIREKPSDIMFEGDMNLHK-FAKMALSNHVKDIVDSILLNDDEK 272
           ++           G+      F ++   +   +    +L   D  
Sbjct: 278 MLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 41/202 (20%), Positives = 79/202 (39%), Gaps = 47/202 (23%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGND--FKALVYEFMHNRSLKEWLYPISKEDET 121
           +   + L  + H N++++ +    +  +     +  +V E++      + L+   +    
Sbjct: 67  LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYR 121

Query: 122 YKRPRNLN--------LLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMT 172
            +              L+R          ++  LH     V  H  +KP NVL++  D T
Sbjct: 122 RQVAPPPILIKVFLFQLIR----------SIGCLHLPSVNV-CHRDIKPHNVLVNEADGT 170

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVG-NEVSTIGDVYSYGIL 225
            ++ DFG A+ L P+    +         YI      APE   G    +T  D++S G +
Sbjct: 171 LKLCDFGSAKKLSPSEPNVA---------YICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221

Query: 226 LLELMIREKPSDIMFEGDMNLH 247
             E+M+  +P   +F GD +  
Sbjct: 222 FAEMMLG-EP---IFRGDNSAG 239

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 39/185 (21%)

Query: 61  KSFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFM--HNRSLKEWLYPIS 116
            S+  E   L  ++  +   I++       DY+  D    +Y  M   N  L  WL    
Sbjct: 52  DSYRNEIAYLNKLQQHSDKIIRLY------DYEITDQY--IYMVMECGNIDLNSWL---- 99

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARV 175
                 K+ ++++   R +   ++  A++ +H H       H  LKP+N L+ D M  ++
Sbjct: 100 ------KKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKL 148

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-----------YGVGNEVSTIGDVYSYGI 224
            DFG+A  + P  T        G++ Y+ PE               +++S   DV+S G 
Sbjct: 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 208

Query: 225 LLLEL 229
           +L  +
Sbjct: 209 ILYYM 213

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 38/186 (20%), Positives = 64/186 (34%), Gaps = 46/186 (24%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+ + H+N++K+       +      K L+ EF    SL   L          + P
Sbjct: 57  EFEVLKKLNHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVL----------EEP 103

Query: 126 RNLNLLRR---LNIAIDVASALNYLH-----H-DCQPVTAHCVLKPSNVLL----DDDMT 172
            N   L     L +  DV   +N+L      H +         +KP N++     D    
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN---------IKPGNIMRVIGEDGQSV 154

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG--------DVYSYGI 224
            ++ DFG AR L       S     G+  Y+ P+      +            D++S G+
Sbjct: 155 YKLTDFGAARELEDDEQFVSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211

Query: 225 LLLELM 230
                 
Sbjct: 212 TFYHAA 217

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 44/214 (20%)

Query: 61  KSFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFM--HNRSLKEWLYPIS 116
            S+  E   L  ++  +   I++       DY+  D    +Y  M   N  L  WL    
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLY------DYEITDQY--IYMVMECGNIDLNSWL---- 118

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARV 175
                 K+ ++++   R +   ++  A++ +H H       H  LKP+N L+ D M  ++
Sbjct: 119 ------KKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKL 167

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-----------YGVGNEVSTIGDVYSYGI 224
            DFG+A  + P  T        G++ Y+ PE               +++S   DV+S G 
Sbjct: 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227

Query: 225 LLLELMIREKPSDIMFEGDMN-LHKFAKMALSNH 257
           +L  +   + P    F+  +N + K   +   NH
Sbjct: 228 ILYYMTYGKTP----FQQIINQISKLHAIIDPNH 257

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 48/222 (21%), Positives = 84/222 (37%), Gaps = 41/222 (18%)

Query: 66  ECKALRNIRHRNLIKVLTACL--GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           E + ++ + H N++               ND   L  E+     L+++L           
Sbjct: 62  EIQIMKKLNHPNVVS-AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----------N 110

Query: 124 RPRNLNLLR---RLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD---DDMTARVGD 177
           +  N   L+      +  D++SAL YLH + + +  H  LKP N++L      +  ++ D
Sbjct: 111 QFENCCGLKEGPIRTLLSDISSALRYLH-ENRII--HRDLKPENIVLQPGPQRLIHKIID 167

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMI 231
            G A+ L      T  +   G++ Y+APE      Y V   V    D +S+G L  E + 
Sbjct: 168 LGYAKELDQGELCTEFV---GTLQYLAPELLEQKKYTV--TV----DYWSFGTLAFECIT 218

Query: 232 REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKL 273
             +P    F  +    ++         + IV    L    K 
Sbjct: 219 GFRP----FLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF 256

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 39/185 (21%)

Query: 61  KSFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFM--HNRSLKEWLYPIS 116
            S+  E   L  ++  +   I++       DY+  D    +Y  M   N  L  WL    
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLY------DYEITDQY--IYMVMECGNIDLNSWL---- 146

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARV 175
                 K+ ++++   R +   ++  A++ +H H       H  LKP+N L+ D M  ++
Sbjct: 147 ------KKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKL 195

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-----------YGVGNEVSTIGDVYSYGI 224
            DFG+A  + P  T        G++ Y+ PE               +++S   DV+S G 
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255

Query: 225 LLLEL 229
           +L  +
Sbjct: 256 ILYYM 260

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 41/226 (18%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E K L  +  R ++  L       ++      LV   M+   ++  +Y + +++  ++
Sbjct: 233 MVEKKILAKVHSRFIVS-LAYA----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFG 179
            PR          A  + S L +LH          +    LKP NVLLDDD   R+ D G
Sbjct: 288 EPRA-----IFYTA-QIVSGLEHLH-------QRNIIYRDLKPENVLLDDDGNVRISDLG 334

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 239
           LA  L   +T+T      G+ G++APE  +G E     D ++ G+ L E++    P    
Sbjct: 335 LAVELKAGQTKTKGY--AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP---- 388

Query: 240 FEGDMNLHKFAKM-------------ALSNHVKDIVDSILLNDDEK 272
           F       +  ++               S   KD  +++L  D EK
Sbjct: 389 FRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEK 434

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 33/135 (24%), Positives = 59/135 (43%), Gaps = 16/135 (11%)

Query: 101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL 160
           E M   SL          D+  K+   +       ++I V   L YL    + +  H  +
Sbjct: 111 EHMDGGSL----------DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM--HRDV 158

Query: 161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVY 220
           KPSN+L++     ++ DFG++  L  +   +      G+  Y++PE   G   S   D++
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYSVQSDIW 214

Query: 221 SYGILLLELMIREKP 235
           S G+ L+E+ +   P
Sbjct: 215 SMGLSLVEMAVGRYP 229

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 38/186 (20%), Positives = 64/186 (34%), Gaps = 46/186 (24%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+ + H+N++K+       +      K L+ EF    SL   L          + P
Sbjct: 57  EFEVLKKLNHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVL----------EEP 103

Query: 126 RNLNLLRR---LNIAIDVASALNYLH-----H-DCQPVTAHCVLKPSNVLL----DDDMT 172
            N   L     L +  DV   +N+L      H +         +KP N++     D    
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN---------IKPGNIMRVIGEDGQSV 154

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG--------DVYSYGI 224
            ++ DFG AR L       S     G+  Y+ P+      +            D++S G+
Sbjct: 155 YKLTDFGAARELEDDEQFVSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211

Query: 225 LLLELM 230
                 
Sbjct: 212 TFYHAA 217

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 28/101 (27%)

Query: 140 VASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           +  A+++LH       A+ +    LKP N+LLDD+M  R+ DFG +  L P        +
Sbjct: 209 LLEAVSFLH-------ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---E 258

Query: 196 VKGSIGYIAPE----------YGVGNEVSTIGDVYSYGILL 226
           + G+ GY+APE           G G EV    D+++ G++L
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVIL 295

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 29/104 (27%), Positives = 44/104 (42%), Gaps = 29/104 (27%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
           +  AL+YL +      D         +KP N+LLD+     + DF +A  LP     T+ 
Sbjct: 124 LVMALDYLQNQRIIHRD---------MKPDNILLDEHGHVHITDFNIAAMLPRETQITT- 173

Query: 194 IDVKGSIGYIAPE-------YGVGNEVSTIGDVYSYGILLLELM 230
             + G+  Y+APE        G    V    D +S G+   EL+
Sbjct: 174 --MAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELL 211

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 22/163 (13%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + +  +RH  L+ +  A     ++ ++   ++YEFM    L E    ++ E       
Sbjct: 204 EIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEK---VADEHNKMSED 255

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV--GDFGLARF 183
             +  +R       V   L ++H        H  LKP N++     +  +   DFGL   
Sbjct: 256 EAVEYMR------QVCKGLCHMHE--NNY-VHLDLKPENIMFTTKRSNELKLIDFGLTAH 306

Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
           L P ++        G+  + APE   G  V    D++S G+L 
Sbjct: 307 LDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 35/186 (18%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           I E   L+ + H N++ ++               LV+EFM    LK+ L       +  K
Sbjct: 67  IREISLLKELHHPNIVSLIDVI-----HSERCLTLVFEFMEK-DLKKVL-------DENK 113

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFG 179
                + ++       +   + + H        H +    LKP N+L++ D   ++ DFG
Sbjct: 114 TGLQDSQIKIY--LYQLLRGVAHCHQ-------HRILHRDLKPQNLLINSDGALKLADFG 164

Query: 180 LAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSD 237
           LAR F  P R+ T  + V  ++ Y AP+  +G++  ST  D++S G +  E++   KP  
Sbjct: 165 LARAFGIPVRSYTHEV-V--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KP-- 218

Query: 238 IMFEGD 243
            +F G 
Sbjct: 219 -LFPGV 223

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 30/98 (30%), Positives = 45/98 (45%), Gaps = 20/98 (20%)

Query: 140 VASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           +   L ++H          V    LKP+N+LLD+    R+ D GLA      +   S   
Sbjct: 301 IILGLEHMH-------NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351

Query: 196 VKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELM 230
             G+ GY+APE    GV  + S   D +S G +L +L+
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLL 385

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 10/99 (10%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           + + +  AL YL      +  H  +KPSN+LLD+    ++ DFG++  L   + +  S  
Sbjct: 129 MTVAIVKALYYLKEKHGVI--HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA- 185

Query: 196 VKGSIGYIAPE-----YGVGNEVSTIGDVYSYGILLLEL 229
             G   Y+APE          +     DV+S GI L+EL
Sbjct: 186 --GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 51/242 (21%), Positives = 88/242 (36%), Gaps = 52/242 (21%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
             ++++   +S + E + L+ + H N++K+        ++   +  LV E      L + 
Sbjct: 62  RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDE 116

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---D 168
           +    +  E               I   V S + Y+H     +  H  LKP N+LL    
Sbjct: 117 IISRKRFSEVDAA----------RIIRQVLSGITYMHK--NKI-VHRDLKPENLLLESKS 163

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-----YGVGNEVSTIGDVYSYG 223
            D   R+ DFGL+     ++      D  G+  YIAPE     Y    +     DV+S G
Sbjct: 164 KDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHGTY--DEKC----DVWSTG 214

Query: 224 ILLLELMIREKPSDIMFEGDMNLHKFAKM-------------ALSNHVKDIVDSILLNDD 270
           ++L  L+    P    F G        K+              +S   KD++  +L    
Sbjct: 215 VILYILLSGCPP----FNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 270

Query: 271 EK 272
             
Sbjct: 271 SM 272

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 36/185 (19%), Positives = 69/185 (37%), Gaps = 20/185 (10%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
            R     +    E    ++++H+N+++     LG   +    K +  E +   SL   L 
Sbjct: 57  ERDSRYSQPLHEEIALHKHLKHKNIVQ----YLGSFSENGFIK-IFMEQVPGGSLSALL- 110

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-T 172
                 +      N   +        +   L YLH +      H  +K  NVL++     
Sbjct: 111 ----RSKWGPLKDNEQTIG--FYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGV 161

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE--YGVGNEVSTIGDVYSYGILLLELM 230
            ++ DFG ++ L      T +    G++ Y+APE             D++S G  ++E+ 
Sbjct: 162 LKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 219

Query: 231 IREKP 235
             + P
Sbjct: 220 TGKPP 224

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 35/174 (20%), Positives = 61/174 (35%), Gaps = 22/174 (12%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
                  +   E   +  + H  LI +  A     ++      L+ EF+    L +    
Sbjct: 87  PYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMVLILEFLSGGELFDR--- 138

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
           I+ ED        +N +R           L ++H     +  H  +KP N++ +    + 
Sbjct: 139 IAAEDYKMSEAEVINYMR------QACEGLKHMHE--HSI-VHLDIKPENIMCETKKASS 189

Query: 175 V--GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
           V   DFGLA  L P            +  + APE      V    D+++ G+L 
Sbjct: 190 VKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 48/204 (23%), Positives = 79/204 (38%), Gaps = 58/204 (28%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFMHNRSLKEWLYPISKEDETYK 123
           E + +R ++H N++  L A    +    D     LV E++      E +Y  S+     K
Sbjct: 82  ELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLK 135

Query: 124 RPRNLN--------LLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDM 171
           +   +         LLR          +L Y+H       +  +    +KP N+LLD   
Sbjct: 136 QTMPMLLIKLYMYQLLR----------SLAYIH-------SIGICHRDIKPQNLLLDPPS 178

Query: 172 TA-RVGDFGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVG-NEVSTIGDVYSYG 223
              ++ DFG A+ L       S         YI      APE   G    +T  D++S G
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVS---------YICSRYYRAPELIFGATNYTTNIDIWSTG 229

Query: 224 ILLLELMIREKPSDIMFEGDMNLH 247
            ++ ELM   +P   +F G+  + 
Sbjct: 230 CVMAELMQG-QP---LFPGESGID 249

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 32/146 (21%), Positives = 57/146 (39%), Gaps = 23/146 (15%)

Query: 140 VASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           +   L  LH          +    LKP N+LLDD    R+ D GLA  +P  +T    + 
Sbjct: 295 ICCGLEDLH-------RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV- 346

Query: 196 VKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI---------REKPSDIMFEGDMNL 246
             G++GY+APE       +   D ++ G LL E++          ++   + +      +
Sbjct: 347 --GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404

Query: 247 HKFAKMALSNHVKDIVDSILLNDDEK 272
            +      S   + +   +L  D  +
Sbjct: 405 PEEYSERFSPQARSLCSQLLCKDPAE 430

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 28/115 (24%), Positives = 42/115 (36%), Gaps = 31/115 (26%)

Query: 140 VASALNYLHHDCQPVTAHCV----LKPSNVLLDDDM-TARVGDFGLARFLPPTRTQTSSI 194
           V +A+ + H          V    +K  N+L+D     A++ DFG    L          
Sbjct: 148 VVAAIQHCHS-------RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199

Query: 195 DVKGSIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
              G+  Y  PE      Y           V+S GILL +++  + P    FE D
Sbjct: 200 ---GTRVYSPPEWISRHQYH-ALPA----TVWSLGILLYDMVCGDIP----FERD 242

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 53/202 (26%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFMH---NRSLKEWLYPISKEDE 120
           E   L++++H N+I +L           +F    LV  FM     + +         +  
Sbjct: 73  ELLLLKHMQHENVIGLLDV-FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL 131

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLLDDDMTARVGD 177
            Y+      +L+           L Y+H      +A   H  LKP N+ +++D   ++ D
Sbjct: 132 VYQ------MLK----------GLKYIH------SAGVVHRDLKPGNLAVNEDCELKILD 169

Query: 178 FGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVGNEVSTIG-DVYSYGILLLELM 230
           FGLAR      T           GY+      APE  +         D++S G ++ E++
Sbjct: 170 FGLARHADAEMT-----------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218

Query: 231 IREKPSDIMFEGDMNLHKFAKM 252
              K    +F+G   L +  ++
Sbjct: 219 TG-KT---LFKGKDYLDQLTQI 236

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 40/222 (18%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   L+ + H N++K+        ++      LV E      L + +    K +E     
Sbjct: 86  EVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA- 139

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLAR 182
                     I   V S + YLH     +  H  LKP N+LL   + D   ++ DFGL+ 
Sbjct: 140 ---------VIIKQVLSGVTYLHK--HNI-VHRDLKPENLLLESKEKDALIKIVDFGLSA 187

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILLLELMIREKP---- 235
                +      +  G+  YIAPE        +     DV+S G++L  L+    P    
Sbjct: 188 VFENQKKMK---ERLGTAYYIAPEVLRKKYDEKC----DVWSIGVILFILLAGYPPFGGQ 240

Query: 236 --SDIM---FEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
              +I+    +G           +S   KD++  +L  D ++
Sbjct: 241 TDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQR 282

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 36/148 (24%), Positives = 65/148 (43%), Gaps = 28/148 (18%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
           + SAL YLH       D         LKP N+LL++DM  ++ DFG A+ L P   Q  +
Sbjct: 139 IVSALEYLHGKGIIHRD---------LKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189

Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-----REKPSDIMFE----GDM 244
               G+  Y++PE           D+++ G ++ +L+      R     ++F+     + 
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 249

Query: 245 NLHKFAKMALSNHVKDIVDSILLNDDEK 272
           +  +          +D+V+ +L+ D  K
Sbjct: 250 DFPEK----FFPKARDLVEKLLVLDATK 273

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 30/186 (16%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           I E   ++ ++H N++++      V +  N    LV+EFM N  LK+++           
Sbjct: 51  IREISLMKELKHENIVRLYD----VIHTENKL-TLVFEFMDN-DLKKYM----DSRTVGN 100

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFG 179
            PR L L         +   L + H        + +    LKP N+L++     ++GDFG
Sbjct: 101 TPRGLELNLVKYFQWQLLQGLAFCHE-------NKILHRDLKPQNLLINKRGQLKLGDFG 153

Query: 180 LAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSD 237
           LAR F  P  T +S + V  ++ Y AP+  +G+   ST  D++S G +L E++   KP  
Sbjct: 154 LARAFGIPVNTFSSEV-V--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KP-- 207

Query: 238 IMFEGD 243
            +F G 
Sbjct: 208 -LFPGT 212

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 35/163 (21%), Positives = 67/163 (41%), Gaps = 22/163 (13%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   L   RHRN++ +  +     ++  +   +++EF+    + E    I+         
Sbjct: 51  EISILNIARHRNILHLHES-----FESMEELVMIFEFISGLDIFER---INTSAFELNER 102

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV--GDFGLARF 183
             ++ +        V  AL +LH     +  H  ++P N++     ++ +   +FG AR 
Sbjct: 103 EIVSYVH------QVCEALQFLHS--HNI-GHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153

Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
           L P         +  +  Y APE    + VST  D++S G L+
Sbjct: 154 LKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 31/98 (31%), Positives = 43/98 (43%), Gaps = 21/98 (21%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           +  A+ YLH     +  H  LKP N+L      D   ++ DFGL++ +           V
Sbjct: 157 ILEAVAYLHE--NGI-VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---TV 210

Query: 197 KGSIGYIAPE----YGVGNEVSTIGDVYSYG----ILL 226
            G+ GY APE       G EV    D++S G    ILL
Sbjct: 211 CGTPGYCAPEILRGCAYGPEV----DMWSVGIITYILL 244

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 29/115 (25%), Positives = 43/115 (37%), Gaps = 31/115 (26%)

Query: 140 VASALNYLHHDCQPVTAHCV----LKPSNVLLD-DDMTARVGDFGLARFLPPTRTQTSSI 194
           V  A+ + H          V    +K  N+L+D +    ++ DFG    L  T       
Sbjct: 158 VLEAVRHCH-------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD- 209

Query: 195 DVKGSIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
              G+  Y  PE      Y  G        V+S GILL +++  + P    FE D
Sbjct: 210 ---GTRVYSPPEWIRYHRYH-GRSA----AVWSLGILLYDMVCGDIP----FEHD 252

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 55.7 bits (135), Expect = 6e-09
 Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 31/182 (17%)

Query: 68  KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHN--RSLKEWLYPISKEDETYKRP 125
           + L    H N+++++  C            LV+E +    R+  +   P     ET K  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK-- 123

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLA 181
              +L+R+          L++LH        +C+    LKP N+L+    T ++ DFGLA
Sbjct: 124 ---DLMRQF------LRGLDFLHA-------NCIVHRDLKPENILVTSGGTVKLADFGLA 167

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE 241
           R        T  + V  ++ Y APE  + +  +T  D++S G +  E+  R KP   +F 
Sbjct: 168 RIYSYQMALTPVV-V--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KP---LFC 220

Query: 242 GD 243
           G+
Sbjct: 221 GN 222

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 55.5 bits (134), Expect = 6e-09
 Identities = 26/181 (14%), Positives = 49/181 (27%), Gaps = 53/181 (29%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
            ++    L  I    + +VL     V  +      +V E++   SL+E            
Sbjct: 78  TLSRTLRLSRIDKPGVARVLDV---VHTRAGGL--VVAEWIRGGSLQEVA---------- 122

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR 182
               + + +  +     +A+A +  H     V A  +  PS V +  D    +       
Sbjct: 123 --DTSPSPVGAIRAMQSLAAAADAAHR--AGV-ALSIDHPSRVRVSIDGDVVLAYPA--- 174

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 242
            +P    Q                           D+   G  L  L++   P       
Sbjct: 175 TMPDANPQD--------------------------DIRGIGASLYALLVNRWP----LPE 204

Query: 243 D 243
            
Sbjct: 205 A 205

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 55.6 bits (135), Expect = 6e-09
 Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 35/186 (18%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           I E   L+ ++H N++K+      V +       LV+E +    LK+ L       +  +
Sbjct: 48  IREISILKELKHSNIVKLY----DVIHTKKRL-VLVFEHLDQ-DLKKLL-------DVCE 94

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFG 179
                   +     + + + + Y H          V    LKP N+L++ +   ++ DFG
Sbjct: 95  GGLESVTAKSF--LLQLLNGIAYCHD-------RRVLHRDLKPQNLLINREGELKIADFG 145

Query: 180 LAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSD 237
           LAR F  P R  T  I V  ++ Y AP+  +G++  ST  D++S G +  E++    P  
Sbjct: 146 LARAFGIPVRKYTHEI-V--TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TP-- 199

Query: 238 IMFEGD 243
            +F G 
Sbjct: 200 -LFPGV 204

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 43/208 (20%), Positives = 79/208 (37%), Gaps = 42/208 (20%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM-HNRSLKEWL 112
           +   G   S   E   LR ++H N+I +    L      +    L++++  H+  L   +
Sbjct: 56  IEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYAEHD--LWHII 110

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVAS-------ALNYLHHDCQPVTAHCV----LK 161
                  + ++  +      +L     V S        ++YLH        + V    LK
Sbjct: 111 -------KFHRASKANKKPVQLPRG-MVKSLLYQILDGIHYLHA-------NWVLHRDLK 155

Query: 162 PSNVLLDDDMTAR----VGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-ST 215
           P+N+L+  +   R    + D G AR F  P +       V  +  Y APE  +G    + 
Sbjct: 156 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTK 215

Query: 216 IGDVYSYGILLLELMIREKPSDIMFEGD 243
             D+++ G +  EL+   +P   +F   
Sbjct: 216 AIDIWAIGCIFAELLTS-EP---IFHCR 239

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 55.7 bits (135), Expect = 6e-09
 Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 27/180 (15%)

Query: 68  KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRN 127
           + L    H N++++   C            LV+E +  + L  +L       +    P  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYL-------DKVPEP-G 116

Query: 128 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLARF 183
           +      ++   +   L++LH        H V    LKP N+L+      ++ DFGLAR 
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHS-------HRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
                  TS + V  ++ Y APE  + +  +T  D++S G +  E+  R KP   +F G 
Sbjct: 170 YSFQMALTSVV-V--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KP---LFRGS 222

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 55.3 bits (134), Expect = 6e-09
 Identities = 41/178 (23%), Positives = 70/178 (39%), Gaps = 27/178 (15%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
           R Q   +   AE + L+++ H N+IK+        ++      +V E      L E +  
Sbjct: 59  RSQVPMEQIEAEIEVLKSLDHPNIIKIFEV-----FEDYHNMYIVMETCEGGELLERIVS 113

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDM 171
                +         L++       + +AL Y H   Q V  H  LKP N+L        
Sbjct: 114 AQARGKALSEGYVAELMK------QMMNALAYFHS--QHV-VHKDLKPENILFQDTSPHS 164

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE---YGVGNEVSTIGDVYSYGILL 226
             ++ DFGLA         T++    G+  Y+APE     V  +     D++S G+++
Sbjct: 165 PIKIIDFGLAELFKSDEHSTNAA---GTALYMAPEVFKRDVTFKC----DIWSAGVVM 215

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 55.3 bits (134), Expect = 7e-09
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 9/98 (9%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           IA+ +  AL +LH     +  H  +KPSNVL++     ++ DFG++ +L     +     
Sbjct: 114 IAVSIVKALEHLHSKLSVI--HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA- 170

Query: 196 VKGSIGYIAPE----YGVGNEVSTIGDVYSYGILLLEL 229
             G   Y+APE           S   D++S GI ++EL
Sbjct: 171 --GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 36/149 (24%), Positives = 61/149 (40%), Gaps = 22/149 (14%)

Query: 140 VASALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           +  A++ +H         H  +KP N+L+D +   R+ DFG    L    T  SS+ V G
Sbjct: 184 MVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-G 238

Query: 199 SIGYIAPEYGVGNEVSTIG-----DVYSYGILLLELMIREKP-----SDIMFEGDMNLHK 248
           +  YI+PE     E          D +S G+ + E++  E P         +   MN  +
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298

Query: 249 FAKM-----ALSNHVKDIVDSILLNDDEK 272
             +       +S + KD++   L+   E 
Sbjct: 299 RFQFPTQVTDVSENAKDLIRR-LICSREH 326

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 24/95 (25%), Positives = 42/95 (44%), Gaps = 18/95 (18%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSID 195
           D+ +A+ +LH     + AH  +KP N+L    + D   ++ DFG A+       QT    
Sbjct: 136 DIGTAIQFLHS--HNI-AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT---- 188

Query: 196 VKGSIGYIAPE----YGVGNEVSTIGDVYSYGILL 226
              +  Y+APE               D++S G+++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 219

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 58/204 (28%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL--VYEFMHNRSLKEWLYPISKEDETYK 123
           E + +R + H N+++ L        +  D   L  V +++      E +Y +++     K
Sbjct: 97  ELQIMRKLDHCNIVR-LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAK 150

Query: 124 RPRNLN--------LLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDM 171
           +   +         L R          +L Y+H       +  +    +KP N+LLD D 
Sbjct: 151 QTLPVIYVKLYMYQLFR----------SLAYIH-------SFGICHRDIKPQNLLLDPDT 193

Query: 172 TA-RVGDFGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVGNEV-STIGDVYSYG 223
              ++ DFG A+ L       S         YI      APE   G    ++  DV+S G
Sbjct: 194 AVLKLCDFGSAKQLVRGEPNVS---------YICSRYYRAPELIFGATDYTSSIDVWSAG 244

Query: 224 ILLLELMIREKPSDIMFEGDMNLH 247
            +L EL++  +P   +F GD  + 
Sbjct: 245 CVLAELLLG-QP---IFPGDSGVD 264

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 55.3 bits (134), Expect = 9e-09
 Identities = 42/186 (22%), Positives = 83/186 (44%), Gaps = 35/186 (18%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           I E   L++++H N++ +      + +       LV+E++  + LK++L       +   
Sbjct: 48  IREVSLLKDLKHANIVTLH----DIIHTEKSL-TLVFEYLD-KDLKQYL-------DDCG 94

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFG 179
              N++ ++     +     L Y H          V    LKP N+L+++    ++ DFG
Sbjct: 95  NIINMHNVKLFLFQL--LRGLAYCHR-------QKVLHRDLKPQNLLINERGELKLADFG 145

Query: 180 LAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSD 237
           LAR    PT+T  + + V  ++ Y  P+  +G+   ST  D++  G +  E+    +P  
Sbjct: 146 LARAKSIPTKTYDNEV-V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RP-- 199

Query: 238 IMFEGD 243
            +F G 
Sbjct: 200 -LFPGS 204

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 16/95 (16%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSID 195
            + SA++++H     V  H  LKP N+L    +D++  ++ DFG AR  PP         
Sbjct: 114 KLVSAVSHMHD--VGV-VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--T 168

Query: 196 VKGSIGYIAPE----YGVGNEVSTIGDVYSYGILL 226
              ++ Y APE     G         D++S G++L
Sbjct: 169 PCFTLHYAAPELLNQNGYDESC----DLWSLGVIL 199

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 36/163 (22%), Positives = 65/163 (39%), Gaps = 22/163 (13%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   +  + H NLI++  A     ++  +   LV E++    L +    I  E       
Sbjct: 136 EISVMNQLDHANLIQLYDA-----FESKNDIVLVMEYVDGGELFDR---IIDESYNLTEL 187

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL--DDDMTARVGDFGLARF 183
             +  ++       +   + ++H     +  H  LKP N+L    D    ++ DFGLAR 
Sbjct: 188 DTILFMK------QICEGIRHMHQ--MYI-LHLDLKPENILCVNRDAKQIKIIDFGLARR 238

Query: 184 LPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
             P           G+  ++APE    + VS   D++S G++ 
Sbjct: 239 YKPREKLK---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 53/243 (21%), Positives = 92/243 (37%), Gaps = 44/243 (18%)

Query: 44  ISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103
              G +   +   +   +    E   L+++ H N+IK+        ++   +  LV EF 
Sbjct: 74  FDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFY 128

Query: 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS 163
               L E +    K DE              NI   + S + YLH     +  H  +KP 
Sbjct: 129 EGGELFEQIINRHKFDECDAA----------NIMKQILSGICYLHK--HNI-VHRDIKPE 175

Query: 164 NVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-----YGVGNEVST 215
           N+LL   +  +  ++ DFGL+ F          +   G+  YIAPE     Y    +   
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---GTAYYIAPEVLKKKY--NEKC-- 228

Query: 216 IGDVYSYGILLLELMIREKP------SDIM---FEGDMNLHKFAKMALSNHVKDIVDSIL 266
             DV+S G+++  L+    P       DI+    +G           +S+  K+++  +L
Sbjct: 229 --DVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLML 286

Query: 267 LND 269
             D
Sbjct: 287 TYD 289

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 29/95 (30%), Positives = 43/95 (45%), Gaps = 20/95 (21%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           V SA+ Y H     V AH  LKP N L      D   ++ DFGLA    P +   + +  
Sbjct: 115 VLSAVAYCHK--LNV-AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-- 169

Query: 197 KGSIGYIAPE-----YGVGNEVSTIGDVYSYGILL 226
            G+  Y++P+     Y  G E     D +S G+++
Sbjct: 170 -GTPYYVSPQVLEGLY--GPEC----DEWSAGVMM 197

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 35/144 (24%), Positives = 61/144 (42%), Gaps = 28/144 (19%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT-QTSSIDVKG 198
           + SA+ YL         H  +K  N+++ +D T ++ DFG A +L   +   T      G
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC----G 191

Query: 199 SIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSD----IMFEGDMNLHK 248
           +I Y APE      Y  G E+    +++S G+ L  L+  E P       + E  ++   
Sbjct: 192 TIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVFEENPFCELEETV-EAAIHPPY 245

Query: 249 FAKMALSNHVKDIVDSILLNDDEK 272
                +S  +  +V  +L    E+
Sbjct: 246 L----VSKELMSLVSGLLQPVPER 265

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 28/102 (27%), Positives = 44/102 (43%), Gaps = 17/102 (16%)

Query: 135 NIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV--GDFGLARFLPPTRTQTS 192
           NI   + SAL+YLH+  Q +  H  +KP N L   + +  +   DFGL++          
Sbjct: 172 NIMRQIFSALHYLHN--QGI-CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228

Query: 193 SI--DVKGSIGYIAPE------YGVGNEVSTIGDVYSYGILL 226
                  G+  ++APE         G +     D +S G+LL
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAWSAGVLL 266

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 42/200 (21%), Positives = 69/200 (34%), Gaps = 55/200 (27%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFM----HN--RSLKEWLYPISK 117
           E + L +  H N++ +    + V ++        LV E M           +  + P   
Sbjct: 79  EIRLLNHFHHPNILGLRD--IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136

Query: 118 EDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLLDDDMTAR 174
           +   Y       +L            L+ LH       A   H  L P N+LL D+    
Sbjct: 137 QYFMYH------ILL----------GLHVLH------EAGVVHRDLHPGNILLADNNDIT 174

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVGNEVSTIG-DVYSYGILLL 227
           + DF LAR       +T          Y+      APE  +  +  T   D++S G ++ 
Sbjct: 175 ICDFNLAREDTADANKT---------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225

Query: 228 ELMIREKPSDIMFEGDMNLH 247
           E+  R K    +F G    +
Sbjct: 226 EMFNR-KA---LFRGSTFYN 241

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 30/150 (20%), Positives = 51/150 (34%), Gaps = 22/150 (14%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
           +  A++ +H   +    H  +KP N+LLD     R+ DFG    L    T  S + V G+
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GT 226

Query: 200 IGYIAPEYGVGNEVSTIGDVY-------SYGILLLELMIREKP----------SDIMFEG 242
             Y++PE             Y       + G+   E+   + P            I+   
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286

Query: 243 DMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
           +          +    +D +   LL   E 
Sbjct: 287 EHLSLPLVDEGVPEEARDFIQR-LLCPPET 315

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 44/197 (22%), Positives = 71/197 (36%), Gaps = 44/197 (22%)

Query: 44  ISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103
           IS   F     R      +   E + L+ + H  +IK+        +   D+  +V E M
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-----FDAEDY-YIVLELM 221

Query: 104 HNRSLKEWLYPISK----EDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV 159
               L + +  +      E                     +  A+ YLH     +  H  
Sbjct: 222 EGGELFDKV--VGNKRLKEATCKL------------YFYQMLLAVQYLHE--NGII-HRD 264

Query: 160 LKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-------YGV 209
           LKP NVLL   ++D   ++ DFG ++ L  T        + G+  Y+APE        G 
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGY 321

Query: 210 GNEVSTIGDVYSYGILL 226
              V    D +S G++L
Sbjct: 322 NRAV----DCWSLGVIL 334

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 54.1 bits (131), Expect = 2e-08
 Identities = 39/190 (20%), Positives = 73/190 (38%), Gaps = 47/190 (24%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+ ++H NL+ +L        +      LV+E+    ++   L       + Y+R 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVF-----RRKRRLHLVFEYCD-HTVLHEL-------DRYQRG 98

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLA 181
              +L++  +I      A+N+ H        H      +KP N+L+      ++ DFG A
Sbjct: 99  VPEHLVK--SITWQTLQAVNFCHK-------HNCIHRDVKPENILITKHSVIKLCDFGFA 149

Query: 182 R-FLPPTRTQTSSIDVKGSIGYI------APEYGVGNEV-STIGDVYSYGILLLELMIRE 233
           R    P+               +      +PE  VG+       DV++ G +  EL+   
Sbjct: 150 RLLTGPSDYYDD---------EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG- 199

Query: 234 KPSDIMFEGD 243
            P   ++ G 
Sbjct: 200 VP---LWPGK 206

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 53.7 bits (130), Expect = 2e-08
 Identities = 30/98 (30%), Positives = 42/98 (42%), Gaps = 22/98 (22%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           V SA+ YLH     +  H  LKP N+L    +++    + DFGL++        T     
Sbjct: 115 VLSAVKYLHE--NGI-VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----A 167

Query: 197 KGSIGYIAPE----YGVGNEVSTIGDVYSYG----ILL 226
            G+ GY+APE          V    D +S G    ILL
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAV----DCWSIGVITYILL 201

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 47/200 (23%), Positives = 80/200 (40%), Gaps = 46/200 (23%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM----HNRSLKEWLYPISKEDET 121
           E K L++ +H N+I +        ++  +   ++ E M    H          IS +  +
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR--------VISTQMLS 110

Query: 122 YKRPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLLDDDMTARVG 176
               +      LR          A+  LH       +   H  LKPSN+L++ +   +V 
Sbjct: 111 DDHIQYFIYQTLR----------AVKVLH------GSNVIHRDLKPSNLLINSNCDLKVC 154

Query: 177 DFGLARFLPPTRTQTSSIDVKGSI--GYI------APEYGVGNEVSTIG-DVYSYGILLL 227
           DFGLAR +  +    S    + S    ++      APE  + +   +   DV+S G +L 
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214

Query: 228 ELMIREKPSDIMFEGDMNLH 247
           EL +R +P   +F G    H
Sbjct: 215 ELFLR-RP---IFPGRDYRH 230

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 9/98 (9%)

Query: 136 IAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSID 195
           I +    ALN+L  + +    H  +KPSN+LLD     ++ DFG++  L  +  +T    
Sbjct: 130 ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA- 186

Query: 196 VKGSIGYIAPE----YGVGNEVSTIGDVYSYGILLLEL 229
             G   Y+APE               DV+S GI L EL
Sbjct: 187 --GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 53.3 bits (129), Expect = 3e-08
 Identities = 26/100 (26%), Positives = 41/100 (41%), Gaps = 25/100 (25%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           +  ++ Y H     +  H  LKP N+LL         ++ DFGLA  +  +         
Sbjct: 114 ILESIAYCHS--NGI-VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GF 167

Query: 197 KGSIGYIAPE------YGVGNEVSTIGDVYSYG----ILL 226
            G+ GY++PE      Y     V    D+++ G    ILL
Sbjct: 168 AGTPGYLSPEVLKKDPY--SKPV----DIWACGVILYILL 201

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 17/95 (17%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSID 195
            +  A+ YLH     + AH  +KP N+L      +   ++ DFG A+      + T    
Sbjct: 169 SIGEAIQYLHS--INI-AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---T 222

Query: 196 VKGSIGYIAPE----YGVGNEVSTIGDVYSYGILL 226
              +  Y+APE               D++S G+++
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 253

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 45/207 (21%), Positives = 75/207 (36%), Gaps = 72/207 (34%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFM--------HNRSLKE----- 110
           E + L++++H N+I +L           +F    LV   M          + L +     
Sbjct: 78  ELRLLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136

Query: 111 WLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLL 167
            +Y I               LR           L Y+H      +A   H  LKPSN+ +
Sbjct: 137 LIYQI---------------LR----------GLKYIH------SADIIHRDLKPSNLAV 165

Query: 168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVGNEVSTIG-DVY 220
           ++D   ++ DFGLAR      T           GY+      APE  +         D++
Sbjct: 166 NEDCELKILDFGLARHTADEMT-----------GYVATRWYRAPEIMLNWMHYNQTVDIW 214

Query: 221 SYGILLLELMIREKPSDIMFEGDMNLH 247
           S G ++ EL+   +    +F G  ++ 
Sbjct: 215 SVGCIMAELLTG-RT---LFPGTDHID 237

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 41/190 (21%), Positives = 75/190 (39%), Gaps = 47/190 (24%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E K L+ +RH NL+ +L  C     +      LV+EF+   ++ + L       E +   
Sbjct: 74  EIKLLKQLRHENLVNLLEVC-----KKKKRWYLVFEFVD-HTILDDL-------ELFPNG 120

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLA 181
            +  +++       + + + + H        H +    +KP N+L+      ++ DFG A
Sbjct: 121 LDYQVVQ--KYLFQIINGIGFCHS-------HNIIHRDIKPENILVSQSGVVKLCDFGFA 171

Query: 182 R-FLPPTRTQTSSIDVKGSIGYI------APEYGVGNEV-STIGDVYSYGILLLELMIRE 233
           R    P                +      APE  VG+       DV++ G L+ E+ +  
Sbjct: 172 RTLAAPGEVYDD---------EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG- 221

Query: 234 KPSDIMFEGD 243
           +P   +F GD
Sbjct: 222 EP---LFPGD 228

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 37/156 (23%), Positives = 60/156 (38%), Gaps = 46/156 (29%)

Query: 142 SALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLARFLPPTRT----QTSS 193
             L YLH       +  +    +KP N+LL    T ++   G+A  L P       +TS 
Sbjct: 120 DGLEYLH-------SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 194 IDVKGSIGYIAPE-------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL 246
               GS  +  PE       +  G +V    D++S G+ L  +     P    FEGD N+
Sbjct: 173 ----GSPAFQPPEIANGLDTF-SGFKV----DIWSAGVTLYNITTGLYP----FEGD-NI 218

Query: 247 HK-FAKMA---------LSNHVKDIVDSILLNDDEK 272
           +K F  +              + D++  +L  +  K
Sbjct: 219 YKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAK 254

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 47/228 (20%), Positives = 80/228 (35%), Gaps = 52/228 (22%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E + L+ + H N++K+         + +    +V E      L + +    +  E     
Sbjct: 71  EVELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA- 124

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLAR 182
                     I   V S + Y+H     +  H  LKP N+LL   + D   ++ DFGL+ 
Sbjct: 125 ---------RIIKQVFSGITYMHK--HNI-VHRDLKPENILLESKEKDCDIKIIDFGLST 172

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPE-----YGVGNEVSTIGDVYSYGILLLELMIREKPSD 237
                       D  G+  YIAPE     Y    +     DV+S G++L  L+    P  
Sbjct: 173 CFQQNTKMK---DRIGTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP-- 221

Query: 238 IMFEGDMNLHKFAKM-------------ALSNHVKDIVDSILLNDDEK 272
             F G        ++              +S+  KD++  +L      
Sbjct: 222 --FYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 32/104 (30%), Positives = 43/104 (41%), Gaps = 24/104 (23%)

Query: 135 NIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQT 191
            I   V S + Y+H     +  H  LKP N+LL   + D   ++ DFGL+          
Sbjct: 125 RIIKQVFSGITYMHK--HNI-VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181

Query: 192 SSIDVKGSIGYIAPE-----YGVGNEVSTIGDVYSYG----ILL 226
              D  G+  YIAPE     Y    +     DV+S G    ILL
Sbjct: 182 ---DRIGTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILL 216

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 26/100 (26%), Positives = 41/100 (41%), Gaps = 25/100 (25%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           +  ++ Y H     +  H  LKP N+LL         ++ DFGLA  +  +         
Sbjct: 137 ILESIAYCHS--NGI-VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GF 190

Query: 197 KGSIGYIAPE------YGVGNEVSTIGDVYSYG----ILL 226
            G+ GY++PE      Y     V    D+++ G    ILL
Sbjct: 191 AGTPGYLSPEVLKKDPY--SKPV----DIWACGVILYILL 224

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 54/203 (26%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFM----HNRSLKEWLYPISKED 119
           E + L+++RH N+I +L      D   +DF    LV  FM          E L     + 
Sbjct: 74  ELRLLKHMRHENVIGLLDV-FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 132

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLLDDDMTARVG 176
             Y+      +L+           L Y+H       A   H  LKP N+ +++D   ++ 
Sbjct: 133 LVYQ------MLK----------GLRYIH------AAGIIHRDLKPGNLAVNEDCELKIL 170

Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVGNEVSTIG-DVYSYGILLLEL 229
           DFGLAR      T           GY+      APE  +     T   D++S G ++ E+
Sbjct: 171 DFGLARQADSEMT-----------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219

Query: 230 MIREKPSDIMFEGDMNLHKFAKM 252
           +   K    +F+G  +L +  ++
Sbjct: 220 ITG-KT---LFKGSDHLDQLKEI 238

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 35/140 (25%), Positives = 61/140 (43%), Gaps = 13/140 (9%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTSSIDVK 197
           + SAL+YLH +   V  +  LK  N++LD D   ++ DFGL +         +T      
Sbjct: 257 IVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---- 310

Query: 198 GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNLHKFAKM 252
           G+  Y+APE    N+     D +  G+++ E+M    P      + +FE  +        
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 370

Query: 253 ALSNHVKDIVDSILLNDDEK 272
            L    K ++  +L  D ++
Sbjct: 371 TLGPEAKSLLSGLLKKDPKQ 390

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 36/168 (21%), Positives = 66/168 (39%), Gaps = 27/168 (16%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E      ++H +++++L       Y  +    +V+EFM    L   +   +     Y   
Sbjct: 76  EASICHMLKHPHIVELLET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLAR 182
              + +R       +  AL Y H     +  H  +KP  VLL   ++    ++G FG+A 
Sbjct: 131 VASHYMR------QILEALRYCHD--NNI-IHRDVKPHCVLLASKENSAPVKLGGFGVAI 181

Query: 183 FLPPTRTQTSSIDVKGSIGYIAPE----YGVGNEVSTIGDVYSYGILL 226
            L    +   +    G+  ++APE       G  V    DV+  G++L
Sbjct: 182 QLG--ESGLVAGGRVGTPHFMAPEVVKREPYGKPV----DVWGCGVIL 223

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 24/76 (31%), Positives = 37/76 (48%), Gaps = 11/76 (14%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSID 195
           DVASAL++LH+  + + AH  LKP N+L    +     ++ DF L   +      +    
Sbjct: 119 DVASALDFLHN--KGI-AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 196 VK-----GSIGYIAPE 206
            +     GS  Y+APE
Sbjct: 176 PELLTPCGSAEYMAPE 191

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 37/173 (21%), Positives = 63/173 (36%), Gaps = 40/173 (23%)

Query: 128 LNLLRRLNIAIDVA--------SALNYLH-HDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
           +NL+   ++    A         AL+ +H         H  +KP N+LLD     ++ DF
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADF 212

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPE----------YGVGNEVSTIGDVYSYGILLLE 228
           G    +           V G+  YI+PE          YG   E     D +S G+ L E
Sbjct: 213 GTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR--EC----DWWSVGVFLYE 265

Query: 229 LMIREKP-----SDIMFE----GDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
           +++ + P         +        +L       +S   K+++ +  L D E 
Sbjct: 266 MLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREV 317

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 39/147 (26%), Positives = 58/147 (39%), Gaps = 32/147 (21%)

Query: 142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL-ARFLPPTRTQTSSIDVKGSI 200
           SA+ Y H        H  LK  N+LLD DM  ++ DFG    F    +         G+ 
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAP 177

Query: 201 GYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAKM 252
            Y APE      Y  G EV    DV+S G++L  L+    P    F+G     L +    
Sbjct: 178 PYAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLP----FDGQNLKELRERVLR 228

Query: 253 A-------LSNHVKDIVDSILLNDDEK 272
                   +S   ++++   L+ +  K
Sbjct: 229 GKYRIPFYMSTDCENLLKRFLVLNPIK 255

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 52.6 bits (127), Expect = 7e-08
 Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 67/200 (33%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E K L+ + H N+I +L          ++  +LV++FM    L+                
Sbjct: 62  EIKLLQELSHPNIIGLL----DAFGHKSNI-SLVFDFME-TDLEV--------------- 100

Query: 126 RNLNLLRRLNIAIDVA----------SALNYLHHDCQPVTAHCV----LKPSNVLLDDDM 171
               +++  ++ +  +            L YLH        H +    LKP+N+LLD++ 
Sbjct: 101 ----IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-------HWILHRDLKPNNLLLDENG 149

Query: 172 TARVGDFGLAR-FLPPTRTQTSSIDVKGSIGYIAPE-------YGVGNEVSTIGDVYSYG 223
             ++ DFGLA+ F  P R  T  + V  +  Y APE       YGVG  V    D+++ G
Sbjct: 150 VLKLADFGLAKSFGSPNRAYTHQV-V--TRWYRAPELLFGARMYGVG--V----DMWAVG 200

Query: 224 ILLLELMIREKPSDIMFEGD 243
            +L EL++R  P      GD
Sbjct: 201 CILAELLLR-VP---FLPGD 216

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 52.3 bits (126), Expect = 8e-08
 Identities = 35/165 (21%), Positives = 67/165 (40%), Gaps = 25/165 (15%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   LR + H N+I +        Y+      L+ E +    L ++L     + E+    
Sbjct: 65  EVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFL----AQKESLSEE 115

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDMTARVGDFGLA 181
              + ++       +   +NYLH   + + AH  LKP N++L          ++ DFGLA
Sbjct: 116 EATSFIK------QILDGVNYLHT--KKI-AHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
             +          ++ G+  ++APE      +    D++S G++ 
Sbjct: 167 HEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 37/169 (21%), Positives = 69/169 (40%), Gaps = 33/169 (19%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   LR + H N+I +        Y+      L+ E +    L ++L     + E+    
Sbjct: 65  EVSILRQVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFL----AQKESLSEE 115

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDMTARVGDFGLA 181
              + ++       +   +NYLH   + + AH  LKP N++L          ++ DFGLA
Sbjct: 116 EATSFIK------QILDGVNYLHT--KKI-AHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPE----YGVGNEVSTIGDVYSYGILL 226
             +          ++ G+  ++APE      +G E     D++S G++ 
Sbjct: 167 HEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEA----DMWSIGVIT 208

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 28/100 (28%), Positives = 42/100 (42%), Gaps = 24/100 (24%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           +  A+ + H     V  H  LKP N+LL         ++ DFGLA  +   +        
Sbjct: 119 ILEAVLHCHQ--MGV-VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GF 173

Query: 197 KGSIGYIAPE------YGVGNEVSTIGDVYSYG----ILL 226
            G+ GY++PE      Y  G  V    D+++ G    ILL
Sbjct: 174 AGTPGYLSPEVLRKDPY--GKPV----DLWACGVILYILL 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 28/101 (27%)

Query: 140 VASALNYLHHDCQPVTAHCV----LKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTS 192
           +  A+ YLH        + +    LKP NVLL   ++D   ++ DFG ++ L  T    +
Sbjct: 123 MLLAVQYLHE-------NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175

Query: 193 SIDVKGSIGYIAPE-------YGVGNEVSTIGDVYSYGILL 226
                G+  Y+APE        G    V    D +S G++L
Sbjct: 176 LC---GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 27/98 (27%), Positives = 40/98 (40%), Gaps = 21/98 (21%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDMTARVGDFGLARFLPPTRTQTSSI 194
            +   + YLH   Q V  H  LKPSN+L      +  + R+ DFG A+ L          
Sbjct: 124 TITKTVEYLH--AQGV-VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-- 178

Query: 195 DVKGSIGYIAPE------YGVGNEVSTIGDVYSYGILL 226
               +  ++APE      Y          D++S G+LL
Sbjct: 179 TPCYTANFVAPEVLERQGY--DAAC----DIWSLGVLL 210

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 34/150 (22%), Positives = 63/150 (42%), Gaps = 27/150 (18%)

Query: 139 DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPP--TRTQTSSIDV 196
           D+   + YLH+  Q +  H  +KPSN+L+ +D   ++ DFG++            +    
Sbjct: 145 DLIKGIEYLHY--QKI-IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV--- 198

Query: 197 KGSIGYIAPEYGVGNEVSTIG---DVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAK 251
            G+  ++APE          G   DV++ G+ L   +  + P    F  +  M LH   K
Sbjct: 199 -GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP----FMDERIMCLHSKIK 253

Query: 252 ---------MALSNHVKDIVDSILLNDDEK 272
                      ++  +KD++  +L  + E 
Sbjct: 254 SQALEFPDQPDIAEDLKDLITRMLDKNPES 283

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 35/182 (19%), Positives = 61/182 (33%), Gaps = 41/182 (22%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE--DET 121
             E    +   H N++          +  ++   +V  FM   S K+ +     +  +E 
Sbjct: 74  QGELHVSKLFNHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL 128

Query: 122 YKRPRNLNLLRRLNIAI---DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
                         IA     V  AL+Y+HH       H  +K S++L+  D    +   
Sbjct: 129 A-------------IAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGL 172

Query: 179 GLARFLPPT--RTQTSSIDVKGSIG---YIAPE------YGVGNEVSTIGDVYSYGILLL 227
                +     R +      K S+    +++PE       G   +     D+YS GI   
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITAC 228

Query: 228 EL 229
           EL
Sbjct: 229 EL 230

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 35/131 (26%), Positives = 58/131 (44%), Gaps = 16/131 (12%)

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA--RVGDFGLA 181
           +  +L L+R+   A  +   L+ LH   + +  HC LKP N+LL     +  +V DFG +
Sbjct: 195 QGFSLPLVRK--FAHSILQCLDALH-KNRII--HCDLKPENILLKQQGRSGIKVIDFGSS 249

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE 241
            +      Q     ++ S  Y APE  +G       D++S G +L EL+        +  
Sbjct: 250 CYE----HQRVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLT----GYPLLP 300

Query: 242 GDMNLHKFAKM 252
           G+    + A M
Sbjct: 301 GEDEGDQLACM 311

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 36/165 (21%), Positives = 66/165 (40%), Gaps = 25/165 (15%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   L+ I+H N+I +        Y+      L+ E +    L ++L     E E+    
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFL----AEKESLTEE 114

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDMTARVGDFGLA 181
                L+       + + + YLH     + AH  LKP N++L          ++ DFGLA
Sbjct: 115 EATEFLK------QILNGVYYLHS--LQI-AHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
             +          ++ G+  ++APE      +    D++S G++ 
Sbjct: 166 HKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 44/191 (23%), Positives = 84/191 (43%), Gaps = 41/191 (21%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           I E   L+ ++HRN+I++ +    V +  +    L++E+     LK+++           
Sbjct: 81  IREVSLLKELQHRNIIELKS----VIHHNHRL-HLIFEYAE-NDLKKYM----------D 124

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVG--- 176
           +  ++++    +    + + +N+ H               LKP N+LL     +      
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHS-------RRCLHRDLKPQNLLLSVSDASETPVLK 177

Query: 177 --DFGLAR-FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIR 232
             DFGLAR F  P R  T  I +  ++ Y  PE  +G+   ST  D++S   +  E++++
Sbjct: 178 IGDFGLARAFGIPIRQFTHEI-I--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

Query: 233 EKPSDIMFEGD 243
             P   +F GD
Sbjct: 235 -TP---LFPGD 241

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 32/129 (24%), Positives = 54/129 (41%), Gaps = 25/129 (19%)

Query: 124 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD------DMTARVGD 177
           R   L  +++  I+  +   L+Y+H  C  +  H  +KP NVL++        +  ++ D
Sbjct: 126 RGIPLIYVKQ--ISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIAD 181

Query: 178 FGLARFLPPTRT---QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK 234
            G A +     T   QT          Y +PE  +G       D++S   L+ EL+    
Sbjct: 182 LGNACWYDEHYTNSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITG-- 231

Query: 235 PSDIMFEGD 243
             D +FE D
Sbjct: 232 --DFLFEPD 238

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 37/150 (24%), Positives = 59/150 (39%), Gaps = 42/150 (28%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
           +     YLH       D         LKP N+L+D     +V DFG A+ +   RT T  
Sbjct: 150 IVLTFEYLHSLDLIYRD---------LKPENLLIDQQGYIQVTDFGFAKRV-KGRTWT-- 197

Query: 194 IDVKGSIGYIAPE----YGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFE--- 241
             + G+   +APE     G    V    D ++ G+L+ E+     P        ++E   
Sbjct: 198 --LCGTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

Query: 242 -GDMNLHKFAKMALSNHVKDIVDSILLNDD 270
            G +          S+ +KD++ + LL  D
Sbjct: 252 SGKVRFPSH----FSSDLKDLLRN-LLQVD 276

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 28/104 (26%), Positives = 44/104 (42%), Gaps = 28/104 (26%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA-RFLPPTRTQTS 192
           +  AL +LH       D         +K  N+LLD +    + DFGL+  F+     +  
Sbjct: 168 IVLALEHLHKLGIIYRD---------IKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218

Query: 193 SIDVKGSIGYIAPE------YGVGNEVSTIGDVYSYGILLLELM 230
                G+I Y+AP+       G    V    D +S G+L+ EL+
Sbjct: 219 DF--CGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELL 256

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 50.2 bits (121), Expect = 4e-07
 Identities = 40/152 (26%), Positives = 65/152 (42%), Gaps = 41/152 (26%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
           V  AL YLH       D         LKP N+LLD +   ++ DFG A+++ P  T T  
Sbjct: 115 VCLALEYLHSKDIIYRD---------LKPENILLDKNGHIKITDFGFAKYV-PDVTYT-- 162

Query: 194 IDVKGSIGYIAPE----YGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFE--- 241
             + G+  YIAPE          +    D +S+GIL+ E++    P     +   +E   
Sbjct: 163 --LCGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216

Query: 242 -GDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
             ++    F     +  VKD++  ++  D  +
Sbjct: 217 NAELRFPPF----FNEDVKDLLSRLITRDLSQ 244

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 33/134 (24%), Positives = 56/134 (41%), Gaps = 27/134 (20%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA---LVYEFM-HNRSLKEWLYPISKEDET 121
           E K L+ ++H N++ ++  C       N  K    LV++F  H+  L   L   S     
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD--LAGLL---SNVLVK 120

Query: 122 YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL----KPSNVLLDDDMTARVGD 177
           +       +++ L       + L Y+H        + +L    K +NVL+  D   ++ D
Sbjct: 121 FTLSEIKRVMQMLL------NGLYYIHR-------NKILHRDMKAANVLITRDGVLKLAD 167

Query: 178 FGLAR-FLPPTRTQ 190
           FGLAR F     +Q
Sbjct: 168 FGLARAFSLAKNSQ 181

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 49.9 bits (120), Expect = 5e-07
 Identities = 36/165 (21%), Positives = 68/165 (41%), Gaps = 25/165 (15%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRP 125
           E   LR IRH N+I +        ++      L+ E +    L ++L     E E+    
Sbjct: 58  EVNILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFL----AEKESLTED 108

Query: 126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDMTARVGDFGLA 181
                L+       +   ++YLH   + + AH  LKP N++L      +   ++ DFG+A
Sbjct: 109 EATQFLK------QILDGVHYLHS--KRI-AHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

Query: 182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
             +          ++ G+  ++APE      +    D++S G++ 
Sbjct: 160 HKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 48/205 (23%), Positives = 74/205 (36%), Gaps = 63/205 (30%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM--------HNRSLKE-----WL 112
           E K L   RH N+I +         +      +V + M          + L       +L
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLLDD 169
           Y                +LR           L Y+H      +A   H  LKPSN+LL+ 
Sbjct: 135 Y---------------QILR----------GLKYIH------SANVLHRDLKPSNLLLNT 163

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVGNEVSTIG-DVYSY 222
               ++ DFGLAR   P    T  +       Y+      APE  + ++  T   D++S 
Sbjct: 164 TCDLKICDFGLARVADPDHDHTGFL-----TEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218

Query: 223 GILLLELMIREKPSDIMFEGDMNLH 247
           G +L E++   +P   +F G   L 
Sbjct: 219 GCILAEMLSN-RP---IFPGKHYLD 239

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 34/156 (21%), Positives = 57/156 (36%), Gaps = 32/156 (20%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY-PISKEDE---- 120
           E   L  + H +++KVL   +  D +  D   +V E       K+    P+   +     
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKT 160

Query: 121 -TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLLDDDMTARVG 176
             Y      NLL            + Y+H      +A   H  LKP+N L++ D + +V 
Sbjct: 161 LLY------NLLV----------GVKYVH------SAGILHRDLKPANCLVNQDCSVKVC 198

Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE 212
           DFGLAR +       S + +      +        +
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 32/147 (21%)

Query: 142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT-QTSSIDVKGSI 200
            A+ Y H        H  LKP N+LLDD++  ++ DFGL+  +      +TS     GS 
Sbjct: 119 CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSP 171

Query: 201 GYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAKM 252
            Y APE      Y  G EV    DV+S GI+L  +++   P    F+ +   NL K    
Sbjct: 172 NYAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLP----FDDEFIPNLFKKVNS 222

Query: 253 A-------LSNHVKDIVDSILLNDDEK 272
                   LS   + ++  +++ D  +
Sbjct: 223 CVYVMPDFLSPGAQSLIRRMIVADPMQ 249

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 49.5 bits (119), Expect = 8e-07
 Identities = 16/40 (40%), Positives = 23/40 (57%), Gaps = 1/40 (2%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
              L  ++ +S N+LTG +      L NL  +D+SRNMLE
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLE 210

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 48.3 bits (116), Expect = 2e-06
 Identities = 11/36 (30%), Positives = 19/36 (52%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
           L  +D+S N L G   +  G  KN + + +++N L 
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 47.9 bits (115), Expect = 2e-06
 Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)

Query: 1   LPSL-----LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
           L  +     L  LD+  N++ G+L   + +LK L  L+VS N L 
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 44.4 bits (106), Expect = 3e-05
 Identities = 10/36 (27%), Positives = 19/36 (52%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
           L  L ++   ++G++   + ++K L  LD S N L 
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 11/35 (31%), Positives = 17/35 (48%), Gaps = 1/35 (2%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNML 39
              + ++ N L   L  +VG  KNL  LD+  N +
Sbjct: 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRI 256

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 42.9 bits (102), Expect = 8e-05
 Identities = 12/35 (34%), Positives = 18/35 (51%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNML 39
           L+ LD S N L+G+L   +  L NL  +    N +
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 40.2 bits (95), Expect = 7e-04
 Identities = 11/38 (28%), Positives = 15/38 (39%), Gaps = 3/38 (7%)

Query: 5  LIALDVSGNKLTGSLHI--EVGKLKNLEILDVS-RNML 39
          +  LD+SG  L     I   +  L  L  L +   N L
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 23/90 (25%), Positives = 43/90 (47%), Gaps = 9/90 (10%)

Query: 140 VASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTSSIDV 196
           +   + YLH     +  H  LKP N+LL         ++ DFG++R +          ++
Sbjct: 140 ILEGVYYLHQ--NNI-VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EI 193

Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
            G+  Y+APE    + ++T  D+++ GI+ 
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 49.1 bits (118), Expect = 8e-07
 Identities = 32/149 (21%), Positives = 57/149 (38%), Gaps = 30/149 (20%)

Query: 142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT----QTSSIDVK 197
           + + YLH     +  H  +KP N+LLD+    ++ DFGLA                    
Sbjct: 116 AGVVYLHG--IGI-THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---- 168

Query: 198 GSIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251
           G++ Y+APE      +     V    DV+S GI+L  ++  E P D   +       + +
Sbjct: 169 GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

Query: 252 --------MALSNHVKDIVDSILLNDDEK 272
                     + +    ++  IL+ +   
Sbjct: 224 KKTYLNPWKKIDSAPLALLHKILVENPSA 252

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 48.9 bits (117), Expect = 9e-07
 Identities = 17/120 (14%), Positives = 39/120 (32%), Gaps = 37/120 (30%)

Query: 134 LNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-------------------MTAR 174
            ++ + V   L Y+H        H  +KPSN+ +                      +  +
Sbjct: 118 KDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPE-----YGVGNEVSTIGDVYSYGILLLEL 229
           +GD G    +   + +       G   ++A E     Y    +     D+++  + ++  
Sbjct: 175 IGDLGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKA----DIFALALTVVCA 224

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 34/170 (20%), Positives = 58/170 (34%), Gaps = 50/170 (29%)

Query: 66  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFM----HN--RSLKEWLYPISK 117
           E   L  ++   +I++    +  D     F    +V E          ++      PI  
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDL--LKFDELYIVLEIADSDLKKLFKT------PIFL 126

Query: 118 EDE-----TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLLDD 169
            +E      Y      NLL             N++H       +   H  LKP+N LL+ 
Sbjct: 127 TEEHIKTILY------NLLL----------GENFIH------ESGIIHRDLKPANCLLNQ 164

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE----VST 215
           D + +V DFGLAR +   +      D++ +         +  +    V T
Sbjct: 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 48.7 bits (117), Expect = 9e-07
 Identities = 45/147 (30%), Positives = 64/147 (43%), Gaps = 32/147 (21%)

Query: 142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT-QTSSIDVKGSI 200
           SA++Y H        H  LKP NVLLD  M A++ DFGL+  +      +TS     GS 
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSP 174

Query: 201 GYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAKM 252
            Y APE      Y  G EV    D++S G++L  L+    P    F+ +    L K  + 
Sbjct: 175 NYAAPEVISGRLY-AGPEV----DIWSCGVILYALLCGTLP----FDDEHVPTLFKKIRG 225

Query: 253 A-------LSNHVKDIVDSILLNDDEK 272
                   L+  V  ++  +L  D  K
Sbjct: 226 GVFYIPEYLNRSVATLLMHMLQVDPLK 252

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 43/206 (20%), Positives = 77/206 (37%), Gaps = 55/206 (26%)

Query: 66  ECKALRNIRHRNLIKVL-------TACLGVDYQGNDFKA--LVYEFM----HNRSLKEWL 112
           E K +R + H N++KV        +          +  +  +V E+M     N   +  L
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL 117

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCVLKPSNVLLD- 168
                    Y+      LLR           L Y+H      +A   H  LKP+N+ ++ 
Sbjct: 118 LEEHARLFMYQ------LLR----------GLKYIH------SANVLHRDLKPANLFINT 155

Query: 169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYI------APEYGVGNEVSTIG-DVYS 221
           +D+  ++GDFGLAR + P  +    +        +      +P   +     T   D+++
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHL-----SEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210

Query: 222 YGILLLELMIREKPSDIMFEGDMNLH 247
            G +  E++   K    +F G   L 
Sbjct: 211 AGCIFAEMLTG-KT---LFAGAHELE 232

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 24/175 (13%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
           + E +A+    H N++   T+     +   D   LV + +   S+ + +  I  + E   
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS 115

Query: 124 RPRNLNLLRRLNIAI---DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                  L    IA    +V   L YLH + Q    H  +K  N+LL +D + ++ DFG+
Sbjct: 116 GV-----LDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGV 167

Query: 181 ARFLPPTRTQTSSIDVKGSIG---YIAPEYGVGNEVSTIG---DVYSYGILLLEL 229
           + FL      T +   K  +G   ++APE  V  +V       D++S+GI  +EL
Sbjct: 168 SAFLATGGDITRNKVRKTFVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIEL 220

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 45/147 (30%), Positives = 62/147 (42%), Gaps = 32/147 (21%)

Query: 142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT-QTSSIDVKGSI 200
           S ++Y H        H  LKP NVLLD  M A++ DFGL+  +      +TS     GS 
Sbjct: 127 SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSP 179

Query: 201 GYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAKM 252
            Y APE      Y  G EV    D++S G++L  L+    P    F+ D    L K    
Sbjct: 180 NYAAPEVISGRLY-AGPEV----DIWSSGVILYALLCGTLP----FDDDHVPTLFKKICD 230

Query: 253 A-------LSNHVKDIVDSILLNDDEK 272
                   L+  V  ++  +L  D  K
Sbjct: 231 GIFYTPQYLNPSVISLLKHMLQVDPMK 257

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 18/58 (31%), Positives = 27/58 (46%), Gaps = 7/58 (12%)

Query: 3   SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE-------ENLISAGTFGFSH 53
             L  L++  N ++GS+  EVG L+ L ILD+S N L+         L        S+
Sbjct: 656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 12/37 (32%), Positives = 22/37 (59%)

Query: 3   SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNML 39
             ++ LD+S N L+G +  E+G +  L IL++  N +
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 47.6 bits (114), Expect = 5e-06
 Identities = 15/86 (17%), Positives = 33/86 (38%), Gaps = 4/86 (4%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENL---ISAGTFGFSHLRRQ 57
           L +L I L +S N  +G++  E+G  ++L  LD++ N+    +   +   +   +     
Sbjct: 513 LENLAI-LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIA 571

Query: 58  GAFKSFIAECKALRNIRHRNLIKVLT 83
           G    +I      +       +    
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQ 597

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 15/38 (39%), Positives = 23/38 (60%)

Query: 3   SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
           S L++L +S N L+G++   +G L  L  L +  NMLE
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)

Query: 1   LPSL-----LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
           +P L     L  LD+SGNKL+G     +     L++L++S N   
Sbjct: 216 IPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 260

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 18/54 (33%), Positives = 27/54 (50%), Gaps = 1/54 (1%)

Query: 3   SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRR 56
           + L  + +S N+LTG +   +G+L+NL IL +S N    N I A       L  
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN-IPAELGDCRSLIW 542

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 13/40 (32%), Positives = 18/40 (45%), Gaps = 1/40 (2%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
             +L   LD+SGN   G++    G    LE L +S N   
Sbjct: 293 CDTLTG-LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 8/38 (21%), Positives = 14/38 (36%)

Query: 3   SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
           S     +++     G          ++  LD+S NML 
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 44.5 bits (106), Expect = 4e-05
 Identities = 11/36 (30%), Positives = 16/36 (44%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
           L  L +  N LTG +   +    NL  + +S N L 
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 43.4 bits (103), Expect = 9e-05
 Identities = 13/40 (32%), Positives = 18/40 (45%), Gaps = 1/40 (2%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE 40
           L  L   L +  N L G +  E+  +K LE L +  N L 
Sbjct: 441 LSKLRD-LKLWLNMLEGEIPQELMYVKTLETLILDFNDLT 479

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 12/37 (32%), Positives = 22/37 (59%), Gaps = 1/37 (2%)

Query: 5   LIALDVSGNKLTGSLHIEV-GKLKNLEILDVSRNMLE 40
           L +L +S N  +G L ++   K++ L++LD+S N   
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 16/37 (43%), Positives = 22/37 (59%), Gaps = 2/37 (5%)

Query: 3   SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNML 39
             L  L +SGNK++G   ++V +  NLE LDVS N  
Sbjct: 178 GELKHLAISGNKISGD--VDVSRCVNLEFLDVSSNNF 212

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 14/59 (23%), Positives = 23/59 (38%), Gaps = 10/59 (16%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEV---GKLKNLEILDVSRNMLEENLISAGTFGFSHLRR 56
           L SL + LD+S N ++G+  +          L+ L +S N +       G    S    
Sbjct: 150 LNSLEV-LDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS------GDVDVSRCVN 201

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 16/55 (29%), Positives = 27/55 (49%), Gaps = 2/55 (3%)

Query: 3   SLLIALDVSGNKLTGSL--HIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLR 55
           + L +LD+S N L+G +     +G    L+ L+VS N L+     +G    + L 
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE 154

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 30/113 (26%), Positives = 51/113 (45%), Gaps = 21/113 (18%)

Query: 137 AIDVASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQ 190
           A ++A  L +L        +  +    LK  NV+LD +   ++ DFG+ +        T+
Sbjct: 448 AAEIAIGLFFLQ-------SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 500

Query: 191 TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
           T      G+  YIAPE           D +++G+LL E++  + P    FEG+
Sbjct: 501 T----FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 545

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 30/116 (25%)

Query: 143 ALNYLHHDCQPVTA---HCVLKPSNVLLD-DDMTARVGDFGLARFLPPTRTQTSSIDVKG 198
           A+ ++H      +    H  +KP N+L++  D T ++ DFG A+ L P+    +      
Sbjct: 153 AVGFIH------SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA------ 200

Query: 199 SIGYI------APEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLH 247
              YI      APE  +G    T   D++S G +  EL++  KP   +F G+ ++ 
Sbjct: 201 ---YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG-KP---LFSGETSID 249

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 22/144 (15%)

Query: 140 VASALNYLHHDCQPVTAHCV----LKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTSS 193
           +   L +LH       +  +    LK  N+LLD D   ++ DFG+ +   L   +T T  
Sbjct: 127 IILGLQFLH-------SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-- 177

Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNLHK 248
               G+  YIAPE  +G + +   D +S+G+LL E++I + P      + +F      + 
Sbjct: 178 --FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235

Query: 249 FAKMALSNHVKDIVDSILLNDDEK 272
           F    L    KD++  + + + EK
Sbjct: 236 FYPRWLEKEAKDLLVKLFVREPEK 259

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 25/112 (22%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT 191
           +A  L +L        D         LK  NV+LD +   ++ DFG+ +        T+T
Sbjct: 130 IAIGLFFLQSKGIIYRD---------LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180

Query: 192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
                 G+  YIAPE           D +++G+LL E++  + P    FEG+
Sbjct: 181 ----FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 224

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 32/149 (21%), Positives = 57/149 (38%), Gaps = 30/149 (20%)

Query: 142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRT----QTSSIDVK 197
           + + YLH     +  H  +KP N+LLD+    ++ DFGLA                    
Sbjct: 116 AGVVYLHG--IGI-THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---- 168

Query: 198 GSIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 251
           G++ Y+APE      +     V    DV+S GI+L  ++  E P D   +       + +
Sbjct: 169 GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

Query: 252 --------MALSNHVKDIVDSILLNDDEK 272
                     + +    ++  IL+ +   
Sbjct: 224 KKTYLNPWKKIDSAPLALLHKILVENPSA 252

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 35/146 (23%), Positives = 59/146 (40%), Gaps = 26/146 (17%)

Query: 140 VASALNYLH------HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT 191
           + SAL YLH       D         +K  N++LD D   ++ DFGL +         +T
Sbjct: 114 IVSALEYLHSRDVVYRD---------IKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164

Query: 192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNL 246
                 G+  Y+APE    N+     D +  G+++ E+M    P      + +FE  +  
Sbjct: 165 ----FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220

Query: 247 HKFAKMALSNHVKDIVDSILLNDDEK 272
                  LS   K ++  +L  D ++
Sbjct: 221 EIRFPRTLSPEAKSLLAGLLKKDPKQ 246

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 21/104 (20%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT 191
           ++ ALNYLH       D         LK  NVLLD +   ++ D+G+ +    P   T T
Sbjct: 119 ISLALNYLHERGIIYRD---------LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169

Query: 192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
                 G+  YIAPE   G +     D ++ G+L+ E+M    P
Sbjct: 170 ----FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 21/104 (20%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT 191
           ++ ALNYLH       D         LK  NVLLD +   ++ D+G+ +    P   T T
Sbjct: 162 ISLALNYLHERGIIYRD---------LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212

Query: 192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
                 G+  YIAPE   G +     D ++ G+L+ E+M    P
Sbjct: 213 ----FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 33/128 (25%)

Query: 143 ALNYLHHDCQPVTA---HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGS 199
            + YLH      +    H  +KPSN+LL+ +   +V DFGL+R     R  T++I +  +
Sbjct: 121 VIKYLH------SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 200 IG-------------------YIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIM 239
                                Y APE  +G+   T G D++S G +L E++   KP   +
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KP---I 230

Query: 240 FEGDMNLH 247
           F G   ++
Sbjct: 231 FPGSSTMN 238

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 38/144 (26%), Positives = 65/144 (45%), Gaps = 18/144 (12%)

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDD 170
           LY + +   T  R  +LNL R+   A  + +AL +L   +   +  HC LKP N+LL + 
Sbjct: 142 LYDLLRN--TNFRGVSLNLTRK--FAQQMCTALLFLATPELSII--HCDLKPENILLCNP 195

Query: 171 MTA--RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLE 228
             +  ++ DFG +  L     Q        S  Y +PE  +G       D++S G +L+E
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQ-----SRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250

Query: 229 LMIREKPSDIMFEGDMNLHKFAKM 252
           +       + +F G   + +  K+
Sbjct: 251 MHT----GEPLFSGANEVDQMNKI 270

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 39/148 (26%), Positives = 62/148 (41%), Gaps = 30/148 (20%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT 191
           +ASAL YLH       D         LKP N+LLD      + DFGL +      + T T
Sbjct: 148 IASALGYLHSLNIVYRD---------LKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198

Query: 192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNL 246
                 G+  Y+APE           D +  G +L E++    P     +  M+  D  L
Sbjct: 199 ----FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY--DNIL 252

Query: 247 HKFAKM--ALSNHVKDIVDSILLNDDEK 272
           +K  ++   ++N  + +++ +L  D  K
Sbjct: 253 NKPLQLKPNITNSARHLLEGLLQKDRTK 280

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 46.8 bits (112), Expect = 6e-06
 Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 25/112 (22%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT 191
           +A AL++LH       D         LKP N+LLD++   ++ DFGL++       +  +
Sbjct: 135 LALALDHLHSLGIIYRD---------LKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185

Query: 192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
                 G++ Y+APE       +   D +S+G+L+ E++    P    F+G 
Sbjct: 186 FC----GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP----FQGK 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 46.4 bits (111), Expect = 8e-06
 Identities = 30/112 (26%), Positives = 50/112 (44%), Gaps = 25/112 (22%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT 191
           ++ AL +LH       D         LKP N++L+     ++ DFGL +      T T T
Sbjct: 130 ISMALGHLHQKGIIYRD---------LKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180

Query: 192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
                 G+I Y+APE  + +  +   D +S G L+ +++    P    F G+
Sbjct: 181 FC----GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 32/112 (28%), Positives = 45/112 (40%), Gaps = 25/112 (22%)

Query: 140 VASALNYLHH------DCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA--RFLPPTRTQT 191
           + SAL +LH       D         LK  NVLLD +   ++ DFG+          T T
Sbjct: 133 IISALMFLHDKGIIYRD---------LKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183

Query: 192 SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 243
                 G+  YIAPE           D ++ G+LL E++    P    FE +
Sbjct: 184 ----FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP----FEAE 227

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 43/188 (22%), Positives = 81/188 (43%), Gaps = 33/188 (17%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           L++Q   +  I E   +R  ++ N++  L +     Y   D   +V E++   SL + + 
Sbjct: 55  LQQQPKKELIINEILVMRENKNPNIVNYLDS-----YLVGDELWVVMEYLAGGSLTD-VV 108

Query: 114 PISKEDETYKRPRNLNLLRRLNIAI---DVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170
             +  DE               IA    +   AL +LH +      H  +K  N+LL  D
Sbjct: 109 TETCMDEGQ-------------IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD 152

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIG---YIAPEYGVGNEVSTIGDVYSYGILLL 227
            + ++ DFG    + P +++ S++     +G   ++APE           D++S GI+ +
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTM-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 207

Query: 228 ELMIREKP 235
           E++  E P
Sbjct: 208 EMIEGEPP 215

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 9/41 (21%), Positives = 19/41 (46%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLIS 45
           +  L + G   +G +   +G+L  LE+L +  +  + N   
Sbjct: 83  VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL 123

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 15/48 (31%), Positives = 22/48 (45%), Gaps = 3/48 (6%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFS 52
           L  L+   N+L G L    G    L  L+++ N + E  I A   GF+
Sbjct: 332 LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE--IPANFCGFT 376

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 10/81 (12%), Positives = 25/81 (30%), Gaps = 10/81 (12%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKSFI 64
           L  ++V        L   +  L  +++++V+ N                L+      +  
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI---------SGEQLKDDWQALADA 301

Query: 65  AECKALRNIR-HRNLIKVLTA 84
              + ++ I    N +K    
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPV 322

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 6/39 (15%), Positives = 13/39 (33%)

Query: 3   SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEE 41
            +    D  GN+        +    +L  L +  N + +
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 14/56 (25%), Positives = 20/56 (35%), Gaps = 4/56 (7%)

Query: 1   LPSLLIALDVSGNKLTG-SLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLR 55
              L   +D+  NKLT  S       L  L  +D+S N   +          S L+
Sbjct: 487 TYLLTS-IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK--FPTQPLNSSTLK 539

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 9/54 (16%), Positives = 22/54 (40%), Gaps = 3/54 (5%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEE---NLISAGTFGFSHLR 55
           + ++++S N+++            L  +++  NML E   N +      F +  
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 8/50 (16%), Positives = 19/50 (38%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHL 54
           +  L ++G    G +   +G+L  L++L    +    +    G    +  
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPD 374

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 15/56 (26%), Positives = 19/56 (33%), Gaps = 4/56 (7%)

Query: 1   LPSLLIALDVSGNKLTG-SLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLR 55
              L   +D+  NKLT  S       L  L  +DVS N              S L+
Sbjct: 727 TYLLTT-IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS--FPTQPLNSSQLK 779

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 6/55 (10%), Positives = 18/55 (32%), Gaps = 3/55 (5%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE---ENLISAGTFGFSHLRR 56
              + +S N++             +  + +S N++    EN +      + +   
Sbjct: 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYL 729

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 41/188 (21%), Positives = 80/188 (42%), Gaps = 33/188 (17%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           LR+Q   +    E   +R+ +H N++++  +     Y   +   ++ EF+   +L + + 
Sbjct: 80  LRKQQRRELLFNEVVIMRDYQHFNVVEMYKS-----YLVGEELWVLMEFLQGGALTD-IV 133

Query: 114 PISKEDETYKRPRNLNLLRRLNIAI---DVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170
              + +E               IA     V  AL YLH        H  +K  ++LL  D
Sbjct: 134 SQVRLNEEQ-------------IATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD 177

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIG---YIAPEYGVGNEVSTIGDVYSYGILLL 227
              ++ DFG    +     +  S+     +G   ++APE    +  +T  D++S GI+++
Sbjct: 178 GRVKLSDFGFCAQISKDVPKRKSL-----VGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232

Query: 228 ELMIREKP 235
           E++  E P
Sbjct: 233 EMVDGEPP 240

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 31/120 (25%), Positives = 47/120 (39%), Gaps = 25/120 (20%)

Query: 142 SALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR--VGDFGL-ARFLPPTRTQTSSIDVKG 198
           S ++Y H        H  LK  N LLD     R  + DFG     +  ++ +++     G
Sbjct: 127 SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----G 179

Query: 199 SIGYIAPE------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
           +  YIAPE      Y  G       DV+S G+ L  +++   P    FE       + K 
Sbjct: 180 TPAYIAPEVLLRQEY-DGKIA----DVWSCGVTLYVMLVGAYP----FEDPEEPRDYRKT 230

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 42/183 (22%), Positives = 74/183 (40%), Gaps = 32/183 (17%)

Query: 60  FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKA-LVYEFMHNRSLKEWLYPISK 117
            +    E   L+    HRN+     A +  +  G D +  LV EF    S+ + +     
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----- 118

Query: 118 EDETYKRPRNLNLLRRLNIAI---DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                 +    N L+   IA    ++   L++LH        H  +K  NVLL ++   +
Sbjct: 119 ------KNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIG---YIAPEYGVGNEVSTIG-----DVYSYGILL 226
           + DFG++  L  T  + ++      IG   ++APE    +E          D++S GI  
Sbjct: 170 LVDFGVSAQLDRTVGRRNTF-----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224

Query: 227 LEL 229
           +E+
Sbjct: 225 IEM 227

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 1e-04
 Identities = 59/419 (14%), Positives = 136/419 (32%), Gaps = 99/419 (23%)

Query: 19  LHIEVG--KLKNLEILDVSRNMLEENLISAGTFGFSHLR--RQGAFKSFIAECKALRNIR 74
           +  E G  + +  +IL V     E+  +    F    ++   +        E   +   +
Sbjct: 7   MDFETGEHQYQYKDILSV----FEDAFVD--NFDCKDVQDMPKSILSK--EEIDHIIMSK 58

Query: 75  HR-NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLK---EWLY-PISKEDETYKRPRNLN 129
              +    L   L +  Q      +V +F+    L+   ++L  PI  E    ++P   +
Sbjct: 59  DAVSGTLRLFWTL-LSKQEE----MVQKFV-EEVLRINYKFLMSPIKTE---QRQP---S 106

Query: 130 LLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS------NVLLDDDMTARVGDFGLARF 183
           ++ R+ I        + L++D Q    + V +          LL+      V   G+   
Sbjct: 107 MMTRMYI-----EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS 161

Query: 184 ----LPPTRTQTSSIDVK--GSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP-- 235
               +      +  +  K    I ++     + N  S    +     +L +L+ +  P  
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIFWL----NLKNCNSPETVL----EMLQKLLYQIDPNW 213

Query: 236 ---SDIMFEGDMNLHKFAKMALSNHV--KDIVDSIL-LND--DEK-----------LVVR 276
              SD      + +H   +  L   +  K   + +L L +  + K           L+  
Sbjct: 214 TSRSDHSSNIKLRIHS-IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT 272

Query: 277 GDQKQTQAKINIIRECVISMVRIGVACSMESPQDR--------MKMTNVVHELQSIKNTL 328
             ++ T   ++      IS+     + ++   + +         +  ++  E+ +     
Sbjct: 273 RFKQVTDF-LSAATTTHISLDH--HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT---- 325

Query: 329 LGPKNLATCKAVI--GRAT-EQLNKYFTKQKKPIFD--LRQEKWSRDQKRLF-SCGCMP 381
             P+ L+     I  G AT +        +   I +  L   +   + +++F      P
Sbjct: 326 -NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE-PAEYRKMFDRLSVFP 382

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 3e-04
 Identities = 45/273 (16%), Positives = 88/273 (32%), Gaps = 62/273 (22%)

Query: 2   PSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFK 61
           P+     D S N +   +H    +L+ L       N L   L+        +++   A+ 
Sbjct: 211 PNWTSRSDHSSN-IKLRIHSIQAELRRLLKSKPYENCL---LV------LLNVQNAKAWN 260

Query: 62  SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED-- 119
           +F   CK L   R + +   L+A        +     +        L ++L     +D  
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL-DCRPQDLP 319

Query: 120 -ETYKR-PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS-NVLLDDDMTARVG 176
            E     PR L+++    I   +A+  N+ H +C  +T   +++ S NVL   +      
Sbjct: 320 REVLTTNPRRLSIIAES-IRDGLATWDNWKHVNCDKLTT--IIESSLNVLEPAEYRKMFD 376

Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPE--------YGVGNEVSTI------------ 216
              +    PP             I    P           + ++V  +            
Sbjct: 377 RLSV---FPP--------SAH--I----PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419

Query: 217 -GDVYSYGILLLELMIREKPSDIMFEGDMNLHK 248
                +  I  + L ++ K  +     +  LH+
Sbjct: 420 QPKESTISIPSIYLELKVKLEN-----EYALHR 447

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 3e-04
 Identities = 55/317 (17%), Positives = 95/317 (29%), Gaps = 98/317 (30%)

Query: 5   LIALDVSGNKLT--GSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQGAFKS 62
           +IA  +     T     H+   KL    I++ S N+LE              R+   F  
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLT--TIIESSLNVLEPAE----------YRKM--FDR 377

Query: 63  F-IAECKALR---NIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSL-----KEWLY 113
             +          +I       +L+  +  D   +D   +V +  H  SL     KE   
Sbjct: 378 LSV-----FPPSAHIP----TILLSL-IWFDVIKSDVMVVVNKL-HKYSLVEKQPKESTI 426

Query: 114 PI--------SKED----------ETYKRPRNLNLLRRLNIAIDVASALNYL-----HHD 150
            I         K +          + Y  P+  +    +   +D      Y      HH 
Sbjct: 427 SIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD-----QYFYSHIGHH- 480

Query: 151 CQPVTAHCVLKPSNVLLDDDMTARV-GDFGLARFLPPT-RTQTSSIDVKGSIGYIAPEYG 208
                    LK         +   V  DF   RFL    R  +++ +  GSI        
Sbjct: 481 ---------LKNIEHPERMTLFRMVFLDF---RFLEQKIRHDSTAWNASGSI-------- 520

Query: 209 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM--NLHKFAKMALSNHVKDIVDSIL 266
               ++T+  +  Y       +    P        +   L K  +  + +   D++   L
Sbjct: 521 ----LNTLQQLKFYK----PYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572

Query: 267 LNDDEKLVVRGDQKQTQ 283
           + +DE +      KQ Q
Sbjct: 573 MAEDEAIFEEA-HKQVQ 588

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 13/55 (23%), Positives = 25/55 (45%), Gaps = 1/55 (1%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLR 55
           L +L+  LD+S      + +     L +LE+L ++ N  +EN +        +L 
Sbjct: 420 LRNLIY-LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 21/94 (22%), Positives = 37/94 (39%), Gaps = 16/94 (17%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEV-GKLKNLEILDVSRNMLEENLISAGTFG-FSHLRR-- 56
           L SL + L ++GN    +   ++  +L+NL  LD+S+  LE+  +S   F   S L+   
Sbjct: 444 LSSLEV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ--LSPTAFNSLSSLQVLN 500

Query: 57  ------QGAFKSFIAECKALR--NIRHRNLIKVL 82
                             +L+  +    N I   
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSL-NHIMTS 533

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 11/51 (21%), Positives = 22/51 (43%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLR 55
           L  L      L    +  +G LK L+ L+V+ N+++   +       ++L 
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 17/56 (30%), Positives = 24/56 (42%), Gaps = 3/56 (5%)

Query: 1  LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTF-GFSHLR 55
          LP     LD+S N L             L++LD+SR  ++   I  G +   SHL 
Sbjct: 26 LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT--IEDGAYQSLSHLS 79

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 9/37 (24%), Positives = 15/37 (40%), Gaps = 1/37 (2%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEE 41
           L  + +    L   L   + +   LE L ++RN L  
Sbjct: 106 LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA 141

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 7/37 (18%), Positives = 16/37 (43%), Gaps = 1/37 (2%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEE 41
            +AL++    L      +  +L +L+ + +    L E
Sbjct: 83  RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME 118

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 33/178 (18%)

Query: 64  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYK 123
             E   L       + K   +     Y  +    ++ E++   S  + L      DET  
Sbjct: 68  QQEITVLSQCDSPYVTKYYGS-----YLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQ- 120

Query: 124 RPRNLNLLRRLNIAI---DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                       IA    ++   L+YLH + +    H  +K +NVLL +    ++ DFG+
Sbjct: 121 ------------IATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 165

Query: 181 ARFLPPTRTQTSSIDVKGSIG---YIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           A  L  T+ + ++      +G   ++APE    +   +  D++S GI  +EL   E P
Sbjct: 166 AGQLTDTQIKRNTF-----VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 14/52 (26%), Positives = 24/52 (46%), Gaps = 3/52 (5%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRR 56
           L  L +S N+L  +L++    +  L++LD+S N L    +      F  L  
Sbjct: 274 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH--VERNQPQFDRLEN 322

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 19/58 (32%), Positives = 26/58 (44%), Gaps = 5/58 (8%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEV-GKLKNLEILDVSRNMLEENLISAGTF-GFSHLRR 56
           L SL   L ++GN    +    V     NL  LD+S+  LE+  IS G F     L+ 
Sbjct: 447 LTSLNT-LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ--ISWGVFDTLHRLQL 501

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 24/164 (14%), Positives = 57/164 (34%), Gaps = 31/164 (18%)

Query: 3   SLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTF-GFSHLRR----- 56
           S L  L+++ NK++         L +LE+LD+  N + +  ++   + G  ++       
Sbjct: 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE-LTGQEWRGLENIFEIYLSY 439

Query: 57  ---QGAFKSFIAECKALRNIR-HRNLIKVLTACLGV----------DYQGNDFKALVYEF 102
                  ++  A   +L+ +   R  +K + +              D   N+   +  + 
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499

Query: 103 MHN-RSLKE---------WLYPISKEDETYKRPRNLNLLRRLNI 136
           +     L+           L+  +         + L+ L  LN+
Sbjct: 500 LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 11/56 (19%), Positives = 22/56 (39%), Gaps = 3/56 (5%)

Query: 1  LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTF-GFSHLR 55
          LP+ +  L+++ N+L         +   L  LDV  N + +  +          L+
Sbjct: 23 LPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK--LEPELCQKLPMLK 76

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 18/58 (31%), Positives = 31/58 (53%), Gaps = 5/58 (8%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEV-GKLKNLEILDVSRNMLEENLISAGTF-GFSHLRR 56
           L SL + L ++GN    +   ++  +L+NL  LD+S+  LE+  +S   F   S L+ 
Sbjct: 444 LSSLEV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ--LSPTAFNSLSSLQV 498

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 17/41 (41%), Positives = 23/41 (56%), Gaps = 2/41 (4%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEE 41
           LP LL  L VS N+L   L  E+     L+I+DV  N L++
Sbjct: 129 LPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK 167

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 14/52 (26%), Positives = 24/52 (46%), Gaps = 3/52 (5%)

Query: 5   LIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRR 56
           L  L +S N+L  +L++    +  L++LD+S N L    +      F  L  
Sbjct: 280 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH--VERNQPQFDRLEN 328

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 39/183 (21%), Positives = 72/183 (39%), Gaps = 33/183 (18%)

Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE- 118
            +  I E   ++     +++K   +     Y  N    +V E+    S+ + +   +K  
Sbjct: 68  LQEIIKEISIMQQCDSPHVVKYYGS-----YFKNTDLWIVMEYCGAGSVSDIIRLRNKTL 122

Query: 119 DETYKRPRNLNLLRRLNIAI---DVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175
            E               IA         L YLH        H  +K  N+LL+ +  A++
Sbjct: 123 TEDE-------------IATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKL 166

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIG---YIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
            DFG+A  L  T  + +++     IG   ++APE       + + D++S GI  +E+   
Sbjct: 167 ADFGVAGQLTDTMAKRNTV-----IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

Query: 233 EKP 235
           + P
Sbjct: 222 KPP 224

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	381
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.58
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.9
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.87
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.81
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.35
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.08
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.99
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.74
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.51
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.31
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.28
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.0
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.69
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.31
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	94.43
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.31
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.0
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.07
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	92.6
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	91.88
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	91.08
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	88.07
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	87.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	87.24
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	84.57

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-58  Score=419.66  Aligned_cols=248  Identities=26%  Similarity=0.412  Sum_probs=192.6

Q ss_pred             ccccccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      +++...++||+|+||+||+++                ....+.|.+|+++|++++|||||+++++|.      .+..+||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~~~~~iV  109 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------KDNLAIV  109 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------CCeEEEE
Confidence            567788999999999998864                124578999999999999999999999863      3457999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      ||||++|+|.++|+         .....+++.+++.++.||+.||.|||   +.+||||||||+|||+++++.+||+|||
T Consensus       110 mEy~~gGsL~~~l~---------~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          110 TQWCEGSSLYKHLH---------VQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             EECCSSCBHHHHHH---------TSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             EEcCCCCCHHHHHh---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeecc
Confidence            99999999999995         34467999999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      +|+..............+||+.|||||++.+   ..|+.++|||||||++|||+||+.||...    .........    
T Consensus       178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~----~~~~~~~~~----  249 (307)
T 3omv_A          178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI----NNRDQIIFM----  249 (307)
T ss_dssp             SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC----CCHHHHHHH----
T ss_pred             CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC----ChHHHHHHH----
Confidence            9987655433333334679999999999864   45899999999999999999999998522    221111111    


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                           +..... .+.             ....+..++..+.+|+.+||+.||++|||+.+|++.|+.+...+
T Consensus       250 -----~~~~~~-~p~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          250 -----VGRGYA-SPD-------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             -----HHTTCC-CCC-------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             -----HhcCCC-CCC-------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                 110000 000             00112356778999999999999999999999999999887654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-56  Score=411.49  Aligned_cols=254  Identities=23%  Similarity=0.386  Sum_probs=200.4

Q ss_pred             cccccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .++|...+.||+|+||+||+++                      ....+.|.+|+++|++|+|||||+++++|.     +
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----e
Confidence            3678889999999999998863                      123578999999999999999999999965     4


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCC---cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKE---DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                      .+..+||||||++|+|.++|+.....   .........+++.+++.++.||+.||.|||   +++||||||||+|||++.
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~  163 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGE  163 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECC
Confidence            67899999999999999999642210   000023457999999999999999999999   669999999999999999


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHK  248 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~  248 (381)
                      ++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||....    . ..
T Consensus       164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~----~-~~  238 (299)
T 4asz_A          164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS----N-NE  238 (299)
T ss_dssp             GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----H-HH
T ss_pred             CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----H-HH
Confidence            99999999999987665444333334568999999999999999999999999999999998 899985321    1 11


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                      ....        +.......                   .+..++.++.+|+.+||+.||++|||+.+|++.|+++.+..
T Consensus       239 ~~~~--------i~~~~~~~-------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          239 VIEC--------ITQGRVLQ-------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             HHHH--------HHHTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHH--------HHcCCCCC-------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            1111        11110000                   12356778999999999999999999999999999987764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.5e-56  Score=413.57  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=192.7

Q ss_pred             ccccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ++|...++||+|+||+||+++                      ....+.|.+|+++|++++|||||+++++|.     +.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence            567888999999999999863                      123578999999999999999999999965     46


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcc-----cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDE-----TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                      +..+||||||++|+|.++++.......     .......+++.+++.++.||+.||.|||   +.+||||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence            789999999999999999964332110     0012456999999999999999999999   66999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH  247 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~  247 (381)
                      .++.+||+|||+++.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||....    . .
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~----~-~  267 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS----N-T  267 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC----H-H
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC----H-H
Confidence            999999999999987765544433344679999999999999999999999999999999999 899985321    1 1


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      ....        .+.....   +                ..+..++.++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus       268 ~~~~--------~i~~g~~---~----------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          268 EAID--------CITQGRE---L----------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHH--------HHHHTCC---C----------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHH--------HHHcCCC---C----------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            1111        1111100   0                01235677899999999999999999999999999999775


Q ss_pred             c
Q 041757          328 L  328 (381)
Q Consensus       328 ~  328 (381)
                      .
T Consensus       321 p  321 (329)
T 4aoj_A          321 P  321 (329)
T ss_dssp             C
T ss_pred             C
Confidence            3

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.5e-56  Score=407.28  Aligned_cols=250  Identities=18%  Similarity=0.245  Sum_probs=197.9

Q ss_pred             ccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           36 RNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .+++..++||+|+||+||++.                       ....+.|.+|+.+|++++|||||+++|+|.     .
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~  100 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----K  100 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----E
Confidence            456677899999999998753                       123578999999999999999999999975     3


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                      .+..+||||||++|||.++|........      .......+++.+++.++.||+.||.|||   +.+||||||||+|||
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NIL  177 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVL  177 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceE
Confidence            6778999999999999999964321110      0012356899999999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCc
Q 041757          167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMN  245 (381)
Q Consensus       167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~  245 (381)
                      +++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||....     
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-----  252 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----  252 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-----
T ss_pred             ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----
Confidence            99999999999999987655443333344679999999999999999999999999999999998 899975321     


Q ss_pred             HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                      .......        +......                   +.+..++..+.+|+.+||+.||++||||.||++.|+++.
T Consensus       253 ~~~~~~~--------i~~~~~~-------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          253 NQDVVEM--------IRNRQVL-------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHHHHH--------HHTTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHH--------HHcCCCC-------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            1111111        1111000                   112457788999999999999999999999999998753

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-55  Score=403.52  Aligned_cols=234  Identities=18%  Similarity=0.284  Sum_probs=194.0

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|...++||+|+||+||++..                    ...+.+.+|+++|++++|||||+++++     +++.+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCC
Confidence            36799999999999999988651                    245678999999999999999999999     55688


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..|||||||+||+|.+++.          ....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+|
T Consensus       106 ~~yivmEy~~gG~L~~~i~----------~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vK  172 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIR----------KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQ  172 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEE
T ss_pred             EEEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEE
Confidence            9999999999999999993          4567999999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||++|+.||...    . ..       
T Consensus       173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~-~~-------  240 (311)
T 4aw0_A          173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----N-EG-------  240 (311)
T ss_dssp             ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS----S-HH-------
T ss_pred             EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----C-HH-------
Confidence            99999999876554444444578999999999999999999999999999999999999998521    1 11       


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           +++...+...+.                ++...+.++.+|+.+||..||++|||+.|++.
T Consensus       241 -----~~~~~i~~~~~~----------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          241 -----LIFAKIIKLEYD----------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             -----HHHHHHHHTCCC----------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             -----HHHHHHHcCCCC----------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence                 111211111110                01234557889999999999999999998753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-55  Score=408.95  Aligned_cols=234  Identities=19%  Similarity=0.286  Sum_probs=184.9

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...++||+|+||+||++..                   ...+.+.+|+++|++|+|||||++++++     .+.+..
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCEE
Confidence            6899999999999999988641                   2356899999999999999999999995     457889


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      |||||||+||+|.++|..        .....+++..++.++.||+.||.|||   +.+||||||||+|||++.++.+||+
T Consensus        99 yiVmEy~~gg~L~~~i~~--------~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~  167 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINA--------QKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLG  167 (350)
T ss_dssp             EEEEECCTTCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEEC
T ss_pred             EEEEeCCCCCcHHHHHHH--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEc
Confidence            999999999999999953        23456789999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      |||+|+.+......  ....+||+.|||||++.+..|+.++|||||||++|||++|+.||..    .. ...        
T Consensus       168 DFGla~~~~~~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~----~~-~~~--------  232 (350)
T 4b9d_A          168 DFGIARVLNSTVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA----GS-MKN--------  232 (350)
T ss_dssp             STTEESCCCHHHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC----SS-HHH--------
T ss_pred             ccccceeecCCccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cC-HHH--------
Confidence            99999876433211  1235799999999999999999999999999999999999999852    21 111        


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          ++...+.....               ..+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       233 ----~~~~i~~~~~~---------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          233 ----LVLKIISGSFP---------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----HHHHHHHTCCC---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHcCCCC---------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                11111111100               001234567889999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4e-55  Score=409.73  Aligned_cols=255  Identities=20%  Similarity=0.284  Sum_probs=200.9

Q ss_pred             cccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCC-Ccccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRH-RNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~   90 (381)
                      .++|..+++||+|+||+||++.                       ....+.|.+|+++|.++.| ||||+++++|.    
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~----  138 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----  138 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE----
Confidence            3678999999999999998763                       1235679999999999975 99999999974    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSN  164 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~N  164 (381)
                      ......+||||||++|+|.++|+.......      .......+++..++.++.||+.||.|||   +++||||||||+|
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~N  215 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN  215 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccc
Confidence            335678999999999999999964321100      0012355899999999999999999999   6699999999999


Q ss_pred             eeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCC
Q 041757          165 VLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGD  243 (381)
Q Consensus       165 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~  243 (381)
                      ||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... 
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-  294 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-  294 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999998766554444444679999999999999999999999999999999998 99998532211 


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                         ..+....        .+....                   ..+..++.++.+++.+||+.||++|||+.+|++.|++
T Consensus       295 ---~~~~~~i--------~~g~~~-------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          295 ---EEFCRRL--------KEGTRM-------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             ---HHHHHHH--------HHTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHHHHH--------HcCCCC-------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence               1111110        000000                   0123466789999999999999999999999999998


Q ss_pred             hhhh
Q 041757          324 IKNT  327 (381)
Q Consensus       324 i~~~  327 (381)
                      +.+.
T Consensus       345 llq~  348 (353)
T 4ase_A          345 LLQA  348 (353)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.9e-54  Score=391.38  Aligned_cols=235  Identities=20%  Similarity=0.320  Sum_probs=182.9

Q ss_pred             ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      |+..++||+|+||+||++..                   ...+.|.+|+++|++|+|||||++++++... .......||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEE
Confidence            36678899999999988641                   2356799999999999999999999997531 123567899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEEee
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARVGD  177 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~D  177 (381)
                      |||||++|+|.+++.          +...+++..+..++.||+.||+|||+. ..+||||||||+|||+++ ++.+||+|
T Consensus       107 vmEy~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A          107 VTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             EEeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEe
Confidence            999999999999994          456799999999999999999999943 223999999999999975 78999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+|+.......    ...+||+.|||||++.+ .|+.++|||||||++|||+||+.||..    ......+........
T Consensus       176 FGla~~~~~~~~----~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~----~~~~~~~~~~i~~~~  246 (290)
T 3fpq_A          176 LGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE----CQNAAQIYRRVTSGV  246 (290)
T ss_dssp             TTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT----CSSHHHHHHHHTTTC
T ss_pred             CcCCEeCCCCcc----CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC----CCcHHHHHHHHHcCC
Confidence            999986443322    23679999999999875 699999999999999999999999752    222222211111100


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                 .+.               ..+...++++.+|+.+||+.||++|||+.|+++
T Consensus       247 -----------~~~---------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 -----------KPA---------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----------CCG---------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----------CCC---------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       000               001223456889999999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.6e-54  Score=399.37  Aligned_cols=234  Identities=20%  Similarity=0.256  Sum_probs=190.1

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ...|...++||+|+||+||++..                 ...+.+.+|+++|++++|||||++++++     .+.+..|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~  147 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELW  147 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            35699999999999999988652                 2356688999999999999999999995     4578899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      ||||||++|+|.+++.           ...+++..+..++.||+.||.|||   +.+||||||||+|||++.++.+||+|
T Consensus       148 ivmEy~~gg~L~~~l~-----------~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~D  213 (346)
T 4fih_A          148 VVMEFLEGGALTDIVT-----------HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSD  213 (346)
T ss_dssp             EEECCCTTEEHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEeCCCCCcHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEec
Confidence            9999999999999984           245899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+|+.+.......  ...+||+.|||||++.+..|+.++|||||||++|||++|+.||..    ......+ ..     
T Consensus       214 FGla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~~~~~~~-~~-----  281 (346)
T 4fih_A          214 FGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN----EPPLKAM-KM-----  281 (346)
T ss_dssp             CTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT----SCHHHHH-HH-----
T ss_pred             CcCceecCCCCCcc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cCHHHHH-HH-----
Confidence            99999876543322  236799999999999999999999999999999999999999852    2211111 11     


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         +.+. ......                .....+.++.+|+.+||..||++|||+.|+++
T Consensus       282 ---i~~~-~~~~~~----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          282 ---IRDN-LPPRLK----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---HHHS-SCCCCS----------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---HHcC-CCCCCC----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               1110 000000                01234567889999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-54  Score=401.27  Aligned_cols=248  Identities=20%  Similarity=0.226  Sum_probs=195.8

Q ss_pred             cccccccceecCCCceEEEeccccc------------HHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQGA------------FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~~------------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      .+.|...++||+|+||+||++....            .....+|+.+|++++|||||++++++     .+.+..||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEE-----EETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEEEEec
Confidence            3567888999999999999876321            12235799999999999999999995     457889999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEeecccc
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVGDFGLA  181 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~~  181 (381)
                      |+||+|.+++.          ....+++..+..++.||+.||.|||   +.+||||||||+|||++.++ .+||+|||+|
T Consensus       132 ~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla  198 (336)
T 4g3f_A          132 LEGGSLGQLIK----------QMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA  198 (336)
T ss_dssp             CTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred             cCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence            99999999994          4567999999999999999999999   77999999999999999887 6999999999


Q ss_pred             eecCCCCCcc---cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          182 RFLPPTRTQT---SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       182 ~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      +.+.......   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ +..+         
T Consensus       199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i---------  268 (336)
T 4g3f_A          199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKI---------  268 (336)
T ss_dssp             EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHH---------
T ss_pred             eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHH---------
Confidence            9876543221   12235799999999999999999999999999999999999999864332221 1111         


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  330 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~  330 (381)
                         ..    ..+.             ....++.++..+.+++.+||+.||.+|||+.|+++.|.........
T Consensus       269 ---~~----~~~~-------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          269 ---AS----EPPP-------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             ---HH----SCCG-------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             ---Hc----CCCC-------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence               10    0000             0011235667889999999999999999999999999888776543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.8e-54  Score=386.84  Aligned_cols=229  Identities=22%  Similarity=0.315  Sum_probs=175.4

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||+||++..                    ...+.+.+|+++|++++|||||+++++     +.+.+.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-----IKSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEECCE
Confidence            6799999999999999988641                    235678999999999999999999999     456888


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .|+||||| +|+|.+++.          ....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||
T Consensus        88 ~~ivmEy~-~g~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl  153 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIV----------QRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKI  153 (275)
T ss_dssp             EEEEEECC-CEEHHHHHH----------HSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEE
T ss_pred             EEEEEeCC-CCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEE
Confidence            99999999 679999993          4567999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      +|||+|+.........   ..+||+.|||||++.+..| +.++||||+||++|||++|+.||...     +.....    
T Consensus       154 ~DFGla~~~~~~~~~~---~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~----  221 (275)
T 3hyh_A          154 ADFGLSNIMTDGNFLK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLF----  221 (275)
T ss_dssp             CCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHH----
T ss_pred             eecCCCeecCCCCccC---CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHH----
Confidence            9999998765433222   3579999999999998876 57999999999999999999998521     111111    


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              .......+.                ++...+.++.+++.+||+.||++|||+.|+++
T Consensus       222 --------~~i~~~~~~----------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          222 --------KNISNGVYT----------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --------HHHHHTCCC----------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --------HHHHcCCCC----------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                    111111110                01234567889999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.7e-53  Score=389.40  Aligned_cols=270  Identities=20%  Similarity=0.240  Sum_probs=190.5

Q ss_pred             cccccccceecCCCceEEEeccc------------ccHHHHHH--HHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------GAFKSFIA--ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------~~~~~~~~--E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      .++|...++||+|+||+||+++.            ...+.+.+  |+..+.+++|||||+++++|...+ ......+|||
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~   80 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence            46788899999999999988652            23344544  455556889999999999986421 1234689999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC-----CCCceeeccCCCCeeeCCCCCeEE
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC-----QPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      |||++|+|.++++           ...+++..+..++.|++.||+|||+..     ..+||||||||+|||++.++.+||
T Consensus        81 Ey~~~gsL~~~l~-----------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           81 DYHEHGSLFDYLN-----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             ECCTTCBHHHHHH-----------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             cCCCCCcHHHHHH-----------hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence            9999999999994           245899999999999999999999431     238999999999999999999999


Q ss_pred             eecccceecCCCCCcc--cccCccCccceeCCCCcCCC------ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          176 GDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGN------EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      +|||+|+.........  .....+||+.|||||++.+.      .++.++|||||||++|||+||..||.........+.
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            9999998775543221  22235799999999998764      478899999999999999999888653322211111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      ....  .......+..........     ...   + ......+++..+.+|+.+||+.||++||||.+|++.|+++.+.
T Consensus       230 ~~~~--~~~~~~~~~~~~~~~~~r-----p~~---p-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          230 DLVP--SDPSVEEMRKVVCEQKLR-----PNI---P-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTSC--SSCCHHHHHHHHTTSCCC-----CCC---C-GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hccc--ccchHHHHHHHHhcccCC-----CCC---C-ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0000  000011111111100000     000   0 0000135677899999999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.3e-54  Score=394.45  Aligned_cols=226  Identities=20%  Similarity=0.224  Sum_probs=177.9

Q ss_pred             ccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ++|+..++||+|+||+||+++.                      .....+.+|+++|++++|||||++++++     .+.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence            5799999999999999987642                      1234688999999999999999999994     557


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..|+|||||+||+|.+++.          +...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~v  165 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHI  165 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCE
T ss_pred             CEEEEEEEcCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCE
Confidence            88999999999999999994          4567999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+|+.........  ...+||+.|||||++.+..|+.++|||||||++|||++|+.||...    .. ..     
T Consensus       166 Kl~DFGla~~~~~~~~~~--~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~-~~-----  233 (304)
T 3ubd_A          166 KLTDFGLSKESIDHEKKA--YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK----DR-KE-----  233 (304)
T ss_dssp             EEESSEEEEC-----CCC--CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SH-HH-----
T ss_pred             EecccccceeccCCCccc--cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc----CH-HH-----
Confidence            999999998654433222  2367999999999999999999999999999999999999998521    11 11     


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                             ++.......+.                ++..++.++.+|+.+||+.||++|||+
T Consensus       234 -------~~~~i~~~~~~----------------~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          234 -------TMTMILKAKLG----------------MPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -------HHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             -------HHHHHHcCCCC----------------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                   11111111110                012345678899999999999999995

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.5e-53  Score=401.54  Aligned_cols=234  Identities=20%  Similarity=0.256  Sum_probs=190.2

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .+.|...++||+|+||+||++..                 ...+.+.+|+.+|++++|||||++++++     .+.+..|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEE
Confidence            45699999999999999988652                 2456789999999999999999999995     4578899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      ||||||+||+|.+++.           ...+++.++..++.||+.||.|||   +.+||||||||+|||++.++.+||+|
T Consensus       225 iVmEy~~gG~L~~~i~-----------~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~D  290 (423)
T 4fie_A          225 VVMEFLEGGALTDIVT-----------HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSD  290 (423)
T ss_dssp             EEEECCTTEEHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECC
T ss_pred             EEEeCCCCCcHHHHHh-----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEec
Confidence            9999999999999984           245899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+|+.+.......  ...+||+.|||||++.+..|+.++|||||||++|||++|+.||..    ......+ ..     
T Consensus       291 FGla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~~~~~~~-~~-----  358 (423)
T 4fie_A          291 FGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN----EPPLKAM-KM-----  358 (423)
T ss_dssp             CTTCEECCSSCCCB--CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT----SCHHHHH-HH-----
T ss_pred             CccceECCCCCccc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cCHHHHH-HH-----
Confidence            99999876543322  236799999999999999999999999999999999999999852    2211111 11     


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         +... ......                ....++.++.+|+.+||..||++|||+.|+++
T Consensus       359 ---i~~~-~~~~~~----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          359 ---IRDN-LPPRLK----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ---HHHS-CCCCCS----------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---HHcC-CCCCCc----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               1110 000000                01234567889999999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.9e-52  Score=379.41  Aligned_cols=240  Identities=22%  Similarity=0.338  Sum_probs=173.3

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc-------
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY-------   90 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-------   90 (381)
                      .+|+..+.||+|+||+||+++.                  ...+.+.+|+++|++|+|||||++++++...+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4689999999999999988641                  234678999999999999999999999764211       


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ....+.|+|||||++|+|.+++....       .....++..++.++.||+.||+|||   +++|+||||||+|||++.+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~  154 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-------TIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMD  154 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-------SGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-------CCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCC
Confidence            12345799999999999999995321       1223456678899999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcc----------cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccc
Q 041757          171 MTARVGDFGLARFLPPTRTQT----------SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF  240 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~  240 (381)
                      +.+||+|||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++   ||....
T Consensus       155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~  231 (299)
T 4g31_A          155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM  231 (299)
T ss_dssp             CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence            999999999998776532211          1123579999999999999999999999999999999996   764210


Q ss_pred             cCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          .....        +..+..   ...+                +......+.+.+++.+||+.||.+|||+.|+++
T Consensus       232 ----~~~~~--------~~~~~~---~~~p----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 ----ERVRT--------LTDVRN---LKFP----------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ----HHHHH--------HHHHHT---TCCC----------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHH--------HHHHhc---CCCC----------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                00000        000000   0000                112344556778999999999999999999976

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-50  Score=381.87  Aligned_cols=267  Identities=19%  Similarity=0.247  Sum_probs=190.3

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccc-cccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGV-DYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~~   93 (381)
                      +.++|...++||+|+||+||++..                   ...+.+.+|+++|++|+|||||++++++... .+.+.
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            446799999999999999988652                   2346788999999999999999999987542 23456


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...|||||||. |+|.+++          .....+++..+..++.||+.||.|||   +.+||||||||+|||++.++.+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i----------~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~  197 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQII----------HSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCEL  197 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHH----------TSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCE
T ss_pred             CEEEEEEeCCC-CCHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCE
Confidence            78999999995 6899999          45678999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCC--cccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          174 RVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      ||+|||+|+.+.....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.    +......+.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~----g~~~~~~l~  273 (398)
T 4b99_A          198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP----GKNYVHQLQ  273 (398)
T ss_dssp             EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC----CSSHHHHHH
T ss_pred             EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC----CCCHHHHHH
Confidence            9999999987654321  2223346899999999998875 56999999999999999999999975    222222211


Q ss_pred             H---HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 K---MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~---~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .   ....... ..............................+....++.+|+.+||..||.+|||+.|+++
T Consensus       274 ~I~~~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          274 LIMMVLGTPSP-AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHCCCCG-GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHhcCCCCh-HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1   1111000 000000000000000000000000001111234567889999999999999999999886

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.8e-49  Score=371.36  Aligned_cols=184  Identities=24%  Similarity=0.291  Sum_probs=156.5

Q ss_pred             hccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCC
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .+.+.|.+.++||+|+||+||+++.                  ....++.+|+++|+.+ +|||||++++++     .+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-----RKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-----EEC
Confidence            3568899999999999999998742                  2346788999999999 599999999994     558


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CC
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MT  172 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~  172 (381)
                      ++.|+|||||++|+|.+++.             .+++.++..++.|++.||+|||   +.+|+||||||+|||++.+ +.
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~  156 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKK  156 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTE
T ss_pred             CEEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCe
Confidence            89999999999999999982             3889999999999999999999   6699999999999999876 79


Q ss_pred             eEEeecccceecCCCCCc--------------------------ccccCccCccceeCCCCcCCC-ccCcccchhhhhHH
Q 041757          173 ARVGDFGLARFLPPTRTQ--------------------------TSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGIL  225 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~i  225 (381)
                      +||+|||+|+........                          ......+||+.|+|||++.+. .|+.++||||+||+
T Consensus       157 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~i  236 (361)
T 4f9c_A          157 YALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI  236 (361)
T ss_dssp             EEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred             EEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHH
Confidence            999999999876543211                          011235799999999998875 58999999999999


Q ss_pred             HHHHHhCCCCCC
Q 041757          226 LLELMIREKPSD  237 (381)
Q Consensus       226 l~el~tg~~Pf~  237 (381)
                      +|||++|+.||.
T Consensus       237 l~ell~G~~Pf~  248 (361)
T 4f9c_A          237 FLSLLSGRYPFY  248 (361)
T ss_dssp             HHHHHHTCSSSS
T ss_pred             HHHHHHCCCCCC
Confidence            999999999984

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-47  Score=380.25  Aligned_cols=233  Identities=19%  Similarity=0.219  Sum_probs=185.2

Q ss_pred             cccccccceecCCCceEEEecccc--------------------cHHHHHHH---HHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAE---CKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E---~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      -++|...++||+|+||+||+++..                    ....+.+|   +.+++.++|||||+++++     ++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~  262 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH  262 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EE
Confidence            478999999999999999887521                    22233444   566777899999999999     56


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      +.+..|||||||+||+|.++|.          ....+++..+..++.||+.||.|||   +.+||||||||+|||++.+|
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~----------~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G  329 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHG  329 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTS
T ss_pred             ECCEEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCC
Confidence            6889999999999999999993          4567999999999999999999999   77999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      .+||+|||+|+.+......    ..+||+.|||||++.. ..|+.++|||||||++|||++|..||......  ......
T Consensus       330 ~vKL~DFGlA~~~~~~~~~----t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i~  403 (689)
T 3v5w_A          330 HVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEID  403 (689)
T ss_dssp             CEEECCCTTCEECSSCCCC----SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHHH
T ss_pred             CEEecccceeeecCCCCCC----CccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH
Confidence            9999999999887554322    3679999999999864 57999999999999999999999998633221  111111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                      ..            .+.....                .+...+.++.+|+.+||..||.+|++     +.||++
T Consensus       404 ~~------------i~~~~~~----------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          404 RM------------TLTMAVE----------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HH------------HHHCCCC----------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             Hh------------hcCCCCC----------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            11            1111100                01234567889999999999999998     677764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.8e-47  Score=379.20  Aligned_cols=236  Identities=19%  Similarity=0.294  Sum_probs=190.5

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .++|.+.+.||+|+||+||++..                 ...+.+.+|+++|+.|+|||||+++++     +.+....|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence            36899999999999999987642                 235678899999999999999999999     45688999


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC--CCeEE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD--MTARV  175 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl  175 (381)
                      ||||||+||+|.++|.         .....+++.++..++.||+.||.|||   +.+|+||||||+|||++.+  +.+||
T Consensus       231 iv~E~~~gg~L~~~i~---------~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl  298 (573)
T 3uto_A          231 MIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL  298 (573)
T ss_dssp             EEEECCCCCBHHHHHT---------CTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEeecCCCcHHHHHH---------HhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEE
Confidence            9999999999999984         34567999999999999999999999   6699999999999999854  79999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+|+.+.......   ..+||+.|||||++.+..|+.++|||||||++|||++|..||..    ......+ .    
T Consensus       299 ~DFG~a~~~~~~~~~~---~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~----~~~~~~~-~----  366 (573)
T 3uto_A          299 IDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG----ENDDETL-R----  366 (573)
T ss_dssp             CCCSSCEECCTTSEEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC----SSHHHHH-H----
T ss_pred             eeccceeEccCCCcee---eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cCHHHHH-H----
Confidence            9999999876544322   25699999999999999999999999999999999999999852    2111111 1    


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          .+.........                ......+.++.+|+.+||..||.+|||+.|+++
T Consensus       367 ----~i~~~~~~~~~----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          367 ----NVKSCDWNMDD----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----HHHTTCCCCCS----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----HHHhCCCCCCc----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                11110000000                001234567889999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-45  Score=343.58  Aligned_cols=273  Identities=27%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             cccccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeec
Q 041757           23 VGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACL   86 (381)
Q Consensus        23 ~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~   86 (381)
                      ...+...++...+++|...+.||+|+||.||++..                ...+.+.+|+.+++.++||||+++++++ 
T Consensus        26 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-  104 (321)
T 2qkw_B           26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-  104 (321)
T ss_dssp             ----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-
T ss_pred             ceeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-
Confidence            34455566677889999999999999999988642                2457899999999999999999999995 


Q ss_pred             cccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           87 GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        87 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                          ...+..++||||+++|+|.+++....      .....+++..++.++.|++.||.|||   ..+|+||||||+||+
T Consensus       105 ----~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil  171 (321)
T 2qkw_B          105 ----DERNEMILIYKYMENGNLKRHLYGSD------LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINIL  171 (321)
T ss_dssp             ----CCTTCCEEEEECCTTCBTGGGSSSSC------CCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEE
T ss_pred             ----cCCCeEEEEEEcCCCCcHHHHHhccC------CCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEE
Confidence                44778899999999999999995321      12346899999999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCC-Cc
Q 041757          167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MN  245 (381)
Q Consensus       167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~-~~  245 (381)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..
T Consensus       172 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~  251 (321)
T 2qkw_B          172 LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN  251 (321)
T ss_dssp             ECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred             ECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence            99999999999999987654333322233568999999999988899999999999999999999999987544322 12


Q ss_pred             HHHHHHHHhh-chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          246 LHKFAKMALS-NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       246 ~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ...+...... ..+...++..+                  .......++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          252 LAEWAVESHNNGQLEQIVDPNL------------------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             HHHHTHHHHTTTCCCSSSSSSC------------------TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhhhccccccHHHhcChhh------------------ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            2221111100 00000000000                  0111346788999999999999999999999999999988


Q ss_pred             hhh
Q 041757          325 KNT  327 (381)
Q Consensus       325 ~~~  327 (381)
                      .+.
T Consensus       314 l~~  316 (321)
T 2qkw_B          314 LRL  316 (321)
T ss_dssp             HHS
T ss_pred             hhc
Confidence            754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-45  Score=342.66  Aligned_cols=277  Identities=19%  Similarity=0.234  Sum_probs=204.2

Q ss_pred             cccchhhhhccccccccceecCCCceEEEeccc--------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           25 KLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ--------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        25 ~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      ...+-++.--.++|...++||+|+||+||+++.              .....+.+|+.++++++||||+++++++.... 
T Consensus        13 ~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-   91 (322)
T 3soc_A           13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-   91 (322)
T ss_dssp             -CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-
T ss_pred             ccCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-
Confidence            334444555578899999999999999988752              22345567899999999999999999976421 


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC----------Cceeecc
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP----------VTAHCVL  160 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~----------~ivHrDl  160 (381)
                      ......++|||||++|+|.+++.           ...+++..++.++.|++.||.|||   +.          +|+||||
T Consensus        92 ~~~~~~~lv~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dl  157 (322)
T 3soc_A           92 SVDVDLWLITAFHEKGSLSDFLK-----------ANVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDI  157 (322)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHH-----------HCCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCC
T ss_pred             CCCceEEEEEecCCCCCHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCC
Confidence            11445799999999999999994           234899999999999999999999   77          9999999


Q ss_pred             CCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCC
Q 041757          161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKP  235 (381)
Q Consensus       161 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~P  235 (381)
                      ||+||+++.++.+||+|||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.|
T Consensus       158 kp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~p  237 (322)
T 3soc_A          158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA  237 (322)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTT
T ss_pred             ChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCC
Confidence            99999999999999999999988766544333334579999999999876     3567889999999999999999999


Q ss_pred             CCccccCCC-cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          236 SDIMFEGDM-NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       236 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                      |........ .+...  ........++.............         ........++..+.+++.+||+.||++|||+
T Consensus       238 f~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (322)
T 3soc_A          238 ADGPVDEYMLPFEEE--IGQHPSLEDMQEVVVHKKKRPVL---------RDYWQKHAGMAMLCETIEECWDHDAEARLSA  306 (322)
T ss_dssp             SSSCCCCCCCTTHHH--HCSSCCHHHHHHHHTTSCCCCCC---------CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCcchhccchhhh--hccCCchhhhhhhhhcccCCCCc---------cccccccchHHHHHHHHHHHccCChhhCcCH
Confidence            875433221 11110  00111122222211111000000         0000012456779999999999999999999


Q ss_pred             HHHHHHHHHhhhh
Q 041757          315 TNVVHELQSIKNT  327 (381)
Q Consensus       315 ~~vl~~L~~i~~~  327 (381)
                      .+|++.|+++.+.
T Consensus       307 ~ell~~L~~l~~~  319 (322)
T 3soc_A          307 GCVGERITQMQRL  319 (322)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=340.28  Aligned_cols=249  Identities=24%  Similarity=0.413  Sum_probs=199.2

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .++|..+++||+|+||+||++..                 ...+.+.+|++++++++||||+++++++.     .....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence            47899999999999999988642                 24577899999999999999999999964     467899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        84 lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  151 (310)
T 3s95_A           84 FITEYIKGGTLRGIIK---------SMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVAD  151 (310)
T ss_dssp             EEEECCTTCBHHHHHH---------HCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECC
T ss_pred             EEEEecCCCcHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEee
Confidence            9999999999999995         23567899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCccc------------ccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCc
Q 041757          178 FGLARFLPPTRTQTS------------SIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN  245 (381)
Q Consensus       178 fg~~~~~~~~~~~~~------------~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~  245 (381)
                      ||+++..........            .....||+.|+|||++.+..++.++||||||+++|||++|..||.........
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~  231 (310)
T 3s95_A          152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD  231 (310)
T ss_dssp             CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred             cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence            999987654332211            11356999999999999999999999999999999999999997643322211


Q ss_pred             HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                      ..        ...........                      +..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       232 ~~--------~~~~~~~~~~~----------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          232 FG--------LNVRGFLDRYC----------------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             SS--------BCHHHHHHHTC----------------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hh--------hhhhccccccC----------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            10        00111111110                      1244567889999999999999999999999999998


Q ss_pred             hhcCC
Q 041757          326 NTLLG  330 (381)
Q Consensus       326 ~~~~~  330 (381)
                      .....
T Consensus       282 ~~~~~  286 (310)
T 3s95_A          282 MHLAG  286 (310)
T ss_dssp             HHHHH
T ss_pred             HhccC
Confidence            77643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.7e-45  Score=340.63  Aligned_cols=272  Identities=32%  Similarity=0.502  Sum_probs=207.9

Q ss_pred             cccccchhhhhccccccccceecCCCceEEEecccc-----------------cHHHHHHHHHHHHccCCCcccceeeee
Q 041757           23 VGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQG-----------------AFKSFIAECKALRNIRHRNLIKVLTAC   85 (381)
Q Consensus        23 ~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~~~~E~~~l~~l~h~nIv~~~~~~   85 (381)
                      +..+..-++....++|...++||+|+||.||++...                 ....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            445566666778899999999999999999886521                 223688999999999999999999995


Q ss_pred             ccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCe
Q 041757           86 LGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNV  165 (381)
Q Consensus        86 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Ni  165 (381)
                      .     .....++||||+++|+|.+++....      .....+++..+..++.|++.||.|||+....+|+||||||+||
T Consensus        97 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  165 (326)
T 3uim_A           97 M-----TPTERLLVYPYMANGSVASCLRERP------ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI  165 (326)
T ss_dssp             C-----CSSCCEEEEECCTTCBHHHHHHCCS------TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred             e-----cCCceEEEEEeccCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence            4     4677899999999999999996432      2344589999999999999999999943233999999999999


Q ss_pred             eeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccc---cC
Q 041757          166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF---EG  242 (381)
Q Consensus       166 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~---~~  242 (381)
                      +++.++.+||+|||+++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||....   ..
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  244 (326)
T 3uim_A          166 LLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD  244 (326)
T ss_dssp             EECTTCCEEECCCSSCEECCSSSSCEE-CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred             EECCCCCEEeccCccccccCccccccc-ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence            999999999999999987754433222 23559999999999988889999999999999999999999985321   11


Q ss_pred             CCcHHHHHHHHhhc-hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          243 DMNLHKFAKMALSN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      ......+....... ....+.+..+                  ........+..+.+++.+||+.||.+|||+.+|++.|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          245 DVMLLDWVKGLLKEKKLEALVDVDL------------------QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             CSBHHHHHTTTTSSCCSTTSSCTTC------------------TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             chhHHHHHHHHhhchhhhhhcChhh------------------ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence            11222211111111 0011111000                  0112346778999999999999999999999999999


Q ss_pred             HHh
Q 041757          322 QSI  324 (381)
Q Consensus       322 ~~i  324 (381)
                      +..
T Consensus       307 ~~~  309 (326)
T 3uim_A          307 EGD  309 (326)
T ss_dssp             HTS
T ss_pred             cCc
Confidence            863

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.2e-45  Score=338.00  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=187.2

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++|...++||+|+||+||+++.                 ...+.+.+|++++++++||||+++++++     ......
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~  109 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPPNL  109 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTTCC
T ss_pred             ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCce
Confidence            357899999999999999988641                 2346789999999999999999999995     456778


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeeccCCCCeeeCCCCCeE
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV--TAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivHrDlkp~Nill~~~~~~k  174 (381)
                      ++||||+++|+|.+++...       .....+++..++.++.|++.||.|||   +.+  |+||||||+||+++.++.+|
T Consensus       110 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~k  179 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKS-------GAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVK  179 (309)
T ss_dssp             EEEEECCTTCBHHHHHHST-------THHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEE
T ss_pred             EEEEecCCCCcHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEE
Confidence            9999999999999999521       11224899999999999999999999   668  99999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++.........  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....     ......  
T Consensus       180 L~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-----~~~~~~--  250 (309)
T 3p86_A          180 VCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----AQVVAA--  250 (309)
T ss_dssp             ECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----HHHHHH--
T ss_pred             ECCCCCCcccccccccc--ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--
Confidence            99999997654432211  225689999999999999999999999999999999999999853211     111000  


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  331 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~  331 (381)
                            +.....  ..                ..+..++..+.+++.+||+.||.+|||+.++++.|+.+.+....+
T Consensus       251 ------~~~~~~--~~----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          251 ------VGFKCK--RL----------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             ------HHHSCC--CC----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             ------HHhcCC--CC----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence                  000000  00                011245567899999999999999999999999999998775443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.4e-44  Score=329.41  Aligned_cols=267  Identities=27%  Similarity=0.394  Sum_probs=207.9

Q ss_pred             ccccchhhhhcccccccc------ceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcc
Q 041757           24 GKLKNLEILDVSRNMLEE------NLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNL   78 (381)
Q Consensus        24 ~~~~~l~~~~~~~~~~~~------~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nI   78 (381)
                      ..+..-++..++++|...      ++||+|+||.||++..                   ...+.+.+|+.++++++||||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   92 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL   92 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence            445566677778887776      9999999999988541                   235778999999999999999


Q ss_pred             cceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceee
Q 041757           79 IKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHC  158 (381)
Q Consensus        79 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHr  158 (381)
                      +++++++     ...+..++||||+++++|.+++...       .....+++..++.++.|++.||.|||   +.+|+||
T Consensus        93 ~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~  157 (307)
T 2nru_A           93 VELLGFS-----SDGDDLCLVYVYMPNGSLLDRLSCL-------DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHR  157 (307)
T ss_dssp             CCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHTG-------GGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred             EEEEEEE-----ecCCceEEEEEecCCCcHHHHHHhc-------cCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecC
Confidence            9999995     4467889999999999999998532       12356899999999999999999999   6699999


Q ss_pred             ccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          159 VLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       159 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      ||||+||+++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999999987765443333333569999999998865 589999999999999999999999874


Q ss_pred             cccCCCcHHHHHHHHh--hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          239 MFEGDMNLHKFAKMAL--SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       239 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                      ...... ...+.....  ...+.+.++..+..                   .+...+..+.+++.+||+.||.+|||+.+
T Consensus       237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~  296 (307)
T 2nru_A          237 HREPQL-LLDIKEEIEDEEKTIEDYIDKKMND-------------------ADSTSVEAMYSVASQCLHEKKNKRPDIKK  296 (307)
T ss_dssp             TBSSSB-TTHHHHHHHTTSCCHHHHSCSSCSC-------------------CCHHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CcchHH-HHHHHHHhhhhhhhhhhhccccccc-------------------cchHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            433221 112211111  11223333222211                   12466788999999999999999999999


Q ss_pred             HHHHHHHhhh
Q 041757          317 VVHELQSIKN  326 (381)
Q Consensus       317 vl~~L~~i~~  326 (381)
                      |++.|+++..
T Consensus       297 l~~~L~~l~~  306 (307)
T 2nru_A          297 VQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHHC-
T ss_pred             HHHHHHHHhc
Confidence            9999998854

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.4e-44  Score=342.69  Aligned_cols=254  Identities=18%  Similarity=0.309  Sum_probs=198.9

Q ss_pred             cccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGV   88 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~   88 (381)
                      .++|..++.||+|+||.||++..                         ...+.+.+|+.+|+.+ +||||++++++|.  
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence            47899999999999999997631                         1346789999999999 8999999999954  


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                         ..+..++||||+++|+|.+++........      .......+++..++.++.||+.||.|||   +.+|+||||||
T Consensus       158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp  231 (370)
T 2psq_A          158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA  231 (370)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred             ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccch
Confidence               46788999999999999999964321000      0012345889999999999999999999   66999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE  241 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~  241 (381)
                      +|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999987765443333333557899999999999999999999999999999999 9999753211


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      .     ..         ...+......                  ..+..++.++.+++.+||+.||.+|||+.++++.|
T Consensus       312 ~-----~~---------~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L  359 (370)
T 2psq_A          312 E-----EL---------FKLLKEGHRM------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  359 (370)
T ss_dssp             G-----GH---------HHHHHTTCCC------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             H-----HH---------HHHHhcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            1     11         0111110000                  00124566889999999999999999999999999


Q ss_pred             HHhhhhc
Q 041757          322 QSIKNTL  328 (381)
Q Consensus       322 ~~i~~~~  328 (381)
                      +++....
T Consensus       360 ~~il~~~  366 (370)
T 2psq_A          360 DRILTLT  366 (370)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9987643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-44  Score=341.90  Aligned_cols=272  Identities=14%  Similarity=0.169  Sum_probs=205.4

Q ss_pred             ccccccccceecCCCceEEEecccc------------------cH---------------HHHHHHHHHHHccCCCcccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG------------------AF---------------KSFIAECKALRNIRHRNLIK   80 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~------------------~~---------------~~~~~E~~~l~~l~h~nIv~   80 (381)
                      ..++|...++||+|+||.||++...                  ..               ..++.|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            3568999999999999999987320                  11               12334555666778999999


Q ss_pred             eeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeecc
Q 041757           81 VLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL  160 (381)
Q Consensus        81 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDl  160 (381)
                      +++++... .......++||||| +++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||
T Consensus       113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDl  178 (364)
T 3op5_A          113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYE---------ANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDI  178 (364)
T ss_dssp             EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHH---------HTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecC
Confidence            99997642 12246689999999 999999995         23467999999999999999999999   669999999


Q ss_pred             CCCCeeeC--CCCCeEEeecccceecCCCCCcc-----cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCC
Q 041757          161 KPSNVLLD--DDMTARVGDFGLARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE  233 (381)
Q Consensus       161 kp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~  233 (381)
                      ||+|||++  .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~  258 (364)
T 3op5_A          179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH  258 (364)
T ss_dssp             CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999998  88999999999998765432211     112345999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC
Q 041757          234 KPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK  313 (381)
Q Consensus       234 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  313 (381)
                      .||...... ..............+.++++..+..                     ..++.++.+++..||+.||.+||+
T Consensus       259 ~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~li~~cl~~~p~~RP~  316 (364)
T 3op5_A          259 LPWEDNLKD-PKYVRDSKIRYRENIASLMDKCFPA---------------------ANAPGEIAKYMETVKLLDYTEKPL  316 (364)
T ss_dssp             CTTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCT---------------------TCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred             CCccccccC-HHHHHHHHHHhhhhHHHHHHHhccc---------------------ccCHHHHHHHHHHHhcCCCCCCCC
Confidence            998643222 1222222333333444444443311                     134668899999999999999999


Q ss_pred             HHHHHHHHHHhhhhcCCCCCcccccccc
Q 041757          314 MTNVVHELQSIKNTLLGPKNLATCKAVI  341 (381)
Q Consensus       314 ~~~vl~~L~~i~~~~~~~~~~~~~~~~~  341 (381)
                      +.+|++.|+++.+..........+|...
T Consensus       317 ~~~l~~~l~~~~~~~~~~~~~~~dw~~~  344 (364)
T 3op5_A          317 YENLRDILLQGLKAIGSKDDGKLDLSVV  344 (364)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCCCCC---
T ss_pred             HHHHHHHHHHHHHHcCCCcCCccceEec
Confidence            9999999999998877666655555544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.9e-45  Score=339.63  Aligned_cols=232  Identities=22%  Similarity=0.293  Sum_probs=188.5

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ..++|...+.||+|+||.||++..                   ...+.+.+|+++|+.++||||+++++++     ...+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            357899999999999999987642                   2346788999999999999999999995     4577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~k  154 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLV----------AHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIK  154 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred             EEEEEEECCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEE
Confidence            8999999999999999994          4567899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccC-cccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVS-TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||++.........   ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...     ....     
T Consensus       155 l~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~-----  221 (328)
T 3fe3_A          155 IADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----NLKE-----  221 (328)
T ss_dssp             ECSTTCCGGGSSSCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH-----
T ss_pred             EeeccCceecCCCCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----CHHH-----
Confidence            9999999866543322   235699999999999887765 7899999999999999999998522     1111     


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                             +..........                .+...+.++.+++.+||..||.+|||+.|+++
T Consensus       222 -------~~~~i~~~~~~----------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          222 -------LRERVLRGKYR----------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -------HHHHHHHCCCC----------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -------HHHHHHhCCCC----------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   11111111110                01134557889999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.1e-44  Score=330.32  Aligned_cols=258  Identities=21%  Similarity=0.310  Sum_probs=198.0

Q ss_pred             ccccccccceecCCCceEEEecc------------cccHHHHHHHHHHHHc--cCCCcccceeeeeccccccCCceEEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR------------QGAFKSFIAECKALRN--IRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~------------~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      ..++|...++||+|+||+||+++            ......+.+|.+++..  ++||||+++++++... .......++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~~~lv   84 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQLWLI   84 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCceeEEe
Confidence            46889999999999999998864            2345667778888877  7899999999987642 2335678999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC-----CCCceeeccCCCCeeeCCCCCeE
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC-----QPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      |||+++|+|.+++.           ...+++..++.++.|++.||.|||...     +.+|+||||||+||+++.++.+|
T Consensus        85 ~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           85 THYHEMGSLYDYLQ-----------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             ECCCTTCBHHHHHT-----------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             hhhccCCCHHHHHh-----------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence            99999999999993           346899999999999999999999211     34899999999999999999999


Q ss_pred             EeecccceecCCCCCcc--cccCccCccceeCCCCcCCC------ccCcccchhhhhHHHHHHHhC----------CCCC
Q 041757          175 VGDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGN------EVSTIGDVYSYGILLLELMIR----------EKPS  236 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlG~il~el~tg----------~~Pf  236 (381)
                      |+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999998765443221  11224699999999998876      566899999999999999999          7887


Q ss_pred             CccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                      ......................       ....+              .......++..+.+++.+||+.||.+|||+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  292 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQ-------RPNIP--------------NRWFSDPTLTSLAKLMKECWYQNPSARLTALR  292 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCC-------CCCCC--------------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cccCCCCcchhhhhHHHhccCC-------CCCCC--------------hhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence            6555444443333222111100       00000              00012356788999999999999999999999


Q ss_pred             HHHHHHHh
Q 041757          317 VVHELQSI  324 (381)
Q Consensus       317 vl~~L~~i  324 (381)
                      |++.|+++
T Consensus       293 i~~~L~~i  300 (301)
T 3q4u_A          293 IKKTLTKI  300 (301)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHhcc
Confidence            99999876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.4e-44  Score=335.86  Aligned_cols=266  Identities=16%  Similarity=0.130  Sum_probs=205.4

Q ss_pred             hccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceE
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ...++|...++||+|+||.||++..               ...+.+.+|+++++++ +||||+++++++     ......
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG-----PCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEE-----EETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecCCcc
Confidence            3568899999999999999988752               2334688999999999 899999999995     447788


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC----
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT----  172 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~----  172 (381)
                      ++||||+ +++|.+++..         ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.    
T Consensus        81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~  147 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDL---------CDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQ  147 (330)
T ss_dssp             EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTT
T ss_pred             EEEEEeC-CCCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCc
Confidence            9999999 9999999952         2467999999999999999999999   669999999999999998887    


Q ss_pred             -eEEeecccceecCCCCCcc-----cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          173 -ARVGDFGLARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       173 -~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                       +||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|..||......  ..
T Consensus       148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~  225 (330)
T 2izr_A          148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TL  225 (330)
T ss_dssp             SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SH
T ss_pred             eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cH
Confidence             9999999998765433211     112367999999999999999999999999999999999999998643211  11


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      ...........        .....               ......++ ++.+++.+||+.||.+||++.+|++.|+++.+
T Consensus       226 ~~~~~~i~~~~--------~~~~~---------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          226 KERYQKIGDTK--------RATPI---------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHHHHHHHHHH--------HHSCH---------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhhh--------ccCCH---------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            11111100000        00000               00011234 89999999999999999999999999999988


Q ss_pred             hcCCCCCccccccccC
Q 041757          327 TLLGPKNLATCKAVIG  342 (381)
Q Consensus       327 ~~~~~~~~~~~~~~~~  342 (381)
                      ...........|....
T Consensus       282 ~~~~~~~~~~dw~~~~  297 (330)
T 2izr_A          282 RKGYMFDYEYDWIGKQ  297 (330)
T ss_dssp             HTTCCCSCCCTTTTSC
T ss_pred             HcCCCCCCCccCCCCC
Confidence            8766655555565433

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.8e-44  Score=334.51  Aligned_cols=232  Identities=24%  Similarity=0.298  Sum_probs=188.1

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|...++||+|+||+||+++.                    .....+.+|+++|+.++||||+++++++     .+.+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            36899999999999999987642                    2346788999999999999999999994     4578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|..++.          ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus        79 ~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vk  145 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIK  145 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEE
Confidence            8999999999999999993          4567899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|..||...     ....      
T Consensus       146 L~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~------  212 (337)
T 1o6l_A          146 ITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHER------  212 (337)
T ss_dssp             ECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHH------
T ss_pred             EeeccchhhcccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-----CHHH------
Confidence            9999999864333222  12356999999999999999999999999999999999999998521     1111      


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                            +....+.....                ++...+.++.+++.+||+.||.+||     ++.++++
T Consensus       213 ------~~~~i~~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          213 ------LFELILMEEIR----------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------HHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------HHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                  11111111100                0123456788999999999999999     8999876

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=336.35  Aligned_cols=246  Identities=22%  Similarity=0.366  Sum_probs=194.8

Q ss_pred             cccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...++||+|+||.||++..                     ...+.+.+|+.++++++||||+++++++     ...
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRG  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            46789999999999999987542                     1346789999999999999999999995     446


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLR---------THDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVC  190 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHH---------TTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred             CccEEEeeCCCCCcHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCE
Confidence            77899999999999999995         23457999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      ||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.....     .    
T Consensus       191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~----  261 (325)
T 3kul_A          191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----R----  261 (325)
T ss_dssp             EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----H----
T ss_pred             EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----H----
Confidence            999999998876543221 1222346788999999998899999999999999999999 9999752211     1    


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  329 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~  329 (381)
                              ++.........               ...+..++..+.+++.+||+.||.+|||+.+|++.|+.+.+...
T Consensus       262 --------~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          262 --------DVISSVEEGYR---------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             --------HHHHHHHTTCC---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             --------HHHHHHHcCCC---------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                    11111100000               00012456688999999999999999999999999999987643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.5e-44  Score=336.65  Aligned_cols=239  Identities=18%  Similarity=0.229  Sum_probs=191.9

Q ss_pred             hhhccccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeecc
Q 041757           31 ILDVSRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLG   87 (381)
Q Consensus        31 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~   87 (381)
                      ...+.+.|...+.||+|+||.||++...                       ..+.+.+|+.+|++++||||+++++++  
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--   84 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY--   84 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE--
Confidence            3456788999999999999999876411                       246789999999999999999999994  


Q ss_pred             ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           88 VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        88 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                         .+....++||||+++|+|.+++          .....+++..+..++.||+.||.|||   +.+|+||||||+||++
T Consensus        85 ---~~~~~~~lv~e~~~gg~L~~~l----------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll  148 (361)
T 2yab_A           85 ---ENRTDVVLILELVSGGELFDFL----------AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIML  148 (361)
T ss_dssp             ---ECSSEEEEEEECCCSCBHHHHH----------TTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred             ---EeCCEEEEEEEcCCCCcHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEE
Confidence               4578899999999999999999          34567999999999999999999999   6699999999999999


Q ss_pred             CCCC----CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757          168 DDDM----TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  243 (381)
Q Consensus       168 ~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~  243 (381)
                      +.++    .+||+|||+++.........   ...||+.|+|||++.+..++.++|||||||++|+|++|..||...    
T Consensus       149 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~----  221 (361)
T 2yab_A          149 LDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----  221 (361)
T ss_dssp             SCTTSSSCCEEECCCSSCEECCTTCCCC---CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS----
T ss_pred             eCCCCCccCEEEEecCCceEcCCCCccc---cCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC----
Confidence            8776    79999999998876543222   256999999999999989999999999999999999999998522    


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...             +.+.........            .........+..+.+++.+||..||.+|||+.|+++
T Consensus       222 ~~~-------------~~~~~i~~~~~~------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          222 TKQ-------------ETLANITAVSYD------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             SHH-------------HHHHHHHTTCCC------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHH-------------HHHHHHHhcCCC------------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111             111111110000            000112244567889999999999999999999985

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.8e-44  Score=330.64  Aligned_cols=236  Identities=19%  Similarity=0.229  Sum_probs=190.2

Q ss_pred             hccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      +..++|...++||+|+||+||++.                 ....+.+.+|+.++++++||||+++++++.     ..+.
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   91 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDE   91 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCE
Confidence            346789999999999999998874                 124577899999999999999999999954     4778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++|+|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        92 ~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl  157 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKL  157 (297)
T ss_dssp             EEEEEECCTTCBHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEEECCCCCCHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEE
Confidence            999999999999999984           235889999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++...........  ...||+.|+|||++.+..++.++|||||||++|+|++|..||...    .........   
T Consensus       158 ~Dfg~~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~~---  228 (297)
T 3fxz_A          158 TDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE----NPLRALYLI---  228 (297)
T ss_dssp             CCCTTCEECCSTTCCBC--CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHH---
T ss_pred             eeCCCceecCCcccccC--CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH---
Confidence            99999987765433222  256999999999999999999999999999999999999998522    111111110   


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            .... ....                ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus       229 ------~~~~-~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          229 ------ATNG-TPEL----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------HHHC-SCCC----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------HhCC-CCCC----------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  0000 0000                001234567889999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-44  Score=332.97  Aligned_cols=237  Identities=21%  Similarity=0.290  Sum_probs=190.7

Q ss_pred             ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +.++|...+.||+|+||.||++..                .....+.+|+.+|+.++||||+++++++     .+.+..+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~   77 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEE
Confidence            568899999999999999988642                2346688999999999999999999995     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC--CCCeEE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD--DMTARV  175 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl  175 (381)
                      +|||||++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.  ++.+||
T Consensus        78 lv~e~~~g~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl  145 (321)
T 1tki_A           78 MIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEECCCCCCBHHHHHT---------SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEEeCCCCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEE
Confidence            9999999999999995         23456899999999999999999999   669999999999999987  789999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+++.........   ...||+.|+|||++.+..++.++|||||||++|+|++|..||....    . .....    
T Consensus       146 ~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~-~~~~~----  213 (321)
T 1tki_A          146 IEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----N-QQIIE----  213 (321)
T ss_dssp             CCCTTCEECCTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----H-HHHHH----
T ss_pred             EECCCCeECCCCCccc---cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC----H-HHHHH----
Confidence            9999998876543222   2458999999999999889999999999999999999999985221    1 11111    


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          .+........                .......+.++.+++.+||..||.+|||+.|+++
T Consensus       214 ----~i~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          214 ----NIMNAEYTFD----------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ----HHHHTCCCCC----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----HHHcCCCCCC----------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                1111110000                0012245668899999999999999999999987

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.3e-45  Score=345.24  Aligned_cols=244  Identities=22%  Similarity=0.317  Sum_probs=194.2

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .++|...+.||+|+||.||++..                  ...+.|.+|+++|++++||||+++++++.     ..+..
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSSC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCCc
Confidence            46788899999999999987642                  12346889999999999999999999964     46778


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       188 ~lv~e~~~~g~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~  255 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLR---------TEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKIS  255 (377)
T ss_dssp             EEEEECCTTCBHHHHHH---------HHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEcCCCCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEEC
Confidence            99999999999999995         23456899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhh
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....     ..       
T Consensus       256 DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~~-------  323 (377)
T 3cbl_A          256 DFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQ-------  323 (377)
T ss_dssp             CGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----HH-------
T ss_pred             cCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HH-------
Confidence            9999987554322222111235778999999988899999999999999999998 9999753211     01       


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                        ..+.+......                  ..+..++..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus       324 --~~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          324 --TREFVEKGGRL------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             --HHHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence              11111110000                  01124566889999999999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-43  Score=325.68  Aligned_cols=262  Identities=14%  Similarity=0.117  Sum_probs=203.4

Q ss_pred             ccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ..++|...+.||+|+||.||++..               ...+.+.+|+.+++.+ +|+||+++++++     ......+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~   82 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNV   82 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeE
Confidence            467899999999999999988751               2345688999999999 699999999984     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC-----
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT-----  172 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~-----  172 (381)
                      +||||+ +++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.     
T Consensus        83 lv~e~~-~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~  149 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANM  149 (298)
T ss_dssp             EEEECC-CCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred             EEEEec-CCCHHHHHH---------HhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCe
Confidence            999999 999999995         23446899999999999999999999   779999999999999987765     


Q ss_pred             eEEeecccceecCCCCCc-----ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          173 ARVGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      +||+|||+++........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ..
T Consensus       150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~  227 (298)
T 1csn_A          150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NK  227 (298)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HH
T ss_pred             EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc--cH
Confidence            999999999877654321     11233569999999999999999999999999999999999999986432211  11


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      .....        +........               .......++..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus       228 ~~~~~--------~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          228 QKYER--------IGEKKQSTP---------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHHH--------HHHHHHHSC---------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHH--------HHhhccCcc---------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            11110        000000000               0001124567899999999999999999999999999999887


Q ss_pred             cCCCCCccccc
Q 041757          328 LLGPKNLATCK  338 (381)
Q Consensus       328 ~~~~~~~~~~~  338 (381)
                      .........+|
T Consensus       285 ~~~~~~~~~dw  295 (298)
T 1csn_A          285 LNTTEDENFDW  295 (298)
T ss_dssp             TTCCSCSCCGG
T ss_pred             cCCCCCCcccc
Confidence            76554444333

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.6e-45  Score=332.95  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=183.6

Q ss_pred             cccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .++|...++||+|+||+||+++.                ...+.+.+|+.++++++||||+++++++      .....++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~~~~~l   96 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TAPQLAI   96 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CSSSCEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cCCccEE
Confidence            57899999999999999988641                2357789999999999999999999974      2456799


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        97 v~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           97 VTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             EEECCCEEEHHHHHT---------TC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             EEEecCCCcHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccc
Confidence            999999999999995         34566899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |++................||+.|+|||++.   +..++.++||||||+++|+|++|+.||....    ...........
T Consensus       165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~  240 (289)
T 3og7_A          165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIEMVGR  240 (289)
T ss_dssp             C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----CHHHHHHHHHH
T ss_pred             eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----hHHHHHHHhcc
Confidence            9998655432222222356899999999886   5678889999999999999999999985321    11111111100


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                              ........               .....++..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       241 --------~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          241 --------GSLSPDLS---------------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             --------TSCCCCTT---------------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --------cccCcchh---------------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                    00000000               0012456789999999999999999999999999998864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-44  Score=335.69  Aligned_cols=243  Identities=23%  Similarity=0.328  Sum_probs=194.4

Q ss_pred             cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .++|...++||+|+||+||++..                      ...+.+.+|+.++++++||||++++++|..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence            57899999999999999987641                      234678999999999999999999999752     


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                       ...++|+||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~  155 (327)
T 3poz_A           89 -STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             -SSEEEEEECCTTCBHHHHHH---------HSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTE
T ss_pred             -CCeEEEEEecCCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCC
Confidence             34789999999999999995         33567899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .      
T Consensus       156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~------  227 (327)
T 3poz_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E------  227 (327)
T ss_dssp             EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--G------
T ss_pred             EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--H------
Confidence            99999999987765544333333457889999999999999999999999999999999 99998632211  1      


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                            ....+.......                  .+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       228 ------~~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          228 ------ISSILEKGERLP------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ------HHHHHHTTCCCC------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ------HHHHHHcCCCCC------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                  111111111000                  0123556788999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-44  Score=329.97  Aligned_cols=258  Identities=21%  Similarity=0.393  Sum_probs=193.8

Q ss_pred             cccccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|+..++||+|+||+||+++                     ....+.+.+|++++++++||||+++++++..   .+.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence            5789999999999999998764                     1134678999999999999999999999753   234


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~  153 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQ---------KHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRV  153 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHH---------HCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred             CceEEEEEeCCCCCHHHHHH---------hcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeE
Confidence            56799999999999999995         23446899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++|..||....      ..+...
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~------~~~~~~  227 (295)
T 3ugc_A          154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRM  227 (295)
T ss_dssp             EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH------HHHHHH
T ss_pred             EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh------HHHHhh
Confidence            99999999876544321 11222447888999999998899999999999999999999999975221      111111


Q ss_pred             Hhhch-----HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          253 ALSNH-----VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       253 ~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      .....     ...+........               ....+..++.++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          228 IGNDKQGQMIVFHLIELLKNNG---------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HCTTCCTHHHHHHHHHHHHTTC---------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcCccccchhHHHHHHHHhccC---------------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            10000     001111100000               0011235667899999999999999999999999999999876


Q ss_pred             c
Q 041757          328 L  328 (381)
Q Consensus       328 ~  328 (381)
                      +
T Consensus       293 l  293 (295)
T 3ugc_A          293 M  293 (295)
T ss_dssp             -
T ss_pred             c
Confidence            5

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-44  Score=341.50  Aligned_cols=256  Identities=20%  Similarity=0.267  Sum_probs=197.6

Q ss_pred             ccccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVD   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~   89 (381)
                      ..++|...+.||+|+||.||++.                       ....+.+.+|++++.++ +||||+++++++..  
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec--
Confidence            46889999999999999999874                       11345789999999999 79999999999643  


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCccc------------------------------------------------
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDET------------------------------------------------  121 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------------------------------------------  121 (381)
                        .....++|||||++|+|.+++.........                                                
T Consensus        98 --~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           98 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             --TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             --CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence              345589999999999999999643210000                                                


Q ss_pred             --------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccc
Q 041757          122 --------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS  193 (381)
Q Consensus       122 --------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  193 (381)
                              ......+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...........
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                    000223899999999999999999999   669999999999999999999999999999876554443333


Q ss_pred             cCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchh
Q 041757          194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK  272 (381)
Q Consensus       194 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  272 (381)
                      ....||+.|+|||++.+..++.++|||||||++|||++ |..||......    .....         .+.......   
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~---------~~~~~~~~~---  316 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCR---------RLKEGTRMR---  316 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----HHHHH---------HHHHTCCCC---
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----HHHHH---------HHHcCCCCC---
Confidence            34568999999999998899999999999999999998 99998532211    11110         011000000   


Q ss_pred             hhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          273 LVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                                     .+..++.++.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus       317 ---------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          317 ---------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                           0123456788999999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-44  Score=337.03  Aligned_cols=245  Identities=23%  Similarity=0.335  Sum_probs=193.9

Q ss_pred             ccccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      ..++|...++||+|+||+||++..                      ...+.+.+|+.++++++||||+++++++.     
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence            457899999999999999988641                      12345678999999999999999999853     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                       ....++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++
T Consensus        86 -~~~~~~v~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~  152 (325)
T 3kex_A           86 -GSSLQLVTQYLPLGSLLDHVR---------QHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPS  152 (325)
T ss_dssp             -BSSEEEEEECCTTCBSHHHHH---------SSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSS
T ss_pred             -CCccEEEEEeCCCCCHHHHHH---------HccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCC
Confidence             456899999999999999995         23457889999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~  250 (381)
                      .+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||......  .     
T Consensus       153 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~-----  225 (325)
T 3kex_A          153 QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--E-----  225 (325)
T ss_dssp             CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--H-----
T ss_pred             eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--H-----
Confidence            999999999998765544333334568889999999998899999999999999999999 99998632111  0     


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                             ..+.+........                  +..++..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus       226 -------~~~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          226 -------VPDLLEKGERLAQ------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             -------HHHHHHTTCBCCC------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             -------HHHHHHcCCCCCC------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                   1111111100000                  1124456788999999999999999999999999987643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.4e-44  Score=339.01  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=184.9

Q ss_pred             ccccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..++|...++||+|+||.||+++.                     ...+.|.+|+.+|++++||||+++++++.     .
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~  117 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----K  117 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----e
Confidence            346899999999999999987641                     13467899999999999999999999954     4


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~  185 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLR---------KHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLV  185 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHH---------TTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCC
T ss_pred             CCceEEEEeCCCCCcHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCC
Confidence            678899999999999999995         23456899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~  250 (381)
                      +||+|||+++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....     ....
T Consensus       186 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~  260 (373)
T 2qol_A          186 CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVI  260 (373)
T ss_dssp             EEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHH
T ss_pred             EEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence            9999999998765433211 1111235778999999998899999999999999999998 9999752211     1111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                               ..+........                  +..++..+.+++.+||+.||.+||++.+|++.|+++....
T Consensus       261 ---------~~i~~~~~~~~------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          261 ---------KAVDEGYRLPP------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ---------HHHHTTEECCC------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ---------HHHHcCCCCCC------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                     11111110000                  1245668899999999999999999999999999997754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=341.66  Aligned_cols=251  Identities=21%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             cccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      .++|...++||+|+||+||++.                       ......+.+|+.++++++||||+++++++.     
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----  144 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----  144 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence            4779999999999999998865                       123456889999999999999999999954     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++|||||++|+|.+++.......   .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~  218 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRP---SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG  218 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCS---SSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSS
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhcccc---CccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCC
Confidence            4677899999999999999996432110   22356899999999999999999999   66999999999999998554


Q ss_pred             ---CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757          172 ---TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH  247 (381)
Q Consensus       172 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~  247 (381)
                         .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....     ..
T Consensus       219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-----~~  293 (367)
T 3l9p_A          219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQ  293 (367)
T ss_dssp             TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HH
T ss_pred             CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HH
Confidence               599999999975533322222223458999999999988899999999999999999998 999975221     11


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      ....         .+........                  +..++..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       294 ~~~~---------~i~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          294 EVLE---------FVTSGGRMDP------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHH---------HHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHH---------HHHcCCCCCC------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            1111         1110000000                  124556789999999999999999999999999998765


Q ss_pred             c
Q 041757          328 L  328 (381)
Q Consensus       328 ~  328 (381)
                      .
T Consensus       347 ~  347 (367)
T 3l9p_A          347 P  347 (367)
T ss_dssp             H
T ss_pred             h
Confidence            4

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.3e-44  Score=329.15  Aligned_cols=260  Identities=23%  Similarity=0.354  Sum_probs=201.5

Q ss_pred             cccccchhhhhccccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccce
Q 041757           23 VGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKV   81 (381)
Q Consensus        23 ~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~   81 (381)
                      ...+....+-....+|...++||+|+||+||++..                     ...+.+.+|+.++++++||||+++
T Consensus        12 ~~~~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   91 (298)
T 3f66_A           12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL   91 (298)
T ss_dssp             HHHHGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             hhhhhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeee
Confidence            34445555666677899999999999999987541                     134678899999999999999999


Q ss_pred             eeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC
Q 041757           82 LTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK  161 (381)
Q Consensus        82 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk  161 (381)
                      ++++.    ......++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+|||||
T Consensus        92 ~~~~~----~~~~~~~~v~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dik  155 (298)
T 3f66_A           92 LGICL----RSEGSPLVVLPYMKHGDLRNFIR---------NETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLA  155 (298)
T ss_dssp             CEEEC----CSSSCCEEEEECCTTCBHHHHHH---------CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eeEEE----cCCCceEEEEeCCCCCCHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCc
Confidence            99864    34567899999999999999995         33556889999999999999999999   6699999999


Q ss_pred             CCCeeeCCCCCeEEeecccceecCCCCCc--ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCc
Q 041757          162 PSNVLLDDDMTARVGDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDI  238 (381)
Q Consensus       162 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~  238 (381)
                      |+||+++.++.+||+|||+++........  .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||..
T Consensus       156 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  235 (298)
T 3f66_A          156 ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  235 (298)
T ss_dssp             GGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999999999999876543221  11223457889999999988899999999999999999999 5555432


Q ss_pred             cccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757          239 MFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV  318 (381)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  318 (381)
                      .....  ...           .+........                   +..++..+.+++.+||+.||.+|||+.+++
T Consensus       236 ~~~~~--~~~-----------~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell  283 (298)
T 3f66_A          236 VNTFD--ITV-----------YLLQGRRLLQ-------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELV  283 (298)
T ss_dssp             SCTTT--HHH-----------HHHTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCHHH--HHH-----------HHhcCCCCCC-------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            21111  100           0011000000                   113456789999999999999999999999


Q ss_pred             HHHHHhhhhcCC
Q 041757          319 HELQSIKNTLLG  330 (381)
Q Consensus       319 ~~L~~i~~~~~~  330 (381)
                      +.|+++......
T Consensus       284 ~~L~~~~~~~~~  295 (298)
T 3f66_A          284 SRISAIFSTFIG  295 (298)
T ss_dssp             HHHHHHHHTSCC
T ss_pred             HHHHHHHHhhcc
Confidence            999999887654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-44  Score=323.97  Aligned_cols=243  Identities=24%  Similarity=0.395  Sum_probs=195.0

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...+.||+|+||.||++..               ...+.+.+|++++++++||||+++++++     .+....++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   83 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICLV   83 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceEEE
Confidence            46799999999999999988642               2457899999999999999999999995     446778999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        84 ~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg  151 (269)
T 4hcu_A           84 FEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFG  151 (269)
T ss_dssp             EECCTTCBHHHHHH---------TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred             EEeCCCCcHHHHHH---------hcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccc
Confidence            99999999999995         33456899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      +++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....     ......       
T Consensus       152 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-----~~~~~~-------  218 (269)
T 4hcu_A          152 MTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVE-------  218 (269)
T ss_dssp             GGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHH-------
T ss_pred             ccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH-------
Confidence            99866543221 1122447888999999988899999999999999999999 999975221     111111       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                       .+........                   +...+..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus       219 -~~~~~~~~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          219 -DISTGFRLYK-------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -HHHTTCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -HHhcCccCCC-------------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence             1111100000                   112456788999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5e-44  Score=328.48  Aligned_cols=248  Identities=20%  Similarity=0.350  Sum_probs=192.3

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...+.||+|+||.||++..                    ...+.+.+|+.++++++||||+++++++     ...
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~   83 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED   83 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence            367899999999999999987641                    2346789999999999999999999994     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~  150 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIE----------SHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTL  150 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred             CeEEEEEeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence            88999999999999999994          4457899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...    ......... 
T Consensus       151 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~----~~~~~~~~~-  224 (294)
T 4eqm_A          151 KIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE----TAVSIAIKH-  224 (294)
T ss_dssp             EECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS----CHHHHHHHH-
T ss_pred             EEEeCCCccccccccccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHH-
Confidence            999999998665433221 12256899999999999999999999999999999999999997522    111111100 


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhhc
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-KMTNVVHELQSIKNTL  328 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~vl~~L~~i~~~~  328 (381)
                      ....           .+.            .........+..+.+++.+||+.||.+|| ++.++.+.|+++....
T Consensus       225 ~~~~-----------~~~------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          225 IQDS-----------VPN------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HSSC-----------CCC------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             hhcc-----------CCC------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            0000           000            00011124567889999999999999998 8999999998876554

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-44  Score=338.85  Aligned_cols=255  Identities=22%  Similarity=0.339  Sum_probs=200.5

Q ss_pred             cccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGV   88 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~   88 (381)
                      .++|...++||+|+||+||++..                         ...+.+.+|+++++++ +||||+++++++.  
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence            57899999999999999987641                         1236788999999999 8999999999954  


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCc------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKED------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                         ..+..++||||+++|+|.+++.......      ........+++..++.++.|++.||.|||   +.+|+||||||
T Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp  219 (382)
T 3tt0_A          146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  219 (382)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred             ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCc
Confidence               4677899999999999999996432110      00012346999999999999999999999   66999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE  241 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~  241 (381)
                      +||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...  
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~--  297 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--  297 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--
Confidence            999999999999999999987765443333333557899999999999999999999999999999999 99997522  


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                         .......         .+.......                  .+..++.++.+++.+||+.||.+|||+.+|++.|
T Consensus       298 ---~~~~~~~---------~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  347 (382)
T 3tt0_A          298 ---PVEELFK---------LLKEGHRMD------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  347 (382)
T ss_dssp             ---CHHHHHH---------HHHTTCCCC------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ---CHHHHHH---------HHHcCCCCC------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence               1111111         111100000                  0123556789999999999999999999999999


Q ss_pred             HHhhhhcC
Q 041757          322 QSIKNTLL  329 (381)
Q Consensus       322 ~~i~~~~~  329 (381)
                      +++.....
T Consensus       348 ~~~~~~~~  355 (382)
T 3tt0_A          348 DRIVALTS  355 (382)
T ss_dssp             HHHHHHSC
T ss_pred             HHHHHHHh
Confidence            99987654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.4e-44  Score=333.20  Aligned_cols=238  Identities=18%  Similarity=0.245  Sum_probs=188.4

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ..++|...++||+|+||+||++..                  ...+.+.+|+.+++.++||||+++++++     ...+.
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~   79 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI   79 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence            357899999999999999988641                  1235688999999999999999999995     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|||||++|+|.+++          .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        80 ~~lv~e~~~~~~L~~~l----------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl  146 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRI----------EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI  146 (323)
T ss_dssp             EEEEEECCTTEEGGGGS----------BTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEcCCCCcHHHHH----------hhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEE
Confidence            89999999999999999          34567999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      +|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++|..||............      
T Consensus       147 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------  220 (323)
T 3tki_A          147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------  220 (323)
T ss_dssp             CCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH------
T ss_pred             EEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH------
Confidence            99999987654333222233679999999999987765 78899999999999999999998633222111111      


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            .........+                  ....+..+.+++.+||+.||.+|||+.|+++
T Consensus       221 ------~~~~~~~~~~------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          221 ------WKEKKTYLNP------------------WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ------HHTTCTTSTT------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------HhcccccCCc------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                  0000000000                  1234557788999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.6e-43  Score=322.32  Aligned_cols=263  Identities=18%  Similarity=0.213  Sum_probs=200.9

Q ss_pred             hccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ...++|...+.||+|+||.||++..               ...+.+.+|+.+++.++|+|++..+..+.    ......+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~   81 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV   81 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCceE
Confidence            4568899999999999999988752               23346889999999999998888877753    3567889


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee---CCCCCeE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTAR  174 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~k  174 (381)
                      +||||+ +++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||++   +.++.+|
T Consensus        82 lv~e~~-~~~L~~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~k  148 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFN---------FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY  148 (296)
T ss_dssp             EEEECC-CCBHHHHHH---------HTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEE
T ss_pred             EEEEcc-CCCHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEE
Confidence            999999 999999985         23456999999999999999999999   6699999999999999   7888999


Q ss_pred             EeecccceecCCCCCc-----ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCC--cHH
Q 041757          175 VGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM--NLH  247 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~--~~~  247 (381)
                      |+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  .+.
T Consensus       149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  228 (296)
T 4hgt_A          149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE  228 (296)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred             EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence            9999999877554321     112235699999999999999999999999999999999999999975432221  111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      .............                           ....++..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus       229 ~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          229 RISEKKMSTPIEV---------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHHHHSCHHH---------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhcccccchhhh---------------------------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            1111111110000                           0123456899999999999999999999999999999888


Q ss_pred             cCCCCCcccccc
Q 041757          328 LLGPKNLATCKA  339 (381)
Q Consensus       328 ~~~~~~~~~~~~  339 (381)
                      .........+|.
T Consensus       282 ~~~~~~~~~dw~  293 (296)
T 4hgt_A          282 QGFSYDYVFDWN  293 (296)
T ss_dssp             HTCCTTCCCGGG
T ss_pred             hCCCccCccchh
Confidence            765544444443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-43  Score=321.58  Aligned_cols=243  Identities=21%  Similarity=0.354  Sum_probs=195.0

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...+.||+|+||.||+++.               ...+.+.+|++++++++||||+++++++     ......++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   81 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIYIV   81 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceEEE
Confidence            57899999999999999987641               2457799999999999999999999995     457788999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 ~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg  149 (268)
T 3sxs_A           82 TEYISNGCLLNYLR---------SHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFG  149 (268)
T ss_dssp             EECCTTCBHHHHHH---------HHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTT
T ss_pred             EEccCCCcHHHHHH---------HcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCc
Confidence            99999999999995         23446899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++........... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....    . ....       
T Consensus       150 ~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~-~~~~-------  216 (268)
T 3sxs_A          150 MTRYVLDDQYVSS-VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----S-EVVL-------  216 (268)
T ss_dssp             CEEECCTTCEEEC-CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----H-HHHH-------
T ss_pred             cceecchhhhhcc-cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----H-HHHH-------
Confidence            9987765433222 22446788999999998899999999999999999999 9999752211    0 1000       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                       .+........                   +...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       217 -~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          217 -KVSQGHRLYR-------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -HHHTTCCCCC-------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -HHHcCCCCCC-------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence             0000000000                   112345788999999999999999999999999988654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=329.82  Aligned_cols=276  Identities=21%  Similarity=0.250  Sum_probs=194.6

Q ss_pred             cccccccceecCCCceEEEeccc------------ccHHHHHHHHHHHH--ccCCCcccceeeeeccccccCCceEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------GAFKSFIAECKALR--NIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------~~~~~~~~E~~~l~--~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      -++|...++||+|+||.||+++.            .....+..|.+++.  .++||||+++++.+...........++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            47899999999999999988642            23456666666654  47999999999876554455666789999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC---------CceeeccCCCCeeeCCCC
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP---------VTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~---------~ivHrDlkp~Nill~~~~  171 (381)
                      |||++|+|.+++..           ...++..++.++.|++.||.|||   +.         +|+||||||+|||++.++
T Consensus        92 e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           92 EYYPNGSLXKYLSL-----------HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             CCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             ecCCCCcHHHHHhh-----------cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCC
Confidence            99999999999942           33488889999999999999999   66         999999999999999999


Q ss_pred             CeEEeecccceecCCCCC------cccccCccCccceeCCCCcCC-------CccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          172 TARVGDFGLARFLPPTRT------QTSSIDVKGSIGYIAPEYGVG-------NEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      .+||+|||+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999999999987754321      111223569999999999887       4577899999999999999999877632


Q ss_pred             cccCCCcHHHHHHHHh-hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757          239 MFEGDMNLHKFAKMAL-SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV  317 (381)
Q Consensus       239 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v  317 (381)
                      ..........+..... .....+. ............       ..........++.++.+++.+||+.||.+|||+.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~  309 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDM-QVLVSREKQRPK-------FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA  309 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHH-HHHHTTSCCCCC-------CCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHH-HhhhcccccCCC-------CCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence            2111110000000000 0111111 100000000000       000000012466789999999999999999999999


Q ss_pred             HHHHHHhhhhcCCCC
Q 041757          318 VHELQSIKNTLLGPK  332 (381)
Q Consensus       318 l~~L~~i~~~~~~~~  332 (381)
                      ++.|+++........
T Consensus       310 l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          310 EERMAELMMIWERNK  324 (336)
T ss_dssp             HHHHHHHHHCCCC--
T ss_pred             HHHHHHHHHHHHhcc
Confidence            999999987765443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=328.31  Aligned_cols=236  Identities=18%  Similarity=0.237  Sum_probs=189.9

Q ss_pred             ccccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      ..+.|...+.||+|+||.||++...                       ..+.+.+|+.+|++++||||+++++++     
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   83 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----   83 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            4678999999999999999886421                       357799999999999999999999995     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ......++||||+++|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.+
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~  150 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDR  150 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHT----------TSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCS
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHH----------hcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecC
Confidence            45778999999999999999993          4567999999999999999999999   6699999999999999887


Q ss_pred             C----CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          171 M----TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       171 ~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                      +    .+||+|||+++.........   ...||+.|+|||++.+..++.++|||||||++|+|++|..||...    ...
T Consensus       151 ~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~  223 (326)
T 2y0a_A          151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQ  223 (326)
T ss_dssp             SSSSCCEEECCCTTCEECCTTSCCC---CCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS----SHH
T ss_pred             CCCCCCEEEEECCCCeECCCCCccc---cccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC----CHH
Confidence            7    79999999998775443222   246999999999999889999999999999999999999997522    111


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ... .        .+....... +               .......+..+.+++.+||+.||.+|||+.++++
T Consensus       224 ~~~-~--------~~~~~~~~~-~---------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          224 ETL-A--------NVSAVNYEF-E---------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHH-H--------HHHHTCCCC-C---------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHH-H--------HHHhcCCCc-C---------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            110 0        000000000 0               0112244567889999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=343.00  Aligned_cols=239  Identities=16%  Similarity=0.198  Sum_probs=188.4

Q ss_pred             hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ....++|...++||+|+||+||++..                   ...+.+.+|+++|+.++||||+++++++     .+
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~   81 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SE   81 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----EC
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EE
Confidence            34578899999999999999987631                   2346788999999999999999999994     55


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC---C
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD---D  169 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~---~  169 (381)
                      .+..++|||||.+|+|.+++.          ....+++..+..++.||+.||.|||   +.+|+||||||+|||++   .
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~----------~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~  148 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIV----------AREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLK  148 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHH----------HCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSST
T ss_pred             CCEEEEEEEeCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCC
Confidence            788999999999999999984          4567999999999999999999999   66999999999999998   4


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      ++.+||+|||++..........  ....||+.|+|||++.+..++.++|||||||++|+|++|..||...    .. ...
T Consensus       149 ~~~vkL~DFG~a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~----~~-~~~  221 (444)
T 3soa_A          149 GAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE----DQ-HRL  221 (444)
T ss_dssp             TCCEEECCCSSCBCCCTTCCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS----SH-HHH
T ss_pred             CCcEEEccCceeEEecCCCcee--ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc----cH-HHH
Confidence            6789999999998765543221  2356999999999999999999999999999999999999998521    11 111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..        .+..........                .....+.++.+++.+||+.||.+|||+.|+++
T Consensus       222 ~~--------~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          222 YQ--------QIKAGAYDFPSP----------------EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HH--------HHHHTCCCCCTT----------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH--------HHHhCCCCCCcc----------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11        111110000000                01234567889999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.9e-43  Score=327.05  Aligned_cols=254  Identities=19%  Similarity=0.323  Sum_probs=198.7

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      ..++|...+.||+|+||.||++..                       ...+.+.+|++++++++||||+++++++     
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   95 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----   95 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----
Confidence            357899999999999999988632                       1346788999999999999999999995     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCc--------------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKED--------------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA  156 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv  156 (381)
                      ...+..++||||+++|+|.+++.......              ........+++..++.++.|++.||.|||   +.+|+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iv  172 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLV  172 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCc
Confidence            44677899999999999999996432100              00012345899999999999999999999   66999


Q ss_pred             eeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCC
Q 041757          157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKP  235 (381)
Q Consensus       157 HrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~P  235 (381)
                      ||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987765543333333557889999999988889999999999999999999 9999


Q ss_pred             CCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          236 SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                      |......  .            ....+.......                  .+..++..+.+++.+||+.||.+|||+.
T Consensus       253 ~~~~~~~--~------------~~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~  300 (314)
T 2ivs_A          253 YPGIPPE--R------------LFNLLKTGHRME------------------RPDNCSEEMYRLMLQCWKQEPDKRPVFA  300 (314)
T ss_dssp             STTCCGG--G------------HHHHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCHH--H------------HHHHhhcCCcCC------------------CCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            8532211  0            111111100000                  0124556889999999999999999999


Q ss_pred             HHHHHHHHhhhh
Q 041757          316 NVVHELQSIKNT  327 (381)
Q Consensus       316 ~vl~~L~~i~~~  327 (381)
                      ++++.|+++...
T Consensus       301 ~l~~~l~~~~~~  312 (314)
T 2ivs_A          301 DISKDLEKMMVK  312 (314)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhh
Confidence            999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-44  Score=338.44  Aligned_cols=250  Identities=22%  Similarity=0.372  Sum_probs=187.7

Q ss_pred             cccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ...|...++||+|+||+||++..                     ...+.|.+|+.++++++||||++++++|.    ...
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~  163 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSE  163 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCS
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCC
Confidence            34577789999999999986531                     23578999999999999999999999864    335


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  231 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIR---------NETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTV  231 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHH---------CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred             CCeEEEEECCCCCCHHHHHh---------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCE
Confidence            67799999999999999995         33456889999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcc--cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~  250 (381)
                      ||+|||+++.........  ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||......  ..... 
T Consensus       232 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~-  308 (373)
T 3c1x_A          232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY-  308 (373)
T ss_dssp             EECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHH-
T ss_pred             EEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHH-
Confidence            999999998664432211  1122457889999999998899999999999999999999 67776532211  11110 


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  330 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~  330 (381)
                                +........                   +..++..+.+++.+||+.||++|||+.++++.|+++...+..
T Consensus       309 ----------~~~~~~~~~-------------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          309 ----------LLQGRRLLQ-------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             ----------HHTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             ----------HHcCCCCCC-------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                      000000000                   123556789999999999999999999999999999887765


Q ss_pred             CC
Q 041757          331 PK  332 (381)
Q Consensus       331 ~~  332 (381)
                      ..
T Consensus       360 ~~  361 (373)
T 3c1x_A          360 EH  361 (373)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=336.41  Aligned_cols=232  Identities=23%  Similarity=0.256  Sum_probs=183.2

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...++||+|+||+||+++.                    ...+.+.+|..++..+ +||||+++++++     .+.
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence            47899999999999999988642                    2345678899999998 699999999994     557


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++|||||++|+|..++.          ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~i  163 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQ----------KSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHC  163 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCE
Confidence            88999999999999999994          4567999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++.........  ...+||+.|+|||++.+..++.++|||||||++|||++|..||...    .. .      
T Consensus       164 kL~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~~-~------  230 (353)
T 3txo_A          164 KLADFGMCKEGICNGVTT--ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE----NE-D------  230 (353)
T ss_dssp             EECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS----SH-H------
T ss_pred             EEccccceeecccCCccc--cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC----CH-H------
Confidence            999999998643332222  2357999999999999888999999999999999999999998522    11 1      


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM------TNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~~vl~  319 (381)
                            ++....+.....                .+......+.+++.+||+.||.+||++      .++++
T Consensus       231 ------~~~~~i~~~~~~----------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          231 ------DLFEAILNDEVV----------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------HHHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------HHHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                  111111111110                011244578889999999999999998      67764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=326.37  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=189.2

Q ss_pred             cccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      .++|...++||+|+||.||+++             ....+.|.+|++++++++||||+++++++.       +..++|||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~lv~e   79 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCLVME   79 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEEEEE
Confidence            4678999999999999998864             234678999999999999999999999853       23689999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC-eEEeeccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT-ARVGDFGL  180 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~-~kl~Dfg~  180 (381)
                      |+++|+|.+++...       .....++...++.++.|++.||.|||+....+|+||||||+||+++.++. +||+|||+
T Consensus        80 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           80 YAEGGSLYNVLHGA-------EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             CCTTCBHHHHHHCS-------SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             cCCCCCHHHHHhcc-------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            99999999999532       11234788899999999999999999531269999999999999988876 79999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      +........     ...||+.|+|||++.+..++.++||||||+++|||++|+.||......   ........       
T Consensus       153 ~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~-------  217 (307)
T 2eva_A          153 ACDIQTHMT-----NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---AFRIMWAV-------  217 (307)
T ss_dssp             -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---HHHHHHHH-------
T ss_pred             ccccccccc-----cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---HHHHHHHH-------
Confidence            976543221     235899999999999989999999999999999999999998632211   11111000       


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  332 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~  332 (381)
                       ....   .+                .....++..+.+++.+||+.||.+|||+.++++.|+.+........
T Consensus       218 -~~~~---~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  269 (307)
T 2eva_A          218 -HNGT---RP----------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD  269 (307)
T ss_dssp             -HTTC---CC----------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred             -hcCC---CC----------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence             0000   00                0012345678899999999999999999999999999988765543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-43  Score=326.35  Aligned_cols=229  Identities=22%  Similarity=0.272  Sum_probs=187.2

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|...++||+|+||.||+++.                    ...+.+.+|+.+++.++||||+++++++     .+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence            36799999999999999987642                    2346678899999999999999999994     4578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        80 ~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~k  146 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIK  146 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHH----------HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEE
Confidence            8999999999999999994          4567899999999999999999999   77999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++......     ...+||+.|+|||++.+..++.++|||||||++|||++|..||...    .. ....    
T Consensus       147 L~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~-~~~~----  212 (318)
T 1fot_A          147 ITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NT-MKTY----  212 (318)
T ss_dssp             ECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SH-HHHH----
T ss_pred             EeecCcceecCCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC----CH-HHHH----
Confidence            99999998764422     1256999999999999999999999999999999999999998521    11 1111    


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                          ..++.....                    .+...+.++.+++.+||..||.+||     ++.++++
T Consensus       213 ----~~i~~~~~~--------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          213 ----EKILNAELR--------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ----HHHHHCCCC--------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----HHHHhCCCC--------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                111111000                    0123445788999999999999999     8888874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7e-43  Score=320.53  Aligned_cols=263  Identities=18%  Similarity=0.214  Sum_probs=204.7

Q ss_pred             hccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ...++|...+.||+|+||.||++..               ...+.+.+|+.+++.++|++++..+..+.    ......+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~   81 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV   81 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence            3578999999999999999988752               23457899999999999988887777653    3467889


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC---CCCCeE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD---DDMTAR  174 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~---~~~~~k  174 (381)
                      +||||+ +++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++   .++.+|
T Consensus        82 lv~e~~-~~~L~~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k  148 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFN---------FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY  148 (296)
T ss_dssp             EEEECC-CCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred             EEEEec-CCCHHHHHH---------hhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEE
Confidence            999999 999999995         23456999999999999999999999   66999999999999994   788999


Q ss_pred             EeecccceecCCCCCcc-----cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCC--CcHH
Q 041757          175 VGDFGLARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLH  247 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~--~~~~  247 (381)
                      |+|||++..........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ..+.
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  228 (296)
T 3uzp_A          149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE  228 (296)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred             EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence            99999998776543211     1223569999999999999999999999999999999999999987443222  1111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      ............                           .....++.++.+++.+||+.||.+|||+.+|++.|+++...
T Consensus       229 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          229 RISEKKMSTPIE---------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHHHHSCHH---------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhcccccCCchH---------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            111111111100                           00123456899999999999999999999999999999887


Q ss_pred             cCCCCCcccccc
Q 041757          328 LLGPKNLATCKA  339 (381)
Q Consensus       328 ~~~~~~~~~~~~  339 (381)
                      ...+.....+|.
T Consensus       282 ~~~~~~~~~dw~  293 (296)
T 3uzp_A          282 QGFSYDYVFDWN  293 (296)
T ss_dssp             TTCCSSCCCGGG
T ss_pred             cCCccccccccc
Confidence            765544444443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=332.77  Aligned_cols=234  Identities=20%  Similarity=0.287  Sum_probs=187.3

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|...++||+|+||.||++..                    ...+.+.+|+++|+.++||||+++++++     .+..
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            47899999999999999987642                    2346788999999999999999999994     4577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+.+|+|..++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vk  155 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQ----------QNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVH  155 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHH----------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEE
Confidence            8999999999999999993          4567999999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      |+|||+++.........   ..+||+.|+|||++..   ..++.++|||||||++|||++|..||.....  ........
T Consensus       156 L~DFG~a~~~~~~~~~~---~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~  230 (384)
T 4fr4_A          156 ITDFNIAAMLPRETQIT---TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS--TSSKEIVH  230 (384)
T ss_dssp             ECCCTTCEECCTTCCBC---CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT--SCHHHHHH
T ss_pred             EeccceeeeccCCCcee---ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC--ccHHHHHH
Confidence            99999998775443222   3569999999999874   4589999999999999999999999863221  11111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-MTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~vl~  319 (381)
                      ..         .......                   +...+..+.+++.+||+.||.+||+ +.+|++
T Consensus       231 ~~---------~~~~~~~-------------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          231 TF---------ETTVVTY-------------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HH---------HHCCCCC-------------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HH---------hhcccCC-------------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            10         0000000                   1234567899999999999999998 666653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-44  Score=333.59  Aligned_cols=256  Identities=23%  Similarity=0.334  Sum_probs=197.0

Q ss_pred             hccccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD   89 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~   89 (381)
                      ...++|...+.||+|+||.||++...                       ..+.+.+|+.++++++||||+++++++    
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----  119 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC----  119 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE----
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE----
Confidence            35688999999999999999886421                       246789999999999999999999995    


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcc--------------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDE--------------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVT  155 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i  155 (381)
                       ...+..++||||+++|+|.+++........              .......+++..++.++.|++.||.|||   +.+|
T Consensus       120 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~i  195 (343)
T 1luf_A          120 -AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF  195 (343)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             -ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence             446788999999999999999964321000              0001257899999999999999999999   6699


Q ss_pred             eeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCC
Q 041757          156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REK  234 (381)
Q Consensus       156 vHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~  234 (381)
                      +||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999987654332222223558899999999988889999999999999999999 999


Q ss_pred             CCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          235 PSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       235 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                      ||....     .......        +.+.....                   .+..++..+.+++.+||+.||.+|||+
T Consensus       276 p~~~~~-----~~~~~~~--------~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~  323 (343)
T 1luf_A          276 PYYGMA-----HEEVIYY--------VRDGNILA-------------------CPENCPLELYNLMRLCWSKLPADRPSF  323 (343)
T ss_dssp             TTTTSC-----HHHHHHH--------HHTTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCCCC-----hHHHHHH--------HhCCCcCC-------------------CCCCCCHHHHHHHHHHcccCcccCCCH
Confidence            975221     1111111        11110000                   012455688999999999999999999


Q ss_pred             HHHHHHHHHhhhhc
Q 041757          315 TNVVHELQSIKNTL  328 (381)
Q Consensus       315 ~~vl~~L~~i~~~~  328 (381)
                      .++++.|+++.+..
T Consensus       324 ~~~~~~L~~~~~~~  337 (343)
T 1luf_A          324 CSIHRILQRMCERA  337 (343)
T ss_dssp             HHHHHHHHHTTC--
T ss_pred             HHHHHHHHHHHhhh
Confidence            99999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6e-44  Score=325.59  Aligned_cols=243  Identities=21%  Similarity=0.343  Sum_probs=184.0

Q ss_pred             ccccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..++|...+.||+|+||.||++..                     ...+.+.+|+.++++++||||+++++++.      
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------   86 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------   86 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence            357899999999999999987542                     12467889999999999999999999852      


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      .+..++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  154 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDC  154 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHH---------HTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTE
T ss_pred             cCccEEEEecCCCCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCC
Confidence            456799999999999999995         23446899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++.......... ....+|+.|+|||++.+..++.++||||||+++|||++ |..||......+  .     
T Consensus       155 ~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~-----  226 (281)
T 1mp8_A          155 VKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--V-----  226 (281)
T ss_dssp             EEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--H-----
T ss_pred             EEECccccccccCccccccc-ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--H-----
Confidence            99999999987654432221 12347789999999988889999999999999999997 999986322111  0     


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                            ...+.......                   .+..++..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       227 ------~~~i~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          227 ------IGRIENGERLP-------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ------HHHHHTTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHcCCCCC-------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                  00111100000                   0124566888999999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.3e-43  Score=340.91  Aligned_cols=241  Identities=25%  Similarity=0.344  Sum_probs=193.3

Q ss_pred             cccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      .++|...++||+|+||.||++.             ....+.|.+|+++|++++||||+++++++..    .....++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceEEEEE
Confidence            4678889999999999998754             2356789999999999999999999999643    3457899999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      ||++|+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       268 ~~~~g~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          268 YMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             CCTTCBHHHHHHH--------HCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            9999999999953        12234789999999999999999999   669999999999999999999999999999


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      +.......     ...+++.|+|||++.+..++.++|||||||++|||++ |..||......+  ..           ..
T Consensus       337 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~-----------~~  398 (450)
T 1k9a_A          337 KEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV-----------PR  398 (450)
T ss_dssp             EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HH-----------HH
T ss_pred             cccccccc-----CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH-----------HH
Confidence            86543221     1247889999999999999999999999999999998 999986332111  10           01


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      +......                   ..+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       399 i~~~~~~-------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          399 VEKGYKM-------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHTTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHcCCCC-------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            1110000                   01235667899999999999999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.5e-43  Score=335.89  Aligned_cols=236  Identities=22%  Similarity=0.260  Sum_probs=183.3

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...++||+|+||+||+++.                    ...+.+.+|..++.++ +||||+++++++     .+.
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence            46799999999999999987641                    1234578899999987 799999999994     557


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++|||||++|+|..++.          ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~i  192 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHI  192 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCE
Confidence            88999999999999999994          4567999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+...       
T Consensus       193 kL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-------  263 (396)
T 4dc2_A          193 KLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------  263 (396)
T ss_dssp             EECCCTTCBCCCCTTCC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------------
T ss_pred             EEeecceeeecccCCCc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-------
Confidence            99999999864332222  223679999999999999999999999999999999999999986332211100       


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                       ......+..........                ++...+.++.+++.+||+.||.+||++
T Consensus       264 -~~~~~~~~~~i~~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          264 -QNTEDYLFQVILEKQIR----------------IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --CCHHHHHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -hhhHHHHHHHHhccccC----------------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence             00000111111111100                112345678899999999999999996

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-43  Score=325.57  Aligned_cols=263  Identities=21%  Similarity=0.288  Sum_probs=196.6

Q ss_pred             hhhhccccccccceecCCCceEEEeccc------------ccHHHHHHHHHHHHcc--CCCcccceeeeeccccccCCce
Q 041757           30 EILDVSRNMLEENLISAGTFGFSHLRRQ------------GAFKSFIAECKALRNI--RHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~------------~~~~~~~~E~~~l~~l--~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ......++|...++||+|+||.||+++.            .....+.+|.+++..+  +||||+++++++... ......
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~  109 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG-TGSWTQ  109 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-CGGGCE
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccC-CCCCCc
Confidence            3344568899999999999999988652            2345667777777765  899999999997641 111267


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC--------CceeeccCCCCeee
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP--------VTAHCVLKPSNVLL  167 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--------~ivHrDlkp~Nill  167 (381)
                      .++||||+++|+|.+++.           ...+++..++.++.|++.||.|||   ..        +|+||||||+||++
T Consensus       110 ~~lv~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLK-----------STTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             EEEEECCCTTCBHHHHHH-----------HCCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEE
T ss_pred             eEEEEeccCCCcHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEE
Confidence            899999999999999994           235899999999999999999999   66        99999999999999


Q ss_pred             CCCCCeEEeecccceecCCCCCccc--ccCccCccceeCCCCcCCCccCcc------cchhhhhHHHHHHHhC-------
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTS--SIDVKGSIGYIAPEYGVGNEVSTI------GDVYSYGILLLELMIR-------  232 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~------sDiwSlG~il~el~tg-------  232 (381)
                      +.++.+||+|||+++..........  .....||+.|+|||++.+..++.+      +|||||||++|||++|       
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            9999999999999987654432211  123469999999999887766555      9999999999999999       


Q ss_pred             ---CCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCC
Q 041757          233 ---EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQ  309 (381)
Q Consensus       233 ---~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  309 (381)
                         ..||.....................        ......             .......++.++.+++.+||+.||.
T Consensus       256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~  314 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSYEDMREIVCIKK--------LRPSFP-------------NRWSSDECLRQMGKLMTECWAHNPA  314 (337)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSC--------CCCCCC-------------GGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred             ccccccHhhhcCCCCchhhhHHHHhhhc--------cCcccc-------------ccchhhHHHHHHHHHHHHhhhhChh
Confidence               5665544433333332222111100        000000             0001236788899999999999999


Q ss_pred             CCCCHHHHHHHHHHhhhhc
Q 041757          310 DRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       310 ~RPs~~~vl~~L~~i~~~~  328 (381)
                      +|||+.+|++.|+++.++.
T Consensus       315 ~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          315 SRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             GSCCHHHHHHHHHHHHHTT
T ss_pred             hCCCHHHHHHHHHHHHhhc
Confidence            9999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=329.08  Aligned_cols=243  Identities=22%  Similarity=0.324  Sum_probs=188.7

Q ss_pred             cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .++|...++||+|+||.||++..                      ...+.+.+|+.++++++||||+++++++..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence            57899999999999999987641                      245789999999999999999999999652     


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                       +..++|+||+.+|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        89 -~~~~~v~~~~~~g~L~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~  155 (327)
T 3lzb_A           89 -STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             -SSEEEEECCCSSCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTE
T ss_pred             -CCceEEEEecCCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCC
Confidence             34789999999999999995         33456899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.......        
T Consensus       156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------  227 (327)
T 3lzb_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------  227 (327)
T ss_dssp             EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred             EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------
Confidence            99999999987755443333333457889999999999999999999999999999999 999986322111        


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                            ....+.......                  .+..++.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus       228 ------~~~~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          228 ------ISSILEKGERLP------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ------HHHHHHTTCCCC------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ------HHHHHHcCCCCC------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                  111111110000                  0123456788999999999999999999999999999754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.6e-43  Score=321.58  Aligned_cols=244  Identities=20%  Similarity=0.352  Sum_probs=192.6

Q ss_pred             ccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..++|...+.||+|+||.||++..               ...+.+.+|++++.+++||||+++++++     ......++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   96 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFI   96 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCeEE
Confidence            457899999999999999987641               2457899999999999999999999995     45778999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        97 v~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Df  164 (283)
T 3gen_A           97 ITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDF  164 (283)
T ss_dssp             EECCCTTCBHHHHHH---------CGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECST
T ss_pred             EEeccCCCcHHHHHH---------HhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccc
Confidence            999999999999995         22456899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhch
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      |+++......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....     ....       
T Consensus       165 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----~~~~-------  231 (283)
T 3gen_A          165 GLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETA-------  231 (283)
T ss_dssp             TGGGGBCCHHHHS-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHH-------
T ss_pred             ccccccccccccc-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----hHHH-------
Confidence            9998665432111 122447888999999998889999999999999999998 9999752211     1100       


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                       ..+........                   +...+..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus       232 -~~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          232 -EHIAQGLRLYR-------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -HHHHTTCCCCC-------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHhcccCCCC-------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence             01111100000                   112345788999999999999999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.5e-43  Score=330.48  Aligned_cols=229  Identities=17%  Similarity=0.202  Sum_probs=187.6

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|...+.||+|+||.||+++.                    ...+.+.+|+++|+.++||||+++++++     .+..
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence            46899999999999999988652                    2346788999999999999999999994     4578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++.          ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       115 ~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~k  181 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQ  181 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEE
Confidence            8999999999999999994          3456899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++......     ...+||+.|+|||++.+..++.++|||||||++|||++|..||...    .. ..      
T Consensus       182 L~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~-~~------  245 (350)
T 1rdq_E          182 VTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QP-IQ------  245 (350)
T ss_dssp             ECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SH-HH------
T ss_pred             EcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC----CH-HH------
Confidence            99999998765432     1256999999999999999999999999999999999999998522    11 11      


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                            +..........                .+...+..+.+++.+||+.||.+||+     +.+|++
T Consensus       246 ------~~~~i~~~~~~----------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          246 ------IYEKIVSGKVR----------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------HHHHHHHCCCC----------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------HHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                  11111111100                01234567889999999999999998     788765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=321.45  Aligned_cols=263  Identities=17%  Similarity=0.187  Sum_probs=197.8

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ..++|...++||+|+||+||++..                  ...+.+.+|++++++++||||+++++++..   .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~   83 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRH   83 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCce
Confidence            467899999999999999987642                  235778899999999999999999998653   33457


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee----CCCC
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDM  171 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~  171 (381)
                      .++||||+++++|.+++...       .....+++..++.++.|++.||.|||   +.+|+||||||+||++    +.++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~  153 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQS  153 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSG-------GGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCE
T ss_pred             EEEEEeCCCCCCHHHHHHHh-------ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCc
Confidence            89999999999999999532       12233899999999999999999999   6699999999999999    7788


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcC--------CCccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV--------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  243 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~  243 (381)
                      .+||+|||+++.........   ...||+.|+|||++.        +..++.++|||||||++|||++|+.||.......
T Consensus       154 ~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  230 (319)
T 4euu_A          154 VYKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (319)
T ss_dssp             EEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred             eEEEccCCCceecCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence            89999999998876544322   245999999999875        5678999999999999999999999986433222


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcc---------cchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRG---------DQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                      ........             .+...+.......         ..................+.+++.+||+.||++|||+
T Consensus       231 ~~~~~~~~-------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~  297 (319)
T 4euu_A          231 RNKEVMYK-------------IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF  297 (319)
T ss_dssp             GCHHHHHH-------------HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred             hhHHHHHH-------------HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH
Confidence            22111111             1111110000000         0000000112235677788999999999999999999


Q ss_pred             HHHHHHHHHhh
Q 041757          315 TNVVHELQSIK  325 (381)
Q Consensus       315 ~~vl~~L~~i~  325 (381)
                      .|+++......
T Consensus       298 ~ell~h~~d~~  308 (319)
T 4euu_A          298 DQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHhhhccHHHh
Confidence            99999887553

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.3e-43  Score=330.24  Aligned_cols=240  Identities=17%  Similarity=0.192  Sum_probs=189.0

Q ss_pred             ccccccccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      ..+.|...+.||+|+||+||++...                      ..+.+.+|+.+++.++||||+++++++     .
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~   96 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----S   96 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            3578999999999999999886411                      356789999999999999999999995     4


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      ..+..++|||||++|+|.+++....      .....+++..+..++.||+.||.|||   +.+|+||||||+||+++.++
T Consensus        97 ~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~  167 (351)
T 3c0i_A           97 SDGMLYMVFEFMDGADLCFEIVKRA------DAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKE  167 (351)
T ss_dssp             ETTEEEEEEECCSSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSS
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHhc------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCC
Confidence            4778999999999999998884321      12345899999999999999999999   66999999999999997655


Q ss_pred             C---eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          172 T---ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       172 ~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      .   +||+|||++..........  ....||+.|+|||++.+..++.++|||||||++|+|++|..||....      ..
T Consensus       168 ~~~~vkl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~  239 (351)
T 3c0i_A          168 NSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ER  239 (351)
T ss_dssp             TTCCEEECCCTTCEECCTTSCBC--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HH
T ss_pred             CCCcEEEecCcceeEecCCCeee--cCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HH
Confidence            4   9999999998876543222  22569999999999999899999999999999999999999985311      11


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .        ...+........+                ......+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~--------~~~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          240 L--------FEGIIKGKYKMNP----------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             H--------HHHHHHTCCCCCH----------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H--------HHHHHcCCCCCCc----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1        1111111110000                001234567899999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-43  Score=332.20  Aligned_cols=232  Identities=21%  Similarity=0.303  Sum_probs=186.3

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..++|...++||+|+||.||+++.                    ...+.+.+|..++..+ +||||+++++++     .+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence            457899999999999999988652                    2345678899999987 899999999994     55


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      .+..++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~  156 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGH  156 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCC
Confidence            788999999999999999994          4457899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +||+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|..||...    .. .     
T Consensus       157 vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~-~-----  224 (345)
T 1xjd_A          157 IKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ----DE-E-----  224 (345)
T ss_dssp             EEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SH-H-----
T ss_pred             EEEeEChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC----CH-H-----
Confidence            999999999864332222  22367999999999999999999999999999999999999998522    11 1     


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT-NVV  318 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl  318 (381)
                             ++........+.                .+...+.++.+++.+||..||.+||++. +++
T Consensus       225 -------~~~~~i~~~~~~----------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          225 -------ELFHSIRMDNPF----------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -------HHHHHHHHCCCC----------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------HHHHHHHhCCCC----------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                   111111111110                0113456788999999999999999997 654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=331.91  Aligned_cols=257  Identities=20%  Similarity=0.251  Sum_probs=195.2

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVD   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~   89 (381)
                      ..++|...+.||+|+||.||++..                       ...+.+.+|+.++.++ +||||+++++++.   
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence            457899999999999999987642                       2346789999999999 8999999999954   


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcc-------------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDE-------------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA  156 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv  156 (381)
                        ..+..++||||+++|+|.+++........             .......+++..++.++.|++.||.|||   +.+|+
T Consensus       120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  194 (344)
T 1rjb_A          120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCV  194 (344)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence              46778999999999999999964221000             0001234899999999999999999999   66999


Q ss_pred             eeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCC
Q 041757          157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKP  235 (381)
Q Consensus       157 HrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~P  235 (381)
                      ||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999987655443333333457889999999988889999999999999999998 9999


Q ss_pred             CCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          236 SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                      |......    ..+         ...+........                  +..++.++.+++.+||+.||.+|||+.
T Consensus       275 ~~~~~~~----~~~---------~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~  323 (344)
T 1rjb_A          275 YPGIPVD----ANF---------YKLIQNGFKMDQ------------------PFYATEEIYIIMQSCWAFDSRKRPSFP  323 (344)
T ss_dssp             STTCCCS----HHH---------HHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cccCCcH----HHH---------HHHHhcCCCCCC------------------CCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            8533211    111         111111110000                  123456789999999999999999999


Q ss_pred             HHHHHHHHhhhhcC
Q 041757          316 NVVHELQSIKNTLL  329 (381)
Q Consensus       316 ~vl~~L~~i~~~~~  329 (381)
                      ++++.|+.+.....
T Consensus       324 ~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          324 NLTSFLGCQLADAE  337 (344)
T ss_dssp             HHHHHHHHHC----
T ss_pred             HHHHHHHHHHHHHH
Confidence            99999999876643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-43  Score=327.91  Aligned_cols=256  Identities=21%  Similarity=0.253  Sum_probs=198.9

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVD   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~   89 (381)
                      ..++|...+.||+|+||.||++..                       ...+.+.+|+.+++++ +||||+++++++.   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---   97 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---   97 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe---
Confidence            357899999999999999987641                       1347789999999999 8999999999954   


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCc--------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKED--------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK  161 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk  161 (381)
                        ..+..++||||+++|+|.+++.......        ........+++..++.++.|++.||.|||   +.+|+|||||
T Consensus        98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk  172 (313)
T 1t46_A           98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA  172 (313)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             --cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCc
Confidence              4677899999999999999996432100        00011235899999999999999999999   6699999999


Q ss_pred             CCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccc
Q 041757          162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMF  240 (381)
Q Consensus       162 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~  240 (381)
                      |+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999999999987766544333333457889999999988899999999999999999999 999975332


Q ss_pred             cCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      ..    ...         ...+........                  +...+..+.+++.+||+.||.+|||+.++++.
T Consensus       253 ~~----~~~---------~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          253 VD----SKF---------YKMIKEGFRMLS------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SS----HHH---------HHHHHHTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ch----hHH---------HHHhccCCCCCC------------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            11    111         111111110000                  12345678999999999999999999999999


Q ss_pred             HHHhhhhc
Q 041757          321 LQSIKNTL  328 (381)
Q Consensus       321 L~~i~~~~  328 (381)
                      |+++....
T Consensus       302 L~~~~~~~  309 (313)
T 1t46_A          302 IEKQISES  309 (313)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHh
Confidence            99987653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-43  Score=330.13  Aligned_cols=258  Identities=21%  Similarity=0.330  Sum_probs=186.1

Q ss_pred             hccccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      ...++|...+.||+|+||.||++..                      ...+.+.+|++++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            3467899999999999999987641                      234678899999999999999999999754111


Q ss_pred             c-CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           91 Q-GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        91 ~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                      . .....++||||+++|+|.+++......    .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~  172 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIG----ENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAE  172 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECT
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhcc----ccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcC
Confidence            1 112348999999999999998532110    12236899999999999999999999   669999999999999999


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHK  248 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~  248 (381)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||......  ..  
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~--  248 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EI--  248 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GH--
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HH--
Confidence            99999999999987655443333333457889999999998899999999999999999999 99997632211  00  


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                               ...+........                   +..++..+.+++.+||+.||.+|||+.++++.|+++.+..
T Consensus       249 ---------~~~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          249 ---------YNYLIGGNRLKQ-------------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ---------HHHHHTTCCCCC-------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ---------HHHHhcCCCCCC-------------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                     011111100000                   1245567899999999999999999999999999998765


Q ss_pred             C
Q 041757          329 L  329 (381)
Q Consensus       329 ~  329 (381)
                      .
T Consensus       301 ~  301 (323)
T 3qup_A          301 S  301 (323)
T ss_dssp             -
T ss_pred             h
Confidence            4

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.3e-43  Score=324.79  Aligned_cols=276  Identities=21%  Similarity=0.333  Sum_probs=190.8

Q ss_pred             cccccccccccccchh--hhhccccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHH
Q 041757           15 LTGSLHIEVGKLKNLE--ILDVSRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKAL   70 (381)
Q Consensus        15 ~~g~~~~~~~~~~~l~--~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l   70 (381)
                      .++........+++.-  +....++|...+.||+|+||.||++..                      ...+.+.+|+.++
T Consensus        11 ~~~~~~~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l   90 (313)
T 3brb_A           11 SSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM   90 (313)
T ss_dssp             -------------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHH
T ss_pred             cCCCCcCchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHH
Confidence            3444444444443321  122357899999999999999986531                      1246688999999


Q ss_pred             HccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcC
Q 041757           71 RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHD  150 (381)
Q Consensus        71 ~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  150 (381)
                      ++++||||+++++++...+.......++||||+++|+|.+++......    .....+++..++.++.|++.||.|||  
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH--  164 (313)
T 3brb_A           91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE----TGPKHIPLQTLLKFMVDIALGMEYLS--  164 (313)
T ss_dssp             HTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBT----TSCCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             hcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhh----cCCccCCHHHHHHHHHHHHHHHHHHH--
Confidence            999999999999997653323334569999999999999998432110    23456899999999999999999999  


Q ss_pred             CCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHH
Q 041757          151 CQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM  230 (381)
Q Consensus       151 ~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~  230 (381)
                       +.+|+||||||+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus       165 -~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  243 (313)
T 3brb_A          165 -NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA  243 (313)
T ss_dssp             -TTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred             -hCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence             6799999999999999999999999999998765543322222345788999999999989999999999999999999


Q ss_pred             h-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCC
Q 041757          231 I-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQ  309 (381)
Q Consensus       231 t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  309 (381)
                      + |..||......  ...           ..+........                   +..++..+.+++.+||+.||.
T Consensus       244 ~~g~~p~~~~~~~--~~~-----------~~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~  291 (313)
T 3brb_A          244 TRGMTPYPGVQNH--EMY-----------DYLLHGHRLKQ-------------------PEDCLDELYEIMYSCWRTDPL  291 (313)
T ss_dssp             TTSCCSSTTCCGG--GHH-----------HHHHTTCCCCC-------------------BTTCCHHHHHHHHHTTCSSGG
T ss_pred             hcCCCCCccCCHH--HHH-----------HHHHcCCCCCC-------------------CccccHHHHHHHHHHcCCChh
Confidence            9 88897532111  000           01111100000                   124556789999999999999


Q ss_pred             CCCCHHHHHHHHHHhhhhcC
Q 041757          310 DRMKMTNVVHELQSIKNTLL  329 (381)
Q Consensus       310 ~RPs~~~vl~~L~~i~~~~~  329 (381)
                      +|||+.++++.|+++.+.+.
T Consensus       292 ~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          292 DRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             GSCCHHHHHHHHHHHHHHC-
T ss_pred             hCcCHHHHHHHHHHHHHhcC
Confidence            99999999999999987653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.5e-44  Score=332.62  Aligned_cols=230  Identities=20%  Similarity=0.288  Sum_probs=186.0

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|...+.||+|+||.||++..                    .....+.+|+.+++.++||||+++++++     ....
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            46899999999999999988752                    1235788999999999999999999995     4577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+ +|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        83 ~~~lv~E~~-~g~l~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~k  148 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIV----------EKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVK  148 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEE
T ss_pred             EEEEEEECC-CCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEE
Confidence            899999999 789999983          4567999999999999999999999   56999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||++..........   ..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........         
T Consensus       149 l~DFG~s~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------  216 (336)
T 3h4j_B          149 IADFGLSNIMTDGNFLK---TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------  216 (336)
T ss_dssp             ECCSSCTBTTTTSBTTC---CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------
T ss_pred             EEEeccceeccCCcccc---cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------
Confidence            99999998765543322   2469999999999988776 7899999999999999999999863321110         


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              .........                ..+...+..+.+++.+||+.||.+|||+.|+++
T Consensus       217 --------~~~i~~~~~----------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          217 --------FKKVNSCVY----------------VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             --------BCCCCSSCC----------------CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             --------HHHHHcCCC----------------CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                    000000000                001234557889999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.4e-43  Score=327.30  Aligned_cols=269  Identities=18%  Similarity=0.322  Sum_probs=202.9

Q ss_pred             ccccccccchhhhhccccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-
Q 041757           20 HIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-   73 (381)
Q Consensus        20 ~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-   73 (381)
                      +.++...+..++  ..++|...+.||+|+||.||++..                         ...+.+.+|+++++++ 
T Consensus        21 ~~~~~~~~~~~~--~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   98 (334)
T 2pvf_A           21 EYELPEDPKWEF--PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG   98 (334)
T ss_dssp             --CCCCCTTTBC--CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC
T ss_pred             cccCCCCccccC--CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh
Confidence            344444444432  357899999999999999987631                         1346788999999999 


Q ss_pred             CCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCccc------ccCCCcccHHHHHHHHHHHHHHHHHh
Q 041757           74 RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDET------YKRPRNLNLLRRLNIAIDVASALNYL  147 (381)
Q Consensus        74 ~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~l~~L  147 (381)
                      +||||+++++++.     ..+..++||||+++|+|.+++.........      ......+++..++.++.|++.||.||
T Consensus        99 ~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  173 (334)
T 2pvf_A           99 KHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL  173 (334)
T ss_dssp             CCTTBCCEEEEEC-----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCEeeEEEEEc-----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            8999999999954     467889999999999999999643211000      00123589999999999999999999


Q ss_pred             hcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHH
Q 041757          148 HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLL  227 (381)
Q Consensus       148 H~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~  227 (381)
                      |   +.+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|
T Consensus       174 H---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  250 (334)
T 2pvf_A          174 A---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW  250 (334)
T ss_dssp             H---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             H---hCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence            9   6699999999999999999999999999998776554333333345788999999998888999999999999999


Q ss_pred             HHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCC
Q 041757          228 ELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSME  306 (381)
Q Consensus       228 el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  306 (381)
                      +|++ |..||...     ........        +.......                   .+..++..+.+++.+||+.
T Consensus       251 ellt~g~~p~~~~-----~~~~~~~~--------~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~  298 (334)
T 2pvf_A          251 EIFTLGGSPYPGI-----PVEELFKL--------LKEGHRMD-------------------KPANCTNELYMMMRDCWHA  298 (334)
T ss_dssp             HHHTTSCCSSTTC-----CHHHHHHH--------HHHTCCCC-------------------CCTTCCHHHHHHHHHHTCS
T ss_pred             HHHhCCCCCcCcC-----CHHHHHHH--------HhcCCCCC-------------------CCccCCHHHHHHHHHHccC
Confidence            9999 99997522     11111111        00000000                   0124556789999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhhhhcCC
Q 041757          307 SPQDRMKMTNVVHELQSIKNTLLG  330 (381)
Q Consensus       307 dP~~RPs~~~vl~~L~~i~~~~~~  330 (381)
                      ||.+|||+.++++.|+++......
T Consensus       299 dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          299 VPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             SGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             ChhhCcCHHHHHHHHHHHHhcccc
Confidence            999999999999999999876543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.1e-43  Score=343.56  Aligned_cols=244  Identities=21%  Similarity=0.361  Sum_probs=194.7

Q ss_pred             ccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..++|...++||+|+||.||++..               ...+.|.+|+++|++++||||+++++++.      .+..++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~l  259 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYI  259 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccEE
Confidence            356788899999999999988642               24678999999999999999999999853      456899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      |||||++|+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus       260 v~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKS--------DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             EECCCTTCBHHHHHHS--------HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECST
T ss_pred             EEeecCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeC
Confidence            9999999999999952        12235788899999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhch
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      |+++......... .....+|+.|+|||++....++.++|||||||++|||++ |+.||....    . .....      
T Consensus       329 G~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~----~-~~~~~------  396 (454)
T 1qcf_A          329 GLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----N-PEVIR------  396 (454)
T ss_dssp             TGGGGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----H-HHHHH------
T ss_pred             CCceEcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC----H-HHHHH------
Confidence            9998765432111 112346889999999988899999999999999999999 999975221    1 11110      


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                        .+........                   +..++..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       397 --~i~~~~~~~~-------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          397 --ALERGYRMPR-------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             --HHHHTCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             --HHHcCCCCCC-------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence              1111100001                   124667899999999999999999999999999988654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-43  Score=321.78  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=195.1

Q ss_pred             cccccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .-.|..+++||+|+||+||++.                     ....+.+.+|+.++++++||||+++++++..    ..
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~   95 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PE   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CC
Confidence            3456778999999999998763                     1234678999999999999999999999642    34


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+.+|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~  163 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIR---------SPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTV  163 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHH---------CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCE
T ss_pred             CCcEEEEecccCCCHHHHHh---------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence            44589999999999999995         33567899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCC--cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          174 RVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      ||+|||+++.......  ........+|+.|+|||.+.+..++.++||||||+++|+|++|..||....... .      
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~------  236 (298)
T 3pls_A          164 KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-D------  236 (298)
T ss_dssp             EECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-G------
T ss_pred             EeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-H------
Confidence            9999999986544321  111223457899999999999999999999999999999999666643111110 0      


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  331 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~  331 (381)
                            ....+........                  +..++..+.+++.+||+.||.+|||+.++++.|+++.+.+...
T Consensus       237 ------~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          237 ------LTHFLAQGRRLPQ------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             ------HHHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             ------HHHHhhcCCCCCC------------------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence                  1111111000000                  1234567889999999999999999999999999999887654


Q ss_pred             C
Q 041757          332 K  332 (381)
Q Consensus       332 ~  332 (381)
                      .
T Consensus       293 ~  293 (298)
T 3pls_A          293 H  293 (298)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.6e-43  Score=329.24  Aligned_cols=232  Identities=19%  Similarity=0.216  Sum_probs=186.1

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~   93 (381)
                      -++|...++||+|+||.||+++.                    ...+.+.+|..++..+ +||||+++++++     .+.
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence            47899999999999999988652                    2346688999999998 799999999994     557


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++|+|.+++.          ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~v  160 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQ----------QVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI  160 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcE
Confidence            88999999999999999994          3456899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...    . ..      
T Consensus       161 kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~-~~------  227 (353)
T 2i0e_A          161 KIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----D-ED------  227 (353)
T ss_dssp             EECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----S-HH------
T ss_pred             EEEeCCcccccccCCcc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC----C-HH------
Confidence            99999999864332222  22357999999999999999999999999999999999999998522    1 11      


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM-----TNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~vl~  319 (381)
                            ++....+.....                .+...+.++.+++.+||+.||.+||++     .++++
T Consensus       228 ------~~~~~i~~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          228 ------ELFQSIMEHNVA----------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ------HHHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ------HHHHHHHhCCCC----------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                  111111111110                012345678899999999999999964     66654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.8e-43  Score=331.91  Aligned_cols=236  Identities=19%  Similarity=0.260  Sum_probs=187.7

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ..++|...+.||+|+||.||++..                   ...+.+.+|+.++++++||||+++++++     .+.+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            457899999999999999987641                   1346788999999999999999999995     4578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC---
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM---  171 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---  171 (381)
                      ..++||||+++|+|.+++.          ....+++..+..++.||+.||.|||   +.+|+||||||+||+++.++   
T Consensus       102 ~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~  168 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGA  168 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHT----------TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTC
T ss_pred             EEEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCC
Confidence            8999999999999999983          4567899999999999999999999   66999999999999997654   


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      .+||+|||++..........   ...||+.|+|||++.+..++.++|||||||++|+|++|..||...    .. .....
T Consensus       169 ~~kl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~----~~-~~~~~  240 (362)
T 2bdw_A          169 AVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQ-HRLYA  240 (362)
T ss_dssp             CEEECCCTTCBCCTTCCSCC---CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SH-HHHHH
T ss_pred             CEEEeecCcceEecCCcccc---cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC----CH-HHHHH
Confidence            59999999998765443222   256999999999999989999999999999999999999997522    11 11111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .        +..........                .....+.++.+++.+||+.||.+|||+.++++
T Consensus       241 ~--------i~~~~~~~~~~----------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          241 Q--------IKAGAYDYPSP----------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             H--------HHHTCCCCCTT----------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             H--------HHhCCCCCCcc----------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0        11100000000                01234567889999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.8e-43  Score=336.76  Aligned_cols=194  Identities=24%  Similarity=0.320  Sum_probs=159.1

Q ss_pred             hhhhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           30 EILDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      ....+.++|...++||+|+||.||++..                   ...+.+.+|+++|++++||||+++++++...+.
T Consensus        20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            3445688999999999999999988741                   134678999999999999999999999765333


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ......|+||||+. |+|.+++          .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.+
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~----------~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~  165 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLF----------KTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQD  165 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHH----------HSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTT
T ss_pred             CcCCeEEEEEecCC-cCHHHHH----------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCC
Confidence            34477999999996 5999999          44567999999999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCc--------------------ccccCccCccceeCCCCc-CCCccCcccchhhhhHHHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQ--------------------TSSIDVKGSIGYIAPEYG-VGNEVSTIGDVYSYGILLLEL  229 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlG~il~el  229 (381)
                      +.+||+|||+++........                    ......+||+.|+|||++ ....++.++|||||||++|||
T Consensus       166 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~el  245 (432)
T 3n9x_A          166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL  245 (432)
T ss_dssp             CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred             CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHH
Confidence            99999999999877543221                    112346799999999985 566799999999999999999


Q ss_pred             HhCCCCCC
Q 041757          230 MIREKPSD  237 (381)
Q Consensus       230 ~tg~~Pf~  237 (381)
                      ++|..||.
T Consensus       246 l~g~~p~~  253 (432)
T 3n9x_A          246 LNMLQSHI  253 (432)
T ss_dssp             HTTCTTTC
T ss_pred             Hhcccccc
Confidence            99766654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4e-43  Score=345.02  Aligned_cols=243  Identities=21%  Similarity=0.339  Sum_probs=195.5

Q ss_pred             cccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..+|...++||+|+||.||++..                ...+.|.+|+.+|++++||||++++++|.     .....++
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcEEE
Confidence            45688899999999999987642                24678999999999999999999999964     4677899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++|+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus       294 v~E~~~~g~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             EEECCTTCBHHHHHHH--------SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred             EEEccCCCCHHHHHHh--------cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeec
Confidence            9999999999999953        12356889999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhch
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      |+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||......  .            
T Consensus       363 G~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~------------  427 (495)
T 1opk_A          363 GLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q------------  427 (495)
T ss_dssp             TCEECCTTCCEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G------------
T ss_pred             ccceeccCCceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--H------------
Confidence            9998765433221 222446789999999998899999999999999999999 99997532111  0            


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      ....+.......                  .+..++..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       428 ~~~~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          428 VYELLEKDYRME------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HHHHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHHHHHcCCCCC------------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            111111111000                  022456788999999999999999999999999998753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=327.92  Aligned_cols=255  Identities=16%  Similarity=0.190  Sum_probs=188.4

Q ss_pred             cccccccceecCCCceEEEecccc-------------------------------cHHHHHHHHHHHHccCCCcccceee
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-------------------------------AFKSFIAECKALRNIRHRNLIKVLT   83 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-------------------------------~~~~~~~E~~~l~~l~h~nIv~~~~   83 (381)
                      .++|...++||+|+||.||++...                               ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            478999999999999999886521                               1234667888999999999999999


Q ss_pred             eeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757           84 ACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS  163 (381)
Q Consensus        84 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~  163 (381)
                      ++... +.+....++||||+ +++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+
T Consensus       116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~  180 (345)
T 2v62_A          116 SGLTE-FKGRSYRFMVMERL-GIDLQKISG----------QNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAA  180 (345)
T ss_dssp             EEEEE-SSSCEEEEEEEECE-EEEHHHHCB----------GGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred             ccccc-cCCCcEEEEEEecc-CCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHH
Confidence            97641 23477899999999 999999994          3447999999999999999999999   669999999999


Q ss_pred             CeeeCCCC--CeEEeecccceecCCCCCc-----ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757          164 NVLLDDDM--TARVGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS  236 (381)
Q Consensus       164 Nill~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf  236 (381)
                      ||+++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99998777  9999999999876543211     1112356999999999999989999999999999999999999998


Q ss_pred             CccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                      ................ ........+.....                     ...++.++.+++.+||+.||.+|||+.+
T Consensus       261 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~  318 (345)
T 2v62_A          261 EQNLKDPVAVQTAKTN-LLDELPQSVLKWAP---------------------SGSSCCEIAQFLVCAHSLAYDEKPNYQA  318 (345)
T ss_dssp             GGGTTCHHHHHHHHHH-HHHTTTHHHHHHSC---------------------TTSCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             cccccccHHHHHHHHh-hcccccHHHHhhcc---------------------ccccHHHHHHHHHHHhhcCcccCCCHHH
Confidence            5322221111111111 11111110000000                     0134568999999999999999999999


Q ss_pred             HHHHHHHhhh
Q 041757          317 VVHELQSIKN  326 (381)
Q Consensus       317 vl~~L~~i~~  326 (381)
                      |++.|+++.-
T Consensus       319 l~~~L~~~~~  328 (345)
T 2v62_A          319 LKKILNPHGI  328 (345)
T ss_dssp             HHHHHCTTCC
T ss_pred             HHHHHhccCC
Confidence            9999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4e-43  Score=329.52  Aligned_cols=236  Identities=22%  Similarity=0.262  Sum_probs=183.5

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...++||+|+||.||+++.                    ...+.+.+|..++.++ +||||+++++++     .+.
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence            36799999999999999987641                    1245678999999988 799999999994     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~  149 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHI  149 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCE
Confidence            88999999999999999994          4457899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........      
T Consensus       150 kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------  221 (345)
T 3a8x_A          150 KLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ------  221 (345)
T ss_dssp             EECCGGGCBCSCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------
T ss_pred             EEEeccccccccCCCCc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc------
Confidence            99999999864332222  2235799999999999999999999999999999999999999863222111000      


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                        .....+..........                ++...+..+.+++.+||+.||.+||++
T Consensus       222 --~~~~~~~~~i~~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          222 --NTEDYLFQVILEKQIR----------------IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ---CHHHHHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             --ccHHHHHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence              0000111111111000                012345678899999999999999996

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.3e-43  Score=322.57  Aligned_cols=263  Identities=19%  Similarity=0.230  Sum_probs=189.5

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ..++|...++||+|+||+||++..                  ...+.+.+|++++++++||||+++++++     .+...
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   93 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERC   93 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSC
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCE
Confidence            568899999999999999988652                  1236788999999999999999999995     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++ +|.+++.         .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        94 ~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl  160 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLD---------ENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKL  160 (311)
T ss_dssp             EEEEEECCSE-EHHHHHH---------TCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEcCCCC-CHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEE
Confidence            9999999975 8888875         33456899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      +|||+++..........  ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+..+.....
T Consensus       161 ~Dfg~a~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~  237 (311)
T 3niz_A          161 ADFGLARAFGIPVRSYT--HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILG  237 (311)
T ss_dssp             CCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHC
T ss_pred             ccCcCceecCCCccccc--CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHC
Confidence            99999987654332221  2458999999999876 568999999999999999999999986433221 1122111111


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ........ ... ..+.-.................+....++.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          238 TPNPREWP-QVQ-ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCTTTSG-GGT-TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCChHHhh-hhh-ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11000000 000 0000000000000000011112234567889999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.3e-43  Score=326.53  Aligned_cols=255  Identities=23%  Similarity=0.338  Sum_probs=196.7

Q ss_pred             cccc-cccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNM-LEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~-~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      .++| ...++||+|+||+||++.                      ....+.+.+|++++++++||||+++++++..   .
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~  105 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---A  105 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---T
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---C
Confidence            4455 899999999999996531                      1235678999999999999999999999753   3


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+++|+|.+++.           ...+++..++.++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~-----------~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~  171 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLP-----------RHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDR  171 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGG-----------GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTC
T ss_pred             CCceEEEEEecccCCcHHHHHh-----------hCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCC
Confidence            3567899999999999999994           234899999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      .+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||......      ..
T Consensus       172 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~------~~  245 (318)
T 3lxp_A          172 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK------FL  245 (318)
T ss_dssp             CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HH
T ss_pred             CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh------hh
Confidence            9999999999887654322 1122345888999999999889999999999999999999999997522110      00


Q ss_pred             HH-Hhhc------hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 041757          251 KM-ALSN------HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS  323 (381)
Q Consensus       251 ~~-~~~~------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~  323 (381)
                      .. ....      ...+.+......                  ..+..++..+.+++.+||+.||.+|||+.++++.|++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          246 ELIGIAQGQMTVLRLTELLERGERL------------------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             HHHCSCCHHHHHHHHHHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhcccccchhHHHHHHHHhcccCC------------------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            00 0000      011111111000                  0123456789999999999999999999999999999


Q ss_pred             hhhhcCC
Q 041757          324 IKNTLLG  330 (381)
Q Consensus       324 i~~~~~~  330 (381)
                      +.+....
T Consensus       308 l~~~~~~  314 (318)
T 3lxp_A          308 VHEKYQG  314 (318)
T ss_dssp             HHHHHHC
T ss_pred             HHHhhcc
Confidence            9877643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-42  Score=317.69  Aligned_cols=238  Identities=24%  Similarity=0.401  Sum_probs=186.8

Q ss_pred             ccccccccceecCCCceEEEecccc------------------------cHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG------------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~------------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~   89 (381)
                      ..++|...+.||+|+||+||++...                        ..+.+.+|+.++++++||||+++++++..  
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   94 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--   94 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT--
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC--
Confidence            3578999999999999999876420                        12788999999999999999999999532  


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeeccCCCCeee
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV--TAHCVLKPSNVLL  167 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivHrDlkp~Nill  167 (381)
                         ..  ++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+  |+||||||+||++
T Consensus        95 ---~~--~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~  157 (287)
T 4f0f_A           95 ---PP--RMVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFL  157 (287)
T ss_dssp             ---TT--EEEEECCTTCBHHHHHH---------CTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEE
T ss_pred             ---CC--eEEEEecCCCCHHHHHh---------cccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEE
Confidence               22  69999999999999885         34557899999999999999999999   567  9999999999999


Q ss_pred             CCCCC-----eEEeecccceecCCCCCcccccCccCccceeCCCCcC--CCccCcccchhhhhHHHHHHHhCCCCCCccc
Q 041757          168 DDDMT-----ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV--GNEVSTIGDVYSYGILLLELMIREKPSDIMF  240 (381)
Q Consensus       168 ~~~~~-----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~  240 (381)
                      +.++.     +||+|||+++.....     .....||+.|+|||++.  ...++.++||||||+++|+|++|+.||....
T Consensus       158 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          158 QSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             SCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            87776     999999999754332     12256899999999984  4568899999999999999999999986332


Q ss_pred             cCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                      ....   .....        ........                  ..+..++..+.+++.+||+.||.+|||+.++++.
T Consensus       233 ~~~~---~~~~~--------~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          233 YGKI---KFINM--------IREEGLRP------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             CCHH---HHHHH--------HHHSCCCC------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccHH---HHHHH--------HhccCCCC------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            2111   00000        00000000                  0012456688999999999999999999999999


Q ss_pred             HHHh
Q 041757          321 LQSI  324 (381)
Q Consensus       321 L~~i  324 (381)
                      |+++
T Consensus       284 L~~l  287 (287)
T 4f0f_A          284 LSEL  287 (287)
T ss_dssp             HHTC
T ss_pred             HHhC
Confidence            9864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-42  Score=338.53  Aligned_cols=231  Identities=23%  Similarity=0.329  Sum_probs=188.2

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .++|..++.||+|+||.||++..                    ...+.+.+|+.+|+.++||||+++++++     ...+
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            47899999999999999988642                    1245788999999999999999999995     4577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++          .....+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        90 ~~~lv~E~~~gg~L~~~l----------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vk  156 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYI----------CKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAK  156 (476)
T ss_dssp             EEEEEEECCSSEEHHHHT----------TSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEEeCCCCCcHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeE
Confidence            899999999999999999          34567999999999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||++..........   ..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...    .. .....  
T Consensus       157 L~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~-~~~~~--  226 (476)
T 2y94_A          157 IADFGLSNMMSDGEFLR---TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD----HV-PTLFK--  226 (476)
T ss_dssp             ECCCSSCEECCTTCCBC---CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS----SS-HHHHH--
T ss_pred             EEeccchhhcccccccc---ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC----CH-HHHHH--
Confidence            99999998875543222   2569999999999988765 68999999999999999999998522    11 11111  


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            .+.+... ..                   +...+..+.+++.+||+.||.+|||+.++++
T Consensus       227 ------~i~~~~~-~~-------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          227 ------KICDGIF-YT-------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ------HHHTTCC-CC-------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------HHhcCCc-CC-------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                  1111110 00                   1123457889999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=319.58  Aligned_cols=235  Identities=17%  Similarity=0.251  Sum_probs=182.1

Q ss_pred             cccccccceecCCCceEEEecccc-------------------------------------------cHHHHHHHHHHHH
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-------------------------------------------AFKSFIAECKALR   71 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-------------------------------------------~~~~~~~E~~~l~   71 (381)
                      .++|...+.||+|+||.||++...                                           ..+.+.+|+++|+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478999999999999999887411                                           1256889999999


Q ss_pred             ccCCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 041757           72 NIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC  151 (381)
Q Consensus        72 ~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  151 (381)
                      +++||||+++++++..   ......++||||+++++|.+++           ....+++..++.++.|++.||.|||   
T Consensus        92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH---  154 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVP-----------TLKPLSEDQARFYFQDLIKGIEYLH---  154 (298)
T ss_dssp             TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSS-----------CSSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred             hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHh-----------hcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence            9999999999999653   2367889999999999998865           2356899999999999999999999   


Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc---cCcccchhhhhHHHHH
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE---VSTIGDVYSYGILLLE  228 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~e  228 (381)
                      +.+|+||||||+||+++.++.+||+|||+++.........  ....||+.|+|||++.+..   ++.++|||||||++|+
T Consensus       155 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~  232 (298)
T 2zv2_A          155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC  232 (298)
T ss_dssp             HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred             HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence            6699999999999999999999999999998765443221  2256999999999988754   4788999999999999


Q ss_pred             HHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCC
Q 041757          229 LMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESP  308 (381)
Q Consensus       229 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  308 (381)
                      |++|+.||...     ........        +...... .+.                 ....+..+.+++.+||+.||
T Consensus       233 l~~g~~pf~~~-----~~~~~~~~--------~~~~~~~-~~~-----------------~~~~~~~l~~li~~~l~~dp  281 (298)
T 2zv2_A          233 FVFGQCPFMDE-----RIMCLHSK--------IKSQALE-FPD-----------------QPDIAEDLKDLITRMLDKNP  281 (298)
T ss_dssp             HHHSSCSSCCS-----SHHHHHHH--------HHHCCCC-CCS-----------------SSCCCHHHHHHHHHHTCSCT
T ss_pred             HHHCCCCCCCc-----cHHHHHHH--------HhcccCC-CCC-----------------ccccCHHHHHHHHHHhhcCh
Confidence            99999998522     11111110        0010000 000                 01345678899999999999


Q ss_pred             CCCCCHHHHHH
Q 041757          309 QDRMKMTNVVH  319 (381)
Q Consensus       309 ~~RPs~~~vl~  319 (381)
                      ++|||+.|+++
T Consensus       282 ~~R~s~~e~l~  292 (298)
T 2zv2_A          282 ESRIVVPEIKL  292 (298)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCCCHHHHhc
Confidence            99999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.1e-43  Score=325.92  Aligned_cols=256  Identities=20%  Similarity=0.283  Sum_probs=197.1

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVD   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~   89 (381)
                      ..++|...+.||+|+||.||++..                       ...+.+.+|++++.++ +||||+++++++..  
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec--
Confidence            467899999999999999988741                       1345788999999999 69999999999642  


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCccc------ccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDET------YKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS  163 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~  163 (381)
                        .....++||||+++|+|.+++.........      ......+++..++.++.|++.||.|||   +.+|+||||||+
T Consensus       103 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~  177 (316)
T 2xir_A          103 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR  177 (316)
T ss_dssp             --TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             --CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccc
Confidence              345689999999999999999642210000      001223899999999999999999999   669999999999


Q ss_pred             CeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccC
Q 041757          164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEG  242 (381)
Q Consensus       164 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~  242 (381)
                      ||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            99999999999999999987655443333333557889999999988899999999999999999998 99997532211


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                          ..+...        +........                   +...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       258 ----~~~~~~--------~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  306 (316)
T 2xir_A          258 ----EEFCRR--------LKEGTRMRA-------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  306 (316)
T ss_dssp             ----HHHHHH--------HHHTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----HHHHHH--------hccCccCCC-------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                111110        000000000                   1134557889999999999999999999999999


Q ss_pred             Hhhhh
Q 041757          323 SIKNT  327 (381)
Q Consensus       323 ~i~~~  327 (381)
                      ++...
T Consensus       307 ~~~~~  311 (316)
T 2xir_A          307 NLLQA  311 (316)
T ss_dssp             HHHHH
T ss_pred             HHHhh
Confidence            98765

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.8e-42  Score=320.51  Aligned_cols=241  Identities=22%  Similarity=0.296  Sum_probs=183.8

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc------
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY------   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~------   90 (381)
                      .++|...+.||+|+||.||++..                  ...+.+.+|+++|++++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            46789999999999999987642                  245789999999999999999999999754210      


Q ss_pred             ----------------------------------------------cCCceEEEEEEcccCCCHHHhhccccCCcccccC
Q 041757           91 ----------------------------------------------QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKR  124 (381)
Q Consensus        91 ----------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  124 (381)
                                                                    ......++|||||++|+|.+++....       .
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~  157 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-------S  157 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-------S
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-------C
Confidence                                                          12234899999999999999996421       2


Q ss_pred             CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCc----------cccc
Q 041757          125 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ----------TSSI  194 (381)
Q Consensus       125 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~  194 (381)
                      ....++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........          ....
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT  234 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence            234566678999999999999999   669999999999999999999999999999887654321          1122


Q ss_pred             CccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhh
Q 041757          195 DVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLV  274 (381)
Q Consensus       195 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  274 (381)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..|+...                   ............    
T Consensus       235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------------------~~~~~~~~~~~~----  291 (332)
T 3qd2_B          235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------------------VRIITDVRNLKF----  291 (332)
T ss_dssp             SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------------------HHHHHHHHTTCC----
T ss_pred             ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------------------HHHHHHhhccCC----
Confidence            356999999999999999999999999999999999988773100                   000110000000    


Q ss_pred             hcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          275 VRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                 ..........+.+++.+||+.||.+|||+.++++
T Consensus       292 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          292 -----------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             -----------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             -----------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence                       0112345567789999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-42  Score=339.07  Aligned_cols=187  Identities=24%  Similarity=0.329  Sum_probs=148.0

Q ss_pred             hccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .+.++|...++||+|+||+||++..                   ...+.+.+|+++|++++||||+++++++...+....
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            3468899999999999999987631                   134678899999999999999999999865444556


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...|+||||+ +++|.+++          .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus       130 ~~~~lv~e~~-~~~L~~~~----------~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~  195 (458)
T 3rp9_A          130 DELYVVLEIA-DSDFKKLF----------RTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSV  195 (458)
T ss_dssp             CCEEEEECCC-SEEHHHHH----------HSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCE
T ss_pred             ceEEEEEecc-ccchhhhc----------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCE
Confidence            7899999998 56999998          34567999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCc-------------------------ccccCccCccceeCCCCc-CCCccCcccchhhhhHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-------------------------TSSIDVKGSIGYIAPEYG-VGNEVSTIGDVYSYGILLL  227 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlG~il~  227 (381)
                      ||+|||+++........                         ......+||+.|+|||++ .+..++.++|||||||++|
T Consensus       196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~  275 (458)
T 3rp9_A          196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA  275 (458)
T ss_dssp             EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred             eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence            99999999876532211                         112235689999999975 5667999999999999999


Q ss_pred             HHHhCC
Q 041757          228 ELMIRE  233 (381)
Q Consensus       228 el~tg~  233 (381)
                      ||++|.
T Consensus       276 elltg~  281 (458)
T 3rp9_A          276 ELLNMI  281 (458)
T ss_dssp             HHHTTS
T ss_pred             HHHHhc
Confidence            999943

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.2e-43  Score=329.60  Aligned_cols=255  Identities=22%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVD   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~   89 (381)
                      ..++|...+.||+|+||.||++..                       ...+.+.+|+.+++++ +||||+++++++.   
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---  120 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT---  120 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence            457899999999999999988641                       1346789999999999 8999999999954   


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCC----cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCe
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKE----DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNV  165 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Ni  165 (381)
                        ..+..++||||+++|+|.+++......    .........+++..++.++.|++.||.|||   +.+|+||||||+||
T Consensus       121 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          121 --HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNV  195 (333)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGC
T ss_pred             --cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceE
Confidence              467789999999999999999532100    000001345789999999999999999999   66999999999999


Q ss_pred             eeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCC
Q 041757          166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDM  244 (381)
Q Consensus       166 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~  244 (381)
                      +++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||....... 
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  274 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-  274 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence            999999999999999986654433322333457889999999988889999999999999999998 999975322111 


Q ss_pred             cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          245 NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                         .         ....+........                  +..++..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus       275 ---~---------~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          275 ---K---------FYKLVKDGYQMAQ------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ---H---------HHHHHHHTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---H---------HHHHHhcCCCCCC------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence               1         0111111110000                  113456788999999999999999999999999988


Q ss_pred             hhh
Q 041757          325 KNT  327 (381)
Q Consensus       325 ~~~  327 (381)
                      ...
T Consensus       325 ~~~  327 (333)
T 2i1m_A          325 AQE  327 (333)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=330.44  Aligned_cols=238  Identities=17%  Similarity=0.227  Sum_probs=189.3

Q ss_pred             hccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ...++|...+.||+|+||.||++..                 .....+.+|+.+|++++||||+++++++     .+...
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  122 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYE  122 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCE
Confidence            3457899999999999999988642                 1345788999999999999999999995     45788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC--CCCe
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD--DMTA  173 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~--~~~~  173 (381)
                      .++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.  .+.+
T Consensus       123 ~~lv~E~~~gg~L~~~l~---------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~v  190 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIA---------AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSV  190 (387)
T ss_dssp             EEEEEECCCCCBHHHHTT---------CTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCE
T ss_pred             EEEEEEcCCCCcHHHHHH---------hhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCce
Confidence            999999999999999985         23457999999999999999999999   669999999999999974  4689


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++..........   ..||+.|+|||++.+..++.++|||||||++|||++|..||...    ...... .  
T Consensus       191 kL~DFG~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~----~~~~~~-~--  260 (387)
T 1kob_A          191 KIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE----DDLETL-Q--  260 (387)
T ss_dssp             EECCCTTCEECCTTSCEEE---ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHH-H--
T ss_pred             EEEecccceecCCCcceee---eccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC----CHHHHH-H--
Confidence            9999999988765433222   45999999999999989999999999999999999999997522    111111 0  


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            .+..........                .....+.++.+++.+||+.||.+|||+.++++
T Consensus       261 ------~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          261 ------NVKRCDWEFDED----------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ------HHHHCCCCCCSS----------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ------HHHhCCCCCCcc----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                  111100000000                01234567889999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.4e-42  Score=320.21  Aligned_cols=231  Identities=20%  Similarity=0.255  Sum_probs=185.1

Q ss_pred             ccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      |...++||+|+||.||++..                 ...+.+.+|+.++++++||||+++++++.     ..+..++||
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv~  121 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL-----VGEELWVLM  121 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEEEE
Confidence            67778999999999987641                 24577899999999999999999999964     367899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++++|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       122 e~~~~~~L~~~l~-----------~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  187 (321)
T 2c30_A          122 EFLQGGALTDIVS-----------QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGF  187 (321)
T ss_dssp             CCCCSCBHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ecCCCCCHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeee
Confidence            9999999999984           245899999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      +..........  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...    ...... .        .
T Consensus       188 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~----~~~~~~-~--------~  252 (321)
T 2c30_A          188 CAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD----SPVQAM-K--------R  252 (321)
T ss_dssp             CEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHH-H--------H
T ss_pred             eeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHH-H--------H
Confidence            98765543222  2356999999999999989999999999999999999999998522    111110 0        0


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +... ......                .....+..+.+++.+||+.||++|||+.++++
T Consensus       253 ~~~~-~~~~~~----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          253 LRDS-PPPKLK----------------NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHS-SCCCCT----------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhcC-CCCCcC----------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1100 000000                01134457889999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.9e-43  Score=340.74  Aligned_cols=244  Identities=23%  Similarity=0.373  Sum_probs=189.4

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...++||+|+||.||++..               ...+.|.+|+++|++++||||+++++++.      .+..++|
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~~iv  256 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIV  256 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc------CCceEEE
Confidence            46788899999999999987642               23578999999999999999999999953      2567999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++|+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       257 ~e~~~~gsL~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             ECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ehhhcCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCc
Confidence            999999999999952        12345889999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      +++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....    . .....       
T Consensus       326 ~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~----~-~~~~~-------  392 (452)
T 1fmk_A          326 LARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----N-REVLD-------  392 (452)
T ss_dssp             TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----H-HHHHH-------
T ss_pred             cceecCCCceec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC----H-HHHHH-------
Confidence            998765432221 122447889999999988899999999999999999999 999975221    1 11110       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                       .+......                   ..+..++..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus       393 -~i~~~~~~-------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          393 -QVERGYRM-------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             -HHHTTCCC-------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -HHHcCCCC-------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence             00000000                   012346678899999999999999999999999999887654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.3e-42  Score=320.23  Aligned_cols=238  Identities=18%  Similarity=0.228  Sum_probs=191.0

Q ss_pred             hhccccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeeccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGV   88 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~   88 (381)
                      ....++|...+.||+|+||.||++...                       ..+.+.+|+.++++++||||+++++++   
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---   84 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY---   84 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE---
Confidence            345678999999999999999886421                       357799999999999999999999995   


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                        ......++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++
T Consensus        85 --~~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~  149 (321)
T 2a2a_A           85 --ENRTDVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLL  149 (321)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHH----------TCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEES
T ss_pred             --ecCCEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEe
Confidence              45778999999999999999993          4567899999999999999999999   66999999999999999


Q ss_pred             CCC----CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757          169 DDM----TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM  244 (381)
Q Consensus       169 ~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~  244 (381)
                      .++    .+||+|||++..........   ...||+.|+|||++.+..++.++||||||+++|+|++|..||...    .
T Consensus       150 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~  222 (321)
T 2a2a_A          150 DKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----T  222 (321)
T ss_dssp             CTTSSSCCEEECCCTTCEECCTTCCCC---CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS----S
T ss_pred             cCCCCcCCEEEccCccceecCcccccc---ccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC----C
Confidence            887    79999999998776543222   245999999999999889999999999999999999999997522    1


Q ss_pred             cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          245 NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . ...            +.........            .........+..+.+++.+||+.||.+|||+.++++
T Consensus       223 ~-~~~------------~~~i~~~~~~------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          223 K-QET------------LANITSVSYD------------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             H-HHH------------HHHHHTTCCC------------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             H-HHH------------HHHHHhcccc------------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1 111            1111100000            000112234567889999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.1e-43  Score=325.23  Aligned_cols=232  Identities=20%  Similarity=0.187  Sum_probs=177.3

Q ss_pred             cccccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      .++|...++||+|+||.||+++.                        .....+.+|+.+|++++||||+++++++     
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   90 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF-----   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence            47899999999999999987542                        1234577899999999999999999995     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ...+..++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~  157 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLE----------REGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ  157 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTT
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCC
Confidence            45778999999999999999994          4456889999999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +.+||+|||+++.........  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....    . ....
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~-~~~~  230 (327)
T 3a62_A          158 GHVKLTDFGLCKESIHDGTVT--HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----R-KKTI  230 (327)
T ss_dssp             SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----H-HHHH
T ss_pred             CcEEEEeCCcccccccCCccc--cccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC----H-HHHH
Confidence            999999999997644332211  22569999999999999899999999999999999999999985221    1 1111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                              ..+......                    .+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       231 --------~~i~~~~~~--------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          231 --------DKILKCKLN--------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --------HHHHHTCCC--------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --------HHHHhCCCC--------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                    111111110                    0123456788999999999999999     6777765

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.1e-43  Score=322.49  Aligned_cols=255  Identities=24%  Similarity=0.397  Sum_probs=195.5

Q ss_pred             cccccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      .+.|+..++||+|+||.||++.                      ....+.+.+|++++++++||||+++++++..   ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CC
Confidence            4668999999999999998764                      1134778999999999999999999999753   23


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~  164 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLP---------KNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ  164 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHH---------HHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred             CceEEEEEEeCCCCcHHHHHH---------hccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCC
Confidence            467899999999999999995         23456899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+....      ..+..
T Consensus       165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~  238 (302)
T 4e5w_A          165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLK  238 (302)
T ss_dssp             EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHH
T ss_pred             EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhh
Confidence            999999999887654322 22223558889999999998899999999999999999999999854221      11111


Q ss_pred             HHhh----chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          252 MALS----NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       252 ~~~~----~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                      ....    .....+........               ....+..++..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          239 MIGPTHGQMTVTRLVNTLKEGK---------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHCSCCGGGHHHHHHHHHHTTC---------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCcccccCHHHHHHHHhccC---------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1000    00111111111000               00012245678999999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=323.58  Aligned_cols=245  Identities=23%  Similarity=0.373  Sum_probs=188.3

Q ss_pred             cccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..+|...++||+|+||.||++..                      .....+.+|+.++++++||||+++++++     ..
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SK  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ec
Confidence            46788889999999999987531                      1345688999999999999999999995     45


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      .+..++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~  185 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLR---------EKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLV  185 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHH---------HTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCc
Confidence            778999999999999999995         23457899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~  250 (381)
                      +||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.....     ....
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~  260 (333)
T 1mqb_A          186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVM  260 (333)
T ss_dssp             EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH
T ss_pred             EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHH
Confidence            9999999998765432211 1112346789999999998899999999999999999999 9999852211     1111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                      .        .+........                   +..++..+.+++.+||+.||.+||++.++++.|+++....
T Consensus       261 ~--------~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          261 K--------AINDGFRLPT-------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             H--------HHHTTCCCCC-------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             H--------HHHCCCcCCC-------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            0        1111000000                   1235567899999999999999999999999999987654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-42  Score=315.61  Aligned_cols=231  Identities=20%  Similarity=0.293  Sum_probs=184.7

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...+.||+|+||.||++..                    .....+.+|+.++++++||||+++++++     .+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecC
Confidence            357899999999999999988742                    1245688999999999999999999995     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~  148 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQ----------KLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL  148 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCE
T ss_pred             CEEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCE
Confidence            78999999999999999994          4456899999999999999999999   6799999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||++.........    ...|++.|+|||++.+..++.++||||||+++|+|++|..||...    . ....    
T Consensus       149 ~l~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~-~~~~----  215 (279)
T 3fdn_A          149 KIADFGWSVHAPSSRRT----DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----T-YQET----  215 (279)
T ss_dssp             EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS----S-HHHH----
T ss_pred             EEEeccccccCCccccc----ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC----c-HHHH----
Confidence            99999998655433222    246899999999999989999999999999999999999997522    1 1111    


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              ..........                .+...+..+.+++.+||+.||.+|||+.++++
T Consensus       216 --------~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          216 --------YKRISRVEFT----------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             --------HHHHHHTCCC----------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             --------HHHHHhCCCC----------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                    1100000000                01234557889999999999999999999997

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=320.67  Aligned_cols=263  Identities=20%  Similarity=0.237  Sum_probs=183.7

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      -++|...++||+|+||+||++..                   ...+.+.+|++++++++||||+++++++.     ..+.
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence            36799999999999999987642                   12466889999999999999999999954     4778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++++|.+++          .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        77 ~~lv~e~~~~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl  143 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELD----------RYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKL  143 (311)
T ss_dssp             EEEEEECCSEEHHHHHH----------HTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEEeCCCchHHHHH----------hhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEE
Confidence            99999999999999988          34566899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      +|||++...........  ...||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+  .........
T Consensus       144 ~Dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~  219 (311)
T 4agu_A          144 CDFGFARLLTGPSDYYD--DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTL  219 (311)
T ss_dssp             CCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHH
T ss_pred             eeCCCchhccCcccccC--CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence            99999987664432221  2458999999999876 568999999999999999999999985321111  111111111


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...................................+..+..+.+++.+||+.||.+|||+.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            11000000000000000000000000000001111245667899999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.1e-43  Score=316.51  Aligned_cols=239  Identities=27%  Similarity=0.364  Sum_probs=180.9

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .++|...++||+|+||.||++..                   ...+.+.+|+++++.++||||+++++++.     ..+.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   80 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KEPN   80 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC--
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCc
Confidence            46899999999999999988641                   23467889999999999999999999954     4677


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC------
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD------  169 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~------  169 (381)
                      .++||||+++++|.+++.           ...+++..++.++.|++.||.|||+....+|+||||||+||+++.      
T Consensus        81 ~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~  149 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLS-----------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD  149 (271)
T ss_dssp             CEEEEECCTTEEHHHHHT-----------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred             eEEEEEcCCCCCHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence            899999999999999983           346899999999999999999999541122999999999999986      


Q ss_pred             --CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          170 --DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       170 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                        ++.+||+|||++.........    ...||+.|+|||++.+..++.++||||||+++|+|++|+.||....    ...
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~  221 (271)
T 3dtc_A          150 LSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----GLA  221 (271)
T ss_dssp             CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC----HHH
T ss_pred             ccCcceEEccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHH
Confidence              678999999999866543322    2458999999999988889999999999999999999999985221    111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ...         ..........                  .+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       222 ~~~---------~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          222 VAY---------GVAMNKLALP------------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHH---------HHHTSCCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHH---------hhhcCCCCCC------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            100         0000000000                  0124456789999999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.2e-43  Score=326.92  Aligned_cols=253  Identities=17%  Similarity=0.304  Sum_probs=195.3

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      ..++|...+.||+|+||.||++..                       .....+.+|+.++++++||||+++++++     
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----   97 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   97 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE-----
Confidence            467899999999999999987531                       1345688999999999999999999995     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      ......++||||+++|+|.+++...............+++..++.++.|++.||.|||   +.+|+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence            4467889999999999999999532110000011245689999999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~  249 (381)
                      +.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||....     ....
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~  249 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQV  249 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----HHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-----HHHH
Confidence            9999999999986654433222233457889999999988889999999999999999999 899975221     1111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      ...        +........                   +..++..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       250 ~~~--------~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          250 LRF--------VMEGGLLDK-------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHH--------HHTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH--------HHcCCcCCC-------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111        111100000                   12455678899999999999999999999999988754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.5e-42  Score=326.60  Aligned_cols=278  Identities=19%  Similarity=0.223  Sum_probs=196.8

Q ss_pred             cccchhhhhccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeec
Q 041757           25 KLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACL   86 (381)
Q Consensus        25 ~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~   86 (381)
                      .+..=+++++.++|...++||+|+||.||++..                  ...+.+.+|++++++++||||+++++++.
T Consensus        16 ~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   95 (364)
T 3qyz_A           16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIR   95 (364)
T ss_dssp             CBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred             EEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEe
Confidence            344445666788999999999999999988641                  13467889999999999999999999976


Q ss_pred             cccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           87 GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        87 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                      ..........++||||+. |+|.+++.           ...+++..++.++.|++.||.|||   +.+|+||||||+||+
T Consensus        96 ~~~~~~~~~~~iv~e~~~-~~L~~~l~-----------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl  160 (364)
T 3qyz_A           96 APTIEQMKDVYIVQDLME-TDLYKLLK-----------TQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLL  160 (364)
T ss_dssp             CSSTTTCCCEEEEEECCS-EEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred             cCCccccceEEEEEcccC-cCHHHHHH-----------hCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEE
Confidence            544445567899999997 59999884           245899999999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeecccceecCCCCCcc-cccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757          167 LDDDMTARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM  244 (381)
Q Consensus       167 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~  244 (381)
                      ++.++.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ 
T Consensus       161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-  239 (364)
T 3qyz_A          161 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-  239 (364)
T ss_dssp             ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-
T ss_pred             ECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-
Confidence            9999999999999998765433221 1223569999999998654 458999999999999999999999985322111 


Q ss_pred             cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          245 NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .+..+........ .+.+..............................+.++.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          240 QLNHILGILGSPS-QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHHHCSCC-HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhCCCC-HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111111111111 1111110000000000000000000011112234567899999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.3e-43  Score=326.97  Aligned_cols=264  Identities=21%  Similarity=0.292  Sum_probs=197.7

Q ss_pred             ccccccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      -.++|...+.||+|+||.||++.                     ....+.+.+|++++++++||||+++++++..   .+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   97 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PG   97 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CC
Confidence            35789999999999999998764                     1134668999999999999999999998653   35


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+++++|.+++..         ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~  165 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQR---------HRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAH  165 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred             CceEEEEEeecCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCC
Confidence            6778999999999999999952         2346899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......  ......
T Consensus       166 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~  243 (327)
T 3lxl_A          166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGC  243 (327)
T ss_dssp             EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC-
T ss_pred             EEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhccc
Confidence            9999999998876543221 2222458889999999998899999999999999999999999975221100  000000


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  329 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~  329 (381)
                      .........+.........               ...+..++..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          244 ERDVPALSRLLELLEEGQR---------------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             ---CCHHHHHHHHHHTTCC---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             ccccccHHHHHHHhhcccC---------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            0000011111111110000               00123456789999999999999999999999999999876543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.1e-43  Score=315.01  Aligned_cols=243  Identities=25%  Similarity=0.393  Sum_probs=193.8

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...+.||+|+||.||++..               ...+.+.+|++++++++||||+++++++.     ..+..++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   81 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV   81 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeEEE
Confidence            36789999999999999987642               24578999999999999999999999954     46778999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||
T Consensus        82 ~e~~~~~~L~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg  149 (267)
T 3t9t_A           82 TEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFG  149 (267)
T ss_dssp             ECCCTTCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTT
T ss_pred             EeCCCCCcHHHHHh---------hCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccc
Confidence            99999999999995         23456899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....     ......       
T Consensus       150 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~-------  216 (267)
T 3t9t_A          150 MTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVE-------  216 (267)
T ss_dssp             GGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHH-------
T ss_pred             ccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-----HHHHHH-------
Confidence            99866443211 1112447889999999988889999999999999999999 899975221     111111       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                       .+........                   +...+..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus       217 -~i~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          217 -DISTGFRLYK-------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -HHHTTCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -HHhcCCcCCC-------------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             1111000000                   113455788999999999999999999999999998764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.5e-43  Score=320.10  Aligned_cols=261  Identities=19%  Similarity=0.224  Sum_probs=184.8

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|...++||+|+||+||++..                   ...+.+.+|+.++++++||||+++++++     .+....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence            5789999999999999988642                   1247788999999999999999999995     447789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++ +|.+++.         .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus        77 ~lv~e~~~~-~l~~~~~---------~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~  143 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFD---------SCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             EEEEECCSE-EHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCC-CHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence            999999976 6666653         34567999999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCc-cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |||+++..........  ...||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........+.........
T Consensus       144 Dfg~~~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~  221 (292)
T 3o0g_A          144 NFGLARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT  221 (292)
T ss_dssp             CCTTCEECCSCCSCCC--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecccceecCCcccccc--CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            9999987754332222  246899999999987765 8999999999999999999988853111111111111111000


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ... ........ .+.... ..............+.....+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~-~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          222 PTE-EQWPSMTK-LPDYKP-YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCT-TTCTTGGG-STTCCC-CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCh-hhhhhhcc-cccccc-cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000 00000000 000000 00000000001112235567889999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.8e-43  Score=317.47  Aligned_cols=243  Identities=17%  Similarity=0.288  Sum_probs=190.3

Q ss_pred             ccccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..++|...+.||+|+||.||++..                     ...+.+.+|+.++++++||||+++++++.      
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------   83 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------   83 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC------
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc------
Confidence            357899999999999999987531                     13567899999999999999999999853      


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      .+..++||||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        84 ~~~~~~v~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  151 (281)
T 3cc6_A           84 EEPTWIIMELYPYGELGHYLE---------RNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPEC  151 (281)
T ss_dssp             SSSCEEEEECCTTCBHHHHHH---------HHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTE
T ss_pred             CCCCEEEEecCCCCCHHHHHH---------hccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCc
Confidence            334689999999999999995         23456899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||++........... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......  ...    
T Consensus       152 ~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~----  224 (281)
T 3cc6_A          152 VKLGDFGLSRYIEDEDYYKA-SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVI----  224 (281)
T ss_dssp             EEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHH----
T ss_pred             EEeCccCCCccccccccccc-ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHH----
Confidence            99999999987654432221 12447889999999988889999999999999999998 99998532111  111    


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                              ..+.......                  .+..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       225 --------~~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          225 --------GVLEKGDRLP------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             --------HHHHHTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------HHHhcCCCCC------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                    1111000000                  0123456788999999999999999999999999988653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-42  Score=328.21  Aligned_cols=240  Identities=20%  Similarity=0.226  Sum_probs=179.6

Q ss_pred             hhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ....++|...++||+|+||+||++..                ...+.+.+|+.+++.++||||+++++++     .+...
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~   90 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI-----LTPTH   90 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCE
Confidence            44578899999999999999987652                2346788999999999999999999995     44778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC--e
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT--A  173 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~--~  173 (381)
                      .++||||+++|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.  +
T Consensus        91 ~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~  157 (361)
T 3uc3_A           91 LAIIMEYASGGELYERIC----------NAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRL  157 (361)
T ss_dssp             EEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCE
T ss_pred             EEEEEEeCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceE
Confidence            999999999999999993          4556999999999999999999999   669999999999999987665  9


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcc-cchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI-GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||+++........   ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ....    
T Consensus       158 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~----  229 (361)
T 3uc3_A          158 KICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRK----  229 (361)
T ss_dssp             EECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHH----
T ss_pred             EEeecCccccccccCCC---CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHH----
Confidence            99999999754332222   12469999999999988777655 899999999999999999986332211 1111    


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              .+...+......              +.....+..+.+++.+||+.||.+|||+.++++
T Consensus       230 --------~~~~~~~~~~~~--------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          230 --------TIQRILSVKYSI--------------PDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             --------HHHHHHTTCCCC--------------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             --------HHHHHhcCCCCC--------------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                    111111110000              000123457889999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.4e-43  Score=331.66  Aligned_cols=235  Identities=23%  Similarity=0.257  Sum_probs=178.0

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHH-HHccCCCcccceeeeeccccccC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKA-LRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..++|...++||+|+||.||+++.                    .....+.+|..+ ++.++||||+++++++     .+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence            347899999999999999988652                    123456677776 4678999999999994     55


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      .+..|+||||+++|+|.+++.          ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~  177 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQ----------RERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGH  177 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCC
Confidence            788999999999999999994          4557889999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +||+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|..||...    . ..     
T Consensus       178 ikL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~-~~-----  245 (373)
T 2r5t_A          178 IVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----N-TA-----  245 (373)
T ss_dssp             EEECCCCBCGGGBCCCCC--CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS----B-HH-----
T ss_pred             EEEeeCccccccccCCCc--cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC----C-HH-----
Confidence            999999999864332221  12357999999999999999999999999999999999999998522    1 11     


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                             ++....+.....                .+...+..+.+++.+||+.||.+||++.+.++.+
T Consensus       246 -------~~~~~i~~~~~~----------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          246 -------EMYDNILNKPLQ----------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             -------HHHHHHHHSCCC----------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             -------HHHHHHHhcccC----------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence                   111111111000                0113445788999999999999999986544433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.5e-42  Score=321.72  Aligned_cols=264  Identities=21%  Similarity=0.281  Sum_probs=200.1

Q ss_pred             hhccccccccceecCCCceEEEecc------------cccHHHHHHHHHHHHc--cCCCcccceeeeeccccccCCceEE
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRR------------QGAFKSFIAECKALRN--IRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~------------~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ....++|...+.||+|+||.||+++            ......+.+|++++..  ++||||+++++++.... ......+
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~  116 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLW  116 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEE
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeE
Confidence            4456889999999999999998864            2345678899999988  78999999999965311 1123789


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC-----CCCceeeccCCCCeeeCCCCC
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC-----QPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivHrDlkp~Nill~~~~~  172 (381)
                      +||||+++|+|.+++.           ...+++..++.++.|++.||.|||...     +.+|+||||||+||+++.++.
T Consensus       117 lv~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLN-----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             EEECCCTTCBHHHHHH-----------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred             EEEeecCCCcHHHHHh-----------ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence            9999999999999994           235899999999999999999999210     238999999999999999999


Q ss_pred             eEEeecccceecCCCCCcc--cccCccCccceeCCCCcCCC------ccCcccchhhhhHHHHHHHhC----------CC
Q 041757          173 ARVGDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGN------EVSTIGDVYSYGILLLELMIR----------EK  234 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlG~il~el~tg----------~~  234 (381)
                      +||+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9999999998765543211  12235699999999998765      345789999999999999999          77


Q ss_pred             CCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          235 PSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       235 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                      ||............+.......        .+......             ......++..+.+++.+||+.||++|||+
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~  324 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQ--------KLRPNIPN-------------RWQSCEALRVMAKIMRECWYANGAARLTA  324 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTS--------CCCCCCCG-------------GGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CccccCcCcccHHHHHHHHHHH--------HhCCCCcc-------------cccchhHHHHHHHHHHHHhccChhhCCCH
Confidence            8765444443333332221111        01000000             00013677789999999999999999999


Q ss_pred             HHHHHHHHHhhhhc
Q 041757          315 TNVVHELQSIKNTL  328 (381)
Q Consensus       315 ~~vl~~L~~i~~~~  328 (381)
                      .+|++.|+++.+..
T Consensus       325 ~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          325 LRIKKTLSQLSQQE  338 (342)
T ss_dssp             HHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHh
Confidence            99999999997653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.6e-43  Score=340.55  Aligned_cols=233  Identities=23%  Similarity=0.273  Sum_probs=178.7

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .++|...++||+|+||.||++..                    .....+.+|+.+++.++||||+++++++.     ..+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence            46799999999999999987542                    12356778999999999999999999954     477


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++.          ....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+|
T Consensus       222 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~k  289 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLS----------RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIK  289 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEE
T ss_pred             EEEEEEeeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEE
Confidence            8999999999999999993          456789999999999999999999931  5999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....     ...      
T Consensus       290 l~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~------  356 (446)
T 4ejn_A          290 ITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEK------  356 (446)
T ss_dssp             ECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHH------
T ss_pred             EccCCCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHH------
Confidence            9999999764333222  123579999999999999999999999999999999999999985221     111      


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                            +..........                ++...+..+.+++.+||+.||.+||     |+.++++
T Consensus       357 ------~~~~i~~~~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          357 ------LFELILMEEIR----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------HHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------HHHHHHhCCCC----------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  11111111100                0123456788999999999999999     9999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-43  Score=323.20  Aligned_cols=238  Identities=18%  Similarity=0.270  Sum_probs=185.9

Q ss_pred             cccccccceecCCCceEEEecc------------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR------------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~------------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      .++|...+.||+|+||+||++.                        ....+.+.+|+.++++++||||+++++++.    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV----   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence            5789999999999999998753                        123577999999999999999999999954    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                       ..+..++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.+
T Consensus        83 -~~~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  149 (289)
T 4fvq_A           83 -CGDENILVQEFVKFGSLDTYLK---------KNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIRE  149 (289)
T ss_dssp             -CTTCCEEEEECCTTCBHHHHHH---------HTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEEC
T ss_pred             -eCCCCEEEEECCCCCCHHHHHH---------hCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecC
Confidence             4677899999999999999995         23345899999999999999999999   6699999999999999888


Q ss_pred             CC--------eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCcccc
Q 041757          171 MT--------ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFE  241 (381)
Q Consensus       171 ~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~  241 (381)
                      +.        +||+|||++.......      ...||+.|+|||++.+ ..++.++||||||+++|||++|..|+...  
T Consensus       150 ~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~--  221 (289)
T 4fvq_A          150 EDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA--  221 (289)
T ss_dssp             CBGGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT--
T ss_pred             CcccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc--
Confidence            76        9999999986543221      1347899999999887 67899999999999999999965553211  


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                       .. .....         ........ .                   +...+.++.+++.+||+.||.+|||+.++++.|
T Consensus       222 -~~-~~~~~---------~~~~~~~~-~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  270 (289)
T 4fvq_A          222 -LD-SQRKL---------QFYEDRHQ-L-------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDL  270 (289)
T ss_dssp             -SC-HHHHH---------HHHHTTCC-C-------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             -cc-hHHHH---------HHhhccCC-C-------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence             11 11100         00000000 0                   012234678899999999999999999999999


Q ss_pred             HHhhhhc
Q 041757          322 QSIKNTL  328 (381)
Q Consensus       322 ~~i~~~~  328 (381)
                      +++...-
T Consensus       271 ~~l~~p~  277 (289)
T 4fvq_A          271 NSLFTPD  277 (289)
T ss_dssp             HTCC---
T ss_pred             HHhcCCC
Confidence            9987643

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=328.52  Aligned_cols=266  Identities=17%  Similarity=0.189  Sum_probs=200.5

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ..++|...++||+|+||+||++..                  ...+.+.+|++++++++||||+++++++..   .....
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~   83 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRH   83 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCe
Confidence            367899999999999999988642                  235778899999999999999999999653   33457


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee----CCCC
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDM  171 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~  171 (381)
                      .++|||||++|+|.+++...       .....+++..++.++.|++.||.|||   +.+|+||||||+||++    +.++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~  153 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEP-------SNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQS  153 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSG-------GGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCE
T ss_pred             eEEEEecCCCCCHHHHHHhh-------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCce
Confidence            89999999999999999532       12233899999999999999999999   6699999999999999    7778


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCC--------CccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  243 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~  243 (381)
                      .+||+|||+++.........   ...||+.|+|||++.+        ..++.++|||||||++|||++|+.||.......
T Consensus       154 ~~kL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~  230 (396)
T 4eut_A          154 VYKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (396)
T ss_dssp             EEEECCGGGCEECCCGGGSS---CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred             eEEEecCCCceEccCCCccc---cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence            89999999998775543222   2569999999998764        567889999999999999999999986433322


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcc---------cchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRG---------DQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                      .....+..             .+...+.......         ..................+.+++.+||+.||++|||+
T Consensus       231 ~~~~~~~~-------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~  297 (396)
T 4eut_A          231 RNKEVMYK-------------IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF  297 (396)
T ss_dssp             TCHHHHHH-------------HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred             chHHHHHH-------------HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH
Confidence            22222111             1111111000000         0000000112235677788999999999999999999


Q ss_pred             HHHHHHHHHhhhhc
Q 041757          315 TNVVHELQSIKNTL  328 (381)
Q Consensus       315 ~~vl~~L~~i~~~~  328 (381)
                      .++++.+..+....
T Consensus       298 ~e~l~~l~~il~~~  311 (396)
T 4eut_A          298 DQFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHHHHHHHTCE
T ss_pred             HHHHHHHHHHhhce
Confidence            99999999887643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-42  Score=314.16  Aligned_cols=240  Identities=23%  Similarity=0.275  Sum_probs=188.8

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      -++|...+.||+|+||.||++..                 ...+.+.+|+.++++++||||+++++++..   ......+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   85 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPHPT   85 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTSSSCE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCCCCeE
Confidence            46789999999999999988642                 234678999999999999999999999653   2247789


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeeccCCCCeeeCCCCCeEE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV--TAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivHrDlkp~Nill~~~~~~kl  175 (381)
                      +||||+++|+|.+++..        .....+++..++.++.|++.||.|||   +.+  ++||||||+||+++.++.++|
T Consensus        86 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l  154 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHE--------GTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARI  154 (271)
T ss_dssp             EEEECCTTCBHHHHHHS--------CSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEE
T ss_pred             eeecccCCCcHHHHHhh--------cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeE
Confidence            99999999999999953        12235899999999999999999999   557  999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCc---ccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVST---IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|||++......       ...||+.|+|||++.+..++.   ++||||||+++|||++|+.||....    ......  
T Consensus       155 ~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~--  221 (271)
T 3kmu_A          155 SMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS----NMEIGM--  221 (271)
T ss_dssp             EGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC----HHHHHH--
T ss_pred             Eeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC----hHHHHH--
Confidence            999887542221       245899999999988766554   7999999999999999999985221    111100  


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                             .........                  ..+..++..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       222 -------~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          222 -------KVALEGLRP------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -------HHHHSCCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -------HHHhcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                   011000000                  0012455678999999999999999999999999998854

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-42  Score=316.67  Aligned_cols=245  Identities=21%  Similarity=0.337  Sum_probs=197.5

Q ss_pred             ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ..++|...+.||+|+||.||++..                ...+.+.+|++++++++||||+++++++     ......+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCEE
Confidence            467899999999999999988642                2457899999999999999999999995     4577889


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~D  154 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD  154 (288)
T ss_dssp             EEEECCTTEEHHHHHHH--------CCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EEEEcCCCCcHHHHHHh--------cccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEcc
Confidence            99999999999999953        23456899999999999999999999   56999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......  .           
T Consensus       155 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~-----------  220 (288)
T 3kfa_A          155 FGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q-----------  220 (288)
T ss_dssp             CCGGGTSCSSSSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G-----------
T ss_pred             CccceeccCCcccc-ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H-----------
Confidence            99998765443222 222447888999999988899999999999999999999 99997532111  0           


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                       ..+.+........                  +..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       221 -~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          221 -VYELLEKDYRMER------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             -HHHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHhccCCCCC------------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence             1111111110000                  124556789999999999999999999999999988765

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.2e-42  Score=323.29  Aligned_cols=193  Identities=25%  Similarity=0.308  Sum_probs=163.7

Q ss_pred             cccccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccC-----CCcccce
Q 041757           23 VGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIR-----HRNLIKV   81 (381)
Q Consensus        23 ~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~-----h~nIv~~   81 (381)
                      +..+..-+.....++|...++||+|+||+||++..                ...+.+..|+.+++.+.     ||||+++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            44444445555688999999999999999988652                12456788999999996     9999999


Q ss_pred             eeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC
Q 041757           82 LTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK  161 (381)
Q Consensus        82 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk  161 (381)
                      ++++.     ..+..++||||+ +++|.+++..        .....+++..++.++.|++.||.|||   +.+|+|||||
T Consensus       102 ~~~~~-----~~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlk  164 (360)
T 3llt_A          102 HGKFM-----YYDHMCLIFEPL-GPSLYEIITR--------NNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLK  164 (360)
T ss_dssp             EEEEE-----ETTEEEEEECCC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred             cceee-----ECCeeEEEEcCC-CCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCC
Confidence            99954     467899999999 9999999953        22345899999999999999999999   6699999999


Q ss_pred             CCCeeeCC-------------------------CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcc
Q 041757          162 PSNVLLDD-------------------------DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTI  216 (381)
Q Consensus       162 p~Nill~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  216 (381)
                      |+|||++.                         ++.+||+|||+++.......     ...||+.|+|||++.+..++.+
T Consensus       165 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~  239 (360)
T 3llt_A          165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG-----SIINTRQYRAPEVILNLGWDVS  239 (360)
T ss_dssp             GGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC-----SCCSCGGGCCHHHHTTCCCCTT
T ss_pred             cccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCc-----CccCcccccCcHHHcCCCCCCc
Confidence            99999975                         78899999999987544322     2568999999999999999999


Q ss_pred             cchhhhhHHHHHHHhCCCCCC
Q 041757          217 GDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       217 sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +|||||||++|+|++|+.||.
T Consensus       240 ~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          240 SDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCC
T ss_pred             cchHHHHHHHHHHHHCCCCCC
Confidence            999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-42  Score=314.76  Aligned_cols=245  Identities=22%  Similarity=0.357  Sum_probs=194.3

Q ss_pred             cccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...+.||+|+||.||++.               ....+.+.+|++++++++||||+++++++.      .+..++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v   85 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYII   85 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcEEE
Confidence            4789999999999999998764               124578999999999999999999999853      3457999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++++|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        86 ~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           86 TEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             EECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCCHHHHHhc--------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence            999999999999942        11236899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++.......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||....    . .....       
T Consensus       155 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~-~~~~~-------  221 (279)
T 1qpc_A          155 LARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----N-PEVIQ-------  221 (279)
T ss_dssp             TCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----H-HHHHH-------
T ss_pred             ccccccCccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC----H-HHHHH-------
Confidence            998776543221 122447889999999988889999999999999999999 899975221    1 11110       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  329 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~  329 (381)
                       .+........                   +..++..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       222 -~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          222 -NLERGYRMVR-------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             -HHHTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -HHhcccCCCC-------------------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence             0100000000                   12345688999999999999999999999999999977653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=314.54  Aligned_cols=233  Identities=22%  Similarity=0.346  Sum_probs=167.5

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      -++|...+.||+|+||.||++..                    ...+.+.+|+.++++++||||+++++++     ...+
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence            46799999999999999988752                    1236788999999999999999999995     4577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~k  152 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLK---------NRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIK  152 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHH---------TCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEE
T ss_pred             eEEEEEecCCCCcHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEE
Confidence            8999999999999999995         23467899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||++...........  ...||+.|+|||++.+..++.++||||||+++|+|++|+.||.......           
T Consensus       153 l~dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------  219 (278)
T 3cok_A          153 IADFGLATQLKMPHEKHY--TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----------  219 (278)
T ss_dssp             ECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------
T ss_pred             EEeecceeeccCCCCcce--eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----------
Confidence            999999987654332211  2458999999999998889999999999999999999999986322111           


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            .+.........                .+...+.++.+++.+||+.||.+|||+.++++
T Consensus       220 ------~~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          220 ------TLNKVVLADYE----------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----------CCSSCCC----------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------HHHHHhhcccC----------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                  00000000000                01124457889999999999999999999885

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-41  Score=331.63  Aligned_cols=264  Identities=19%  Similarity=0.184  Sum_probs=185.0

Q ss_pred             hccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccC
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQG   92 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~   92 (381)
                      ...++|...++||+|+||+||++..                   ...+.+.+|+.+|+.++||||+++++++.... ...
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            3468899999999999999987631                   23567889999999999999999999976421 133


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+.+ +|.+.+.            ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~------------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~  202 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT  202 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSC
T ss_pred             CCeEEEEEeCCCC-CHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCC
Confidence            4678999999976 5777662            23889999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +||+|||+++.........   ..+||+.|+|||++.+..++.++|||||||++|||++|+.||.    +......+...
T Consensus       203 ~kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~----g~~~~~~~~~i  275 (464)
T 3ttj_A          203 LKILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP----GRDYIDQWNKV  275 (464)
T ss_dssp             EEECCCCCC-----CCCC-------CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC----CSSHHHHHHHH
T ss_pred             EEEEEEEeeeecCCCcccC---CCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC----CCCHHHHHHHH
Confidence            9999999998765433222   2569999999999999999999999999999999999999975    22222222111


Q ss_pred             H--hhchHHHHHhh-------hhccCchhhh----hcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 A--LSNHVKDIVDS-------ILLNDDEKLV----VRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~--~~~~~~~~~~~-------~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .  ......+.+..       .+...+....    ....................++.+|+.+||..||.+|||+.|+++
T Consensus       276 ~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          276 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1  11111111110       0000000000    000000000001112334678899999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.6e-42  Score=312.25  Aligned_cols=235  Identities=22%  Similarity=0.269  Sum_probs=187.8

Q ss_pred             ccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++|...++||+|+||.||++.                 ....+.+.+|++++++++||||+++++++     ......
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeE
Confidence            46789999999999999998764                 22457899999999999999999999995     457789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee---CCCCCe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTA  173 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~  173 (381)
                      ++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||++   +.++.+
T Consensus        82 ~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~  148 (277)
T 3f3z_A           82 YLVMELCTGGELFERVV----------HKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPL  148 (277)
T ss_dssp             EEEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCE
T ss_pred             EEEEeccCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcE
Confidence            99999999999999983          4556899999999999999999999   6699999999999999   788899


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||++..........   ...||+.|+|||++.+. ++.++||||||+++|+|++|..||.....     .....  
T Consensus       149 ~l~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~--  217 (277)
T 3f3z_A          149 KLIDFGLAARFKPGKMMR---TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-----SEVML--  217 (277)
T ss_dssp             EECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--
T ss_pred             EEEecccceeccCccchh---ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-----HHHHH--
Confidence            999999998776543322   24589999999988764 89999999999999999999999853211     11100  


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            .+...... .+.               ......+..+.+++.+||+.||.+|||+.++++
T Consensus       218 ------~~~~~~~~-~~~---------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          218 ------KIREGTFT-FPE---------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ------HHHHCCCC-CCH---------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------HHHhCCCC-CCc---------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  01110000 000               001134568899999999999999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=326.23  Aligned_cols=238  Identities=20%  Similarity=0.210  Sum_probs=174.7

Q ss_pred             hccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .+.++|...+.||+|+||.||++..               ...+.+.+|+++|++++||||+++++++     ......+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeEE
Confidence            3567899999999999999988652               2345688899999999999999999995     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CCCeE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DMTAR  174 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~k  174 (381)
                      +||||+++|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.   ++.+|
T Consensus       125 lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~k  191 (349)
T 2w4o_A          125 LVLELVTGGELFDRIV----------EKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLK  191 (349)
T ss_dssp             EEECCCCSCBHHHHHT----------TCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEE
T ss_pred             EEEEeCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEE
Confidence            9999999999999993          4556899999999999999999999   669999999999999975   78999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++.........   ...||+.|+|||++.+..++.++|||||||++|||++|..||....    .......   
T Consensus       192 l~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~---  261 (349)
T 2w4o_A          192 IADFGLSKIVEHQVLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER----GDQFMFR---  261 (349)
T ss_dssp             ECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT----CHHHHHH---
T ss_pred             EccCccccccCcccccc---cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc----ccHHHHH---
Confidence            99999998765432221   2468999999999999899999999999999999999999975221    1111111   


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           .+.........                ......+..+.+++.+||+.||++|||+.++++
T Consensus       262 -----~i~~~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          262 -----RILNCEYYFIS----------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -----HHHTTCCCCCT----------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----HHHhCCCccCC----------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 11111000000                001234567889999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.5e-42  Score=319.21  Aligned_cols=254  Identities=22%  Similarity=0.250  Sum_probs=186.7

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...+.||+|+||.||++..                    ...+.+.+|+.++++++||||+++++++.     ..
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----ED  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cC
Confidence            456899999999999999987641                    23467889999999999999999999964     36


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++++|.+++....      .....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~  175 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFK------KQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVV  175 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred             CcEEEEEecCCCCCHHHHHHHhc------ccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCE
Confidence            78999999999999999985321      23456899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||++..........  ....|++.|+|||++.+..++.++||||||+++|+|++|..||....   ..........
T Consensus       176 kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~  250 (310)
T 2wqm_A          176 KLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKI  250 (310)
T ss_dssp             EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC------CCHHHHHHHH
T ss_pred             EEEeccceeeecCCCccc--cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc---hhHHHHHHHh
Confidence            999999998665432221  12458999999999999899999999999999999999999975221   1111111110


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  332 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~  332 (381)
                              ........+                  ....+..+.+++.+||+.||.+|||+.+|++.|+++.....++.
T Consensus       251 --------~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          251 --------EQCDYPPLP------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             --------HTTCSCCCC------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             --------hcccCCCCc------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence                    000000000                  01345678899999999999999999999999999988765543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.8e-42  Score=322.70  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=192.9

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|...+.||+|+||.||++..                    ...+.+.+|+++++++ +||||+++++++.     ..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence            7899999999999999987641                    1345688999999999 8999999999954     477


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                      ..++||||+++|+|.+++........      .......+++..++.++.|++.||.|||   +.+|+||||||+||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEc
Confidence            89999999999999999953210000      0011246899999999999999999999   66999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLH  247 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~  247 (381)
                      .++.+||+|||+++.........   ...+++.|+|||++.+..++.++||||||+++|+|++ |..||....     ..
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~  248 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYVKKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CA  248 (327)
T ss_dssp             GGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH
T ss_pred             CCCeEEEcccCcCcccccccccc---CCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-----HH
Confidence            99999999999997443222111   1347889999999988889999999999999999998 999985221     11


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      .            +..........               ..+..++..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus       249 ~------------~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          249 E------------LYEKLPQGYRL---------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             H------------HHHHGGGTCCC---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             H------------HHHHhhcCCCC---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1            11111100000               00123456789999999999999999999999999999877


Q ss_pred             cCC
Q 041757          328 LLG  330 (381)
Q Consensus       328 ~~~  330 (381)
                      ...
T Consensus       302 ~~~  304 (327)
T 1fvr_A          302 RKT  304 (327)
T ss_dssp             SSC
T ss_pred             hcC
Confidence            544

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.2e-42  Score=322.42  Aligned_cols=253  Identities=17%  Similarity=0.232  Sum_probs=188.1

Q ss_pred             hhhhccccccccceecCCCceEEEeccc----------------------ccHHHHHHHHHHHHccCCCcccceeeeecc
Q 041757           30 EILDVSRNMLEENLISAGTFGFSHLRRQ----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLG   87 (381)
Q Consensus        30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~   87 (381)
                      .+..+.++|...+.||+|+||.||++..                      ...+.+.+|++++++++||||+++++++  
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--   97 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY--   97 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh--
Confidence            4456789999999999999999987642                      2346788999999999999999999995  


Q ss_pred             ccccCCceEEEEEEcccCCCHHHhhccccCCc------------------------------ccccCCCcccHHHHHHHH
Q 041757           88 VDYQGNDFKALVYEFMHNRSLKEWLYPISKED------------------------------ETYKRPRNLNLLRRLNIA  137 (381)
Q Consensus        88 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------~~~~~~~~l~~~~~~~i~  137 (381)
                         .+.+..++|||||++|+|.+++.......                              ........+++..++.++
T Consensus        98 ---~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  174 (345)
T 3hko_A           98 ---EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM  174 (345)
T ss_dssp             ---ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred             ---ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence               45778999999999999999985211100                              000113345788889999


Q ss_pred             HHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC--CeEEeecccceecCCCCC--cccccCccCccceeCCCCcCC--C
Q 041757          138 IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM--TARVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPEYGVG--N  211 (381)
Q Consensus       138 ~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~--~  211 (381)
                      .|++.||.|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||++.+  .
T Consensus       175 ~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  251 (345)
T 3hko_A          175 RQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE  251 (345)
T ss_dssp             HHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred             HHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence            99999999999   66999999999999998766  899999999987643221  111223569999999999875  6


Q ss_pred             ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHH
Q 041757          212 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE  291 (381)
Q Consensus       212 ~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  291 (381)
                      .++.++||||||+++|||++|+.||....    ....         ...+..........                ....
T Consensus       252 ~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~---------~~~~~~~~~~~~~~----------------~~~~  302 (345)
T 3hko_A          252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVN----DADT---------ISQVLNKKLCFENP----------------NYNV  302 (345)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---------HHHHHHCCCCTTSG----------------GGGG
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----hHHH---------HHHHHhcccccCCc----------------cccc
Confidence            78999999999999999999999975221    1111         11111111100000                0123


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          292 CVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       292 ~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .+..+.+++.+||+.||.+|||+.++++
T Consensus       303 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          303 LSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            4567889999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.6e-42  Score=311.90  Aligned_cols=237  Identities=18%  Similarity=0.235  Sum_probs=188.1

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .++|...+.||+|+||.||++..                  ...+.+.+|+.+++.++||||+++++++.     ..+..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence            46899999999999999988641                  23477899999999999999999999954     47788


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+
T Consensus        81 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~  147 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS  147 (276)
T ss_dssp             EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEecCCCcHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEe
Confidence            99999999999999983          4567899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |||++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........+..       
T Consensus       148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------  220 (276)
T 2yex_A          148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-------  220 (276)
T ss_dssp             CCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH-------
T ss_pred             eCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------
Confidence            9999987644332222223568999999999987665 78899999999999999999998643222111111       


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                           +........+                  ....+..+.+++.+||+.||.+|||+.++++
T Consensus       221 -----~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          221 -----WKEKKTYLNP------------------WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----HHTTCTTSTT------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----hhhcccccCc------------------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 0000000000                  1134557888999999999999999999876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-42  Score=314.71  Aligned_cols=247  Identities=20%  Similarity=0.301  Sum_probs=196.1

Q ss_pred             cccccccc-eecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEEN-LISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~-~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...+ .||+|+||.||++.                    ....+.+.+|++++++++||||+++++++.      .
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~   81 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A   81 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------C
Confidence            45666665 99999999998763                    124567889999999999999999999952      4


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~  149 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYA  149 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHT---------TCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEE
T ss_pred             CCcEEEEEeCCCCCHHHHHH---------hCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCE
Confidence            45899999999999999995         23456899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      ||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....     .....
T Consensus       150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~  224 (287)
T 1u59_A          150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMA  224 (287)
T ss_dssp             EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHH
T ss_pred             EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HHHHH
Confidence            99999999887544322 11222446899999999988889999999999999999998 9999853211     11110


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  331 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~  331 (381)
                               .+......                  ..+..++..+.+++.+||+.||.+|||+.++++.|+++..+...+
T Consensus       225 ---------~i~~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          225 ---------FIEQGKRM------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             ---------HHHTTCCC------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             ---------HHhcCCcC------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence                     01100000                  001245678999999999999999999999999999998876544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=345.64  Aligned_cols=245  Identities=20%  Similarity=0.310  Sum_probs=189.6

Q ss_pred             ccccccc-eecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           36 RNMLEEN-LISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~-~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +++...+ .||+|+||.||++.                    ....+.|.+|+++|++++|||||+++++|.      .+
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~------~~  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE------SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec------cC
Confidence            3444444 89999999998652                    124678999999999999999999999964      24


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++|||||++|+|.+++.         .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       409 ~~~lv~E~~~~g~L~~~l~---------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vk  476 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAK  476 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHT---------TCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred             CeEEEEEeCCCCcHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEE
Confidence            5899999999999999995         23456899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      |+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....    .. ..  
T Consensus       477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~-~~--  549 (613)
T 2ozo_A          477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PE-VM--  549 (613)
T ss_dssp             ECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----HH-HH--
T ss_pred             EeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----HH-HH--
Confidence            9999999876543221 11112335789999999988899999999999999999998 9999863211    11 11  


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  330 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~  330 (381)
                             ..+.....                  ...+..++.++.+++.+||+.||++|||+.+|++.|+.+......
T Consensus       550 -------~~i~~~~~------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          550 -------AFIEQGKR------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             -------HHHHTTCC------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             -------HHHHcCCC------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence                   11110000                  001235667899999999999999999999999999998776644

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.4e-42  Score=328.56  Aligned_cols=266  Identities=16%  Similarity=0.139  Sum_probs=187.8

Q ss_pred             hccccccccceecCC--CceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           33 DVSRNMLEENLISAG--TFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G--~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      ...++|...++||+|  +||+||++..                   ...+.+.+|+.+++.++|||||++++++.     
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----   96 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----   96 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----
Confidence            346789999999999  9999988652                   23467788999999999999999999954     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      ..+..++|||||++|+|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~  165 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICT--------HFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDG  165 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHH--------TCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred             ECCEEEEEEEccCCCCHHHHHhh--------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence            47789999999999999999953        22356899999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCC-----cccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757          172 TARVGDFGLARFLPPTRT-----QTSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM  244 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~  244 (381)
                      .+||+|||.+........     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  245 (389)
T 3gni_B          166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM  245 (389)
T ss_dssp             CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH
T ss_pred             CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999999999865432211     111112468999999999887  5799999999999999999999999864322211


Q ss_pred             cHHHHHHHHhhchHHHHHhhhhc------cCchh------------hhhcccchhhhhHHHHHHHHHHHHHHHHHhccCC
Q 041757          245 NLHKFAKMALSNHVKDIVDSILL------NDDEK------------LVVRGDQKQTQAKINIIRECVISMVRIGVACSME  306 (381)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~------~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  306 (381)
                      . ....    ......+.+....      .....            ....................+..+.+|+.+||+.
T Consensus       246 ~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  320 (389)
T 3gni_B          246 L-LEKL----NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR  320 (389)
T ss_dssp             H-HHC------------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred             H-HHHh----cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence            1 0000    0000000000000      00000            0000000000001122345567899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 041757          307 SPQDRMKMTNVVH  319 (381)
Q Consensus       307 dP~~RPs~~~vl~  319 (381)
                      ||.+|||+.|+++
T Consensus       321 dP~~Rpta~ell~  333 (389)
T 3gni_B          321 NPDARPSASTLLN  333 (389)
T ss_dssp             CTTTSCCHHHHTT
T ss_pred             CcccCCCHHHHhc
Confidence            9999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.9e-42  Score=322.47  Aligned_cols=237  Identities=20%  Similarity=0.255  Sum_probs=167.3

Q ss_pred             cceecCCCceEEEeccc--------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEEEEcccC
Q 041757           41 ENLISAGTFGFSHLRRQ--------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFMHN  105 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~~--------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~  105 (381)
                      +++||+|+||+||++..              .....+.+|+.+++.+. ||||+++++++     .+....++||||+++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEEEEEccCC
Confidence            48899999999988642              24577889999999997 99999999995     457889999999999


Q ss_pred             CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC---CeEEeecccce
Q 041757          106 RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM---TARVGDFGLAR  182 (381)
Q Consensus       106 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~~~  182 (381)
                      |+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++   .+||+|||+++
T Consensus        91 ~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           91 GELFERIK----------KKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             CBHHHHHH----------HCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             CcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999994          4567999999999999999999999   66999999999999997665   89999999998


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHH
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIV  262 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (381)
                      ..........  ...||+.|+|||++.+..++.++|||||||++|+|++|..||........          .....+++
T Consensus       158 ~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~  225 (325)
T 3kn6_A          158 LKPPDNQPLK--TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAVEIM  225 (325)
T ss_dssp             ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHHHHH
T ss_pred             ecCCCCCccc--ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHHHHH
Confidence            7654432221  24589999999999999999999999999999999999999864322110          01111222


Q ss_pred             hhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          263 DSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       263 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..........            ........+.++.+++.+||+.||.+|||+.++++
T Consensus       226 ~~i~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          226 KKIKKGDFSF------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHTTTCCCC------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHcCCCCC------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            2221111100            00112345678899999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-41  Score=332.79  Aligned_cols=258  Identities=19%  Similarity=0.192  Sum_probs=197.1

Q ss_pred             ccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      +.++|...++||+|+||.||++..               .....+.+|+++++.++|++++..+..+    .......++
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~----~~~~~~~~l   80 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWF----GVEGDYNVL   80 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEE----EEETTEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEE----EeeCCEEEE
Confidence            468899999999999999988752               2335688999999999875544444433    234778899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee---CCCCCeEE
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMTARV  175 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl  175 (381)
                      ||||+ +++|.+++.         .....+++..++.++.||+.||.|||   ..+|+||||||+|||+   +.++.+||
T Consensus        81 vme~~-g~sL~~ll~---------~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL  147 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFN---------FCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYI  147 (483)
T ss_dssp             EEECC-CCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEE
T ss_pred             EEECC-CCCHHHHHH---------hhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEE
Confidence            99999 999999995         23557999999999999999999999   6699999999999999   57889999


Q ss_pred             eecccceecCCCCCcc-----cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          176 GDFGLARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .....
T Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~  225 (483)
T 3sv0_A          148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQKY  225 (483)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--HHHHH
T ss_pred             EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh--HHHHH
Confidence            9999998776543211     1123669999999999999999999999999999999999999987433221  11111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  330 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~  330 (381)
                      ...........                       .......++.++.+++.+||+.||++||++.+|++.|+.+......
T Consensus       226 ~~i~~~~~~~~-----------------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~  282 (483)
T 3sv0_A          226 EKISEKKVATS-----------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF  282 (483)
T ss_dssp             HHHHHHHHHSC-----------------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHhhcccccc-----------------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence            11000000000                       0011234567899999999999999999999999999999776544


Q ss_pred             CCC
Q 041757          331 PKN  333 (381)
Q Consensus       331 ~~~  333 (381)
                      ...
T Consensus       283 ~~~  285 (483)
T 3sv0_A          283 QFD  285 (483)
T ss_dssp             CCS
T ss_pred             Ccc
Confidence            433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.7e-42  Score=312.02  Aligned_cols=230  Identities=21%  Similarity=0.297  Sum_probs=187.3

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .++|...+.||+|+||.||++..                    ...+.+.+|++++++++||||+++++++     ...+
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence            47899999999999999988642                    1246788999999999999999999995     4477


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k  154 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQ----------KHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELK  154 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEE
T ss_pred             EEEEEEEeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEE
Confidence            8999999999999999994          3456899999999999999999999   67999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||++.........    ...|++.|+|||++.+..++.++||||||+++|+|++|..||....    . ....    
T Consensus       155 l~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~-~~~~----  221 (284)
T 2vgo_A          155 IADFGWSVHAPSLRRR----TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS----H-TETH----  221 (284)
T ss_dssp             ECCCTTCEECSSSCBC----CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----H-HHHH----
T ss_pred             EecccccccCcccccc----cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC----H-hHHH----
Confidence            9999999766543221    2468999999999999899999999999999999999999985221    1 1110    


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          ..+..    ....                .+...+..+.+++.+||+.||.+|||+.++++
T Consensus       222 ----~~~~~----~~~~----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          222 ----RRIVN----VDLK----------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ----HHHHT----TCCC----------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----HHHhc----cccC----------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                01111    0000                01234557889999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.8e-41  Score=314.75  Aligned_cols=269  Identities=18%  Similarity=0.238  Sum_probs=173.7

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ..++|...+.||+|+||.||++..                  ...+.+.+|++++++++||||+++++++     ...+.
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   77 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENK   77 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCe
Confidence            357899999999999999987641                  2346789999999999999999999995     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||++ |+|.+++......    .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl  149 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVG----NTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKL  149 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSS----SCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEEecC-CCHHHHHHhcccc----ccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEE
Confidence            999999998 5999998532110    12346899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      +|||+++.........  ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..+.....
T Consensus       150 ~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~  226 (317)
T 2pmi_A          150 GDFGLARAFGIPVNTF--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMG  226 (317)
T ss_dssp             CCCSSCEETTSCCCCC--CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             CcCccceecCCCcccC--CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence            9999998765432221  12468999999999876 468999999999999999999999985321100 0001100000


Q ss_pred             hchHHHHHh---hhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVD---SILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ... .....   ......+......................+.++.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          227 TPN-ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             SCC-TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCC-hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000 00000   00000000000000000000000001134567899999999999999999999886

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=326.71  Aligned_cols=268  Identities=14%  Similarity=0.115  Sum_probs=198.4

Q ss_pred             cccccccceecCCCceEEEeccccc--------------------HHHHHHHHHHHHccCCCcccceeeeecc-------
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQGA--------------------FKSFIAECKALRNIRHRNLIKVLTACLG-------   87 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~~--------------------~~~~~~E~~~l~~l~h~nIv~~~~~~~~-------   87 (381)
                      .++|...+.||+|+||.||++....                    .+.+.+|++++++++||||+++++....       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            4789999999999999999885321                    2458899999999999999984332110       


Q ss_pred             ----ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757           88 ----VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS  163 (381)
Q Consensus        88 ----~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~  163 (381)
                          .........++||||+ +++|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+
T Consensus       121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~  188 (352)
T 2jii_A          121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDV--------SPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAE  188 (352)
T ss_dssp             CCCEEEEETTTEEEEEEECC-CEEHHHHHHH--------SGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGG
T ss_pred             chhhccccCCcEEEEEecCC-CcCHHHHHHh--------CCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHH
Confidence                0012367889999999 9999999953        12367999999999999999999999   669999999999


Q ss_pred             CeeeCCCC--CeEEeecccceecCCCCCcc-----cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757          164 NVLLDDDM--TARVGDFGLARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS  236 (381)
Q Consensus       164 Nill~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf  236 (381)
                      ||+++.++  .+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999988  89999999998765432211     112246999999999999989999999999999999999999998


Q ss_pred             CccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                      .........+.....        .+..... .....      .       ......+..+.+++.+||+.||.+|||+.+
T Consensus       269 ~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  326 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQ--------KFVDKPG-PFVGP------C-------GHWIRPSETLQKYLKVVMALTYEEKPPYAM  326 (352)
T ss_dssp             GGGTTCHHHHHHHHH--------HHHHSCC-CEECT------T-------SCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             ccCCcCHHHHHHHHH--------hccCChh-hhhhh------c-------cccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence            633221111111100        0000000 00000      0       000123567899999999999999999999


Q ss_pred             HHHHHHHhhhhcCCCCCccc
Q 041757          317 VVHELQSIKNTLLGPKNLAT  336 (381)
Q Consensus       317 vl~~L~~i~~~~~~~~~~~~  336 (381)
                      |++.|+++.+..........
T Consensus       327 l~~~L~~~~~~~~~~~~~~~  346 (352)
T 2jii_A          327 LRNNLEALLQDLRVSPYDPI  346 (352)
T ss_dssp             HHHHHHHHHHHTTCCTTSCC
T ss_pred             HHHHHHHHHHhcCCCcCccc
Confidence            99999999888765544333

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.9e-42  Score=326.15  Aligned_cols=232  Identities=21%  Similarity=0.261  Sum_probs=179.5

Q ss_pred             cccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           39 LEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      ...++||+|+||.||++..                 ...+.+.+|+++|++++||||+++++++     ...+..++|||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E  166 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVME  166 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEe
Confidence            3367899999999988641                 2457789999999999999999999995     44778999999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee--CCCCCeEEeecc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL--DDDMTARVGDFG  179 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill--~~~~~~kl~Dfg  179 (381)
                      |+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+|||+  +.++.+||+|||
T Consensus       167 ~~~~~~L~~~l~---------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG  234 (373)
T 2x4f_A          167 YVDGGELFDRII---------DESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFG  234 (373)
T ss_dssp             CCTTCEEHHHHH---------HTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred             CCCCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCC
Confidence            999999999885         23456899999999999999999999   6699999999999999  667799999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      +++.........   ...||+.|+|||++.+..++.++|||||||++|||++|..||...    .....         +.
T Consensus       235 ~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~---------~~  298 (373)
T 2x4f_A          235 LARRYKPREKLK---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD----NDAET---------LN  298 (373)
T ss_dssp             SCEECCTTCBCC---CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS----SHHHH---------HH
T ss_pred             CceecCCccccc---cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC----CHHHH---------HH
Confidence            998876543322   245999999999999889999999999999999999999997522    11111         11


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .++.........                .....+..+.+++.+||+.||.+|||+.++++
T Consensus       299 ~i~~~~~~~~~~----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          299 NILACRWDLEDE----------------EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHHHTCCCSCSG----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHhccCCCChh----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111111110000                01234567899999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-42  Score=325.14  Aligned_cols=264  Identities=17%  Similarity=0.206  Sum_probs=183.7

Q ss_pred             hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-cc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQ   91 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~   91 (381)
                      ..+.++|...+.||+|+||.||++..                   ...+.+.+|+++|+.++||||+++++++.... ..
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence            44678899999999999999987641                   12467889999999999999999999975421 11


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+ +++|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~  165 (367)
T 1cm8_A          101 DFTDFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDC  165 (367)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTC
T ss_pred             cCceEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCC
Confidence            234569999999 889999984           246889999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      .+||+|||+++......     ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..    ......+.
T Consensus       166 ~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~----~~~~~~l~  236 (367)
T 1cm8_A          166 ELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG----SDHLDQLK  236 (367)
T ss_dssp             CEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHH
T ss_pred             CEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC----CCHHHHHH
Confidence            99999999998765432     22568999999998877 6799999999999999999999999752    22221111


Q ss_pred             HH--HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KM--ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..  .......+++..............................+..+.+++.+||..||.+|||+.++++
T Consensus       237 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            11  0111111111110000000000000000000000112234567899999999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-42  Score=314.06  Aligned_cols=238  Identities=22%  Similarity=0.309  Sum_probs=181.4

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ..++|...++||+|+||.||++..                  ...+.+.+|++++++++||||+++++++     .+...
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence            457899999999999999987541                  2357889999999999999999999995     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee---CCCCC
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMT  172 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~  172 (381)
                      .++||||+++|+|.+++....      .....+++..++.++.|++.||.|||   +.+|+||||||+||++   +.++.
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~  165 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQ------ARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSP  165 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhh------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCC
Confidence            999999999999999985321      22467899999999999999999999   6699999999999999   45678


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +||+|||++..........   ...||+.|+|||++. ..++.++||||||+++|+|++|..||....     ....   
T Consensus       166 ~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-----~~~~---  233 (285)
T 3is5_A          166 IKIIDFGLAELFKSDEHST---NAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-----LEEV---  233 (285)
T ss_dssp             EEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH---
T ss_pred             EEEEeeecceecCCcccCc---CcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-----HHHH---
Confidence            9999999998665433222   245899999999876 468899999999999999999999985321     1111   


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                               ........+....             .....+..+.+++.+||+.||.+|||+.|+++
T Consensus       234 ---------~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          234 ---------QQKATYKEPNYAV-------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---------HHHHHHCCCCCCC---------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---------HhhhccCCccccc-------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     1100000000000             00113457889999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.7e-42  Score=332.95  Aligned_cols=239  Identities=18%  Similarity=0.169  Sum_probs=187.7

Q ss_pred             ccccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...++||+|+||+||+++..                    ....+.+|+.++..++||||++++++|     .+.
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  146 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD  146 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence            4678999999999999999887521                    122378899999999999999999995     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++|||||++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~---------~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~v  214 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLS---------KFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHI  214 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHH---------TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             CEEEEEEecCCCCcHHHHHH---------HccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCE
Confidence            88999999999999999995         22467999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      ||+|||+++.......... ...+||+.|+|||++.     ...++.++|||||||++|||++|+.||...    .....
T Consensus       215 kL~DFGla~~~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~----~~~~~  289 (437)
T 4aw2_A          215 RLADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVET  289 (437)
T ss_dssp             EECCCTTCEECCTTSCEEC-CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHH
T ss_pred             EEcchhhhhhcccCCCccc-ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC----ChhHH
Confidence            9999999987655433222 2357999999999987     567899999999999999999999998522    11111


Q ss_pred             HHHHHhhchHHHHHhhhhc-cCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILL-NDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQD--RMKMTNVVH  319 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~  319 (381)
                      + .        .++..... .-+..                ....+.++.+++.+||..+|++  ||++.|+++
T Consensus       290 ~-~--------~i~~~~~~~~~p~~----------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          290 Y-G--------KIMNHKERFQFPTQ----------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             H-H--------HHHTHHHHCCCCSS----------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             H-H--------hhhhccccccCCcc----------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1 1        11110000 00000                0124567888999999888888  999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.1e-42  Score=315.03  Aligned_cols=245  Identities=20%  Similarity=0.280  Sum_probs=194.2

Q ss_pred             ccccccccc-eecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           34 VSRNMLEEN-LISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        34 ~~~~~~~~~-~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      ..++|...+ .||+|+||.||++.                     ....+.+.+|+++++.++||||+++++++      
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~------   87 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC------   87 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE------
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE------
Confidence            356788887 99999999998862                     11256789999999999999999999995      


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      ..+..++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~  154 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQH  154 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred             CCCCcEEEEEeCCCCCHHHHHH----------hCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCC
Confidence            2456899999999999999994          3456899999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~  249 (381)
                      .+||+|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.....     ...
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~  229 (291)
T 1xbb_A          155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEV  229 (291)
T ss_dssp             EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHH
T ss_pred             cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHH
Confidence            99999999998775543321 1122346789999999988889999999999999999999 9999753211     111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  329 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~  329 (381)
                      .         ..+......                  ..+..++..+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus       230 ~---------~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          230 T---------AMLEKGERM------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             H---------HHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             H---------HHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            1         111100000                  0012456688999999999999999999999999999977653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-42  Score=332.64  Aligned_cols=236  Identities=18%  Similarity=0.188  Sum_probs=186.6

Q ss_pred             ccccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...++||+|+||+||+++..                    ..+.+.+|+.+++.++||||+++++++     .+.
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            4678999999999999999886521                    223477899999999999999999995     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++|||||++|+|.+++.           ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~-----------~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~i  207 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL  207 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCE
Confidence            88999999999999999984           235899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCc----cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE----VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      ||+|||+++......... ....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...    ... ..
T Consensus       208 kL~DFG~a~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~-~~  281 (410)
T 3v8s_A          208 KLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLV-GT  281 (410)
T ss_dssp             EECCCTTCEECCTTSEEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS----SHH-HH
T ss_pred             EEeccceeEeeccCCccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC----Chh-hH
Confidence            999999998776543222 12367999999999987655    889999999999999999999998521    111 11


Q ss_pred             HHHHhhchHHHHHhhhhc-cCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILL-NDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQD--RMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~vl~  319 (381)
                      ..        .++..... .-+.                 ....+..+.+++.+||..+|.+  ||++.||++
T Consensus       282 ~~--------~i~~~~~~~~~p~-----------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          282 YS--------KIMNHKNSLTFPD-----------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HH--------HHHTHHHHCCCCT-----------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HH--------HHHhccccccCCC-----------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            11        11110000 0000                 0134567889999999999988  999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.7e-41  Score=310.63  Aligned_cols=236  Identities=20%  Similarity=0.320  Sum_probs=184.1

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .+.|...+.||+|+||.||++..                   ...+.+.+|+.++++++||||+++++++... ......
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCce
Confidence            34478889999999999987641                   2346788999999999999999999986532 234677


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeeccCCCCeeeC-CCCC
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV--TAHCVLKPSNVLLD-DDMT  172 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivHrDlkp~Nill~-~~~~  172 (381)
                      .++||||+++|+|.+++.          ....+++..++.++.|++.||.|||   +.+  |+||||||+||+++ .++.
T Consensus       104 ~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~  170 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGS  170 (290)
T ss_dssp             EEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSC
T ss_pred             EEEEEEecCCCCHHHHHH----------HccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCC
Confidence            899999999999999994          4466899999999999999999999   557  99999999999997 7889


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +||+|||++.........    ...||+.|+|||++.+ .++.++||||||+++|+|++|..||...    .........
T Consensus       171 ~kl~Dfg~~~~~~~~~~~----~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~  241 (290)
T 1t4h_A          171 VKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYRR  241 (290)
T ss_dssp             EEECCTTGGGGCCTTSBE----ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHHH
T ss_pred             EEEeeCCCcccccccccc----cccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCc----CcHHHHHHH
Confidence            999999999755443222    2458999999998865 5899999999999999999999997522    111111111


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .....           .+.               ......+..+.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~-----------~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          242 VTSGV-----------KPA---------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HTTTC-----------CCG---------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhccC-----------Ccc---------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11000           000               001123457889999999999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-43  Score=326.79  Aligned_cols=237  Identities=20%  Similarity=0.297  Sum_probs=178.9

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCC--CcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRH--RNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~~   93 (381)
                      ..+.|...+.||+|+||.||++..                  ...+.+.+|+.+|.+++|  |||+++++++     ...
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~   81 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITD   81 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeC
Confidence            467799999999999999987631                  134678899999999986  9999999995     447


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||| +.+++|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++ ++.+
T Consensus        82 ~~~~lv~e-~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~  146 (343)
T 3dbq_A           82 QYIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGML  146 (343)
T ss_dssp             SEEEEEEC-CCSEEHHHHHH----------HSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEE
T ss_pred             CEEEEEEe-CCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcE
Confidence            78999999 56889999994          4567899999999999999999999   66999999999999997 5789


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCC-----------CccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----------NEVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      ||+|||+++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||..... 
T Consensus       147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-  225 (343)
T 3dbq_A          147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-  225 (343)
T ss_dssp             EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-
T ss_pred             EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-
Confidence            9999999987755443322333569999999999754           6788999999999999999999999853211 


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                        ....         ...+++.......                  +...+..+.+++.+||+.||.+|||+.++++.
T Consensus       226 --~~~~---------~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          226 --QISK---------LHAIIDPNHEIEF------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             --HHHH---------HHHHHCTTSCCCC------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHH---------HHHHhcCCcccCC------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence              1111         1111111110000                  11223568899999999999999999999863

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-41  Score=310.32  Aligned_cols=236  Identities=19%  Similarity=0.259  Sum_probs=187.8

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ..++|...+.||+|+||.||++..                   ...+.+.+|+.++++++||||+++++++     ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   78 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence            478999999999999999988631                   1346788999999999999999999995     4577


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC--
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT--  172 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~--  172 (381)
                      ..++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.  
T Consensus        79 ~~~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~  145 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGA  145 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTC
T ss_pred             EEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCC
Confidence            8899999999999999883          4466899999999999999999999   669999999999999976654  


Q ss_pred             -eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 -ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                       +||+|||++..........   ...||+.|+|||++.+..++.++||||||+++|+|++|..||...    .. .....
T Consensus       146 ~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~-~~~~~  217 (284)
T 3kk8_A          146 AVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQ-HRLYA  217 (284)
T ss_dssp             CEEECCCTTCEECCSSCBCC---CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SH-HHHHH
T ss_pred             cEEEeeceeeEEcccCcccc---CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC----ch-hHHHH
Confidence             9999999998765543322   246999999999999999999999999999999999999997522    11 11111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .        +..........                .....+..+.+++.+||+.||.+|||+.|+++
T Consensus       218 ~--------~~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          218 Q--------IKAGAYDYPSP----------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             H--------HHHTCCCCCTT----------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             H--------HHhccccCCch----------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0        00000000000                01134567889999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=317.09  Aligned_cols=258  Identities=21%  Similarity=0.262  Sum_probs=186.7

Q ss_pred             ccccccccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccC---CCcccceeeeeccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIR---HRNLIKVLTACLGV   88 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~   88 (381)
                      ..++|...++||+|+||+||++...                      ....+.+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3678999999999999999887521                      1347788888888775   99999999997653


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                      ........++||||+. |+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+||+++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~  154 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDK--------APPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVT  154 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHT--------CCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEc
Confidence            2222336899999997 599999953        22334899999999999999999999   66999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      .++.+||+|||+++.........   ...||+.|+|||++.+..++.++|||||||++|+|++|+.||...    .....
T Consensus       155 ~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~  227 (308)
T 3g33_A          155 SGGTVKLADFGLARIYSYQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN----SEADQ  227 (308)
T ss_dssp             TTSCEEECSCSCTTTSTTCCCSG---GGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS----SHHHH
T ss_pred             CCCCEEEeeCccccccCCCcccC---CccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHH
Confidence            99999999999998665433322   256899999999999989999999999999999999999997532    11111


Q ss_pred             HHHHHhhchHHHHHhhhhccCchh---h----hhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEK---L----VVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...         +...........   .    ................+..+..+.+++.+||+.||.+|||+.|+++
T Consensus       228 ~~~---------i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          228 LGK---------IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHH---------HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHH---------HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            111         111000000000   0    0000000000111122345678899999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.4e-42  Score=320.90  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=191.6

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      ..++|...+.||+|+||.||++..                       .....+.+|+.++++++||||+++++++.    
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----  103 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----  103 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc----
Confidence            357899999999999999988651                       23467889999999999999999999954    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-  169 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-  169 (381)
                       .....++||||+++|+|.+++.......   .....+++..++.++.|++.||.|||   +.+|+||||||+||+++. 
T Consensus       104 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A          104 -QSLPRFILMELMAGGDLKSFLRETRPRP---SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTSCCS---SSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCS
T ss_pred             -CCCCcEEEEecCCCCcHHHHHHhhcccc---cccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecC
Confidence             4667899999999999999996432110   12356899999999999999999999   669999999999999984 


Q ss_pred             --CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcH
Q 041757          170 --DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL  246 (381)
Q Consensus       170 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~  246 (381)
                        +..+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....     .
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~  251 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----N  251 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-----H
Confidence              44699999999976544332222223457899999999988889999999999999999998 999975221     1


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      .....         .+........                  +..++..+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       252 ~~~~~---------~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          252 QEVLE---------FVTSGGRMDP------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHHHH---------HHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH---------HHhcCCCCCC------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            11111         1110000000                  12345678899999999999999999999999998876


Q ss_pred             hc
Q 041757          327 TL  328 (381)
Q Consensus       327 ~~  328 (381)
                      ..
T Consensus       305 ~~  306 (327)
T 2yfx_A          305 DP  306 (327)
T ss_dssp             CH
T ss_pred             CH
Confidence            43

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.8e-42  Score=317.06  Aligned_cols=258  Identities=20%  Similarity=0.261  Sum_probs=182.5

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...+.||+|+||+||++..                  ...+.+.+|++++++++||||+++++++     ...+..+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRLV   76 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeEE
Confidence            5788999999999999988642                  1246788999999999999999999995     4467899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++ +|.+++.         .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D  143 (288)
T 1ob3_A           77 LVFEHLDQ-DLKKLLD---------VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIAD  143 (288)
T ss_dssp             EEEECCSE-EHHHHHH---------TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEecCC-CHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeE
Confidence            99999976 9999885         23466899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||+++.........  ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+ .+..........
T Consensus       144 fg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  220 (288)
T 1ob3_A          144 FGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTP  220 (288)
T ss_dssp             TTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             CccccccCcccccc--ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCC
Confidence            99998765432211  12458999999999876 458999999999999999999999985321100 001111000000


Q ss_pred             hHHHH--HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDI--VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .....  +......++..     ...............+.++.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          221 NSKNWPNVTELPKYDPNF-----TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTTSTTGGGSTTCCTTC-----CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Chhhchhhhccccccccc-----ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000  00000000000     000000000111234567889999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-42  Score=328.48  Aligned_cols=186  Identities=23%  Similarity=0.335  Sum_probs=148.7

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...++||+|+||.||++..                   ...+.+.+|+.+|.++. ||||+++++++..   .+.
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence            457899999999999999988631                   23466789999999997 9999999999653   345


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++|||||+ ++|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~  148 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIR-----------ANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHV  148 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHH-----------HTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCE
T ss_pred             CEEEEEecccC-cCHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCE
Confidence            57899999997 59999884           246889999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCC-------------------cccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCC
Q 041757          174 RVGDFGLARFLPPTRT-------------------QTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIRE  233 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~  233 (381)
                      ||+|||+++.......                   .......+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus       149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  228 (388)
T 3oz6_A          149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK  228 (388)
T ss_dssp             EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence            9999999987643111                   111223579999999999876 67899999999999999999999


Q ss_pred             CCCC
Q 041757          234 KPSD  237 (381)
Q Consensus       234 ~Pf~  237 (381)
                      .||.
T Consensus       229 ~pf~  232 (388)
T 3oz6_A          229 PIFP  232 (388)
T ss_dssp             CSCC
T ss_pred             CCCC
Confidence            9975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.6e-42  Score=317.77  Aligned_cols=255  Identities=21%  Similarity=0.387  Sum_probs=196.4

Q ss_pred             cccccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...+.||+|+||.||+++                     ....+.+.+|++++++++||||+++++++..   ...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence            5679999999999999998764                     1235678999999999999999999998653   234


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++++|.+++.         .....+++..++.++.|++.||.|||   ..+|+||||||+||+++.++.+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~  184 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQ---------KHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRV  184 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHH---------HSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEE
T ss_pred             CceEEEEECCCCCCHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcE
Confidence            57899999999999999995         23356899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||....      ..+...
T Consensus       185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~------~~~~~~  258 (326)
T 2w1i_A          185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRM  258 (326)
T ss_dssp             EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH------HHHHHH
T ss_pred             EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH------HHHHHh
Confidence            999999998876543221 1122447888999999988889999999999999999999999964211      111111


Q ss_pred             Hhhc--------hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          253 ALSN--------HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       253 ~~~~--------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ....        .+.+.+.....                  ...+..++.++.+++.+||+.||.+|||+.+|++.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          259 IGNDKQGQMIVFHLIELLKNNGR------------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HCTTCCTHHHHHHHHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hccccchhhhHHHHHHHhhcCCC------------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1000        01111111000                  001234567899999999999999999999999999999


Q ss_pred             hhhc
Q 041757          325 KNTL  328 (381)
Q Consensus       325 ~~~~  328 (381)
                      .+.+
T Consensus       321 ~~~l  324 (326)
T 2w1i_A          321 RDQM  324 (326)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            8764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-41  Score=314.38  Aligned_cols=248  Identities=16%  Similarity=0.147  Sum_probs=183.7

Q ss_pred             hhccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      -..-++|...++||+|+||.||++..                    ...+.+.+|+.++++++||||+++++++.     
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----  104 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----  104 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----
Confidence            33457899999999999999988641                    12367889999999999999999999954     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      ..+..++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~  171 (309)
T 2h34_A          105 IDGQLYVDMRLINGVDLAAMLR----------RQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADD  171 (309)
T ss_dssp             ETTEEEEEEECCCCEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTS
T ss_pred             eCCeEEEEEEecCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCC
Confidence            4778999999999999999994          3456899999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      .+||+|||++.......... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.....     ...  
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~--  243 (309)
T 2h34_A          172 FAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----SVM--  243 (309)
T ss_dssp             CEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----HHH--
T ss_pred             CEEEecCccCcccccccccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----HHH--
Confidence            99999999997665433221 1124689999999999998999999999999999999999999852210     000  


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhhc
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-KMTNVVHELQSIKNTL  328 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~vl~~L~~i~~~~  328 (381)
                             ...+..... .+               ......++..+.+++.+||+.||++|| |+.++++.|++.....
T Consensus       244 -------~~~~~~~~~-~~---------------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          244 -------GAHINQAIP-RP---------------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             -------HHHHHSCCC-CG---------------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             -------HHHhccCCC-Cc---------------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                   011110000 00               001124556788999999999999999 9999999999886654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-42  Score=315.78  Aligned_cols=241  Identities=26%  Similarity=0.333  Sum_probs=185.6

Q ss_pred             cccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYE  101 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e  101 (381)
                      .++|...+.||+|+||.||+++             ....+.+.+|++++++++||||+++++++.    ...+..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceEEEEe
Confidence            5789999999999999998864             224678999999999999999999999864    23457899999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLA  181 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~  181 (381)
                      |+++++|.+++..        .....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           96 YMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             CCTTEEHHHHHHH--------HHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             cCCCCCHHHHHHh--------cccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccc
Confidence            9999999999952        11233788999999999999999999   669999999999999999999999999998


Q ss_pred             eecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          182 RFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      .........     ..+++.|+|||++.+..++.++||||||+++|+|++ |..||......     ...         .
T Consensus       165 ~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~---------~  225 (278)
T 1byg_A          165 KEASSTQDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVV---------P  225 (278)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHH---------H
T ss_pred             ccccccccC-----CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH---------H
Confidence            765433221     347889999999988889999999999999999998 99998532111     000         0


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      .+.......                  .+..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       226 ~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          226 RVEKGYKMD------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHTTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCC------------------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            010000000                  0124556889999999999999999999999999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-41  Score=328.22  Aligned_cols=236  Identities=19%  Similarity=0.209  Sum_probs=177.6

Q ss_pred             ccccccccceecCCCceEEEecccc-------------------------cHHHHHHHHHHHHccCCCcccceeeeeccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-------------------------AFKSFIAECKALRNIRHRNLIKVLTACLGV   88 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~   88 (381)
                      ..++|...++||+|+||+||++...                         ....+.+|+.+|++++||||+++++++.  
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--  210 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--  210 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence            3577999999999999999886421                         1124789999999999999999999853  


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                          .+..++||||+++|+|.+++          .....+++..+..++.|++.||.|||   +.+|+||||||+|||++
T Consensus       211 ----~~~~~lv~e~~~~g~L~~~l----------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~  273 (419)
T 3i6u_A          211 ----AEDYYIVLELMEGGELFDKV----------VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLS  273 (419)
T ss_dssp             ----SSEEEEEEECCTTCBGGGGT----------SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEES
T ss_pred             ----cCceEEEEEcCCCCcHHHHH----------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEe
Confidence                34579999999999999998          34567999999999999999999999   66999999999999997


Q ss_pred             CCC---CeEEeecccceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          169 DDM---TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       169 ~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      .++   .+||+|||+++.........   ...||+.|+|||++.+   ..++.++|||||||++|+|++|..||......
T Consensus       274 ~~~~~~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  350 (419)
T 3i6u_A          274 SQEEDCLIKITDFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  350 (419)
T ss_dssp             SSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred             cCCCcceEEEeecccceecCCCcccc---ccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence            544   59999999998765433222   2569999999999863   56889999999999999999999998633221


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . .+.....           .......                .......+..+.+++.+||+.||.+|||+.++++
T Consensus       351 ~-~~~~~i~-----------~~~~~~~----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          351 V-SLKDQIT-----------SGKYNFI----------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             C-CHHHHHH-----------TTCCCCC----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H-HHHHHHh-----------cCCCCCC----------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1 1111100           0000000                0112235567899999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.7e-42  Score=312.46  Aligned_cols=244  Identities=24%  Similarity=0.364  Sum_probs=194.1

Q ss_pred             ccccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeeccccc----------
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY----------   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----------   90 (381)
                      ..++|...+.||+|+||.||++...             ..+.+.+|++++++++||||+++++++...++          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            4578999999999999999887521             23568899999999999999999998654211          


Q ss_pred             -cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           91 -QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        91 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                       ......++||||+++|+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEK--------RRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHH--------GGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEE
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcC
Confidence             224568999999999999999953        22356899999999999999999999   669999999999999999


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      ++.+||+|||++..........   ...||+.|+|||++.+..++.++||||||+++|+|++|..||...       .. 
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~-  226 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SK-  226 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HH-
T ss_pred             CCCEEECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HH-
Confidence            9999999999998776543322   245899999999999989999999999999999999999885210       00 


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                             ....+....+                      ....+..+.+++.+||+.||.+|||+.++++.|..+.+..
T Consensus       227 -------~~~~~~~~~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          227 -------FFTDLRDGII----------------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             -------HHHHHHTTCC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             -------HHHHhhcccc----------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                   0111111110                      0123456788999999999999999999999999987654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.9e-42  Score=336.02  Aligned_cols=252  Identities=20%  Similarity=0.257  Sum_probs=190.2

Q ss_pred             cccccccccccchhhhhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCc
Q 041757           17 GSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRN   77 (381)
Q Consensus        17 g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~n   77 (381)
                      |.++...+.+-....-...+.|...++||+|+||+||++..                   .....+.+|+.+|+.++|||
T Consensus        18 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn   97 (494)
T 3lij_A           18 GDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN   97 (494)
T ss_dssp             GGCCCCGGGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTT
T ss_pred             ceeccchhheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCC
Confidence            44444444443333334556799999999999999987642                   23567899999999999999


Q ss_pred             ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 041757           78 LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH  157 (381)
Q Consensus        78 Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  157 (381)
                      |+++++++     .+....++|||||++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+|
T Consensus        98 iv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH  159 (494)
T 3lij_A           98 IMKLYDFF-----EDKRNYYLVMECYKGGELFDEII----------HRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVH  159 (494)
T ss_dssp             BCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             CCeEEEEE-----EeCCEEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcee
Confidence            99999995     45778999999999999999883          4466899999999999999999999   669999


Q ss_pred             eccCCCCeeeCCC---CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCC
Q 041757          158 CVLKPSNVLLDDD---MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK  234 (381)
Q Consensus       158 rDlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~  234 (381)
                      |||||+|||++..   +.+||+|||++..........   ...||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus       160 ~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~  235 (494)
T 3lij_A          160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYP  235 (494)
T ss_dssp             SCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC---CCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc---ccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCC
Confidence            9999999999764   459999999998775543322   2569999999998864 69999999999999999999999


Q ss_pred             CCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH
Q 041757          235 PSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM  314 (381)
Q Consensus       235 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  314 (381)
                      ||....    . .....        .+..........                .....+..+.+++.+||+.||.+|||+
T Consensus       236 pf~~~~----~-~~~~~--------~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~R~s~  286 (494)
T 3lij_A          236 PFGGQT----D-QEILR--------KVEKGKYTFDSP----------------EWKNVSEGAKDLIKQMLQFDSQRRISA  286 (494)
T ss_dssp             SSCCSS----H-HHHHH--------HHHHTCCCCCSG----------------GGTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCCCC----H-HHHHH--------HHHhCCCCCCch----------------hcccCCHHHHHHHHHHCCCChhhCccH
Confidence            985221    1 11111        111110000000                012345678899999999999999999


Q ss_pred             HHHHH
Q 041757          315 TNVVH  319 (381)
Q Consensus       315 ~~vl~  319 (381)
                      .++++
T Consensus       287 ~e~l~  291 (494)
T 3lij_A          287 QQALE  291 (494)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.7e-43  Score=322.68  Aligned_cols=250  Identities=20%  Similarity=0.319  Sum_probs=183.6

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...++||+|+||.||++..                    .....+.+|+.++++++||||+++++++.... ...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence            468899999999999999987651                    12457889999999999999999999975421 122


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~  155 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAV  155 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCE
T ss_pred             cccEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCE
Confidence            34599999999999999994          3456899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...    .........
T Consensus       156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~----~~~~~~~~~  231 (311)
T 3ork_A          156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----SPVSVAYQH  231 (311)
T ss_dssp             EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHH
T ss_pred             EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHH
Confidence            99999999876543221 1222356899999999999999999999999999999999999998522    111111100


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHHHHhhh
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV-HELQSIKN  326 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl-~~L~~i~~  326 (381)
                                   .......            ........+.++.+++.+||+.||.+||++.+++ ..+.++..
T Consensus       232 -------------~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          232 -------------VREDPIP------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             -------------HHCCCCC------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             -------------hcCCCCC------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                         0000000            0000123556789999999999999999766554 56655544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.9e-42  Score=329.03  Aligned_cols=235  Identities=20%  Similarity=0.286  Sum_probs=178.5

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC--CCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR--HRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .++|...++||+|+||.||++..                  ...+.+.+|+.+|++++  ||||+++++++.     ..+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~  129 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ  129 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence            45699999999999999987631                  23467899999999996  599999999954     467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||| +.+++|.+++.          ....+++..++.++.||+.||.|||   +.+|+||||||+|||++ ++.+|
T Consensus       130 ~~~lv~E-~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~k  194 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLK  194 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHH----------HCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEE
T ss_pred             EEEEEEe-cCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEE
Confidence            7999999 66889999994          3457888999999999999999999   67999999999999996 57899


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCC-----------CccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  243 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~  243 (381)
                      |+|||+++.+.............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....  
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--  272 (390)
T 2zmd_A          195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--  272 (390)
T ss_dssp             ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--
T ss_pred             EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--
Confidence            999999987654433222233569999999998865           3688999999999999999999999853211  


Q ss_pred             CcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          244 MNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        ....        +..+++.......                  +...+..+.+++.+||+.||.+|||+.++++
T Consensus       273 --~~~~--------~~~~~~~~~~~~~------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          273 --QISK--------LHAIIDPNHEIEF------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             --HHHH--------HHHHHCTTSCCCC------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHH--------HHHHhCccccCCC------------------CccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence              1110        1111111111000                  0112456889999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.9e-42  Score=313.90  Aligned_cols=234  Identities=21%  Similarity=0.271  Sum_probs=188.8

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...++||+|+||.||++..                    ...+.+.+|+.+++.++||||+++++++     ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccC
Confidence            457899999999999999987542                    2356788999999999999999999995     447


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~  154 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHK----------RRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV  154 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCE
T ss_pred             CEEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCE
Confidence            78999999999999999983          4457899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||++..........  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....    . .....  
T Consensus       155 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~-~~~~~--  225 (294)
T 2rku_A          155 KIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----L-KETYL--  225 (294)
T ss_dssp             EECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS----H-HHHHH--
T ss_pred             EEEeccCceecccCcccc--ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----H-HHHHH--
Confidence            999999998765433222  12468999999999998889999999999999999999999985221    1 11100  


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                            .+...    ...                .+...+..+.+++.+||+.||++|||+.++++.
T Consensus       226 ------~~~~~----~~~----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          226 ------RIKKN----EYS----------------IPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ------HHHTT----CCC----------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------HHhhc----cCC----------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  00000    000                011334578889999999999999999999873

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=316.44  Aligned_cols=228  Identities=20%  Similarity=0.206  Sum_probs=177.7

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||+||++..                   .....+.+|+..+.++ +||||++++++|.     ..+.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            6799999999999999988642                   1233556677666666 8999999999954     4788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+ +++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl  198 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCE---------AWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKL  198 (311)
T ss_dssp             EEEEEECC-CCBHHHHHH---------HHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEE
T ss_pred             EEEEEecc-CCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEE
Confidence            99999999 679999885         23456999999999999999999999   569999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++..........   ...||+.|+|||++.+ .++.++|||||||++|||++|..||...    ..          
T Consensus       199 ~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~----------  260 (311)
T 3p1a_A          199 GDFGLLVELGTAGAGE---VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EG----------  260 (311)
T ss_dssp             CCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HH----------
T ss_pred             ccceeeeecccCCCCc---ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cH----------
Confidence            9999998765443322   2458999999999876 7899999999999999999997765311    00          


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        ...+.....                  ....+...+.++.+++.+||+.||++|||+.++++
T Consensus       261 --~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          261 --WQQLRQGYL------------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --HHHHTTTCC------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --HHHHhccCC------------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              011111000                  00112345678999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.5e-42  Score=323.91  Aligned_cols=245  Identities=11%  Similarity=0.044  Sum_probs=194.1

Q ss_pred             ccccccccceecCCCceEEEecc-------------------cccHHHHHHHHHHHHccC---CCcccceeeeecccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-------------------QGAFKSFIAECKALRNIR---HRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-------------------~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~   91 (381)
                      ..++|...++||+|+||+||++.                   ......+.+|++++..++   |+||+++++++.     
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~-----  137 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL-----  137 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-----
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeee-----
Confidence            45779999999999999999982                   224567889999999987   999999999954     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC--
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD--  169 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~--  169 (381)
                      ..+..++|||||++|+|.+++.....     .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.  
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKN-----TPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHT-----STTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGG
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhc-----ccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccc
Confidence            46788999999999999999953211     13466999999999999999999999   679999999999999988  


Q ss_pred             ---------CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccc
Q 041757          170 ---------DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF  240 (381)
Q Consensus       170 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~  240 (381)
                               ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence                     89999999999986653333333334679999999999999999999999999999999999999985332


Q ss_pred             cCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCC-CCHHHHHH
Q 041757          241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDR-MKMTNVVH  319 (381)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~~vl~  319 (381)
                      .+....                ...+...                     .....+.+++..|++.+|.+| |++.++.+
T Consensus       290 ~~~~~~----------------~~~~~~~---------------------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          290 GGECKP----------------EGLFRRL---------------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             TTEEEE----------------CSCCTTC---------------------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             CCceee----------------chhcccc---------------------CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            211000                0000000                     113355677789999999999 68888999


Q ss_pred             HHHHhhhhc
Q 041757          320 ELQSIKNTL  328 (381)
Q Consensus       320 ~L~~i~~~~  328 (381)
                      .|+++....
T Consensus       333 ~l~~~l~~~  341 (365)
T 3e7e_A          333 KLKKVFQQH  341 (365)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHh
Confidence            998887653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9e-42  Score=316.28  Aligned_cols=253  Identities=21%  Similarity=0.217  Sum_probs=182.5

Q ss_pred             cccccc-cceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCce
Q 041757           35 SRNMLE-ENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~-~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .+.|.+ +++||+|+||.||++..                 ...+.+.+|++++.++ +||||+++++++.     ..+.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence            467777 47899999999988641                 2367899999999995 7999999999954     4778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC---
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT---  172 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~---  172 (381)
                      .++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   
T Consensus        86 ~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~  152 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIH----------KRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSP  152 (316)
T ss_dssp             EEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCS
T ss_pred             EEEEEEcCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCc
Confidence            999999999999999994          3456899999999999999999999   669999999999999988765   


Q ss_pred             eEEeecccceecCCCCC-----cccccCccCccceeCCCCcCC-----CccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          173 ARVGDFGLARFLPPTRT-----QTSSIDVKGSIGYIAPEYGVG-----NEVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      +||+|||++........     ........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......
T Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  232 (316)
T 2ac3_A          153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS  232 (316)
T ss_dssp             EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence            99999999876543221     111112458999999999875     56889999999999999999999999754433


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +..+....  ........+...........            ........+..+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~--~~~~~~~~~~~~i~~~~~~~------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          233 DCGWDRGE--ACPACQNMLFESIQEGKYEF------------PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CSCC------CCHHHHHHHHHHHHHCCCCC------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccccc--cchhHHHHHHHHHhccCccc------------CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            22111100  00000011111111110000            00001234567899999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.2e-41  Score=314.46  Aligned_cols=264  Identities=19%  Similarity=0.189  Sum_probs=191.7

Q ss_pred             ccccccccceecCCCceEEEecc--------------cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR--------------QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~--------------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..++|...++||+|+||+||++.              ....+.+.+|+.++++++ ||||+++++++..   ......++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~l  110 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPAL  110 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceEE
Confidence            35789999999999999998874              234678999999999997 9999999999653   23667899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEee
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVGD  177 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~D  177 (381)
                      ||||+.+++|.+++.             .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++ .+||+|
T Consensus       111 v~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~D  174 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLID  174 (330)
T ss_dssp             EEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEe
Confidence            999999999999883             3788899999999999999999   66999999999999999776 899999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||+++.........   ...|+..|+|||++.+ ..++.++|||||||++|+|++|..||.........+..........
T Consensus       175 fg~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~  251 (330)
T 3nsz_A          175 WGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  251 (330)
T ss_dssp             CTTCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             CCCceEcCCCCccc---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence            99998765543322   2458999999999877 6789999999999999999999999843222111122222222222


Q ss_pred             hHHHHHhhhhccC-chhhhhccc--c-h-hhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLND-DEKLVVRGD--Q-K-QTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~-~~~~~~~~~--~-~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...+.++...... +........  . . ............+.++.+++.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2222222211100 000000000  0 0 000000011224668899999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.5e-42  Score=337.32  Aligned_cols=237  Identities=22%  Similarity=0.293  Sum_probs=189.2

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .++|...++||+|+||.||++..                    .....+.+|+++|+.++||||+++++++     .+.+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence            46799999999999999988642                    2345678999999999999999999994     4578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++..        .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~--------~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vK  326 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYH--------MGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIR  326 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHS--------SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeE
Confidence            89999999999999999853        12345899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++.........   ..+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+...  
T Consensus       327 L~DFGla~~~~~~~~~~---~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~--  400 (576)
T 2acx_A          327 ISDLGLAVHVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERL--  400 (576)
T ss_dssp             ECCCTTCEECCTTCCEE---CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHH--
T ss_pred             EEecccceecccCcccc---ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHH--
Confidence            99999998875543222   2469999999999999999999999999999999999999986432211 11111111  


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                             +..   ....                .+...+.++.+++.+||+.||.+||     ++.||++
T Consensus       401 -------i~~---~~~~----------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          401 -------VKE---VPEE----------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -------HHH---CCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -------hhc---cccc----------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                   110   0000                0123456788999999999999999     7788875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-41  Score=334.58  Aligned_cols=240  Identities=23%  Similarity=0.301  Sum_probs=189.8

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .++|...++||+|+||.||++..                    ...+.+.+|+++|++++||||+++++++     .+..
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCC
Confidence            47799999999999999988642                    2346788999999999999999999994     5578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++|+|.+++....      .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~------~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vk  329 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVD------EDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVR  329 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSS------TTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEEeccCCCHHHHHHHhh------cccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEE
Confidence            8999999999999999985321      12456899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++.+.......  ...+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+..   
T Consensus       330 L~DFGla~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~---  403 (543)
T 3c4z_A          330 ISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQ---  403 (543)
T ss_dssp             ECCCTTCEECCTTCCCB--CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHH---
T ss_pred             EeecceeeeccCCCccc--ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHH---
Confidence            99999998776543322  22579999999999999999999999999999999999999986432211 1111111   


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM-----TNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~vl~  319 (381)
                               ..+.....                .+...+..+.+++.+||+.||.+||++     .+|++
T Consensus       404 ---------~i~~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          404 ---------RVLEQAVT----------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---------HHHHCCCC----------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---------HHhhcccC----------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                     11111000                012345678899999999999999975     56653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=322.55  Aligned_cols=226  Identities=24%  Similarity=0.321  Sum_probs=186.4

Q ss_pred             ccccccccceecCCCceEEEecccc-------------------------cHHHHHHHHHHHHccCCCcccceeeeeccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-------------------------AFKSFIAECKALRNIRHRNLIKVLTACLGV   88 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~   88 (381)
                      ..++|...++||+|+||.||++...                         ..+.+.+|+.+|++++||||+++++++   
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            4678999999999999999887411                         223567899999999999999999995   


Q ss_pred             cccCCceEEEEEEcccCC-CHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           89 DYQGNDFKALVYEFMHNR-SLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                        .+.+..++||||+.+| +|.+++          .....+++..++.++.|++.||.|||   ..+|+||||||+||++
T Consensus        99 --~~~~~~~lv~e~~~~g~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll  163 (335)
T 3dls_A           99 --ENQGFFQLVMEKHGSGLDLFAFI----------DRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVI  163 (335)
T ss_dssp             --ECSSEEEEEEECCTTSCBHHHHH----------HTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             --eeCCEEEEEEEeCCCCccHHHHH----------HhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEE
Confidence              4578899999999777 999999          34567999999999999999999999   6699999999999999


Q ss_pred             CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                      +.++.+||+|||+++..........   ..||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....     
T Consensus       164 ~~~~~~kL~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----  235 (335)
T 3dls_A          164 AEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----  235 (335)
T ss_dssp             CTTSCEEECCCTTCEECCTTCCBCE---ECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----
T ss_pred             cCCCcEEEeecccceECCCCCceec---cCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----
Confidence            9999999999999987765443222   459999999999988776 8899999999999999999999853111     


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                    ........                    +...+..+.+++.+||+.||.+|||+.++++
T Consensus       236 --------------~~~~~~~~--------------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          236 --------------TVEAAIHP--------------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             --------------GTTTCCCC--------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------HHhhccCC--------------------CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                          00000000                    1123457889999999999999999999987

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-42  Score=326.21  Aligned_cols=241  Identities=18%  Similarity=0.217  Sum_probs=186.6

Q ss_pred             hccccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEE
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ...++|...+.||+|+||.||++...             ......+|++++.++ +||||+++++++     .+....++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~l   93 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYV   93 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEE
Confidence            34678999999999999999886521             123456899999998 699999999994     55788999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC----CCeE
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD----MTAR  174 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~----~~~k  174 (381)
                      |||||++|+|.+++.          ....+++..+..++.||+.||.|||   +.+|+||||||+||++...    +.+|
T Consensus        94 v~E~~~gg~L~~~i~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~k  160 (342)
T 2qr7_A           94 VTELMKGGELLDKIL----------RQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIR  160 (342)
T ss_dssp             EECCCCSCBHHHHHH----------TCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEE
T ss_pred             EEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEE
Confidence            999999999999993          4567999999999999999999999   6699999999999998443    3599


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++.........  ...+||+.|+|||++.+..++.++|||||||++|+|++|..||....  ......+.    
T Consensus       161 l~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~~----  232 (342)
T 2qr7_A          161 ICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP--DDTPEEIL----  232 (342)
T ss_dssp             ECCCTTCEECBCTTCCB--CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST--TSCHHHHH----
T ss_pred             EEECCCcccCcCCCCce--eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC--cCCHHHHH----
Confidence            99999998765443222  22568999999999988889999999999999999999999986321  11111111    


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              ..........   .         .......+..+.+++.+||+.||.+|||+.++++
T Consensus       233 --------~~i~~~~~~~---~---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          233 --------ARIGSGKFSL---S---------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --------HHHHHCCCCC---C---------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------HHHccCCccc---C---------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    1111110000   0         0001234567889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.8e-42  Score=320.48  Aligned_cols=233  Identities=21%  Similarity=0.279  Sum_probs=188.7

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...++||+|+||.||++..                    ...+.+.+|+.+++.++||||+++++++     .+.
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence            457899999999999999987641                    2356788999999999999999999995     447


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  180 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHK----------RRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV  180 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCE
T ss_pred             CeEEEEEecCCCCCHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCE
Confidence            78999999999999999983          4467899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||++..........  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....     ......  
T Consensus       181 kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~--  251 (335)
T 2owb_A          181 KIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKETYL--  251 (335)
T ss_dssp             EECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHH--
T ss_pred             EEeeccCceecccCcccc--cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-----HHHHHH--
Confidence            999999998765433222  12568999999999999889999999999999999999999985221     111100  


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            .+...    ...                .+......+.+++.+||+.||++|||+.++++
T Consensus       252 ------~~~~~----~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          252 ------RIKKN----EYS----------------IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ------HHHHT----CCC----------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ------HHhcC----CCC----------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00000    000                01133456888999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-41  Score=324.61  Aligned_cols=248  Identities=16%  Similarity=0.160  Sum_probs=182.0

Q ss_pred             hcccccccc-ceecCCCceEEEecccc------------cHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEE
Q 041757           33 DVSRNMLEE-NLISAGTFGFSHLRRQG------------AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        33 ~~~~~~~~~-~~lG~G~fg~V~~~~~~------------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ...++|... ++||+|+||+||++...            ....+.+|+.++.++ +||||+++++++... ..+....++
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~~l  136 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCLLI  136 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEEEE
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEEEE
Confidence            345667765 78999999999887532            246788999998554 799999999986431 233667899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CCCeEE
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DMTARV  175 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl  175 (381)
                      |||||++|+|.+++..        .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||
T Consensus       137 v~E~~~gg~L~~~l~~--------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          137 VMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             EEECCCSEEHHHHHHC--------C---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEeCCCCcHHHHHHH--------hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEE
Confidence            9999999999999953        12346899999999999999999999   669999999999999987   789999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+++.........   ..+||+.|+|||++.+..++.++|||||||++|||++|..||............       
T Consensus       206 ~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------  275 (400)
T 1nxk_A          206 TDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------  275 (400)
T ss_dssp             CCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH-------
T ss_pred             EecccccccCCCCccc---cCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH-------
Confidence            9999998765433222   256899999999999999999999999999999999999998643222110000       


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                        ...+....... +.               .....++.++.+++.+||+.||++|||+.++++.
T Consensus       276 --~~~i~~~~~~~-~~---------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          276 --KTRIRMGQYEF-PN---------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             --HHHHHHTCCCC-CT---------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --HHHHHcCcccC-CC---------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              00000000000 00               0012345678899999999999999999999973

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.9e-42  Score=321.05  Aligned_cols=258  Identities=21%  Similarity=0.310  Sum_probs=184.9

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      -++|...++||+|+||.||++..                   ...+.+.+|+.++++++||||+++++++.     ....
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence            46799999999999999987642                   12456789999999999999999999954     4778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++++|.+++          .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        99 ~~lv~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl  165 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLE----------LFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKL  165 (331)
T ss_dssp             EEEEEECCSEEHHHHHH----------HSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecCCcchHHHHH----------hhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEE
Confidence            99999999999999887          34567999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH-
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-  253 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~-  253 (381)
                      +|||+++..........  ...||+.|+|||++.+. .++.++|||||||++|+|++|+.||...    .......... 
T Consensus       166 ~Dfg~~~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~  239 (331)
T 4aaa_A          166 CDFGFARTLAAPGEVYD--DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD----SDIDQLYHIMM  239 (331)
T ss_dssp             CCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHH
T ss_pred             EeCCCceeecCCccccC--CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHH
Confidence            99999986654332221  24589999999998875 7899999999999999999999997532    2211111111 


Q ss_pred             -hhc---hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 -LSN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 -~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       ...   ..............   ................+.++..+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          240 CLGNLIPRHQELFNKNPVFAG---VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHCSCCHHHHHHHHHCGGGTT---CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HhCCCChhhhhHhhhcccccc---ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             000   01111111000000   0000000000011112245678999999999999999999999886

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=318.47  Aligned_cols=254  Identities=19%  Similarity=0.242  Sum_probs=193.3

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++|...+.||+|+||.||++..                 ...+.+.+|+++++.++||||+++++++... .......
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCcee
Confidence            357899999999999999987652                 2456788999999999999999999997531 1235678


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++||||+++|+|.+++....      .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLK------DKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCcHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEE
Confidence            99999999999999995322      23567899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcc-------cccCccCccceeCCCCcCCCc---cCcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          177 DFGLARFLPPTRTQT-------SSIDVKGSIGYIAPEYGVGNE---VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                      |||++..........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||..........
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  256 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV  256 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence            999987654321110       001134799999999987643   6899999999999999999999985322221111


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      ..            .+........                  ....+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       257 ~~------------~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          257 AL------------AVQNQLSIPQ------------------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HH------------HHHCC--CCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hH------------HhhccCCCCc------------------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            11            1111000000                  12345678999999999999999999999999998864


Q ss_pred             h
Q 041757          327 T  327 (381)
Q Consensus       327 ~  327 (381)
                      .
T Consensus       307 ~  307 (317)
T 2buj_A          307 P  307 (317)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=328.34  Aligned_cols=238  Identities=18%  Similarity=0.169  Sum_probs=185.8

Q ss_pred             ccccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...++||+|+||.||+++..                    ..+.+.+|..++..++||||+++++++     .+.
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence            4688999999999999999886521                    223478899999999999999999994     557


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..|+||||+++|+|.+++..         ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~v  201 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSK---------FGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHI  201 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH---------HSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             CEEEEEEcCCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCE
Confidence            889999999999999999952         2347899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcC-------CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                      ||+|||+++......... ....+||+.|+|||++.       ...++.++|||||||++|||++|+.||...    ...
T Consensus       202 kL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~  276 (412)
T 2vd5_A          202 RLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD----STA  276 (412)
T ss_dssp             EECCCTTCEECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS----SHH
T ss_pred             EEeechhheeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC----CHH
Confidence            999999998776543322 12357999999999987       457899999999999999999999998522    111


Q ss_pred             HHHHHHHhhchHHHHHhhhh-ccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 041757          247 HKFAKMALSNHVKDIVDSIL-LNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDR---MKMTNVVH  319 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~~vl~  319 (381)
                      ..+ .        .++.... ...+                ......+.++.+++.+||. +|.+|   |++.++++
T Consensus       277 ~~~-~--------~i~~~~~~~~~p----------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          277 ETY-G--------KIVHYKEHLSLP----------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHH-H--------HHHTHHHHCCCC--------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHH-H--------HHHhcccCcCCC----------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            111 1        1111000 0000                0012355688999999999 99998   58888875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.4e-42  Score=342.52  Aligned_cols=244  Identities=24%  Similarity=0.370  Sum_probs=193.5

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...++||+|+||.||++..               ...+.|.+|+++|++++||||+++++++.      .+..++|
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~~~~lv  339 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIV  339 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe------eccceEe
Confidence            46788899999999999987642               23478999999999999999999999953      2568999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      |||+++|+|.+++..        .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       340 ~e~~~~gsL~~~l~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             ECCCTTEEHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             eehhcCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            999999999999952        12345889999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      +++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||....    . ....        
T Consensus       409 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~----~-~~~~--------  474 (535)
T 2h8h_A          409 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----N-REVL--------  474 (535)
T ss_dssp             STTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC----H-HHHH--------
T ss_pred             cceecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----H-HHHH--------
Confidence            99866532211 1112347889999999988899999999999999999999 999975321    1 1111        


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                       ..+......                  ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       475 -~~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          475 -DQVERGYRM------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             -HHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             -HHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence             001100000                  001245678899999999999999999999999999886554

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-41  Score=308.57  Aligned_cols=241  Identities=19%  Similarity=0.247  Sum_probs=188.5

Q ss_pred             cccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      .++|...+.||+|+||.||++...                       ..+.+.+|+.++++++||||+++++++     .
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~   78 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----E   78 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----c
Confidence            467999999999999999886421                       367899999999999999999999995     4


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~  145 (283)
T 3bhy_A           79 NKTDVVLILELVSGGELFDFLA----------EKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKN  145 (283)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSS
T ss_pred             CCCeEEEEEeecCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCC
Confidence            4778999999999999999994          3456899999999999999999999   66999999999999998877


Q ss_pred             ----CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          172 ----TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       172 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                          .+||+|||++..........   ...|++.|+|||++.+..++.++||||||+++|+|++|..||....    ...
T Consensus       146 ~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~  218 (283)
T 3bhy_A          146 VPNPRIKLIDFGIAHKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET----KQE  218 (283)
T ss_dssp             SSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHH
T ss_pred             CCCCceEEEecccceeccCCCccc---ccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc----hHH
Confidence                89999999998765443222   2458999999999998899999999999999999999999975321    111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH--ELQSIK  325 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~--~L~~i~  325 (381)
                      . ..        .+.......                ........+..+.+++.+||+.||.+|||+.++++  .++.+.
T Consensus       219 ~-~~--------~~~~~~~~~----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          219 T-LT--------NISAVNYDF----------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             H-HH--------HHHTTCCCC----------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             H-HH--------HhHhcccCC----------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            1 00        000000000                00112244567889999999999999999999997  455543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.3e-41  Score=343.42  Aligned_cols=232  Identities=19%  Similarity=0.230  Sum_probs=187.8

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...++||+|+||.||++..                    ...+.+..|..+|..+ +||||++++++     +.+.
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~~  414 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTM  414 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBCS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEeC
Confidence            35789999999999999987642                    2345678899999998 69999999999     5668


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..|+||||+++|+|.+++.          ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~i  481 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQ----------QVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI  481 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCE
T ss_pred             CEEEEEEeCcCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcE
Confidence            88999999999999999994          4467999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...    ..        
T Consensus       482 kL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~----~~--------  547 (674)
T 3pfq_A          482 KIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DE--------  547 (674)
T ss_dssp             EECCCTTCEECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----SH--------
T ss_pred             EEeecceeeccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC----CH--------
Confidence            99999999865433322  22367999999999999999999999999999999999999998522    11        


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKM-----TNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~vl~  319 (381)
                           .+++...+.....                ++...+.++.+|+.+||+.||.+||++     .+|++
T Consensus       548 -----~~~~~~i~~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          548 -----DELFQSIMEHNVA----------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -----HHHHHHHHSSCCC----------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -----HHHHHHHHhCCCC----------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                 1122222211110                012345678999999999999999998     66654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=315.93  Aligned_cols=251  Identities=20%  Similarity=0.225  Sum_probs=179.3

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccC-CCcccceeeeecccc---ccC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVD---YQG   92 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~---~~~   92 (381)
                      ...+|...++||+|+||.||++..                 ...+.+.+|+.++.++. ||||+++++++....   ...
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            456899999999999999988652                 23567889999999996 999999999974211   134


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeeccCCCCeeeCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV--TAHCVLKPSNVLLDDD  170 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivHrDlkp~Nill~~~  170 (381)
                      ....++||||+. |+|.+++...       .....+++..++.++.|++.||.|||   ..+  |+||||||+||+++.+
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKM-------ESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHH-------HTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTT
T ss_pred             CceEEEEEEecC-CCHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCC
Confidence            566899999995 6999988532       13456999999999999999999999   557  9999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcc----------cccCccCccceeCCCCc---CCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          171 MTARVGDFGLARFLPPTRTQT----------SSIDVKGSIGYIAPEYG---VGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      +.+||+|||+++.........          ......||+.|+|||++   .+..++.++||||||+++|+|++|+.||.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            999999999998765432211          11124589999999998   56678999999999999999999999985


Q ss_pred             ccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757          238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV  317 (381)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v  317 (381)
                      .....                 .++.......+                  ....+..+.+++.+||+.||.+|||+.++
T Consensus       255 ~~~~~-----------------~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~  299 (337)
T 3ll6_A          255 DGAKL-----------------RIVNGKYSIPP------------------HDTQYTVFHSLIRAMLQVNPEERLSIAEV  299 (337)
T ss_dssp             ----------------------------CCCCT------------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred             chhHH-----------------HhhcCcccCCc------------------ccccchHHHHHHHHHccCChhhCcCHHHH
Confidence            22110                 01111111000                  01223357789999999999999999999


Q ss_pred             HHHHHHhhhhcCC
Q 041757          318 VHELQSIKNTLLG  330 (381)
Q Consensus       318 l~~L~~i~~~~~~  330 (381)
                      ++.|+.+......
T Consensus       300 l~~l~~~~~~~~~  312 (337)
T 3ll6_A          300 VHQLQEIAAARNV  312 (337)
T ss_dssp             HHHHHHHHHHTTC
T ss_pred             HHHHHHHHhccCC
Confidence            9999999876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.4e-41  Score=331.97  Aligned_cols=236  Identities=21%  Similarity=0.253  Sum_probs=186.2

Q ss_pred             hccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ...++|...++||+|+||+||++..                   .....+.+|+++|++++||||+++++++     ...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcC
Confidence            3567899999999999999987642                   2456789999999999999999999995     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC---CC
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD---DD  170 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~---~~  170 (381)
                      ...++|||||.+|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||+++   .+
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~  160 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEII----------KRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKD  160 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTT
T ss_pred             CEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCC
Confidence            88999999999999999983          4467899999999999999999999   66999999999999995   45


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +.+||+|||+++.........   ...||+.|+|||++.+ .++.++|||||||++|+|++|..||...    ... ...
T Consensus       161 ~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~-~~~  231 (486)
T 3mwu_A          161 CDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK----NEY-DIL  231 (486)
T ss_dssp             CCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHH-HHH
T ss_pred             CCEEEEECCcCeECCCCCccC---CCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC----CHH-HHH
Confidence            679999999998665443222   2469999999999876 5899999999999999999999998522    111 111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .        .+.........                +.....+..+.+++.+||+.||.+|||+.++++
T Consensus       232 ~--------~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          232 K--------RVETGKYAFDL----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             H--------HHHHTCCCSCS----------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             H--------HHHhCCCCCCC----------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1        11111000000                001234567889999999999999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.6e-42  Score=343.94  Aligned_cols=237  Identities=20%  Similarity=0.289  Sum_probs=185.6

Q ss_pred             cceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           41 ENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++||+|+||.||++.                     ....+.+.+|+++|++++|||||+++++|.      .+..++|
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv  447 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLV  447 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEE
Confidence            3589999999998751                     112578999999999999999999999963      3457899


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      ||||++|+|.+++.          ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       448 ~E~~~~g~L~~~l~----------~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFG  514 (635)
T 4fl3_A          448 MEMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFG  514 (635)
T ss_dssp             EECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred             EEccCCCCHHHHHh----------hCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcC
Confidence            99999999999994          4567899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhch
Q 041757          180 LARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       180 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      +++.+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....     ...        
T Consensus       515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~--------  581 (635)
T 4fl3_A          515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEV--------  581 (635)
T ss_dssp             HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHH--------
T ss_pred             CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHH--------
Confidence            99877554321 12222446889999999998899999999999999999998 9999753211     111        


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                       ...+......                  ..+..++.++.+++.+||+.||++|||+.+|++.|+++...+
T Consensus       582 -~~~i~~~~~~------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          582 -TAMLEKGERM------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             -HHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -HHHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence             1111110000                  012346678999999999999999999999999999887654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.1e-41  Score=306.58  Aligned_cols=231  Identities=22%  Similarity=0.315  Sum_probs=178.5

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .++|...+.||+|+||.||++..                    ...+.+.+|+.+++.++||||+++++++     ...+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence            47899999999999999988642                    1245788999999999999999999995     4477


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~  151 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYIC----------KHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAK  151 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeccCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEE
Confidence            8999999999999999994          3456899999999999999999999   56999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||++..........   ...|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...     ........ 
T Consensus       152 l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~-  222 (276)
T 2h6d_A          152 IADFGLSNMMSDGEFLR---TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-----HVPTLFKK-  222 (276)
T ss_dssp             ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH-
T ss_pred             EeecccccccCCCccee---cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHH-
Confidence            99999998765433222   2458999999999988765 68999999999999999999998522     11111110 


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              +.......                   +...+..+.+++.+||+.||.+|||+.++++
T Consensus       223 --------~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          223 --------IRGGVFYI-------------------PEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             --------HHHCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------hhcCcccC-------------------chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                    00000000                   1123457889999999999999999999987

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.7e-42  Score=321.21  Aligned_cols=231  Identities=23%  Similarity=0.309  Sum_probs=182.4

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .+.|...+.||+|+||+||++..                    ...+.+.+|++++++++||||+++++++.     ..+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REH  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence            45689999999999999987641                    12357889999999999999999999964     467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+. |+|.+++.         .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus       128 ~~~lv~e~~~-g~l~~~l~---------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k  194 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVK  194 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEE
T ss_pred             eEEEEEecCC-CCHHHHHH---------HhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence            8999999997 68888874         23457899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      |+|||++.......      ...||+.|+|||++.   ...++.++|||||||++|||++|+.||...    ....... 
T Consensus       195 L~DfG~a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~----~~~~~~~-  263 (348)
T 1u5q_A          195 LGDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALY-  263 (348)
T ss_dssp             ECCCTTCBSSSSBC------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHH-
T ss_pred             EeeccCceecCCCC------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----ChHHHHH-
Confidence            99999997654321      246999999999874   567899999999999999999999997522    1111111 


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                              .+....   .+..               .....+..+.+++.+||+.||.+|||+.++++.
T Consensus       264 --------~~~~~~---~~~~---------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          264 --------HIAQNE---SPAL---------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             --------HHHHSC---CCCC---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --------HHHhcC---CCCC---------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                    111100   0000               001334568889999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.1e-41  Score=331.05  Aligned_cols=236  Identities=20%  Similarity=0.292  Sum_probs=186.3

Q ss_pred             hccccccccceecCCCceEEEeccc------------------------------ccHHHHHHHHHHHHccCCCccccee
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ------------------------------GAFKSFIAECKALRNIRHRNLIKVL   82 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~------------------------------~~~~~~~~E~~~l~~l~h~nIv~~~   82 (381)
                      .+.++|...++||+|+||+||++..                              ...+.+.+|+.+|++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3568899999999999999987541                              2246788999999999999999999


Q ss_pred             eeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           83 TACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        83 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                      +++     .+....++|||||++|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||
T Consensus       113 ~~~-----~~~~~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp  174 (504)
T 3q5i_A          113 DVF-----EDKKYFYLVTEFYEGGELFEQII----------NRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKP  174 (504)
T ss_dssp             EEE-----ECSSEEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred             EEE-----EcCCEEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcH
Confidence            995     45788999999999999999983          4566999999999999999999999   66999999999


Q ss_pred             CCeeeCCCC---CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcc
Q 041757          163 SNVLLDDDM---TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM  239 (381)
Q Consensus       163 ~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~  239 (381)
                      +||+++.++   .+||+|||++..........   ...||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus       175 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             GGEEESSTTCCSSEEECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEEecCCCCccEEEEECCCCEEcCCCCccc---cccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999998775   69999999998776543322   2469999999999874 6899999999999999999999998522


Q ss_pred             ccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          240 FEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .    . ..            ++.........            .........+..+.+++.+||+.||.+|||+.++++
T Consensus       251 ~----~-~~------------~~~~i~~~~~~------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          251 N----D-QD------------IIKKVEKGKYY------------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             S----H-HH------------HHHHHHHCCCC------------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C----H-HH------------HHHHHHcCCCC------------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1    1 11            11111111000            000011234567899999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-41  Score=320.73  Aligned_cols=262  Identities=19%  Similarity=0.215  Sum_probs=186.9

Q ss_pred             hhhhccccccccceecCCCceEEEecccc---------------------------cHHHHHHHHHHHHccCCCccccee
Q 041757           30 EILDVSRNMLEENLISAGTFGFSHLRRQG---------------------------AFKSFIAECKALRNIRHRNLIKVL   82 (381)
Q Consensus        30 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~---------------------------~~~~~~~E~~~l~~l~h~nIv~~~   82 (381)
                      ++....++|...++||+|+||.||++...                           ..+.+.+|++++++++||||++++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   95 (362)
T 3pg1_A           16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR   95 (362)
T ss_dssp             HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence            34456899999999999999999886421                           127899999999999999999999


Q ss_pred             eeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           83 TACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        83 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                      +++...+.......++||||+. |+|.+++.         .....+++..+..++.|++.||.|||   +.+|+||||||
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  162 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---------DQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHP  162 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCS-EEHHHHHH---------CTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred             eeEEeccCCCcceEEEEEccCC-CCHHHHHH---------hcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCCh
Confidence            9976533345567899999997 58888885         34457899999999999999999999   66999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCcccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFE  241 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~  241 (381)
                      +||+++.++.+||+|||+++.........   ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTADANKT---HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             HHEEEcCCCCEEEEecCcccccccccccc---eecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999997554433222   2458999999998876 6789999999999999999999999853211


Q ss_pred             CCCcHHHHHHHHhhchHHHH-----------HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCC
Q 041757          242 GDMNLHKFAKMALSNHVKDI-----------VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQD  310 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~-----------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~  310 (381)
                      . ................+.           +.......+           ........+.....+.+++.+||+.||.+
T Consensus       240 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~  307 (362)
T 3pg1_A          240 Y-NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP-----------ARAWTAVVPTADPVALDLIAKMLEFNPQR  307 (362)
T ss_dssp             H-HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCC-----------CCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred             H-HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCC-----------hhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence            0 011111111111111111           111110000           00011122344567899999999999999


Q ss_pred             CCCHHHHHH
Q 041757          311 RMKMTNVVH  319 (381)
Q Consensus       311 RPs~~~vl~  319 (381)
                      |||+.++++
T Consensus       308 Rpt~~ell~  316 (362)
T 3pg1_A          308 RISTEQALR  316 (362)
T ss_dssp             SCCHHHHHT
T ss_pred             CCCHHHHHc
Confidence            999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.6e-42  Score=323.89  Aligned_cols=264  Identities=17%  Similarity=0.191  Sum_probs=173.6

Q ss_pred             hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccc-ccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGV-DYQ   91 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~   91 (381)
                      ..+.++|...+.||+|+||.||++..                   ...+.+.+|+++|+.++||||+++++++... ...
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            44568999999999999999988741                   1346788999999999999999999997542 122


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....++||||+ +++|.+++.           ...+++..+..++.||+.||.|||   +.+|+||||||+||+++.++
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~  169 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC  169 (367)
T ss_dssp             GCCCCEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred             cCCeEEEEeccc-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCC
Confidence            346689999999 789998883           256899999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      .+||+|||+++......     ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..    ......+.
T Consensus       170 ~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~----~~~~~~l~  240 (367)
T 2fst_X          170 ELKILDFGLARHTADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLK  240 (367)
T ss_dssp             CEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHH
T ss_pred             CEEEeeccccccccccC-----CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC----CCHHHHHH
Confidence            99999999998654321     22568999999999877 6789999999999999999999999752    22211111


Q ss_pred             H--HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 K--MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~--~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .  ........+.+.................................+.+|+.+||..||.+|||+.++++
T Consensus       241 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          241 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            1  11111111111110000000000000000000011111234567899999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.4e-41  Score=308.88  Aligned_cols=238  Identities=20%  Similarity=0.288  Sum_probs=184.0

Q ss_pred             ccccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..++|...+.||+|+||.||++..                     ...+.+.+|++++++++||||+++++++..   ..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   79 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EE   79 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C-
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CC
Confidence            357899999999999999987642                     124678899999999999999999999642   34


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+.++ |.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        80 ~~~~~lv~e~~~~~-l~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~  147 (305)
T 2wtk_C           80 KQKMYMVMEYCVCG-MQEMLDS--------VPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGT  147 (305)
T ss_dssp             --CEEEEEECCSEE-HHHHHHH--------STTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred             CCeEEEEehhccCC-HHHHHHh--------CcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCc
Confidence            66789999999876 7777743        23456899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCc--cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE--VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +||+|||++................||+.|+|||++.+..  ++.++||||||+++|+|++|..||...     ......
T Consensus       148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~  222 (305)
T 2wtk_C          148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-----NIYKLF  222 (305)
T ss_dssp             EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHH
T ss_pred             EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHH
Confidence            9999999998775433333333356899999999987643  478999999999999999999998521     111111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                  .........                .+..++..+.+++.+||+.||.+|||+.++++
T Consensus       223 ------------~~i~~~~~~----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          223 ------------ENIGKGSYA----------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             ------------HHHHHCCCC----------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------HHHhcCCCC----------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                        111000000                01234567889999999999999999999996

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-41  Score=312.02  Aligned_cols=247  Identities=24%  Similarity=0.315  Sum_probs=187.8

Q ss_pred             hhccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGV   88 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~   88 (381)
                      ....++|...+.||+|+||+||++..                       ...+.+.+|++++++++||||+++++++.. 
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   92 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   92 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-
Confidence            33468899999999999999987641                       134678899999999999999999999642 


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                          . ..++||||+++++|.+++.         .....+++..+..++.|++.||.|||   +.+++||||||+||+++
T Consensus        93 ----~-~~~~v~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~  155 (291)
T 1u46_A           93 ----P-PMKMVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLA  155 (291)
T ss_dssp             ----S-SCEEEEECCTTCBHHHHHH---------HHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEE
T ss_pred             ----C-CceeeEecccCCCHHHHHH---------hccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEc
Confidence                2 3789999999999999995         23456899999999999999999999   66999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL  246 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~  246 (381)
                      .++.+||+|||++.......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||....     .
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~  230 (291)
T 1u46_A          156 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----G  230 (291)
T ss_dssp             ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----H
T ss_pred             CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-----H
Confidence            99999999999998776543221 1122457888999999988889999999999999999999 999975221     1


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      ..            ++..........              ..+..++..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       231 ~~------------~~~~~~~~~~~~--------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          231 SQ------------ILHKIDKEGERL--------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HH------------HHHHHHTSCCCC--------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HH------------HHHHHHccCCCC--------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            11            111111000000              0012455688999999999999999999999999998764


Q ss_pred             h
Q 041757          327 T  327 (381)
Q Consensus       327 ~  327 (381)
                      .
T Consensus       285 ~  285 (291)
T 1u46_A          285 T  285 (291)
T ss_dssp             -
T ss_pred             c
Confidence            3

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.1e-41  Score=319.30  Aligned_cols=286  Identities=16%  Similarity=0.194  Sum_probs=196.4

Q ss_pred             EccCCccccccccccccccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHc
Q 041757            9 DVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRN   72 (381)
Q Consensus         9 ~~~~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~   72 (381)
                      ++.++.-.|..|..++.+.       .++|...++||+|+||+||++..                ...+.+.+|+++++.
T Consensus        17 ~~~~~~~~~~~~~~~g~~~-------~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~   89 (397)
T 1wak_A           17 DPNDYCKGGYHLVKIGDLF-------NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKS   89 (397)
T ss_dssp             -----CC--CCSSCTTCEE-------TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHH
T ss_pred             ccccCCCCCceEEehhhhc-------CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHH
Confidence            3445555566666555543       58899999999999999988742                235678899999999


Q ss_pred             cC--------CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHH
Q 041757           73 IR--------HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASAL  144 (381)
Q Consensus        73 l~--------h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l  144 (381)
                      ++        |+||+++++++... .......++||||+ +++|.+++..        .....+++..++.++.||+.||
T Consensus        90 l~~~~~~~~~~~~iv~~~~~~~~~-~~~~~~~~lv~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL  159 (397)
T 1wak_A           90 VRNSDPNDPNREMVVQLLDDFKIS-GVNGTHICMVFEVL-GHHLLKWIIK--------SNYQGLPLPCVKKIIQQVLQGL  159 (397)
T ss_dssp             HHHSCTTCGGGGGBCCEEEEEEEE-ETTEEEEEEEECCC-CCBHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHH
T ss_pred             HhhcCCCCCCcceeeeeecceeec-CCCCceEEEEEecc-CccHHHHHHh--------cccCCCCHHHHHHHHHHHHHHH
Confidence            95        78899999986531 12466889999999 6677777642        2235689999999999999999


Q ss_pred             HHhhcCCCC-CceeeccCCCCeeeCCCC-------------------------------------------------CeE
Q 041757          145 NYLHHDCQP-VTAHCVLKPSNVLLDDDM-------------------------------------------------TAR  174 (381)
Q Consensus       145 ~~LH~~~~~-~ivHrDlkp~Nill~~~~-------------------------------------------------~~k  174 (381)
                      .|||   +. +|+||||||+|||++.++                                                 .+|
T Consensus       160 ~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k  236 (397)
T 1wak_A          160 DYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK  236 (397)
T ss_dssp             HHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEE
T ss_pred             HHHH---HhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceE
Confidence            9999   66 999999999999998775                                                 799


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH--HH--H
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH--KF--A  250 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~--~~--~  250 (381)
                      |+|||++........     ...||+.|+|||++.+..++.++|||||||++|||++|+.||...........  ..  .
T Consensus       237 l~DfG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  311 (397)
T 1wak_A          237 IADLGNACWVHKHFT-----EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI  311 (397)
T ss_dssp             ECCGGGCEETTBCSC-----SCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHH
T ss_pred             eccccccccccccCc-----cCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHH
Confidence            999999987654321     24689999999999998999999999999999999999999874433222111  10  0


Q ss_pred             HHHhhchHHHHH-hhhhc-----cCchhh-hhccc----chhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMALSNHVKDIV-DSILL-----NDDEKL-VVRGD----QKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~-~~~l~-----~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..........++ .....     ...... .....    .................+.+|+.+||+.||++|||+.|+++
T Consensus       312 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          312 IELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            001111111111 00000     000000 00000    00000011223567788999999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.1e-42  Score=312.87  Aligned_cols=241  Identities=22%  Similarity=0.275  Sum_probs=186.7

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .++|...+.||+|+||.||++..                   ...+.+.+|+.++++++||||+++++++..   .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence            57899999999999999987642                   234678899999999999999999998653   34667


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC-----ceeeccCCCCeeeCCC
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPV-----TAHCVLKPSNVLLDDD  170 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivHrDlkp~Nill~~~  170 (381)
                      .++||||+++++|.+++....      .....+++..++.++.|++.||.|||+   .+     |+||||||+||+++.+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~  152 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGK  152 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSS
T ss_pred             EEEEEeCCCCCCHHHHHHhhc------ccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCC
Confidence            899999999999999995321      123458999999999999999999994   46     9999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +.+||+|||++..........  ....|++.|+|||++.+..++.++||||||+++|+|++|..||....     .....
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~  225 (279)
T 2w5a_A          153 QNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKELA  225 (279)
T ss_dssp             SCEEECCCCHHHHC---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH
T ss_pred             CCEEEecCchheeeccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-----HHHHH
Confidence            999999999998765432211  12458999999999998889999999999999999999999975321     11111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                      .        .+.......                   .+..++..+.+++.+||+.||.+|||+.+|++.+
T Consensus       226 ~--------~i~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          226 G--------KIREGKFRR-------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             H--------HHHHTCCCC-------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             H--------HHhhccccc-------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            1        111110000                   0123456789999999999999999999999854

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=320.94  Aligned_cols=261  Identities=18%  Similarity=0.243  Sum_probs=180.2

Q ss_pred             ccccccceecCCCceEEEecccc------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...++||+|+||+||++...                  ....+.+|++++++++||||+++++++     ......+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence            57899999999999999887521                  111345799999999999999999995     4577899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||++ |+|.+++.         .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~D  143 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLD---------DCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLAD  143 (324)
T ss_dssp             EEEECCS-EEHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECS
T ss_pred             EEecccc-cCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEcc
Confidence            9999997 59999885         33456899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||+++..........  ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ........ ...
T Consensus       144 fg~a~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~-~~~  219 (324)
T 3mtl_A          144 FGLARAKSIPTKTYD--NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRI-LGT  219 (324)
T ss_dssp             SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH-HCC
T ss_pred             CcccccccCCccccc--cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-hCC
Confidence            999986544322211  2458999999999876 568999999999999999999999985321110 00111110 000


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .............. .......................++.+++.+||+.||.+|||+.|+++
T Consensus       220 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          220 PTEETWPGILSNEE-FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCTTTSTTGGGCHH-HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CChHhchhhhcchh-hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000000000000 000000000000111112345567889999999999999999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.6e-41  Score=310.46  Aligned_cols=235  Identities=20%  Similarity=0.264  Sum_probs=189.7

Q ss_pred             hccccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ...+.|...+.||+|+||.||++.                  ....+.+.+|+.++++++||||+++++++.     ...
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   93 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDT   93 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCC
Confidence            356779999999999999998863                  124578999999999999999999999954     467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++.           ...+++..++.++.|++.||.|||   ..+|+||||||+||+++.++.+|
T Consensus        94 ~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k  159 (303)
T 3a7i_A           94 KLWIIMEYLGGGSALDLLE-----------PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVK  159 (303)
T ss_dssp             EEEEEEECCTTEEHHHHHT-----------TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred             eEEEEEEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEE
Confidence            8999999999999999983           346899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||++..........  ....||+.|+|||++.+..++.++||||||+++|+|++|..||....    .. ....   
T Consensus       160 l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~-~~~~---  229 (303)
T 3a7i_A          160 LADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH----PM-KVLF---  229 (303)
T ss_dssp             ECCCTTCEECBTTBCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HH-HHHH---
T ss_pred             EeecccceecCcccccc--CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC----HH-HHHH---
Confidence            99999998765443222  22568999999999999899999999999999999999999975221    11 1000   


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                            .+.......                  ....++..+.+++.+||+.||.+|||+.++++.
T Consensus       230 ------~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          230 ------LIPKNNPPT------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ------HHHHSCCCC------------------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ------HhhcCCCCC------------------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                  000000000                  011345578899999999999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.1e-41  Score=311.12  Aligned_cols=236  Identities=19%  Similarity=0.258  Sum_probs=185.9

Q ss_pred             hccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ...++|...++||+|+||.||++..                 ...+.+.+|+.++++++||||+++++++     .....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   80 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTH   80 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCE
Confidence            3467899999999999999987642                 1345688999999999999999999995     45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee---CCCCC
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDDMT  172 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~  172 (381)
                      .++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~  147 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRIL----------ERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSK  147 (304)
T ss_dssp             EEEEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCC
T ss_pred             EEEEEEcCCCccHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCC
Confidence            999999999999999984          3456899999999999999999999   6699999999999999   77889


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +||+|||++.........    ...||+.|+|||++.+..++.++||||||+++|+|++|..||....    . ....  
T Consensus       148 ~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~-~~~~--  216 (304)
T 2jam_A          148 IMITDFGLSKMEQNGIMS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET----E-SKLF--  216 (304)
T ss_dssp             EEBCSCSTTCCCCCBTTH----HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC----H-HHHH--
T ss_pred             EEEccCCcceecCCCccc----cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----H-HHHH--
Confidence            999999999765432211    2458999999999999999999999999999999999999985221    1 1111  


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            ..+.........                ......+..+.+++.+||+.||.+|||+.++++
T Consensus       217 ------~~i~~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          217 ------EKIKEGYYEFES----------------PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ------HHHHHCCCCCCT----------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ------HHHHcCCCCCCc----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  011111000000                001234567899999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-41  Score=323.70  Aligned_cols=269  Identities=17%  Similarity=0.166  Sum_probs=188.3

Q ss_pred             ccccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeeccccc----------
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY----------   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----------   90 (381)
                      ..++|...++||+|+||+||++...             ......+|+++|+.++||||+++++++.....          
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            4678999999999999999887521             12334579999999999999999999754211          


Q ss_pred             -----------------------cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHh
Q 041757           91 -----------------------QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL  147 (381)
Q Consensus        91 -----------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L  147 (381)
                                             ......++||||++ |+|.+.+....      .....+++..+..++.|++.||.||
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI------RSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------CCEEEEEECCCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                   34556889999998 48887774321      3456799999999999999999999


Q ss_pred             hcCCCCCceeeccCCCCeeeC-CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHH
Q 041757          148 HHDCQPVTAHCVLKPSNVLLD-DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGIL  225 (381)
Q Consensus       148 H~~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~i  225 (381)
                      |   +.+|+||||||+||+++ .++.+||+|||+++.........   ...||+.|+|||++.+. .++.++|||||||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   77999999999999997 68899999999998765543322   24589999999988764 48999999999999


Q ss_pred             HHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccC
Q 041757          226 LLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSM  305 (381)
Q Consensus       226 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  305 (381)
                      +|||++|+.||...... ..+..+...........+....  ...... .............++...+..+.+++.+||+
T Consensus       232 l~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  307 (383)
T 3eb0_A          232 FGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMN--PHYTEV-RFPTLKAKDWRKILPEGTPSLAIDLLEQILR  307 (383)
T ss_dssp             HHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHC--TTC--C-CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             HHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhC--cccccc-cCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence            99999999997532111 1111111111111111111100  000000 0000001111112223456678999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 041757          306 ESPQDRMKMTNVVH  319 (381)
Q Consensus       306 ~dP~~RPs~~~vl~  319 (381)
                      .||.+|||+.|+++
T Consensus       308 ~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          308 YEPDLRINPYEAMA  321 (383)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-42  Score=321.50  Aligned_cols=238  Identities=21%  Similarity=0.268  Sum_probs=185.3

Q ss_pred             cccccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVD   89 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~   89 (381)
                      .++|...++||+|+||.||+++.                        ...+.+.+|+++|+++ +||||+++++++    
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----  128 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----  128 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence            37899999999999999987542                        1235677899999999 699999999995    


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                       ......++||||+++|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.
T Consensus       129 -~~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~  194 (355)
T 1vzo_A          129 -QTETKLHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDS  194 (355)
T ss_dssp             -EETTEEEEEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred             -eeCceEEEEeecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECC
Confidence             44778999999999999999994          3456899999999999999999999   669999999999999999


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      ++.+||+|||+++......... .....||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... ...
T Consensus       195 ~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~  272 (355)
T 1vzo_A          195 NGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQA  272 (355)
T ss_dssp             TSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHH
T ss_pred             CCcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHH
Confidence            9999999999998765432221 223569999999999885  347899999999999999999999986332221 111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVHE  320 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~~  320 (381)
                      .+..            ......+.                .+...+..+.+++.+||+.||.+||     |+.++++.
T Consensus       273 ~~~~------------~~~~~~~~----------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          273 EISR------------RILKSEPP----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHH------------HHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHH------------HHhccCCC----------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            1111            11111110                0123456788999999999999999     88888763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.1e-41  Score=342.66  Aligned_cols=242  Identities=21%  Similarity=0.332  Sum_probs=190.0

Q ss_pred             cccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...+.||+|+||.||++..                     ...+.+.+|+.+|++++||||+++++++.      .
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~  462 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E  462 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------S
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------c
Confidence            46688899999999999987631                     12377899999999999999999999853      3


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~---------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~v  530 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQ---------VRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV  530 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHH---------HTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred             CceEEEEEcCCCCcHHHHHH---------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCE
Confidence            45799999999999999995         23446899999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||+++.......... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.....     ..... 
T Consensus       531 kL~DFG~a~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~~~~~-  603 (656)
T 2j0j_A          531 KLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIG-  603 (656)
T ss_dssp             EECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH-
T ss_pred             EEEecCCCeecCCCcceec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----HHHHH-
Confidence            9999999987654432221 12447889999999988899999999999999999997 9999752211     11110 


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                             .+......                   ..+..++..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus       604 -------~i~~~~~~-------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          604 -------RIENGERL-------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             -------HHHHTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------HHHcCCCC-------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                   01110000                   01224567889999999999999999999999999998654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-41  Score=332.96  Aligned_cols=235  Identities=22%  Similarity=0.300  Sum_probs=187.9

Q ss_pred             ccccccccceecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..+.|...++||+|+||.||++.                    ....+.+.+|+.+|++++||||+++++++     ...
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   98 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK   98 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            45789999999999999998754                    12467799999999999999999999995     457


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee---CCC
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL---DDD  170 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~  170 (381)
                      ...++|||||.+|+|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||++   +.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~  165 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEII----------SRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKD  165 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHH----------TCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTT
T ss_pred             CEEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCC
Confidence            88999999999999999983          4567999999999999999999999   6699999999999999   567


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +.+||+|||+++.........   ...||+.|+|||++.+ .++.++|||||||++|+|++|..||...    .... ..
T Consensus       166 ~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~-~~  236 (484)
T 3nyv_A          166 ANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA----NEYD-IL  236 (484)
T ss_dssp             CCEEECCTTHHHHBCCCCSHH---HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHH-HH
T ss_pred             CcEEEEeeeeeEEcccccccc---cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC----CHHH-HH
Confidence            899999999998765543322   2459999999999876 6899999999999999999999998522    1111 11


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .        .+.........                +.....+..+.+++.+||+.||.+|||+.++++
T Consensus       237 ~--------~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          237 K--------KVEKGKYTFEL----------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             H--------HHHHCCCCCCS----------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--------HHHcCCCCCCC----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            1        11111000000                001234567889999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1e-41  Score=321.80  Aligned_cols=182  Identities=21%  Similarity=0.298  Sum_probs=157.8

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .++|...++||+|+||.||++..                  ...+.+.+|+.++++++||||+++++++.     ..+..
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEE
Confidence            57899999999999999988642                  23467899999999999999999999954     47789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeeccCCCCeeeCCCCCeEE
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP-VTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      ++||||+++++|.+++.          ....+++..+..++.|++.||.|||   .. +|+||||||+||+++.++.+||
T Consensus       107 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl  173 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKL  173 (360)
T ss_dssp             EEEECCCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEECCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEE
Confidence            99999999999999994          3456899999999999999999999   54 8999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      +|||++........    ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       174 ~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          174 CDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             CCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             EECCCCcccccccc----cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999865432211    124689999999999999999999999999999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-40  Score=313.15  Aligned_cols=268  Identities=18%  Similarity=0.209  Sum_probs=185.6

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc---cC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY---QG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---~~   92 (381)
                      .++|...++||+|+||.||++..                   .....+.+|+++++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            47899999999999999988652                   124578899999999999999999999764211   11


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      .+..++||||+.+ +|.+.+.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLS---------NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHH---------CTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred             CceEEEEEeccCC-CHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCC
Confidence            4578999999975 7877774         33456999999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCC--cccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          173 ARVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      +||+|||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...    ......
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~  238 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN----TEQHQL  238 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHH
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC----ChHHHH
Confidence            99999999987653322  112223568999999998876 45899999999999999999999997632    111111


Q ss_pred             HH--HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHH-HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AK--MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINI-IRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~--~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..  ........+.....-...................... .......+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11  0000000000000000000000000000000000000 1112456889999999999999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-41  Score=315.37  Aligned_cols=253  Identities=21%  Similarity=0.256  Sum_probs=178.3

Q ss_pred             hccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ...++|...++||+|+||+||++..                   ...+.+.+|++++++++||||+++++++     ...
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HHN  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EET
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ecC
Confidence            3467899999999999999988741                   1245678999999999999999999995     447


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee-----C
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL-----D  168 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill-----~  168 (381)
                      ...++||||+++ +|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||++     +
T Consensus       106 ~~~~lv~e~~~~-~L~~~~~----------~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~  171 (329)
T 3gbz_A          106 HRLHLIFEYAEN-DLKKYMD----------KNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDAS  171 (329)
T ss_dssp             TEEEEEEECCSE-EHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC----
T ss_pred             CEEEEEEecCCC-CHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCC
Confidence            789999999975 9999994          4456899999999999999999999   6699999999999999     4


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      ..+.+||+|||+++.........  ....||+.|+|||++.+. .++.++|||||||++|||++|..||...    ....
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~  245 (329)
T 3gbz_A          172 ETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD----SEID  245 (329)
T ss_dssp             -CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHH
T ss_pred             ccceEEECcCCCccccCCccccc--CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC----CHHH
Confidence            45569999999998765432221  124589999999998874 4899999999999999999999997532    2211


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchh----------hhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEK----------LVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV  317 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v  317 (381)
                      .....         +..........          ......................++.+++.+||+.||.+|||+.|+
T Consensus       246 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  316 (329)
T 3gbz_A          246 QLFKI---------FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA  316 (329)
T ss_dssp             HHHHH---------HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHH---------HHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence            11111         10000000000          000000000011111122345678999999999999999999999


Q ss_pred             HH
Q 041757          318 VH  319 (381)
Q Consensus       318 l~  319 (381)
                      ++
T Consensus       317 l~  318 (329)
T 3gbz_A          317 LE  318 (329)
T ss_dssp             HT
T ss_pred             hC
Confidence            85

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.1e-41  Score=317.93  Aligned_cols=282  Identities=16%  Similarity=0.181  Sum_probs=189.8

Q ss_pred             EccCCccccccccccccccchhhhhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHH
Q 041757            9 DVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKA   69 (381)
Q Consensus         9 ~~~~n~~~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~   69 (381)
                      +++.-.-.|..+..+..-.    ..+.++|...+.||+|+||.||++..                   ...+.+.+|+.+
T Consensus        19 ~m~~~~~~g~~~~~~~~~~----~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~   94 (371)
T 4exu_A           19 SMSLIRKKGFYKQDVNKTA----WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL   94 (371)
T ss_dssp             --CCSSCTTEEEEEETTEE----EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHH
T ss_pred             ceeeeccccceeeeeccce----ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHH
Confidence            3444444455444433222    23568999999999999999988641                   124678899999


Q ss_pred             HHccCCCcccceeeeeccccc-cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhh
Q 041757           70 LRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLH  148 (381)
Q Consensus        70 l~~l~h~nIv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH  148 (381)
                      ++.++||||+++++++...+. ......++||||+. ++|.+++.            ..+++..+..++.|++.||.|||
T Consensus        95 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH  161 (371)
T 4exu_A           95 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIH  161 (371)
T ss_dssp             HHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999754111 11123499999997 58988872            34899999999999999999999


Q ss_pred             cCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHH
Q 041757          149 HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLL  227 (381)
Q Consensus       149 ~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~  227 (381)
                         +.+|+||||||+||+++.++.+||+|||+++.......     ...||+.|+|||++.+ ..++.++|||||||++|
T Consensus       162 ---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (371)
T 4exu_A          162 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA  233 (371)
T ss_dssp             ---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred             ---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCcC-----CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHH
Confidence               66999999999999999999999999999986543321     2468999999999877 67899999999999999


Q ss_pred             HHHhCCCCCCccccCCCcHHHHHHHH--hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccC
Q 041757          228 ELMIREKPSDIMFEGDMNLHKFAKMA--LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSM  305 (381)
Q Consensus       228 el~tg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  305 (381)
                      +|++|+.||...    .....+....  ......+................................+..+.+++.+||+
T Consensus       234 el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  309 (371)
T 4exu_A          234 EMLTGKTLFKGK----DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLE  309 (371)
T ss_dssp             HHHHSSCSCCCS----SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSC
T ss_pred             HHHhCCCCCCCC----ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCC
Confidence            999999998532    1111111110  0000011111000000000000000000000111122446789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 041757          306 ESPQDRMKMTNVVH  319 (381)
Q Consensus       306 ~dP~~RPs~~~vl~  319 (381)
                      .||.+|||+.|+++
T Consensus       310 ~dP~~Rpt~~ell~  323 (371)
T 4exu_A          310 LDVDKRLTAAQALT  323 (371)
T ss_dssp             SCTTTSCCHHHHHT
T ss_pred             CChhhcCCHHHHhc
Confidence            99999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.1e-42  Score=317.71  Aligned_cols=248  Identities=21%  Similarity=0.243  Sum_probs=184.4

Q ss_pred             ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ..++|...++||+|+||.||++..                ...+.+.+|+.++++++||||+++++++.     .....+
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~  105 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SPPHLA  105 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CSSCEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCCceE
Confidence            357899999999999999988641                23456788999999999999999999954     466799


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +||||+++++|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++ ++.+||+|
T Consensus       106 iv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~D  172 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVR---------DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITD  172 (319)
T ss_dssp             EECBCCCSEEHHHHTT---------SSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECC
T ss_pred             EEeecccCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEee
Confidence            9999999999999995         23446899999999999999999999   66999999999999998 67999999


Q ss_pred             cccceecCCCCC---cccccCccCccceeCCCCcCC---------CccCcccchhhhhHHHHHHHhCCCCCCccccCCCc
Q 041757          178 FGLARFLPPTRT---QTSSIDVKGSIGYIAPEYGVG---------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN  245 (381)
Q Consensus       178 fg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~---------~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~  245 (381)
                      ||++........   ........|++.|+|||++.+         ..++.++||||||+++|||++|..||....     
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----  247 (319)
T 2y4i_B          173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----  247 (319)
T ss_dssp             CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-----
T ss_pred             cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Confidence            999876532211   111122458999999998864         357889999999999999999999985221     


Q ss_pred             HHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          246 LHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                      .......        +... ......                 ...++..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       248 ~~~~~~~--------~~~~-~~~~~~-----------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          248 AEAIIWQ--------MGTG-MKPNLS-----------------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             HHHHHHH--------HHTT-CCCCCC-----------------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             HHHHHHH--------hccC-CCCCCC-----------------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            1111111        0000 000000                 0123456889999999999999999999999999987


Q ss_pred             hhcCC
Q 041757          326 NTLLG  330 (381)
Q Consensus       326 ~~~~~  330 (381)
                      +....
T Consensus       302 ~~~~~  306 (319)
T 2y4i_B          302 KRNRR  306 (319)
T ss_dssp             -----
T ss_pred             Hhhcc
Confidence            76543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.9e-41  Score=313.85  Aligned_cols=248  Identities=16%  Similarity=0.207  Sum_probs=190.0

Q ss_pred             ccccchhhhhcccccccc-ceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccC-CCccccee
Q 041757           24 GKLKNLEILDVSRNMLEE-NLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIR-HRNLIKVL   82 (381)
Q Consensus        24 ~~~~~l~~~~~~~~~~~~-~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~-h~nIv~~~   82 (381)
                      +++..-......+.|... ++||+|+||.||++..                   .....+.+|+.++..+. ||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            455555555567778777 8999999999987641                   23578999999999995 79999999


Q ss_pred             eeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           83 TACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        83 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                      +++     ......++||||+++|+|.+++..        .....+++..++.++.|++.||.|||   ..+|+||||||
T Consensus        96 ~~~-----~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp  159 (327)
T 3lm5_A           96 EVY-----ENTSEIILILEYAAGGEIFSLCLP--------ELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKP  159 (327)
T ss_dssp             EEE-----ECSSEEEEEEECCTTEEGGGGGSS--------CC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred             EEE-----EeCCeEEEEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCh
Confidence            995     457789999999999999999843        23467899999999999999999999   66999999999


Q ss_pred             CCeeeCC---CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCcc
Q 041757          163 SNVLLDD---DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM  239 (381)
Q Consensus       163 ~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~  239 (381)
                      +||+++.   ++.+||+|||+++.........   ...||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       160 ~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (327)
T 3lm5_A          160 QNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE  236 (327)
T ss_dssp             GGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEEecCCCCCcEEEeeCccccccCCccccc---cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999987   7899999999998775443222   246999999999999999999999999999999999999997522


Q ss_pred             ccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          240 FEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          .......         .+.........                .....++..+.+++.+||+.||.+|||+.++++
T Consensus       237 ----~~~~~~~---------~i~~~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          237 ----DNQETYL---------NISQVNVDYSE----------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ----SHHHHHH---------HHHHTCCCCCT----------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----CchHHHH---------HHHhcccccCc----------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                1111110         01110000000                001234567889999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.4e-40  Score=312.77  Aligned_cols=263  Identities=17%  Similarity=0.148  Sum_probs=180.6

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~   93 (381)
                      ..++|...+.||+|+||.||++..                   ...+.+.+|+.+++.++||||+++++++.... ....
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            468899999999999999987631                   23467889999999999999999999975421 1233


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...++||||+.+ +|.+++.            ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~  166 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  166 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred             cceEEEEEcCCC-CHHHHHh------------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCE
Confidence            478999999975 7888873            34888999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++.........   ...||+.|+|||++.+..++.++|||||||++|+|++|..||...    .....+....
T Consensus       167 kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~  239 (371)
T 2xrw_A          167 KILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT----DHIDQWNKVI  239 (371)
T ss_dssp             EECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHH
T ss_pred             EEEEeecccccccccccC---CceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHH
Confidence            999999998665432221   246899999999999989999999999999999999999997532    2222111111


Q ss_pred             h--hchHHHHHhh-------hhccCchhh----hhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 L--SNHVKDIVDS-------ILLNDDEKL----VVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~--~~~~~~~~~~-------~l~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .  .....++...       .....+...    .....................++.+++.+||..||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            0  0000111100       000000000    0000000000001122345678999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.2e-41  Score=310.44  Aligned_cols=239  Identities=21%  Similarity=0.253  Sum_probs=184.2

Q ss_pred             hhccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++..+.|...+.||+|+||.||++..                 ...+.+.+|+++++.++||||+++++++.     ..+
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   89 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDG   89 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCC
Confidence            35678899999999999999988652                 24578999999999999999999999954     467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+++++|.+++.         .....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+|
T Consensus        90 ~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k  157 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIML---------ELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIR  157 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEE
T ss_pred             eEEEEEEeCCCCcHHHHHH---------hhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEE
Confidence            8899999999999999985         23456899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCc-----CCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG-----VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      |+|||++........  ......||+.|+|||++     .+..++.++||||||+++|+|++|..||....    .....
T Consensus       158 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~  231 (302)
T 2j7t_A          158 LADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVL  231 (302)
T ss_dssp             ECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH
T ss_pred             EEECCCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC----HHHHH
Confidence            999998753221111  11124589999999987     46678999999999999999999999975221    11110


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .         .+..    ......             ..+..++..+.+++.+||+.||.+|||+.++++
T Consensus       232 ~---------~~~~----~~~~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          232 L---------KIAK----SDPPTL-------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             H---------HHHH----SCCCCC-------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             H---------HHhc----cCCccc-------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0         0000    000000             001234567889999999999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.2e-41  Score=317.36  Aligned_cols=256  Identities=19%  Similarity=0.253  Sum_probs=189.1

Q ss_pred             hccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      .+.++|...+.||+|+||.||++..                  .....+.+|++++++++||||+++++++....+....
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            4678999999999999999988642                  1245678999999999999999999997654445567


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++||||+. |+|.+++.           ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        88 ~~~lv~e~~~-~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~k  152 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIS-----------TQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLK  152 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEE
T ss_pred             eEEEEEeccC-ccHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEE
Confidence            8999999997 59999884           246899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcc--------cccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCc
Q 041757          175 VGDFGLARFLPPTRTQT--------SSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN  245 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~  245 (381)
                      |+|||+++.........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....    .
T Consensus       153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~  228 (353)
T 2b9h_A          153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD----Y  228 (353)
T ss_dssp             ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----H
T ss_pred             EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC----c
Confidence            99999998775432211        1122468999999998754 678999999999999999999999985321    1


Q ss_pred             HHHHHHH---Hhhc------------hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCC
Q 041757          246 LHKFAKM---ALSN------------HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQD  310 (381)
Q Consensus       246 ~~~~~~~---~~~~------------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~  310 (381)
                      .......   ....            ...+.+......            .........+..+.++.+++.+||+.||.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  296 (353)
T 2b9h_A          229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY------------PAAPLEKMFPRVNPKGIDLLQRMLVFDPAK  296 (353)
T ss_dssp             HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCC------------CCCCHHHHSTTSCHHHHHHHHHHSCSSGGG
T ss_pred             HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCC------------CCcchhhhcccCCHHHHHHHHHhcCcCccc
Confidence            1111100   0000            001111100000            000001112345678899999999999999


Q ss_pred             CCCHHHHHH
Q 041757          311 RMKMTNVVH  319 (381)
Q Consensus       311 RPs~~~vl~  319 (381)
                      |||+.++++
T Consensus       297 Rpt~~ell~  305 (353)
T 2b9h_A          297 RITAKEALE  305 (353)
T ss_dssp             SCCHHHHHT
T ss_pred             CCCHHHHhc
Confidence            999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.7e-41  Score=306.11  Aligned_cols=231  Identities=16%  Similarity=0.196  Sum_probs=182.8

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...+.||+|+||+||++..                   .....+.+|+..+..+ +||||+++++++.     ..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----ED   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ET
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cC
Confidence            357899999999999999988642                   2456788999999999 8999999999954     47


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC----
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD----  169 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~----  169 (381)
                      +..++||||+++++|.+++....      .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.    
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~  154 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENY------RIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIP  154 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----
T ss_pred             CeEEEEEEecCCCcHHHHHHhhc------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCC
Confidence            78999999999999999995321      12256899999999999999999999   669999999999999984    


Q ss_pred             ---------------CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCC
Q 041757          170 ---------------DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIRE  233 (381)
Q Consensus       170 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~  233 (381)
                                     ...+||+|||.+........      ..||+.|+|||++.+. .++.++||||||+++|+|++|.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~  228 (289)
T 1x8b_A          155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE  228 (289)
T ss_dssp             ---------------CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence                           44799999999987654332      3489999999998775 5678999999999999999999


Q ss_pred             CCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC
Q 041757          234 KPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK  313 (381)
Q Consensus       234 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  313 (381)
                      +|+..    ...            ...+........                   +..++..+.+++.+||+.||++|||
T Consensus       229 ~~~~~----~~~------------~~~~~~~~~~~~-------------------~~~~~~~~~~li~~~l~~dp~~Rps  273 (289)
T 1x8b_A          229 PLPRN----GDQ------------WHEIRQGRLPRI-------------------PQVLSQEFTELLKVMIHPDPERRPS  273 (289)
T ss_dssp             CCCSS----SHH------------HHHHHTTCCCCC-------------------SSCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCcc----hhH------------HHHHHcCCCCCC-------------------CcccCHHHHHHHHHHhCCCcccCCC
Confidence            87531    111            111111111000                   1234567899999999999999999


Q ss_pred             HHHHHH
Q 041757          314 MTNVVH  319 (381)
Q Consensus       314 ~~~vl~  319 (381)
                      +.++++
T Consensus       274 ~~~ll~  279 (289)
T 1x8b_A          274 AMALVK  279 (289)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.1e-41  Score=311.31  Aligned_cols=236  Identities=19%  Similarity=0.205  Sum_probs=182.6

Q ss_pred             ccccccccceecCCCceEEEecccc-------------------------cHHHHHHHHHHHHccCCCcccceeeeeccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-------------------------AFKSFIAECKALRNIRHRNLIKVLTACLGV   88 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~   88 (381)
                      ..++|...+.||+|+||.||++...                         ....+.+|+++|++++||||+++++++.  
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--   85 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--   85 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc--
Confidence            4578999999999999999886421                         1234789999999999999999999953  


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                         .. ..++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+++
T Consensus        86 ---~~-~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~  148 (322)
T 2ycf_A           86 ---AE-DYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLS  148 (322)
T ss_dssp             ---SS-SEEEEEECCTTEETHHHHS----------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEES
T ss_pred             ---CC-ceEEEEecCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEe
Confidence               23 3799999999999999983          4567899999999999999999999   66999999999999998


Q ss_pred             CCCC---eEEeecccceecCCCCCcccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          169 DDMT---ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       169 ~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      .++.   +||+|||+++.........   ...||+.|+|||++.   ...++.++|||||||++|+|++|..||......
T Consensus       149 ~~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          149 SQEEDCLIKITDFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             SSSSSCCEEECCCTTCEECCCCHHHH---HHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             cCCCCCeEEEccCccceecccccccc---cccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence            7654   9999999998765432211   245899999999863   567899999999999999999999998633222


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .. +.....           .......                .......+..+.+++.+||+.||.+|||+.++++
T Consensus       226 ~~-~~~~~~-----------~~~~~~~----------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          226 VS-LKDQIT-----------SGKYNFI----------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SC-HHHHHH-----------HTCCCCC----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HH-HHHHHH-----------hCccccC----------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11 111110           0000000                0112234568899999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=312.64  Aligned_cols=255  Identities=21%  Similarity=0.258  Sum_probs=182.9

Q ss_pred             hhccccccccceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeecccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD   89 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~   89 (381)
                      ....++|...+.||+|+||.||++...                      ..+.+.+|++++++++||||+++++++    
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----   81 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF----   81 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence            345688999999999999999886421                      124678999999999999999999995    


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                       ......++||||+++ +|.+++.         .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.
T Consensus        82 -~~~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~  147 (346)
T 1ua2_A           82 -GHKSNISLVFDFMET-DLEVIIK---------DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDE  147 (346)
T ss_dssp             -CCTTCCEEEEECCSE-EHHHHHT---------TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred             -eeCCceEEEEEcCCC-CHHHHHH---------hcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcC
Confidence             457788999999986 8998885         23456888899999999999999999   669999999999999999


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      ++.+||+|||+++.........  ....||+.|+|||++.+. .++.++|||||||++|+|++|..||..    ......
T Consensus       148 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~----~~~~~~  221 (346)
T 1ua2_A          148 NGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG----DSDLDQ  221 (346)
T ss_dssp             TCCEEECCCGGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC----SSHHHH
T ss_pred             CCCEEEEecccceeccCCcccC--CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC----CCHHHH
Confidence            9999999999998765433221  124689999999998764 589999999999999999999999752    222211


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhh------hh--cccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKL------VV--RGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~------~~--~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +..         ++...........      ..  .................+.++.+++.+||+.||.+|||+.|+++
T Consensus       222 ~~~---------i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          222 LTR---------IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHH---------HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHH---------HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            111         1111000000000      00  00000000001111344568999999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=307.77  Aligned_cols=237  Identities=19%  Similarity=0.225  Sum_probs=183.9

Q ss_pred             ccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..++|...+.||+|+||.||++..               ...+.+.+|+.++++++||||+++++++.     .....++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEEE
Confidence            457799999999999999988642               23578999999999999999999999954     4678899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      ||||+++++|.+++.         .....+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+||+||
T Consensus       102 v~e~~~~~~L~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df  169 (314)
T 3com_A          102 VMEYCGAGSVSDIIR---------LRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADF  169 (314)
T ss_dssp             EEECCTTEEHHHHHH---------HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EeecCCCCCHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeec
Confidence            999999999999984         23467899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      |++..........  ....|++.|+|||++.+..++.++||||||+++|+|++|..||....    .......       
T Consensus       170 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~-------  236 (314)
T 3com_A          170 GVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH----PMRAIFM-------  236 (314)
T ss_dssp             TTCEECBTTBSCB--CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHH-------
T ss_pred             ccchhhhhhcccc--CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----hHHHHHH-------
Confidence            9998765433221  22468999999999999899999999999999999999999985221    1111000       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                         +........                ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus       237 ---~~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          237 ---IPTNPPPTF----------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---HHHSCCCCC----------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---HhcCCCccc----------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               000000000                001234567889999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.4e-40  Score=318.54  Aligned_cols=184  Identities=23%  Similarity=0.269  Sum_probs=156.3

Q ss_pred             hhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc------CCCcccceeeeecccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI------RHRNLIKVLTACLGVD   89 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l------~h~nIv~~~~~~~~~~   89 (381)
                      ..+.++|...++||+|+||+||++..                ...+.+.+|+++++.+      .|+||+++++++.   
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~---  169 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT---  169 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE---
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc---
Confidence            34567899999999999999988742                1246778899998887      5679999999954   


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                        .....++||||+. ++|.+++..        .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.
T Consensus       170 --~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~  235 (429)
T 3kvw_A          170 --FRNHICMTFELLS-MNLYELIKK--------NKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQ  235 (429)
T ss_dssp             --ETTEEEEEECCCC-CBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESS
T ss_pred             --cCCeEEEEEeccC-CCHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcc
Confidence              4678999999996 699999853        22345899999999999999999999   569999999999999999


Q ss_pred             CCC--eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          170 DMT--ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       170 ~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ++.  +||+|||++........     ...||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       236 ~~~~~vkL~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~  300 (429)
T 3kvw_A          236 QGRSGIKVIDFGSSCYEHQRVY-----TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP  300 (429)
T ss_dssp             TTSCCEEECCCTTCEETTCCCC-----SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCcceEEeecccceecCCccc-----ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence            887  99999999976543322     2468999999999999999999999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6e-42  Score=325.58  Aligned_cols=242  Identities=14%  Similarity=0.145  Sum_probs=178.3

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHH---HHHHccCCCcccceeeeecccc-
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAEC---KALRNIRHRNLIKVLTACLGVD-   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~---~~l~~l~h~nIv~~~~~~~~~~-   89 (381)
                      ..++|...+.||+|+||.||++..                    ...+.+.+|+   ++|++++|||||++++.+.... 
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357799999999999999987651                    2347888999   4555668999999995433100 


Q ss_pred             -ccCCc-----------------eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 041757           90 -YQGND-----------------FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC  151 (381)
Q Consensus        90 -~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  151 (381)
                       +...+                 ..++||||+ +|+|.+++.......   .....+++..++.++.|++.||.|||   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH---  223 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---STHKSLVHHARLQLTLQVIRLLASLH---  223 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT---TTTHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc---cccccccHHHHHHHHHHHHHHHHHHH---
Confidence             11111                 378999999 689999995321100   11234566888899999999999999   


Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-----------ccCcccchh
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-----------EVSTIGDVY  220 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~sDiw  220 (381)
                      +.+|+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++.+.           .++.++|||
T Consensus       224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw  297 (377)
T 3byv_A          224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW  297 (377)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence            669999999999999999999999999999864331     122457 999999999887           899999999


Q ss_pred             hhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHH
Q 041757          221 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG  300 (381)
Q Consensus       221 SlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  300 (381)
                      ||||++|||++|+.||........                 ...... .                   ...++.++.+++
T Consensus       298 SlG~il~elltg~~Pf~~~~~~~~-----------------~~~~~~-~-------------------~~~~~~~~~~li  340 (377)
T 3byv_A          298 ALGLVIYWIWCADLPITKDAALGG-----------------SEWIFR-S-------------------CKNIPQPVRALL  340 (377)
T ss_dssp             HHHHHHHHHHHSSCCC------CC-----------------SGGGGS-S-------------------CCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCcccccccc-----------------hhhhhh-h-------------------ccCCCHHHHHHH
Confidence            999999999999999853221110                 000000 0                   013456788999


Q ss_pred             HhccCCCCCCCCCHHHHHH--HHHHhh
Q 041757          301 VACSMESPQDRMKMTNVVH--ELQSIK  325 (381)
Q Consensus       301 ~~cl~~dP~~RPs~~~vl~--~L~~i~  325 (381)
                      .+||+.||++|||+.++++  .++.+.
T Consensus       341 ~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          341 EGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            9999999999999999986  444443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.1e-41  Score=321.58  Aligned_cols=268  Identities=18%  Similarity=0.150  Sum_probs=185.6

Q ss_pred             cccccccceecCCCceEEEecccc------------cHHHHHHHHHHHHccCCCcccceeeeeccccc-cCCceEEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYE  101 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~~~~~~lv~e  101 (381)
                      ..+|...++||+|+||+||+++..            ......+|+++|+.++||||+++++++..... .+....++|||
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            456999999999999999887531            12233479999999999999999999765322 34455789999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC-CCCCeEEeeccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMTARVGDFGL  180 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~  180 (381)
                      |++++ +...+....      .....+++..++.++.|++.||.|||   +.+|+||||||+|||++ .++.+||+|||+
T Consensus       119 ~~~~~-l~~~~~~~~------~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          119 YVPET-VYRASRHYA------KLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             CCSEE-HHHHHHHHH------HTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ccCcc-HHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            99874 443332111      23567899999999999999999999   66999999999999998 789999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      ++.........   ...||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+..........
T Consensus       189 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          189 AKILIAGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             CEECCTTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHH
T ss_pred             cccccCCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence            98775443322   25689999999988764 5899999999999999999999997522110 1111111111111111


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .+ ..+. ....... ............+....+.++.+++.+||+.||.+|||+.++++
T Consensus       265 ~~-~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          265 QI-KTMN-PNYMEHK-FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HH-HHHC-GGGSSSC-CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH-HhhC-hhhhhhc-cccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            11 1100 0000000 00000000111112235568999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.3e-40  Score=313.19  Aligned_cols=236  Identities=20%  Similarity=0.313  Sum_probs=186.1

Q ss_pred             ccccccccceecCCCceEEEecccc-------------------------cHHHHHHHHHHHHcc-CCCcccceeeeecc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQG-------------------------AFKSFIAECKALRNI-RHRNLIKVLTACLG   87 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~~-------------------------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~   87 (381)
                      ..++|...+.||+|+||.||++...                         ..+.+.+|+.+++++ +||||+++++++  
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--  169 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY--  169 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE--
Confidence            4567999999999999999886421                         145678999999999 799999999995  


Q ss_pred             ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           88 VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        88 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                         ......++||||+++++|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+||++
T Consensus       170 ---~~~~~~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~  233 (365)
T 2y7j_A          170 ---ESSSFMFLVFDLMRKGELFDYLT----------EKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILL  233 (365)
T ss_dssp             ---EBSSEEEEEECCCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             ---eeCCEEEEEEEeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence               45778999999999999999994          3456899999999999999999999   5699999999999999


Q ss_pred             CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC------CccCcccchhhhhHHHHHHHhCCCCCCcccc
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG------NEVSTIGDVYSYGILLLELMIREKPSDIMFE  241 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~  241 (381)
                      +.++.+||+|||++..+.......   ...||+.|+|||++.+      ..++.++|||||||++|+|++|..||...  
T Consensus       234 ~~~~~ikl~DfG~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--  308 (365)
T 2y7j_A          234 DDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--  308 (365)
T ss_dssp             CTTCCEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred             CCCCCEEEEecCcccccCCCcccc---cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC--
Confidence            999999999999998776543322   2569999999998753      35889999999999999999999998521  


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        ... ....        .+.........                ......+..+.+++.+||+.||.+|||+.++++
T Consensus       309 --~~~-~~~~--------~i~~~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          309 --RQI-LMLR--------MIMEGQYQFSS----------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             --SHH-HHHH--------HHHHTCCCCCH----------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --CHH-HHHH--------HHHhCCCCCCC----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              111 1110        01110000000                001234567889999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.9e-41  Score=310.61  Aligned_cols=252  Identities=19%  Similarity=0.214  Sum_probs=185.4

Q ss_pred             ccccchhhhhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHcc-CCCcccceeeeec
Q 041757           24 GKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNI-RHRNLIKVLTACL   86 (381)
Q Consensus        24 ~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~   86 (381)
                      ..+..-++....++|...+.||+|+||.||++..                ...+.+.+|+.+++++ +||||+++++++.
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3344445566789999999999999999988652                2457899999999999 7999999999976


Q ss_pred             cccc-cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCe
Q 041757           87 GVDY-QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNV  165 (381)
Q Consensus        87 ~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Ni  165 (381)
                      .... ......++||||+++|+|.+++..        .....+++..++.++.|++.||.|||   ..+|+||||||+||
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NI  160 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNV  160 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHH--------SGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHE
Confidence            4211 125678999999999999999953        12356889999999999999999999   66999999999999


Q ss_pred             eeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccc
Q 041757          166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMF  240 (381)
Q Consensus       166 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~  240 (381)
                      +++.++.+||+|||++..........  ....||+.|+|||++.     +..++.++|||||||++|+|++|..||....
T Consensus       161 l~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          161 LLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             EEcCCCCEEEeeCcCceecCcCcccc--ccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            99999999999999998664432211  1245899999999987     4568999999999999999999999975221


Q ss_pred             cCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          .......         +...   ..+..               ....++..+.+++.+||+.||.+|||+.++++
T Consensus       239 ----~~~~~~~---------~~~~---~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          239 ----PMRALFL---------IPRN---PAPRL---------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ----HHHHHHH---------HHHS---CCCCC---------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHH---------hhcC---ccccC---------------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                1111100         0000   00000               00123457889999999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.9e-40  Score=311.43  Aligned_cols=259  Identities=15%  Similarity=0.182  Sum_probs=188.0

Q ss_pred             cccccccceecCCCceEEEecccc------------------c--------------HHHHHHHHHHHHccCCCccccee
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG------------------A--------------FKSFIAECKALRNIRHRNLIKVL   82 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~------------------~--------------~~~~~~E~~~l~~l~h~nIv~~~   82 (381)
                      .++|...+.||+|+||.||++...                  .              .+.+.+|+.++++++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            478999999999999999887421                  0              18899999999999999999999


Q ss_pred             eeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           83 TACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        83 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                      +++.     ..+..++||||+++|+|.+++.......  ......+++..++.++.|++.||.|||+  ..+|+||||||
T Consensus       110 ~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p  180 (348)
T 2pml_X          110 GIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLD--KNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKP  180 (348)
T ss_dssp             EEEE-----SSSEEEEEEECCTTCBSSEESSSEESSC--SSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCG
T ss_pred             EEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhh--hccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCCh
Confidence            9954     4678999999999999999832110000  0125679999999999999999999994  16999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCc-ccchhhhhHHHHHHHhCCCCCCccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVST-IGDVYSYGILLLELMIREKPSDIMF  240 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~sDiwSlG~il~el~tg~~Pf~~~~  240 (381)
                      +||+++.++.+||+|||++.......    .....|++.|+|||++.+. .++. ++||||||+++|+|++|..||....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HhEEEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998765432    1225689999999999887 6766 9999999999999999999986322


Q ss_pred             cCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..    ...........        .. .+......................+..+.+++.+||+.||.+|||+.++++
T Consensus       257 ~~----~~~~~~i~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          257 SL----VELFNNIRTKN--------IE-YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CS----HHHHHHHTSCC--------CC-CCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cH----HHHHHHHhccC--------cC-CccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11    11111111100        00 000000000000000000111345668899999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=305.90  Aligned_cols=239  Identities=20%  Similarity=0.255  Sum_probs=181.3

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..++|....+||+|+||.||++..                 ...+.+.+|+.+++.++||||+++++++.     ..+..
T Consensus        20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~   94 (295)
T 2clq_A           20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFI   94 (295)
T ss_dssp             CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcE
Confidence            345566667999999999988642                 23577899999999999999999999954     46789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCCeEE
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARV  175 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl  175 (381)
                      ++||||+++++|.+++...       .....+++..+..++.|++.||.|||   +.+|+||||||+||+++. ++.+||
T Consensus        95 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl  164 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSK-------WGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKI  164 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHT-------TCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEE
T ss_pred             EEEEEeCCCCCHHHHHHhh-------ccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEE
Confidence            9999999999999999531       12335678889999999999999999   669999999999999987 889999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCc--cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE--VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      +|||++..........  ....|++.|+|||++.+..  ++.++||||||+++|+|++|+.||.....   ........ 
T Consensus       165 ~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~-  238 (295)
T 2clq_A          165 SDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE---PQAAMFKV-  238 (295)
T ss_dssp             CCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS---HHHHHHHH-
T ss_pred             eecccccccCCCCCcc--cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc---hhHHHHhh-
Confidence            9999998765432211  1246899999999987643  78999999999999999999999852211   00000000 


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                ......+.                .+...+..+.+++.+||+.||++|||+.++++
T Consensus       239 ----------~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          239 ----------GMFKVHPE----------------IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----------HHHCCCCC----------------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----------cccccccc----------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                      00000000                01234567889999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.3e-41  Score=322.43  Aligned_cols=265  Identities=17%  Similarity=0.201  Sum_probs=185.8

Q ss_pred             cccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeeccccc-cCCceEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVY  100 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~~~~~~lv~  100 (381)
                      ..+|...++||+|+||.||++...             ....+.+|+++|++++||||+++++++..... .+..+.++||
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  132 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL  132 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence            346999999999999999887531             12334579999999999999999999764221 2334567999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC-CCeEEeecc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD-MTARVGDFG  179 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~Dfg  179 (381)
                      ||+++ +|.+++....      .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.+ +.+||+|||
T Consensus       133 e~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          133 DYVPE-TVYRVARHYS------RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             ECCCE-EHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             hcccc-cHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccch
Confidence            99976 6766663211      23567899999999999999999999   7799999999999999955 578999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH---HHHHhh
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF---AKMALS  255 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~~~~  255 (381)
                      +++.........   ...||+.|+|||++.+. .++.++|||||||++|||++|+.||..    ......+   ......
T Consensus       203 ~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~----~~~~~~l~~i~~~lg~  275 (420)
T 1j1b_A          203 SAKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG----DSGVDQLVEIIKVLGT  275 (420)
T ss_dssp             TCEECCTTCCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHHHCS
T ss_pred             hhhhcccCCCce---eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHHHhCC
Confidence            998765443222   25689999999998764 789999999999999999999999753    2222222   111111


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..... +..+ ......... ...........+....+.++.+|+.+||..||.+|||+.|+++
T Consensus       276 p~~~~-~~~~-~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          276 PTREQ-IREM-NPNYTEFKF-PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCHHH-HHHH-CSCCCCCCC-CCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHH-HHhh-Chhhhhhcc-CccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            11111 1111 000000000 0000001111111234568899999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.4e-40  Score=301.69  Aligned_cols=236  Identities=21%  Similarity=0.277  Sum_probs=187.1

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------------ccHHHHHHHHHHHHccC-CCcccceeeeec
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------------GAFKSFIAECKALRNIR-HRNLIKVLTACL   86 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~   86 (381)
                      ..++|...+.||+|+||.||++..                          ...+.+.+|+++++++. ||||+++++++ 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-   93 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   93 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence            468899999999999999987642                          12456789999999996 99999999995 


Q ss_pred             cccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           87 GVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        87 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                          ......++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+++||||||+||+
T Consensus        94 ----~~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil  156 (298)
T 1phk_A           94 ----ETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL  156 (298)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             ----ccCCeEEEEEeccCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEE
Confidence                45788999999999999999994          3457899999999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcC------CCccCcccchhhhhHHHHHHHhCCCCCCccc
Q 041757          167 LDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV------GNEVSTIGDVYSYGILLLELMIREKPSDIMF  240 (381)
Q Consensus       167 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~  240 (381)
                      ++.++.+||+|||++..........   ...|++.|+|||++.      ...++.++||||||+++|+|++|..||....
T Consensus       157 ~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  233 (298)
T 1phk_A          157 LDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  233 (298)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EcCCCcEEEecccchhhcCCCcccc---cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence            9999999999999998765443222   245899999999875      4568899999999999999999999975221


Q ss_pred             cCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          . .....        .+..........                .....+..+.+++.+||+.||.+|||+.++++
T Consensus       234 ----~-~~~~~--------~~~~~~~~~~~~----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          234 ----Q-MLMLR--------MIMSGNYQFGSP----------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             ----H-HHHHH--------HHHHTCCCCCTT----------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----H-HHHHH--------HHhcCCcccCcc----------------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                1 11111        111110000000                01234567899999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4e-40  Score=310.72  Aligned_cols=275  Identities=19%  Similarity=0.218  Sum_probs=178.8

Q ss_pred             hhccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc--cCC
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY--QGN   93 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--~~~   93 (381)
                      ....++|...++||+|+||.||++..                .....+.+|++.+..++||||+++++++.....  ...
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            34457899999999999999987652                124567788899999999999999999865222  223


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-CCC
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMT  172 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~  172 (381)
                      ...++||||+++ +|...+....      .....+++..+..++.|++.||.|||.+ +.+|+||||||+||+++. ++.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYY------RRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred             eeEEEEeecccc-cHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence            347899999976 5555442111      3456788999999999999999999954 559999999999999986 889


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++.........   ...||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~  246 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVR  246 (360)
T ss_dssp             EEECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred             EEEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHH
Confidence            9999999998766543322   24589999999998664 4899999999999999999999998532111 01111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhccc-chhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGD-QKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . ......+.+................ ..............+..+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          247 V-LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             H-HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             H-cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1 1111111111111000000000000 00000000111125678999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.8e-40  Score=304.93  Aligned_cols=262  Identities=16%  Similarity=0.175  Sum_probs=187.0

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCc------ccceeeeeccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRN------LIKVLTACLGVDY   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~n------Iv~~~~~~~~~~~   90 (381)
                      ..++|...++||+|+||.||++..                 ...+.+.+|+++++.++|+|      |+++++++     
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-----   86 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-----   86 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence            357899999999999999998632                 12467889999999987654      89999985     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-  169 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-  169 (381)
                      ...+..++||||+ +++|.+++..        .....+++..+..++.|++.||.|||   +.+|+||||||+||+++. 
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKE--------NGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS  154 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCC
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHh--------cCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEecc
Confidence            4477899999999 8899999853        22346889999999999999999999   669999999999999987 


Q ss_pred             ------------------CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh
Q 041757          170 ------------------DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI  231 (381)
Q Consensus       170 ------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t  231 (381)
                                        ++.+||+|||+++.......     ...||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  229 (339)
T 1z57_A          155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS-----TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             CEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCC-----SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccCCccccccccccCCCceEeeCcccccCccccc-----cccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence                              66899999999987543321     2468999999999999899999999999999999999


Q ss_pred             CCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCc---hhhhhccc----------chhhhhHHHHHHHHHHHHHH
Q 041757          232 REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDD---EKLVVRGD----------QKQTQAKINIIRECVISMVR  298 (381)
Q Consensus       232 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~  298 (381)
                      |..||.....  .................+.........   ........          .............++.++.+
T Consensus       230 g~~pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  307 (339)
T 1z57_A          230 GFTVFPTHDS--KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD  307 (339)
T ss_dssp             SSCSCCCSCH--HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred             CCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence            9999853211  111111111111111111111000000   00000000          00000000012345678999


Q ss_pred             HHHhccCCCCCCCCCHHHHHH
Q 041757          299 IGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       299 l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ++.+||+.||.+|||+.|+++
T Consensus       308 li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          308 LIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHhCcCcccccCHHHHhc
Confidence            999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.2e-41  Score=308.45  Aligned_cols=253  Identities=20%  Similarity=0.282  Sum_probs=173.5

Q ss_pred             ccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ..++|...+.||+|+||.||++..                  ...+.+.+|+.++++++||||+++++++.     ..+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKDE   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSSC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecCC
Confidence            357899999999999999988642                  23466789999999999999999999954     4667


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+++++|.+++........  .....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGE--HKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTT--TTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             cEEEehhccCCchHHHHHHHhhccc--cccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEE
Confidence            8999999999999999853211000  12456899999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCc---ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          176 GDFGLARFLPPTRTQ---TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +|||++.........   .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......    ....
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~  238 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VLML  238 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHH
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HHHH
Confidence            999999766543211   11122468999999998875 568999999999999999999999986322111    1000


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . ...            .+.....      ...........+..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~-~~~------------~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          239 T-LQN------------DPPSLET------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             H-HTS------------SCCCTTC-----------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             H-hcc------------CCCcccc------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0 000            0000000      00000001134457889999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-40  Score=304.42  Aligned_cols=238  Identities=19%  Similarity=0.266  Sum_probs=171.8

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ..++|...++||+|+||+||++..                   ...+.+.++...++.++||||+++++++.     ..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence            357899999999999999988652                   11223444555578889999999999954     467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeeccCCCCeeeCCCCCe
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP-VTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivHrDlkp~Nill~~~~~~  173 (381)
                      ..++||||++ |+|.+++....      .....+++..++.++.|++.||.|||   +. +|+||||||+||+++.++.+
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~  149 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVI------DKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQV  149 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCE
T ss_pred             CEEEEEehhc-cchHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCE
Confidence            8899999997 48888874321      24567999999999999999999999   65 99999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCc----CCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG----VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      ||+|||+++..........   ..||+.|+|||++    .+..++.++||||||+++|+|++|..||...   .......
T Consensus       150 kl~Dfg~~~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~  223 (290)
T 3fme_A          150 KMCDFGISGYLVDDVAKDI---DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW---GTPFQQL  223 (290)
T ss_dssp             EBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC---SCHHHHH
T ss_pred             EEeecCCcccccccccccc---cCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc---CchHHHH
Confidence            9999999987655433222   3589999999995    5567899999999999999999999998521   1111111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                               ...+.......+                  ....+.++.+++.+||+.||.+|||+.++++
T Consensus       224 ---------~~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          224 ---------KQVVEEPSPQLP------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---------HHHHHSCCCCCC------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---------HHHhccCCCCcc------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                     111111000000                  1134567899999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=319.89  Aligned_cols=197  Identities=21%  Similarity=0.299  Sum_probs=144.2

Q ss_pred             ccccccc-cceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           34 VSRNMLE-ENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        34 ~~~~~~~-~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ..+.|.. +++||+|+||+||++..                 .....+.+|+.+|++++||||+++++++..   .....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~   94 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRK   94 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence            3455665 56899999999998752                 124578999999999999999999999753   45778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee----CCCC
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----DDDM  171 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~  171 (381)
                      .++||||+. |+|.+++....... .......+++..++.++.||+.||.|||   +.+|+||||||+|||+    +.++
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTT
T ss_pred             EEEEEeCCC-CCHHHHHHHhcccc-ccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCC
Confidence            999999996 48888874221100 0012335899999999999999999999   6699999999999999    6778


Q ss_pred             CeEEeecccceecCCCCCc-ccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          172 TARVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      .+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9999999999876543211 112235689999999998874 589999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=310.62  Aligned_cols=264  Identities=16%  Similarity=0.165  Sum_probs=182.1

Q ss_pred             hccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc-cC
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY-QG   92 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~   92 (381)
                      .+.++|...+.||+|+||.||++..                   ...+.+.+|+.+++.++||||+++++++..... ..
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            4568899999999999999988741                   124678899999999999999999999653110 11


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||||+. ++|.+++.            ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~  164 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCE  164 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCC
T ss_pred             ceeEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCc
Confidence            224599999997 58888772            24899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..+.....
T Consensus       165 ~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~  238 (353)
T 3coi_A          165 LKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILK  238 (353)
T ss_dssp             EEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHH
T ss_pred             EEEeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            9999999997654322     12458999999998877 67899999999999999999999998532110 00111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      . ......+................................+..+.+++.+||+.||++|||+.++++
T Consensus       239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          239 V-TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             H-HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             H-hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0 000001111100000000000000000000000111245678899999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.2e-40  Score=306.29  Aligned_cols=260  Identities=21%  Similarity=0.263  Sum_probs=189.4

Q ss_pred             hhccccccccceecCCCceEEEecccc--------------------cHHHHHHHHHHHHcc---CCCcccceeeeeccc
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAECKALRNI---RHRNLIKVLTACLGV   88 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~   88 (381)
                      ....++|...+.||+|+||.||++...                    ....+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            345788999999999999999887421                    123577888888777   899999999997633


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                      ........++||||+. |+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+||+++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~  154 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDK--------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVT  154 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHH--------SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEc
Confidence            2335678899999997 699999853        12345899999999999999999999   66999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      .++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...    .....
T Consensus       155 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~  227 (326)
T 1blx_A          155 SSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS----SDVDQ  227 (326)
T ss_dssp             TTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHH
T ss_pred             CCCCEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC----CHHHH
Confidence            999999999999976543221   12256899999999999889999999999999999999999997532    11111


Q ss_pred             HHHHHhhchHHHHHhhhhccCchh---hh----hcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEK---LV----VRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~---~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +.         .+++.........   ..    ..................+..+.+++.+||+.||.+|||+.++++
T Consensus       228 ~~---------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          228 LG---------KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HH---------HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HH---------HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11         1111000000000   00    000000000011112345567889999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-39  Score=309.18  Aligned_cols=266  Identities=16%  Similarity=0.210  Sum_probs=187.1

Q ss_pred             cccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccC-----------CCcccceeeeecc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIR-----------HRNLIKVLTACLG   87 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~-----------h~nIv~~~~~~~~   87 (381)
                      .++|...+.||+|+||+||++..                ...+.+.+|++++++++           ||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            57899999999999999988752                13467889999999886           8999999999754


Q ss_pred             ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeeccCCCCee
Q 041757           88 VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP-VTAHCVLKPSNVL  166 (381)
Q Consensus        88 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivHrDlkp~Nil  166 (381)
                      .. .+....++||||+ +++|.+++..        .....+++..++.++.||+.||.|||   +. +|+||||||+|||
T Consensus        98 ~~-~~~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIl  164 (373)
T 1q8y_A           98 KG-PNGVHVVMVFEVL-GENLLALIKK--------YEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVL  164 (373)
T ss_dssp             EE-TTEEEEEEEECCC-CEEHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEE
T ss_pred             cC-CCCceEEEEEecC-CCCHHHHHHH--------hhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeE
Confidence            21 1234789999999 8899999953        22445899999999999999999999   66 9999999999999


Q ss_pred             eC------CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccc
Q 041757          167 LD------DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF  240 (381)
Q Consensus       167 l~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~  240 (381)
                      ++      ..+.+||+|||++........     ...||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          165 MEIVDSPENLIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EeccCCCcCcceEEEcccccccccCCCCC-----CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            94      445899999999987654322     2458999999999999899999999999999999999999986432


Q ss_pred             cCCC--c---HHHHHHHHhhchHHHHHhh------hhccC-----chhhhhcccchhhhhHHHHHHHHHHHHHHHHHhcc
Q 041757          241 EGDM--N---LHKFAKMALSNHVKDIVDS------ILLND-----DEKLVVRGDQKQTQAKINIIRECVISMVRIGVACS  304 (381)
Q Consensus       241 ~~~~--~---~~~~~~~~~~~~~~~~~~~------~l~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  304 (381)
                      ....  .   +...... .......+...      .....     ...................+...+.++.+++.+||
T Consensus       240 ~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  318 (373)
T 1q8y_A          240 GHSYTKDDDHIAQIIEL-LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  318 (373)
T ss_dssp             -----CHHHHHHHHHHH-HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             ccccCChHHHHHHHHHh-cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence            2110  0   1111110 00000000000      00000     00000000000001111233567889999999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 041757          305 MESPQDRMKMTNVVH  319 (381)
Q Consensus       305 ~~dP~~RPs~~~vl~  319 (381)
                      +.||.+|||+.|+++
T Consensus       319 ~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          319 QLDPRKRADAGGLVN  333 (373)
T ss_dssp             CSSTTTCBCHHHHHT
T ss_pred             ccCccccCCHHHHhh
Confidence            999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.2e-40  Score=300.63  Aligned_cols=243  Identities=19%  Similarity=0.276  Sum_probs=178.9

Q ss_pred             ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeecccc--------
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD--------   89 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--------   89 (381)
                      ..++|...+.||+|+||.||++..                ...+.+.+|+.++++++||||+++++++....        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457899999999999999988752                23567889999999999999999999875411        


Q ss_pred             ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC
Q 041757           90 YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD  169 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~  169 (381)
                      .......++||||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~  151 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIH---------SENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDE  151 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHH---------HSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred             cccCCceEEEEecCCCCCHHHhhh---------ccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcC
Confidence            123567899999999999999995         23456788999999999999999999   669999999999999999


Q ss_pred             CCCeEEeecccceecCCCCC------------cccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCC
Q 041757          170 DMTARVGDFGLARFLPPTRT------------QTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPS  236 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf  236 (381)
                      ++.+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~  228 (303)
T 1zy4_A          152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF  228 (303)
T ss_dssp             TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence            99999999999986643211            1111234589999999998764 68999999999999999998   54


Q ss_pred             CccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                      ....    .....        ...+...... .+.               ......+..+.+++.+||+.||.+|||+.+
T Consensus       229 ~~~~----~~~~~--------~~~~~~~~~~-~~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  280 (303)
T 1zy4_A          229 STGM----ERVNI--------LKKLRSVSIE-FPP---------------DFDDNKMKVEKKIIRLLIDHDPNKRPGART  280 (303)
T ss_dssp             SSHH----HHHHH--------HHHHHSTTCC-CCT---------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCch----hHHHH--------HHhccccccc-cCc---------------cccccchHHHHHHHHHHHhcCcccCcCHHH
Confidence            3110    00000        0001000000 000               011234557889999999999999999999


Q ss_pred             HHH
Q 041757          317 VVH  319 (381)
Q Consensus       317 vl~  319 (381)
                      +++
T Consensus       281 ll~  283 (303)
T 1zy4_A          281 LLN  283 (303)
T ss_dssp             HHH
T ss_pred             HhC
Confidence            986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3e-39  Score=303.65  Aligned_cols=261  Identities=17%  Similarity=0.168  Sum_probs=184.2

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCc------ccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRN------LIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~n------Iv~~~~~~~~~~~~   91 (381)
                      .++|...+.||+|+||+||++..                 ...+.+.+|+.++++++|+|      ++.+++++     .
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----~   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----N   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----E
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----e
Confidence            68999999999999999987641                 23467888999999997765      88888874     4


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee----
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL----  167 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill----  167 (381)
                      .....++||||+ +++|.+++..        .....+++..++.++.||+.||.|||   +.+|+||||||+|||+    
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~--------~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~  160 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKE--------NNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSE  160 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCC
T ss_pred             eCCeEEEEEecc-CCChHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccc
Confidence            477899999999 6678777742        22346899999999999999999999   7799999999999999    


Q ss_pred             ---------------CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhC
Q 041757          168 ---------------DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR  232 (381)
Q Consensus       168 ---------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg  232 (381)
                                     +.++.+||+|||+++.......     ...||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT-----TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccccccCCCcEEEeecCcccccccccc-----CCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence                           5678999999999987543322     24699999999999998999999999999999999999


Q ss_pred             CCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCch---hhhhcccc----------hhhhhHHHHHHHHHHHHHHH
Q 041757          233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDE---KLVVRGDQ----------KQTQAKINIIRECVISMVRI  299 (381)
Q Consensus       233 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~----------~~~~~~~~~~~~~~~~l~~l  299 (381)
                      ..||.....  .................+..........   ........          ...............++.++
T Consensus       236 ~~pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  313 (355)
T 2eu9_A          236 FTLFQTHEN--REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL  313 (355)
T ss_dssp             SCSCCCSSH--HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred             CCCCCCCCH--HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence            999863211  1111111111111111111110000000   00000000          00000000012345688999


Q ss_pred             HHhccCCCCCCCCCHHHHHH
Q 041757          300 GVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       300 ~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +.+||+.||++|||+.++++
T Consensus       314 i~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          314 MRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHhcCChhhCcCHHHHhc
Confidence            99999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=302.30  Aligned_cols=267  Identities=18%  Similarity=0.228  Sum_probs=181.0

Q ss_pred             hccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeecccc------
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD------   89 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------   89 (381)
                      ...++|...+.||+|+||.||++..                 ...+.+.+|++++++++||||+++++++....      
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            4568899999999999999988642                 23577899999999999999999999864211      


Q ss_pred             ---ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           90 ---YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        90 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                         .......++||||+. |+|.+++.           ...+++..++.++.|++.||.|||   +.+|+||||||+||+
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil  152 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLE-----------QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLF  152 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhh-----------cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEE
Confidence               134578899999997 59999983           245889999999999999999999   669999999999999


Q ss_pred             eC-CCCCeEEeecccceecCCCCCc-ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757          167 LD-DDMTARVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  243 (381)
Q Consensus       167 l~-~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~  243 (381)
                      ++ .++.+||+|||+++........ .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||....   
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---  229 (320)
T 2i6l_A          153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH---  229 (320)
T ss_dssp             EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred             EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC---
Confidence            97 5679999999999876533211 11122457899999998765 678999999999999999999999986322   


Q ss_pred             CcHHHHHHHH--hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          244 MNLHKFAKMA--LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       244 ~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       .........  ................+........ .............+.++.+++.+||+.||.+|||+.++++
T Consensus       230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          230 -ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMT-EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             -HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTT-SCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHHHhcCCCchhhhhhhhhcCccccccccc-CCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence             111111110  0000000000000000000000000 0000001112245678999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-39  Score=297.48  Aligned_cols=237  Identities=20%  Similarity=0.231  Sum_probs=186.0

Q ss_pred             hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      -...++|...++||+|+||.||++..                   ...+.+.+|++++++++||||+++++++     ..
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   92 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----ED   92 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eC
Confidence            33567899999999999999988642                   2457889999999999999999999995     44


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC--
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD--  170 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~--  170 (381)
                      ....++||||+++++|.+++.          ....+++..++.++.|++.||.|||   +.+++||||||+||+++.+  
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~  159 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEII----------KRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEK  159 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSST
T ss_pred             CCeEEEEEEccCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCC
Confidence            778999999999999999884          3456899999999999999999999   6699999999999999754  


Q ss_pred             -CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          171 -MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       171 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                       +.+||+|||++..........   ...||+.|+|||.+.+ .++.++||||||+++|+|++|..||....     ....
T Consensus       160 ~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~  230 (287)
T 2wei_A          160 DCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----EYDI  230 (287)
T ss_dssp             TCCEEECSTTGGGTBCCCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred             cccEEEeccCcceeecCCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-----HHHH
Confidence             479999999998665443222   2348999999998876 48999999999999999999999975321     1111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..        .+..........                .....+..+.+++.+||+.||.+|||+.++++
T Consensus       231 ~~--------~~~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          231 LK--------RVETGKYAFDLP----------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HH--------HHHHCCCCCCSG----------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH--------HHHcCCCCCCch----------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            11        111110000000                01234567889999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.5e-40  Score=306.30  Aligned_cols=237  Identities=20%  Similarity=0.294  Sum_probs=178.0

Q ss_pred             hccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccC--CCcccceeeeeccccccC
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIR--HRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~   92 (381)
                      ...++|...+.||+|+||.||++..                  ...+.+.+|++++.+++  ||||+++++++.     .
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~   99 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T   99 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----C
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----c
Confidence            3467899999999999999987641                  13467899999999997  599999999954     4


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++||| +.+++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||++++ +.
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~  164 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GM  164 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHH----------HCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TE
T ss_pred             CCEEEEEEe-cCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-Ce
Confidence            778999999 66889999994          4457899999999999999999999   669999999999999965 79


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-----------CccCcccchhhhhHHHHHHHhCCCCCCcccc
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-----------NEVSTIGDVYSYGILLLELMIREKPSDIMFE  241 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~  241 (381)
                      +||+|||++................||+.|+|||++.+           ..++.++||||||+++|+|++|..||.....
T Consensus       165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (313)
T 3cek_A          165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  244 (313)
T ss_dssp             EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence            99999999987654433222223568999999999865           4688899999999999999999999853221


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .   ...         ....++.......                  +...+..+.+++.+||+.||.+|||+.++++
T Consensus       245 ~---~~~---------~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          245 Q---ISK---------LHAIIDPNHEIEF------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             H---HHH---------HHHHHCTTSCCCC------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H---HHH---------HHHHHhcccccCC------------------cccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            1   111         1111111110000                  1123457889999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-40  Score=316.09  Aligned_cols=243  Identities=9%  Similarity=-0.001  Sum_probs=163.7

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc--CCCcccceeeeec------
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI--RHRNLIKVLTACL------   86 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l--~h~nIv~~~~~~~------   86 (381)
                      ..+|...++||+|+||.||++..                    ...+.+.+|+.+++.|  +||||++++..+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            45699999999999999988641                    2345667785544444  6999888653322      


Q ss_pred             -cccc------------cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHH------HHHHHHHHHHHHHh
Q 041757           87 -GVDY------------QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRR------LNIAIDVASALNYL  147 (381)
Q Consensus        87 -~~~~------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~~l~~L  147 (381)
                       ....            ......++|||||+ |+|.+++...         ...+....+      ..++.|++.||+||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---------~~~~~~~~~~~~~vk~~i~~qi~~aL~~L  210 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---------DFVYVFRGDEGILALHILTAQLIRLAANL  210 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---------HHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---------ccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence             1000            00145899999998 8999999532         222333344      67779999999999


Q ss_pred             hcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC--CccCcccchhhhhHH
Q 041757          148 HHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGIL  225 (381)
Q Consensus       148 H~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~i  225 (381)
                      |   +.+|+||||||+|||++.++.+||+|||+++.......     ...+|+.|+|||++.+  ..++.++|||||||+
T Consensus       211 H---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i  282 (371)
T 3q60_A          211 Q---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLS  282 (371)
T ss_dssp             H---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred             H---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence            9   66999999999999999999999999999987643221     1347799999999987  679999999999999


Q ss_pred             HHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccC
Q 041757          226 LLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSM  305 (381)
Q Consensus       226 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  305 (381)
                      +|||++|+.||..........               ..........         ...........++..+.+++.+||+
T Consensus       283 l~elltg~~Pf~~~~~~~~~~---------------~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~  338 (371)
T 3q60_A          283 IYRVWCLFLPFGLVTPGIKGS---------------WKRPSLRVPG---------TDSLAFGSCTPLPDFVKTLIGRFLN  338 (371)
T ss_dssp             HHHHHHSSCSTTBCCTTCTTC---------------CCBCCTTSCC---------CCSCCCTTSSCCCHHHHHHHHHHTC
T ss_pred             HHHHHhCCCCCCCcCcccccc---------------hhhhhhhhcc---------ccccchhhccCCCHHHHHHHHHHcC
Confidence            999999999986443221100               0000000000         0000000012345688999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 041757          306 ESPQDRMKMTNVVH  319 (381)
Q Consensus       306 ~dP~~RPs~~~vl~  319 (381)
                      .||++|||+.++++
T Consensus       339 ~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          339 FDRRRRLLPLEAME  352 (371)
T ss_dssp             SSTTTCCCHHHHTT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-39  Score=305.27  Aligned_cols=246  Identities=16%  Similarity=0.158  Sum_probs=162.8

Q ss_pred             hcccccccc-ceecCCCceEEEecccc------------cHHHHHHHHH-HHHccCCCcccceeeeeccccccCCceEEE
Q 041757           33 DVSRNMLEE-NLISAGTFGFSHLRRQG------------AFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        33 ~~~~~~~~~-~~lG~G~fg~V~~~~~~------------~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .+.++|... ++||+|+||+||++...            ......+|+. .++.+.||||+++++++... .......++
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~~l  103 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENM-HHGKRCLLI  103 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCceEEE
Confidence            457889985 57999999999887522            1123344444 45667899999999996541 122556899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CCCeEE
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DMTARV  175 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl  175 (381)
                      |||||++|+|.+++..        .....+++..++.++.|++.||.|||   ..+|+||||||+||+++.   ++.+||
T Consensus       104 v~e~~~gg~L~~~l~~--------~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A          104 IMECMEGGELFSRIQE--------RGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             EEECCTTEEHHHHHHT--------C-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             EEeccCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEE
Confidence            9999999999999953        22346999999999999999999999   669999999999999976   445999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+++........    ...||+.|+|||++.+..++.++||||||+++|+|++|..||............       
T Consensus       173 ~Dfg~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------  241 (336)
T 3fhr_A          173 TDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-------  241 (336)
T ss_dssp             CCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             eccccceeccccccc----cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-------
Confidence            999999876543322    245899999999998889999999999999999999999998533221100000       


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        ...+....... +.               .....++..+.+++.+||+.||.+|||+.++++
T Consensus       242 --~~~~~~~~~~~-~~---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          242 --KRRIRLGQYGF-PN---------------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----------CC-CT---------------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --HHhhhcccccc-Cc---------------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              00000000000 00               001234567889999999999999999999997

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.7e-39  Score=305.59  Aligned_cols=184  Identities=23%  Similarity=0.277  Sum_probs=154.8

Q ss_pred             ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccC-CCc-----ccceeeeecccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIR-HRN-----LIKVLTACLGVDYQ   91 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~-h~n-----Iv~~~~~~~~~~~~   91 (381)
                      ..++|...++||+|+||+||++..                .....+.+|++++..++ |+|     |+++++++.     
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~-----  126 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM-----  126 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE-----
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec-----
Confidence            468899999999999999988742                12456778999999885 554     888888854     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC--C
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD--D  169 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~--~  169 (381)
                      ..+..++||||+. |+|.+++..        .....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++  .
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRN--------TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPK  196 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTT
T ss_pred             cCCceEEEEecCC-CCHHHHHhh--------cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCC
Confidence            4678999999996 599999853        2234689999999999999999999964 56999999999999994  4


Q ss_pred             CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCC
Q 041757          170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSD  237 (381)
Q Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~  237 (381)
                      ++.+||+|||+++.......     ...||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       197 ~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQRIY-----QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             SCCEEECCCTTCEETTCCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCcEEEEeccCceecccccc-----cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            77899999999987754322     2468999999999999999999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.5e-40  Score=304.25  Aligned_cols=226  Identities=19%  Similarity=0.213  Sum_probs=183.1

Q ss_pred             hccccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccC--CCcccceeeeecc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIR--HRNLIKVLTACLG   87 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~   87 (381)
                      ...++|...++||+|+||.||++...                       ..+.+.+|+.++++++  |+||+++++++  
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~--  117 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--  117 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE--
Confidence            35788999999999999999886421                       1245678999999996  59999999995  


Q ss_pred             ccccCCceEEEEEEcccC-CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           88 VDYQGNDFKALVYEFMHN-RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        88 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                         ...+..++|||++.+ ++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+||+
T Consensus       118 ---~~~~~~~lv~e~~~~~~~L~~~l~----------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIl  181 (320)
T 3a99_A          118 ---ERPDSFVLILERPEPVQDLFDFIT----------ERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENIL  181 (320)
T ss_dssp             ---ECSSEEEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred             ---ecCCcEEEEEEcCCCCccHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEE
Confidence               457789999999976 89999994          4467899999999999999999999   669999999999999


Q ss_pred             eC-CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCC
Q 041757          167 LD-DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDM  244 (381)
Q Consensus       167 l~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~  244 (381)
                      ++ .++.+||+|||+++........    ...||+.|+|||++.+..+ +.++||||||+++|||++|+.||....    
T Consensus       182 l~~~~~~~kL~Dfg~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----  253 (320)
T 3a99_A          182 IDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----  253 (320)
T ss_dssp             EETTTTEEEECCCTTCEECCSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred             EeCCCCCEEEeeCcccccccccccc----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence            98 7789999999999877643322    2458999999999877665 788999999999999999999985210    


Q ss_pred             cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          245 NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                     +........                    ....+.++.+++.+||+.||.+|||+.++++
T Consensus       254 ---------------~~~~~~~~~--------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 ---------------EIIRGQVFF--------------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---------------HHHHCCCCC--------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------------hhhcccccc--------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                           111110000                    0124457889999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.9e-39  Score=310.97  Aligned_cols=246  Identities=18%  Similarity=0.259  Sum_probs=172.4

Q ss_pred             ccccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      ..+.|...++||+|+||+||...             ....+.+.+|+++|+++ +||||+++++++     .+....++|
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv   87 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA   87 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence            34556678999999999996432             22346788999999987 799999999984     457889999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC---------
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD---------  170 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---------  170 (381)
                      ||||. |+|.+++.......   ......++..++.++.||+.||.|||   +.+|+||||||+|||++.+         
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             ECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             EecCC-CCHHHHHhccCCCc---hhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCccccccccc
Confidence            99995 69999995322100   00011133346789999999999999   6699999999999999654         


Q ss_pred             ----CCeEEeecccceecCCCCCcc--cccCccCccceeCCCCcCC-------CccCcccchhhhhHHHHHHHh-CCCCC
Q 041757          171 ----MTARVGDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVG-------NEVSTIGDVYSYGILLLELMI-REKPS  236 (381)
Q Consensus       171 ----~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlG~il~el~t-g~~Pf  236 (381)
                          +.+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                489999999999876543211  1223569999999999865       568999999999999999999 99998


Q ss_pred             CccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041757          237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN  316 (381)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  316 (381)
                      ......    .           ..++..........             .......+.++.+++.+||+.||.+|||+.+
T Consensus       241 ~~~~~~----~-----------~~i~~~~~~~~~~~-------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (434)
T 2rio_A          241 GDKYSR----E-----------SNIIRGIFSLDEMK-------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMK  292 (434)
T ss_dssp             CSTTTH----H-----------HHHHHTCCCCCCCT-------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCchhh----H-----------HHHhcCCCCccccc-------------ccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence            532211    0           01111111000000             0001356678899999999999999999999


Q ss_pred             HHH
Q 041757          317 VVH  319 (381)
Q Consensus       317 vl~  319 (381)
                      |++
T Consensus       293 il~  295 (434)
T 2rio_A          293 VLR  295 (434)
T ss_dssp             HHT
T ss_pred             HHh
Confidence            985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=300.01  Aligned_cols=226  Identities=19%  Similarity=0.233  Sum_probs=176.1

Q ss_pred             hccccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHcc----CCCcccceeeee
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNI----RHRNLIKVLTAC   85 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l----~h~nIv~~~~~~   85 (381)
                      ...++|...++||+|+||.||++...                       ....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            35688999999999999999887421                       123355799999999    899999999995


Q ss_pred             ccccccCCceEEEEEEc-ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCC
Q 041757           86 LGVDYQGNDFKALVYEF-MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSN  164 (381)
Q Consensus        86 ~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~N  164 (381)
                           ...+..++|||| +.+++|.+++.          ....+++..++.++.|++.||.|||   +.+|+||||||+|
T Consensus       108 -----~~~~~~~~v~e~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~N  169 (312)
T 2iwi_A          108 -----ETQEGFMLVLERPLPAQDLFDYIT----------EKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDEN  169 (312)
T ss_dssp             ----------CEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGG
T ss_pred             -----ecCCeEEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhh
Confidence                 446778999999 78999999994          3456899999999999999999999   5699999999999


Q ss_pred             eeeC-CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          165 VLLD-DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       165 ill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      |+++ .++.+||+|||++.........    ...|+..|+|||++.+..+ +.++||||||+++|+|++|+.||...   
T Consensus       170 il~~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---  242 (312)
T 2iwi_A          170 ILIDLRRGCAKLIDFGSGALLHDEPYT----DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---  242 (312)
T ss_dssp             EEEETTTTEEEECCCSSCEECCSSCBC----CCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---
T ss_pred             EEEeCCCCeEEEEEcchhhhcccCccc----ccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---
Confidence            9998 7889999999999877654322    2458999999998877665 45899999999999999999998521   


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                      .+........                    +...+..+.+++.+||+.||++|||+.++++
T Consensus       243 ----------------~~~~~~~~~~--------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          243 ----------------QEILEAELHF--------------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----------------HHHHHTCCCC--------------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------HHHhhhccCC--------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                            0111111100                    1134557889999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=311.96  Aligned_cols=238  Identities=21%  Similarity=0.275  Sum_probs=169.8

Q ss_pred             ccccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      ...+|...++||+|+||+|+...             ......+.+|+++|+++ +|||||++++++     .+....++|
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv   96 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIA   96 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEE
Confidence            34579999999999999963321             12223467899999999 799999999984     457789999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-----CCCeE
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-----DMTAR  174 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-----~~~~k  174 (381)
                      ||||. |+|.+++..         ....+.+..++.++.||+.||.|||   +.+|+||||||+||+++.     ...+|
T Consensus        97 ~E~~~-g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~k  163 (432)
T 3p23_A           97 IELCA-ATLQEYVEQ---------KDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAM  163 (432)
T ss_dssp             EECCS-EEHHHHHHS---------SSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred             EECCC-CCHHHHHHh---------cCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEE
Confidence            99996 599999953         2233444556789999999999999   669999999999999943     34688


Q ss_pred             EeecccceecCCCCCc-ccccCccCccceeCCCCcC---CCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757          175 VGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGV---GNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~  249 (381)
                      |+|||+++........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.....     .. 
T Consensus       164 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~-  237 (432)
T 3p23_A          164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQ-  237 (432)
T ss_dssp             ECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HH-
T ss_pred             EecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HH-
Confidence            9999999877543221 1222356999999999987   4567889999999999999999 9999742211     00 


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...        +..........                ........+.+++.+||+.||.+|||+.+|++
T Consensus       238 ~~~--------~~~~~~~~~~~----------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          238 ANI--------LLGACSLDCLH----------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHH--------HTTCCCCTTSC----------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHH--------HhccCCccccC----------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            000        00000000000                01134456788999999999999999999984

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.2e-39  Score=299.88  Aligned_cols=241  Identities=21%  Similarity=0.238  Sum_probs=162.3

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHH-HHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .++|...+.||+|+||.||++..                  .....+.+|+. +++.++||||+++++++.     ..+.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence            57899999999999999987542                  12345666666 677789999999999954     4678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeeccCCCCeeeCCCCCeE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP-VTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivHrDlkp~Nill~~~~~~k  174 (381)
                      .++||||+.+ +|.+++.....     .....+++..+..++.|++.||.|||   .. +|+||||||+||+++.++.+|
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYS-----VLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHH-----TTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEE
T ss_pred             eEEEEeecCC-ChHHHHHHHHh-----hhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEE
Confidence            8999999975 88887742110     12567899999999999999999999   66 999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCc----CCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG----VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      |+|||+++.........   ...||+.|+|||++    .+..++.++||||||+++|+|++|+.||......        
T Consensus       167 l~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------  235 (327)
T 3aln_A          167 LCDFGISGQLVDSIAKT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--------  235 (327)
T ss_dssp             ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             EccCCCceecccccccc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--------
Confidence            99999998765433222   23589999999998    4567899999999999999999999998532110        


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              .+.+.......+.....           .....++..+.+++.+||+.||.+|||+.++++
T Consensus       236 --------~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          236 --------FDQLTQVVKGDPPQLSN-----------SEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ------------CCCCCSCCCCCCC-----------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------HHHHHHHhcCCCCCCCC-----------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                    00011111100000000           000134567899999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-38  Score=318.55  Aligned_cols=269  Identities=19%  Similarity=0.224  Sum_probs=187.1

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc-ccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~~~   95 (381)
                      .++|...++||+|+||.||++..                  ...+.+.+|++++++++||||+++++++.... ......
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            37899999999999999987542                  23567899999999999999999999965421 223677


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC---
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT---  172 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~---  172 (381)
                      .++|||||++|+|.+++...       .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.   
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~-------~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQF-------ENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSS-------SCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCE
T ss_pred             EEEEEEeCCCCCHHHHHHhc-------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCcee
Confidence            89999999999999999532       12235888899999999999999999   669999999999999987664   


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +||+|||++..........   ...||+.|+|||++.+..++.++||||||+++|+|++|..||....    ....+...
T Consensus       163 vKL~DFG~a~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~  235 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGELCT---EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGK  235 (676)
T ss_dssp             EEECSCCCCCBTTSCCCCC---CCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTT
T ss_pred             EEEcccccccccccccccc---cccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhh
Confidence            8999999998765543322   2569999999999999999999999999999999999999985321    00000000


Q ss_pred             HhhchHHHH-HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHHHHhhh
Q 041757          253 ALSNHVKDI-VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN-----VVHELQSIKN  326 (381)
Q Consensus       253 ~~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~-----vl~~L~~i~~  326 (381)
                      ......... .........   ...   .............+..+.+++.+||..||.+|||+.+     ..+.++.+..
T Consensus       236 i~~~~~~~~~~~~~l~g~~---~~~---~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          236 VREKSNEHIVVYDDLTGAV---KFS---SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CC------CCSCCCCSSSC---CCC---SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhcccchhhhhhhhhcccc---ccc---cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            000000000 000000000   000   0000000112345678899999999999999999988     4566666654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=293.94  Aligned_cols=235  Identities=17%  Similarity=0.190  Sum_probs=162.1

Q ss_pred             cccccccceecCCCceEEEecccc-------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      -++|...+.||+|+||.||++...                   ..+.+..+..+++.++||||+++++++.     ..+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence            478899999999999999886421                   1233444556788889999999999954     4678


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeeccCCCCeeeCCCCCeE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQP-VTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivHrDlkp~Nill~~~~~~k  174 (381)
                      .++||||+ ++.+..+..         .....+++..++.++.|++.||.|||   .. +|+||||||+||+++.++.+|
T Consensus        99 ~~lv~e~~-~~~~~~l~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~k  165 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKK---------RMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIK  165 (318)
T ss_dssp             EEEEECCC-SEEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEecc-CCcHHHHHH---------HhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEE
Confidence            99999999 555655553         22456899999999999999999999   53 899999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      |+|||++..........   ...||+.|+|||++.     ...++.++||||||+++|+|++|+.||....    .....
T Consensus       166 l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~  238 (318)
T 2dyl_A          166 LCDFGISGRLVDDKAKD---RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK----TDFEV  238 (318)
T ss_dssp             ECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC----SHHHH
T ss_pred             EEECCCchhccCCcccc---ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC----ccHHH
Confidence            99999997665433222   245899999999984     4568899999999999999999999985221    11111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..        .+........+.                 ...++..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~--------~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          239 LT--------KVLQEEPPLLPG-----------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HH--------HHHHSCCCCCCS-----------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HH--------HHhccCCCCCCc-----------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11        111100000000                 0124457889999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-38  Score=321.07  Aligned_cols=231  Identities=20%  Similarity=0.275  Sum_probs=181.2

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      +.++|.+.++||+|+||+||++..                   .....+.+|++++.+++||||+++++++...+.....
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            357899999999999999988642                   1235688999999999999999999997653222233


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..||||||+++++|.+++.          .  .+++..++.++.||+.||.|||   +.+|+||||||+|||++.+ .+|
T Consensus       158 ~~~lv~E~~~g~~L~~~~~----------~--~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~k  221 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKG----------Q--KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLK  221 (681)
T ss_dssp             EEEEEEECCCCEECC--------------C--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEE
T ss_pred             eeEEEEEeCCCCcHHHHHh----------C--CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEE
Confidence            3799999999999998772          2  6899999999999999999999   6699999999999999875 899


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.........         
T Consensus       222 l~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------  285 (681)
T 2pzi_A          222 LIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------  285 (681)
T ss_dssp             ECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------
T ss_pred             EEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc---------
Confidence            9999999876543      124699999999988764 488999999999999999999987533221110         


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHHHhhh
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-MTNVVHELQSIKN  326 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~vl~~L~~i~~  326 (381)
                       .           ..                  ........+.+++.+||+.||.+||+ +.++...|..+..
T Consensus       286 -~-----------~~------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          286 -E-----------DD------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             -T-----------TC------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             -c-----------cc------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence             0           00                  01234457889999999999999995 6667777776644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.6e-38  Score=286.47  Aligned_cols=219  Identities=12%  Similarity=0.043  Sum_probs=168.0

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..++|...+.||+|+||.||++..                    ...+.+.+|+.++.+++||||+++++++.     ..
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~  103 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TR  103 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----EC
Confidence            357899999999999999988642                    12378999999999999999999999954     46


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..|+||||+++++|.+++.          ..  ....++..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~----------~~--~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~  168 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVAD----------TS--PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDV  168 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHT----------TC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCE
T ss_pred             CcEEEEEEecCCCCHHHHHh----------cC--CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCE
Confidence            78999999999999999993          21  345578899999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+++|                      |++       .++.++|||||||++|||++|+.||............     
T Consensus       169 kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----  214 (286)
T 3uqc_A          169 VLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----  214 (286)
T ss_dssp             EECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----
T ss_pred             EEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----
Confidence            998543                      233       3688999999999999999999998643221100000     


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                               ...+...+            .........++.++.+++.+||+.||.+| |+.++++.|+++....
T Consensus       215 ---------~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          215 ---------ERDTAGQP------------IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             ---------CBCTTSCB------------CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             ---------HHHhccCC------------CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence                     00000000            00001112456678999999999999999 9999999999987654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-36  Score=279.72  Aligned_cols=226  Identities=16%  Similarity=0.208  Sum_probs=168.9

Q ss_pred             hcccccccc-ceecCCCceEEEeccc------------ccHHHHHHHHHHH-HccCCCcccceeeeeccccccCCceEEE
Q 041757           33 DVSRNMLEE-NLISAGTFGFSHLRRQ------------GAFKSFIAECKAL-RNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        33 ~~~~~~~~~-~~lG~G~fg~V~~~~~------------~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ...++|... ++||+|+||.||++..            .....+.+|+.++ +.++||||+++++++... .......++
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~~l   92 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCLLI   92 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceEEE
Confidence            345677776 7899999999988753            1346788999998 555899999999996531 223667899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CCCeEE
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DMTARV  175 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl  175 (381)
                      ||||+++|+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.   ++.+||
T Consensus        93 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl  161 (299)
T 3m2w_A           93 VMECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKL  161 (299)
T ss_dssp             EECCCCSCBHHHHHHH--------CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             EEeecCCCcHHHHHHh--------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEE
Confidence            9999999999999953        22346999999999999999999999   669999999999999998   789999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||++....                        +..++.++|||||||++|||++|..||........          .
T Consensus       162 ~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~  207 (299)
T 3m2w_A          162 TDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------S  207 (299)
T ss_dssp             CCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------
T ss_pred             eccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------h
Confidence            9999986432                        23578899999999999999999999853211100          0


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..   .........            ..........++.++.+++.+||+.||.+|||+.++++
T Consensus       208 ~~---~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          208 PG---MKTRIRMGQ------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CC---SCCSSCTTC------------CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH---HHHHHhhcc------------ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00   000000000            00000111245678899999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=8.9e-37  Score=293.27  Aligned_cols=236  Identities=15%  Similarity=0.119  Sum_probs=170.1

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCC-Ccccceeee--------
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRH-RNLIKVLTA--------   84 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h-~nIv~~~~~--------   84 (381)
                      ..++|..+++||+|+||+||++..                    ...+.+.+|+.+++.+.| +|...+..+        
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345688899999999999988762                    125778999999999987 332221111        


Q ss_pred             -e------------ccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 041757           85 -C------------LGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC  151 (381)
Q Consensus        85 -~------------~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  151 (381)
                       +            ...........+++|+++ +++|.+++.......   .....+++..++.++.|++.||.|||   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH---  228 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---STHKSLVHHARLQLTLQVIRLLASLH---  228 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc---ccCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence             0            000000123456777766 679999984221000   23456888999999999999999999   


Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCc----------CCCccCcccchhh
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYG----------VGNEVSTIGDVYS  221 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~sDiwS  221 (381)
                      +.+|+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          ....++.++||||
T Consensus       229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence            669999999999999999999999999999875443     222457 999999998          6667899999999


Q ss_pred             hhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHH
Q 041757          222 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGV  301 (381)
Q Consensus       222 lG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  301 (381)
                      |||++|||++|+.||........                 ....+...                    ...+..+.+++.
T Consensus       303 lGvil~elltg~~Pf~~~~~~~~-----------------~~~~~~~~--------------------~~~~~~~~~li~  345 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALGG-----------------SEWIFRSC--------------------KNIPQPVRALLE  345 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSC-----------------SGGGGSSC--------------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCcchhhh-----------------HHHHHhhc--------------------ccCCHHHHHHHH
Confidence            99999999999999863321110                 00101000                    123467899999


Q ss_pred             hccCCCCCCCCCHHHHHH
Q 041757          302 ACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       302 ~cl~~dP~~RPs~~~vl~  319 (381)
                      +||+.||.+|||+.++++
T Consensus       346 ~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          346 GFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHTCSSGGGSCCHHHHTT
T ss_pred             HHccCChhhCcCHHHHHh
Confidence            999999999999877754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5e-36  Score=280.30  Aligned_cols=232  Identities=14%  Similarity=0.096  Sum_probs=170.0

Q ss_pred             cccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccC---------CCccccee
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIR---------HRNLIKVL   82 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~---------h~nIv~~~   82 (381)
                      .++|...++||+|+||+||+++..                       ..+.+.+|+.+|+.++         |||||++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            578999999999999999886421                       1278999999999886         55555555


Q ss_pred             eee-----------------ccc--------cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHH
Q 041757           83 TAC-----------------LGV--------DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIA  137 (381)
Q Consensus        83 ~~~-----------------~~~--------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  137 (381)
                      +++                 ...        ++......++|||||++|++.+.+.           ...+++..++.++
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----------~~~~~~~~~~~i~  167 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----------TKLSSLATAKSIL  167 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----------TTCCCHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----------hcCCCHHHHHHHH
Confidence            543                 210        0113678999999999997777662           2457999999999


Q ss_pred             HHHHHHHHHhh-cCCCCCceeeccCCCCeeeCCCC--------------------CeEEeecccceecCCCCCcccccCc
Q 041757          138 IDVASALNYLH-HDCQPVTAHCVLKPSNVLLDDDM--------------------TARVGDFGLARFLPPTRTQTSSIDV  196 (381)
Q Consensus       138 ~qi~~~l~~LH-~~~~~~ivHrDlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~  196 (381)
                      .||+.||.||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....       ..
T Consensus       168 ~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~  237 (336)
T 2vuw_A          168 HQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IV  237 (336)
T ss_dssp             HHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EE
T ss_pred             HHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cE
Confidence            99999999999 55   899999999999999887                    8999999999876532       14


Q ss_pred             cCccceeCCCCcCCCccCcccchhhhhHH-HHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhh
Q 041757          197 KGSIGYIAPEYGVGNEVSTIGDVYSYGIL-LLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVV  275 (381)
Q Consensus       197 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~i-l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  275 (381)
                      .||+.|+|||++.+.. +.++|||||+++ .+++++|..||...        .+.    ......+.........     
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~----~~~~~~~~~~~~~~~~-----  299 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWL----HYLTDKMLKQMTFKTK-----  299 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHH----HHHHHHHHHTCCCSSC-----
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhh----hHHHHhhhhhhccCcc-----
Confidence            6999999999998766 889999998777 77788899985310        000    0001111111000000     


Q ss_pred             cccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041757          276 RGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVV  318 (381)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl  318 (381)
                              .........+.++.+|+.+||+.|     |+.|++
T Consensus       300 --------~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          300 --------CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             --------CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             --------cchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence                    001124567889999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.5e-31  Score=266.05  Aligned_cols=153  Identities=20%  Similarity=0.078  Sum_probs=114.0

Q ss_pred             cHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHH
Q 041757           59 AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIA  137 (381)
Q Consensus        59 ~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  137 (381)
                      ..++|.+|+++|+++ .|+||++++++     ++++...||||||++|++|.++|.          ....++..   +|+
T Consensus       284 ~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~~~yLVMEyv~G~~L~d~i~----------~~~~l~~~---~I~  345 (569)
T 4azs_A          284 NKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQSGWLVMEKLPGRLLSDMLA----------AGEEIDRE---KIL  345 (569)
T ss_dssp             HHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSSEEEEEEECCCSEEHHHHHH----------TTCCCCHH---HHH
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECCEEEEEEecCCCCcHHHHHH----------hCCCCCHH---HHH
Confidence            456799999999999 69999999999     567889999999999999999994          44556654   578


Q ss_pred             HHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCccc
Q 041757          138 IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG  217 (381)
Q Consensus       138 ~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~s  217 (381)
                      .||+.||.|+|   +.|||||||||+|||++.++.+||+|||+|+..........  ..+||+.|+|||++.+ .+..++
T Consensus       346 ~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~--t~vGTp~YmAPE~l~g-~~~~~~  419 (569)
T 4azs_A          346 GSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT--NLVQSFFVFVNELFAE-NKSWNG  419 (569)
T ss_dssp             HHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH--HHHHHHHHHHHHHC---------
T ss_pred             HHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc--CceechhhccHHHhCC-CCCCcc
Confidence            99999999999   66999999999999999999999999999987765433222  2579999999999876 467789


Q ss_pred             chhhhhHHHHHHHhCCCC
Q 041757          218 DVYSYGILLLELMIREKP  235 (381)
Q Consensus       218 DiwSlG~il~el~tg~~P  235 (381)
                      |+||+|++++++.++..+
T Consensus       420 d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          420 FWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---------CCCCTTHHH
T ss_pred             cccccccchhhhccccch
Confidence            999999998887665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=8.4e-28  Score=237.74  Aligned_cols=170  Identities=16%  Similarity=0.137  Sum_probs=130.1

Q ss_pred             cccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           39 LEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ...++||+|+||.||++..                       ...+++.+|+++|++++||||+++..++.     ..+.
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~~~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-----DLDN  413 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-----ETTT
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-----eCCc
Confidence            3457899999999994320                       12355899999999999999995544432     2445


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|||||++++|.+++.          .        +..++.|++.||.|||   +.+|+||||||+|||++.  .+||
T Consensus       414 ~~lVmE~~~ggsL~~~l~----------~--------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL  470 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIE----------D--------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYI  470 (540)
T ss_dssp             TEEEEECCCSEEHHHHST----------T--------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEE
T ss_pred             cEEEEECCCCCCHHHHHH----------H--------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEE
Confidence            699999999999999994          2        5689999999999999   669999999999999998  9999


Q ss_pred             eecccceecCCCCCcc-----cccCccCccceeCCCCcCC--CccCcccchhhhhHHHHHHHhCCCCC
Q 041757          176 GDFGLARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVG--NEVSTIGDVYSYGILLLELMIREKPS  236 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~el~tg~~Pf  236 (381)
                      +|||+++.........     ......||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|
T Consensus       471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9999999876532211     1123569999999999887  66888899999999988888777765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=1.7e-22  Score=183.63  Aligned_cols=130  Identities=15%  Similarity=0.025  Sum_probs=102.0

Q ss_pred             ccccccceecCCCceEEEecccc----------------------------------cHHHHHHHHHHHHccCCCcccce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG----------------------------------AFKSFIAECKALRNIRHRNLIKV   81 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~----------------------------------~~~~~~~E~~~l~~l~h~nIv~~   81 (381)
                      ..|..++.||+|+||.||++...                                  ....+.+|+.+|++++  | +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            33556699999999999886420                                  2456889999999999  5 666


Q ss_pred             eeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccC
Q 041757           82 LTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLK  161 (381)
Q Consensus        82 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlk  161 (381)
                      ++++.      .+..++||||+++|+|.+ +.          .      .....++.|++.||.|||   +.+|+|||||
T Consensus       167 ~~~~~------~~~~~lvmE~~~g~~L~~-l~----------~------~~~~~i~~qi~~~l~~lH---~~giiHrDlk  220 (282)
T 1zar_A          167 PKVYA------WEGNAVLMELIDAKELYR-VR----------V------ENPDEVLDMILEEVAKFY---HRGIVHGDLS  220 (282)
T ss_dssp             CCEEE------EETTEEEEECCCCEEGGG-CC----------C------SCHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred             CeEEe------ccceEEEEEecCCCcHHH-cc----------h------hhHHHHHHHHHHHHHHHH---HCCCEeCCCC
Confidence            66531      244699999999999988 52          1      123469999999999999   6699999999


Q ss_pred             CCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC
Q 041757          162 PSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG  210 (381)
Q Consensus       162 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  210 (381)
                      |+|||++ ++.+||+|||+++.               +..++|||++..
T Consensus       221 p~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          221 QYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             TTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             HHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            9999999 99999999999863               344678887643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=3e-18  Score=153.60  Aligned_cols=120  Identities=22%  Similarity=0.133  Sum_probs=92.5

Q ss_pred             ccccceecCCCceEEEeccc--------ccH-----------------------------------HHHHHHHHHHHccC
Q 041757           38 MLEENLISAGTFGFSHLRRQ--------GAF-----------------------------------KSFIAECKALRNIR   74 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~--------~~~-----------------------------------~~~~~E~~~l~~l~   74 (381)
                      |...+.||+|+||.||++..        -.+                                   ..+.+|+.+|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            66789999999999987643        111                                   25788999999998


Q ss_pred             CCcc--cceeeeeccccccCCceEEEEEEcccC-C----CHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHh
Q 041757           75 HRNL--IKVLTACLGVDYQGNDFKALVYEFMHN-R----SLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYL  147 (381)
Q Consensus        75 h~nI--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L  147 (381)
                      |+||  ..+++.         ...+|||||+.+ |    +|.++..             ..++..+..++.|++.||.||
T Consensus       129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~-------------~~~~~~~~~i~~qi~~~l~~l  186 (258)
T 1zth_A          129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGR-------------ELKELDVEGIFNDVVENVKRL  186 (258)
T ss_dssp             HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGG-------------GGGGSCHHHHHHHHHHHHHHH
T ss_pred             hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhh-------------ccChHHHHHHHHHHHHHHHHH
Confidence            8864  333332         245899999942 4    6666542             123446778999999999999


Q ss_pred             h-cCCCCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757          148 H-HDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL  184 (381)
Q Consensus       148 H-~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~  184 (381)
                      | +.   +|+||||||+|||++.  .++|+|||+|...
T Consensus       187 H~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          187 YQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9 65   9999999999999988  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.58  E-value=5.3e-16  Score=145.12  Aligned_cols=128  Identities=9%  Similarity=0.022  Sum_probs=83.3

Q ss_pred             ccccceecCCCceEEEecccc------------------------------cHHHHHHHHHHHHccCCCcccceeeeecc
Q 041757           38 MLEENLISAGTFGFSHLRRQG------------------------------AFKSFIAECKALRNIRHRNLIKVLTACLG   87 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~~------------------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~   87 (381)
                      |.+++.||.|+||.||++...                              .....+.++++.....|+|+++++.....
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            888999999999999886410                              01122223333333333343333322110


Q ss_pred             cc-ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCee
Q 041757           88 VD-YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL  166 (381)
Q Consensus        88 ~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nil  166 (381)
                      .. .-.....+|||||++|++|.++..          .      .....++.|++.+|.+||   ..|||||||||.|||
T Consensus       177 vp~p~~~~~~~LVME~i~G~~L~~l~~----------~------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          177 VPEPIAQSRHTIVMSLVDALPMRQVSS----------V------PDPASLYADLIALILRLA---KHGLIHGDFNEFNIL  237 (397)
T ss_dssp             CCCEEEEETTEEEEECCSCEEGGGCCC----------C------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred             CCeeeeccCceEEEEecCCccHhhhcc----------c------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEE
Confidence            00 000112379999999988876542          1      123567899999999999   569999999999999


Q ss_pred             eCCCC----------CeEEeecccceec
Q 041757          167 LDDDM----------TARVGDFGLARFL  184 (381)
Q Consensus       167 l~~~~----------~~kl~Dfg~~~~~  184 (381)
                      ++.++          .+.|+||+.+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98766          3889999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.11  E-value=7.2e-11  Score=105.46  Aligned_cols=127  Identities=14%  Similarity=-0.017  Sum_probs=95.0

Q ss_pred             ccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .+|.....+|.|+++.||....               .....+.+|+++++.+. +.++.++++++.     ..+..|+|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv   88 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNLL   88 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEEE
Confidence            4577777788888888866431               22346889999999995 677888888843     46778999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcC-----------------------------
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHD-----------------------------  150 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----------------------------  150 (381)
                      |||++|.+|.+.+..               ......++.+++.+|..||+-                             
T Consensus        89 ~e~i~G~~l~~~~~~---------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T 3tm0_A           89 MSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             EECCSSEEHHHHCCT---------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             EEecCCeehhhccCC---------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence            999999999876410               112246788899999999961                             


Q ss_pred             ---------------------------CCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          151 ---------------------------CQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       151 ---------------------------~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                                                 ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                       01458999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.90  E-value=1.9e-09  Score=95.79  Aligned_cols=99  Identities=16%  Similarity=0.083  Sum_probs=70.8

Q ss_pred             HHHHHHHHHHHccCCCc--ccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHH
Q 041757           61 KSFIAECKALRNIRHRN--LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAI  138 (381)
Q Consensus        61 ~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  138 (381)
                      ..+.+|+.+++.+.+.+  +.+++++.     ...+..++||||++|.+|.  ..          .   .+   ...++.
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~~~~~v~e~i~G~~l~--~~----------~---~~---~~~~~~  114 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPGQDLL--SS----------H---LA---PAEKVS  114 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSSEETT--TS----------C---CC---HHHHHH
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCCCCEEEEEecCCcccC--cC----------c---CC---HhHHHH
Confidence            56789999999996544  45577763     3356689999999998884  21          0   01   124566


Q ss_pred             HHHHHHHHhhcCC-------------------------------------------------------CCCceeeccCCC
Q 041757          139 DVASALNYLHHDC-------------------------------------------------------QPVTAHCVLKPS  163 (381)
Q Consensus       139 qi~~~l~~LH~~~-------------------------------------------------------~~~ivHrDlkp~  163 (381)
                      +++..|..||...                                                       ...++|+|++|.
T Consensus       115 ~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~  194 (264)
T 1nd4_A          115 IMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLP  194 (264)
T ss_dssp             HHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGG
T ss_pred             HHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCC
Confidence            6777777777431                                                       123999999999


Q ss_pred             CeeeCCCCCeEEeecccce
Q 041757          164 NVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       164 Nill~~~~~~kl~Dfg~~~  182 (381)
                      ||+++++..++|+|||.+.
T Consensus       195 Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          195 NIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GEEEETTEEEEECCCTTCE
T ss_pred             cEEEECCcEEEEEcchhcc
Confidence            9999877667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.87  E-value=5.3e-09  Score=97.80  Aligned_cols=131  Identities=13%  Similarity=0.118  Sum_probs=94.7

Q ss_pred             cccceecCCCceEEEeccc---------c---------cHHHHHHHHHHHHccC--CCcccceeeeeccccccCCceEEE
Q 041757           39 LEENLISAGTFGFSHLRRQ---------G---------AFKSFIAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~~---------~---------~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ...+.|+.|.++.||+...         .         ....+.+|+.+++.|.  +..+.+++.++.+.  ...+..++
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~~  118 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAFY  118 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCEE
T ss_pred             ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeEE
Confidence            3457788888888866421         1         1346788999999997  45678888886431  11245789


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC---------------------------
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC---------------------------  151 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------  151 (381)
                      ||||++|..+.+..            ...++..+...++.+++..|..||...                           
T Consensus       119 vme~v~G~~l~~~~------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY  186 (359)
T ss_dssp             EEECCCCBCCCCTT------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred             EEEecCCeecCCCc------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence            99999998775422            223677788889999999999999620                           


Q ss_pred             ----------------------------CCCceeeccCCCCeeeCCCCC--eEEeeccccee
Q 041757          152 ----------------------------QPVTAHCVLKPSNVLLDDDMT--ARVGDFGLARF  183 (381)
Q Consensus       152 ----------------------------~~~ivHrDlkp~Nill~~~~~--~kl~Dfg~~~~  183 (381)
                                                  ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                        257999999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.81  E-value=2.7e-09  Score=97.46  Aligned_cols=180  Identities=16%  Similarity=0.145  Sum_probs=108.1

Q ss_pred             cceecCCCceEEEeccc----------ccHHHHHHHHHHHHccC-CCc--ccceeeeeccccccCCceEEEEEEcccCCC
Q 041757           41 ENLISAGTFGFSHLRRQ----------GAFKSFIAECKALRNIR-HRN--LIKVLTACLGVDYQGNDFKALVYEFMHNRS  107 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~~----------~~~~~~~~E~~~l~~l~-h~n--Iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~  107 (381)
                      .+.++.|.+..||....          .....+.+|+++|+.+. +..  +.+++.....  .......|+|||+++|.+
T Consensus        25 i~~~~~G~~n~v~~v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm~~i~G~~  102 (304)
T 3sg8_A           25 IEISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGFTKIKGVP  102 (304)
T ss_dssp             CCEEEECSSEEEEESTTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEEECCCCEE
T ss_pred             eEecCCCCcceEEEECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEEcccCCeE
Confidence            35588888888876431          13467889999999884 333  3344444211  111124589999999988


Q ss_pred             HHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 041757          108 LKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHD-------------------------------------  150 (381)
Q Consensus       108 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------------------------------------  150 (381)
                      |.....            ..++..+...++.+++..|..||+-                                     
T Consensus       103 l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A          103 LTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             CCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             CCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            765331            2345556666667777777666641                                     


Q ss_pred             ------------------CCCCceeeccCCCCeeeCC--CCCeEEeecccceecCCCCCcccccCc---cCcc-------
Q 041757          151 ------------------CQPVTAHCVLKPSNVLLDD--DMTARVGDFGLARFLPPTRTQTSSIDV---KGSI-------  200 (381)
Q Consensus       151 ------------------~~~~ivHrDlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~---~gt~-------  200 (381)
                                        ....++|+|++|.||+++.  +..+.|+||+.+...............   .+..       
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence                              1245899999999999988  456789999988764321111000000   0000       


Q ss_pred             ce--eC-CCCcCCCccCcccchhhhhHHHHHHHhCCCCC
Q 041757          201 GY--IA-PEYGVGNEVSTIGDVYSYGILLLELMIREKPS  236 (381)
Q Consensus       201 ~y--~a-PE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf  236 (381)
                      .|  .. |+...  ......+.|+++.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            01  00 11100  1122258899999999999998774

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.08  E-value=1.6e-05  Score=72.28  Aligned_cols=65  Identities=12%  Similarity=0.091  Sum_probs=42.3

Q ss_pred             ceecCCCceEEEecc---------c-ccHHHHHHHHHHHHccCCC---cccceeeeeccccccCCceEEEEEEcccCCCH
Q 041757           42 NLISAGTFGFSHLRR---------Q-GAFKSFIAECKALRNIRHR---NLIKVLTACLGVDYQGNDFKALVYEFMHNRSL  108 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~---------~-~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  108 (381)
                      +.++.|....||...         . .....+.+|+++|..|.+.   .+.+++.++.    ...+..++||||++|.+|
T Consensus        25 ~~l~~G~~n~v~~vg~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~i~G~~l  100 (306)
T 3tdw_A           25 ESLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRKVQGQIL  100 (306)
T ss_dssp             EEEEECSSEEEEEETTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEECCCSEEC
T ss_pred             eecCCCcceeEEEECCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEeccCCeEC
Confidence            345556655554431         1 2346788999999999753   3455555532    234567899999999888


Q ss_pred             HH
Q 041757          109 KE  110 (381)
Q Consensus       109 ~~  110 (381)
                      .+
T Consensus       101 ~~  102 (306)
T 3tdw_A          101 GE  102 (306)
T ss_dssp             HH
T ss_pred             ch
Confidence            65

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.99  E-value=1.9e-05  Score=70.17  Aligned_cols=107  Identities=17%  Similarity=0.050  Sum_probs=71.4

Q ss_pred             cccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHH
Q 041757           57 QGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLN  135 (381)
Q Consensus        57 ~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~  135 (381)
                      ......+.+|...|+.+. +--+.++++++.     +.+..++|||+++|.++.+.....              ......
T Consensus        60 ~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l~G~~~~~~~~~~--------------~~~~~~  120 (272)
T 4gkh_A           60 GSVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAIPGKTAFQVLEEY--------------PDSGEN  120 (272)
T ss_dssp             THHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECCCSEEHHHHHHHC--------------GGGHHH
T ss_pred             CCCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEeeCCccccccccCC--------------HHHHHH
Confidence            445567889999999885 334667777743     356789999999998877654210              011122


Q ss_pred             HHHHHHHHHHHhhcC-------------------------------------------------------CCCCceeecc
Q 041757          136 IAIDVASALNYLHHD-------------------------------------------------------CQPVTAHCVL  160 (381)
Q Consensus       136 i~~qi~~~l~~LH~~-------------------------------------------------------~~~~ivHrDl  160 (381)
                      +..+++..|.-||.-                                                       ....++|+|+
T Consensus       121 ~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl  200 (272)
T 4gkh_A          121 IVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDF  200 (272)
T ss_dssp             HHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCC
T ss_pred             HHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCC
Confidence            334444444444421                                                       0224799999


Q ss_pred             CCCCeeeCCCCCeEEeecccce
Q 041757          161 KPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       161 kp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      .+.||+++.++.+-|+||+.+.
T Consensus       201 ~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          201 SLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCeEEEECCeEEEEEECcccc
Confidence            9999999987777899998774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.51  E-value=0.00016  Score=67.00  Aligned_cols=31  Identities=26%  Similarity=0.250  Sum_probs=26.2

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ...++|+|+.|.||+++++..+.|+||+.+.
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            4579999999999999865457899999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.31  E-value=0.00089  Score=61.27  Aligned_cols=31  Identities=23%  Similarity=0.234  Sum_probs=27.7

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5689999999999999877889999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.28  E-value=0.00055  Score=58.05  Aligned_cols=103  Identities=15%  Similarity=0.114  Sum_probs=65.6

Q ss_pred             CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecC
Q 041757          106 RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLP  185 (381)
Q Consensus       106 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~  185 (381)
                      -+|.+.|.         ....+++++++|.++.|.+.+|.-+-..  ..-..+=+.|..|++..+|.+.+.+ +.+.   
T Consensus        33 vSL~eIL~---------~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---   97 (229)
T 2yle_A           33 LSLEEILR---------LYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---   97 (229)
T ss_dssp             EEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C------
T ss_pred             ccHHHHHH---------HcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc---
Confidence            47888886         4578899999999999999998876211  0111233557888888888887664 1110   


Q ss_pred             CCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCC
Q 041757          186 PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP  235 (381)
Q Consensus       186 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~P  235 (381)
                                 .....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus        98 -----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                       0233466888763 3445677899999999998854433

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.00  E-value=0.0013  Score=61.88  Aligned_cols=30  Identities=17%  Similarity=0.171  Sum_probs=25.9

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ...++|+|+.|.||+++.+ .++++||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            5689999999999999876 48999998775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.69  E-value=0.0056  Score=55.49  Aligned_cols=63  Identities=16%  Similarity=0.095  Sum_probs=44.5

Q ss_pred             cceecCCCceEEEecc------------cccHHHHHHHHHHHHccC---CCcccceeeeeccccccCCceEEEEEEcccC
Q 041757           41 ENLISAGTFGFSHLRR------------QGAFKSFIAECKALRNIR---HRNLIKVLTACLGVDYQGNDFKALVYEFMHN  105 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~------------~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~  105 (381)
                      .+.|+.|.+..+|...            ......+.+|+..|+.|.   ...+.+++.++.     ..+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEeccC
Confidence            4567777777665432            233567889999999884   356778887743     34678999999999


Q ss_pred             CCH
Q 041757          106 RSL  108 (381)
Q Consensus       106 g~L  108 (381)
                      .++
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.31  E-value=0.01  Score=53.29  Aligned_cols=31  Identities=19%  Similarity=0.251  Sum_probs=25.6

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ...++|+|+.+.||+ ..++.+.++||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            456899999999999 5566789999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.35  E-value=0.021  Score=53.17  Aligned_cols=31  Identities=23%  Similarity=0.273  Sum_probs=26.7

Q ss_pred             CCCceeeccCCCCeeeCCC----CCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDD----MTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~  182 (381)
                      ...++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             CEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            4579999999999999876    689999998764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=94.43  E-value=0.0029  Score=61.21  Aligned_cols=28  Identities=14%  Similarity=0.135  Sum_probs=24.4

Q ss_pred             HHHHHHHHHHHHccCCCcccceeeeecc
Q 041757           60 FKSFIAECKALRNIRHRNLIKVLTACLG   87 (381)
Q Consensus        60 ~~~~~~E~~~l~~l~h~nIv~~~~~~~~   87 (381)
                      .+.|..|++.+.+++|+|+|+++|||..
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s  350 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRT  350 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcC
Confidence            5689999999999999999999999864

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.31  E-value=0.04  Score=51.96  Aligned_cols=32  Identities=19%  Similarity=0.196  Sum_probs=28.2

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccceec
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARFL  184 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~  184 (381)
                      ...++|+|++|.||+++.++ ++++||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            66899999999999998776 999999988653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=94.00  E-value=0.072  Score=47.30  Aligned_cols=61  Identities=13%  Similarity=-0.067  Sum_probs=38.5

Q ss_pred             cccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCC---CcccceeeeeccccccCCceEEEE
Q 041757           39 LEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRH---RNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        39 ~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      ...+.+|.|..+.||..+.                .....|..|+..|+.|.-   --+.+++++.         ..++|
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~lv   88 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRTLA   88 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTEEE
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------CceEE
Confidence            3446677777777765431                112457889999998852   2345555541         23789


Q ss_pred             EEcccCCCH
Q 041757          100 YEFMHNRSL  108 (381)
Q Consensus       100 ~e~~~~g~L  108 (381)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=92.60  E-value=0.13  Score=46.62  Aligned_cols=32  Identities=25%  Similarity=0.227  Sum_probs=27.6

Q ss_pred             CCCceeeccCCCCeeeCCC----CCeEEeeccccee
Q 041757          152 QPVTAHCVLKPSNVLLDDD----MTARVGDFGLARF  183 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~~~~  183 (381)
                      ...++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            5689999999999999874    6789999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=91.88  E-value=0.04  Score=49.74  Aligned_cols=31  Identities=26%  Similarity=0.180  Sum_probs=26.3

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ..+++|+|+.+.||+++++..+.|+||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            4579999999999999877666899998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=91.08  E-value=0.22  Score=44.81  Aligned_cols=29  Identities=24%  Similarity=0.212  Sum_probs=25.3

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ...++|+|+++.||+++ + .+.|+||+.+.
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            55789999999999998 4 89999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=88.07  E-value=0.17  Score=46.55  Aligned_cols=30  Identities=23%  Similarity=0.297  Sum_probs=24.8

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ...++|+|+.+.||+++++. +.|+||..+.
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            45799999999999998654 8999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=87.24  E-value=0.17  Score=46.08  Aligned_cols=32  Identities=19%  Similarity=0.293  Sum_probs=27.8

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45799999999999999878899999987653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=87.24  E-value=0.57  Score=44.64  Aligned_cols=36  Identities=25%  Similarity=0.251  Sum_probs=25.0

Q ss_pred             HHHHHHHHccCCCcc-cceeeeeccccccCCceEEEEEEcccCCCH
Q 041757           64 IAECKALRNIRHRNL-IKVLTACLGVDYQGNDFKALVYEFMHNRSL  108 (381)
Q Consensus        64 ~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  108 (381)
                      .+|..++..|...++ .++++.+     . +   .+||||++|.+|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~I~G~~l  188 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEFMDGYAL  188 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEECCCSEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEeeCCccC
Confidence            489999999975454 4566653     1 1   359999988554

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.50  E-value=2.8  Score=35.20  Aligned_cols=89  Identities=17%  Similarity=0.244  Sum_probs=63.2

Q ss_pred             CcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCC
Q 041757          126 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAP  205 (381)
Q Consensus       126 ~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  205 (381)
                      ..++...+++++..|+.-..+++     .-+|--|.|+|++++.++.+++.-.|+-..+                   +|
T Consensus        76 k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P  131 (215)
T 4ann_A           76 KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFFTRDGLPIAKTRGLQNVV-------------------DP  131 (215)
T ss_dssp             GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEECTTSCEEESCCEETTTB-------------------SC
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEEcCCCCEEEEEccCccCC-------------------CC
Confidence            45778889999999998887776     3467789999999999999999877764221                   22


Q ss_pred             CCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCC
Q 041757          206 EYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  243 (381)
Q Consensus       206 E~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~  243 (381)
                      .     ..+...=.-.+=+++..+++++..|..-..|.
T Consensus       132 ~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~  164 (215)
T 4ann_A          132 L-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGN  164 (215)
T ss_dssp             C-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSC
T ss_pred             C-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcCh
Confidence            2     11111123356788888999999886554444

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=84.57  E-value=0.31  Score=46.00  Aligned_cols=39  Identities=23%  Similarity=0.380  Sum_probs=26.9

Q ss_pred             HHHHHHHHHHHccCCCcc-cceeeeeccccccCCceEEEEEEcccCCCH
Q 041757           61 KSFIAECKALRNIRHRNL-IKVLTACLGVDYQGNDFKALVYEFMHNRSL  108 (381)
Q Consensus        61 ~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  108 (381)
                      ..+.+|..+++.|...++ .++++.+     .+    .+|+||++|.+|
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIF-----SG----GRLEEYIPSRPL  159 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----CEEEEEeCCccc
Confidence            677899999998863333 5666652     21    389999987444

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	381
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-43
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-35
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-34
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-34
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-33
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-32
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-31
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-31
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-31
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-31
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-30
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-30
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-30
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-29
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-29
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-29
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-29
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-29
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-29
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-29
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-28
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-28
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-28
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-27
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-26
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-24
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-24
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-23
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-23
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-22
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-22
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-22
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-21
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-21
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-20
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-20
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-20
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-19
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-19
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-18
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-18
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-18
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-17
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-17
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-16
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-16
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-15
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-15
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-15
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-15
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-14
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 50/276 (18%)

Query: 60  FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
            ++F  E   LR  RH N++  +       Y      A+V ++    SL   L+      
Sbjct: 48  LQAFKNEVGVLRKTRHVNILLFM------GYSTAPQLAIVTQWCEGSSLYHHLH------ 95

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG 179
                     +++ ++IA   A  ++YLH        H  LK +N+ L +D+T ++GDFG
Sbjct: 96  ---IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 149

Query: 180 LARFLPPTRTQTSSIDVKGSIGYIAPEY---GVGNEVSTIGDVYSYGILLLELMIREKPS 236
           LA              + GSI ++APE       N  S   DVY++GI+L ELM  + P 
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP- 208

Query: 237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISM 296
              +    N  +   M    ++   +  +  N  + +              ++ EC+   
Sbjct: 209 ---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM------------KRLMAECL--- 250

Query: 297 VRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK 332
                    +   +R     ++  ++ +  +L  PK
Sbjct: 251 --------KKKRDERPLFPQILASIELLARSL--PK 276

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 1e-35
 Identities = 37/180 (20%), Positives = 70/180 (38%), Gaps = 21/180 (11%)

Query: 56  RQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPI 115
           +       I E + L       ++    A        +   ++  E M   SL + L   
Sbjct: 44  KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVL--- 95

Query: 116 SKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175
                  K+   +       ++I V   L YL    + +  H  +KPSN+L++     ++
Sbjct: 96  -------KKAGRIPEQILGKVSIAVIKGLTYLREKHKIM--HRDVKPSNILVNSRGEIKL 146

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
            DFG++  L  +   +      G+  Y++PE   G   S   D++S G+ L+E+ +   P
Sbjct: 147 CDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-35
 Identities = 57/273 (20%), Positives = 97/273 (35%), Gaps = 51/273 (18%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           ++     ++F+AE   +  +RH NL+++L        +      +V E+M   SL ++L 
Sbjct: 38  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLR 93

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
                    +    L     L  ++DV  A+ YL  +      H  L   NVL+ +D  A
Sbjct: 94  S--------RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 142

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE 233
           +V DFGL +    T+        K  + + APE     + ST  DV+S+GILL E+    
Sbjct: 143 KVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197

Query: 234 KPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV 293
           +         + L          +  D  D                            C 
Sbjct: 198 RV----PYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCP 226

Query: 294 ISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326
            ++  +   C       R     +  +L+ IK 
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-35
 Identities = 59/344 (17%), Positives = 116/344 (33%), Gaps = 78/344 (22%)

Query: 18  SLHIEVGKL-----KNLEILDVSRNMLE---ENLISAGTFG------------------- 50
           ++HI++  L     + ++ + +  + L      +I  G FG                   
Sbjct: 1   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 51  --FSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSL 108
              + +   G    F+ E   +++  H N++ +L  C     +      +V  +M +  L
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGSPLVVLPYMKHGDL 116

Query: 109 KEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168
           + +               N  +   +   + VA  +            H  L   N +LD
Sbjct: 117 RNF---------IRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLD 164

Query: 169 DDMTARVGDFGLARFLPP--TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL 226
           +  T +V DFGLAR +      +  +    K  + ++A E     + +T  DV+S+G+LL
Sbjct: 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224

Query: 227 LELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI 286
            ELM R  P       D+N        L                              ++
Sbjct: 225 WELMTRGAP----PYPDVNTFDITVYLLQGR---------------------------RL 253

Query: 287 NIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 330
                C   +  + + C     + R   + +V  + +I +T +G
Sbjct: 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 5e-34
 Identities = 50/277 (18%), Positives = 93/277 (33%), Gaps = 36/277 (12%)

Query: 63  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETY 122
             AE      +RH N++  + A    +        LV ++  + SL ++L          
Sbjct: 44  REAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYL---------- 92

Query: 123 KRPRNLNLLRRLNIAIDVASALNYLHHDC-----QPVTAHCVLKPSNVLLDDDMTARVGD 177
                + +   + +A+  AS L +LH +      +P  AH  LK  N+L+  + T  + D
Sbjct: 93  -NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151

Query: 178 FGLARFLPPTR--TQTSSIDVKGSIGYIAPEY------GVGNEVSTIGDVYSYGILLLEL 229
            GLA            +     G+  Y+APE           E     D+Y+ G++  E+
Sbjct: 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

Query: 230 MIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINII 289
             R     I  +  +  +       S           + +  K+V     +         
Sbjct: 212 ARRCSIGGIHEDYQLPYYDLVPSDPS-----------VEEMRKVVCEQKLRPNIPNRWQS 260

Query: 290 RECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 326
            E +  M +I   C   +   R+    +   L  +  
Sbjct: 261 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 5e-34
 Identities = 51/228 (22%), Positives = 87/228 (38%), Gaps = 27/228 (11%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +   +  ++E   LR ++H N+++     +    + N    +V E+     L   +   +
Sbjct: 44  EAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGT 100

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLH--HDCQPVTAHCVLKPSNVLLDDDMTAR 174
           KE +       L+    L +   +  AL   H   D      H  LKP+NV LD     +
Sbjct: 101 KERQY------LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK 234
           +GDFGLAR L    +   +    G+  Y++PE       +   D++S G LL EL     
Sbjct: 155 LGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212

Query: 235 PSDIMFEGDMNLHKFAKMA----------LSNHVKDIVDSILLNDDEK 272
           P    F          K+            S+ + +I+  +L   D  
Sbjct: 213 P----FTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYH 256

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 8e-34
 Identities = 44/221 (19%), Positives = 91/221 (41%), Gaps = 22/221 (9%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +   + F  E + L+ ++H N+++   +      +G     LV E M + +LK +L    
Sbjct: 49  KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYL---- 103

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-DMTARV 175
                 KR + + +    +    +   L +LH    P+  H  LK  N+ +     + ++
Sbjct: 104 ------KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI-IHRDLKCDNIFITGPTGSVKI 156

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKP 235
           GD GLA     +  +     V G+  ++APE     +     DVY++G+ +LE+   E P
Sbjct: 157 GDLGLATLKRASFAKA----VIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 211

Query: 236 SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVR 276
               +    N  +  +   S       D + + + ++++  
Sbjct: 212 ----YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 6e-33
 Identities = 51/271 (18%), Positives = 108/271 (39%), Gaps = 51/271 (18%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
           +   + F++E   +    H N+I +           +    ++ EFM N SL  +     
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSF----- 117

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                 +      +++ + +   +A+ + YL         H  L   N+L++ ++  +V 
Sbjct: 118 ----LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV---HRDLAARNILVNSNLVCKVS 170

Query: 177 DFGLARFLPP---TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE 233
           DFGL+RFL       T TS++  K  I + APE     + ++  DV+SYGI++ E+M   
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230

Query: 234 KPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV 293
           +     +    N             +D++++I  +                ++    +C 
Sbjct: 231 ERP---YWDMTN-------------QDVINAIEQDY---------------RLPPPMDCP 259

Query: 294 ISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
            ++ ++ + C  +    R K   +V+ L  +
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (307), Expect = 9e-33
 Identities = 55/284 (19%), Positives = 97/284 (34%), Gaps = 53/284 (18%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
                   F  E   +    + N++K+L  C            L++E+M    L E+L  
Sbjct: 55  ASADMQADFQREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRS 109

Query: 115 ISKEDETY--------------KRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVL 160
           +S                      P  L+   +L IA  VA+ + YL         H  L
Sbjct: 110 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDL 166

Query: 161 KPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVY 220
              N L+ ++M  ++ DFGL+R +       +  +    I ++ PE    N  +T  DV+
Sbjct: 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 226

Query: 221 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQK 280
           +YG++L E+                   +  MA    +  + D  +L   E         
Sbjct: 227 AYGVVLWEIFSYGLQP------------YYGMAHEEVIYYVRDGNILACPE--------- 265

Query: 281 QTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
                      C + +  +   C  + P DR    ++   LQ +
Sbjct: 266 ----------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-32
 Identities = 47/264 (17%), Positives = 100/264 (37%), Gaps = 49/264 (18%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
            +F+AE   ++ ++H+ L+++            +   ++ E+M N SL ++L        
Sbjct: 53  DAFLAEANLMKQLQHQRLVRLY------AVVTQEPIYIITEYMENGSLVDFLK------- 99

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                  L + + L++A  +A  + ++         H  L+ +N+L+ D ++ ++ DFGL
Sbjct: 100 -TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGL 155

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR +            K  I + APE       +   DV+S+GILL E++   +      
Sbjct: 156 ARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---- 210

Query: 241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG 300
                   +  M     ++++     +   +                    C   + ++ 
Sbjct: 211 --------YPGMTNPEVIQNLERGYRMVRPDN-------------------CPEELYQLM 243

Query: 301 VACSMESPQDRMKMTNVVHELQSI 324
             C  E P+DR     +   L+  
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDF 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-31
 Identities = 43/230 (18%), Positives = 94/230 (40%), Gaps = 35/230 (15%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
           + L + G       E +   ++RH N++++                L+ E+    ++   
Sbjct: 42  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATRVYLILEYAPLGTVYRE 96

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
           L          ++    +  R      ++A+AL+Y H   + V  H  +KP N+LL    
Sbjct: 97  L----------QKLSKFDEQRTATYITELANALSYCHS--KRV-IHRDIKPENLLLGSAG 143

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
             ++ DFG +   P +R  T    + G++ Y+ PE   G       D++S G+L  E ++
Sbjct: 144 ELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199

Query: 232 REKPSDIMFEGDMNLHKFAKMA---------LSNHVKDIVDSILLNDDEK 272
            + P    FE +     + +++         ++   +D++  +L ++  +
Sbjct: 200 GKPP----FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQ 245

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-31
 Identities = 43/278 (15%), Positives = 93/278 (33%), Gaps = 50/278 (17%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
             +   +  + E + +  + +  +++++  C            LV E      L ++L  
Sbjct: 48  TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLV- 100

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                    +   + +     +   V+  + YL         H  L   NVLL +   A+
Sbjct: 101 --------GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAK 149

Query: 175 VGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE 233
           + DFGL++ L    +  T+    K  + + APE     + S+  DV+SYG+ + E +   
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 209

Query: 234 KPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV 293
           +     ++        A                       + +G       ++    EC 
Sbjct: 210 QKP---YKKMKGPEVMAF----------------------IEQGK------RMECPPECP 238

Query: 294 ISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP 331
             +  +   C +   +DR     V   +++   +L   
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 6e-31
 Identities = 51/267 (19%), Positives = 98/267 (36%), Gaps = 49/267 (18%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + FI E + +  + H  L+++   C            LV+EFM +  L ++         
Sbjct: 45  EDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICLVFEFMEHGCLSDY--------- 90

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
              +         L + +DV   + YL   C     H  L   N L+ ++   +V DFG+
Sbjct: 91  LRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGM 147

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
            RF+   +  TSS   K  + + +PE    +  S+  DV+S+G+L+ E+    K      
Sbjct: 148 TRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI----P 202

Query: 241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG 300
             + +  +  +   +                             ++   R     + +I 
Sbjct: 203 YENRSNSEVVEDISTGF---------------------------RLYKPRLASTHVYQIM 235

Query: 301 VACSMESPQDRMKMTNVVHELQSIKNT 327
             C  E P+DR   + ++ +L  I  +
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 7e-31
 Identities = 52/281 (18%), Positives = 91/281 (32%), Gaps = 52/281 (18%)

Query: 57  QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL--- 112
               ++ ++E K +  +  H N++ +L AC       +    L++E+     L  +L   
Sbjct: 81  SSEREALMSELKMMTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSK 135

Query: 113 ----------YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP 162
                     Y   K  E  +    L     L  A  VA  + +L    +    H  L  
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCV-HRDLAA 192

Query: 163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSY 222
            NVL+      ++ DFGLAR +          + +  + ++APE       +   DV+SY
Sbjct: 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252

Query: 223 GILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQT 282
           GILL E+          + G      F K+  +                           
Sbjct: 253 GILLWEIFSLGVN---PYPGIPVDANFYKLIQNGF------------------------- 284

Query: 283 QAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQS 323
             K++        +  I  +C     + R    N+   L  
Sbjct: 285 --KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 3e-30
 Identities = 52/272 (19%), Positives = 107/272 (39%), Gaps = 49/272 (18%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           ++F+ E + ++ +RH  L+++            +   +V E+M   SL ++L        
Sbjct: 57  EAFLQEAQVMKKLRHEKLVQLY------AVVSEEPIYIVTEYMSKGSLLDFLK------- 103

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
             +  + L L + +++A  +AS + Y+         H  L+ +N+L+ +++  +V DFGL
Sbjct: 104 -GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 159

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           AR +            K  I + APE  +    +   DV+S+GILL EL  + +     +
Sbjct: 160 ARLIEDNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PY 215

Query: 241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG 300
            G +N             ++++D +                         EC  S+  + 
Sbjct: 216 PGMVN-------------REVLDQVERGYRMP---------------CPPECPESLHDLM 247

Query: 301 VACSMESPQDRMKMTNVVHELQSIKNTLLGPK 332
             C  + P++R     +   L+    +     
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 3e-30
 Identities = 49/315 (15%), Positives = 99/315 (31%), Gaps = 72/315 (22%)

Query: 32  LDVSRNMLEENLISAGTFG---------------------FSHLRRQGAFKSFIAECKAL 70
           LD     LE+  + +G FG                      +           +AE   +
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 71  RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNL 130
           + + +  +++++  C        +   LV E      L ++L           + R++  
Sbjct: 63  QQLDNPYIVRMIGICE------AESWMLVMEMAELGPLNKYLQ----------QNRHVKD 106

Query: 131 LRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ 190
              + +   V+  + YL         H  L   NVLL     A++ DFGL++ L      
Sbjct: 107 KNIIELVHQVSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163

Query: 191 -TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF 249
             +    K  + + APE     + S+  DV+S+G+L+ E     +     + G       
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK---PYRGM------ 214

Query: 250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQ 309
                     ++   +   +               ++     C   M  +   C     +
Sbjct: 215 -------KGSEVTAMLEKGE---------------RMGCPAGCPREMYDLMNLCWTYDVE 252

Query: 310 DRMKMTNVVHELQSI 324
           +R     V   L++ 
Sbjct: 253 NRPGFAAVELRLRNY 267

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 3e-30
 Identities = 47/266 (17%), Positives = 88/266 (33%), Gaps = 49/266 (18%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           K  + E   + ++ + ++ ++L  CL           L+ + M    L ++         
Sbjct: 56  KEILDEAYVMASVDNPHVCRLLGICL------TSTVQLITQLMPFGCLLDY--------- 100

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
             +   N+     LN  + +A  +NYL         H  L   NVL+      ++ DFGL
Sbjct: 101 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGL 157

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           A+ L     +  +   K  I ++A E  +    +   DV+SYG+ + ELM          
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----P 213

Query: 241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG 300
              +   + + +                                ++     C I +  I 
Sbjct: 214 YDGIPASEISSILEKGE---------------------------RLPQPPICTIDVYMIM 246

Query: 301 VACSMESPQDRMKMTNVVHELQSIKN 326
           V C M     R K   ++ E   +  
Sbjct: 247 VKCWMIDADSRPKFRELIIEFSKMAR 272

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 5e-30
 Identities = 50/308 (16%), Positives = 110/308 (35%), Gaps = 71/308 (23%)

Query: 40  EENLISAGTFG----------------------FSHLRRQGAFKSFIAECKALRNIRHRN 77
            + +I AG FG                            +     F+ E   +    H N
Sbjct: 11  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70

Query: 78  LIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIA 137
           +I++                ++ E+M N +L ++           ++    ++L+ + + 
Sbjct: 71  IIRLEGVI-----SKYKPMMIITEYMENGALDKF---------LREKDGEFSVLQLVGML 116

Query: 138 IDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQT-SSIDV 196
             +A+ + YL +       H  L   N+L++ ++  +V DFGL+R L      T ++   
Sbjct: 117 RGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 197 KGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN 256
           K  I + APE     + ++  DV+S+GI++ E+M   +        +++ H+  K     
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER----PYWELSNHEVMKAINDG 229

Query: 257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTN 316
                                       ++    +C  ++ ++ + C  +    R K  +
Sbjct: 230 F---------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262

Query: 317 VVHELQSI 324
           +V  L  +
Sbjct: 263 IVSILDKL 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (285), Expect = 2e-29
 Identities = 46/236 (19%), Positives = 80/236 (33%), Gaps = 42/236 (17%)

Query: 51  FSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKE 110
           +S  +    ++  I E + L+ +RH N I+                 LV E+    +   
Sbjct: 50  YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHTAWLVMEYCLGSASDL 104

Query: 111 WLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170
                          + L  +    +       L YLH        H  +K  N+LL + 
Sbjct: 105 LE----------VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEP 151

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG---DVYSYGILLL 227
              ++GDFG A  + P  +        G+  ++APE  +  +        DV+S GI  +
Sbjct: 152 GLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205

Query: 228 ELMIREKPSDIMFEGDMNLHKFAKMA-----------LSNHVKDIVDSILLNDDEK 272
           EL  R+ P          +     +A            S + ++ VDS L    + 
Sbjct: 206 ELAERKPP----LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-29
 Identities = 50/279 (17%), Positives = 84/279 (30%), Gaps = 47/279 (16%)

Query: 55  RRQGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
                 ++ ++E K L  +  H N++ +L AC            ++ E+     L  +L 
Sbjct: 65  AHLTEREALMSELKVLSYLGNHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLR 119

Query: 114 PISKEDETYKRPRN--------LNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNV 165
                    K            L+L   L+ +  VA  + +L         H  L   N+
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176

Query: 166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL 225
           LL      ++ DFGLAR +          + +  + ++APE       +   DV+SYGI 
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236

Query: 226 LLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAK 285
           L EL             D   +K  K                                 +
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGF------------------------------R 266

Query: 286 INIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
           +         M  I   C    P  R     +V  ++  
Sbjct: 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-29
 Identities = 40/227 (17%), Positives = 80/227 (35%), Gaps = 27/227 (11%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
           R     ++   E    + + H N++K          +  + + L  E+     L + +  
Sbjct: 42  RAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDRI-- 94

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                   +    +           + + + YLH        H  +KP N+LLD+    +
Sbjct: 95  --------EPDIGMPEPDAQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLK 143

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIRE 233
           + DFGLA        +     + G++ Y+APE     E      DV+S GI+L  ++  E
Sbjct: 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

Query: 234 KPSDIMFEGDMNLHKFAKM--------ALSNHVKDIVDSILLNDDEK 272
            P D   +       + +          + +    ++  IL+ +   
Sbjct: 204 LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSA 250

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 3e-29
 Identities = 50/264 (18%), Positives = 91/264 (34%), Gaps = 49/264 (18%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
             FI E K + N+ H  L+++   C            ++ E+M N  L  +L        
Sbjct: 44  DEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFIITEYMANGCLLNYLRE------ 92

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                      + L +  DV  A+ YL         H  L   N L++D    +V DFGL
Sbjct: 93  ---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGL 146

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           +R++      TSS+  K  + +  PE  + ++ S+  D++++G+L+ E+    K     +
Sbjct: 147 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---Y 202

Query: 241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG 300
           E   N               I   + L                            +  I 
Sbjct: 203 ERFTNSETAEH---------IAQGLRLYRPH-------------------LASEKVYTIM 234

Query: 301 VACSMESPQDRMKMTNVVHELQSI 324
            +C  E   +R     ++  +  +
Sbjct: 235 YSCWHEKADERPTFKILLSNILDV 258

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 4e-29
 Identities = 39/269 (14%), Positives = 92/269 (34%), Gaps = 39/269 (14%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
                 F+ E   ++     +++++L               ++ E M    LK +L  + 
Sbjct: 64  MRERIEFLNEASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLR 118

Query: 117 KEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG 176
                       +L + + +A ++A  + YL+ +      H  L   N ++ +D T ++G
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175

Query: 177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPS 236
           DFG+ R +  T            + +++PE       +T  DV+S+G++L E+    +  
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ- 234

Query: 237 DIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISM 296
                  ++  +  +  +   + D  D                            C   +
Sbjct: 235 ---PYQGLSNEQVLRFVMEGGLLDKPD---------------------------NCPDML 264

Query: 297 VRIGVACSMESPQDRMKMTNVVHELQSIK 325
             +   C   +P+ R     ++  ++   
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 5e-29
 Identities = 47/237 (19%), Positives = 85/237 (35%), Gaps = 40/237 (16%)

Query: 53  HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
             + +   + ++ E   L +  H N++K+L A         +   ++ EF    ++   +
Sbjct: 46  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVM 100

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
                     +  R L   +   +      ALNYLH +      H  LK  N+L   D  
Sbjct: 101 L---------ELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGD 148

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEY-----GVGNEVSTIGDVYSYGILLL 227
            ++ DFG++     T  +  S    G+  ++APE                DV+S GI L+
Sbjct: 149 IKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 206

Query: 228 ELMIREKPSDIMFEGDMNLHKFAKMA------------LSNHVKDIVDSILLNDDEK 272
           E+   E P          +    K+A             S++ KD +   L  + + 
Sbjct: 207 EMAEIEPP----HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 5e-29
 Identities = 55/275 (20%), Positives = 87/275 (31%), Gaps = 49/275 (17%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
             L +  A   FI E  A+ ++ HRNLI++    L           +V E     SL + 
Sbjct: 47  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL------TPPMKMVTELAPLGSLLDR 100

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
                      K   +  L      A+ VA  + YL         H  L   N+LL    
Sbjct: 101 ---------LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI---HRDLAARNLLLATRD 148

Query: 172 TARVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
             ++GDFGL R LP            K    + APE       S   D + +G+ L E+ 
Sbjct: 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208

Query: 231 IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIR 290
              +     + G              +   I+  I    +              ++    
Sbjct: 209 TYGQE---PWIGL-------------NGSQILHKIDKEGE--------------RLPRPE 238

Query: 291 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 325
           +C   +  + V C    P+DR     +   L   +
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (276), Expect = 2e-28
 Identities = 49/264 (18%), Positives = 101/264 (38%), Gaps = 48/264 (18%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           + F+ E   ++ I+H NL+++L  C            ++ EFM   +L ++L        
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLR------- 105

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
                + ++ +  L +A  ++SA+ YL    +    H  L   N L+ ++   +V DFGL
Sbjct: 106 -ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 161

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 240
           +R +        +   K  I + APE    N+ S   DV+++G+LL E+           
Sbjct: 162 SRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----P 216

Query: 241 EGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIG 300
              ++L +  ++   ++                           ++     C   +  + 
Sbjct: 217 YPGIDLSQVYELLEKDY---------------------------RMERPEGCPEKVYELM 249

Query: 301 VACSMESPQDRMKMTNVVHELQSI 324
            AC   +P DR     +    +++
Sbjct: 250 RACWQWNPSDRPSFAEIHQAFETM 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-28
 Identities = 45/230 (19%), Positives = 84/230 (36%), Gaps = 31/230 (13%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
            H+ ++        E   +  + H   +K+         Q ++       +  N  L ++
Sbjct: 44  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKY 98

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
           +  I   DET                   A  ++ L +       H  LKP N+LL++DM
Sbjct: 99  IRKIGSFDET-------------CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 145

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
             ++ DFG A+ L P   Q  +    G+  Y++PE           D+++ G ++ +L+ 
Sbjct: 146 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205

Query: 232 REKPSDIMFEGDMNLHKFAKMA---------LSNHVKDIVDSILLNDDEK 272
              P    F        F K+               +D+V+ +L+ D  K
Sbjct: 206 GLPP----FRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 251

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 6e-28
 Identities = 47/232 (20%), Positives = 95/232 (40%), Gaps = 37/232 (15%)

Query: 53  HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
           +L++Q   +  I E   +R  ++ N++  L +         D   +V E++   SL + +
Sbjct: 54  NLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVV 108

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
                ++            +   +  +   AL +LH +      H  +K  N+LL  D +
Sbjct: 109 TETCMDEG-----------QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
            ++ DFG    + P +++ S++   G+  ++APE           D++S GI+ +E++  
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Query: 233 EKPSDIMFEGDMNLHKFAKMA------------LSNHVKDIVDSILLNDDEK 272
           E P    +  +  L     +A            LS   +D ++  L  D EK
Sbjct: 213 EPP----YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 7e-28
 Identities = 55/311 (17%), Positives = 106/311 (34%), Gaps = 69/311 (22%)

Query: 41  ENLISAGTFG--------------------FSHLRRQGAFKSFIAECKALRNI-RHRNLI 79
           +++I  G FG                          +   + F  E + L  +  H N+I
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 80  KVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRR 133
            +L AC     +   +  L  E+  + +L ++L      +              L+  + 
Sbjct: 75  NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 134 LNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSS 193
           L+ A DVA  ++YL    Q    H  L   N+L+ ++  A++ DFGL+R       +T  
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 185

Query: 194 IDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA 253
              +  + ++A E    +  +T  DV+SYG+LL E++             M   +  +  
Sbjct: 186 --GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYEKL 239

Query: 254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK 313
              +                           ++     C   +  +   C  E P +R  
Sbjct: 240 PQGY---------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPS 272

Query: 314 MTNVVHELQSI 324
              ++  L  +
Sbjct: 273 FAQILVSLNRM 283

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 3e-27
 Identities = 50/274 (18%), Positives = 88/274 (32%), Gaps = 42/274 (15%)

Query: 57  QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPIS 116
               ++ ++E K L +I H   +  L    G   +      ++ EF    +L  +L    
Sbjct: 57  HSEHRALMSELKILIHIGHHLNVVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKR 113

Query: 117 KEDETYK------RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170
            E   YK          L L   +  +  VA  + +L         H  L   N+LL + 
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEK 170

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
              ++ DFGLAR +          D +  + ++APE       +   DV+S+G+LL E+ 
Sbjct: 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230

Query: 231 IREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIR 290
                    + G     +F +           D                           
Sbjct: 231 SLGAS---PYPGVKIDEEFCRRLKEGTRMRAPD--------------------------- 260

Query: 291 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
                M +  + C    P  R   + +V  L ++
Sbjct: 261 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  104 bits (261), Expect = 6e-26
 Identities = 45/235 (19%), Positives = 83/235 (35%), Gaps = 39/235 (16%)

Query: 53  HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
               +   ++   E + +  +RH  L+ +  A      + ++   ++YEFM    L E +
Sbjct: 60  MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKV 114

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
                          ++    +     V   L ++H +      H  LKP N++     +
Sbjct: 115 A---------DEHNKMSEDEAVEYMRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRS 162

Query: 173 ARV--GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
             +   DFGL   L P ++        G+  + APE   G  V    D++S G+L   L+
Sbjct: 163 NELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219

Query: 231 IREKPSDIMFEGDMNLHKFAKMA-------------LSNHVKDIVDSILLNDDEK 272
               P    F G+ +      +              +S   KD +  +LL D   
Sbjct: 220 SGLSP----FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 270

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-25
 Identities = 44/273 (16%), Positives = 98/273 (35%), Gaps = 50/273 (18%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
            +       + F+ E   +R   H +++K++           +   ++ E      L+ +
Sbjct: 44  KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSF 97

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
                       R  +L+L   +  A  +++AL YL         H  +   NVL+  + 
Sbjct: 98  ---------LQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSND 145

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
             ++GDFGL+R++  +    +S   K  I ++APE       ++  DV+ +G+ + E+++
Sbjct: 146 CVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204

Query: 232 REKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRE 291
                                       D++  I   +               ++ +   
Sbjct: 205 HGVKPFQG----------------VKNNDVIGRIENGE---------------RLPMPPN 233

Query: 292 CVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
           C  ++  +   C    P  R + T +  +L +I
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 4e-24
 Identities = 51/275 (18%), Positives = 98/275 (35%), Gaps = 46/275 (16%)

Query: 57  QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPI 115
           +      I+E + ++ I +H+N+I +L AC       +    ++ E+    +L+E+L   
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQAR 113

Query: 116 SKEDETYKRP------RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169
                 Y           L+    ++ A  VA  + YL         H  L   NVL+ +
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE 170

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLEL 229
           D   ++ DFGLAR +        + + +  + ++APE       +   DV+S+G+LL E+
Sbjct: 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

Query: 230 MIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINII 289
                         + + +  K+    H                           +++  
Sbjct: 231 FTLGGS----PYPGVPVEELFKLLKEGH---------------------------RMDKP 259

Query: 290 RECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 324
             C   +  +   C    P  R     +V +L  I
Sbjct: 260 SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 97.5 bits (242), Expect = 6e-24
 Identities = 50/235 (21%), Positives = 89/235 (37%), Gaps = 32/235 (13%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
              R    +  F  E +    + H  ++ V          G     +V E++   +L++ 
Sbjct: 43  DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDI 101

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
           +               +   R + +  D   ALN+ H +      H  +KP+N+++    
Sbjct: 102 V----------HTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATN 148

Query: 172 TARVGDFGLARFL-PPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
             +V DFG+AR +     + T +  V G+  Y++PE   G+ V    DVYS G +L E++
Sbjct: 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 208

Query: 231 IREKPSDIMFEGDMNLHKFAKMA-------------LSNHVKDIVDSILLNDDEK 272
             E P    F GD  +    +               LS  +  +V   L  + E 
Sbjct: 209 TGEPP----FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 259

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 96.6 bits (240), Expect = 2e-23
 Identities = 42/231 (18%), Positives = 77/231 (33%), Gaps = 35/231 (15%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
             +G   S   E   L  I+H N++ +         +      L+ + +    L + +  
Sbjct: 46  ALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRI-- 98

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                                +   V  A+ YLH                  LD+D    
Sbjct: 99  --------VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM 150

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK 234
           + DFGL++   P    +++    G+ GY+APE       S   D +S G++   L+    
Sbjct: 151 ISDFGLSKMEDPGSVLSTAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207

Query: 235 PSDIMFEGDMNLHKFAKMA-------------LSNHVKDIVDSILLNDDEK 272
           P    F  + +   F ++              +S+  KD +  ++  D EK
Sbjct: 208 P----FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 254

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 97.4 bits (242), Expect = 3e-23
 Identities = 40/227 (17%), Positives = 77/227 (33%), Gaps = 39/227 (17%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
            +   E   +  + H  LI +  A      +      L+ EF+    L + +        
Sbjct: 71  YTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIA------- 118

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD--DDMTARVGDF 178
                  ++    +N        L ++H   +    H  +KP N++ +     + ++ DF
Sbjct: 119 --AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDF 173

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238
           GLA  L P            +  + APE      V    D+++ G+L   L+    P   
Sbjct: 174 GLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP--- 227

Query: 239 MFEGDMNLHKFAKMA-------------LSNHVKDIVDSILLNDDEK 272
            F G+ +L     +              +S   KD + ++L  +  K
Sbjct: 228 -FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 95.5 bits (237), Expect = 4e-23
 Identities = 55/238 (23%), Positives = 90/238 (37%), Gaps = 37/238 (15%)

Query: 51  FSHLRRQGAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLK 109
           FS    Q   ++ + E   LR +  H N+I++         + N F  LV++ M    L 
Sbjct: 44  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELF 98

Query: 110 EWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD 169
           ++L               L+      I   +   +  LH        H  LKP N+LLDD
Sbjct: 99  DYL----------TEKVTLSEKETRKIMRALLEVICALHKLNI---VHRDLKPENILLDD 145

Query: 170 DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG------DVYSYG 223
           DM  ++ DFG +  L P         V G+  Y+APE    +            D++S G
Sbjct: 146 DMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202

Query: 224 ILLLELMIREKPSD---------IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
           +++  L+    P           ++  G+           S+ VKD+V   L+   +K
Sbjct: 203 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.0 bits (233), Expect = 3e-22
 Identities = 45/227 (19%), Positives = 82/227 (36%), Gaps = 39/227 (17%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
                E   L   RHRN++ +  +      +  +   +++EF+    + E +        
Sbjct: 46  VLVKKEISILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERIN------- 93

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV--GDF 178
                  LN    ++    V  AL +LH        H  ++P N++     ++ +   +F
Sbjct: 94  --TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEF 148

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238
           G AR L P         +  +  Y APE    + VST  D++S G L+  L+    P   
Sbjct: 149 GQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--- 202

Query: 239 MFEGDMNLHKFAKMA-------------LSNHVKDIVDSILLNDDEK 272
            F  + N      +              +S    D VD +L+ + + 
Sbjct: 203 -FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 93.2 bits (231), Expect = 4e-22
 Identities = 42/230 (18%), Positives = 82/230 (35%), Gaps = 36/230 (15%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
             + R    +    E   L  + H  +I++         Q      ++ +++    L   
Sbjct: 40  EIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSL 94

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
           L    +      +            A +V      L +       +  LKP N+LLD + 
Sbjct: 95  LRKSQRFPNPVAK----------FYAAEVC---LALEYLHSKDIIYRDLKPENILLDKNG 141

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
             ++ DFG A+++P          + G+  YIAPE       +   D +S+GIL+ E++ 
Sbjct: 142 HIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 196

Query: 232 REKPSDIMFEGDMNLHKFAKMA---------LSNHVKDIVDSILLNDDEK 272
              P    F     +  + K+           +  VKD++  ++  D  +
Sbjct: 197 GYTP----FYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQ 242

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 6e-22
 Identities = 47/227 (20%), Positives = 89/227 (39%), Gaps = 26/227 (11%)

Query: 52  SHLRRQGAFKSFIAECKAL-RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKE 110
             +      +  + E + L     H  L  +         Q  +    V E+++   L  
Sbjct: 38  DVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMY 92

Query: 111 WLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170
            +          +     +L R    A ++   L +LH        +  LK  N+LLD D
Sbjct: 93  HI----------QSCHKFDLSRATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKD 139

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
              ++ DFG+ +       +T++    G+  YIAPE  +G + +   D +S+G+LL E++
Sbjct: 140 GHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197

Query: 231 IREKP-----SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
           I + P      + +F      + F    L    KD++  + + + EK
Sbjct: 198 IGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEK 244

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 90.6 bits (224), Expect = 6e-21
 Identities = 35/231 (15%), Positives = 77/231 (33%), Gaps = 31/231 (13%)

Query: 51  FSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKE 110
               + +    +       +       ++ +  A         D  + + + M+   L  
Sbjct: 42  IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHY 96

Query: 111 WLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170
            L           +    +       A ++   L ++H+       +  LKP+N+LLD+ 
Sbjct: 97  HL----------SQHGVFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEH 143

Query: 171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLEL 229
              R+ D GLA      +         G+ GY+APE         +  D +S G +L +L
Sbjct: 144 GHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 199

Query: 230 MIREKPSD--------IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEK 272
           +    P           +    + +      + S  ++ +++ +L  D  +
Sbjct: 200 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 250

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.6 bits (221), Expect = 8e-21
 Identities = 38/194 (19%), Positives = 72/194 (37%), Gaps = 19/194 (9%)

Query: 59  AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKE 118
           +    +A  + L    H N++++   C            LV+E +               
Sbjct: 53  STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK----- 107

Query: 119 DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF 178
                    +      ++   +   L++LH        H  LKP N+L+      ++ DF
Sbjct: 108 ----VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238
           GLAR        TS +    ++ Y APE  + +  +T  D++S G +  E+  R+     
Sbjct: 161 GLARIYSFQMALTSVV---VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--- 214

Query: 239 MFEGDMNLHKFAKM 252
            F G  ++ +  K+
Sbjct: 215 -FRGSSDVDQLGKI 227

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 1e-20
 Identities = 46/198 (23%), Positives = 79/198 (39%), Gaps = 25/198 (12%)

Query: 56  RQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPI 115
           + G  ++ + E K L+ + H N+I +L A            +LV++FM            
Sbjct: 40  KDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISLVFDFMETDLEVII---- 90

Query: 116 SKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV 175
                       L         +     L YLH        H  LKP+N+LLD++   ++
Sbjct: 91  ------KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKL 141

Query: 176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREK 234
            DFGLA+         +      +  Y APE   G  +  +G D+++ G +L EL++R  
Sbjct: 142 ADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199

Query: 235 PSDIMFEGDMNLHKFAKM 252
                  GD +L +  ++
Sbjct: 200 F----LPGDSDLDQLTRI 213

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 3e-20
 Identities = 45/204 (22%), Positives = 73/204 (35%), Gaps = 21/204 (10%)

Query: 51  FSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKE 110
            S    Q   +  + E K L   RH N+I +         +      LV   M       
Sbjct: 41  ISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG------ 94

Query: 111 WLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD 170
                  +     + ++L+          +   L Y+H        H  LKPSN+LL+  
Sbjct: 95  ------ADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTT 145

Query: 171 MTARVGDFGLARFLPPTRTQTSSID-VKGSIGYIAPEYGVGNEVSTI-GDVYSYGILLLE 228
              ++ DFGLAR   P    T  +     +  Y APE  + ++  T   D++S G +L E
Sbjct: 146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205

Query: 229 LMIREKPSDIMFEGDMNLHKFAKM 252
           ++         F G   L +   +
Sbjct: 206 MLSNRPI----FPGKHYLDQLNHI 225

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.4 bits (213), Expect = 8e-20
 Identities = 44/235 (18%), Positives = 83/235 (35%), Gaps = 42/235 (17%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
           RR  + +    E   L+ I+H N+I +         +      L+ E +    L ++   
Sbjct: 52  RRGVSREDIEREVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDF--- 103

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                       +L           + + +   ++      AH  LKP N++L D    +
Sbjct: 104 -------LAEKESLTEEEATEFLKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPK 153

Query: 175 ----VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELM 230
               + DFGLA  +          ++ G+  ++APE      +    D++S G++   L+
Sbjct: 154 PRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210

Query: 231 IREKPSDIMFEGDMNLHKFAKMA-------------LSNHVKDIVDSILLNDDEK 272
               P    F GD      A ++              S   KD +  +L+ D +K
Sbjct: 211 SGASP----FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 261

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.8 bits (209), Expect = 5e-19
 Identities = 47/229 (20%), Positives = 88/229 (38%), Gaps = 33/229 (14%)

Query: 40  EENLISAGTFG------FSHLRRQGAFK-------SFIAECKALRNIRHRNLIKVLTACL 86
           +  +I  G+FG              A K           E + +R + H N++++     
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83

Query: 87  GVDYQGND-FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALN 145
               + ++ +  LV +++     +   +         +  + L ++        +  +L 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYS-------RAKQTLPVIYVKLYMYQLFRSLA 136

Query: 146 YLHHDCQPVTAHCVLKPSNVLLDDD-MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIA 204
           Y+H        H  +KP N+LLD D    ++ DFG A+ L       S I  +    Y A
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRA 190

Query: 205 PEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 252
           PE   G    T   DV+S G +L EL++ +      F GD  + +  ++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEI 235

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.6 bits (206), Expect = 6e-19
 Identities = 39/229 (17%), Positives = 71/229 (31%), Gaps = 32/229 (13%)

Query: 51  FSHLRRQGAFKSFIAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSL 108
            S             E   L+ +      +I++L        +  D   L+ E       
Sbjct: 42  ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQD 96

Query: 109 KEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD 168
                              L      +    V  A+ + H+       H  +K  N+L+D
Sbjct: 97  LFDFI---------TERGALQEELARSFFWQVLEAVRHCHNCGV---LHRDIKDENILID 144

Query: 169 -DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILL 226
            +    ++ DFG    L  T          G+  Y  PE+   +        V+S GILL
Sbjct: 145 LNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

Query: 227 LELMIREKPSDIMFEGD---MNLHKFAKMALSNHVKDIVDSILLNDDEK 272
            +++  + P    FE D   +    F +  +S+  + ++   L      
Sbjct: 201 YDMVCGDIP----FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 245

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.6 bits (206), Expect = 1e-18
 Identities = 38/223 (17%), Positives = 76/223 (34%), Gaps = 39/223 (17%)

Query: 70  LRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLN 129
            R  +  ++++++     + Y G     +V E +    L   +          +  +   
Sbjct: 59  WRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFT 109

Query: 130 LLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD---DDMTARVGDFGLARFLPP 186
                 I   +  A+ YLH       AH  +KP N+L      +   ++ DFG A+    
Sbjct: 110 EREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166

Query: 187 TRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL 246
                S      +  Y+APE     +     D++S G+++  L+    P    F  +  L
Sbjct: 167 ---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGL 219

Query: 247 HKFAKMA-----------------LSNHVKDIVDSILLNDDEK 272
                M                  +S  VK ++ ++L  +  +
Sbjct: 220 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 262

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.9 bits (201), Expect = 4e-18
 Identities = 40/204 (19%), Positives = 79/204 (38%), Gaps = 23/204 (11%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA---LVYEFMHNRSLKEW 111
            ++G   + + E K L+ ++H N++ ++  C       N  K    LV++F  +      
Sbjct: 48  EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL 107

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              + K                  I   +   LN L++  +    H  +K +NVL+  D 
Sbjct: 108 SNVLVK-------------FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 154

Query: 172 TARVGDFGLARFLPPTRT--QTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLE 228
             ++ DFGLAR     +        +   ++ Y  PE  +G  +     D++  G ++ E
Sbjct: 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 214

Query: 229 LMIREKPSDIMFEGDMNLHKFAKM 252
           +  R        +G+   H+ A +
Sbjct: 215 MWTRSPI----MQGNTEQHQLALI 234

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 81.0 bits (199), Expect = 7e-18
 Identities = 37/222 (16%), Positives = 72/222 (32%), Gaps = 27/222 (12%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
              +        E K  + ++    I  +  C        D+  +V E +       +  
Sbjct: 40  ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNVMVMELLGPSLEDLFN- 94

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVL---LDDD 170
                       R  +L   L +A  + S + Y+H        H  +KP N L       
Sbjct: 95  ---------FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKG 142

Query: 171 MTARVGDFGLARFLPPTRTQT-----SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGIL 225
               + DFGLA+     RT        + ++ G+  Y +    +G E S   D+ S G +
Sbjct: 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 202

Query: 226 LLELMIREKPSDIMFEGD--MNLHKFAKMALSNHVKDIVDSI 265
           L+   +   P   +          + ++  +S  ++ +    
Sbjct: 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (197), Expect = 2e-17
 Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 33/230 (14%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
             +  +      + E + L+N RH  L  +  A      Q +D    V E+ +   L   
Sbjct: 41  EVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVMEYANGGELFFH 95

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
           L           R R     R      ++ SAL    +       +  +K  N++LD D 
Sbjct: 96  L----------SRERVFTEERARFYGAEIVSAL---EYLHSRDVVYRDIKLENLMLDKDG 142

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
             ++ DFGL +               G+  Y+APE    N+     D +  G+++ E+M 
Sbjct: 143 HIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

Query: 232 REKPSDIMFEGDMNLHKFAKMA---------LSNHVKDIVDSILLNDDEK 272
              P    F    +   F  +          LS   K ++  +L  D ++
Sbjct: 201 GRLP----FYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 246

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 78.3 bits (192), Expect = 5e-17
 Identities = 33/227 (14%), Positives = 67/227 (29%), Gaps = 31/227 (13%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
             R+        E +  + +     I  +        Q      LV + +          
Sbjct: 38  EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF----GQEGLHNVLVIDLLGP-------- 85

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT- 172
             S ED      R  ++      A  + + +  +H        +  +KP N L+    + 
Sbjct: 86  --SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSK 140

Query: 173 ----ARVGDFGLARFLPPTRTQTSSI-----DVKGSIGYIAPEYGVGNEVSTIGDVYSYG 223
                 V DFG+ +F     T+         ++ G+  Y++    +G E S   D+ + G
Sbjct: 141 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 200

Query: 224 ILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDD 270
            + +  +       + ++G        K       K       L   
Sbjct: 201 HVFMYFLRGS----LPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (185), Expect = 7e-16
 Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 26/202 (12%)

Query: 53  HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK-ALVYEFMHNRSLKEW 111
             + +   K    E + L+++RH N+I +L      +   +     LV  FM     K  
Sbjct: 54  PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK-- 111

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
                       +   L   R   +   +   L Y+H        H  LKP N+ +++D 
Sbjct: 112 ----------LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDC 158

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILLLELM 230
             ++ DFGLAR      T         +  Y APE  +     T   D++S G ++ E++
Sbjct: 159 ELKILDFGLARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 213

Query: 231 IREKPSDIMFEGDMNLHKFAKM 252
             +      F+G  +L +  ++
Sbjct: 214 TGKTL----FKGSDHLDQLKEI 231

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 74.9 bits (183), Expect = 7e-16
 Identities = 42/264 (15%), Positives = 91/264 (34%), Gaps = 25/264 (9%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
             +G   + I E   L+ ++H N++K+                LV+E +     K     
Sbjct: 39  EDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLD-- 91

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
                        L  +   +  + + + + Y H        H  LKP N+L++ +   +
Sbjct: 92  --------VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELK 140

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIRE 233
           + DFGLAR       + +      ++ Y AP+  +G++  ST  D++S G +  E++   
Sbjct: 141 IADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

Query: 234 KPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECV 293
                 F G     +  ++       +  +   + +  K        +     + ++   
Sbjct: 199 PL----FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254

Query: 294 ISMVRIGVACSMESPQDRMKMTNV 317
            S + +        P  R+     
Sbjct: 255 ESGIDLLSKMLKLDPNQRITAKQA 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.1 bits (181), Expect = 1e-15
 Identities = 45/265 (16%), Positives = 82/265 (30%), Gaps = 22/265 (8%)

Query: 53  HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL 112
               +G   + I E   L+ + H N++K+L           +   LV+EF+H    K   
Sbjct: 38  DTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMD 92

Query: 113 YPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT 172
                          + L    +    +   L + H        H  LKP N+L++ +  
Sbjct: 93  A---------SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGA 140

Query: 173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIR 232
            ++ DFGLAR         +   V                 ST  D++S G +  E++ R
Sbjct: 141 IKLADFGLARAFGVPVRTYTHE-VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199

Query: 233 EKPSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIREC 292
                  F GD  + +  ++  +    D V    +           +   Q    ++   
Sbjct: 200 RAL----FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPL 255

Query: 293 VISMVRIGVACSMESPQDRMKMTNV 317
                 +        P  R+     
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAA 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.4 bits (179), Expect = 2e-15
 Identities = 41/263 (15%), Positives = 85/263 (32%), Gaps = 22/263 (8%)

Query: 55  RRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYP 114
             +G   S + E   L+ ++H+N++++           +    LV+EF      K +   
Sbjct: 40  DDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSC 94

Query: 115 ISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR 174
               D               +    +   L + H        H  LKP N+L++ +   +
Sbjct: 95  NGDLDPE----------IVKSFLFQLLKGLGFCHSRNVL---HRDLKPQNLLINRNGELK 141

Query: 175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK 234
           + +FGLAR       +  S +V                 ST  D++S G +  EL    +
Sbjct: 142 LANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

Query: 235 PSDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVI 294
           P     + D  L +  ++  +   +       L D +   +          +  +     
Sbjct: 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260

Query: 295 SMVRIGVACSMESPQDRMKMTNV 317
            +++        +P  R+     
Sbjct: 261 DLLQ---NLLKCNPVQRISAEEA 280

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 73.3 bits (179), Expect = 4e-15
 Identities = 48/216 (22%), Positives = 85/216 (39%), Gaps = 25/216 (11%)

Query: 61  KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           K    E K L N+R   N+I +           +   ALV+E ++N   K+         
Sbjct: 74  KKIKREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQLY------- 123

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMTARVGDF 178
                 + L          ++  AL+Y H        H  +KP NV++D +    R+ D+
Sbjct: 124 ------QTLTDYDIRFYMYEILKALDYCHSMGIM---HRDVKPHNVMIDHEHRKLRLIDW 174

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSD 237
           GLA F  P +     +    S  +  PE  V  +      D++S G +L  ++ R++P  
Sbjct: 175 GLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231

Query: 238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKL 273
              +    L + AK+  +  + D +D   +  D + 
Sbjct: 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (179), Expect = 4e-15
 Identities = 47/234 (20%), Positives = 90/234 (38%), Gaps = 37/234 (15%)

Query: 54  LRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLY 113
           +++    +    E + L +IR    +  L       +Q      L+ ++++   L   L 
Sbjct: 66  VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLS 121

Query: 114 PISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA 173
              +  E               + I V   +  L H  +    +  +K  N+LLD +   
Sbjct: 122 QRERFTEHE-------------VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV 168

Query: 174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE--VSTIGDVYSYGILLLELMI 231
            + DFGL++      T   + D  G+I Y+AP+   G +       D +S G+L+ EL+ 
Sbjct: 169 VLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227

Query: 232 REKPSDIMFEGDMNLHKFAKMA-------------LSNHVKDIVDSILLNDDEK 272
              P    F  D   +  A+++             +S   KD++  +L+ D +K
Sbjct: 228 GASP----FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 277

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.1 bits (178), Expect = 6e-15
 Identities = 42/201 (20%), Positives = 76/201 (37%), Gaps = 24/201 (11%)

Query: 53  HLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFMHNRSLKEW 111
             + Q   K    E   ++ + H+N+I +L         +      LV E M     +  
Sbjct: 53  PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 112

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
              +  E             R   +   +   + +LH        H  LKPSN+++  D 
Sbjct: 113 QMELDHE-------------RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDC 156

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
           T ++ DFGLAR    +   T  +    +  Y APE  +G       D++S G ++ E++ 
Sbjct: 157 TLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213

Query: 232 REKPSDIMFEGDMNLHKFAKM 252
            +      F G   + ++ K+
Sbjct: 214 HKIL----FPGRDYIDQWNKV 230

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 72.1 bits (176), Expect = 1e-14
 Identities = 42/230 (18%), Positives = 84/230 (36%), Gaps = 36/230 (15%)

Query: 52  SHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEW 111
             + +    +  + E + L+ +    L+K+  +      + N    +V E++    +   
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGGEMFSH 131

Query: 112 LYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM 171
           L           R    +       A  +     YLH        +  LKP N+L+D   
Sbjct: 132 LR----------RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQG 178

Query: 172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI 231
             +V DFG A+ +           + G+   +APE  +    +   D ++ G+L+ E+  
Sbjct: 179 YIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

Query: 232 REKPSDIMFEGDMNLHKFAKMA---------LSNHVKDIVDSILLNDDEK 272
              P    F  D  +  + K+           S+ +KD++ ++L  D  K
Sbjct: 234 GYPP----FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTK 279

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 70.4 bits (171), Expect = 4e-14
 Identities = 35/185 (18%), Positives = 66/185 (35%), Gaps = 8/185 (4%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFMHNRSLKEWLYPISKED 119
           ++   E K L+ +   +  K  +     +    + F       +H   + E L       
Sbjct: 54  EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113

Query: 120 ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMTARVGDF 178
                 R + L+    I+  +   L+Y+H  C  +  H  +KP NVL++  D    +   
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQI 171

Query: 179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 238
            +A             +   +  Y +PE  +G       D++S   L+ EL+  +     
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--- 228

Query: 239 MFEGD 243
            FE D
Sbjct: 229 -FEPD 232

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.3 bits (171), Expect = 5e-14
 Identities = 37/193 (19%), Positives = 68/193 (35%), Gaps = 24/193 (12%)

Query: 61  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDE 120
           K    E + L++++H N+I +L                +   +    L            
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--------- 112

Query: 121 TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL 180
              + + L       +   +   L Y+H        H  LKPSN+ +++D   ++ DFGL
Sbjct: 113 --VKCQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGL 167

Query: 181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIG-DVYSYGILLLELMIREKPSDIM 239
           AR      T         +  Y APE  +         D++S G ++ EL+         
Sbjct: 168 ARHTDDEMTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL---- 218

Query: 240 FEGDMNLHKFAKM 252
           F G  ++ +   +
Sbjct: 219 FPGTDHIDQLKLI 231

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 45.2 bits (106), Expect = 3e-06
 Identities = 25/176 (14%), Positives = 50/176 (28%), Gaps = 23/176 (13%)

Query: 44  ISAGTFGFSHLRRQGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFM 103
           +   +F     +R      F            R L K+    +   Y      A++ E +
Sbjct: 34  VGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN-AVLMELI 92

Query: 104 HNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS 163
             + L         E                 +   +   +   +H       H  L   
Sbjct: 93  DAKELYRVRVENPDE-----------------VLDMILEEVAKFYHRG---IVHGDLSQY 132

Query: 164 NVLLDDDMTARVGDFGLARFLP-PTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGD 218
           NVL+  +    + DF  +  +      +    DV+  I Y +  Y    ++++  D
Sbjct: 133 NVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAID 187

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 40.1 bits (92), Expect = 3e-04
 Identities = 13/41 (31%), Positives = 21/41 (51%)

Query: 9   DVSGNKLTGSLHIEVGKLKNLEILDVSRNMLEENLISAGTF 49
           D+  N++ G+L   + +LK L  L+VS N L   +   G  
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 36.7 bits (83), Expect = 0.003
 Identities = 11/37 (29%), Positives = 18/37 (48%), Gaps = 2/37 (5%)

Query: 1   LPSLLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRN 37
           L  L   L+VS N L G +  + G L+  ++   + N
Sbjct: 267 LKFLHS-LNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	381
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.95
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.31
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.97
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.39
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.76
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	86.48

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=400.56  Aligned_cols=249  Identities=25%  Similarity=0.377  Sum_probs=193.3

Q ss_pred             cccccccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .++|...++||+|+||+||+++                ....+.|.+|+++|++++|||||++++++.      .+..++
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccEEEE
Confidence            4678999999999999998864                234678999999999999999999999853      345799


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      |||||++|+|.+++.         .....+++..++.++.||+.||+|||   +++||||||||+|||++.++.+||+||
T Consensus        81 v~Ey~~~g~L~~~l~---------~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DF  148 (276)
T d1uwha_          81 VTQWCEGSSLYHHLH---------IIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDF  148 (276)
T ss_dssp             EEECCCEEEHHHHHH---------TSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCC
T ss_pred             EEecCCCCCHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccc
Confidence            999999999999995         23456999999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |+|+...............||+.|+|||++.+   ..|+.++|||||||++|||+||+.||...    ............
T Consensus       149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~----~~~~~~~~~~~~  224 (276)
T d1uwha_         149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGR  224 (276)
T ss_dssp             CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC----CCHHHHHHHHHH
T ss_pred             cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC----ChHHHHHHHHhc
Confidence            99987765443333334679999999999864   35899999999999999999999998532    111111111000


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                              .......               ......+++++.+++.+||+.||++|||+.+|++.|+.+.+++
T Consensus       225 --------~~~~p~~---------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         225 --------GYLSPDL---------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             --------TSCCCCG---------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             --------CCCCCcc---------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence                    0000000               0112356678999999999999999999999999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-54  Score=383.97  Aligned_cols=229  Identities=20%  Similarity=0.292  Sum_probs=189.7

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||+||++..                    ...+.+.+|+++|++++|||||++++++     .+.+.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence            5799999999999999988641                    2356788999999999999999999995     45788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|||||++|+|.+++.          ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        81 ~~ivmEy~~~g~L~~~l~----------~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl  147 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQ----------KLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI  147 (263)
T ss_dssp             EEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeecCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEee
Confidence            999999999999999993          4567999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+|+........    ...||+.|+|||++.+..++.++|||||||++|||++|+.||...    . ....      
T Consensus       148 ~DFG~a~~~~~~~~~----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~-~~~~------  212 (263)
T d2j4za1         148 ADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----T-YQET------  212 (263)
T ss_dssp             CCCCSCSCCCCCCCE----ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS----S-HHHH------
T ss_pred             cccceeeecCCCccc----ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC----C-HHHH------
Confidence            999999876544322    256999999999999999999999999999999999999998521    1 1111      


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            +.......+.                .+...+.++.+++.+||+.||++|||+.|+++
T Consensus       213 ------~~~i~~~~~~----------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         213 ------YKRISRVEFT----------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ------HHHHHTTCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHcCCCC----------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                  1111111110                01234567889999999999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=388.28  Aligned_cols=237  Identities=18%  Similarity=0.256  Sum_probs=188.8

Q ss_pred             cccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .++|+..++||+|+||+||++..                  ...+.+.+|+++|++++|||||++++++     .+.+..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence            46899999999999999988641                  2345688999999999999999999995     457889


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      |+|||||++|+|.+++          .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        79 ~ivmEy~~gg~L~~~l----------~~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~  145 (271)
T d1nvra_          79 YLFLEYCSGGELFDRI----------EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS  145 (271)
T ss_dssp             EEEEECCTTEEGGGGS----------BTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEeccCCCcHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEc
Confidence            9999999999999999          44567999999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      |||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........   .+...   
T Consensus       146 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~~~---  219 (271)
T d1nvra_         146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDW---  219 (271)
T ss_dssp             CCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---HHHHH---
T ss_pred             cchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---HHHHH---
Confidence            9999998755443333344679999999999988776 6789999999999999999999863322111   11100   


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            ........+                  ....+.++.+++.+||+.||++|||+.|+++
T Consensus       220 ------~~~~~~~~~------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         220 ------KEKKTYLNP------------------WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ------HTTCTTSTT------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------hcCCCCCCc------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  000000000                  1234557788999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-53  Score=388.97  Aligned_cols=243  Identities=23%  Similarity=0.371  Sum_probs=185.9

Q ss_pred             ccccccceecCCCceEEEeccc---------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ---------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~---------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|...++||+|+||+||++..                     ...+.|.+|+++|++++|||||+++++|.     ..+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCC
Confidence            5688889999999999987641                     23467999999999999999999999964     467


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++|||||++|+|.+++.         .....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~---------~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~K  168 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLR---------QNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCK  168 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHH---------TTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred             EEEEEEEecCCCcceeeec---------cccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEE
Confidence            7899999999999999885         33456899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcc---cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHH
Q 041757          175 VGDFGLARFLPPTRTQT---SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~  250 (381)
                      |+|||+++.+.......   ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....     ....
T Consensus       169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~~~~  243 (299)
T d1jpaa_         169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDVI  243 (299)
T ss_dssp             ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH
T ss_pred             ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence            99999998776543221   1222457999999999999999999999999999999998 8999753211     1111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      .         .+..-...                  +.+..++..+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus       244 ~---------~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         244 N---------AIEQDYRL------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             H---------HHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             H---------HHHcCCCC------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            1         11110000                  01235667899999999999999999999999999988654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=383.53  Aligned_cols=243  Identities=24%  Similarity=0.397  Sum_probs=185.6

Q ss_pred             ccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++|...+.||+|+||+||++.               ....+.|.+|++++++++|||||+++++|.     ..+..++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEEEE
Confidence            578889999999999998864               224578999999999999999999999964     367789999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      |||++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        80 E~~~~g~L~~~l~---------~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGl  147 (263)
T d1sm2a_          80 EFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGM  147 (263)
T ss_dssp             ECCTTCBHHHHHH---------TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred             EecCCCcHHHHhh---------ccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccch
Confidence            9999999999985         34566889999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVKD  260 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  260 (381)
                      ++.......... ....||+.|+|||++.+..++.++|||||||++|||+|+..|+.   .. .........        
T Consensus       148 a~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~---~~-~~~~~~~~~--------  214 (263)
T d1sm2a_         148 TRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY---EN-RSNSEVVED--------  214 (263)
T ss_dssp             ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT---CS-CCHHHHHHH--------
T ss_pred             heeccCCCceee-cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC---CC-CCHHHHHHH--------
Confidence            987755433222 22568999999999999999999999999999999999644432   11 111111111        


Q ss_pred             HHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          261 IVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       261 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      +........                   +..++.++.+++.+||+.||++|||+.+|++.|+++.++
T Consensus       215 i~~~~~~~~-------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         215 ISTGFRLYK-------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHTCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCC-------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            111000001                   124566889999999999999999999999999998754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=384.04  Aligned_cols=234  Identities=18%  Similarity=0.286  Sum_probs=188.4

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|..++.||+|+||+||++..                    ...+.+.+|+++|++++|||||++++++     .+.+.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            5799999999999999988641                    2346789999999999999999999994     55788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .|+|||||++|+|.+++          .....+++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||
T Consensus        83 ~~ivmEy~~gg~L~~~~----------~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl  149 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYI----------RKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI  149 (288)
T ss_dssp             EEEEECCCTTEEHHHHH----------HHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEEEccCCCCHHHhh----------hccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEe
Confidence            99999999999999998          44567999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+|+.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||...    .. ..       
T Consensus       150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~-~~-------  217 (288)
T d1uu3a_         150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NE-YL-------  217 (288)
T ss_dssp             CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SH-HH-------
T ss_pred             cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc----CH-HH-------
Confidence            9999999876554433333467999999999999999999999999999999999999998521    11 11       


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHE  320 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~  320 (381)
                           +........+.                ++...+.++.+|+.+||+.||.+|||+.|++..
T Consensus       218 -----~~~~i~~~~~~----------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         218 -----IFQKIIKLEYD----------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -----HHHHHHTTCCC----------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -----HHHHHHcCCCC----------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                 11111111110                012345678899999999999999999998653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=383.42  Aligned_cols=242  Identities=21%  Similarity=0.266  Sum_probs=179.3

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      .++|+..+.||+|+||+||+++.                   ...+.+.+|+++|++++|||||++++++.+   .....
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence            36899999999999999988641                   235678999999999999999999999653   34567


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC--CCCceeeccCCCCeeeCCCCCe
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC--QPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      .|+|||||++|+|.+++....      .....+++..++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v  153 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV  153 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence            899999999999999985321      23457999999999999999999999531  1359999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      ||+|||+++.+.......  ....||+.|+|||++.+..|+.++|||||||++|||++|+.||...     +....... 
T Consensus       154 kl~DFG~a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-----~~~~~~~~-  225 (269)
T d2java1         154 KLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQKELAGK-  225 (269)
T ss_dssp             EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHH-
T ss_pred             EEeeccceeecccCCCcc--ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-----CHHHHHHH-
Confidence            999999998875543322  2256999999999999999999999999999999999999998522     11111111 


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                             +........                   +..++.++.+++.+||+.||.+|||+.|+++
T Consensus       226 -------i~~~~~~~~-------------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         226 -------IREGKFRRI-------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -------HHHTCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHcCCCCCC-------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   111111000                   1235567899999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=379.10  Aligned_cols=244  Identities=20%  Similarity=0.323  Sum_probs=195.8

Q ss_pred             cccccccce-ecCCCceEEEecc--------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           35 SRNMLEENL-ISAGTFGFSHLRR--------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        35 ~~~~~~~~~-lG~G~fg~V~~~~--------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .++|...+. ||+|+||+||++.                    ....+.|.+|+++|++++|||||+++++|.      .
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~   80 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A   80 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec------c
Confidence            356777774 9999999998862                    123577999999999999999999999963      2


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++|||||++|+|.+++.         .....+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+
T Consensus        81 ~~~~lvmE~~~~g~L~~~l~---------~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~  148 (285)
T d1u59a_          81 EALMLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYA  148 (285)
T ss_dssp             SSEEEEEECCTTEEHHHHHT---------TCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEE
T ss_pred             CeEEEEEEeCCCCcHHHHhh---------ccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCce
Confidence            35799999999999999984         34467999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~  251 (381)
                      ||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....    . .....
T Consensus       149 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~----~-~~~~~  223 (285)
T d1u59a_         149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----G-PEVMA  223 (285)
T ss_dssp             EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----T-HHHHH
T ss_pred             eeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC----H-HHHHH
Confidence            99999999987654332 22223568999999999998999999999999999999998 899986321    1 11111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                      .         +..-..                  ...+..++.++.+|+.+||+.||++|||+.+|++.|+.+..++
T Consensus       224 ~---------i~~~~~------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         224 F---------IEQGKR------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             H---------HHTTCC------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             H---------HHcCCC------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            1         110000                  0112356678999999999999999999999999998876554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=380.88  Aligned_cols=243  Identities=21%  Similarity=0.356  Sum_probs=193.3

Q ss_pred             cccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|...+.||+|+||+||++.               ....+.|.+|+++|++++|||||++++++.      .+..++|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~~~iv   85 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYII   85 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec------cCCeEEE
Confidence            4678899999999999998865               234678999999999999999999999863      3456899


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      ||||++|+|.+++..        .....+++..++.++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||
T Consensus        86 ~Ey~~~g~L~~~~~~--------~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          86 TEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             EECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEeCCCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeecccc
Confidence            999999999998853        22345899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      +|+.......... ....||+.|+|||++.+..++.++|||||||++|||+||..|+..   . .........       
T Consensus       155 la~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~---~-~~~~~~~~~-------  222 (272)
T d1qpca_         155 LARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP---G-MTNPEVIQN-------  222 (272)
T ss_dssp             TCEECSSSCEECC-TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST---T-CCHHHHHHH-------
T ss_pred             ceEEccCCccccc-cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC---C-CCHHHHHHH-------
Confidence            9998765433222 235689999999999988999999999999999999997666431   1 111111111       


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                       +.......                   .+..++.++.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       223 -i~~~~~~~-------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         223 -LERGYRMV-------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -HHTTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHhcCCCC-------------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence             11100000                   012456688999999999999999999999999988753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-52  Score=381.86  Aligned_cols=244  Identities=21%  Similarity=0.344  Sum_probs=197.3

Q ss_pred             cccccccceecCCCceEEEecc----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .++|...++||+|+||+||++.                ....++|.+|+++|++++|||||+++++|.     +.+..++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCeeEE
Confidence            4678899999999999998864                224678999999999999999999999964     4678899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      |||||++|+|.+++..        .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus        91 v~E~~~~g~l~~~l~~--------~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          91 ITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             EEECCTTCBHHHHHHH--------SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EeecccCcchHHHhhh--------ccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccc
Confidence            9999999999999853        23467899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      |+|+.......... ....|++.|+|||++.+..|+.++|||||||++|||++|..||..    ........        
T Consensus       160 G~a~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~----~~~~~~~~--------  226 (287)
T d1opja_         160 GLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP----GIDLSQVY--------  226 (287)
T ss_dssp             CCTTTCCSSSSEEE-TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST----TCCHHHHH--------
T ss_pred             cceeecCCCCceee-ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC----cchHHHHH--------
Confidence            99987665443322 224588999999999999999999999999999999998777531    11211111        


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                       +.+......                  ..+..++.++.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus       227 -~~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         227 -ELLEKDYRM------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -HHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -HHHhcCCCC------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             111111100                  0123456789999999999999999999999999988754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-52  Score=377.66  Aligned_cols=234  Identities=18%  Similarity=0.239  Sum_probs=189.9

Q ss_pred             cccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      .++|...+.||+|+||+||++.                 ....+.+.+|+++|++++|||||++++++     .+.+..|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~   93 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW   93 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEE
Confidence            4679999999999999998864                 23457799999999999999999999995     4477899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      +|||||++|+|.+++.           ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        94 ivmEy~~gg~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~D  159 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTD  159 (293)
T ss_dssp             EEEECCTTCBHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCcHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeecc
Confidence            9999999999999873           246899999999999999999999   66999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+|+.+.......  ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||..    ..........     
T Consensus       160 FG~a~~~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~----~~~~~~~~~~-----  228 (293)
T d1yhwa1         160 FGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN----ENPLRALYLI-----  228 (293)
T ss_dssp             CTTCEECCSTTCCB--CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT----SCHHHHHHHH-----
T ss_pred             chhheeeccccccc--cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC----CCHHHHHHHH-----
Confidence            99999875543322  235699999999999999999999999999999999999999852    2111111110     


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          ...   ..+.              ...+..++..+.+++.+||+.||.+|||+.|+++
T Consensus       229 ----~~~---~~~~--------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         229 ----ATN---GTPE--------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ----HHH---CSCC--------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----HhC---CCCC--------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000   0000              0001245567889999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=386.99  Aligned_cols=248  Identities=21%  Similarity=0.273  Sum_probs=193.2

Q ss_pred             ccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHcc-CCCcccceeeeecccccc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~   91 (381)
                      ++|..+++||+|+||+||++..                       .....+.+|+.+|.++ +|||||++++++     .
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~  111 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----T  111 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----e
Confidence            6799999999999999987641                       2345788999999998 799999999995     4


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCc-------------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceee
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKED-------------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHC  158 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHr  158 (381)
                      +.+..++|||||++|+|.++|.......             ........+++..++.++.||+.||+|||   +.+||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            4778899999999999999996432100             00011245899999999999999999999   6699999


Q ss_pred             ccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCC
Q 041757          159 VLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSD  237 (381)
Q Consensus       159 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~  237 (381)
                      ||||+||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987765554443334568999999999999999999999999999999998 899975


Q ss_pred             ccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041757          238 IMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNV  317 (381)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v  317 (381)
                      .....    ..+         ..++......                  +.+..++.++.+|+.+||+.||++|||+.||
T Consensus       269 ~~~~~----~~~---------~~~~~~~~~~------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei  317 (325)
T d1rjba_         269 GIPVD----ANF---------YKLIQNGFKM------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  317 (325)
T ss_dssp             TCCCS----HHH---------HHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCHH----HHH---------HHHHhcCCCC------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            32111    111         1111111100                  0123456789999999999999999999999


Q ss_pred             HHHHH
Q 041757          318 VHELQ  322 (381)
Q Consensus       318 l~~L~  322 (381)
                      ++.|.
T Consensus       318 ~~~L~  322 (325)
T d1rjba_         318 TSFLG  322 (325)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            99985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=371.54  Aligned_cols=235  Identities=20%  Similarity=0.322  Sum_probs=182.6

Q ss_pred             ccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           38 MLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      |+..++||+|+||+||++..                   ...+.|.+|+++|++++|||||++++++... ..+....++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEE
Confidence            35677899999999988641                   2346789999999999999999999997541 234567899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC-CCCCeEEee
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD-DDMTARVGD  177 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~D  177 (381)
                      |||||++|+|.+++.          ....+++..++.++.||+.||+|||+. ..+|+||||||+|||++ .++.+||+|
T Consensus        90 vmE~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~D  158 (270)
T d1t4ha_          90 VTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGD  158 (270)
T ss_dssp             EEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEeCCCCCcHHHHHh----------ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEee
Confidence            999999999999994          456789999999999999999999944 22399999999999996 478999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+|+........    ..+||+.|+|||++.+ .++.++|||||||++|||++|+.||..    .............  
T Consensus       159 FGla~~~~~~~~~----~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~----~~~~~~~~~~i~~--  227 (270)
T d1t4ha_         159 LGLATLKRASFAK----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE----CQNAAQIYRRVTS--  227 (270)
T ss_dssp             TTGGGGCCTTSBE----ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT----CSSHHHHHHHHTT--
T ss_pred             cCcceeccCCccC----CcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC----cccHHHHHHHHHc--
Confidence            9999865433222    2579999999999876 699999999999999999999999752    2222222111111  


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                ....              .......++++.+++.+||+.||++|||+.|+++
T Consensus       228 ----------~~~~--------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         228 ----------GVKP--------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----------TCCC--------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----------CCCC--------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                      0000              0001233456889999999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=378.68  Aligned_cols=244  Identities=20%  Similarity=0.339  Sum_probs=187.8

Q ss_pred             ccccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      ..|..+++||+|+||.||++.                      ......|.+|+++|++++|||||+++|+|.     ..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence            458889999999999998753                      113457899999999999999999999964     46


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..++|||||.+|++.+++.         .....+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~  149 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLR---------EKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC  149 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHH---------HTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred             CceEEEEEecccCcchhhhh---------cccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeE
Confidence            77899999999999999875         34567999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||...    .........
T Consensus       150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~----~~~~~~~~~  225 (283)
T d1mqba_         150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----LSNHEVMKA  225 (283)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT----CCHHHHHHH
T ss_pred             EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc----CCHHHHHHH
Confidence            99999999877554322 2222345899999999999999999999999999999999976664311    111111111


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                               +......                  +.+..++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       226 ---------i~~~~~~------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         226 ---------INDGFRL------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             ---------HHTTCCC------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---------HhccCCC------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                     1110000                  01234567899999999999999999999999999988764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=385.47  Aligned_cols=183  Identities=21%  Similarity=0.288  Sum_probs=160.3

Q ss_pred             cccccccceecCCCceEEEecc------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      .++|+..++||+|+||+||++.                  ....+.+.+|+.+|++++|||||+++++|     .+.+..
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            6789999999999999998864                  12356789999999999999999999995     457789


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++|||||++|+|.+++.          +...+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+
T Consensus        80 ~iVmEy~~gg~L~~~l~----------~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~  147 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC  147 (322)
T ss_dssp             EEEEECCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEe
Confidence            99999999999999994          456799999999999999999999931  289999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCc
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  238 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~  238 (381)
                      |||+|+.......    ...+||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus       148 DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         148 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             CCCCCHHHHHHTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             eCCCccccCCCcc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999986543222    235799999999999999999999999999999999999999853

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-52  Score=374.63  Aligned_cols=234  Identities=20%  Similarity=0.289  Sum_probs=186.8

Q ss_pred             ceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           42 NLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        42 ~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++||+|+||+||++.                     ....+.|.+|+++|++++|||||+++++|.      .+..+|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~------~~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec------cCCEEEEE
Confidence            579999999998753                     112467999999999999999999999963      23468999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      |||++|+|.+++.          ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        87 E~~~~g~L~~~l~----------~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGl  153 (277)
T d1xbba_          87 EMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL  153 (277)
T ss_dssp             ECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EcCCCCcHHHHHh----------hccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhh
Confidence            9999999999993          4567999999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCc-ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchH
Q 041757          181 ARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHV  258 (381)
Q Consensus       181 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  258 (381)
                      ++.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....     ......       
T Consensus       154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~~~~~-------  221 (277)
T d1xbba_         154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVTA-------  221 (277)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHH-------
T ss_pred             hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----HHHHHH-------
Confidence            9987654332 22223568999999999999999999999999999999998 899985221     111111       


Q ss_pred             HHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          259 KDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       259 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                        .+.....                  ...+..++.++.+|+.+||+.||++|||+.+|++.|+....
T Consensus       222 --~i~~~~~------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         222 --MLEKGER------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             --HHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --HHHcCCC------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence              1111000                  01123466789999999999999999999999999887643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=379.17  Aligned_cols=237  Identities=19%  Similarity=0.244  Sum_probs=188.1

Q ss_pred             ccccccccceecCCCceEEEecc-----------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRR-----------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~-----------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ..+.|+..+.||+|+||+||++.                 ....+.+.+|+++|++++|||||++++++     .+.+..
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~   84 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNL   84 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeE
Confidence            45679999999999999998864                 23457889999999999999999999995     447889


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++|||||++|+|.+++.         .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        85 ~lvmEy~~~g~L~~~~~---------~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~  152 (288)
T d2jfla1          85 WILIEFCAGGAVDAVML---------ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLA  152 (288)
T ss_dssp             EEEEECCTTEEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEE
Confidence            99999999999999974         23456999999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcC-----CCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGV-----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      |||+|+.......  ......||+.|+|||++.     +..|+.++|||||||++|||++|+.||....    ....+. 
T Consensus       153 DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~----~~~~~~-  225 (288)
T d2jfla1         153 DFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN----PMRVLL-  225 (288)
T ss_dssp             CCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC----GGGHHH-
T ss_pred             echhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC----HHHHHH-
Confidence            9999976543211  112356999999999874     4568999999999999999999999985321    111111 


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              .+..    ..+..             ...+..++.++.+++.+||+.||.+|||+.|+++
T Consensus       226 --------~i~~----~~~~~-------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         226 --------KIAK----SEPPT-------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --------HHHH----SCCCC-------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------HHHc----CCCCC-------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    1111    00000             0001245567889999999999999999999865

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=366.54  Aligned_cols=239  Identities=21%  Similarity=0.362  Sum_probs=195.0

Q ss_pred             ccccccceecCCCceEEEecc---------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRR---------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~---------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      ++|+..++||+|+||+||+++               ....+.|.+|+.++++++||||++++++|.     +.+..++||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEEE
Confidence            688999999999999998854               225678999999999999999999999964     467899999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeeccc
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGL  180 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~  180 (381)
                      ||+++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        79 Ey~~~g~l~~~~~---------~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~  146 (258)
T d1k2pa_          79 EYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL  146 (258)
T ss_dssp             ECCTTEEHHHHHH---------SGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred             EccCCCcHHHhhh---------ccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchh
Confidence            9999999999975         34567889999999999999999999   66999999999999999999999999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      ++......... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....     ......       
T Consensus       147 a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----~~~~~~-------  213 (258)
T d1k2pa_         147 SRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAEH-------  213 (258)
T ss_dssp             CCBCSSSSCCC-CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HHHHHH-------
T ss_pred             heeccCCCcee-ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----HHHHHH-------
Confidence            98776543332 223568999999999999999999999999999999998 8999753211     111111       


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                       +........                   +..++..+.+++.+||+.||++|||+.+|++.|..|
T Consensus       214 -i~~~~~~~~-------------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         214 -IAQGLRLYR-------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -HHTTCCCCC-------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -HHhCCCCCC-------------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence             111100011                   124556889999999999999999999999998653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-51  Score=378.49  Aligned_cols=237  Identities=21%  Similarity=0.263  Sum_probs=176.1

Q ss_pred             hccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           33 DVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        33 ~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++.+.|...++||+|+||+||++..                  ...+.+.+|+++|++++|||||++++++     .+.+
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~   80 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGG   80 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            3556799999999999999988641                  2345677899999999999999999994     5578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC---CCC
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD---DDM  171 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~---~~~  171 (381)
                      ..|+|||||++|+|.+++          .....+++..+..++.||+.||.|||   +.+|+||||||+||++.   .++
T Consensus        81 ~~~lvmE~~~gg~L~~~l----------~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~  147 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRI----------VEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS  147 (307)
T ss_dssp             EEEEEECCCCSCBHHHHH----------HTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTC
T ss_pred             EEEEEEeccCCCcHHHhh----------hcccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCc
Confidence            899999999999999999          34567999999999999999999999   66999999999999994   578


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      .+||+|||+|+.........   ..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...    .. ..   
T Consensus       148 ~vkl~DFG~a~~~~~~~~~~---~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~-~~---  216 (307)
T d1a06a_         148 KIMISDFGLSKMEDPGSVLS---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE----ND-AK---  216 (307)
T ss_dssp             CEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SH-HH---
T ss_pred             eEEEeccceeEEccCCCeee---eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC----CH-HH---
Confidence            99999999998765443222   256999999999999999999999999999999999999998521    11 11   


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                               +....+......            ..+.....+.++.+++.+||+.||++|||+.|+++
T Consensus       217 ---------~~~~i~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         217 ---------LFEQILKAEYEF------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ---------HHHHHHTTCCCC------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---------HHHHHhccCCCC------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                     111111111000            00011245567899999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=372.18  Aligned_cols=241  Identities=22%  Similarity=0.345  Sum_probs=184.8

Q ss_pred             ccccccceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|..++.||+|+||.||++.                     ....+.|.+|+++|++++|||||++++++.      .+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~~   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------SS
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cC
Confidence            679999999999999998763                     123467899999999999999999999953      45


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..++|||||++|+|.+++.         .....+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+|
T Consensus        81 ~~~iv~E~~~~g~l~~~~~---------~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~K  148 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK  148 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHH---------HTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred             eEEEEEEeccCCcHHhhhh---------ccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEE
Confidence            6899999999999999875         34567899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHH
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMA  253 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~  253 (381)
                      |+|||+++.......... ....||+.|+|||++.+..++.++|||||||++|||++ |.+||.......  ..      
T Consensus       149 l~DfG~a~~~~~~~~~~~-~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~------  219 (273)
T d1mp8a_         149 LGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VI------  219 (273)
T ss_dssp             ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH------
T ss_pred             EccchhheeccCCcceec-cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HH------
Confidence            999999987654433222 22568999999999999999999999999999999998 899975332111  10      


Q ss_pred             hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          254 LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       254 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                           ..+......                   +.+..++..+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus       220 -----~~i~~~~~~-------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         220 -----GRIENGERL-------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -----HHHHTTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----HHHHcCCCC-------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                 011110000                   01235667899999999999999999999999999988654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=368.56  Aligned_cols=236  Identities=19%  Similarity=0.239  Sum_probs=191.3

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      +.+.|..++.||+|+||+||++..                       ...+.+.+|+++|++++|||||++++++     
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----   82 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----   82 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            467899999999999999988641                       1357899999999999999999999994     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      .+.+..++|||||++|+|.+++.          ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~----------~~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~  149 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDR  149 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCS
T ss_pred             EECCEEEEEEEcCCCccccchhc----------cccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecC
Confidence            55888999999999999999994          4567999999999999999999999   6699999999999999877


Q ss_pred             C----CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          171 M----TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       171 ~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                      +    .+||+|||+++.........   ...||+.|+|||++.+..++.++|||||||++|||++|+.||...    ...
T Consensus       150 ~~~~~~vkl~DfG~a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~  222 (293)
T d1jksa_         150 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQ  222 (293)
T ss_dssp             SSSSCCEEECCCTTCEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHH
T ss_pred             CCcccceEecchhhhhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC----CHH
Confidence            6    59999999998876544332   246899999999999999999999999999999999999997522    111


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ..             +.........            .....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       223 ~~-------------~~~i~~~~~~------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         223 ET-------------LANVSAVNYE------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HH-------------HHHHHTTCCC------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HH-------------HHHHHhcCCC------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11             1111111000            001112345667889999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-51  Score=376.25  Aligned_cols=242  Identities=23%  Similarity=0.332  Sum_probs=193.3

Q ss_pred             ccccccceecCCCceEEEecc----------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           36 RNMLEENLISAGTFGFSHLRR----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      .+|+..++||+|+||+||++.                      ....+.|.+|+++|++++|||||+++++|.+      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            569999999999999998753                      1235679999999999999999999999752      


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      +..+++|||+.+|+|.+++.         .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~  150 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV  150 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHH---------HTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred             CCeeEEEEeccCCccccccc---------ccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCe
Confidence            35688999999999999885         34567999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      ||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||......  .+      
T Consensus       151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~------  222 (317)
T d1xkka_         151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EI------  222 (317)
T ss_dssp             EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GH------
T ss_pred             EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HH------
Confidence            9999999998766554443334568999999999999999999999999999999998 78887532111  11      


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                            ...+......                  ..+..++.++.+|+.+||+.||++|||+.+|++.|..+.+.
T Consensus       223 ------~~~i~~~~~~------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         223 ------SSILEKGERL------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             ------HHHHHHTCCC------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ------HHHHHcCCCC------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                  1111110000                  01234667889999999999999999999999999888654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=373.03  Aligned_cols=231  Identities=24%  Similarity=0.304  Sum_probs=190.1

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||+||+++.                    ...+.+.+|+.+|++++|||||+++++     +.+.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----eccccc
Confidence            6799999999999999988652                    245778899999999999999999999     456889


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .|+|||||++|+|.+++          .....+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus        80 ~~iv~ey~~gg~L~~~~----------~~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl  146 (337)
T d1o6la_          80 LCFVMEYANGGELFFHL----------SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI  146 (337)
T ss_dssp             EEEEEECCTTCBHHHHH----------HHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred             cccceeccCCCchhhhh----------hcccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEE
Confidence            99999999999999999          45677999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+|+.........  ...+||+.|+|||++.+..|+.++|||||||++|||++|+.||...    . ...       
T Consensus       147 ~DFG~a~~~~~~~~~~--~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~----~-~~~-------  212 (337)
T d1o6la_         147 TDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----D-HER-------  212 (337)
T ss_dssp             CCCTTCBCSCCTTCCB--CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS----S-HHH-------
T ss_pred             eecccccccccCCccc--ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc----C-HHH-------
Confidence            9999998765433222  2367999999999999999999999999999999999999997522    1 111       


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                           +........+.                ++...+.++.+|+.+||+.||.+||+     +.|+++
T Consensus       213 -----~~~~i~~~~~~----------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         213 -----LFELILMEEIR----------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----HHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----HHHHHhcCCCC----------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                 11111111110                12234567889999999999999995     778775

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-51  Score=375.36  Aligned_cols=229  Identities=23%  Similarity=0.294  Sum_probs=184.0

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      +.|+..+.||+|+||+||++..                    ...+.+.+|+++|++++|||||++++++.     +.+.
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCE
Confidence            4599999999999999988641                    23467899999999999999999999954     4778


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++|||||++|+|..++          .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        90 ~~iv~E~~~~g~l~~~~----------~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl  156 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLE----------VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL  156 (309)
T ss_dssp             EEEEEECCSEEHHHHHH----------HHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEE
T ss_pred             EEEEEEecCCCchHHHH----------HhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEE
Confidence            99999999999998776          34567999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCC---CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|||+|+......      ...||+.|+|||++.+   ..|+.++|||||||++|||++|..||...    .....+.. 
T Consensus       157 ~DFG~a~~~~~~~------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~----~~~~~~~~-  225 (309)
T d1u5ra_         157 GDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYH-  225 (309)
T ss_dssp             CCCTTCBSSSSBC------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHH-
T ss_pred             eecccccccCCCC------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC----CHHHHHHH-
Confidence            9999998654322      2569999999999864   45899999999999999999999997521    11111111 


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                              +.........                  ...++..+.+++.+||+.||.+|||+.|+++
T Consensus       226 --------i~~~~~~~~~------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         226 --------IAQNESPALQ------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             --------HHHSCCCCCS------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------HHhCCCCCCC------------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                    1110000000                  1134567889999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=371.31  Aligned_cols=245  Identities=22%  Similarity=0.350  Sum_probs=189.7

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++|+.++.||+|+||.||++..               ...+.|.+|+.+|++++|||||+++++|.      .+..++|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~lv   89 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIV   89 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeEEE
Confidence            36799999999999999988752               23578999999999999999999999963      3457899


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      ||||++|+|..++..        .....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        90 ~Ey~~~g~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfG  158 (285)
T d1fmka3          90 TEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG  158 (285)
T ss_dssp             ECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEecCCCchhhhhhh--------cccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccc
Confidence            999999999999853        23456899999999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          180 LARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      +++.......... ....||+.|+|||++....++.++|||||||++|||++|..||..    ..........       
T Consensus       159 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~----~~~~~~~~~~-------  226 (285)
T d1fmka3         159 LARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP----GMVNREVLDQ-------  226 (285)
T ss_dssp             TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST----TCCHHHHHHH-------
T ss_pred             hhhhccCCCceee-ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC----CCCHHHHHHH-------
Confidence            9987654433222 225689999999999999999999999999999999997777531    1111111111       


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                        +......                  +.+..++.++.+++.+||+.||++|||+.+|++.|+......
T Consensus       227 --i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         227 --VERGYRM------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             --HHTTCCC------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             --HHhcCCC------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence              1110000                  012355678899999999999999999999999999876554

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.9e-50  Score=376.42  Aligned_cols=236  Identities=19%  Similarity=0.281  Sum_probs=190.1

Q ss_pred             cccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      -++|.+.++||+|+||+||++..                 ...+.+.+|+++|++++|||||++++++     .+.+..+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            35899999999999999988652                 2356788999999999999999999995     4578899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC--CCCeEE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD--DMTARV  175 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl  175 (381)
                      +|||||++|+|.+++.         .....+++..+..++.||+.||.|||   +.+||||||||+|||++.  ++.+||
T Consensus       100 ivmE~~~gg~L~~~l~---------~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL  167 (350)
T d1koaa2         100 MIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL  167 (350)
T ss_dssp             EEECCCCSCBHHHHHT---------CTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEE
T ss_pred             EEEEcCCCCCHHHHHH---------hhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEE
Confidence            9999999999999984         34557999999999999999999999   669999999999999954  578999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+++.+........   ..||+.|+|||++.+..++.++|||||||++|||++|+.||...    .. .....    
T Consensus       168 ~DFG~a~~~~~~~~~~~---~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~-~~~~~----  235 (350)
T d1koaa2         168 IDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----ND-DETLR----  235 (350)
T ss_dssp             CCCTTCEECCTTSCEEE---ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SH-HHHHH----
T ss_pred             eecchheecccccccce---ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC----CH-HHHHH----
Confidence            99999998765543322   56999999999999999999999999999999999999997522    11 11111    


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          .+..........                .....+.++.+++.+||+.||++|||+.|+++
T Consensus       236 ----~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         236 ----NVKSCDWNMDDS----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ----HHHHTCCCSCCG----------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----HHHhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                111110000000                01234567889999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=370.72  Aligned_cols=254  Identities=20%  Similarity=0.271  Sum_probs=189.3

Q ss_pred             ccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHcc-CCCcccceeeeecccccc
Q 041757           36 RNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~   91 (381)
                      ++|...++||+|+||.||++.                       ....+.+.+|..++.++ +|+||+.+++++.    .
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~----~   88 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----K   88 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----S
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec----c
Confidence            679999999999999998753                       12345688888888888 5899999999864    3


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcc------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCe
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDE------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNV  165 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Ni  165 (381)
                      .....++|||||++|+|.+++........      .......+++..++.++.||+.||.|||   +++||||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccce
Confidence            45678999999999999999964321100      0012345899999999999999999999   66999999999999


Q ss_pred             eeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCC-CCCCccccCCC
Q 041757          166 LLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE-KPSDIMFEGDM  244 (381)
Q Consensus       166 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~-~Pf~~~~~~~~  244 (381)
                      |++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. .||...    .
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~----~  241 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----K  241 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----C
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC----C
Confidence            99999999999999998776555444444467999999999999999999999999999999999975 565422    1


Q ss_pred             cHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          245 NLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ....+...         +......                  ..+..+++++.+++.+||+.||++|||+.||++.|+++
T Consensus       242 ~~~~~~~~---------~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         242 IDEEFCRR---------LKEGTRM------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CSHHHHHH---------HHHTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHH---------HhcCCCC------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11111111         1100000                  01124566789999999999999999999999999988


Q ss_pred             hhh
Q 041757          325 KNT  327 (381)
Q Consensus       325 ~~~  327 (381)
                      .+.
T Consensus       295 lq~  297 (299)
T d1ywna1         295 LQA  297 (299)
T ss_dssp             HHH
T ss_pred             HhC
Confidence            653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=370.29  Aligned_cols=244  Identities=23%  Similarity=0.372  Sum_probs=193.8

Q ss_pred             cceecCCCceEEEecc---------------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEE
Q 041757           41 ENLISAGTFGFSHLRR---------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV   99 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~---------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv   99 (381)
                      .++||+|+||+||++.                     ....++|.+|+++|++++|||||+++|+|..    .+...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence            5789999999998753                     1245779999999999999999999999753    35678999


Q ss_pred             EEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecc
Q 041757          100 YEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFG  179 (381)
Q Consensus       100 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg  179 (381)
                      ||||++|+|.+++.         .....+++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||
T Consensus       108 ~E~~~~g~l~~~~~---------~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         108 LPYMKHGDLRNFIR---------NETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             EECCTTCBHHHHHH---------CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             EEEeecCchhhhhc---------cccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEeccc
Confidence            99999999999986         34566788899999999999999999   6699999999999999999999999999


Q ss_pred             cceecCCCCCc--ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          180 LARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       180 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      +++........  .......||+.|+|||.+....++.++||||||+++|||++|..||........    +.       
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~-------  244 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----IT-------  244 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CH-------
T ss_pred             chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HH-------
Confidence            99877654322  222235689999999999999999999999999999999998888653221111    00       


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  331 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~~~~  331 (381)
                       ..+........                   +..++..+.+++.+||+.||++|||+.||++.|+++.+.....
T Consensus       245 -~~i~~g~~~~~-------------------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         245 -VYLLQGRRLLQ-------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             -HHHHTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             -HHHHcCCCCCC-------------------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence             01111100000                   1245668899999999999999999999999999998775543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.5e-50  Score=374.92  Aligned_cols=237  Identities=18%  Similarity=0.225  Sum_probs=191.0

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      +.++|+..++||+|+||+||++..                 ...+.+.+|+++|++++|||||++++++     .+++..
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~  101 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEM  101 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            346799999999999999988652                 2346788999999999999999999994     558889


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC--CCCCeE
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD--DDMTAR  174 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~--~~~~~k  174 (381)
                      |+|||||++|+|.+++.         .....+++.+++.++.||+.||.|||   +.+|+||||||+|||++  .++.+|
T Consensus       102 ~ivmE~~~gg~L~~~~~---------~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vk  169 (352)
T d1koba_         102 VLILEFLSGGELFDRIA---------AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVK  169 (352)
T ss_dssp             EEEEECCCCCBHHHHTT---------CTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEE
T ss_pred             EEEEEcCCCChHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEE
Confidence            99999999999998874         34557999999999999999999999   66999999999999997  578999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+|+.+........   ..||+.|+|||++.+..++.++|||||||++|||++|+.||..    .....       
T Consensus       170 L~DFGla~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~----~~~~~-------  235 (352)
T d1koba_         170 IIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG----EDDLE-------  235 (352)
T ss_dssp             ECCCTTCEECCTTSCEEE---ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC----SSHHH-------
T ss_pred             EeecccceecCCCCceee---ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC----CCHHH-------
Confidence            999999998766543322   4599999999999999999999999999999999999999752    21111       


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                            ++..........            ........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       236 ------~~~~i~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         236 ------TLQNVKRCDWEF------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             ------HHHHHHHCCCCC------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHHhCCCCC------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  111111111000            00001235567889999999999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.4e-50  Score=367.31  Aligned_cols=228  Identities=21%  Similarity=0.276  Sum_probs=188.9

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...+.||+|+||+||+++.                    ...+.+.+|+.+|++++|||||++++++     .+.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            6799999999999999988752                    2356788999999999999999999994     55889


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .|+|||||+||+|..++          .....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||
T Consensus        79 ~~ivmE~~~gg~l~~~~----------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL  145 (316)
T d1fota_          79 IFMIMDYIEGGELFSLL----------RKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI  145 (316)
T ss_dssp             EEEEECCCCSCBHHHHH----------HHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEE
T ss_pred             eeeEeeecCCccccccc----------cccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEE
Confidence            99999999999999998          45667888999999999999999999   779999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+|+.......     ..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...    .. .        
T Consensus       146 ~DFG~a~~~~~~~~-----~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~----~~-~--------  207 (316)
T d1fota_         146 TDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NT-M--------  207 (316)
T ss_dssp             CCCSSCEECSSCBC-----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SH-H--------
T ss_pred             ecCccceEeccccc-----cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc----CH-H--------
Confidence            99999988754332     257999999999999999999999999999999999999998521    11 1        


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                          ++....+.....                .+...+.++.+++.+||..||.+||     |+.++++
T Consensus       208 ----~~~~~i~~~~~~----------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         208 ----KTYEKILNAELR----------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----HHHHHHHHCCCC----------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----HHHHHHHcCCCC----------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                111111111110                0123456788999999999999996     8899875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=364.91  Aligned_cols=241  Identities=24%  Similarity=0.306  Sum_probs=187.3

Q ss_pred             cccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHccCCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~   91 (381)
                      .++|+..+.||+|+||.||+++                       ....+.|.+|+.+|++++|||||+++++|.     
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----   81 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----   81 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----
Confidence            5779999999999999998753                       123467899999999999999999999964     


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                       .+..++|||||++|+|.+++.         .....+++..++.++.||+.||.|||   +++|+||||||+||+++.++
T Consensus        82 -~~~~~lv~e~~~~~~l~~~~~---------~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~  148 (273)
T d1u46a_          82 -TPPMKMVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRD  148 (273)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHH---------HHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETT
T ss_pred             -ecchheeeeeecCcchhhhhh---------cccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhcccccc
Confidence             235689999999999999885         34567999999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcc-cccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQT-SSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~  249 (381)
                      .+||+|||+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...     +....
T Consensus       149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~  223 (273)
T d1u46a_         149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQI  223 (273)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHH
T ss_pred             ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHHHH
Confidence            99999999999876654322 2223457889999999999999999999999999999998 89997522     11111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  324 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i  324 (381)
                      ....        ......  +                +.+..++..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus       224 ~~~i--------~~~~~~--~----------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         224 LHKI--------DKEGER--L----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHH--------HTSCCC--C----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH--------HhCCCC--C----------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1111        110000  0                01234566889999999999999999999999998864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-50  Score=369.60  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=196.0

Q ss_pred             ccccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY   90 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~   90 (381)
                      ..++|...+.||+|+||+||+++.                       ...+.|.+|+++|++++||||++++++|.    
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~----   86 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----   86 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec----
Confidence            467899999999999999988741                       12467999999999999999999999964    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCc--------------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKED--------------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA  156 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv  156 (381)
                       .....++||||+++|+|.+++.......              ........+++..++.++.|++.||+|||   +.+||
T Consensus        87 -~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv  162 (301)
T d1lufa_          87 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  162 (301)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             -cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence             4678899999999999999995432110              00112345889999999999999999999   66999


Q ss_pred             eeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCC-CC
Q 041757          157 HCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE-KP  235 (381)
Q Consensus       157 HrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~-~P  235 (381)
                      ||||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998765554444333466899999999999999999999999999999999986 56


Q ss_pred             CCccccCCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041757          236 SDIMFEGDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT  315 (381)
Q Consensus       236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  315 (381)
                      |...    . .......        +.+....                   ..+..++.++.+|+.+||+.||++||||.
T Consensus       243 ~~~~----~-~~e~~~~--------v~~~~~~-------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~  290 (301)
T d1lufa_         243 YYGM----A-HEEVIYY--------VRDGNIL-------------------ACPENCPLELYNLMRLCWSKLPADRPSFC  290 (301)
T ss_dssp             TTTS----C-HHHHHHH--------HHTTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCC----C-HHHHHHH--------HHcCCCC-------------------CCCccchHHHHHHHHHHcCCChhHCcCHH
Confidence            5421    1 1111111        1111000                   01234566889999999999999999999


Q ss_pred             HHHHHHHHhh
Q 041757          316 NVVHELQSIK  325 (381)
Q Consensus       316 ~vl~~L~~i~  325 (381)
                      ||++.|+++.
T Consensus       291 ev~~~L~~i~  300 (301)
T d1lufa_         291 SIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHHhc
Confidence            9999999885

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=362.89  Aligned_cols=239  Identities=26%  Similarity=0.351  Sum_probs=185.0

Q ss_pred             ccccccceecCCCceEEEecc-------------cccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEEEEEc
Q 041757           36 RNMLEENLISAGTFGFSHLRR-------------QGAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF  102 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~-------------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~e~  102 (381)
                      ++|+.+++||+|+||.||++.             ....+.|.+|+++|++++||||++++++|.    +..+..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEEEEEec
Confidence            568889999999999998764             334688999999999999999999999974    334567999999


Q ss_pred             ccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          103 MHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       103 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      +++|+|.+++..        .....+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~g~L~~~l~~--------~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          83 MAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             CTTEEHHHHHHH--------HHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             cCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccce
Confidence            999999999953        22345899999999999999999999   6699999999999999999999999999998


Q ss_pred             ecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCccccCCCcHHHHHHHHhhchHHHH
Q 041757          183 FLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALSNHVKDI  261 (381)
Q Consensus       183 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  261 (381)
                      .......     ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||......  .+   ...         
T Consensus       152 ~~~~~~~-----~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~---~~~---------  212 (262)
T d1byga_         152 EASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DV---VPR---------  212 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GH---HHH---------
T ss_pred             ecCCCCc-----cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HH---HHH---------
Confidence            6543322     2358899999999998899999999999999999998 67776522111  11   110         


Q ss_pred             HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          262 VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       262 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      +....  .                .+.+..++.++.+++.+||+.||.+|||+.+|++.|++++.
T Consensus       213 i~~~~--~----------------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         213 VEKGY--K----------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HTTTC--C----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCC--C----------------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            10000  0                01123455688999999999999999999999999999865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.4e-49  Score=358.51  Aligned_cols=250  Identities=21%  Similarity=0.325  Sum_probs=190.1

Q ss_pred             ccccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~   93 (381)
                      +.++|.+.+.||+|+||+||++..                    ...+.|.+|+++|+.++|||||++++++... ....
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~   83 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAG   83 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSS
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-cCCC
Confidence            467899999999999999988641                    2345789999999999999999999997642 1223


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      ...|+|||||++|+|.+++          .....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++..
T Consensus        84 ~~~~lvmE~~~g~~L~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~  150 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIV----------HTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAV  150 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHH----------HHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCE
T ss_pred             ceEEEEEECCCCCEehhhh----------cccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccc
Confidence            4689999999999999998          34567999999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCC-cccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH
Q 041757          174 RVGDFGLARFLPPTRT-QTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM  252 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  252 (381)
                      +|+|||.+........ .......+||+.|+|||++.+..++.++|||||||++|||+||+.||..    ......    
T Consensus       151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~----~~~~~~----  222 (277)
T d1o6ya_         151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG----DSPVSV----  222 (277)
T ss_dssp             EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC----SSHHHH----
T ss_pred             eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC----cCHHHH----
Confidence            9999999876654322 2222336799999999999999999999999999999999999999852    221111    


Q ss_pred             HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhh
Q 041757          253 ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-KMTNVVHELQSIKN  326 (381)
Q Consensus       253 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~vl~~L~~i~~  326 (381)
                               +...+...+...            .......+.++.+++.+||+.||.+|| |+.++++.|.++.+
T Consensus       223 ---------~~~~~~~~~~~~------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         223 ---------AYQHVREDPIPP------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             ---------HHHHHHCCCCCG------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             ---------HHHHHhcCCCCC------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence                     111111111000            000123556889999999999999999 89999999988753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=365.51  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=194.1

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|+.+++||+|+||+||++..                    ...+.|.+|+++|+++ +|||||+++++|.     .++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cCC
Confidence            7888899999999999987541                    1345789999999999 6999999999965     377


Q ss_pred             eEEEEEEcccCCCHHHhhccccCC------cccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKE------DETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                      ..++|||||++|+|.++++.....      .........+++..++.++.||+.||.|||   +.+|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEc
Confidence            899999999999999999532100      000023467899999999999999999999   66999999999999999


Q ss_pred             CCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCC-CCCccccCCCcHH
Q 041757          169 DDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREK-PSDIMFEGDMNLH  247 (381)
Q Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~-Pf~~~~~~~~~~~  247 (381)
                      .++.+||+|||+++.........   ...||..|+|||.+.+..++.++|||||||++|||++|.. ||..     .+..
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-----~~~~  233 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVKKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-----MTCA  233 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-----CCHH
T ss_pred             CCCceEEcccccccccccccccc---ceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-----CCHH
Confidence            99999999999998654433222   2458999999999999999999999999999999999765 5531     1111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      ...            .......               +...+..++.++.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       234 ~~~------------~~i~~~~---------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         234 ELY------------EKLPQGY---------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHH------------HHGGGTC---------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHH------------HHHHhcC---------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            211            1111100               0001234567899999999999999999999999999999875


Q ss_pred             cC
Q 041757          328 LL  329 (381)
Q Consensus       328 ~~  329 (381)
                      ..
T Consensus       287 ~~  288 (309)
T d1fvra_         287 RK  288 (309)
T ss_dssp             SS
T ss_pred             Cc
Confidence            43

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-49  Score=367.36  Aligned_cols=228  Identities=18%  Similarity=0.210  Sum_probs=188.3

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCce
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDF   95 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~   95 (381)
                      ++|...++||+|+||+||++..                    ...+.+.+|+++|+.++|||||++++++     .....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence            6799999999999999988642                    2346788999999999999999999994     55788


Q ss_pred             EEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEE
Q 041757           96 KALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus        96 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      .++||||+.+|+|..++.          ....+++..++.++.||+.||.|||   +.+||||||||+|||++.++.+||
T Consensus       116 ~~~v~e~~~~g~l~~~l~----------~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL  182 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             cccccccccccchhhhHh----------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEe
Confidence            999999999999999993          4567999999999999999999999   669999999999999999999999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+|+.+.....     ...||+.|||||++.+..++.++|||||||++|||++|+.||..    ... ...      
T Consensus       183 ~DFG~a~~~~~~~~-----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~----~~~-~~~------  246 (350)
T d1rdqe_         183 TDFGFAKRVKGRTW-----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA----DQP-IQI------  246 (350)
T ss_dssp             CCCTTCEECSSCBC-----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----SSH-HHH------
T ss_pred             eeceeeeecccccc-----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC----cCH-HHH------
Confidence            99999998754322     25699999999999999999999999999999999999999852    211 111      


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM-----KMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~vl~  319 (381)
                            +.......+.                .+...+.++.+++.+||+.||.+|+     |+.++++
T Consensus       247 ------~~~i~~~~~~----------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         247 ------YEKIVSGKVR----------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------HHHHHHCCCC----------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------HHHHhcCCCC----------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                  1111111110                0123556788999999999999994     8999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=361.22  Aligned_cols=237  Identities=21%  Similarity=0.293  Sum_probs=189.5

Q ss_pred             ccccccccceecCCCceEEEeccc----------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ----------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      +.++|.+.+.||+|+||+||++..                .....+.+|+++|+.++|||||++++++     .+.+..|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~   77 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            457899999999999999988652                1345688999999999999999999994     5578899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC--CCeEE
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD--MTARV  175 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl  175 (381)
                      +|||||++|+|.+++.         .....+++.++..++.||+.||.|||   +.+|+||||||+|||++.+  ..+||
T Consensus        78 lvmE~~~gg~L~~~i~---------~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl  145 (321)
T d1tkia_          78 MIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEECCCCCCBHHHHHT---------SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEecCCCCcHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEE
Confidence            9999999999999995         23447999999999999999999999   6699999999999999854  48999


Q ss_pred             eecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhh
Q 041757          176 GDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALS  255 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  255 (381)
                      +|||+++.........   ...+|+.|+|||.+.+..++.++|||||||++|+|++|..||...    .. .        
T Consensus       146 ~DFG~~~~~~~~~~~~---~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~----~~-~--------  209 (321)
T d1tkia_         146 IEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE----TN-Q--------  209 (321)
T ss_dssp             CCCTTCEECCTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS----SH-H--------
T ss_pred             cccchhhccccCCccc---ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC----CH-H--------
Confidence            9999998765543322   245899999999999999999999999999999999999998522    11 1        


Q ss_pred             chHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          256 NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       256 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                          +++...+.....            .........+.++.+++.+||..||.+|||+.|+++
T Consensus       210 ----~~~~~i~~~~~~------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         210 ----QIIENIMNAEYT------------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ----HHHHHHHHTCCC------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHHHhCCCC------------CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                111111111100            000112234567889999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=360.57  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=194.3

Q ss_pred             cccccccceecCCCceEEEeccc-------------------------ccHHHHHHHHHHHHcc-CCCcccceeeeeccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------------GAFKSFIAECKALRNI-RHRNLIKVLTACLGV   88 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~   88 (381)
                      .++|..++.||+|+||.||+++.                         .....+.+|...+.++ +|||||+++++|.  
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~--   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence            46889999999999999988641                         2346788899999998 7999999999964  


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCc------ccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKED------ETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                         .+...++|||||++|+|.+++.......      ........+++.+++.++.||+.||.|||   +.+||||||||
T Consensus        90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp  163 (299)
T d1fgka_          90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  163 (299)
T ss_dssp             ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             ---cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecc
Confidence               3678899999999999999996432110      01122456899999999999999999999   66999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHh-CCCCCCcccc
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE  241 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~t-g~~Pf~~~~~  241 (381)
                      +|||++.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++ |..||...  
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~--  241 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--  241 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--
T ss_pred             cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC--
Confidence            999999999999999999988766554444445679999999999999999999999999999999998 68886421  


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHEL  321 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L  321 (381)
                         .......         .+.......                  .+..++.++.+|+.+||+.||.+|||+.||++.|
T Consensus       242 ---~~~~~~~---------~i~~~~~~~------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L  291 (299)
T d1fgka_         242 ---PVEELFK---------LLKEGHRMD------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  291 (299)
T ss_dssp             ---CHHHHHH---------HHHTTCCCC------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ---CHHHHHH---------HHHcCCCCC------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence               1111111         111100000                  0123556789999999999999999999999999


Q ss_pred             HHhhhh
Q 041757          322 QSIKNT  327 (381)
Q Consensus       322 ~~i~~~  327 (381)
                      +++.+.
T Consensus       292 ~~i~a~  297 (299)
T d1fgka_         292 DRIVAL  297 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHhhc
Confidence            998653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-49  Score=359.32  Aligned_cols=270  Identities=20%  Similarity=0.251  Sum_probs=192.4

Q ss_pred             cccccccceecCCCceEEEecc------------cccHHHHHHHHHHH--HccCCCcccceeeeeccccccCCceEEEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRR------------QGAFKSFIAECKAL--RNIRHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~------------~~~~~~~~~E~~~l--~~l~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      .+.|...++||+|+||.||+++            ....+.+.+|.+++  .+++|||||+++++|...+ ......++||
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~   80 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence            4677888999999999998865            22345555565554  5789999999999987521 2234689999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCC-----CCCceeeccCCCCeeeCCCCCeEE
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDC-----QPVTAHCVLKPSNVLLDDDMTARV  175 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~kl  175 (381)
                      |||++|+|.++++           ...+++..++.++.|++.||.|||+..     .++||||||||+|||++.++.+||
T Consensus        81 Ey~~~g~L~~~l~-----------~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          81 DYHEHGSLFDYLN-----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             ECCTTCBHHHHHH-----------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             ecccCCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            9999999999994           235889999999999999999999521     359999999999999999999999


Q ss_pred             eecccceecCCCCCcc--cccCccCccceeCCCCcCCC------ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHH
Q 041757          176 GDFGLARFLPPTRTQT--SSIDVKGSIGYIAPEYGVGN------EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH  247 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~  247 (381)
                      +|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||+||..||...........
T Consensus       150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            9999998775543221  22236799999999998764      367899999999999999999988753322211111


Q ss_pred             HHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 041757          248 KFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  327 (381)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~  327 (381)
                      ....  .......+.+........     .   .. .......+.+..+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus       230 ~~~~--~~~~~~~~~~~~~~~~~~-----p---~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         230 DLVP--SDPSVEEMRKVVCEQKLR-----P---NI-PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTSC--SSCCHHHHHHHHTTSCCC-----C---CC-CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hccc--ccchHHHHHHHHhccccC-----C---CC-CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0000  000111111111000000     0   00 00001235667899999999999999999999999999999765

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=363.08  Aligned_cols=231  Identities=22%  Similarity=0.318  Sum_probs=186.6

Q ss_pred             ccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHH-ccCCCcccceeeeeccccccCCc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALR-NIRHRNLIKVLTACLGVDYQGND   94 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~~~~~~   94 (381)
                      ++|..+++||+|+||+||++..                    ...+.+.+|..++. .++|||||++++++     .+.+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            5799999999999999988652                    23456777888776 68999999999994     5578


Q ss_pred             eEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeE
Q 041757           95 FKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTAR  174 (381)
Q Consensus        95 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  174 (381)
                      ..|+|||||++|+|.+++.          ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~----------~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~k  143 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIK  143 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred             ceeEEEeecCCCcHHHHhh----------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCcee
Confidence            8999999999999999994          4567899999999999999999999   66999999999999999999999


Q ss_pred             EeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHh
Q 041757          175 VGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL  254 (381)
Q Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  254 (381)
                      |+|||+++..........  ...||+.|+|||++.+..++.++|||||||++|||++|+.||...    .. ..      
T Consensus       144 l~DFG~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~----~~-~~------  210 (320)
T d1xjda_         144 IADFGMCKENMLGDAKTN--TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ----DE-EE------  210 (320)
T ss_dssp             ECCCTTCBCCCCTTCCBC--CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SH-HH------
T ss_pred             ccccchhhhccccccccc--ccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC----CH-HH------
Confidence            999999986654433222  256999999999999999999999999999999999999998521    11 11      


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMT-NVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~vl~  319 (381)
                            +........+.                .+..++.++.+|+.+||+.||.+|||+. ++++
T Consensus       211 ------~~~~i~~~~~~----------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         211 ------LFHSIRMDNPF----------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ------HHHHHHHCCCC----------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------HHHHHHcCCCC----------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                  11111111111                0123456789999999999999999995 6753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-48  Score=366.08  Aligned_cols=232  Identities=19%  Similarity=0.202  Sum_probs=183.3

Q ss_pred             ccccccceecCCCceEEEecccc--------------------cHHHHHHH---HHHHHccCCCcccceeeeeccccccC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG--------------------AFKSFIAE---CKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~--------------------~~~~~~~E---~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ++|.+.++||+|+||+||+++..                    ....+.+|   +++++.++|||||++++++     .+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----EE
Confidence            67999999999999999887521                    12234444   6677788899999999994     45


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      .+..|+|||||++|+|.+++.          ....+++..++.++.||+.||.|||   +.+||||||||+|||++.++.
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~  145 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH  145 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSC
T ss_pred             CCEEEEEEEecCCCcHHHHHH----------hcccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCc
Confidence            788999999999999999993          4567899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+|+.+......    ...||+.|+|||++.. ..|+.++|||||||++|||++|+.||......  ....   
T Consensus       146 iKl~DFGla~~~~~~~~~----~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~---  216 (364)
T d1omwa3         146 VRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHE---  216 (364)
T ss_dssp             EEECCCTTCEECSSSCCC----SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHH---
T ss_pred             EEEeeeceeeecCCCccc----ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHH---
Confidence            999999999877654322    2569999999999864 56899999999999999999999998633221  1111   


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                               +........+.                .+...+.++.+++.+||+.||.+|||     +.|+++
T Consensus       217 ---------~~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         217 ---------IDRMTLTMAVE----------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---------HHHHSSSCCCC----------------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---------HHHhcccCCCC----------------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                     11111111110                01234567889999999999999999     688875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=360.50  Aligned_cols=255  Identities=20%  Similarity=0.237  Sum_probs=198.2

Q ss_pred             cccccccceecCCCceEEEecc-----------------------cccHHHHHHHHHHHHcc-CCCcccceeeeeccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRR-----------------------QGAFKSFIAECKALRNI-RHRNLIKVLTACLGVDY   90 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~-----------------------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~   90 (381)
                      .++|..+++||+|+||.||+++                       ......|.+|+.+++++ +|||||+++++|.    
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~----   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe----
Confidence            4788899999999999998763                       12345789999999999 6999999999964    


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcc--------cccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDE--------TYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKP  162 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp  162 (381)
                       +....++|||||++|+|.+++........        .......+++..+..++.||+.||.|||   ++++|||||||
T Consensus        98 -~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp  173 (311)
T d1t46a_          98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA  173 (311)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccc
Confidence             46778999999999999999964321100        0122346899999999999999999999   66999999999


Q ss_pred             CCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          163 SNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       163 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      +||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+..||......
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999999877655544444567999999999999999999999999999999999955543211111


Q ss_pred             CCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 041757          243 DMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQ  322 (381)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~  322 (381)
                      ...+.            .++........                  +..++..+.+|+.+||+.||++|||+.+|+++|+
T Consensus       254 ~~~~~------------~~i~~~~~~~~------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~  303 (311)
T d1t46a_         254 DSKFY------------KMIKEGFRMLS------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (311)
T ss_dssp             SHHHH------------HHHHHTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHH------------HHHhcCCCCCC------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            11111            11111111100                  1235568999999999999999999999999998


Q ss_pred             Hhhhh
Q 041757          323 SIKNT  327 (381)
Q Consensus       323 ~i~~~  327 (381)
                      ++..+
T Consensus       304 ~~i~~  308 (311)
T d1t46a_         304 KQISE  308 (311)
T ss_dssp             HHHHH
T ss_pred             Hhhcc
Confidence            87654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-48  Score=353.00  Aligned_cols=235  Identities=22%  Similarity=0.295  Sum_probs=188.0

Q ss_pred             cccccccceecCCCceEEEeccc--------------------------ccHHHHHHHHHHHHccC-CCcccceeeeecc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------------GAFKSFIAECKALRNIR-HRNLIKVLTACLG   87 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~   87 (381)
                      .++|...++||+|+||+||+++.                          ...+.+.+|+.+|++++ |||||++++++  
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--   79 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence            36899999999999999988652                          12346889999999997 99999999994  


Q ss_pred             ccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeee
Q 041757           88 VDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLL  167 (381)
Q Consensus        88 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill  167 (381)
                         .+++..|||||||++|+|.+++.          ....+++.+++.++.||+.||+|||   ..+|+||||||+|||+
T Consensus        80 ---~~~~~~~ivmE~~~~g~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill  143 (277)
T d1phka_          80 ---ETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILL  143 (277)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             ---ccCcceEEEEEcCCCchHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEE
Confidence               56889999999999999999994          4567999999999999999999999   6699999999999999


Q ss_pred             CCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC------CccCcccchhhhhHHHHHHHhCCCCCCcccc
Q 041757          168 DDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG------NEVSTIGDVYSYGILLLELMIREKPSDIMFE  241 (381)
Q Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~  241 (381)
                      +.++.+||+|||+++.+.......   ...||+.|+|||++.+      ..++.++||||+||++|||++|+.||...  
T Consensus       144 ~~~~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~--  218 (277)
T d1phka_         144 DDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--  218 (277)
T ss_dssp             CTTCCEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred             cCCCCeEEccchheeEccCCCcee---eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC--
Confidence            999999999999999876544332   2569999999998753      34688999999999999999999998522  


Q ss_pred             CCCcHHHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          242 GDMNLHKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        ... .....        +.........                ......++++.+++.+||+.||++|||+.||++
T Consensus       219 --~~~-~~~~~--------i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         219 --KQM-LMLRM--------IMSGNYQFGS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             --SHH-HHHHH--------HHHTCCCCCT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --CHH-HHHHH--------HHhCCCCCCC----------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              111 11111        1111000000                001245568899999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=360.17  Aligned_cols=245  Identities=16%  Similarity=0.175  Sum_probs=188.4

Q ss_pred             ccccccc-ceecCCCceEEEecccc------------cHHHHHHHHHHHHcc-CCCcccceeeeeccccccCCceEEEEE
Q 041757           35 SRNMLEE-NLISAGTFGFSHLRRQG------------AFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVY  100 (381)
Q Consensus        35 ~~~~~~~-~~lG~G~fg~V~~~~~~------------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~~lv~  100 (381)
                      .++|.+. ++||+|+||+||++...            ..+.+.+|+.++.++ +|||||++++++.+. .......|+||
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~~~ivm   88 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCLLIVM   88 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCEEEEEE
Confidence            4688876 56999999999998631            346788999997765 799999999986431 23357789999


Q ss_pred             EcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CCCeEEee
Q 041757          101 EFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DMTARVGD  177 (381)
Q Consensus       101 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~D  177 (381)
                      |||+||+|.+++..        .....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.   .+.+||+|
T Consensus        89 Ey~~gg~L~~~i~~--------~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          89 ECLDGGELFSRIQD--------RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ECCCSEEHHHHHHS--------CSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ECCCCCcHHHHHHh--------cCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccc
Confidence            99999999999952        22457999999999999999999999   669999999999999975   45799999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhch
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNH  257 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  257 (381)
                      ||+|+.........   ...||+.|+|||++.+..|+.++|||||||++|+|+||+.||........ ..          
T Consensus       158 FG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~----------  223 (335)
T d2ozaa1         158 FGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SP----------  223 (335)
T ss_dssp             CTTCEECCCCCCCC---CCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred             cceeeeccCCCccc---cccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HH----------
Confidence            99998776544332   25699999999999999999999999999999999999999853221110 00          


Q ss_pred             HHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          258 VKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       258 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                        .+..........            .........+.++.+|+.+||+.||++|||+.|+++
T Consensus       224 --~~~~~i~~~~~~------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         224 --GMKTRIRMGQYE------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ------CCCSCSSS------------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHHHhcCCCC------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              000000000000            000112356678999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=360.03  Aligned_cols=251  Identities=17%  Similarity=0.298  Sum_probs=196.0

Q ss_pred             ccccccceecCCCceEEEeccc-----------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-----------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-----------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ++|...++||+|+||+||++..                       .....|.+|++++++++|||||+++++|.     .
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~   94 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----Q   94 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-----S
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-----c
Confidence            6888999999999999986431                       12356899999999999999999999964     4


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      .+..++|||||++|+|.+++...............+++..+..++.|++.||.|||   ..+|+||||||+|||++.+++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCce
Confidence            67789999999999999998542211111122345788999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCC-CCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIRE-KPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~-~Pf~~~~~~~~~~~~~~~  251 (381)
                      +||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||..     .+......
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-----~~~~~~~~  246 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-----LSNEQVLR  246 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCHHHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-----CCHHHHHH
Confidence            9999999998776554444444456899999999999999999999999999999999985 56531     11111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  326 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~  326 (381)
                      .        +.+.....                   .+..++..+.+++.+||+.||++|||+.+|++.|++..+
T Consensus       247 ~--------i~~~~~~~-------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 F--------VMEGGLLD-------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             H--------HHTTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             H--------HHhCCCCC-------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1        11111100                   122456789999999999999999999999999877643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=351.25  Aligned_cols=258  Identities=20%  Similarity=0.253  Sum_probs=186.2

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|+..++||+|+||+||++..                   ...+.+.+|+++|++++|||||++++++     .+....
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence            5899999999999999988641                   2357889999999999999999999995     457889


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++|||||.++ +..++..        .....+++..+..++.|++.||.|||   +.+||||||||+|||++.++.+||+
T Consensus        77 ~iv~e~~~~~-~~~~~~~--------~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~  144 (298)
T d1gz8a_          77 YLVFEFLHQD-LKKFMDA--------SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLA  144 (298)
T ss_dssp             EEEEECCSEE-HHHHHHH--------TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEeecCCc-hhhhhhh--------hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceec
Confidence            9999999764 4444422        34567999999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCc-cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHH--
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--  253 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~--  253 (381)
                      |||+|+..........  ...||+.|+|||++.... ++.++|||||||++|+|++|+.||...    .....+....  
T Consensus       145 DFG~a~~~~~~~~~~~--~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~----~~~~~~~~i~~~  218 (298)
T d1gz8a_         145 DFGLARAFGVPVRTYT--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD----SEIDQLFRIFRT  218 (298)
T ss_dssp             STTHHHHHCCCSBCTT--CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHH
T ss_pred             cCCcceeccCCcccce--eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC----CHHHHHHHHHHh
Confidence            9999987755433222  246999999999877655 578999999999999999999998522    2211111110  


Q ss_pred             -hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          254 -LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       254 -~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       .... ...... ....+...... .................++.+++.+||..||.+|||+.|+++
T Consensus       219 ~~~~~-~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         219 LGTPD-EVVWPG-VTSMPDYKPSF-PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             HCCCC-TTTSTT-GGGSTTCCTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCc-hhhccc-ccccccccccc-ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             0000 000000 00000000000 000000011112234567889999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=349.45  Aligned_cols=251  Identities=21%  Similarity=0.226  Sum_probs=181.8

Q ss_pred             cceecCCCceEEEecccc----------------------cHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           41 ENLISAGTFGFSHLRRQG----------------------AFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        41 ~~~lG~G~fg~V~~~~~~----------------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .++||+|+||+||++...                      ..+.+.+|+.+|++++|||||++++++     ..++..++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~i   77 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISL   77 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCceee
Confidence            478999999999886521                      124688999999999999999999995     45778999


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEeec
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGDF  178 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  178 (381)
                      |||||.++++..+.          .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        78 vmE~~~~~~~~~~~----------~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DF  144 (299)
T d1ua2a_          78 VFDFMETDLEVIIK----------DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF  144 (299)
T ss_dssp             EEECCSEEHHHHHT----------TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             hhhhhcchHHhhhh----------hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccC
Confidence            99999998877766          45667899999999999999999999   669999999999999999999999999


Q ss_pred             ccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHH---Hh
Q 041757          179 GLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM---AL  254 (381)
Q Consensus       179 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~---~~  254 (381)
                      |+++..........  ..+||+.|+|||++.. ..|+.++|||||||++|||++|..||..    ......+...   ..
T Consensus       145 G~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~----~~~~~~l~~i~~~~~  218 (299)
T d1ua2a_         145 GLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG----DSDLDQLTRIFETLG  218 (299)
T ss_dssp             GGGSTTTSCCCCCC--CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHHHC
T ss_pred             ccccccCCCccccc--ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC----CCHHHHHHHHHHhcC
Confidence            99987655433222  2569999999998865 4679999999999999999999999752    2222211111   00


Q ss_pred             hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          255 SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       255 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ........+. ... ....  ...................++.+|+.+||+.||++|||+.|+++
T Consensus       219 ~~~~~~~~~~-~~~-~~~~--~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         219 TPTEEQWPDM-CSL-PDYV--TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCTTTSSST-TSS-TTCC--CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCChhhccch-hcc-chhh--hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000000000 000 0000  00000000001111234567899999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=350.21  Aligned_cols=264  Identities=19%  Similarity=0.194  Sum_probs=189.1

Q ss_pred             cccccccceecCCCceEEEeccc--------------------ccHHHHHHHHHHHHcc---CCCcccceeeeecccccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ--------------------GAFKSFIAECKALRNI---RHRNLIKVLTACLGVDYQ   91 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~--------------------~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~   91 (381)
                      .++|++.++||+|+||+||++..                    .....+.+|+.+|+.|   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            57899999999999999988641                    1223567888887776   799999999998754445


Q ss_pred             CCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC
Q 041757           92 GNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM  171 (381)
Q Consensus        92 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  171 (381)
                      .....+++||||.++++.....         .....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~  153 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSG  153 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH---------SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred             cCceEEEEEEeccCCchhhhhh---------ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCC
Confidence            6678899999998877765543         34567899999999999999999999   66999999999999999999


Q ss_pred             CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          172 TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      .+||+|||+++.......   .....||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ..+..+..
T Consensus       154 ~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~  229 (305)
T d1blxa_         154 QIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILD  229 (305)
T ss_dssp             CEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred             Ceeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence            999999999876543332   22356999999999999999999999999999999999999998522110 00111111


Q ss_pred             HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ........+... ... .+.   .....................+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~-~~~-~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         230 VIGLPGEEDWPR-DVA-LPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHCCCCGGGSCT-TCS-SCG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhCCCchhcccc-ccc-chh---hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            110000000000 000 000   000000000111112234567888999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-48  Score=347.23  Aligned_cols=224  Identities=19%  Similarity=0.214  Sum_probs=180.9

Q ss_pred             cccccccceecCCCceEEEecccc-----------------------cHHHHHHHHHHHHccC--CCcccceeeeecccc
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQG-----------------------AFKSFIAECKALRNIR--HRNLIKVLTACLGVD   89 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~~-----------------------~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~   89 (381)
                      .++|.++++||+|+||+||++...                       ...++.+|+.+|++++  |||||++++++    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            568999999999999999886521                       1133678999999997  89999999994    


Q ss_pred             ccCCceEEEEEEcccC-CCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           90 YQGNDFKALVYEFMHN-RSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        90 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                       .+.+..++||||+.+ +++.+++          .....+++..++.++.|++.||.|||   +.+|+||||||+|||++
T Consensus        79 -~~~~~~~lv~e~~~~~~~l~~~~----------~~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~  144 (273)
T d1xwsa_          79 -ERPDSFVLILERPEPVQDLFDFI----------TERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILID  144 (273)
T ss_dssp             -ECSSEEEEEEECCSSEEEHHHHH----------HHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred             -eeCCeEEEEEEeccCcchHHHHH----------hccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEe
Confidence             557889999999976 6888888          34567999999999999999999999   66999999999999998


Q ss_pred             C-CCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCcc-CcccchhhhhHHHHHHHhCCCCCCccccCCCcH
Q 041757          169 D-DMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEV-STIGDVYSYGILLLELMIREKPSDIMFEGDMNL  246 (381)
Q Consensus       169 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~  246 (381)
                      . ++.+||+|||+|+........    ...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...       
T Consensus       145 ~~~~~vkl~DFG~a~~~~~~~~~----~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------  213 (273)
T d1xwsa_         145 LNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------  213 (273)
T ss_dssp             TTTTEEEECCCTTCEECCSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------
T ss_pred             cCCCeEEECccccceeccccccc----ccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------
Confidence            5 479999999999876544322    2569999999999887665 67789999999999999999998521       


Q ss_pred             HHHHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          247 HKFAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                                  .++.......                    +...+.++.+++.+||+.||++|||+.|+++
T Consensus       214 ------------~~i~~~~~~~--------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         214 ------------EEIIRGQVFF--------------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ------------HHHHHCCCCC--------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------------hHHhhcccCC--------------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                        0111111100                    1124457889999999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-46  Score=341.49  Aligned_cols=263  Identities=18%  Similarity=0.208  Sum_probs=195.5

Q ss_pred             ccccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      +.++|+..+.||+|+||+||++..               ...+.+.+|+++++.++|+|++..+..+.    ...+..++
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i   80 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM   80 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence            456799999999999999988652               23356889999999999877666665543    45778899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC---CCCeEE
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD---DMTARV  175 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl  175 (381)
                      ||||+ +++|...+.         .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.   +..+||
T Consensus        81 vme~~-~~~l~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl  147 (299)
T d1ckia_          81 VMELL-GPSLEDLFN---------FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYI  147 (299)
T ss_dssp             EEECC-CCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             EEEEc-CCchhhhhh---------hccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeee
Confidence            99999 557776664         34567999999999999999999999   669999999999999854   457999


Q ss_pred             eecccceecCCCCCc-----ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcH--HH
Q 041757          176 GDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL--HK  248 (381)
Q Consensus       176 ~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~  248 (381)
                      +|||+|+.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........  ..
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~  227 (299)
T d1ckia_         148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  227 (299)
T ss_dssp             CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred             eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence            999999987654321     12234679999999999999999999999999999999999999986433222111  11


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  328 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~~~~  328 (381)
                      ...........                           .....++.++.+++.+||+.||++||++.++.+.|+.+....
T Consensus       228 ~~~~~~~~~~~---------------------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         228 ISEKKMSTPIE---------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHHHHHSCHH---------------------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hhcccCCCChh---------------------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            11110111000                           011245678999999999999999999999999998886554


Q ss_pred             CCCCCccccccc
Q 041757          329 LGPKNLATCKAV  340 (381)
Q Consensus       329 ~~~~~~~~~~~~  340 (381)
                      ....+...+|..
T Consensus       281 ~~~~~~~~Dw~~  292 (299)
T d1ckia_         281 GFSYDYVFDWNM  292 (299)
T ss_dssp             TCCCSCCCHHHH
T ss_pred             CCCCCCCcCchh
Confidence            333333333433

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-46  Score=348.35  Aligned_cols=272  Identities=19%  Similarity=0.221  Sum_probs=186.5

Q ss_pred             hhhccccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           31 ILDVSRNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        31 ~~~~~~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      +.+++.+|...++||+|+||+||++..                  ...+.+.+|+.+|++++||||+++++++...+...
T Consensus         3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence            345678899999999999999988641                  23467889999999999999999999987544444


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....+++ +|+.+|+|.+++.           ...+++..++.++.|++.||+|||   +.+||||||||+|||++.++.
T Consensus        83 ~~~~~l~-~~~~~g~L~~~l~-----------~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~  147 (345)
T d1pmea_          83 MKDVYLV-THLMGADLYKLLK-----------TQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCD  147 (345)
T ss_dssp             CCCEEEE-EECCCEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCC
T ss_pred             cceEEEE-EeecCCchhhhhh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCC
Confidence            4455555 5566899999994           236899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCc-ccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQ-TSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  250 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  250 (381)
                      +||+|||+++........ ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+. .....
T Consensus       148 ~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~  226 (345)
T d1pmea_         148 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHIL  226 (345)
T ss_dssp             EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH
T ss_pred             EEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHh
Confidence            999999999876554322 12233669999999999855 5678999999999999999999999853221110 00111


Q ss_pred             HHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          251 KMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ........... ................................++.+++.+||+.||.+|||+.|+++
T Consensus       227 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         227 GILGSPSQEDL-NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHCSCCHHHH-HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhccCCChhhh-hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111100 000000000000000000000001111233457889999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=348.94  Aligned_cols=276  Identities=18%  Similarity=0.208  Sum_probs=191.1

Q ss_pred             ccccccccccccchhhhhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCC
Q 041757           16 TGSLHIEVGKLKNLEILDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHR   76 (381)
Q Consensus        16 ~g~~~~~~~~~~~l~~~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~   76 (381)
                      +|..+.++++...    +..+.|+..++||+|+||+||++..                   ...+.+.+|+++|++++||
T Consensus         2 ~~~~~~~~~~~~~----~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hp   77 (346)
T d1cm8a_           2 SGFYRQEVTKTAW----EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE   77 (346)
T ss_dssp             CSBCCEECSSSEE----CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBT
T ss_pred             CCcEEEeccCcee----ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCC
Confidence            6788888887542    2578999999999999999988641                   2356788999999999999


Q ss_pred             cccceeeeecccc-ccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 041757           77 NLIKVLTACLGVD-YQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVT  155 (381)
Q Consensus        77 nIv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i  155 (381)
                      |||+++++|...+ .......++||||| +.+|..++.           ...+++..++.++.||+.||.|||   +.+|
T Consensus        78 niv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH---~~~I  142 (346)
T d1cm8a_          78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQMLKGLRYIH---AAGI  142 (346)
T ss_dssp             TBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             CeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-----------hccccHHHHHHHHHHHHHHHHHHH---hCCC
Confidence            9999999976422 12345679999999 667887763           356999999999999999999999   6699


Q ss_pred             eeeccCCCCeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCC
Q 041757          156 AHCVLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREK  234 (381)
Q Consensus       156 vHrDlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~  234 (381)
                      +||||||+|||++.++.+|++|||+|+.......     ...||+.|+|||++.+ ..++.++||||+||++|+|++|+.
T Consensus       143 iHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~  217 (346)
T d1cm8a_         143 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT  217 (346)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cccccCcchhhcccccccccccccceeccCCccc-----cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcC
Confidence            9999999999999999999999999987654332     2569999999998876 457899999999999999999999


Q ss_pred             CCCccccCCCcHHHHHHHH--hhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCC
Q 041757          235 PSDIMFEGDMNLHKFAKMA--LSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRM  312 (381)
Q Consensus       235 Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  312 (381)
                      ||...    .....+....  ......+...................................+.+|+.+||..||.+||
T Consensus       218 pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~  293 (346)
T d1cm8a_         218 LFKGS----DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV  293 (346)
T ss_dssp             SSCCS----SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred             CCCCC----ChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc
Confidence            97532    2111111110  00000011100000000000000000000000011123445778999999999999999


Q ss_pred             CHHHHHH
Q 041757          313 KMTNVVH  319 (381)
Q Consensus       313 s~~~vl~  319 (381)
                      |+.|+++
T Consensus       294 ta~eiL~  300 (346)
T d1cm8a_         294 TAGEALA  300 (346)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-45  Score=335.76  Aligned_cols=258  Identities=14%  Similarity=0.144  Sum_probs=199.4

Q ss_pred             cccccccceecCCCceEEEeccc---------------ccHHHHHHHHHHHHccCC-CcccceeeeeccccccCCceEEE
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ---------------GAFKSFIAECKALRNIRH-RNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~---------------~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      .++|.++++||+|+||+||++..               ...+.+.+|++.++.|+| +||+.+++++     ......++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEE
Confidence            57899999999999999988752               233557889999999975 8999999884     45788899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCC-----CCCe
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDD-----DMTA  173 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~-----~~~~  173 (381)
                      ||||+ +++|.+++.         .....++...+..++.|++.||.|||   +.+|+||||||+|||++.     ++.+
T Consensus        79 vme~~-~~~l~~~~~---------~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~v  145 (293)
T d1csna_          79 VIDLL-GPSLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMI  145 (293)
T ss_dssp             EEECC-CCBHHHHHH---------HTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             EEEec-CCCHHHHHH---------hhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCce
Confidence            99999 789999885         34457899999999999999999999   779999999999999964     5689


Q ss_pred             EEeecccceecCCCCCc-----ccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          174 RVGDFGLARFLPPTRTQ-----TSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      ||+|||+|+........     ......+||+.|||||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~-~~~  224 (293)
T d1csna_         146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQK  224 (293)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHH
T ss_pred             EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH-HHH
Confidence            99999999987543221     122236799999999999999999999999999999999999999863322211 111


Q ss_pred             HHH---HHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 041757          249 FAK---MALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  325 (381)
Q Consensus       249 ~~~---~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~~L~~i~  325 (381)
                      +..   ........                           .....+++++.+++..||..+|++||++..+.+.|+++.
T Consensus       225 ~~~i~~~~~~~~~~---------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         225 YERIGEKKQSTPLR---------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHHHHHHSCHH---------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCChH---------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            110   00000011                           111245668899999999999999999999999999887


Q ss_pred             hhcCCCCCccccc
Q 041757          326 NTLLGPKNLATCK  338 (381)
Q Consensus       326 ~~~~~~~~~~~~~  338 (381)
                      +......+...+|
T Consensus       278 ~~~~~~~~~~~Dw  290 (293)
T d1csna_         278 ERLNTTEDENFDW  290 (293)
T ss_dssp             HHTTCCSCSCCGG
T ss_pred             HHcCCCCCCCCCC
Confidence            7665444433333

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-46  Score=342.26  Aligned_cols=260  Identities=18%  Similarity=0.227  Sum_probs=185.5

Q ss_pred             ccccccceecCCCceEEEeccc------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA   97 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~~   97 (381)
                      ++|...++||+|+||+||+++.                  ...+.+.+|+.+|++++|||||++++++     ...+..+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRLV   76 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCcee
Confidence            5789999999999999988652                  2357899999999999999999999995     4578899


Q ss_pred             EEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEee
Q 041757           98 LVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVGD  177 (381)
Q Consensus        98 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  177 (381)
                      ++|||+.++.+..+.          .....+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|
T Consensus        77 i~~e~~~~~~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~D  143 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLD----------VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIAD  143 (286)
T ss_dssp             EEEECCSEEHHHHHH----------TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeehhhhHHHHH----------hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecc
Confidence            999999887777766          45678999999999999999999999   56999999999999999999999999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||.+...........  ...+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+ .+..........
T Consensus       144 fG~a~~~~~~~~~~~--~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~  220 (286)
T d1ob3a_         144 FGLARAFGIPVRKYT--HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTP  220 (286)
T ss_dssp             TTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             cccceecccCccccc--eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCC
Confidence            999987655433222  24589999999998764 56899999999999999999999985322110 011111111111


Q ss_pred             hHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ......+..-.....   .....................+.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         221 NSKNWPNVTELPKYD---PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTTSTTGGGSTTCC---TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Chhhccchhhhhhcc---cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000000000000   000000000011112334567889999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4e-45  Score=338.71  Aligned_cols=264  Identities=19%  Similarity=0.187  Sum_probs=188.7

Q ss_pred             ccccccccceecCCCceEEEeccc--------------ccHHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEE
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ--------------GAFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKAL   98 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~--------------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~l   98 (381)
                      ..++|++.++||+|+||+||+++.              ...+++.+|+++|++++ ||||+++++++..   ......++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~  109 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPAL  109 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeE
Confidence            346799999999999999988752              34678999999999996 9999999999652   34667899


Q ss_pred             EEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEee
Q 041757           99 VYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVGD  177 (381)
Q Consensus        99 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~D  177 (381)
                      |||||.+++|..+.             ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+|
T Consensus       110 v~e~~~~~~L~~~~-------------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~D  173 (328)
T d3bqca1         110 VFEHVNNTDFKQLY-------------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLID  173 (328)
T ss_dssp             EEECCCSCBGGGTT-------------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEeecCCCcHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecc
Confidence            99999999997654             35899999999999999999999   66999999999999998655 689999


Q ss_pred             cccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhc
Q 041757          178 FGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSN  256 (381)
Q Consensus       178 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  256 (381)
                      ||+|+.........   ...+|+.|+|||.+.+. .++.++||||+||++||+++|+.||....................
T Consensus       174 FG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~  250 (328)
T d3bqca1         174 WGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  250 (328)
T ss_dssp             GGGCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             cccceeccCCCccc---ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence            99998876544332   25689999999997765 479999999999999999999999853221111111111111111


Q ss_pred             hHHHHHhhhhccCchhhhh-c--ccc--hhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          257 HVKDIVDSILLNDDEKLVV-R--GDQ--KQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       257 ~~~~~~~~~l~~~~~~~~~-~--~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ...+............... .  ...  ...............++.+|+.+||..||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1222221111100000000 0  000  0000000111234557889999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-45  Score=336.99  Aligned_cols=270  Identities=17%  Similarity=0.183  Sum_probs=184.6

Q ss_pred             cccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeecccc---ccC
Q 041757           35 SRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVD---YQG   92 (381)
Q Consensus        35 ~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---~~~   92 (381)
                      -++|++.++||+|+||+||++..                   ...+++.+|+++|++++||||+++++++....   ...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999988652                   24567889999999999999999999976421   123


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....++|||||.++.+..+.          .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~----------~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~  155 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS----------NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGV  155 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT----------CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSC
T ss_pred             CceEEEEEeccCCCccchhh----------hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCc
Confidence            56789999999887776655          45667899999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCc--ccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQ--TSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF  249 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  249 (381)
                      +||+|||+++........  ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ......
T Consensus       156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i  234 (318)
T d3blha1         156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALI  234 (318)
T ss_dssp             EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred             EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHH
Confidence            999999999876643321  122235699999999998764 6899999999999999999999998532110 000111


Q ss_pred             HHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHH-HHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          250 AKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN-IIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      ........ .+........................... ........+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         235 SQLCGSIT-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHCCCC-TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCCC-hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            11100000 00000000000000000000000000000 11123456788999999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=342.99  Aligned_cols=267  Identities=18%  Similarity=0.175  Sum_probs=184.3

Q ss_pred             ccccccceecCCCceEEEecccc-------------cHHHHHHHHHHHHccCCCcccceeeeecccc-ccCCceEEEEEE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG-------------AFKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYE  101 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~~~~~~lv~e  101 (381)
                      .+|...++||+|+||+||+++..             ......+|+++|++++||||+++++++.... ..+..+.++|||
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            36889999999999999987632             1223457999999999999999999976422 234567899999


Q ss_pred             cccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCC-CeEEeeccc
Q 041757          102 FMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDM-TARVGDFGL  180 (381)
Q Consensus       102 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~  180 (381)
                      ||+++.+..+.. ..      .....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+
T Consensus       100 y~~~~~~~~l~~-~~------~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_         100 YVPETVYRVARH-YS------RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             CCSEEHHHHHHH-HH------HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             ccCCccHHHHHh-hh------hccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccc
Confidence            998754333321 11      34567999999999999999999999   77999999999999999765 899999999


Q ss_pred             ceecCCCCCcccccCccCccceeCCCCcCC-CccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHHHHhhchHH
Q 041757          181 ARFLPPTRTQTSSIDVKGSIGYIAPEYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALSNHVK  259 (381)
Q Consensus       181 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  259 (381)
                      ++.........   ...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+..+........ .
T Consensus       170 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~-~  244 (350)
T d1q5ka_         170 AKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPT-R  244 (350)
T ss_dssp             CEECCTTSCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCC-H
T ss_pred             hhhccCCcccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCCh-H
Confidence            98775544332   2569999999998765 57899999999999999999999998522111 11111111111111 1


Q ss_pred             HHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          260 DIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       260 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      +.+.......... .... ................++.+|+.+||..||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         245 EQIREMNPNYTEF-KFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHHCC---CC-CCCC-CCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Hhhhhhccchhhc-cccc-cccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111111000000 0000 00000000011234557889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=337.60  Aligned_cols=236  Identities=21%  Similarity=0.262  Sum_probs=186.1

Q ss_pred             ccccccceecCCCceEEEeccc------------------------ccHHHHHHHHHHHHccCC-Ccccceeeeeccccc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ------------------------GAFKSFIAECKALRNIRH-RNLIKVLTACLGVDY   90 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~------------------------~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~   90 (381)
                      ++|+..++||+|+||+||++..                        ...+.+.+|+++|++++| |||+++++++     
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-----   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence            6799999999999999988631                        123567899999999976 8999999994     


Q ss_pred             cCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCC
Q 041757           91 QGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDD  170 (381)
Q Consensus        91 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  170 (381)
                      .+....++||||+.+|+|.+++.          ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.+
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~----------~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~  165 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN  165 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred             ccCCceeeeeecccccHHHHHHH----------hcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCC
Confidence            55788999999999999999994          4566788999999999999999999   6699999999999999999


Q ss_pred             CCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCC--ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHH
Q 041757          171 MTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN--EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHK  248 (381)
Q Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  248 (381)
                      +.+||+|||+++.+......... ...|++.|+|||.+.+.  .++.++|||||||++|||++|+.||........ ...
T Consensus       166 ~~vkL~DFG~a~~~~~~~~~~~~-~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~  243 (322)
T d1vzoa_         166 GHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAE  243 (322)
T ss_dssp             SCEEESCSSEEEECCGGGGGGGC-GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHH
T ss_pred             CCEEEeeccchhhhccccccccc-ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence            99999999999877554333222 25699999999998764  468899999999999999999999864433221 111


Q ss_pred             HHHHHhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041757          249 FAKMALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMK-----MTNVVH  319 (381)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~vl~  319 (381)
                      .....            ....+.                .+..++.++.+++.+||+.||.+|||     +.|+++
T Consensus       244 i~~~~------------~~~~~~----------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         244 ISRRI------------LKSEPP----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHH------------HHCCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHhc------------ccCCCC----------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            11111            111110                12245678899999999999999995     778765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=329.91  Aligned_cols=256  Identities=18%  Similarity=0.218  Sum_probs=188.3

Q ss_pred             ccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccCCceE
Q 041757           36 RNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK   96 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~   96 (381)
                      ++|+..++||+|+||+||+++.                   ...+++.+|+.+|+.++||||+++++++     .+....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            4799999999999999988651                   2467889999999999999999999995     457788


Q ss_pred             EEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCeEEe
Q 041757           97 ALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTARVG  176 (381)
Q Consensus        97 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  176 (381)
                      ++|+|++.+++|..++          .....+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+
T Consensus        77 ~iv~~~~~~~~l~~~~----------~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~  143 (292)
T d1unla_          77 TLVFEFCDQDLKKYFD----------SCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             EEEEECCSEEHHHHHH----------HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             eEEeeecccccccccc----------ccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeee
Confidence            9999999999998887          45667899999999999999999999   6699999999999999999999999


Q ss_pred             ecccceecCCCCCcccccCccCccceeCCCCcCCCc-cCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHH---HHH
Q 041757          177 DFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNE-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF---AKM  252 (381)
Q Consensus       177 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~  252 (381)
                      |||.++...........  ..+++.|+|||.+.+.. ++.++|||||||++|||++|+.||.   .+......+   ...
T Consensus       144 DFG~a~~~~~~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~---~~~~~~~~~~~~~~~  218 (292)
T d1unla_         144 NFGLARAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF---PGNDVDDQLKRIFRL  218 (292)
T ss_dssp             CCTTCEECCSCCSCCCS--CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC---CCSSHHHHHHHHHHH
T ss_pred             ecchhhcccCCCcccee--eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC---CCCCHHHHHHHHHhh
Confidence            99999987654433222  45788999999887655 6899999999999999999999973   222211111   111


Q ss_pred             HhhchHHHH--HhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          253 ALSNHVKDI--VDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       253 ~~~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .........  ..........     ...................+.+|+.+||+.||.+|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         219 LGTPTEEQWPSMTKLPDYKPY-----PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HCCCCTTTCTTGGGSTTCCCC-----CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCCChhhhhhhhhccccccc-----ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111000000  0000000000     0000000111112234457888999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=331.04  Aligned_cols=263  Identities=19%  Similarity=0.154  Sum_probs=180.7

Q ss_pred             ccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccc-cCC
Q 041757           34 VSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDY-QGN   93 (381)
Q Consensus        34 ~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~~   93 (381)
                      +.++|++.++||+|+||+||++..                   ...+++.+|+.+|++++|||||++++++...+. +..
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            347799999999999999988642                   234568899999999999999999999764221 356


Q ss_pred             ceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCCe
Q 041757           94 DFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMTA  173 (381)
Q Consensus        94 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  173 (381)
                      .+.|+|||||.++ +.+.+.            ..+++..++.++.|++.||.|||   +.||+||||||+|||++.++.+
T Consensus        95 ~~~~iv~Ey~~~~-l~~~~~------------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~  158 (355)
T d2b1pa1          95 QDVYLVMELMDAN-LCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_dssp             CEEEEEEECCSEE-HHHHHT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred             ceeEEEEeccchH-HHHhhh------------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccce
Confidence            8899999999765 444442            34789999999999999999999   6699999999999999999999


Q ss_pred             EEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH--
Q 041757          174 RVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK--  251 (381)
Q Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~--  251 (381)
                      |++|||+++.........   ...+|+.|+|||++.+..++.++||||+||++|+|++|+.||...    ........  
T Consensus       159 kl~df~~~~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~----~~~~~~~~i~  231 (355)
T d2b1pa1         159 KILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR----DYIDQWNKVI  231 (355)
T ss_dssp             EECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHH
T ss_pred             eeechhhhhccccccccc---cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC----CHHHHHHHHH
Confidence            999999988765544332   256899999999999999999999999999999999999997522    11111111  


Q ss_pred             -HHh----------hchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 -MAL----------SNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 -~~~----------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                       ...          .....++.................................++.+|+.+||..||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             110          11112222211111000000000000001111223456778999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=337.65  Aligned_cols=265  Identities=16%  Similarity=0.176  Sum_probs=182.6

Q ss_pred             hhccccccccceecCCCceEEEeccc-------------------ccHHHHHHHHHHHHccCCCcccceeeeeccccccC
Q 041757           32 LDVSRNMLEENLISAGTFGFSHLRRQ-------------------GAFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG   92 (381)
Q Consensus        32 ~~~~~~~~~~~~lG~G~fg~V~~~~~-------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~   92 (381)
                      ..+.++|+..++||+|+||+||++..                   ...+++.+|+++|++++|||||++++++.......
T Consensus        14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            34567899999999999999988741                   13457889999999999999999999976432223


Q ss_pred             CceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeCCCCC
Q 041757           93 NDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLDDDMT  172 (381)
Q Consensus        93 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  172 (381)
                      ....+++|+|+.+|+|.+++.           ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~-----------~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~  159 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCE  159 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCC
T ss_pred             cCceEEEEEeecCCchhhhcc-----------cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCcccccccccc
Confidence            344566677788999999983           246999999999999999999999   669999999999999999999


Q ss_pred             eEEeecccceecCCCCCcccccCccCccceeCCCCcCCC-ccCcccchhhhhHHHHHHHhCCCCCCccccCCCcHHHHHH
Q 041757          173 ARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK  251 (381)
Q Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  251 (381)
                      +|++|||++.......     ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||..    .........
T Consensus       160 ~kl~dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~----~~~~~~~~~  230 (348)
T d2gfsa1         160 LKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKL  230 (348)
T ss_dssp             EEECCC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHH
T ss_pred             ccccccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC----CCHHHHHHH
Confidence            9999999997653322     225689999999987665 468999999999999999999999752    221111111


Q ss_pred             H--HhhchHHHHHhhhhccCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041757          252 M--ALSNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSMESPQDRMKMTNVVH  319 (381)
Q Consensus       252 ~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~vl~  319 (381)
                      .  .......+..................................++.+|+.+||..||.+|||+.|+++
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            0  0000000110000000000000000000000000111234567889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6e-39  Score=300.95  Aligned_cols=266  Identities=16%  Similarity=0.151  Sum_probs=178.9

Q ss_pred             ccccccceecCCCceEEEecccc----------------cHHHHHHHHHHHHccC-----------CCcccceeeeeccc
Q 041757           36 RNMLEENLISAGTFGFSHLRRQG----------------AFKSFIAECKALRNIR-----------HRNLIKVLTACLGV   88 (381)
Q Consensus        36 ~~~~~~~~lG~G~fg~V~~~~~~----------------~~~~~~~E~~~l~~l~-----------h~nIv~~~~~~~~~   88 (381)
                      +.|.+.++||+|+||+||+++..                ..+.+.+|+++++.++           |+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~-   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH-   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE-
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee-
Confidence            45999999999999999987521                2367788999998885           4789999988652 


Q ss_pred             cccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCCCeeeC
Q 041757           89 DYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPSNVLLD  168 (381)
Q Consensus        89 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~Nill~  168 (381)
                        ......+++|+++..+.........       .....+++..+..++.|++.||.|||+.  .+|+||||||+|||++
T Consensus        92 --~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~  160 (362)
T d1q8ya_          92 --KGPNGVHVVMVFEVLGENLLALIKK-------YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLME  160 (362)
T ss_dssp             --EETTEEEEEEEECCCCEEHHHHHHH-------TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEE
T ss_pred             --ccccceeeeeeeccccccccccccc-------ccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeee
Confidence              3455667777776555433322111       3556788999999999999999999952  5899999999999997


Q ss_pred             CCC------CeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHHHHHHhCCCCCCccccC
Q 041757          169 DDM------TARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG  242 (381)
Q Consensus       169 ~~~------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~el~tg~~Pf~~~~~~  242 (381)
                      .++      .++++|||.+........     ...||+.|+|||++....++.++||||+||++++|++|+.||......
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~  235 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  235 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccCcccccceeeEeecccccccccccc-----cccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence            654      389999999986543322     256999999999999999999999999999999999999998633211


Q ss_pred             C-Cc----HHHHHHHHhhchHHHHHhhh------hc-----cCchhhhhcccchhhhhHHHHHHHHHHHHHHHHHhccCC
Q 041757          243 D-MN----LHKFAKMALSNHVKDIVDSI------LL-----NDDEKLVVRGDQKQTQAKINIIRECVISMVRIGVACSME  306 (381)
Q Consensus       243 ~-~~----~~~~~~~~~~~~~~~~~~~~------l~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  306 (381)
                      . ..    +....... ...........      ..     ............................+.+|+.+||..
T Consensus       236 ~~~~~~~~~~~~~~~l-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         236 SYTKDDDHIAQIIELL-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ---CHHHHHHHHHHHH-CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             cccchhHHHHHHHHHh-CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            1 00    11111111 10000110000      00     000000000000001111122356778899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 041757          307 SPQDRMKMTNVVH  319 (381)
Q Consensus       307 dP~~RPs~~~vl~  319 (381)
                      ||.+|||+.|+++
T Consensus       315 dP~~Rpta~e~L~  327 (362)
T d1q8ya_         315 DPRKRADAGGLVN  327 (362)
T ss_dssp             STTTCBCHHHHHT
T ss_pred             ChhHCcCHHHHhc
Confidence            9999999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=2.4e-22  Score=170.07  Aligned_cols=154  Identities=16%  Similarity=0.050  Sum_probs=107.1

Q ss_pred             ccccceecCCCceEEEecccc----------------------------------cHHHHHHHHHHHHccCCCcccceee
Q 041757           38 MLEENLISAGTFGFSHLRRQG----------------------------------AFKSFIAECKALRNIRHRNLIKVLT   83 (381)
Q Consensus        38 ~~~~~~lG~G~fg~V~~~~~~----------------------------------~~~~~~~E~~~l~~l~h~nIv~~~~   83 (381)
                      +.++++||+|+||+||++...                                  ......+|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            356899999999999886421                                  1133456889999999999999887


Q ss_pred             eeccccccCCceEEEEEEcccCCCHHHhhccccCCcccccCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeeccCCC
Q 041757           84 ACLGVDYQGNDFKALVYEFMHNRSLKEWLYPISKEDETYKRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCVLKPS  163 (381)
Q Consensus        84 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivHrDlkp~  163 (381)
                      +.         ..+++|||+++..+.++                 +...+..++.|++.+|.|||   ..+|+||||||+
T Consensus        82 ~~---------~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~  132 (191)
T d1zara2          82 WE---------GNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFY---HRGIVHGDLSQY  132 (191)
T ss_dssp             EE---------TTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred             ec---------CCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHh---hCCEEEccCChh
Confidence            62         12799999988654432                 22335678999999999999   669999999999


Q ss_pred             CeeeCCCCCeEEeecccceecCCCCCcccccCccCccceeCCCCcCCCccCcccchhhhhHHH
Q 041757          164 NVLLDDDMTARVGDFGLARFLPPTRTQTSSIDVKGSIGYIAPEYGVGNEVSTIGDVYSYGILL  226 (381)
Q Consensus       164 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il  226 (381)
                      |||++++ .++|+|||+|.....+.......   .....+ .+.+ ...|+.++|+||..--+
T Consensus       133 NILv~~~-~~~liDFG~a~~~~~~~~~~~l~---rd~~~~-~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         133 NVLVSEE-GIWIIDFPQSVEVGEEGWREILE---RDVRNI-ITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             SEEEETT-EEEECCCTTCEETTSTTHHHHHH---HHHHHH-HHHH-HHHHCCCCCHHHHHHHH
T ss_pred             heeeeCC-CEEEEECCCcccCCCCCcHHHHH---HHHHHH-HHHH-cCCCCCcccHHHHHHHH
Confidence            9999865 58999999997654332211000   000000 0111 24678999999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.95  E-value=6e-06  Score=70.97  Aligned_cols=48  Identities=13%  Similarity=-0.017  Sum_probs=34.3

Q ss_pred             HHHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEEEEcccCCCHHHhh
Q 041757           60 FKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKEWL  112 (381)
Q Consensus        60 ~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l  112 (381)
                      ...+.+|...+..+. +--+.+++.++     ...+..++||++++|.++.+..
T Consensus        53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          53 TYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEECCSSEEHHHHT
T ss_pred             hhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEEEEEecccccccccc
Confidence            345778999988875 43356666663     3467789999999998886554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.31  E-value=0.00014  Score=61.75  Aligned_cols=53  Identities=15%  Similarity=0.106  Sum_probs=34.8

Q ss_pred             EecccccHHHHHHHHHHHHccCCC--cccceeeeeccccccCCceEEEEEEcccCCCHHH
Q 041757           53 HLRRQGAFKSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFMHNRSLKE  110 (381)
Q Consensus        53 ~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~  110 (381)
                      +.........+..|...|+.+...  .+.+++.++     .+.+..++||+|++|.++.+
T Consensus        41 K~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          41 KTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             EEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSSEETTT
T ss_pred             EeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEeeecccccc
Confidence            333344445678899999887533  355666663     34567899999998866543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.97  E-value=0.0005  Score=62.42  Aligned_cols=31  Identities=16%  Similarity=0.220  Sum_probs=26.2

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeeccccee
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLARF  183 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~~  183 (381)
                      ...++|+|+.|.|||++++ .++|+||..+..
T Consensus       222 ~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         222 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             CCEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             CcceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            4479999999999999876 489999988753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.74  E-value=0.03  Score=50.12  Aligned_cols=39  Identities=15%  Similarity=0.154  Sum_probs=26.8

Q ss_pred             HHHHHHHHHHHccC-CCcccceeeeeccccccCCceEEEEEEcccCCCH
Q 041757           61 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFMHNRSL  108 (381)
Q Consensus        61 ~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  108 (381)
                      -...+|..+++.+. +.-..++++++.         -++||||++|.+|
T Consensus        89 idr~~E~~i~~~ls~~gl~Pkll~~~~---------~g~I~efi~g~~l  128 (395)
T d1nw1a_          89 SHLVAESVIFTLLSERHLGPKLYGIFS---------GGRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEET---------TEEEECCCCEEEC
T ss_pred             hHHHHHHHHHHHHHhCCCCCeEEEEcC---------CceEEEEeccccC
Confidence            34568999999886 433456777632         1689999987554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.39  E-value=0.13  Score=44.40  Aligned_cols=29  Identities=24%  Similarity=0.226  Sum_probs=24.2

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ..++||+|+.+.|||++++  ..++||+-+.
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            5679999999999999754  4589999875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.76  E-value=0.0071  Score=52.54  Aligned_cols=31  Identities=26%  Similarity=0.180  Sum_probs=27.7

Q ss_pred             CCCceeeccCCCCeeeCCCCCeEEeecccce
Q 041757          152 QPVTAHCVLKPSNVLLDDDMTARVGDFGLAR  182 (381)
Q Consensus       152 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~~~  182 (381)
                      ..++||+|+.++||+++++...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5689999999999999988777899999874

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=86.48  E-value=0.1  Score=44.57  Aligned_cols=37  Identities=38%  Similarity=0.408  Sum_probs=32.5

Q ss_pred             ceEeEEccCCccccccccccccccchhhhhccccccc
Q 041757            4 LLIALDVSGNKLTGSLHIEVGKLKNLEILDVSRNMLE   40 (381)
Q Consensus         4 ~~~~l~~~~n~~~g~~~~~~~~~~~l~~~~~~~~~~~   40 (381)
                      -++.|||++|+++|.+|..++++++|+.++++.|...
T Consensus       245 ~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~  281 (313)
T d1ogqa_         245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC  281 (313)
T ss_dssp             TCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred             ccccccCccCeecccCChHHhCCCCCCEEECcCCccc
Confidence            3567999999999999999999999999999887544